<SEC-DOCUMENT>0001071739-23-000047.txt : 20230221
<SEC-HEADER>0001071739-23-000047.hdr.sgml : 20230221
<ACCEPTANCE-DATETIME>20230221162925
ACCESSION NUMBER:		0001071739-23-000047
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		136
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230221
DATE AS OF CHANGE:		20230221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CENTENE CORP
		CENTRAL INDEX KEY:			0001071739
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				041406317
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31826
		FILM NUMBER:		23648636

	BUSINESS ADDRESS:	
		STREET 1:		7700 FORSYTH BLVD.
		CITY:			ST LOUIS
		STATE:			MO
		ZIP:			63105
		BUSINESS PHONE:		3147254477

	MAIL ADDRESS:	
		STREET 1:		7700 FORSYTH BLVD.
		CITY:			ST LOUIS
		STATE:			MO
		ZIP:			63105
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>cnc-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:0b97e17d-6106-45f4-89d6-4fad8114f6eb,g:0be59ac2-4e57-4dab-9620-00ce2b3b169c,d:9dee570cfbd043d6a1700298c14b2446--><html xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:cnc="http://www.centene.com/20221231" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cnc-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl80L2ZyYWc6YTRjOTIxYWI2NzgyNDE0YWEyZjdjMTZlNWI2NDE0MGIvdGFibGU6MTU1MTlkNTFlMzhlNDI5MTkzOWRjZjlkOTU3MDBhZWUvdGFibGVyYW5nZToxNTUxOWQ1MWUzOGU0MjkxOTM5ZGNmOWQ5NTcwMGFlZV80LTEtMS0xLTM1NDAxOA_9966e243-dea5-4284-88f3-579d4dc2eafa">0001071739</ix:nonNumeric><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl80L2ZyYWc6YTRjOTIxYWI2NzgyNDE0YWEyZjdjMTZlNWI2NDE0MGIvdGFibGU6MTU1MTlkNTFlMzhlNDI5MTkzOWRjZjlkOTU3MDBhZWUvdGFibGVyYW5nZToxNTUxOWQ1MWUzOGU0MjkxOTM5ZGNmOWQ5NTcwMGFlZV85LTEtMS0xLTM1NDAxOA_db508322-3c6f-4768-a48d-0c9e032b38c8">2022</ix:nonNumeric><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl80L2ZyYWc6YTRjOTIxYWI2NzgyNDE0YWEyZjdjMTZlNWI2NDE0MGIvdGFibGU6MTU1MTlkNTFlMzhlNDI5MTkzOWRjZjlkOTU3MDBhZWUvdGFibGVyYW5nZToxNTUxOWQ1MWUzOGU0MjkxOTM5ZGNmOWQ5NTcwMGFlZV8xMC0xLTEtMS0zNTQwMTg_5daf5fd1-f1fb-4b7a-986f-0741227dcc2e">FY</ix:nonNumeric><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl80L2ZyYWc6YTRjOTIxYWI2NzgyNDE0YWEyZjdjMTZlNWI2NDE0MGIvdGFibGU6MTU1MTlkNTFlMzhlNDI5MTkzOWRjZjlkOTU3MDBhZWUvdGFibGVyYW5nZToxNTUxOWQ1MWUzOGU0MjkxOTM5ZGNmOWQ5NTcwMGFlZV8xMS0xLTEtMS0zNTQwMTg_57ab3229-b9fd-4e80-b708-b1d0d0b38969">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzEwNTE_c9c93204-9871-484c-a20b-e44dba7e3ac9">http://fasb.org/us-gaap/2022#OtherAssetsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzEwNTg_296f7fee-e19d-4aef-8f1c-7793183430b5">http://fasb.org/us-gaap/2022#OtherAssetsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMS0xLTEtMzU0MDE4_199e3251-c3e9-421e-aaf9-eda971b806fd">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMy0xLTEtMzU0MDE4_25d5eafe-3f10-47e5-a022-23bca263c61e">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMS0xLTEtMzU0MDE4_53c5f53c-16be-4589-801c-7882d412dd63">http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMy0xLTEtMzU0MDE4_ca13f2de-0327-4128-b4b7-a1cf2eacc73a">http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMS0xLTEtMzU0MDE4_f7d03d1c-fd2a-4fb1-b8d2-c6a9e69f4553">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMy0xLTEtMzU0MDE4_83602f08-9569-4028-8eb3-50c7d80f55b9">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ibdb10359bdf9470da1ce1cc23be870ee_I20221231" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzE1ODI_9a1af50d-4299-45b3-b023-ef6bb807076b">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i710e1a1e967847a5bfd25febe427afbe_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTA_555f768d-bd53-493d-899f-ffdf3d5a60f0">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="id4e35ffd327d45e280e358485568b79f_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTg_0f5667b6-1669-434f-8a62-05af54a230a9">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ia2c6097d9fc34e458585987bbb311fea_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTg_d969fa16-d3ae-4cf3-a934-197b9b0e25e4">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cnc-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04652939d67241d39001577da981b842_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ie567ad4d3dfb4202acf278d4fe91232a_I20230217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2eadcd3758bd48558b2055d1213fc6f5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c83c53bcfae4452bc7f79564bebc856_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85fbc70041964c1a8bd77082880bf5c5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib80ff9d53361464b80c69f222a08fd78_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28166a0649364f7486e28e0475aa1937_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ba97cd7426845cea3497f057312fa44_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if74f20f9672c42969aaf06d880b02823_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id53035e323dd4a8a8791395cc30ffafe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefd78604c8af4b3eb7e7763dd317e282_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b6ce4061fae4dd2bf7bfef4711d6df6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i205075141d20449391c609023aa905f8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i116b2020b2da4f3ea027f5a137798310_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22a603f1ec5a4ed6ac95d0033583c8ae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a00c10b57c34ba7b04e400d6d51804c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i677e18bc38214dc8aa867bdadeb3507e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i007f9f25b89a4328b4843c47ad28463f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i463620403a104db8bdb4789fd3025d04_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaab02486f5a340caa2b7a035d3d61cfd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89efa37b183c4c618c28149ddb506553_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4325cafc5d4145589b2f8c8a9708b14d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65cbc7d56bfd4ffb861729ca1b540ab1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70228d9f45fe464887fc03a805d9f728_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbc613d20c5e4995abeaccfb2d2a2ffd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b2f9a41ae484e65bfe6464f3b6bcc36_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if18a7a7ccfa44c02a607ea5b90c04d27_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddfa338597904f0eba0c96789f0d0ed5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2fe5e0012c04cccb9b042e45cdf6198_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75d4d36b1dce42f98b2a5b7237c1773e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43b316ad31204bf786dbb981cb93be17_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2185a9a104a3441390ac2f06aefa122a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e696a8243e449cea4c408643b0c8316_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied7399d5bbf14198bf9416f0242b68b1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if228d12dc7ec48dbabc207800e70e561_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4141bf74d4f4cf2a006bd905970e699_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia335774c94194c9e9df1cee6eca206c1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87039d6a8fdd4824bbf66cc17f0022f6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59eb9977480d4e3891765c8703b4e646_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d8aca346cdc405eb8ae3ab1bb1a0e8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i253a5454e6f34367b12d67c6674b4320_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i831e8980ca404c60aa04c6cee3dd1a38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07517ae73bdd457783095996579e8053_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2d17142024e44a0b55466c586719466_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00ea1fbc2e9c4c9f8ef3db694f5e19cb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fe2f9326b88400aa8db63ee38c9dc25_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifad2424f092c43c5aef13a515b9bf557_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e9d6d9ad10d41afb05597363822ad5c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idda5d167ac1a435ba11ce095d9bf8926_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1d80c4c83dd418ebc09acf400b5608c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b68b2bcce604d8997c874bfd621f1fd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ff8138305244a25baa6cc2d532766f2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cnc:segment</xbrli:measure></xbrli:unit><xbrli:context id="id7f45234b97a4a8db9cc70838a92e915_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2359cd8d83d04e01929e44fe25fcb92f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4607d979606c4f7fa36ae2f1b825cb49_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35e17c2ca0f64a168f7fe15e237ef8d1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34c5f25db0f84955937399bdc59bc0f8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib42047c8782d4d33831b521cdbbe8d2f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9cb6bb95198406b9dc757a3fe689c48_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39698c8d4f5741c2bd5f7bb1c215d1c2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0e7605c14854f1298823da0004e7bcd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67e4e863732140539a2d0c4798909e31_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74119b927bec4965b1fd97a0689f4f10_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f0027dbc67f4fcfb5bb6efed06c4909_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4d49678d798431db2da34d388ffc987_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnc:ProviderContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae0603c3ac604874a3f063c971cb1131_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnc:ProviderContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcdf168f01c14287ab8225cc4e5ac2a2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7c90459707d4aa69df99c5cbc3d379b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5054b3e6c71b40e494d1cacca5fded80_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77c71d30602b434bb2aa3deac20d8334_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6cdbd424736484b93b773b56ebf2191_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="if869d22d0f044d3d9bfb60d75bc74fbe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i906fa59240054e0ca347d7e3ce1f9812_D20220104-20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-04</xbrli:startDate><xbrli:endDate>2022-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3799e2d4c58049f4bac2714882700574_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fd457add58740c084e97e1c414ce9f9_I20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea27c4aa651545eaa7d30d7a626031a7_D20220104-20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-04</xbrli:startDate><xbrli:endDate>2022-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1b54f2cbfd746b8a13ac300eb5f594d_I20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InsuranceContractsAcquiredInBusinessCombinationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic898092fd2d349718cfc66201cf1e5db_D20220104-20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InsuranceContractsAcquiredInBusinessCombinationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-04</xbrli:startDate><xbrli:endDate>2022-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9adcef2d77d24557bc8ed47f59f80d11_I20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb157bc574b24e8ea7212ed38cddbc14_D20220104-20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-04</xbrli:startDate><xbrli:endDate>2022-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68d8c947320f402488ed555c813a0394_I20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2f7de6d3ba44de9a27dfe4b0d2086cd_D20220104-20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-04</xbrli:startDate><xbrli:endDate>2022-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8676d1a500a445dfbdfe2ed3255b473a_D20220714-20220714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:PANTHERxRareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-14</xbrli:startDate><xbrli:endDate>2022-07-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fad3c7a923b4e3ea96e190945650528_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:SpanishAndCentralEuropeanBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a752c4a069849f8a31ceb9055f487f2_D20221202-20221202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:MagellanRxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-02</xbrli:startDate><xbrli:endDate>2022-12-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40a749aec9b14d808f4fa50726eaa259_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:MagellanSpecialtyHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4727fabbef274d23a97b2b7195f75143_I20230120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:MagellanSpecialtyHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1032a3c41f4546a19e08100bbd31888f_D20230120-20230120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:MagellanSpecialtyHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-20</xbrli:startDate><xbrli:endDate>2023-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie93c74b491b34072ae22f37b005de9da_D20230120-20230120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:MagellanSpecialtyHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-20</xbrli:startDate><xbrli:endDate>2023-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ided6cdd3afac49e7905a2933ce43623e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:CenturionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fc78fa9a34b400587dbebfb3ac1f1e0_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:CenturionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86423bee35dc4d99be0b3b984e6903db_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:HealthSmartMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6bd664dd1964db0a6890c587570d306_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:HealthSmartMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i499a3149a68f43d197206136874ec7aa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i486a37f6a0154762895b4f1f4cd9ca74_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf473a0753b24a40bd69716fc04aff8f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5313c9c8ef254fd3990dc4af6888052c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecda6a96704c4e55abf2859375ea8c57_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cnc:RestrictedCertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5a4abd7dcb44577b824de2cb64ccc35_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cnc:RestrictedCertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eb00ce8440f4809aea66ea9110d64fa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cnc:RestrictedCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fbea513469f43a3b9e290efb35c514f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cnc:RestrictedCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9983f6fb6634358b6dacbf534d64ca5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26daba9ff8ae466cb9021364a5170509_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f21479b9405481aaa26f40d779ddb4e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbcf20613be2440d8fe8fbcdc3292971_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62cd5054218c428380088f2fb37a4a38_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a80b9a6c7ea417db21376c703ac065f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20374a9ab1a44d948a3ce54237e30bae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifff1bb111f3d44fbbc41cd705208898f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51d11822d99c47479c5a2eb3e89364a4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04e2a006b9ac457da4ba57b86f6e47ed_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">cnc:RatedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">cnc:InvestmentSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExternalCreditRatingByGroupingAxis">us-gaap:ExternalCreditRatingInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb1c5e81b8794292b604efa3e3607763_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="position"><xbrli:measure>cnc:position</xbrli:measure></xbrli:unit><xbrli:context id="i556fc29a81414ce8a1faff7d6b5ca940_I20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:CircleHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4603a3c3a78b4cf6befa775abe6f9136_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:CircleHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90289acf8f4c42b891561c01ab371852_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:CircleHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06e20193ad1d4a6dbe47803672976cf0_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cnc:RxAdvanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dfd24ddae8241599cc88560c625724a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c52ea456a784db98386d3d5e55fe44a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f801e952ab24058bc3bbd7e74346274_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d47874d2cff447d94764455a4adb274_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe885a414a174f139a113b8c48656f0c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide98fb1c086841bba65730c9e9d0e5c3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5739f0204cdd40bba7cfc286758eb99d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedfc351c3aa441b898074cff9cb2f90d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i825be3c8cf254b448365fca017922b84_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8356e0b9cfbd4b0db5eae0058bb52f71_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i127bbbf2926f42efa993800b43144c0b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27d15395c0854bfc84fc70f257308756_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97902e8b6d3543a38beee90270b3e1ff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d86972bd8ff440db8e9af798cbcff0d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a7ebe084b2d42bd9909a9b07d2e00f6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia09367fbf6484c039eeb488ad6dcf554_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idadbc4c70fb443308a1c36faac206d9d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if05e29f0742c42d1ac24bff7df962924_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6425ad722cf84deabeab468c2d10b6a0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia457c3f6b68a498ba18886372c07c24a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i194a19a31fe840fdb6c8c759266afa3b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6634f441212f425fbe5da6bca4e48783_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i153a782b2ac745db920b4785f8268200_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e9cd9d12c3f43ec9d70ee7e0d8076c1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6477b8c63c58454499074d398a80a373_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f9e3a31c01942a391fbfab0d89c3f8a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb29efff83384a97be4e90505f07645f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic16bff1ee9254c80a89f582ee2e9b3d3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic86ea1d5b6dc44f2af63bb7d314c17d5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bf59ef98b1545adac077505ac7e83d0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5c115dbb53c47ffa08fb896b39bd7b6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39665844725c4209a15066dc801d7fe6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8282158849cc4f238ec41de28faa2d35_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied071109707642119601cf0ea5c86d13_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82eb3754c9b94d449778e6b6e63c6591_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd47e5c8ab1d4ffa93389f360a448165_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a73e4388fe442ff84fc2ffc6a2c6266_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e0d2df27c5e4c51a64b0329476580fc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id72eb9f8ac6f4c728bdaa099f9836385_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1cff2bd501f465094c089dec54779c4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i426b68aa333f427d93dad8edc44dcfab_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id30239d3660e4d4e85eea70a9128120a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib614a9b3d9dd414cadb853523d634e9c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if285b05be18e4ded8654557403239a51_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i249d2de894e0473fb963ddd614601836_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i245f71d6b43543a69ba7ea32da0f2548_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fa6f8785ba04ad2bb2c6f69131c343b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74784b40d1ef48b4a3940d2a5c85d9da_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d30f208873344438005137cb7dcd673_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i463216755f0b40bd89cd2299509f861d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cd578a7ae594d1eb11c60355e3eda18_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i100fd78a36ac4838b8fdcf17fc398935_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a41716be165442ebf2bc3d198eeae9e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcb39c9bd51e4ed3982382b5190d3215_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35ee59d0ad594d20a7367f83c5d42181_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6f446cc848c4d8fa4602eaa87f92478_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib02b7ea5d28e49ecba973f7748fd0c3a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59b0c1e5f1b94a69a226785725883c7b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0768ba92b27244339b1a4a4e64b0bd8a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedd975f60e2e4f52bb7a01b3588ba5d8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i187b2a05bec94d17b6890569f214fb4e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id146c5c9a6ff4458bb147ee4d06bcceb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6480f6a8b344d4da26190ba7e2b134a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idca2cbb365924fe08d1fca9331f9da1f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d9e0273ef794fc09e5b2df846ddc972_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2aed0c146004449ae3c852aea7d1b98_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4826ba2c9157409bba218177c880c8c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d7b7c7689844e74893cf79348121605_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32d48e9a7c194db7a29153a53ba29a2a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b3b2780690e461ca82dd12d2d5dea77_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia002a77fe35d43898743d9977eabc858_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e5d0bc94d8549d38b7acb1bb04d6f9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie109b7ada8cc4654be6dcb72b936b2df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fb9a57293054024a366990a739e6596_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3597245e7cf440a7a7ae6ac45addecab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id22add844f974bf8b07a30cbc2cefe30_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf8cebd612ae46269efac158f2dd98f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic527e2e72ab14196892caa07ca0316e6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71fd9e78e4214b78976cc93ea78ffce2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d746bbdd1cd469ea1b06db720fb369c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if17efe1115fb48509286959669ffc628_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i625be35b035e4450b7053b827871d006_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33f404899e1b4c598c4445ab4bd72151_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04c7968a4f2a40c6a44dabd77d8b77e6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2c93ff1086147fe9a512996471b4758_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9816bbb59837427d84449a8fd8eb65cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8115e874d4641dbae3a0cd214707412_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38d0ee4467e84cb3835ebbfe019c4b73_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb9927142500410bb4d9ae681347e21a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30c71d0c43ce416697a4a799bd7c4d1f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf8c88bbd7e141e7b68274a9caaec1aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5950552df0e54a939965751bc3cd51fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i130febd9b4734349a2f8f9936469e9c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8bae7a6f996464ba2b7a6100620166e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d506e3cd8b44e8ea7ee6f72aa813850_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a87d5a6e486446c962961764c10fbe0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9edce9fba80c47b48d09fea184945683_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dd964793f9f461fac181d8ef8a81d1b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ef9ed30634649e4b045916294d297c9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30cf143adc074a69bb21722cf2cc8d97_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i367faaa9b8c24d72b8fa062cc2dd99ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcd5875603574767bf2ff59bc4998ce3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaf506fcaacf4a9c9bf01628e13c738c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2df834d688e1427a96aae1a432497373_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9a410191f824e1d812f6139c4125641_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ac8c808851e491b96fe0b5a20350edd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8600bfef99244855ad7eb86ab1559616_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bdb686a074e4acf9ab3712cd681a240_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia685ebb6c459475f8ad0e6a8307326bd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02f6517e534d4e87a32cacd9b1d43a6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife540dc14d1e40cab44feeb7eef313d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic50a20d112914cc4ab63d1807d98ab0a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i961947f6659e41f1bea8348eb926b5a0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib15d07215a9d4d18aff3f2e340e78ee3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8802b984efc41ec94e160ab0bbca2fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i118155f938754467a285e3cd573f13ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia00f1e5c743a40a290330dfdc47180cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i984f2728edad403096ab760c7297e528_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec7c0676d1274e64a619cdde89d6aa4f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1f91cce64b3471488b001aaa80a426d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36b0789820344a6381068e7895a8cc6b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia19da1ea96814ca79e2518469b123c9c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65e7424994e04f29bb2b11d17ca82c2d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i216cffbfe6cc49fea999c1a173ee7d01_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48bf1c0bd1314a1c90835a095147262c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife87f5c217a845f2a51cd1c4a41ade32_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f2e4216a4ce40698cac894107c3c948_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b936995e0d14a0e9066d6970142374e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11d6455065c14916bedcc4b31887f1f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cnc:ComputerHardwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if190281df1454b0d9f5770396612743e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cnc:ComputerHardwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b6b990671ab4dd8acf8fa985ca2d4e4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i100a54adfd364d5fb0858e40985a6181_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73c2a614f2d145f98965ad96053b0c7e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cnc:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if22e34d79ca74c90b70c889d03c57bff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cnc:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06f29161405549d4ac55bc80cc166ac5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib38956abc3fb4d8e8499d7bb2fe5d94d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29be61bb7bd449499dfb1c0c4a885854_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cnc:RealEstateOwnedAndRelatedFixedAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3a179811ece4f09918f2e0f0934aad0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cnc:FixedAssetsLeasedRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe9c3a7c196249c9a9c9c18973bfaf0c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3600301874b74a97849c262419053cdf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6447d75d16c04ef5b131401dd27e366b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2bebbc40fd54b4b8b61324fc370f6f6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92213e6837f747a4af84a01d94d1a0e5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ebf3857ac8d4d779658871d0f01e499_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a0d132e8b0f4c5e9eabdf2f63c857e9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i181e950b83264a488f15aa5b9518e0ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7849ad351f3a4c2c85f3c60fa5e30c67_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cnc:FederalServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i328ddde551924916887c2898ccb4dd3b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d16b33d8c444b8481c9b42434c97635_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03902f10bd8f4acb93c88c3d43810400_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58a9fd19cada4c13b08e45b396931905_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b18a16cf3a0445a91bf4830e4787fa6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16afdebec9994bc7a8b3f04e5c78b0d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e59224fa1b1425dae4c36a43f5ca733_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib287146fc44b4771b7ffa29552be6cfb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1efb4143fcd4b1aaef7a1ba3c72805f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnc:ProviderContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cf15dae4e23403b853ee515df157fa4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnc:ProviderContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77a6398252454629906ae6fadb232df2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnc:ProviderContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49909ff543254622b7916b96f58bad77_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnc:ProviderContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e453e9028df40d18c170e5c715a855a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1db28c738ca41c9b8de3081714dc705_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia59410e42a404d6697fe2e242a44ea5a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46026d8e014347bd85d04fc8a7960c3c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73627a9d2f3f4c7890caac11b561d45e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id73d46c1711b4b3da426964338d0f2df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19d7002bf5504374ba94620ad1f9d850_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa9b52eb00894da485bfb964ba7dce6c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0bdad4169ab4f599480c131c7206ae1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d2f58523cb7466b8aecbc8fdbe138a8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41b58c91b23541a8a008f29061d225c8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>cnc:claim</xbrli:measure></xbrli:unit><xbrli:context id="ieedd2924db2741fca6d7ee512adc93cd_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if59e715c4ba4443c81f2e83328a8a425_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2500Million425SeniorNotesDueDecember2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if498067e62854af781939df76fc7b035_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2500Million425SeniorNotesDueDecember2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id75e90133d6e4c55b389cae1596db986_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2300Million245SeniorNotesDueJuly2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b3779cadebd4a4a8a5ddcba3d40c0d3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2300Million245SeniorNotesDueJuly2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i250c45b9e6554e22b18804fe0e46eccf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A3500Million4625SeniorNotesDueDecember2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93f572be795842d992415254cf1b1974_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A3500Million4625SeniorNotesDueDecember2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd89fe164f074e05acdf55f863fcc0a3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2000Million3375SeniorNotesDueFebruary2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae25ea5bc64c484ebad2cc5c1bc36113_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2000Million3375SeniorNotesDueFebruary2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i078d28b9b7034dd79780964d934280a4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2200Million30SeniorNotesDueOctober2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f64aca31038437e9b59b40bd0c68e62_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2200Million30SeniorNotesDueOctober2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1b9e385a1ff409aa6196f98517e19f0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2200Million250SeniorNotesDueMarch2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0e4077697e84a6aacad32e78a712191_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2200Million250SeniorNotesDueMarch2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78293ad1cf844c17be18714b5b518d0d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A1300Million2625SeniorNotesDueAugust2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b35f9af5214457fa8305485b8f5f80b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A1300Million2625SeniorNotesDueAugust2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3889e7dc9b3e43e2a89701b5ac996351_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c97fc5b57a3422fa0bc98e9660b7eae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86309d5b4d1e4ad9b29778c622cf58d4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic251ef2ec19d480a85766f384559792b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6e2a887cb3d462b82d112eb5f97f89a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoanPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifffd6515bcf049398572bfc7345e86dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoanPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7582e6a18d214d5683a70f95e9969290_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditAvailabilityConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">cnc:LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">cnc:DebtTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i197f99f81f0748d8ba59ab12609ea196_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditAvailabilityConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">cnc:DebtTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fded93a3db84d59b9c64760d9785611_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">cnc:SterlingOvernightIndexAverageSONIAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditAvailabilityConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">cnc:DebtTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71b9b8cb331c423a90a34a1f496e8463_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i474329559a594a6db005b911431a9b0d_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15f1c30fc6e14d85b699a2ed36b96775_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc4208797a9b45e58c4c6d017a4605de_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2200Million250SeniorNotesDue2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b0acc9d6b8245e5961cda862a186a59_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2200Million475SeniorNotesDueJanuary2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf49d7094f0e45829152639ae4685492_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2200Million475SeniorNotesDueJanuary2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i055c199b26fc4eaaae9f9b983763a177_I20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A1800Million245SeniorNotesDueMarch2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5a2e2fdf251412ca928d6700728fd1c_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f91eaa1ade34d99a4b37902e16b46fb_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A1800Million245SeniorNotesDueMarch2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a76b04856c549278fbebee384e77959_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A1300Million2625SeniorNotesDueAugust2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2af47f4133f54a42b12356bc6030758a_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A750Million5375SeniorNotesDueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cf2b5d34cdd49e092806cd5c281dddf_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A750Million5375SeniorNotesDueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i628d01f64b184de1b7b5efff1732a9d8_I20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7b1ceee886645d6a8088bd5d3047f69_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="i9533de2ead4446adb1c44eb2cb595111_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i512923a399a94c85a9f81f1c02440f82_D20220331-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf8926fc8ce441d596b2ad6011782776_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ForeignLineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i300c0cc925174961aa324cbb7cf6b0ad_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ForeignLineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7421b87407a64ef3a02518501627c5ff_I20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id87680544d5e40f493d0ad0a03ad37db_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec2cac8396b94542a2646f54a9d68328_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a40221e9a2a4afc802c9416ad92a8cf_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b51f86196b74c5d81b9dbbe890e9cd5_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68f6f5e3a4564d01bf741fa247876509_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaf48712843846db970ca72f1062bb57_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cnc:DebtInstrumentPaymentPeriodAxis">cnc:DebtInstrumentPaymentPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ced5abd56064636b901e0fb233dc37e_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cnc:DebtInstrumentPaymentPeriodAxis">cnc:DebtInstrumentPaymentPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09c848e42b694dbdb1f15b4c4e6aa8d2_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cnc:DebtInstrumentPaymentPeriodAxis">cnc:DebtInstrumentPaymentPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i177a913a1fb447848f07559f4f84f998_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b3d244dd3854164a91cb86ed9b12891_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07f12668f2cd4f52a84d59666eb6d3ce_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6086520b355b4f8cbc019750e6f19c0d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb5e31256d79442d9db9f7a1fd150824_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9edeffc055d4939acb82ad908f07cbe_I20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoanPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a8103ddaf8e4f1baaddc98a488f091f_D20171001-20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoanPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2017-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aefa7ec1d0042b6a41fc0a03595d12d_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoanPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96f3204307ae4fdfb13dc11441d5072d_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoanPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e6dc3e560e84de0a5d2f02722587893_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoanPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ca911cb3026492eb537e47263364487_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68ee5cfa5b3041a9aa1e9d4f1e223aa1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b502a06d63b40bebe5407d59dadc678_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:SuretyBondMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdb10359bdf9470da1ce1cc23be870ee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2972405604564d108b785acc0e0173ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd22c4115d4947d6878c9e6781a372d1_D20220601-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b616f4f2341472dbd385786d0a01c38_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief504e0f21434c29b6eea0887f48d0e5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cnc:AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29cb5a3f49f1494e8f6826eff1bd9010_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cnc:AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6584fae5af246acaeeca245d13601b3_D20221001-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cnc:AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide855c65da574e12a7000a0c1c5d15dd_D20221001-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cnc:AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i798439eca4864894a14ab00bbc412860_D20220701-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cnc:AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b5a6df0e62840ec938274ece6e23cb2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cf082093f37453aa852faade614d285_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bc71fec53d748409f78d934b69f1f56_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8a8cf81a11c41a893d0995455479cd6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cnc:EmployeeStockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9f4a1f99a204f11946360404ec006fb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cnc:EmployeeStockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e3759b9cf8a44728c767939b67b86ae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cnc:EmployeeStockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dd496b069e94c7f84fc2916ec5f8a53_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:WellCareHealthPlansIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cnc:EmployeeStockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i411fcfa45e664b36954eea6f3adec1d3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:WellCareHealthPlansIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cnc:EmployeeStockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i544615d6498841d8b5bd747233c5fb23_D20200123-20200123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:WellCareHealthPlansIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-23</xbrli:startDate><xbrli:endDate>2020-01-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0934fe54808484a9ec9bca372c35cb2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1d6506c5c5d40a788e453632be65da8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10545d0936824fd6b5972c4e49790df4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i565504036a2e459fa252e3436ba28dea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">us-gaap:SettlementWithTaxingAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i710e1a1e967847a5bfd25febe427afbe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i660d37afc2d64a069401dc54b4c69ba9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4e35ffd327d45e280e358485568b79f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2c6097d9fc34e458585987bbb311fea_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96654801b9964ae2b8f134e8859eac41_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7772399e744a48908f193c434d6d6a34_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e6ac045f07846a0a20f759b986b78a4_I20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:PurchaserBusinessGroupOnHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic47ddeb6bff94082ad9cbbcb46104c2d_D20220104-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:PurchaserBusinessGroupOnHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-04</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56eac86dba6e4053a7ca2c5c5581989e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b9698336fd64b6e87b61c763e298e1d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddb3faf7d44a4e5c8ad7bb4b13280732_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0872678e89e4daeb40637a4f74959f1_D20160101-20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0c316f54cfe4b9fa7a39964c5a1d5f0_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentServiceCenterinCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib82f610c9738480cb8bbbc7d5b5a8247_D20160101-20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentServiceCenterinCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i892f84f1e688414fa51beaf4c47f0a87_D20160101-20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentServiceCenterinCaliforniaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="newemployee"><xbrli:measure>cnc:newEmployee</xbrli:measure></xbrli:unit><xbrli:context id="ib2a9aa63979e4693b2198d2bf9cbd715_D20160101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentServiceCenterinCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8e887f935d34e8aa8685f28daf85a31_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i422ca41ca2bc487dab910fa58cd7b380_D20160101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87ea845a685c481cb90b1ac715f64443_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4d87dee1a254093b133d2780a8d3d4f_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie10b1c36a39645fd98b8f6652a9ea7aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1408e06a90864ff9b0dadeb355581288_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1c2cca7f4f74960a51897309069b67d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0679197c607142fab0cde5bfadf6106e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5edc68c239804a80814acb778ec0cec8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81fb523ea67d40f5940533702a20d4a3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6897fe7f407348408f329013f91d65d4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i597b4c195cb04959abb207f4c5a9d77b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdc35ca45e39441388aa8777389f4f17_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfc51f1798d2493e9397d897df02b75d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c52c3388e80478599272c3d556863c1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73a2cbaeddfd400e90e0ac804c3f053d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08f2668a7ad14973b713bb5cfbcf8727_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6991fd72507b46dc832dd05186288635_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fd30ab791664c4f9c22d79dbf638763_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7155450c86684d8ba820c2c57095f767_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06642903404e4397841d66d835b14359_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if516d478048c4636bd145efe65e63d37_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51a6cef996834ef6bafb08a049d5359c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0152a1872d414c68a590ec9403c7ff34_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0033f462240348c2a7b3d5fe00b22f47_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f75ea8b064c4d4a8f2d206bf5351a9c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41f276fba4a64c09ba22940633f73652_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001071739</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9dee570cfbd043d6a1700298c14b2446_1"></div><div style="min-height:40.5pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.159%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%">&#160;&#160;Form <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTk3_02b56393-aaf6-479b-8dbb-38d35f8329ac">10-K</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Mark One) </span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTkw_5eba0293-94e1-4147-963c-f42791f79b1d">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;For the fiscal year ended <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV80OTQ3ODAyMzI4MjEy_ff1f2b71-f00c-4f9f-8e44-13138fd9a50f"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV80OTQ3ODAyMzI4MjEy_1b8204dd-3708-44d5-a7ac-84bad9f8c5ee">December 31</ix:nonNumeric>, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTk5_023e7351-ba4a-4860-83f4-10ac7357905e">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTkx_6af76cbc-1c1c-407c-ae41-243cf08cd895">001-31826</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTg2_99cae993-dc5e-4468-9dd5-d5a212d3407d">Centene Corporation</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.937%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NjlmMGRmYTAxOGM5NDBiN2FjYmJjZWM5YWUwNDlkNDUvdGFibGVyYW5nZTo2OWYwZGZhMDE4Yzk0MGI3YWNiYmNlYzlhZTA0OWQ0NV8wLTAtMS0xLTM1NDAxOA_e8f4d215-6eb0-4df8-8aae-06b7f20d224d">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NjlmMGRmYTAxOGM5NDBiN2FjYmJjZWM5YWUwNDlkNDUvdGFibGVyYW5nZTo2OWYwZGZhMDE4Yzk0MGI3YWNiYmNlYzlhZTA0OWQ0NV8wLTItMS0xLTM1NDAxOA_0a143143-0cba-4b38-bdb2-9d716540dca5">42-1406317</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NjlmMGRmYTAxOGM5NDBiN2FjYmJjZWM5YWUwNDlkNDUvdGFibGVyYW5nZTo2OWYwZGZhMDE4Yzk0MGI3YWNiYmNlYzlhZTA0OWQ0NV8zLTAtMS0xLTM1NDAxOA_680fed11-f4c4-4a75-a059-88e645121efd">7700 Forsyth Boulevard</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NjlmMGRmYTAxOGM5NDBiN2FjYmJjZWM5YWUwNDlkNDUvdGFibGVyYW5nZTo2OWYwZGZhMDE4Yzk0MGI3YWNiYmNlYzlhZTA0OWQ0NV80LTAtMS0xLTM1NDAxOA_0925f4e3-47ab-40e2-938d-aa286de01e56">St. Louis,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NjlmMGRmYTAxOGM5NDBiN2FjYmJjZWM5YWUwNDlkNDUvdGFibGVyYW5nZTo2OWYwZGZhMDE4Yzk0MGI3YWNiYmNlYzlhZTA0OWQ0NV80LTEtMS0xLTM1NDAxOA_024df02d-b75a-4156-8de7-9baef248ab15">Missouri</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NjlmMGRmYTAxOGM5NDBiN2FjYmJjZWM5YWUwNDlkNDUvdGFibGVyYW5nZTo2OWYwZGZhMDE4Yzk0MGI3YWNiYmNlYzlhZTA0OWQ0NV80LTItMS0xLTM1NDAxOA_de074009-d796-47c6-94f1-0bbd3c8ac5f4">63105</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant's telephone number, including area code: (<ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTg3_5cf55909-4be2-4345-8edb-9bcfbaad2be5">314</ix:nonNumeric>) <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTk4_a1718823-8299-41ae-821f-5a3622cc6f64">725-4477</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.937%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NzVhOWE1ZDcxYzVmNGU2NDkzYjM0NGU3MDk4ODc5Y2YvdGFibGVyYW5nZTo3NWE5YTVkNzFjNWY0ZTY0OTNiMzQ0ZTcwOTg4NzljZl8xLTAtMS0xLTM1NDAxOA_bc65cfc7-206e-4051-8b98-1a03a76f51b5">Common Stock, $0.001 Par Value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NzVhOWE1ZDcxYzVmNGU2NDkzYjM0NGU3MDk4ODc5Y2YvdGFibGVyYW5nZTo3NWE5YTVkNzFjNWY0ZTY0OTNiMzQ0ZTcwOTg4NzljZl8xLTEtMS0xLTM1NDAxOA_255a4c80-7859-4d8a-a40b-2f143968fa9c">CNC</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NzVhOWE1ZDcxYzVmNGU2NDkzYjM0NGU3MDk4ODc5Y2YvdGFibGVyYW5nZTo3NWE5YTVkNzFjNWY0ZTY0OTNiMzQ0ZTcwOTg4NzljZl8xLTItMS0xLTM1NDAxOA_b946111c-3a6f-46b4-9308-9e641d4923cb">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">None </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Title of Class) </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTk0_d558ec85-3a18-41a5-9f68-e1e8aa1a3b55">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;<ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTky_208e0884-4fef-496d-a0fc-ee52d969c78b">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTg4_6800e6d5-9143-4c72-ab50-b218809e0944">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTk1_5d036af5-9bd4-4d05-92a2-4a3b91c1f48b">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.949%"><tr><td style="width:1.0%"></td><td style="width:40.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.801%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NzRmZjBlYzA1ZDliNGM5NGJlMDg1NzM2ZmU1ZGJlOTEvdGFibGVyYW5nZTo3NGZmMGVjMDVkOWI0Yzk0YmUwODU3MzZmZTVkYmU5MV8wLTAtMS0xLTM1NDAxOA_db932fc5-9696-4490-8b84-a6e3773661ad">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NzRmZjBlYzA1ZDliNGM5NGJlMDg1NzM2ZmU1ZGJlOTEvdGFibGVyYW5nZTo3NGZmMGVjMDVkOWI0Yzk0YmUwODU3MzZmZTVkYmU5MV8xLTMtMS0xLTM1NDAxOA_5d87eb1b-a4a6-46d5-9cac-012d5791289c">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NzRmZjBlYzA1ZDliNGM5NGJlMDg1NzM2ZmU1ZGJlOTEvdGFibGVyYW5nZTo3NGZmMGVjMDVkOWI0Yzk0YmUwODU3MzZmZTVkYmU5MV8yLTMtMS0xLTM1NDAxOA_63979e36-5292-40ae-9b79-65718680518c">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTg5_e71b648d-8ba6-48c6-ac45-bc6a0724aaff">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statement of the registrant included in the filing reflect the correction of an error to the previously issued financial statements. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b) </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTkz_02e73f11-45d2-4727-81d9-50fd8708d54d">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant, based upon the last reported sale price of the common stock on the New York Stock Exchange on June&#160;30, 2022, was $<ix:nonFraction unitRef="usd" contextRef="i04652939d67241d39001577da981b842_I20220630" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8yOTA2_010aec79-74d5-43aa-80da-a0d8e0154f3f">49.2</ix:nonFraction> billion.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of February&#160;17, 2023, the registrant had <ix:nonFraction unitRef="shares" contextRef="ie567ad4d3dfb4202acf278d4fe91232a_I20230217" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8yOTQw_fe1430e8-01a5-4726-8bd3-e26e5f04fe9a">551,264,559</ix:nonFraction> shares of common stock issued and outstanding.</span></div><div style="margin-bottom:5pt;text-align:center;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTk2_52468cec-0222-453e-bc22-2228e74b8beb" escape="true">Portions of the Proxy Statement for the registrant's 2023 annual meeting of stockholders are incorporated by reference in Part III, Items 10, 11, 12, 13 and 14.</ix:nonNumeric> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.159%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><span><br/></span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CENTENE CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT ON FORM 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.076%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PAGE</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_22">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_22">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_25">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_25">18</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_31">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_31">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_34">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_34">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_37">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_37">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_40">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_40">33</a></span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_46">Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_46">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_49">Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_49">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_52">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_52">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7A.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_73">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_73">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_76">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_76">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_175">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_175">102</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_178">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_178">102</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_184">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_184">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_187">Disclosure Regarding Foreign Jurisdictions that Prevent Implications</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_187">104</a></span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part III</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_193">Directors, Executive Officers, and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_193">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_196">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_196">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_199">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_199">105</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_202">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_202">105</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_205">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_205">105</a></span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part IV</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;15.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_208">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_208">105</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_214">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_214">110</a></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_217">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_217">111</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><span><br/></span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All statements, other than statements of current or historical fact, contained in this filing are forward-looking statements.&#160;Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue," and other similar words or expressions (and the negative thereof). Centene Corporation and its subsidiaries (Centene, the Company, our or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in connection with completed and future acquisitions and dispositions, our investments, and the adequacy of our available cash resources.&#160;These statements may be found in the various sections of this filing, such as Part I, Item 1. "Business," Part I, Item IA "Risk Factors," Part I, Item 3. "Legal Proceedings," and Part II, Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations."</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments, and other factors we believe appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive, and other factors that may cause our or our industry's actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements.&#160;These statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All forward-looking statements included in this filing are based on information available to us on the date of this filing. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this filing, whether as a result of new information, future events, or otherwise, after&#160;the date of this filing.&#160;You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables, and events including, but not limited to:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to design and price products that are competitive and/or actuarially sound including but not limited to any impacts resulting from Medicaid redeterminations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition, including our ability to reprocure our contracts and grow organically;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and extent of benefits from our value creation strategy, including the possibility that the benefits received may be lower than expected, may not occur, or will not be realized within the expected time periods;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruption, unexpected costs, or similar risks from business transactions, including acquisitions, divestitures, and changes in our relationships with third parties; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impairments to real estate, investments, goodwill, and intangible assets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risk that the election of new directors, changes in senior management, and any inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">membership and revenue declines or unexpected trends;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in healthcare practices, new technologies, and advances in medicine;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased healthcare costs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inflation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in economic, political, or market conditions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">tax matters;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disasters or major epidemics;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in expected contract start dates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provider, state, federal, foreign, and other contract changes and timing of regulatory approval of contracts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE, or other customers);</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Centene Pharmacy Services (formerly Envolve Pharmacy Solutions, Inc. (Envolve)), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we previously recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations will be brought by states, the federal government or shareholder litigants, or government investigations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">challenges to our contract awards;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cyber-attacks or other privacy or data security incidents;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental, or third party consents or approvals for acquisitions or dispositions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any changes in expected closing dates, estimated purchase price, and accretion for acquisitions or dispositions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions and limitations in connection with our indebtedness;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a downgrade of the credit rating of our indebtedness;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of debt and equity financing on terms that are favorable to us; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">foreign currency fluctuations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition, and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><span><br/></span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY OF RISK FACTORS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to numerous risks and uncertainties that you should be aware of in evaluating our business, including risks that may prevent us from achieving our business objectives or may adversely affect our business, financial condition, results of operations, cash flows, and prospects.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks include, but are not limited to, the following, all of which are more fully described in Part 1, Item 1A "Risk Factors". This summary should be read in conjunction with the Risk Factors section and should not be relied upon as an exhaustive summary of the material risks facing our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failure to accurately estimate and price our medical expenses or effectively manage our medical costs or related administrative costs could have a material adverse effect on our business; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our Medicare programs are subject to a variety of unique risks that could adversely impact our financial results;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk-adjustment payment systems make our revenue and results of operations more difficult to estimate and could result in retroactive adjustments that have a material adverse effect on our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any failure to adequately price products offered or any reduction in products offered for Medicare Advantage and in the Health Insurance Marketplace may have a material adverse effect on our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We derive a portion of our cash flow and gross margin from our prescription drug plan (PDP) operations, for which we submit annual bids for participation. The results of our bids could have a material adverse effect on our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our encounter data may be inaccurate or incomplete, which could have a material adverse effect on our business and ability to bid for, and continue to participate in, certain programs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are not successful in procuring new government contracts or renewing existing government contracts, or if we receive an adverse finding or review resulting from an audit or investigation, our business may be adversely affected; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business could be materially adversely affected by the effects of widespread public health pandemics, such as COVID-19;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ineffectiveness of state-operated systems and subcontractors could adversely affect our business; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Execution of our value creation strategy may create disruptions in our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If state regulators do not approve payments of dividends and distributions by our subsidiaries to us, we may not have sufficient funds to implement our business strategy;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We derive a significant portion of our premium revenues from operations in a number of states, and our business could be materially affected by a decrease in premium revenues or profitability in any one of those states; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competition may limit our ability to increase penetration of the markets that we serve;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are unable to maintain relationships with our provider networks, our profitability may be harmed; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we or our third-party vendors are unable to integrate and manage information systems effectively, our operations could be disrupted; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A failure in or breach of our operational or security systems or infrastructure, or those of third parties with which we do business, including as a result of cyber-attacks, could have a material adverse effect on our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unable to attract, retain or effectively manage the succession of key personnel;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An impairment charge with respect to our real estate portfolio, recorded goodwill, and intangible assets could have a material impact on our results of operations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reductions in funding, changes to eligibility requirements for government-sponsored healthcare programs in which we participate, and any inability on our part to effectively adapt to changes to these programs could have a material adverse effect on our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Significant changes or judicial challenges to the ACA could materially and adversely affect our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business activities are highly regulated and new laws or regulations or changes in existing laws or regulations or their enforcement or application could force us to change how we operate and could harm our business; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our pharmacy services face regulatory and other risks and uncertainties which could materially and adversely affect our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have been and may from time to time become involved in costly and time-consuming litigation and other regulatory proceedings, which require significant attention from our management and could adversely affect our business; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to comply with applicable privacy, security, and data laws, regulations, and standards, including with respect to third-party service providers that utilize sensitive personal information on our behalf, our business could be materially and adversely affected;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to comply with the extensive federal and state fraud, waste and abuse laws, our business could be materially and adversely affected;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We might be adversely impacted by tax legislation or challenges to our tax positions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our investment portfolio may suffer losses which could materially and adversely affect our results of operations or liquidity; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adverse credit market conditions may have a material adverse effect on our liquidity or our ability to obtain credit on acceptable terms;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have substantial indebtedness outstanding and may incur additional indebtedness in the future. Such indebtedness could reduce our agility and may adversely affect our financial condition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Phasing out of London Interbank Offered Rate (LIBOR) may increase our interest expense or affect the value of the financial obligations to be held or issued by us that are linked to LIBOR, which may adversely affect our financial condition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mergers and acquisitions may not perform as expected and we may not realize the savings expected from divestitures, which may cause the market price of our common stock to decline;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unable to successfully integrate our existing business with acquired businesses and realize the anticipated benefits of such acquisitions; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business and results of operations may be materially adversely affected if we fail to manage and complete divestitures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><span><br/></span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Presentation </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is providing certain non-GAAP financial measures in this report as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. The Company uses the presented non-GAAP financial measures internally in evaluating the Company's performance and for planning purposes, by allowing management to focus on period-to-period changes in the Company's core business operations, and in determining employee incentive compensation. Therefore, the Company believes that this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, the Company believes the presentation of non-GAAP financial information that excludes amortization of acquired intangible assets and acquisition and divestiture related expenses, as well as other items, allows investors to develop a more meaningful understanding of the Company's core performance over time. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below provide reconciliations of non-GAAP items ($ in millions, except per share data):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP net earnings attributable to Centene</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,808&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and divestiture related expenses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax effects of adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP diluted earnings per share (EPS) attributable to Centene</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and divestiture related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax effects of adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Diluted EPS</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.78&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:40.5pt;text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Other adjustments include the following pre-tax items:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;text-decoration:underline">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">:</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) real estate impairments of $1,642 million, or $2.82 per share ($2.08 after-tax); PANTHERx Rare (PANTHERx) divestiture gain of $490 million, or $0.84 per share ($0.65 after-tax); impairments of assets associated with the divestitures of our Spanish and Central European, Centurion, and HealthSmart businesses of $458 million, or $0.78 per share ($0.60 after-tax); Magellan Rx divestiture gain of $269 million, or $0.46 per share ($0.17 after-tax); Health Net Federal Services asset impairment of $233 million, or $0.40 per share ($0.39 after-tax); gain on debt extinguishment of $27 million, or $0.04 per share ($0.03 after-tax); increase to the previously reported gain on the divestiture of U.S. Medical Management (USMM) due to the finalization of working capital adjustments of $13 million, or $0.02 per share ($0.02 after-tax); and costs related to the PBM legal settlement of $6 million, or $0.01 per share ($0.00 after-tax).</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;text-decoration:underline">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">:</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) PBM legal settlement expense of $1,264 million, or $2.14 per share ($1.76 after-tax); gain related to the acquisition of the remaining 60% interest of Circle Health of $309 million, or $0.52 per share ($0.52 after-tax); impairment of our equity method investment in RxAdvance of $229 million, or $0.39 per share ($0.32 after-tax); gain related to the divestiture of USMM of $150 million, or $0.25 per share ($0.23 after-tax); debt extinguishment costs of $125 million, or $0.21 per share ($0.16 after-tax); reduction to the previously reported gain on divestiture of certain products of our Illinois health plan of $62 million, or $0.10 per share ($0.08 after-tax); and severance costs due to a restructuring of $54 million, or $0.09 per share ($0.06 after-tax).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;text-decoration:underline">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">: </span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) gain related to the divestiture of certain products of our Illinois health plan of $104 million, or $0.18 per share ($0.10 after-tax); impairment of $72 million, or $0.12 per share ($0.10 after-tax); and debt extinguishment costs of $61 million, or $0.11 per share ($0.07 after-tax). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The income tax effects of adjustments are based on the effective income tax rates applicable to each adjustment. In addition, the year ended December 31, 2022, includes tax expense of $107 million, or $0.18 per share, related to the Magellan Specialty Health divestiture and a $15 million, or $0.03 per share, tax benefit related to the RxAdvance impairment.</span></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP selling, general and administrative expenses</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,589&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,601&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,380&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and divestiture related expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs related to the PBM legal settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate optimization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted selling, general and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Note: Beginning in 2022, we have included a separate line item for depreciation expense on the Consolidated Statements of Operations, which was previously included in selling, general and administrative (SG&amp;A) expenses. Prior period SG&amp;A expenses have been conformed to the current presentation.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i9dee570cfbd043d6a1700298c14b2446_22"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Purpose</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transforming the health of the community, one person at a time.</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.452%"></td><td style="width:0.1%"></td></tr><tr style="height:84pt"><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="cnc-20221231_g1.jpg" alt="cnc-20221231_g1.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="cnc-20221231_g2.jpg" alt="cnc-20221231_g2.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="cnc-20221231_g3.jpg" alt="cnc-20221231_g3.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Focus on the Individual</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Whole Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Active Local Involvement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Empowering people to create and maintain lifelong healthy habits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Delivering a full spectrum of care from physical health to emotional wellness</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Helping our neighbors create stronger, healthier communities</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Who We Are</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mission as a leading healthcare enterprise is to help people live healthier lives, with an established expertise in lower-income and medically complex populations. We provide access to high-quality healthcare, innovative programs, and a wide range of health solutions that help families and individuals get well, stay well, and be well. We believe that our local approach enables us to provide accessible, quality, culturally sensitive healthcare coverage to our communities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a competitive advantage being on the ground, enabling us to establish strong relationships with our partners and providing us with first-hand knowledge, which enables us to provide the best possible care to our members. We have a commitment to the communities and people we serve to transform their health at the local level.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our value creation efforts, initiated in mid-2021, are the foundation of our long-term strategy, focused on making strategic decisions and investments to create additional value in the short-term and to seek opportunities that position the organization for long-term strength, profitability, growth, and innovation. In addition to creating shareholder value, this plan is an ongoing effort to modernize and improve how we work in order to propel our organization to new levels of success and elevate the member and provider experiences.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we operated in two segments: Managed Care and Specialty Services. Our Managed Care segment provided health plan coverage to individuals through government subsidized and commercial programs. Our Specialty Services segment included companies offering diversified healthcare services and products to our Managed Care segment and other external customers. For the year ended December&#160;31, 2022, our Managed Care and Specialty Services segments accounted for 93% and 7%, respectively, of our total external revenues. Our membership totaled 27.1 million as of December&#160;31, 2022. For the year ended December&#160;31, 2022, our total revenues and net earnings attributable to Centene were $144.5 billion and $1.2 billion, respectively, and our total cash flow from operations was $6.3 billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In early 2023, and in conjunction with our updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, we have revised the way we manage the business, evaluate performance, and allocate resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. We will begin reporting under this new segment structure in 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our initial health plan commenced operations in Wisconsin in 1984. We were organized in Wisconsin in 1993 as a holding company for our initial health plan and reincorporated in Delaware in 2001. Our stock is publicly traded on the New York Stock Exchange under the ticker symbol "CNC."</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDUSTRY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide a full spectrum of managed healthcare products and services, primarily through Medicaid, Medicare, and commercial products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicaid</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid is the largest publicly funded program in the United States and provides health insurance to low-income families and individuals with disabilities. Medicaid is funded jointly by federal and state governments, with the majority of funding provided by the federal government and administered by the states. Each state establishes its own eligibility standards, benefit packages, payment rates, and program administration within federal standards. As a result, there are 56 Medicaid programs - one for each U.S. state, each U.S. territory, and the District of Columbia. Eligibility is based on a combination of household income and assets, often determined by an income level relative to the federal poverty level. Many states have selected Medicaid managed care as a means of delivering quality healthcare and controlling costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid helps meet the needs of various populations through the following products and programs:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Temporary Assistance for Needy Families (TANF) program covers low-income families with children.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medicaid Expansion covers all individuals under age 65 with incomes up to 138% of the federal poverty level, subject to each states' election. The federal government pays 90% of the costs for Medicaid Expansion coverage for these beneficiaries.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Aged, Blind, or Disabled (ABD) program covers low-income individuals with chronic physical disabilities or behavioral health impairments. ABD beneficiaries represent a growing portion of all Medicaid recipients and typically utilize more services as a result of their more complicated health status.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Children's Health Insurance Program (CHIP) helps to expand coverage primarily to children whose families earn too much to qualify for Medicaid, yet not enough to afford private health insurance. Historically, children have represented the largest eligibility group. Costs are primarily composed of pediatrics and family care, which tend to be more predictable than those associated with other healthcare issues predominantly affecting the adult population. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Long-Term Services and Supports (LTSS) is a Medicaid product that covers Institutional/Residential Care (Nursing and Intermediate Care Facilities) and Home and Community Based Services (HCBS) for beneficiaries requiring assistance with their activities of daily living. The largest groups receiving LTSS, by spending, are older individuals and individuals with physical disabilities, followed by individuals with intellectual and developmental disabilities, those with serious mental illness and/or serious emotional disturbance, and other populations. States are increasingly turning to managed care as a solution to provide coordinated, holistic care to their LTSS beneficiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The majority of children in foster care qualify for Medicaid. The federal government has enacted legislation establishing requirements for state child welfare agencies related to the health and well-being of children in foster care, including the provision of grants and technical assistance to enable states to meet these needs and make explicit connections with Medicaid. In addition, under the ACA, former foster care children are eligible for Medicaid until the age of 26, provided that they turned 18 while in foster care and were enrolled in Medicaid at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A portion of Medicaid beneficiaries are dual-eligible, low-income seniors and people with disabilities who are enrolled in both Medicaid and Medicare. According to the CMS, there were approximately 11.6 million dual-eligible enrollees in 2021. These members may receive assistance from Medicaid for benefits, such as nursing home care, HCBS, and/or assistance with Medicare premiums and cost-sharing depending on their income level. Dual-eligibles use more services due to their tendency to have more chronic health issues. We serve dual-eligibles primarily through our ABD, LTSS, Medicare-Medicaid Plan (MMP), and Medicare Advantage Dual Eligible Special Needs Plan (DSNP) lines of business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Medicaid programs have directed funds to many individuals who cannot afford or otherwise maintain health insurance coverage, they did not initially address the inefficient and costly manner in which the Medicaid population tends to access healthcare. Medicaid recipients in non-managed care programs typically have not sought preventive care or routine treatment for chronic conditions, such as asthma and diabetes. Rather, they have sought healthcare in hospital emergency departments, which is typically more expensive. As a result, many states without managed care programs have found that the costs of providing Medicaid benefits have increased while the medical outcomes for the recipients remained unsatisfactory.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, in an effort to improve quality of care and lower costs, the majority of states have mandated that their Medicaid recipients enroll in managed care plans and are considering moving to a mandated managed care approach for additional populations and products. CMS estimates the total Medicaid market will grow from $700&#160;billion in 2021 to $1.1&#160;trillion by 2029. Medicaid spending is estimated to have increased by 5.7% in 2022 and is projected to increase at an average annual rate of 5.6% between 2021 and 2030. Based on these trends, we believe a significant market opportunity exists for managed care organizations (MCOs) with operations and programs focused on the distinct socio-economic, cultural, and healthcare needs of the uninsured population and the Medicaid populations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are the largest Medicaid health insurer in the country, serving 16&#160;million Medicaid recipients in 29 states as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare is the federal health insurance program for people ages 65 and over, which was expanded to cover people under 65 with certain disabilities and people with end-stage renal disease requiring dialysis or kidney transplant. Medicare consists of four parts, labeled A through D. Part A provides hospitalization benefits financed largely through Social Security taxes and requires beneficiaries to pay out-of-pocket deductibles and coinsurance. Part B provides benefits for medically necessary services and supplies including outpatient care, physician services, and home health care. Parts A and B are referred to as Original Medicare.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an alternative to Original Medicare, beneficiaries may elect to receive their Medicare benefits through Part C, also known as Medicare Advantage. Under Medicare Advantage, MCOs contract with CMS to provide services directly to Medicare beneficiaries as well as through employer and union groups. MCOs typically receive fixed monthly premium per member from CMS that varies based upon the county in which the member resides, demographic factors of the member such as age, gender, and institutionalized status, and the health status of the member. Any benefits that are not covered by Medicare may result in an additional monthly premium charged to the enrollee or through portions of payments received from CMS that may be allocated to these benefits, according to CMS regulations and guidance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS estimates the total Medicare market will grow from $865&#160;billion in 2021 to $1.5&#160;trillion by 2029. Medicare spending is estimated to have increased 7.5% in fiscal 2022 and is projected to increase at an average annual rate of 7.2% between 2021 and 2030. More than half of Medicare eligible members in 2022 were not enrolled in a Medicare Advantage product, representing a notable market opportunity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we served 1.5&#160;million Medicare Advantage members across 36 states, primarily under the brand name WellCare, with the highest concentration of lower-income, medically complex members compared to our competitors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare Prescription Drug Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare prescription drug coverage, or Medicare Part D, is a voluntary benefit for Medicare beneficiaries. The Medicare Part D prescription drug benefit is supported by risk sharing with the federal government through risk corridors designed to limit the losses and gains of the participating drug plans and by providing reinsurance for catastrophic drug costs. The government subsidy is based on the national weighted average monthly bid for this coverage, adjusted for risk factor payments. Additional subsidies are provided for dually-eligible beneficiaries and specified low-income beneficiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MCOs contract with CMS to serve as plan sponsors offering stand-alone Medicare Part D PDPs to Medicare-eligible beneficiaries. PDPs offer national in-network prescription drug coverage, including a preferred pharmacy network, subject to limitations in certain circumstances. Unless CMS is notified of non-renewal and the non-renewal is effectuated by not filing a bid on the first Monday in June, Medicare Advantage and PDP contracts with CMS are renewed for successive one-year terms each September. Should CMS decide not to renew a contract, CMS must notify MCOs on or before August 1, and the plan would be terminated effective December 31 of that year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer stand-alone PDPs in 50 states and the District of Columbia, serving 4.2&#160;million members as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA created the Health Insurance Marketplace, which is a key component of the ACA and provide an opportunity for individuals and families to obtain health insurance. States have the option of operating their own Marketplace or partnering with the federal government. States choosing neither option default to a federally-facilitated Marketplace. Access to the Marketplace is limited to U.S. citizens and legal immigrants. Insurers are required to offer a minimum level of benefits with coverage that varies based on premiums and out-of-pocket costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium subsidies, extended through 2025, are provided to individuals and families without access to other coverage and with incomes above 100% of the federal poverty level to make coverage more affordable. Consumers who qualify for subsidies may choose how much of the tax credit to apply to their premiums each month, up to the maximum amount for which they are eligible. The amount of subsidy an enrollee may receive depends on household income and the cost of the second lowest cost silver plan available to enrollees in their local area.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">W</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e also offer commercial healthcare products to individuals through large and small employer groups. We offer plans with differing benefit designs and varying levels of co-payments at different premium rates. These plans are offered generally through contracts with participating network physicians, hospitals, and other providers. Coverage typically is subject to copays and can be subject to deductibles and coinsurance. As our commercial members reach their deductibles and out-of-pocket maximums, our medical costs rise, creating seasonality in the business with a higher percentage of earnings in the first half of the year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are the largest Marketplace carrier, serving 2.1&#160;million members across 27 states as of December&#160;31, 2022, under the brand name Ambetter Health.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUR COMPETITIVE STRENGTHS</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our approach is based on the following key competitive strengths: </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expertise in Government-Sponsored Programs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more than 35 years, we have developed a specialized services expertise that has helped us establish and maintain relationships with members, providers, and our government customers. Our products are tailored to achieve savings for our government customers and are designed to enable our providers to deliver high-quality care to members. Complex populations represent a larger share of our Medicaid portfolio, more than any other payer in the country. As states increasingly look to a managed model for these populations, we believe we will be seen as a must-have partner.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Localized Approach with Centralized Support Infrastructure. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We take a localized approach to delivering healthcare. This approach enables us to facilitate member access to high-quality, culturally sensitive healthcare services. Our product designs are tailored to the unique populations in each community and address community-specific challenges through outreach, education, transportation, and other member support activities. We complement this localized approach with a centralized infrastructure. We believe this combined approach enables a culture that protects local agility and innovation while delivering scaled efficiency.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Financial Strength and Scale. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are the largest Medicaid health insurer and Marketplace carrier in the country and our growing Medicare product has the highest concentration of lower-income, medically complex members. In 2022, we had $144.5 billion in revenue and $6.3 billion in operating cash flow. Our strong operating performance, size, and scale allow us to continue to invest in our businesses through technology, strategic acquisitions, and key resources that support our business and enable us to navigate the changing healthcare landscape.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Data-Driven Innovation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our rich, local data amassed over decades allows us to curate networks of community partners and community resources, identify low-cost, sustainable interventions tailored to our unique populations, and guide high-impact investments into the community. We are investing in scalable innovation and transformation to harness our data. In this way, our data will enable us to transform the health of our communities long-term and deliver value to both members and shareholders. </span></div><div style="padding-left:2.25pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGED CARE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Benefits to Customers</span></div><div style="padding-left:2.25pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We feel that our ability to establish and maintain a leadership position in the markets we serve results primarily from our demonstrated success in providing quality care while reducing and managing costs, and from our specialized programs with state governments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are among the benefits we provide to our government partners, providers, and members:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Accurate and timely claims payments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to ensuring that our information systems and claims payment systems meet or exceed state requirements. We continuously improve our claims processing strategies, expertise, configuration, and tools to achieve operational excellence, including timely payments to our providers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Care management for complex populations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our experience with Medicaid populations and long-time presence in states with experience in long-term care for children and adolescents in the foster care system, we have developed care management, service coordination, and crisis prevention/response programs that improve healthcare outcomes through decreasing preventable emergency department utilization and improving access to primary care and behavioral health intervention. This experience has led to sole source and specialized contracts in Florida, Illinois, Missouri, Texas, and Washington.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Commitment to quality and improved health outcomes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented programs to encourage effective and transparent collaboration between the member and their provider. We demonstrate this through obtaining health plan accreditations, such as National Committee for Quality Assurance (NCQA), which is a critical step in demonstrating the effectiveness of our structure and processes, clinical quality, and member satisfaction. Additionally, we have launched a multi-year plan to build and improve quality across the enterprise with a strong focus on enhanced patient experience and access to care, which lays the foundation for strong Medicare Star ratings in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Community-specific healthcare programs and a focus on addressing health equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our expertise in government-sponsored programs has helped us establish and maintain strong relationships with our constituent communities of members, providers, and federal and state governments. We provide access to services through local providers and staff that focus on the cultural norms of their individual communities. To that end, systems and procedures have been designed to address community-specific challenges, including but not limited to, food insecurity, housing instability, employment, and access to transportation, which contribute to health disparities among underserved and vulnerable populations. We remain focused on identifying and removing social barriers to health in the communities we serve.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Data-driven approach to improve health outcomes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have employed an investment strategy designed to increase our capability to collect and analyze data and insights. We gather data from multiple sources including medical, vision, and behavioral health claims and encounter data, pharmacy data, dental vendor claims, and authorization data. We use this data to track utilization trends, identify health disparities, monitor quality of care, and evaluate the effectiveness of our programs. Through these analyses, we identify and implement interventions that improve health outcomes, advance health equity and population health, and ensure members receive timely and appropriate services. The value and accuracy in the data we collect is important in demonstrating an auditable program for federal and state agencies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Member programs and services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our comprehensive set of programs and services help members achieve whole-person health while supporting the overall goals of the government program. Covered healthcare benefits vary from customer to customer but cover a wide range of services, including transportation assistance, provision of durable medical equipment, behavioral health and substance use disorder services, 24-hour nurse advice line, social work services, and telehealth services.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Value-based arrangements. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our health plans offer a combination of value-based contracting models, including quality incentives and risk arrangements, that address the continuum of whole-person care. We believe value-based collaboration with providers leads to improved health outcomes, reduced costs, and better member and provider experiences.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Providers</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each of our service areas, we establish a provider network consisting of primary and specialty care physicians, hospitals, and ancillary providers. Our network of primary care physicians is a critical component of care delivery, cost optimization, and the attraction and retention of new members. Primary care physicians include family and general practitioners, pediatricians, internal medicine physicians, obstetricians, and gynecologists. Specialty care physicians provide medical care to members generally upon referral by primary care physicians. Specialty care physicians include a wide array of provider types including, but not limited to, orthopedic surgeons, cardiologists, and otolaryngologists. When necessary, we also contract with third-party providers on a negotiated fee arrangement for physical therapy, home healthcare, diagnostic laboratory tests, x-ray examinations, transportation, ambulance services, and durable medical equipment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our health plans facilitate access to healthcare services for our members primarily through contracts with our providers. Our contracts with primary and specialty care physicians and hospitals are usually for a term of one to three years and renew automatically for successive one-year terms, but generally are subject to termination by either party upon prior written notice. In the absence of a contract, we typically pay providers at applicable state or federal reimbursement levels, depending on the product (e.g., Medicaid or Medicare). We pay providers under a variety of methods, including fee-for-service, capitation arrangements, and value-based arrangements. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Under our fee-for-service contracts with providers, we pay a negotiated fee for covered services. This model is characterized as having no financial risk for the provider. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Under our capitated contracts, providers can be paid a set amount for their services as outlined in their respective provider agreements. A provider group's financial instability or failure to pay secondary providers for services rendered could lead secondary providers to demand payment from us, even though we have made our regular capitated payments to the provider group. Depending on state law and the regulatory environment, it may be necessary for us to pay such claims.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Under value-based arrangements, providers can be paid under either a capitated or fee-for-service model. The arrangement, however, contains provisions for additional payments to the providers or reimbursement from the providers based on their performance in cost and quality measures. We are committed to value-based contracting, up and downside risk, assigning members to the highest quality providers and capitation. This is done in complete partnership with our providers to increase quality outcomes and overall member satisfaction. We anticipate our membership in up and downside risk arrangements will continue to grow.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The continuum of value-based contracting includes the following models: pay-for-performance, shared savings, shared risk, and full risk. We often start our provider relationships in a pay-for-performance model, in which providers are reimbursed for the fair market value of services provided. Providers benefit from this model as it gives complete transparency and clarity on actions that earn incentives. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We then transition to a risk-sharing model, in which providers are reimbursed based on the total cost of care. As we advance along this continuum, it strengthens our partnerships with our providers, enabling the delivery of high-quality care. We believe having the strongest provider partners who know how to operate well in a value-based model and who can help us drive positive outcomes for our members and good member experience is more important than owning providers, which occurs on an exception basis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We work with physicians to help them operate efficiently by providing actionable financial and utilization information, physician and patient educational programs, and disease and population health management programs. Our programs are also designed to help physicians coordinate care rendered by other providers.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our local and collaborative approach with physicians and other providers gives us a competitive advantage in entering new markets. Our physicians serve on local committees that assist us in implementing preventive care programs, optimizing costs, and improving the overall quality of care delivered to our members, while also simplifying the administrative burdens on our providers. This approach has enabled us to strengthen our provider networks through improved physician recruitment and retention which, in turn, has helped to increase our membership base. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are among the services we provide to support physicians:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Provider Engagement Performance Tools and Processes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lead to measurable improvements in quality and health outcomes, healthcare costs, and member satisfaction. High-quality provider support and service levels are important as our key customers are increasingly using performance-based measures to select and pay health plans. We have a suite of network performance tools for use by physicians and other providers which monitor the outcomes and care gaps of their individual patient panels. We meet with the providers to review their performance issues and recommend strategies for improvements in their patient panel outcomes. Our tools also allow the physician and others to see where they stand within their value-based contract.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Our Integrated Care Model </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is member-centric and managed by one care manager assigned to a member who looks at the care for the member in a holistic manner. This single care manager will coordinate all care for that member including behavioral health, medical health, and home-based primary care in accordance with an individualized, integrated care plan. This care manager also coordinates meetings with the member's integrated care team to assess and alter the care plan as needed. This results in better clinical outcomes and improved member satisfaction.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">The Provider Portal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> delivers claims and eligibility research, prior authorizations, member panels, care gaps, patient analytics, and provider analytics to contracted providers to drive provider engagement and improve patient outcomes. Data and reporting are delivered via a secure, user-friendly web-based provider portal. This is provided through our suite of technology platforms.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracted physicians also benefit from several of the services offered to our members and population health management programs, which assist physicians in managing their patients with chronic diseases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quality Management</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quality management represents an integral part of our organization's foundation. Ensuring we continue advancing our mission of achieving better health outcomes for our members has led to recent investments in key initiatives involving people, processes, technology, and partner management.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through these initiatives, we have:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">brought in key talent to the Company with a focus on individuals who have been successful in driving improvement in other organizations and increased staffing in critical customer-facing areas;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">centralized the oversight of quality programs, including the implementation of real-time operational dashboards, tracking numerous quality key performance metrics;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">invested in new technology to enhance our access to clinical data around gaps in care, committed to integrating our numerous quality platforms into a single unified workflow, and developed advanced analytics to orchestrate pivotal member engagement and increase positive clinical outcomes and satisfaction in the care being delivered to our members; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">taken steps to strengthen relationships with providers to improve the quality of care for our members; specifically, we are increasing our value-based provider engagements as those enhanced partnerships have proven to drive higher quality care and continue to promote local physician participation in quality improvement through physician committees chaired by local physician leaders, which ensures clinical oversight and is critical to the success of clinical quality improvement programs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe these initiatives will improve the member's overall health and healthcare experience and help us achieve strong Medicare Star ratings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS developed the Medicare Advantage Five-Star Quality Rating System to help consumers choose among competing plans, awarding between 1.0 and 5.0 stars to Medicare Advantage plans based on performance in certain measures of quality. The parent organization Star rating is used for new Medicare Advantage contracts while existing contracts follow their individual Star ratings to determine bonus payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plans receive additional Medicare revenue related to the achievement of higher Star ratings that can be used to offer more attractive benefit packages to members and/or achieve higher profit margins. In addition, plans with Star ratings of 5.0 are eligible for year-round open enrollment, whereas plans with lower Star ratings have more restrictions on enrollment criteria and timing. Part C or Part D Medicare plans with Star ratings of less than three stars for three consecutive years are denoted as "low performing" plans on the CMS website and in the CMS "Medicare and You" handbook. In addition, CMS could exercise its authority to terminate the Medicare Advantage and PDP contracts for plans rated below three stars for three consecutive years. As a result, plans that achieve higher Star ratings may have a competitive advantage over plans with lower Star ratings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further validation of our quality objectives, we pursue accreditation by independent organizations that have been established to promote healthcare quality. NCQA Health Plan Accreditation programs provide unbiased, third-party reviews to verify and publicly report results on specific quality care metrics. We pursue and achieve accreditation in the majority of states where we currently have health plan operations. We also verify the credentials and backgrounds of our partner providers using standards supported by NCQA to ensure the quality of our networks.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accreditation is only one measure of our ability to provide access to quality care for our members. State and market Healthcare Effectiveness Data and Information Set reporting constitutes the core of the information base that drives our clinical quality performance efforts. This reporting is monitored by health plan quality improvement committees and our corporate population health management and quality improvement teams.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remain committed to our quality initiatives and continue to focus on investments that we expect to translate into value over the next few years.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIALTY SERVICES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our specialty companies provide a variety of products and services to deliver integrated healthcare to our members and other organizations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Behavioral Health. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Magellan Health Inc. (Magellan) provides carve-out management services for behavioral health and employee assistance plans. These services are provided through Magellan's comprehensive network of medical and behavioral health professionals, clinics, hospitals, skilled nursing facilities, home care agencies, and ancillary service providers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Clinical Healthcare. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Community Medical Group (CMG) provides clinical healthcare, encompassing primary care, access to certain specialty services, and a suite of social and other support services. CMG operates in Florida through an at-risk primary care provider model, focusing on clinical and social care for at-risk beneficiaries. Additionally, Bayless Integrated Healthcare provides outpatient primary care and behavioral healthcare services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Data Analytics. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Apixio offers, among other solutions, artificial intelligence technology that performs retrospective chart reviews for more accurate risk score submission to CMS. Apixio provides services to third-party customers as well as our health plans. Interpreta uses its analytics engine to provide real-time insights to providers, care managers, and payers in the areas of member prioritization, quality management, and risk adjustment. These businesses continue to digitize the administration of healthcare and accelerate innovation and modernization across the enterprise.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Federal Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Health Net Federal Services has a Managed Support Contract in the West Region for the Department of Defense (DoD) TRICARE program. We provide administrative services to Military Health System eligible beneficiaries, which includes eligible active duty service members and their families, retired service members and their families, survivors of retired service members, and qualified former spouses. Our current contract for health care delivery services is in place through early 2024. In December 2022, the DoD announced that the TRICARE Managed Care Support Contracts commencing in 2024 were not awarded to Health Net Federal Services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy Solutions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Utilizing innovative, flexible solutions and customized care management, we offer traditional pharmacy clinical and administrative services as well as comprehensive specialized pharmacy benefit services through our specialty pharmacy business, AcariaHealth. Our programs offer progressive services&#160;that are specifically designed to improve quality of care&#160;while containing costs. Services that we provide include drug utilization review, formulary and rebate management, patient and physician interventions, and prior authorization services and analytics. AcariaHealth offers specialized care management services for complex diseases and enhances the patient care offering through collaboration with providers and the capture of relevant data to measure patient outcomes. We have historically provided comprehensive PBM services, however, we have transitioned substantially all of our PBM business to a third party as of January 1, 2023. We continue to provide pharmacy benefit administration for state Medicaid and other government-sponsored programs through Centene Pharmacy Services.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Vision and Dental Services. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Envolve Benefit Options coordinates benefits beyond traditional medical benefits to offer fully integrated vision and dental health services. Our vision benefit program administers routine and medical surgical eye care benefits through a contracted national network of eye care providers. Through the dental benefit, we are dedicated to improving oral health through a contracted network of dental healthcare providers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have NCQA accreditation and/or URAC accreditation for several of our specialty services companies.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CORPORATE COMPLIANCE</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Ethics and Compliance program assists the organization in developing effective internal controls that promote the prevention and detection of fraud, waste and abuse and the resolution of instances of conduct that do not conform to federal and state law, private payor healthcare program requirements, or our ethics and business policies. Responsibilities also include the ongoing maintenance of our privacy program and oversight of the Health Insurance Portability and Accountability Act (HIPAA) as they pertain to us and our business units from a compliance, business, and technical perspective.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three standards by which corporate compliance programs in the healthcare industry are measured are the Federal Organizational Sentencing Guidelines, the CMS Chapter Guidance, and the Compliance Program Guidance series issued by the Department of Health and Human Services' Office of the Inspector General. Our program contains each of the seven elements suggested by these authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These key components are:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">written standards of conduct; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">designation of compliance officers and compliance committees;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effective training and education;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effective lines for reporting and communication;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enforcement of standards through well-publicized disciplinary guidelines and actions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">internal monitoring and auditing; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prompt response to detected offenses and development of corrective action plans. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goal of our program is to build a culture of integrity, ethics, and compliance, which is assessed periodically to measure engagement and effectiveness. Our Corporate Compliance intranet site, accessible to all employees, contains our Compliance Program description, our Business Ethics and Code of Conduct Policy, and resources for employees to report concerns or ask questions. If needed, employees have access to the contact information for our Board of Directors' Audit and Compliance Committee Chairman to report concerns. Our Ethics and Compliance Helpline is a toll-free number and web-based reporting tool operated by a third-party independent of the Company and allows employees or other persons to anonymously report suspected incidents of misconduct, fraud, waste, abuse, or other compliance violations, concerns, or questions. Furthermore, our Board of Directors' Audit and Compliance Committee reviews ethics and compliance reports quarterly.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ENVIRONMENTAL, SOCIAL, HEALTH, GOVERNANCE AND CORPORATE RESPONSIBILITY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our steadfast commitment to the environment, the health and social well-being of our communities, and our culture of sound and ethical corporate governance extends far beyond individual programs or initiatives. Through the delivery of high-quality healthcare to at-risk populations, our responsibilities to members, stakeholders, and our planet serve as a living expression of our purpose &#8211; transforming the health of communities, one person at a time. Continued focus on environmental, social, and governance (ESG) matters remains foundational to supporting our strategy and long-term value creation. The services and value we provide to improve the lives of our members are essential to our business model. Our focus on the whole health of our members by delivering a full spectrum of care, including continually enhanced social determinants of health services, has allowed us to become a national leader in healthcare. These themes are core to our Environmental, Social, Health, and Governance (ESHG) Strategic Framework (the Framework), which highlights our commitment to healthy individuals and healthy communities and builds upon our long history of identifying and removing barriers to health. Implementation of the Framework is overseen by the Board of Directors Governance Committee and ESHG initiatives throughout the organization are driven by a cross-functional network comprised of executive representatives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annually, we issue an ESHG Report to the Community to communicate the value of our ESHG efforts, a Task Force on Climate-related Financial Disclosures (TCFD) Index report outlining our governance structure, strategy, risks, opportunities, and metrics and target-setting related to managing climate change, and a Sustainability Accounting Standards Board (SASB) index report aligned with the SASB Managed Care standard, providing sustainability disclosures to our stakeholders. The Framework enables us to align our business strategy and long-term planning with our initiatives and commitments to protect our planet, serve our communities, cultivate healthier lives, and live our values. Interested parties can find our ESG / ESHG-related reports within the Investors section of our website, the URL of which is https://investors.centene.com/esg. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Please note: Nothing on our website, including our ESG / ESHG reports or sections thereof, shall be deemed incorporated by reference into this Annual Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPETITION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a highly competitive environment in an industry subject to ongoing significant changes, including business consolidations, new strategic alliances, market pressures, and regulatory and legislative reform both at the federal and state level. This includes, but is not limited to, the federal and state healthcare reform legislation described under the heading "Regulation." In addition, changes to the political environment may drive additional changes to the competitive landscape. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with other MCOs and specialty companies to acquire and retain state, county, federal, and commercial contracts. In addition, competitors could include technology companies, new joint ventures, financial services firms, consulting firms, and other non-traditional competitors. Before granting a contract, state and federal government agencies consider many competitive factors. These factors include quality of care, financial condition, stability and resources, and established or scalable infrastructure with a demonstrated ability to deliver services and establish comprehensive provider networks.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also compete to enroll new members and retain existing members. People who wish to enroll in a managed healthcare plan or to change healthcare plans typically choose a plan based on the quality of care and services offered, ease of access to services, a specific provider being part of the network, and the availability of supplemental benefits. We believe that the principal competitive features affecting our ability to retain and increase membership include the range and prices of benefit plans offered, size and quality of provider network, quality of service, responsiveness to customer demands, financial stability, comprehensiveness of coverage, diversity of product offerings, market presence, and reputation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also compete with other MCOs in establishing provider networks. When contracting with various health plans, we believe that providers consider existing and potential member volume, reimbursement rates, population health management programs, speed of reimbursement, and administrative service capabilities. See "Risk Factors - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Competition may limit our ability to increase penetration of the markets that we serve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The relative importance of each of the aforementioned competitive factors and the identity of our key competitors varies by market, including by geography and by product. We believe that we compete effectively against other healthcare industry participants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REGULATION</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are comprehensively regulated at the local, state, and federal levels. Government regulation of the provision of healthcare products and services is a changing area of law that varies from jurisdiction to jurisdiction. States have implemented National Association of Insurance Commissioners (NAIC) model regulations, requiring governance practices and risk and solvency assessment reporting. States have adopted these or similar measures to enhance regulations relating to corporate governance and internal controls of health maintenance organizations (HMOs) and insurance companies. We are required to maintain a risk management framework and file reports with state insurance regulators.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory agencies have substantial discretion to issue regulations and interpret and enforce laws and rules. Changes in the regulatory environment and applicable laws and rules also may occur periodically, including in connection with changes in political party or administration at the state and federal levels. The ultimate content, timing, or effect of any potential future legislation enacted under the new administration remains uncertain.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our regulated subsidiaries are licensed to operate as HMOs, preferred provider organizations (PPOs), third party administrators, utilization review organizations, pharmacies, direct care providers, and/or insurance companies in their respective states. In each of the jurisdictions in which we operate, we are regulated by the relevant health and/or human services departments, departments of insurance, boards of pharmacy and other healthcare providers, and departments of health that oversee the activities of MCOs and health plans providing or arranging to provide services to enrollees.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process for obtaining authorization to operate as a MCO, health insurance plan, prescription drug plan, pharmacy, or provider organization is complex and requires us to demonstrate to the regulators the adequacy of the health plan's organizational structure, financial resources, utilization review, quality assurance programs, proper billing, complaint procedures, and an adequate provider network and procedures for covering emergency medical conditions. For example, under both state MCO statutes and insurance laws, our health plan subsidiaries, as well as our applicable specialty companies, must comply with minimum statutory capital and other financial solvency requirements, such as deposit and surplus requirements. Insurance regulations may also require prior state approval of acquisitions of other MCO businesses and the payment of dividends, as well as notice for loans or the transfer of funds. Our subsidiaries are also subject to periodic state and federal reporting requirements. In addition, each health plan and individual healthcare provider must meet criteria to secure the approval of state regulatory authorities before implementing certain operational changes, including, without limitation, changes to existing offerings, the development of new product offerings, certain organizational restructurings, and, in some states, the expansion of service areas.&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States have adopted a number of regulations that may affect our business and results of operations. These regulations in certain states include:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">premium taxes or similar assessments imposed on us;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">stringent prompt payment laws requiring us to pay claims within a specified period of time;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disclosure requirements regarding provider fee schedules and coding procedures; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">programs to monitor and supervise the activities and financial solvency of provider groups.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are regulated as an insurance holding company and are subject to the insurance holding company acts of the states in which our insurance company and HMO subsidiaries are domiciled. These acts contain certain reporting requirements as well as restrictions on transactions between an insurer or HMO and its affiliates. These holding company laws and regulations generally require insurance companies and HMOs within an insurance holding company system to register with the insurance department of each state where they are domiciled and to file with those states' insurance departments reports describing the capital structure, ownership, financial condition, intercompany transactions, and general business operations. In addition, depending on the size and nature of the transaction, various notice and reporting requirements generally apply to transactions between insurance companies and HMOs and their affiliates within an insurance holding company structure. Some insurance holding company laws and regulations require prior regulatory approval or, in certain circumstances, prior notice of certain material intercompany transfers of assets as well as certain transactions between insurance companies, HMOs, their parent holding companies, and affiliates. Among other provisions, state insurance and HMO laws may restrict the ability of our regulated subsidiaries to pay dividends.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the holding company regulations of the states in which our subsidiaries are domiciled restrict the ability of any person to obtain control of an insurance company or HMO without prior regulatory approval. Under those statutes, without such approval or an exemption, no person may acquire any voting security of an insurance holding company that controls an insurance company or HMO, or merge with such a holding company, if as a result of such transaction such person would "control" the insurance holding company. "Control" is generally defined as the direct or indirect power to direct or cause the direction of the management and policies of a company and is presumed to exist if a person directly or indirectly owns or controls 10% or more of the voting securities of a company. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PPO regulation also varies by state and covers all or most of the subject areas referred to above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pharmacies must be licensed to do business as pharmacies in the states in which they are located. Our pharmacies must also register with the U.S. Drug Enforcement Administration and individual state controlled substance authorities to dispense controlled substances. In many of the states where our pharmacies deliver pharmaceuticals, there are laws and regulations that require out-of-state mail order pharmacies to register with that state's board of pharmacy or similar regulatory body. These states generally permit the pharmacy to follow the laws of the state in which the mail order pharmacy is located, although some states require that we also comply with certain laws in that state.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our healthcare providers must be licensed to practice medicine and do business as care providers in the state in which they are located. In addition, they must be in good standing with the applicable medical board, board of nursing, or other applicable entity. Furthermore, they must not be excluded from participation at either the state or federal levels. Our facilities are periodically reviewed by state departments of health and other regulatory agencies to ensure the environment is safe to provide care.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal law has also implemented other health programs that are partially funded by the federal government, such as Medicaid and Medicare programs. Our Medicaid programs are regulated and administered by various state regulatory bodies. Federal funding remains critical to the viability of these programs. Federal law permits the federal government to oversee and, in some cases, to enact, regulations and other requirements that must be followed by states with respect to these programs. Medicaid is administered at the federal level by CMS. Comprehensive legislation, specifically Title XVIII of the Social Security Act, governs our Medicare program. In addition, our Medicare contracts are subject to regulation by CMS. CMS has the right to audit Medicare contractors and the healthcare providers and administrative contractors who provide certain services on their behalf to determine the quality of care being rendered and the degree of compliance with CMS contracts and regulations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA transformed the U.S. healthcare system through a series of complex initiatives. Some of the ACA's most significant provisions include the imposition of significant fees, assessments, and taxes, the establishment of federally-facilitated and state-based Health Insurance Marketplaces where individuals and small groups may purchase health coverage; the implementation of certain premium stabilization programs designed to apportion risk amongst insurers; and optional Medicaid Expansion. State and federal regulators have continued to provide additional guidance and specificity to the ACA, and we continue to monitor this new information and evaluate its potential impact on our business. For a further discussion of the ACA, see "Risk Factors - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant changes or judicial challenges to the ACA could materially and adversely affect our results of operations, financial condition, and cash flows.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must also comply with laws and regulations related to the award, administration, and performance of U.S. Government contracts. Government contract laws and regulations affect how we do business with our customers and, in some instances, impose added costs on our business. For example, money laundering is a method of attempting to conceal the origins of money gained through illegal activity and is itself a crime that can result in substantial criminal and civil sanctions including fines and imprisonment. To ensure compliance with anti-money laundering laws and regulations, it is our policy to conduct business only with legitimate customers and counterparties whose funds are derived from legitimate commercial activity. In addition, as a result of our international operations, we are subject to the U.S. Foreign Corrupt Practices Act (FCPA) and similar worldwide anti-corruption laws, including the U.K. Bribery Act of 2010, which generally prohibit companies and their intermediaries from making improper payments to non-U.S. officials for the purpose of obtaining or retaining business. A violation of specific laws and regulations by us and/or our agents could result in, among other things, the imposition of fines and penalties on us, changes to our business practices, the termination of our contracts, or debarment from bidding on contracts. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">State and Federal Businesses; Contracts</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to being a licensed insurance company or HMO, in order to be a Medicaid MCO in each of the states in which we operate, we generally must operate under a contract with the state's Medicaid agency. States generally either use a formal proposal process, reviewing a number of bidders, or award individual contracts to qualified applicants that apply for entry to the program. Under these state Medicaid program contracts, we receive monthly payments based on specified capitation rates determined on an actuarial basis. These rates differ by membership category and by state depending on the specific benefits and policies adopted by each state. In addition, several of our Medicaid contracts require us to maintain Medicare Advantage special needs plans, which are regulated by CMS, for dual-eligible individuals within the state.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide Medicare Advantage, PDPs, DSNPs, and MMPs which are provided under contracts with CMS and subject to federal regulation regarding the award, administration, and performance of such contracts.&#160;CMS also has the right to audit our performance to determine our compliance with these contracts, as well as other CMS regulations and the quality of care we provide to Medicare beneficiaries under these contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we operated in 27 states under federally-facilitated Marketplace contracts with CMS and state-based exchanges. We operate under a contract with the Arkansas Department of Human Services Division of Medical Services and the Arkansas Insurance Department to participate in the Medicaid expansion model that Arkansas has adopted (referred to as Arkansas Works).</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our government contracts include government-sponsored managed care and administrative services contracts through the TRICARE program and certain other healthcare-related government contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our state and federal contracts and the regulatory provisions applicable to us generally set forth requirements for operating, including provisions relating to:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">eligibility, enrollment, and dis-enrollment processes;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">covered services;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">eligible providers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">subcontractors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">record-keeping and record retention;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">periodic financial and informational reporting;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">quality assurance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accreditation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">health education and wellness and prevention programs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">timeliness of claims payment;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">financial standards;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">safeguarding of member information;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fraud, waste and abuse detection and reporting;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">grievance procedures; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">organization and administrative systems.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A health plan or individual health insurance provider's compliance with these requirements is subject to monitoring by state regulators and by CMS. A health plan is also subject to periodic comprehensive quality assurance evaluations by a third-party reviewing organization and generally by the insurance department of the jurisdiction that licenses the health plan. A health plan or individual health insurance provider must also submit reports to various regulatory agencies, including quarterly and annual statutory financial statements and utilization reports.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our health plans operate through individual state contracts, generally with an initial term of one to five years. The contracts often have renewal or extension terms or are renewable through the state's reprocurement process. The contracts generally are subject to termination for cause, an event of default, or lack of funding, among other things.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our federally-facilitated Marketplace contracts and state-based exchanges are renewable on an annual basis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Privacy Regulations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various international, federal, state, and local laws and rules regarding the use, security, and disclosure of protected health information, personal information, and other categories of confidential or legally protected data that our businesses handle. Such laws and rules include, without limitation, HIPAA, the Federal Trade Commission Act, the Gramm-Leach-Bliley Financial Modernization Act of 1999 (Gramm-Leach-Bliley Act), the General Data Protection Regulation, and state privacy and security laws such as the California Confidentiality of Medical Information Act and the California Online Privacy Protection Act. Privacy and security laws and regulations often change due to new or amended legislation, regulations, or administrative interpretation. A variety of state and federal regulators enforce these laws, including but not limited to the U.S. Department of Health and Human Services (HHS), the Federal Trade Commission, state attorneys general, and other state regulators.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA is designed to improve the portability and continuity of health insurance coverage, simplify the administration of health insurance through standard transactions and ensure the privacy and security of individual health information. Among the requirements of HIPAA are the Administrative Simplification provisions which include: standards for processing health insurance claims and related transactions (Transactions Standards); requirements for protecting the privacy and limiting the use and disclosure of medical records and other personal health information (Privacy Rule); and standards and specifications for safeguarding personal health information which is maintained, stored or transmitted in electronic format (Security Rule). The Health Information Technology for Economic and Clinical Health (HITECH) Act amended certain provisions of HIPAA and enhanced data security obligations for covered entities and their business associates. HITECH also mandated individual notifications in instances of a data breach, provided enhanced penalties for HIPAA violations, and granted enforcement authority to states' Attorneys General in addition to the HHS Office for Civil Rights. The HIPAA Omnibus Rule further enhanced the changes under the HITECH Acts and the Genetic Information Nondiscrimination Act of 2008 which clarified that genetic information is protected under HIPAA and prohibits most health plans from using or disclosing genetic information for underwriting purposes. These regulations also establish significant criminal penalties and civil sanctions for non-compliance. The preemption provisions of HIPAA provide that the federal standards will not preempt state laws that are more stringent than the related federal requirements. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Privacy and Security Rules and HITECH/Omnibus enhancements established requirements to protect the privacy of medical records and safeguard personal health information maintained and used by healthcare providers, health plans, healthcare clearinghouses, and their business associates. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Security Rule requires healthcare providers, health plans, healthcare clearinghouses, and their business associates to implement administrative, physical, and technical safeguards to ensure the privacy and confidentiality of health information electronically stored, maintained, or transmitted. The HITECH Act and Omnibus Rule enhanced a federal requirement for notification when the security of protected health information is breached. In addition, there are state laws that have been adopted to provide for, among other things, private rights of action for breaches of data security and mandatory notification to persons whose identifiable information is obtained without authorization.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The requirements of the Transactions Standards apply to certain healthcare related transactions conducted using "electronic media." Since "electronic media" is defined broadly to include "transmissions that are physically moved from one location to another using portable data, magnetic tape, disk or compact disk media," many communications are considered to be electronically transmitted. Under HIPAA, health plans and providers are required to have the capacity to accept and send all covered transactions in a standardized electronic format. Penalties can be imposed for failure to comply with these requirements. The transaction standards were modified in October 2015 with the implementation of the ICD-10 coding system.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we process and maintain personal card data, particularly in connection with our Marketplace business. As a result, we must maintain compliance with the Payment Card Industry Data Security Standard, which is a multifaceted security standard intended to optimize the&#160;security of credit, debit, and cash card transactions and protect cardholders against misuse of their personal information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Fraud, Waste and Abuse Laws</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investigating and prosecuting healthcare fraud, waste and abuse continues to be a top priority for state and federal law enforcement entities. The focus of these efforts has been directed at Medicare, Medicaid, Health Insurance Marketplace, and commercial products. The fraud, waste and abuse laws include the federal False Claims Act, which prohibits the known filing of a false claim or the known use of false statements to obtain payment from the federal government. Many states have false claim act statutes that closely resemble the federal False Claims Act. Additional fraud, waste and abuse prohibitions include a wide range of operating activities, such as kickbacks or other inducements for the referral of members or coverage of products (such as prescription drugs) by a plan, billing for unnecessary medical services by a provider, improper marketing and violation of patient privacy rights. The laws and regulations relating to fraud, waste and abuse and the requirements applicable to health plans, PDPs, and providers participating in these programs are complex and change regularly. Compliance with these laws may require substantial resources. We are constantly looking for ways to improve our fraud, waste and abuse detection methods. While we have both prospective and retrospective processes to identify abusive patterns and fraudulent billing, we continue to increase our capabilities to proactively detect inappropriate billing prior to payment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HUMAN CAPITAL RESOURCES</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the pace of change, complexity, and uncertainty in the broader environment accelerates, we continue our strong investment in creating a purpose-driven culture. We intentionally attract, develop, and retain top talent who have diverse voices and experiences, passion, and vision well-positioned to help us transform the health of communities for those we serve. Our entrepreneurial and mission-driven workforce is anchored by a steadfast commitment to a diverse, equitable, inclusive, and safe workplace. Our employees are further enabled through robust talent development programs and supported by competitive compensation, benefits, and health and well-being programs. Finally, our workforce is emboldened by their alignment with our purpose, values, and strategy through meaningful connections between our employees and their communities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had approximately 74,300 full-time equivalent (FTE) employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our most recent Shaping Centene Employee Engagement pulse survey, 88% of employees reported strong engagement. Based on their responses, we surpassed the 75th percentile of Fortune 100 benchmark companies (benchmark data from 2019-2021) in a number of areas, including but not limited to the Company's commitment to and people leaders' support of diversity, equity and inclusion in the workplace, and having a clear understanding of our mission and values, as measured in our annual DEI Index, People Leader Effectiveness, Culture, and Employee Engagement surveys.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Workforce Culture and Compensation and Benefits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain the health and well-being of our employees as one of the main driving factors of business decisions. We offer benefits to our employees to help them achieve optimum work-life balance and meet their needs and the needs of their families. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on feedback from our employees, we have adopted a modern work environment, including remote and hybrid work arrangements utilized by the majority of our employees. We believe that work flexibility empowers our employees to do their best work in the way they work best. With a largely remote workforce, we are intentional in our efforts to foster a collaborative, inclusive, and engaging work environment. We create meaningful "moments that matter," including monthly forums for people leaders, weekly communications for all employees, virtual all-employee meetings, and employee programming to help amplify multiple perspectives and lived experiences.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compensation and benefits programs are market competitive and designed to attract and retain talent. Our overall compensation philosophy is to pay for performance by linking the achievement of both Company and individual goals to total compensation. In addition to base pay, these programs may include annual bonuses, stock awards, an employee stock purchase plan, and a 401(k) plan. Our benefits cover various aspects of an employee's life, including medical, dental, and vision insurance, short- and long-term disability, supplemental accidental death and dismemberment and life insurance, wellness programs, flexible spending accounts, parental leave, and caregiver leave. We recently updated our parental leave to six weeks of fully compensated time for caregivers with an additional eight weeks for mothers, providing up to 14 weeks of fully compensated maternity leave. We also offer vacation, paid personal and sick time, paid company holidays, an employee assistance program, tuition reimbursement/educational assistance, and adoption reimbursement. In addition, we offer paid community volunteer time to encourage our employees to participate in individual and work-related volunteer programs and support the communities in which we serve.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diversity, Equity and Inclusion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that a diverse workforce and an equitable, inclusive environment enable competitive advantage and fuel improved service, innovation, and performance with all stakeholders. Our talent advisors, in partnership with hiring leaders, work to nurture a pipeline that connects us to a diverse workforce. Each of our talent advisors receives training to become Certified Diversity Recruiters and participate in the Association of Talent Acquisition Professionals Diversity, Equity and Inclusion (DEI) Excellence Program.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a wide range of programs focused on early identification and accelerated development of diverse talent, including our Employee Inclusion Groups (EIGs), which are key drivers of our culture. These voluntary, employee-led groups provide professional and leadership opportunities for women, military veterans and their families, individuals with disabilities and caregivers of individuals with disabilities, LGBTQIA+, and multicultural employees. EIGs support the attraction, development, and retention of talent at all levels, contribute to community engagement initiatives, and support business innovation and corporate best practices. Today, there are over 15,000 employees participating in our EIGs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our DEI strategy extends beyond the workforce and emphasizes supplier diversity, community engagement, and stakeholder collaboration. As a company committed to advancing whole health in communities, we recognize that economic inclusion is vital to positive health outcomes. Accordingly, we invest and partner with organizations that share our mission and values, with a focus on small businesses that provide employment opportunities to our member population.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Diversity, Equity &amp; Inclusion Annual Report, which includes detailed information regarding our Human Capital programs and initiatives, can be found within the Investors section of our website at https://www.centene.com/who-we-are/corporate-facts-reports.html. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Please note: Nothing on our website, including our Diversity, Equity and Inclusion Report or sections thereof, shall be deemed incorporated by reference into this Annual Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Talent Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our robust talent infrastructure, we continue working to deepen and prepare our diverse talent bench and workforce, which is instrumental to our Value Creation Plan and business strategy. We are committed to developing a workforce who can thrive in the evolving world of work, enabling our organization to further accelerate growth, inclusivity, and innovation. Through Centene University, we have designed learning and development at scale, using new digital tools, real-time virtual learnings, and customized leadership development programs, accessible to all employees, in a modern learning environment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, a refreshed new leader development program, LEAD, was launched in 2022, to support newly promoted or hired people leaders. This 10-week program helps accelerate culture immersion and upskill leaders to lead in a modern era of hybrid work and continuous change. We also strategically identify talent to participate in leading external professional development programs designed for women and people of color.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to building new workforce skills, we utilize our ongoing enterprise talent reviews, succession planning, career development planning, and comprehensive workforce analytics to provide insights to senior leaders to inform actions and drive intentional talent results through our People Plans, the integrated human capital component of our annual operating plans.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION ABOUT OUR EXECUTIVE OFFICERS</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding our executive officers, including their ages, at February&#160;17, 2023:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:69.078%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sarah M. London</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew L. Asher</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Katie N. Casso</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Corporate Controller and Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kenneth J. Fasola</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher A. Koster</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Secretary and General Counsel</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James E. Murray</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Operating Officer</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Sarah M. London</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ms. London has served as our Chief Executive Officer since March 2022. From September 2021 to March 2022, she served as Vice Chairman. She served as President, Centene Health Care Enterprises and Executive Vice President, Advanced Technology from March 2021 to September 2021. From September 2020 to February 2021, she served as Senior Vice President, Technology Innovation and Modernization. Prior to joining Centene, she served as both Senior Principal and Partner for Optum Ventures from May 2018 to March 2020 and Chief Product Officer of Optum from March 2016 to May 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Andrew L. Asher</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Mr. Asher has served as our Executive Vice President, Chief Financial Officer since May 2021. From January 2020 to May 2021, he served as Executive Vice President, Specialty. Prior to joining Centene, he served as the Chief Financial Officer of WellCare from November 2014 to January 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Katie N. Casso</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Ms. Casso has served as our Senior Vice President, Corporate Controller and Chief Accounting Officer since April 2021. From January 2016 to March 2021, she served as Vice President, Assistant Controller.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kenneth J. Fasola</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Mr. Fasola has served as our President since December 2022. From January 2022 to December 2022, he served as Executive Vice President, Health Care Enterprises. Mr. Fasola joined Centene upon the acquisition of Magellan Health in January 2022, where he served as the Chief Executive Officer since November 2019. From April 2019 to November 2019, he served as Chief Growth Officer of Ancillary and Individual Health Services at United Healthcare. From October 2010 to April 2019, he served as Chairman, President and Chief Executive Officer of HealthMarkets, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Christopher A. Koster. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Koster has served as our Executive Vice President, Secretary and General Counsel since December 2021. From February 2020 to December 2021, he served as Senior Vice President, Secretary and General Counsel. From February 2017 to February 2020, he served as Senior Vice President, Corporate Services. Prior to joining Centene, Mr. Koster served as Missouri Attorney General for eight years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">James E. Murray.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Mr. Murray has served as our Executive Vice President, Chief Operating Officer since December 2022. From January 2022 to December 2022, he served as Executive Vice President, Chief Transformation Officer. Mr. Murray joined Centene upon the acquisition of Magellan Health in January 2022, where he had served as the President and Chief Operating Officer since January 2020. During 2019, he served as President of PrimeWest Health. From 2017 to 2019, he served as Chief Executive Officer of LifeCare Health Partners.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the reporting and information requirements of the Securities Exchange Act of 1934, as amended (Exchange Act) and, as a result, we file periodic reports and other information with the Securities and Exchange Commission, or SEC. We make these filings available on our website free of charge, the URL of which is https://www.centene.com, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The SEC maintains a website (https://www.sec.gov) that contains our annual, quarterly, and current reports and other information we file electronically with the SEC. Stockholders may obtain a copy of this Annual Report on Form 10-K, without charge, by writing: Investor Relations, Centene Corporation, 7700 Forsyth Boulevard, St. Louis, MO 63105. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Please note: Information on our website does not constitute part of this Annual Report on Form&#160;10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Factors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the risks described below before making an investment decision.&#160;The trading price of our common stock could decline due to any of these risks, in which case you could lose all or part of your investment.&#160;You should also refer to the other information in this filing, including our consolidated financial statements and related notes.&#160;The risks and uncertainties described below are those that we currently believe may materially affect our Company.&#160;Additional risks and uncertainties that we are unaware of or that we currently deem immaterial also may become important factors that affect our Company. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risks Relating to Our Business</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to accurately estimate and price our medical expenses or effectively manage our medical costs or related administrative costs could have a material adverse effect on our results of operations, financial condition, and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our profitability depends to a significant degree on our ability to estimate and effectively manage expenses related to health benefits through, among other things, our ability to contract favorably with hospitals, physicians, and other healthcare providers. For example, our government-sponsored health programs revenue is often based on bids submitted before the start of the initial contract year. If our actual medical expenses exceed our estimates, our health benefits ratio (HBR), or our expenses related to medical services as a percentage of premium revenues, would increase and our profits would decline. Because of the narrow margins of our health plan business, relatively small changes in our HBR can create significant changes in our financial results. Changes in healthcare regulations and practices, the level of utilization of healthcare services, out-of-network utilization and pricing, hospital and pharmaceutical costs, unexpected events, such as disasters, the effects of climate change, major epidemics, pandemics, or newly emergent diseases (such as COVID-19), new medical technologies, new pharmaceutical compounds, increases in provider fraud, and other external factors, including general economic conditions such as inflation and unemployment levels, are generally beyond our control and could reduce our ability to accurately predict and effectively control the costs of providing health benefits. Also, member behavior could continue to be influenced by the uncertainty surrounding the ACA, including potential further legal challenges to the ACA or potential changes in premium subsidies.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our medical expenses include claims reported but not paid, estimates for claims incurred but not reported (IBNR), and estimates for the costs necessary to process unpaid claims at the end of each period. Our development of the medical claims liability estimate is a continuous process which we monitor and refine on a monthly basis as claims receipts and payment information as well as inpatient acuity information becomes available. As more complete information becomes available, we adjust the amount of the estimate, and include the changes in estimates in medical expenses in the period in which the changes are identified. Given the uncertainties inherent in such estimates, there can be no assurance that our medical claims liability estimate will be adequate, and any adjustments to the estimate may unfavorably impact our results of operations and may be material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, when we commence operations in a new state or region or launch a new product, we have limited information with which to estimate our medical claims liability. For a period of time after the inception of the new business, we base our estimates on government-provided historical actuarial data and limited actual incurred and received claims and inpatient acuity information. The addition of new categories of eligible individuals, as well as evolving Health Insurance Marketplace plans, may pose difficulty in estimating our medical claims liability. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time in the past, our actual results have varied from our estimates, particularly in times of significant changes in the number of our members. If it is determined that our estimates are significantly different than actual results, our results of operations and financial condition could be adversely affected. In addition, if there is a significant delay in our receipt of premiums, our business operations, cash flows, or earnings could be negatively impacted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Medicare programs are subject to a variety of unique risks that could adversely impact our financial results.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to design and maintain programs that are attractive to Medicare participants; if our Medicare operations are subject to negative outcomes from program audits, sanctions, penalties or other actions; if we do not submit adequate bids in our existing markets or any expansion markets; if our existing contracts are modified or terminated; or if we fail to maintain or improve our quality Star ratings, our current Medicare business and our ability to expand our Medicare operations could be materially and adversely affected, negatively impacting our financial performance. For example, the achievement of Star ratings of 4-star or higher qualifies Medicare Advantage plans for premium bonuses. For rating year 2023, only 3% of our total December 31, 2022 Medicare Advantage membership is in a plan that received an overall rating of 4.0 stars or higher. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our operational efforts to improve our Star ratings, there can be no assurances that we will be successful in improving our Star ratings in future years. Our quality bonus and rebates may continue to be negatively impacted and the attractiveness of our Medicare Advantage plans may be reduced if we are unable to improve these ratings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are also specific additional risks under Title XVIII, Part D of the Social Security Act associated with our provision of Medicare Part D prescription drug benefits as part of our Medicare Advantage plan offerings. These risks include potential uncollectibility of receivables, inadequacy of pricing assumptions, inability to receive and process information and increased pharmaceutical costs, as well as the underlying seasonality of this business, and extended settlement periods for claims submissions. Our failure to comply with Part D program requirements can result in financial and/or operational sanctions on our Part D products, as well as on our Medicare Advantage products that offer no prescription drug coverage.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk-adjustment payment systems make our revenue and results of operations more difficult to estimate and could result in retroactive adjustments that have a material adverse effect on our results of operations, financial condition, and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our government customers employ risk-adjustment models to determine the premium amount they pay for each member. This model pays more for members with predictably higher costs according to the health status of each beneficiary enrolled. Premium payments are generally established at fixed intervals according to the contract terms and then adjusted on a retroactive basis. We reassess the estimates of the risk adjustment settlements each reporting period and any resulting adjustments are made to premium revenue. In addition, revisions by our government customers to the risk-adjustment models have reduced and may continue to reduce our premium revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the variability of certain factors that determine estimates for risk-adjusted premiums, including plan risk scores, the actual amount of retroactive payments could be materially more or less than our estimates. Consequently, our estimate of our plans' risk scores for any period, and any resulting change in our accrual of premium revenues related thereto, could have a material adverse effect on our results of operations, financial condition, and cash flows. The data provided to our government customers to determine the risk score are subject to audit by them even after the annual settlements occur. These audits may result in the refund of premiums to the government customer previously received by us, which could be significant and would reduce our premium revenue in the year that repayment is required.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government customers have performed and continue to perform audits of selected plans to validate the provider coding practices under the risk adjustment model used to calculate the premium paid for each member. In 2023, CMS announced the removal of the fee-for-service adjuster from the risk adjustment data validation audit methodology beginning for audit year 2018, which could increase our audit error scores. We anticipate that CMS will continue to conduct audits of our Medicare contracts and contract years on an on-going basis. An audit may result in the refund of premiums to CMS. It is likely that a payment adjustment could occur as a result of these audits; and any such adjustment could have a material adverse effect on our results of operations, financial condition, and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any failure to adequately price products offered or any reduction in products offered for Medicare Advantage and in the Health Insurance Marketplace may have a material adverse effect on our results of operations, financial condition, and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Health Insurance Marketplace, we may be adversely impacted by being selected by individuals who have higher acuity levels than those individuals who selected us in the past and healthy individuals may decide to opt out of the pool altogether. In addition, the risk adjustment provisions of the ACA established to apportion risk amongst insurers may not be effective in appropriately mitigating the financial risks related to the Health Insurance Marketplace product, are subject to a high degree of estimation and variability and are affected by our members' acuity relative to the membership acuity of other insurers. Further, changes in the competitive market for both Health Insurance Marketplace and the Medicare Advantage products over time, changes to member eligibility in the program design or changes in the financial incentives of individuals and competitors to participate in such products may make pricing difficult to predict. For example, competitors may introduce pricing, or broker incentives that we may not be able to match, which may adversely affect our ability to compete effectively. Competitors may also choose to exit the market altogether or otherwise suffer financial difficulty, which could adversely impact the pool of potential insured, or require us to increase premium rates. Any significant variation from our expectations regarding acuity, enrollment levels, adverse selection, out-of-network costs, or other assumptions utilized in setting adequate premium rates could have a material adverse effect on our results of operations, financial condition, and cash flows for both our Health Insurance Marketplace and Medicare Advantage products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We derive a portion of our cash flow and gross margin from our PDP operations, for which we submit annual bids for participation. The results of our bids could have a material adverse effect on our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">results of operations, financial condition, and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our PDP membership is obtained from the auto-assignment of beneficiaries in CMS-designated regions where our PDP premium bids are below benchmarks of other plans' bids. In general, our premium bids are based on assumptions regarding PDP membership, utilization, drug costs, drug rebates, and other factors for each region. Our 2023 PDP bids resulted in 34 of the 34 CMS regions in which we were below the benchmarks, consistent with our 2022 PDP bids.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our future Part D premium bids are not below the CMS benchmarks, we risk losing PDP members who were previously assigned to us and we may not have additional PDP members auto-assigned to us, which could materially reduce our revenue and profits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our encounter data may be inaccurate or incomplete, which could have a material adverse effect on our results of operations, financial condition, and cash flows and ability to bid for, and continue to participate in, certain programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts require the submission of complete and correct encounter data. The accurate and timely reporting of encounter data is increasingly important to the success of our programs because more states are using encounter data to determine compliance with performance standards and to set premium rates. We have expended and may continue to expend additional effort and incur significant additional costs to collect or correct inaccurate or incomplete encounter data and have been and continue to be, exposed to operating sanctions and financial fines and penalties for noncompliance. In some instances, our government clients have established retroactive requirements for the encounter data we must submit. There also may be periods of time in which we are unable to meet existing requirements. In either case, it may be prohibitively expensive or impossible for us to collect or reconstruct this historical data.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may experience challenges in obtaining complete and accurate encounter data, due to difficulties with providers and third-party vendors submitting claims in a timely fashion in the proper format, and with state agencies in coordinating such submissions. As states increase their reliance on encounter data, these difficulties could adversely affect the premium rates we receive and how membership is assigned to us and subject us to financial penalties, which could have a material adverse effect on our results of operations, financial condition, cash flows and our ability to bid for, and continue to participate in, certain programs.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not successful in procuring new government contracts or renewing existing government contracts, or if we receive an adverse finding or review resulting from an audit or investigation, our business may be adversely affected. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of our business relates to the provision of managed care programs and selected services to individuals receiving benefits under governmental assistance or entitlement programs. We provide these and other healthcare services under contracts with government entities in the areas in which we operate. Our government contracts are generally intended to run for a fixed number of years and may be extended for an additional specified number of years if the contracting entity or its agent elects to do so. Initial bids for these contracts and initial implementation of these contracts can have substantial start up costs, and may ultimately be unsuccessful. For example, in order to obtain a certificate of authority in most jurisdictions, we must first establish a provider network, have systems in place, and demonstrate our ability to administer a state contract and process claims. Once a new contract is awarded, we may experience delays in operational start dates. As a result of these factors, start-up operations may decrease our profitability, or we may not grow as quickly as we anticipated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When our contracts with government entities expire, they may be opened for bidding by competing healthcare providers, and there is no guarantee that our contracts will be renewed or extended. Competitors may buy their way into the market by submitting bids with lower pricing. Even if our responsive bids are successful, the bids may be based upon assumptions or other factors which could result in the contracts being less profitable than we had anticipated. Further, our government contracts contain certain provisions regarding eligibility, enrollment and dis-enrollment processes for covered services, eligible providers, periodic financial and informational reporting, quality assurance, timeliness of claims payment, compliance with contract terms and law, and agreement to maintain a Medicare plan in the state and financial standards, among other things, and are subject to cancellation if we fail to perform in accordance with the standards set by regulatory agencies. For example, our subsidiary, Health Net of California, was selected by the California Department of Health Care Services (DHCS) for direct Medicaid contracts in 10 counties, including Los Angeles (in which a portion will be subcontracted). The contracts are anticipated to begin in January 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to various reviews, audits, and investigations, as well as self-reporting requirements, to verify our compliance with the terms of our contracts with various governmental agencies, as well as compliance with applicable laws and regulations. Any non-compliance with our government contracts, adverse review, audit, or investigation, could result in, among other things: cancellation of our contracts; refunding of amounts we have been paid pursuant to our contracts; imposition of fines, penalties, and other sanctions on us; loss of our right to participate in various programs; increased difficulty in selling our products and services; loss of one or more of our licenses; lowered quality Star ratings; harm to our reputation; or required changes to the way we do business. For example, several states have made claims related to services previously provided by Envolve, which historically provided PBM and specialty pharmacy services, including among other things, (i) seeking payment for services already reimbursed, (ii) not accurately disclosing to the true cost of the PBM services and (iii) inflating dispensing fees for prescription drugs. For additional information, see Note 18. Contingencies to the consolidated financial statements included in Part II of this Annual Report on Form 10-K. Additional claims, reviews, or investigations may still be brought by other states, the federal government, or shareholder litigants, and there is no guarantee we will have the ability to settle such claims with other states within the reserve estimate we have recorded and on other acceptable terms, or at all. In addition, under government procurement regulations and practices, a negative determination resulting from a government audit of our business practices could result in a contractor being fined, debarred, and/or suspended from being able to bid on, or be awarded, new government contracts for a period of time.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our government contracts are terminated, not renewed, renewed on less favorable terms, or not renewed on a timely basis, or if we receive an adverse finding or review resulting from an audit or investigation, our business and reputation may be adversely impacted, our goodwill could be impaired and our financial condition, results of operations, or cash flows may be materially affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We contract with independent third-party vendors and service providers who provide services to us and our subsidiaries or to whom we delegate selected functions. Violations of, or noncompliance with, laws and regulations governing our business by such third parties, or governing our dealings with such parties, could, among other things, subject us to additional audits, reviews, investigations, self-reporting requirements, and other adverse effects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be materially adversely affected by the effects of widespread public health pandemics, such as COVID-19.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Public health pandemics or widespread outbreaks of contagious diseases, such as COVID-19, could materially adversely impact our business. Our business has been affected by the spread of COVID-19, and the extent to which COVID-19 continues to impact our business will depend on future developments, which are highly uncertain and cannot be predicted with confidence. Factors that may determine the severity of the impact include the duration and scale of the outbreak, new information which may emerge concerning the severity of COVID-19 (including new strains or variants, which may be more contagious, more severe or less responsive to treatment or vaccines), the costs of prevention and treatment of COVID-19 and the potential that we will not receive government reimbursement of additional expenses incurred by our members who contract or require testing for COVID-19 or who experience other health impacts as a result of the pandemic, employee retention, mobility, productivity and utilization of leave and other benefits, financial and other impacts on the healthcare provider community, disruptions or delays in the supply chain for testing and treatment supplies, protective equipment and other products and services, and the actions to contain COVID-19 or address its impact (including laws, regulations and emergency orders, such as stay at home orders, physical distancing requirements, forced business closures and vaccine requirements or mandates and directives related to the timing and scope of vaccine distribution), among other factors. In addition, increased utilization patterns (including deferred demand) have had, and may continue to have, an impact on our business as members' pattern of seeking healthcare fluctuates. Additionally, the spread of COVID-19 has previously caused disruption and volatility in the global capital markets, and future disruptions could adversely impact our access to capital. Finally, the impact of the above items on our government partners could result in program changes or delays or reduced capitation payments to us. We cannot at this time predict the ultimate impact of the COVID-19 pandemic, but it could have a material adverse effect on our business, including our financial condition, results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ineffectiveness of state-operated systems and subcontractors could adversely affect our business. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of our health plans rely on other state-operated systems or subcontractors to qualify, solicit, educate, and assign eligible members into managed care plans. The effectiveness of these state operations and subcontractors can have a material effect on a health plan's enrollment in a particular month or over an extended period. When a state implements either new programs to determine eligibility or new processes to assign or enroll eligible members into health plans, or when it chooses new subcontractors, or has not adequately maintained systems, there is an increased potential for an unanticipated impact on the overall number of members assigned to managed care plans.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Execution of our value creation strategy may create disruptions in our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our value creation strategy requires the successful execution of operational initiatives and change management, which may not occur. These initiatives include contracting with new third-party vendors and are subject to a variety of risks including, without limitation: significant initial investment with the anticipated financial or quality benefits not being realized or not at the levels or on the timing anticipated; delays or challenges in execution; diversion of management's time and attention; our inability to effectively manage significant organizational change negatively impacting our corporate culture; inability of third parties to successfully comply with the terms, transition deadlines, and service levels stated forth in the contracts, and unexpected costs in the completion of initiatives, including as a result of unexpected factors or events.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to effectively execute our value creation strategy, our future growth may suffer, and our results of operations could be harmed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If state regulators do not approve payments of dividends and distributions by our subsidiaries to us, we may not have sufficient funds to implement our business strategy.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We principally operate through our health plan subsidiaries. As part of normal operations, we may make requests for dividends and distributions from our subsidiaries to fund our operations. In addition to state corporate law limitations, these subsidiaries are subject to more stringent state insurance and HMO laws and regulations that limit the amount of dividends and distributions that can be paid to us without prior approval of, or notification to, state regulators. If these regulators were to deny or delay our subsidiaries' requests to pay dividends, the funds available to us would be limited, which could harm our ability to implement our business strategy.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We derive a significant portion of our premium revenues from operations in a number of states, and our results of operations, financial condition, or cash flows could be materially affected by a decrease in premium revenues or profitability in any one of those states. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operations in a number of states have accounted for a significant portion of our premium revenues to date. If we were unable to continue to operate in any of those states or if our current operations in any portion of one of those states were significantly curtailed, our revenues could decrease materially. Our reliance on operations in a limited number of states could cause our revenues and profitability to change suddenly and unexpectedly depending on legislative or other governmental or regulatory actions and decisions, economic conditions, and similar factors in those states. Government entities in states we currently serve may open the bidding for their Medicaid or other healthcare programs to other health insurers through a request for proposal process. For example, our subsidiary, Health Net of California, was selected by the California DHCS for direct Medicaid contracts in 10 counties, including Los Angeles (in which a portion will be subcontracted). The contracts are anticipated to begin in January 2024. Reductions in our service area or services provided in any of the states in which we operate could harm our business.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Competition may limit our ability to increase penetration of the markets that we serve.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete for members principally on the basis of size and quality of provider networks, the design and cost of benefits provided, and quality of service. We compete with numerous types of competitors, including other health plans and traditional state Medicaid programs that reimburse providers as care is provided, as well as technology companies, new joint ventures, financial services firms, consulting firms, and other non-traditional competitors. In addition, the administration of the ACA has the potential to shift the competitive landscape in our segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the health plans with which we compete have greater financial and other resources and offer a broader scope of products than we do. In addition, significant merger and acquisition activity continues to occur in the managed care industry, as well as complementary industries, such as the hospital, physician, pharmaceutical, medical device, and health information systems businesses. To the extent that competition intensifies in any market that we serve, as a result of industry consolidation or otherwise, our ability to retain or increase members and providers, or maintain or increase our revenue growth, pricing flexibility, and control over medical cost trends may be adversely affected.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to maintain relationships with our provider networks, our profitability may be harmed. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our profitability depends, in large part, upon our ability to contract at competitive prices with hospitals, physicians, and other healthcare providers. Our provider arrangements with our primary care physicians, specialists, and hospitals generally may be canceled by either party without cause upon 90 to 120 days prior written notice. We cannot provide any assurance that we will be able to continue to renew our existing contracts or enter into new contracts on a timely basis or under favorable terms enabling us to service our members profitably. Healthcare providers with whom we contract may not properly manage the costs of, and access to services, be able to provide effective telehealth services, maintain financial solvency, or avoid disputes with other providers. Any of these events could have a material adverse effect on the provision of services to our members and our operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In any particular market, physicians and other healthcare providers could refuse to contract, demand higher payments, or take other actions that could result in higher medical costs or difficulty in meeting regulatory or accreditation requirements, among other things. In some markets, certain healthcare providers, particularly hospitals, physician/hospital organizations, or multi-specialty physician groups, may have significant market positions or near monopolies that could result in diminished bargaining power on our part. In addition, accountable care organizations, practice management companies, which aggregate physician practices for administrative efficiency and marketing leverage, and other organizational structures that physicians, hospitals, and other healthcare providers choose may change the way in which these providers interact with us and may change the competitive landscape. Such organizations or groups of healthcare providers may compete directly with us, which could adversely affect our operations, and our results of operations, financial condition, and cash flows by impacting our relationships with these providers or affecting the way that we price our products and estimate our costs, which might require us to incur costs to change our operations. Provider networks may consolidate or be acquired by our direct competitors, resulting in a reduction in the competitive environment. In addition, if these providers refuse to contract with us, use their market position to negotiate contracts unfavorable to us, or place us at a competitive disadvantage, our ability to market products or to be profitable in those areas could be materially and adversely affected. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, healthcare providers assert or threaten to assert claims seeking to terminate non-cancelable agreements due to alleged actions or inactions by us. If we are unable to retain our current provider contract terms or enter into new provider contracts timely or on favorable terms, our profitability may be harmed. In addition, from time to time, we may be subject to class action or other lawsuits by healthcare providers with respect to claim payment procedures or similar matters. For example, our wholly owned subsidiary, Health Net Life Insurance Company (HNL), is and may continue to be subject to such disputes with respect to HNL's payment levels in connection with the processing of out-of-network provider reimbursement claims for the provision of certain substance abuse related services. HNL expects to vigorously defend its claims payment practices. Nevertheless, in the event HNL receives an adverse finding in any related legal proceeding or from a regulator or is otherwise required to reimburse providers for these claims at rates that are higher than expected or for claims HNL otherwise believes are unallowable, our financial condition and results of operations may be materially adversely affected. In addition, regardless of whether any such lawsuits brought against us are successful or have merit, they will still be time-consuming and costly and could distract our management's attention. As a result, under such circumstances, we may incur significant expenses and may be unable to operate our business effectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our third-party vendors are unable to integrate and manage information systems effectively, our operations could be disrupted. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and our value creation strategy depend significantly on effective information systems. The information gathered and processed by information systems assists us in, among other things, monitoring utilization and other cost factors, processing provider claims, and providing data to our regulators. Our healthcare providers also depend upon our information systems for membership verifications, claims status, and other information. Our information systems and applications require continual maintenance, upgrading, and enhancement to meet our operational needs and regulatory requirements. We regularly upgrade and expand our information systems' capabilities. If we or our third-party vendors experience difficulties with the transition to or from information systems or do not appropriately integrate, maintain, enhance, or expand information systems, we could suffer, among other things, operational disruptions, loss of existing members and providers, and difficulty in attracting new members and providers, complaints, regulatory problems and increases in administrative expenses. In addition, our or our third-party vendors' ability to integrate and manage information systems may be impaired as the result of events outside our control, including acts of nature, such as earthquakes or fires, or acts of terrorists, which may include cyber-attacks by terrorists or other governmental or non-governmental actors. In addition, we may from time to time obtain significant portions of our systems-related or other services or facilities from independent third parties, which may make our operations vulnerable if such third parties fail to perform adequately.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A failure in or breach of our operational or security systems or infrastructure, or those of third parties with which we do business, including as a result of cyber-attacks, could have a material adverse effect on our business. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information security risks have significantly increased in recent years in part because of the proliferation of new technologies, the use of the internet and telecommunications technologies to conduct our operations, and the increased sophistication and activities of organized crime, hackers, terrorists, and other external parties, including foreign state agents. Our operations rely on the secure processing, transmission, and storage of confidential, proprietary, and other information in our computer systems and networks as well as those of third parties with which we do business. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Security breaches may arise from external or internal threats. External breaches include hacking personal information for financial gain, attempting to cause harm or interruption to our operations, or intending to obtain competitive information. We experience attempted external hacking or malicious attacks on a regular basis. We maintain a rigorous system of prevention and detection controls through our security programs; however, our prevention and detection controls may not prevent or identify all such attacks on a timely basis, or at all. Internal breaches may result from inappropriate security access to confidential information by rogue employees, consultants, or third-party service providers. Any security breach involving the misappropriation, loss, or other unauthorized disclosure or use of confidential member information, financial data, competitively sensitive information, or other proprietary data, whether by us or a third party, could have a material adverse effect on our business reputation, financial condition, cash flows, or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to attract, retain or effectively manage the succession of key personnel. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are highly dependent on our ability to attract and retain qualified personnel to operate and expand our business. We may be adversely impacted if we are unable to adequately plan for the succession of our executives and senior management. While we have succession plans in place for members of our executive and senior management team, these plans do not guarantee that the services of our executive and senior management team will continue to be available to us. Our ability to replace any departed members of our executive and senior management team or other key employees may be difficult and may take an extended period of time because of the limited number of individuals in the Managed Care and Specialty Services industry with the breadth of skills and experience required to operate and successfully expand a business such as ours. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain, or motivate these personnel. Further, the increased availability of hybrid or remote working arrangements has expanded the pool of companies that can compete for our employees and employment candidates. Our recently adopted modern work environment, including remote and hybrid work arrangements which is utilized by the majority of our employees, may present operational, cybersecurity and workplace culture challenges. If we are unable to attract, retain and effectively manage the succession plans for key personnel, executives, and senior management, our business and financial condition, results of operations or cash flows could be harmed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An impairment charge with respect to our real estate portfolio, recorded goodwill, and intangible assets could have a material impact on our results of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in business strategy, divestitures, government regulations, or economic or market conditions and non-renewal of government contracts have resulted and may result in impairments of our real estate portfolio, goodwill, and other intangible assets at any time in the future. In connection with our real estate optimization initiative, divestitures and the DoD's December 2022 announcement to not award Health Net Federal Services a TRICARE Managed Care Support Contract, we have recorded a total of $2.3 billion in impairment charges during the year ended December 31, 2022. We anticipate additional future charges of approximately $60 million related to real estate optimization. For additional information, see Note 7. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements included in Part II of this Annual Report on Form 10-K. We may have additional impairment charges in connection with our periodic evaluation of our goodwill and intangible assets. Our judgments regarding the existence of impairment indicators are based on, among other things, legal factors, contract terms, market conditions, and operational performance. If an event or events occur that would cause us to revise our estimates and assumptions used in analyzing the value of our goodwill and other intangible assets, such revision could result in a non-cash impairment charge that could have a material impact on our results of operations in the period in which the impairment occurs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risks Relating to Regulatory and Legal Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reductions in funding, changes to eligibility requirements for government-sponsored healthcare programs in which we participate, and any inability on our part to effectively adapt to changes to these programs could have a material adverse effect on our results of operations, financial condition, and cash flows.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our revenues come from government subsidized healthcare programs including Medicaid, Medicare, TRICARE, CHIP, LTSS, ABD, Foster Care, and Health Insurance Marketplace premiums. Changes in these programs could change the number of persons enrolled in or eligible for these programs and increase our administrative and healthcare costs under these programs. For example, we currently expect Medicaid eligibility redeterminations, which have been suspended as a result of COVID-19, to begin on April 1, 2023, which we expect to significantly reduce our membership in our Medicaid programs. We may not be able to offset the loss of this membership by increased enrollment in our Health Insurance Marketplace products. Maintaining current eligibility levels could cause states to reduce reimbursement or reduce benefits in order for states to afford to maintain eligibility levels. If any state in which we operate were to decrease premiums paid to us or pay us less than the amount necessary to keep pace with our cost trends, it could have a material adverse effect on our results of operations, financial condition, and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under most of these programs, the base premium rate paid for each program differs, depending on a combination of factors such as defined upper payment limits, a member's health status, age, gender, county or region, and benefit mix. Since Medicaid was created in 1965, the federal government and the states have shared the costs for this program, with the federal share currently averaging approximately 60%. We are therefore exposed to risks associated with federal and state government contracting or participating in programs involving a government payor, including but not limited to the general ability of the federal and/or state governments to terminate or modify contracts with them, in whole or in part, without prior notice, for convenience or for default based on performance; potential regulatory or legislative action that may materially modify amounts owed; our dependence upon Congressional or legislative appropriation and allotment of funds and the impact that delays in government payments could have on our operating cash flow and liquidity; and other regulatory, legislative or judicial actions that may have an impact on the operations of government subsidized healthcare programs including ongoing litigation involving the ACA. For example, future levels of funding and premium rates may be affected by continuing government efforts to contain healthcare costs and may further be affected by state and federal budgetary constraints. Governments periodically consider reducing or reallocating the amount of money they spend for Medicaid, Medicare, TRICARE, CHIP, LTSS, ABD, and Foster Care. Furthermore, Medicare remains subject to the automatic spending reductions imposed by the Budget Control Act of 2011 and the American Taxpayer Relief Act of 2012 (sequestration), subject to a 2% cap, which was extended by the Bipartisan Budget Act of 2019 through 2029. The Coronavirus Aid, Relief, and Economic Security Act of 2020 temporarily suspended the Medicare sequestration for the period of May 1, 2020 through December 31, 2020, while also extending the mandatory sequestration policy by an additional one year, through 2030. The Bipartisan-Bicameral Omnibus COVID Relief Deal passed in December 2020 further extended the suspension of the Medicare sequestration until March 31, 2021, and the Protecting Medicare and American Farmers from Sequester Cuts Act passed in December 2021 extended the sequester through March 31, 2022 and adjusted the sequester to 1% for the period between April 1, 2022 and June 30, 2022.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, reductions in defense spending could have an adverse impact on certain government programs in which we currently participate by, among other things, terminating or materially changing such programs, or by decreasing or delaying payments made under such programs. Adverse economic conditions may put pressures on state budgets as tax and other state revenues decrease while the population that is eligible to participate in these programs remains steady or increases, creating more need for funding. We anticipate this will require government agencies to find funding alternatives, which may result in reductions in funding for programs, contraction of covered benefits, and limited or no premium rate increases or premium rate decreases. A reduction (or less than expected increase), a protracted delay, or a change in allocation methodology in government funding for these programs, as well as termination of one or more contracts for the convenience of the government, may materially and adversely affect our results of operations, financial condition, and cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As has been widely reported, the United States Treasury Secretary has stated that the federal government may not be able to meet its debt payments in the relatively near future unless the federal debt ceiling is raised. If legislation increasing the debt ceiling is not enacted and the debt ceiling is reached, the federal government may stop or delay making payments on its obligations, or if another federal government shutdown were to occur for a prolonged period of time, federal government payment obligations, including its obligations under Medicaid, Medicare, TRICARE, CHIP, LTSS, ABD, Foster Care, and the Health Insurance Marketplace, may be delayed. Similarly, if state government shutdowns were to occur, state payment obligations may be delayed. If the federal or state governments fail to make payments under these programs on a timely basis, our business could suffer, and our financial condition, results of operations, or cash flows may be materially affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments from government payors may be delayed in the future, which, if extended for any significant period of time, could have a material adverse effect on our results of operations, financial condition, cash flows or liquidity. In addition, delays in obtaining, or failure to obtain or maintain, governmental approvals, or moratoria imposed by regulatory authorities, could adversely affect our revenues or membership, increase costs or adversely affect our ability to bring new products to market as forecasted. Other changes to our government programs could affect our willingness or ability to participate in any of these programs or otherwise have a material adverse effect on our business, financial condition, or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant changes or judicial challenges to the ACA could materially and adversely affect our results of operations, financial condition, and cash flows.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The enactment of the ACA in March 2010 transformed the U.S. healthcare delivery system through a series of complex initiatives; however, the ACA has faced, and continues to face, administrative, judicial and legislative challenges to repeal or change certain of its significant provisions. Changes to portions or the entirety of the ACA, as well as judicial interpretations in response to constitutional and other legal challenges, as well as the uncertainty generated by such actual or potential challenges, could materially and adversely affect our business and financial condition, results of operations or cash flows. The ultimate content, timing, or effect of any potential future legislation or litigation and the outcome of other lawsuits cannot be predicted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among the most significant of the ACA's provisions was the establishment of the Health Insurance Marketplace for individuals and small employers to purchase health insurance coverage that included a minimum level of benefits and restrictions on coverage limitations and premium rates, as well as the expansion of Medicaid coverage to all individuals under age 65 with incomes up to 138% of the federal poverty level beginning January 1, 2014, subject to each state's election. The HHS additionally indicated that it would consider a limited number of premium assistance demonstration proposals from states that want to privatize Medicaid expansion. Several states in which we operate have obtained Section 1115 waivers to implement the ACA's Medicaid expansion in ways that extend beyond the flexibility provided by the federal law, with additional states pursuing Section 1115 waivers regarding eligibility criteria, benefits, and cost-sharing, and provider payments across their Medicaid programs. Litigation challenging Section 1115 waiver activity for both new and previously approved waivers is expected to continue both through administrative actions and the courts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been significant efforts from the previous administration to repeal or amend certain provisions of the ACA through changes in regulations. Such initiatives included repeal of the individual mandate effective in 2019, as well as easing the regulatory restrictions placed on short-term health plans and association health plans (AHPs), which plans often provide fewer benefits than the traditional ACA insurance benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the U.S. Department of Labor issued a final rule on June 19, 2018, which expanded flexibility regarding the regulation and formation of AHPs provided by small employer groups and associations. On June 13, 2019, the HHS, the U.S. Department of Labor, and the U.S. Treasury issued a final rule allowing employers of all sizes that do not offer a group coverage plan to fund a new kind of health reimbursement arrangement (HRA), known as an individual coverage HRA (ICHRA). Beginning January 1, 2020, employees became able to use employer-funded ICHRAs to buy individual-market insurance, including insurance purchased on the public exchanges formed under the ACA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It remains uncertain whether or when the current administration will propose changes to restrict these insurance plan options that are not required to meet ACA requirements, and what the impact of such potential changes may be.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The constitutionality of the ACA itself continues to face judicial challenge. The ultimate content, timing or effect of any potential future legislation or litigation and the outcome of other lawsuits cannot be predicted and may be delayed as a result of court closures and reduced court dockets as a result of the COVID-19 pandemic.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In contrast to previous executive and legislative efforts to restrict or limit certain provisions of the ACA, the American Rescue Act, enacted on March 11, 2021, contained provisions aimed at leveraging Medicaid and the Health Insurance Marketplace to expand health insurance coverage and affordability to consumers. The American Rescue Act authorized an additional $1.9 trillion in federal spending to address the COVID-19 public health emergency (PHE), and contained several provisions designed to increase coverage of certain healthcare services, expand eligibility and benefits, incentivize state Medicaid expansion, and adjust federal financing for state Medicaid programs, the ultimate impact of which remain uncertain. The American Rescue Act enhanced eligibility for the advance premium tax credit for certain enrollees in the Health Insurance Marketplace. The Inflation Reduction Act, enacted on August 16, 2022, extended the enhanced eligibility for the advance premium tax credit for Marketplace members through the 2025 tax year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These changes and other potential changes involving the functioning of the Health Insurance Marketplace as a result of additional new legislation, regulation, executive action, or litigation, including those related to extending enrollment periods, increasing eligibility in the program design, changing the eligibility and amount of the advanced premium tax credit and expanding navigator services, could impact our business and results of operations adversely or in other ways that we do not currently anticipate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business activities are highly regulated and new laws or regulations or changes in existing laws or regulations or their enforcement or application could force us to change how we operate and could harm our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is extensively regulated by the states in which we operate and by the federal government. In addition, the managed care industry has received negative publicity that has led to increased legislation, regulation, review of industry practices, and private litigation in the commercial sector. Such negative publicity may adversely affect our stock price and damage our reputation in various markets. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In each of the jurisdictions in which we operate, we are regulated by the relevant insurance, health, and/or human services or government departments that oversee the activities of MCOs providing or arranging to provide services to Medicaid, Medicare, Health Insurance Marketplace enrollees, or other beneficiaries. For example, our health plan subsidiaries, as well as our applicable specialty companies, must comply with minimum statutory capital and other financial solvency requirements, such as deposit and surplus requirements. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The frequent enactment of, changes to, or interpretations of laws and regulations could, among other things: force us to restructure our relationships with providers within our network; require us to implement additional or different programs and systems; restrict revenue and enrollment growth; increase our healthcare and administrative costs; impose additional capital and surplus requirements; and increase or change our liability to members in the event of malpractice by our contracted providers. In addition, changes in political party, or administrations at the state or federal level in the United States or internationally may change the attitude towards healthcare programs and result in changes to the existing legislative or regulatory environment.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the taxes and fees paid to federal, state, local, and international governments may increase due to several factors, including:&#160;enactment of, changes to, or interpretations of tax laws and regulations, audits by governmental authorities, geographic expansions into higher taxing jurisdictions and the effect of expansions into international markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are often required to maintain a minimum HBR or share profits in excess of certain levels, which may be retroactive. In certain circumstances, our plans have returned premiums back to the states, enrollees, or other beneficiaries in the event profits exceed established levels or HBR does not meet the minimum requirement. The amount of premium returned may include transparent pharmacy pricing and rebate initiatives. Other states may require us to meet certain performance and quality metrics in order to maintain our contract or receive additional or full contractual revenue. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The governmental healthcare programs in which we participate are subject to the satisfaction of certain regulations and performance standards. Regulators require numerous steps for continued implementation of the ACA, including the promulgation of a substantial number of potentially more onerous federal regulations. If we fail to effectively implement or appropriately adjust our operational and strategic initiatives with respect to the implementation of healthcare reform, or do not do so as effectively as our competitors, our results of operations may be materially adversely affected. For example, under the ACA, Congress authorized CMS and the states to implement managed care demonstration programs to serve dually eligible beneficiaries to improve the coordination of their care. Participation in these demonstration programs is subject to CMS approval and the satisfaction of conditions to participation, including meeting certain performance requirements. Our inability to improve or maintain adequate quality scores and Star ratings to meet government performance requirements or to match the performance of our competitors could result in limitations to our participation in or exclusion from these or other government programs. Specifically, several of our Medicaid contracts require us to maintain a Medicare health plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2016, CMS issued final regulations that revised existing Medicaid managed care rules by establishing a minimum medical loss ratio standard for Medicaid of 85% and strengthening provisions related to network adequacy and access to care, enrollment and disenrollment protections, beneficiary support information, continued service during beneficiary appeals, and delivery system and payment reform initiatives, among others. On November 13, 2020, CMS finalized revisions to the Medicaid managed care regulations, many of which became effective in December 2020. While not a wholesale revision of the 2016 regulations, the November 2020 final rule adopted changes in areas including network adequacy, beneficiary protections, quality oversight, and the establishment of capitation rates and payment policies. Although we strive to comply with all existing regulations and to meet performance standards applicable to our business, failure to meet these requirements could result in financial fines and penalties. Also, states or other governmental entities may carve out certain services and benefits from the government programs in which we participate, or they may not allow us to continue to participate in their government programs, or we may fail to win procurements to participate in such programs, either of which could materially and adversely affect our results of operations, financial condition, and cash flows. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a result of the expansion of our businesses and operations conducted in foreign countries, we face political, economic, legal, compliance, regulatory, operational, and other risks and exposures that are unique and vary by jurisdiction. These foreign regulatory requirements with respect to, among other items, environmental, tax, licensing, intellectual property, privacy, data protection, investment, capital, management control, labor relations, and fraud and corruption regulations are different than those faced by our domestic businesses. In addition, we are subject to U.S. laws that regulate the conduct and activities of U.S.-based businesses operating abroad, such as the FCPA. Any failure to comply with laws and regulations governing our conduct outside the United States or to successfully navigate international regulatory regimes that apply to us could adversely affect our ability to market our products and services, which may have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our pharmacy services face regulatory and other risks and uncertainties which could materially and adversely affect our results of operations, financial condition, and cash flows.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Centene Pharmacy Services (formerly Envolve Pharmacy Solutions) product historically provided PBM services and continues to provide pharmacy benefits administration and specialty pharmacy services. We have transitioned substantially all of our PBM business to a third party as of January 1, 2023. These businesses are subject to federal and state laws and regulations that, among other requirements, govern the relationships of the business with pharmaceutical manufacturers, physicians, pharmacies, customers, and consumers. For example, several states have made claims related to services provided by Envolve including among other things, (i) seeking payment for services already reimbursed, (ii) not accurately disclosing the true cost of the PBM services, and (iii) inflating dispensing fees for prescription drugs. For additional information, see Note 18. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements included in Part II of this Annual Report on Form 10-K. Additional claims, reviews, or investigations may still be brought by other states, the federal government, or shareholder litigants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also conduct business as a mail order pharmacy and specialty pharmacy, which subjects these businesses to extensive federal, state, and local laws and regulations. In addition, federal and state legislatures and regulators regularly consider new regulations for the industry that could materially and adversely affect current industry practices, including the receipt or disclosure of rebates from pharmaceutical companies, the development and use of formularies, and the use of average wholesale prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our specialty pharmacy businesses would be materially and adversely affected by an inability to contract on favorable terms with pharmaceutical manufacturers and other suppliers, including with respect to the structuring of rebates and pricing of new specialty and generic drugs. In addition, our specialty pharmacy businesses could face potential claims in connection with purported errors by our mail order or specialty pharmacies, including in connection with the risks inherent in the authorization, compounding, packaging, and distribution of pharmaceuticals and other healthcare products. Disruptions at any of our mail order or specialty pharmacies due to an event that is beyond our control could affect our ability to process and dispense prescriptions in a timely manner and could materially and adversely affect our results of operations, financial condition, and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have been and may from time to time become involved in costly and time-consuming litigation and other regulatory proceedings, which require significant attention from our management and could adversely affect our business. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are a defendant in lawsuits and regulatory actions and are subject to investigations relating to our business, including, without limitation, medical malpractice claims, claims by members alleging failure to pay for or provide healthcare, claims related to non-payment or insufficient payments for out-of-network services, claims related to network adequacy, claims alleging bad faith, investigations regarding our submission of risk adjuster claims, putative securities class actions, protests and appeals related to Medicaid procurement awards, cybersecurity issues, including those related to our or our third-party vendors' information systems; employment-related disputes, including wage and hour claims, submissions to state agencies related to payments or state false claims acts and claims related to the imposition of new taxes, including but not limited to claims that may have retroactive application. For example, several states have made claims related to services previously provided by Envolve, which historically provided PBM and specialty pharmacy services, including among other things, (i) seeking payment for services already reimbursed, (ii) not accurately disclosing the true cost of the PBM services and (iii) inflating dispensing fees for prescription drugs. For additional information, see Note 18. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements included in Part II of this Annual Report on Form 10-K. Additional claims, reviews, or investigations may be brought by other states, the federal government, or shareholder litigants, and there is no guarantee we will have the ability to settle such claims with other states within the reserve estimate we have recorded, on other acceptable terms, or at all. In addition, regardless of the outcome of any litigation or regulatory proceedings, such proceedings are costly and time-consuming and require significant attention from our management, and could therefore have a material adverse effect on our business and financial condition, results of operations, or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with applicable privacy, security, and data laws, regulations, and standards, including with respect to third-party service providers that utilize sensitive personal information on our behalf, our business, reputation, results of operations, financial condition, and cash flows could be materially and adversely affected. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our normal operations, we collect, process, and retain confidential member information. We are subject to various federal, state, and international laws, regulations, rules, and contractual requirements regarding the use and disclosure of confidential member information, including the Health Insurance Portability and Accountability Act of 1996 (HIPAA), the HITECH Act of 2009, the Gramm-Leach-Bliley Act, and the General Data Protection Regulation, which require us to protect the privacy of medical records and safeguard personal health information we maintain and use. Certain of our businesses are also subject to the Payment Card Industry Data Security Standard, which is a multifaceted security standard that is designed to protect credit card account data as mandated by payment card industry entities. Despite our best attempts to maintain adherence to information privacy and security best practices, as well as compliance with applicable laws, rules, and contractual requirements, our facilities and systems, and those of our third-party service providers may be vulnerable to privacy or security breaches, acts of vandalism or theft, malware or other forms of cyber-attack, misplaced or lost data including paper or electronic media, programming and/or human errors or other similar events. In the past, we have had data breaches resulting in disclosure of confidential or protected health information that have not resulted in any material financial loss or penalty to date. For example, in 2021, we learned that Accellion, a third-party data transfer provider with whom we contract, had a system vulnerability that resulted in unauthorized access to certain sensitive data of our customers, including protected health information, as well as unauthorized access to the data of several of Accellion's other clients. This incident led to putative class action lawsuits that were filed against us and our subsidiaries, Health Net, LLC, Health Net of California, Inc., Health Net Life Insurance Company, Health Net Community Solutions, Inc., and California Health &amp; Wellness, and Accellion on behalf of the affected customers. To date, this incident has not had, and we do not believe that this incident is likely to have a material adverse effect on our business, reputation, results of operations, financial condition, and cash flows. However, there can be no assurance that this incident and other privacy or security breaches will not require us to expend significant resources to remediate any damage, interrupt our operations and damage our business or reputation, subject us to state, federal, or international agency review, and result in enforcement actions, material fines and penalties, litigation or other actions which could have a material adverse effect on our business, reputation, results of operations, financial condition, and cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, HIPAA broadened the scope of fraud, waste and abuse laws applicable to healthcare companies and established enforcement mechanisms to combat fraud, waste and abuse, including civil and, in some instances, criminal penalties for failure to comply with specific standards relating to the privacy, security and electronic transmission of protected health information.&#160;The HITECH Act expanded the scope of these provisions by mandating individual notification in instances of breaches of protected health information, providing enhanced penalties for HIPAA violations, and granting enforcement authority to states' Attorneys General in addition to the HHS Office for Civil Rights. It is possible that Congress may enact additional legislation in the future to increase the amount or application of penalties and to create a private right of action under HIPAA, which could entitle patients to seek monetary damages for violations of the privacy rules.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with the extensive federal and state fraud, waste and abuse laws, our business, reputation, results of operations, financial condition, and cash flows could be materially and adversely affected.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, along with other companies involved in public healthcare programs, have been, and from time to time are, the subject of federal and state fraud, waste and abuse investigations. The regulations and contractual requirements applicable to participants in these public sector programs are complex and subject to change. Violations of fraud, waste and abuse laws applicable to us could result in civil monetary penalties, criminal fines and imprisonment, and/or exclusion from participation in Medicaid, Medicare, TRICARE, and other federal healthcare programs and federally funded state health programs. Fraud, waste and abuse prohibitions encompass a wide range of activities, including kickbacks for referral of members, incorrect and unsubstantiated billing or billing for unnecessary medical services, improper marketing, and violations of patient privacy rights. These fraud, waste and abuse laws include the federal False Claims Act, which prohibits the known filing of a false claim or the known use of false statements to obtain payment from the federal government, and the federal anti-kickback statute, which prohibits the payment or receipt of remuneration to induce referrals or recommendations of healthcare items or services. Many states have fraud, waste and abuse laws, including false claim act and anti-kickback statutes that closely resemble the federal False Claims Act and the federal anti-kickback statute. In addition, the Deficit Reduction Act of 2005 encouraged states to enact state-versions of the federal False Claims Act that establish liability to the state for false and fraudulent Medicaid claims and that provide for, among other things, claims to be filed by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relators (private parties acting on the government's behalf). Federal and state governments have made investigating and prosecuting healthcare fraud, waste and abuse a priority. In the event we fail to comply with the extensive federal and state fraud, waste and abuse laws, our business, reputation, results of operations, financial condition, and cash flows could be materially and adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by tax legislation or challenges to our tax positions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the tax laws in the U.S. at the federal, state, and local government levels and to the tax laws of other jurisdictions in which we operate. Tax laws might change in ways that adversely affect our tax positions, effective tax rate, and cash flow. In August 2022, the U.S. federal government enacted the Inflation Reduction Act, which imposed a 15% corporate minimum tax on certain large corporations and a 1% tax on share repurchases after December 31, 2022. The tax laws are extremely complex and subject to varying interpretations. We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us. Our tax reporting positions might be challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts. Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals. Any of these risks might have a material adverse impact on our business, results of operations, financial condition, and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risks Relating to Conditions in the Financial Markets and Economy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investment portfolio may suffer losses which could materially and adversely affect our results of operations or liquidity. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a significant investment portfolio of cash equivalents and short-term and long-term investments in a variety of securities, which are subject to general credit, liquidity, market, and interest rate risks and will decline in value if interest rates increase or one of the issuers' credit ratings is reduced. As a result, we may experience a reduction in value or loss of our investments, which may have an adverse effect on our results of operations, liquidity, and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse credit market conditions may have a material adverse effect on our liquidity or our ability to obtain credit on acceptable terms.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, the securities and credit markets have experienced extreme volatility and disruption. The availability of credit, from virtually all types of lenders, has at times been restricted. In the event we need access to additional capital to pay our operating expenses, fund subsidiary surplus requirements, make payments on or refinance our indebtedness, pay capital expenditures, or fund acquisitions, our ability to obtain such capital may be limited and the cost of any such capital may be significant, particularly if we are unable to access our existing revolving credit facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our access to additional financing will depend on a variety of factors such as prevailing economic and credit market conditions, the general availability of credit, the overall availability of credit to our industry, our credit ratings and credit capacity, and perceptions of our financial prospects. Similarly, our access to funds may be impaired if regulatory authorities or rating agencies take negative actions against us. If one or any combination of these factors were to occur, our internal sources of liquidity may prove to be insufficient, and in such case, we may not be able to successfully obtain sufficient additional financing on favorable terms, within an acceptable time, or at all. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have substantial indebtedness outstanding and may incur additional indebtedness in the future. Such indebtedness could reduce our agility and may adversely affect our financial condition.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had consolidated indebtedness of $18.0 billion. We may further increase or refinance our indebtedness in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This may have the effect, among other things, of reducing our flexibility to respond to changing business and economic conditions and increasing borrowing costs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, our revolving credit facility and term loan facility (collectively, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company Credit Facility)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the indentures governing our notes require us to comply with various covenants that impose restrictions on our operations, including our ability to incur additional indebtedness, create liens, pay dividends, make certain investments or other restricted payments, sell or otherwise dispose of substantially all of our assets and engage in other activities. Our Company Credit Facility also requires us to comply with a maximum debt to EBITDA ratio and a minimum fixed charge coverage ratio. These restrictive covenants could limit our ability to pursue our business strategies. In addition, any failure by us to comply with these restrictive covenants could result in an event of default under our Company Credit Facility and, in some circumstances, under the indentures governing our notes, which, in any case, could have a material adverse effect on our financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Phasing out of LIBOR may increase our interest expense or affect the value of the financial obligations to be held or issued by us that are linked to LIBOR, which may adversely affect our financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, borrowings under our Company Credit Facility bear interest based upon various reference rates, including LIBOR. LIBOR is expected to transition to Secured Overnight Financing Rate (SOFR), a new index calculated by short-term repurchase agreements backed by treasury securities, on or about June 30, 2023. We believe that our credit agreement allows SOFR to be used as the new reference rate upon LIBOR's discontinuance. However, our interest expense could increase and our available cash flow for general corporate requirements may be adversely affected. Additionally, the phase-out of LIBOR may cause disruption in the overall financial markets and other reforms could have an adverse impact on the market for, or value of, any LIBOR-linked securities, loans, and other financial obligations or extensions of credit held by or due to us or on our overall financial condition or results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risks Associated with Mergers, Acquisitions, and Divestitures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mergers and acquisitions may not perform as expected and we may not realize the savings expected from divestitures, which may cause the market price of our common stock to decline.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our common stock is generally subject to volatility, and there can be no assurances regarding the level or stability of our share price at any time. The market price of our common stock may decline as a result of acquisitions and divestitures if, among other things, we are unable to achieve the expected cost and revenue synergies or growth in earnings, the operational cost savings estimates are not realized as rapidly or to the extent anticipated, the transaction costs related to the acquisitions or divestitures are greater than expected or if any financing related to the transactions is on unfavorable terms. The market price also may decline if we do not achieve the perceived benefits of the acquisitions and divestitures as rapidly or to the extent anticipated by financial or industry analysts or if the effect of the acquisitions and divestitures on our financial condition, results of operations, or cash flows is not consistent with the expectations of financial or industry analysts.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to successfully integrate our existing business with acquired businesses and realize the anticipated benefits of such acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may acquire health plans participating in government-sponsored healthcare programs and specialty services businesses, contract rights, and related assets of other health plans both in our existing service areas and in new markets and start-up operations in new markets or new products in existing markets. Although we review the records of companies or businesses we plan to acquire, it is possible that we could assume unanticipated liabilities or adverse operating conditions. In addition, the success of acquisitions we make will depend, in part, on our ability to successfully combine the existing business of Centene with such acquired businesses and realize the anticipated benefits, including synergies, cost savings, growth in earnings, innovation, and operational efficiencies, from the combinations. If we are unable to achieve these objectives within the anticipated time frame, or at all, the anticipated benefits may not be realized fully or at all, or may take longer to realize than expected and the value of our common stock may be harmed.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The integration of acquired businesses with our existing business is a complex, costly, and time-consuming process. The integration may result in material challenges, including, without limitation:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the diversion of management's attention from ongoing business concerns and performance shortfalls as a result of the devotion of management's attention to the integration;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">managing a larger company;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintaining employee morale and retaining key management and other employees;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possibility of faulty assumptions underlying expectations regarding the integration process;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">retaining existing business and operational relationships and attracting new business and operational relationships;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">consolidating corporate and administrative infrastructures and eliminating duplicative operations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">coordinating geographically separate organizations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated issues in integrating information technology, communications, and other systems;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated changes in federal or state laws or regulations, including the ACA and any regulations enacted thereunder;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unforeseen expenses or delays associated with the acquisition and/or integration; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">achieving actual cost savings at the anticipated levels; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreases in premiums paid under government-sponsored healthcare programs by any state in which we operate.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of these factors will be outside of our control and any one of them could result in delays, increased costs, decreases in the amount of expected revenues, and diversion of management's time and energy, which could materially affect our financial condition, results of operations, and cash flows. Our ability to successfully manage the expanded business following any given acquisition will depend, in part, upon management's ability to design and implement strategic initiatives that address not only the integration of two independent stand-alone companies, but also the increased scale and scope of the combined business with its associated increased costs and complexity. There can be no assurances that we will be successful in managing our expanded operations as a result of acquisitions or that we will realize the expected growth in earnings, operating efficiencies, cost savings, and other benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business and results of operations may be materially adversely affected if we fail to manage and complete divestitures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate our portfolio to determine whether an asset or business is still consistent with our business strategy or whether there may be a more advantaged owner for that asset or business. When we decide to sell assets or a business, we may encounter difficulty finding buyers or alternative exit strategies, which could delay the achievement of our business strategy. Further, divestitures may be delayed due to failure to obtain required approvals on a timely basis, if at all, from governmental authorities, or may become more difficult to execute due to conditions placed upon approval that could, among other things, delay or prevent us from completing a transaction, or otherwise restrict our ability to realize the expected financial or strategic goals of a transaction. We might have financial exposure in a divested business, such as through minority equity ownership, financial or performance guarantees, indemnities, or other obligations, such that conditions outside of our control might negate the expected benefits of the disposition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unresolved Staff Comments</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i9dee570cfbd043d6a1700298c14b2446_34"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Properties</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own our corporate office headquarters buildings and land located in St. Louis, Missouri, which is used by each of our reportable segments. We generally lease space in the states where our health plans, specialty companies, and claims processing facilities operate. We are required by various insurance and regulatory authorities to have offices in the service areas where we provide benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the adoption of a more modern, flexible work environment, we undertook a real estate optimization initiative to evaluate future real estate needs and downsize our real estate footprint for owned and leased properties. As a result of this evaluation, we substantially changed the use or abandoned various properties and recognized an impairment charge for the year ended December 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our current facilities are adequate to meet our operational needs for the foreseeable future.</span></div><div id="i9dee570cfbd043d6a1700298c14b2446_37"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of the legal proceedings to which we and our subsidiaries are a party is contained in Note 18. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the consolidated financial statements included in Part II of this Annual Report on Form 10-K, and is incorporated herein by reference. </span></div><div id="i9dee570cfbd043d6a1700298c14b2446_40"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mine Safety Disclosures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="text-align:justify"><span><br/></span></div><div id="i9dee570cfbd043d6a1700298c14b2446_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market for Registrant's Common Equity, Related Stockholder Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and Issuer Purchases of Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market for Common Stock </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock has been traded and quoted on the New York Stock Exchange (NYSE) under the symbol "CNC" since October 16, 2003.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholders</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;17, 2023, there were</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,036 holders of record of our common stock. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, our Board of Directors authorized increases to the Company's existing stock repurchase program, including $3.0 billion in June 2022 and an additional $2.0 billion in December 2022. With these increases, the Company is authorized to repurchase up to $6.0 billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock repurchase program is effected primarily through regular open-market purchases (which may include repurchase plans designed to comply with Rule 10b5-1 and accelerated share repurchases), the amounts and timing of which are subject to our discretion as part of our capital allocation strategy, and may be based upon general market conditions and the prevailing price and trading volumes of our common stock. No duration has been placed on the repurchase program. We reserve the right to discontinue the repurchase program at any time.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuer Purchases of Equity Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fourth Quarter 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Shares in thousands)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price Paid per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs ($ in millions) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October&#160;1, 2022 - October&#160;31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,842</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.25&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,840&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November&#160;1, 2022 - November&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,105</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December&#160;1, 2022 - December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,306</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,253</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Shares purchased through a publicly announced plan or program and shares relinquished to the Company by certain employees for payment of taxes or option cost upon vesting of restricted stock units or option exercise.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2022, the Company's Board of Directors authorized an additional $2.0 billion increase to the stock repurchase program. A remaining amount of approximately $2.8 billion is available under the program as of December&#160;31, 2022. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Includes 3.0 million shares delivered through an accelerated share repurchase (ASR) initiated in July 2022, which was settled based on the volume-weighted average price (VWAP) over the term of the agreement, less a discount, of $86.21. See Note 12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below compares the cumulative total stockholder return on our common stock for the period from December&#160;31, 2017 to December&#160;31, 2022, with the cumulative total return of the New York Stock Exchange Composite Index, the Standard &amp; Poor's Supercomposite Managed Healthcare Index and the Standard &amp; Poor's 500 over the same period. Standard &amp; Poor's 500 is included because our common stock is within the index. The graph assumes an investment of $100 on December&#160;31, 2017 in our common stock (at the last reported sale price on such day), the New York Stock Exchange Composite Index, the Standard &amp; Poor's Supercomposite Managed Healthcare Index, and the Standard &amp; Poor's 500 and assumes the reinvestment of any dividends.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><img src="cnc-20221231_g4.jpg" alt="cnc-20221231_g4.jpg" style="height:466px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.850%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene Corporation</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.29&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.64&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.01&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.36&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.59&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York Stock Exchange Composite Index</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P Supercomposite Managed Healthcare Index</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene Corporation closing stock price</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.03&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.01&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene Corporation annual stockholder return</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the rules of the SEC, the information contained in the Stock Performance Graph on this page shall not be deemed to be "soliciting material," or to be "filed" with the SEC or subject to the SEC's Regulation 14A, or to the liabilities of Section 18 of the Exchange Act, except to the extent that Centene specifically requests that the information be treated as soliciting material or specifically incorporates it by reference into a document filed under the Securities Act, or the Exchange Act. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserved.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes included elsewhere in this filing. The discussion contains forward-looking statements that involve known and unknown risks and uncertainties, including those set forth under Part I, Item 1A."Risk Factors" of this Form 10-K. The following discussion and analysis does not include certain items related to the year ended December&#160;31, 2020, including year-to-year comparisons between the year ended December&#160;31, 2021 and the year ended December&#160;31, 2020. For a comparison of our results of operations for the fiscal years ended December&#160;31, 2021 and December&#160;31, 2020, see Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December&#160;31, 2021, filed with the SEC on February&#160;22, 2022.</span></div><div id="i9dee570cfbd043d6a1700298c14b2446_55"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OVERVIEW</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mission</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading healthcare enterprise, committed to helping people live healthier lives, with an established expertise in lower-income and medically complex populations. We provide access to high-quality healthcare, innovative programs, and a wide range of health solutions that help families and individuals get well, stay well, and be well. We believe that our local approach enables us to provide accessible, quality, culturally sensitive healthcare coverage to our communities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We feel we have a competitive advantage being on the ground, enabling us to establish strong relationships with our partners and providing us with first-hand knowledge, which allows us to provide the best possible care to our members. We have a commitment to the communities and people we serve to transform their health at the local level. In 2022, when members of the Uvalde, Texas community faced unbelievable tragedy, we showed up to help serve their short-term needs and have since made an investment in a multipurpose community center in the city through our charitable foundation, just one example of our mission in action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our record of organic growth and strategic acquisitions has given us the size, scale, and privilege of providing local high-quality and affordable health care to more than 27&#160;million Americans. As of December&#160;31, 2022, we were the largest Medicaid health insurer in the country, serving 16&#160;million Medicaid recipients in 29 states. We were the largest Marketplace carrier, serving 2.1&#160;million members across 27 states, and served 1.5&#160;million Medicare members across 36 states, with the highest concentration of lower-income, medically complex members.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we are transforming our operating model to take advantage of our national scale, our commitment to remain local in the communities we serve will not change.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations depend on our ability to manage expenses associated with health benefits (including estimated costs incurred) and selling, general and administrative (SG&amp;A) costs. We measure operating performance based upon two key ratios. The health benefits ratio (HBR) represents medical costs as a percentage of premium revenues, excluding premium tax revenues that are separately billed, and reflects the direct relationship between the premiums received and the medical services provided. The SG&amp;A expense ratio represents SG&amp;A costs as a percentage of premium and service revenues, excluding premium taxes separately billed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Value Creation Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We established our Value Creation Plan to drive margin expansion by leveraging our scale and generating sustainable, profitable growth. In addition to creating shareholder value, this plan is an ongoing effort to modernize and improve how we work in order to propel our organization to new levels of success and elevate the member and provider experiences. The three major pillars of the Value Creation Plan are: SG&amp;A expense savings, gross margin expansion, and strategic capital management.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our Value Creation Plan, we are assessing our portfolio and are focused on making strategic decisions and investments to create additional value in the short-term and to seek opportunities that position the organization for long-term strength, profitability, growth, and innovation. We continue to move forward with our value creation initiatives including the streamlining of certain operations, such as key call centers and utilization management, and have begun early-stage platform consolidations. Building on that foundation, we intend to drive sustainable, profitable growth and long-term value to our members and shareholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we completed the following key milestones in our Value Creation Plan:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Initiated a reduction of our real estate footprint following a strategic review of our real estate portfolio resulting in a $1.6 billion impairment related to leased and owned real estate and related fixed assets. This represents an approximate 70% decrease in domestic leased space and is expected to result in annualized lease expense savings of more than $200 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Signed a multi-year contract with Express Scripts, Inc. to provide our pharmacy benefit services, commencing in 2024. The new pharmacy benefits management (PBM) contract is expected to drive significant value in 2024 and beyond.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Completed the divestitures of PANTHERx Rare (PANTHERx), our Spanish and Central European businesses, and Magellan Rx.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Completed $3.0 billion of common stock repurchases, $318 million of senior note repurchases, repaid our $180 million construction loan, and repaid over $100 million in revolver and term loan borrowings. Common stock and debt repurchases were funded primarily through proceeds from divestitures and free cash flow generated from operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in January 2023, we completed the divestitures of Magellan Specialty Health, Centurion, and HealthSmart.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segments Update</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In early 2023, and in conjunction with our updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, we have revised the way we manage the business, evaluate performance, and allocate resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. We will begin reporting under this new segment structure in 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions and Divestitures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we acquired all of the issued and outstanding shares of Magellan Health, Inc. (Magellan). Total consideration for the acquisition was $2.5 billion, consisting of $2.4 billion in cash and $60 million related to the fair value of replacement equity awards associated with pre-combination service.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our portfolio review and strategic plan to exit the PBM business, during 2022 we divested PANTHERx and Magellan Rx. We completed the divestiture of PANTHERx in July 2022 for $1.4 billion and recognized a gain of $490&#160;million, or $382 million after-tax. In December 2022, we completed the divestiture of Magellan Rx for $1.3 billion and recognized a gain of $269 million, or $99&#160;million after-tax.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, as part of our review of strategic alternatives for our international portfolio, in November 2022 we divested our ownership stakes in our Spanish and Central European businesses and as a result recorded an impairment charge of $163 million, or $140&#160;million after-tax.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above-noted acquisitions and divestitures are significant drivers of the year-over-year variances discussed throughout this section.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, we completed the divestitures of Magellan Specialty Health, Centurion, our prison healthcare business, and HealthSmart, our third party health plan administration business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Trends and Uncertainties </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States government, policymakers, and healthcare experts continue to discuss and debate various elements of the United States healthcare model. We remain focused on the promise of delivering access to high-quality, affordable healthcare to all of our members and believe we are well positioned to meet the needs of the changing healthcare landscape.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In contrast to previous executive and legislative efforts to restrict or limit certain provisions of the Affordable Care Act (ACA), the American Rescue Plan Act (ARPA), enacted in March 2021, contained provisions aimed at leveraging Medicaid and the Health Insurance Marketplace to expand health insurance coverage and affordability to consumers. The ARPA authorized an additional $1.9 trillion in federal spending to address the COVID-19 public health emergency (PHE), and contained several provisions designed to increase coverage of certain healthcare services, expand eligibility and benefits, incentivize state Medicaid expansion, and adjust federal financing for state Medicaid programs, the ultimate impact of which remain uncertain.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ARPA initially enhanced eligibility for the advance premium tax credit for enrollees in the Health Insurance Marketplace, which was extended through the 2025 tax year by the Inflation Reduction Act, enacted in August 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, the Treasury Department issued a final rule to address the family glitch in the ACA, which relates to determining who is eligible for premium subsidies. We see this as a significant step in making Marketplace more affordable for working families.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has impacted and may continue to affect our business. The Families First Coronavirus Response Act, enacted in March 2020, increased federal matching rates for state Medicaid programs with a requirement that states suspend Medicaid redeterminations throughout the PHE. As a result, since the onset of the PHE, our Medicaid membership has increased by 3.2 million members (excluding the new North Carolina and Missouri membership). The Consolidated Appropriations Act, 2023, signed into law on December 29, 2022, delinked the Medicaid continuous coverage requirements from the PHE and, as a result, states can begin Medicaid disenrollments on April 1, 2023. All pending redeterminations must be initiated within 12 months, by March 31, 2024, and be concluded by May 31, 2024. Our Ambetter Health product covers the majority of our Medicaid states, and we believe we are among the best positioned in the healthcare market to capture those transitioning coverage through redeterminations. We remain agile in working with our state partners and are prepared to support our members and promote continuity of coverage when redeterminations resume. Although Medicaid continuous coverage requirements were decoupled from the PHE, we are working to prepare for other provisions still tied to the end of the PHE including COVID costs and coverage requirements, various other payment structures, and electronic prescribing of controlled substances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have more than three decades of experience, spanning seven presidents from both sides of the aisle, in delivering high-quality healthcare services on behalf of states and the federal government to under-insured and uninsured families, commercial organizations, and military families. This expertise has allowed us to deliver cost-effective services to our government sponsors and our members. While healthcare experts maintain a focus on personalized healthcare technology, we continue to make strategic decisions to accelerate the development of new software platforms and analytical capabilities. We continue to believe we have both the capacity and capability to successfully navigate industry changes to the benefit of our members, customers, and shareholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding regulatory trends and uncertainties, see Part I, Item&#160;1 "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business - Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and Item&#160;1A, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Highlights</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial performance for 2022 is summarized as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Year-end membership of 27.1 million, an increase of 1.2 million members, or 5% over 2021.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues of $144.5 billion, representing 15% growth year-over-year.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Premium and service revenues of $135.5 billion, representing 15% growth year-over-year.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HBR of 87.7% for 2022, compared to 87.8% for 2021.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SG&amp;A expense ratio of 8.6% for 2022, compared to 8.1% for 2021. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted SG&amp;A expense ratio of 8.4% for 2022, compared to 7.9% for 2021. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Diluted earnings per share (EPS) of $2.07 for 2022, compared to $2.28 for 2021.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted diluted EPS of $5.78 for 2022, compared to $5.15 for 2021.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating cash flows of $6.3 billion, or 5.2 times net earnings, for 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation from GAAP diluted EPS to Adjusted Diluted EPS is highlighted below, and additional detail is provided under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Financial Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">": </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP diluted EPS attributable to Centene</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and divestiture related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax effects of adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Diluted EPS</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.78&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Other adjustments include the following pre-tax items:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) real estate impairments of $1,642 million, or $2.82 per share ($2.08 after-tax); PANTHERx divestiture gain of $490 million, or $0.84 per share ($0.65 after-tax); impairments of assets associated with the divestitures of our Spanish and Central European, Centurion, and HealthSmart businesses of $458 million, or $0.78 per share ($0.60 after-tax); Magellan Rx divestiture gain of $269 million, or $0.46 per share ($0.17 after-tax); Health Net Federal Services asset impairment of $233 million, or $0.40 per share ($0.39 after-tax); gain on debt extinguishment of $27 million, or $0.04 per share ($0.03 after-tax); increase to the previously reported gain on the divestiture of U.S. Medical Management (USMM) due to the finalization of working capital adjustments of $13 million, or $0.02 per share ($0.02 after-tax); and costs related to the PBM legal settlement of $6 million, or $0.01 per share ($0.00 after-tax).</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) PBM legal settlement expense of $1,264 million, or $2.14 per share ($1.76 after-tax); gain related to the acquisition of the remaining 60% interest of Circle Health of $309 million, or $0.52 per share ($0.52 after-tax); impairment of our equity method investment in RxAdvance of $229 million, or $0.39 per share ($0.32 after-tax); gain related to the divestiture of USMM of $150 million, or $0.25 per share ($0.23 after-tax); debt extinguishment costs of $125 million, or $0.21 per share ($0.16 after-tax); reduction to the previously reported gain on divestiture of certain products of our Illinois health plan of $62 million, or $0.10 per share ($0.08 after-tax); and severance costs due to a restructuring of $54 million, or $0.09 per share ($0.06 after-tax).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The income tax effects of adjustments are based on the effective income tax rates applicable to each adjustment. In addition, the year ended December 31, 2022, includes tax expense of $107 million, or $0.18 per share, related to the Magellan Specialty Health divestiture and a $15 million, or $0.03 per share, tax benefit related to the RxAdvance impairment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Current and Future Operating Drivers</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following items contributed to our results of operations as compared to the previous year:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicaid</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In October 2022, the state of Ohio removed pharmacy services in connection with the state's transition from managed care to a single PBM.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July 2022, our subsidiary, Home State Health, commenced the MO HealthNet Managed Care General Plan and Specialty Plan contracts. Under the General Plan, Home State Health continues to serve multiple MO HealthNet programs including Children's Health Insurance members and the state's newly implemented Medicaid expansion population, across all regions of Missouri. Additionally, as the sole provider of the newly awarded Specialty Plan, Home State Health now serves approximately 52,100 foster children and children receiving adoption subsidy assistance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In January 2022, the state of California carved out pharmacy services in connection with the state's transition of pharmacy services from managed care to fee-for-service. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July 2021, we began operating under two new statewide contracts in Hawaii to continue administering covered services to eligible Medicaid and Children's Health Insurance Program (CHIP) members for medically necessary medical, behavioral health, and long-term services and support and to continue administering services through the Community Care Services program in partnership with the Hawaii Department of Human Services' Med-QUEST Division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July 2021, our subsidiary, WellCare of North Carolina, commenced operations under a new statewide contract in North Carolina providing Medicaid managed care services. In addition, we also began operating under a new contract to provide Medicaid managed care services in three regions in North Carolina through our provider-led North Carolina joint venture, Carolina Complete Health.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Beginning in 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the federal government issued a PHE which suspended Medicaid eligibility redeterminations. The ongoing suspensions, which have been extended to April 2023, have driven increased membership.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In 2022, we experienced strong Medicare membership growth as a result of the 2022 annual enrollment period. We introduced WellCare into three new states, as well as expanded coverage to 327 new counties across existing states. We now serve members in 36 states across the country in 1,575 counties. We were negatively impacted by the decrease in the number of our Medicare members in a 4.0 star or above plan for the 2021 rating year (2022 revenue year).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In 2022, our Health Insurance Marketplace product, Ambetter Health, was introduced into five new states, as well as expanded coverage to 274 new counties across 13 existing states. During 2022, we served Marketplace members in 27 states across the country in 1,480 counties. Additionally, we introduced three new Ambetter Health product offerings to address the growing needs of our members: Ambetter Value, Ambetter Select, and Ambetter Virtual Access.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Specialty and Other</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In December 2022, we completed the divestiture of Magellan Rx, which was part of the Magellan business acquired in January 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In November 2022, we completed the divestiture of our ownership stakes in our Spanish and Central European businesses, including Ribera Salud, Torrej&#243;n Salud, and Pro Diagnostics Group.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July 2022, we completed the divestiture of PANTHERx.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In January 2022, we acquired all of the issued and outstanding shares of Magellan.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In December 2021, we sold a majority stake in USMM, our physician home health business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July 2021, we acquired the remaining interest in our equity method investment in Circle Health, one of the U.K.'s largest independent operators of hospitals.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect the following items to impact our future results of operations:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicaid</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In February 2023, our subsidiary, Buckeye Health Plan, commenced the Medicaid contract awarded by the Ohio Department of Medicaid to continue servicing members with quality healthcare, coordinated services, and benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In January 2023, our subsidiary, Delaware First Health, commenced its contract for the statewide Medicaid managed care programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In January 2023, our subsidiary, Louisiana Healthcare Connections, commenced the Medicaid contract awarded by the Louisiana Department of Health to continue administering quality, integrated healthcare services to members across the state.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In January 2023, our subsidiary, Managed Health Services, commenced the contract awarded by the Indiana Department of Administration to continue serving Hoosier Healthwise and Health Indiana Plan members with Medicaid and Medicaid alternative managed care and care coordination services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In December 2022, our subsidiary, Health Net of California, was selected by the California Department of Health Care Services for direct Medicaid contracts in 10 counties, including Los Angeles (in which a portion will be subcontracted). The contracts are anticipated to begin in January 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In September 2022, our subsidiary, Nebraska Total Care, was awarded the Nebraska Department of Health and Human Services statewide Medicaid managed care contract. Under the new contract, Nebraska Total Care will continue serving the state's Medicaid Managed Care Program, known as Heritage Health. The new contract term is five years and includes the option for two, one-year renewals. The contract is anticipated to begin in January 2024, subject to the resolution of third-party protests.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In September 2022, our subsidiary, Superior HealthPlan (Superior), was awarded a new, six-year contract by the Texas Health and Human Services Commission to continue providing youth in foster care with healthcare coverage through the STAR Health Medicaid program. Superior has been the sole provider of STAR Health coverage since the program launched in 2008. The contract is anticipated to begin in September 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In August 2022, our subsidiary, Magnolia Health Plan (Magnolia), was awarded the Mississippi Division of Medicaid contract. Under the new contract, Magnolia will continue serving the state's Coordinated Care Organization Program, which will consist of the Mississippi Coordinated Access Network and the Mississippi CHIP. The contract is anticipated to begin in July 2023, subject to the resolution of third-party protests.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In August 2021, our subsidiaries, Carolina Complete Health and WellCare of North Carolina, were selected to coordinate physical and/or other health services with Local Management Entities/Managed Care Organizations under the state's new Tailored Plans. The Tailored Plans, which are expected to launch in April 2023, are integrated health plans designed for individuals with significant behavioral health needs and intellectual/developmental disabilities. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We expect Medicaid eligibility redeterminations to begin in April 2023 and extend over a 14-month period, concluding in May 2024. In addition to delinking the Medicaid continuous enrollment provision from the PHE, the year-end spending bill also outlines key coverage expansion provisions, including CHIP coverage. The provision requires states to provide 12 months of continuous coverage for children under Medicaid and CHIP effective January of 2024 and made the state option to extend coverage for postpartum women for up to 12 months permanent.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In October 2022, the Centers for Medicare and Medicaid Services (CMS) published updated Medicare Star quality ratings for the 2023 rating year, which impacts the 2024 revenue year. The decrease in Star quality ratings is driven by the expiration of certain disaster relief provisions as well as deterioration in select metrics. Over the past year, our leadership team launched a multi-year plan to build and improve quality across the enterprise with a strong focus on enhanced patient experience and access to care. We expect to begin to see the results of these efforts with the 2024 rating year (2025 revenue year).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In January 2023, our Health Insurance Marketplace product, Ambetter Health, expanded into Alabama and extended its footprint by more than 60 counties across 12 existing states. In total, the Marketplace plan is available in more than 1,500 counties across 28 states.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Specialty and Other</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In January 2023, we completed the divestitures of Magellan Specialty Health, Centurion, our prison healthcare business, and HealthSmart, our third party health plan administration business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In December 2022, the Department of Defense (DoD) announced that the TRICARE Managed Care Support Contracts were not awarded to our subsidiary, Health Net Federal Services. Our current contract for health care delivery services is in place through early 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We continue to execute on Value Creation Plan initiatives including the award of the new PBM contract commencing in 2024, portfolio review, real estate optimization, stock and debt repurchases, along with an ongoing focus on quality improvement actions. We expect these actions will drive future margin expansion, create shareholder value, and improve the experience for our members and providers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEMBERSHIP</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From December&#160;31, 2021 to December&#160;31, 2022, we increased our managed care membership by 1.2 million, or 5%. The following table sets forth our membership by line of business:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.807%"><tr><td style="width:1.0%"></td><td style="width:1.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.813%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Traditional Medicaid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,264,800&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,328,400&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High Acuity Medicaid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,686,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicaid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,974,800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,014,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Marketplace</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,076,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Group</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Commercial</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,517,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,602,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) (4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,511,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,252,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare PDP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,226,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,070,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total at-risk membership</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,229,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,939,800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRICARE eligibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,832,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,874,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,061,400&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,814,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Membership includes Temporary Assistance for Needy Families (TANF), Medicaid Expansion, Children's Health Insurance Program (CHIP), Foster Care, and Behavioral Health.</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Membership includes Aged, Blind, or Disabled (ABD), Intellectual and Developmental Disabilities (IDD), Long-Term Services and Supports (LTSS), and Medicare-Medicaid Plans (MMP) Duals.</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Membership includes Medicare Advantage and Medicare Supplement.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Medicaid and Medicare membership includes 1,291,300 and 1,178,000 dual-eligible beneficiaries for the periods ending December&#160;31, 2022, and December&#160;31, 2021, respectively.</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis is based on our Consolidated Statements of Operations, which reflect our results of operations for years ended December 31, 2022 and 2021, respectively, prepared in accordance with generally accepted accounting principles in the United States (GAAP) ($ in millions, except per share data in dollars):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.277%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change 2021-2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,131&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,319&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,479&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,983&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,547&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,982&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n.m.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n.m.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n.m.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(665)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(665)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income tax expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n.m.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to Centene Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share attributable to Centene Corporation</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">n.m.: not meaningful</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Year Ended December 31, 2022 Compared to Year Ended December 31, 2021</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth supplemental revenue information for the year ended December 31, ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change 2021-2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,157&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,139&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,547&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,982&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare includes Medicare Advantage, Medicare Supplement, and Medicare prescription drug plan (PDP).</span></div></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues increased 15% in the year ended December 31, 2022, over the corresponding period in 2021, primarily due to Medicaid membership growth resulting from the ongoing suspension of eligibility redeterminations, membership growth in the Medicare business, our acquisition of Magellan, and the commencement of our contracts in North Carolina in mid-2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The HBR for the year ended December 31, 2022 was 87.7%, compared to 87.8% in 2021. The HBR for 2022 was positively impacted by disciplined Marketplace pricing and 2021 risk adjustment recorded in 2022, partially offset by a return to more normalized Medicaid utilization and higher flu costs compared to 2021. Additionally, 2021 was negatively impacted by unfavorable 2020 risk adjustment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Services </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of services increased by $2.1 billion in the year ended December 31, 2022, compared to the corresponding period in 2021, driven by the acquisition of Magellan. The cost of service ratio for the year ended December 31, 2022 was 84.2%, compared to 86.4% in 2021. The decrease in the cost of service ratio was driven by recent acquisitions and divestitures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, General &amp; Administrative Expenses</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SG&amp;A expense ratio was 8.6% for the year ended December 31, 2022, compared to 8.1% for the year ended December 31, 2021. The Adjusted SG&amp;A expense ratio was 8.4% for the year ended December 31, 2022, compared to 7.9% for the year ended December 31, 2021. The increases were due to the additions of the Magellan and Circle Health businesses, which operate at higher SG&amp;A ratios due to the nature of their respective businesses. Increases were also driven by costs associated with Medicare marketing, including annual enrollment, value creation investment spending, and variable compensation. These impacts were partially offset by the leveraging of expenses over higher revenues as a result of increased membership.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, we recorded total impairment charges of $2.3 billion primarily driven by $1.6 billion associated with our ongoing real estate optimization initiative, consisting of leased and owned real estate assets and related fixed assets. Additionally, we recorded impairment charges associated with the divestitures of our Spanish and Central European, Centurion, and HealthSmart businesses of $458 million. We also recorded a $233 million impairment charge related to Health Net Federal Services business as a result of the DoD's December 2022 announcement to not award Health Net Federal Services a TRICARE Managed Care Support Contract.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, we recorded a $229&#160;million impairment of our equity method investment in RxAdvance, a pharmacy benefit manager.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Settlement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, we recorded a legal settlement reserve estimate of $1.25 billion (inclusive of the states with which we have reached no-fault agreements) related to services previously provided by Envolve Pharmacy Solutions, Inc. (Envolve), which historically provided PBM and specialty pharmacy services, essentially during 2017 and 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Income (Expense)</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of other income (expense) for the year ended December 31, ($ in millions):&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(665)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(665)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment and other income. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment and other income increased by $460 million for the year ended December 31, 2022 compared to 2021, driven by the $490 million PANTHERx divestiture gain, the $269 million Magellan Rx divestiture gain, and higher interest rates on larger investment balances. The 2021 investment income was driven by the gain related to the acquisition of the remaining 60% interest of Circle Health of $309 million and the gain related to the divestiture of USMM of $150 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt extinguishment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we repurchased $95 million of our 4.25% Senior Notes due 2027 and $223 million of our 4.625% Senior Notes due 2029 through our senior note debt repurchase program, resulting in a pre-tax gain on extinguishment of $14 million. Additionally, we recognized a $13 million pre-tax gain on the extinguishment of debt related to the refinancing of debt for our Circle Health subsidiary. The 2022 debt extinguishment also includes an immaterial gain related to the redemption of Magellan's outstanding Senior Notes in January 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we redeemed all of our outstanding 5.375% Senior Notes due 2026 and all WellCare Health Plans, Inc.'s outstanding 5.375% Senior Notes due 2026, including all premiums and accrued interest. We recognized a pre-tax loss on extinguishment of $79 million, including the call premium, the write-off of the unamortized premium and debt issuance costs, and expenses related to the redemptions. Additionally, we tendered or redeemed all of our outstanding $2.2 billion 4.75% Senior Notes, due 2025, and recognized a pre-tax loss on extinguishment of approximately $46 million. The loss includes the call premium and the write-off of unamortized premium and debt issuance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the year ended December 31, 2022 was $665 million compared to $665 million for the corresponding period in 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2022, we recorded an income tax expense of $760 million on pre-tax earnings of $2.0 billion, or an effective tax rate of 38.8%. The effective tax rate for the year ended December 31, 2022 is driven by the tax effects of pending and completed divestitures and impairments associated with our ongoing portfolio review, including the Magellan Rx divestiture gain, the non-deductible impairment of our Health Net Federal Services business, and tax impacts related to the reclassification of the Magellan Specialty Health business to held for sale. For the year ended December 31, 2021, we recorded income tax expense of $477 million on pre-tax earnings of $1.8 billion, or an effective tax rate of 26.3%, which reflects the non-taxable gain related to the acquisition of the remaining 60% interest in Circle Health, the partial non-deductibility of the legal settlement reserve, and the gain on the sale of our majority stake in USMM.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Results</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our consolidated operating results by segment for the year ended December 31, ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change 2021-2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Care</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,063&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,795)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,982&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings from Operations</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Care</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(595)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n.m.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">n.m.: not meaningful</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Managed Care</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues increased 12% in the year ended December 31, 2022, compared to the corresponding period in 2021, driven by organic Medicaid growth, primarily due to the ongoing suspension of eligibility redeterminations, membership growth in the Medicare business, and the commencement of our contracts in North Carolina. Earnings from operations increased $124 million between years primarily as a result of Medicaid and Medicare membership growth, favorable Marketplace 2021 risk adjustment recorded in 2022, and lower traditional utilization in the Marketplace business, partially offset by the $1.6 billion pre-tax real estate impairment. Additionally, 2021 was negatively impacted by the PBM legal settlement expense of $1.25 billion and higher utilization in the Marketplace business in 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Specialty Services</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues increased 22% in the year ended December 31, 2022, compared to the corresponding period in 2021, resulting primarily from our acquisition of Magellan, increased services associated with membership growth in the Managed Care segment, and new contracts in our correctional business. Earnings from operations decreased $590 million between years, primarily due to divestitures and impairments. The decrease was partially offset by favorable Magellan operations and the prior year impairment of our equity method investment in RxAdvance.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a condensed schedule of cash flows used in the discussion of liquidity and capital resources ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,261&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,205&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,921)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,299)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(868)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Provided by Operating Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Normal operations are funded primarily through operating cash flows and borrowings under our Revolving Credit Facility.&#160;In 2022, operating activities provided cash of $6.3 billion, or 5.2 times net earnings, compared to $4.2 billion in 2021. Cash flows provided by operations in 2022 were driven by net earnings before the non-cash real estate and divestiture related impairment charges and an increase in medical claims liabilities driven by the timing of claims payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows provided by operations in 2021 were due to net earnings before the legal settlement reserve, an increase in state risk sharing mechanism payables, partially offset by risk adjustment and minimum medical loss ratio (MLR) payments for the Health Insurance Marketplace 2020 plan year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Used in Investing Activities</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities used cash of $2.9 billion for the year ended December 31, 2022 and $3.3 billion in 2021. Cash flows used in investing activities in 2022 primarily consisted of net additions to the investment portfolio of our regulated subsidiaries and our acquisition of Magellan, partially offset by our PANTHERx and Magellan Rx divestiture proceeds.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We spent $1.0 billion and $910 million in the years ended December 31, 2022 and 2021, respectively, on capital expenditures for system enhancements, market growth, and our corporate and regional buildings.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, our investment portfolio consisted primarily of fixed-income securities with a weighted average duration of 3.4 years. We had unregulated cash and investments of $1.4 billion at December&#160;31, 2022. The majority of the excess unregulated cash and cash equivalents was utilized in January 2023 to complete planned pass-through payments. At December&#160;31, 2021 we had unregulated cash and investments of $3.4 billion, which was substantially reduced in January 2022 to fund the Magellan acquisition. Unregulated cash and investments include private equity investments and company owned life insurance contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows used in investing activities in&#160;2021&#160;primarily consisted of the net additions to the investment portfolio of our regulated subsidiaries (including transfers from cash and cash equivalents to long-term investments), acquisition and divestiture activity primarily related to the acquisition of the remaining 60% interest of Circle Health, and capital expenditures, offset by proceeds received related to the sale of our majority interest in USMM.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows (Used in) Provided by Financing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities used cash of $4.2 billion in the year ended December 31, 2022, compared to providing cash of $1.4 billion in the comparable period in 2021. Financing activities in 2022 were driven by stock repurchases of $3.0 billion, the redemption of Magellan's outstanding debt of $535 million assumed in the transaction using Magellan's cash on hand, senior note debt repurchases of $318 million, and the repayment of our construction loan. In 2021, financing activities were driven by increased borrowings offset by debt repayments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity Metrics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a stock repurchase program authorizing us to repurchase common stock from time to time on the open market or through privately negotiated transactions. In 2022, in preparation for the closing of divestitures as well as planning for the future, the Company's Board of Directors authorized up to a total of $6.0 billion of repurchases under the program.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we repurchased a total of 35.7 million shares for $3.0 billion through our stock repurchase program, primarily funded through divestiture proceeds. A portion of the repurchases were completed through an accelerated share repurchase (ASR) agreement, which was executed in July 2022. At inception, we received an initial delivery of approximately 8.6 million shares representing 80% of the $1.0 billion notional amount. In October 2022, an additional 3.0 million shares were delivered upon settlement based upon the volume-weighted average price (VWAP) over the term of the agreement, less a discount. In total, 11.6 million shares were purchased through the $1.0 billion ASR.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have approximately $2.8 billion remaining under the stock repurchase program as of December&#160;31, 2022. No duration has been placed on the repurchase program. We reserve the right to discontinue the repurchase program at any time. Refer to Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on stock repurchases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had an aggregate principal amount of $15.7 billion of senior notes issued and outstanding. The indentures governing our various maturities of senior notes contain limited restrictive covenants. As of December&#160;31, 2022, we were in compliance with all covenants. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our capital allocation strategy, we may decide to repurchase debt or raise capital through the issuance of debt in the form of senior notes. In 2022, the Company's Board of Directors also authorized a new $1.0 billion senior note debt repurchase program. During 2022, we repurchased $318 million of our par value senior notes for $300 million. As of December&#160;31, 2022, there was $700 million available under the senior note debt repurchase program. Refer to Note 10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information regarding the issuance and redemption of senior notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit agreement underlying our Revolving Credit Facility and Term Loan Facility contains customary covenants, as well as financial covenants, including, a minimum fixed charge coverage ratio and a maximum debt to EBITDA ratio. Our maximum debt to EBITDA ratio under the credit agreement may not exceed 4.0 to 1.0. As of December&#160;31, 2022, we had $58 million of borrowings outstanding under our Revolving Credit Facility, $2.2 billion of borrowings outstanding under our Term Loan Facility, and we were in compliance with all covenants. As of December&#160;31, 2022, there were no limitations on the availability of our Revolving Credit Facility as a result of the debt to EBITDA ratio.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, we executed a $200 million non-recourse construction loan to fund the expansion of our corporate headquarters. In December 2022, we paid off the outstanding balance of the construction loan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had outstanding letters of credit of $217 million as of December&#160;31, 2022, which were not part of our Revolving Credit Facility. The letters of credit bore weighted interest of 0.6% as of December&#160;31, 2022. In addition, we had outstanding surety bonds of $1.3 billion as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, our debt to capital ratio, defined as total debt divided by the sum of total debt and total equity, was 42.7%, compared to 41.2% at December&#160;31, 2021. The debt to capital ratio increase was driven by stock repurchases in 2022. We utilize the debt to capital ratio as a measure, among others, of our leverage and financial flexibility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had working capital, defined as current assets less current liabilities, of $1.7 billion, compared to $2.7 billion at December&#160;31, 2021. Working capital was substantially reduced in January 2022 upon the closing of the Magellan acquisition for the purchase price payment and corresponding closing costs. We manage our short-term and long-term investments with the goal of ensuring that a sufficient portion is held in investments that are highly liquid and can be sold to fund short-term requirements as needed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2022 and 2021, we received dividends of $1.6&#160;billion and $2.5&#160;billion, respectively, from our regulated subsidiaries.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2023 Expectations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, we expect to receive net dividends of approximately $2.1&#160;billion from our regulated subsidiaries and expect to spend approximately $845&#160;million in capital expenditures primarily associated with system enhancements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have material debt, short-term medical claims, lease, and contingencies obligations. Refer to Note 10. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 8. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Claims Liability, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Note 18. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our operating plan, we expect that our available cash, cash equivalents and investments, cash from our operations, and cash available under our Revolving Credit Facility will be sufficient to finance our general operations and capital expenditures for at least 12 months from the date of this filing. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we are currently in a strong liquidity position and believe we have adequate access to capital, we may elect to increase borrowings on our Revolving Credit Facility. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time we may elect to raise additional funds for these and other purposes, either through issuance of debt or equity, the sale of investment securities, or otherwise, as appropriate. In addition, we may strategically pursue refinancing or redemption opportunities to extend maturities and/or improve terms of our indebtedness if we believe such opportunities are favorable to us. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to continue to evaluate strategic actions in connection with our Value Creation Plan, targeting initiatives to improve productivity, efficiencies, and reduced organizational costs, as well as capital deployment activities, including stock repurchases, portfolio optimization, and the evaluation of refinancing opportunities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REGULATORY CAPITAL AND DIVIDEND RESTRICTIONS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are conducted through our subsidiaries.&#160;As managed care organizations (MCOs), most of our subsidiaries are subject to state regulations and other requirements that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state, and restrict the timing, payment, and amount of dividends and other distributions that may be paid to us.&#160;Generally, the amount of dividend distributions that may be paid by a regulated subsidiary without prior approval by state regulatory authorities is limited based on the entity's level of statutory net income and statutory capital and surplus.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, our subsidiaries had aggregate statutory capital and surplus of $16.4 billion, compared with the required minimum aggregate statutory capital and surplus requirements of $8.0 billion.&#160;During the year ended December&#160;31, 2022, we received dividends of $1.6 billion from and made $729&#160;million of capital contributions to our regulated subsidiaries. For our subsidiaries that file with the National Association of Insurance Commissioners (NAIC), we estimate our Risk Based Capital (RBC) percentage to be in excess of 350% of the Authorized Control Level.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the California Knox-Keene Health Care Service Plan Act of 1975, as amended (Knox-Keene), certain of our California subsidiaries must comply with tangible net equity (TNE) requirements. Under these Knox-Keene TNE requirements, actual net worth less unsecured receivables and intangible assets must be more than the greater of (i) a fixed minimum amount, (ii) a minimum amount based on premiums, or (iii) a minimum amount based on healthcare expenditures, excluding capitated amounts.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the New York State Department of Health Codes, Rules and Regulations Title 10, Part 98, our New York subsidiary must comply with contingent reserve requirements. Under these requirements, net worth based upon admitted assets must equal or exceed a minimum amount based on annual net premium income.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NAIC has adopted rules which set minimum risk-based capital requirements for insurance companies, MCOs, and other entities bearing risk for healthcare coverage.&#160;As of December&#160;31, 2022, each of our health plans was in compliance with the risk-based capital requirements enacted in those states.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the above requirements and other regulatory requirements, certain of our subsidiaries are subject to restrictions on their ability to make dividend payments, loans, or other transfers of cash to their parent companies. Such restrictions, unless amended or waived or unless regulatory approval is granted, limit the use of any cash generated by these subsidiaries to pay our obligations. The maximum amount of dividends that can be paid by our insurance company subsidiaries without prior approval of the applicable state insurance departments is subject to restrictions relating to statutory surplus, statutory income, and unassigned surplus. As of December&#160;31, 2022, the amount of capital and surplus or net worth that was unavailable for the payment of dividends or return of capital to us was&#160;$8.0 billion&#160;in the aggregate.&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For this information, refer to Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the Notes to the Consolidated Financial Statements, included herein. </span></div><div style="text-align:center;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING ESTIMATES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discussion and analysis of our results of operations and liquidity and capital resources are based on our consolidated financial statements which have been prepared in accordance with GAAP. Our significant accounting policies are more fully described in Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included elsewhere herein. Our accounting policies regarding intangible assets, medical claims liability, and revenue recognition are particularly important to the portrayal of our financial condition and results of operations and require the application of significant judgment by our management. As a result, they are subject to an inherent degree of uncertainty. We have reviewed these critical accounting policies and related disclosures with the Audit and Compliance Committee of our Board of Directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and Intangible Assets </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made several acquisitions that have resulted in our recording of intangible assets. These intangible assets primarily consist of purchased contract rights and customer relationships, provider contracts, trade names, developed technologies, and goodwill. Key assumptions used in the valuation of these intangible assets include, but are not limited to, member attrition rates, contract renewal probabilities, revenue growth rates, expectations of profitability, and discount and royalty rates. We allocate the fair value of purchase consideration to the assets acquired and liabilities assumed based on their fair values at the acquisition date. The excess of the fair value of consideration transferred over the fair value of the net assets acquired is recorded as goodwill. Goodwill is generally attributable to the value of the synergies between the combined companies and the value of the acquired assembled workforce, neither of which qualifies for recognition as an intangible asset. At December&#160;31, 2022, we had $18.8 billion of goodwill and $6.9 billion of other intangible assets.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are amortized using the straight-line method over the following periods:</span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.245%"><tr><td style="width:1.0%"></td><td style="width:71.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.798%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights and customer relationships</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 21 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 - 15 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 - 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 7 years</span></div></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management evaluates whether events or circumstances have occurred that may affect the estimated useful life or the recoverability of the remaining balance of goodwill and other identifiable intangible assets. If the events or circumstances indicate that the remaining balance of the intangible asset or goodwill may be impaired, the potential impairment will be measured based upon the difference between the carrying amount of the intangible asset or goodwill and the fair value of such asset. Our management must make assumptions and estimates, such as the discount factor, future utility, and other internal and external factors, in determining the estimated fair values. While we believe these assumptions and estimates are appropriate, other assumptions and estimates could be applied and might produce significantly different results. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is reviewed annually during the fourth quarter for impairment. In addition, an impairment analysis of intangible assets would be performed based on other factors. These factors include significant changes in membership, financial performance, state funding, medical contracts, and provider networks and contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a reporting unit's carrying amount exceeds its fair value, an entity will record an impairment charge based on that difference. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. We first assess qualitative factors to determine if a quantitative impairment test is necessary. We generally do not calculate the fair value of a reporting unit unless we determine, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. However, in certain circumstances, such as recent acquisitions, we may elect to perform a quantitative assessment without first assessing qualitative factors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe any of our reporting units are currently at risk for impairment. However, as part of our Value Creation Plan, we are completing a portfolio review and may identify changes in strategic focus, which could result in future impairments of goodwill or intangibles based on market indicators at that time.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical Claims Liability </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our medical claims liability includes claims reported but not yet paid, or inventory, estimates for claims incurred but not reported (IBNR), and estimates for the costs necessary to process unpaid claims at the end of each period.&#160;We estimate our medical claims liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice.&#160;These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actuarial Standards of Practice generally require that the medical claims liability estimates be adequate to cover obligations under moderately adverse conditions.&#160;Moderately adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of estimate.&#160;The claims amounts ultimately settled will most likely be different than the estimate that satisfies the Actuarial Standards of Practice. We include in our IBNR an estimate for medical claims liability under moderately adverse conditions which represents the risk of adverse deviation of the estimates in our actuarial method of reserving.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use our judgment to determine the assumptions to be used in the calculation of the required estimates. The assumptions we consider when estimating IBNR include, without limitation, claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, healthcare service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known outbreaks of disease or increased incidence of illness such as influenza, provider contract changes, changes to fee schedules, and the incidence of high dollar or catastrophic claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply various estimation methods depending on the claim type and the period for which claims are being estimated.&#160;For more recent periods, incurred non-inpatient claims are estimated based on historical per member per month claims experience adjusted for known factors.&#160;Incurred hospital inpatient claims are estimated based on known inpatient utilization data and prior claims experience adjusted for known factors.&#160;For older periods, we utilize an estimated completion factor based on our historical experience to develop IBNR estimates.&#160;The completion factor is an actuarial estimate of the percentage of claims that have been received or adjudicated as of the end of a reporting period relative to the estimate of the total ultimate incurred costs for that same period.&#160;When we commence operations in a new state or region, we have limited information with which to estimate our medical claims liability.&#160;See "Risk Factors - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to accurately estimate and price our medical expenses or effectively manage our medical costs or related administrative costs could have a material adverse effect on our results of operations, financial condition, and cash flows.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" These approaches are consistently applied to each period presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our development of the medical claims liability estimate is a continuous process which we monitor and refine on a monthly basis as additional claims receipts and payment information becomes available. As more complete claims information becomes available, we adjust the amount of the estimates and include the changes in estimates in medical costs in the period in which the changes are identified. In every reporting period, our operating results include the effects of more completely developed medical claims liability estimates associated with previously reported periods. We consistently apply our reserving methodology from period to period. As additional information becomes known to us, we adjust our actuarial models accordingly to establish medical claims liability estimates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The paid and received completion factors, claims per member per month, and per diem cost trend factors are the most significant factors affecting the IBNR estimate.&#160;The following table illustrates the sensitivity of these factors and the estimated potential impact on our operating results caused by changes in these factors based on December&#160;31, 2022 data:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:23.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Completion Factors: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost Trend Factors: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease) Increase <br/>in Factors</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease) in<br/>Medical Claims Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease) Increase <br/>in Factors</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease) in<br/>Medical Claims Liabilities</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.00)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.00)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(782)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,038)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="21" style="padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Reflects estimated potential changes in medical claims liability caused by changes in completion factors.</span></div></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Reflects estimated potential changes in medical claims liability caused by changes in cost trend factors for the most recent periods.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe our estimates are appropriate, it is possible future events could require us to make significant adjustments for revisions to these estimates.&#160;For example, a 1% increase or decrease in our estimated medical claims liability would have affected net earnings by $103 million for the year ended December&#160;31, 2022, excluding the effect of any return of premium, risk corridor, or minimum MLR programs.&#160;The estimates are based on our historical experience, terms of existing contracts, our observance of trends in the industry, information provided by our providers, and information available from other outside sources.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in medical claims liability is summarized as follows (in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1,</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,243&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,473&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,453&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,783)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31,</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,745&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,243&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Days in claims payable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Days in claims payable is a calculation of medical claims liability at the end of the period divided by average expense per calendar day for the fourth quarter of each year.</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical claims are usually paid within a few months of the member receiving service from the physician or other healthcare provider.&#160;As a result, the liability generally is described as having a "short-tail," which causes less than 5% of our medical claims liability as of the end of any given year to be outstanding the following year.&#160;We believe that substantially all the development of the estimate of medical claims liability as of December&#160;31, 2022 will be known by the end of 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. Additionally, as a result of minimum HBR and other return of premium programs, approximately $198 million, $492 million, and $86 million of the "Incurred related to: Prior years" was recorded as a reduction to premium revenues in 2022, 2021, and 2020, respectively. Further, claims processing initiatives yielded increased claim payment recoveries and coordination of benefits related to prior year dates of service. Changes in medical utilization and cost trends and the effect of population health management initiatives may also contribute to changes in medical claim liability estimates.&#160;While we have evidence that population health management initiatives are effective on a case by case basis, these initiatives primarily focus on events and behaviors prior to the incurrence of the medical event and generation of a claim. Accordingly, any change in behavior, leveling of care, or coordination of treatment occurs prior to claim generation and as a result, the costs prior to the population health management initiative are not known by us. Additionally, certain population health management initiatives are focused on member and provider education with the intent of influencing behavior to appropriately align the medical services provided with the member's acuity. In these cases, determining whether the population health management initiative changed the behavior cannot be determined. Because of the complexity of our business, the number of states in which we operate, and the volume of claims that we process, we are unable to practically quantify the impact of these initiatives on our changes in estimates of IBNR.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are examples of population health management initiatives that may have contributed to the favorable development through lower medical utilization and cost trends:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Appropriate leveling of care for neonatal intensive care unit hospital admissions, other inpatient hospital admissions, and observation admissions, in accordance with InterQual or other evidence-based criteria or clinical policy. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management of our pre-authorization list, monitoring for over utilized services, and stringent review of durable medical equipment and injectables.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Emergency department programs designed to collaboratively work with hospitals and members to steer non-emergent care to a more appropriate and cost effective setting (through patient education, on-site alternative urgent care settings, etc.).</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased emphasis on care management and clinical rounding where nurse or social worker care managers assist selected high-risk members with the coordination of healthcare services in order to meet a patient's specific healthcare needs.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Incorporation of disease management, which is a comprehensive, multidisciplinary, collaborative approach to chronic illnesses such as asthma.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prenatal and infant health programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our health plans generate revenues primarily from premiums received from the states in which we operate health plans, premiums received from our members and CMS for our Medicare product, and premiums from members of our commercial health plans. In addition to member premium payments, our Marketplace contracts also generate revenues from subsidies received from CMS. We generally receive a fixed premium per member per month pursuant to our contracts and recognize premium revenues during the period in which we are obligated to provide services to our members at the amount reasonably estimable. In some instances, our base premiums are subject to an adjustment, in the form of a risk score or risk adjustment, based on the acuity of our membership. Generally, the risk score or risk adjustment is determined by the state or CMS analyzing submissions of processed claims and medical record data to determine the acuity of our membership, often relative to the respective program's membership. We estimate the amount of risk score and risk adjustment based upon the processed claims and medical record data submitted and expected to be submitted to CMS and record revenues on a risk adjusted basis. Some contracts allow for additional premiums related to certain supplemental services provided such as maternity deliveries.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with states may require us to maintain a minimum HBR or may require us to share cost-savings in excess of certain levels. In certain circumstances, including commercial plans, our plans may be required to return premium to the state or policyholders in the event costs are below established levels. We estimate the effect of these programs and recognize reductions in revenue in the current period. Other states may require us to meet certain performance and quality metrics in order to receive additional or full contractual revenue. For performance-based contracts, we do not recognize revenue subject to refund until data is sufficient to measure performance.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recorded based on membership and eligibility data provided by the states or CMS, which is adjusted on a monthly basis by the states or CMS for retroactive additions or deletions to membership data. These eligibility adjustments are estimated monthly and subsequent adjustments are made in the period known. We continuously review and update those estimates as new information becomes available.&#160;It is possible that new information could require us to make additional adjustments, which could be significant, to these estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medicare Advantage contracts are with CMS. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model pays more for members whose medical history would indicate that they are expected to have higher medical costs. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis data from hospital inpatient, hospital outpatient, physician treatment settings as well as prescription drug events. We and the healthcare providers collect, compile and submit the necessary and available diagnosis data to CMS within prescribed deadlines. We estimate risk adjustment revenues based upon the diagnosis data submitted and expected to be submitted to CMS and record revenues on a risk adjusted basis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For qualifying low-income prescription drug benefit members, CMS pays for some, or all, of the member's monthly premium. We receive certain Part D prospective subsidy payments from CMS for these members as a fixed monthly per member amount, based on the estimated costs of providing prescription drug benefits over the plan year, as reflected in our bids. Approximately nine to ten months subsequent to the end of the plan year, or later in the case of the coverage gap discount subsidy, a settlement payment is made between CMS and our plans based on the difference between the prospective payments and actual claims experience. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our specialty services generate revenues under contracts with state and federal programs, healthcare organizations, and other commercial organizations, as well as from our own subsidiaries. Revenues are recognized when the related services are provided or as ratably earned over the covered period of services. For performance-based measures in our contracts, revenue is recognized as data sufficient to measure performance is available. We recognize revenue related to administrative services under the TRICARE government-sponsored Managed Care Support Contract for the DoD's TRICARE program on a straight-line basis over the option period, when the fees become fixed and determinable. The TRICARE contract includes various performance-based measures.&#160;For each of the measures, an estimate of the amount that has been earned is made at each interim date, and revenue is recognized accordingly.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states enact premium taxes, similar assessments, and provider pass-through payments, collectively premium taxes, and these taxes are recorded as a separate component of both revenues and operating expenses. Additionally, our insurance subsidiaries were previously subject to the ACA annual health insurer fee (HIF). Beginning in 2021, the HIF was permanently repealed. This revenue was recorded as premium tax and health insurer fee revenue in the Consolidated Statements of Operations. For certain products, premium taxes, state assessments, and the HIF are not pass-through payments and are recorded as premium revenue and premium tax expense or health insurer fee expense in the Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states require state directed payments that have minimal risk, but are administered as a premium adjustment.&#160;These payments are recorded as premium revenue and medical costs at close to a 100% HBR. In many instances, we have little visibility to the timing of these payments until they are paid by the state.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk represents the risk of loss that may impact our financial condition due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in interest rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INVESTMENTS AND DEBT</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had short-term investments of $2.3 billion and long-term investments of $15.9 billion, including restricted deposits of $1.2 billion.&#160;The short-term investments generally consist of highly liquid securities with maturities between three and 12 months.&#160;The long-term investments consist of municipal, corporate and U.S. Treasury securities, government-sponsored obligations, life insurance contracts, asset backed securities, equity securities, and private equity investments and have maturities greater than one year.&#160;Restricted deposits consist of investments required by various state statutes to be deposited or pledged to state agencies.&#160;Due to the nature of the states' requirements, these investments are classified as long-term regardless of the contractual maturity date.&#160;Substantially all of our investments are subject to interest rate risk and will decrease in value if market rates increase.&#160;Assuming a hypothetical and immediate 1% increase in market interest rates at December&#160;31, 2022, the fair value of our fixed income investments would decrease by approximately $583 million.&#160;Declines in interest rates over time will reduce our investment income. The Company does not hold or issue any derivative instruments for trading or speculative purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of&#160;the interest rate risk that our investments are subject to, see "Risk Factors -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investment portfolio may suffer losses which could materially and adversely affect our results of operations or liquidity.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Statements and Supplementary Data</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div id="i9dee570cfbd043d6a1700298c14b2446_79"></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:15pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and Board of Directors</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Centene Corporation:</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opinion on the Consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Centene Corporation and&#160;subsidiaries (the Company) as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive earnings (loss), stockholders' equity, and cash flows for each of the years in the three&#8209;year period ended December&#160;31, 2022, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the three&#8209;year period ended December&#160;31, 2022, in conformity with U.S.&#160;generally accepted accounting principles.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December&#160;31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February&#160;21, 2023 expressed an unqualified opinion on the effectiveness of the Company's internal control over financial reporting.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matters</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit and compliance committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of the estimated medical claims liability </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 2 to the consolidated financial statements, the Company's medical claims liability includes claims reported but not yet paid, estimates for claims incurred but not reported, and estimates for the costs necessary to process unpaid claims. As discussed in Note 8 to the consolidated financial statements, the balance at December&#160;31, 2022 was $16,745 million.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the evaluation of the estimated medical claims liability as a critical audit matter. The Company estimates its medical claims liability using actuarial methods. Specialized skills were required to evaluate these actuarial methods, which include analyzing historical claims data in order to estimate the medical claims liability. The medical claims liability included an estimate for medical claims developing under moderately adverse conditions, which represents the risk of adverse deviation in the Company's actuarial methods of reserving, which required auditor judgment to evaluate.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the critical audit matter. This included controls over the Company's process to evaluate the estimate of the medical claims liability. We involved actuarial professionals with specialized skills and knowledge who evaluated the actuarial methods used by the Company to estimate the medical claims liability. With the assistance of the actuarial professionals, we challenged the Company's estimate of the medical claims liability, including the effects of moderately adverse conditions, by developing an independent estimate for certain health plans using the Company's medical claims data, and relative range. We assessed the potential for management bias by evaluating the Company's position and movement within the actuarial professionals' relative range. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of the estimated Affordable Care Act risk adjustment accruals</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 2 to the consolidated financial statements, the Affordable Care Act (ACA) established a permanent risk adjustment program. This program transfers funds from qualified individual and small group insurance plans with below average risk scores to those insurance plans with above average risk scores within each state. The final settlement of the December 31, 2022 ACA risk adjustment accruals is scheduled to be determined by the Centers for Medicare and Medicaid Services (CMS) in June 2023, based on data submitted by insurance companies through April 2023. As discussed in Note 9, the Company recorded an estimated asset and liability (the ACA risk adjustment accruals) of $838 million, and $780 million, respectively at December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the evaluation of the estimated ACA risk adjustment accruals as a critical audit matter. Specialized skills and a higher degree of auditor judgment were required to evaluate the Company's estimates. The Company's estimates are based on its analysis of member data, claims data, and projections of claims data expected to be submitted by the Company, and other insurance plans, to CMS for settlement.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the Company's process to develop the estimated ACA risk adjustment accruals. We involved actuarial professionals with specialized skills and knowledge who assisted in evaluating the Company's methodology used in estimating the ACA risk adjustment accruals for consistency with the federally developed risk adjustment methodology. Additionally, the actuarial professionals assisted in evaluating the projections of claims data utilized to estimate the ACA risk adjustment accruals, and assessed the methodologies utilized by the Company for consistency with industry practice. We assessed the Company's process to estimate the ACA risk adjustment accruals, in order to consider the potential for management bias, by performing a retrospective review of the prior period ACA risk adjustment accruals and assessing the consistency of those estimated balances with the subsequent settlement.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ KPMG LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2005.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">St. Louis, Missouri</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;21, 2023 </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CENTENE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except shares in thousands and per share data in dollars)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMy0xLTEtMS0zNTQwMTg_fc7e1b1e-d49e-40ff-bbf6-c25bf6799ee8">12,074</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMy0zLTEtMS0zNTQwMTg_966465b2-f6b3-46b9-8b08-298df70b6666">13,118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and trade receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:PremiumsAndOtherReceivablesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNC0xLTEtMS0zNTQwMTg_e5dca235-26c4-4963-a75c-3b115d607459">13,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:PremiumsAndOtherReceivablesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNC0zLTEtMS0zNTQwMTg_a5dbce99-b9ba-4dee-b0b4-054623bb49cb">12,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNS0xLTEtMS0zNTQwMTg_07d895a1-baf8-47a7-86f4-92ead7960fcf">2,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNS0zLTEtMS0zNTQwMTg_266de068-cb56-4ee6-9f9d-511a1e3ea62c">1,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNi0xLTEtMS0zNTQwMTg_c4be5939-595e-4046-accf-4012d0767bb6">2,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNi0zLTEtMS0zNTQwMTg_4b812ef4-d98e-4938-83dd-2c5013cf606a">1,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNy0xLTEtMS0zNTQwMTg_0264682a-0c49-40bb-bf0d-81f111cfd490">30,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNy0zLTEtMS0zNTQwMTg_8fb20643-1ad6-4f39-9df9-66288ec7061d">28,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfOC0xLTEtMS0zNTQwMTg_3e7f6820-ea42-4454-89dd-c5618dcdb946">14,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfOC0zLTEtMS0zNTQwMTg_c3f493e0-99af-465c-a8ea-850a1e289590">14,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:OtherRestrictedAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfOS0xLTEtMS0zNTQwMTg_70a52387-7725-4221-8033-8137b45fea4a">1,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:OtherRestrictedAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfOS0zLTEtMS0zNTQwMTg_9df4bc5e-a89e-4d2a-bc8a-d85982ed73fe">1,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTAtMS0xLTEtMzU0MDE4_fa050f43-66ab-4b25-8423-c3a5c5eab270">2,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTAtMy0xLTEtMzU0MDE4_afefffee-0279-411b-b92e-dae86e55499f">3,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTEtMS0xLTEtMzU0MDE4_e6c488e1-91cd-44f3-b7c0-0eb659685ca3">18,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTEtMy0xLTEtMzU0MDE4_fbee738f-1b49-4012-aa0a-5f3f9fd7bec8">19,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTItMS0xLTEtMzU0MDE4_6f4e55e4-6c62-4b3b-a52b-581230c6d739">6,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTItMy0xLTEtMzU0MDE4_7f3090d3-c86d-47f0-8a99-73ade2a78832">7,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTMtMS0xLTEtMzU0MDE4_d7823b54-939f-4bc6-b377-e5b39c2bf329">2,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTMtMy0xLTEtMzU0MDE4_fe0abc4e-26e5-4fed-b796-7be7d513ad3e">3,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTQtMS0xLTEtMzU0MDE4_a243075a-b462-4363-8761-8fedb8c97f94">76,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTQtMy0xLTEtMzU0MDE4_ee1413c6-8a3c-4a09-a5af-269358a32bb9">78,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTctMS0xLTEtMzU0MDE4_aa7ecf64-35bf-4cf2-b13a-77197b8f71f6">16,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTctMy0xLTEtMzU0MDE4_4b83a123-cc41-49f7-8f84-2068c5a33b21">14,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTgtMS0xLTEtMzU0MDE4_94432841-77aa-49f8-a280-24a3289dc7a7">9,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTgtMy0xLTEtMzU0MDE4_c62503f7-9b66-40f3-aecb-798f6277e31a">8,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return of premium payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:ReturnofPremiumPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTktMS0xLTEtMzU0MDE4_0d727a6a-ca29-4c30-a435-c6b9ea2fe57a">1,634</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:ReturnofPremiumPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTktMy0xLTEtMzU0MDE4_08e66756-f12f-43ff-b636-cb652faa8255">2,328</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjAtMS0xLTEtMzU0MDE4_a58e2cab-795a-42e1-8018-97116944b03e">478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjAtMy0xLTEtMzU0MDE4_de3a47fa-1d4d-4263-9ba5-9980cd0739ba">434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjEtMS0xLTEtMzU0MDE4_11979356-d22b-4115-a38f-5ed94bf89824">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjEtMy0xLTEtMzU0MDE4_18123ac6-1fbc-4826-b2ea-63812ed3c362">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjItMS0xLTEtMzU0MDE4_216e2fd4-14be-45bc-89bb-39e4516f6107">28,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjItMy0xLTEtMzU0MDE4_a53162eb-61e2-4e97-a29e-ba2d9e9d39e5">25,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjMtMS0xLTEtMzU0MDE4_d899c840-54d4-404b-bc1e-3164866c6e2a">17,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjMtMy0xLTEtMzU0MDE4_6b4878db-609e-437a-a670-1e7552d82304">18,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjQtMS0xLTEtMzU0MDE4_740233b3-dd92-405d-a9eb-f7d11621c6e0">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjQtMy0xLTEtMzU0MDE4_b8564e27-4485-4caf-8f2a-be0120407316">1,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjUtMS0xLTEtMzU0MDE4_00fc0593-ed49-4067-b199-ec8fc880fa18">5,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjUtMy0xLTEtMzU0MDE4_3f9c3d61-f7a4-4d58-98c3-bf30b3ef511c">5,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjYtMS0xLTEtMzU0MDE4_dfbd19b9-d99a-4118-b0b6-dd5a2c1bc88e">52,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjYtMy0xLTEtMzU0MDE4_23ad92e8-c687-4990-a0bd-df9db9c0ab93">51,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjctMS0xLTEtMzU0MDE4_1543b5d7-5c5e-46ad-b20a-a86a05cbe12a"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjctMy0xLTEtMzU0MDE4_ddf8b36d-6bdc-4ac6-8b8c-ae699be4f50b"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjgtMS0xLTEtMzU0MDE4_dddaec5a-0f5a-4e37-b05c-9da4808c4fe2">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjgtMy0xLTEtMzU0MDE4_c5907aa3-acca-4222-96e1-1d7b0a91304e">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfMjI_888445f4-32a0-4368-92ef-364ca80825cf"><ix:nonFraction unitRef="usdPerShare" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfMjI_e820cdef-5285-4e72-9468-fd6a17fde4fd">0.001</ix:nonFraction></ix:nonFraction> par value; authorized <ix:nonFraction unitRef="shares" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfNDc_af888ec6-5db5-442e-9f92-f8d728a1ffdc"><ix:nonFraction unitRef="shares" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfNDc_b12a205a-7dc0-459d-8857-b4fae54b6e45">10,000</ix:nonFraction></ix:nonFraction> shares; <ix:nonFraction unitRef="shares" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfNTg_2490bed5-fc3d-41a6-ae7e-39558272797b"><ix:nonFraction unitRef="shares" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfNTg_455f80f2-805d-4cb8-9abc-597b4406a6a7"><ix:nonFraction unitRef="shares" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfNTg_74c00518-70b5-4303-85d0-e80437186398"><ix:nonFraction unitRef="shares" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfNTg_98b64db9-b964-4baa-ba6a-152066191454">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding at December&#160;31, 2022 and December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMS0xLTEtMzU0MDE4_497010cc-80dc-4165-af9c-ae435c650976">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMy0xLTEtMzU0MDE4_4d9e9eff-76f4-4fbc-9935-b989c5a655b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfMTk_05f69653-cfe2-4b83-9829-ecc85109f483"><ix:nonFraction unitRef="usdPerShare" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfMTk_60c9f3e0-badf-442d-80db-f820211af5e3">0.001</ix:nonFraction></ix:nonFraction> par value; authorized <ix:nonFraction unitRef="shares" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfNDQ_bc438f08-de75-4463-b6f4-2c76e330ad2e"><ix:nonFraction unitRef="shares" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfNDQ_f04f5f32-19b7-425e-97e5-de239bcc26fd">800,000</ix:nonFraction></ix:nonFraction> shares; <ix:nonFraction unitRef="shares" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfNTU_802c9535-cce7-4983-8245-44435714c993">607,847</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfNjk_21480e59-a1cf-4661-a8eb-866bcf1f85aa">550,754</ix:nonFraction> outstanding at December&#160;31, 2022, and <ix:nonFraction unitRef="shares" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfOTU_9305475e-e4df-4fa5-ba31-86667d9f4f48">602,704</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfMTA5_223a113d-e4c4-4d18-b3aa-cbc78d2419f0">582,479</ix:nonFraction> outstanding at December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMS0xLTEtMzU0MDE4_f0d2bf76-836e-4f3e-bb5c-fd557be0f0c7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMy0xLTEtMzU0MDE4_c190e523-aa71-4618-88a0-e9e330a2730d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzMtMS0xLTEtMzU0MDE4_74097a93-81f9-4023-9af0-9684ab2b1d3e">20,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzMtMy0xLTEtMzU0MDE4_f697e4b6-9753-4f8b-9402-7dd9346fe6ba">19,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive earnings (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzUtMS0xLTEtMzU0MDE4_b2c0d15d-de89-4585-bd25-e1426e4159ae">1,132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzUtMy0xLTEtMzU0MDE4_094ecc08-f901-457f-ae7a-3430b6027130">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzYtMS0xLTEtMzU0MDE4_e2e5d530-9dc9-4678-a7ef-f2e96e77a2c5">9,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzYtMy0xLTEtMzU0MDE4_9264d546-987c-44b2-87d2-551f0f415a6a">8,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost (<ix:nonFraction unitRef="shares" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzctMC0xLTEtMzU0MDE4L3RleHRyZWdpb246ZGNjZjY2YjIwNTU4NDMwZWFhNmFmMGQ3ODI4OTk0NTFfMjk_6680628e-f434-4f05-a5ed-db1656a9f2a0">57,093</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzctMC0xLTEtMzU0MDE4L3RleHRyZWdpb246ZGNjZjY2YjIwNTU4NDMwZWFhNmFmMGQ3ODI4OTk0NTFfMzY_58df2bcc-f393-4f37-beb0-cdeb06fb226d">20,225</ix:nonFraction> shares, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzctMS0xLTEtMzU0MDE4_27d734eb-8579-4ae8-94dc-ba79f0339962">4,213</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzctMy0xLTEtMzU0MDE4_a77ba4d2-62b6-465a-aac5-2978567704ec">1,094</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Centene stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzgtMS0xLTEtMzU0MDE4_1ed1a698-271b-4bfa-8ca3-7ddea7ce81c4">24,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzgtMy0xLTEtMzU0MDE4_b724af7a-5a7d-4c1d-af4d-cfe1b218a578">26,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonredeemable noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzktMS0xLTEtMzU0MDE4_d6d50c50-90a5-40ce-8d68-daa7898a2360">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzktMy0xLTEtMzU0MDE4_9333f1b2-cab0-4d35-8a79-29fb736c081b">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNDAtMS0xLTEtMzU0MDE4_a3cfd6f4-5aaa-4081-8d13-1891dbb65dce">24,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNDAtMy0xLTEtMzU0MDE4_ea33028b-c236-4c3a-b5b5-8d39d5445a78">26,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, redeemable noncontrolling interests and stockholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNDEtMS0xLTEtMzU0MDE4_678312d3-c796-43e2-8266-4eadacf1d4a4">76,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNDEtMy0xLTEtMzU0MDE4_f42e36c1-3eb6-41bf-8956-7892798ae096">78,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes to the consolidated financial statements are an integral part of these statements.&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CENTENE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except shares in thousands and per share data in dollars)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eadcd3758bd48558b2055d1213fc6f5_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMy0xLTEtMS0zNTQwMTg_4fe26460-903e-4672-9b95-ff675c671c9f">127,131</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c83c53bcfae4452bc7f79564bebc856_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMy0zLTEtMS0zNTQwMTg_fd45b889-46f6-485c-8d6f-89d91d1a65f2">112,319</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fbc70041964c1a8bd77082880bf5c5_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMy01LTEtMS0zNTQwMTg_f6fd8ca1-10af-452f-ba0b-37b420fa5bc8">100,055</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib80ff9d53361464b80c69f222a08fd78_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNC0xLTEtMS0zNTQwMTg_45f17ad2-ee65-46e0-bba0-929ca33dbcd2">8,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28166a0649364f7486e28e0475aa1937_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNC0zLTEtMS0zNTQwMTg_73bacd6c-2a1e-4759-a903-f33b04d7bb8d">5,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ba97cd7426845cea3497f057312fa44_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNC01LTEtMS0zNTQwMTg_f4b98192-9ca2-433a-bfe1-0801dfd9f89b">3,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNS0xLTEtMS0zNTQwMTg_fc9f13b7-5490-4501-b153-04162b36a667">135,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNS0zLTEtMS0zNTQwMTg_c61de2a6-5fed-40df-9cf8-bff6ae440022">117,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNS01LTEtMS0zNTQwMTg_d799ace2-8642-4732-82ab-af000c1ab102">103,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax and health insurer fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="cnc:PremiumTaxRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNi0xLTEtMS0zNTQwMTg_5299c610-50a6-4f6a-b354-b1d490d2bc15">9,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="cnc:PremiumTaxRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNi0zLTEtMS0zNTQwMTg_59e2a63c-5be7-48c9-9605-41e4d15e4cfd">7,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="cnc:PremiumTaxRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNi01LTEtMS0zNTQwMTg_368d9998-39d5-40ed-b257-0d07842e7e1f">7,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNy0xLTEtMS0zNTQwMTg_4e206f2f-1b9c-4345-af73-0502b0bc4736">144,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNy0zLTEtMS0zNTQwMTg_84f02b63-b0fc-42f3-8b1a-093327739ecd">125,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNy01LTEtMS0zNTQwMTg_1863c9b5-33a6-40e2-8772-e259533a83c0">111,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfOS0xLTEtMS0zNTQwMTg_9af3e218-7f50-4031-b63c-3dc14565a0f0">111,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfOS0zLTEtMS0zNTQwMTg_aa791694-e8af-49bc-86c6-4de4c5af00fd">98,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfOS01LTEtMS0zNTQwMTg_ee777d47-af03-4053-8c70-2bd1daa814b8">86,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTAtMS0xLTEtMzU0MDE4_36ad99ca-526f-4374-9ceb-362de60b0d19">7,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTAtMy0xLTEtMzU0MDE4_f2f9476e-dfcc-4513-a569-3c33ed0a09be">4,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTAtNS0xLTEtMzU0MDE4_cbb3a01d-ab8c-4dbd-a573-40ed23eb285e">3,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTEtMS0xLTEtMzU0MDE4_9c37e260-29dd-4ef7-be7b-be6b3a508f29">11,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTEtMy0xLTEtMzU0MDE4_1d77f7d6-c6e6-4a86-9a20-a9bf1ae18a7d">9,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTEtNS0xLTEtMzU0MDE4_fff865b4-2002-4975-93e9-70632388c848">9,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTItMS0xLTEtMzU0MDE4_057f95d2-590a-4085-85e1-2e2e770d3d0b">614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTItMy0xLTEtMzU0MDE4_392fab8d-2abd-49fd-b519-86932b3e03b7">565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTItNS0xLTEtMzU0MDE4_581b83c2-5279-4e59-840a-8046a985511c">487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTMtMS0xLTEtMzU0MDE4_372c5b98-5131-4d26-8a96-4250b69c3d7e">817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTMtMy0xLTEtMzU0MDE4_98500083-244c-4788-9627-2b132aa943a4">770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTMtNS0xLTEtMzU0MDE4_c09f4550-0212-4315-b1e4-570e7ca2f6cb">719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="cnc:PremiumTaxExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTQtMS0xLTEtMzU0MDE4_74beaccb-3aee-4324-b260-a34b56b5a8c1">9,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="cnc:PremiumTaxExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTQtMy0xLTEtMzU0MDE4_9fd2b2aa-7a80-4173-9a18-78e065ca8693">8,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="cnc:PremiumTaxExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTQtNS0xLTEtMzU0MDE4_55e38905-1564-4d3e-8293-ce262aa1284a">6,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurer fee expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="cnc:HealthInsurerFeeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTUtMS0xLTEtMzU0MDE4_96ee9d3a-1160-4480-b4fa-5c986a9fb71b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="cnc:HealthInsurerFeeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTUtMy0xLTEtMzU0MDE4_ad0ce2d2-9379-45d4-9b0d-e901086989a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="cnc:HealthInsurerFeeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTUtNS0xLTEtMzU0MDE4_bb2b050b-070c-4533-922b-52e775217ff6">1,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTYtMS0xLTEtMzU0MDE4_cb6f9798-5979-4749-9210-5b3e4a06d550">2,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTYtMy0xLTEtMzU0MDE4_cfda68bc-3e44-46dc-8bc5-c01ccb41f2b0">229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTYtNS0xLTEtMzU0MDE4_a8ef76a7-38ba-430d-ab85-3c12ec136988">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTctMS0xLTEtMzU0MDE4_98979f25-2020-4e34-a7ed-1dd822a8c21d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTctMy0xLTEtMzU0MDE4_d3a6eaf2-f448-45ff-bd63-2151f2211734">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTctNS0xLTEtMzU0MDE4_8d0c2601-ffc4-44eb-a7aa-5cfa10fdf1e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTgtMS0xLTEtMzU0MDE4_fa406dfc-21a6-46b8-b2a2-08753c7cf451">143,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTgtMy0xLTEtMzU0MDE4_a499b5f5-35f9-4f6c-95f6-350bf70ad39e">124,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTgtNS0xLTEtMzU0MDE4_aa0df5d5-d64e-45ba-914b-1af6ba64201c">108,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTktMS0xLTEtMzU0MDE4_f087b011-d793-491f-a74f-657e14e6b960">1,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTktMy0xLTEtMzU0MDE4_0e4f89d8-15bd-4d7b-905b-b11ea8da7eb0">1,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTktNS0xLTEtMzU0MDE4_8c8bb7d8-9781-4734-b778-2eaa8a03b687">3,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeNonoperating" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjEtMS0xLTEtMzU0MDE4_3457e954-9b91-4a06-ac84-826cc462a472">1,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjEtMy0xLTEtMzU0MDE4_755b36c1-ec6e-4ee1-b45b-3fcd555151de">819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjEtNS0xLTEtMzU0MDE4_888c5387-222d-4a64-9d83-9a465390b55e">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjItMS0xLTEtMzU0MDE4_aecbade8-f080-4bda-bc09-920215e11d83">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjItMy0xLTEtMzU0MDE4_59639112-e7cd-4147-aaf7-2d659dcd8e47">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" sign="-" name="cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjItNS0xLTEtMzU0MDE4_36f9faab-3e74-4436-a00a-6cf1d93f7be1">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjMtMS0xLTEtMzU0MDE4_942cf900-1803-4762-a1d4-6b5189371cdd">665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjMtMy0xLTEtMzU0MDE4_7968da6f-0fdb-4fb0-b45d-ccf6e14f25b5">665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjMtNS0xLTEtMzU0MDE4_19fcb8bf-4ab7-487a-a1b3-c444c58ef728">728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjQtMS0xLTEtMzU0MDE4_9055478a-5e65-419f-befa-dbf1c8701ceb">1,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjQtMy0xLTEtMzU0MDE4_d923b2d0-2084-4384-a2e3-84bde3943012">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjQtNS0xLTEtMzU0MDE4_46775a47-5839-4a41-b495-280591e7d6e1">2,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjUtMS0xLTEtMzU0MDE4_285a1714-0a9c-4bcb-831b-5fefd403e65a">760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjUtMy0xLTEtMzU0MDE4_6bf85bf6-f717-4082-8db2-a88786dbd5fa">477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjUtNS0xLTEtMzU0MDE4_b6857440-689d-47fd-901e-f82277f1a604">979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjgtMS0xLTEtMzU0MDE4_de1e1989-69d6-49fd-93cc-d799750b10dc">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjgtMy0xLTEtMzU0MDE4_9517b3b7-aa7c-4092-a48f-1b2f5ad80e70">1,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjgtNS0xLTEtMzU0MDE4_2b945164-3ada-4308-9e65-23aaf5a34404">1,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjktMS0xLTEtMzU0MDE4_6303e2cc-cf0f-437d-ba45-124996013355">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjktMy0xLTEtMzU0MDE4_0455846e-b49f-44bd-b085-7a008fc60100">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjktNS0xLTEtMzU0MDE4_c55c6166-b432-4d6d-bfec-551c1444c3c1">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to Centene Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMzAtMS0xLTEtMzU0MDE4_954bb2c4-2be6-4ead-be7a-5d7bfa61481e">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMzAtMy0xLTEtMzU0MDE4_62b97976-d84f-4719-9019-59c9b8bb8671">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMzAtNS0xLTEtMzU0MDE4_4531b261-2b00-4708-ad40-84293a688437">1,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDEtMS0xLTEtMzU0MDE4_729a3f95-6681-4bed-8e32-ee0eee59d62a">2.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDEtMy0xLTEtMzU0MDE4_30f13cb9-d4ed-410f-bd06-95c09fed3284">2.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDEtNS0xLTEtMzU0MDE4_9ccfdcb5-ff9e-4d71-b824-9a07cdbadecb">3.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDYtMS0xLTEtMzU0MDE4_59d5d2ab-21e1-44f8-9985-cb7204f42679">2.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDYtMy0xLTEtMzU0MDE4_6c04aca9-fb3d-45d7-b51c-eccd6bc73962">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDYtNS0xLTEtMzU0MDE4_8639590c-df0b-498a-812b-460d082b30f1">3.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average number of common shares outstanding:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDktMS0xLTEtMzU0MDE4_c31e101d-9980-474f-aa78-ef684ff9bdef">575,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDktMy0xLTEtMzU0MDE4_870077c9-642a-4309-a112-b8788461d6cf">582,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDktNS0xLTEtMzU0MDE4_b979288c-8772-456a-b695-f16fdc3d0088">570,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNTAtMS0xLTEtMzU0MDE4_51bce433-df28-408a-bccd-d3fc6e25aa4b">582,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNTAtMy0xLTEtMzU0MDE4_fb4a005d-129f-4fb8-986a-58b78402e6ae">590,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNTAtNS0xLTEtMzU0MDE4_a5d9540a-31eb-4a99-847e-d49eb7169e53">579,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes to the consolidated financial statements are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CENTENE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfMi0xLTEtMS0zNTQwMTg_929cf6d2-3919-4684-ad88-7e0bf7373fbb">1,202</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfMi0zLTEtMS0zNTQwMTg_93e84156-93c5-40a9-96a8-371cc78c156c">1,336</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfMi01LTEtMS0zNTQwMTg_d3e6cd1d-591c-4755-a2f5-d9c553e714d5">1,794</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrealized gain (loss) on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNC0xLTEtMS00Nzk2ODc_348a2a02-e023-47ac-9230-0033577ca30d">1,475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNC0zLTEtMS00Nzk2OTQ_f623fe30-98bc-426d-bdda-2ea53f2d2cf9">296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNC01LTEtMS00Nzk3MDI_9a1e0d3b-1938-41c3-bb6a-8a933c6b8216">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrealized gain (loss) on investments, tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNS0xLTEtMS00Nzk2ODc_8141ac93-f6c0-4375-b7e2-fbe716059d03">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNS0zLTEtMS00Nzk2OTQ_a52f9bdb-aaa4-4038-82fa-d4ebd2475f04">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNS01LTEtMS00Nzk3MDI_fa54c984-5d94-4f28-8169-0d4a304f8d64">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrealized gain (loss) on investments, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNC0xLTEtMS0zNTQwMTg_0514c0bb-1e64-4ee1-8e25-dc750271fb45">1,126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNC0zLTEtMS0zNTQwMTg_dfe992c4-ca77-48b1-af5f-418e8fa6eff6">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNC01LTEtMS0zNTQwMTg_85c76833-0bec-425b-93c1-963930b05f51">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification adjustment, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOC0xLTEtMS00Nzk3MTk_ad72ec94-692b-4995-9967-2885f716e14e">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOC0zLTEtMS00Nzk3MTk_80beb991-d061-4dc9-885d-874ae91fb0bc">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOC01LTEtMS00Nzk3MTk_a11aa378-f417-42fa-8e26-bdedb8161b6a">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNi0xLTEtMS0zNTQwMTg_749a033b-372e-4846-b567-f08e59431010">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNi0zLTEtMS0zNTQwMTg_51143a76-dc82-46a7-80df-1fbbd02a4c51">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNi01LTEtMS0zNTQwMTg_80dbf900-671f-423d-bdff-31a2aedcef35">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNy0xLTEtMS0zNTQwMTg_a9725b45-a740-4b3f-a0bb-baf4177e3c57">1,209</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNy0zLTEtMS0zNTQwMTg_604d7d62-d096-40ed-9931-a0e6c72f0c96">260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNy01LTEtMS0zNTQwMTg_793a66f6-916d-4c78-9828-0b5d273a18fd">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOC0xLTEtMS0zNTQwMTg_43f7ec4b-d5f3-42e4-8a06-b9e093dcec20">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOC0zLTEtMS0zNTQwMTg_f6d9376a-e3b3-45fe-9c3a-4412d111f4e4">1,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOC01LTEtMS0zNTQwMTg_58bc6092-db22-49f1-b350-eaca826c8a6f">1,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOS0xLTEtMS0zNTQwMTg_89f6c5b2-e49f-4ef9-8cd2-2f36dbded412">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOS0zLTEtMS0zNTQwMTg_1a223f47-9b45-41f9-bea5-e2492fba60c8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOS01LTEtMS0zNTQwMTg_aaa5a083-42af-4ed9-8b47-ff17777be082">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings (loss) attributable to Centene Corporation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfMTAtMS0xLTEtMzU0MDE4_c79db779-37ea-484a-8410-289033a11c82">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfMTAtMy0xLTEtMzU0MDE4_6b44fb42-9c68-4be4-a170-d666fc35b520">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfMTAtNS0xLTEtMzU0MDE4_3bd00b5d-115e-4da7-ae5f-9a30f5cd2b4a">2,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes to the consolidated financial statements are an integral part of these statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CENTENE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except shares in thousands and per share data in dollars)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.305%"><tr><td style="width:1.0%"></td><td style="width:21.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.377%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.928%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.377%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.928%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="39" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Centene Stockholders' Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="if74f20f9672c42969aaf06d880b02823_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xLTEtMS0zNTQwMTgvdGV4dHJlZ2lvbjo5NzAwMzc0MDE3YWU0OWVmOWNjYjgyYzRjZGMzOWUyZl80_9c817287-1159-4b60-87ed-a703324f5094"><ix:nonFraction unitRef="usdPerShare" contextRef="id53035e323dd4a8a8791395cc30ffafe_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xLTEtMS0zNTQwMTgvdGV4dHJlZ2lvbjo5NzAwMzc0MDE3YWU0OWVmOWNjYjgyYzRjZGMzOWUyZl80_b3f4b1a1-decd-4274-89bc-7fedc43aff0f"><ix:nonFraction unitRef="usdPerShare" contextRef="iefd78604c8af4b3eb7e7763dd317e282_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xLTEtMS0zNTQwMTgvdGV4dHJlZ2lvbjo5NzAwMzc0MDE3YWU0OWVmOWNjYjgyYzRjZGMzOWUyZl80_d4ef21a7-10cd-4e17-91cf-b5977e797052"><ix:nonFraction unitRef="usdPerShare" contextRef="i4b6ce4061fae4dd2bf7bfef4711d6df6_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xLTEtMS0zNTQwMTgvdGV4dHJlZ2lvbjo5NzAwMzc0MDE3YWU0OWVmOWNjYjgyYzRjZGMzOWUyZl80_de6dd1d9-3691-4796-a5cd-5f7b9c82c474">0.001</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> Par Value Shares</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive<br/>&#160;Earnings (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i205075141d20449391c609023aa905f8_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xMS0xLTEtMzU0MDE4L3RleHRyZWdpb246MDliMjcxYjgxNjcxNDNjZmI5MzMyZTU4OWYxZmViYzlfNA_03d04c9c-45d4-440a-a8de-e7b836061d76"><ix:nonFraction unitRef="usdPerShare" contextRef="i116b2020b2da4f3ea027f5a137798310_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xMS0xLTEtMzU0MDE4L3RleHRyZWdpb246MDliMjcxYjgxNjcxNDNjZmI5MzMyZTU4OWYxZmViYzlfNA_2384c785-e1e8-4367-883b-5e2f62d61616"><ix:nonFraction unitRef="usdPerShare" contextRef="i22a603f1ec5a4ed6ac95d0033583c8ae_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xMS0xLTEtMzU0MDE4L3RleHRyZWdpb246MDliMjcxYjgxNjcxNDNjZmI5MzMyZTU4OWYxZmViYzlfNA_4d344090-617e-4574-aca6-39fc98420c37"><ix:nonFraction unitRef="usdPerShare" contextRef="i0a00c10b57c34ba7b04e400d6d51804c_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xMS0xLTEtMzU0MDE4L3RleHRyZWdpb246MDliMjcxYjgxNjcxNDNjZmI5MzMyZTU4OWYxZmViYzlfNA_6dfd5fcb-e166-408a-a30f-4f6f5a8d6b72">0.001</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> Par Value Shares</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id53035e323dd4a8a8791395cc30ffafe_I20191231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy0xLTEtMS0zNTQwMTg_95f5fbb6-f461-4257-9b36-41de3cc57163">421,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53035e323dd4a8a8791395cc30ffafe_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy0zLTEtMS0zNTQwMTg_2f79b47c-ec5e-432a-bac2-3e0ccc15382d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i677e18bc38214dc8aa867bdadeb3507e_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy01LTEtMS0zNTQwMTg_6be74d03-1be2-413f-8e7d-8936b34ebf52">7,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007f9f25b89a4328b4843c47ad28463f_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy03LTEtMS0zNTQwMTg_4bd212d7-24a8-408b-be41-f763e8533b40">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463620403a104db8bdb4789fd3025d04_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy05LTEtMS0zNTQwMTg_a77e1702-9c18-446d-b57f-8445ba8a1bee">4,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i205075141d20449391c609023aa905f8_I20191231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy0xMS0xLTEtMzU0MDE4_9df4ae77-c6b8-4177-9146-1ea2370f0b49">6,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i205075141d20449391c609023aa905f8_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy0xMy0xLTEtMzU0MDE4_d44ad7cc-8b86-4651-8dcf-88ac5213a90d">214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaab02486f5a340caa2b7a035d3d61cfd_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy0xNS0xLTEtMzU0MDE4_1473ebbb-7e75-4055-94e2-0d1557afdc4d">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89efa37b183c4c618c28149ddb506553_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy0xNy0xLTEtMzU0MDE4_b1e19d55-d039-4b76-b626-dc8f52843917">12,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4325cafc5d4145589b2f8c8a9708b14d_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNC05LTEtMS0zNTQwMTg_ee9d4b02-bc49-4e0e-847e-d79909d1a594">1,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65cbc7d56bfd4ffb861729ca1b540ab1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNC0xNS0xLTEtMzU0MDE4_78a93d30-069d-4c7c-961b-e7b74b179d9e">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNC0xNy0xLTEtMzU0MDE4_57b35c85-e5e0-4939-bed7-2115ba35eefb">1,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive earnings, net of $<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNS0wLTEtMS0zNTQwMTgvdGV4dHJlZ2lvbjplMDY0ODc1MzM2NTc0ODkwYTVmMDVjOTViN2EwNGNmZV80MQ_9d9e3539-fb15-4fd4-af8d-ecf57c292b0f">60</ix:nonFraction> tax</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70228d9f45fe464887fc03a805d9f728_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNS03LTEtMS0zNTQwMTg_769f73be-03d1-400e-a075-62f2bcbee142">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNS0xNy0xLTEtMzU0MDE4_28c1db7a-2465-4e72-9554-2f108be5b3de">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued for acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icbc613d20c5e4995abeaccfb2d2a2ffd_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNi0xLTEtMS0zNTQwMTg_3c2aeace-b3ab-42d9-9f26-812e2aeb10f1">171,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbc613d20c5e4995abeaccfb2d2a2ffd_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNi0zLTEtMS0zNTQwMTg_62701d31-5d64-49cb-9898-696cbaaf9eb8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b2f9a41ae484e65bfe6464f3b6bcc36_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNi01LTEtMS0zNTQwMTg_5dff4120-4f6b-4665-9948-1a54ecc9069c">11,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNi0xNy0xLTEtMzU0MDE4_3199d03c-3bc9-4f0b-a8cc-e7b2f95a670c">11,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued for employee benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icbc613d20c5e4995abeaccfb2d2a2ffd_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNy0xLTEtMS0zNTQwMTg_7a38f437-d3f3-46fb-b24a-26f58e4f93ea">5,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b2f9a41ae484e65bfe6464f3b6bcc36_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNy01LTEtMS0zNTQwMTg_bdca7777-e4a1-4e94-a4e4-19395250d62b">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNy0xNy0xLTEtMzU0MDE4_6a5ff2aa-1e60-4ffa-9873-3b8a8439eeb4">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="icbc613d20c5e4995abeaccfb2d2a2ffd_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfOC0xLTEtMS0zNTQwMTg_afe9b4fc-1c9a-40d5-b76d-357b58806fa4">407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b2f9a41ae484e65bfe6464f3b6bcc36_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfOC01LTEtMS0zNTQwMTg_ea92c279-1002-4092-a986-4582182aab95">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if18a7a7ccfa44c02a607ea5b90c04d27_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfOC0xMS0xLTEtMzU0MDE4_e5cf048e-3c08-4752-92d9-0c0133eebc51">10,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18a7a7ccfa44c02a607ea5b90c04d27_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfOC0xMy0xLTEtMzU0MDE4_518adc38-bf37-493c-994e-5468211b9fae">602</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfOC0xNy0xLTEtMzU0MDE4_482b3367-df94-474e-a25b-3f1a4ec2a553">626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b2f9a41ae484e65bfe6464f3b6bcc36_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfOS01LTEtMS0zNTQwMTg_8cff3017-235e-42d8-9290-e305fe9c3499">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfOS0xNy0xLTEtMzU0MDE4_d4ad71d9-02db-4cf4-9740-76e96ea9fad7">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contribution from noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65cbc7d56bfd4ffb861729ca1b540ab1_D20200101-20201231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTAtMTUtMS0xLTM1NDAxOA_73a4c834-2ced-4e06-9400-c16ef0cc3f61">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTAtMTctMS0xLTM1NDAxOA_ac8825bb-58ae-4712-8653-651011ae6168">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4b6ce4061fae4dd2bf7bfef4711d6df6_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItMS0xLTEtMzU0MDE4_0dff45a5-3068-4910-b6f7-db8c97eea00c">598,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b6ce4061fae4dd2bf7bfef4711d6df6_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItMy0xLTEtMzU0MDE4_e3f52be4-6284-44b1-971c-6b4122510c88">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddfa338597904f0eba0c96789f0d0ed5_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItNS0xLTEtMzU0MDE4_1febaea9-05f6-4a00-9ca7-65373fc490fc">19,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2fe5e0012c04cccb9b042e45cdf6198_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItNy0xLTEtMzU0MDE4_e1add0cb-c958-4aac-8c95-d1b96aea6d6e">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75d4d36b1dce42f98b2a5b7237c1773e_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItOS0xLTEtMzU0MDE4_dc66cd8b-21b5-4391-86e3-0d1420ab292b">6,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a00c10b57c34ba7b04e400d6d51804c_I20201231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItMTEtMS0xLTM1NDAxOA_d286f3fb-a0b4-47f6-9774-0105402f5387">16,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a00c10b57c34ba7b04e400d6d51804c_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItMTMtMS0xLTM1NDAxOA_e4cee386-a1da-443b-85f3-15f9c57772b1">816</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43b316ad31204bf786dbb981cb93be17_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItMTUtMS0xLTM1NDAxOA_d59b86b8-96dc-4644-b611-9fa58ce628b3">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItMTctMS0xLTM1NDAxOA_ed239121-df25-4fd5-8a20-56a2821e11b7">25,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e696a8243e449cea4c408643b0c8316_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTMtOS0xLTEtMzU0MDE4_0a889766-65a4-4fa9-b230-4496b13f3e78">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied7399d5bbf14198bf9416f0242b68b1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTMtMTUtMS0xLTM1NDAxOA_bdfa5713-d26b-4e1a-8f52-7a34e0ec2214">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTMtMTctMS0xLTM1NDAxOA_7058d249-d47e-4f89-a024-b9d72b83ba6a">1,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of $(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTQtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246ZWI0ODNjZmZhMWY3NDQxNjljMDhhZTYzZTk3NmM4YzRfMzc_55b249c7-e99c-407d-b6af-694177bd1fc4">75</ix:nonFraction>) tax</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if228d12dc7ec48dbabc207800e70e561_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTQtNy0xLTEtMzU0MDE4_ff6495f2-1500-4a50-ac48-92fd1a92352c">260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTQtMTctMS0xLTM1NDAxOA_1cef3a91-6a69-465c-989e-d2688201e95a">260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued for employee benefit plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia4141bf74d4f4cf2a006bd905970e699_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTUtMS0xLTEtMzU0MDE4_1b5dfc23-6787-499d-9aa4-b500c6957ccb">4,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia335774c94194c9e9df1cee6eca206c1_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTUtNS0xLTEtMzU0MDE4_c308bbea-7bb2-4992-95a1-0d7634f24799">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTUtMTctMS0xLTM1NDAxOA_f3346fe2-0284-47f0-897b-8d555b4f8d72">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia4141bf74d4f4cf2a006bd905970e699_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTYtMS0xLTEtMzU0MDE4_6c8d0d34-6c94-4845-a9b1-a72acd9c8612">326</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia335774c94194c9e9df1cee6eca206c1_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTYtNS0xLTEtMzU0MDE4_b4f9f781-d87b-4ad7-a5dc-01e401298da4">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i87039d6a8fdd4824bbf66cc17f0022f6_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTYtMTEtMS0xLTM1NDAxOA_327b73e9-8d4f-4698-823d-7e4ba2d09528">3,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87039d6a8fdd4824bbf66cc17f0022f6_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTYtMTMtMS0xLTM1NDAxOA_98b11b55-8a30-4ca7-b377-53388931132b">278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTYtMTctMS0xLTM1NDAxOA_a0671963-886a-45ea-925f-bcbe61353c94">297</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia335774c94194c9e9df1cee6eca206c1_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTctNS0xLTEtMzU0MDE4_c832c11d-5387-497a-941c-4ad4b8045552">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTctMTctMS0xLTM1NDAxOA_c9bd1bcf-e3ea-4e14-84dd-2c56cd9e3b6a">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contribution from noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7399d5bbf14198bf9416f0242b68b1_D20210101-20211231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTgtMTUtMS0xLTM1NDAxOA_7403c134-d30d-4b3f-9898-3ceedb0da226">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTgtMTctMS0xLTM1NDAxOA_8db3e82d-1616-4934-8b79-2c52780a9e56">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Divestiture of noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia335774c94194c9e9df1cee6eca206c1_D20210101-20211231" decimals="-6" name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTktNS0xLTEtMzU0MDE4_1ab0ffe7-485b-4dc4-b686-0286495629a7">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7399d5bbf14198bf9416f0242b68b1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTktMTUtMS0xLTM1NDAxOA_659ff3e7-6130-410e-8cfd-1f39ee2df487">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTktMTctMS0xLTM1NDAxOA_5715978c-b86b-4a10-ad0d-2c711fbd8ddd">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition resulting in noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7399d5bbf14198bf9416f0242b68b1_D20210101-20211231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjAtMTUtMS0xLTM1NDAxOA_b2383a9a-06db-4831-9e4d-4884e4d16d08">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjAtMTctMS0xLTM1NDAxOA_e79cfea9-d238-469d-8e99-92ea3896caaa">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefd78604c8af4b3eb7e7763dd317e282_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtMS0xLTEtMzU0MDE4_b0d21700-7afe-46b1-8ad5-9aaed55755a8">602,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefd78604c8af4b3eb7e7763dd317e282_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtMy0xLTEtMzU0MDE4_65cda9f6-e7ee-461a-9ece-1f2d09f8f92f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59eb9977480d4e3891765c8703b4e646_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtNS0xLTEtMzU0MDE4_dc879232-a6b5-43e7-9ff0-6e2f797f57b4">19,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8aca346cdc405eb8ae3ab1bb1a0e8a_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtNy0xLTEtMzU0MDE4_04f03ecb-fe32-4419-b76d-3a68d55eb822">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253a5454e6f34367b12d67c6674b4320_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtOS0xLTEtMzU0MDE4_88d6d07e-3b46-43cf-812e-b67a6c26c062">8,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i116b2020b2da4f3ea027f5a137798310_I20211231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtMTEtMS0xLTM1NDAxOA_302d8159-6b09-405c-84ad-cd89cf9d4646">20,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i116b2020b2da4f3ea027f5a137798310_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtMTMtMS0xLTM1NDAxOA_dd0c2b73-04f4-4108-b41d-9f6df6beebc0">1,094</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i831e8980ca404c60aa04c6cee3dd1a38_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtMTUtMS0xLTM1NDAxOA_b48ce77c-d327-4eb8-8c1f-c6ef57446c6a">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtMTctMS0xLTM1NDAxOA_3516850b-7658-435e-be74-79459019c41d">26,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07517ae73bdd457783095996579e8053_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjItOS0xLTEtMzU0MDE4_39f14de8-ecb0-4709-9e7a-f2dab08fecc7">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2d17142024e44a0b55466c586719466_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjItMTUtMS0xLTM1NDAxOA_a1be528c-aabc-4663-b7c9-665471124fc6">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjItMTctMS0xLTM1NDAxOA_96d32110-c87c-41ae-b3ba-c7dd0f464bcd">1,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjMtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246ZDBmMmQ0MDM0ZTE1NDg0ZjkwZGNhZmJmMjFmMjdhNmFfMjE5OTAyMzI1NTU3NA_bcd1ad08-661f-4270-a746-e9752b74b75d">349</ix:nonFraction> tax</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00ea1fbc2e9c4c9f8ef3db694f5e19cb_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjMtNy0xLTEtMzU0MDE4_e5058ed7-0906-41b7-b45e-1ee89bd29d15">1,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjMtMTctMS0xLTM1NDAxOA_70ea14c3-d185-42da-b1ed-8c1d919ce9dd">1,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued for employee benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6fe2f9326b88400aa8db63ee38c9dc25_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjYtMS0xLTEtMzU0MDE4_051ff82a-cfa6-4382-8cdc-180f5b5aeb62">5,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifad2424f092c43c5aef13a515b9bf557_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjYtNS0xLTEtMzU0MDE4_87acd8d0-7712-4182-8b26-3b7a4edfc69a">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjYtMTctMS0xLTM1NDAxOA_6721d955-cbbf-4719-baf4-5810cd42ecba">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of unvested equity awards in connection with acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifad2424f092c43c5aef13a515b9bf557_D20220101-20221231" decimals="-6" name="cnc:SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjctNS0xLTEtMzgwNzA4_66e6a60c-9c46-418a-a597-c7e7e8c15663">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="cnc:SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjctMTctMS0xLTM4MDcwOA_c79ad9c3-433d-49fc-b522-32d4a1069c63">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifad2424f092c43c5aef13a515b9bf557_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjctNS0xLTEtMzU0MDE4_1210425c-03fb-464e-a832-b88ac46e8e4f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e9d6d9ad10d41afb05597363822ad5c_D20220101-20221231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjctMTEtMS0xLTM1NDAxOA_7a018293-780d-4fb1-b428-22cf98c28960">36,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e9d6d9ad10d41afb05597363822ad5c_D20220101-20221231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjctMTMtMS0xLTM1NDAxOA_1076f708-7f4f-4746-a548-aa49edeff59f">3,119</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjctMTctMS0xLTM1NDAxOA_c20f2b89-2260-4c39-950d-93e27723775d">3,096</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifad2424f092c43c5aef13a515b9bf557_D20220101-20221231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjgtNS0xLTEtMzU0MDE4_99ca5cb8-6cc1-409c-9f80-2a0a34e09c16">234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjgtMTctMS0xLTM1NDAxOA_a7823f16-2c3f-4ae9-932b-21d11f770b32">234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification to non-redeemable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2d17142024e44a0b55466c586719466_D20220101-20221231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzMtMTUtMS0xLTQ2NDExNQ_07b1b937-f974-4793-93bf-818aaf8e51db">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzMtMTctMS0xLTQ2NDEyNA_0f793a2a-28ea-4aa2-9e7b-5d38cca7e172">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Divestiture of noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2d17142024e44a0b55466c586719466_D20220101-20221231" decimals="-6" name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzItMTUtMS0xLTM1NDAxOA_09962603-b424-4a9c-88b6-ec580135becd">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzItMTctMS0xLTM1NDAxOA_c510235a-b138-4baa-bcde-0438cbf9e90b">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividend to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2d17142024e44a0b55466c586719466_D20220101-20221231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzMtMTUtMS0xLTM1NDAxOA_77f06ed7-e522-47ad-a07b-d14a4096c81c">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzMtMTctMS0xLTM1NDAxOA_13346a73-937e-4475-84aa-c5c2c4471ce7">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2d17142024e44a0b55466c586719466_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzQtMTUtMS0xLTM1NDAxOA_ca2a3881-488b-421d-a6d2-a60c6f19d5ab">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzQtMTctMS0xLTM1NDAxOA_d8d91bc1-ac54-4fe3-b926-14ff94ae148f">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if74f20f9672c42969aaf06d880b02823_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtMS0xLTEtMzU0MDE4_1079ca24-9a9f-4ddb-a152-ee0cb918a16f">607,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if74f20f9672c42969aaf06d880b02823_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtMy0xLTEtMzU0MDE4_f3552c89-5412-4454-bf90-7d3602b78a22">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idda5d167ac1a435ba11ce095d9bf8926_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtNS0xLTEtMzU0MDE4_cb2efd0b-dabf-41e4-ab95-6a259e21f427">20,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1d80c4c83dd418ebc09acf400b5608c_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtNy0xLTEtMzU0MDE4_8ee19fea-5064-4177-9b63-1dceb302b2dc">1,132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b68b2bcce604d8997c874bfd621f1fd_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtOS0xLTEtMzU0MDE4_21b6551e-bd44-4d42-a9a3-a2dbfaf036bb">9,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22a603f1ec5a4ed6ac95d0033583c8ae_I20221231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtMTEtMS0xLTM1NDAxOA_09ffd22d-4e4e-41c8-a227-81e01be5abbe">57,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22a603f1ec5a4ed6ac95d0033583c8ae_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtMTMtMS0xLTM1NDAxOA_cd3c27b4-2a7a-41e6-bd6a-671172e8886d">4,213</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ff8138305244a25baa6cc2d532766f2_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtMTUtMS0xLTM1NDAxOA_83002638-0ffe-49c6-a9c0-e87f13d89749">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtMTctMS0xLTM1NDAxOA_55b34b65-31a8-4edf-98d7-ba9fbd2ca710">24,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes to the consolidated financial statements are an integral part of this statement.&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CENTENE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:71.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMy0xLTEtMS0zNTQwMTg_de1e1989-69d6-49fd-93cc-d799750b10dc">1,202</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMy0zLTEtMS0zNTQwMTg_9517b3b7-aa7c-4092-a48f-1b2f5ad80e70">1,336</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMy01LTEtMS0zNTQwMTg_2b945164-3ada-4308-9e65-23aaf5a34404">1,794</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operating activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNS0xLTEtMS0zNTQwMTg_d8e84042-5cfe-4840-84b6-32ce0e21d57d">1,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNS0zLTEtMS0zNTQwMTg_63d914bb-c04c-422a-b4b9-1facc3b8191b">1,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNS01LTEtMS0zNTQwMTg_b2cee311-0d34-427d-8280-80c2c0f0bd06">1,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNi0xLTEtMS0zNTQwMTg_453d3e18-83e8-4b4b-b017-461be75e6448">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNi0zLTEtMS0zNTQwMTg_aca2c84d-21c6-428d-a981-ded026c8aea0">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNi01LTEtMS0zNTQwMTg_21caf962-e566-490a-9d46-6dc432f962dc">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNy0xLTEtMS0zNTQwMTg_32e1f8ec-9c77-487c-b28d-dd1ed915848d">2,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNy0zLTEtMS0zNTQwMTg_51183f18-fde4-4216-99bd-3b4eb3864e4b">229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNy01LTEtMS0zNTQwMTg_e4be244c-7288-48de-b6c3-51a07816487a">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on debt extinguishment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfOC0xLTEtMS0zNTQwMTg_e239d3e5-dbb9-4315-8a2e-d09b059f573e">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfOC0zLTEtMS0zNTQwMTg_e76b4d7f-9e17-4a71-8daf-d429c1d51dd2">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfOC01LTEtMS0zNTQwMTg_38c487de-149b-4303-9b9e-3adfd387d234">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) on acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfOS0xLTEtMS0zNTQwMTg_13cb3ed5-3afb-4c6f-a663-7608a02411aa">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfOS0zLTEtMS0zNTQwMTg_d3dbfda0-1d95-4bce-b2e7-7dd208dd0c64">309</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfOS01LTEtMS0zNTQwMTg_d37fbd5f-8204-466c-a1a0-63d886ff3d88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTAtMS0xLTEtMzU0MDE4_8cc602d8-065c-4e0a-9136-6677ffd191ab">631</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTAtMy0xLTEtMzU0MDE4_28da490b-5950-41ca-8031-6c0a86d86370">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTAtNS0xLTEtMzU0MDE4_d59515c3-a165-4586-8806-815b259698e6">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) on divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTEtMS0xLTEtMzU0MDE4_a4fcd3ad-c2b3-4d5d-bc59-d167be4e7b9f">772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTEtMy0xLTEtMzU0MDE4_e32c5383-49d6-486b-8bf4-4a84139c076d">88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTEtNS0xLTEtMzU0MDE4_8274ffa3-d2e4-481e-a433-426008def5ca">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTItMS0xLTEtNDM0NjE3_edd9cebe-896e-4650-a349-875146763684">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTItMy0xLTEtNDM0NjE3_2b607e30-9411-4e2a-a37d-139036039046">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTItNS0xLTEtNDM0NjE3_7bb21f5a-78f3-479e-ba04-2e3fd09e035b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTItMS0xLTEtMzU0MDE4_5b7e1160-7249-43aa-98c1-36b02f853c8c">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTItMy0xLTEtMzU0MDE4_613cfcba-aa16-492d-84bb-1c36084b697d">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTItNS0xLTEtMzU0MDE4_a7c4025d-1a17-4b06-b579-03ff39a67de6">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and trade receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInPremiumsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTQtMS0xLTEtMzU0MDE4_dd6a2f49-52a4-49e0-89f9-305b6dba6f8f">1,627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInPremiumsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTQtMy0xLTEtMzU0MDE4_4cf84721-603d-481d-abce-a2d84ffb532d">2,453</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInPremiumsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTQtNS0xLTEtMzU0MDE4_12864fc7-3651-4088-b367-7aea0afa5072">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTUtMS0xLTEtMzU0MDE4_eaeea676-c406-48d4-a35b-a462e801391e">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTUtMy0xLTEtMzU0MDE4_dfafa58a-9950-4c67-a394-0a3f95684ae9">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTUtNS0xLTEtMzU0MDE4_24001106-8c59-4577-874c-ac33fbf5a050">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTYtMS0xLTEtMzU0MDE4_1b54f475-4e8e-41cd-95f4-4407fbac405e">2,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTYtMy0xLTEtMzU0MDE4_314c7445-f403-4460-8797-25dc71d76edc">1,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTYtNS0xLTEtMzU0MDE4_91fdbaf0-6132-472a-99ab-c19f9306bb7b">1,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTctMS0xLTEtMzU0MDE4_edb8f9f6-47b0-40c0-b885-a6768dd41772">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTctMy0xLTEtMzU0MDE4_3f4a0c70-0070-4639-b9f4-ac87a655d28b">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTctNS0xLTEtMzU0MDE4_acb122bb-7287-4e01-b5bf-8b6de66ed2f4">528</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTgtMS0xLTEtMzU0MDE4_2566105e-bb32-4a0a-994c-0fbcff9dea9d">421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTgtMy0xLTEtMzU0MDE4_f5a31b88-a504-4285-979b-ef4e652e6bf7">1,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTgtNS0xLTEtMzU0MDE4_8ea298d6-b98e-4396-ba35-cfcd5a34ab2c">585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTktMS0xLTEtMzU0MDE4_6dcc3148-fbd8-4d19-a8b6-467b32684f28">842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTktMy0xLTEtMzU0MDE4_3d590c4e-44ff-467e-91c4-9440668aac9b">1,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTktNS0xLTEtMzU0MDE4_6bd7ae28-f778-4536-ac4b-65282cd0fec5">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating activities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjAtMS0xLTEtMzU0MDE4_221bb6e4-314c-467d-b6e4-16f9bdd46825">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjAtMy0xLTEtMzU0MDE4_9f670433-e3b5-4832-9a95-585ceeb956ab">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjAtNS0xLTEtMzU0MDE4_e4700adc-938c-4d6c-b964-c64c621c014e">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjEtMS0xLTEtMzU0MDE4_855b71fd-4b86-4d9b-aaeb-338d3981bff2">6,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjEtMy0xLTEtMzU0MDE4_c9b055d7-5ff7-4855-b4b3-0139c64f9152">4,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjEtNS0xLTEtMzU0MDE4_f154dac8-332d-4d88-b55d-2960d50008a1">5,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjMtMS0xLTEtMzU0MDE4_d352f4c4-af91-444a-8977-5c8be143f6bc">1,004</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjMtMy0xLTEtMzU0MDE4_347588da-0af8-47d5-948c-6686b53f7cff">910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjMtNS0xLTEtMzU0MDE4_cc614661-6569-40cb-8d21-1ee7b7714006">869</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjQtMS0xLTEtMzU0MDE4_e2c7d32f-7723-4eab-a63e-d5cc7fd76890">6,736</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjQtMy0xLTEtMzU0MDE4_4f8ccea8-3e92-43dc-b9b4-a1dcfd886bad">7,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjQtNS0xLTEtMzU0MDE4_4cf1a3c5-9b59-4f1d-8cad-f55a2cc68a5a">7,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and maturities of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjUtMS0xLTEtMzU0MDE4_06077a94-a88e-468c-a38f-7ed96aebe6e6">3,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjUtMy0xLTEtMzU0MDE4_8862bdc5-25f5-44be-bf16-1e44ee8fcbe1">5,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjUtNS0xLTEtMzU0MDE4_64312e1f-b1fb-443a-a31c-77b8db9f7e91">4,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjYtMS0xLTEtMzU0MDE4_ae83aeef-bb65-4210-a4de-a5632060cd34">1,460</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjYtMy0xLTEtMzU0MDE4_02268597-f23a-4956-bf49-1906373ea31c">534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjYtNS0xLTEtMzU0MDE4_776b031a-9500-4040-9f6a-6eca7795504e">4,049</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture proceeds, net of divested cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjctMS0xLTEtMzU0MDE4_2a593c9d-9a20-46f3-b5d4-e5d30b80aa6e">2,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjctMy0xLTEtMzU0MDE4_409ad41c-e059-4154-b4e6-18dbc6164a03">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjctNS0xLTEtMzU0MDE4_1d6d96dd-b0e8-4456-b5f3-bce14da2b02f">466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investing activities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjktMS0xLTEtMzU0MDE4_2d006898-8fc6-4945-a1f7-9b0b939b27e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjktMy0xLTEtMzU0MDE4_1b77edc6-0d08-49dd-83d7-98651c6042ec">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjktNS0xLTEtMzU0MDE4_6b936579-30b5-4b23-af30-249149c5c8fc">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzAtMS0xLTEtMzU0MDE4_a233e675-dbd3-48d5-9391-4672b71a5513">2,921</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzAtMy0xLTEtMzU0MDE4_1895fa85-5ecd-4a00-b691-462b3ab65996">3,299</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzAtNS0xLTEtMzU0MDE4_6a858e43-eada-49fd-b776-21b34fc305ee">6,955</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzMtMS0xLTEtMzU0MDE4_9b583097-f111-44fe-a5bb-97edc0dfa308">360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzMtMy0xLTEtMzU0MDE4_ad75ca11-b7bd-4502-8e64-06c7b0d99b07">9,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzMtNS0xLTEtMzU0MDE4_033d6d34-367a-4e84-9a11-c262902fbbef">5,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and repurchases of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzQtMS0xLTEtMzU0MDE4_232966c8-7db2-472e-8ea2-fb7016f41bab">1,490</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzQtMy0xLTEtMzU0MDE4_b6050072-2acb-4ddb-925f-edf464c2d597">7,434</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzQtNS0xLTEtMzU0MDE4_ebd02234-ffb9-4258-a554-c8de09fa9185">4,067</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzUtMS0xLTEtMzU0MDE4_5286a65e-efa4-41ae-99d5-ebe55eaeeee6">3,096</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzUtMy0xLTEtMzU0MDE4_2f25edac-2b29-4027-a77d-6fc48128b3d1">297</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzUtNS0xLTEtMzU0MDE4_6ce2db13-4fb3-4f78-bec0-92d3cd97cfed">626</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzctMS0xLTEtMzU0MDE4_e2e90832-718e-48d2-9bad-3e053cd7ca3f">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzctMy0xLTEtMzU0MDE4_376e5b00-f5b0-4dd4-8eea-a17a63da4042">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzctNS0xLTEtMzU0MDE4_568a8341-046f-42d9-8401-cf627b6793b2">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for debt extinguishment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzgtMS0xLTEtMzU0MDE4_7eac91d3-7402-4fbc-85f3-802ec250f198">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzgtMy0xLTEtMzU0MDE4_e0e51804-c068-498c-958e-58a7c7afd86d">157</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzgtNS0xLTEtMzU0MDE4_38df86d8-21bb-4289-b5a4-aa2232c02c92">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzktMS0xLTEtMzU0MDE4_0c3b6f47-6792-4ee7-ab61-e58e8f40802c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzktMy0xLTEtMzU0MDE4_f309388a-31a3-4769-a553-68041c0cb0fd">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzktNS0xLTEtMzU0MDE4_c44b05be-847f-482d-a60e-b597c1e8541b">120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDAtMS0xLTEtMzU0MDE4_13ab4497-9581-424b-9685-716e75f2f1bb">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDAtMy0xLTEtMzU0MDE4_ebc1d9d4-a026-4e04-a19b-87366d634529">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDAtNS0xLTEtMzU0MDE4_1a51c3d3-f0b1-41ac-8e54-fee161edb390">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDEtMS0xLTEtMzU0MDE4_284d235e-e160-4b6e-ba95-8914fde6a753">4,197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDEtMy0xLTEtMzU0MDE4_cd619336-c86f-477c-8d3d-899818f611ee">1,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDEtNS0xLTEtMzU0MDE4_bd23fe30-aa1c-48e9-b355-28637add4f5d">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDItMS0xLTEtMzU0MDE4_ee04e25e-a334-4d2a-9c53-75204c3b807c">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDItMy0xLTEtMzU0MDE4_bcd0aadd-5cce-40e1-beb2-b63e2d9f553f">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDItNS0xLTEtMzU0MDE4_2e810325-e5d1-4f95-bf73-f5a01c992e3a">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDMtMS0xLTEtMzU0MDE4_4ad69000-d602-4338-b414-c5216c634edc">868</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDMtMy0xLTEtMzU0MDE4_4bcd7845-7851-426f-83b5-4f6815f6038e">2,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDMtNS0xLTEtMzU0MDE4_8dd9932c-70aa-4a54-81da-5ceb7c6add57">1,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents reclassified (to) from held for sale</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDQtMS0xLTEtNDMwMDc1_eb33a5f3-7163-4aeb-bc69-24db553ab875">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDQtMy0xLTEtNDU4MzA2_12b93574-9983-44e0-9ac3-9bbb6d8d2ace">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDQtNS0xLTEtNDU4MzI5_3a6ee163-12fb-4a7e-8c5e-02bac8ceb720">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents, and restricted cash and cash equivalents,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDQtMS0xLTEtMzU0MDE4_5b99291a-b2a4-4b99-8ce1-7fb1de6e7ba7">13,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDQtMy0xLTEtMzU0MDE4_1b74efa6-74e8-472e-bdd5-661a4a35fd96">10,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89efa37b183c4c618c28149ddb506553_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDQtNS0xLTEtMzU0MDE4_72054d52-b2fb-4a1c-90cc-998c3d891385">12,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents, and restricted cash and cash equivalents,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> end of period</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDUtMS0xLTEtMzU0MDE4_895a6bc5-9b2c-4817-8e06-96abdf97ed87">12,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDUtMy0xLTEtMzU0MDE4_992c09d9-10e3-4177-bf85-ec5e7295847c">13,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDUtNS0xLTEtMzU0MDE4_645d7c59-8d7f-4b59-8255-7cf55cd443bb">10,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental disclosures of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDctMS0xLTEtMzU0MDE4_f330c377-23ab-4406-8780-e2584baf844c">657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDctMy0xLTEtMzU0MDE4_837c153a-af21-4ce2-a84f-79ef67d08602">658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDctNS0xLTEtMzU0MDE4_6b3d2d27-7e2b-4e0e-a6fa-ee626f40d6f3">725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDgtMS0xLTEtMzU0MDE4_0c540800-7eb7-4224-8121-0ea3a41fa119">1,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDgtMy0xLTEtMzU0MDE4_90cc6a0b-2fed-4ae0-bb6d-7d07cab70503">678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDgtNS0xLTEtMzU0MDE4_c34a19f7-b501-4652-b200-36f00bb0213e">1,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity issued in connection with acquisitions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDktMS0xLTEtMzU0MDE4_34bb22a3-d8c1-4fbf-8c04-1c68f7126732">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDktMy0xLTEtMzU0MDE4_d16fbf4f-7398-4c3b-ab43-5f96219bdf93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDktNS0xLTEtMzU0MDE4_dbb6fcae-8a82-4739-8ea9-5893faaadfbe">11,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTItMS0xLTEtMzU0MDE4_2e78bb03-004d-4fa6-8545-0cebc9f66c69">12,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTItMy0xLTEtMzU0MDE4_725a1b4d-f4e3-4ceb-a4cc-99696b93b823">13,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTItNS0xLTEtMzU0MDE4_4ac72f0a-92e9-4dab-8012-8ad73ce6124b">10,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents, included in restricted deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTMtMS0xLTEtMzU0MDE4_3d096c24-72e9-47d2-bb22-9f7e15b115bb">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTMtMy0xLTEtMzU0MDE4_db0280aa-394e-4a7f-a24a-ce2a3d8ce82d">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTMtNS0xLTEtMzU0MDE4_334c64f4-9bf7-4af4-bf7b-ce902038d5b3">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTQtMS0xLTEtMzU0MDE4_b427e373-6a99-4d99-93b0-8f682eddcb11">12,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTQtMy0xLTEtMzU0MDE4_45fd8d5f-d624-41dc-b756-173ad86cc357">13,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTQtNS0xLTEtMzU0MDE4_25f48d69-8dc6-4690-b520-ca774cf38a69">10,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes to the consolidated financial statements are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CENTENE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="i9dee570cfbd043d6a1700298c14b2446_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDAvZnJhZzo1ZDE3MjUyZDg1ODA0ZGUyYTlmMGJkZTRiZWZhNGEyYy90ZXh0cmVnaW9uOjVkMTcyNTJkODU4MDRkZTJhOWYwYmRlNGJlZmE0YTJjXzE3NzQ_d340688a-3772-40fe-ad1a-3e4d3c96ed79" continuedAt="ib51e57239c99465ab2f8e7215aee9d16" escape="true">Organization and Operations </ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib51e57239c99465ab2f8e7215aee9d16">Centene Corporation, or the Company, is a leading healthcare enterprise, committed to helping people live healthier lives, with an established expertise in lower-income and medically complex populations. The Company provides access to high-quality healthcare, innovative programs, and a wide range of health solutions that help families and individuals get well, stay well, and be well. During 2022, the Company operated in <ix:nonFraction unitRef="segment" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDAvZnJhZzo1ZDE3MjUyZDg1ODA0ZGUyYTlmMGJkZTRiZWZhNGEyYy90ZXh0cmVnaW9uOjVkMTcyNTJkODU4MDRkZTJhOWYwYmRlNGJlZmE0YTJjXzQyNg_82a453be-e967-4ba2-bd68-10f6c488b7c1">two</ix:nonFraction> segments: Managed Care and Specialty Services. The Managed Care segment provided health plan coverage to individuals through government subsidized programs, including Medicaid, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare, the Supplemental Security Income Program, also known as the Aged, Blind, or Disabled Program (ABD), Medicare (including Medicare Prescription Drug Plans), and the Health Insurance Marketplace. The Company also offered a variety of individual, small group, and large group commercial healthcare products, both to employers and directly to members in the Managed Care segment. The Specialty Services segment consisted of the Company's specialty companies offering auxiliary healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations, as well as to the Company's own subsidiaries. The Specialty Services segment also included the government contracts business, including the Company's government-sponsored Managed Care Support Contract with the U.S. Department of Defense (DoD) under the TRICARE program and other healthcare related government contracts.</ix:continuation></span></div><div id="i9dee570cfbd043d6a1700298c14b2446_103"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjQy_be58bd1a-8c25-4060-9fb1-c6e04369f261" continuedAt="id6bf9cb0087b47448f6435e7e4270a13" escape="true">Summary of Significant Accounting Policies </ix:nonNumeric></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><ix:continuation id="id6bf9cb0087b47448f6435e7e4270a13" continuedAt="i6ce749dd45cb49d7b4164e2ebcea7f96"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjk2_7c5661f0-91b4-4dd1-9389-bd91c486d29f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of Centene Corporation and all majority owned subsidiaries and subsidiaries over which the Company exercises the power and control to direct activities significantly impacting financial performance. All material intercompany balances and transactions have been eliminated. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the consolidated financial statements and notes have been reclassified to conform to the 2022 presentation. Beginning in 2022, the Company has included a separate line item for depreciation expense on the Consolidated Statement of Operations, which was previously included in selling, general and administrative (SG&amp;A) expenses. Prior period SG&amp;A expense ratios have also been conformed to the current presentation. These reclassifications have no effect on net earnings, cash flow, or stockholders' equity as previously reported.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 2022, the Company acquired all of the issued and outstanding shares of Magellan Health, Inc. (Magellan). The acquisition was accounted for as a business combination. Additionally, during 2022 the Company completed the divestitures of PANTHERx Rare (PANTHERx), its Spanish and Central European businesses, and Magellan Rx. See Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further details.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjU3_ece4cb61-1c16-4d0d-abf9-80df25839286" continuedAt="i4f2dcc76788f4a74a72d15e1660a65fb" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4f2dcc76788f4a74a72d15e1660a65fb">The preparation of financial statements in conformity with generally accepted accounting principles in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Future events and their effects cannot be predicted with certainty; accordingly, the accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes. The Company evaluates and updates its assumptions and estimates on an ongoing basis and may employ outside experts to assist in its evaluation, as considered necessary. Actual results could differ from those estimates.</ix:continuation> </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i6ce749dd45cb49d7b4164e2ebcea7f96" continuedAt="i00dbba6151664e848f155fce1098480d"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTQ5_cf946741-1c14-44b0-95d7-02b3a8ef47a6" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business combinations are accounted for using the acquisition method of accounting. The Company allocates the fair value of purchase consideration to the assets acquired and liabilities assumed based on their fair values at the acquisition date. The excess of the fair value of consideration transferred over the fair value of the net assets acquired is recorded as goodwill. Goodwill is generally attributable to the value of the synergies between the combined companies and the value of the acquired assembled workforce, neither of which qualifies for recognition as an intangible asset. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses its best estimates and assumptions to value assets acquired and liabilities assumed at the acquisition date; however, these estimates are sometimes preliminary and, in some instances, all information required to value the assets acquired and liabilities assumed may not be available or final as of the end of a reporting period subsequent to the business combination. If the accounting for the business combination is incomplete, provisional amounts are recorded. The provisional amounts are updated during the period determined, up to one year from the acquisition date. The Company includes the results of operations of acquired businesses in the Company's consolidated results prospectively from the date of acquisition. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition related expenses and post-acquisition restructuring costs are recognized separately from the business combination and are expensed as incurred.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjQ2_b544eb5c-2d9a-439f-8b0f-43cf37d3e5de" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments with original maturities of three months or less are considered to be cash equivalents. Cash equivalents consist of money market funds, bank certificates of deposit, and savings accounts. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains amounts on deposit with various financial institutions, which may exceed federally insured limits. However, management periodically evaluates the credit-worthiness of those institutions, and the Company has not experienced any losses on such deposits.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMzI1_334ce47d-9322-46da-afd5-74b9c501f698" continuedAt="iefaa52a096d941aaabc885ea597c9ff9" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments include securities with maturities greater than three months to one year. Long-term investments include securities with maturities greater than one year. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term and long-term investments are generally classified as available-for-sale and are carried at fair value. Certain equity investments are recorded using the fair value or equity method. The Company monitors the difference between the carrying value and fair value of its available-for-sale debt investments and whether declines in fair value are credit related. Unrealized gains and losses on debt investments available-for-sale are excluded from earnings and reported in accumulated other comprehensive earnings (loss), a separate component of stockholders' equity, net of income tax effects. If a loss is deemed to be credit related, the Company recognizes an allowance through earnings. For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes.&#160;If the security meets this criterion, the decline in fair value is recorded in earnings through investment and other income. Premiums and discounts are amortized or accreted over the life of the related security using the effective interest method. To calculate realized gains and losses on the sale of investments, the Company uses the specific amortized cost of each investment sold. Realized gains and losses are recorded in investment and other income. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iefaa52a096d941aaabc885ea597c9ff9">The Company uses the equity method to account for investments in entities that it does not control but has the ability to exercise significant influence over operating and financial policies. Generally, under the equity method, original investments in these entities are recorded at cost and subsequently adjusted by the Company's share of equity in income or losses after the date of acquisition&#160;as well as capital contributions to and distributions from these companies.</ix:continuation> </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTIy_5960163e-040b-462e-97e9-0148f4fa5fa3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Deposits </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted deposits consist of investments required by various state statutes to be deposited or pledged to state agencies. These investments are classified as long-term, regardless of the contractual maturity date, due to the nature of the states' requirements. The Company is required to annually adjust the amount of the deposit pledged to certain states.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i00dbba6151664e848f155fce1098480d" continuedAt="ideaddd4e71134d0089859fa43f6808a8"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjc3_db7f2064-a928-48bf-af79-7890e5f022ef" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value&#160;Measurements</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company invests in various financial assets and&#160;incurs various financial liabilities. Fair values are disclosed for all financial instruments, whether or not such values are recognized in the Consolidated Balance Sheets. Management obtains quoted market prices and other observable inputs for these disclosures. The carrying amounts reported in the Consolidated Balance Sheets for cash and cash equivalents, premium and&#160;trade receivables, medical claims liability, accounts payable and accrued expenses, unearned revenue, and certain other current assets and liabilities are carried at cost, which approximates fair value because of their short-term nature. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used to estimate the fair value of each financial instrument: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Available-for-sale investments and restricted deposits: The carrying amount is stated at fair value, based on quoted market prices, where available. For securities not actively traded, fair values were estimated using values obtained from independent pricing services or quoted market prices of comparable instruments.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Senior unsecured notes: Estimated based on third-party quoted market prices for the same or similar issues.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Variable rate debt: The carrying amount of the Company's floating rate debt approximates fair value since the interest rates adjust based on market rate adjustments.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency swap: Estimated based on Great British Pound to US Dollar foreign exchange rates.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Contingent consideration: Estimated based on expected achievement of metrics included in the acquisition agreement considering circumstances that exist as of the acquisition date.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMzIx_869bbf32-aeec-4d99-bada-d7b6dee53cb9" continuedAt="ifb2d3311af9347168c6903826e373757" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Software and Equipment </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, software and equipment are stated at cost less accumulated depreciation. Computer hardware and software includes certain costs incurred in the development of internal-use software, including external direct costs of materials and services and payroll costs of employees devoted to specific software development. Depreciation is calculated principally by the straight-line method over estimated useful lives. Leasehold improvements are depreciated using the straight-line method over the shorter of the expected useful life or the remaining term of the lease. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="cnc:ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjQ4_f29c2841-8557-48e1-be97-af44b5669150" continuedAt="i1be2647dc883484a8a4c335ff6bb0b54" escape="true">Property, software and equipment are depreciated over the following periods:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i1be2647dc883484a8a4c335ff6bb0b54"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"></td><td style="width:67.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.266%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed Asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation Period</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonNumeric contextRef="id7f45234b97a4a8db9cc70838a92e915_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzEtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YjM4YWUzYjQ1YWQxNDdiODhmODVjNjhjMTMzNzk2YTZfNQ_48a4b1e0-4f3d-4336-9998-023c1033e933">5</ix:nonNumeric> - <ix:nonNumeric contextRef="i2359cd8d83d04e01929e44fe25fcb92f_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzEtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YjM4YWUzYjQ1YWQxNDdiODhmODVjNjhjMTMzNzk2YTZfMTA_c8988613-fed8-4859-88b5-ad8c4298056c">40</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4607d979606c4f7fa36ae2f1b825cb49_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzItMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YTI4OTAzZGM2OTU2NDhjYjkyNWFhMDA1MmU2YTNiMzlfNA_08bbeb03-196c-41b8-9051-680323b32f36">3</ix:nonNumeric> - <ix:nonNumeric contextRef="i35e17c2ca0f64a168f7fe15e237ef8d1_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzItMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YTI4OTAzZGM2OTU2NDhjYjkyNWFhMDA1MmU2YTNiMzlfOQ_d32a22c1-a639-4a9e-a7eb-4b4185864335">5</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonNumeric contextRef="i34c5f25db0f84955937399bdc59bc0f8_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzMtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246NGM0MmEyYmVmMzMzNDI0YTlmMmZiZmZhMzA1ZDM1OWFfNQ_10d0614b-7e3d-4101-b75a-861969a6cc81">3</ix:nonNumeric> - <ix:nonNumeric contextRef="ib42047c8782d4d33831b521cdbbe8d2f_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzMtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246NGM0MmEyYmVmMzMzNDI0YTlmMmZiZmZhMzA1ZDM1OWFfMTA_c0323480-d5fb-4e39-9b84-9ca20edf2c9d">10</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonNumeric contextRef="ib9cb6bb95198406b9dc757a3fe689c48_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzQtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YzA0NzgwNzQyMzQ1NGM3NWJjNjM5NmIzNjlhYTk4NDRfNQ_021fe84c-dd50-445b-9fe1-e52eb6f47a57">10</ix:nonNumeric> - <ix:nonNumeric contextRef="i39698c8d4f5741c2bd5f7bb1c215d1c2_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzQtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YzA0NzgwNzQyMzQ1NGM3NWJjNjM5NmIzNjlhYTk4NDRfMTA_83d100cc-2c22-4994-abb1-f7f491db53be">20</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonNumeric contextRef="ib0e7605c14854f1298823da0004e7bcd_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzUtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246ZTRiZjg3NDgyODYxNDg5N2EzY2U5YTBhZTE3MTA4NjhfNQ_e9986e9c-813d-421a-bed5-76f8884f4268">1</ix:nonNumeric> - <ix:nonNumeric contextRef="i67e4e863732140539a2d0c4798909e31_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzUtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246ZTRiZjg3NDgyODYxNDg5N2EzY2U5YTBhZTE3MTA4NjhfMTA_1ceb520f-cc88-40b7-8d13-3636da161601">20</ix:nonNumeric> years</span></div></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of all long-lived assets are evaluated to determine if adjustment to the depreciation and amortization period or to the unamortized balance is warranted. Such evaluation is based principally on the expected utilization of the long-lived assets.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifb2d3311af9347168c6903826e373757">The Company retains fully depreciated assets in property and accumulated depreciation accounts until it removes them from service. In the case of sale, retirement, or disposal, the asset cost and related accumulated depreciation balance is removed from the respective account, and the resulting net amount, less any proceeds, is included as a component of earnings from operations in the Consolidated Statements of Operations.</ix:continuation> </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="ideaddd4e71134d0089859fa43f6808a8" continuedAt="i7760b468746348768cecf3c4790f2b45"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjQw_f2bd426a-a567-4b39-9696-d329770a1395" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets represent assets acquired in purchase transactions and consist primarily of purchased contract rights and customer relationships, provider contracts, trade names, developed technologies, and goodwill. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="cnc:ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTUz_8d94bb01-aaad-4e89-a49f-b7ceefdc19f5" continuedAt="ie49c4d66de8a4901b3bdca65370bd5dc" escape="true">Intangible assets are amortized using the straight-line method over the following periods:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="ie49c4d66de8a4901b3bdca65370bd5dc"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"></td><td style="width:67.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.266%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights and customer relationships</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i74119b927bec4965b1fd97a0689f4f10_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzEtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246ZTI3ZGRjNmYxMDRhNDYxNTgxMTBmNmZkMWE3OTliNzFfNA_42b8c2bd-bbc5-46e4-a840-86525538933f">3</ix:nonNumeric> - <ix:nonNumeric contextRef="i7f0027dbc67f4fcfb5bb6efed06c4909_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzEtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246ZTI3ZGRjNmYxMDRhNDYxNTgxMTBmNmZkMWE3OTliNzFfOQ_d0058679-3902-4a52-a19b-83ed7cdf32b3">21</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if4d49678d798431db2da34d388ffc987_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzItMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YzAwNjc2MjIzMWNmNGE3OWIzZTVmZDc4NjViYjJiNzBfNA_ef8f4dfc-4ff4-4501-a4aa-99237f5d5f12">4</ix:nonNumeric> - <ix:nonNumeric contextRef="iae0603c3ac604874a3f063c971cb1131_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzItMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YzAwNjc2MjIzMWNmNGE3OWIzZTVmZDc4NjViYjJiNzBfOQ_5efc8bf4-5a8a-4440-bce3-35f2e16463cc">15</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifcdf168f01c14287ab8225cc4e5ac2a2_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzMtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246ZmZmODJhZTMxMzgwNGI3YmEwYzc5ZjdkNDMxZDU3YzhfNA_11f2e390-4419-481d-9c43-296f6e9dba48">7</ix:nonNumeric> - <ix:nonNumeric contextRef="id7c90459707d4aa69df99c5cbc3d379b_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzMtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246ZmZmODJhZTMxMzgwNGI3YmEwYzc5ZjdkNDMxZDU3YzhfOQ_e1322719-1f84-44b9-b5a0-4c876bb02c75">20</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5054b3e6c71b40e494d1cacca5fded80_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzQtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246NDNmNzYyM2EyZWY1NDcxNDlmMmQ3NTJmNGM3MGUxN2ZfNA_d9a21936-3278-4172-a2d1-f014d0ce1b1f">2</ix:nonNumeric> - <ix:nonNumeric contextRef="i77c71d30602b434bb2aa3deac20d8334_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzQtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246NDNmNzYyM2EyZWY1NDcxNDlmMmQ3NTJmNGM3MGUxN2ZfOQ_1ba70ff2-8ca1-43f9-8ec6-d83a236490e5">7</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests for impairment of intangible assets, as well as long-lived assets, whenever events or changes in circumstances indicate that the carrying value of an asset or asset group (hereinafter referred to as "asset group") may not be recoverable by comparing the sum of the estimated undiscounted future cash flows expected to result from use of the asset group and its eventual disposition to the carrying value. Such factors include, but are not limited to, significant changes in membership, state funding, state contracts, and provider networks and contracts. If the sum of the estimated undiscounted future cash flows is less than the carrying value, an impairment determination is required. The amount of impairment is calculated by subtracting the fair value of the asset group from the carrying value of the asset group. An impairment charge, if any, is recognized within earnings from operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill for impairment using a fair value approach. The Company is required to test for impairment at least annually, absent a triggering event, which could include a significant decline in operating performance that would require an impairment assessment. Absent any impairment indicators, the Company performs its goodwill impairment testing during the fourth quarter of each year. The Company recognizes an impairment charge for any amount by which the carrying amount of goodwill exceeds its fair value. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company first assesses qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. The Company generally does not calculate the fair value of a reporting unit unless it determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the quantitative test is deemed necessary, the Company determines an appropriate valuation technique to estimate a reporting unit's fair value as of the testing date. The Company utilizes either the income approach or the market approach, whichever is most appropriate for the respective reporting unit. The income approach is based on an internally developed discounted cash flow model that includes many assumptions related to future growth rates, discount factors, future tax rates, and other various assumptions. The market approach is based on financial multiples of comparable companies derived from current market data. The Company then compares the fair value of the reporting unit calculated using the income approach or market approach with its carrying amount and recognizes an impairment charge for the amount by which the carrying amount exceeds fair value. The impairment charge is limited to the total amount of goodwill allocated to the reporting unit. Changes in economic and operating conditions impacting assumptions used in the Company's analyses could result in goodwill impairment in future periods.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjA0_80303528-e009-412d-a180-e387dada3bbc" continuedAt="i8bb8ada1d22341b9b9b9f5b1f2c38f8d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Claims Liability</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical claims liability includes claims reported but not yet paid, or inventory, estimates for claims incurred but not reported, or IBNR, and estimates for the costs necessary to process unpaid claims at the end of each period.&#160;The Company estimates its medical claims liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice.&#160;These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actuarial Standards of Practice generally require that the medical claims liability estimates be adequate to cover obligations under moderately adverse conditions.&#160;Moderately adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of estimate.&#160;In many situations, the claims amounts ultimately settled will be different than the estimate that satisfies the Actuarial Standards of Practice. The Company includes in its IBNR an estimate for medical claims liability under moderately adverse conditions which represents the risk of adverse deviation of the estimates in its actuarial method of reserving.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i7760b468746348768cecf3c4790f2b45" continuedAt="ia8aac5c0e9ad4586aaf1e6c15e3675dd"><ix:continuation id="i8bb8ada1d22341b9b9b9f5b1f2c38f8d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses its judgment to determine the assumptions to be used in the calculation of the required estimates. The assumptions it considers when estimating IBNR include, without limitation, claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, healthcare service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known outbreaks of disease or increased incidence of illness such as influenza or COVID-19, provider contract changes, changes to fee schedules, and the incidence of high-dollar or catastrophic claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's development of the medical claims liability estimate is a continuous process which it monitors and refines on a monthly basis as additional claims receipts and payment information becomes available. As more complete claims information becomes available, the Company adjusts the amount of the estimates, and includes the changes in estimates in medical costs in the period in which the changes are identified. In every reporting period, the operating results include the effects of more completely developed medical claims liability estimates associated with previously reported periods. The Company consistently applies its reserving methodology from period to period. As additional information becomes known, it adjusts the actuarial model accordingly to establish medical claims liability estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement, and maintenance costs. For purposes of determining premium deficiencies, contracts are grouped in a manner consistent with the method of acquiring, servicing, and measuring the profitability of such contracts.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjUx_2116e564-2245-464c-a1b9-2bd66908565e" continuedAt="i070c7d9eb2fc42e799c625a3a8f2baf8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's health plans generate revenues primarily from premiums received from the states in which it operates health plans, premiums received from its members and the Centers for Medicare and Medicaid Services (CMS) for its Medicare product, and premiums from members of its commercial health plans. In addition to member premium payments, its Marketplace contracts also generate revenues from subsidies received from CMS. The Company generally receives a fixed premium per member per month pursuant to its contracts and recognizes premium revenues during the period in which it is obligated to provide services to its members at the amount reasonably estimable. In some instances, the Company's base premiums are subject to an adjustment factor, in the form of a risk score or risk adjustment, based on the acuity of its membership. Generally, the risk score or risk adjustment is determined by the state or CMS analyzing submissions of processed claims and medical record data to determine the acuity of the Company's membership, often relative to the respective program's membership. The Company estimates the amount of risk score and risk adjustment based upon the processed claims and medical record data submitted and expected to be submitted to CMS and records revenues on a risk adjusted basis. Some contracts allow for additional premiums related to certain supplemental services provided such as maternity deliveries.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts with states may require it to maintain a minimum health benefits ratio (HBR) or may require it to share cost-savings in excess of certain levels. In certain circumstances, including commercial plans, its plans may be required to return premium to the state or policyholders in the event costs are below established levels. The Company estimates the effect of these programs and recognizes reductions in revenue in the current period. Other states may require us to meet certain performance and quality metrics in order to receive additional or full contractual revenue. For performance-based contracts, the Company does not recognize revenue subject to refund until data is sufficient to measure performance.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recorded based on membership and eligibility data provided by the states or CMS, which is adjusted on a monthly basis by the states or CMS for retroactive additions or deletions to membership data. These eligibility adjustments are estimated monthly and subsequent adjustments are made in the period known. The Company reviews and updates those estimates as new information becomes available.&#160;It is possible that new information could require us to make additional adjustments, which could be significant, to these estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Medicare Advantage contracts are with CMS. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model pays more for members whose medical history would indicate that they are expected to have higher medical costs. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis data from hospital inpatient, hospital outpatient, physician treatment settings as well as prescription drug events. The Company and the healthcare providers collect, compile, and submit the necessary and available diagnosis data to CMS within prescribed deadlines. The Company estimates risk adjustment revenues based upon the diagnosis data submitted and expected to be submitted to CMS and records revenues on a risk adjusted basis.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="ia8aac5c0e9ad4586aaf1e6c15e3675dd" continuedAt="ic48e993def8f4a96886b934595b1e249"><ix:continuation id="i070c7d9eb2fc42e799c625a3a8f2baf8" continuedAt="i0eb0b9edfe2a43868453ced0788d613f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For qualifying low-income prescription drug benefit members, CMS pays for some, or all, of the member's monthly premium. The Company receives certain Part D prospective subsidy payments from CMS for these members as a fixed monthly per member amount, based on the estimated costs of providing prescription drug benefits over the plan year, as reflected in its bids. Approximately nine to ten months subsequent to the end of the plan year, or later in the case of the coverage gap discount subsidy, a settlement payment is made between CMS and the Company's plans based on the difference between the prospective payments and actual claims experience. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's specialty services generate revenues under contracts with state and federal programs, healthcare organizations, and other commercial organizations, as well as from its own subsidiaries. Revenues are recognized when the related services are provided, when inventory is shipped, or as ratably earned over the covered period of services. The Company recognizes revenue related to administrative services under the TRICARE government-sponsored Managed Care Support Contract for the DoD's TRICARE program on a straight-line basis over the option period, when the fees become fixed and determinable. The TRICARE contract includes various performance-based measures.&#160;For each of the measures, an estimate of the amount that has been earned is made at each interim date, and revenue is recognized accordingly. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states enact premium taxes, similar assessments, and provider pass-through payments, collectively premium taxes, and these taxes are recorded as a separate component of both revenues and operating expenses. Additionally, the Company's insurance subsidiaries were previously subject to the Affordable Care Act (ACA) annual health insurer fee (HIF). Beginning in 2021, the HIF was permanently repealed. This revenue was recorded as premium tax and health insurer fee revenue in the Consolidated Statements of Operations. For certain products, premium taxes, state assessments, and the HIF are not pass-through payments and are recorded as premium revenue and premium tax expense or health insurer fee expense in the Consolidated Statements of Operations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0eb0b9edfe2a43868453ced0788d613f">Some states require state directed payments that have minimal risk, but are administered as a premium adjustment.&#160;These payments are recorded as premium revenue and medical costs at close to a 100% HBR. In many instances, the Company has little visibility to the timing of these payments until they are paid by the state.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="cnc:HealthInsuranceMarketplaceDisclosurePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTc0_bc56e995-837f-47b5-bd15-3a2f31be4980" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Affordable Care Act</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established risk spreading premium stabilization programs as well as minimum medical loss ratio (MLR) and cost sharing reductions (CSRs). The Company's accounting policies for the programs are as follows: </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Risk Adjustment </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The permanent risk adjustment program established by the ACA transfers funds from qualified individual and small group insurance plans with below average risk scores to those plans with above average risk scores within each state. The Company estimates the receivable or payable under the risk adjustment program based on its estimated risk score compared to the state average risk score. The Company may record a receivable or payable as an adjustment to premium revenues to reflect the year-to-date impact of the risk adjustment based on its best estimate. The Company refines its estimate as new information becomes available. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Minimum Medical Loss Ratio</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the ACA established a minimum MLR for the Health Insurance Marketplace. The risk adjustment program described above is taken into consideration to determine if the Company's estimated annual medical costs are less than the minimum MLR and require an adjustment to premium revenues to meet the minimum MLR. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Cost Sharing Reductions</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA directs issuers to reduce the Company's members' cost sharing for essential health benefits for individuals with Federal Poverty Levels (FPLs) between 100% and 250% who are enrolled in a silver tier product; eliminate cost sharing for Indians/Alaska Natives with a FPL less than 300% and eliminate cost sharing for Indians/Alaska Natives regardless of FPL when services are provided by an Indian Health Service. In order to compensate issuers for reduced cost sharing provided to enrollees, CMS pays an advance CSR payment to the Company each month based on the Company's certification data provided at the time of the qualified health plan application. In October 2017, the Trump Administration issued an executive order that immediately ceased payments of CSRs to issuers, and beginning in 2018 premium rates for Health Insurance Marketplace were set without factoring in the cost sharing subsidy payments from the federal government.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="ic48e993def8f4a96886b934595b1e249" continuedAt="idcd24b2221a149a3a2595bd71a38eee2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="cnc:PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTU5_4c7d8e53-40c9-4660-98df-881eb7c468ad" continuedAt="idde883e21b344933a277de9cec139766" escape="true">Premium and Trade Receivables and Unearned Revenue</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idde883e21b344933a277de9cec139766">Premium and service revenues collected in advance are recorded as unearned revenue. For performance-based contracts, the Company does not recognize revenue subject to refund until data is sufficient to measure performance. Premiums and service revenues due to the Company are recorded as premium and trade receivables and are recorded net of an allowance based on historical trends and management's judgment on the collectability of these accounts. As the Company generally receives payments during the month in which services are provided, the allowance is typically not significant in comparison to total revenues and does not have a material impact on the presentation of the financial condition or results of operations. Amounts receivable under federal contracts are comprised primarily of contractually defined billings, accrued contract incentives under the terms of the contract, and amounts related to change orders for services not originally specified in the contract.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="cnc:ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjMz_77140b51-55f1-49e2-aed7-cc9e73fee8ea" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity in the allowance for uncollectible accounts is summarized below ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzEtMS0xLTEtMzU0MDE4_ad9580c6-1591-4206-99fe-c1f33d6b50a5">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzEtMy0xLTEtMzU0MDE4_281d9424-869d-4906-898c-1f8dc07368ed">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89efa37b183c4c618c28149ddb506553_I20191231" decimals="-6" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzEtNS0xLTEtMzU0MDE4_9c2417f5-ae79-4cb6-95d7-c44ad6a6baf1">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts charged to expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:PremiumReceivableCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzMtMS0xLTEtMzU0MDE4_2f4d9a8c-eeb0-4681-83c6-bc253e173cb2">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:PremiumReceivableCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzMtMy0xLTEtMzU0MDE4_0e4ac23a-012b-41f9-9e37-6cca934967c1">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:PremiumReceivableCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzMtNS0xLTEtMzU0MDE4_6f20597e-f120-4ea7-80de-3466b5deefbe">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzQtMS0xLTEtMzU0MDE4_76130f8a-745c-4161-bbb8-37a17453722f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzQtMy0xLTEtMzU0MDE4_1c9d84be-7b1e-4334-aa05-50c9d83042ff">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzQtNS0xLTEtMzU0MDE4_dce4c10a-9b55-43eb-a1fb-3de60b77383f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of uncollectible receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzUtMS0xLTEtMzU0MDE4_4d8658c5-6038-46b4-b92c-f733177975b8">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzUtMy0xLTEtMzU0MDE4_892c7d80-6aed-48ef-9ceb-b79db18a305f">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzUtNS0xLTEtMzU0MDE4_694a8382-edda-4680-820e-2ff228e412eb">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzYtMS0xLTEtMzU0MDE4_e479aa52-1ab0-464e-b1ee-4b4e1796c2d7">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzYtMy0xLTEtMzU0MDE4_9b26a00a-7bbf-461d-99e6-48fcfa96b3c5">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzYtNS0xLTEtMzU0MDE4_f594cd13-7a97-4414-a01b-ac4f848e81ce">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="cnc:SignificantCustomersPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTY1_b0852979-8538-445a-af70-10fea6a5191c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Customers </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company receives the majority of its revenues under contracts or subcontracts with state Medicaid managed care programs. Customers where the aggregate annual contract revenues exceeded 10% of total annual revenues included the state of New York, where the percentage of the Company's total revenue was <ix:nonFraction unitRef="number" contextRef="if6cdbd424736484b93b773b56ebf2191_D20210101-20211231" decimals="2" name="cnc:PercentageOfRevenuesUnderContractsOrSubcontracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzI2Mjg2_1356ed16-26e5-4f34-8139-b7a8f696e74a">10</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if869d22d0f044d3d9bfb60d75bc74fbe_D20200101-20201231" decimals="2" name="cnc:PercentageOfRevenuesUnderContractsOrSubcontracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzI2Mjk0_658252a8-e3dd-4cc7-97ff-fff9227598f8">11</ix:nonFraction>% for the years ended December 31, 2021 and 2020. <ix:nonFraction unitRef="number" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="2" name="cnc:PercentageOfRevenuesUnderContractsOrSubcontracts" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzQ5NDc4MDIzNjA0NzQ_b3fddb06-0d28-4f9a-8473-728611f57ffc">None</ix:nonFraction> of the Company's customers exceeded 10% of total annual revenues for the year ended December 31, 2022.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="cnc:OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTcx_f38a8b90-1c06-4a53-89b2-0efaddc782e4" continuedAt="i582eca60c89640c39e1a148365b16a4b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense) </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i582eca60c89640c39e1a148365b16a4b">Other income (expense) consists routinely of investment income, interest expense, and equity method earnings from investments. Investment income is derived from the Company's cash, cash equivalents, restricted deposits and investments. Interest expense relates to borrowings under the senior notes, credit facilities, mortgage and construction loans, and capital leases. Further, other income (expense) includes gains or losses on sales of investments, divestitures, and acquisitions as well as debt extinguishment costs.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTE5_fb1343fb-953c-4703-bdc9-e2562af5420d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recorded for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law or tax rates is recognized in income in the period that includes the enactment date. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowances are provided when it is considered more likely than not that deferred tax assets will not be realized. In determining if a deductible temporary difference or net operating loss can be realized, the Company considers future reversals of existing taxable temporary differences, future taxable income, taxable income in prior carryback periods, and tax planning strategies.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTg1_fe3065ed-4565-4f9c-94ec-2c858b306056" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accrues for loss contingencies associated with outstanding litigation, claims, and assessments for which it has determined it is probable that a loss contingency exists and the amount of loss can be reasonably estimated. The Company expenses professional fees associated with litigation claims and assessments as incurred.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="idcd24b2221a149a3a2595bd71a38eee2"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTMz_8d8ffc21-ac5d-4422-8281-1506284a65b9" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Based Compensation</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock based compensation expense is recognized at grant date fair value over the period during which an employee is required to provide service in exchange for the award. Excess tax benefits related to stock compensation are presented as a cash inflow from operating activities. The Company accounts for forfeitures when they occur.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMzIz_54959396-1a17-4fd2-b244-4698d3289b13" continuedAt="i0996d77115da41d0be8f232d5258ce1f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0996d77115da41d0be8f232d5258ce1f">The Company is exposed to foreign currency exchange risk through its international subsidiaries whose functional currencies include the Euro and Great British Pound. The assets and liabilities of the Company's subsidiaries are translated into United States dollars at the balance sheet date. The Company translates its proportionate share of earnings using average rates during the year. The resulting foreign currency translation adjustments are recorded as a separate component of accumulated other comprehensive earnings (loss).</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjI4_9cf3b29a-656a-4b3d-b3c5-9402c5322911" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial condition, results of operations, or cash flows.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzQ2MTE_005d8826-2441-4ece-9b2c-5df158a9049d" continuedAt="i1ab1ef7ef0034dfebed89e57ebe89ebf" escape="true">Acquisitions and Divestitures</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i1ab1ef7ef0034dfebed89e57ebe89ebf" continuedAt="i2926f6d8ef1347fc960bc728867f65a4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Magellan Acquisition </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On&#160;January&#160;4, 2022, the Company acquired all of the issued and outstanding shares of Magellan. Total consideration for the acquisition was $<ix:nonFraction unitRef="usd" contextRef="i906fa59240054e0ca347d7e3ce1f9812_D20220104-20220104" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzE1Mw_bc00fc9d-83e5-4a05-bdae-d750c29c000e">2,491</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="i906fa59240054e0ca347d7e3ce1f9812_D20220104-20220104" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzE3MQ_bdd6600b-3579-4455-9c15-4ab34e5df7e0">2,431</ix:nonFraction> million in cash and $<ix:nonFraction unitRef="usd" contextRef="i906fa59240054e0ca347d7e3ce1f9812_D20220104-20220104" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredOther1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzE4Ng_d38aa1e1-04db-4485-9da9-03de225bcf81">60</ix:nonFraction> million related to the fair value of replacement equity awards associated with pre-combination service. The purchase price has been adjusted to reflect the net effective settlement of preexisting relationships between the Company and Magellan of $<ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzQyNw_91ada634-a844-4a13-b14e-0d5ba9288784">70</ix:nonFraction>&#160;million. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i3799e2d4c58049f4bac2714882700574_D20220101-20221231" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzQ1NA_e46ba8e7-db13-47e4-ab34-5ac372ffdf58">106</ix:nonFraction> million of acquisition related expenses related to Magellan for the year ended December 31, 2022.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Magellan acquisition was accounted for as a business combination using the acquisition method of accounting that requires assets acquired and liabilities assumed to be recognized at fair value as of the acquisition date. The valuation of all assets acquired and liabilities assumed was finalized in the fourth quarter of 2022.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzQ2MTM_b5400c05-38ce-4cf2-89af-9bc2c7cf783b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's allocation of the fair value of assets acquired and liabilities assumed as of the acquisition date of January&#160;4, 2022 is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"><tr><td style="width:1.0%"></td><td style="width:71.342%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzEtMi0xLTEtMzU0MDE4_64a8620d-7c06-4c3b-a14c-a3fc23b430c5">995</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and related receivables</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzItMi0xLTEtMzU0MDE4_4f242bf0-9ca1-4af8-9edd-a73962893811">791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzMtMi0xLTEtMzU0MDE4_0f275883-335e-4e9e-a0a9-efe098e1aa8d">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzQtMi0xLTEtMzU0MDE4_d60fffc0-5e8f-4a05-9300-07c7159db819">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzUtMi0xLTEtMzU0MDE4_4b8b752d-961d-47d0-9185-fe514eb4cb9d">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzYtMi0xLTEtMzU0MDE4_f44f4e66-64c0-427a-9e72-2be9a89f152f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzctMi0xLTEtMzU0MDE4_f8f7cc1f-fd77-4e35-ae27-d3eb045235fd">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzgtMi0xLTEtMzU0MDE4_7a35e091-def5-4331-82bf-0e3c8cc76ac3">889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzktMi0xLTEtMzU0MDE4_0f6623a5-500a-4198-aa00-dfd7d4c4cf11">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzEwLTItMS0xLTM1NDAxOA_758b9d07-32cf-4878-a09f-45c2cb361d84">3,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims liability</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzEyLTItMS0xLTM1NDAxOA_47bf8134-e0d5-4aae-bac5-f4b8aec8bf2f">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzEzLTItMS0xLTM1NDAxOA_3408bc42-2a49-4a29-ba52-b707df8e0730">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return of premium payable</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzE0LTItMS0xLTM1NDAxOA_16fcc353-9fa9-4025-8e1e-e0450945e1c1">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzE1LTItMS0xLTM1NDAxOA_578d6728-47b0-4d26-a418-03d5d3606bfe">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzE2LTItMS0xLTM1NDAxOA_ddc58ac4-c28c-4d69-a3fa-c3270fa26ea6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzE3LTItMS0xLTM1NDAxOA_85974fca-29ac-4b82-8de5-0a362cb06dfc">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzE4LTItMS0xLTM1NDAxOA_83813743-f146-41c3-9f02-329084453531">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzE5LTItMS0xLTM1NDAxOA_1284801f-6405-4ae1-b110-6daf32341a82">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzIwLTItMS0xLTM1NDAxOA_d31b42e9-ede6-45c2-b9d2-51094a8ffc37">1,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzIxLTItMS0xLTM1NDAxOA_04884c64-cee1-4e33-be06-1c8a3ad5f7d5">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzIyLTItMS0xLTM1NDAxOA_bfade448-8b20-4d08-b669-c8d3c5f76d79">1,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzIzLTItMS0xLTM1NDAxOA_eb0ff89d-0deb-43da-958b-58205997b3bd">905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired and liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzI0LTItMS0xLTM1NDAxOA_48d7d481-3c3b-48d5-9eea-5f561b6d2d64">2,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant fair value adjustments are noted as follows:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The identifiable intangible assets acquired are to be measured at fair value as of the completion of the acquisition. The fair value of intangible assets is determined primarily using variations of the income approach, which is based on the present value of the future after-tax cash flows attributable to each identified intangible asset. Other valuation methods, including the market approach and cost approach, were also considered in estimating the fair value. The identifiable intangible assets include purchased contract rights, provider contracts, developed technologies, and trade names. The Company has estimated the fair value of intangible assets to be $<ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzIxODM_7a35e091-def5-4331-82bf-0e3c8cc76ac3">889</ix:nonFraction> million with a weighted average life of <ix:nonNumeric contextRef="i906fa59240054e0ca347d7e3ce1f9812_D20220104-20220104" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzIyMTg_3877498e-de8c-4aef-aa23-54c01814ffba">12</ix:nonNumeric> years.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i2926f6d8ef1347fc960bc728867f65a4" continuedAt="i22be8b00ff6945d28debd7ba22f7dd90"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzQ2MTU_9dfab382-b5b5-4434-9b08-8cedc300749c" escape="true"><div style="padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values and weighted average useful lives for identifiable intangible assets acquired are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.736%"><tr><td style="width:1.0%"></td><td style="width:43.554%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.524%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Useful Life in Years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd457add58740c084e97e1c414ce9f9_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzEtMi0xLTEtMzU0MDE4_b02c1ddb-3c10-4537-95be-1d452443ee1d">581</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iea27c4aa651545eaa7d30d7a626031a7_D20220104-20220104" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzEtNC0xLTEtMzU0MDE4_289d5da8-4833-4ea1-b871-654453ce2b32">13</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1b54f2cbfd746b8a13ac300eb5f594d_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzItMi0xLTEtMzU0MDE4_fdb06423-1dd6-4e93-8985-85b554d2ba72">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic898092fd2d349718cfc66201cf1e5db_D20220104-20220104" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzItNC0xLTEtMzU0MDE4_908bd728-686d-47f9-8167-0192b6906f8f">15</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9adcef2d77d24557bc8ed47f59f80d11_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzMtMi0xLTEtNDY5MDUy_8990ab36-0c6e-47ae-9bc9-82588edb34aa">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idb157bc574b24e8ea7212ed38cddbc14_D20220104-20220104" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzMtNC0xLTEtNDY5MDUy_14f4c0a3-e27f-4f0d-a211-f13cb3352c88">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68d8c947320f402488ed555c813a0394_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzMtMi0xLTEtMzU0MDE4_93c3189c-0afb-4ce9-a47f-68711a9b8744">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie2f7de6d3ba44de9a27dfe4b0d2086cd_D20220104-20220104" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzMtNC0xLTEtMzU0MDE4_9bc603aa-01ab-4474-9b7b-de46b9aab215">17</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzUtMi0xLTEtMzU0MDE4_28f24c3f-5df3-4b4c-bee3-cdbad05b9e11">889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i906fa59240054e0ca347d7e3ce1f9812_D20220104-20220104" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzUtNC0xLTEtMzU0MDE4_3877498e-de8c-4aef-aa23-54c01814ffba">12</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Debt is required to be measured at fair value under the acquisition method of accounting. The fair value of Magellan's&#160;Senior Notes and Credit Agreement assumed in the acquisition was&#160;$<ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzI4MjY_a0bd4420-76fa-4eb7-8732-7a6446dbb4e6">535</ix:nonFraction> million. In January 2022, the Company paid off Magellan's debt acquired in the transaction using Magellan's cash on hand.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The deferred tax liabilities are presented net of $<ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzI5OTg_eafba6f3-227e-4be3-9af6-7ef5ef8dee74">102</ix:nonFraction> million of deferred tax assets.</span></div><div style="padding-left:9pt;text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The acquisition resulted in $<ix:nonFraction unitRef="usd" contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzMwNTg_eb0ff89d-0deb-43da-958b-58205997b3bd">905</ix:nonFraction> million of goodwill primarily related to synergies expected from the acquisition and the assembled workforce of Magellan. All of the goodwill was assigned to the Specialty segment. The majority of the goodwill is not deductible for income tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PANTHERx Rare Divestiture</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;14, 2022, the Company completed the divestiture of PANTHERx for $<ix:nonFraction unitRef="usd" contextRef="i8676d1a500a445dfbdfe2ed3255b473a_D20220714-20220714" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzM0NDc_8736b330-551b-4f8f-9d1f-5147a0d7f76e">1,373</ix:nonFraction> million. The Company recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="i8676d1a500a445dfbdfe2ed3255b473a_D20220714-20220714" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzM0ODQ_d1a9872b-a471-4e8b-bab5-4cb8c60a55fc">490</ix:nonFraction>&#160;million, or $<ix:nonFraction unitRef="usd" contextRef="i8676d1a500a445dfbdfe2ed3255b473a_D20220714-20220714" decimals="-6" name="cnc:GainLossOnDispositionOfBusinessNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzM0OTE_2f0a578b-dab9-4e97-a9cd-b5027859b8c6">382</ix:nonFraction> million after-tax, which is included in investment and other income on the Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Spanish and Central European Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;16, 2022, as part of the Company's review of strategic alternatives for its international portfolio, the Company completed the divestiture of its ownership stakes in its Spanish and Central European businesses, including Ribera Salud, Torrej&#243;n Salud, and Pro Diagnostics Group.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Company recorded an impairment charge primarily related to intangible assets and goodwill associated with the divestiture of $<ix:nonFraction unitRef="usd" contextRef="i3fad3c7a923b4e3ea96e190945650528_D20220101-20221231" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgyMDYwMg_93f4c5ec-8881-449a-a158-f690577702d2">163</ix:nonFraction> million, or $<ix:nonFraction unitRef="usd" contextRef="i3fad3c7a923b4e3ea96e190945650528_D20220101-20221231" decimals="-6" name="cnc:AssetImpairmentChargesNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzOTYxMQ_fc68b0a6-39d5-4adb-9940-83301eb59cf4">140</ix:nonFraction> million after-tax.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Magellan Rx Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;2, 2022, the Company completed the divestiture of Magellan Rx for $<ix:nonFraction unitRef="usd" contextRef="i6a752c4a069849f8a31ceb9055f487f2_D20221202-20221202" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNzUyNg_12793293-43a3-425c-9507-8725e74a51d7">1,337</ix:nonFraction> million. The Company recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="i6a752c4a069849f8a31ceb9055f487f2_D20221202-20221202" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNzU2NA_c0bdc307-f5b6-41a6-adb6-d2e445ff5246">269</ix:nonFraction>&#160;million, or $<ix:nonFraction unitRef="usd" contextRef="i6a752c4a069849f8a31ceb9055f487f2_D20221202-20221202" decimals="-6" sign="-" name="cnc:GainLossOnDispositionOfBusinessNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNzU3Mg_8d355370-1790-4000-8fb8-9986922f7294">99</ix:nonFraction>&#160;million after-tax, which is included in investment and other income on the Consolidated Statements of Operations and is subject to a final working capital adjustment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Magellan Specialty Health Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;17, 2022, the Company signed a definitive agreement to divest Magellan Specialty Health. As of December&#160;31, 2022, the assets and liabilities of Magellan Specialty Health were considered held for sale, resulting in $<ix:nonFraction unitRef="usd" contextRef="i40a749aec9b14d808f4fa50726eaa259_I20221231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzMyOTg1MzQ4OTcxODM_04ba49a8-a5fe-4b56-af6b-3155ee7f6234">645</ix:nonFraction>&#160;million of assets held for sale in other current assets and $<ix:nonFraction unitRef="usd" contextRef="i40a749aec9b14d808f4fa50726eaa259_I20221231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzMyOTg1MzQ4OTcxOTg_0bdf16cf-9da1-410f-aa75-86536d3621fa">87</ix:nonFraction>&#160;million of liabilities held for sale in accounts payable and accrued expenses on the Consolidated Balance Sheet. The majority of the of held for sale assets were previously reported as goodwill and intangible assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;20, 2023, the Company completed the divestiture for approximately $<ix:nonFraction unitRef="usd" contextRef="i4727fabbef274d23a97b2b7195f75143_I20230120" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzMyOTg1MzQ4OTcyNDg_a52bbb99-b1a9-45e5-a4cb-640fe8618170">646</ix:nonFraction>&#160;million in cash and stock, including an estimated working capital adjustment. The Company estimates that it will recognize an initial pre-tax gain of approximately $<ix:nonFraction unitRef="usd" contextRef="i1032a3c41f4546a19e08100bbd31888f_D20230120-20230120" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNzM5Mg_4aa3d40d-838e-4098-a9f2-b1da9d9cc100">85</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="ie93c74b491b34072ae22f37b005de9da_D20230120-20230120" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNzQyMQ_8d613845-76b0-4270-a9b2-9a863ba4e084">95</ix:nonFraction> million. The Company could also receive up to an additional $<ix:nonFraction unitRef="usd" contextRef="i4727fabbef274d23a97b2b7195f75143_I20230120" decimals="-6" name="cnc:DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzEwOTk1MTE2NTUxNDA_c0e9267b-0617-4200-8f7a-0d2277865459">150</ix:nonFraction>&#160;million in cash and stock in 2024 based on certain 2023 performance metrics. The Company will recognize the appropriate amount of contingent consideration related to the $<ix:nonFraction unitRef="usd" contextRef="i4727fabbef274d23a97b2b7195f75143_I20230120" decimals="-6" name="cnc:DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzEwOTk1MTE2NTUxNDg_c0e9267b-0617-4200-8f7a-0d2277865459">150</ix:nonFraction>&#160;million when realized or realizable.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i22be8b00ff6945d28debd7ba22f7dd90"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Centurion Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;10, 2023, the Company signed and closed a definitive agreement to divest Centurion, its prison healthcare business. As of December&#160;31, 2022, the assets and liabilities of Centurion were considered held for sale resulting in $<ix:nonFraction unitRef="usd" contextRef="ided6cdd3afac49e7905a2933ce43623e_I20221231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNDE1Mg_44e20e58-84a9-4d6b-a2ee-4785b5e6ab47">236</ix:nonFraction>&#160;million of assets held for sale in other current assets and $<ix:nonFraction unitRef="usd" contextRef="ided6cdd3afac49e7905a2933ce43623e_I20221231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNDE1OQ_943cf08e-767a-41b8-9ebe-2f1bbbe34dbc">198</ix:nonFraction>&#160;million of liabilities held for sale in accounts payable and accrued expenses on the Consolidated Balance Sheet. The majority of the held for sale assets were previously reported as premium and trade receivables. The majority of the liabilities were previously reported as medical claims liability and accounts payable and accrued liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company recorded an impairment charge related to goodwill and other current assets associated with the divestiture of $<ix:nonFraction unitRef="usd" contextRef="i0fc78fa9a34b400587dbebfb3ac1f1e0_D20221001-20221231" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNDE4OA_8b695447-0d19-4bf9-98ac-9c4de1f2d87d">259</ix:nonFraction> million, or $<ix:nonFraction unitRef="usd" contextRef="i0fc78fa9a34b400587dbebfb3ac1f1e0_D20221001-20221231" decimals="-6" name="cnc:AssetImpairmentChargesNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNDE5Ng_56469b9f-0e7b-465d-bd53-4cd9d159bd3b">181</ix:nonFraction> million after-tax.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HealthSmart Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;1, 2022, the Company signed a definitive agreement to divest HealthSmart, its third party health plan administration business. The divestiture was completed on January&#160;5, 2023. As of December&#160;31, 2022, the assets and liabilities of HealthSmart were considered held for sale resulting in $<ix:nonFraction unitRef="usd" contextRef="i86423bee35dc4d99be0b3b984e6903db_I20221231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzOTA2Nw_d8b09dbe-a787-4ec0-8e5e-fdcd87ce11a1">66</ix:nonFraction> million of assets held for sale in other current assets and $<ix:nonFraction unitRef="usd" contextRef="i86423bee35dc4d99be0b3b984e6903db_I20221231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzOTA3NQ_8dd7f2fa-2198-411a-a141-6611d2b0ddbd">34</ix:nonFraction> million of liabilities held for sale in accounts payable and accrued expenses on the Consolidated Balance Sheet. The majority of the held for sale assets were previously reported as cash and cash equivalents, premium and trade receivables, and goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company recorded an impairment charge related to goodwill associated with the divestiture of $<ix:nonFraction unitRef="usd" contextRef="ie6bd664dd1964db0a6890c587570d306_D20221001-20221231" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNDE3MA_eee37834-ccc7-4772-875f-b3e50c2b91c6">36</ix:nonFraction> million, or $<ix:nonFraction unitRef="usd" contextRef="ie6bd664dd1964db0a6890c587570d306_D20221001-20221231" decimals="-6" name="cnc:AssetImpairmentChargesNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNDE3OQ_cdc97b0a-e98e-4902-a023-b12b4fd04c24">27</ix:nonFraction> million after-tax.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzQ5MzQ_f0c3d40b-508c-4937-8487-d774801cb117" continuedAt="i508091ec0d53439fa909bab5ad042745" escape="true">Short-term and Long-term Investments, Restricted Deposits </ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i508091ec0d53439fa909bab5ad042745" continuedAt="i56a79b2ed8c94eaa8f311595bdd82005"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzQ5MjQ_107d43f5-388f-4619-a2f0-6b0c8feb8b40" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.320%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499a3149a68f43d197206136874ec7aa_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtMS0xLTEtMzU0MDE4_fcf7de4f-d908-4b0b-9bb1-6ea441382b5d">695</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499a3149a68f43d197206136874ec7aa_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtMy0xLTEtMzU0MDE4_1fbd8486-efba-4098-b0e6-0fca3fc7e039">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i499a3149a68f43d197206136874ec7aa_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtNS0xLTEtMzU0MDE4_56445113-4a3d-44bb-884c-8dc3c0649dfe">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499a3149a68f43d197206136874ec7aa_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtNy0xLTEtMzU0MDE4_6c59218c-a6f4-4a29-94cf-1b6e06335a19">679</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtOS0xLTEtMzU0MDE4_462e1326-0b7e-4b9d-b840-249c5a55e0ab">642</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtMTEtMS0xLTM1NDAxOA_da3197ee-b335-4add-bdd0-09f148a70bf0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtMTMtMS0xLTM1NDAxOA_8593895d-9c97-41fc-afda-62267e94f7c6">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtMTUtMS0xLTM1NDAxOA_f6392a75-5781-4f28-b9ee-6361c071009c">640</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtMS0xLTEtMzU0MDE4_5b5ca197-6e95-4b4a-af54-9ba2fba75799">10,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtMy0xLTEtMzU0MDE4_055b8c05-294b-4075-a1fd-876d7373e4b1">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtNS0xLTEtMzU0MDE4_46d073fc-1f25-43ab-a081-eea25e9fc1c8">778</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtNy0xLTEtMzU0MDE4_3449de7d-040e-4a4b-821b-940f0bf61a55">9,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtOS0xLTEtMzU0MDE4_a254d2ef-37e2-467e-9d98-46b3a9690346">8,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtMTEtMS0xLTM1NDAxOA_b30bb79f-f422-45c3-8171-11150b8913a5">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtMTMtMS0xLTM1NDAxOA_bacd3def-4ad8-4481-a48b-7848e15ef769">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtMTUtMS0xLTM1NDAxOA_8607d01f-842f-43cc-9412-87039d46cfee">8,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecda6a96704c4e55abf2859375ea8c57_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtMS0xLTEtMzU0MDE4_92a769e8-6b4e-4f73-a259-1caf1302e975">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecda6a96704c4e55abf2859375ea8c57_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtMy0xLTEtMzU0MDE4_ad063a0e-1926-45d6-847c-8fb9414d1682">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecda6a96704c4e55abf2859375ea8c57_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtNS0xLTEtMzU0MDE4_6b35fe43-394b-4324-8c93-51658130070c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecda6a96704c4e55abf2859375ea8c57_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtNy0xLTEtMzU0MDE4_a100163a-7ddb-4154-a892-3a646551b224">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a4abd7dcb44577b824de2cb64ccc35_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtOS0xLTEtMzU0MDE4_76241005-0333-424d-b076-2c06c38334f7">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a4abd7dcb44577b824de2cb64ccc35_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtMTEtMS0xLTM1NDAxOA_6bc1a74b-645d-4ec1-9487-bbbc00575d63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a4abd7dcb44577b824de2cb64ccc35_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtMTMtMS0xLTM1NDAxOA_1dfd98c4-cb1c-4e44-ac2a-e3eb19e500e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a4abd7dcb44577b824de2cb64ccc35_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtMTUtMS0xLTM1NDAxOA_35c46f33-57be-4cd7-af8a-75ae83c78d80">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eb00ce8440f4809aea66ea9110d64fa_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtMS0xLTEtMzU0MDE4_de85da8b-a91b-44bf-8fb0-cbfce44b3370">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eb00ce8440f4809aea66ea9110d64fa_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtMy0xLTEtMzU0MDE4_cd76ccd1-10b8-4104-9840-c99409a1ee32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eb00ce8440f4809aea66ea9110d64fa_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtNS0xLTEtMzU0MDE4_70f895a3-2ded-41b3-9393-81ad7381fe6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eb00ce8440f4809aea66ea9110d64fa_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtNy0xLTEtMzU0MDE4_88ef0aef-ab38-4fd4-9580-77c019502fa7">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fbea513469f43a3b9e290efb35c514f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtOS0xLTEtMzU0MDE4_8e19484f-7aa8-436d-b4c1-0b3944309097">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fbea513469f43a3b9e290efb35c514f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtMTEtMS0xLTM1NDAxOA_41ad8841-d4ad-4287-8469-2e7f33f01554">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fbea513469f43a3b9e290efb35c514f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtMTMtMS0xLTM1NDAxOA_72dab587-ad58-408d-9d17-65e6bd77323d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fbea513469f43a3b9e290efb35c514f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtMTUtMS0xLTM1NDAxOA_173b05c6-4918-490c-90b4-1bf6cf592f40">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9983f6fb6634358b6dacbf534d64ca5_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctMS0xLTEtMzU0MDE4_83d785ac-136f-471d-8b9a-0c79755e1a48">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9983f6fb6634358b6dacbf534d64ca5_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctMy0xLTEtMzU0MDE4_e2a39ad2-30ff-4764-b946-8b2c0b335d12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9983f6fb6634358b6dacbf534d64ca5_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctNS0xLTEtMzU0MDE4_467040d1-0189-4d88-a82b-82a7d2cc3fb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9983f6fb6634358b6dacbf534d64ca5_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctNy0xLTEtMzU0MDE4_6fe0c34e-dcd7-4ca2-8535-11b69cc4889a">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26daba9ff8ae466cb9021364a5170509_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctOS0xLTEtMzU0MDE4_d19d7156-4752-429b-bfe6-30b615eb2a1b">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26daba9ff8ae466cb9021364a5170509_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctMTEtMS0xLTM1NDAxOA_c9f7f4aa-f947-41c0-b065-d86f71c1bc87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26daba9ff8ae466cb9021364a5170509_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctMTMtMS0xLTM1NDAxOA_37542acf-f664-4d5e-9ff0-abbe55558cc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26daba9ff8ae466cb9021364a5170509_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctMTUtMS0xLTM1NDAxOA_eb5db183-2512-4764-92a7-e0de2a02860b">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtMS0xLTEtMzU0MDE4_01307fb9-7a56-4bc6-ba5d-4e8364a9ff4f">4,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtMy0xLTEtMzU0MDE4_c7af5ddd-c497-4990-bea2-858218ff413a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtNS0xLTEtMzU0MDE4_079547d2-37bb-4c45-8012-012dbf171719">280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtNy0xLTEtMzU0MDE4_fe9ffbbc-19e3-4ca0-a3b3-cbd11210906c">3,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtOS0xLTEtMzU0MDE4_5fb68c13-f6c1-4b05-9b0f-cacd0c07fa3a">3,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtMTEtMS0xLTM1NDAxOA_41ad260a-6762-41bb-a0bd-88490e92c1c9">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtMTMtMS0xLTM1NDAxOA_cd39d4d6-af80-4229-a4b0-cfc4dc5b8696">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtMTUtMS0xLTM1NDAxOA_d75f1f62-a373-42cb-b6dc-3e462ef35e30">3,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktMS0xLTEtMzU0MDE4_5a108be0-7c9f-42c4-911e-57893be7bea4">1,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktMy0xLTEtMzU0MDE4_bd1f9e1c-59eb-4652-b603-725b0b3d4bab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktNS0xLTEtMzU0MDE4_6a0d6acd-be9d-43d7-9f92-7c8aedbd5bed">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktNy0xLTEtMzU0MDE4_3ec48d9a-430c-4ae4-a222-1e04635831d4">1,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktOS0xLTEtMzU0MDE4_f5cf815d-8cd9-407a-8615-367904e874ee">1,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktMTEtMS0xLTM1NDAxOA_148de718-0e0c-403a-8f81-eb20528a42e4">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktMTMtMS0xLTM1NDAxOA_622466b0-644f-4230-9508-93cdbd84b311">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktMTUtMS0xLTM1NDAxOA_695d15ad-df5c-47f7-95a7-7f8a54007f7e">1,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTEtMS0xLTM1NDAxOA_af759a4b-4a25-462b-80eb-b0bfcfee6c91">1,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTMtMS0xLTM1NDAxOA_cbcac26d-4211-45ad-84ea-6d003d038b58">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTUtMS0xLTM1NDAxOA_43112baf-18f8-43d8-b611-6c7b8c5a2467">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTctMS0xLTM1NDAxOA_214c1432-749c-4373-883e-b2abe064ff35">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTktMS0xLTM1NDAxOA_232d4179-f10b-4e09-ac27-1fe4cdb93c44">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTExLTEtMS0zNTQwMTg_d7fe76b1-9810-40fb-872c-861b239d6798">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTEzLTEtMS0zNTQwMTg_d1976e19-e255-4dab-b69c-7d184ecf6431">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTE1LTEtMS0zNTQwMTg_f153cc2c-ea11-44a5-98d7-90f515e1ac7c">853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTEtMS0xLTM1NDAxOA_5d73e797-52a9-47b0-97e4-dce4626cb6f9">961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTMtMS0xLTM1NDAxOA_02f249c9-4a4a-471f-bd75-2840063d92a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTUtMS0xLTM1NDAxOA_d40d209e-d9e4-48b8-8c1f-c0cdf4d723d9">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTctMS0xLTM1NDAxOA_7a70c5e0-e82c-44ab-a84a-b88cab289e5d">862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTktMS0xLTM1NDAxOA_45230a13-41e9-4cd7-9e7c-2f15809b6fab">870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTExLTEtMS0zNTQwMTg_b597020f-64e2-4d6d-bfc4-4b56e3ba8f79">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTEzLTEtMS0zNTQwMTg_e1e1f3ea-c937-40f8-aa45-230c2716ec9b">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTE1LTEtMS0zNTQwMTg_12fe7752-75b6-4945-9ab3-5e9dff4b4404">873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEyLTEtMS0xLTM1NDAxOA_942d5ffa-8b4c-4dde-bc08-8fdb64e005bd">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEyLTctMS0xLTM1NDAxOA_0ad2a03e-734b-49dc-b558-c73cb256e8d5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEyLTktMS0xLTM1NDAxOA_59d3ba88-e65f-4c51-8955-2014c8b2dd8a">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEyLTE1LTEtMS0zNTQwMTg_290fb0b3-0b8a-4445-bdc9-b863839cf278">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEzLTEtMS0xLTM1NDAxOA_e0a376cf-65ea-4efa-b097-1af8d156716c">529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEzLTctMS0xLTM1NDAxOA_54214210-45fe-4fde-a365-f20d79cb2716">529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEzLTktMS0xLTM1NDAxOA_0ce97741-ccd6-4e6f-a3fe-7d3c6139c1c4">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEzLTE1LTEtMS0zNTQwMTg_2fbbb4d0-c479-4676-a959-c525218d3b28">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LifeInsuranceCorporateOrBankOwnedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE0LTEtMS0xLTM1NDAxOA_da2e6e3a-96a3-4635-a05f-ac37ba667239">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LifeInsuranceCorporateOrBankOwnedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE0LTctMS0xLTM1NDAxOA_e1020206-e7f1-447a-91c6-9abd7a12e85e">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LifeInsuranceCorporateOrBankOwnedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE0LTktMS0xLTM1NDAxOA_e820b163-229e-4834-8d96-d0e374a668a9">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LifeInsuranceCorporateOrBankOwnedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE0LTE1LTEtMS0zNTQwMTg_a4a007dc-cadf-49e9-bdb2-af70eb19749d">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTEtMS0xLTM1NDAxOA_5d1f5230-c356-495d-871e-42ecca7cc91d">19,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTMtMS0xLTM1NDAxOA_c991eb75-6e23-448e-ad9b-f5bc486e05fb">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTUtMS0xLTM1NDAxOA_7326b098-5e3c-47e6-8568-d99235db2ea4">1,364</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTctMS0xLTM1NDAxOA_11389d32-4396-469d-b01a-a5e38c35a654">18,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTktMS0xLTM1NDAxOA_15c60902-2385-49a4-9ad7-98a12ff9af3b">16,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTExLTEtMS0zNTQwMTg_ddd11df5-3fbd-451e-9c01-edcb376241fa">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTEzLTEtMS0zNTQwMTg_e399d43c-dc5c-4995-9186-672fcfbece30">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTE1LTEtMS0zNTQwMTg_dadca3da-1472-4302-8325-43baf0cf2826">16,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:10.8pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments in equity securities as of December&#160;31, 2021 primarily consisted of exchange traded funds in fixed income securities.</span></div></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments, and life insurance contracts.&#160;The Company's investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with a focus on high credit quality securities.&#160;The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of December&#160;31, 2022, <ix:nonFraction unitRef="number" contextRef="i04e2a006b9ac457da4ba57b86f6e47ed_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzY3OA_9d9844a0-541f-4a18-9cca-ce4a86eae2c9">98</ix:nonFraction>% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations.&#160;At December&#160;31, 2022, the Company held certificates of deposit, equity securities, private equity investments, and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzEwNTE_c9c93204-9871-484c-a20b-e44dba7e3ac9"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzEwNTE_91196d18-aa01-41c3-b373-1f306cf7c4f0">132</ix:nonFraction>&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzEwNTg_296f7fee-e19d-4aef-8f1c-7793183430b5"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzEwNTg_c92529a9-214b-4718-8b8e-a77ef9bd9131">96</ix:nonFraction>&#160;million</span> at December 31, 2022 and 2021, respectively, and is included in other current assets on the Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association, or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AAA and a weighted average duration of <ix:nonNumeric contextRef="idb1c5e81b8794292b604efa3e3607763_D20220101-20221231" name="cnc:InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzIxOTkwMjMyNjA5OTA_bdc5b43f-7780-4ec8-a65c-022060789c13">4</ix:nonNumeric> years at December&#160;31, 2022.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i56a79b2ed8c94eaa8f311595bdd82005" continuedAt="iac48179782e2481da5feafeb808696c3"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzQ5Mzg_da2f34dc-f98a-45b6-afa8-373ae2a01517" escape="true"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:19.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.584%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i499a3149a68f43d197206136874ec7aa_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtMS0xLTEtMzU0MDE4_00f0fe44-d26e-4f02-b8be-2148c1e73e9a">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499a3149a68f43d197206136874ec7aa_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtMy0xLTEtMzU0MDE4_47aca917-5ec2-4360-907d-a67ed2709dd1">342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i499a3149a68f43d197206136874ec7aa_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtNS0xLTEtMzU0MDE4_f1ed3119-d1b7-42d3-a26a-a24d1bc1f6d3">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499a3149a68f43d197206136874ec7aa_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtNy0xLTEtMzU0MDE4_117811f6-3be3-4a4d-8f9d-5c7aa9c08b4b">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtOS0xLTEtMzU0MDE4_5b86d0b3-44ff-4659-924f-e45c820ac0c5">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtMTEtMS0xLTM1NDAxOA_5a34a00a-7b06-433d-9377-1247ac78f372">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtMTMtMS0xLTM1NDAxOA_7ca55d4b-83f8-4d2e-826e-30e4f89f0198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtMTUtMS0xLTM1NDAxOA_97f78cd4-dfcf-4198-b657-ec1663e4a02d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtMS0xLTEtMzU0MDE4_685f3a6d-517f-4bb5-beee-d19a305fff6d">340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtMy0xLTEtMzU0MDE4_168e15ef-225d-4ac7-9b93-413386b2c0aa">5,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtNS0xLTEtMzU0MDE4_562bf30b-8df7-4db3-b824-fa773676051a">438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtNy0xLTEtMzU0MDE4_70c74f2f-bab2-4a76-81d4-259eca2d04f4">3,400</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtOS0xLTEtMzU0MDE4_93912a90-10da-4bbd-be7a-7d4b596f02c7">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtMTEtMS0xLTM1NDAxOA_fd6c9367-8e21-4559-9193-05adad12e9c3">4,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtMTMtMS0xLTM1NDAxOA_dc31d997-0e4c-4f6c-931c-ec11b8df6876">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtMTUtMS0xLTM1NDAxOA_da7aefd9-90e0-4fb0-b0f0-59cbab6c2c75">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtMS0xLTEtMzU0MDE4_c84495a2-7114-4712-906f-8bc6311fcc2c">142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtMy0xLTEtMzU0MDE4_05ea4670-bf8a-4477-b391-169d1b315fd7">2,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtNS0xLTEtMzU0MDE4_03ad2736-6968-4c14-bec8-d3d1b6e77c18">138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtNy0xLTEtMzU0MDE4_4ba18bcb-e305-439d-a540-a8f387fc08a4">995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtOS0xLTEtMzU0MDE4_1ea6ef4a-0015-4f45-8601-aa05bf38728f">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtMTEtMS0xLTM1NDAxOA_f61584c9-f8cb-444f-8516-2a01268e6268">1,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtMTMtMS0xLTM1NDAxOA_6bcb77f7-d283-4f6c-a498-0c9ea79ab463">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtMTUtMS0xLTM1NDAxOA_595238f2-4e06-489c-9424-0d196e72aee0">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtMS0xLTEtMzU0MDE4_913e4f33-2b2f-46b4-b469-fa771119fd7e">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtMy0xLTEtMzU0MDE4_5f53206c-dd52-410c-89f5-be5c99544a5b">786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtNS0xLTEtMzU0MDE4_6c6e6677-e047-4972-bc6a-716b65206638">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtNy0xLTEtMzU0MDE4_2d54e3fa-8abb-4e4b-882b-0f632bafeba3">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtOS0xLTEtMzU0MDE4_7ed624a3-4e14-48a5-924d-2677261d5bf9">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtMTEtMS0xLTM1NDAxOA_7da23a7b-9551-4a25-8c78-f304162cade1">770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtMTMtMS0xLTM1NDAxOA_6a9da86b-0b6f-42c5-8756-6b51a76132ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtMTUtMS0xLTM1NDAxOA_0342cef2-16a1-42cc-976f-21939777f487">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctMS0xLTEtMzU0MDE4_d7a135da-a701-45cc-86b9-c27f2e289bf7">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctMy0xLTEtMzU0MDE4_ef10ace9-2e85-49d5-9460-c1e48877882e">629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctNS0xLTEtMzU0MDE4_3aa28e9b-87b0-4c5d-8caa-75b5baf2916a">66</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctNy0xLTEtMzU0MDE4_83a40527-5921-4c0d-8090-4593b455bb63">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctOS0xLTEtMzU0MDE4_75d7685a-101a-4c93-9517-cd90702c589a">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctMTEtMS0xLTM1NDAxOA_dfe253b1-99a5-4afa-a013-542013452de0">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctMTMtMS0xLTM1NDAxOA_38937dcb-59df-4be7-9d11-c8c7fd6f755b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctMTUtMS0xLTM1NDAxOA_bab33c01-5c41-47cb-a460-f372480fc810">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtMS0xLTEtMzU0MDE4_ab4856d7-7fe1-4283-a8a0-7c79d8a72776">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtMy0xLTEtMzU0MDE4_ccb38573-3fce-42ab-a401-0245ba9622b4">513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtNS0xLTEtMzU0MDE4_5c97840b-7f21-49f0-adec-2bd70f165aad">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtNy0xLTEtMzU0MDE4_9a7b85ae-3fc3-42a9-8b5c-337abce5469a">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtOS0xLTEtMzU0MDE4_92e1c9c6-e737-4247-b55d-ac76a3859957">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtMTEtMS0xLTM1NDAxOA_3c027ed4-5157-4c7a-a036-5f63e7ada0d6">380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtMTMtMS0xLTM1NDAxOA_2ebbcc8f-2a66-4910-9b7e-0a72aea3d6e4">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtMTUtMS0xLTM1NDAxOA_36ffc634-305e-4fb5-9fcc-05907c4579ca">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTEtMS0xLTM1NDAxOA_46bcaf88-5a87-4736-b16d-2b22a81a2276">620</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTMtMS0xLTM1NDAxOA_d048a28b-fbd6-43ce-ae2b-304dd4e89da7">10,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTUtMS0xLTM1NDAxOA_74255d22-45a4-4901-a3bb-d476ca4906d9">744</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTctMS0xLTM1NDAxOA_9e7875ca-752c-4ab9-88a2-153b012736fe">5,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTktMS0xLTM1NDAxOA_db3efd62-a57e-4369-aeb3-5584360a5656">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTExLTEtMS0zNTQwMTg_8c7d274a-e578-4573-952f-8039ff2374b3">7,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTEzLTEtMS0zNTQwMTg_3dfa7456-9670-4512-973b-de6a8596bcf6">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTE1LTEtMS0zNTQwMTg_985f24c3-c661-4c1b-8f64-b250939f0372">331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the gross unrealized losses were generated from <ix:nonFraction unitRef="position" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzE4OTM_ce77e06d-7165-4e08-93da-35eea1cb369a">6,423</ix:nonFraction> positions out of a total of <ix:nonFraction unitRef="position" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="INF" name="cnc:DebtSecuritiesAvailableForSaleNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzE5MjQ_bfefcea7-42f4-4e05-a95d-7af0b009e82f">6,854</ix:nonFraction> positions.&#160;The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual, or regulatory purposes.&#160;If the security meets this criterion, the decline in fair value is recorded in earnings.&#160;The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates, and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit related loss may include rating agency actions, adverse conditions specifically related to the security, or failure of the issuer of the security to make scheduled payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company acquired the remaining <ix:nonFraction unitRef="number" contextRef="i556fc29a81414ce8a1faff7d6b5ca940_I20210731" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzM1MzI_5fe1bd4d-cddb-441c-b476-87a88054e1ba">60</ix:nonFraction>% interest of Circle Health for $<ix:nonFraction unitRef="usd" contextRef="i4603a3c3a78b4cf6befa775abe6f9136_D20210701-20210731" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzM1NjU_194b626f-745d-4cd3-87db-e3e4c0803398">705</ix:nonFraction>&#160;million. As a result of the acquisition, the Company recorded a non-cash gain of $<ix:nonFraction unitRef="usd" contextRef="i90289acf8f4c42b891561c01ab371852_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzM2NDE_45104b51-e1d8-4944-b2a4-cdab2c81b0fd">309</ix:nonFraction>&#160;million on its original investment in the year ended December&#160;31, 2021. The gain was included in investment and other income on the Consolidated Statement of Operations. Beginning in July 2021, the Company consolidates <ix:nonFraction unitRef="number" contextRef="i556fc29a81414ce8a1faff7d6b5ca940_I20210731" decimals="INF" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzM4NDk_de21115a-3319-4456-bf8b-3cd7f3ceb0c9">100</ix:nonFraction>% of Circle Health.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i06e20193ad1d4a6dbe47803672976cf0_D20210901-20210930" decimals="-6" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzIxOTkwMjMyNjEwMjM_901b8230-f9a7-4c2b-97e2-c3742c11f27e">229</ix:nonFraction> million impairment of its equity method investment in RxAdvance, a pharmacy benefit manager. The impairment was the result of the Company&#8217;s focus on simplification of its pharmacy operations. The impairment was based on the Company's estimate of RxAdvance's future cash flows and other market indicators of fair value. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="iac48179782e2481da5feafeb808696c3"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzQ5NDE_0c745c43-ac8c-46e1-bb1d-86e266eb1b16" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.136%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year or less</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtMS0xLTEtMzU0MDE4_69cb3bf5-0087-4226-a041-1d1d96505971">2,207</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtMy0xLTEtMzU0MDE4_075ec188-ff08-463f-af93-e1f4ac6f6e68">2,179</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtNS0xLTEtMzU0MDE4_376f39ec-d9f9-41f0-bea9-de194ff82194">534</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtNy0xLTEtMzU0MDE4_18778fb1-481d-4264-82e0-57f4a9d2eb8e">532</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtOS0xLTEtMzU0MDE4_017beecb-6cd9-48fe-b5d6-b3964d183597">1,390</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtMTEtMS0xLTM1NDAxOA_fa1d97c7-8b7b-4eb5-94e3-de052fd896d4">1,396</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d47874d2cff447d94764455a4adb274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtMTMtMS0xLTM1NDAxOA_5a3cb30d-46bc-47f5-b20e-9392a27a0987">368</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d47874d2cff447d94764455a4adb274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtMTUtMS0xLTM1NDAxOA_6e7c39db-8045-4af6-bc7b-668ca0b1afb2">368</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtMS0xLTEtMzU0MDE4_2a3afd38-1270-46dd-a53d-5cfa2dd3b709">7,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtMy0xLTEtMzU0MDE4_1b0af060-3665-454e-8e15-264ad87aaaaa">7,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtNS0xLTEtMzU0MDE4_f6602eb4-990f-48b3-9429-10f988624d03">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtNy0xLTEtMzU0MDE4_0c0ab080-86fd-4eb8-90a7-edbdf78833a2">490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtOS0xLTEtMzU0MDE4_9ee2689f-f97d-46a8-a6fd-b4b9baf8a2a6">6,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtMTEtMS0xLTM1NDAxOA_875ec686-9bd9-443a-ba30-ab96271bc3c3">6,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d47874d2cff447d94764455a4adb274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtMTMtMS0xLTM1NDAxOA_3c6136e5-c06e-4b94-915a-f9dfb4d82c15">460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d47874d2cff447d94764455a4adb274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtMTUtMS0xLTM1NDAxOA_61549372-da6d-4a52-9914-046acea6ece1">457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtMS0xLTEtMzU0MDE4_2c3861b7-8b43-46e2-af7c-730a15739905">4,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtMy0xLTEtMzU0MDE4_e679d113-add3-4c2a-a269-161b64ac65bc">3,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtNS0xLTEtMzU0MDE4_3d847194-bebf-4d9a-91b2-a2d3f92894b7">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtNy0xLTEtMzU0MDE4_74cd5626-2177-4c47-a664-31924517b7e7">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtOS0xLTEtMzU0MDE4_e95d8fd5-2073-458c-8bb3-a02de3a30994">3,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtMTEtMS0xLTM1NDAxOA_a48bc79f-aea1-48ac-b55b-3f84d8d6a1d5">3,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d47874d2cff447d94764455a4adb274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtMTMtMS0xLTM1NDAxOA_f998d57f-6696-4f72-8d0e-c07c89b9e884">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d47874d2cff447d94764455a4adb274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtMTUtMS0xLTM1NDAxOA_49c0bed7-2acb-447d-b5f9-ba701f41a9ad">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtMS0xLTEtMzU0MDE4_137481e8-0f34-4e32-8833-914f2056890a">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtMy0xLTEtMzU0MDE4_9fcc60fd-5da2-42e5-955c-d9e859541969">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtNS0xLTEtMzU0MDE4_01a68b74-3645-45ff-97a4-5180f10d6a08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtNy0xLTEtMzU0MDE4_dea06ab7-dc0b-45e2-8396-78d16efb0a21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtOS0xLTEtMzU0MDE4_0defc8f8-4fe2-48df-8dd1-5ed28456724e">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtMTEtMS0xLTM1NDAxOA_e7edaa7b-ad67-4801-8598-289b12653fe4">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d47874d2cff447d94764455a4adb274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtMTMtMS0xLTM1NDAxOA_fbc32575-c08c-46e6-9e99-0fa441c28e37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d47874d2cff447d94764455a4adb274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtMTUtMS0xLTM1NDAxOA_da21f2c5-a11d-47c5-9e8b-17145bcad4a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctMS0xLTEtMzU0MDE4_2aea5e5b-50f2-438f-9f93-1657ce5bc755">3,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctMy0xLTEtMzU0MDE4_ae97dbd3-d7a7-4acb-80d0-91d9ccd307a3">3,234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctNS0xLTEtMzU0MDE4_603fa85f-abe6-4c31-9bf6-c1273a07809d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctNy0xLTEtMzU0MDE4_6ff40d69-4e2c-41a2-9201-a2141822243a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctOS0xLTEtMzU0MDE4_44c8d82d-ccb7-4664-b854-b56a24d0e0e4">3,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctMTEtMS0xLTM1NDAxOA_01732d49-ddcc-487c-a9da-351dcdbc4e6a">3,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d47874d2cff447d94764455a4adb274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctMTMtMS0xLTM1NDAxOA_8d6ba074-31fc-41e7-b78d-128b768ee39f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d47874d2cff447d94764455a4adb274_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctMTUtMS0xLTM1NDAxOA_437ab1dc-5ecd-4efa-8f85-52ec11c22ea4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtMS0xLTEtMzU0MDE4_d1de1524-97b8-43fd-aef7-87af99e3c008">17,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtMy0xLTEtMzU0MDE4_f2db2724-523b-4814-b9d2-7e84d3fe7f9e">16,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtNS0xLTEtMzU0MDE4_2f211b80-3aae-4b0b-ba87-9feb4b6ec25d">1,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtNy0xLTEtMzU0MDE4_84e5dde7-3870-4b45-9d97-32c8a3e33f29">1,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtOS0xLTEtMzU0MDE4_c7a32e82-7073-4fb1-a3b9-326a8f4a03b7">14,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtMTEtMS0xLTM1NDAxOA_83bed815-a861-41d0-bbd0-dbfc5694ad09">14,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d47874d2cff447d94764455a4adb274_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtMTMtMS0xLTM1NDAxOA_daca9aaa-d3f7-4ec9-a0fb-798e37f2adf0">1,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d47874d2cff447d94764455a4adb274_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtMTUtMS0xLTM1NDAxOA_81f9879c-7360-4020-a118-04256f8cf00c">1,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from contractual maturities due to call or prepayment options.&#160;Equity securities, private equity investments, and life insurance contracts are excluded from the table above because they do not have a contractual maturity.&#160;The Company has an option to redeem substantially all of the securities included in the greater than ten years category listed above at amortized cost.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90ZXh0cmVnaW9uOjFlYjAzNTk3YTE0OTRjNTJiM2Y4N2Y2ZWU4OWNhZDc4Xzk1MA_ec4c7e59-dbf5-4bf0-a77a-7d0c087cefc5" continuedAt="i4f3fbb8b8cc64fa9929e49e945a96abc" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i4f3fbb8b8cc64fa9929e49e945a96abc" continuedAt="i636372af8f604d79ad9c98e5ca29db4c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value.&#160;<ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="cnc:FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90ZXh0cmVnaW9uOjFlYjAzNTk3YTE0OTRjNTJiM2Y4N2Y2ZWU4OWNhZDc4Xzk1Mw_8b3a7b28-09c3-46b1-931f-53336f00ea67" continuedAt="i6ba61aca1a2a4a868c7ddcecb9b95720" escape="true">Level inputs are as follows:&#160;</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i6ba61aca1a2a4a868c7ddcecb9b95720"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;Input:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Input Definition:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level&#160;I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level&#160;II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level&#160;III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90ZXh0cmVnaW9uOjFlYjAzNTk3YTE0OTRjNTJiM2Y4N2Y2ZWU4OWNhZDc4Xzk2MA_8b07e5c2-dd80-407f-8d3b-ca4b4ca63704" continuedAt="i53ba825e3ab14c6cbb7e1150f4440ebd" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at December&#160;31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe885a414a174f139a113b8c48656f0c_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzItMS0xLTEtMzU0MDE4_eb357ec5-afc7-4916-bad1-58948c8d941a">12,074</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide98fb1c086841bba65730c9e9d0e5c3_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzItMy0xLTEtMzU0MDE4_260d962a-7ffd-4f7a-b3ff-6725a8cf8441">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5739f0204cdd40bba7cfc286758eb99d_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzItNS0xLTEtMzU0MDE4_ab0e99ea-c0b3-42da-82c6-e62dd096ce71">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzItNy0xLTEtMzU0MDE4_54565b57-76be-498b-a144-25773d84cf0c">12,074</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedfc351c3aa441b898074cff9cb2f90d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzQtMS0xLTEtMzU0MDE4_bcfde046-20cc-448f-a979-a9fb38c12deb">366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i825be3c8cf254b448365fca017922b84_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzQtMy0xLTEtMzU0MDE4_a488e3ec-2cb2-4184-8bc2-276997bdbd7e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8356e0b9cfbd4b0db5eae0058bb52f71_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzQtNS0xLTEtMzU0MDE4_9c681e39-8ca6-4f85-8307-5f3fc995d7ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127bbbf2926f42efa993800b43144c0b_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzQtNy0xLTEtMzU0MDE4_e9f6ede4-578d-4d6d-b911-7154b45fa333">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27d15395c0854bfc84fc70f257308756_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzUtMS0xLTEtMzU0MDE4_5807cd81-092c-4ff7-ad7e-dae9d2d366cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97902e8b6d3543a38beee90270b3e1ff_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzUtMy0xLTEtMzU0MDE4_70154977-4863-4a41-9e9a-457e289dc424">9,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d86972bd8ff440db8e9af798cbcff0d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzUtNS0xLTEtMzU0MDE4_33bff37c-8243-4485-9a16-923b88a44196">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a7ebe084b2d42bd9909a9b07d2e00f6_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzUtNy0xLTEtMzU0MDE4_eaf29216-5cc8-446a-91d9-dd2f3db1df0d">9,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia09367fbf6484c039eeb488ad6dcf554_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzYtMS0xLTEtMzU0MDE4_17f00b37-a94f-484b-b8a7-60425cac5448">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idadbc4c70fb443308a1c36faac206d9d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzYtMy0xLTEtMzU0MDE4_353b2ef2-191f-4d74-8642-240d359c0651">3,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05e29f0742c42d1ac24bff7df962924_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzYtNS0xLTEtMzU0MDE4_45cde25c-b451-4f14-b1c1-9b051f379924">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6425ad722cf84deabeab468c2d10b6a0_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzYtNy0xLTEtMzU0MDE4_24873339-36ff-454f-b89e-4003b175988f">3,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia457c3f6b68a498ba18886372c07c24a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzctMS0xLTEtMzU0MDE4_c4dd10c5-fcb6-44b7-b434-9ed263e0ee95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i194a19a31fe840fdb6c8c759266afa3b_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzctMy0xLTEtMzU0MDE4_d9506ac1-d668-4e3b-9942-5cf4e6eddec7">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6634f441212f425fbe5da6bca4e48783_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzctNS0xLTEtMzU0MDE4_f17615c6-1e0f-4aea-9727-b956eaeb5025">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i153a782b2ac745db920b4785f8268200_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzctNy0xLTEtMzU0MDE4_44de2326-923f-48aa-8d2d-90fabf5444a2">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e9cd9d12c3f43ec9d70ee7e0d8076c1_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzgtMS0xLTEtMzU0MDE4_fb70556f-4405-4aa3-b0b5-fabc133ea81f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6477b8c63c58454499074d398a80a373_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzgtMy0xLTEtMzU0MDE4_05fbef92-29bb-4a9b-bb19-718916149c46">1,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f9e3a31c01942a391fbfab0d89c3f8a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzgtNS0xLTEtMzU0MDE4_faf160c9-1b07-4067-96c4-d1c703effe8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb29efff83384a97be4e90505f07645f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzgtNy0xLTEtMzU0MDE4_203897bc-0d1b-4822-8e1c-c13ff33dc52a">1,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic16bff1ee9254c80a89f582ee2e9b3d3_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzktMS0xLTEtMzU0MDE4_ea97f121-61ab-4ac6-ae17-84ff82535756">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic86ea1d5b6dc44f2af63bb7d314c17d5_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzktMy0xLTEtMzU0MDE4_a10570ce-d866-44e1-b879-affcd2627d24">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bf59ef98b1545adac077505ac7e83d0_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzktNS0xLTEtMzU0MDE4_e4379b1d-da75-4e8b-943a-cc4d0eb3bc14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5c115dbb53c47ffa08fb896b39bd7b6_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzktNy0xLTEtMzU0MDE4_de137a78-6990-4684-a328-f417ff31df76">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39665844725c4209a15066dc801d7fe6_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEwLTEtMS0xLTM1NDAxOA_2ebe79f3-1caa-40c4-95cc-b0a64114bd9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8282158849cc4f238ec41de28faa2d35_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEwLTMtMS0xLTM1NDAxOA_8e561d96-ac1b-4058-b861-26a0c8dab78b">862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied071109707642119601cf0ea5c86d13_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEwLTUtMS0xLTM1NDAxOA_eaec4a92-63b5-4def-ae67-13343449ce27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82eb3754c9b94d449778e6b6e63c6591_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEwLTctMS0xLTM1NDAxOA_27fe246f-913b-42b5-8273-908cca2c047b">862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe885a414a174f139a113b8c48656f0c_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzExLTEtMS0xLTM1NDAxOA_2c90fcd3-44b6-4ed6-8d3e-c2f2e89e8f8f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide98fb1c086841bba65730c9e9d0e5c3_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzExLTMtMS0xLTM1NDAxOA_5747516b-2236-422c-b206-05a5f64b867e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5739f0204cdd40bba7cfc286758eb99d_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzExLTUtMS0xLTM1NDAxOA_3c4c71c9-ff42-426b-9ba6-3c51707b004b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzExLTctMS0xLTM1NDAxOA_096a97da-ffa6-43f4-86fc-73381fd91ae7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd47e5c8ab1d4ffa93389f360a448165_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEyLTEtMS0xLTM1NDAxOA_91cacc05-e235-44d6-9b9d-e653ded97100">369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a73e4388fe442ff84fc2ffc6a2c6266_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEyLTMtMS0xLTM1NDAxOA_b3ec6cd5-e509-48c8-b6bd-2ceb669b1ac7">15,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e0d2df27c5e4c51a64b0329476580fc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEyLTUtMS0xLTM1NDAxOA_b5809bec-ba3a-4d6a-b76b-784d3ee35895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id72eb9f8ac6f4c728bdaa099f9836385_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEyLTctMS0xLTM1NDAxOA_c933ee17-07d3-4d60-831f-72ed0425d8c9">16,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1cff2bd501f465094c089dec54779c4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE0LTEtMS0xLTM1NDAxOA_2d907fdd-7273-437b-9ad6-e2ecbd7129b0">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426b68aa333f427d93dad8edc44dcfab_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE0LTMtMS0xLTM1NDAxOA_393369c3-015e-471f-a957-f05c569db6f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id30239d3660e4d4e85eea70a9128120a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE0LTUtMS0xLTM1NDAxOA_28b0cc3b-ff80-4ff7-865f-755884c5893d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib614a9b3d9dd414cadb853523d634e9c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE0LTctMS0xLTM1NDAxOA_5c6be021-93f0-4773-a2a6-c30ab31732ca">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if285b05be18e4ded8654557403239a51_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTEtMS0xLTQ5NjUxNQ_d1557f69-8412-495c-b49c-2a252bab86ea">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i249d2de894e0473fb963ddd614601836_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTMtMS0xLTQ5NjUxNQ_c3197e8d-8167-41d2-a3a7-a3117f92cde9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245f71d6b43543a69ba7ea32da0f2548_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTUtMS0xLTQ5NjUxNQ_561c1584-0158-4119-b136-57018f759358">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa6f8785ba04ad2bb2c6f69131c343b_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTctMS0xLTQ5NjUxNQ_9cc6a767-98d0-4936-834d-2aa67b2fc2f8">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74784b40d1ef48b4a3940d2a5c85d9da_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE2LTEtMS0xLTQ5NjUyMA_8d9c328b-75e9-4468-9e85-daae10b02fbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d30f208873344438005137cb7dcd673_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE2LTMtMS0xLTQ5NjUyMA_c4a79319-b0e9-4f95-9f7c-607b3be639f6">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463216755f0b40bd89cd2299509f861d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE2LTUtMS0xLTQ5NjUyMA_cf91beb3-2bab-4385-966b-118db8e792e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd578a7ae594d1eb11c60355e3eda18_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE2LTctMS0xLTQ5NjUyMA_5ada1579-3bee-4a99-8749-4e3591161413">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100fd78a36ac4838b8fdcf17fc398935_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTEtMS0xLTM1NDAxOA_501ab44b-0a24-42f1-a7e3-7b65928720cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a41716be165442ebf2bc3d198eeae9e_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTMtMS0xLTM1NDAxOA_e1bfacbe-30d6-48e9-bb08-4e8516572cb8">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcb39c9bd51e4ed3982382b5190d3215_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTUtMS0xLTM1NDAxOA_0517e9d9-993e-480f-b57c-aeacb98b463f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ee59d0ad594d20a7367f83c5d42181_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTctMS0xLTM1NDAxOA_1fa767df-028f-4749-a6bd-8359d44ccefc">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f446cc848c4d8fa4602eaa87f92478_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE3LTEtMS0xLTM1NDAxOA_38a18814-53ee-4e6c-b6f9-9cca8aa0cb04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib02b7ea5d28e49ecba973f7748fd0c3a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE3LTMtMS0xLTM1NDAxOA_2f16f407-2ddf-4c17-b92a-9b7d92d0b490">616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59b0c1e5f1b94a69a226785725883c7b_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE3LTUtMS0xLTM1NDAxOA_e6057db8-5d6b-4c6f-a067-8537657bd7f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0768ba92b27244339b1a4a4e64b0bd8a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE3LTctMS0xLTM1NDAxOA_46a462a9-c0e2-4d42-8033-4cc45ceade2d">616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd975f60e2e4f52bb7a01b3588ba5d8_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE5LTEtMS0xLTM1NDAxOA_0a26319a-fb0f-4653-8127-9b519b9b98c2">564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i187b2a05bec94d17b6890569f214fb4e_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE5LTMtMS0xLTM1NDAxOA_685ffb03-61a6-4932-9bfc-9afd905d774e">653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id146c5c9a6ff4458bb147ee4d06bcceb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE5LTUtMS0xLTM1NDAxOA_b3a88f1f-1f3c-4998-b5e9-89f24d829a27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE5LTctMS0xLTM1NDAxOA_0e9a25b8-40a5-477d-9d04-2b2314b38907">1,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe885a414a174f139a113b8c48656f0c_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzIyLTEtMS0xLTM1NDAxOA_402245fb-df66-4e88-82b8-fd0eb40abbee">13,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide98fb1c086841bba65730c9e9d0e5c3_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzIyLTMtMS0xLTM1NDAxOA_3c2ec3a3-c6f2-48da-a10f-1cdd3ff57046">16,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5739f0204cdd40bba7cfc286758eb99d_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzIyLTUtMS0xLTM1NDAxOA_127c628a-5edf-45a6-840c-c98ad1029332">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzIyLTctMS0xLTM1NDAxOA_5286397c-7073-4b5c-98d4-5b144106beb2">29,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i636372af8f604d79ad9c98e5ca29db4c"><ix:continuation id="i53ba825e3ab14c6cbb7e1150f4440ebd"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at December&#160;31, 2021, for assets and liabilities measured at fair value on a recurring basis ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6480f6a8b344d4da26190ba7e2b134a_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzItMS0xLTEtMzU0MDE4_d6f7cb40-6843-47e7-b47f-6d27799738a1">13,118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca2cbb365924fe08d1fca9331f9da1f_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzItMy0xLTEtMzU0MDE4_bf01a9de-50a8-4bda-9246-5b5ddbfea5b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d9e0273ef794fc09e5b2df846ddc972_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzItNS0xLTEtMzU0MDE4_116dbcb9-0941-4dbf-9611-e9f5dd6b1956">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzItNy0xLTEtMzU0MDE4_53a47496-d812-4b58-bd97-afea7bdd84f8">13,118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2aed0c146004449ae3c852aea7d1b98_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzQtMS0xLTEtMzU0MDE4_4b57c865-5cbc-41e1-bb20-245437d099d7">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4826ba2c9157409bba218177c880c8c0_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzQtMy0xLTEtMzU0MDE4_ad962fa2-da15-43de-8985-66290e160c99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7b7c7689844e74893cf79348121605_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzQtNS0xLTEtMzU0MDE4_8038e7bc-eee8-43fd-bf91-cdf7c7c7b23c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32d48e9a7c194db7a29153a53ba29a2a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzQtNy0xLTEtMzU0MDE4_de841fb7-5702-4893-8a88-ec95693880b0">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b2780690e461ca82dd12d2d5dea77_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzUtMS0xLTEtMzU0MDE4_76010ff6-54b1-4ffa-9163-6c4861afcc2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia002a77fe35d43898743d9977eabc858_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzUtMy0xLTEtMzU0MDE4_7ec0710d-d7c5-4f1d-9847-33772117e4bc">8,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5d0bc94d8549d38b7acb1bb04d6f9f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzUtNS0xLTEtMzU0MDE4_653e313d-a362-47d6-881d-56bf4b144c27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie109b7ada8cc4654be6dcb72b936b2df_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzUtNy0xLTEtMzU0MDE4_98944521-4cc9-4779-90d5-fb2cb31626c5">8,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb9a57293054024a366990a739e6596_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzYtMS0xLTEtMzU0MDE4_0c9a8642-c132-41f8-aeaf-15995706af02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3597245e7cf440a7a7ae6ac45addecab_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzYtMy0xLTEtMzU0MDE4_a8632064-1d26-4584-b25d-b530ccd36cfe">2,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id22add844f974bf8b07a30cbc2cefe30_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzYtNS0xLTEtMzU0MDE4_2eb4777e-2343-4a0b-bf86-e39dca8aaf5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf8cebd612ae46269efac158f2dd98f3_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzYtNy0xLTEtMzU0MDE4_b6dd5b35-dc79-497e-adca-d328ebead4fb">2,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic527e2e72ab14196892caa07ca0316e6_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzctMS0xLTEtMzU0MDE4_cb793abe-d28f-401f-acc5-8719824de50a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fd9e78e4214b78976cc93ea78ffce2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzctMy0xLTEtMzU0MDE4_bf4b9274-2b4b-4c8a-8dd9-d0facba38818">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d746bbdd1cd469ea1b06db720fb369c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzctNS0xLTEtMzU0MDE4_2deed20d-8482-4581-aade-1e7fddc23337">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if17efe1115fb48509286959669ffc628_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzctNy0xLTEtMzU0MDE4_1e85e2b2-e65d-40b9-a5bd-c0cb6b1e604d">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i625be35b035e4450b7053b827871d006_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzgtMS0xLTEtMzU0MDE4_149130b3-3f44-44ec-92da-076503227673">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33f404899e1b4c598c4445ab4bd72151_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzgtMy0xLTEtMzU0MDE4_30bd7d08-ed5c-410b-ae08-5b08fc68b08a">1,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04c7968a4f2a40c6a44dabd77d8b77e6_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzgtNS0xLTEtMzU0MDE4_5ebd28cf-ef8e-4e89-83e8-f042c8523b07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2c93ff1086147fe9a512996471b4758_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzgtNy0xLTEtMzU0MDE4_6af01bc8-3f83-435c-a31b-72470785c996">1,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9816bbb59837427d84449a8fd8eb65cc_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzktMS0xLTEtMzU0MDE4_59915613-c2e9-4420-9119-4098a5d2eb6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8115e874d4641dbae3a0cd214707412_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzktMy0xLTEtMzU0MDE4_1689a3b5-1f53-4d64-acd4-701ec78e2310">853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38d0ee4467e84cb3835ebbfe019c4b73_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzktNS0xLTEtMzU0MDE4_3e9110af-6250-4dee-a832-972442ee1ea7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9927142500410bb4d9ae681347e21a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzktNy0xLTEtMzU0MDE4_696722a6-ed1e-4ac1-b46f-c714419668af">853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c71d0c43ce416697a4a799bd7c4d1f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEwLTEtMS0xLTM1NDAxOA_d9c1a597-0816-445c-8360-2040582c3803">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8c88bbd7e141e7b68274a9caaec1aa_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEwLTMtMS0xLTM1NDAxOA_fb03f939-0f2a-4b9c-8149-2fd4a436cfc8">873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5950552df0e54a939965751bc3cd51fc_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEwLTUtMS0xLTM1NDAxOA_4b4b2637-472a-42f3-9613-8db12ea9597e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i130febd9b4734349a2f8f9936469e9c1_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEwLTctMS0xLTM1NDAxOA_6260ee74-2a3f-443d-b6d8-c8d05ba89a06">873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6480f6a8b344d4da26190ba7e2b134a_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzExLTEtMS0xLTM1NDAxOA_c0271f89-76db-4deb-b00f-a0825f7cb032">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca2cbb365924fe08d1fca9331f9da1f_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzExLTMtMS0xLTM1NDAxOA_a5067548-ffdf-4bb1-9f06-290cecc4b028">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d9e0273ef794fc09e5b2df846ddc972_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzExLTUtMS0xLTM1NDAxOA_7a0456a4-196e-4fb8-856e-6fc73644731e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzExLTctMS0xLTM1NDAxOA_e95c9004-e536-46e6-94ea-0e7d98323acd">326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8bae7a6f996464ba2b7a6100620166e_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEyLTEtMS0xLTM1NDAxOA_047dc2a1-ef55-4272-9861-1a6de7376cb3">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d506e3cd8b44e8ea7ee6f72aa813850_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEyLTMtMS0xLTM1NDAxOA_fa4b1091-1dd7-4db3-8fd8-2bb2b237c09e">14,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a87d5a6e486446c962961764c10fbe0_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEyLTUtMS0xLTM1NDAxOA_7c25e015-0fb7-4bea-a7b9-feaf4c6331ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9edce9fba80c47b48d09fea184945683_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEyLTctMS0xLTM1NDAxOA_95f966b7-0340-4c1c-b828-b747fc289dff">14,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dd964793f9f461fac181d8ef8a81d1b_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE0LTEtMS0xLTM1NDAxOA_9e6b0b69-7db5-4783-8402-4c6b519de629">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ef9ed30634649e4b045916294d297c9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE0LTMtMS0xLTM1NDAxOA_6d704d7b-bc41-428e-99b9-7eef18d6d80a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30cf143adc074a69bb21722cf2cc8d97_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE0LTUtMS0xLTM1NDAxOA_39cafe68-c84b-435b-b46e-900765dfdde0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i367faaa9b8c24d72b8fa062cc2dd99ab_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE0LTctMS0xLTM1NDAxOA_97d9d38f-7714-4499-b717-9e4a50559c4d">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcd5875603574767bf2ff59bc4998ce3_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTEtMS0xLTQ5NjUyNw_62d8077b-8bef-48fb-8166-90670d868f74">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaf506fcaacf4a9c9bf01628e13c738c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTMtMS0xLTQ5NjUyNw_ed887455-44dc-4200-aff8-176a724ad97c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df834d688e1427a96aae1a432497373_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTUtMS0xLTQ5NjUyNw_a5b6e5f7-bfe9-40bb-82ae-f4d2066d66b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a410191f824e1d812f6139c4125641_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTctMS0xLTQ5NjUyNw_98753907-ee1b-446d-8d1a-b5e880938463">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac8c808851e491b96fe0b5a20350edd_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE2LTEtMS0xLTQ5NjUzMA_fa42b426-7dc5-483c-9b5e-e9757b5cbb42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8600bfef99244855ad7eb86ab1559616_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE2LTMtMS0xLTQ5NjUzMA_4858d4b3-e2f7-4b1a-875d-6818ca072d10">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bdb686a074e4acf9ab3712cd681a240_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE2LTUtMS0xLTQ5NjUzMA_216002b6-435b-4775-9ba2-7a4a1f4f92d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia685ebb6c459475f8ad0e6a8307326bd_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE2LTctMS0xLTQ5NjUzMA_e28f09b7-844a-41ca-bc06-ac93d3bfc905">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02f6517e534d4e87a32cacd9b1d43a6f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTEtMS0xLTM1NDAxOA_a10d60c6-fcd2-462e-a0b9-0b3b7c6e9138">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife540dc14d1e40cab44feeb7eef313d4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTMtMS0xLTM1NDAxOA_6c1074e7-b82f-4855-852a-749bb1e5a663">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic50a20d112914cc4ab63d1807d98ab0a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTUtMS0xLTM1NDAxOA_290c55b7-1205-43ab-af66-cf0553c58c55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961947f6659e41f1bea8348eb926b5a0_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTctMS0xLTM1NDAxOA_2358b983-1abf-41fc-babd-3de0b75ff3ca">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib15d07215a9d4d18aff3f2e340e78ee3_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE3LTEtMS0xLTM1NDAxOA_46777d71-672e-40f4-a56b-0c49526622fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8802b984efc41ec94e160ab0bbca2fd_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE3LTMtMS0xLTM1NDAxOA_7d794848-a9a5-4840-b272-7e2e5171cf23">469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118155f938754467a285e3cd573f13ce_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE3LTUtMS0xLTM1NDAxOA_9b748cf6-44ab-4987-a962-3381b67a2ba8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00f1e5c743a40a290330dfdc47180cd_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE3LTctMS0xLTM1NDAxOA_0a14ad1c-d8c4-4b2d-b025-a6f00135066f">469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i984f2728edad403096ab760c7297e528_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE5LTEtMS0xLTM1NDAxOA_888f7281-22ef-499b-868b-50f0811d4294">565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec7c0676d1274e64a619cdde89d6aa4f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE5LTMtMS0xLTM1NDAxOA_1c0e24d8-429e-44cc-9b26-780fee2c6a06">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1f91cce64b3471488b001aaa80a426d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE5LTUtMS0xLTM1NDAxOA_99632a16-5144-4ff1-a36c-9bc51bee33e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d47874d2cff447d94764455a4adb274_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE5LTctMS0xLTM1NDAxOA_e2fc2852-fddc-4d88-b2bb-e8be64733e28">1,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency swap agreement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b0789820344a6381068e7895a8cc6b_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIxLTEtMS0xLTM1NDAxOA_56d68c91-c648-4fc6-b306-81a5bffc2977">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia19da1ea96814ca79e2518469b123c9c_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIxLTMtMS0xLTM1NDAxOA_e0c94ba9-9ca7-491f-bdde-97b2a87ad046">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e7424994e04f29bb2b11d17ca82c2d_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIxLTUtMS0xLTM1NDAxOA_c6ac0885-4514-4dfc-9324-9450eca268b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216cffbfe6cc49fea999c1a173ee7d01_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIxLTctMS0xLTM1NDAxOA_d3a20be9-f4b8-49b4-a16e-fd750f634b4b">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6480f6a8b344d4da26190ba7e2b134a_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIyLTEtMS0xLTM1NDAxOA_12f3904e-7268-4dbd-8356-f1d4acc26a0a">14,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca2cbb365924fe08d1fca9331f9da1f_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIyLTMtMS0xLTM1NDAxOA_4b216f36-a231-4c2f-99a5-74fe32cbc1ea">14,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d9e0273ef794fc09e5b2df846ddc972_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIyLTUtMS0xLTM1NDAxOA_a2e700a5-e9b8-4b8f-ada3-838d1d2a97a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIyLTctMS0xLTM1NDAxOA_85be5982-44cf-4356-9649-21a0222944c7">29,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes matrix pricing services to estimate fair value for securities which are not actively traded on the measurement date.&#160;The Company designates these securities as Level II fair value measurements.&#160;In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90ZXh0cmVnaW9uOjFlYjAzNTk3YTE0OTRjNTJiM2Y4N2Y2ZWU4OWNhZDc4XzkwOA_3d4f1c77-354e-483a-a4b8-bd795571df91">698</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90ZXh0cmVnaW9uOjFlYjAzNTk3YTE0OTRjNTJiM2Y4N2Y2ZWU4OWNhZDc4XzkxNQ_ea4cd90f-b951-4cba-88e4-24a631114a38">773</ix:nonFraction> million as of December&#160;31, 2022, and December&#160;31, 2021, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzY4Mw_79dfce97-4785-433b-9c36-bcd94839c25d" continuedAt="ic4b5c932861a48aa8c41d333a1e9caa8" escape="true">Property, Software and Equipment</ix:nonNumeric></span></div><ix:continuation id="ic4b5c932861a48aa8c41d333a1e9caa8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzY4Ng_512c75a5-d8b1-41c4-8313-42ef1ac14bdc" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, software and equipment consist of the following ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bf1c0bd1314a1c90835a095147262c_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzEtMS0xLTEtMzU0MDE4_202e228d-c3c7-4d28-9545-fd5d6634638c">2,224</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife87f5c217a845f2a51cd1c4a41ade32_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzEtMy0xLTEtMzU0MDE4_f60c2ac9-1c6a-4d7e-a3eb-07d903f46bcf">1,825</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2e4216a4ce40698cac894107c3c948_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzItMS0xLTEtMzU0MDE4_61c5f47d-ec4f-48b6-b806-bfb8fc318f2a">659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b936995e0d14a0e9066d6970142374e_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzItMy0xLTEtMzU0MDE4_e8e2b5bb-48ab-4f76-ac57-af0e475e57b1">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d6455065c14916bedcc4b31887f1f5_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzMtMS0xLTEtMzU0MDE4_e02c57b7-e72a-4865-8778-5b0e6a20d0f0">604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if190281df1454b0d9f5770396612743e_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzMtMy0xLTEtMzU0MDE4_9ef0a2ce-2493-460a-a08c-684e85ba698d">617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b6b990671ab4dd8acf8fa985ca2d4e4_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzQtMS0xLTEtMzU0MDE4_7746b15c-c94f-4aec-ab73-7eedb2029ede">467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100a54adfd364d5fb0858e40985a6181_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzQtMy0xLTEtMzU0MDE4_c3bfae58-481f-4b54-bc8a-2432a1574348">732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73c2a614f2d145f98965ad96053b0c7e_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzUtMS0xLTEtMzU0MDE4_811ec73f-b828-406a-b438-e4d4fb55315c">366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if22e34d79ca74c90b70c889d03c57bff_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzUtMy0xLTEtMzU0MDE4_e338cba9-cc4f-40be-bfe0-e55eb70aee0c">753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06f29161405549d4ac55bc80cc166ac5_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzYtMS0xLTEtMzU0MDE4_dc7414a9-6f13-49e7-bbf0-15988c2990f1">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib38956abc3fb4d8e8499d7bb2fe5d94d_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzYtMy0xLTEtMzU0MDE4_383450c1-092a-4d57-9648-51b483e52134">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzctMS0xLTEtMzU0MDE4_ebd17917-3d55-427a-9045-58a544ff4534">4,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzctMy0xLTEtMzU0MDE4_74e69062-ece2-4468-acd8-6bfd1ed29066">5,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzgtMS0xLTEtMzU0MDE4_83674609-8417-4143-abbc-710ae966a8b0">2,066</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzgtMy0xLTEtMzU0MDE4_8ee1bc4f-4d59-45e4-917f-1a73a6683580">1,900</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzktMS0xLTEtMzU0MDE4_0d905f9a-045b-47c2-9b42-e101a1f4a844">2,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzktMy0xLTEtMzU0MDE4_112ef29b-1668-4d0c-8e3c-b5fbb707da06">3,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the years ended December 31, 2022, 2021, and 2020 was $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzE2MA_7726d180-f3f4-4c7b-ad6f-9529bd7da18f">614</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzE2NA_a23119d8-0fca-4cce-897a-a69753555ee8">565</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzE3Mg_caa5e1fb-f859-4a11-a593-5d2eeb81a4eb">487</ix:nonFraction> million, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2022, in connection with the adoption of a more modern, flexible work environment, the Company undertook a real estate optimization initiative to evaluate future real estate needs and downsize its real estate footprint for owned and leased properties. As a result of this evaluation, the Company substantially changed the use or abandoned various properties and assessed for impairment. The Company engaged a third-party real estate specialist to determine the fair value of its owned properties. The valuation primarily considered comparable properties in each market as well as future cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the optimization, the Company recognized impairment charges related to owned real estate of $<ix:nonFraction unitRef="usd" contextRef="i29be61bb7bd449499dfb1c0c4a885854_D20220101-20221231" decimals="-6" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzMxNQ_8d6221c8-163f-487e-ac57-ffce3d552aba">808</ix:nonFraction> million for the year ended December 31, 2022. The Company also recognized impairment on fixed assets related to leased real estate of $<ix:nonFraction unitRef="usd" contextRef="ie3a179811ece4f09918f2e0f0934aad0_D20220101-20221231" decimals="-6" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzQxOA_56147880-39ad-4b8b-8d6c-4899f963d387">242</ix:nonFraction> million for the year ended December 31, 2022. These impairments are primarily related to the Managed Care segment. The remainder of the $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:OtherAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzUyMw_ad7f4024-c9b7-4483-8d4e-50e5a081db52">1,627</ix:nonFraction> million charge relates to right-of-use (ROU) asset impairments, which is included within other long-term assets on the Consolidated Balance Sheet, refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Leases.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i9dee570cfbd043d6a1700298c14b2446_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 7. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzc3MQ_defc027e-2dfa-4719-8e1d-62346a801b8d" continuedAt="i8013615090154d64b7b46e118138e257" escape="true">Goodwill and Intangible Assets</ix:nonNumeric></span></div><div style="text-indent:18pt"><span><br/></span></div><ix:continuation id="i8013615090154d64b7b46e118138e257" continuedAt="ib12389f273744d4389b0a7d7896891fa"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzc3MA_44c1d5d7-832b-42c3-8d1a-0e48f6a3059c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in goodwill by operating segment ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.840%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Managed&#160;Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe9c3a7c196249c9a9c9c18973bfaf0c_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEtMS0xLTEtMzU0MDE4_5f2fdbde-f569-4728-8bc6-92e0aa478687">16,974</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3600301874b74a97849c262419053cdf_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEtMy0xLTEtMzU0MDE4_d4d4973e-dd80-4aff-9078-12d39b0f8ff7">1,678</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEtNS0xLTEtMzU0MDE4_4d065499-d32a-4a97-ac2b-a27808241bba">18,652</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6447d75d16c04ef5b131401dd27e366b_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzItMS0xLTEtMzU0MDE4_227e589a-f125-4751-9aec-834117af1ddb">1,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2bebbc40fd54b4b8b61324fc370f6f6_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzItMy0xLTEtMzU0MDE4_6375a28c-b0e4-4a48-8a62-c430fac42c20">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzItNS0xLTEtMzU0MDE4_f78049dc-6d0a-4ba8-9d1c-ac1eed57dbfb">1,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6447d75d16c04ef5b131401dd27e366b_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzMtMS0xLTEtMzU0MDE4_077abdd0-0148-4ecc-b1fb-e70654aef5af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2bebbc40fd54b4b8b61324fc370f6f6_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzMtMy0xLTEtMzU0MDE4_1bdabdae-edef-406b-99d5-96908d5a174f">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzMtNS0xLTEtMzU0MDE4_070c12b7-65fb-4ae7-a680-0c74af95581e">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reallocation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6447d75d16c04ef5b131401dd27e366b_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzQtMS0xLTEtMzU0MDE4_7afc1bec-d4fa-4fd3-8869-bcf4542770eb">250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2bebbc40fd54b4b8b61324fc370f6f6_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzQtMy0xLTEtMzU0MDE4_643f834b-fb7e-4851-a6f3-3dba31941c2c">250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzQtNS0xLTEtMzU0MDE4_59f788b9-d1d3-421f-a732-8600b0bf4974">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6447d75d16c04ef5b131401dd27e366b_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzYtMS0xLTEtMzU0MDE4_981cd506-9798-448c-bd02-3f99ac9bc608">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2bebbc40fd54b4b8b61324fc370f6f6_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzYtMy0xLTEtMzU0MDE4_3ccccaea-27e9-40b1-92a5-9f4e05590a01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzYtNS0xLTEtMzU0MDE4_4d754b16-86ef-447f-b355-74690cacb224">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92213e6837f747a4af84a01d94d1a0e5_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzctMS0xLTEtMzU0MDE4_17c75a40-c7c6-4511-aabe-86921d2a68af">18,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ebf3857ac8d4d779658871d0f01e499_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzctMy0xLTEtMzU0MDE4_159aa213-3e83-453d-9909-bbaf4f49984b">1,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzctNS0xLTEtMzU0MDE4_55500557-7adb-49f7-9188-c5a6eb0f7c2b">19,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and purchase accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzgtMS0xLTEtMzU0MDE4_3a03dc67-015b-405b-9c28-d0e797710cbe">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzgtMy0xLTEtMzU0MDE4_34ceb36b-3e1b-459a-a867-86c26625d784">905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzgtNS0xLTEtMzU0MDE4_e5d18122-38ff-4dce-afca-1db366fb0bd1">1,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzktMS0xLTEtMzU0MDE4_22801c25-e576-40ea-a1e9-ee39aa7846da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzktMy0xLTEtMzU0MDE4_858e2955-c705-40dc-bcf1-fa0d088bf373">1,533</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzktNS0xLTEtMzU0MDE4_45200633-e6ef-43bf-b8f8-891f9d51cce1">1,533</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reallocation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEwLTEtMS0xLTM1NDAxOA_507ab6b2-914e-40b8-b4d4-ac6717e5af8a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEwLTMtMS0xLTM1NDAxOA_5fa3d343-7241-4178-ac0d-4efa02638145">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEwLTUtMS0xLTM1NDAxOA_290e5b0a-add1-4f3c-95f4-0dd7d4a984e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzExLTEtMS0xLTM1NDAxOA_f8795d12-a882-4435-9197-36fcb77311f6">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzExLTMtMS0xLTM1NDAxOA_73682e81-3e77-4842-813b-10666be8ff8f">304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzExLTUtMS0xLTM1NDAxOA_2edf7e17-cfa7-4ea3-8730-1f242d0c30ec">370</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEyLTEtMS0xLTM1NDAxOA_4f965d34-37fd-4803-a324-50d93ddad397">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEyLTMtMS0xLTM1NDAxOA_34a360f9-ba88-48d7-bbcb-8776ebec40a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEyLTUtMS0xLTM1NDAxOA_25750b95-aa73-474a-80ff-b13d03699758">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a0d132e8b0f4c5e9eabdf2f63c857e9_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEzLTEtMS0xLTM1NDAxOA_3824454b-c777-4b78-a214-c7700d62e575">18,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i181e950b83264a488f15aa5b9518e0ac_I20221231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEzLTMtMS0xLTM1NDAxOA_8f73a2a0-fcd9-4c49-a5c1-15252ab56d18">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEzLTUtMS0xLTM1NDAxOA_a73f6854-7799-479e-8e94-6b988bfd0f1d">18,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in the Specialty Services segment goodwill in 2022 was primarily driven by the ongoing portfolio review divestiture related activity during the year as discussed in Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, divestiture related reductions to goodwill included the completed divestitures of PANTHERx and Magellan Rx, as well as goodwill reclassified to other current assets associated with the divestiture of Magellan Specialty Health, which was considered held for sale as of December&#160;31, 2022. The acquired goodwill in 2022 represents goodwill associated with the Magellan acquisition.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ib12389f273744d4389b0a7d7896891fa"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Specialty Services segment impairments in 2022 was primarily the result of the impairment of Federal Services business, which included $<ix:nonFraction unitRef="usd" contextRef="i7849ad351f3a4c2c85f3c60fa5e30c67_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzE2NDkyNjc0NDU3NzA_e77f8043-8981-43bc-ad35-43d9d1b7ddd5">216</ix:nonFraction> million of goodwill, in conjunction with the December 2022 announcement from the DoD that the Company was not awarded a TRICARE Managed Care Support Contract. The Managed Care segment impairment was the result of the divestiture of the Spanish and Central European businesses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the increase in the Managed Care segment goodwill in 2021 was related to the acquisition of the remaining <ix:nonFraction unitRef="number" contextRef="i556fc29a81414ce8a1faff7d6b5ca940_I20210731" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzQxNw_5fe1bd4d-cddb-441c-b476-87a88054e1ba">60</ix:nonFraction>% interest in Circle Health.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzc3Mw_407df1b5-6be9-4d31-9d21-21c1264f9b64" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets at December 31, consist of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:49.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.684%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average&#160;Life in Years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights and customer relationships</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i328ddde551924916887c2898ccb4dd3b_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzItMS0xLTEtMzU0MDE4_b7b36f7f-714d-43dc-ae1f-cdcde1dab784">7,850</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d16b33d8c444b8481c9b42434c97635_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzItMy0xLTEtMzU0MDE4_069d7ae9-8444-464a-a12e-4265aff644d9">8,068</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i03902f10bd8f4acb93c88c3d43810400_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzItNS0xLTEtMzU0MDE4_bc5247e6-93c3-4679-868c-6b1adaa138ea">13.4</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i58a9fd19cada4c13b08e45b396931905_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzItNy0xLTEtMzU0MDE4_3f87f43f-5667-477b-981e-3e64ba52165a">13.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b18a16cf3a0445a91bf4830e4787fa6_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzMtMS0xLTEtMzU0MDE4_913a43d4-c46c-4150-aef2-443a06f94895">983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16afdebec9994bc7a8b3f04e5c78b0d5_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzMtMy0xLTEtMzU0MDE4_76a3535d-52b1-4d7b-903a-3d311286e51c">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e59224fa1b1425dae4c36a43f5ca733_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzMtNS0xLTEtMzU0MDE4_7e7fc661-e4f9-4e13-84c8-a9efa28eef5e">15.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib287146fc44b4771b7ffa29552be6cfb_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzMtNy0xLTEtMzU0MDE4_acdb8fae-4cf9-49d7-ac2a-d0acb1580326">13.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1efb4143fcd4b1aaef7a1ba3c72805f_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzQtMS0xLTEtMzU0MDE4_3af74e13-c328-4dd5-92ef-e1a8c04d5ca6">612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf15dae4e23403b853ee515df157fa4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzQtMy0xLTEtMzU0MDE4_819f931c-5278-4e58-9f75-baec7742b0cc">492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i77a6398252454629906ae6fadb232df2_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzQtNS0xLTEtMzU0MDE4_c3f0b3e6-786c-4ded-b181-0368b5a2bcc5">14.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i49909ff543254622b7916b96f58bad77_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzQtNy0xLTEtMzU0MDE4_797cec03-f7c3-4e4f-add0-5552866a8110">13.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e453e9028df40d18c170e5c715a855a_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzUtMS0xLTEtMzU0MDE4_179f76ee-7313-4a4d-bdf4-132b1c49a019">390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1db28c738ca41c9b8de3081714dc705_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzUtMy0xLTEtMzU0MDE4_a842b1e7-894f-48cc-bd33-386af9ad121c">369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia59410e42a404d6697fe2e242a44ea5a_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzUtNS0xLTEtMzU0MDE4_6500a2db-f77d-43b8-8f61-9b34d543eb6d">5.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i46026d8e014347bd85d04fc8a7960c3c_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzUtNy0xLTEtMzU0MDE4_bd278d44-541a-4bf3-a7bd-9eff9a326676">5.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzctMS0xLTEtMzU0MDE4_444d4287-5e28-445c-94f4-f4195a1ad4fb">9,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzctMy0xLTEtMzU0MDE4_885f3a4b-3774-4f64-ab80-519a9f261206">10,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzctNS0xLTEtMzU0MDE4_b558490b-852b-4cd4-b7d8-74bb29df68cf">13.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzctNy0xLTEtMzU0MDE4_1df30582-2181-4376-9c09-5ef71dc4f094">13.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights and customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i328ddde551924916887c2898ccb4dd3b_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzktMS0xLTEtMzU0MDE4_cb8fd0d9-806f-4e80-b655-ccf677465dba">2,193</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d16b33d8c444b8481c9b42434c97635_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzktMy0xLTEtMzU0MDE4_6b09a8c1-607f-4b6f-9fc2-cfac8d388089">1,642</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b18a16cf3a0445a91bf4830e4787fa6_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzEwLTEtMS0xLTM1NDAxOA_14ce355b-54db-4ae1-b6dc-67ea90433a48">263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16afdebec9994bc7a8b3f04e5c78b0d5_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzEwLTMtMS0xLTM1NDAxOA_1eef8040-5b5d-40e1-ba89-e745c5fa01a1">206</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1efb4143fcd4b1aaef7a1ba3c72805f_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzExLTEtMS0xLTM1NDAxOA_a58bcc80-ab24-419c-92e3-5472f9daff35">183</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cf15dae4e23403b853ee515df157fa4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzExLTMtMS0xLTM1NDAxOA_209238eb-900a-4a95-b394-0fabe0d121eb">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e453e9028df40d18c170e5c715a855a_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzEyLTEtMS0xLTM1NDAxOA_7edc2b6e-284c-4225-8c7f-6a2654a96f88">285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1db28c738ca41c9b8de3081714dc705_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzEyLTMtMS0xLTM1NDAxOA_6152e0cf-8820-4b1d-987e-3156a9fd6cc9">225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzE0LTEtMS0xLTM1NDAxOA_97e5aa17-2861-4a3f-847f-a322f459d3da">2,924</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzE0LTMtMS0xLTM1NDAxOA_e4499c10-40b8-4843-b0bf-5e175dc2615e">2,212</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzE1LTEtMS0xLTM1NDAxOA_fa136916-1904-41e7-85f2-b4f68af9ad70">6,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzE1LTMtMS0xLTM1NDAxOA_4465af9e-17fa-44fe-8f39-d23a59476538">7,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described above, the decrease in intangible assets in 2022 was primarily driven by divestiture related activity, which included related impairments, during the year as discussed with goodwill above and in Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzU1MQ_372c5b98-5131-4d26-8a96-4250b69c3d7e">817</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzU1NQ_98500083-244c-4788-9627-2b132aa943a4">770</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzU2Mw_c09f4550-0212-4315-b1e4-570e7ca2f6cb">719</ix:nonFraction> million for the years ended December 31, 2022, 2021, and 2020, respectively. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzc1NA_4f6c047d-4568-447a-bb5b-a3cb21a40341" continuedAt="i575a409d839447779acd129fdde31139" escape="true">Estimated total amortization expense related to the December&#160;31, 2022 intangible assets for each of the five succeeding fiscal years is as follows ($ in millions):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i575a409d839447779acd129fdde31139"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"></td><td style="width:67.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.266%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Total Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo5N2Q2ZjRkYTRiZGE0YzllYWM3YzNiMTRlODQwNDlhMy90YWJsZXJhbmdlOjk3ZDZmNGRhNGJkYTRjOWVhYzdjM2IxNGU4NDA0OWEzXzEtMi0xLTEtMzU0MDE4_7c4c82f7-e2fb-4b91-805b-7ed4b6cdef9b">723</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo5N2Q2ZjRkYTRiZGE0YzllYWM3YzNiMTRlODQwNDlhMy90YWJsZXJhbmdlOjk3ZDZmNGRhNGJkYTRjOWVhYzdjM2IxNGU4NDA0OWEzXzItMi0xLTEtMzU0MDE4_c8145a6f-aee9-434a-9952-400dd78f5069">707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo5N2Q2ZjRkYTRiZGE0YzllYWM3YzNiMTRlODQwNDlhMy90YWJsZXJhbmdlOjk3ZDZmNGRhNGJkYTRjOWVhYzdjM2IxNGU4NDA0OWEzXzMtMi0xLTEtMzU0MDE4_0fd35e90-6574-455c-bab8-364f231e5327">706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo5N2Q2ZjRkYTRiZGE0YzllYWM3YzNiMTRlODQwNDlhMy90YWJsZXJhbmdlOjk3ZDZmNGRhNGJkYTRjOWVhYzdjM2IxNGU4NDA0OWEzXzQtMi0xLTEtMzU0MDE4_632fe723-2508-4deb-9f03-ac653ec179c8">689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo5N2Q2ZjRkYTRiZGE0YzllYWM3YzNiMTRlODQwNDlhMy90YWJsZXJhbmdlOjk3ZDZmNGRhNGJkYTRjOWVhYzdjM2IxNGU4NDA0OWEzXzUtMi0xLTEtMzU0MDE4_0a43619e-72c8-40ce-bdcc-f56409070f9a">678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:InsuranceDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90ZXh0cmVnaW9uOjYwNDVlNWRlYTVkZDQ4NDVhZDk3MTllMDZlOTNmNmUxXzQyOTg_4abcf009-ef58-4817-8bf9-72bf60ad0e14" continuedAt="i9d97e582720f4930bbcce99f1479166c" escape="true">Medical Claims Liability</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i9d97e582720f4930bbcce99f1479166c" continuedAt="ia4814bc30d634a97a008c19c5eb6736f"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90ZXh0cmVnaW9uOjYwNDVlNWRlYTVkZDQ4NDVhZDk3MTllMDZlOTNmNmUxXzQzMDY_3207c522-7cc2-4650-9b74-9935131eeb3a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzItMi0xLTEtMzU0MDE4_63098723-4d5a-4698-ad59-29d616ced2e0">14,243</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzItNC0xLTEtMzU0MDE4_fe9306df-6caa-4221-9233-8358a8388489">12,438</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89efa37b183c4c618c28149ddb506553_I20191231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzItNi0xLTEtMzU0MDE4_b74e4006-81c6-4acf-a22f-dcb4ac6feca1">7,473</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzMtMi0xLTEtMzU0MDE4_6b4a2947-9610-47c8-82ce-ea05739e4e2a">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzMtNC0xLTEtMzU0MDE4_d8498ec4-146e-4188-8961-0c56d58a6a3b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89efa37b183c4c618c28149ddb506553_I20191231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzMtNi0xLTEtMzU0MDE4_8dbda97b-5b64-409c-90c5-bcd1c5ca049e">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzQtMi0xLTEtMzU0MDE4_97e68326-07cd-48f1-b55a-3a57bba948b9">14,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzQtNC0xLTEtMzU0MDE4_100adefd-45a2-4e07-b456-927bb40fa125">12,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89efa37b183c4c618c28149ddb506553_I20191231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzQtNi0xLTEtMzU0MDE4_41b83665-5c84-4a53-8a29-18622655d1cc">7,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzUtMi0xLTEtMzU0MDE4_2877b5e3-7a13-4342-8d3c-a9f5e0671c00">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzUtNC0xLTEtMzU0MDE4_607819bf-c0c3-433a-950a-30a17a759b42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzUtNi0xLTEtMzU0MDE4_67a5d0f5-0e66-4fa8-b86a-15aa488879d1">3,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzgtMi0xLTEtMzU0MDE4_3d133d35-2aff-4868-9279-482c54053d73">112,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzgtNC0xLTEtMzU0MDE4_cc888a85-7e66-4b89-b592-a4c03059f8a4">100,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzgtNi0xLTEtMzU0MDE4_afbe9f80-c434-4b20-9fc7-0d8410cd107d">86,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzktMi0xLTEtMzU0MDE4_99ba2c45-2ee0-4946-917e-644bd009c136">1,367</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzktNC0xLTEtMzU0MDE4_c4af01d1-9194-4355-bf05-7202fc95e02f">1,783</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzktNi0xLTEtMzU0MDE4_65611967-a878-4d9b-b585-59155f7895b0">501</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEwLTItMS0xLTM1NDAxOA_3bc4fb72-f251-4fa6-b569-591cf385f975">111,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEwLTQtMS0xLTM1NDAxOA_b2808b73-a418-498f-99fb-39398395b22a">98,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEwLTYtMS0xLTM1NDAxOA_3f2ecc8a-23b2-4b74-8689-85489d959c5f">86,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEyLTItMS0xLTM1NDAxOA_b3321ceb-855c-4a22-92d1-af7f999ae891">97,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEyLTQtMS0xLTM1NDAxOA_0c4d0033-e245-4117-bb06-c90f589ac7f5">87,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEyLTYtMS0xLTM1NDAxOA_714713d3-3fcc-4718-b747-50172abe7097">78,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEzLTItMS0xLTM1NDAxOA_e2527aa7-bfd2-4f06-bb4d-08094468201c">11,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEzLTQtMS0xLTM1NDAxOA_56bfebff-5a87-4b18-b389-79b9704029ae">9,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEzLTYtMS0xLTM1NDAxOA_e7ad4240-7881-4ab5-b27c-664ae7c16ff6">6,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE0LTItMS0xLTM1NDAxOA_1629ec19-e6ac-4f49-a4bf-15638255aae3">109,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE0LTQtMS0xLTM1NDAxOA_0e748bfd-ced4-4d56-bed5-2696d82c1696">96,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE0LTYtMS0xLTM1NDAxOA_a4353bc6-a4f9-4bdd-a34c-76772bb28bd8">85,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE1LTItMS0xLTM1NDAxOA_3638a909-8632-4b13-a411-7e08c9cba949">16,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE1LTQtMS0xLTM1NDAxOA_ada72253-b16c-4b3a-9bec-e2b61613ddd8">14,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE1LTYtMS0xLTM1NDAxOA_1b463992-a3f6-4cc4-9ac7-d271cf6d9c13">12,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE2LTItMS0xLTM1NDAxOA_938c2489-3c35-4ed8-ac57-3a97f3fc33a8">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE2LTQtMS0xLTM1NDAxOA_cc593e49-59bc-4b33-8bf7-767365d365c9">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE2LTYtMS0xLTM1NDAxOA_f97e8924-95a2-4dab-9f45-45dbbd08ea8c">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE3LTItMS0xLTM1NDAxOA_016b6629-386b-48a5-a4f2-db51f8050994">16,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE3LTQtMS0xLTM1NDAxOA_c15308ec-0a8f-4f9d-9fcc-a8aa9afdadd9">14,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE3LTYtMS0xLTM1NDAxOA_f0c5391e-e39d-4673-a3bf-a3d6ddd76081">12,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. The impact from COVID-19 on healthcare utilization and medical claims submission patterns provided increased estimation uncertainty on the IBNR liability. Additionally, as a result of minimum HBR and other return of premium programs, the Company recorded approximately $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="cnc:AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90ZXh0cmVnaW9uOjYwNDVlNWRlYTVkZDQ4NDVhZDk3MTllMDZlOTNmNmUxXzE2NDkyNjc0NDYwMzQ_0e8bbaef-e49a-4ce3-b900-e645aac21523">198</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="cnc:AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90ZXh0cmVnaW9uOjYwNDVlNWRlYTVkZDQ4NDVhZDk3MTllMDZlOTNmNmUxXzE2NDkyNjc0NDYwMTk_a866c4f2-ed5e-4385-9b81-73298289518b">492</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="cnc:AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90ZXh0cmVnaW9uOjYwNDVlNWRlYTVkZDQ4NDVhZDk3MTllMDZlOTNmNmUxXzE2NDkyNjc0NDYwMjY_d0265cfb-ae55-47fd-b1c6-39a285505713">86</ix:nonFraction> million of the "Incurred related to: Prior years" as a reduction to premium revenues in 2022, 2021, and 2020, respectively. Further, claims processing initiatives yielded increased claim payment recoveries and coordination of benefits related to prior year dates of service.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in medical utilization and cost trends and the effect of population health management initiatives may also contribute to changes in medical claim liability estimates.&#160;While the Company has evidence that population health management initiatives are effective on a case by case basis, population health management initiatives primarily focus on events and behaviors prior to the incurrence of the medical event and generation of a claim. Accordingly, any change in behavior, leveling of care, or coordination of treatment occurs prior to claim generation and as a result, the costs prior to the population health management initiative are not known by the Company. Additionally, certain population health management initiatives are focused on member and provider education with the intent of influencing behavior to appropriately align the medical services provided with the member's acuity. In these cases, determining whether the population health management initiative changed the behavior cannot be determined. Because of the complexity of its business, the number of states in which it operates, and the volume of claims that it processes, the Company is unable to practically quantify the impact of these initiatives on its changes in estimates of IBNR. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement, and maintenance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Specialty Services segment has an insignificant amount of medical claims liability and, therefore, disclosures related to medical claims liabilities have been aggregated and are presented on a consolidated basis. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="ia4814bc30d634a97a008c19c5eb6736f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about incurred and paid claims development as of December&#160;31, 2022 is included in the table below. The claims development information for all periods preceding the most recent reporting period is considered required supplementary information. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90ZXh0cmVnaW9uOjYwNDVlNWRlYTVkZDQ4NDVhZDk3MTllMDZlOTNmNmUxXzQzMTI_14ffbad8-74f4-4458-8e90-626dc4beeca8" continuedAt="idd7ec22833324c608238f850c058a187" escape="true">Incurred and paid claims development as of December&#160;31, 2022 is as follows ($ in millions):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="idd7ec22833324c608238f850c058a187" continuedAt="icc01e432bbfd4c0ea9d87372b7d6608a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:23.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance</span></td></tr><tr><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Claim Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 (unaudited)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 (unaudited)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73627a9d2f3f4c7890caac11b561d45e_I20201231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzQtMi0xLTEtMzU0MDE4_8aa0c581-0090-410f-ac21-94b775d7b485">88,206</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id73d46c1711b4b3da426964338d0f2df_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzQtNC0xLTEtMzU0MDE4_f7f5eb05-8252-47b3-b4ae-814216a411bf">86,502</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19d7002bf5504374ba94620ad1f9d850_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzQtNi0xLTEtMzU0MDE4_b3f52128-9b7e-4674-b5d0-60856dae4783">86,433</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa9b52eb00894da485bfb964ba7dce6c_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzUtNC0xLTEtMzU0MDE4_6b126bb1-8dc9-46d1-a899-7c119ae90b65">100,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0bdad4169ab4f599480c131c7206ae1_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzUtNi0xLTEtMzU0MDE4_bf40d89e-bb56-4758-89b6-ed154a84d6ad">99,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2f58523cb7466b8aecbc8fdbe138a8_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzYtNi0xLTEtMzU0MDE4_d9245ab3-e739-4e72-8c85-fcd79c6181ed">112,896</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred claims</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41b58c91b23541a8a008f29061d225c8_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzctNi0xLTEtMzU0MDE4_5e584a43-862e-4f59-886e-e4ff657ce0e2">298,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance</span></td></tr><tr><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Claim Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 (unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 (unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73627a9d2f3f4c7890caac11b561d45e_I20201231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzEzLTItMS0xLTM1NDAxOA_be2f6a60-4ce1-42a2-a114-f3f5a447f55a">76,722</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id73d46c1711b4b3da426964338d0f2df_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzEzLTQtMS0xLTM1NDAxOA_89cb0d34-f049-4879-aed5-9c341c2078a3">85,593</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19d7002bf5504374ba94620ad1f9d850_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzEzLTYtMS0xLTM1NDAxOA_4c954364-aefc-4f30-a43c-11d21ca77d8b">86,021</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa9b52eb00894da485bfb964ba7dce6c_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzE0LTQtMS0xLTM1NDAxOA_8343dd38-94a4-4375-9730-d501002f94be">87,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0bdad4169ab4f599480c131c7206ae1_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzE0LTYtMS0xLTM1NDAxOA_f579b31a-f2b8-40e4-b9f1-271b8a75e9a4">98,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2f58523cb7466b8aecbc8fdbe138a8_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzE1LTYtMS0xLTM1NDAxOA_b96ccdc6-3401-4d8c-a5f9-3a19c08cf18c">97,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total payment of incurred claims</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41b58c91b23541a8a008f29061d225c8_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzE2LTYtMS0xLTM1NDAxOA_b8eec6e0-7691-47f0-b74e-8680fdd362f5">281,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All outstanding liabilities prior to 2020, net of reinsurance</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41b58c91b23541a8a008f29061d225c8_I20221231" decimals="-6" name="cnc:ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzE3LTYtMS0xLTM1NDAxOA_5e69c351-c387-4eca-bc8c-595709f61034">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims liability, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41b58c91b23541a8a008f29061d225c8_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzE4LTYtMS0xLTM1NDAxOA_a5acdc4d-ed3d-4050-9765-825e18d13b13">16,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incurred claims and allocated claim adjustment expenses, net of reinsurance, total IBNR plus expected development on reported claims and cumulative claims data as of December&#160;31, 2022 are included in the following table. For claims frequency information summarized below, a claim is defined as the financial settlement of a single medical event in which remuneration was paid to the servicing provider. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims, and estimates for the costs necessary to process unpaid claims at the end of each period.&#160;The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice.&#160;These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.&#160;<ix:continuation id="icc01e432bbfd4c0ea9d87372b7d6608a" continuedAt="i5f4cde0828944bab86b08573ba30853c">Information is summarized as follows (in millions):</ix:continuation></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i5f4cde0828944bab86b08573ba30853c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:23.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative Paid Claims</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19d7002bf5504374ba94620ad1f9d850_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzQtMS0xLTEtMzU0MDE4_c3367d78-0135-44b5-9ae2-f1059147c412">86,433</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19d7002bf5504374ba94620ad1f9d850_I20221231" decimals="-6" name="cnc:ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzQtMy0xLTEtMzU0MDE4_7f30e1e2-6287-4309-8de7-8e485a4b4583">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i19d7002bf5504374ba94620ad1f9d850_I20221231" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzQtNS0xLTEtMzU0MDE4_3a834325-9875-4bd9-b886-48681ba78280">568.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0bdad4169ab4f599480c131c7206ae1_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzUtMS0xLTEtMzU0MDE4_88ca6e13-2f2b-4d08-807a-bb2abb3645f1">99,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0bdad4169ab4f599480c131c7206ae1_I20221231" decimals="-6" name="cnc:ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzUtMy0xLTEtMzU0MDE4_252144d3-0248-484b-bce8-7911fa7cc7c5">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ic0bdad4169ab4f599480c131c7206ae1_I20221231" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzUtNS0xLTEtMzU0MDE4_2c2f2905-f569-4845-8e80-17845c0aa4f2">623.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2f58523cb7466b8aecbc8fdbe138a8_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzYtMS0xLTEtMzU0MDE4_c0e083d2-5021-43f9-b97f-232db9e98f2b">112,896</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2f58523cb7466b8aecbc8fdbe138a8_I20221231" decimals="-6" name="cnc:ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzYtMy0xLTEtMzU0MDE4_8f74f033-930d-473c-a4cc-9eb6e98b5bbd">11,081</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i7d2f58523cb7466b8aecbc8fdbe138a8_I20221231" decimals="-5" name="us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzYtNS0xLTEtMzU0MDE4_7c6204bf-e29e-4a9e-866b-0b057214cbf1">608.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="cnc:AffordableCareActDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90ZXh0cmVnaW9uOjY2OTA5Zjc1YmY4ZjQ4ZjhhMzI5MzA3MzU1OThhY2VmXzU3OA_7f18e56c-4a6a-4df2-a6f9-7ddab6a57696" continuedAt="i7bec3b1835b149579fb03b6591f8ba26" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Affordable Care Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i7bec3b1835b149579fb03b6591f8ba26" continuedAt="i7ab2e6f6f6f64d428d7dce80874cb741"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established risk spreading premium stabilization programs as well as a minimum annual MLR and cost sharing reductions. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90ZXh0cmVnaW9uOjY2OTA5Zjc1YmY4ZjQ4ZjhhMzI5MzA3MzU1OThhY2VmXzU4NA_cc1a34ff-eb8c-4667-bee4-e281f496f881" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's net receivables (payables) for each of the programs are as follows ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment receivable</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:AffordableCareActRiskAdjustmentReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzEtMS0xLTEtMzU0MDE4_475fd411-802d-4749-b810-fc15bfb8ca7a">838</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:AffordableCareActRiskAdjustmentReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzEtMy0xLTEtMzU0MDE4_02ace0eb-78f5-4a2a-889f-7155563c2b23">522</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:AffordableCareActReinsurancePayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzItMS0xLTEtMzU0MDE4_5d58bb36-2bb2-400b-a7d7-ff4db8c063cd">780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:AffordableCareActReinsurancePayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzItMy0xLTEtMzU0MDE4_eb2a0396-f0d4-4b1d-badf-120c038fafda">536</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum medical loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:AffordableCareActMinimumMedicalLossRatio" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzQtMS0xLTEtMzU0MDE4_e1da6955-3c76-4987-bc1b-de4510d2d601">103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:AffordableCareActMinimumMedicalLossRatio" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzQtMy0xLTEtMzU0MDE4_d580ee06-5b5d-4234-b111-f3ac9efa3b1c">196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:AffordableCareActCostSharingReductionReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzUtMy0xLTEtMzU0MDE4_b2199ed0-51f4-4c76-a6d4-92b33b4c7199">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:AffordableCareActCostSharingReductionsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzYtMS0xLTEtMzU0MDE4_33de4cd4-5799-4c6f-8708-488e8a922bbc">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:AffordableCareActCostSharingReductionsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzYtMy0xLTEtMzU0MDE4_8451ea4c-b504-47e9-ac32-848e557d0f0c">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7ab2e6f6f6f64d428d7dce80874cb741">In June 2022, CMS announced the final risk adjustment transfers for the 2021 benefit year. As a result of the announcement, the Company increased its risk adjustment net receivables by $<ix:nonFraction unitRef="usd" contextRef="ieedd2924db2741fca6d7ee512adc93cd_D20220101-20220630" decimals="-6" name="cnc:AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90ZXh0cmVnaW9uOjY2OTA5Zjc1YmY4ZjQ4ZjhhMzI5MzA3MzU1OThhY2VmXzQzNg_4ae9c886-9ebc-4d8f-807f-2015239663f9">403</ix:nonFraction> million from December&#160;31, 2021. After consideration of minimum MLR and other related impacts, the net pre-tax benefit recognized was approximately $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="cnc:AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90ZXh0cmVnaW9uOjY2OTA5Zjc1YmY4ZjQ4ZjhhMzI5MzA3MzU1OThhY2VmXzU2Mw_ccdf547e-8d7d-486c-a431-e04f31773813">368</ix:nonFraction> million for the year ended December&#160;31, 2022.</ix:continuation> </span></div><div id="i9dee570cfbd043d6a1700298c14b2446_130"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzk5MDU_cb411c95-1f0d-4add-ab99-2f4502b4da74" continuedAt="i9e68728e4a454ae0b68e4448b0be1c83" escape="true">Debt </ix:nonNumeric></span></div><ix:continuation id="i9e68728e4a454ae0b68e4448b0be1c83" continuedAt="i30677ff9eed34f6390b578b317f76da8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzk4ODY_f8a1472f-c4a0-4feb-85cf-6a0900152bd1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if59e715c4ba4443c81f2e83328a8a425_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246ZTE4MTM2MjlkMmExNGQ1MjhhZmM1YzZiMTk2NGZlZjZfNA_3c8a67d3-8a20-4eea-9852-e1505b98e07c">2,500</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="if59e715c4ba4443c81f2e83328a8a425_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246ZTE4MTM2MjlkMmExNGQ1MjhhZmM1YzZiMTk2NGZlZjZfNw_11f44b94-94cb-4515-b6bf-4c4399117149">4.25</ix:nonFraction>% Senior Notes, due December 15, 2027</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if59e715c4ba4443c81f2e83328a8a425_I20221231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEtMS0xLTEtMzU0MDE4_a7f3cef0-fc9d-4121-8116-aaf1f8547986">2,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if498067e62854af781939df76fc7b035_I20211231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEtMy0xLTEtMzU0MDE4_4543c3e2-0b01-40af-9823-93efcb1115b7">2,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id75e90133d6e4c55b389cae1596db986_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MzgxNzQ0NTUyNWM1NDFkODgxOTJjZTQ1ZTIyYTE3N2ZfNA_55f47f6c-4733-4c06-95c8-7b32f05bf8ce">2,300</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="id75e90133d6e4c55b389cae1596db986_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MzgxNzQ0NTUyNWM1NDFkODgxOTJjZTQ1ZTIyYTE3N2ZfNw_4f2310df-7c5e-41e6-b1ac-fcd2883fdaad">2.45</ix:nonFraction>% Senior Notes, due July 15, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id75e90133d6e4c55b389cae1596db986_I20221231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzItMS0xLTEtMzU0MDE4_211169c2-c6b9-4e78-8556-d44d1264ccb4">2,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3779cadebd4a4a8a5ddcba3d40c0d3_I20211231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzItMy0xLTEtMzU0MDE4_a9d085ca-caac-444d-9606-5c4f3b7c71f4">2,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i250c45b9e6554e22b18804fe0e46eccf_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzMtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246NjEyMDZmOTQ5ZGM2NGY1MTgzNjI5OWFlMzQ0ZTYwYWVfNA_2b6d04c5-386e-44c2-963d-e45c1e7b3f45">3,500</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i250c45b9e6554e22b18804fe0e46eccf_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzMtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246NjEyMDZmOTQ5ZGM2NGY1MTgzNjI5OWFlMzQ0ZTYwYWVfNw_f016fcd3-f123-4bc4-91d7-15c250d21822">4.625</ix:nonFraction>% Senior Notes, due December 15, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i250c45b9e6554e22b18804fe0e46eccf_I20221231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzMtMS0xLTEtMzU0MDE4_95d9aab2-a5a3-469a-8d15-35e278fa8376">3,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93f572be795842d992415254cf1b1974_I20211231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzMtMy0xLTEtMzU0MDE4_191f5a45-844d-4f62-a40b-babe1efb0eac">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ifd89fe164f074e05acdf55f863fcc0a3_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzQtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MWUxZmE2NzEwODI3NGNhZTkyZGE1M2NmMmM4MzVhYzRfNA_65b47058-4500-4535-befe-da02bcd0a6fe">2,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ifd89fe164f074e05acdf55f863fcc0a3_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzQtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MWUxZmE2NzEwODI3NGNhZTkyZGE1M2NmMmM4MzVhYzRfNw_26c8549f-844b-41c8-8caa-1fe12271d9d9">3.375</ix:nonFraction>% Senior Notes, due February 15, 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd89fe164f074e05acdf55f863fcc0a3_I20221231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzQtMS0xLTEtMzU0MDE4_a8442df6-6b7a-4426-945b-7e84877c3501">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae25ea5bc64c484ebad2cc5c1bc36113_I20211231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzQtMy0xLTEtMzU0MDE4_aabfb514-7a6a-43cb-a40a-50794d68c33d">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i078d28b9b7034dd79780964d934280a4_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzUtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246NGEyYTI4MjA0ZmEyNGZhYmIyOTVjOTNlMDJjZjkzNmJfNA_625b6036-16bd-4315-90f1-799cdb194d5b">2,200</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i078d28b9b7034dd79780964d934280a4_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzUtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246NGEyYTI4MjA0ZmEyNGZhYmIyOTVjOTNlMDJjZjkzNmJfNw_da4a5179-8de3-4274-8acf-f3682e80f67f">3.00</ix:nonFraction>% Senior Notes, due October 15, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i078d28b9b7034dd79780964d934280a4_I20221231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzUtMS0xLTEtMzU0MDE4_2dcd69ca-e646-439c-ab1c-93583cc63d62">2,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f64aca31038437e9b59b40bd0c68e62_I20211231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzUtMy0xLTEtMzU0MDE4_d11fdaf0-829a-47fd-a235-5e79c13a7d96">2,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id1b9e385a1ff409aa6196f98517e19f0_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzYtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246NzY1OGFmZGIxMjQyNDFjMmI0ODIxZmQ4NTgzMzQ2MDdfNA_0a5c082c-0114-4c8d-baa6-e6fa3c7aff99">2,200</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="id1b9e385a1ff409aa6196f98517e19f0_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzYtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246NzY1OGFmZGIxMjQyNDFjMmI0ODIxZmQ4NTgzMzQ2MDdfNw_f20315a9-0405-4484-bf34-31153d10360d">2.50</ix:nonFraction>% Senior Notes, due March 1, 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1b9e385a1ff409aa6196f98517e19f0_I20221231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzYtMS0xLTEtMzU0MDE4_74a54676-03a6-44ea-98ce-50ebbd9ea8b8">2,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0e4077697e84a6aacad32e78a712191_I20211231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzYtMy0xLTEtMzU0MDE4_68d1dbd2-5ac4-4810-b603-9cf42c2d9aa9">2,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i78293ad1cf844c17be18714b5b518d0d_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzctMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MjMyNWU3Y2YwNTY3NDIzZGFmNjNmOGExMmMwNzY2MjJfNA_a10e094e-d1c2-40f6-a599-83498386fe1a">1,300</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i78293ad1cf844c17be18714b5b518d0d_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzctMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MjMyNWU3Y2YwNTY3NDIzZGFmNjNmOGExMmMwNzY2MjJfNw_7febd840-5330-4c8d-a508-63aa3d15cdb1">2.625</ix:nonFraction>% Senior Notes, due August 1, 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78293ad1cf844c17be18714b5b518d0d_I20221231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzctMS0xLTEtMzU0MDE4_ecef0cb8-12c9-485a-8db9-1dc2e75feed6">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b35f9af5214457fa8305485b8f5f80b_I20211231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzctMy0xLTEtMzU0MDE4_e6519d2c-41e6-4d92-b447-34cfcf98a432">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:SeniorNotesTotal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzgtMS0xLTEtMzU0MDE4_b7052d89-6738-4af1-943d-971df308e579">15,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:SeniorNotesTotal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzgtMy0xLTEtMzU0MDE4_7fb14bed-d5ae-4ff9-9b18-c8edd4b333a8">15,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3889e7dc9b3e43e2a89701b5ac996351_I20221231" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzktMS0xLTEtMzU0MDE4_a3b7adf0-c044-4293-9fe0-b5089716b596">2,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c97fc5b57a3422fa0bc98e9660b7eae_I20211231" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzktMy0xLTEtMzU0MDE4_57b05038-5dd4-4a07-823c-9793aec9ab27">2,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86309d5b4d1e4ad9b29778c622cf58d4_I20221231" decimals="-6" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEwLTEtMS0xLTM1NDAxOA_51f1b6c0-f5e5-4103-b308-16ed907d9c3a">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic251ef2ec19d480a85766f384559792b_I20211231" decimals="-6" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEwLTMtMS0xLTM1NDAxOA_ad7f1ca6-a5f2-47db-a3a9-6f9b94c2b559">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction loan payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6e2a887cb3d462b82d112eb5f97f89a_I20221231" decimals="-6" name="us-gaap:LoansPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzExLTEtMS0xLTM1NDAxOA_afda1018-e6a9-4862-a774-39cb45f3db84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifffd6515bcf049398572bfc7345e86dd_I20211231" decimals="-6" name="us-gaap:LoansPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzExLTMtMS0xLTM1NDAxOA_da12eaf4-8296-435e-9746-cada9b82014c">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:FinanceLeaseLiabilityAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEyLTEtMS0xLTM1NDAxOA_2cc985e3-7da8-4d77-b7f6-ea826f85f1e9">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:FinanceLeaseLiabilityAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEyLTMtMS0xLTM1NDAxOA_595f40aa-95b6-4b0d-932c-f2569ad0a0e9">493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEzLTEtMS0xLTM1NDAxOA_9f494ada-cae2-43ae-b76c-d9fca7c67dfd">147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEzLTMtMS0xLTM1NDAxOA_1ccc8d73-1c57-4bca-8c53-2a53897b6b92">171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzE0LTEtMS0xLTM1NDAxOA_f01fef6e-4c13-4913-ad06-af032c298678">18,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzE0LTMtMS0xLTM1NDAxOA_cfa9c96f-b4e1-40e6-938f-b203ea5dc6ef">18,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzE1LTEtMS0xLTM1NDAxOA_b138b3da-12ec-46a0-a543-8ad58c0b3c5d">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzE1LTMtMS0xLTM1NDAxOA_6452fd53-7fc9-47f0-85b4-aae569724854">267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzE2LTEtMS0xLTM1NDAxOA_c8a282c7-6a5f-4c48-9b35-acef6c026b2c">17,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzE2LTMtMS0xLTM1NDAxOA_c55a89b5-297f-435b-842a-38012712b0c3">18,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the Company's total debt, approximately <ix:nonFraction unitRef="number" contextRef="i7582e6a18d214d5683a70f95e9969290_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc2OTA_7fc57c58-e879-4384-be24-1b767ae02b6f">13</ix:nonFraction>% is variable rate debt. Approximately <ix:nonFraction unitRef="number" contextRef="i197f99f81f0748d8ba59ab12609ea196_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzU0OTc1NTgyOTQ4NA_f6674250-42ef-4c6c-afed-34db874186dc">12</ix:nonFraction>% uses the London Interbank Offered Rate (LIBOR) as a reference rate pursuant to the terms of the Company Credit Facility and approximately <ix:nonFraction unitRef="number" contextRef="i7fded93a3db84d59b9c64760d9785611_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzU0OTc1NTgzMDEzOQ_93177b71-a7d5-46ac-994f-6c0199997aa7">1</ix:nonFraction>% uses the Sterling Overnight Index Average (SONIA) as a reference rate. The Company believes that the credit agreement will allow Secured Overnight Financing Rate (SOFR) to be used as the new reference rate upon LIBOR's discontinuance. The debt agreements that may be impacted by the discontinuation of LIBOR have provisions included that are sufficient for the Company to transition from the existing LIBOR rates to the prevailing successor market rates as necessary. The document governing the Company Credit Facility includes provisions to convert from LIBOR to SOFR at the time LIBOR ceases to be published.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i30677ff9eed34f6390b578b317f76da8" continuedAt="i07bdc80a3094499c8f1021386fda8b00"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Magellan acquisition in January 2022, the Company paid off Magellan's debt of $<ix:nonFraction unitRef="usd" contextRef="i71b9b8cb331c423a90a34a1f496e8463_D20220101-20220131" decimals="-6" name="us-gaap:RepaymentsOfAssumedDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzU0OTc1NTgzNDU5NA_52552038-4bf9-4028-91b0-3faf46ca8718">535</ix:nonFraction> million acquired in the transaction using Magellan's cash on hand. Specifically, the Company redeemed Magellan's existing outstanding <ix:nonFraction unitRef="number" contextRef="i474329559a594a6db005b911431a9b0d_I20220131" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc2OTY_70e4530e-2c6f-4bb7-af8f-d5ec70d8bde4">4.4</ix:nonFraction>% Senior Notes due 2024 and paid off the existing Credit Agreement. The Company recognized an immaterial net pre-tax gain on extinguishment including related fees and expenses and the write-off of the unamortized premium.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company utilized a portion of the proceeds from the PANTHERx divestiture to repurchase $<ix:nonFraction unitRef="usd" contextRef="if59e715c4ba4443c81f2e83328a8a425_I20221231" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzkwNQ_4c21a6b1-e2b1-4167-be38-9cba3e1f714a">95</ix:nonFraction> million of its par value Senior Notes due 2027 and $<ix:nonFraction unitRef="usd" contextRef="i250c45b9e6554e22b18804fe0e46eccf_I20221231" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzk0OQ_8abd4e6c-de1b-42a0-b5cb-640b9d624216">223</ix:nonFraction> million of its par value Senior Notes due 2029 through the Company's senior note debt repurchase program. The Company recognized a $<ix:nonFraction unitRef="usd" contextRef="i15f1c30fc6e14d85b699a2ed36b96775_D20220101-20221231" decimals="-6" name="us-gaap:GainLossOnRepurchaseOfDebtInstrument" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzM4NDgyOTA3MDc0ODg_a39dade1-d077-458f-89e4-c75772beef48">14</ix:nonFraction> million gain on the redemptions of the notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company issued $<ix:nonFraction unitRef="usd" contextRef="ibc4208797a9b45e58c4c6d017a4605de_I20210228" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzExNDY_4e7af662-d783-4909-9e2a-57407619880b">2,200</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ibc4208797a9b45e58c4c6d017a4605de_I20210228" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzExNDk_4807fdfa-9029-46cf-a787-c6486b540fc6">2.50</ix:nonFraction>% Senior Notes due 2031 (the 2031 Notes). In conjunction with the 2031 Notes offering, the Company completed a tender offer (the Tender Offer) to purchase for cash, subject to certain conditions, any and all of the outstanding aggregate principal amount of the $<ix:nonFraction unitRef="usd" contextRef="i5b0acc9d6b8245e5961cda862a186a59_I20210228" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzE0MTE_9100433b-804c-4af1-be4b-79699ec5fd75">2,200</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i5b0acc9d6b8245e5961cda862a186a59_I20210228" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzE0MTQ_51dd015a-50c9-48fc-8bc1-3b78e3255db1">4.75</ix:nonFraction>% Senior Notes due 2025 (the 2025 Notes). The Company used the net proceeds from the 2031 Notes, together with available cash on hand, to fund the purchase price for the 2025 Notes accepted for purchase in the Tender Offer (approximately <ix:nonFraction unitRef="number" contextRef="i5b0acc9d6b8245e5961cda862a186a59_I20210228" decimals="2" name="cnc:NotesAcceptedForTenderOfferPrincipalOutstandingPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzE2NTM_fd4f31a6-f792-427a-98f4-37671cfa67cd">36</ix:nonFraction>% of the aggregate principal amount outstanding) and used the remaining proceeds to redeem any of the 2025 Notes that remained outstanding following the Tender Offer, including all premiums and accrued interest. The Company recognized a pre-tax loss on extinguishment of $<ix:nonFraction unitRef="usd" contextRef="iaf49d7094f0e45829152639ae4685492_D20210201-20210228" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzE5MjU_da5894c8-0bf3-4c57-81a7-f9cd74091145">46</ix:nonFraction>&#160;million on the redemption of the 2025 Notes, including the call premium, the write-off of the unamortized premium and debt issuance costs, and expenses related to the redemption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i055c199b26fc4eaaae9f9b983763a177_I20210731" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzIxMzM_9de71288-13d3-47c1-8152-22738c9c2042">1,800</ix:nonFraction>&#160;million <ix:nonFraction unitRef="number" contextRef="i055c199b26fc4eaaae9f9b983763a177_I20210731" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzIxMzY_13b8b6d1-5cc4-4e74-9bd1-1b7ac8225fd8">2.45</ix:nonFraction>% Senior Notes due 2028 (the 2028 Notes). The Company used the net proceeds from the offering of the 2028 Notes to finance a portion of the cash consideration payable in connection with the acquisition of Magellan Health Inc., which closed in January 2022, and to pay related fees and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company issued $<ix:nonFraction unitRef="usd" contextRef="ic5a2e2fdf251412ca928d6700728fd1c_I20210831" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzI1ODc_adc0e8b7-9117-49e1-abbb-4edb1b9a3f5d">1,800</ix:nonFraction>&#160;million aggregate principal amount of Senior Notes which included $<ix:nonFraction unitRef="usd" contextRef="i6f91eaa1ade34d99a4b37902e16b46fb_I20210831" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzI2NDg_c7a7b4ae-eaf4-463c-b7a4-bd260459d016">500</ix:nonFraction>&#160;million aggregate principal amount of additional 2028 Notes at a premium to yield <ix:nonFraction unitRef="number" contextRef="i6f91eaa1ade34d99a4b37902e16b46fb_I20210831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzI3MjU_d6e935fc-8c5d-46ad-97c5-96cf141b8a0d">2.31</ix:nonFraction>% and $<ix:nonFraction unitRef="usd" contextRef="i9a76b04856c549278fbebee384e77959_I20210831" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzI3MzI_10940e6a-63ac-4e99-a611-f6649af08c2c">1,300</ix:nonFraction>&#160;million aggregate principal amount of new <ix:nonFraction unitRef="number" contextRef="i9a76b04856c549278fbebee384e77959_I20210831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzI3Njk_c3142a2b-5cf8-419d-ba7f-6bb1745fc7bc">2.625</ix:nonFraction>% Senior Notes due 2031. The Company used the net proceeds of the offering, together with cash on hand and term loan facility borrowings, to redeem all of its outstanding <ix:nonFraction unitRef="number" contextRef="i2af47f4133f54a42b12356bc6030758a_I20210831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzI5NDE_3a87e41e-6e05-4094-984f-b1ac11b2f01e">5.375</ix:nonFraction>% Senior Notes due 2026 and WellCare Health Plans, Inc.'s outstanding <ix:nonFraction unitRef="number" contextRef="i2af47f4133f54a42b12356bc6030758a_I20210831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzMwMTI_3a87e41e-6e05-4094-984f-b1ac11b2f01e">5.375</ix:nonFraction>% Senior Notes due 2026 (together the 2026 Notes), including all premiums and accrued interest. The Company recognized a pre-tax loss on extinguishment of $<ix:nonFraction unitRef="usd" contextRef="i5cf2b5d34cdd49e092806cd5c281dddf_D20210801-20210831" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzMxNjg_726eb0bc-7209-4e07-915d-6772f580a767">79</ix:nonFraction>&#160;million on the redemptions of the 2026 Notes, including the call premium, the write-off of the unamortized premium and debt issuance costs, and expenses related to the redemptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indentures governing the senior notes listed in the table above contain restrictive covenants of Centene Corporation. At December&#160;31, 2022, the Company was in compliance with all covenants.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Swap</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to manage the foreign exchange risk associated with an intercompany note receivable related to the Circle Health acquisition, the Company entered into a foreign currency swap agreement for a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i628d01f64b184de1b7b5efff1732a9d8_I20210731" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzM3Njc_4eb990c0-7bf5-4b9d-a901-fb53979a0987">705</ix:nonFraction>&#160;million, to purchase &#163;<ix:nonFraction unitRef="gbp" contextRef="ie7b1ceee886645d6a8088bd5d3047f69_D20210701-20210731" decimals="-6" name="us-gaap:PaymentsForHedgeInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzM3ODM_1dde2514-b86d-4cb8-8c12-c1b07d4ca442">509</ix:nonFraction>&#160;million. The swap agreement was formally designated and qualified as a fair value hedge. All gains and losses due to changes in the fair value of the foreign currency swap completely offset changes in the remeasurement of the intercompany note receivable within investment and other income in the Consolidated Statement of Operations, resulting in no net impact to the Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the swap agreement as of December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i9533de2ead4446adb1c44eb2cb595111_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzQyMzY_0c1a5381-97f0-4da3-887d-b4933b42c181">15</ix:nonFraction>&#160;million, which was recorded in other current assets in the Consolidated Balance Sheet. The offsetting changes in fair value of the foreign currency swap and the remeasurement on the underlying intercompany note receivable were both recognized in investment and other income in the Consolidated Statements of Operations. The Company does not hold or issue any derivative instruments for trading or speculative purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2022, the foreign currency swap settled in connection with its expiration, and the Company received cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i512923a399a94c85a9f81f1c02440f82_D20220331-20220331" decimals="-6" name="us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzQ3Nzg_a081fc3e-0513-458f-bc97-89d89bedafbb">35</ix:nonFraction> million. The Company does not hold or issue any derivative instruments for trading or speculative purposes.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i07bdc80a3094499c8f1021386fda8b00" continuedAt="ia52dc43587c544d5929b3ce2a4dd8ab6"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Circle Health Debt Refinancing</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company refinanced certain debt agreements for its Circle Health subsidiary with a new &#163;<ix:nonFraction unitRef="gbp" contextRef="iaf8926fc8ce441d596b2ad6011782776_I20221231" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzUwMTg_53eb8f53-f60a-4a94-afec-9895f4306aa4">250</ix:nonFraction> million credit facility maturing in May 2025. The Company recognized a $<ix:nonFraction unitRef="usd" contextRef="i300c0cc925174961aa324cbb7cf6b0ad_D20220501-20220531" decimals="-6" name="cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzUwODQ_a55c04dd-ab48-406b-9d48-3821189d8b20">13</ix:nonFraction> million pre-tax gain on the extinguishment of the existing debt. As of December&#160;31, 2022, &#163;<ix:nonFraction unitRef="gbp" contextRef="iaf8926fc8ce441d596b2ad6011782776_I20221231" decimals="-6" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzUxNTQ_c86eef19-5d1f-4076-aa22-d9505a011309">160</ix:nonFraction>&#160;million was drawn on the facility, which is included within Finance leases and other in the table above. The new facility is guaranteed by the Company and has similar borrowing rates and covenants to the Company's Revolving Credit Agreement, except it uses the SONIA as the reference rate for the interest rate payable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revolving Credit Facility and Term Loan Credit Facility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company amended and restated its existing credit agreement to, among other things, (i) extend the various maturities under the existing Credit Agreement until 2026, (ii) increase the aggregate principal amount of the U.S. dollar unsecured term loan facility under the existing Credit Agreement from $<ix:nonFraction unitRef="usd" contextRef="i7421b87407a64ef3a02518501627c5ff_I20210731" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4MzY_1a7892c7-7226-4bb3-bdac-1e4cb11c7e9a">1,450</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="id87680544d5e40f493d0ad0a03ad37db_I20210831" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4NDE_3d2f3245-60be-474d-a8f4-1d102210907a">2,200</ix:nonFraction> million, (iii) increase the maximum total net leverage ratio permitted under the total debt to EBITDA financial covenant from <ix:nonFraction unitRef="number" contextRef="iec2cac8396b94542a2646f54a9d68328_D20210701-20210731" decimals="INF" name="cnc:DebtInstrumentCovenantNetLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4NDY_f09ff0a6-b014-454d-9805-d1a3654e6cfc">3.5</ix:nonFraction> to 1.0 to <ix:nonFraction unitRef="number" contextRef="i2a40221e9a2a4afc802c9416ad92a8cf_D20210801-20210831" decimals="INF" name="cnc:DebtInstrumentCovenantNetLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4NTA_5380737d-93c7-4645-a36b-45094046993c">4.0</ix:nonFraction> to 1.0, (iv) reduce the applicable margin with respect to borrowings to between <ix:nonFraction unitRef="number" contextRef="i6b51f86196b74c5d81b9dbbe890e9cd5_D20210801-20210831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc5MTc_11b13112-a962-44e7-afad-e67cba81a5a2">1.50</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i68f6f5e3a4564d01bf741fa247876509_D20210801-20210831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc5MjI_510d66d7-2cba-4d0a-9154-f70ac0135ca2">1.125</ix:nonFraction>%, based on the total debt to EBITDA ratio and type of borrowing and (v) include scheduled amortization payments with respect to the term loan facility equal to <ix:nonFraction unitRef="number" contextRef="icaf48712843846db970ca72f1062bb57_I20210831" decimals="INF" name="cnc:DebtInstrumentAmortizationPaymentRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4NTQ_61174a85-1aa0-437c-9922-9eb47e21a533">0</ix:nonFraction>% for the first year following closing, <ix:nonFraction unitRef="number" contextRef="i0ced5abd56064636b901e0fb233dc37e_I20210831" decimals="INF" name="cnc:DebtInstrumentAmortizationPaymentRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4NTg_8a216d9d-81bc-4a6f-a4cd-a949d3c6459b">2.5</ix:nonFraction>% for the second year following closing and <ix:nonFraction unitRef="number" contextRef="i09c848e42b694dbdb1f15b4c4e6aa8d2_I20210831" decimals="INF" name="cnc:DebtInstrumentAmortizationPaymentRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4NjM_f1a80393-2eaa-4a2c-8edf-3ddb0c2f1ab3">5</ix:nonFraction>% thereafter until maturity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has (i) unsecured $<ix:nonFraction unitRef="usd" contextRef="i86309d5b4d1e4ad9b29778c622cf58d4_I20221231" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4Njc_1f291d17-5c42-4836-9a12-57f87a5fb621">2,000</ix:nonFraction> million multi-currency revolving credit facility (the Revolving Credit Facility), which includes a $<ix:nonFraction unitRef="usd" contextRef="i177a913a1fb447848f07559f4f84f998_I20221231" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4NzI_9f7bb082-11ef-453c-aa56-ded64ffa9e4a">300</ix:nonFraction> million sub-limit for letters of credit and a $<ix:nonFraction unitRef="usd" contextRef="i9b3d244dd3854164a91cb86ed9b12891_I20221231" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4Nzc_c287a5b8-a260-4358-b98b-15500b86e2e1">200</ix:nonFraction> million sub-limit for swingline loans and (ii) a $<ix:nonFraction unitRef="usd" contextRef="i07f12668f2cd4f52a84d59666eb6d3ce_I20221231" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4ODI_810d1d72-32da-4b82-b91d-f47ee93fb05b">2,200</ix:nonFraction> million unsecured delayed-draw term loan facility (the Term Loan Facility, and, together with the Revolving Credit Facility, the Company Credit Facility). Borrowings under the Revolving Credit Facility bear interest, at the Company's option, at LIBOR, EURIBOR, CDOR, BBR, or base rates plus, in each case, an applicable margin between <ix:nonFraction unitRef="number" contextRef="i6086520b355b4f8cbc019750e6f19c0d_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzU0OTc1NTgyNDEzNg_dd591db3-7872-4009-a081-4352ad01845b">1.50</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ieb5e31256d79442d9db9f7a1fd150824_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzU0OTc1NTgyNDE0MQ_47dff6a1-8770-43ab-a822-9ffe9c21fd67">1.125</ix:nonFraction>%, based on the total debt to EBITDA ratio and type of borrowing. Borrowings under the Term Loan Facility bear interest, at the Company's option, at LIBOR or base rates plus, in each case, an applicable margin based on the total debt to EBITDA ratio. The Company has an uncommitted option to increase its Company Credit Facility by an additional $<ix:nonFraction unitRef="usd" contextRef="i86309d5b4d1e4ad9b29778c622cf58d4_I20221231" decimals="-6" name="cnc:LineofCreditFacilityAccordionFeatureIncreaseLimit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4OTU_1f491cef-41e1-4c5f-8b04-3301b779e09d">500</ix:nonFraction> million plus certain additional amounts based on its total debt to EBITDA ratio. The Company believes that the credit agreement will allow SOFR to be used as the new reference rate upon LIBOR's discontinuance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company Credit Facility contains financial covenants including maintenance of a minimum fixed charge coverage ratio and a restriction on the Company's maximum total debt to EBITDA ratio not to exceed <ix:nonFraction unitRef="number" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="INF" name="cnc:LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc5MDA_91d68d8b-4adb-43af-bf2b-d9f4945004ac">4.0</ix:nonFraction> to 1.0. It also contains certain non-financial covenants including: limitations on incurrence of additional indebtedness; restrictions on incurrence of liens; restrictions on dividends and other restricted payments; restrictions on investments, mergers, consolidations, and asset sales; and limitations on transactions with affiliates. As of December&#160;31, 2022, the Company was in compliance with all financial and non-financial covenants under the Company Credit Facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="i86309d5b4d1e4ad9b29778c622cf58d4_I20221231" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzc5MzE_51f1b6c0-f5e5-4103-b308-16ed907d9c3a">58</ix:nonFraction> million of borrowings outstanding under the Revolving Credit Facility, with a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="i86309d5b4d1e4ad9b29778c622cf58d4_I20221231" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzgwMzg_0a517624-c96e-460e-883f-e0965923d42c">4.80</ix:nonFraction>%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility and the Term Loan Facility will mature on August&#160;16, 2026.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Construction Loan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, the Company executed a $<ix:nonFraction unitRef="usd" contextRef="ib9edeffc055d4939acb82ad908f07cbe_I20171031" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzgxNzk_5e68a29a-5549-4997-b9dd-afb12a53760e">200</ix:nonFraction> million non-recourse construction loan to fund the expansion of the Company's corporate headquarters. Until final completion of the project, which occurred in July 2021, the loan bore interest based on the one month LIBOR plus <ix:nonFraction unitRef="number" contextRef="i7a8103ddaf8e4f1baaddc98a488f091f_D20171001-20171031" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzg0MDE_77b2cc20-ba9a-427a-8c22-89ccbd94c154">2.70</ix:nonFraction>%, which reduced to LIBOR plus <ix:nonFraction unitRef="number" contextRef="i1aefa7ec1d0042b6a41fc0a03595d12d_D20210701-20210731" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzg0MzM_69194960-030d-46b7-989d-3e5abd47b83f">2.00</ix:nonFraction>%&#160;at the time construction completed. The agreement contains financial and non-financial covenants similar to those contained in the Company Credit Facility. The Company guaranteed completion of the construction project associated with the loan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, the Company extended the term of the loan for an additional <ix:nonNumeric contextRef="i96f3204307ae4fdfb13dc11441d5072d_D20220401-20220430" name="cnc:DebtInstrumentExtensionTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzg4ODc_cf566631-4289-443e-b0f6-e5d524fbac3e">one year</ix:nonNumeric>. The extension reduced interest on the loan to SOFR plus <ix:nonFraction unitRef="number" contextRef="i1e6dc3e560e84de0a5d2f02722587893_D20220401-20220430" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzg5NDc_f87d008e-c820-4b2d-b336-a47f53a37776">1.85</ix:nonFraction>% and matures in April 2023. In December 2022, the Company paid off the outstanding balance of the construction loan.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="ia52dc43587c544d5929b3ce2a4dd8ab6"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Note Debt Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company's Board of Directors authorized a new $<ix:nonFraction unitRef="usd" contextRef="i04652939d67241d39001577da981b842_I20220630" decimals="-6" name="cnc:DebtRepurchaseProgramAuthorizedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzkwNjA_3ab872bd-8a0b-4e41-8939-ea03e6079b1c">1,000</ix:nonFraction> million senior note debt repurchase program in preparation for future debt reductions as part of the Company's strategic value creation initiatives. During the year ended December 31, 2022, the Company repurchased $<ix:nonFraction unitRef="usd" contextRef="i7ca911cb3026492eb537e47263364487_I20221231" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzkyMzE_8cc8a1d2-ac29-47a8-ab46-ec38b3f5e9b8">318</ix:nonFraction> million of its par value senior notes, as described above, for $<ix:nonFraction unitRef="usd" contextRef="i15f1c30fc6e14d85b699a2ed36b96775_D20220101-20221231" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzkyODk_dbbf28de-0daf-4259-b46c-f7074d62c75e">300</ix:nonFraction> million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzkzMTQ_6f9773db-ad0b-4b43-ad7c-23dabebeca6d">700</ix:nonFraction> million available under the senior note debt repurchase program.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit &amp; Surety Bonds</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i68ee5cfa5b3041a9aa1e9d4f1e223aa1_I20221231" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzk1Mjg_574b4fa6-e75b-4a4f-b2db-c25debe9d51d">217</ix:nonFraction> million as of December&#160;31, 2022, which were not part of the Revolving Credit Facility.&#160;The letters of credit bore interest at <ix:nonFraction unitRef="number" contextRef="i68ee5cfa5b3041a9aa1e9d4f1e223aa1_I20221231" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzk2MzQ_68311675-3eff-4ca1-a8ba-4e1372794fa6">0.6</ix:nonFraction>% as of December&#160;31, 2022. The Company had outstanding surety bonds of $<ix:nonFraction unitRef="usd" contextRef="i0b502a06d63b40bebe5407d59dadc678_I20221231" decimals="-6" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzk2OTE_d317327c-4618-4da2-9894-694240e0588a">1,292</ix:nonFraction> million as of December&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzk4OTQ_61644d20-c8e6-4b82-b55f-a9edc963c0ae" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate maturities for the Company's debt for the years ending December 31, are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"></td><td style="width:67.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.266%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Maturities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZTo4MGZjZjEzMDY3YWU0ODEzOTk5YjczYzBkNTEwYmQ2NS90YWJsZXJhbmdlOjgwZmNmMTMwNjdhZTQ4MTM5OTliNzNjMGQ1MTBiZDY1XzAtMi0xLTEtMzU0MDE4_1e1d9cb5-c6f3-4368-82b5-78be61308ab0">82</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZTo4MGZjZjEzMDY3YWU0ODEzOTk5YjczYzBkNTEwYmQ2NS90YWJsZXJhbmdlOjgwZmNmMTMwNjdhZTQ4MTM5OTliNzNjMGQ1MTBiZDY1XzEtMi0xLTEtMzU0MDE4_2b9c5c19-7f66-412f-91de-9832188abded">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZTo4MGZjZjEzMDY3YWU0ODEzOTk5YjczYzBkNTEwYmQ2NS90YWJsZXJhbmdlOjgwZmNmMTMwNjdhZTQ4MTM5OTliNzNjMGQ1MTBiZDY1XzItMi0xLTEtMzU0MDE4_dd1912c9-6578-4eed-ae3c-d37584a3a9ac">313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZTo4MGZjZjEzMDY3YWU0ODEzOTk5YjczYzBkNTEwYmQ2NS90YWJsZXJhbmdlOjgwZmNmMTMwNjdhZTQ4MTM5OTliNzNjMGQ1MTBiZDY1XzMtMi0xLTEtMzU0MDE4_4236b0fe-be9e-4fe7-8c06-c2a5d15033cc">1,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZTo4MGZjZjEzMDY3YWU0ODEzOTk5YjczYzBkNTEwYmQ2NS90YWJsZXJhbmdlOjgwZmNmMTMwNjdhZTQ4MTM5OTliNzNjMGQ1MTBiZDY1XzQtMi0xLTEtMzU0MDE4_4e36f807-3a50-4b02-9d15-82124a121c57">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZTo4MGZjZjEzMDY3YWU0ODEzOTk5YjczYzBkNTEwYmQ2NS90YWJsZXJhbmdlOjgwZmNmMTMwNjdhZTQ4MTM5OTliNzNjMGQ1MTBiZDY1XzUtMi0xLTEtMzU0MDE4_ee9fa6e9-cc3d-4bdf-9bd9-eea67ad7e85f">13,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZTo4MGZjZjEzMDY3YWU0ODEzOTk5YjczYzBkNTEwYmQ2NS90YWJsZXJhbmdlOjgwZmNmMTMwNjdhZTQ4MTM5OTliNzNjMGQ1MTBiZDY1XzYtMi0xLTEtMzU0MDE4_c38a3b61-5aeb-4bff-bdd8-a3a2379b8fa2">18,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of outstanding debt was approximately $<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc5MjY_66ede9c7-bf5c-4644-8078-9f01134fca6e">15,791</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc5MzE_3f908b96-0e7b-477d-8ad6-85e554fe976f">19,256</ix:nonFraction> million at December 31, 2022 and 2021, respectively.</span></div></ix:continuation><div id="i9dee570cfbd043d6a1700298c14b2446_133"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzI4ODA_a468222b-11c4-4d20-8881-99c7928bf770" continuedAt="idbb433c66aa340f5a19c37f75969f98b" escape="true">Leases</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="idbb433c66aa340f5a19c37f75969f98b" continuedAt="i02061b596aed4f529b3fd3ddccf5fc8e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records ROU assets and lease liabilities for non-cancelable operating leases primarily for real estate and equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet. Expense related to leases is recorded on a straight-line basis over the lease term, including rent holidays. The Company recognized operating lease expense of $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzM4NA_169109b9-9d71-4378-9a27-513dad95fcfd">429</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzM5MQ_ac09f9e5-c10d-4844-a97b-92ffad91c9a1">390</ix:nonFraction>&#160;million during the years ended December 31, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers the existence of options to extend or terminate leases in its analysis of the lease term for the purposes of measuring its ROU assets and lease liabilities. The renewal options are not included in the measurement of the ROU assets and lease liabilities unless the Company is reasonably certain to exercise the optional renewal periods.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzI4ODc_a8a762ad-2a51-4558-98a8-95e45748f28e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the ROU assets and lease liabilities ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:70.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets (recorded within other long-term assets)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMS0xLTEtMzU0MDE4_199e3251-c3e9-421e-aaf9-eda971b806fd"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMS0xLTEtMzU0MDE4_31b01a93-63b2-42a7-b255-f63bcda90095">2,554</ix:nonFraction></span>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMy0xLTEtMzU0MDE4_25d5eafe-3f10-47e5-a022-23bca263c61e"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMy0xLTEtMzU0MDE4_71aa30b6-3897-4664-aa63-818c8312aeaa">3,566</ix:nonFraction></span>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term (recorded within accounts payable and accrued expenses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMS0xLTEtMzU0MDE4_53c5f53c-16be-4589-801c-7882d412dd63"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMS0xLTEtMzU0MDE4_b3e6e229-f943-4c27-9e9b-bccf4bf71782">180</ix:nonFraction></span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMy0xLTEtMzU0MDE4_ca13f2de-0327-4128-b4b7-a1cf2eacc73a"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMy0xLTEtMzU0MDE4_2fce69ad-63d0-4431-a5dd-11e87b3b649d">204</ix:nonFraction></span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term (recorded within other long-term liabilities)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMS0xLTEtMzU0MDE4_f7d03d1c-fd2a-4fb1-b8d2-c6a9e69f4553"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMS0xLTEtMzU0MDE4_dab10104-cd44-418e-9a11-6e263e3a80d5">3,133</ix:nonFraction></span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMy0xLTEtMzU0MDE4_83602f08-9569-4028-8eb3-50c7d80f55b9"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMy0xLTEtMzU0MDE4_ab207255-0e9c-4af8-ab9a-28a7a6f7b0fe">3,619</ix:nonFraction></span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzgtMS0xLTEtMzU0MDE4_e16bc598-df39-462b-9af0-b0db225e7887">3,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzgtMy0xLTEtMzU0MDE4_a7c8ef64-b7f4-4fb4-b285-5ea9616b486a">3,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i02061b596aed4f529b3fd3ddccf5fc8e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities, recorded as operating cash flows in the Consolidated Statements of Cash Flows, was $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzEwNDU_2515f0d4-87af-44b3-99f5-00b10ea06904">440</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzEwNTI_ab720119-48ec-4f95-a4a1-bc7b5d9e7e7f">385</ix:nonFraction>&#160;million during the years ended December 31, 2022 and 2021, respectively. New operating leases commenced resulting in the recognition of ROU assets and lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="cnc:LesseeOperatingLeaseLeasesCommencedLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzExODM_a5a40299-aa3c-44ed-8508-f63632f3c2ba"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzExODM_ce78ba41-bb72-4e9f-8e47-e9347daeae1f">60</ix:nonFraction></ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzExOTA_a645593b-60a2-45bd-aa53-7b381a303edf"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="cnc:LesseeOperatingLeaseLeasesCommencedLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzExOTA_d2fb3237-f185-47ac-b2f8-01b26dd88081">177</ix:nonFraction></ix:nonFraction>&#160;million during the years ended December 31, 2022 and 2021, respectively. In connection with the acquisition of Magellan in January 2022, the Company acquired $<ix:nonFraction unitRef="usd" contextRef="i474329559a594a6db005b911431a9b0d_I20220131" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzM4NDgyOTA3MDA5NDQ_73bb1ea2-c19e-4f75-84ce-ce6965aeb180"><ix:nonFraction unitRef="usd" contextRef="i474329559a594a6db005b911431a9b0d_I20220131" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzM4NDgyOTA3MDA5NDQ_bdec1e70-5bfe-4215-bc5a-f13c524479b3">30</ix:nonFraction></ix:nonFraction> million of ROU assets and lease liabilities. As of December&#160;31, 2022, the Company had additional operating leases that have not yet commenced of $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="cnc:LesseeOperatingLeaseLeaseNotYetCommencedLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzE1MDU_87c03c18-697a-4a78-b09a-57b28f254a2c">8</ix:nonFraction> million. These operating leases will commence in 2023 with lease terms ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzE1ODI_9a1af50d-4299-45b3-b023-ef6bb807076b">one</span> to <ix:nonNumeric contextRef="i2972405604564d108b785acc0e0173ac_I20221231" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzU0OTc1NTgxNzcwOQ_2f74d039-b261-48a3-90b1-ab22d3beacc6">eight years</ix:nonNumeric>.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the real estate optimization initiative as described in Note 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Property, Software and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company vacated and abandoned various domestic leased properties. As a result, the Company assessed the ROU assets for impairment. The Company engaged a third-party real estate specialist to determine the recoverability of the leased properties. The valuation primarily considered comparable leased properties in each market and the assessment of potential future rental income that could be generated by the ROU assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the optimization, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzIxNTY_c094cd7a-822b-49a4-afe7-59eb97703a64">577</ix:nonFraction> million of ROU asset impairments in the year ended December 31, 2022, primarily related to the Managed Care segment. The remainder of the $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:OtherAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzIyNjM_ad7f4024-c9b7-4483-8d4e-50e5a081db52">1,627</ix:nonFraction> million charge was recorded within Property, Software and Equipment, refer to Note 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Property, Software and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term of the Company's operating leases was <ix:nonNumeric contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzI2NTA_b2f61139-749c-48fb-bc0a-eea98e865983">20.5</ix:nonNumeric></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and <ix:nonNumeric contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzI2NTc_b363d31e-9992-46cd-8667-949032102288">21.1</ix:nonNumeric> years as of December 31, 2022 and 2021, respectively. The lease liabilities reflect a weighted average discount rate of <ix:nonFraction unitRef="number" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzI3NTY_28d2001b-9ce7-4cfb-87bd-5de1666da67f">5.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzI3NjM_2781eb3a-e018-47ab-ac45-8aeaa061ece2">5.7</ix:nonFraction>% as of December 31, 2022 and 2021, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzI4ODQ_0e7d68af-bcdd-4207-9ae6-541556c4c278" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease payments over the next five years and thereafter are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"></td><td style="width:67.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.266%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Payments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzItMS0xLTEtMzU0MDE4_e578d17a-abc0-4735-9043-dc1c07f39d32">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzMtMS0xLTEtMzU0MDE4_db6e4a29-8c66-4e63-b18d-eb7e058a0dfc">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzQtMS0xLTEtMzU0MDE4_169333ce-5f19-407c-80a1-b43f75b67882">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzUtMS0xLTEtMzU0MDE4_34b039db-1c82-498e-9aed-919de501ca57">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzYtMS0xLTEtMzU0MDE4_759e5571-dd37-4878-b95e-a1b8d4d7e8d9">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzctMS0xLTEtMzU0MDE4_9435411d-37e6-4d96-82d8-6f28533bc21c">4,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzgtMS0xLTEtMzU0MDE4_73088d55-717f-428d-8163-3580b419808a">6,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzktMS0xLTEtMzU0MDE4_a5b19039-88c1-46f6-be46-58450a47f703">2,927</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzEwLTEtMS0xLTM1NDAxOA_77df39f0-556a-4ae6-b64e-9e2a4cc033dc">3,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i9dee570cfbd043d6a1700298c14b2446_136"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzM1NDY_e976d6ab-3d52-459a-a8e2-d27013083981" continuedAt="i5e1cb35bdfd343a6b8bdb3d4e2867e9d" escape="true">Stockholders' Equity</ix:nonNumeric></span></div><ix:continuation id="i5e1cb35bdfd343a6b8bdb3d4e2867e9d" continuedAt="i699e7021180d4019ac529af603295455"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Board of Directors has authorized a stock repurchase program of the Company's common stock from time to time on the open market or through privately negotiated transactions. In 2022, in preparation for the closing of divestitures as well as planning for the future, the Company's Board of Directors authorized increases under the program including $<ix:nonFraction unitRef="usd" contextRef="icd22c4115d4947d6878c9e6781a372d1_D20220601-20220630" decimals="-6" name="cnc:StockRepurchaseProgramIncreaseAuthorizedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzEwMzg_be03d111-68b1-4ee0-a027-d40951662d23">3,000</ix:nonFraction> million in June 2022 and an additional $<ix:nonFraction unitRef="usd" contextRef="i7b616f4f2341472dbd385786d0a01c38_D20221201-20221231" decimals="-6" name="cnc:StockRepurchaseProgramIncreaseAuthorizedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzc2OTY1ODE0MDUyOTM_3612a3ea-be42-4963-a7e8-bf79ce8fb0ed">2,000</ix:nonFraction> million in December 2022. With these increases, the Company is authorized to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzc2OTY1ODE0MDUzNTE_1ece062c-79ab-4474-bd5f-2e267bdf9989">6,000</ix:nonFraction> million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company entered into an accelerated share repurchase (ASR) agreement with Bank of America to purchase $<ix:nonFraction unitRef="usd" contextRef="ief504e0f21434c29b6eea0887f48d0e5_D20220701-20220930" decimals="-6" name="cnc:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzEzODA_73900b91-3fb1-4f63-b770-d9a7214d0a95">1,000</ix:nonFraction> million of the Company's common stock in aggregate under the Company's stock repurchase program. In July 2022, <ix:nonFraction unitRef="shares" contextRef="i29cb5a3f49f1494e8f6826eff1bd9010_D20220701-20220731" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzE0Nzk_bd822d3c-de2f-4c62-b55f-a00b979676eb">8.6</ix:nonFraction> million shares were delivered to the Company, representing <ix:nonFraction unitRef="number" contextRef="i29cb5a3f49f1494e8f6826eff1bd9010_D20220701-20220731" decimals="2" name="cnc:TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzE1MzM_51299f5c-5d6c-44b6-8ebd-06038feb25f2">80</ix:nonFraction>% of the notional amount under the ASR. In October 2022, an additional <ix:nonFraction unitRef="shares" contextRef="ia6584fae5af246acaeeca245d13601b3_D20221001-20221031" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzE2MDU_9d27d4bc-11d8-435a-ba62-73c4cd74cb52">3.0</ix:nonFraction> million shares were delivered upon settlement of the ASR based upon the volume-weighted average price (VWAP) over the term of the agreement, less a discount, of $<ix:nonFraction unitRef="usdPerShare" contextRef="ide855c65da574e12a7000a0c1c5d15dd_D20221001-20221031" decimals="2" name="cnc:AcceleratedShareRepurchasesDiscountPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzU0OTc1NTgzNTEwMA_b8abb12c-ebce-42c5-afbf-f97d6480cbd2">86.21</ix:nonFraction>. In total, <ix:nonFraction unitRef="shares" contextRef="i798439eca4864894a14ab00bbc412860_D20220701-20221031" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzE3Njg_0694c1f7-8cc4-4466-81c9-590efe0c1829">11.6</ix:nonFraction> million shares were purchased through the $<ix:nonFraction unitRef="usd" contextRef="ief504e0f21434c29b6eea0887f48d0e5_D20220701-20220930" decimals="-6" name="cnc:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzE4MDU_73900b91-3fb1-4f63-b770-d9a7214d0a95">1,000</ix:nonFraction> million ASR. In addition, the Company purchased additional shares throughout the year through open market repurchases, including repurchase plans designed to comply with Rule 10b5-1.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i699e7021180d4019ac529af603295455" continuedAt="i8323632379704111a571ee5a0fc139e5"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share repurchases in 2022, 2021, and 2020 were primarily funded through divestiture proceeds. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzQ5NDc4MDIzNDU1ODI_fa2ee556-a95f-4649-8615-e22fc2ea5d1c" continuedAt="i9d363e36fe904e47a0f4b7bb2d0ffdf8" escape="true">The following represents the Company's share repurchase activity ($ in millions, shares in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i9d363e36fe904e47a0f4b7bb2d0ffdf8"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.429%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share buybacks</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b5a6df0e62840ec938274ece6e23cb2_D20220101-20221231" decimals="-3" name="cnc:TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzItMC0xLTEtNDE1ODYx_814f7968-3e48-429e-8e31-9f0d8a7fff64">35,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5a6df0e62840ec938274ece6e23cb2_D20220101-20221231" decimals="-6" name="cnc:TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzItMS0xLTEtNDE1ODIy_4ef7cda5-80c4-4a44-89e2-d7d403e04479">2,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2cf082093f37453aa852faade614d285_D20210101-20211231" decimals="-3" name="cnc:TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzItMy0xLTEtNDE1ODc1_62ef6e79-ef7f-44ac-9342-dd9b2afffef4">2,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf082093f37453aa852faade614d285_D20210101-20211231" decimals="-6" name="cnc:TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzItMy0xLTEtNDE1ODIy_0458d6c8-94d2-47fc-9b99-0d119e2304c5">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bc71fec53d748409f78d934b69f1f56_D20200101-20201231" decimals="-3" name="cnc:TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzItNS0xLTEtNDE1ODIy_d91da177-ec14-460c-9971-28a327ee495d">8,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc71fec53d748409f78d934b69f1f56_D20200101-20201231" decimals="-6" name="cnc:TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzItOC0xLTEtNDU4NjUx_91fde2bc-cc24-4968-ba85-3183d1a47d94">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax withholding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8a8cf81a11c41a893d0995455479cd6_D20220101-20221231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzMtMS0xLTEtNDE5MTQy_ca7faa7c-6e44-40fc-97c6-1107062449db">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8a8cf81a11c41a893d0995455479cd6_D20220101-20221231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzMtMi0xLTEtNDE5MTUw_5733b9ed-aba2-4668-8b45-70231ea937aa">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic9f4a1f99a204f11946360404ec006fb_D20210101-20211231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzMtNC0xLTEtNDE2MDA4_0c924332-396e-4ea3-ae05-3623429d74ae">1,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9f4a1f99a204f11946360404ec006fb_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzMtNS0xLTEtNDE2MTE3_88d680d9-7022-4e1a-b984-02d20384287a">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e3759b9cf8a44728c767939b67b86ae_D20200101-20201231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzMtNy0xLTEtNDE2MTI1_e9b305cf-ac0a-4bf9-8f64-4b05ed953467">2,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e3759b9cf8a44728c767939b67b86ae_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzMtOC0xLTEtNDE2MTA5_86e889ef-ade4-460b-81b6-470bde7454f9">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share repurchases</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b5a6df0e62840ec938274ece6e23cb2_D20220101-20221231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzQtMS0xLTEtNDU4NjQx_879bee59-b805-465b-877d-316799a76257">36,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5a6df0e62840ec938274ece6e23cb2_D20220101-20221231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzQtMi0xLTEtNDU4NjQx_9bee2e37-4f86-4b34-bac1-393c264a3a1f">3,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2cf082093f37453aa852faade614d285_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzQtNC0xLTEtNDU4NjQ1_205746af-4fcc-4e09-9542-352241713cea">3,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf082093f37453aa852faade614d285_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzQtNS0xLTEtNDU4NjQ1_60b72d02-1085-484d-bba2-59142ecf2b07">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bc71fec53d748409f78d934b69f1f56_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzQtNy0xLTEtNDU4NjQ4_a466e2ca-7165-42d2-bd0c-673230368e67">10,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc71fec53d748409f78d934b69f1f56_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzQtOC0xLTEtNDU4NjUx_15d11977-4d61-4f3f-b211-28807b626749">626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased for income tax withholding are shares withheld in connection with employee stock plans to meet applicable tax withholding requirements. These shares are typically included in the Company's treasury stock, except for the vesting of certain shares assumed in connection with the WellCare acquisition in 2020 and 2021, which were withheld rather than repurchased. Although these shares are not issued, they are treated as common stock repurchases as they reduce the number of shares that would have been issued upon vesting. Shares withheld were <ix:nonFraction unitRef="shares" contextRef="i5dd496b069e94c7f84fc2916ec5f8a53_D20210101-20211231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzU0OTc1NTgzNDY3MQ_45cf442f-539a-4040-a6af-9c31babc9b0d">326</ix:nonFraction>&#160;thousand shares at an aggregate cost of $<ix:nonFraction unitRef="usd" contextRef="i5dd496b069e94c7f84fc2916ec5f8a53_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzEwOTk1MTE2MzE0MTI_853982eb-215a-48c1-b532-f5bd73a5dac5">19</ix:nonFraction> million, and <ix:nonFraction unitRef="shares" contextRef="i411fcfa45e664b36954eea6f3adec1d3_D20200101-20201231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzU0OTc1NTgzNDY2Mg_836a4b07-a024-4a9c-a696-9d21ed3c4eb6">407</ix:nonFraction>&#160;thousand at an aggregate cost of $<ix:nonFraction unitRef="usd" contextRef="i411fcfa45e664b36954eea6f3adec1d3_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzc2OTY1ODE0MDk2NDQ_6d238a50-ef85-4b8b-98fe-8cf3893e8b76">24</ix:nonFraction> million, for the years ended December 31, 2021 and 2020, respectively. No shares were withheld under this method in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had a remaining amount of $<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzc2OTY1ODE0MTAyMjg_349b5243-c51c-4fed-8973-5db4a0366e94">2,806</ix:nonFraction> million available under the Company's stock repurchase program. No duration has been placed on the repurchase program. The Company reserves the right to discontinue the repurchase program at any time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shares Issued for Acquisition</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8323632379704111a571ee5a0fc139e5">In January 2020, the Company issued <ix:nonFraction unitRef="shares" contextRef="i544615d6498841d8b5bd747233c5fb23_D20200123-20200123" decimals="-6" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzU0OTc1NTgzMjcyMw_63d1dc70-507f-49e7-8ef7-02f76792e357">171</ix:nonFraction>&#160;million shares of Centene common stock with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i544615d6498841d8b5bd747233c5fb23_D20200123-20200123" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzU0OTc1NTgzMjczNg_c446dd35-5601-4ba8-8883-bf53192bef2f">11,431</ix:nonFraction>&#160;million and paid $<ix:nonFraction unitRef="usd" contextRef="i544615d6498841d8b5bd747233c5fb23_D20200123-20200123" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzU0OTc1NTgzMjgxMQ_89dcb334-90f1-401e-8f2f-ef07e087398f">6,079</ix:nonFraction>&#160;million in cash in exchange for all the outstanding shares of WellCare common stock. In addition, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i544615d6498841d8b5bd747233c5fb23_D20200123-20200123" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredOther1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzU0OTc1NTgzMjgyNw_9cfd0069-8711-42df-b296-d4ad3e4ef240">95</ix:nonFraction>&#160;million related to the fair value of replacement equity awards associated with pre-combination service.</ix:continuation> </span></div><div id="i9dee570cfbd043d6a1700298c14b2446_139"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="cnc:StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzkvZnJhZzowNGRhNjg1NWEzNTM0OTAyYjVkMDNlZTM0NDQwZDk2OC90ZXh0cmVnaW9uOjA0ZGE2ODU1YTM1MzQ5MDJiNWQwM2VlMzQ0NDBkOTY4XzU5OQ_07faf2a4-61ac-4509-8d14-12e4672f2b57" continuedAt="i2c5ad803ad254efca60b6f18d8a3f02e" escape="true">Statutory Capital Requirements and Dividend Restrictions</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:continuation id="i2c5ad803ad254efca60b6f18d8a3f02e" continuedAt="ie7f9cf84d5bd4e91a8dfc0ed9731c157">&#160;</ix:continuation></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie7f9cf84d5bd4e91a8dfc0ed9731c157">Various state laws require Centene's regulated subsidiaries to maintain minimum capital levels specified by each state and restrict the amount of dividends that may be paid without prior regulatory approval. At December 31, 2022 and 2021, Centene's subsidiaries had aggregate statutory capital and surplus of $<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzkvZnJhZzowNGRhNjg1NWEzNTM0OTAyYjVkMDNlZTM0NDQwZDk2OC90ZXh0cmVnaW9uOjA0ZGE2ODU1YTM1MzQ5MDJiNWQwM2VlMzQ0NDBkOTY4XzE2NDkyNjc0NDIyODg_0794e11b-5b4a-4dbb-b2e4-600c8d40f026">16,436</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzkvZnJhZzowNGRhNjg1NWEzNTM0OTAyYjVkMDNlZTM0NDQwZDk2OC90ZXh0cmVnaW9uOjA0ZGE2ODU1YTM1MzQ5MDJiNWQwM2VlMzQ0NDBkOTY4XzMwNg_86fcd4e1-1df1-4968-a3cc-7f1da1083fef">14,039</ix:nonFraction> million, respectively, compared with the required minimum aggregate statutory capital and surplus of $<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzkvZnJhZzowNGRhNjg1NWEzNTM0OTAyYjVkMDNlZTM0NDQwZDk2OC90ZXh0cmVnaW9uOjA0ZGE2ODU1YTM1MzQ5MDJiNWQwM2VlMzQ0NDBkOTY4XzE2NDkyNjc0NDIyNzc_217b7051-c2a4-4214-8812-77dd7f65532e">7,979</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzkvZnJhZzowNGRhNjg1NWEzNTM0OTAyYjVkMDNlZTM0NDQwZDk2OC90ZXh0cmVnaW9uOjA0ZGE2ODU1YTM1MzQ5MDJiNWQwM2VlMzQ0NDBkOTY4XzQwOQ_f1280621-dcd0-4c5a-8bb1-b8cacb128055">6,706</ix:nonFraction> million, respectively. As of December&#160;31, 2022, the amount of capital and surplus or net worth that was unavailable for the payment of dividends or return of capital to the Company was $<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzkvZnJhZzowNGRhNjg1NWEzNTM0OTAyYjVkMDNlZTM0NDQwZDk2OC90ZXh0cmVnaW9uOjA0ZGE2ODU1YTM1MzQ5MDJiNWQwM2VlMzQ0NDBkOTY4XzEwOTk1MTE2Mjg1MjY_e8d58213-e5c6-4da9-a187-bfbbe37745bd">7,979</ix:nonFraction> million in the aggregate.</ix:continuation>&#160;</span></div><div id="i9dee570cfbd043d6a1700298c14b2446_142"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzMyMDQ_ff8fdd80-97e7-40f9-84cc-6e80283671b8" continuedAt="i7379c83239824f5a9912cb87fae24a1e" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i7379c83239824f5a9912cb87fae24a1e" continuedAt="i1a178331d4994d029f20e7917e6a758a"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzMyMDc_44554983-0563-439e-97d1-e9db5cbcb111" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated income tax expense consists of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current provision</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzItMS0xLTEtMzU0MDE4_dff5119c-2d12-4767-939f-92c38708f862">1,144</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzItMy0xLTEtMzU0MDE4_6b856126-4acc-4428-abb7-b5b1c76aa034">507</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzItNS0xLTEtMzU0MDE4_3f2c7e2b-25a9-46f0-b109-2f80ff2459ea">959</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzMtMS0xLTEtMzU0MDE4_bbf39fa4-b1ea-4995-96fd-911fc99b031a">261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzMtMy0xLTEtMzU0MDE4_092b87fd-dcd0-449d-973e-9a945f49f9d2">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzMtNS0xLTEtMzU0MDE4_9df79cf8-d0f8-4a28-a4ee-9ff9cda94641">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzQtMS0xLTEtMzU0MDE4_4537055a-3d6c-46b3-a9ed-82b3d3d29f0a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzQtMy0xLTEtMzU0MDE4_c580241c-5c07-4cff-a7ad-6986a4dfeebd">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzQtNS0xLTEtMzU0MDE4_9d490541-a92d-4470-a374-fbc62e25837f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzUtMS0xLTEtMzU0MDE4_29972638-d8f7-4f18-9fb3-f5fa56e13acd">1,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzUtMy0xLTEtMzU0MDE4_64a4569e-42b6-413d-9436-ed9c094c723e">628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzUtNS0xLTEtMzU0MDE4_f0e62f4a-b256-4371-9f25-287c9567d233">1,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredOtherTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzYtMS0xLTEtMzU0MDE4_ef84e7af-c138-4a3e-8686-88b24609700c">649</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredOtherTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzYtMy0xLTEtMzU0MDE4_d1554389-1f63-48a8-92f6-d9b7f339ae94">151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredOtherTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzYtNS0xLTEtMzU0MDE4_f249e89f-71f5-4c32-b862-5021ad16f338">136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzctMS0xLTEtMzU0MDE4_d07ab67e-899f-4bec-8268-c354b34b686a">760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzctMy0xLTEtMzU0MDE4_8cba08bf-096b-4404-a9eb-8ea2a2550f71">477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzctNS0xLTEtMzU0MDE4_f3fae0fb-c6ba-4be8-a4f0-a9f2a4ea62eb">979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i1a178331d4994d029f20e7917e6a758a" continuedAt="i39d5c51eedc5484ea5483b7de962595a"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzMxOTc_321cc3f5-899c-40fd-8784-8992f0add984" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the tax provision at the U.S. federal statutory rate to income tax expense is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income tax expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEtMS0xLTEtMzU0MDE4_e90ac4ad-654a-4de0-b347-4a2ef02a7964">1,962</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEtMy0xLTEtMzU0MDE4_a547819b-1aad-421e-8275-535369c2f8db">1,813</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEtNS0xLTEtMzU0MDE4_b24362dc-2dde-4ae6-85e0-64d22927709e">2,773</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (earnings) attributable to flow through noncontrolling interest </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="cnc:LossEarningsAttributableToFlowThroughNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzItMS0xLTEtMzU0MDE4_ee47bcdf-f4ef-4b91-ae8b-29bb0d85d032">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="cnc:LossEarningsAttributableToFlowThroughNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzItMy0xLTEtMzU0MDE4_117668f6-657b-42e3-a4d9-c5ea9316ae9f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="cnc:LossEarningsAttributableToFlowThroughNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzItNS0xLTEtMzU0MDE4_daabe39b-63d8-4b4a-ba7c-9857e77a1335">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings less noncontrolling interest before income tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="cnc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzMtMS0xLTEtMzU0MDE4_b40ab06f-b5c1-438c-bf79-d391bebe55be">1,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="cnc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzMtMy0xLTEtMzU0MDE4_70f68aef-1ecd-4960-8f59-124500745244">1,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="cnc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzMtNS0xLTEtMzU0MDE4_3395eac4-d356-4011-b9c1-2c90bbd5f78a">2,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at the U.S. federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzUtMS0xLTEtMzU0MDE4_81404979-e2d9-4d2c-bcbb-84c2e7b091e5">411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzUtMy0xLTEtMzU0MDE4_1c7ca898-a562-4318-b826-cda1187b19ed">381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzUtNS0xLTEtMzU0MDE4_a084ab24-4d55-49f7-bacf-04602f35bff5">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzYtMS0xLTEtMzU0MDE4_36326f99-3d6b-4613-a76f-ac179aee6eaf">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzYtMy0xLTEtMzU0MDE4_2cceb63f-2ea1-48d0-a8e0-afbea7345e3d">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzYtNS0xLTEtMzU0MDE4_81464548-576f-4bac-b38e-e31ce9bc43fb">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzctMS0xLTEtMzU0MDE4_e98ad38c-a818-4b96-86e3-cf505c8fb9b8">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzctMy0xLTEtMzU0MDE4_b870e3f8-eb4f-40b3-9142-6e1732a0e087">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzctNS0xLTEtMzU0MDE4_930b9d61-f02e-4659-b1bc-620e69d0376a">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible PBM legal settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="cnc:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzgtMS0xLTEtMzU0MDE4_5371329f-c580-481a-ba06-44d5dc8770b0">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="cnc:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzgtMy0xLTEtMzU0MDE4_b1ef5801-44a3-4460-92a4-e35b9154839a">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="cnc:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzgtNS0xLTEtMzU0MDE4_e00de318-5fd0-4734-931b-1165055110d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nontaxable divestiture (gains) losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzktMS0xLTEtMzU0MDE4_28a03aad-dbd6-4f3a-9833-be64f7fc749a">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzktMy0xLTEtMzU0MDE4_dab8a6c9-0ed7-40ab-b4e2-c854f3db871e">95</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzktNS0xLTEtMzU0MDE4_337e3a29-817d-4489-8238-7565d2d420e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes for investments in subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="cnc:EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEwLTEtMS0xLTQ1NjY4Ng_5729b3bb-febe-4720-949f-18838a6a6472">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="cnc:EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEwLTMtMS0xLTQ1NjY4Ng_9122ad7e-13c2-43d9-969f-96e320f0a2c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="cnc:EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEwLTUtMS0xLTQ1NjY4Ng_8c68f43e-1908-423c-998b-7d933cffea49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACA health insurer fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="cnc:ACAHealthInsurerFee" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEwLTEtMS0xLTM1NDAxOA_2212d813-dd6e-4b4e-8d99-56bd51b1b05e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="cnc:ACAHealthInsurerFee" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEwLTMtMS0xLTM1NDAxOA_0a46910e-a5ab-4afb-b4a9-00eee95dd3dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="cnc:ACAHealthInsurerFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEwLTUtMS0xLTM1NDAxOA_d1963700-8b40-4e6b-8d2d-8b1e8b552a1c">316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzExLTEtMS0xLTM1NDAxOA_e3f9d140-f642-4e28-b723-d6b52a7cceb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzExLTMtMS0xLTM1NDAxOA_41e6b045-6507-4187-b399-4d4b4a503e31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationTaxSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzExLTUtMS0xLTM1NDAxOA_8bf7a3aa-7566-408e-9ff2-f39dfcabfcf5">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEyLTEtMS0xLTM1NDAxOA_11e32193-1e5c-453c-a490-56cd095c65b0">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEyLTMtMS0xLTM1NDAxOA_1f6033da-f9a3-4d40-bf87-5b053fc24854">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEyLTUtMS0xLTM1NDAxOA_59ab1c82-a1ca-416a-9ef3-dfdbf8ba2477">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="cnc:EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEzLTEtMS0xLTM1NDAxOA_cc6938a8-0895-4f77-89a5-2b90e7e98610">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="cnc:EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEzLTMtMS0xLTM1NDAxOA_3d1a4ce7-6393-4322-9e99-5ff90a1fa435">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="cnc:EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEzLTUtMS0xLTM1NDAxOA_64b8ba28-845f-4374-b7c7-758aecc723ee">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzE0LTEtMS0xLTM1NDAxOA_b1830715-3830-40a0-ac24-afc2d6c1b988">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzE0LTMtMS0xLTM1NDAxOA_2f694697-a8ad-466c-ad11-ccaff21f5ca3">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzE0LTUtMS0xLTM1NDAxOA_89c94742-d93d-4331-baaf-9a1c3b90e192">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzE1LTEtMS0xLTM1NDAxOA_ed934b14-f678-46bf-bec4-7a1e0337a0c4">760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzE1LTMtMS0xLTM1NDAxOA_cd51e405-77ad-422b-b02f-46b075483125">477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzE1LTUtMS0xLTM1NDAxOA_e5e1c0a1-a6bd-4e81-8b31-214b9e79b6b2">979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to recognize deferred tax assets and liabilities for consolidated subsidiaries that are determined to be held for sale as of December 31, 2022. The Company established a net deferred tax liability of $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="cnc:EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzI3NDg3NzkwNzMzODA_b2960c23-debd-4e81-b67b-a0249179444d">84</ix:nonFraction> million for these investments in subsidiaries.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzMyMDE_83314a86-0442-4e55-be5f-87bd4330afc0" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences which give rise to deferred tax assets and liabilities are presented below ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims liability</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzItMS0xLTEtMzU0MDE4_21d62185-8212-49e6-848a-b1c538da9ee1">132</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzItMy0xLTEtMzU0MDE4_18a5c8f7-7fa1-4673-ab67-7510ab37fcc2">120</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzMtMS0xLTEtMzU0MDE4_2f937111-ad0f-4b97-923f-aa7aa9d1362f">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzMtMy0xLTEtMzU0MDE4_2680c5a0-0b55-4cf9-acc0-8af2e760b2e2">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzQtMS0xLTEtMzU0MDE4_a869689e-94cb-4350-8036-37469662a879">341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzQtMy0xLTEtMzU0MDE4_018b6f72-174e-46e3-a5da-41e30973a347">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzUtMS0xLTEtMzU0MDE4_5d54cbe7-8c23-4ae6-a1b3-3d3b99b01482">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzUtMy0xLTEtMzU0MDE4_62f63c74-5768-4939-9c56-39fa637ca7dd">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and trade receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:DeferredTaxAssetPremiumAndTradeReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzctMS0xLTEtMzU0MDE4_996b6cf4-809c-4475-b483-c8f8965f6fae">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:DeferredTaxAssetPremiumAndTradeReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzctMy0xLTEtMzU0MDE4_12ec304a-0ed3-4091-be24-f8c7553b8c01">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:DeferredTaxAssetOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzgtMS0xLTEtMzU0MDE4_a7dd9672-72b4-4b1f-a9ba-83b397a26730">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:DeferredTaxAssetOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzgtMy0xLTEtMzU0MDE4_de7f9a8d-2390-49b4-901b-9be1f639b810">445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:DeferredTaxAssetsInvestmentUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEwLTEtMS0xLTQ1Njc5Nw_4bc2699f-f413-4ee4-baea-113e4b2ec931">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:DeferredTaxAssetsInvestmentUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEwLTMtMS0xLTQ1Njc5Nw_7dd62dd0-db32-42a7-b48a-80e1919e83d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:DeferredTaxAssetSoftwareDevelopmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzExLTEtMS0xLTQ1Njc5Nw_e2352b35-b51e-4218-95d4-e79f4a6676f8">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:DeferredTaxAssetSoftwareDevelopmentCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzExLTMtMS0xLTQ1Njc5Nw_12dacaf1-1ec6-4f4c-a375-d0543817b40a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEwLTEtMS0xLTM1NDAxOA_f561ba4b-3088-4604-83ba-b785df630ac3">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEwLTMtMS0xLTM1NDAxOA_ee784317-92f9-4087-88c8-e171766cd8a4">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzExLTEtMS0xLTM1NDAxOA_d1f68aa7-cb18-405e-9f78-2135e971cf71">1,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzExLTMtMS0xLTM1NDAxOA_6eb44412-1913-4e58-9366-7816fcc6be61">1,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEyLTEtMS0xLTM1NDAxOA_3dfb2216-6bcc-48c4-bef6-3330b9bb7e3e">205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEyLTMtMS0xLTM1NDAxOA_e0522c38-8e4b-4661-b7ed-e3b5add9d09d">212</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEzLTEtMS0xLTM1NDAxOA_5d66c894-9df9-482d-8deb-1ed52a40665f">1,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEzLTMtMS0xLTM1NDAxOA_fa731b5d-11e2-42b4-9d33-21ff7bdf192d">1,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzE2LTEtMS0xLTM1NDAxOA_3d94161e-fb1f-4584-959f-bd6d71cb3098">1,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzE2LTMtMS0xLTM1NDAxOA_cdac2cbf-b525-4aa6-95d6-5c0f48a30775">1,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzE3LTEtMS0xLTM1NDAxOA_4e3c49b1-becc-4539-8609-48fc0a5f15ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzE3LTMtMS0xLTM1NDAxOA_c3d9cd35-6936-4377-bbe3-974f72ef288c">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzE4LTEtMS0xLTM1NDAxOA_c6294929-9d55-4139-8d08-f06f674b8c64">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzE4LTMtMS0xLTM1NDAxOA_0960f349-adfa-4421-971d-53f7b5d93662">409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:DeferredTaxLiabilitiesRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzIxLTEtMS0xLTM1NDAxOA_fca7deb6-4e9e-4f52-b735-a1b1c751255d">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:DeferredTaxLiabilitiesRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzIxLTMtMS0xLTM1NDAxOA_501208b1-7b2f-4105-b0fc-e045f241ba20">444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzIyLTEtMS0xLTM1NDAxOA_8bca62a8-d959-48b2-a482-4fc4e06435f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="cnc:DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzIyLTMtMS0xLTM1NDAxOA_f2d6efd3-de6c-40c0-88b0-e24084d90d32">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzIzLTEtMS0xLTM1NDAxOA_449baf26-e75c-46eb-a7c0-48652e3c8349">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzIzLTMtMS0xLTM1NDAxOA_d91f887c-6182-4f49-93eb-ea8bb4a593cd">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzI0LTEtMS0xLTM1NDAxOA_9a22f3ff-4855-4d95-be4d-d59456bfb5b5">2,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzI0LTMtMS0xLTM1NDAxOA_4699b93c-ce01-4b78-8e76-3c65bd991baa">2,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzI1LTEtMS0xLTM1NDAxOA_8172d483-5a33-43f7-8f12-77a2b34f1f16">615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzI1LTMtMS0xLTM1NDAxOA_5d72970a-b2b0-4f6d-ae68-37bef91116ed">1,407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><ix:continuation id="i39d5c51eedc5484ea5483b7de962595a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had not historically provided for deferred income taxes on the undistributed earnings of foreign subsidiaries as they were considered indefinitely reinvested outside the U.S. During the fourth quarter of 2022, as part of the Company's review of strategic alternatives for its international portfolio, the Company evaluated its assertion regarding its ability and intent to indefinitely reinvest undistributed earnings of the foreign subsidiaries. Upon evaluating the assertion, the Company determined that any historical or future undistributed earnings of foreign subsidiaries are no longer considered to be indefinitely reinvested. There is no deferred tax liability associated with these earnings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase to the unrealized loss deferred tax asset reflects the change in the fair market value of the Company's investment portfolio. Decreases to the fixed assets and ROU asset deferred tax liabilities are primarily related to the impairments recorded as part of the Company's real estate optimization initiative.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowances are provided when it is considered more likely than not that deferred tax assets will not be realized. The valuation allowances primarily relate to future tax benefits on certain federal, state, and foreign net operating loss, federal and state capital loss, and tax credit carryforwards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal net operating loss and credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ie0934fe54808484a9ec9bca372c35cb2_I20221231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzE1MjQ_04873f95-6f0a-4600-94f5-c0d6a052230e">69</ix:nonFraction> million expire beginning in 2023 through 2043. State net operating loss and tax credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ie1d6506c5c5d40a788e453632be65da8_I20221231" decimals="-6" name="cnc:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzE2MTk_92630e77-eda3-47a2-ada3-84452b9e1f1a">51</ix:nonFraction> million expire beginning in 2023 through 2042, while the remaining $<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="cnc:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzI3NDg3NzkwNzM0OTU_a8a2e6f9-ba57-4565-b928-7c7a664aaaa3">15</ix:nonFraction> million have indefinite carryforward periods. Substantially all the non-U.S. tax loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i10545d0936824fd6b5972c4e49790df4_I20221231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzE3MTQ_54c4f3df-7c13-4ba2-9069-8439ecbd3682">206</ix:nonFraction> million have indefinite carryforward periods.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzMyMTY_e002b175-4120-4f87-89fc-c3e99d5ca2dd" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a reserve for uncertain tax positions that may be challenged by a tax authority. A rollforward of the beginning and ending amount of uncertain tax positions, exclusive of related interest and penalties, is as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, January 1</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzItMS0xLTEtMzU0MDE4_dfd1c96a-c86d-4ada-be92-3b0dc78be83a">355</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzItMy0xLTEtMzU0MDE4_c990cbe0-e7f2-4135-848f-1d7c3c923873">354</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzQtMS0xLTEtMzU0MDE4_152e16b4-e946-489c-aafa-6952ca21ab69">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzQtMy0xLTEtMzU0MDE4_0ad888ff-7e4b-47db-8638-bd207d0c234d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="cnc:UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzUtMS0xLTEtMzU0MDE4_b7816d8c-26a0-4c3c-9bef-aec9271e5372">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="cnc:UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzUtMy0xLTEtMzU0MDE4_c2e73fb1-7c4e-4e0e-8aff-87346a38b2be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzYtMS0xLTEtMzU0MDE4_9ae8a4aa-3a5f-4ca3-b9e6-3bf5c7bedd70">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzYtMy0xLTEtMzU0MDE4_1653d63f-487f-452e-9663-c6129e42b97f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzgtMS0xLTEtMzU0MDE4_b3c1507f-aff9-40b1-a6a5-921aeacc0676">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzgtMy0xLTEtMzU0MDE4_0478eaeb-3a76-4f3e-b3dd-5dc53b52eb2d">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzktMS0xLTEtMzU0MDE4_4ed8c1b0-da6c-4900-a17a-f7a8bbe97f1f">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzktMy0xLTEtMzU0MDE4_5260b15d-caae-4a50-8e8e-dff180edd690">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitation lapses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzEwLTEtMS0xLTM1NDAxOA_44bc1873-59aa-4661-8e53-4e3dd0a6a85e">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzEwLTMtMS0xLTM1NDAxOA_83379521-1d44-405f-a063-c6fd757b4536">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzExLTEtMS0xLTM1NDAxOA_55d27a64-a065-44ed-b957-34dbd841bd6e">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzExLTMtMS0xLTM1NDAxOA_7e1e81a9-9947-464c-ba38-8be6905fa826">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzEwOTk1MTE2MzEwMDM_581f414f-aacc-407f-a0be-80ecb450268d">303</ix:nonFraction> million of unrecognized tax benefits would impact the Company's effective tax rate in future periods, if recognized.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table above excludes interest and penalties, net of related tax benefits, which are treated as income tax expense (benefit) under the Company's accounting policy. The Company recognized net interest expense and penalties related to uncertain positions of $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzEwOTk1MTE2MzEwMTc_b451ddf6-c59c-455e-b347-685f5e86f057">23</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzEwOTk1MTE2MzEwNDU_7edebb66-de45-4432-99d4-2ea48f3a7c50">1</ix:nonFraction> million expense for the years ended December 31, 2022 and 2021, respectively. The Company had $<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzEwOTk1MTE2MzEwNjA_75c551be-29f2-4344-a73c-83ecebbcdb90">66</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzEwOTk1MTE2MzEwNTE_5758c6cd-6596-40c7-b58d-83b17eb63a4c">43</ix:nonFraction> million of accrued interest and penalties for uncertain tax positions as of December 31, 2022 and 2021, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files federal tax returns as well as returns for numerous state and international tax jurisdictions and is engaged in multiple audit proceedings for its state and foreign filings. Generally, no further state or foreign audit activity is expected for years prior to 2015. As of December&#160;31, 2022, the Company's tax returns are under federal examination for the tax years 2014 through 2017, only with respect to Internal Revenue Service (IRS) proposed adjustments relating to the Company's claims to the Domestic Production Activities Deduction for these years. The Company has appealed the IRS adjustments and the appeals process is expected to be conducted within the next 12 months. The Company believes it is reasonably possible that its liability for unrecognized tax benefits will decrease by approximately $<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzU0OTc1NTgzMzg5Mg_7e751620-62cc-46c2-a333-02d859638d1b">124</ix:nonFraction> million within the next 12 months if the Company reaches a satisfactory agreement with the IRS during the appeals process and an additional $<ix:nonFraction unitRef="usd" contextRef="i565504036a2e459fa252e3436ba28dea_I20221231" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzI0NDU5_d089477c-942e-49ca-abe1-079b162c4980">3</ix:nonFraction>&#160;million decrease as a result of the expiration of statutes of limitations and projected audit settlements in certain jurisdictions.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i9dee570cfbd043d6a1700298c14b2446_145"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzE5Mzc_12bdbe1b-1e62-48ea-b8da-ed0e21550690" continuedAt="i9d38d883604945edab1a16d6d3e6f496" escape="true">Stock Incentive Plans</ix:nonNumeric></span></div><ix:continuation id="i9d38d883604945edab1a16d6d3e6f496" continuedAt="ibddc3b1183ae471aa8b4ed684958a990"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's stock incentive plans allow for the granting of restricted stock or restricted stock unit awards and options to purchase common stock. Both incentive stock options and nonqualified stock options can be awarded under the plans. However, an immaterial amount of options were granted, exercised, or outstanding in 2022. The plans have <ix:nonFraction unitRef="shares" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5NjM_c700c600-d4ed-4ef5-acd9-93b70de7de35">17</ix:nonFraction> million shares available for future awards. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for stock options and restricted stock unit awards is recognized on a straight-line basis over the vesting period, generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTA_555f768d-bd53-493d-899f-ffdf3d5a60f0">three</span> to <ix:nonNumeric contextRef="i660d37afc2d64a069401dc54b4c69ba9_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTQ_8eaee3e8-7a99-46be-a330-2dbd698475fb">five years</ix:nonNumeric> for stock options and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTg_0f5667b6-1669-434f-8a62-05af54a230a9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTg_d969fa16-d3ae-4cf3-a934-197b9b0e25e4">one</span></span> to <ix:nonNumeric contextRef="i96654801b9964ae2b8f134e8859eac41_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwMDI_a5384e49-cebc-4288-81da-9b82faf15b2d"><ix:nonNumeric contextRef="i7772399e744a48908f193c434d6d6a34_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwMDI_ab9f5486-7383-429b-afdd-01e82e42d763">three years</ix:nonNumeric></ix:nonNumeric> for restricted stock or restricted stock unit awards. Vesting is accelerated by <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="cnc:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwMDY_7261f157-22ba-41f8-9190-d00b1b088fd5">one year</ix:nonNumeric> for individuals who qualify under the Company's retirement eligible provisions. The fair value of restricted stock and restricted stock units is determined using the previous day's market close price at the time of grant. The fair value of stock options is determined based on the Black-Scholes option-pricing model. Forfeitures for all stock awards are recognized as they occur. Certain restricted stock unit awards contain performance-based as well as service-based provisions. Certain awards provide for accelerated vesting if there is a change in control as defined in the plans. The total compensation cost that has been charged against income for the stock incentive plans was $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwMTk_c848a451-d5fa-4560-b921-f63e23854d69">234</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwMjQ_85bf6146-d495-4584-8c32-185b9207fe36">203</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwMjk_facc71a7-51f9-4f95-9705-8825c9c3c10a">281</ix:nonFraction> million for the years ended December 31, 2022, 2021, and 2020, respectively. The total income tax benefit recognized in the Statements of Operations for stock-based compensation arrangements was $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwNTk_ecd62e81-e6b4-447f-b6c8-b6bfe8c6ef6d">48</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwNjQ_a6fcd3d9-58ee-4246-8492-06d2d3d91d6a">35</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwNjk_a89fa84a-eda3-4717-a0c4-9f3f8079a0a9">34</ix:nonFraction> million for the years ended December 31, 2022, 2021, and 2020, respectively. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzE5NjU_372b476b-0a8f-494d-97d0-c72f978d2a96" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the&#160;Company's non-vested&#160;restricted stock and restricted stock unit shares as of December&#160;31, 2022, and changes during the year ended December&#160;31, 2022, is presented below (shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested balance, December 31, 2021</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzEtMS0xLTEtMzU0MDE4_3367386d-0f96-47ee-9ba8-4182d7e0f3ee">7,142</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzEtMy0xLTEtMzU0MDE4_aa59af3d-5ce8-42f0-9401-159204aaae4d">65.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzItMS0xLTEtMzU0MDE4_f1056f09-19c0-4886-94b9-da85b2c7a3d4">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzItMy0xLTEtMzU0MDE4_f1cf821b-974f-4527-b2fd-31a1290cc390">84.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Converted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-3" name="cnc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzMtMS0xLTEtMzU0MDE4_bf47b2ea-7f60-4064-b38c-b95b4a0fcdfc">917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="2" name="cnc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzMtMy0xLTEtMzU0MDE4_126fef5b-39db-4a1f-a4a1-1ff7eb638af2">82.65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzQtMS0xLTEtMzU0MDE4_39c247a2-3b9e-44fa-a5b3-9a181e200d79">3,553</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzQtMy0xLTEtMzU0MDE4_e066fe26-599e-415b-aec6-61a0200d3056">67.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzUtMS0xLTEtMzU0MDE4_c207236f-8827-458c-b1c3-8178abdf359d">877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzUtMy0xLTEtMzU0MDE4_2c5da2c8-b624-4bd8-8e89-5e2be5f9bb98">70.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested balance, December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzYtMS0xLTEtMzU0MDE4_74147599-410f-4431-b183-d8058825c62b">6,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzYtMy0xLTEtMzU0MDE4_4f0f6bde-d713-4bd5-b643-193d1f8e1474">74.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Magellan awards converted in connection with the acquisition.</span></div></td></tr></table></div></ix:nonNumeric><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of restricted stock and restricted stock units vested during the years ended December 31, 2022, 2021, and 2020, was $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwNzQ_46e027a8-3dd3-495a-9679-94c0dc5fa8f5">298</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAxMDM_9656d99e-a771-40c7-b997-b80bae46afdc">264</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAxMDg_529350de-dfe4-49c0-8bf1-188a8d490fa6">364</ix:nonFraction> million, respectively.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAxMTM_296f7cba-ca06-4f33-88d3-5ad9bb6e5666">249</ix:nonFraction> million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the plans; that cost is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAxMzQ_2e22dcfe-3152-4aea-854e-4c0a3c8d6ea8">1.8</ix:nonNumeric> years. </span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibddc3b1183ae471aa8b4ed684958a990">The Company maintains an employee stock purchase plan and issued <ix:nonFraction unitRef="shares" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAxNDk_658f1462-2caf-4e00-a22b-8fbf28376f8b">449</ix:nonFraction> thousand shares, <ix:nonFraction unitRef="shares" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAxNjY_34f265fe-7d4e-44fa-b9e6-c0131a1aa0b2">516</ix:nonFraction> thousand shares, and <ix:nonFraction unitRef="shares" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAxODI_c14b7249-945c-4a90-88b5-70d0d88a29b4">487</ix:nonFraction> thousand shares in 2022, 2021, and 2020, respectively.</ix:continuation> </span></div><div id="i9dee570cfbd043d6a1700298c14b2446_151"></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTEvZnJhZzplNjU2OTMyYmFiY2E0MjZjODFmOWY4MTkzNDFiZTIxOS90ZXh0cmVnaW9uOmU2NTY5MzJiYWJjYTQyNmM4MWY5ZjgxOTM0MWJlMjE5XzQzOQ_55c3d581-b7b5-4503-8201-f5e364d6f967" continuedAt="if52d4dd7923b43dc960fd36ff9295234" escape="true">Retirement Plan </ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if52d4dd7923b43dc960fd36ff9295234" continuedAt="i1acb61bfb23546f7b54cfd2fd006780b">&#160;</ix:continuation></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1acb61bfb23546f7b54cfd2fd006780b">Centene has a defined contribution plan which covers substantially all employees who are at least <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="cnc:DefinedContributionPlanMinimumAgeForCoverage" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTEvZnJhZzplNjU2OTMyYmFiY2E0MjZjODFmOWY4MTkzNDFiZTIxOS90ZXh0cmVnaW9uOmU2NTY5MzJiYWJjYTQyNmM4MWY5ZjgxOTM0MWJlMjE5XzExMw_84e85050-b460-4201-86f9-2fdf60a4b5df">21</ix:nonNumeric> years of age. Under the plan, eligible employees may contribute a percentage of their base salary, subject to certain limitations. Centene may elect to match a portion of the employee's contribution. Company expense related to matching contributions to the plan was $<ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTEvZnJhZzplNjU2OTMyYmFiY2E0MjZjODFmOWY4MTkzNDFiZTIxOS90ZXh0cmVnaW9uOmU2NTY5MzJiYWJjYTQyNmM4MWY5ZjgxOTM0MWJlMjE5XzEwOTk1MTE2MjgyNTk_24f125ac-ce1e-4b8f-9310-24cc67d65673">133</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTEvZnJhZzplNjU2OTMyYmFiY2E0MjZjODFmOWY4MTkzNDFiZTIxOS90ZXh0cmVnaW9uOmU2NTY5MzJiYWJjYTQyNmM4MWY5ZjgxOTM0MWJlMjE5XzM4Ng_339a84b8-9e53-400c-b754-5eb54052d893">105</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTEvZnJhZzplNjU2OTMyYmFiY2E0MjZjODFmOWY4MTkzNDFiZTIxOS90ZXh0cmVnaW9uOmU2NTY5MzJiYWJjYTQyNmM4MWY5ZjgxOTM0MWJlMjE5XzM5NA_12da5400-1366-46b6-90df-00024bb16361">91</ix:nonFraction> million during the years ended December 31, 2022, 2021, and 2020, respectively.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_154"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:CommitmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNjQwOA_123d7745-f1c2-450c-907e-7e442d8f93e9" continuedAt="i890c435d0eb3446c8abf9c2f9d283608" escape="true">Commitments </ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i890c435d0eb3446c8abf9c2f9d283608"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with obtaining regulatory approval of the Magellan Health acquisition, the Company entered into certain undertakings with the Department of Managed Health Care in 2022. These undertakings contain various commitments by the Company effective upon completion of the Magellan Health acquisition. As part of the undertaking, the Company shall contribute $<ix:nonFraction unitRef="usd" contextRef="i4e6ac045f07846a0a20f759b986b78a4_I20220104" decimals="-6" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzQ5NDc4MDIzMzQzMTk_5e8f44c8-882e-425c-ab68-7e76a1668d8d">10</ix:nonFraction>&#160;million to the Purchaser Business Group on Health (PBGH) to be paid over a <ix:nonNumeric contextRef="ic47ddeb6bff94082ad9cbbcb46104c2d_D20220104-20221231" name="cnc:OtherCommitmentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzQ5NDc4MDIzMzQ0Nzg_973c6013-ebff-4bfd-b84a-b326037a2c31">five-year</ix:nonNumeric> period for initiatives consistent with the Company's mission of implementing and spreading innovative programs and best practices to increase health care value. As a result of the closing of the Magellan acquisition, the $<ix:nonFraction unitRef="usd" contextRef="ic47ddeb6bff94082ad9cbbcb46104c2d_D20220104-20221231" decimals="-6" name="cnc:OtherCommitmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxOTEzMg_c87857dc-7f5e-41d1-b556-ee150ded8790">10</ix:nonFraction> million contribution to PBGH was expensed during 2022. As of December&#160;31, 2022, the Company has paid $<ix:nonFraction unitRef="usd" contextRef="ic47ddeb6bff94082ad9cbbcb46104c2d_D20220104-20221231" decimals="-5" name="cnc:OtherCommitmentsPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxOTIxNA_0a9d2051-2cd9-4b65-92b1-0a605d8490f8">1.5</ix:nonFraction> million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with obtaining regulatory approval of the Fidelis Care acquisition, the Company entered into certain undertakings with the New York State Department of Health in 2018. These undertakings contain various commitments by the Company effective upon completion of the Fidelis Care acquisition. One of the undertakings includes a $<ix:nonFraction unitRef="usd" contextRef="i56eac86dba6e4053a7ca2c5c5581989e_I20181231" decimals="-6" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNjU3NA_78b6503d-00b8-44ca-916b-b156372f86a8">340</ix:nonFraction>&#160;million contribution by the Company to the State of New York to be paid over a <ix:nonNumeric contextRef="i6b9698336fd64b6e87b61c763e298e1d_D20180101-20181231" name="cnc:OtherCommitmentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzQ5NDc4MDIzMzQ0Nzc_39b43e4f-0178-4bdb-abcb-384769fc627f">five-year</ix:nonNumeric> period for initiatives consistent with the Company's mission of providing high-quality healthcare to vulnerable populations within New York State. The Company has fulfilled this undertaking as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also committed to certain undertakings with the California Department of Insurance and the California Department of Managed Health Care in connection with obtaining regulatory approval of the Health Net acquisition in 2016. The Health Net commitments related to the undertakings are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">invest an additional $<ix:nonFraction unitRef="usd" contextRef="iddb3faf7d44a4e5c8ad7bb4b13280732_I20161231" decimals="-6" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNTg5MQ_4e2fbe22-d407-4544-9618-dee351e80efa">30</ix:nonFraction> million through the California Organized Investment Network over the <ix:nonNumeric contextRef="if0872678e89e4daeb40637a4f74959f1_D20160101-20161231" name="cnc:OtherCommitmentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNTg4Mw_9833e343-4fc0-49ee-8a6c-f54c17e29307">five years</ix:nonNumeric> following completion of the acquisition; the Company fulfilled this undertaking in 2020;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">build a service center in an economically distressed community in California, investing $<ix:nonFraction unitRef="usd" contextRef="if0c316f54cfe4b9fa7a39964c5a1d5f0_I20161231" decimals="-6" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNTkwMA_0b142828-68a3-4a9e-bbf3-9449993e7279">200</ix:nonFraction> million over <ix:nonNumeric contextRef="ib82f610c9738480cb8bbbc7d5b5a8247_D20160101-20161231" name="cnc:OtherCommitmentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNTkwOA_d061e0ea-b674-48ad-a1fc-f4ea18d7993f">10</ix:nonNumeric> years and employing at least <ix:nonFraction unitRef="newemployee" contextRef="i892f84f1e688414fa51beaf4c47f0a87_D20160101-20161231" decimals="INF" name="cnc:OtherCommitmentEmployees" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNjA5OA_00eab40e-c4c6-4a1a-8d4a-06222c9394e7">300</ix:nonFraction> people, of which the Company has incurred $<ix:nonFraction unitRef="usd" contextRef="ib2a9aa63979e4693b2198d2bf9cbd715_D20160101-20221231" decimals="-6" name="cnc:OtherCommitmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNTkxNA_69e4872a-70bd-4281-a97e-a9ad1e36b8c1">109</ix:nonFraction> million through 2022;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contribute $<ix:nonFraction unitRef="usd" contextRef="ie8e887f935d34e8aa8685f28daf85a31_I20161231" decimals="-6" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNjEwNQ_bd63c9fe-724c-4b1b-8e18-3dda12eebe81">65</ix:nonFraction> million to improve enrollee health outcomes, support locally-based consumer assistance programs, and strengthen the healthcare delivery system, of which the Company has contributed $<ix:nonFraction unitRef="usd" contextRef="i422ca41ca2bc487dab910fa58cd7b380_D20160101-20221231" decimals="-6" name="cnc:OtherCommitmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzIxOTkwMjMyNTg0ODY_e53739c7-96a6-4081-bf7a-274d1fbb78ed">49</ix:nonFraction> million through 2022 with remaining $<ix:nonFraction unitRef="usd" contextRef="i87ea845a685c481cb90b1ac715f64443_I20221231" decimals="-6" name="cnc:OtherCommitmentToBePaidYearOneAndYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzIxOTkwMjMyNTg3MjU_45a79ab1-fe05-46ef-82fe-ac4e7b859369">16</ix:nonFraction> million scheduled to be paid equally over 2023 and 2024; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">invest $<ix:nonFraction unitRef="usd" contextRef="ie4d87dee1a254093b133d2780a8d3d4f_I20161231" decimals="-6" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNjQxMA_66c6b8c9-6bfc-4a2f-a93a-d863d36a359f">75</ix:nonFraction> million of its investment portfolio in vehicles supporting California's healthcare infrastructure, and the Company fulfilled this undertaking in 2022.</span></div></ix:continuation><div id="i9dee570cfbd043d6a1700298c14b2446_157"></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTcvZnJhZzpjYTY3ZDJjNjM1ODU0YjI1ODMyM2NiMTFhNjY0ODFhOC90ZXh0cmVnaW9uOmNhNjdkMmM2MzU4NTRiMjU4MzIzY2IxMWE2NjQ4MWE4XzEwMjU1_92f2b3a0-652e-4a44-9536-7b2f7ecb5f56" continuedAt="i6abca520cf114d1ebe1f9d6b0a0d91e7" escape="true">Contingencies </ix:nonNumeric></span></div><ix:continuation id="i6abca520cf114d1ebe1f9d6b0a0d91e7" continuedAt="i9e0244fb76114c2682e55d0a7d418ed5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, submissions to CMS for risk adjustment payments, or the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, cybersecurity issues, including those related to the Company's or the Company's third-party vendors' information systems, and the Health Insurance Portability and Accountability Act of 1996 and other federal and state fraud, waste and abuse laws;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property, and employment-related claims; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions, and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups, and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i9e0244fb76114c2682e55d0a7d418ed5" continuedAt="i2caf23a72b84490eadcf5470c18961b8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, these matters may result in awards of damages, fines, or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as described below with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company&#8217;s pharmacy benefits management (PBM) subsidiary. It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow, and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings, including as described below. Except for the proceedings discussed below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow, or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">California</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 20, 2015, the Company's California subsidiary, Health Net of California, Inc. (Health Net California), was named as a defendant in a California taxpayer action filed in Los Angeles County Superior Court, captioned as Michael D. Myers v. State Board of Equalization, Dave Jones, Insurance Commissioner of the State of California, Betty T. Yee, Controller of the State of California, et al., Los Angeles Superior Court Case No. BS158655. This action is brought under a California statute that permits an individual taxpayer to sue a governmental agency when the taxpayer believes the agency has failed to enforce governing law. Plaintiff contends that Health Net California, a California licensed Health Care Service Plan (HCSP), is an "insurer" for purposes of taxation despite acknowledging it is not an "insurer" under regulatory law. Under California law, "insurers" must pay a gross premiums tax (GPT), calculated as 2.35% on gross premiums. As a licensed HCSP, Health Net California has paid the California Corporate Franchise Tax (CFT), the tax generally paid by California businesses. Plaintiff contends that Health Net California must pay the GPT rather than the CFT. Plaintiff seeks a writ of mandate directing the California taxing agencies to collect the GPT, and seeks an order requiring Health Net California to pay GPT, interest, and penalties for a period dating to eight years prior to the October 2015 filing of the complaint. This lawsuit is being coordinated with similar lawsuits filed against other entities (collectively, Related Actions). In March 2018, the Court overruled the Company's demurrer seeking to dismiss the complaint and denied the Company's motion to strike allegations seeking retroactive relief. In August 2018, the trial court stayed all the Related Actions pending determination of a writ of mandate by the California Court of Appeals in two of the Related Actions. In March 2019, the California Court of Appeals denied the writ of mandate. The defendants in those Related Actions sought review by the California Supreme Court, which declined to review the matter. Upon the return of the matter to the Los Angeles County Superior Court, motions for summary judgment were scheduled. Health Net California's motion for summary judgment was heard by the Court in March 2020. In March 2020, the Court granted Health Net California's motion for summary judgment. In September 2020, the plaintiff appealed the Court's decision. The Company intends to continue its vigorous defense against these claims; however, this matter is subject to many uncertainties, and an adverse outcome in this matter could potentially have a materially adverse impact on the Company's financial condition, results of operations, and cash flows.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i2caf23a72b84490eadcf5470c18961b8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in April 2021, several lawsuits have been filed against the Company and its subsidiaries, alleging that the defendants failed to prevent Health Net members' personal and health data from being exposed in connection with a data breach involving Accellion's File Transfer Appliance. The Company denies any wrongdoing and is seeking indemnification from Accellion for these claims. In December 2021, the plaintiffs in <ix:nonFraction unitRef="claim" contextRef="ie10b1c36a39645fd98b8f6652a9ea7aa_I20211231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTcvZnJhZzpjYTY3ZDJjNjM1ODU0YjI1ODMyM2NiMTFhNjY0ODFhOC90ZXh0cmVnaW9uOmNhNjdkMmM2MzU4NTRiMjU4MzIzY2IxMWE2NjQ4MWE4Xzc0NzQ_a760215f-1df7-45b2-9a87-f14e4446d8c5">three</ix:nonFraction> of the pending actions filed a motion for preliminary approval of a settlement with the Company and its subsidiaries, which, if approved by the court, should resolve most or all of the pending litigation. In addition, claims related to these lawsuits are anticipated to be covered in part by the Company's insurance carrier. As a result, while these matters are subject to many uncertainties, the Company does not believe that an adverse outcome in these matters is likely to have a materially adverse impact on the Company's financial condition, results of operations, and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Benefits Management Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2021, the State of Ohio filed a civil action against the Company and the Company's subsidiaries, Buckeye Health Plan Community Solutions, Inc. and Envolve, in Franklin County Court of Common Pleas, captioned as Ohio Department of Medicaid, et al. v. Centene Corporation, et al. The complaint alleged breaches of contract with the Ohio Department of Medicaid relating to the provision of PBM services and violations of Ohio law relating to such contracts, including among other things, by (i) seeking payment for services already reimbursed, (ii) not accurately disclosing to the Ohio Department of Medicaid the true cost of the PBM services and (iii) inflating dispensing fees for prescription drugs. The plaintiffs sought an undisclosed sum of money in damages, penalties, and possible termination of the contract with Buckeye Health Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has reached no-fault agreements with the Attorney Generals, including Ohio, to resolve claims and/or allegations made by the states related to services previously provided by Envolve. As a result of the settlement, the Ohio Attorney General's litigation against the Company was dismissed. Additionally, the Company is in discussions to bring final resolution to similar concerns in other affected states. Consistent with those discussions, the Company recorded a reserve estimate of $<ix:nonFraction unitRef="usd" contextRef="i1408e06a90864ff9b0dadeb355581288_I20210630" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTcvZnJhZzpjYTY3ZDJjNjM1ODU0YjI1ODMyM2NiMTFhNjY0ODFhOC90ZXh0cmVnaW9uOmNhNjdkMmM2MzU4NTRiMjU4MzIzY2IxMWE2NjQ4MWE4Xzk0ODU_f52f81ce-03d4-495c-a29f-8dd22606e992">1,250</ix:nonFraction>&#160;million in the second quarter of 2021 related to this issue, inclusive of the above settlements and rebates that the Company determined in the course of the matter are payable across products. Additional claims, reviews, or investigations relating to the Company's historical PBM business across products may be brought by other states, the federal government, or shareholder litigants, and there is no guarantee the Company will have the ability to settle such claims with other states within the reserve estimate the Company has recorded and on other acceptable terms, or at all. This matter is subject to many uncertainties, and an adverse outcome in this matter could have an adverse impact on the Company's financial condition, results of operations, and cash flows.</span></div></ix:continuation><div id="i9dee570cfbd043d6a1700298c14b2446_160"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90ZXh0cmVnaW9uOjExOGI3NzU5NzE2YjQwMzNiOGUzYTk2YjdmYzdhMjEwXzQ0Nw_5045b4e8-4b03-4bea-b23b-5946460d6f87" continuedAt="icb631ca38a8148698eb5912c47f33249" escape="true">Earnings Per Share</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="icb631ca38a8148698eb5912c47f33249"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90ZXh0cmVnaW9uOjExOGI3NzU5NzE2YjQwMzNiOGUzYTk2YjdmYzdhMjEwXzQ1Ng_ead9ece3-5866-46d0-b296-13f905dfbd78" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:61.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to Centene Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzQtMS0xLTEtMzU0MDE4_957647bc-d0c4-4830-8b7f-d46cdd591de1">1,202</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzQtMy0xLTEtMzU0MDE4_ac7d6950-e2e2-44c8-ad38-cad7eac014a3">1,347</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzQtNS0xLTEtMzU0MDE4_27773c3f-51b5-406a-a23c-20309812ea71">1,808</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing per share amounts:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzctMS0xLTEtMzU0MDE4_c31e101d-9980-474f-aa78-ef684ff9bdef">575,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzctMy0xLTEtMzU0MDE4_870077c9-642a-4309-a112-b8788461d6cf">582,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzctNS0xLTEtMzU0MDE4_b979288c-8772-456a-b695-f16fdc3d0088">570,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents (as determined by applying the treasury stock method)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzgtMS0xLTEtMzU0MDE4_1b1b5ab5-c654-4d9d-bc7b-175d25506d6f">6,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzgtMy0xLTEtMzU0MDE4_9c88e954-aff9-48bc-920a-5b236b270c78">7,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzgtNS0xLTEtMzU0MDE4_edc0e40b-7a8b-4e5d-9b0c-be86d305dd37">8,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares and potential dilutive common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzktMS0xLTEtMzU0MDE4_51bce433-df28-408a-bccd-d3fc6e25aa4b">582,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzktMy0xLTEtMzU0MDE4_fb4a005d-129f-4fb8-986a-58b78402e6ae">590,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzktNS0xLTEtMzU0MDE4_a5d9540a-31eb-4a99-847e-d49eb7169e53">579,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzE1LTEtMS0xLTM1NDAxOA_729a3f95-6681-4bed-8e32-ee0eee59d62a">2.09</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzE1LTMtMS0xLTM1NDAxOA_30f13cb9-d4ed-410f-bd06-95c09fed3284">2.31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzE1LTUtMS0xLTM1NDAxOA_9ccfdcb5-ff9e-4d71-b824-9a07cdbadecb">3.17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzIwLTEtMS0xLTM1NDAxOA_59d5d2ab-21e1-44f8-9985-cb7204f42679">2.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzIwLTMtMS0xLTM1NDAxOA_6c04aca9-fb3d-45d7-b51c-eccd6bc73962">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzIwLTUtMS0xLTM1NDAxOA_8639590c-df0b-498a-812b-460d082b30f1">3.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted earnings per common share for 2022, 2021, and 2020 excludes the impact of <ix:nonFraction unitRef="shares" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90ZXh0cmVnaW9uOjExOGI3NzU5NzE2YjQwMzNiOGUzYTk2YjdmYzdhMjEwXzMwMw_b5a9a63f-470b-4ee4-a13d-daaaf7150bea">187</ix:nonFraction>&#160;thousand shares, <ix:nonFraction unitRef="shares" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90ZXh0cmVnaW9uOjExOGI3NzU5NzE2YjQwMzNiOGUzYTk2YjdmYzdhMjEwXzMxNA_b2807e15-e244-44f9-9a1c-1b453859de08">44</ix:nonFraction>&#160;thousand shares, and <ix:nonFraction unitRef="shares" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90ZXh0cmVnaW9uOjExOGI3NzU5NzE2YjQwMzNiOGUzYTk2YjdmYzdhMjEwXzMyOQ_bce14f0b-63c8-4b88-8f95-16b1a31aebb7">398</ix:nonFraction>&#160;thousand shares, respectively, related to anti-dilutive stock options and restricted stock units.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90ZXh0cmVnaW9uOjBkYmMxODAwNzgyMjQwMTE4Njg3NjRmYmMxOGJmYTU0XzEwODQ_407e8fd1-7ba6-4fff-9589-3d571af421f0" continuedAt="ief082900a2554bf4bf059016ad616719" escape="true">Segment Information</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ief082900a2554bf4bf059016ad616719"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Centene operates in <ix:nonFraction unitRef="segment" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90ZXh0cmVnaW9uOjBkYmMxODAwNzgyMjQwMTE4Njg3NjRmYmMxOGJmYTU0XzMz_4452ea48-2a41-44f0-837e-805fc7536a6f">two</ix:nonFraction> segments: Managed Care and Specialty Services. The Managed Care segment consists of Centene's health plans, including all of the functions needed to operate them. The Specialty Services segment consists of Centene's specialty companies offering auxiliary healthcare services and products. Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams, and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In early 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company has revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. The Company will begin reporting under this new segment structure in 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not report total assets by segment since this is not a metric used to allocate resources or evaluate segment performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further discussed in Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as part of the Company's ongoing portfolio review various divestitures were pending or completed during the year ended December&#160;31, 2022. The Spanish and Central European businesses were included in the Managed Care segment. The PANTHERx, Magellan Rx, Magellan Specialty Health, Centurion, and HealthSmart businesses were included in the Specialty Services segment.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90ZXh0cmVnaW9uOjBkYmMxODAwNzgyMjQwMTE4Njg3NjRmYmMxOGJmYTU0XzEwODY_ce05f7db-5de0-4cc9-97bd-5a7d368cf912" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the year ended December&#160;31, 2022, follows ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.566%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Managed&#160;Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1c2cca7f4f74960a51897309069b67d_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzEtMS0xLTEtMzU0MDE4_97852315-d6cb-4421-9483-a33e17139db7">135,055</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0679197c607142fab0cde5bfadf6106e_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzEtMy0xLTEtMzU0MDE4_02859d1c-1e3f-49fc-9888-bc66393707ea">9,492</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzEtNy0xLTEtMzU0MDE4_99a34df3-4926-46ef-823c-fbcece135ad0">144,547</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5edc68c239804a80814acb778ec0cec8_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzItMS0xLTEtMzU0MDE4_a6edc92a-cf82-47e0-a558-44a8749aebae">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81fb523ea67d40f5940533702a20d4a3_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzItMy0xLTEtMzU0MDE4_d228915f-0fc1-4ada-a317-1a3808749e9d">13,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6897fe7f407348408f329013f91d65d4_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzItNS0xLTEtMzU0MDE4_6c346441-feb5-48c7-bc03-2e1a2204d1a5">13,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzMtMS0xLTEtMzU0MDE4_ab31190d-a233-46fd-826d-cfec40d38c4e">135,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzMtMy0xLTEtMzU0MDE4_ebe5ba0b-2fd1-4957-aa4f-aa70ac1e8aab">22,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6897fe7f407348408f329013f91d65d4_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzMtNS0xLTEtMzU0MDE4_203d529e-1b16-44b4-bca2-323cdc07d014">13,281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzMtNy0xLTEtMzU0MDE4_f69a6fd8-8ee9-462c-8fff-421fdf80e639">144,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzQtMS0xLTEtMzU0MDE4_90689bc9-6a41-4a48-bc64-f0b6a21d3492">1,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzQtMy0xLTEtMzU0MDE4_a4ddaba9-60e6-43e4-ad70-4b92702b27ba">595</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzQtNy0xLTEtMzU0MDE4_d3afd85e-9537-4a33-bb37-748af136f888">1,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the year ended December&#160;31, 2021, follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.566%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Managed&#160;Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i597b4c195cb04959abb207f4c5a9d77b_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzEtMS0xLTEtMzU0MDE4_59003bca-c756-48e3-a38a-4e78e5b59e82">120,119</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdc35ca45e39441388aa8777389f4f17_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzEtMy0xLTEtMzU0MDE4_fe938f82-43cf-4ead-8e7c-5eaf927812cf">5,863</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzEtNy0xLTEtMzU0MDE4_9ad14f77-9e17-4c63-bbca-2f208bacc437">125,982</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfc51f1798d2493e9397d897df02b75d_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzItMS0xLTEtMzU0MDE4_e8507963-0eb5-46cb-9422-781ef917c65b">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c52c3388e80478599272c3d556863c1_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzItMy0xLTEtMzU0MDE4_f5d49aef-9351-462d-8404-4469b67370da">12,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73a2cbaeddfd400e90e0ac804c3f053d_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzItNS0xLTEtMzU0MDE4_9f6ff25c-5ae0-45d2-8d42-c5d542954b37">12,795</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6447d75d16c04ef5b131401dd27e366b_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzMtMS0xLTEtMzU0MDE4_ba31abbf-a5cc-4fda-a581-c525874d2233">120,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2bebbc40fd54b4b8b61324fc370f6f6_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzMtMy0xLTEtMzU0MDE4_9b7a8f15-d9c4-40fb-b7ac-a856eca4a8a1">18,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73a2cbaeddfd400e90e0ac804c3f053d_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzMtNS0xLTEtMzU0MDE4_11364768-7b12-4471-818f-90ec015cbf4b">12,795</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzMtNy0xLTEtMzU0MDE4_49eb350e-c6d7-49cd-8286-d5b7bf1fb212">125,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6447d75d16c04ef5b131401dd27e366b_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzQtMS0xLTEtMzU0MDE4_70ab40a1-962b-4de9-85fa-ad314f69d897">1,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2bebbc40fd54b4b8b61324fc370f6f6_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzQtMy0xLTEtMzU0MDE4_32f078b3-acaa-4017-af3e-50ff8804cbd3">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzQtNy0xLTEtMzU0MDE4_b343c6ce-15fa-4214-93b8-2d8075af6219">1,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the year ended December&#160;31, 2020, follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.566%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Managed&#160;Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f2668a7ad14973b713bb5cfbcf8727_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzEtMS0xLTEtMzU0MDE4_41194d22-3a6c-4311-ad1a-d521e8058ddf">106,862</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6991fd72507b46dc832dd05186288635_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzEtMy0xLTEtMzU0MDE4_808f8178-4eb4-4176-a308-dfdb69bc844f">4,253</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzEtNy0xLTEtMzU0MDE4_e6512739-a6b9-42c0-8bcf-55921ec9091e">111,115</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fd30ab791664c4f9c22d79dbf638763_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzItMS0xLTEtMzU0MDE4_086991b1-15ad-4a82-9798-de28534773ce">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7155450c86684d8ba820c2c57095f767_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzItMy0xLTEtMzU0MDE4_63a7d35e-7f40-429e-99a8-0f3e75f2ce49">10,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06642903404e4397841d66d835b14359_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzItNS0xLTEtMzU0MDE4_e9cce9fa-bbe9-428c-9d36-7a4a3be0160f">10,746</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if516d478048c4636bd145efe65e63d37_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzMtMS0xLTEtMzU0MDE4_6cb63afb-fc9a-4f02-94d5-4b42369d54ee">106,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a6cef996834ef6bafb08a049d5359c_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzMtMy0xLTEtMzU0MDE4_ca707b9f-da41-47c2-b393-0c7b717ecde0">14,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06642903404e4397841d66d835b14359_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzMtNS0xLTEtMzU0MDE4_e356de78-5566-4b22-ae0d-3a8082287cbd">10,746</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzMtNy0xLTEtMzU0MDE4_cf1bad82-c67d-4000-b2b6-f9cb4bb82d34">111,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if516d478048c4636bd145efe65e63d37_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzQtMS0xLTEtMzU0MDE4_a8d44026-5843-4dd2-bf4d-a216662cc5f7">3,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a6cef996834ef6bafb08a049d5359c_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzQtMy0xLTEtMzU0MDE4_b1421f07-975c-441a-bc9d-0f9add7cb4d5">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzQtNy0xLTEtMzU0MDE4_a787a6a7-ef4c-418d-b1a9-73e0ce0a9327">3,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21. <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90ZXh0cmVnaW9uOjM4ZGM4YjEwODJmMTRkNjA4MGYzZDIwYzEyNWVlY2U3XzIzMzk_795f9640-6fea-48e9-817d-b00aefa40b54" continuedAt="iea0cc1ce1354444a9fe0d7c6a22a973b" escape="true">Condensed Financial Information of Registrant</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iea0cc1ce1354444a9fe0d7c6a22a973b" continuedAt="i839df414d19f4271974e6199936b9259"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="srt:ScheduleOfCondensedBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90ZXh0cmVnaW9uOjM4ZGM4YjEwODJmMTRkNjA4MGYzZDIwYzEyNWVlY2U3XzIzNjg_f48ddfef-41d4-46a2-ad0c-21e519ffda56" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Centene Corporation (Parent Company Only)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except shares in thousands and per share data in dollars)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzQtMS0xLTEtMzU0MDE4_4fc2e473-7742-4995-9505-bbff8c818d2e">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzQtMy0xLTEtMzU0MDE4_103b93cf-ee88-4273-9903-c78756de7fa4">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzYtMS0xLTEtMzU0MDE4_729d2e6e-8c09-41fb-83c6-eb84ff895151">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzYtMy0xLTEtMzU0MDE4_67f19abe-7b07-44db-a3e1-9d143369cbac">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzctMS0xLTEtMzU0MDE4_0858c48e-6575-46c0-9116-3828667e243d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzctMy0xLTEtMzU0MDE4_e2376f98-ec03-448a-9a42-4246ae3e41f7">738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzgtMS0xLTEtMzU0MDE4_8e001c2d-8ce7-4ab5-843b-f0cbf93b2056">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzgtMy0xLTEtMzU0MDE4_20ca6dfd-fde9-411c-bf13-2ebb04c64955">748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzktMS0xLTEtMzU0MDE4_f8d82d33-a5f1-439a-8e99-38baf17619c8">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzktMy0xLTEtMzU0MDE4_b819ce2c-8909-4b19-99c6-08f4bb96f51f">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzEwLTEtMS0xLTM1NDAxOA_be9e1670-7aa5-4d19-b4d4-3c7caefc56fe">42,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzEwLTMtMS0xLTM1NDAxOA_285540b7-d1e2-4fde-9398-d82a696d453f">45,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzExLTEtMS0xLTM1NDAxOA_d8af4035-4db8-49d7-906c-ecb30e1e9b68">422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzExLTMtMS0xLTM1NDAxOA_a0234864-9ca2-4816-9055-2197db3247a7">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzEyLTEtMS0xLTM1NDAxOA_0333f312-6767-4a52-b247-b3d98a7d9e80">42,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzEyLTMtMS0xLTM1NDAxOA_7e7d54d7-65b4-40eb-8617-c31c93f8b97d">46,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE1LTEtMS0xLTM1NDAxOA_510f5587-493c-445e-9961-75238770b308">534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE1LTMtMS0xLTM1NDAxOA_0acc6c7e-2b0a-472f-84cb-d7c129be3397">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE2LTEtMS0xLTM1NDAxOA_751befdd-8818-40e1-9624-c2581568728f">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE2LTMtMS0xLTM1NDAxOA_8fee6d44-1962-4978-b04d-fada5c328dfc">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE3LTEtMS0xLTM1NDAxOA_ac8d825d-9c81-4907-b5df-0f2121de299d">603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE3LTMtMS0xLTM1NDAxOA_2fc07091-0aad-4cc0-b6cb-1f3012d3a8ae">633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE4LTEtMS0xLTM1NDAxOA_c0393305-9c01-416c-a12a-77c467ec7b44">17,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE4LTMtMS0xLTM1NDAxOA_bfb5a560-e259-4618-9537-2edfcd986e2b">18,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE5LTEtMS0xLTM1NDAxOA_2669802f-5cb4-4ec8-bd08-1fea011808a0">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE5LTMtMS0xLTM1NDAxOA_74ef2dcb-3dbc-44db-adc2-5080ef455e47">461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIwLTEtMS0xLTM1NDAxOA_9cab9656-7ab0-4b45-8e34-1d1ab45062ff">18,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIwLTMtMS0xLTM1NDAxOA_9006840c-ce7c-4df1-aaa9-3666f5ae951c">19,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIxLTEtMS0xLTM1NDAxOA_704bae8f-1b9c-44ee-8715-fa9a73db4de7">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIxLTMtMS0xLTM1NDAxOA_4bc88b70-81f8-455a-9b9b-c7f51e7d8a3f">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3NjU_87ba514a-d080-469a-b12e-16332cab8b43"><ix:nonFraction unitRef="usdPerShare" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3NjU_c0187be6-e296-4579-ac86-281e8b461680">0.001</ix:nonFraction></ix:nonFraction> par value; authorized <ix:nonFraction unitRef="shares" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3Njk_1d5c4135-9606-46c7-98bb-eb7d35385d9d"><ix:nonFraction unitRef="shares" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3Njk_37312559-4fd0-48d2-9f88-c666db353b3d">10,000</ix:nonFraction></ix:nonFraction> shares; <ix:nonFraction unitRef="shares" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3NzM_28259bf0-6ce3-4186-a6d6-79ba24f1b613"><ix:nonFraction unitRef="shares" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3NzM_37a0db18-79da-464c-8b0d-36905899c946"><ix:nonFraction unitRef="shares" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3NzM_58f01dbc-03ef-41b4-853c-d7850c371485"><ix:nonFraction unitRef="shares" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3NzM_9bfc78a4-d0eb-4604-8217-b34aff47ed72">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding at December&#160;31, 2022 and December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTEtMS0xLTM1NDAxOA_dde18463-ea3d-4480-9fc1-e30936acdcee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTMtMS0xLTM1NDAxOA_fd8f7c77-3958-4bd2-8e73-3ec4062b630d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE3OTM_2153c91f-b98a-4124-88ca-a288a0af61e9"><ix:nonFraction unitRef="usdPerShare" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE3OTM_7e7927ec-4525-4118-937e-e0e1aee34432">0.001</ix:nonFraction></ix:nonFraction> par value; authorized <ix:nonFraction unitRef="shares" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE3OTc_02dab9bc-b035-4f4d-880c-520dfad50e47"><ix:nonFraction unitRef="shares" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE3OTc_bfe0fce6-fd53-4856-9fad-14b9417e9136">800,000</ix:nonFraction></ix:nonFraction> shares; <ix:nonFraction unitRef="shares" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE4MDA_9c8c0bc2-1978-4298-8ed4-60c22dee937c">607,847</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE4MDQ_0aef50c6-2876-4683-bc68-afaf580854e8">550,754</ix:nonFraction> outstanding at December&#160;31, 2022, and <ix:nonFraction unitRef="shares" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE4MDk_d42cf621-44de-46b5-9765-2eeb8d55a063">602,704</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE4MTI_6f4e7f72-0e38-464a-b548-c10952696003">582,479</ix:nonFraction> outstanding at December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTEtMS0xLTM1NDAxOA_96d2947f-cde7-4e19-aa4f-e2eabd3ef1d8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTMtMS0xLTM1NDAxOA_7e2f8b6c-514f-4647-8729-e93a81a7f832">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI1LTEtMS0xLTM1NDAxOA_adf284b3-fca7-40ce-816a-9b753d8f571f">20,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI1LTMtMS0xLTM1NDAxOA_ad1b6517-62d6-404e-8f08-5fb834be0110">19,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive earnings (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI2LTEtMS0xLTM1NDAxOA_bf9eed49-042e-471b-847b-1eab9bae2787">1,132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI2LTMtMS0xLTM1NDAxOA_9e50b810-d60d-4223-bdc8-375391547611">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI3LTEtMS0xLTM1NDAxOA_22228499-0d25-4cef-847b-d3cdc69b7dd5">9,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI3LTMtMS0xLTM1NDAxOA_d96ebb29-af8d-4365-93e3-46671ccd9693">8,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost (<ix:nonFraction unitRef="shares" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI4LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOjYzMTU4ZTI5YzhkNDQ0MTFiMWY5NWEwMTlhOWRlZDRiXzE2NDkyNjc0NDE3MjQ_a3f32649-9cbf-4d6e-b530-22d11dc5dfbe">57,093</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI4LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOjYzMTU4ZTI5YzhkNDQ0MTFiMWY5NWEwMTlhOWRlZDRiXzE2NDkyNjc0NDE3Mjg_b1a17f34-4a51-4f6f-8e22-9b0ce1fcdb5e">20,225</ix:nonFraction> shares, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI4LTEtMS0xLTM1NDAxOA_826d29ed-28f6-4484-a23c-a97e13be29fd">4,213</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI4LTMtMS0xLTM1NDAxOA_0dfb6cbf-9ee5-4c38-9bef-9d8eba600d8a">1,094</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Centene stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI5LTEtMS0xLTM1NDAxOA_ae498483-cc01-4188-808a-ea12f11f5605">24,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI5LTMtMS0xLTM1NDAxOA_82e7218e-63a8-46bb-963c-af1d2308ebb8">26,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzMwLTEtMS0xLTM1NDAxOA_2d0a1240-ac9b-486e-a2d1-1a514ec62aa4">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzMwLTMtMS0xLTM1NDAxOA_e641a641-6835-4cfc-8239-58c49636ec4c">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzMxLTEtMS0xLTM1NDAxOA_625ab23f-4ef9-43f8-b3ab-3cff56e99c31">24,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzMxLTMtMS0xLTM1NDAxOA_a9e4fdad-48b3-49a0-9f22-6c1a6451c850">26,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, redeemable noncontrolling interests and stockholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzMyLTEtMS0xLTM1NDAxOA_83aaf67f-d96a-4ba0-9147-f71d3f6c20e9">42,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzMyLTMtMS0xLTM1NDAxOA_094161be-1064-4385-9a07-ef1ff5df5e54">46,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed financial information of registrant.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><ix:continuation id="i839df414d19f4271974e6199936b9259" continuedAt="id55c945996ce454680214c3b957e4c1c"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="srt:ScheduleOfCondensedIncomeStatementTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90ZXh0cmVnaW9uOjM4ZGM4YjEwODJmMTRkNjA4MGYzZDIwYzEyNWVlY2U3XzIzNTE_a514c37d-c623-40aa-8f8b-8267a7f9ddcd" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Centene Corporation (Parent Company Only)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share data in dollars)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzMtMS0xLTEtMzU0MDE4_c4e0f18f-4f42-4f7e-b082-c88f155b09d6">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzMtMy0xLTEtMzU0MDE4_540c152a-bc8a-4777-b17d-70049e920b52">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzMtNS0xLTEtMzU0MDE4_400df855-a868-4b6b-90e0-701d201efff7">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzQtMS0xLTEtMzU0MDE4_233844f4-618e-4f7b-b533-e5f4eef16262">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzQtMy0xLTEtMzU0MDE4_558dfb41-32f3-4dd4-9e92-55590602ddd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzQtNS0xLTEtMzU0MDE4_aa3d60d5-9af2-4929-bea5-e632ca29ec23">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzUtMS0xLTEtMzU0MDE4_76faa319-9398-4acd-900b-3c3bbb4c9f36">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzUtMy0xLTEtMzU0MDE4_d20f9fc5-44a5-4d65-83df-bb9a011b319b">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzUtNS0xLTEtMzU0MDE4_ac89a3f9-7d5c-4243-8b04-3d56625d1bd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzctMS0xLTEtMzU0MDE4_8215b0a7-cd42-466e-a941-73c35f0a7fa7">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzctMy0xLTEtMzU0MDE4_e5678f12-7f82-4a6f-b04c-d2f88e5ad4d4">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzctNS0xLTEtMzU0MDE4_295da1c7-9b32-41cc-94d7-209dc4eb1fe3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzgtMS0xLTEtMzU0MDE4_e7c8fd16-9869-462f-87ba-b70b18002012">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzgtMy0xLTEtMzU0MDE4_59da2b92-9338-415e-95f6-39d06c4a7d3d">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzgtNS0xLTEtMzU0MDE4_fea4cf40-8f31-4412-8d6e-5907e39636e0">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzktMS0xLTEtMzU0MDE4_57c62a12-e1e1-4fb4-88d7-c7d45f763379">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" sign="-" name="cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzktMy0xLTEtMzU0MDE4_8334dc8a-5233-4db0-bac8-03b4f1290dc9">125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" sign="-" name="cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzktNS0xLTEtMzU0MDE4_d736078f-4925-4d0e-95bd-c032e215099b">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEwLTEtMS0xLTM1NDAxOA_3733cb89-674a-44a3-bdc4-12faf9a037a1">643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEwLTMtMS0xLTM1NDAxOA_3b6aa16e-f94c-4b90-97e4-2ef26d2570cc">641</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEwLTUtMS0xLTM1NDAxOA_462d0a2e-795c-4bf4-acc9-58e985976262">723</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzExLTEtMS0xLTM1NDAxOA_febe222b-e0c8-4b8a-abfd-3ca742863c61">615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzExLTMtMS0xLTM1NDAxOA_e13c7a48-9c2b-49c4-a45f-5a657b878746">1,735</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzExLTUtMS0xLTM1NDAxOA_1b9ced90-f90f-40c1-8d6a-447b82ee2ea4">687</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEyLTEtMS0xLTM1NDAxOA_11e85a09-7cee-497e-9631-0271bf0407fa">208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEyLTMtMS0xLTM1NDAxOA_274a95ee-8dea-4862-b1f0-f35546da7eb0">308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEyLTUtMS0xLTM1NDAxOA_fb54a069-72b1-43cc-a333-d418d4139ea5">331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) before equity in subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" sign="-" name="cnc:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEzLTEtMS0xLTM1NDAxOA_42ed97ae-5a46-45dc-9fc1-24135f69fa0d">407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" sign="-" name="cnc:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEzLTMtMS0xLTM1NDAxOA_46b64e2c-b847-4044-a9a5-1a56ee636647">1,427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" sign="-" name="cnc:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEzLTUtMS0xLTM1NDAxOA_b53f8cef-227b-48c9-b3aa-c56e80bed8e8">356</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings from subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE0LTEtMS0xLTM1NDAxOA_8313e08d-42af-44f9-8d87-496c73965c4e">1,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE0LTMtMS0xLTM1NDAxOA_e90cea97-c70c-44ce-ad3c-660fa00ac869">2,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE0LTUtMS0xLTM1NDAxOA_2dfbaaaf-a7f8-432b-876a-26716f75c335">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE1LTEtMS0xLTM1NDAxOA_b7e1dce3-c864-4688-9ad9-a63fc31d7a00">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE1LTMtMS0xLTM1NDAxOA_d919c025-45cb-403a-92cb-4f0ae5b98a43">1,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE1LTUtMS0xLTM1NDAxOA_7b5875f6-4107-49ea-8377-7aa66c35e25e">1,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE2LTEtMS0xLTM1NDAxOA_058cdcc0-742c-446b-b749-ef7845ab5bcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE2LTMtMS0xLTM1NDAxOA_0028de76-1637-4cab-975f-334a3ea97287">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE2LTUtMS0xLTM1NDAxOA_a8d6e37c-4b77-4321-939b-c6820e959068">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to Centene Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE3LTEtMS0xLTM1NDAxOA_63ef2351-a819-4263-944d-c4751192b59b">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE3LTMtMS0xLTM1NDAxOA_f858fa28-678a-4d21-a1a5-3e4ed9303835">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE3LTUtMS0xLTM1NDAxOA_942fa478-7d39-48c9-b540-3ed42b3cca85">1,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzIwLTEtMS0xLTM1NDAxOA_842187c0-ddb5-4d63-9ac5-d4faa4ba8301">2.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzIwLTMtMS0xLTM1NDAxOA_5504dca2-c389-4a08-9e0d-5b7b4cc362ce">2.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzIwLTUtMS0xLTM1NDAxOA_a2479d1c-2db9-4192-8f55-dfb1020210ce">3.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzIxLTEtMS0xLTM1NDAxOA_271b4d31-a623-4d21-b55f-6ca2c2a2341a">2.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzIxLTMtMS0xLTM1NDAxOA_66cf7384-5f46-45b3-bc63-4e1fe77b7fbe">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzIxLTUtMS0xLTM1NDAxOA_f9abafd7-bb0f-45f5-87dc-055c09bbf57d">3.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed financial information of registrant.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="id55c945996ce454680214c3b957e4c1c" continuedAt="i7917ec5d4ac045dbbbae64836ab8a40d"><ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="srt:ScheduleOfCondensedCashFlowStatementTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90ZXh0cmVnaW9uOjM4ZGM4YjEwODJmMTRkNjA4MGYzZDIwYzEyNWVlY2U3XzIzMzc_13eeeec4-993b-432f-b242-c7f44d7115da" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Centene Corporation (Parent Company Only)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:71.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends from subsidiaries, return on investment</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="cnc:DividendsfromSubsidiariesOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMtMS0xLTEtMzU0MDE4_ebe618b1-2078-4ba0-902c-ed38dc7f8251">1,706</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="cnc:DividendsfromSubsidiariesOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMtMy0xLTEtMzU0MDE4_83280e76-643e-4fda-94cb-045d70e3f72b">2,194</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="cnc:DividendsfromSubsidiariesOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMtNS0xLTEtMzU0MDE4_7d4100ff-498c-46af-bf5d-e87b400bf230">739</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for legal settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzQtMS0xLTEtMzU0MDE4_f1aa7227-c77f-407c-8f8b-233dac1508c6">282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzQtMy0xLTEtMzU0MDE4_9b977d59-0cb8-49ca-9352-bcc24bb2e982">298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzQtNS0xLTEtMzU0MDE4_b639c3d9-d2cd-4ded-97cc-9d640b30c79f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzUtMS0xLTEtMzU0MDE4_2d4eb085-094c-43ed-a33e-1c730a908fdc">450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzUtMy0xLTEtMzU0MDE4_7ea68c85-ae3e-4607-b754-f7983d4e191c">582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzUtNS0xLTEtMzU0MDE4_5f97705d-2321-4706-a525-c34cb7cae872">287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzYtMS0xLTEtMzU0MDE4_10b4fcc3-b653-496e-b926-9cdc89d97a1b">974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzYtMy0xLTEtMzU0MDE4_fd5b5a0d-5ef4-42f8-9bd6-41f6d6e1bad5">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzYtNS0xLTEtMzU0MDE4_566eaac0-0561-47c5-a54d-792394c835ba">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contributions to subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="cnc:CapitalContributionsToSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzgtMS0xLTEtMzU0MDE4_ec8f2344-591e-4a37-82d5-3a9e0e69f8e1">880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="cnc:CapitalContributionsToSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzgtMy0xLTEtMzU0MDE4_0f9a53d9-d1f8-46c8-9115-7ebcbf447e46">1,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="cnc:CapitalContributionsToSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzgtNS0xLTEtMzU0MDE4_dba937ee-37bb-4456-8391-3e3ac200d0c8">761</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzktMS0xLTEtMzU0MDE4_a8894d01-e490-4f5f-908e-49ca2a137c4a">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzktMy0xLTEtMzU0MDE4_00d9e5d2-36f0-4791-b950-0a066880f89c">723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzktNS0xLTEtMzU0MDE4_37e1430d-6ac6-47bf-a247-df56d0ca61b3">111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and maturities of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEwLTEtMS0xLTM1NDAxOA_af65c466-0539-4e4d-a466-86b73b1c6845">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEwLTMtMS0xLTM1NDAxOA_dd17a15b-e663-4807-8f39-f5f83976538a">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEwLTUtMS0xLTM1NDAxOA_52e2a3bb-1a02-45d4-9a53-5608bd216ad5">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends from subsidiaries, return of investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:CashDividendsPaidToParentCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzExLTEtMS0xLTM1NDAxOA_4b156c8c-918e-4b6d-80e5-bd0aec3d3afc">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:CashDividendsPaidToParentCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzExLTMtMS0xLTM1NDAxOA_26a3c2dd-a780-4b88-99db-8156edfbf46a">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:CashDividendsPaidToParentCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzExLTUtMS0xLTM1NDAxOA_e1a5aaa8-9401-4d2a-a93c-284848b65553">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEyLTEtMS0xLTM1NDAxOA_d760cf05-1af6-424c-befa-dfdb13a1f1f7">2,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEyLTMtMS0xLTM1NDAxOA_59cfab72-8745-4951-9ed6-63513af17138">151</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEyLTUtMS0xLTM1NDAxOA_365af0f4-e597-4d16-806d-d82a066ea86f">7,188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEzLTEtMS0xLTM1NDAxOA_6d04d3d7-a850-4103-a813-24dc609f2903">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEzLTMtMS0xLTM1NDAxOA_70f3d456-c1fb-4603-8269-60d34acb2a24">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEzLTUtMS0xLTM1NDAxOA_6836db80-2fce-4896-bb3b-0ee8cd890426">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="cnc:ProceedsFromPaymentsForIntercompanyActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE0LTEtMS0xLTM1NDAxOA_ea3f13f9-0946-41e3-b59a-f52466ed08e1">5,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" sign="-" name="cnc:ProceedsFromPaymentsForIntercompanyActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE0LTMtMS0xLTM1NDAxOA_2ec6750a-a6cc-43a7-9cdb-dfd93dc2147b">1,709</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="cnc:ProceedsFromPaymentsForIntercompanyActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE0LTUtMS0xLTM1NDAxOA_6c555001-489d-408f-b2c7-0c9b7dd2fe43">1,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investing activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE1LTEtMS0xLTM1NDAxOA_5f1b803d-78db-4422-8ece-6d258b4be0bf">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE1LTMtMS0xLTM1NDAxOA_54603a0a-5729-460c-a7e9-50b5f4bda23b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE1LTUtMS0xLTM1NDAxOA_deb2d349-ef87-4e7a-a15a-16821ec45e05">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE2LTEtMS0xLTM1NDAxOA_bb20eedc-de80-4296-94c8-b357fa8a9983">2,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE2LTMtMS0xLTM1NDAxOA_138049d1-24c6-4e9e-bf5c-392387fcf9b4">3,363</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE2LTUtMS0xLTM1NDAxOA_8c39e3d2-8de3-4c0d-a914-14050097e156">6,256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE4LTEtMS0xLTM1NDAxOA_ab13e2ee-da1a-4d84-88f5-1c6f1efc133b">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE4LTMtMS0xLTM1NDAxOA_7962772e-00c2-4c3d-ae40-db2f32414e5c">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE4LTUtMS0xLTM1NDAxOA_11e07253-c9c0-4072-bd73-f26369314dd0">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE5LTEtMS0xLTM1NDAxOA_44de5993-6f44-4d9d-a8fa-7dbcb39555ee">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE5LTMtMS0xLTM1NDAxOA_b13538c6-66b8-4323-bd6b-d74f9adbeb5d">9,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE5LTUtMS0xLTM1NDAxOA_e851e791-c307-4506-bd5e-411f5a06f2b3">4,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and repurchases of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIwLTEtMS0xLTM1NDAxOA_f3222756-021f-4269-883e-4d72baa6a744">491</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIwLTMtMS0xLTM1NDAxOA_8087aa12-35f4-480e-8be9-7fca69bd2a91">7,207</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIwLTUtMS0xLTM1NDAxOA_3e5ce4d8-4cf8-4dfc-acbc-9e4e845dd0e9">3,875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIxLTEtMS0xLTM1NDAxOA_387a9068-f1c5-44f5-b2bb-3272c87847ca">3,096</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIxLTMtMS0xLTM1NDAxOA_1ac3a2c6-a6e4-4e24-bed0-c1709598ae4e">297</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIxLTUtMS0xLTM1NDAxOA_658ced1f-32b8-4b33-ba30-d63e373d23b8">626</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIzLTEtMS0xLTM1NDAxOA_f5f39ab5-efaa-425a-96d9-646dbc6f2110">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIzLTMtMS0xLTM1NDAxOA_d95bb1e2-9eb4-4e01-8644-b0ca6475d536">157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIzLTUtMS0xLTM1NDAxOA_7cc340a2-9472-4b69-958e-3210329a8e20">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI0LTEtMS0xLTM1NDAxOA_5a4d543b-a234-457c-9e2f-af624c66ac38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI0LTMtMS0xLTM1NDAxOA_0a870ba4-0a6a-4f6b-b886-1b4fe6d2d249">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI0LTUtMS0xLTM1NDAxOA_cda662d5-9ee9-4bf5-b10b-7f476e410345">120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI2LTEtMS0xLTM1NDAxOA_d0a72f51-bcd6-46f2-ae8f-9b4b81889c88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI2LTMtMS0xLTM1NDAxOA_89df214a-7748-472d-8142-d6791e2943da">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI2LTUtMS0xLTM1NDAxOA_00340182-1bbe-4799-a89a-38634f2c5b48">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI3LTEtMS0xLTM1NDAxOA_095b95d1-1816-4152-a95c-319d534480d0">3,456</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI3LTMtMS0xLTM1NDAxOA_6d512e99-b487-4b45-8431-f7300420a1c8">1,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI3LTUtMS0xLTM1NDAxOA_02b91e74-fe55-472c-930e-a0a577b7c61c">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI5LTEtMS0xLTM1NDAxOA_aa54e01a-6c85-4df9-9f3c-28bd10999b89">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI5LTMtMS0xLTM1NDAxOA_94e6c74c-9ebb-4870-a9ba-968956acac87">659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI5LTUtMS0xLTM1NDAxOA_81b777f7-f395-4463-8750-6d5ae50ac29d">5,589</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> beginning of period</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMwLTEtMS0xLTM1NDAxOA_877c6cf3-c071-4c04-af8e-f2f3b1040ab0">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f75ea8b064c4d4a8f2d206bf5351a9c_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMwLTMtMS0xLTM1NDAxOA_42cf9bfe-9cb6-4ef9-9eff-aae41b024b8e">668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41f276fba4a64c09ba22940633f73652_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMwLTUtMS0xLTM1NDAxOA_429b34b5-6c9b-4235-8739-7148f1b6a17e">6,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMxLTEtMS0xLTM1NDAxOA_24a52da7-5446-4f1a-b83e-17b3e8fcbe0c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMxLTMtMS0xLTM1NDAxOA_d37625f8-8ac9-4e04-975c-b46c0088605a">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f75ea8b064c4d4a8f2d206bf5351a9c_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMxLTUtMS0xLTM1NDAxOA_52d81a78-c4de-4f36-9fb4-c51352b03ea2">668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed financial information of registrant.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i7917ec5d4ac045dbbbae64836ab8a40d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Information of Registrant</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note A - Basis of Presentation and Significant Accounting Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parent company only financial statements should be read in conjunction with Centene Corporation's audited consolidated financial statements and the notes to consolidated financial statements included in this Form 10-K.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parent company's investment in subsidiaries is stated at cost plus equity in undistributed earnings of the subsidiaries. The parent company's share of net income of its unconsolidated subsidiaries is included in income using the equity method of accounting. Certain unrestricted subsidiaries receive monthly management fees from the Company's restricted subsidiaries. The management and service fees received by its unrestricted subsidiaries are associated with all of the functions required to manage the restricted subsidiaries including but not limited to salaries and wages for all personnel, rent, utilities, population health management, provider contracting, compliance, member services, claims processing, information technology, cash management, finance and accounting, and other services. The management fees are based either on a percentage of the restricted subsidiaries' revenue or a cost basis reimbursement.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the Company's centralized cash management function, cash flows generated by its unrestricted subsidiaries are utilized by the parent company to the extent required, primarily to repay borrowings on the parent company's credit facilities, repurchase the parent company's common stock, make acquisitions, fund capital contributions to subsidiaries, and fund its operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts presented in the parent company only financial statements are eliminated in the consolidated financial statements of Centene Corporation.</span></div></ix:continuation><div id="i9dee570cfbd043d6a1700298c14b2446_175"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i9dee570cfbd043d6a1700298c14b2446_178"></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Controls and Procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of December&#160;31, 2022. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls, and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of December&#160;31, 2022, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management's Report on Internal Control Over Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Internal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Control - Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our management concluded that our internal control over financial reporting was effective at the reasonable assurance level as of December&#160;31, 2022. Our management's assessment of the effectiveness of our internal control over financial reporting as of December&#160;31, 2022, has been audited by KPMG LLP, an independent registered public accounting firm, as stated in their report which is included herein.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the year ended December&#160;31, 2022, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_181"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and Board of Directors</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Centene Corporation:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opinion on Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Centene Corporation and subsidiaries' (the Company) internal control over financial reporting as of December&#160;31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December&#160;31, 2022 and 2021, the related consolidated statements of operations, comprehensive earnings (loss), stockholders' equity, and cash flows for each of the years in the three-year period ended December&#160;31, 2022, and the related notes (collectively, the consolidated financial statements), and our report dated February&#160;21, 2023, expressed an unqualified opinion on those consolidated financial statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinion </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2)&#160;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ KPMG LLP</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">St. Louis, Missouri</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;21, 2023 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_184"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 20, 2023, in connection with the appointment of Kenneth Fasola as President of the Company and James E. Murray as Chief Operating Officer of the Company in December 2022, the Company entered into employment agreements with Messrs. Fasola and Murray. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of Mr. Fasola's employment agreement, Mr. Fasola will receive (i) an annual base salary of $1,100,000, (ii) an annual cash incentive bonus target under the Centene Corporation Short-Term Executive Compensation Plan of 125% of base salary, (iii) long-term equity incentive awards under the Centene Corporation 2012 Stock Incentive Plan, as amended (the "2012 Plan") with amounts and terms determined by the Compensation Committee (with an aggregate grant date value of $6,025,000 for 2023), (iv) a one-time $1,000,000 cash award, and (v) cash severance upon a qualifying termination equal to annual base salary, a prorated annual bonus, and continued medical benefits at active employee rates for 12 months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of Mr. Murray's employment agreement, Mr. Murray will receive (i) an annual base salary of $750,000, (ii) an annual cash incentive bonus target under the Centene Corporation Short-Term Executive Compensation Plan of 100% of base salary, (iii) long-term equity incentive awards under the 2012 Plan with amounts and terms determined by the Compensation Committee (with an aggregate grant date value of $4,250,000 for 2023), and (iv) cash severance upon a qualifying termination equal to annual base salary, a prorated annual bonus, and continued medical benefits at active employee rates for 12 months.</span></div><div id="i9dee570cfbd043d6a1700298c14b2446_187"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable</span></div><div id="i9dee570cfbd043d6a1700298c14b2446_190"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III </span></div><div id="i9dee570cfbd043d6a1700298c14b2446_193"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Directors, Executive Officers and Corporate Governance</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a) Directors of the Registrant </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning our directors will appear in our Proxy Statement for our 2023 annual meeting of stockholders under "Proposal One: Election of Directors." This portion of the Proxy Statement is incorporated herein by reference.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b) Information about our Executive Officers</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to General Instruction G(3) to Form 10-K and the Instruction to Item 401 of Regulation S-K, information regarding our executive officers is provided in Item 1 of Part I of this Annual Report on Form 10-K under the caption "Information about our Executive Officers."</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning our executive officers' compliance with Section 16(a) of the Exchange Act will appear in our Proxy Statement for our 2023 annual meeting of stockholders under "Delinquent Section 16(a) Reports," if applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c) Corporate Governance </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning certain&#160;corporate governance matters, including information concerning our audit committee financial expert and identification of our Audit and Compliance Committee, and our code of ethics will appear in our Proxy Statement for our 2023 annual meeting of stockholders under "Corporate Governance." These portions of our Proxy Statement&#160;are incorporated herein by reference. </span></div><div id="i9dee570cfbd043d6a1700298c14b2446_196"></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning executive compensation will appear in our Proxy Statement for our 2023 Annual Meeting of Stockholders under "Executive Compensation." Information concerning Compensation and Talent Committee interlocks and insider participation will appear in the Proxy Statement for our 2023 Annual Meeting of Stockholders under "Compensation Committee Interlocks and Insider Participation." These portions of the Proxy Statement are incorporated herein by reference. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_199"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning the security ownership of certain beneficial owners and management and our equity compensation plans will appear in our Proxy Statement for our 2023 annual meeting of stockholders under "Beneficial Stock Ownership" and "Equity Compensation Plan Information." These portions of the Proxy Statement are incorporated herein by reference. </span></div><div id="i9dee570cfbd043d6a1700298c14b2446_202"></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Relationships and Related Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and Director Independence</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning director independence, certain relationships, and related transactions will appear in our Proxy Statement for our 2023 annual meeting of stockholders under "Corporate Governance," "Independence of Directors," and "Related Party Transactions." These portions of our Proxy Statement are incorporated herein by reference.</span></div><div id="i9dee570cfbd043d6a1700298c14b2446_205"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principal Accountant Fees and Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent registered public accounting firm is <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8yMDUvZnJhZzphMzY3YTg1MDU0NWE0ZTExYWU0NThkNjJiNDE5OGE3ZC90ZXh0cmVnaW9uOmEzNjdhODUwNTQ1YTRlMTFhZTQ1OGQ2MmI0MTk4YTdkXzQ3NQ_d48a3930-781b-4977-ad87-6e5c377d6849">KPMG LLP</ix:nonNumeric>, <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8yMDUvZnJhZzphMzY3YTg1MDU0NWE0ZTExYWU0NThkNjJiNDE5OGE3ZC90ZXh0cmVnaW9uOmEzNjdhODUwNTQ1YTRlMTFhZTQ1OGQ2MmI0MTk4YTdkXzQ3Ng_b04ad614-1848-4cb1-a89b-2e03929d92ac">St. Louis, MO</ix:nonNumeric>. The Auditor Firm ID is <ix:nonNumeric contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8yMDUvZnJhZzphMzY3YTg1MDU0NWE0ZTExYWU0NThkNjJiNDE5OGE3ZC90ZXh0cmVnaW9uOmEzNjdhODUwNTQ1YTRlMTFhZTQ1OGQ2MmI0MTk4YTdkXzE1Ng_19b45f8e-86a1-40b1-bd37-f46081cea788">185</ix:nonNumeric>.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning principal accountant fees and services will appear in our Proxy Statement for our 2023 annual meeting of stockholders under "Proposal Four: Ratification of Appointment of Independent Registered Public Accounting Firm." This portion of our Proxy Statement is incorporated herein by reference. </span></div><div id="i9dee570cfbd043d6a1700298c14b2446_208"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exhibits and Financial Statement Schedules </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.91pt">Financial Statements and Schedules</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed under Item 8 of this report: </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:45pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Financial Statements:</span></div><div style="padding-left:45pt;text-indent:-9pt"><span><br/></span></div><div style="padding-left:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="padding-left:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Balance Sheets as of December 31, 2022 and 2021 </span></div><div style="padding-left:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Operations for the years ended December 31, 2022, 2021 and 2020 </span></div><div style="padding-left:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Comprehensive Earnings (Loss) for the years ended December 31, 2022, 2021 and 2020</span></div><div style="padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Stockholders' Equity for the years ended December 31, 2022, 2021 and 2020 </span></div><div style="padding-left:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Cash Flows for the years ended December 31, 2022, 2021 and 2020 </span></div><div style="padding-left:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="padding-left:45pt;text-indent:-9pt"><span><br/></span></div><div style="padding-left:45pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Financial Statement Schedules:</span></div><div style="padding-left:45pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-left:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="padding-left:45pt;text-indent:-9pt"><span><br/></span></div><div style="padding-left:45pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;The exhibits listed in the accompanying Exhibit Index are filed or incorporated by reference as part of this filing.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_211"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">INCORPORATED BY REFERENCE</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">EXHIBIT NUMBER</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">DESCRIPTION&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FILED WITH <br/>THIS FORM<br/>10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FORM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FILING DATE WITH SEC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">EXHIBIT NUMBER</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000119312519087588/d612092dex21.htm">Agreement and Plan of Merger, dated as of March 26, 2019, by and among Centene Corporation, Wellington Merger Sub I, Inc., Wellington Merger Sub II, Inc., and WellCare Health Plans, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 27, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000114036121000086/brhc10018583_ex2-1.htm">Agreement and Plan of Merger, dated as of January 4, 2021, by and among Centene Corporation, Mayflower Merger Sub, Inc. and Magellan Health, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 4, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173922000331/a20220927exhibit31.htm">Amended and Restated Certificate of Incorporation of Centene Corporation, dated September 27, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173922000331/a20220927exhibit32.htm">Amended and Restated By-laws of Centene Corporation, effective September 27, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit41.htm">Description of Securities of the Company</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000114036119022065/nc10006710x1_ex4-2.htm">Indenture, dated as of December 6, 2019, by and between Centene Corporation, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to the Company's 4.25% Senior Notes due 2027 (including the Form of Global Note attached thereto)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 6, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000114036119022065/nc10006710x1_ex4-3.htm">Indenture, dated as of December 6, 2019, by and between Centene Corporation, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to the Company's 4.625% Senior Notes due 2029 (including the Form of Global Note attached thereto)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 6, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000114036120003140/nc10008630x1_ex4-1.htm">Indenture, dated as of February 13, 2020, by and between Centene Corporation, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to the Company's 3.375% Senior Notes due 2030 (including the Form of Global Note attached thereto)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000114036120022652/brhc10015782_ex4-1.htm">Base Indenture, dated as of October 7, 2020, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 7, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000114036120022652/brhc10015782_ex4-2.htm">First Supplemental Indenture, dated as of October 7, 2020, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 7, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000114036121005231/nt10019947x5_ex4-2.htm">Second Supplemental Indenture, dated as of February 17, 2021, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 17, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001071739/000114036121023163/nt10023682x6_ex4-2.htm">Third Supplemental Indenture, dated as of July 1, 2021, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000114036121028103/brhc10027869_ex4-4.htm">Fourth Supplemental Indenture, dated as of August 12, 2021, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 12, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000107173919000082/exhibit101q22019.htm">2002 Employee Stock Purchase Plan, As Amended and Restated</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 23, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000114036120012246/nt10012142x1_ex4-2.htm">Amendment No.1 to the 2002 Employee Stock Purchase Plan, As Amended and Restated</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001071739/000107173921000121/a20210430exhibit101.htm">Centene Corporation 2012 Stock Incentive Plan, as amended</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000107173915000092/exhibit101.htm">Amended and Restated Non-Employee Directors Deferred Stock Compensation Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 28, 2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit105.htm">Amended and Restated Voluntary Nonqualified Deferred Compensation Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173921000039/a2020123110-kexhibit106.htm">Centene Corporation 2007 Long-Term Incentive Plan, as Amended</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000107173911000012/exhibit1012.htm">Centene Corporation Short-Term Executive Compensation Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2011</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000119312504189970/dex101.htm">Executive Employment Agreement between Centene Corporation and Michael F. Neidorff, dated November 8, 2004</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 9, 2004</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8a</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000107173908000034/exhibit102.htm">Amendment No. 1 of Executive Employment Agreement between Centene Corporation and Michael F. Neidorff</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2008</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8b</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000107173909000011/exhibit102.htm">Amendment No. 2 of Executive Employment Agreement between Centene Corporation and Michael F. Neidorff</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 28, 2009</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8c</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000107173912000061/amendmentno3mfnagreement.htm">Amendment No. 3 of Executive Employment Agreement between Centene Corporation and Michael F. Neidorff</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 23, 2012</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8d</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000107173913000078/exhibit101.htm">Amendment No. 4 of Executive Employment Agreement between Centene Corporation and Michael F. Neidorff</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 16, 2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8e</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000107173916000319/exhibit101.htm">Amendment No. 5 of Executive Employment Agreement between Centene Corporation and Michael F. Neidorff</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 14, 2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8f</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000107173919000017/exhibit10120190204.htm">Amendment No. 6 of Executive Employment Agreement between Centene Corporation and Michael F. Neidorff</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 4, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8g</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173922000071/a2021123110-kexhibit108g.htm">Amendment No 7. of Executive Employment Agreement between Centene Corporation and Michael F. Neidorff</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8g</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8h</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173922000071/a2021123110-kexhibit108h.htm">Amendment No.8 of Executive Employment Agreement between Centene Corporation and Michael F. Neidorff</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8h</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000107173908000034/exhibit103.htm">Form of Executive Severance and Change in Control Agreement</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2008</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9a</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000107173912000061/amendmentno1executiveagree.htm">Amendment No. 1 of Form of Executive Severance and Change in Control Agreement</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 23, 2012</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9b</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000107173915000051/exhibit101.htm">Amendment No. 2 of Form of Executive Severance and Change in Control Agreement</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 28, 2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000107173908000034/exhibit105.htm">Form of Non-statutory Stock Option Agreement (Employees)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2008</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173921000039/a2020123110-kexhibit1011.htm">Form of Non-statutory Stock Option Agreement (Employees) #2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173922000071/a2021123110-kexhibit1012.htm">Form of Non-statutory Stock Option Agreement (Employees) #3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit1013.htm">Form of Non-statutory Stock Option Agreement (Directors)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit1014.htm">Form of Restricted Stock Agreement (Directors)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173917000018/exhibit1020.htm">Form of Restricted Stock Unit Agreement #1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173920000281/a20201215-exhibit101.htm">Form of Restricted Stock Unit Agreement #2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1071739/000107173917000018/exhibit1023.htm">Form of Performance Based Restricted Stock Unit Agreement #1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173920000281/a20201215-exhibit102.htm">Form of Performance Based Restricted Stock Unit Agreement #2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173920000281/a20201215-exhibit103.htm">Form of Long-Term Incentive Plan Agreement</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001071739/000114036121028770/brhc10028154_ex1-1.htm">Fourth Amended and Restated Credit Agreement, dated as of August 16, 2021, among the Company, Wells Fargo Bank, National Association, as administrative agent, and the lenders and other parties thereto </a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 18, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1071739/000114036121041462/brhc10031842_8k.htm">Cooperation Agreement between Centene Corporation and Politan Capital Management LP, dated December 14, 2021</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 14, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173922000286/a2022063010-qexhibit101.htm">Executive Employment Agreement between Centene Corporation and Sarah M. London, dated April 27, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 26, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22a</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit1022a.htm">Amendment of Executive Employment Agreement between Centene Corporation and Sarah M. London, dated February 20, 2023</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173922000286/a2022063010-qexhibit103.htm">Executive Employment Agreement between Centene Corporation and Andrew Asher, dated April 28, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 26, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23a</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit1023a.htm">Amendment of Executive Employment Agreement between Centene Corporation and Andrew Asher, dated February 20, 2023</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit1024.htm">Executive Employment Agreement between Centene Corporation and Kenneth Fasola, dated February 20, 2023</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit1025.htm">Executive Employment Agreement between Centene Corporation and James E. Murray, dated February 20, 2023</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173922000286/a2022063010-qexhibit102.htm">Executive Employment Agreement between Centene Corporation and Brent Layton, dated April 27, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 26, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26a</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173922000388/a20221214exhibit101.htm">Amendment of Executive Employment Agreement between Centene Corporation and Brent Layton dated December 13, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 14, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173921000039/a2020123110-kexhibit1025.htm">Transition Services Agreement between Centene Corporation and Kenneth Burdick, dated February 21, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1071739/000107173922000071/a2021123110-kexhibit1030.htm">Transition Agreement between Centene Corporation and Jesse Hunter, dated October 26, 2021</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/19411/000104746916012038/a2228053zdef14a.htm#dw15701_appendix_a">Magellan Health, Inc. 2016 Management Incentive Plan, effective as of May 18, 2016</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEF14A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 8, 2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/19411/000104746911003422/a2203181zdef14a.htm#ga45701_appendix_a">Magellan Health Services, Inc. 2011 Management Incentive Plan, effective as of May 18, 2011</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEF14A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 8, 2011</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit1031.htm">Executive Officer Cash Severance Policy</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit21.htm">List of subsidiaries</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit23.htm">Consent of Independent Registered Public Accounting Firm incorporated by reference in each prospectus constituting part of the Registration Statements on Form S-8 (File Numbers 333-261993, 333-255735, 333-238597, 333-236036, 333-217634, 333-210376, 333-197737, 333-180976, 333-108467, and 333-90976) and on Form S-3 (File Number</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit23.htm"> 333-238050</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit23.htm">)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit311.htm">Certification Pursuant to Rule 13a-14(a) and 15d-14(a) of the Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit312.htm">Certification Pursuant to Rule 13a-14(a) and 15d-14(a) of the Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Chief Financial Officer)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit321.htm">Certification Pursuant to 18 U.S.C. Section 1350 (Chief Executive Officer)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022123110-kexhibit322.htm">Certification Pursuant to 18 U.S.C. Section 1350 (Chief Financial Officer)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the Centene Corporation Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Earnings (Loss), (iv) the Consolidated Statements of Stockholders' Equity, (v) the Consolidated Statements of Cash Flows and (vi) related notes.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">1 SEC File No. 001-06639</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">+ Schedules (as similar attachments) have been omitted from this filing pursuant to Item 601(a)(5) of Regulation S-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;* Indicates a management contract or compensatory plan or arrangement. </span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><div id="i9dee570cfbd043d6a1700298c14b2446_214"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Form 10-K Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9dee570cfbd043d6a1700298c14b2446_7">Table of Contents</a></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i9dee570cfbd043d6a1700298c14b2446_217"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, as of February&#160;21, 2023. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.000%"><tr><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.404%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CENTENE CORPORATION</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;SARAH M. LONDON</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sarah M. London<br/>Chief Executive Officer</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities as indicated, as of February&#160;21, 2023. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Signature</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;Sarah M. London</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer<br/>(principal executive officer)</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sarah M. London</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Andrew L. Asher</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer <br/>(principal financial officer)</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Andrew L. Asher</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Katie N. Casso</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Corporate Controller and Chief Accounting Officer <br/>(principal accounting officer)</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Katie N. Casso</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Orlando Ayala</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Orlando Ayala</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jessica L. Blume</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jessica L. Blume</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kenneth A. Burdick</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Kenneth A. Burdick</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christopher J. Coughlin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Christopher J. Coughlin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ H. James Dallas</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">H. James Dallas</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Wayne S. DeVeydt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Wayne S. DeVeydt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Fred H. Eppinger</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fred H. Eppinger</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Monte E. Ford</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Monte E. Ford</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Richard A. Gephardt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Richard A. Gephardt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Lori J. Robinson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lori J. Robinson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Theodore R. Samuels</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Theodore R. Samuels</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ William L. Trubeck</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">William L. Trubeck</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>cnc-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0b97e17d-6106-45f4-89d6-4fad8114f6eb,g:0be59ac2-4e57-4dab-9620-00ce2b3b169c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cnc="http://www.centene.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.centene.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnc-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnc-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnc-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnc-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.centene.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.centene.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandOperations" roleURI="http://www.centene.com/role/OrganizationandOperations">
        <link:definition>0000010 - Disclosure - Organization and Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000011 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestitures" roleURI="http://www.centene.com/role/AcquisitionsandDivestitures">
        <link:definition>0000012 - Disclosure - Acquisitions and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandLongtermInvestmentsRestrictedDeposits" roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits">
        <link:definition>0000013 - Disclosure - Short-term and Long-term Investments, Restricted Deposits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.centene.com/role/FairValueMeasurements">
        <link:definition>0000014 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertySoftwareandEquipment" roleURI="http://www.centene.com/role/PropertySoftwareandEquipment">
        <link:definition>0000015 - Disclosure - Property, Software and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.centene.com/role/GoodwillandIntangibleAssets">
        <link:definition>0000016 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsLiability" roleURI="http://www.centene.com/role/MedicalClaimsLiability">
        <link:definition>0000017 - Disclosure - Medical Claims Liability</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffordableCareAct" roleURI="http://www.centene.com/role/AffordableCareAct">
        <link:definition>0000018 - Disclosure - Affordable Care Act</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.centene.com/role/Debt">
        <link:definition>0000019 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.centene.com/role/Leases">
        <link:definition>0000020 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.centene.com/role/StockholdersEquity">
        <link:definition>0000021 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatutoryCapitalRequirementsandDividendRestrictions" roleURI="http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictions">
        <link:definition>0000022 - Disclosure - Statutory Capital Requirements and Dividend Restrictions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.centene.com/role/IncomeTaxes">
        <link:definition>0000023 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlans" roleURI="http://www.centene.com/role/StockIncentivePlans">
        <link:definition>0000024 - Disclosure - Stock Incentive Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlan" roleURI="http://www.centene.com/role/RetirementPlan">
        <link:definition>0000025 - Disclosure - Retirement Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Commitments" roleURI="http://www.centene.com/role/Commitments">
        <link:definition>0000026 - Disclosure - Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.centene.com/role/Contingencies">
        <link:definition>0000027 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.centene.com/role/EarningsPerShare">
        <link:definition>0000028 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.centene.com/role/SegmentInformation">
        <link:definition>0000029 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedFinancialInformationofRegistrant" roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrant">
        <link:definition>0000030 - Disclosure - Condensed Financial Information of Registrant</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000031 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000032 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresTables" roleURI="http://www.centene.com/role/AcquisitionsandDivestituresTables">
        <link:definition>0000033 - Disclosure - Acquisitions and Divestitures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandLongtermInvestmentsRestrictedDepositsTables" roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables">
        <link:definition>0000034 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.centene.com/role/FairValueMeasurementsTables">
        <link:definition>0000035 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertySoftwareandEquipmentTables" roleURI="http://www.centene.com/role/PropertySoftwareandEquipmentTables">
        <link:definition>0000036 - Disclosure - Property, Software and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.centene.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>0000037 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsLiabilityTables" roleURI="http://www.centene.com/role/MedicalClaimsLiabilityTables">
        <link:definition>0000038 - Disclosure - Medical Claims Liability (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffordableCareActTables" roleURI="http://www.centene.com/role/AffordableCareActTables">
        <link:definition>0000039 - Disclosure - Affordable Care Act (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.centene.com/role/DebtTables">
        <link:definition>0000040 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.centene.com/role/LeasesTables">
        <link:definition>0000041 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.centene.com/role/StockholdersEquityTables">
        <link:definition>0000042 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.centene.com/role/IncomeTaxesTables">
        <link:definition>0000043 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansTables" roleURI="http://www.centene.com/role/StockIncentivePlansTables">
        <link:definition>0000044 - Disclosure - Stock Incentive Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.centene.com/role/EarningsPerShareTables">
        <link:definition>0000045 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.centene.com/role/SegmentInformationTables">
        <link:definition>0000046 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedFinancialInformationofRegistrantTables" roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantTables">
        <link:definition>0000047 - Disclosure - Condensed Financial Information of Registrant (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandOperationsDetails" roleURI="http://www.centene.com/role/OrganizationandOperationsDetails">
        <link:definition>0000048 - Disclosure - Organization and Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails" roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails">
        <link:definition>0000049 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property, Software and Equipment Depreciation Periods (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails" roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails">
        <link:definition>0000050 - Disclosure - Summary of Significant Accounting Policies - Schedule of Amortization Period for Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofAllowanceforUncollectibleAccountsDetails" roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAllowanceforUncollectibleAccountsDetails">
        <link:definition>0000051 - Disclosure - Summary of Significant Accounting Policies - Schedule of Allowance for Uncollectible Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSignificantCustomersDetails" roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails">
        <link:definition>0000052 - Disclosure - Summary of Significant Accounting Policies - Significant Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresNarrativeDetails" roleURI="http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails">
        <link:definition>0000053 - Disclosure - Acquisitions and Divestitures - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>0000054 - Disclosure - Acquisitions and Divestitures - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" roleURI="http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails">
        <link:definition>0000055 - Disclosure - Acquisitions and Divestitures - Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresDivestituresDetails" roleURI="http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails">
        <link:definition>0000056 - Disclosure - Acquisitions and Divestitures - Divestitures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails">
        <link:definition>0000057 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails">
        <link:definition>0000058 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails" roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails">
        <link:definition>0000059 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-for-Sale Investments in a Continuous Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails">
        <link:definition>0000060 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>0000061 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.centene.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>0000062 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertySoftwareandEquipmentComponentsDetails" roleURI="http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails">
        <link:definition>0000063 - Disclosure - Property, Software and Equipment - Components (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertySoftwareandEquipmentNarrativeDetails" roleURI="http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails">
        <link:definition>0000064 - Disclosure - Property, Software and Equipment - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails" roleURI="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails">
        <link:definition>0000065 - Disclosure - Goodwill and Intangible Assets - Schedule of Changes in Goodwill by Operating Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNarrativeDetails" roleURI="http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails">
        <link:definition>0000066 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails" roleURI="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails">
        <link:definition>0000067 - Disclosure - Goodwill and Intangible Assets - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpensesDetails" roleURI="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpensesDetails">
        <link:definition>0000068 - Disclosure - Goodwill and Intangible Assets - Schedule of Future Amortization Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" roleURI="http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails">
        <link:definition>0000069 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsLiabilityNarrativeDetails" roleURI="http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails">
        <link:definition>0000070 - Disclosure - Medical Claims Liability - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails" roleURI="http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails">
        <link:definition>0000071 - Disclosure - Medical Claims Liability - Cumulative Incurred and Paid Claims (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails" roleURI="http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails">
        <link:definition>0000072 - Disclosure - Medical Claims Liability - Incurred Claims and Allocated Claims Adjustment Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffordableCareActDetails" roleURI="http://www.centene.com/role/AffordableCareActDetails">
        <link:definition>0000073 - Disclosure - Affordable Care Act (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofDebtDetails" roleURI="http://www.centene.com/role/DebtScheduleofDebtDetails">
        <link:definition>0000074 - Disclosure - Debt - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofDebtDetails_1" roleURI="http://www.centene.com/role/DebtScheduleofDebtDetails_1">
        <link:definition>0000074 - Disclosure - Debt - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtAdditionalInformationDetails" roleURI="http://www.centene.com/role/DebtAdditionalInformationDetails">
        <link:definition>0000075 - Disclosure - Debt - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSeniorNotesDetails" roleURI="http://www.centene.com/role/DebtSeniorNotesDetails">
        <link:definition>0000076 - Disclosure - Debt - Senior Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails" roleURI="http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails">
        <link:definition>0000077 - Disclosure - Debt - Foreign Currency Swaps and Circle Health Debt Refinancing (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtRevolvingCreditFacilityandTermLoanDetails" roleURI="http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails">
        <link:definition>0000078 - Disclosure - Debt - Revolving Credit Facility and Term Loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtConstructionLoanDetails" roleURI="http://www.centene.com/role/DebtConstructionLoanDetails">
        <link:definition>0000079 - Disclosure - Debt - Construction Loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDebtRepurchaseProgramDetails" roleURI="http://www.centene.com/role/DebtDebtRepurchaseProgramDetails">
        <link:definition>0000080 - Disclosure - Debt - Debt Repurchase Program (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtLettersofCreditSuretyBondsDetails" roleURI="http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails">
        <link:definition>0000081 - Disclosure - Debt - Letters of Credit &amp; Surety Bonds (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofAggregateMaturitiesofDebtDetails" roleURI="http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails">
        <link:definition>0000082 - Disclosure - Debt - Schedule of Aggregate Maturities of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.centene.com/role/LeasesNarrativeDetails">
        <link:definition>0000083 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesROUAssetsandLiabilitiesDetails" roleURI="http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails">
        <link:definition>0000084 - Disclosure - Leases - ROU Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesOperatingLeaseMaturityDetails" roleURI="http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails">
        <link:definition>0000085 - Disclosure - Leases - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesOperatingLeaseMaturityDetails_1" roleURI="http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails_1">
        <link:definition>0000085 - Disclosure - Leases - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.centene.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>0000086 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityShareRepurchaseActivityDetails" roleURI="http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails">
        <link:definition>0000087 - Disclosure - Stockholders' Equity -Share Repurchase Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatutoryCapitalRequirementsandDividendRestrictionsDetails" roleURI="http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictionsDetails">
        <link:definition>0000088 - Disclosure - Statutory Capital Requirements and Dividend Restrictions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesConsolidatedIncomeTaxExpenseDetails" roleURI="http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails">
        <link:definition>0000089 - Disclosure - Income Taxes - Consolidated Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails" roleURI="http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails">
        <link:definition>0000090 - Disclosure - Income Taxes - Reconciliation of the Tax Provision at the U.S. Federal Statutory Rate to the Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>0000091 - Disclosure - Income Taxes - Tax Effects of Temporary Differences Which Give Rise to Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.centene.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000092 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails" roleURI="http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails">
        <link:definition>0000093 - Disclosure - Income Taxes - Schedule of Reserve for Uncertain Tax Positions That May be Challenged (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansNarrativeDetails" roleURI="http://www.centene.com/role/StockIncentivePlansNarrativeDetails">
        <link:definition>0000094 - Disclosure - Stock Incentive Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails" roleURI="http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails">
        <link:definition>0000095 - Disclosure - Stock Incentive Plans - Non-Vested Restricted Stock and Restricted Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlanDetails" roleURI="http://www.centene.com/role/RetirementPlanDetails">
        <link:definition>0000096 - Disclosure - Retirement Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsDetails" roleURI="http://www.centene.com/role/CommitmentsDetails">
        <link:definition>0000097 - Disclosure - Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesDetails" roleURI="http://www.centene.com/role/ContingenciesDetails">
        <link:definition>0000098 - Disclosure - Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.centene.com/role/EarningsPerShareDetails">
        <link:definition>0000099 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDetails" roleURI="http://www.centene.com/role/SegmentInformationDetails">
        <link:definition>0000100 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails">
        <link:definition>0000101 - Disclosure - Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails" roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails">
        <link:definition>0000102 - Disclosure - Condensed Financial Information of Registrant - Condensed Balance Sheets Additional (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails" roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails">
        <link:definition>0000103 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails">
        <link:definition>0000104 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cnc_EmployeeStockCompensationPlanMember" abstract="true" name="EmployeeStockCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_CircleHealthMember" abstract="true" name="CircleHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_DeferredTaxAssetSoftwareDevelopmentCosts" abstract="false" name="DeferredTaxAssetSoftwareDevelopmentCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cnc_MagellanSpecialtyHealthMember" abstract="true" name="MagellanSpecialtyHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_AffordableCareActCostSharingReductionsPayable" abstract="false" name="AffordableCareActCostSharingReductionsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_DefinedContributionPlanMinimumAgeForCoverage" abstract="false" name="DefinedContributionPlanMinimumAgeForCoverage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cnc_FurnitureAndOfficeEquipmentMember" abstract="false" name="FurnitureAndOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_RealEstateOwnedAndRelatedFixedAssetsMember" abstract="true" name="RealEstateOwnedAndRelatedFixedAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration" abstract="false" name="DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation" abstract="false" name="TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cnc_A2200Million250SeniorNotesDue2031Member" abstract="true" name="A2200Million250SeniorNotesDue2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease" abstract="false" name="AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_ProviderContractsMember" abstract="false" name="ProviderContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_OtherCommitmentExpense" abstract="false" name="OtherCommitmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_HealthSmartMember" abstract="true" name="HealthSmartMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit" abstract="false" name="AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_ComputerHardwareMember" abstract="false" name="ComputerHardwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_AffordableCareActCostSharingReductionReceivable" abstract="false" name="AffordableCareActCostSharingReductionReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock" abstract="false" name="StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cnc_ACAHealthInsurerFee" abstract="false" name="ACAHealthInsurerFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_AffordableCareActReinsurancePayable" abstract="false" name="AffordableCareActReinsurancePayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_DebtTotalMember" abstract="true" name="DebtTotalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_A1800Million245SeniorNotesDueMarch2028Member" abstract="true" name="A1800Million245SeniorNotesDueMarch2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_SpecialtyServicesMember" abstract="true" name="SpecialtyServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_PremiumTaxExpense" abstract="false" name="PremiumTaxExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_CapitalContributionsToSubsidiaries" abstract="false" name="CapitalContributionsToSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_A2500Million425SeniorNotesDueDecember2027Member" abstract="true" name="A2500Million425SeniorNotesDueDecember2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_AffordableCareActMinimumMedicalLossRatio" abstract="false" name="AffordableCareActMinimumMedicalLossRatio" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration" abstract="false" name="InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_PANTHERxRareMember" abstract="true" name="PANTHERxRareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_SignificantCustomersPolicyTextBlock" abstract="false" name="SignificantCustomersPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cnc_GrossDecreasesAbstract" abstract="true" name="GrossDecreasesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cnc_DebtInstrumentExtensionTerm" abstract="false" name="DebtInstrumentExtensionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cnc_RxAdvanceMember" abstract="true" name="RxAdvanceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue" abstract="false" name="LifeInsuranceContractsAndEquityInvestmentsFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock" abstract="false" name="PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cnc_StockRepurchaseProgramIncreaseAuthorizedAmount" abstract="false" name="StockRepurchaseProgramIncreaseAuthorizedAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms" abstract="false" name="AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_A3500Million4625SeniorNotesDueDecember2029Member" abstract="true" name="A3500Million4625SeniorNotesDueDecember2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_DebtInstrumentPaymentPeriodTwoMember" abstract="true" name="DebtInstrumentPaymentPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit" abstract="false" name="LineofCreditFacilityAccordionFeatureIncreaseLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram" abstract="false" name="TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cnc_PremiumTaxRevenue" abstract="false" name="PremiumTaxRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember" abstract="true" name="LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_AcceleratedShareRepurchasesDiscountPricePerShare" abstract="false" name="AcceleratedShareRepurchasesDiscountPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss" abstract="false" name="DeferredTaxAssetsInvestmentUnrealizedGainLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock" abstract="false" name="OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease" abstract="false" name="LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock" abstract="false" name="ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cnc_SterlingOvernightIndexAverageSONIAMember" abstract="true" name="SterlingOvernightIndexAverageSONIAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_RestrictedCashEquivalentsMember" abstract="true" name="RestrictedCashEquivalentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_AffordableCareActDisclosureTextBlock" abstract="false" name="AffordableCareActDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cnc_RestrictedCertificatesOfDepositMember" abstract="true" name="RestrictedCertificatesOfDepositMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_DeferredTaxLiabilitiesRightOfUseAssets" abstract="false" name="DeferredTaxLiabilitiesRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember" abstract="true" name="LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries" abstract="false" name="NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_A2200Million475SeniorNotesDueJanuary2025Member" abstract="true" name="A2200Million475SeniorNotesDueJanuary2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_AffordableCareActAbstract" abstract="true" name="AffordableCareActAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock" abstract="false" name="ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cnc_DebtSecuritiesAvailableForSaleNumberOfPositions" abstract="false" name="DebtSecuritiesAvailableForSaleNumberOfPositions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cnc_MagellanHealthMember" abstract="true" name="MagellanHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cnc_A2200Million30SeniorNotesDueOctober2030Member" abstract="true" name="A2200Million30SeniorNotesDueOctober2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired" abstract="false" name="UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_OtherCommitmentsPaid" abstract="false" name="OtherCommitmentsPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_InvestmentSecuritiesMember" abstract="true" name="InvestmentSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_SpanishAndCentralEuropeanBusinessesMember" abstract="true" name="SpanishAndCentralEuropeanBusinessesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock" abstract="false" name="ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cnc_WellCareHealthPlansIncMember" abstract="true" name="WellCareHealthPlansIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount" abstract="false" name="DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_ProceedsFromPaymentsForIntercompanyActivities" abstract="false" name="ProceedsFromPaymentsForIntercompanyActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_PercentageOfRevenuesUnderContractsOrSubcontracts" abstract="false" name="PercentageOfRevenuesUnderContractsOrSubcontracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion" abstract="false" name="GainLossOnExtinguishmentOfDebtIncludingCashPortion" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_A2000Million3375SeniorNotesDueFebruary2030Member" abstract="true" name="A2000Million3375SeniorNotesDueFebruary2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_RatedSecuritiesMember" abstract="true" name="RatedSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_DividendsfromSubsidiariesOperatingActivities" abstract="false" name="DividendsfromSubsidiariesOperatingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock" abstract="false" name="FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cnc_LongTermInvestmentServiceCenterinCaliforniaMember" abstract="true" name="LongTermInvestmentServiceCenterinCaliforniaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_AcceleratedShareRepurchasesAgreementAmount" abstract="false" name="AcceleratedShareRepurchasesAgreementAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cnc_FixedAssetsLeasedRealEstateMember" abstract="true" name="FixedAssetsLeasedRealEstateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_A2300Million245SeniorNotesDueJuly2028Member" abstract="true" name="A2300Million245SeniorNotesDueJuly2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest" abstract="false" name="LossEarningsAttributableToFlowThroughNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost" abstract="false" name="InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_FinanceLeaseLiabilityAndOther" abstract="false" name="FinanceLeaseLiabilityAndOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_DebtInstrumentPaymentPeriodOneMember" abstract="true" name="DebtInstrumentPaymentPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_DebtInstrumentPaymentPeriodThreeMember" abstract="true" name="DebtInstrumentPaymentPeriodThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture" abstract="false" name="SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill" abstract="false" name="EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_DeferredTaxAssetPremiumAndTradeReceivables" abstract="false" name="DeferredTaxAssetPremiumAndTradeReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember" abstract="true" name="LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_GainLossOnDispositionOfBusinessNetOfTax" abstract="false" name="GainLossOnDispositionOfBusinessNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_ReturnofPremiumPayable" abstract="false" name="ReturnofPremiumPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_CenturionMember" abstract="true" name="CenturionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest" abstract="false" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember" abstract="true" name="LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_SeniorNotesTotal" abstract="false" name="SeniorNotesTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_TermLoanCreditAgreementMember" abstract="true" name="TermLoanCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock" abstract="false" name="HealthInsuranceMarketplaceDisclosurePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cnc_GrossIncreasesAbstract" abstract="true" name="GrossIncreasesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cnc_A2200Million250SeniorNotesDueMarch2031Member" abstract="true" name="A2200Million250SeniorNotesDueMarch2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue" abstract="false" name="InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_DebtInstrumentPaymentPeriodDomain" abstract="true" name="DebtInstrumentPaymentPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" abstract="false" name="DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes" abstract="false" name="TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_HealthInsurerFeeExpense" abstract="false" name="HealthInsurerFeeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_AffordableCareActRiskAdjustmentReceivable" abstract="false" name="AffordableCareActRiskAdjustmentReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims" abstract="false" name="ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock" abstract="false" name="ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cnc_DebtRepurchaseProgramAuthorizedAmount" abstract="false" name="DebtRepurchaseProgramAuthorizedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss" abstract="false" name="DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_AcceleratedShareRepurchaseAgreementMember" abstract="true" name="AcceleratedShareRepurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_OtherCommitmentEmployees" abstract="false" name="OtherCommitmentEmployees" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther" abstract="false" name="ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_FederalServicesMember" abstract="true" name="FederalServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_DebtInstrumentCovenantNetLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantNetLeverageRatioMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock" abstract="false" name="ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cnc_LesseeOperatingLeaseLeasesCommencedLiability" abstract="false" name="LesseeOperatingLeaseLeasesCommencedLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_MagellanRxMember" abstract="true" name="MagellanRxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_OtherCommitmentTerm" abstract="false" name="OtherCommitmentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage" abstract="false" name="NotesAcceptedForTenderOfferPrincipalOutstandingPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cnc_ManagedCareMember" abstract="true" name="ManagedCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_A1300Million2625SeniorNotesDueAugust2031Member" abstract="true" name="A1300Million2625SeniorNotesDueAugust2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract" abstract="true" name="StatutoryCapitalRequirementsAndDividendRestrictionsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration" abstract="false" name="DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_AssetImpairmentChargesNetOfTax" abstract="false" name="AssetImpairmentChargesNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_OtherCommitmentToBePaidYearOneAndYearTwo" abstract="false" name="OtherCommitmentToBePaidYearOneAndYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_A750Million5375SeniorNotesDueJune2026Member" abstract="true" name="A750Million5375SeniorNotesDueJune2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_DebtInstrumentAmortizationPaymentRatePercentage" abstract="false" name="DebtInstrumentAmortizationPaymentRatePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember" abstract="true" name="LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnc_DeferredTaxAssetOperatingLeaseLiability" abstract="false" name="DeferredTaxAssetOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnc_DebtInstrumentPaymentPeriodAxis" abstract="true" name="DebtInstrumentPaymentPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cnc_PurchaserBusinessGroupOnHealthMember" abstract="true" name="PurchaserBusinessGroupOnHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>3
<FILENAME>cnc-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0b97e17d-6106-45f4-89d6-4fad8114f6eb,g:0be59ac2-4e57-4dab-9620-00ce2b3b169c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="cnc-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9c3e7d25-77a8-4433-b517-e4c4724b0605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_8ea9fd0a-4908-4e27-a896-0fc5e2b67bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c3e7d25-77a8-4433-b517-e4c4724b0605" xlink:to="loc_us-gaap_PreferredStockValue_8ea9fd0a-4908-4e27-a896-0fc5e2b67bf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5516c695-0912-4b28-9115-559e214181da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c3e7d25-77a8-4433-b517-e4c4724b0605" xlink:to="loc_us-gaap_CommonStockValue_5516c695-0912-4b28-9115-559e214181da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9bd900fa-2726-425a-9bde-9c0a10988ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c3e7d25-77a8-4433-b517-e4c4724b0605" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9bd900fa-2726-425a-9bde-9c0a10988ea5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_59068dbd-a092-44d4-9973-92e8b3f28a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c3e7d25-77a8-4433-b517-e4c4724b0605" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_59068dbd-a092-44d4-9973-92e8b3f28a20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_87e2af0f-88f5-4ddb-8435-6710deef1540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c3e7d25-77a8-4433-b517-e4c4724b0605" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_87e2af0f-88f5-4ddb-8435-6710deef1540" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_7b81e201-730b-49fd-aa88-0ffdd25d1578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c3e7d25-77a8-4433-b517-e4c4724b0605" xlink:to="loc_us-gaap_TreasuryStockValue_7b81e201-730b-49fd-aa88-0ffdd25d1578" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2e7faa2d-0ea1-4901-bc1f-0c7459837581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_609cbede-77fb-4730-9751-d7001fc43536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2e7faa2d-0ea1-4901-bc1f-0c7459837581" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_609cbede-77fb-4730-9751-d7001fc43536" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d1007074-3b0a-4ed0-811d-323bccce0762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2e7faa2d-0ea1-4901-bc1f-0c7459837581" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d1007074-3b0a-4ed0-811d-323bccce0762" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f52d718d-e12e-48a9-a4f4-5f3df4b89014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2e7faa2d-0ea1-4901-bc1f-0c7459837581" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f52d718d-e12e-48a9-a4f4-5f3df4b89014" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_0775a025-7657-4134-bc49-8210de332293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2e7faa2d-0ea1-4901-bc1f-0c7459837581" xlink:to="loc_us-gaap_LongTermDebtCurrent_0775a025-7657-4134-bc49-8210de332293" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ReturnofPremiumPayable_ebfb8953-30f3-494f-9945-5cfda295099a" xlink:href="cnc-20221231.xsd#cnc_ReturnofPremiumPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2e7faa2d-0ea1-4901-bc1f-0c7459837581" xlink:to="loc_cnc_ReturnofPremiumPayable_ebfb8953-30f3-494f-9945-5cfda295099a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5d191bb0-6021-458f-8a03-46ca463fa179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6210f7ad-b101-4470-b20e-d296f4af2806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5d191bb0-6021-458f-8a03-46ca463fa179" xlink:to="loc_us-gaap_Liabilities_6210f7ad-b101-4470-b20e-d296f4af2806" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_9cd3f8d4-542a-426c-bfcc-3076522d9c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5d191bb0-6021-458f-8a03-46ca463fa179" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_9cd3f8d4-542a-426c-bfcc-3076522d9c0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_6472c292-508f-49a8-8e9d-ab35a23bff98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5d191bb0-6021-458f-8a03-46ca463fa179" xlink:to="loc_us-gaap_CommitmentsAndContingencies_6472c292-508f-49a8-8e9d-ab35a23bff98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_127647c3-c774-44fc-a2d4-ace431e49fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5d191bb0-6021-458f-8a03-46ca463fa179" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_127647c3-c774-44fc-a2d4-ace431e49fc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3484d9a3-4b9f-440d-85f7-9247dbb96c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a7c5bff3-11ff-4dd5-a4d9-80070dfd173c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3484d9a3-4b9f-440d-85f7-9247dbb96c6d" xlink:to="loc_us-gaap_StockholdersEquity_a7c5bff3-11ff-4dd5-a4d9-80070dfd173c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_aca60a55-8992-40c3-8295-104437c85aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3484d9a3-4b9f-440d-85f7-9247dbb96c6d" xlink:to="loc_us-gaap_MinorityInterest_aca60a55-8992-40c3-8295-104437c85aa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3376850d-dfff-418e-9792-ad5ba2f550fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6e34c5ea-ad71-4e25-89a5-3344605fd5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3376850d-dfff-418e-9792-ad5ba2f550fd" xlink:to="loc_us-gaap_AssetsCurrent_6e34c5ea-ad71-4e25-89a5-3344605fd5bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_e6289c24-f9dd-4fe1-b8fd-637f463d3cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3376850d-dfff-418e-9792-ad5ba2f550fd" xlink:to="loc_us-gaap_LongTermInvestments_e6289c24-f9dd-4fe1-b8fd-637f463d3cd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestrictedAssetsNoncurrent_66903531-dd87-42a7-aca8-f3d7905e61ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestrictedAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3376850d-dfff-418e-9792-ad5ba2f550fd" xlink:to="loc_us-gaap_OtherRestrictedAssetsNoncurrent_66903531-dd87-42a7-aca8-f3d7905e61ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_81945a3d-06b2-4eb5-b918-bc907139f5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3376850d-dfff-418e-9792-ad5ba2f550fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_81945a3d-06b2-4eb5-b918-bc907139f5b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8bbb29ef-114c-40be-a22f-7f31b105a9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3376850d-dfff-418e-9792-ad5ba2f550fd" xlink:to="loc_us-gaap_Goodwill_8bbb29ef-114c-40be-a22f-7f31b105a9e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e5835480-571f-4e2e-af9d-3ddd0dbce1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3376850d-dfff-418e-9792-ad5ba2f550fd" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e5835480-571f-4e2e-af9d-3ddd0dbce1e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0126e2e2-3530-4dc5-a354-19e345d2b8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3376850d-dfff-418e-9792-ad5ba2f550fd" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_0126e2e2-3530-4dc5-a354-19e345d2b8db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6be81e8a-e45b-49d3-9bf9-f55c063f301f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4d783f13-d6fa-4d24-84d8-6513fe868293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6be81e8a-e45b-49d3-9bf9-f55c063f301f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4d783f13-d6fa-4d24-84d8-6513fe868293" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a71a984e-4ebf-42a7-873f-a5e3b1575a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6be81e8a-e45b-49d3-9bf9-f55c063f301f" xlink:to="loc_us-gaap_LiabilitiesCurrent_a71a984e-4ebf-42a7-873f-a5e3b1575a06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3283f2fc-f3d7-4ff1-9d0b-8309975955f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6be81e8a-e45b-49d3-9bf9-f55c063f301f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3283f2fc-f3d7-4ff1-9d0b-8309975955f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6dfaa71e-c885-46dc-a48f-6663481ec1df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6be81e8a-e45b-49d3-9bf9-f55c063f301f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6dfaa71e-c885-46dc-a48f-6663481ec1df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f96defe5-0e22-4194-87cd-e88b5c9a3a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1ec60a9b-229e-4732-8065-3a71582ef1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f96defe5-0e22-4194-87cd-e88b5c9a3a57" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1ec60a9b-229e-4732-8065-3a71582ef1bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsAndOtherReceivablesNet_8c9bc83c-94ab-4379-9dc7-2275875c6785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsAndOtherReceivablesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f96defe5-0e22-4194-87cd-e88b5c9a3a57" xlink:to="loc_us-gaap_PremiumsAndOtherReceivablesNet_8c9bc83c-94ab-4379-9dc7-2275875c6785" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_6319399f-ee1d-4911-9ba4-37c2c83d7960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f96defe5-0e22-4194-87cd-e88b5c9a3a57" xlink:to="loc_us-gaap_ShortTermInvestments_6319399f-ee1d-4911-9ba4-37c2c83d7960" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_ae28bbca-dd7f-48d6-afc7-316262536393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f96defe5-0e22-4194-87cd-e88b5c9a3a57" xlink:to="loc_us-gaap_OtherAssetsCurrent_ae28bbca-dd7f-48d6-afc7-316262536393" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="cnc-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b24c0f40-8cc3-4a34-8220-643517465fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7f8adbe3-15be-4305-93e1-1d5cda0dd7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b24c0f40-8cc3-4a34-8220-643517465fb1" xlink:to="loc_us-gaap_ProfitLoss_7f8adbe3-15be-4305-93e1-1d5cda0dd7ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2561a0a5-6cdc-4dfd-ae9d-5de2ec2c4173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b24c0f40-8cc3-4a34-8220-643517465fb1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2561a0a5-6cdc-4dfd-ae9d-5de2ec2c4173" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_60a7f321-9dcf-4ce5-ac99-77f44ae1abb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ace1f3e5-cb61-417c-8051-819476f845d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_60a7f321-9dcf-4ce5-ac99-77f44ae1abb9" xlink:to="loc_us-gaap_Revenues_ace1f3e5-cb61-417c-8051-819476f845d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_08c849ad-5289-4a89-b41b-277f4610db9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_60a7f321-9dcf-4ce5-ac99-77f44ae1abb9" xlink:to="loc_us-gaap_CostsAndExpenses_08c849ad-5289-4a89-b41b-277f4610db9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0c4c4e1f-00ab-4c1e-9bba-7e01b654f2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PremiumTaxRevenue_f5af9b87-fe67-470a-b3ad-7c10eaf45b8d" xlink:href="cnc-20221231.xsd#cnc_PremiumTaxRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_0c4c4e1f-00ab-4c1e-9bba-7e01b654f2c4" xlink:to="loc_cnc_PremiumTaxRevenue_f5af9b87-fe67-470a-b3ad-7c10eaf45b8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5832023c-ef53-4a6f-a0d9-95bb57689ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_0c4c4e1f-00ab-4c1e-9bba-7e01b654f2c4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5832023c-ef53-4a6f-a0d9-95bb57689ffe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1bc1cdeb-ff50-4178-b973-63face471434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_42723af2-a409-4411-a9c7-4195c0cca622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1bc1cdeb-ff50-4178-b973-63face471434" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_42723af2-a409-4411-a9c7-4195c0cca622" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_fe055645-f904-45bb-8418-2a1f2f8c402a" xlink:href="cnc-20221231.xsd#cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1bc1cdeb-ff50-4178-b973-63face471434" xlink:to="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_fe055645-f904-45bb-8418-2a1f2f8c402a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e865228a-6b47-49a7-8136-401d5e077647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1bc1cdeb-ff50-4178-b973-63face471434" xlink:to="loc_us-gaap_InterestExpense_e865228a-6b47-49a7-8136-401d5e077647" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c46d19f8-ef2b-4ffb-ac31-5a28992b965f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1bc1cdeb-ff50-4178-b973-63face471434" xlink:to="loc_us-gaap_OperatingIncomeLoss_c46d19f8-ef2b-4ffb-ac31-5a28992b965f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c89fdb5c-7d9a-4be3-9446-cd6918ed00ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2c1e5967-8156-4c25-bd36-1acca1d47fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_c89fdb5c-7d9a-4be3-9446-cd6918ed00ab" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2c1e5967-8156-4c25-bd36-1acca1d47fd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_70fce339-9026-468b-ab73-a09741a0d60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_c89fdb5c-7d9a-4be3-9446-cd6918ed00ab" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_70fce339-9026-468b-ab73-a09741a0d60e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_607be718-f529-4414-a39a-62a92485e22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_75f0f838-544e-4bcf-925b-6bf8643df4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_607be718-f529-4414-a39a-62a92485e22c" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_75f0f838-544e-4bcf-925b-6bf8643df4f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PremiumTaxExpense_2b75be73-75bc-45de-a4de-97f5e1d071bb" xlink:href="cnc-20221231.xsd#cnc_PremiumTaxExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_607be718-f529-4414-a39a-62a92485e22c" xlink:to="loc_cnc_PremiumTaxExpense_2b75be73-75bc-45de-a4de-97f5e1d071bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_HealthInsurerFeeExpense_f93560d4-2c9a-4487-ab8d-c7535cb03485" xlink:href="cnc-20221231.xsd#cnc_HealthInsurerFeeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_607be718-f529-4414-a39a-62a92485e22c" xlink:to="loc_cnc_HealthInsurerFeeExpense_f93560d4-2c9a-4487-ab8d-c7535cb03485" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f8e40cc4-25cb-4667-bdf2-eda198453618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_607be718-f529-4414-a39a-62a92485e22c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f8e40cc4-25cb-4667-bdf2-eda198453618" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6dedc8db-42f7-4671-a32a-255cd84418bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_607be718-f529-4414-a39a-62a92485e22c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6dedc8db-42f7-4671-a32a-255cd84418bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a997688c-3fd0-4133-b6e9-ff67040cefc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_607be718-f529-4414-a39a-62a92485e22c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a997688c-3fd0-4133-b6e9-ff67040cefc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_c9f507e2-7b34-4183-93a4-e4bdc899b089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_607be718-f529-4414-a39a-62a92485e22c" xlink:to="loc_us-gaap_AssetImpairmentCharges_c9f507e2-7b34-4183-93a4-e4bdc899b089" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_f0ef22c1-4104-4fff-8d0f-4510a2732fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_607be718-f529-4414-a39a-62a92485e22c" xlink:to="loc_us-gaap_LitigationSettlementExpense_f0ef22c1-4104-4fff-8d0f-4510a2732fa4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1928ac1a-f197-49f8-a705-9fdbf7b70cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_607be718-f529-4414-a39a-62a92485e22c" xlink:to="loc_us-gaap_Depreciation_1928ac1a-f197-49f8-a705-9fdbf7b70cf4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" xlink:type="simple" xlink:href="cnc-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_577257f8-30a1-4178-83c1-47ec52907e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_c00d95e6-6790-4676-9764-07f6ed364f64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_577257f8-30a1-4178-83c1-47ec52907e23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_c00d95e6-6790-4676-9764-07f6ed364f64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1ce3c85f-bbc4-407b-8171-e333c0ee1e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_577257f8-30a1-4178-83c1-47ec52907e23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1ce3c85f-bbc4-407b-8171-e333c0ee1e64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6d28c15b-8a14-49be-a655-5775ce4844ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_dee60049-3848-46a7-ae22-a3ed25397a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6d28c15b-8a14-49be-a655-5775ce4844ea" xlink:to="loc_us-gaap_ProfitLoss_dee60049-3848-46a7-ae22-a3ed25397a6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_99313952-fa11-4cd7-bc35-c564b025bdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6d28c15b-8a14-49be-a655-5775ce4844ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_99313952-fa11-4cd7-bc35-c564b025bdbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_121d72c0-846e-4864-813e-75e8bd363282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e275b594-954d-47a8-8e8a-e2770859329d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_121d72c0-846e-4864-813e-75e8bd363282" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e275b594-954d-47a8-8e8a-e2770859329d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f482ba55-a20f-4270-b123-cde80347aaa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_121d72c0-846e-4864-813e-75e8bd363282" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f482ba55-a20f-4270-b123-cde80347aaa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cd134115-cc94-477a-91b3-a3a72d22e604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_0355228f-abd2-4a0e-8f7f-bcbce1d7d875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cd134115-cc94-477a-91b3-a3a72d22e604" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_0355228f-abd2-4a0e-8f7f-bcbce1d7d875" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6a92cc41-2056-49a4-a3cc-1cc016b0bf4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cd134115-cc94-477a-91b3-a3a72d22e604" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6a92cc41-2056-49a4-a3cc-1cc016b0bf4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ccf761f7-1cdf-43ef-8654-4ac04693f04b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cd134115-cc94-477a-91b3-a3a72d22e604" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ccf761f7-1cdf-43ef-8654-4ac04693f04b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="cnc-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d2e2c36d-5f26-47c1-b7dc-72e6a37053f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_756c58db-deff-4bd8-a02c-19c501de476f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d2e2c36d-5f26-47c1-b7dc-72e6a37053f9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_756c58db-deff-4bd8-a02c-19c501de476f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b9b21e7d-e643-4977-82d6-4261e5bdcc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d2e2c36d-5f26-47c1-b7dc-72e6a37053f9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b9b21e7d-e643-4977-82d6-4261e5bdcc9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f50bd2e4-b242-406d-885e-0d454394279f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d2e2c36d-5f26-47c1-b7dc-72e6a37053f9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f50bd2e4-b242-406d-885e-0d454394279f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6d39a326-ce2a-4f89-96ec-21e8b98a3b20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d2e2c36d-5f26-47c1-b7dc-72e6a37053f9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6d39a326-ce2a-4f89-96ec-21e8b98a3b20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fb4ca169-0513-4e4d-8d10-785650afb972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_84b15152-d720-4dfe-b03f-b0e8f20c9c23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fb4ca169-0513-4e4d-8d10-785650afb972" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_84b15152-d720-4dfe-b03f-b0e8f20c9c23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8536d522-cf01-42dc-abb9-3cb238ab9384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fb4ca169-0513-4e4d-8d10-785650afb972" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8536d522-cf01-42dc-abb9-3cb238ab9384" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c431fb6-d791-4f87-b201-f89e1148dbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_88612cb4-70e9-4b09-9c7a-5521ed237d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c431fb6-d791-4f87-b201-f89e1148dbb2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_88612cb4-70e9-4b09-9c7a-5521ed237d43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_03b8b110-6473-47b8-ae6b-141161e61458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c431fb6-d791-4f87-b201-f89e1148dbb2" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_03b8b110-6473-47b8-ae6b-141161e61458" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_aaf29a71-a4b2-4455-ac96-aefdc60788fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c431fb6-d791-4f87-b201-f89e1148dbb2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_aaf29a71-a4b2-4455-ac96-aefdc60788fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_0ea1eadc-4274-43df-8983-d97ce09b86c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c431fb6-d791-4f87-b201-f89e1148dbb2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_0ea1eadc-4274-43df-8983-d97ce09b86c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_505a9fa4-7bb5-4eaa-8c0c-0e6d26b7cb47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c431fb6-d791-4f87-b201-f89e1148dbb2" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_505a9fa4-7bb5-4eaa-8c0c-0e6d26b7cb47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2df57677-0f68-4c6d-a059-a7da27cbbcad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c431fb6-d791-4f87-b201-f89e1148dbb2" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2df57677-0f68-4c6d-a059-a7da27cbbcad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_398aeb46-b124-4ed1-8257-799e2c9f95b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c431fb6-d791-4f87-b201-f89e1148dbb2" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_398aeb46-b124-4ed1-8257-799e2c9f95b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e7012deb-77ed-4fc9-ab97-114e09f25a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4f704296-7ce2-459b-ac60-5bbad16048ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e7012deb-77ed-4fc9-ab97-114e09f25a1f" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4f704296-7ce2-459b-ac60-5bbad16048ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_91a54688-8cfa-4fc0-a9c2-3580050e0f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e7012deb-77ed-4fc9-ab97-114e09f25a1f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_91a54688-8cfa-4fc0-a9c2-3580050e0f7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_15764abc-96bb-4859-b06a-dfefeeb9181f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e7012deb-77ed-4fc9-ab97-114e09f25a1f" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_15764abc-96bb-4859-b06a-dfefeeb9181f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2bc08f0f-b6b6-47b2-924c-884cdc71bdd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e7012deb-77ed-4fc9-ab97-114e09f25a1f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2bc08f0f-b6b6-47b2-924c-884cdc71bdd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bc296376-03e9-4d58-aea0-e44b6aaa43ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e7012deb-77ed-4fc9-ab97-114e09f25a1f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bc296376-03e9-4d58-aea0-e44b6aaa43ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_fd26a8fb-faa6-4b2c-9b44-27191ad63119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e7012deb-77ed-4fc9-ab97-114e09f25a1f" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_fd26a8fb-faa6-4b2c-9b44-27191ad63119" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9a20c3c0-414f-4df4-b37b-1a98bfdebf02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_ProfitLoss_9a20c3c0-414f-4df4-b37b-1a98bfdebf02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_162e51f6-1e90-4a2c-a705-4e4503bc61ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_DepreciationAndAmortization_162e51f6-1e90-4a2c-a705-4e4503bc61ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e2b460ec-6a9d-4976-bea5-872b5a22be36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_ShareBasedCompensation_e2b460ec-6a9d-4976-bea5-872b5a22be36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8518daea-2212-48d8-b608-e4af61159e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8518daea-2212-48d8-b608-e4af61159e3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_78ed43c6-f3ba-4e09-858b-67b2db8eba35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_78ed43c6-f3ba-4e09-858b-67b2db8eba35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_c6d93950-d8bd-498a-86fe-28fca58db15a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_c6d93950-d8bd-498a-86fe-28fca58db15a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_81df3701-0851-4d1c-8a76-012ee7854759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_81df3701-0851-4d1c-8a76-012ee7854759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_bfef4dc0-88c9-4010-b031-a03721b76c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPremiumsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_bfef4dc0-88c9-4010-b031-a03721b76c08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_15ce6c56-496d-4e44-a910-041c8914fec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_15ce6c56-496d-4e44-a910-041c8914fec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_5fc6a093-a641-4f06-aa63-73b9ac691a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_5fc6a093-a641-4f06-aa63-73b9ac691a46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b108ff3b-f325-49f3-a348-76d2a4cbccac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b108ff3b-f325-49f3-a348-76d2a4cbccac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_5b6ddd7f-2019-4f75-b1de-7fe742aeedd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_5b6ddd7f-2019-4f75-b1de-7fe742aeedd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_696914ec-8ff9-418f-9b1b-98cd690629a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_696914ec-8ff9-418f-9b1b-98cd690629a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_c6c28afb-bf41-4c91-ae50-96eacf1d5407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_c6c28afb-bf41-4c91-ae50-96eacf1d5407" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_4aa792dc-70a5-4028-a08f-d8a9181027f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_4aa792dc-70a5-4028-a08f-d8a9181027f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_ec0f318d-616b-4647-b5a2-a52ce69d34d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_AssetImpairmentCharges_ec0f318d-616b-4647-b5a2-a52ce69d34d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_bde1e57e-ef99-425c-a39f-9bc0be453dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4f7bd535-83e2-4cdf-9ad1-6a789a2e40a8" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_bde1e57e-ef99-425c-a39f-9bc0be453dcf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#AcquisitionsandDivestituresNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ac9712ea-19cf-4dd2-a484-88d0e7f93f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_798fdcf6-131c-4e1c-8e0a-ca643d16f708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ac9712ea-19cf-4dd2-a484-88d0e7f93f13" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_798fdcf6-131c-4e1c-8e0a-ca643d16f708" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f31bbaf2-11f8-4ed0-ac82-d1285ed0531b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ac9712ea-19cf-4dd2-a484-88d0e7f93f13" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f31bbaf2-11f8-4ed0-ac82-d1285ed0531b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f1da3a93-e2fb-488f-99bb-942bff507e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_afcc7c55-b62c-45b9-b0fc-9dba15c70411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f1da3a93-e2fb-488f-99bb-942bff507e3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_afcc7c55-b62c-45b9-b0fc-9dba15c70411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f9c26af9-492d-4393-af87-1c75f09cd7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f1da3a93-e2fb-488f-99bb-942bff507e3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f9c26af9-492d-4393-af87-1c75f09cd7b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0ed9b127-6a97-44d9-9adc-f72cb501fdab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f1da3a93-e2fb-488f-99bb-942bff507e3e" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0ed9b127-6a97-44d9-9adc-f72cb501fdab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_23bf28a2-20bb-4d80-b481-48ae93af8f18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_d14131af-d39e-4e6a-9437-9e22397a0dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_23bf28a2-20bb-4d80-b481-48ae93af8f18" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_d14131af-d39e-4e6a-9437-9e22397a0dfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a978e044-0f52-4767-bd1c-2e2627df9d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_23bf28a2-20bb-4d80-b481-48ae93af8f18" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a978e044-0f52-4767-bd1c-2e2627df9d2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_bab7684d-b370-4019-9034-778a8e6d0477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_23bf28a2-20bb-4d80-b481-48ae93af8f18" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_bab7684d-b370-4019-9034-778a8e6d0477" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_863705c0-85b6-434f-afa2-3e7d84208088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_23bf28a2-20bb-4d80-b481-48ae93af8f18" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_863705c0-85b6-434f-afa2-3e7d84208088" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability_a1746a70-01d0-4619-ae5f-accfb1a3d821" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_23bf28a2-20bb-4d80-b481-48ae93af8f18" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability_a1746a70-01d0-4619-ae5f-accfb1a3d821" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable_e70d5247-3b27-437f-95e5-2f0da1a8153e" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_23bf28a2-20bb-4d80-b481-48ae93af8f18" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable_e70d5247-3b27-437f-95e5-2f0da1a8153e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0dc55400-de36-4702-9690-4594a5237409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_23bf28a2-20bb-4d80-b481-48ae93af8f18" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0dc55400-de36-4702-9690-4594a5237409" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_b010cef9-9338-4e87-8cd5-f9561e41e98d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_23bf28a2-20bb-4d80-b481-48ae93af8f18" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_b010cef9-9338-4e87-8cd5-f9561e41e98d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bb9c0aab-2b4c-43f5-a813-b7f38e75d156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5d0daf26-07d8-4790-94b8-ad3ff2d8ffd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bb9c0aab-2b4c-43f5-a813-b7f38e75d156" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5d0daf26-07d8-4790-94b8-ad3ff2d8ffd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8097aafa-77b8-44b7-9591-23f17e0f3a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bb9c0aab-2b4c-43f5-a813-b7f38e75d156" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8097aafa-77b8-44b7-9591-23f17e0f3a61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_72ea1944-c459-4d14-91f4-8d429bad5e82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bb9c0aab-2b4c-43f5-a813-b7f38e75d156" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_72ea1944-c459-4d14-91f4-8d429bad5e82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits_cf7caf96-35ff-41af-9348-2b22851c26ed" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bb9c0aab-2b4c-43f5-a813-b7f38e75d156" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits_cf7caf96-35ff-41af-9348-2b22851c26ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4ff50ffd-f4d1-402f-97df-7fe8bbd9ca78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bb9c0aab-2b4c-43f5-a813-b7f38e75d156" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4ff50ffd-f4d1-402f-97df-7fe8bbd9ca78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a94e12aa-e412-460d-bb48-b4945ec4af78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bb9c0aab-2b4c-43f5-a813-b7f38e75d156" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a94e12aa-e412-460d-bb48-b4945ec4af78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_29ddf12b-4374-424d-8803-5a835758fe30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bb9c0aab-2b4c-43f5-a813-b7f38e75d156" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_29ddf12b-4374-424d-8803-5a835758fe30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments_81db13b7-5fdd-4d80-809a-ea5b96017a63" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bb9c0aab-2b4c-43f5-a813-b7f38e75d156" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments_81db13b7-5fdd-4d80-809a-ea5b96017a63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments_0a32a3a3-db41-4673-a207-55975d74683c" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bb9c0aab-2b4c-43f5-a813-b7f38e75d156" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments_0a32a3a3-db41-4673-a207-55975d74683c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d535e842-346c-4f70-b450-e9072d933514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_bcd8c585-655e-4879-b96d-4de7aa33afc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d535e842-346c-4f70-b450-e9072d933514" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_bcd8c585-655e-4879-b96d-4de7aa33afc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_74d8bb32-7da8-45bc-95aa-045674ad690b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d535e842-346c-4f70-b450-e9072d933514" xlink:to="loc_us-gaap_Goodwill_74d8bb32-7da8-45bc-95aa-045674ad690b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_e9257067-498a-47e5-96ca-c0a94dfe7515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_655fe583-493a-4007-aa49-7472b6c7a8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_e9257067-498a-47e5-96ca-c0a94dfe7515" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_655fe583-493a-4007-aa49-7472b6c7a8ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_19e0e2dc-1521-4faf-8078-928cfa5b10a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_e9257067-498a-47e5-96ca-c0a94dfe7515" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_19e0e2dc-1521-4faf-8078-928cfa5b10a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_fd4de01b-a9bf-4cec-9adc-42a844fd03b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_e9257067-498a-47e5-96ca-c0a94dfe7515" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_fd4de01b-a9bf-4cec-9adc-42a844fd03b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue_64159e8d-f2bc-4248-aa8c-fda47b67ae63" xlink:href="cnc-20221231.xsd#cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_4bcbae19-a4a8-4370-8621-9e8dcc9afdf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue_64159e8d-f2bc-4248-aa8c-fda47b67ae63" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_4bcbae19-a4a8-4370-8621-9e8dcc9afdf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_e00ccf29-4b35-4231-9bad-7997add4f556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue_64159e8d-f2bc-4248-aa8c-fda47b67ae63" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_e00ccf29-4b35-4231-9bad-7997add4f556" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_a1a2e702-a138-4e91-9c80-17b4e97c81be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue_64159e8d-f2bc-4248-aa8c-fda47b67ae63" xlink:to="loc_us-gaap_EquityMethodInvestments_a1a2e702-a138-4e91-9c80-17b4e97c81be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount_6fe9fa60-6475-4843-a0f8-97d6fd21134f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LifeInsuranceCorporateOrBankOwnedAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue_64159e8d-f2bc-4248-aa8c-fda47b67ae63" xlink:to="loc_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount_6fe9fa60-6475-4843-a0f8-97d6fd21134f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost_1cda829b-cc88-4bf8-b8c4-20c5d0e9dc47" xlink:href="cnc-20221231.xsd#cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_aaca7458-91e1-423c-af4b-879f494973ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost_1cda829b-cc88-4bf8-b8c4-20c5d0e9dc47" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_aaca7458-91e1-423c-af4b-879f494973ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5ef94119-8864-4e8c-b439-d4138bbc975e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost_1cda829b-cc88-4bf8-b8c4-20c5d0e9dc47" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5ef94119-8864-4e8c-b439-d4138bbc975e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_a9d59dcf-929e-4d52-bbad-97f3d370b0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost_1cda829b-cc88-4bf8-b8c4-20c5d0e9dc47" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_a9d59dcf-929e-4d52-bbad-97f3d370b0f7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_2c178965-f0f5-4cec-a498-6c17d8f5580b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_82582cc1-ee67-4685-a5de-9cd339c520d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_2c178965-f0f5-4cec-a498-6c17d8f5580b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_82582cc1-ee67-4685-a5de-9cd339c520d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_5e91905a-918c-46ec-a255-a0dbba234a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_2c178965-f0f5-4cec-a498-6c17d8f5580b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_5e91905a-918c-46ec-a255-a0dbba234a61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_f4c75bc7-dd5f-4ea0-98f5-fa953ec8e65f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_2c178965-f0f5-4cec-a498-6c17d8f5580b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_f4c75bc7-dd5f-4ea0-98f5-fa953ec8e65f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_73dcbb05-a085-4bed-9606-5b8e96139e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_2c178965-f0f5-4cec-a498-6c17d8f5580b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_73dcbb05-a085-4bed-9606-5b8e96139e80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_b00922bc-3237-4bb5-8db7-179f8eef911f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_2c178965-f0f5-4cec-a498-6c17d8f5580b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_b00922bc-3237-4bb5-8db7-179f8eef911f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_9e6fad49-3593-4ddf-adbe-f067ec28bebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_2806f7a4-ea18-4a33-ad55-2ab7a5c9a45b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_9e6fad49-3593-4ddf-adbe-f067ec28bebc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_2806f7a4-ea18-4a33-ad55-2ab7a5c9a45b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_68e6df7f-f8f2-422e-9498-0436df5f8541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_9e6fad49-3593-4ddf-adbe-f067ec28bebc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_68e6df7f-f8f2-422e-9498-0436df5f8541" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_534d462a-6602-461d-a337-f760e30aed74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_9e6fad49-3593-4ddf-adbe-f067ec28bebc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_534d462a-6602-461d-a337-f760e30aed74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_658d4a14-38b8-4e2b-93d1-a274d19f15dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_9e6fad49-3593-4ddf-adbe-f067ec28bebc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_658d4a14-38b8-4e2b-93d1-a274d19f15dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_ba455278-f6df-4652-b90f-a8e9d231a0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_9e6fad49-3593-4ddf-adbe-f067ec28bebc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_ba455278-f6df-4652-b90f-a8e9d231a0a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_8b9a6c95-dce1-44ac-ab3c-8e3439f4afd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_eab6ab52-cbc8-4a8f-90e4-7576cac799e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_8b9a6c95-dce1-44ac-ab3c-8e3439f4afd0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_eab6ab52-cbc8-4a8f-90e4-7576cac799e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3bf6e048-40ff-4859-a7bb-7b0f1125f88b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_8b9a6c95-dce1-44ac-ab3c-8e3439f4afd0" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_3bf6e048-40ff-4859-a7bb-7b0f1125f88b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6d47ccf4-0746-4a4a-b437-b60beef7eb5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_8b9a6c95-dce1-44ac-ab3c-8e3439f4afd0" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6d47ccf4-0746-4a4a-b437-b60beef7eb5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_3e867cb1-b9a7-488b-a476-ada3d5d9803e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_8b9a6c95-dce1-44ac-ab3c-8e3439f4afd0" xlink:to="loc_us-gaap_DerivativeAssets_3e867cb1-b9a7-488b-a476-ada3d5d9803e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#PropertySoftwareandEquipmentComponentsDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8c56941e-d687-42ba-a399-4d2ddc44ea09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_dc2830c0-c72a-48a9-92f0-61880f31c1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_8c56941e-d687-42ba-a399-4d2ddc44ea09" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_dc2830c0-c72a-48a9-92f0-61880f31c1a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f1613c4f-8d3a-4cc8-80b9-2c3f6937a530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_8c56941e-d687-42ba-a399-4d2ddc44ea09" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f1613c4f-8d3a-4cc8-80b9-2c3f6937a530" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_177c81f5-a196-46c8-b4ed-4427107f1939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6893f004-782d-4fb0-bd2a-05dd9599f21d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_177c81f5-a196-46c8-b4ed-4427107f1939" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6893f004-782d-4fb0-bd2a-05dd9599f21d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_465f61ab-917a-40a8-b71c-dbf671545df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_177c81f5-a196-46c8-b4ed-4427107f1939" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_465f61ab-917a-40a8-b71c-dbf671545df3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_6894d46e-e64a-4bb9-b53f-03de5c46465a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_32a5f003-84c7-4d68-aa5e-d94de2cd10f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_6894d46e-e64a-4bb9-b53f-03de5c46465a" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_32a5f003-84c7-4d68-aa5e-d94de2cd10f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_b1e52930-8e9a-4634-aac1-8b5314e83398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_6894d46e-e64a-4bb9-b53f-03de5c46465a" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_b1e52930-8e9a-4634-aac1-8b5314e83398" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_a67b06c4-1170-4efa-b039-b3d786f76a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_88c76f2b-eb3f-434e-968f-21c78333aecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_a67b06c4-1170-4efa-b039-b3d786f76a53" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_88c76f2b-eb3f-434e-968f-21c78333aecf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_488c7309-d2ec-40e8-8b2c-0c69648e3280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_a67b06c4-1170-4efa-b039-b3d786f76a53" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_488c7309-d2ec-40e8-8b2c-0c69648e3280" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_20e13fcd-8fff-4c93-a407-bc90cb57e9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_a3fb37a6-327d-42d8-8dc8-5cabd99c8ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_20e13fcd-8fff-4c93-a407-bc90cb57e9c5" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_a3fb37a6-327d-42d8-8dc8-5cabd99c8ef7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_861e16d0-6c0a-40a5-a44e-ce58e3f8ce9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_20e13fcd-8fff-4c93-a407-bc90cb57e9c5" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_861e16d0-6c0a-40a5-a44e-ce58e3f8ce9a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_5022dbad-f0a2-41f3-8def-c6d1fa3461fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_c704ade3-07bb-4283-8b56-cfcd3a53d20d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_5022dbad-f0a2-41f3-8def-c6d1fa3461fb" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_c704ade3-07bb-4283-8b56-cfcd3a53d20d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_69f47952-0ec6-4a03-9623-c4ddc57fa907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_5022dbad-f0a2-41f3-8def-c6d1fa3461fb" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_69f47952-0ec6-4a03-9623-c4ddc57fa907" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther_ce7115db-3239-4895-b795-4a4838eab5ac" xlink:href="cnc-20221231.xsd#cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_5022dbad-f0a2-41f3-8def-c6d1fa3461fb" xlink:to="loc_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther_ce7115db-3239-4895-b795-4a4838eab5ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/DebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_c1a5efae-54bf-4f8f-b302-18b71d0b7a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_9f0f1872-e78e-4d9e-9637-28148bd711ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_c1a5efae-54bf-4f8f-b302-18b71d0b7a69" xlink:to="loc_us-gaap_LongTermDebtCurrent_9f0f1872-e78e-4d9e-9637-28148bd711ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6f7a5298-6a52-4a8c-817d-35ce01cba8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_c1a5efae-54bf-4f8f-b302-18b71d0b7a69" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6f7a5298-6a52-4a8c-817d-35ce01cba8b8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtScheduleofDebtDetails_1" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtScheduleofDebtDetails_1"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/DebtScheduleofDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_8aee70cb-5340-4920-b543-cf5418a1a308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_b3e08e04-b145-4af7-ac77-47f68ddec014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_8aee70cb-5340-4920-b543-cf5418a1a308" xlink:to="loc_us-gaap_LineOfCredit_b3e08e04-b145-4af7-ac77-47f68ddec014" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayable_61ca6198-2737-4186-abee-e6b9c622a862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_8aee70cb-5340-4920-b543-cf5418a1a308" xlink:to="loc_us-gaap_LoansPayable_61ca6198-2737-4186-abee-e6b9c622a862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_6d53db75-acd9-40ff-a207-12fdf51f6eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_8aee70cb-5340-4920-b543-cf5418a1a308" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_6d53db75-acd9-40ff-a207-12fdf51f6eae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SeniorNotesTotal_6cd53b60-bd88-4b98-979d-f40229e9258c" xlink:href="cnc-20221231.xsd#cnc_SeniorNotesTotal"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_8aee70cb-5340-4920-b543-cf5418a1a308" xlink:to="loc_cnc_SeniorNotesTotal_6cd53b60-bd88-4b98-979d-f40229e9258c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FinanceLeaseLiabilityAndOther_deb63f68-304a-41ac-a26c-dba4c0631f14" xlink:href="cnc-20221231.xsd#cnc_FinanceLeaseLiabilityAndOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_8aee70cb-5340-4920-b543-cf5418a1a308" xlink:to="loc_cnc_FinanceLeaseLiabilityAndOther_deb63f68-304a-41ac-a26c-dba4c0631f14" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtScheduleofAggregateMaturitiesofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_69fb20c1-16d9-4a73-b80b-c0307ace3728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_efee71c6-f6fc-443b-9268-724891928509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_69fb20c1-16d9-4a73-b80b-c0307ace3728" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_efee71c6-f6fc-443b-9268-724891928509" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_f3b6aec4-2842-4ee3-bc30-9955e25224c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_69fb20c1-16d9-4a73-b80b-c0307ace3728" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_f3b6aec4-2842-4ee3-bc30-9955e25224c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_cc677c28-3744-4fc2-b39e-d333c47b709b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_69fb20c1-16d9-4a73-b80b-c0307ace3728" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_cc677c28-3744-4fc2-b39e-d333c47b709b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_bce2ba51-115c-46bb-afda-fbd574e27c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_69fb20c1-16d9-4a73-b80b-c0307ace3728" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_bce2ba51-115c-46bb-afda-fbd574e27c5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_17b233b3-beaa-4ede-aa6a-2b55e380bec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_69fb20c1-16d9-4a73-b80b-c0307ace3728" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_17b233b3-beaa-4ede-aa6a-2b55e380bec5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_12abce6e-3ccf-4e4d-aa34-1be4fdad222b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_69fb20c1-16d9-4a73-b80b-c0307ace3728" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_12abce6e-3ccf-4e4d-aa34-1be4fdad222b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#LeasesROUAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_309688c1-509c-4c4b-8f85-6215e4b6e764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b70fe4f6-da77-4935-b334-6caeafdccf86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_309688c1-509c-4c4b-8f85-6215e4b6e764" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b70fe4f6-da77-4935-b334-6caeafdccf86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7729206f-a1c9-47e0-83fc-86b47f16382c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_309688c1-509c-4c4b-8f85-6215e4b6e764" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7729206f-a1c9-47e0-83fc-86b47f16382c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#LeasesOperatingLeaseMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e900d145-4f69-443f-9c67-8729b9425331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e68c8182-fd27-4fc5-bc77-2668636274f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e900d145-4f69-443f-9c67-8729b9425331" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e68c8182-fd27-4fc5-bc77-2668636274f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_62587473-b6d7-4181-aaa4-c4a08c807e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e900d145-4f69-443f-9c67-8729b9425331" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_62587473-b6d7-4181-aaa4-c4a08c807e48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d1211a4a-e401-4cfc-9b66-77e6f16cc3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e900d145-4f69-443f-9c67-8729b9425331" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d1211a4a-e401-4cfc-9b66-77e6f16cc3fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a17e9bcc-b02d-4d8a-ac5d-6cfe887dd9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e900d145-4f69-443f-9c67-8729b9425331" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a17e9bcc-b02d-4d8a-ac5d-6cfe887dd9e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6d358ecb-9f9c-48fb-934d-c58c9bc6b371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e900d145-4f69-443f-9c67-8729b9425331" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6d358ecb-9f9c-48fb-934d-c58c9bc6b371" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6d2b7fd3-3f4c-4933-9577-7b493d68a18e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e900d145-4f69-443f-9c67-8729b9425331" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6d2b7fd3-3f4c-4933-9577-7b493d68a18e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="cnc-20221231.xsd#LeasesOperatingLeaseMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_092460cd-c01b-4860-b6b6-557896a84608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_bba57fbb-1b10-42c4-9b78-a09604924507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_092460cd-c01b-4860-b6b6-557896a84608" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_bba57fbb-1b10-42c4-9b78-a09604924507" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_78eb8aef-a776-4f0a-b308-f8e71aefe574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_092460cd-c01b-4860-b6b6-557896a84608" xlink:to="loc_us-gaap_OperatingLeaseLiability_78eb8aef-a776-4f0a-b308-f8e71aefe574" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#IncomeTaxesConsolidatedIncomeTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c59c627e-448f-40e2-a0b7-468687520952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_047aeb59-ea3b-4c54-8571-93c0fd397a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c59c627e-448f-40e2-a0b7-468687520952" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_047aeb59-ea3b-4c54-8571-93c0fd397a12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOtherTaxExpenseBenefit_96a98a54-4d1e-4ffc-9464-0e8c5419b35d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOtherTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c59c627e-448f-40e2-a0b7-468687520952" xlink:to="loc_us-gaap_DeferredOtherTaxExpenseBenefit_96a98a54-4d1e-4ffc-9464-0e8c5419b35d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d6024090-79b3-457f-9e7a-b0cbadde5cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_183450ca-23f8-411e-93a9-c6b07f7f7d36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d6024090-79b3-457f-9e7a-b0cbadde5cb8" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_183450ca-23f8-411e-93a9-c6b07f7f7d36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_11ce6195-783e-4108-a87f-decec822ff46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d6024090-79b3-457f-9e7a-b0cbadde5cb8" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_11ce6195-783e-4108-a87f-decec822ff46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7750166f-57e6-47aa-bc93-e2b65ce1b580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d6024090-79b3-457f-9e7a-b0cbadde5cb8" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7750166f-57e6-47aa-bc93-e2b65ce1b580" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_52435902-617a-415b-ac65-df0bdba1cb00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e7a60e81-9a0e-4303-a519-8c8e99e90dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_52435902-617a-415b-ac65-df0bdba1cb00" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e7a60e81-9a0e-4303-a519-8c8e99e90dd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_53fa481d-e121-4a96-a394-7386035c3bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_52435902-617a-415b-ac65-df0bdba1cb00" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_53fa481d-e121-4a96-a394-7386035c3bb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill_cde76297-6007-4268-858e-e1f822de6abd" xlink:href="cnc-20221231.xsd#cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_52435902-617a-415b-ac65-df0bdba1cb00" xlink:to="loc_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill_cde76297-6007-4268-858e-e1f822de6abd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ACAHealthInsurerFee_239e4dff-f3ba-4756-943e-c7ac0787668b" xlink:href="cnc-20221231.xsd#cnc_ACAHealthInsurerFee"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_52435902-617a-415b-ac65-df0bdba1cb00" xlink:to="loc_cnc_ACAHealthInsurerFee_239e4dff-f3ba-4756-943e-c7ac0787668b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_500cc068-3bda-4e06-8b7e-8746a91549cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_52435902-617a-415b-ac65-df0bdba1cb00" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_500cc068-3bda-4e06-8b7e-8746a91549cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_27542d30-0edf-45e9-b40d-b476931f1c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_52435902-617a-415b-ac65-df0bdba1cb00" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_27542d30-0edf-45e9-b40d-b476931f1c33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_9ad496bf-fce9-4e36-83e6-91cf4c5af813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_52435902-617a-415b-ac65-df0bdba1cb00" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_9ad496bf-fce9-4e36-83e6-91cf4c5af813" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_8f38f9d8-3d01-4176-a471-50306177172f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_52435902-617a-415b-ac65-df0bdba1cb00" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_8f38f9d8-3d01-4176-a471-50306177172f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement_9bd65ce9-b72f-42fd-b1f0-082f26faca03" xlink:href="cnc-20221231.xsd#cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_52435902-617a-415b-ac65-df0bdba1cb00" xlink:to="loc_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement_9bd65ce9-b72f-42fd-b1f0-082f26faca03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_00a43734-2a92-4a15-b576-c10804abdac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_52435902-617a-415b-ac65-df0bdba1cb00" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_00a43734-2a92-4a15-b576-c10804abdac2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries_44608a38-ff92-4893-ad95-8c8506baa078" xlink:href="cnc-20221231.xsd#cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_52435902-617a-415b-ac65-df0bdba1cb00" xlink:to="loc_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries_44608a38-ff92-4893-ad95-8c8506baa078" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b05976bb-0c26-46cc-aea2-f8e8303fbec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest_23e81133-afe3-4631-adf4-bedaa349fc48" xlink:href="cnc-20221231.xsd#cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b05976bb-0c26-46cc-aea2-f8e8303fbec9" xlink:to="loc_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest_23e81133-afe3-4631-adf4-bedaa349fc48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest_ef006686-1765-40fd-9774-98adfaa58274" xlink:href="cnc-20221231.xsd#cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b05976bb-0c26-46cc-aea2-f8e8303fbec9" xlink:to="loc_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest_ef006686-1765-40fd-9774-98adfaa58274" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_579567e8-e91f-437a-8dea-3b46899b8a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_581a7fa6-d366-4f6c-9ca0-5bf6c9910691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_579567e8-e91f-437a-8dea-3b46899b8a16" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_581a7fa6-d366-4f6c-9ca0-5bf6c9910691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_56db6031-2376-4022-bcd9-ba4da59c293b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_579567e8-e91f-437a-8dea-3b46899b8a16" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_56db6031-2376-4022-bcd9-ba4da59c293b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_fc9d7363-32bd-458d-a53e-67c0b9b294e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_579567e8-e91f-437a-8dea-3b46899b8a16" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_fc9d7363-32bd-458d-a53e-67c0b9b294e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_b4fc68ca-f1dd-4980-9d6f-954b36a908de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_579567e8-e91f-437a-8dea-3b46899b8a16" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_b4fc68ca-f1dd-4980-9d6f-954b36a908de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxLiabilitiesRightOfUseAssets_62e61391-7cae-41e6-bd2e-1e40bd99c422" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_579567e8-e91f-437a-8dea-3b46899b8a16" xlink:to="loc_cnc_DeferredTaxLiabilitiesRightOfUseAssets_62e61391-7cae-41e6-bd2e-1e40bd99c422" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss_e43d61c7-4777-4c73-a36a-f12c89f2cef5" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_579567e8-e91f-437a-8dea-3b46899b8a16" xlink:to="loc_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss_e43d61c7-4777-4c73-a36a-f12c89f2cef5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_eebe8fc1-f0b7-4759-8cfd-13e9b908268e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_81faf7fd-187d-4657-9f0a-5166d1cac53e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eebe8fc1-f0b7-4759-8cfd-13e9b908268e" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_81faf7fd-187d-4657-9f0a-5166d1cac53e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_6331c51a-89bd-495c-9fda-492038835ef6" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eebe8fc1-f0b7-4759-8cfd-13e9b908268e" xlink:to="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_6331c51a-89bd-495c-9fda-492038835ef6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetSoftwareDevelopmentCosts_8a12bf7b-bc6f-47fc-ade0-6bf5fa28ba27" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetSoftwareDevelopmentCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eebe8fc1-f0b7-4759-8cfd-13e9b908268e" xlink:to="loc_cnc_DeferredTaxAssetSoftwareDevelopmentCosts_8a12bf7b-bc6f-47fc-ade0-6bf5fa28ba27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_f30cb26b-7d7f-46d7-a156-6ba600d890d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eebe8fc1-f0b7-4759-8cfd-13e9b908268e" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_f30cb26b-7d7f-46d7-a156-6ba600d890d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_b8992e51-96eb-4dca-a90a-12f4dc880b37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eebe8fc1-f0b7-4759-8cfd-13e9b908268e" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_b8992e51-96eb-4dca-a90a-12f4dc880b37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetOperatingLeaseLiability_03aa57b8-bb50-4f48-a38d-2ef274d50744" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetOperatingLeaseLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eebe8fc1-f0b7-4759-8cfd-13e9b908268e" xlink:to="loc_cnc_DeferredTaxAssetOperatingLeaseLiability_03aa57b8-bb50-4f48-a38d-2ef274d50744" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetPremiumAndTradeReceivables_0017c53b-b314-4c29-b920-dc8673c3057c" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetPremiumAndTradeReceivables"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eebe8fc1-f0b7-4759-8cfd-13e9b908268e" xlink:to="loc_cnc_DeferredTaxAssetPremiumAndTradeReceivables_0017c53b-b314-4c29-b920-dc8673c3057c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_cc487015-5d4c-47c7-8cab-dfe120e4cb73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eebe8fc1-f0b7-4759-8cfd-13e9b908268e" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_cc487015-5d4c-47c7-8cab-dfe120e4cb73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss_0d6565ef-4df6-4911-8d42-c17012bf6d92" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eebe8fc1-f0b7-4759-8cfd-13e9b908268e" xlink:to="loc_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss_0d6565ef-4df6-4911-8d42-c17012bf6d92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_b7eb5bbb-5ec4-428f-bf0e-5869bc7a0f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d2a3c5fa-e65c-4cf8-9998-0a1029cc5574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b7eb5bbb-5ec4-428f-bf0e-5869bc7a0f61" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_d2a3c5fa-e65c-4cf8-9998-0a1029cc5574" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e100705b-1b1a-4304-b0b2-686988c8403d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b7eb5bbb-5ec4-428f-bf0e-5869bc7a0f61" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e100705b-1b1a-4304-b0b2-686988c8403d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_ab068cd8-8b4a-4062-8d6e-9c5d04412244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_810589aa-671f-4be1-9e62-19b6b11634d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_ab068cd8-8b4a-4062-8d6e-9c5d04412244" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_810589aa-671f-4be1-9e62-19b6b11634d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_3973ad3b-a14c-4b74-a4cc-47808040db32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_ab068cd8-8b4a-4062-8d6e-9c5d04412244" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_3973ad3b-a14c-4b74-a4cc-47808040db32" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#EarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d00b03d5-d190-4a03-ae89-36cd8f86eefe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20ad9fcc-ea20-47ab-a8ce-f4beb3c4cc41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d00b03d5-d190-4a03-ae89-36cd8f86eefe" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20ad9fcc-ea20-47ab-a8ce-f4beb3c4cc41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9eee6a09-39cf-4ff0-874c-44db0c9b6f36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d00b03d5-d190-4a03-ae89-36cd8f86eefe" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9eee6a09-39cf-4ff0-874c-44db0c9b6f36" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_70508e58-1ddd-4ec1-8201-5f801785ec45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries_411ebff5-e59c-4246-85bc-c1cee94cafdc" xlink:href="cnc-20221231.xsd#cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_70508e58-1ddd-4ec1-8201-5f801785ec45" xlink:to="loc_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries_411ebff5-e59c-4246-85bc-c1cee94cafdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2fee968c-a97b-451d-a1b1-79b439b49564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_70508e58-1ddd-4ec1-8201-5f801785ec45" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2fee968c-a97b-451d-a1b1-79b439b49564" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries_0bd461f1-7bda-4a71-ba50-48f85ee87e5c" xlink:href="cnc-20221231.xsd#cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_239a5471-6744-4213-813e-e4c6bfc9a3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries_0bd461f1-7bda-4a71-ba50-48f85ee87e5c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_239a5471-6744-4213-813e-e4c6bfc9a3b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3117357b-3b1d-41ff-8790-f43a5e79b327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries_0bd461f1-7bda-4a71-ba50-48f85ee87e5c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3117357b-3b1d-41ff-8790-f43a5e79b327" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>cnc-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0b97e17d-6106-45f4-89d6-4fad8114f6eb,g:0be59ac2-4e57-4dab-9620-00ce2b3b169c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="cnc-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i077766b5d9614694940a7301b4c33152_CONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_c408f964-8e29-436b-9b9f-84ab0102e4df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_RevenuesAbstract_c408f964-8e29-436b-9b9f-84ab0102e4df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_81b31ff1-e964-4112-bf8b-4aaa4e2bb459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_c408f964-8e29-436b-9b9f-84ab0102e4df" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_81b31ff1-e964-4112-bf8b-4aaa4e2bb459" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PremiumTaxRevenue_cb6adb1d-beb9-4dfa-9b66-b6472fe77c5b" xlink:href="cnc-20221231.xsd#cnc_PremiumTaxRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_c408f964-8e29-436b-9b9f-84ab0102e4df" xlink:to="loc_cnc_PremiumTaxRevenue_cb6adb1d-beb9-4dfa-9b66-b6472fe77c5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a909284e-f707-4cee-90ea-46facfcb0f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_c408f964-8e29-436b-9b9f-84ab0102e4df" xlink:to="loc_us-gaap_Revenues_a909284e-f707-4cee-90ea-46facfcb0f8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_74c93f7c-384a-49b1-bc6e-11dc843316f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_74c93f7c-384a-49b1-bc6e-11dc843316f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4c25f350-d951-4720-892c-1f6e88c28290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4c25f350-d951-4720-892c-1f6e88c28290" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cb78768e-f7d1-4066-b94b-fc1e8cf1a802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cb78768e-f7d1-4066-b94b-fc1e8cf1a802" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b95c95d5-b015-4bc5-9c4c-d4211150deb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_Depreciation_b95c95d5-b015-4bc5-9c4c-d4211150deb0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0c433dc4-9a80-4930-8dee-4d9c9e325150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0c433dc4-9a80-4930-8dee-4d9c9e325150" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PremiumTaxExpense_92f779a4-6dac-43c1-bbfd-a8845a5f2fd7" xlink:href="cnc-20221231.xsd#cnc_PremiumTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_cnc_PremiumTaxExpense_92f779a4-6dac-43c1-bbfd-a8845a5f2fd7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_HealthInsurerFeeExpense_98bd8fb1-87f6-4e5d-a0d1-92ffee43b640" xlink:href="cnc-20221231.xsd#cnc_HealthInsurerFeeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_cnc_HealthInsurerFeeExpense_98bd8fb1-87f6-4e5d-a0d1-92ffee43b640" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_53a7bd5e-cc9d-4574-99e4-ca881b3acf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_AssetImpairmentCharges_53a7bd5e-cc9d-4574-99e4-ca881b3acf2c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_16eaf284-b1f3-46e4-8c77-1365a973c750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_LitigationSettlementExpense_16eaf284-b1f3-46e4-8c77-1365a973c750" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e9ab4134-ea8a-451d-8aee-99a3329b99c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_CostsAndExpenses_e9ab4134-ea8a-451d-8aee-99a3329b99c4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_33d0c352-ccc7-473e-989d-2894b5f6d2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_OperatingIncomeLoss_33d0c352-ccc7-473e-989d-2894b5f6d2c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ef50329-cabb-4c6a-abc1-8aec313197f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ef50329-cabb-4c6a-abc1-8aec313197f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_6a63ebfc-7adf-4fce-b6d2-a5dd96d54aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ef50329-cabb-4c6a-abc1-8aec313197f7" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_6a63ebfc-7adf-4fce-b6d2-a5dd96d54aaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_4171ca03-a55a-4258-b346-049858315e56" xlink:href="cnc-20221231.xsd#cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ef50329-cabb-4c6a-abc1-8aec313197f7" xlink:to="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_4171ca03-a55a-4258-b346-049858315e56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_efee1e4c-f837-40e8-9465-8763127b2aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ef50329-cabb-4c6a-abc1-8aec313197f7" xlink:to="loc_us-gaap_InterestExpense_efee1e4c-f837-40e8-9465-8763127b2aba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_18495b68-233f-45a9-8275-7a6b320ffd69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_18495b68-233f-45a9-8275-7a6b320ffd69" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e2312a55-e489-4107-b524-d8f06e5baa3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e2312a55-e489-4107-b524-d8f06e5baa3f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ad747a46-44a7-4394-9a36-09626903508a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_ProfitLoss_ad747a46-44a7-4394-9a36-09626903508a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2e513cd0-9e9f-43e8-8a49-1ede21253815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2e513cd0-9e9f-43e8-8a49-1ede21253815" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e82b17fe-93b1-4fe8-98fe-8a173ac780eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_NetIncomeLoss_e82b17fe-93b1-4fe8-98fe-8a173ac780eb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8d0fbb2e-4258-4b54-bd78-07894e23ab54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8d0fbb2e-4258-4b54-bd78-07894e23ab54" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ed0ef447-f772-45ba-b474-7bbee116a842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8d0fbb2e-4258-4b54-bd78-07894e23ab54" xlink:to="loc_us-gaap_EarningsPerShareBasic_ed0ef447-f772-45ba-b474-7bbee116a842" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f9d93a60-626f-427c-b27c-47a9afbf4bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8d0fbb2e-4258-4b54-bd78-07894e23ab54" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f9d93a60-626f-427c-b27c-47a9afbf4bb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_50077e3a-7794-4223-9066-9d17bfe3ab57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_50077e3a-7794-4223-9066-9d17bfe3ab57" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dfcdd056-bb8e-4d81-b3df-d2beb2487dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_50077e3a-7794-4223-9066-9d17bfe3ab57" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dfcdd056-bb8e-4d81-b3df-d2beb2487dc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_340c1b6c-d724-4194-9d2f-6e8860c598ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_50077e3a-7794-4223-9066-9d17bfe3ab57" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_340c1b6c-d724-4194-9d2f-6e8860c598ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b75cdabc-51e6-4229-8f4c-5f7a4d0001ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_StatementTable_b75cdabc-51e6-4229-8f4c-5f7a4d0001ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e6ec12a4-e866-47c7-88a5-04a0247d84f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b75cdabc-51e6-4229-8f4c-5f7a4d0001ce" xlink:to="loc_srt_ProductOrServiceAxis_e6ec12a4-e866-47c7-88a5-04a0247d84f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e6ec12a4-e866-47c7-88a5-04a0247d84f3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e6ec12a4-e866-47c7-88a5-04a0247d84f3" xlink:to="loc_srt_ProductsAndServicesDomain_e6ec12a4-e866-47c7-88a5-04a0247d84f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_785cbe7e-adde-4a60-8ba8-0758968d278f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e6ec12a4-e866-47c7-88a5-04a0247d84f3" xlink:to="loc_srt_ProductsAndServicesDomain_785cbe7e-adde-4a60-8ba8-0758968d278f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePremiumMember_1802c226-57d3-4f07-a1bc-8fd905aa876b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCarePremiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_785cbe7e-adde-4a60-8ba8-0758968d278f" xlink:to="loc_us-gaap_HealthCarePremiumMember_1802c226-57d3-4f07-a1bc-8fd905aa876b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_1321326a-77fa-4572-a9c4-e62bedc2cffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_785cbe7e-adde-4a60-8ba8-0758968d278f" xlink:to="loc_us-gaap_ServiceMember_1321326a-77fa-4572-a9c4-e62bedc2cffe" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="cnc-20221231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i7b6c0e9c471043ea9c986fa6034b8726_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2bc58c2a-ee05-431f-a48b-370b67ee9d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2bc58c2a-ee05-431f-a48b-370b67ee9d83" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2f7b8fe0-2662-4e8c-9168-516772be45e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2f7b8fe0-2662-4e8c-9168-516772be45e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4073f571-8a7e-480b-9879-687a711ad50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4073f571-8a7e-480b-9879-687a711ad50b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_67b626ad-e573-42c9-b8f7-d46c22353fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_TreasuryStockShares_67b626ad-e573-42c9-b8f7-d46c22353fd6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_73870193-b525-4b1c-992e-35264ec5b60c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_73870193-b525-4b1c-992e-35264ec5b60c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_42450139-f91e-4447-acc0-66f2b4ca11fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_42450139-f91e-4447-acc0-66f2b4ca11fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_33345fb7-e9a8-44f4-be96-0e0ca1e31337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_33345fb7-e9a8-44f4-be96-0e0ca1e31337" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_7b6bb52a-35c2-4374-89d9-75c50d4fd2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_7b6bb52a-35c2-4374-89d9-75c50d4fd2dc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_3b4ac966-ab85-43be-8886-de170860fef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_3b4ac966-ab85-43be-8886-de170860fef5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_63601520-6720-46b2-96ac-f7348db07267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_63601520-6720-46b2-96ac-f7348db07267" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture_bf7cdfeb-6643-4719-8bfb-79ab73da70d0" xlink:href="cnc-20221231.xsd#cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture_bf7cdfeb-6643-4719-8bfb-79ab73da70d0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5dde1a94-101d-423f-9aac-5d48f8207754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5dde1a94-101d-423f-9aac-5d48f8207754" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_d49736c8-4831-42e4-abe1-d9a38c597dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_d49736c8-4831-42e4-abe1-d9a38c597dfc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f9a7ea6a-d012-447f-8891-afd58a9264d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f9a7ea6a-d012-447f-8891-afd58a9264d3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_2ecab748-431d-4d35-9c16-c9a8f33d79cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_2ecab748-431d-4d35-9c16-c9a8f33d79cc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_aedfe33e-4c6c-4fb3-95f9-0d8fce5bb970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_aedfe33e-4c6c-4fb3-95f9-0d8fce5bb970" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_945ccbb5-5246-4416-b9b6-86a474ab46c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_945ccbb5-5246-4416-b9b6-86a474ab46c8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_9225d99e-a61e-4d29-8c2a-f400a157434a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_9225d99e-a61e-4d29-8c2a-f400a157434a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_82a48760-fcbb-4c5a-9669-2ac7fa7e5bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_82a48760-fcbb-4c5a-9669-2ac7fa7e5bd9" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_bbc92d0a-65f0-4628-849c-6df220312377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_bbc92d0a-65f0-4628-849c-6df220312377" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d428f44e-2582-4b68-8649-73175f1f0f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c6eeaece-09b6-4586-8ff2-8232afd37cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_8bb28a6a-32c4-4724-89f7-4839b292559a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7f6f0b8f-d44e-4f57-84a2-1eeb432f8943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2bc58c2a-ee05-431f-a48b-370b67ee9d83" xlink:to="loc_us-gaap_StatementTable_7f6f0b8f-d44e-4f57-84a2-1eeb432f8943" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8496e663-ce91-49e3-8103-29dd19a10da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7f6f0b8f-d44e-4f57-84a2-1eeb432f8943" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8496e663-ce91-49e3-8103-29dd19a10da9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8496e663-ce91-49e3-8103-29dd19a10da9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8496e663-ce91-49e3-8103-29dd19a10da9" xlink:to="loc_us-gaap_EquityComponentDomain_8496e663-ce91-49e3-8103-29dd19a10da9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8496e663-ce91-49e3-8103-29dd19a10da9" xlink:to="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f220c8b2-4cfe-497d-bbcb-72f2156b2567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:to="loc_us-gaap_CommonStockMember_f220c8b2-4cfe-497d-bbcb-72f2156b2567" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6f20569d-a3bb-4674-a488-80e57d4666f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6f20569d-a3bb-4674-a488-80e57d4666f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eaf4ac44-7e0b-460c-9ce2-714c9746f15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eaf4ac44-7e0b-460c-9ce2-714c9746f15e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_69f4383b-d0b0-4db8-a060-bbe7fd5de898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:to="loc_us-gaap_RetainedEarningsMember_69f4383b-d0b0-4db8-a060-bbe7fd5de898" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_e0d18262-52ff-47c1-a085-e384be1871a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:to="loc_us-gaap_TreasuryStockCommonMember_e0d18262-52ff-47c1-a085-e384be1871a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_79ba3862-52f4-47b9-968f-c45170c08ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:to="loc_us-gaap_NoncontrollingInterestMember_79ba3862-52f4-47b9-968f-c45170c08ccc" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="simple" xlink:href="cnc-20221231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="extended" id="ic319be631454439eb490d1f1e0cf2c50_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2cb548de-95cd-4e06-b5e9-745b99f569be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_714faf6c-492b-461c-9f26-4a7f5ecc7c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2cb548de-95cd-4e06-b5e9-745b99f569be" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_714faf6c-492b-461c-9f26-4a7f5ecc7c33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_5f4d068b-c52c-42fe-8695-f3ae7f79bbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2cb548de-95cd-4e06-b5e9-745b99f569be" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_5f4d068b-c52c-42fe-8695-f3ae7f79bbc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6d4af45d-31ec-4f3a-b342-c5e6d715125b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2cb548de-95cd-4e06-b5e9-745b99f569be" xlink:to="loc_us-gaap_StatementTable_6d4af45d-31ec-4f3a-b342-c5e6d715125b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_570cd374-0191-40c0-93d1-bf285b39200b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6d4af45d-31ec-4f3a-b342-c5e6d715125b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_570cd374-0191-40c0-93d1-bf285b39200b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_570cd374-0191-40c0-93d1-bf285b39200b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_570cd374-0191-40c0-93d1-bf285b39200b" xlink:to="loc_us-gaap_EquityComponentDomain_570cd374-0191-40c0-93d1-bf285b39200b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fdd637db-a7f1-4132-b9c0-af3dc4430d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_570cd374-0191-40c0-93d1-bf285b39200b" xlink:to="loc_us-gaap_EquityComponentDomain_fdd637db-a7f1-4132-b9c0-af3dc4430d47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f2c1ab2e-7f76-4906-b70f-639e863417f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fdd637db-a7f1-4132-b9c0-af3dc4430d47" xlink:to="loc_us-gaap_CommonStockMember_f2c1ab2e-7f76-4906-b70f-639e863417f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_a5fdd789-4e16-4f69-94a6-84c134a62ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fdd637db-a7f1-4132-b9c0-af3dc4430d47" xlink:to="loc_us-gaap_TreasuryStockCommonMember_a5fdd789-4e16-4f69-94a6-84c134a62ce6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails" xlink:type="extended" id="ib76afee1cfea4c4780feea5091b955ea_SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7ba47fa-f46e-4de3-baf6-c8b49ddc64a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_57d8a327-c5e3-4251-b6fb-0ab447582036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7ba47fa-f46e-4de3-baf6-c8b49ddc64a2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_57d8a327-c5e3-4251-b6fb-0ab447582036" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d5e66f1c-88cb-4f60-ae4f-893473ba773e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7ba47fa-f46e-4de3-baf6-c8b49ddc64a2" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d5e66f1c-88cb-4f60-ae4f-893473ba773e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_73f63f57-8be0-4f1d-8923-e5785f7c4b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d5e66f1c-88cb-4f60-ae4f-893473ba773e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_73f63f57-8be0-4f1d-8923-e5785f7c4b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73f63f57-8be0-4f1d-8923-e5785f7c4b48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_73f63f57-8be0-4f1d-8923-e5785f7c4b48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73f63f57-8be0-4f1d-8923-e5785f7c4b48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_307f048c-8e5c-4b42-b378-32667e0811f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_73f63f57-8be0-4f1d-8923-e5785f7c4b48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_307f048c-8e5c-4b42-b378-32667e0811f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_0812de16-e138-4bc7-a12d-75ea13b0784b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_307f048c-8e5c-4b42-b378-32667e0811f6" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_0812de16-e138-4bc7-a12d-75ea13b0784b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_83612d5d-e726-4d70-88fd-357e53de076d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_307f048c-8e5c-4b42-b378-32667e0811f6" xlink:to="loc_us-gaap_ComputerEquipmentMember_83612d5d-e726-4d70-88fd-357e53de076d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_302d83a8-3634-40bf-8b09-d0ec5b709f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_307f048c-8e5c-4b42-b378-32667e0811f6" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_302d83a8-3634-40bf-8b09-d0ec5b709f7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandImprovementsMember_fa94ad25-80f3-45e2-a0cc-1880b73812af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_307f048c-8e5c-4b42-b378-32667e0811f6" xlink:to="loc_us-gaap_LandImprovementsMember_fa94ad25-80f3-45e2-a0cc-1880b73812af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_a508fe0b-e1b0-46fd-8979-80a008c97475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_307f048c-8e5c-4b42-b378-32667e0811f6" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_a508fe0b-e1b0-46fd-8979-80a008c97475" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_79c4b689-c974-4529-ac0f-03b5bef32223" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d5e66f1c-88cb-4f60-ae4f-893473ba773e" xlink:to="loc_srt_RangeAxis_79c4b689-c974-4529-ac0f-03b5bef32223" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_79c4b689-c974-4529-ac0f-03b5bef32223_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_79c4b689-c974-4529-ac0f-03b5bef32223" xlink:to="loc_srt_RangeMember_79c4b689-c974-4529-ac0f-03b5bef32223_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1a5fd33b-2b0b-49ed-88a2-01f5361ee23c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_79c4b689-c974-4529-ac0f-03b5bef32223" xlink:to="loc_srt_RangeMember_1a5fd33b-2b0b-49ed-88a2-01f5361ee23c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0cba1058-b8d0-4ba7-877c-6b9104a8b264" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1a5fd33b-2b0b-49ed-88a2-01f5361ee23c" xlink:to="loc_srt_MinimumMember_0cba1058-b8d0-4ba7-877c-6b9104a8b264" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_770d0dc8-c1f8-41cc-9681-47ca6c4b035c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1a5fd33b-2b0b-49ed-88a2-01f5361ee23c" xlink:to="loc_srt_MaximumMember_770d0dc8-c1f8-41cc-9681-47ca6c4b035c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails" xlink:type="extended" id="i51d6a88c2b74439cb60dee73d8181a84_SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_27892b36-5caa-4cb3-9256-5acb305cf3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_761dd8cc-27d5-4ea4-8c74-70ec4334b214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_27892b36-5caa-4cb3-9256-5acb305cf3f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_761dd8cc-27d5-4ea4-8c74-70ec4334b214" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4aa671e2-948f-4457-a58f-292d96507c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_27892b36-5caa-4cb3-9256-5acb305cf3f6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4aa671e2-948f-4457-a58f-292d96507c74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ea113eee-0cd8-4b12-bd72-79ffea207bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4aa671e2-948f-4457-a58f-292d96507c74" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ea113eee-0cd8-4b12-bd72-79ffea207bce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ea113eee-0cd8-4b12-bd72-79ffea207bce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ea113eee-0cd8-4b12-bd72-79ffea207bce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ea113eee-0cd8-4b12-bd72-79ffea207bce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_781fd59e-3de0-4ab7-9c0e-e65d236a40f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ea113eee-0cd8-4b12-bd72-79ffea207bce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_781fd59e-3de0-4ab7-9c0e-e65d236a40f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_390148b2-7159-454d-b56c-418dd5ab7477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_781fd59e-3de0-4ab7-9c0e-e65d236a40f9" xlink:to="loc_us-gaap_CustomerContractsMember_390148b2-7159-454d-b56c-418dd5ab7477" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ProviderContractsMember_42422bdc-fc66-4f70-abf2-e4d6836110d2" xlink:href="cnc-20221231.xsd#cnc_ProviderContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_781fd59e-3de0-4ab7-9c0e-e65d236a40f9" xlink:to="loc_cnc_ProviderContractsMember_42422bdc-fc66-4f70-abf2-e4d6836110d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_174d975e-9417-47b1-99cc-ecd23ea41f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_781fd59e-3de0-4ab7-9c0e-e65d236a40f9" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_174d975e-9417-47b1-99cc-ecd23ea41f8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_994313e3-7906-41f5-b736-7e7ea6f7eac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_781fd59e-3de0-4ab7-9c0e-e65d236a40f9" xlink:to="loc_us-gaap_TradeNamesMember_994313e3-7906-41f5-b736-7e7ea6f7eac5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_69e0f658-7969-4583-a8b3-b2acedf15cf3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4aa671e2-948f-4457-a58f-292d96507c74" xlink:to="loc_srt_RangeAxis_69e0f658-7969-4583-a8b3-b2acedf15cf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_69e0f658-7969-4583-a8b3-b2acedf15cf3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_69e0f658-7969-4583-a8b3-b2acedf15cf3" xlink:to="loc_srt_RangeMember_69e0f658-7969-4583-a8b3-b2acedf15cf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_83ac12e9-6761-475e-9c5e-4ffc101ce828" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_69e0f658-7969-4583-a8b3-b2acedf15cf3" xlink:to="loc_srt_RangeMember_83ac12e9-6761-475e-9c5e-4ffc101ce828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6c6c2f7d-ffd6-4104-bc81-d350a51aa9f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_83ac12e9-6761-475e-9c5e-4ffc101ce828" xlink:to="loc_srt_MinimumMember_6c6c2f7d-ffd6-4104-bc81-d350a51aa9f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4e54ae7d-3e27-47aa-a976-28837cdc47f5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_83ac12e9-6761-475e-9c5e-4ffc101ce828" xlink:to="loc_srt_MaximumMember_4e54ae7d-3e27-47aa-a976-28837cdc47f5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails" xlink:type="extended" id="i4d38abe8bc75417daa180f4f3a3458af_SummaryofSignificantAccountingPoliciesSignificantCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cc1699b7-e7ce-4e82-9d5d-f39214d241b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts_38a54aa4-afe6-42ef-9bec-2cffd2acf6b0" xlink:href="cnc-20221231.xsd#cnc_PercentageOfRevenuesUnderContractsOrSubcontracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cc1699b7-e7ce-4e82-9d5d-f39214d241b6" xlink:to="loc_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts_38a54aa4-afe6-42ef-9bec-2cffd2acf6b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1496f09a-3dbc-4113-8f07-b8e02bbaa396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cc1699b7-e7ce-4e82-9d5d-f39214d241b6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1496f09a-3dbc-4113-8f07-b8e02bbaa396" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_51471c66-2cac-4b60-aafa-c902605f704b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1496f09a-3dbc-4113-8f07-b8e02bbaa396" xlink:to="loc_srt_StatementGeographicalAxis_51471c66-2cac-4b60-aafa-c902605f704b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_51471c66-2cac-4b60-aafa-c902605f704b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_51471c66-2cac-4b60-aafa-c902605f704b" xlink:to="loc_srt_SegmentGeographicalDomain_51471c66-2cac-4b60-aafa-c902605f704b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c2a96c7c-b0e1-4ce2-9886-7d901d0ba780" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_51471c66-2cac-4b60-aafa-c902605f704b" xlink:to="loc_srt_SegmentGeographicalDomain_c2a96c7c-b0e1-4ce2-9886-7d901d0ba780" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_2e0282a7-725e-4f52-8abf-b3cb19e54b2d" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c2a96c7c-b0e1-4ce2-9886-7d901d0ba780" xlink:to="loc_stpr_NY_2e0282a7-725e-4f52-8abf-b3cb19e54b2d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#AcquisitionsandDivestituresNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="extended" id="i44ee9f306a9b406286fbc19def940440_AcquisitionsandDivestituresNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_318bef2d-96f7-48b1-b1a8-1c2f04f0a883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ca8b6fb3-ac64-4568-86e8-156ec050abe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_318bef2d-96f7-48b1-b1a8-1c2f04f0a883" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ca8b6fb3-ac64-4568-86e8-156ec050abe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_182057e9-8145-43b6-b765-2d65c7522d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_318bef2d-96f7-48b1-b1a8-1c2f04f0a883" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_182057e9-8145-43b6-b765-2d65c7522d4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_df16f041-ff95-482f-9b91-ceee676c417a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_318bef2d-96f7-48b1-b1a8-1c2f04f0a883" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_df16f041-ff95-482f-9b91-ceee676c417a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_089e46d5-afd1-47be-88d7-23e11e9a2d26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_318bef2d-96f7-48b1-b1a8-1c2f04f0a883" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_089e46d5-afd1-47be-88d7-23e11e9a2d26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0709c4f4-c923-477e-ac12-cafb06a1b4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_318bef2d-96f7-48b1-b1a8-1c2f04f0a883" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0709c4f4-c923-477e-ac12-cafb06a1b4d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d5542af4-d488-4cf9-bcaa-9dadb63059cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_318bef2d-96f7-48b1-b1a8-1c2f04f0a883" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d5542af4-d488-4cf9-bcaa-9dadb63059cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_09a8bdd8-1db7-4e5b-956e-f8e3ec5d763b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d5542af4-d488-4cf9-bcaa-9dadb63059cc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_09a8bdd8-1db7-4e5b-956e-f8e3ec5d763b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09a8bdd8-1db7-4e5b-956e-f8e3ec5d763b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_09a8bdd8-1db7-4e5b-956e-f8e3ec5d763b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09a8bdd8-1db7-4e5b-956e-f8e3ec5d763b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec64b8d4-31e3-4ff5-8597-aad70f600cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_09a8bdd8-1db7-4e5b-956e-f8e3ec5d763b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec64b8d4-31e3-4ff5-8597-aad70f600cd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanHealthMember_09b6eaf0-a8bc-4c4e-b432-e480d099481b" xlink:href="cnc-20221231.xsd#cnc_MagellanHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec64b8d4-31e3-4ff5-8597-aad70f600cd9" xlink:to="loc_cnc_MagellanHealthMember_09b6eaf0-a8bc-4c4e-b432-e480d099481b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="ia1d5e3cd495e4886b36cb1c7fb9943a4_AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ef5ea39a-9992-4297-8122-02dcd2270a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ef5ea39a-9992-4297-8122-02dcd2270a2f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_08baf72f-4d73-4a2c-a172-008b1af06bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_08baf72f-4d73-4a2c-a172-008b1af06bf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_ae63d09a-b8fb-467e-97f1-40dab5b1428b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_ae63d09a-b8fb-467e-97f1-40dab5b1428b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments_b35372a1-a9ff-4b4a-96ab-9b151732c55f" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments_b35372a1-a9ff-4b4a-96ab-9b151732c55f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_361b0c1c-caf9-4692-baef-aaecd2cccfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_361b0c1c-caf9-4692-baef-aaecd2cccfb8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments_34fbdf1b-2e3e-42e3-9e34-7457ca3a0aaa" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments_34fbdf1b-2e3e-42e3-9e34-7457ca3a0aaa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits_dda59bb4-fecf-4d72-9d68-d1696d7dd0d6" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits_dda59bb4-fecf-4d72-9d68-d1696d7dd0d6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_12d38dd0-ac19-4b08-824f-2a55035c8d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_12d38dd0-ac19-4b08-824f-2a55035c8d77" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5579c130-676f-4956-a550-9ad28eb83e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5579c130-676f-4956-a550-9ad28eb83e23" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_ede5842f-dd0f-4340-ae9c-ee9d53f5a1db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_ede5842f-dd0f-4340-ae9c-ee9d53f5a1db" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_86310566-9884-45ee-a51a-d1ef68684685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_86310566-9884-45ee-a51a-d1ef68684685" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability_9efaa0a3-1197-4d50-8567-5e83ed32901e" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability_9efaa0a3-1197-4d50-8567-5e83ed32901e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1500b7f4-73ec-4e1d-9da4-3323ecf0623e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1500b7f4-73ec-4e1d-9da4-3323ecf0623e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable_8fabcea9-8608-4f98-b059-ad031f2ad3fb" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable_8fabcea9-8608-4f98-b059-ad031f2ad3fb" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0a5321c0-01a4-441b-82c0-41343d9c7f74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0a5321c0-01a4-441b-82c0-41343d9c7f74" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_4d254d32-e3dc-45d6-81e7-521d0bec689d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_4d254d32-e3dc-45d6-81e7-521d0bec689d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_dc437926-c207-4d22-af44-48ff9920fd73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_dc437926-c207-4d22-af44-48ff9920fd73" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_cb832967-b028-496a-967e-081523ba48ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_cb832967-b028-496a-967e-081523ba48ca" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_1acab893-8dfd-4ec9-9fa2-44128d7a1c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_1acab893-8dfd-4ec9-9fa2-44128d7a1c60" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_10a88296-2235-4abd-ab10-de801f23b7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_10a88296-2235-4abd-ab10-de801f23b7b8" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_4e4f5417-a91b-4dcb-9022-e7f4f6b8fe83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_4e4f5417-a91b-4dcb-9022-e7f4f6b8fe83" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ece64b51-cd0b-4873-8d05-2a3c5a20feee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ece64b51-cd0b-4873-8d05-2a3c5a20feee" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ec069703-294f-4541-b977-67f61a8a02ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_Goodwill_ec069703-294f-4541-b977-67f61a8a02ae" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9bbf317f-b1a3-4120-a4f4-11a147686895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9bbf317f-b1a3-4120-a4f4-11a147686895" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_36ab6a72-4db0-4e72-b3e3-7f1469096526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_36ab6a72-4db0-4e72-b3e3-7f1469096526" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal_bda0ca21-53eb-41c1-9276-d17b8d2c43ff" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal_bda0ca21-53eb-41c1-9276-d17b8d2c43ff" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_bdeb821a-b149-4e04-9747-9ffd3b9ed924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_bdeb821a-b149-4e04-9747-9ffd3b9ed924" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_12ed0ccb-7a72-4582-bcdd-3047329bad23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1224aabf-46e6-488a-8a11-13a301fb0e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ef5ea39a-9992-4297-8122-02dcd2270a2f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1224aabf-46e6-488a-8a11-13a301fb0e46" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7a175100-d516-40f3-b374-fb46b8d9f85b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1224aabf-46e6-488a-8a11-13a301fb0e46" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7a175100-d516-40f3-b374-fb46b8d9f85b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a175100-d516-40f3-b374-fb46b8d9f85b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7a175100-d516-40f3-b374-fb46b8d9f85b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a175100-d516-40f3-b374-fb46b8d9f85b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1634949a-3a86-48a8-b2e7-0481add06bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7a175100-d516-40f3-b374-fb46b8d9f85b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1634949a-3a86-48a8-b2e7-0481add06bc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanHealthMember_dca2ae5c-43ac-409d-aa32-92b5fb4f0a9c" xlink:href="cnc-20221231.xsd#cnc_MagellanHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1634949a-3a86-48a8-b2e7-0481add06bc4" xlink:to="loc_cnc_MagellanHealthMember_dca2ae5c-43ac-409d-aa32-92b5fb4f0a9c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="i3932b94a71e6468193ffe8705c5237b1_AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_eb66cc4f-c2a4-4637-a164-3dc2eec0cecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ee25715d-fdf4-4941-9863-e87ded28ea05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_eb66cc4f-c2a4-4637-a164-3dc2eec0cecd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ee25715d-fdf4-4941-9863-e87ded28ea05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e96b2f5e-5d57-488a-a9d1-9ae1c1e71925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_eb66cc4f-c2a4-4637-a164-3dc2eec0cecd" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e96b2f5e-5d57-488a-a9d1-9ae1c1e71925" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1cd11d32-b525-44da-99e3-a8475a235434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_eb66cc4f-c2a4-4637-a164-3dc2eec0cecd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1cd11d32-b525-44da-99e3-a8475a235434" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a357d240-a860-4232-b8c2-8a485a76d3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1cd11d32-b525-44da-99e3-a8475a235434" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a357d240-a860-4232-b8c2-8a485a76d3bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a357d240-a860-4232-b8c2-8a485a76d3bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a357d240-a860-4232-b8c2-8a485a76d3bc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a357d240-a860-4232-b8c2-8a485a76d3bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36363a6c-b249-4ba7-970a-c99b88c923d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a357d240-a860-4232-b8c2-8a485a76d3bc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36363a6c-b249-4ba7-970a-c99b88c923d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanHealthMember_7f10a451-c068-4efa-a68c-43be68700915" xlink:href="cnc-20221231.xsd#cnc_MagellanHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36363a6c-b249-4ba7-970a-c99b88c923d1" xlink:to="loc_cnc_MagellanHealthMember_7f10a451-c068-4efa-a68c-43be68700915" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_589dff99-f28e-4d76-b3b9-95f9ae8e98c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1cd11d32-b525-44da-99e3-a8475a235434" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_589dff99-f28e-4d76-b3b9-95f9ae8e98c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_589dff99-f28e-4d76-b3b9-95f9ae8e98c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_589dff99-f28e-4d76-b3b9-95f9ae8e98c8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_589dff99-f28e-4d76-b3b9-95f9ae8e98c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_89973149-cb29-430b-8273-1aed6e25d9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_589dff99-f28e-4d76-b3b9-95f9ae8e98c8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_89973149-cb29-430b-8273-1aed6e25d9b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_8df42708-0a7e-44a1-97b9-08c58475b4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_89973149-cb29-430b-8273-1aed6e25d9b6" xlink:to="loc_us-gaap_ContractualRightsMember_8df42708-0a7e-44a1-97b9-08c58475b4b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember_dc45a051-2a37-4d27-bd6f-2a906999faba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_89973149-cb29-430b-8273-1aed6e25d9b6" xlink:to="loc_us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember_dc45a051-2a37-4d27-bd6f-2a906999faba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_4bc30fe2-21cd-4eec-85f5-fa2227e90fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_89973149-cb29-430b-8273-1aed6e25d9b6" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_4bc30fe2-21cd-4eec-85f5-fa2227e90fd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ba412827-b53a-49e5-b415-5db5deb8b2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_89973149-cb29-430b-8273-1aed6e25d9b6" xlink:to="loc_us-gaap_TradeNamesMember_ba412827-b53a-49e5-b415-5db5deb8b2a2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#AcquisitionsandDivestituresDivestituresDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" xlink:type="extended" id="icaf13cfa67c340f28f9eb41c93be9d69_AcquisitionsandDivestituresDivestituresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_9de4694a-6640-400d-9b55-b828d55ed4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_9de4694a-6640-400d-9b55-b828d55ed4f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_5f0354d9-5b2a-4ba3-bb97-cc5613e3ba77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_5f0354d9-5b2a-4ba3-bb97-cc5613e3ba77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GainLossOnDispositionOfBusinessNetOfTax_3e3eb985-d172-48aa-ae02-f440aa98bd79" xlink:href="cnc-20221231.xsd#cnc_GainLossOnDispositionOfBusinessNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_cnc_GainLossOnDispositionOfBusinessNetOfTax_3e3eb985-d172-48aa-ae02-f440aa98bd79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_8e26bb56-2432-4830-a5c5-8158dfecdaae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_us-gaap_AssetImpairmentCharges_8e26bb56-2432-4830-a5c5-8158dfecdaae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AssetImpairmentChargesNetOfTax_ec612d94-f36b-4fb6-a61c-7cb81bdd2022" xlink:href="cnc-20221231.xsd#cnc_AssetImpairmentChargesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_cnc_AssetImpairmentChargesNetOfTax_ec612d94-f36b-4fb6-a61c-7cb81bdd2022" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_d5942aaa-a6a1-47cd-aa58-e91ea05ad67e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_d5942aaa-a6a1-47cd-aa58-e91ea05ad67e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a8bddc7e-ec65-49db-aa49-27ccd2ef3ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a8bddc7e-ec65-49db-aa49-27ccd2ef3ba7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_830214e2-4938-4a57-8c0f-aaf4036de6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_830214e2-4938-4a57-8c0f-aaf4036de6ae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh_67e31e80-d735-415e-a869-8a16853de410" xlink:href="cnc-20221231.xsd#cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh_67e31e80-d735-415e-a869-8a16853de410" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_300338c4-202c-404a-a5a6-042ddd52b5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_300338c4-202c-404a-a5a6-042ddd52b5f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f309ad1d-726a-4e95-a758-0fe8674426f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_300338c4-202c-404a-a5a6-042ddd52b5f4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f309ad1d-726a-4e95-a758-0fe8674426f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f309ad1d-726a-4e95-a758-0fe8674426f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f309ad1d-726a-4e95-a758-0fe8674426f9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f309ad1d-726a-4e95-a758-0fe8674426f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f309ad1d-726a-4e95-a758-0fe8674426f9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PANTHERxRareMember_3876b294-e9f8-49f2-89ee-7e14179d32db" xlink:href="cnc-20221231.xsd#cnc_PANTHERxRareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:to="loc_cnc_PANTHERxRareMember_3876b294-e9f8-49f2-89ee-7e14179d32db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SpanishAndCentralEuropeanBusinessesMember_f63bdfa4-7391-48f3-a938-07b3002fc92c" xlink:href="cnc-20221231.xsd#cnc_SpanishAndCentralEuropeanBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:to="loc_cnc_SpanishAndCentralEuropeanBusinessesMember_f63bdfa4-7391-48f3-a938-07b3002fc92c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanRxMember_f7e81b80-8d5a-458e-9a65-acb49313dcd4" xlink:href="cnc-20221231.xsd#cnc_MagellanRxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:to="loc_cnc_MagellanRxMember_f7e81b80-8d5a-458e-9a65-acb49313dcd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanSpecialtyHealthMember_5b202339-8128-4380-845e-0759500efd42" xlink:href="cnc-20221231.xsd#cnc_MagellanSpecialtyHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:to="loc_cnc_MagellanSpecialtyHealthMember_5b202339-8128-4380-845e-0759500efd42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_CenturionMember_dd3b9b46-997c-453c-87ce-ea0c26293e6f" xlink:href="cnc-20221231.xsd#cnc_CenturionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:to="loc_cnc_CenturionMember_dd3b9b46-997c-453c-87ce-ea0c26293e6f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_HealthSmartMember_80fca831-7f63-40b7-b963-60a37aee364b" xlink:href="cnc-20221231.xsd#cnc_HealthSmartMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:to="loc_cnc_HealthSmartMember_80fca831-7f63-40b7-b963-60a37aee364b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3b03f909-233d-493e-b087-04c68fa4e544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_300338c4-202c-404a-a5a6-042ddd52b5f4" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3b03f909-233d-493e-b087-04c68fa4e544" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3b03f909-233d-493e-b087-04c68fa4e544_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3b03f909-233d-493e-b087-04c68fa4e544" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3b03f909-233d-493e-b087-04c68fa4e544_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b70ee1fe-9b3b-432a-92cf-f9c6d1d3afd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3b03f909-233d-493e-b087-04c68fa4e544" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b70ee1fe-9b3b-432a-92cf-f9c6d1d3afd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_c109d49c-fb2c-461b-b290-5232a13681b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b70ee1fe-9b3b-432a-92cf-f9c6d1d3afd8" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_c109d49c-fb2c-461b-b290-5232a13681b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_8848f655-2815-4e18-ac99-b8738c1e54be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b70ee1fe-9b3b-432a-92cf-f9c6d1d3afd8" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_8848f655-2815-4e18-ac99-b8738c1e54be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_bc1aa7b6-f754-4866-a5ba-9f7ac7545be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_300338c4-202c-404a-a5a6-042ddd52b5f4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_bc1aa7b6-f754-4866-a5ba-9f7ac7545be1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bc1aa7b6-f754-4866-a5ba-9f7ac7545be1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bc1aa7b6-f754-4866-a5ba-9f7ac7545be1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bc1aa7b6-f754-4866-a5ba-9f7ac7545be1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3f703ff0-2f12-478a-ba9a-c4ce065cdf9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bc1aa7b6-f754-4866-a5ba-9f7ac7545be1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3f703ff0-2f12-478a-ba9a-c4ce065cdf9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1d56175b-01e3-4094-8761-1f5e11164b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3f703ff0-2f12-478a-ba9a-c4ce065cdf9d" xlink:to="loc_us-gaap_SubsequentEventMember_1d56175b-01e3-4094-8761-1f5e11164b9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_744ca6a2-6c27-49ff-b15b-2bc37c4c76fa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_300338c4-202c-404a-a5a6-042ddd52b5f4" xlink:to="loc_srt_RangeAxis_744ca6a2-6c27-49ff-b15b-2bc37c4c76fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_744ca6a2-6c27-49ff-b15b-2bc37c4c76fa_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_744ca6a2-6c27-49ff-b15b-2bc37c4c76fa" xlink:to="loc_srt_RangeMember_744ca6a2-6c27-49ff-b15b-2bc37c4c76fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7c3e6676-e4c5-4de8-86b0-06571dfc3d7c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_744ca6a2-6c27-49ff-b15b-2bc37c4c76fa" xlink:to="loc_srt_RangeMember_7c3e6676-e4c5-4de8-86b0-06571dfc3d7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_96bec48f-849c-442f-bd38-5718c80be8d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7c3e6676-e4c5-4de8-86b0-06571dfc3d7c" xlink:to="loc_srt_MinimumMember_96bec48f-849c-442f-bd38-5718c80be8d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7ddbc12f-541b-470a-8fa0-817838919c27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7c3e6676-e4c5-4de8-86b0-06571dfc3d7c" xlink:to="loc_srt_MaximumMember_7ddbc12f-541b-470a-8fa0-817838919c27" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" xlink:type="extended" id="ida9a1dacf28b47dfacbd3f50e0152cee_ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_8a3aacab-c1cc-45fa-b784-85e4bc12a3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:to="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_8a3aacab-c1cc-45fa-b784-85e4bc12a3ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_cd903330-38f0-4d05-8a2a-76d54437dd67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_8a3aacab-c1cc-45fa-b784-85e4bc12a3ab" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_cd903330-38f0-4d05-8a2a-76d54437dd67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_33e8650f-23ac-4213-8eba-6e08f6e554b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_8a3aacab-c1cc-45fa-b784-85e4bc12a3ab" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_33e8650f-23ac-4213-8eba-6e08f6e554b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_08ecd24b-3b62-42cc-9292-5c1d000944fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_8a3aacab-c1cc-45fa-b784-85e4bc12a3ab" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_08ecd24b-3b62-42cc-9292-5c1d000944fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_3db88d46-c7b7-4b27-8c4e-6fb846faf79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_8a3aacab-c1cc-45fa-b784-85e4bc12a3ab" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_3db88d46-c7b7-4b27-8c4e-6fb846faf79e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_1dbd4a69-4b69-464a-aab0-669ebcdd30b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_1dbd4a69-4b69-464a-aab0-669ebcdd30b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_c88b3cc7-0d7a-4f5c-9973-ed466ff80169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:to="loc_us-gaap_EquityMethodInvestments_c88b3cc7-0d7a-4f5c-9973-ed466ff80169" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount_d64455ad-d50f-4c18-82e8-c87ebc20a176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LifeInsuranceCorporateOrBankOwnedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:to="loc_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount_d64455ad-d50f-4c18-82e8-c87ebc20a176" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost_a28ef2df-d4f6-4d0c-a037-c7791a464d49" xlink:href="cnc-20221231.xsd#cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:to="loc_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost_a28ef2df-d4f6-4d0c-a037-c7791a464d49" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue_be025170-a70c-45b9-9159-89daae3df91f" xlink:href="cnc-20221231.xsd#cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:to="loc_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue_be025170-a70c-45b9-9159-89daae3df91f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_a992e12d-a32c-4e33-9e4d-9630d127a529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_a992e12d-a32c-4e33-9e4d-9630d127a529" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1210be18-7a01-442a-a9f3-fa6ac2b6bd46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_a992e12d-a32c-4e33-9e4d-9630d127a529" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1210be18-7a01-442a-a9f3-fa6ac2b6bd46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1210be18-7a01-442a-a9f3-fa6ac2b6bd46_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1210be18-7a01-442a-a9f3-fa6ac2b6bd46" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1210be18-7a01-442a-a9f3-fa6ac2b6bd46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1210be18-7a01-442a-a9f3-fa6ac2b6bd46" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_b0f47860-1dc9-4c47-9436-c507ebdc1020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_b0f47860-1dc9-4c47-9436-c507ebdc1020" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_6ea92673-52f9-4f6e-9bbf-c3a891b7c70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_6ea92673-52f9-4f6e-9bbf-c3a891b7c70e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RestrictedCertificatesOfDepositMember_a1514113-68da-4ae8-93f7-714182ff1f6a" xlink:href="cnc-20221231.xsd#cnc_RestrictedCertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_cnc_RestrictedCertificatesOfDepositMember_a1514113-68da-4ae8-93f7-714182ff1f6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RestrictedCashEquivalentsMember_786fee33-261b-4222-8975-654758061390" xlink:href="cnc-20221231.xsd#cnc_RestrictedCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_cnc_RestrictedCashEquivalentsMember_786fee33-261b-4222-8975-654758061390" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_d1c454e1-b654-4bde-8cfc-f1a43acd840a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_us-gaap_BankTimeDepositsMember_d1c454e1-b654-4bde-8cfc-f1a43acd840a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_c3a5058a-ebb6-4efc-8ccd-d57abac35ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_us-gaap_MunicipalBondsMember_c3a5058a-ebb6-4efc-8ccd-d57abac35ea4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_0af7b84b-6069-4d99-bcc4-59af1862b555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_0af7b84b-6069-4d99-bcc4-59af1862b555" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_4957a39f-57e5-4662-adc1-f91d2fbf290f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_4957a39f-57e5-4662-adc1-f91d2fbf290f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_db00583c-f4dd-464e-8416-12ef71a6e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_db00583c-f4dd-464e-8416-12ef71a6e7f8" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" xlink:type="extended" id="ib715eee9d5154fb5b4333920105005b0_ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ebaec284-2da9-4d8d-8589-800e96b90428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ebaec284-2da9-4d8d-8589-800e96b90428" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_abfd3bf3-4a2a-494f-be3d-913628345277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_abfd3bf3-4a2a-494f-be3d-913628345277" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList_0120e057-caca-4b96-9876-5ee9f613f9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList_0120e057-caca-4b96-9876-5ee9f613f9fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration_aa7d7f29-c953-4920-9081-481ad4bd480f" xlink:href="cnc-20221231.xsd#cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration_aa7d7f29-c953-4920-9081-481ad4bd480f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_9b8cab8a-88ca-4464-b64c-e004ff0230c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_9b8cab8a-88ca-4464-b64c-e004ff0230c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions_f017d87c-1fb1-4375-8ca5-f4555e8995f6" xlink:href="cnc-20221231.xsd#cnc_DebtSecuritiesAvailableForSaleNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions_f017d87c-1fb1-4375-8ca5-f4555e8995f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_627750b3-94bf-47a0-bf5c-0997d416506e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_627750b3-94bf-47a0-bf5c-0997d416506e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_57be221c-6c3c-4ac1-b88b-82f7b1bb9996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_57be221c-6c3c-4ac1-b88b-82f7b1bb9996" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_ed56760b-a3d7-40bd-9b01-c457a255c834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_ed56760b-a3d7-40bd-9b01-c457a255c834" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_18e5b901-8f7e-45cb-99c0-0f5617f988cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_18e5b901-8f7e-45cb-99c0-0f5617f988cc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_feb394e1-a4b0-42d7-a3a0-3112874a095c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_feb394e1-a4b0-42d7-a3a0-3112874a095c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8931f24-94f1-479d-8085-fa40d70439a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8931f24-94f1-479d-8085-fa40d70439a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f8931f24-94f1-479d-8085-fa40d70439a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8931f24-94f1-479d-8085-fa40d70439a6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f8931f24-94f1-479d-8085-fa40d70439a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f31771b7-6bfe-451f-8688-0cd518c218d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8931f24-94f1-479d-8085-fa40d70439a6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f31771b7-6bfe-451f-8688-0cd518c218d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RatedSecuritiesMember_26712c7b-e516-442f-ad76-adc30c3497e6" xlink:href="cnc-20221231.xsd#cnc_RatedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f31771b7-6bfe-451f-8688-0cd518c218d0" xlink:to="loc_cnc_RatedSecuritiesMember_26712c7b-e516-442f-ad76-adc30c3497e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingByGroupingAxis_2697ea78-ba80-46d6-a49e-054d7c0b71bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingByGroupingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:to="loc_us-gaap_ExternalCreditRatingByGroupingAxis_2697ea78-ba80-46d6-a49e-054d7c0b71bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingByGroupingDomain_2697ea78-ba80-46d6-a49e-054d7c0b71bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingByGroupingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExternalCreditRatingByGroupingAxis_2697ea78-ba80-46d6-a49e-054d7c0b71bc" xlink:to="loc_us-gaap_ExternalCreditRatingByGroupingDomain_2697ea78-ba80-46d6-a49e-054d7c0b71bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingByGroupingDomain_a38ed24d-7347-4fbd-9676-1974ad998931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingByGroupingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExternalCreditRatingByGroupingAxis_2697ea78-ba80-46d6-a49e-054d7c0b71bc" xlink:to="loc_us-gaap_ExternalCreditRatingByGroupingDomain_a38ed24d-7347-4fbd-9676-1974ad998931" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingInvestmentGradeMember_34ec6b5e-23e5-4277-b04b-ae3d6d47c753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingInvestmentGradeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExternalCreditRatingByGroupingDomain_a38ed24d-7347-4fbd-9676-1974ad998931" xlink:to="loc_us-gaap_ExternalCreditRatingInvestmentGradeMember_34ec6b5e-23e5-4277-b04b-ae3d6d47c753" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e9b2567a-13e9-4cb2-8493-f870e9d4e5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e9b2567a-13e9-4cb2-8493-f870e9d4e5f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e9b2567a-13e9-4cb2-8493-f870e9d4e5f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e9b2567a-13e9-4cb2-8493-f870e9d4e5f5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e9b2567a-13e9-4cb2-8493-f870e9d4e5f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ebdb7243-8c42-46c3-b77b-4f80d81c10de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e9b2567a-13e9-4cb2-8493-f870e9d4e5f5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ebdb7243-8c42-46c3-b77b-4f80d81c10de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_InvestmentSecuritiesMember_e846e7ef-9a2c-4615-8f0d-ddad0c35adee" xlink:href="cnc-20221231.xsd#cnc_InvestmentSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ebdb7243-8c42-46c3-b77b-4f80d81c10de" xlink:to="loc_cnc_InvestmentSecuritiesMember_e846e7ef-9a2c-4615-8f0d-ddad0c35adee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_81b7cf93-9b63-445b-ac3c-fd68ac47ee2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:to="loc_us-gaap_FinancialInstrumentAxis_81b7cf93-9b63-445b-ac3c-fd68ac47ee2e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_81b7cf93-9b63-445b-ac3c-fd68ac47ee2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_81b7cf93-9b63-445b-ac3c-fd68ac47ee2e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_81b7cf93-9b63-445b-ac3c-fd68ac47ee2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f18ce15f-86a1-48c7-b6af-903d9c2af5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_81b7cf93-9b63-445b-ac3c-fd68ac47ee2e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f18ce15f-86a1-48c7-b6af-903d9c2af5d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_91abfea8-47af-46ed-a0a4-0f10a2cc7b10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f18ce15f-86a1-48c7-b6af-903d9c2af5d9" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_91abfea8-47af-46ed-a0a4-0f10a2cc7b10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1d9d5617-b078-42b5-ab3b-9a1d0c8c7764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1d9d5617-b078-42b5-ab3b-9a1d0c8c7764" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9d5617-b078-42b5-ab3b-9a1d0c8c7764_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d9d5617-b078-42b5-ab3b-9a1d0c8c7764" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9d5617-b078-42b5-ab3b-9a1d0c8c7764_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a94fb8e-b182-4ee5-87ab-d969471077e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d9d5617-b078-42b5-ab3b-9a1d0c8c7764" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a94fb8e-b182-4ee5-87ab-d969471077e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_CircleHealthMember_53f93718-8cee-429f-8e60-ad087f4341ad" xlink:href="cnc-20221231.xsd#cnc_CircleHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a94fb8e-b182-4ee5-87ab-d969471077e8" xlink:to="loc_cnc_CircleHealthMember_53f93718-8cee-429f-8e60-ad087f4341ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_21a9a477-cfe7-4dc9-a413-b034a99ab161" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_21a9a477-cfe7-4dc9-a413-b034a99ab161" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_21a9a477-cfe7-4dc9-a413-b034a99ab161_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_21a9a477-cfe7-4dc9-a413-b034a99ab161" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_21a9a477-cfe7-4dc9-a413-b034a99ab161_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_85453132-4bb6-439b-bcb6-715be327a869" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_21a9a477-cfe7-4dc9-a413-b034a99ab161" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_85453132-4bb6-439b-bcb6-715be327a869" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RxAdvanceMember_9502c724-9c09-43c4-aee6-894aa11d1660" xlink:href="cnc-20221231.xsd#cnc_RxAdvanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_85453132-4bb6-439b-bcb6-715be327a869" xlink:to="loc_cnc_RxAdvanceMember_9502c724-9c09-43c4-aee6-894aa11d1660" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails" xlink:type="extended" id="i78e129b9c660440b848f62ad5be907db_ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ab5ae346-6a68-4848-a422-342bbb209b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_c007ed29-33ad-486f-bd59-abdc4b8cd822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ab5ae346-6a68-4848-a422-342bbb209b51" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_c007ed29-33ad-486f-bd59-abdc4b8cd822" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_9b0e8c5b-baf8-4687-a61a-e3ac685fc01e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_c007ed29-33ad-486f-bd59-abdc4b8cd822" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_9b0e8c5b-baf8-4687-a61a-e3ac685fc01e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_ece22fb5-5b1e-4914-adba-9d55ecc9799a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_c007ed29-33ad-486f-bd59-abdc4b8cd822" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_ece22fb5-5b1e-4914-adba-9d55ecc9799a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract_7fc966dc-7491-4beb-9352-93fbaac79a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ab5ae346-6a68-4848-a422-342bbb209b51" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract_7fc966dc-7491-4beb-9352-93fbaac79a8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_a6b6057d-4249-4a93-a6dc-b8dab606a291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract_7fc966dc-7491-4beb-9352-93fbaac79a8c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_a6b6057d-4249-4a93-a6dc-b8dab606a291" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_ac748816-7332-40ad-bc03-e1a301ac3105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract_7fc966dc-7491-4beb-9352-93fbaac79a8c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_ac748816-7332-40ad-bc03-e1a301ac3105" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1e4618be-dd4e-4759-b19a-de67e14bd83c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ab5ae346-6a68-4848-a422-342bbb209b51" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1e4618be-dd4e-4759-b19a-de67e14bd83c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6cb5ec2c-4022-46ac-95e9-5a2c0916599c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1e4618be-dd4e-4759-b19a-de67e14bd83c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6cb5ec2c-4022-46ac-95e9-5a2c0916599c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6cb5ec2c-4022-46ac-95e9-5a2c0916599c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6cb5ec2c-4022-46ac-95e9-5a2c0916599c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6cb5ec2c-4022-46ac-95e9-5a2c0916599c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6cb5ec2c-4022-46ac-95e9-5a2c0916599c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_a399742b-64d9-456b-adce-66c82a8616d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_a399742b-64d9-456b-adce-66c82a8616d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_70c97b94-7e1b-42b7-b356-fb0deee83b77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_70c97b94-7e1b-42b7-b356-fb0deee83b77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_8acabd8d-7a23-44d6-8193-f770450734fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:to="loc_us-gaap_MunicipalBondsMember_8acabd8d-7a23-44d6-8193-f770450734fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_2547186a-c295-4596-8582-7bfd9e42bdc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_2547186a-c295-4596-8582-7bfd9e42bdc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c5c35779-dcce-4bf6-8483-ba46f6206a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c5c35779-dcce-4bf6-8483-ba46f6206a94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_605ed8b4-1d29-4713-bb64-6ce663f2bd96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_605ed8b4-1d29-4713-bb64-6ce663f2bd96" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" xlink:type="extended" id="i5c8f03f159a64b6c96252f76315f3a51_ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_71ce1495-aaf5-4343-9ab7-638cc94220b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_71ce1495-aaf5-4343-9ab7-638cc94220b3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f028704a-864a-4a43-a957-829245717490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f028704a-864a-4a43-a957-829245717490" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_032ded2e-b64e-4032-a238-35b9e72c1c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_032ded2e-b64e-4032-a238-35b9e72c1c0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_6772f4e6-2592-4a96-8fb9-33dd5ce7debb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_6772f4e6-2592-4a96-8fb9-33dd5ce7debb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_c7460c1c-9502-4bbb-85c2-c808e841b810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_c7460c1c-9502-4bbb-85c2-c808e841b810" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_d5db3793-6396-4c19-b8b7-d74eb7c5a346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_d5db3793-6396-4c19-b8b7-d74eb7c5a346" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_d9e59f72-92f0-46de-9fe5-c3d9bfabde97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_d9e59f72-92f0-46de-9fe5-c3d9bfabde97" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_71ce1495-aaf5-4343-9ab7-638cc94220b3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0aa339e9-587b-4228-9649-cdccc0ab29d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0aa339e9-587b-4228-9649-cdccc0ab29d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_86fbab91-ddca-4b2f-8bdd-02ecfaa4b3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_86fbab91-ddca-4b2f-8bdd-02ecfaa4b3d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_f983f8c0-6891-4da2-8ede-7c2abc8d5c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_f983f8c0-6891-4da2-8ede-7c2abc8d5c76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_0d6a4889-be2d-407b-a11e-2b18fe64b5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_0d6a4889-be2d-407b-a11e-2b18fe64b5e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_11397423-0729-4ed0-abb9-61df76b34a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_11397423-0729-4ed0-abb9-61df76b34a1e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_4e77f5cd-9794-428b-b2a1-96b34b7ef61c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_4e77f5cd-9794-428b-b2a1-96b34b7ef61c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_247871ec-ca57-4eab-8f95-444dfee152c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_71ce1495-aaf5-4343-9ab7-638cc94220b3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_247871ec-ca57-4eab-8f95-444dfee152c6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_a7142dd4-fc8b-4579-b137-c9fa76fcf19a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_247871ec-ca57-4eab-8f95-444dfee152c6" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_a7142dd4-fc8b-4579-b137-c9fa76fcf19a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a7142dd4-fc8b-4579-b137-c9fa76fcf19a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_a7142dd4-fc8b-4579-b137-c9fa76fcf19a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a7142dd4-fc8b-4579-b137-c9fa76fcf19a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3efdc46-0c67-4e26-bda2-0263fa474c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_a7142dd4-fc8b-4579-b137-c9fa76fcf19a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3efdc46-0c67-4e26-bda2-0263fa474c11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_d24d6105-1b18-48f9-be40-c33167277800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3efdc46-0c67-4e26-bda2-0263fa474c11" xlink:to="loc_us-gaap_InvestmentsMember_d24d6105-1b18-48f9-be40-c33167277800" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsMember_20cce6f8-b00e-4ce3-af15-3e815ced9176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3efdc46-0c67-4e26-bda2-0263fa474c11" xlink:to="loc_us-gaap_DepositsMember_20cce6f8-b00e-4ce3-af15-3e815ced9176" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended" id="i8dab8584917b4ef0801399cb3381fba5_FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b718daad-c33f-4ba8-8370-d31910195737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_c4a23f42-58b5-4bde-803c-b51e0778d92a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b718daad-c33f-4ba8-8370-d31910195737" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_c4a23f42-58b5-4bde-803c-b51e0778d92a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7cb3d760-e20e-49f4-a195-9d8e0ba0e0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_c4a23f42-58b5-4bde-803c-b51e0778d92a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7cb3d760-e20e-49f4-a195-9d8e0ba0e0b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_5d0df84a-6f81-4c1d-9a85-a56ac54fbc84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_c4a23f42-58b5-4bde-803c-b51e0778d92a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_5d0df84a-6f81-4c1d-9a85-a56ac54fbc84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_91fec213-6a6e-4979-96d7-48654154ae44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_5d0df84a-6f81-4c1d-9a85-a56ac54fbc84" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_91fec213-6a6e-4979-96d7-48654154ae44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_03f2fcb6-3b61-4f94-86ae-3a4cbf583e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_5d0df84a-6f81-4c1d-9a85-a56ac54fbc84" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_03f2fcb6-3b61-4f94-86ae-3a4cbf583e65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_6f6e7cca-7e8e-46a3-bbba-87c1bd8dd575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_c4a23f42-58b5-4bde-803c-b51e0778d92a" xlink:to="loc_us-gaap_OtherAssetsAbstract_6f6e7cca-7e8e-46a3-bbba-87c1bd8dd575" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_2f88c596-424b-4ddf-bfa7-e8b62b65e4be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherAssetsAbstract_6f6e7cca-7e8e-46a3-bbba-87c1bd8dd575" xlink:to="loc_us-gaap_DerivativeAssets_2f88c596-424b-4ddf-bfa7-e8b62b65e4be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_824ea3f8-a20e-411a-8ea8-61d97e79abdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b718daad-c33f-4ba8-8370-d31910195737" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_824ea3f8-a20e-411a-8ea8-61d97e79abdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_24c12f31-211b-4c84-b40e-bf3675ee5038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b718daad-c33f-4ba8-8370-d31910195737" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_24c12f31-211b-4c84-b40e-bf3675ee5038" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_c0586a83-f2bb-4a71-a9bc-ac6047d7e706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_24c12f31-211b-4c84-b40e-bf3675ee5038" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_c0586a83-f2bb-4a71-a9bc-ac6047d7e706" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_c0586a83-f2bb-4a71-a9bc-ac6047d7e706_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_c0586a83-f2bb-4a71-a9bc-ac6047d7e706" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_c0586a83-f2bb-4a71-a9bc-ac6047d7e706_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3d82e4af-7282-44e5-95ec-af51cbfcb67c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_c0586a83-f2bb-4a71-a9bc-ac6047d7e706" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3d82e4af-7282-44e5-95ec-af51cbfcb67c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_a87e459f-7fea-4f78-a732-101e07f951cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3d82e4af-7282-44e5-95ec-af51cbfcb67c" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_a87e459f-7fea-4f78-a732-101e07f951cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsMember_772e3b4f-1de1-4ca5-9400-08867a7e5cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3d82e4af-7282-44e5-95ec-af51cbfcb67c" xlink:to="loc_us-gaap_DepositsMember_772e3b4f-1de1-4ca5-9400-08867a7e5cca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_2e5c2fb7-75ce-4a0c-9ed9-dad94bff1111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3d82e4af-7282-44e5-95ec-af51cbfcb67c" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_2e5c2fb7-75ce-4a0c-9ed9-dad94bff1111" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8d2a1ed8-05f2-4249-b031-c99c20c7d879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_24c12f31-211b-4c84-b40e-bf3675ee5038" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8d2a1ed8-05f2-4249-b031-c99c20c7d879" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8d2a1ed8-05f2-4249-b031-c99c20c7d879_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8d2a1ed8-05f2-4249-b031-c99c20c7d879" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8d2a1ed8-05f2-4249-b031-c99c20c7d879_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c409662b-3f7a-4745-b1b2-63675845f8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8d2a1ed8-05f2-4249-b031-c99c20c7d879" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c409662b-3f7a-4745-b1b2-63675845f8bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a5feceda-faba-4ea5-ae4b-35337debc481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c409662b-3f7a-4745-b1b2-63675845f8bb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a5feceda-faba-4ea5-ae4b-35337debc481" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_13cbe9eb-8e99-4fa9-99a4-a72c6a3c2f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c409662b-3f7a-4745-b1b2-63675845f8bb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_13cbe9eb-8e99-4fa9-99a4-a72c6a3c2f1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_654169a0-0237-4027-b37e-07e747f2fd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c409662b-3f7a-4745-b1b2-63675845f8bb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_654169a0-0237-4027-b37e-07e747f2fd1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d95da925-7043-4358-bf5a-34cdffd49097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_24c12f31-211b-4c84-b40e-bf3675ee5038" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d95da925-7043-4358-bf5a-34cdffd49097" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d95da925-7043-4358-bf5a-34cdffd49097_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d95da925-7043-4358-bf5a-34cdffd49097" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d95da925-7043-4358-bf5a-34cdffd49097_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d95da925-7043-4358-bf5a-34cdffd49097" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_613b8404-7346-4ac0-8202-049d8d498271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_613b8404-7346-4ac0-8202-049d8d498271" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_f35628cc-8c82-4ecf-8fee-dd7c9b46359f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_f35628cc-8c82-4ecf-8fee-dd7c9b46359f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_e7b8f1a4-9f0b-40aa-8689-859313c938eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_MunicipalBondsMember_e7b8f1a4-9f0b-40aa-8689-859313c938eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_4aea29ec-f9a0-4b4c-a705-c3358a976a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_BankTimeDepositsMember_4aea29ec-f9a0-4b4c-a705-c3358a976a66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_c0df14d0-3f25-4c54-b68c-084b69325041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_c0df14d0-3f25-4c54-b68c-084b69325041" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_0d7aff49-cdee-4523-982e-4366aae4573f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_0d7aff49-cdee-4523-982e-4366aae4573f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d3f06b56-c115-4e44-8050-16ed790d0e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d3f06b56-c115-4e44-8050-16ed790d0e31" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_2c508144-ecf1-4fd9-9c8e-2ab57664e1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_2c508144-ecf1-4fd9-9c8e-2ab57664e1a3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_924e6a50-bcfe-463d-8865-f9d283c1b26e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_CertificatesOfDepositMember_924e6a50-bcfe-463d-8865-f9d283c1b26e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5b50f94f-fd0a-4550-a826-96a890780c10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_InterestRateSwapMember_5b50f94f-fd0a-4550-a826-96a890780c10" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#PropertySoftwareandEquipmentComponentsDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" xlink:type="extended" id="i11ac69aa47924e468b0a7bfc6c56c9e7_PropertySoftwareandEquipmentComponentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a5f8e167-4886-447b-a2d9-e7719188e7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ab79b961-9bf6-433e-bd78-20d821ab38a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a5f8e167-4886-447b-a2d9-e7719188e7df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ab79b961-9bf6-433e-bd78-20d821ab38a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_065ec495-f0cb-4f3c-96d3-760c9fb0d145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a5f8e167-4886-447b-a2d9-e7719188e7df" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_065ec495-f0cb-4f3c-96d3-760c9fb0d145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_92b88e4a-8ea6-4db3-b1cb-3f61216c4cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a5f8e167-4886-447b-a2d9-e7719188e7df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_92b88e4a-8ea6-4db3-b1cb-3f61216c4cbc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_be26e390-ffb3-4f3f-a3e5-1e3a3caf72fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a5f8e167-4886-447b-a2d9-e7719188e7df" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_be26e390-ffb3-4f3f-a3e5-1e3a3caf72fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a6ad83a9-5371-4fd2-b2ce-7585874c2634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_be26e390-ffb3-4f3f-a3e5-1e3a3caf72fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a6ad83a9-5371-4fd2-b2ce-7585874c2634" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a6ad83a9-5371-4fd2-b2ce-7585874c2634_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a6ad83a9-5371-4fd2-b2ce-7585874c2634" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a6ad83a9-5371-4fd2-b2ce-7585874c2634_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a6ad83a9-5371-4fd2-b2ce-7585874c2634" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_c45340ba-fe8d-4dfa-86a6-e7741313208d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_c45340ba-fe8d-4dfa-86a6-e7741313208d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_6299dc0a-b8ae-4c89-909e-f6920bec54d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:to="loc_us-gaap_BuildingMember_6299dc0a-b8ae-4c89-909e-f6920bec54d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ComputerHardwareMember_6a5153dc-55ae-4ce8-b855-2bfc352f8840" xlink:href="cnc-20221231.xsd#cnc_ComputerHardwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:to="loc_cnc_ComputerHardwareMember_6a5153dc-55ae-4ce8-b855-2bfc352f8840" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_65a0f5fb-58ac-47a0-8317-fba2119c0651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_65a0f5fb-58ac-47a0-8317-fba2119c0651" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FurnitureAndOfficeEquipmentMember_c1ebb6c1-1307-47c5-b0c3-215fc570bd25" xlink:href="cnc-20221231.xsd#cnc_FurnitureAndOfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:to="loc_cnc_FurnitureAndOfficeEquipmentMember_c1ebb6c1-1307-47c5-b0c3-215fc570bd25" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_65eb7ca8-ab2c-4f6d-adcd-c8fe44eb3756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:to="loc_us-gaap_LandMember_65eb7ca8-ab2c-4f6d-adcd-c8fe44eb3756" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#PropertySoftwareandEquipmentNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails" xlink:type="extended" id="i41f62b4129844ca38b34e6bd6c16523b_PropertySoftwareandEquipmentNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3b2b85c-562f-49cd-a334-67f6c05b7249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_823adbfb-1f7c-4c9c-8673-200093e268af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3b2b85c-562f-49cd-a334-67f6c05b7249" xlink:to="loc_us-gaap_Depreciation_823adbfb-1f7c-4c9c-8673-200093e268af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_7962fdfc-a6e6-49a5-8274-2375c5a53d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3b2b85c-562f-49cd-a334-67f6c05b7249" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_7962fdfc-a6e6-49a5-8274-2375c5a53d75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_95b7d061-43f8-4af2-9bbe-27f5cdf13ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3b2b85c-562f-49cd-a334-67f6c05b7249" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_95b7d061-43f8-4af2-9bbe-27f5cdf13ab6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_17a28791-9a3a-4262-99d6-4f8ea5573862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3b2b85c-562f-49cd-a334-67f6c05b7249" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_17a28791-9a3a-4262-99d6-4f8ea5573862" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e85ba87-08f1-4e5e-bba1-50c5902e26f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_17a28791-9a3a-4262-99d6-4f8ea5573862" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e85ba87-08f1-4e5e-bba1-50c5902e26f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e85ba87-08f1-4e5e-bba1-50c5902e26f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e85ba87-08f1-4e5e-bba1-50c5902e26f6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e85ba87-08f1-4e5e-bba1-50c5902e26f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7da21ad-3b2e-4b21-ae5c-05eaa60fa0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e85ba87-08f1-4e5e-bba1-50c5902e26f6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7da21ad-3b2e-4b21-ae5c-05eaa60fa0eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RealEstateOwnedAndRelatedFixedAssetsMember_ec8f617d-dba3-40df-8542-1e19622940b4" xlink:href="cnc-20221231.xsd#cnc_RealEstateOwnedAndRelatedFixedAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7da21ad-3b2e-4b21-ae5c-05eaa60fa0eb" xlink:to="loc_cnc_RealEstateOwnedAndRelatedFixedAssetsMember_ec8f617d-dba3-40df-8542-1e19622940b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FixedAssetsLeasedRealEstateMember_b89275ae-bca3-43b1-8b59-c2474a9b4c23" xlink:href="cnc-20221231.xsd#cnc_FixedAssetsLeasedRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7da21ad-3b2e-4b21-ae5c-05eaa60fa0eb" xlink:to="loc_cnc_FixedAssetsLeasedRealEstateMember_b89275ae-bca3-43b1-8b59-c2474a9b4c23" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails" xlink:type="extended" id="idfaa524e1d524e03a82602b2a7586d8e_GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_ac5e17d8-e6a5-453b-86cc-e5f8ac8a6b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_ac5e17d8-e6a5-453b-86cc-e5f8ac8a6b82" xlink:to="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_47c1884a-b40b-46da-b28f-69cb2a531f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:to="loc_us-gaap_Goodwill_47c1884a-b40b-46da-b28f-69cb2a531f81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_fbfdc250-999e-4276-9281-ea93b5c2f7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_fbfdc250-999e-4276-9281-ea93b5c2f7b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_b5828917-0376-4c25-80de-f863e0307e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_b5828917-0376-4c25-80de-f863e0307e6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_0e08f416-8617-48f6-8496-275e6f280d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:to="loc_us-gaap_GoodwillTransfers_0e08f416-8617-48f6-8496-275e6f280d94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2b605d79-2555-48d7-a534-7d780a48d6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2b605d79-2555-48d7-a534-7d780a48d6d9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_45913592-1475-4166-897f-704d07cc3a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_45913592-1475-4166-897f-704d07cc3a0b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7ed3da81-2a89-43e9-834f-a5e384de5d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_f7c56a0a-da71-4c41-9819-110f1d09ad22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_ac5e17d8-e6a5-453b-86cc-e5f8ac8a6b82" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_f7c56a0a-da71-4c41-9819-110f1d09ad22" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b7c86782-03d3-4579-af40-77482c515217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f7c56a0a-da71-4c41-9819-110f1d09ad22" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b7c86782-03d3-4579-af40-77482c515217" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b7c86782-03d3-4579-af40-77482c515217_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b7c86782-03d3-4579-af40-77482c515217" xlink:to="loc_us-gaap_SegmentDomain_b7c86782-03d3-4579-af40-77482c515217_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e532baf7-282e-472b-b717-2b66a9fc2c12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b7c86782-03d3-4579-af40-77482c515217" xlink:to="loc_us-gaap_SegmentDomain_e532baf7-282e-472b-b717-2b66a9fc2c12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ManagedCareMember_1e602f85-b848-44a2-9675-9310ca740f76" xlink:href="cnc-20221231.xsd#cnc_ManagedCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e532baf7-282e-472b-b717-2b66a9fc2c12" xlink:to="loc_cnc_ManagedCareMember_1e602f85-b848-44a2-9675-9310ca740f76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SpecialtyServicesMember_b74d6733-54bb-4b21-bedc-0d06a5708d00" xlink:href="cnc-20221231.xsd#cnc_SpecialtyServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e532baf7-282e-472b-b717-2b66a9fc2c12" xlink:to="loc_cnc_SpecialtyServicesMember_b74d6733-54bb-4b21-bedc-0d06a5708d00" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended" id="i7b08add7902445f28dc54c6f96264ee7_GoodwillandIntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_bee27735-a363-447f-88d3-24c3f7279063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_59c74531-1e24-48de-9f5d-490b45f4e05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_bee27735-a363-447f-88d3-24c3f7279063" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_59c74531-1e24-48de-9f5d-490b45f4e05b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_83631ed3-bee9-4244-9dc7-09c105b7f07b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_bee27735-a363-447f-88d3-24c3f7279063" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_83631ed3-bee9-4244-9dc7-09c105b7f07b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0d348c78-b586-47ef-8a6a-bc8732c80064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_bee27735-a363-447f-88d3-24c3f7279063" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0d348c78-b586-47ef-8a6a-bc8732c80064" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_734ac086-0f43-4787-bada-e18593a1dc82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_bee27735-a363-447f-88d3-24c3f7279063" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_734ac086-0f43-4787-bada-e18593a1dc82" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_23afdca3-74d3-42b8-8845-527a1c0cc8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_734ac086-0f43-4787-bada-e18593a1dc82" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_23afdca3-74d3-42b8-8845-527a1c0cc8d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_23afdca3-74d3-42b8-8845-527a1c0cc8d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_23afdca3-74d3-42b8-8845-527a1c0cc8d7" xlink:to="loc_us-gaap_SegmentDomain_23afdca3-74d3-42b8-8845-527a1c0cc8d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_edbcba06-3ac0-4bce-80a2-b7bb79a09780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_23afdca3-74d3-42b8-8845-527a1c0cc8d7" xlink:to="loc_us-gaap_SegmentDomain_edbcba06-3ac0-4bce-80a2-b7bb79a09780" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SpecialtyServicesMember_8aebdcbb-5e31-4859-9eef-59dcb93f4d65" xlink:href="cnc-20221231.xsd#cnc_SpecialtyServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_edbcba06-3ac0-4bce-80a2-b7bb79a09780" xlink:to="loc_cnc_SpecialtyServicesMember_8aebdcbb-5e31-4859-9eef-59dcb93f4d65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_591574e7-6413-429e-a310-00bc2342f7af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_734ac086-0f43-4787-bada-e18593a1dc82" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_591574e7-6413-429e-a310-00bc2342f7af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_591574e7-6413-429e-a310-00bc2342f7af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_591574e7-6413-429e-a310-00bc2342f7af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_591574e7-6413-429e-a310-00bc2342f7af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8d46ef2-3a59-497c-baca-18edaff66780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_591574e7-6413-429e-a310-00bc2342f7af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8d46ef2-3a59-497c-baca-18edaff66780" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_CircleHealthMember_192ce6d2-297d-4c85-85a3-09d5e9304d4f" xlink:href="cnc-20221231.xsd#cnc_CircleHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8d46ef2-3a59-497c-baca-18edaff66780" xlink:to="loc_cnc_CircleHealthMember_192ce6d2-297d-4c85-85a3-09d5e9304d4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_6a702f53-94e2-41ee-be55-24dce4501d60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_734ac086-0f43-4787-bada-e18593a1dc82" xlink:to="loc_us-gaap_SubsegmentsAxis_6a702f53-94e2-41ee-be55-24dce4501d60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_6a702f53-94e2-41ee-be55-24dce4501d60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_6a702f53-94e2-41ee-be55-24dce4501d60" xlink:to="loc_us-gaap_SubsegmentsDomain_6a702f53-94e2-41ee-be55-24dce4501d60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_28bdbcc6-0e27-4670-9267-54a678e919ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_6a702f53-94e2-41ee-be55-24dce4501d60" xlink:to="loc_us-gaap_SubsegmentsDomain_28bdbcc6-0e27-4670-9267-54a678e919ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FederalServicesMember_e5e1610c-3d18-47c6-a050-6d08d5ab9766" xlink:href="cnc-20221231.xsd#cnc_FederalServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_28bdbcc6-0e27-4670-9267-54a678e919ba" xlink:to="loc_cnc_FederalServicesMember_e5e1610c-3d18-47c6-a050-6d08d5ab9766" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="extended" id="i0b33997c22b9418aabfb78ebfdd8821a_GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_384e7b6f-b8a7-4d8d-bf42-7af6418623e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ece6bf2b-b01c-4414-9e96-482b3d11df58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_384e7b6f-b8a7-4d8d-bf42-7af6418623e1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ece6bf2b-b01c-4414-9e96-482b3d11df58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5f024df2-e2ca-4050-ab2a-00f22052ecec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_384e7b6f-b8a7-4d8d-bf42-7af6418623e1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5f024df2-e2ca-4050-ab2a-00f22052ecec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bd177848-e5a3-40e1-8801-095dbcce4d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_384e7b6f-b8a7-4d8d-bf42-7af6418623e1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bd177848-e5a3-40e1-8801-095dbcce4d53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_43b446db-52e9-489a-b38f-8aa930062c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_384e7b6f-b8a7-4d8d-bf42-7af6418623e1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_43b446db-52e9-489a-b38f-8aa930062c17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4b8ed8d7-005f-42f2-a51c-0779e4aac482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_384e7b6f-b8a7-4d8d-bf42-7af6418623e1" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4b8ed8d7-005f-42f2-a51c-0779e4aac482" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_96b945ad-938c-46b5-9f42-e8ca60b691f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4b8ed8d7-005f-42f2-a51c-0779e4aac482" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_96b945ad-938c-46b5-9f42-e8ca60b691f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96b945ad-938c-46b5-9f42-e8ca60b691f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_96b945ad-938c-46b5-9f42-e8ca60b691f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96b945ad-938c-46b5-9f42-e8ca60b691f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516cd007-9640-4399-be28-e1a9a1fef905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_96b945ad-938c-46b5-9f42-e8ca60b691f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516cd007-9640-4399-be28-e1a9a1fef905" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_6a6b7ec2-b7c9-4249-9f86-ffed12333c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516cd007-9640-4399-be28-e1a9a1fef905" xlink:to="loc_us-gaap_CustomerContractsMember_6a6b7ec2-b7c9-4249-9f86-ffed12333c4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_64d1e365-509d-4d9a-90e1-2f0ce28cc25c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516cd007-9640-4399-be28-e1a9a1fef905" xlink:to="loc_us-gaap_TradeNamesMember_64d1e365-509d-4d9a-90e1-2f0ce28cc25c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ProviderContractsMember_3003a2f8-793d-4a39-a94a-9d8d3dfa5dec" xlink:href="cnc-20221231.xsd#cnc_ProviderContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516cd007-9640-4399-be28-e1a9a1fef905" xlink:to="loc_cnc_ProviderContractsMember_3003a2f8-793d-4a39-a94a-9d8d3dfa5dec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_6a15ecf0-e2ba-41b2-a35b-de6cc29f2b14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516cd007-9640-4399-be28-e1a9a1fef905" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_6a15ecf0-e2ba-41b2-a35b-de6cc29f2b14" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails" xlink:type="extended" id="if0555c932a4a47e190b9b38c820db82e_MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_5b62db88-1ae3-4f72-91d7-72a966242e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_14892645-a9f9-4aae-8df6-558bcf3e7c81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_5b62db88-1ae3-4f72-91d7-72a966242e63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_14892645-a9f9-4aae-8df6-558bcf3e7c81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_f7c8af40-5626-443e-9feb-6deea3dc7bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_5b62db88-1ae3-4f72-91d7-72a966242e63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_f7c8af40-5626-443e-9feb-6deea3dc7bcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther_862d5783-b337-4081-80b7-9a3eff0a6e83" xlink:href="cnc-20221231.xsd#cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_5b62db88-1ae3-4f72-91d7-72a966242e63" xlink:to="loc_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther_862d5783-b337-4081-80b7-9a3eff0a6e83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_eff0aa96-4269-4b12-b285-65235ab0835a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_5b62db88-1ae3-4f72-91d7-72a966242e63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_eff0aa96-4269-4b12-b285-65235ab0835a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_0d77cad8-bb5e-4df1-a454-82760dc4458d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_5b62db88-1ae3-4f72-91d7-72a966242e63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_0d77cad8-bb5e-4df1-a454-82760dc4458d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_6e1f68bd-1342-4607-af25-12899e689017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_0d77cad8-bb5e-4df1-a454-82760dc4458d" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_6e1f68bd-1342-4607-af25-12899e689017" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_6e1f68bd-1342-4607-af25-12899e689017_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_6e1f68bd-1342-4607-af25-12899e689017" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_6e1f68bd-1342-4607-af25-12899e689017_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0dfb5e88-3f99-4973-a2aa-fe0732dbc70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_6e1f68bd-1342-4607-af25-12899e689017" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0dfb5e88-3f99-4973-a2aa-fe0732dbc70f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_cfc80f5e-449a-4eba-9091-bb18e7f885a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0dfb5e88-3f99-4973-a2aa-fe0732dbc70f" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_cfc80f5e-449a-4eba-9091-bb18e7f885a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_d9322c83-1ff7-4283-b63d-e8cd8d451231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0dfb5e88-3f99-4973-a2aa-fe0732dbc70f" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_d9322c83-1ff7-4283-b63d-e8cd8d451231" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_a4c008db-0fff-4f90-a729-1feecde65868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0dfb5e88-3f99-4973-a2aa-fe0732dbc70f" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_a4c008db-0fff-4f90-a729-1feecde65868" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d77e41a3-5b31-4ccd-b064-1c643f3e9347" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_0d77cad8-bb5e-4df1-a454-82760dc4458d" xlink:to="loc_srt_ProductOrServiceAxis_d77e41a3-5b31-4ccd-b064-1c643f3e9347" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d77e41a3-5b31-4ccd-b064-1c643f3e9347_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d77e41a3-5b31-4ccd-b064-1c643f3e9347" xlink:to="loc_srt_ProductsAndServicesDomain_d77e41a3-5b31-4ccd-b064-1c643f3e9347_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3861bb9c-5461-47ad-bbd2-06ddc0b36d8f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d77e41a3-5b31-4ccd-b064-1c643f3e9347" xlink:to="loc_srt_ProductsAndServicesDomain_3861bb9c-5461-47ad-bbd2-06ddc0b36d8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_6282e86a-7c85-4029-93f9-7183b6dd6ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3861bb9c-5461-47ad-bbd2-06ddc0b36d8f" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_6282e86a-7c85-4029-93f9-7183b6dd6ab6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails" xlink:type="extended" id="i06befa9972344d698e492da99cbe66ea_MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_e401f11d-a804-4d85-9163-9c69361481e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_678f3d65-b855-49df-b3d2-03c67e1e64a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e401f11d-a804-4d85-9163-9c69361481e0" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_678f3d65-b855-49df-b3d2-03c67e1e64a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims_90bca9d3-fa2b-400d-87b8-f86e4e3158ab" xlink:href="cnc-20221231.xsd#cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e401f11d-a804-4d85-9163-9c69361481e0" xlink:to="loc_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims_90bca9d3-fa2b-400d-87b8-f86e4e3158ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_b84788af-80a1-42ed-a66a-5509cabd08e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e401f11d-a804-4d85-9163-9c69361481e0" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_b84788af-80a1-42ed-a66a-5509cabd08e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_13fb6eba-3a53-426e-a419-3f98ca2e1605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e401f11d-a804-4d85-9163-9c69361481e0" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_13fb6eba-3a53-426e-a419-3f98ca2e1605" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_dba9bef2-772d-4318-a47d-f626893cf1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_13fb6eba-3a53-426e-a419-3f98ca2e1605" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_dba9bef2-772d-4318-a47d-f626893cf1c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_dba9bef2-772d-4318-a47d-f626893cf1c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_dba9bef2-772d-4318-a47d-f626893cf1c1" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_dba9bef2-772d-4318-a47d-f626893cf1c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_de82ea26-1042-496c-a0c4-98fdbc1877db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_dba9bef2-772d-4318-a47d-f626893cf1c1" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_de82ea26-1042-496c-a0c4-98fdbc1877db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_82bff4d1-fcdc-4794-a7b7-0bfb719057e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_de82ea26-1042-496c-a0c4-98fdbc1877db" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_82bff4d1-fcdc-4794-a7b7-0bfb719057e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_c263993f-2d72-4ae8-b709-af513ef4eb75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_de82ea26-1042-496c-a0c4-98fdbc1877db" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_c263993f-2d72-4ae8-b709-af513ef4eb75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_63b5d202-7506-4c53-b537-6cdbcadc404b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_de82ea26-1042-496c-a0c4-98fdbc1877db" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_63b5d202-7506-4c53-b537-6cdbcadc404b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ca62c0cc-9597-44b8-a155-5e35e8882978" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_13fb6eba-3a53-426e-a419-3f98ca2e1605" xlink:to="loc_srt_ProductOrServiceAxis_ca62c0cc-9597-44b8-a155-5e35e8882978" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ca62c0cc-9597-44b8-a155-5e35e8882978_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ca62c0cc-9597-44b8-a155-5e35e8882978" xlink:to="loc_srt_ProductsAndServicesDomain_ca62c0cc-9597-44b8-a155-5e35e8882978_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cfe1b858-12d7-4617-9cad-a71d654e33fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ca62c0cc-9597-44b8-a155-5e35e8882978" xlink:to="loc_srt_ProductsAndServicesDomain_cfe1b858-12d7-4617-9cad-a71d654e33fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_4ed87648-a165-45bb-8e8b-ffb24c413689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cfe1b858-12d7-4617-9cad-a71d654e33fc" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_4ed87648-a165-45bb-8e8b-ffb24c413689" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/DebtScheduleofDebtDetails" xlink:type="extended" id="i2442564b9a9e40d3960eb661f818bc01_DebtScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_56eb7f8a-62f5-4dc8-81a3-7793cc557ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_56eb7f8a-62f5-4dc8-81a3-7793cc557ea8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6cfe111d-047e-4409-b3ca-a1c805615740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6cfe111d-047e-4409-b3ca-a1c805615740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_b0d675b5-835e-40fc-b218-ea5913b4a91d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_SeniorNotes_b0d675b5-835e-40fc-b218-ea5913b4a91d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SeniorNotesTotal_81c23ff4-0bad-4098-9bd4-30f6ef21b1ff" xlink:href="cnc-20221231.xsd#cnc_SeniorNotesTotal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_cnc_SeniorNotesTotal_81c23ff4-0bad-4098-9bd4-30f6ef21b1ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_f7596bb4-70f7-4653-8007-5f56e3525aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_LineOfCredit_f7596bb4-70f7-4653-8007-5f56e3525aa6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayable_6758da31-a42f-44af-9b83-714a64a968fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_LoansPayable_6758da31-a42f-44af-9b83-714a64a968fe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FinanceLeaseLiabilityAndOther_2909f132-c868-4af6-b539-198316ab2535" xlink:href="cnc-20221231.xsd#cnc_FinanceLeaseLiabilityAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_cnc_FinanceLeaseLiabilityAndOther_2909f132-c868-4af6-b539-198316ab2535" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_9e9165af-7867-45f4-ad52-ebb26eae041f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_9e9165af-7867-45f4-ad52-ebb26eae041f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_42f5ddde-e082-4c8b-b3a2-9379b217931a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_42f5ddde-e082-4c8b-b3a2-9379b217931a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3a3c8151-d5fd-4511-a63e-86b4557e5c23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_LongTermDebtCurrent_3a3c8151-d5fd-4511-a63e-86b4557e5c23" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_42f25e07-3476-4d47-88a2-78ba3644ce31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_42f25e07-3476-4d47-88a2-78ba3644ce31" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_31746410-8bff-4b75-823b-c0302929abc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_DebtInstrumentTable_31746410-8bff-4b75-823b-c0302929abc2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_949ae3c7-af1d-4898-a2d8-1d08935a0a27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_31746410-8bff-4b75-823b-c0302929abc2" xlink:to="loc_us-gaap_DebtInstrumentAxis_949ae3c7-af1d-4898-a2d8-1d08935a0a27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_949ae3c7-af1d-4898-a2d8-1d08935a0a27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_949ae3c7-af1d-4898-a2d8-1d08935a0a27" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_949ae3c7-af1d-4898-a2d8-1d08935a0a27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_949ae3c7-af1d-4898-a2d8-1d08935a0a27" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2500Million425SeniorNotesDueDecember2027Member_ed7641e6-2206-4b81-b4df-fc15a56b3dea" xlink:href="cnc-20221231.xsd#cnc_A2500Million425SeniorNotesDueDecember2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:to="loc_cnc_A2500Million425SeniorNotesDueDecember2027Member_ed7641e6-2206-4b81-b4df-fc15a56b3dea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2300Million245SeniorNotesDueJuly2028Member_44665001-9899-4f3c-8018-d2976ab77008" xlink:href="cnc-20221231.xsd#cnc_A2300Million245SeniorNotesDueJuly2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:to="loc_cnc_A2300Million245SeniorNotesDueJuly2028Member_44665001-9899-4f3c-8018-d2976ab77008" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A3500Million4625SeniorNotesDueDecember2029Member_f2c69804-39fe-4296-b820-5bebf446b037" xlink:href="cnc-20221231.xsd#cnc_A3500Million4625SeniorNotesDueDecember2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:to="loc_cnc_A3500Million4625SeniorNotesDueDecember2029Member_f2c69804-39fe-4296-b820-5bebf446b037" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2000Million3375SeniorNotesDueFebruary2030Member_9474b0a5-2a3f-4738-a755-21b6fd73c835" xlink:href="cnc-20221231.xsd#cnc_A2000Million3375SeniorNotesDueFebruary2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:to="loc_cnc_A2000Million3375SeniorNotesDueFebruary2030Member_9474b0a5-2a3f-4738-a755-21b6fd73c835" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2200Million30SeniorNotesDueOctober2030Member_4df56441-0427-4402-80f4-1de8862f2362" xlink:href="cnc-20221231.xsd#cnc_A2200Million30SeniorNotesDueOctober2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:to="loc_cnc_A2200Million30SeniorNotesDueOctober2030Member_4df56441-0427-4402-80f4-1de8862f2362" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2200Million250SeniorNotesDueMarch2031Member_0ccf2365-832f-468d-859d-7456f4f26143" xlink:href="cnc-20221231.xsd#cnc_A2200Million250SeniorNotesDueMarch2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:to="loc_cnc_A2200Million250SeniorNotesDueMarch2031Member_0ccf2365-832f-468d-859d-7456f4f26143" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A1300Million2625SeniorNotesDueAugust2031Member_6227ee20-7355-4bf7-b604-9b3a6419d5e2" xlink:href="cnc-20221231.xsd#cnc_A1300Million2625SeniorNotesDueAugust2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:to="loc_cnc_A1300Million2625SeniorNotesDueAugust2031Member_6227ee20-7355-4bf7-b604-9b3a6419d5e2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9aee1f7c-6494-400e-ac79-d1dadca6c1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_31746410-8bff-4b75-823b-c0302929abc2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9aee1f7c-6494-400e-ac79-d1dadca6c1aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9aee1f7c-6494-400e-ac79-d1dadca6c1aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9aee1f7c-6494-400e-ac79-d1dadca6c1aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9aee1f7c-6494-400e-ac79-d1dadca6c1aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_787315dc-396c-4848-a3eb-eedfc4b97d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9aee1f7c-6494-400e-ac79-d1dadca6c1aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_787315dc-396c-4848-a3eb-eedfc4b97d65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_70b654c0-c7da-4cf8-a49d-7acc64466b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787315dc-396c-4848-a3eb-eedfc4b97d65" xlink:to="loc_us-gaap_SeniorNotesMember_70b654c0-c7da-4cf8-a49d-7acc64466b7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_TermLoanCreditAgreementMember_e589dbec-c225-4646-a975-d1f0b1452cbe" xlink:href="cnc-20221231.xsd#cnc_TermLoanCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787315dc-396c-4848-a3eb-eedfc4b97d65" xlink:to="loc_cnc_TermLoanCreditAgreementMember_e589dbec-c225-4646-a975-d1f0b1452cbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionLoanPayableMember_1d749489-b254-4173-b49d-02e59ea2de71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionLoanPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787315dc-396c-4848-a3eb-eedfc4b97d65" xlink:to="loc_us-gaap_ConstructionLoanPayableMember_1d749489-b254-4173-b49d-02e59ea2de71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8a2cb6aa-365e-448f-a0e7-fe732c46cfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_31746410-8bff-4b75-823b-c0302929abc2" xlink:to="loc_us-gaap_CreditFacilityAxis_8a2cb6aa-365e-448f-a0e7-fe732c46cfa3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8a2cb6aa-365e-448f-a0e7-fe732c46cfa3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_8a2cb6aa-365e-448f-a0e7-fe732c46cfa3" xlink:to="loc_us-gaap_CreditFacilityDomain_8a2cb6aa-365e-448f-a0e7-fe732c46cfa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_93da5574-2973-46a5-aade-991ea7881255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_8a2cb6aa-365e-448f-a0e7-fe732c46cfa3" xlink:to="loc_us-gaap_CreditFacilityDomain_93da5574-2973-46a5-aade-991ea7881255" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3a17d4ad-7b0f-4606-bb49-df6d1d374c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_93da5574-2973-46a5-aade-991ea7881255" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3a17d4ad-7b0f-4606-bb49-df6d1d374c0a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtAdditionalInformationDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/DebtAdditionalInformationDetails" xlink:type="extended" id="ib05f882290744ae8aae39c2fd367fb3c_DebtAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8f67c2c0-ca3d-4945-ae62-81578d62d1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c41c9141-b528-4e68-b337-841a62801273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8f67c2c0-ca3d-4945-ae62-81578d62d1cd" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c41c9141-b528-4e68-b337-841a62801273" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_60b3b5d6-e8f9-4851-9bea-24255a1e80e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8f67c2c0-ca3d-4945-ae62-81578d62d1cd" xlink:to="loc_us-gaap_DebtInstrumentTable_60b3b5d6-e8f9-4851-9bea-24255a1e80e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_aede13ff-1544-42a2-98ca-ce74da89f8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_60b3b5d6-e8f9-4851-9bea-24255a1e80e4" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_aede13ff-1544-42a2-98ca-ce74da89f8e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_aede13ff-1544-42a2-98ca-ce74da89f8e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_aede13ff-1544-42a2-98ca-ce74da89f8e5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_aede13ff-1544-42a2-98ca-ce74da89f8e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_48252a93-9a09-4ae5-a8bc-43a449b057f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_aede13ff-1544-42a2-98ca-ce74da89f8e5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_48252a93-9a09-4ae5-a8bc-43a449b057f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtTotalMember_329d97af-c270-4417-ae90-b99188361756" xlink:href="cnc-20221231.xsd#cnc_DebtTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_48252a93-9a09-4ae5-a8bc-43a449b057f2" xlink:to="loc_cnc_DebtTotalMember_329d97af-c270-4417-ae90-b99188361756" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_f775631c-99eb-4bea-b7a8-357d7e788859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_60b3b5d6-e8f9-4851-9bea-24255a1e80e4" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_f775631c-99eb-4bea-b7a8-357d7e788859" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f775631c-99eb-4bea-b7a8-357d7e788859_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f775631c-99eb-4bea-b7a8-357d7e788859" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f775631c-99eb-4bea-b7a8-357d7e788859_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6905fcb6-a823-4175-8bb5-c17abcc0c541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f775631c-99eb-4bea-b7a8-357d7e788859" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6905fcb6-a823-4175-8bb5-c17abcc0c541" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditAvailabilityConcentrationRiskMember_d24908dc-e9df-4ef2-ad71-c06aceeed16d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditAvailabilityConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_6905fcb6-a823-4175-8bb5-c17abcc0c541" xlink:to="loc_us-gaap_CreditAvailabilityConcentrationRiskMember_d24908dc-e9df-4ef2-ad71-c06aceeed16d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_fe9daab5-6649-4ff9-b1c6-c93611d15467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_60b3b5d6-e8f9-4851-9bea-24255a1e80e4" xlink:to="loc_us-gaap_VariableRateAxis_fe9daab5-6649-4ff9-b1c6-c93611d15467" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_fe9daab5-6649-4ff9-b1c6-c93611d15467_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_fe9daab5-6649-4ff9-b1c6-c93611d15467" xlink:to="loc_us-gaap_VariableRateDomain_fe9daab5-6649-4ff9-b1c6-c93611d15467_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_5187079d-6b71-45aa-bca6-c2b06f4815f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_fe9daab5-6649-4ff9-b1c6-c93611d15467" xlink:to="loc_us-gaap_VariableRateDomain_5187079d-6b71-45aa-bca6-c2b06f4815f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember_ff66ba80-765b-4418-9628-e464d7ddebfc" xlink:href="cnc-20221231.xsd#cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_5187079d-6b71-45aa-bca6-c2b06f4815f8" xlink:to="loc_cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember_ff66ba80-765b-4418-9628-e464d7ddebfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8afc38d1-2aab-4714-841f-45300ee2a469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_5187079d-6b71-45aa-bca6-c2b06f4815f8" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8afc38d1-2aab-4714-841f-45300ee2a469" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SterlingOvernightIndexAverageSONIAMember_65fa1b64-c54a-4039-a6e0-1f82cff2d4db" xlink:href="cnc-20221231.xsd#cnc_SterlingOvernightIndexAverageSONIAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_5187079d-6b71-45aa-bca6-c2b06f4815f8" xlink:to="loc_cnc_SterlingOvernightIndexAverageSONIAMember_65fa1b64-c54a-4039-a6e0-1f82cff2d4db" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtSeniorNotesDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/DebtSeniorNotesDetails" xlink:type="extended" id="i3a5e436f6abd42f98b0b212fa0f09fe8_DebtSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAssumedDebt_75b67eb3-050e-490c-a4a9-2f93ac6d9a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfAssumedDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_RepaymentsOfAssumedDebt_75b67eb3-050e-490c-a4a9-2f93ac6d9a5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_85992407-a9a9-42ae-a747-3b4ae6482f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_85992407-a9a9-42ae-a747-3b4ae6482f58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_144f458e-4ba8-4f6a-999d-feace889fd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_144f458e-4ba8-4f6a-999d-feace889fd5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnRepurchaseOfDebtInstrument_b37fa14e-ec65-4983-8896-7937bd5eef62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnRepurchaseOfDebtInstrument"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_GainLossOnRepurchaseOfDebtInstrument_b37fa14e-ec65-4983-8896-7937bd5eef62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_01fc7428-aa0e-4885-870f-90daa806e6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_01fc7428-aa0e-4885-870f-90daa806e6f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage_71ea3b7a-bcc2-46ce-8ee7-1a6035aec483" xlink:href="cnc-20221231.xsd#cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage_71ea3b7a-bcc2-46ce-8ee7-1a6035aec483" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e651aea3-0715-490a-8712-e00fc8e88d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e651aea3-0715-490a-8712-e00fc8e88d17" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c89d6d16-367f-4769-a4a4-9786a59c41ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c89d6d16-367f-4769-a4a4-9786a59c41ac" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6950b109-08ef-4e71-abf4-fe4905e7cb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_DebtInstrumentTable_6950b109-08ef-4e71-abf4-fe4905e7cb0b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_414cc6af-914e-4fc3-9473-adee88304f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6950b109-08ef-4e71-abf4-fe4905e7cb0b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_414cc6af-914e-4fc3-9473-adee88304f77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_414cc6af-914e-4fc3-9473-adee88304f77_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_414cc6af-914e-4fc3-9473-adee88304f77" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_414cc6af-914e-4fc3-9473-adee88304f77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36340264-d296-4a7b-8dd0-7e31843241ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_414cc6af-914e-4fc3-9473-adee88304f77" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36340264-d296-4a7b-8dd0-7e31843241ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanHealthMember_36a524f3-0498-40cd-8262-d8c139320162" xlink:href="cnc-20221231.xsd#cnc_MagellanHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36340264-d296-4a7b-8dd0-7e31843241ff" xlink:to="loc_cnc_MagellanHealthMember_36a524f3-0498-40cd-8262-d8c139320162" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_352716b8-f66c-417c-bb9b-d42d54f0cdda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6950b109-08ef-4e71-abf4-fe4905e7cb0b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_352716b8-f66c-417c-bb9b-d42d54f0cdda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_352716b8-f66c-417c-bb9b-d42d54f0cdda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_352716b8-f66c-417c-bb9b-d42d54f0cdda" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_352716b8-f66c-417c-bb9b-d42d54f0cdda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_66592332-7689-4343-b62f-e255e0393e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_352716b8-f66c-417c-bb9b-d42d54f0cdda" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_66592332-7689-4343-b62f-e255e0393e4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_8bb2dfbf-9ae4-4bca-b5d0-f9d10b89994a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_66592332-7689-4343-b62f-e255e0393e4d" xlink:to="loc_us-gaap_SeniorNotesMember_8bb2dfbf-9ae4-4bca-b5d0-f9d10b89994a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_becf3e97-80bc-42f9-b987-844fe1a89bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6950b109-08ef-4e71-abf4-fe4905e7cb0b" xlink:to="loc_us-gaap_DebtInstrumentAxis_becf3e97-80bc-42f9-b987-844fe1a89bb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_becf3e97-80bc-42f9-b987-844fe1a89bb0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_becf3e97-80bc-42f9-b987-844fe1a89bb0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_becf3e97-80bc-42f9-b987-844fe1a89bb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_becf3e97-80bc-42f9-b987-844fe1a89bb0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A3500Million4625SeniorNotesDueDecember2029Member_43be0e11-288a-40a7-819b-bed59fdf659e" xlink:href="cnc-20221231.xsd#cnc_A3500Million4625SeniorNotesDueDecember2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:to="loc_cnc_A3500Million4625SeniorNotesDueDecember2029Member_43be0e11-288a-40a7-819b-bed59fdf659e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2500Million425SeniorNotesDueDecember2027Member_307563d7-c25a-4a97-a175-57a738372421" xlink:href="cnc-20221231.xsd#cnc_A2500Million425SeniorNotesDueDecember2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:to="loc_cnc_A2500Million425SeniorNotesDueDecember2027Member_307563d7-c25a-4a97-a175-57a738372421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2200Million250SeniorNotesDue2031Member_f3b19696-3cb1-4850-80df-48246943b9da" xlink:href="cnc-20221231.xsd#cnc_A2200Million250SeniorNotesDue2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:to="loc_cnc_A2200Million250SeniorNotesDue2031Member_f3b19696-3cb1-4850-80df-48246943b9da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2200Million475SeniorNotesDueJanuary2025Member_dd393233-517c-4592-83f4-c297eb9ba466" xlink:href="cnc-20221231.xsd#cnc_A2200Million475SeniorNotesDueJanuary2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:to="loc_cnc_A2200Million475SeniorNotesDueJanuary2025Member_dd393233-517c-4592-83f4-c297eb9ba466" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A1800Million245SeniorNotesDueMarch2028Member_e4a1c53b-f93d-4050-bd9b-a8f37adb8552" xlink:href="cnc-20221231.xsd#cnc_A1800Million245SeniorNotesDueMarch2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:to="loc_cnc_A1800Million245SeniorNotesDueMarch2028Member_e4a1c53b-f93d-4050-bd9b-a8f37adb8552" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A1300Million2625SeniorNotesDueAugust2031Member_d951c7cb-b255-4caa-b235-ace223c0762b" xlink:href="cnc-20221231.xsd#cnc_A1300Million2625SeniorNotesDueAugust2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:to="loc_cnc_A1300Million2625SeniorNotesDueAugust2031Member_d951c7cb-b255-4caa-b235-ace223c0762b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A750Million5375SeniorNotesDueJune2026Member_0964dd2c-4ba7-4881-9b70-642e4145f379" xlink:href="cnc-20221231.xsd#cnc_A750Million5375SeniorNotesDueJune2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:to="loc_cnc_A750Million5375SeniorNotesDueJune2026Member_0964dd2c-4ba7-4881-9b70-642e4145f379" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails" xlink:type="extended" id="ic244c737a288475fa7e5c20990746593_DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_7a8068b8-7a16-4d2e-a91d-9634c2b08967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_us-gaap_DerivativeNotionalAmount_7a8068b8-7a16-4d2e-a91d-9634c2b08967" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities_fc8fac10-193a-457b-98b6-24df24902d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_us-gaap_PaymentsForHedgeInvestingActivities_fc8fac10-193a-457b-98b6-24df24902d8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_15f32900-3d48-44eb-adfe-03877c209a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_15f32900-3d48-44eb-adfe-03877c209a61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_79d4caff-df77-4c82-a484-c83c081c6195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_79d4caff-df77-4c82-a484-c83c081c6195" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c39c3a43-e994-406a-bb09-93b94f444c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c39c3a43-e994-406a-bb09-93b94f444c48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_79896def-7f91-4120-a7bf-259fee4ceaab" xlink:href="cnc-20221231.xsd#cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_79896def-7f91-4120-a7bf-259fee4ceaab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_36491a72-6824-4289-aa5f-afc092bef562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_us-gaap_LongTermLineOfCredit_36491a72-6824-4289-aa5f-afc092bef562" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f8dd37a5-abd6-4081-abc6-7d898d4a1b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_us-gaap_DebtInstrumentTable_f8dd37a5-abd6-4081-abc6-7d898d4a1b16" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7d503429-611a-4ee2-a56c-5d8cc9fdce1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f8dd37a5-abd6-4081-abc6-7d898d4a1b16" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7d503429-611a-4ee2-a56c-5d8cc9fdce1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7d503429-611a-4ee2-a56c-5d8cc9fdce1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7d503429-611a-4ee2-a56c-5d8cc9fdce1a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7d503429-611a-4ee2-a56c-5d8cc9fdce1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9d15f702-f337-4eb5-b6f9-25bb77e1ca71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7d503429-611a-4ee2-a56c-5d8cc9fdce1a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9d15f702-f337-4eb5-b6f9-25bb77e1ca71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignLineOfCreditMember_752e7ced-19c7-4445-94a4-c6cb4516f389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignLineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9d15f702-f337-4eb5-b6f9-25bb77e1ca71" xlink:to="loc_us-gaap_ForeignLineOfCreditMember_752e7ced-19c7-4445-94a4-c6cb4516f389" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1ec56084-6751-4a0c-bc9e-7fc983036da8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f8dd37a5-abd6-4081-abc6-7d898d4a1b16" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1ec56084-6751-4a0c-bc9e-7fc983036da8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1ec56084-6751-4a0c-bc9e-7fc983036da8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1ec56084-6751-4a0c-bc9e-7fc983036da8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1ec56084-6751-4a0c-bc9e-7fc983036da8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5da2b08b-a403-4cbf-a30e-654e05ed56f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1ec56084-6751-4a0c-bc9e-7fc983036da8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5da2b08b-a403-4cbf-a30e-654e05ed56f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_b15b7307-cd4b-4cf6-84c3-3d8ac2b0b9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5da2b08b-a403-4cbf-a30e-654e05ed56f4" xlink:to="loc_us-gaap_CurrencySwapMember_b15b7307-cd4b-4cf6-84c3-3d8ac2b0b9e5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtRevolvingCreditFacilityandTermLoanDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails" xlink:type="extended" id="i8a05e10a9f7140648139ecddd6d58dcc_DebtRevolvingCreditFacilityandTermLoanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bcecb629-b13d-4b48-9faf-9ef56a82fbc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bcecb629-b13d-4b48-9faf-9ef56a82fbc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0132fac4-0a69-4c21-9eb8-8d065b95d262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0132fac4-0a69-4c21-9eb8-8d065b95d262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum_16c2473c-b2f2-470d-9d2b-fea247796097" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentCovenantNetLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum_16c2473c-b2f2-470d-9d2b-fea247796097" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d459bbc0-ebfe-417a-be49-144a6f455017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d459bbc0-ebfe-417a-be49-144a6f455017" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentAmortizationPaymentRatePercentage_a1255a13-5ec3-44be-8d66-0aa9546b747e" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentAmortizationPaymentRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_cnc_DebtInstrumentAmortizationPaymentRatePercentage_a1255a13-5ec3-44be-8d66-0aa9546b747e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit_73787d06-c0a0-44c5-ae02-637328240e65" xlink:href="cnc-20221231.xsd#cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit_73787d06-c0a0-44c5-ae02-637328240e65" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease_dd1a81bd-639a-4558-8f24-0f8cc25f3d5b" xlink:href="cnc-20221231.xsd#cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease_dd1a81bd-639a-4558-8f24-0f8cc25f3d5b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_c7243452-5206-4be1-a99d-3e66ca7d37eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_us-gaap_LineOfCredit_c7243452-5206-4be1-a99d-3e66ca7d37eb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_4f237d2d-e381-4ab9-a328-1edb9ac25406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_4f237d2d-e381-4ab9-a328-1edb9ac25406" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_96b6192a-467a-484b-ac91-dbc75bc6b0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:to="loc_us-gaap_DebtInstrumentAxis_96b6192a-467a-484b-ac91-dbc75bc6b0c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_96b6192a-467a-484b-ac91-dbc75bc6b0c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_96b6192a-467a-484b-ac91-dbc75bc6b0c2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_96b6192a-467a-484b-ac91-dbc75bc6b0c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_df7881e1-0117-45b3-9bd0-c7825e14f5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_96b6192a-467a-484b-ac91-dbc75bc6b0c2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_df7881e1-0117-45b3-9bd0-c7825e14f5a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_TermLoanCreditAgreementMember_c21f4e8f-237e-4ccf-9fec-3c2a45c57440" xlink:href="cnc-20221231.xsd#cnc_TermLoanCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_df7881e1-0117-45b3-9bd0-c7825e14f5a0" xlink:to="loc_cnc_TermLoanCreditAgreementMember_c21f4e8f-237e-4ccf-9fec-3c2a45c57440" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d6affea2-4251-4dfc-85fb-633843f1ccd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:to="loc_us-gaap_CreditFacilityAxis_d6affea2-4251-4dfc-85fb-633843f1ccd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d6affea2-4251-4dfc-85fb-633843f1ccd0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_d6affea2-4251-4dfc-85fb-633843f1ccd0" xlink:to="loc_us-gaap_CreditFacilityDomain_d6affea2-4251-4dfc-85fb-633843f1ccd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ad5cd5e4-681b-447b-8dbc-73beced8cea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_d6affea2-4251-4dfc-85fb-633843f1ccd0" xlink:to="loc_us-gaap_CreditFacilityDomain_ad5cd5e4-681b-447b-8dbc-73beced8cea2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_297ff045-21ce-4413-85a0-3fc507d653ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_ad5cd5e4-681b-447b-8dbc-73beced8cea2" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_297ff045-21ce-4413-85a0-3fc507d653ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_d1fa87a1-de22-4ece-aff4-e73498d6e4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BridgeLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_ad5cd5e4-681b-447b-8dbc-73beced8cea2" xlink:to="loc_us-gaap_BridgeLoanMember_d1fa87a1-de22-4ece-aff4-e73498d6e4f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_07d62e49-8a8f-455f-b3ff-c12039e0469b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_ad5cd5e4-681b-447b-8dbc-73beced8cea2" xlink:to="loc_us-gaap_LetterOfCreditMember_07d62e49-8a8f-455f-b3ff-c12039e0469b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_85f0d22b-e044-4217-bbfc-d4eaaaabf4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_85f0d22b-e044-4217-bbfc-d4eaaaabf4c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_85f0d22b-e044-4217-bbfc-d4eaaaabf4c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_85f0d22b-e044-4217-bbfc-d4eaaaabf4c1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_85f0d22b-e044-4217-bbfc-d4eaaaabf4c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2e346e3e-1d29-497c-9274-94f229edd813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_85f0d22b-e044-4217-bbfc-d4eaaaabf4c1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2e346e3e-1d29-497c-9274-94f229edd813" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_ad4f9676-3414-418e-8245-dc1a47c8cfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2e346e3e-1d29-497c-9274-94f229edd813" xlink:to="loc_us-gaap_LineOfCreditMember_ad4f9676-3414-418e-8245-dc1a47c8cfb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_24d9aa11-1a96-4b0e-bdcd-8a280fb1f264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2e346e3e-1d29-497c-9274-94f229edd813" xlink:to="loc_us-gaap_UnsecuredDebtMember_24d9aa11-1a96-4b0e-bdcd-8a280fb1f264" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_beff2754-bbed-45c1-a2bd-562e4a1950e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:to="loc_srt_RangeAxis_beff2754-bbed-45c1-a2bd-562e4a1950e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_beff2754-bbed-45c1-a2bd-562e4a1950e5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_beff2754-bbed-45c1-a2bd-562e4a1950e5" xlink:to="loc_srt_RangeMember_beff2754-bbed-45c1-a2bd-562e4a1950e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d865d281-293a-45a3-9df4-6163b674b1a3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_beff2754-bbed-45c1-a2bd-562e4a1950e5" xlink:to="loc_srt_RangeMember_d865d281-293a-45a3-9df4-6163b674b1a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_886b7ab4-5814-4897-86c8-26205b9d5a59" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d865d281-293a-45a3-9df4-6163b674b1a3" xlink:to="loc_srt_MaximumMember_886b7ab4-5814-4897-86c8-26205b9d5a59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2a2e3908-f4c3-4b27-9858-f2ede81a1d6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d865d281-293a-45a3-9df4-6163b674b1a3" xlink:to="loc_srt_MinimumMember_2a2e3908-f4c3-4b27-9858-f2ede81a1d6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodAxis_54b64f88-c441-4fcd-9513-32cce161a783" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:to="loc_cnc_DebtInstrumentPaymentPeriodAxis_54b64f88-c441-4fcd-9513-32cce161a783" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodDomain_54b64f88-c441-4fcd-9513-32cce161a783_default" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cnc_DebtInstrumentPaymentPeriodAxis_54b64f88-c441-4fcd-9513-32cce161a783" xlink:to="loc_cnc_DebtInstrumentPaymentPeriodDomain_54b64f88-c441-4fcd-9513-32cce161a783_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodDomain_c5cd2670-dd46-44aa-8533-deabece5324c" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cnc_DebtInstrumentPaymentPeriodAxis_54b64f88-c441-4fcd-9513-32cce161a783" xlink:to="loc_cnc_DebtInstrumentPaymentPeriodDomain_c5cd2670-dd46-44aa-8533-deabece5324c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodOneMember_f97bbb8c-9900-4772-b686-4d6d5a892a84" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnc_DebtInstrumentPaymentPeriodDomain_c5cd2670-dd46-44aa-8533-deabece5324c" xlink:to="loc_cnc_DebtInstrumentPaymentPeriodOneMember_f97bbb8c-9900-4772-b686-4d6d5a892a84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodTwoMember_e465dcfa-f903-43ef-94dc-85229c36df2b" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnc_DebtInstrumentPaymentPeriodDomain_c5cd2670-dd46-44aa-8533-deabece5324c" xlink:to="loc_cnc_DebtInstrumentPaymentPeriodTwoMember_e465dcfa-f903-43ef-94dc-85229c36df2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodThreeMember_ebf74f20-ba49-431f-94a0-aaf412b93817" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnc_DebtInstrumentPaymentPeriodDomain_c5cd2670-dd46-44aa-8533-deabece5324c" xlink:to="loc_cnc_DebtInstrumentPaymentPeriodThreeMember_ebf74f20-ba49-431f-94a0-aaf412b93817" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtConstructionLoanDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtConstructionLoanDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/DebtConstructionLoanDetails" xlink:type="extended" id="ic27b1c6d3ac543f6ac43a257af7529b3_DebtConstructionLoanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2f6a5b9b-327d-4aa2-9bc1-82ad44b1fe46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6875e053-c997-469d-8ce4-67cc86e611d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f6a5b9b-327d-4aa2-9bc1-82ad44b1fe46" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6875e053-c997-469d-8ce4-67cc86e611d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_efcc27b9-b248-4038-bde6-1a74a8b2caca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f6a5b9b-327d-4aa2-9bc1-82ad44b1fe46" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_efcc27b9-b248-4038-bde6-1a74a8b2caca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentExtensionTerm_26ebf02b-491d-4ca0-92ec-69f0f6a5b6ac" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentExtensionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f6a5b9b-327d-4aa2-9bc1-82ad44b1fe46" xlink:to="loc_cnc_DebtInstrumentExtensionTerm_26ebf02b-491d-4ca0-92ec-69f0f6a5b6ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b0cd38af-68ac-4d82-998d-2bba0e04f16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f6a5b9b-327d-4aa2-9bc1-82ad44b1fe46" xlink:to="loc_us-gaap_DebtInstrumentTable_b0cd38af-68ac-4d82-998d-2bba0e04f16a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d817f307-ec27-477f-9fea-b0c00d623fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b0cd38af-68ac-4d82-998d-2bba0e04f16a" xlink:to="loc_us-gaap_VariableRateAxis_d817f307-ec27-477f-9fea-b0c00d623fc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d817f307-ec27-477f-9fea-b0c00d623fc1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_d817f307-ec27-477f-9fea-b0c00d623fc1" xlink:to="loc_us-gaap_VariableRateDomain_d817f307-ec27-477f-9fea-b0c00d623fc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_60cff639-aa40-400f-9f83-3e826bce3b14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_d817f307-ec27-477f-9fea-b0c00d623fc1" xlink:to="loc_us-gaap_VariableRateDomain_60cff639-aa40-400f-9f83-3e826bce3b14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2d1d94b5-781d-4e70-9415-bb6659ee4f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_60cff639-aa40-400f-9f83-3e826bce3b14" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2d1d94b5-781d-4e70-9415-bb6659ee4f8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_f7f175f0-d1cb-4601-bf96-f2146c479439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_60cff639-aa40-400f-9f83-3e826bce3b14" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_f7f175f0-d1cb-4601-bf96-f2146c479439" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5e318922-d1b7-48f2-8bb7-376196da667a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b0cd38af-68ac-4d82-998d-2bba0e04f16a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5e318922-d1b7-48f2-8bb7-376196da667a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5e318922-d1b7-48f2-8bb7-376196da667a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5e318922-d1b7-48f2-8bb7-376196da667a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5e318922-d1b7-48f2-8bb7-376196da667a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b1a001c4-2e0f-481e-b60f-17a307d5b65d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5e318922-d1b7-48f2-8bb7-376196da667a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b1a001c4-2e0f-481e-b60f-17a307d5b65d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionLoanPayableMember_6e333993-7764-4428-ab2b-dd3f8885514a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionLoanPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b1a001c4-2e0f-481e-b60f-17a307d5b65d" xlink:to="loc_us-gaap_ConstructionLoanPayableMember_6e333993-7764-4428-ab2b-dd3f8885514a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_014c78e1-ab06-46b7-8ea8-96e6b71f47d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b0cd38af-68ac-4d82-998d-2bba0e04f16a" xlink:to="loc_srt_RangeAxis_014c78e1-ab06-46b7-8ea8-96e6b71f47d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_014c78e1-ab06-46b7-8ea8-96e6b71f47d6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_014c78e1-ab06-46b7-8ea8-96e6b71f47d6" xlink:to="loc_srt_RangeMember_014c78e1-ab06-46b7-8ea8-96e6b71f47d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6b6354d1-a84a-45d5-a08b-be7ed13c9d12" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_014c78e1-ab06-46b7-8ea8-96e6b71f47d6" xlink:to="loc_srt_RangeMember_6b6354d1-a84a-45d5-a08b-be7ed13c9d12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_16e20d9b-e236-4f39-9b4a-70bce8911d7e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6b6354d1-a84a-45d5-a08b-be7ed13c9d12" xlink:to="loc_srt_MaximumMember_16e20d9b-e236-4f39-9b4a-70bce8911d7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_44b5b8c5-007c-4825-a0ab-8974e674231b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6b6354d1-a84a-45d5-a08b-be7ed13c9d12" xlink:to="loc_srt_MinimumMember_44b5b8c5-007c-4825-a0ab-8974e674231b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtDebtRepurchaseProgramDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtDebtRepurchaseProgramDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/DebtDebtRepurchaseProgramDetails" xlink:type="extended" id="i0fe1a6f5837c4def94964bba774f38df_DebtDebtRepurchaseProgramDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_def34592-1dae-4f01-93c5-7b79fcb6beb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_591072a1-e640-4281-af1c-564d162221cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_def34592-1dae-4f01-93c5-7b79fcb6beb1" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_591072a1-e640-4281-af1c-564d162221cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_39c29d68-c224-49df-a2dc-2723d6b9dd76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_def34592-1dae-4f01-93c5-7b79fcb6beb1" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_39c29d68-c224-49df-a2dc-2723d6b9dd76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount_16416440-2e27-4b4a-861d-897da78f0e1e" xlink:href="cnc-20221231.xsd#cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_def34592-1dae-4f01-93c5-7b79fcb6beb1" xlink:to="loc_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount_16416440-2e27-4b4a-861d-897da78f0e1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_09e870e5-10d4-4a36-8c2b-817d73d36a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_def34592-1dae-4f01-93c5-7b79fcb6beb1" xlink:to="loc_us-gaap_DebtInstrumentTable_09e870e5-10d4-4a36-8c2b-817d73d36a50" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6d29d585-7620-4d10-942d-8072291744c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_09e870e5-10d4-4a36-8c2b-817d73d36a50" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6d29d585-7620-4d10-942d-8072291744c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6d29d585-7620-4d10-942d-8072291744c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6d29d585-7620-4d10-942d-8072291744c9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6d29d585-7620-4d10-942d-8072291744c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_567d8f5c-64cc-4b22-bfa0-058550678b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6d29d585-7620-4d10-942d-8072291744c9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_567d8f5c-64cc-4b22-bfa0-058550678b03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_04508d10-eed4-49d7-905e-249a08826d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_567d8f5c-64cc-4b22-bfa0-058550678b03" xlink:to="loc_us-gaap_SeniorNotesMember_04508d10-eed4-49d7-905e-249a08826d54" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtLettersofCreditSuretyBondsDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails" xlink:type="extended" id="i8bc8ed32888847cc8c902f2f2d4def72_DebtLettersofCreditSuretyBondsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_226a8c2a-6a0a-4f80-a563-4dac0c6204f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_277a993e-fd7d-46f1-9064-4ae94d6e16e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_226a8c2a-6a0a-4f80-a563-4dac0c6204f0" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_277a993e-fd7d-46f1-9064-4ae94d6e16e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_c7719351-2c26-42f2-9b15-fa5734a880c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_226a8c2a-6a0a-4f80-a563-4dac0c6204f0" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_c7719351-2c26-42f2-9b15-fa5734a880c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_dfe99f1a-3725-4f9c-acf9-69fad614667d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_226a8c2a-6a0a-4f80-a563-4dac0c6204f0" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_dfe99f1a-3725-4f9c-acf9-69fad614667d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9b2a909d-13ac-4b13-8665-9f183ca93999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_226a8c2a-6a0a-4f80-a563-4dac0c6204f0" xlink:to="loc_us-gaap_DebtInstrumentTable_9b2a909d-13ac-4b13-8665-9f183ca93999" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5c53ecf7-ac68-4e2f-8146-824af8cd5ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9b2a909d-13ac-4b13-8665-9f183ca93999" xlink:to="loc_us-gaap_CreditFacilityAxis_5c53ecf7-ac68-4e2f-8146-824af8cd5ca8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5c53ecf7-ac68-4e2f-8146-824af8cd5ca8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_5c53ecf7-ac68-4e2f-8146-824af8cd5ca8" xlink:to="loc_us-gaap_CreditFacilityDomain_5c53ecf7-ac68-4e2f-8146-824af8cd5ca8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5926e57c-b1c3-4b8e-99ce-a490b76bc74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_5c53ecf7-ac68-4e2f-8146-824af8cd5ca8" xlink:to="loc_us-gaap_CreditFacilityDomain_5926e57c-b1c3-4b8e-99ce-a490b76bc74e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_a6f300ca-53be-4cb5-9af1-ff5ca28b5602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5926e57c-b1c3-4b8e-99ce-a490b76bc74e" xlink:to="loc_us-gaap_LetterOfCreditMember_a6f300ca-53be-4cb5-9af1-ff5ca28b5602" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_00e8948e-0859-490b-8230-e80010209a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9b2a909d-13ac-4b13-8665-9f183ca93999" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_00e8948e-0859-490b-8230-e80010209a88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_00e8948e-0859-490b-8230-e80010209a88_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_00e8948e-0859-490b-8230-e80010209a88" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_00e8948e-0859-490b-8230-e80010209a88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_359d1c51-7362-4d2f-ad36-35e80c860154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_00e8948e-0859-490b-8230-e80010209a88" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_359d1c51-7362-4d2f-ad36-35e80c860154" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuretyBondMember_9bd7da5f-5c50-4c6a-8ac8-aaf386c691ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuretyBondMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_359d1c51-7362-4d2f-ad36-35e80c860154" xlink:to="loc_us-gaap_SuretyBondMember_9bd7da5f-5c50-4c6a-8ac8-aaf386c691ed" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i140a86e85ddf4e3f94859607bc81fa4e_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_47d2ba66-94e3-412a-9ad6-9b68dd0fd3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OperatingLeaseExpense_47d2ba66-94e3-412a-9ad6-9b68dd0fd3e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_cba779ac-1f81-433e-83a6-5d56bb5391f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OperatingLeasePayments_cba779ac-1f81-433e-83a6-5d56bb5391f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4c7e14ce-311e-4d23-b6e4-1ca4fc866fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4c7e14ce-311e-4d23-b6e4-1ca4fc866fbc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LesseeOperatingLeaseLeasesCommencedLiability_6adc11f2-2352-4ee7-8e91-65f8df10491f" xlink:href="cnc-20221231.xsd#cnc_LesseeOperatingLeaseLeasesCommencedLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_cnc_LesseeOperatingLeaseLeasesCommencedLiability_6adc11f2-2352-4ee7-8e91-65f8df10491f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_449066f5-3510-4906-a014-e5f9348c930d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_449066f5-3510-4906-a014-e5f9348c930d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_fa69dd0d-289f-4b62-84a6-ee960cdedc67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OperatingLeaseLiability_fa69dd0d-289f-4b62-84a6-ee960cdedc67" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability_a6c18ff1-8e81-4032-b062-9e8b51de4100" xlink:href="cnc-20221231.xsd#cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability_a6c18ff1-8e81-4032-b062-9e8b51de4100" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_b03c6961-ca13-400f-a81b-ab01ef68f219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_b03c6961-ca13-400f-a81b-ab01ef68f219" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_47afce71-1582-4dea-98a8-cc488ab32247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_47afce71-1582-4dea-98a8-cc488ab32247" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_fc4250b5-08bc-435f-aa15-141131397e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_fc4250b5-08bc-435f-aa15-141131397e2a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1e83a414-3e74-4476-95eb-c1b7c220b454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1e83a414-3e74-4476-95eb-c1b7c220b454" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_11bf9449-e491-4bd8-adb3-ebc6f0506d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_11bf9449-e491-4bd8-adb3-ebc6f0506d7b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b22417c7-5b18-4eae-9206-6beb22b526fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b22417c7-5b18-4eae-9206-6beb22b526fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_62fd2748-d40d-47b5-a72a-3414babda6a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b22417c7-5b18-4eae-9206-6beb22b526fe" xlink:to="loc_srt_RangeAxis_62fd2748-d40d-47b5-a72a-3414babda6a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_62fd2748-d40d-47b5-a72a-3414babda6a7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_62fd2748-d40d-47b5-a72a-3414babda6a7" xlink:to="loc_srt_RangeMember_62fd2748-d40d-47b5-a72a-3414babda6a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f7b10196-0ed8-469e-af29-7190b97f1301" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_62fd2748-d40d-47b5-a72a-3414babda6a7" xlink:to="loc_srt_RangeMember_f7b10196-0ed8-469e-af29-7190b97f1301" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_51276634-09ba-4754-b38c-074fb048c5f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f7b10196-0ed8-469e-af29-7190b97f1301" xlink:to="loc_srt_MinimumMember_51276634-09ba-4754-b38c-074fb048c5f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_008913c2-dd6c-4048-9988-6b89cc40c040" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f7b10196-0ed8-469e-af29-7190b97f1301" xlink:to="loc_srt_MaximumMember_008913c2-dd6c-4048-9988-6b89cc40c040" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d09911d5-706f-43a6-b6c9-5d07a05cd3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b22417c7-5b18-4eae-9206-6beb22b526fe" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d09911d5-706f-43a6-b6c9-5d07a05cd3b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d09911d5-706f-43a6-b6c9-5d07a05cd3b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d09911d5-706f-43a6-b6c9-5d07a05cd3b4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d09911d5-706f-43a6-b6c9-5d07a05cd3b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28d40876-ddb8-40cd-a01b-79e0f52bdb52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d09911d5-706f-43a6-b6c9-5d07a05cd3b4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28d40876-ddb8-40cd-a01b-79e0f52bdb52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanHealthMember_49e47045-a41e-4a3c-8ebb-62e269bb5926" xlink:href="cnc-20221231.xsd#cnc_MagellanHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28d40876-ddb8-40cd-a01b-79e0f52bdb52" xlink:to="loc_cnc_MagellanHealthMember_49e47045-a41e-4a3c-8ebb-62e269bb5926" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="i8009f76ec3184588aa0cbbe318a60a06_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount_6f3175cd-2d74-4744-a953-c727f20cb675" xlink:href="cnc-20221231.xsd#cnc_StockRepurchaseProgramIncreaseAuthorizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount_6f3175cd-2d74-4744-a953-c727f20cb675" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_11be9548-dd59-42e7-a8cb-1d30a6568eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_11be9548-dd59-42e7-a8cb-1d30a6568eac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AcceleratedShareRepurchasesAgreementAmount_06bc331f-855d-4422-960c-fad3e97a9cf6" xlink:href="cnc-20221231.xsd#cnc_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_cnc_AcceleratedShareRepurchasesAgreementAmount_06bc331f-855d-4422-960c-fad3e97a9cf6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_d5476a72-1010-405b-9c71-6ff9b5c5a342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_d5476a72-1010-405b-9c71-6ff9b5c5a342" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram_5d2deced-9c40-4bd3-be87-216cf3a2241a" xlink:href="cnc-20221231.xsd#cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram_5d2deced-9c40-4bd3-be87-216cf3a2241a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AcceleratedShareRepurchasesDiscountPricePerShare_4148f9bc-63ca-4b9f-9cba-66131e7b1fa0" xlink:href="cnc-20221231.xsd#cnc_AcceleratedShareRepurchasesDiscountPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_cnc_AcceleratedShareRepurchasesDiscountPricePerShare_4148f9bc-63ca-4b9f-9cba-66131e7b1fa0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_652cc6b9-de54-4eab-a3c7-21808ae16f33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_652cc6b9-de54-4eab-a3c7-21808ae16f33" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_25814a6c-f02f-4400-a89f-90891f1ee81f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_25814a6c-f02f-4400-a89f-90891f1ee81f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_376b8912-63ec-48f0-a6d3-86b7950bf004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_376b8912-63ec-48f0-a6d3-86b7950bf004" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f64f62df-016c-4ac5-9530-fc33b3c4c073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f64f62df-016c-4ac5-9530-fc33b3c4c073" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_17ae36f3-b307-4025-accb-b4d6a2e11110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_17ae36f3-b307-4025-accb-b4d6a2e11110" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_0f8f3887-3061-4fdd-9df3-2cb7f635eea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_0f8f3887-3061-4fdd-9df3-2cb7f635eea3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_6a895f66-b383-48f0-886c-e53cd877847d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_6a895f66-b383-48f0-886c-e53cd877847d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_2fd2fb9b-80f1-4152-ad1b-c1c108dcc25b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_2fd2fb9b-80f1-4152-ad1b-c1c108dcc25b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_cb623ffb-82e6-48b0-93be-0c63e92fe9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_2fd2fb9b-80f1-4152-ad1b-c1c108dcc25b" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_cb623ffb-82e6-48b0-93be-0c63e92fe9cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_cb623ffb-82e6-48b0-93be-0c63e92fe9cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cb623ffb-82e6-48b0-93be-0c63e92fe9cb" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_cb623ffb-82e6-48b0-93be-0c63e92fe9cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_a16a1878-6c26-48aa-b136-2d6bf1ac47ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cb623ffb-82e6-48b0-93be-0c63e92fe9cb" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_a16a1878-6c26-48aa-b136-2d6bf1ac47ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AcceleratedShareRepurchaseAgreementMember_64a1645b-481d-4046-b8d3-47ae174277b8" xlink:href="cnc-20221231.xsd#cnc_AcceleratedShareRepurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_a16a1878-6c26-48aa-b136-2d6bf1ac47ea" xlink:to="loc_cnc_AcceleratedShareRepurchaseAgreementMember_64a1645b-481d-4046-b8d3-47ae174277b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_098dfd61-4fd3-4673-99ce-a3081b1b16f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_2fd2fb9b-80f1-4152-ad1b-c1c108dcc25b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_098dfd61-4fd3-4673-99ce-a3081b1b16f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_098dfd61-4fd3-4673-99ce-a3081b1b16f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_098dfd61-4fd3-4673-99ce-a3081b1b16f8" xlink:to="loc_us-gaap_ClassOfStockDomain_098dfd61-4fd3-4673-99ce-a3081b1b16f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cbab7291-78dd-4d8a-9b8c-b676f228cc3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_098dfd61-4fd3-4673-99ce-a3081b1b16f8" xlink:to="loc_us-gaap_ClassOfStockDomain_cbab7291-78dd-4d8a-9b8c-b676f228cc3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5d8f7c1a-597d-4996-9a2b-de1707899398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_cbab7291-78dd-4d8a-9b8c-b676f228cc3e" xlink:to="loc_us-gaap_CommonStockMember_5d8f7c1a-597d-4996-9a2b-de1707899398" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_2c9f0a99-e502-41d7-8e88-228b25ed4660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_2fd2fb9b-80f1-4152-ad1b-c1c108dcc25b" xlink:to="loc_us-gaap_PlanNameAxis_2c9f0a99-e502-41d7-8e88-228b25ed4660" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_2c9f0a99-e502-41d7-8e88-228b25ed4660_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_2c9f0a99-e502-41d7-8e88-228b25ed4660" xlink:to="loc_us-gaap_PlanNameDomain_2c9f0a99-e502-41d7-8e88-228b25ed4660_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_941ea825-5038-41cd-817d-2af127aa1eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_2c9f0a99-e502-41d7-8e88-228b25ed4660" xlink:to="loc_us-gaap_PlanNameDomain_941ea825-5038-41cd-817d-2af127aa1eed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EmployeeStockCompensationPlanMember_90b7cf7c-e75a-4c7b-9537-4c01f018a661" xlink:href="cnc-20221231.xsd#cnc_EmployeeStockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_941ea825-5038-41cd-817d-2af127aa1eed" xlink:to="loc_cnc_EmployeeStockCompensationPlanMember_90b7cf7c-e75a-4c7b-9537-4c01f018a661" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_77c60466-7768-4c02-8b55-d57139283088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_2fd2fb9b-80f1-4152-ad1b-c1c108dcc25b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_77c60466-7768-4c02-8b55-d57139283088" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77c60466-7768-4c02-8b55-d57139283088_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_77c60466-7768-4c02-8b55-d57139283088" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77c60466-7768-4c02-8b55-d57139283088_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_132dd06b-ed8f-4464-a505-dd13d4339404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_77c60466-7768-4c02-8b55-d57139283088" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_132dd06b-ed8f-4464-a505-dd13d4339404" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_WellCareHealthPlansIncMember_bf070612-a97c-41b5-8ff6-22a5429a8828" xlink:href="cnc-20221231.xsd#cnc_WellCareHealthPlansIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_132dd06b-ed8f-4464-a505-dd13d4339404" xlink:to="loc_cnc_WellCareHealthPlansIncMember_bf070612-a97c-41b5-8ff6-22a5429a8828" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#StockholdersEquityShareRepurchaseActivityDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" xlink:type="extended" id="i530de6fa7efc4e10a5c807d53dbbdab6_StockholdersEquityShareRepurchaseActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation_7c2d37ba-0399-45d1-a808-3164166efaa2" xlink:href="cnc-20221231.xsd#cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:to="loc_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation_7c2d37ba-0399-45d1-a808-3164166efaa2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_6ee93fc7-42f0-4472-8d71-bc0900eb9a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_6ee93fc7-42f0-4472-8d71-bc0900eb9a10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_c3b17ebd-28ef-4a66-9e2f-55bad8355d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_c3b17ebd-28ef-4a66-9e2f-55bad8355d63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes_3348559a-306b-4855-9285-e0e3fb2b550a" xlink:href="cnc-20221231.xsd#cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:to="loc_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes_3348559a-306b-4855-9285-e0e3fb2b550a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_68a30207-18d8-455f-8466-064d4bd72286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_68a30207-18d8-455f-8466-064d4bd72286" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_308f9747-6823-4cd2-a553-1c8250f6fdaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_308f9747-6823-4cd2-a553-1c8250f6fdaa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6367ea83-b3d0-4186-91eb-1471dfee9708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6367ea83-b3d0-4186-91eb-1471dfee9708" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_26d8dc26-3bb2-471b-b06f-842105a62f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6367ea83-b3d0-4186-91eb-1471dfee9708" xlink:to="loc_us-gaap_StatementClassOfStockAxis_26d8dc26-3bb2-471b-b06f-842105a62f0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_26d8dc26-3bb2-471b-b06f-842105a62f0d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_26d8dc26-3bb2-471b-b06f-842105a62f0d" xlink:to="loc_us-gaap_ClassOfStockDomain_26d8dc26-3bb2-471b-b06f-842105a62f0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3bdb6a9c-b00e-4a8e-9730-0470fc121f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_26d8dc26-3bb2-471b-b06f-842105a62f0d" xlink:to="loc_us-gaap_ClassOfStockDomain_3bdb6a9c-b00e-4a8e-9730-0470fc121f3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_df6929e9-91cd-41af-8c6d-fbc6a5f420fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3bdb6a9c-b00e-4a8e-9730-0470fc121f3b" xlink:to="loc_us-gaap_CommonStockMember_df6929e9-91cd-41af-8c6d-fbc6a5f420fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_791eaa9e-07aa-4d03-aa8f-1a0505711ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6367ea83-b3d0-4186-91eb-1471dfee9708" xlink:to="loc_us-gaap_PlanNameAxis_791eaa9e-07aa-4d03-aa8f-1a0505711ba5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_791eaa9e-07aa-4d03-aa8f-1a0505711ba5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_791eaa9e-07aa-4d03-aa8f-1a0505711ba5" xlink:to="loc_us-gaap_PlanNameDomain_791eaa9e-07aa-4d03-aa8f-1a0505711ba5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_aa1ad465-34ba-4430-a2b5-e8d16cbd03b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_791eaa9e-07aa-4d03-aa8f-1a0505711ba5" xlink:to="loc_us-gaap_PlanNameDomain_aa1ad465-34ba-4430-a2b5-e8d16cbd03b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EmployeeStockCompensationPlanMember_e0d07bb5-bede-4d88-9507-7093a9e8c5ef" xlink:href="cnc-20221231.xsd#cnc_EmployeeStockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_aa1ad465-34ba-4430-a2b5-e8d16cbd03b8" xlink:to="loc_cnc_EmployeeStockCompensationPlanMember_e0d07bb5-bede-4d88-9507-7093a9e8c5ef" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i578882ec24cd47fbaca4f1a2192d8e99_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_97134f1f-f9e0-4fbe-8f09-4321108c58b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_us-gaap_OperatingLossCarryforwards_97134f1f-f9e0-4fbe-8f09-4321108c58b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration_0abec748-5027-435a-b10e-5ddb969c4cf4" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration_0abec748-5027-435a-b10e-5ddb969c4cf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration_7a2aa3c9-98fc-49b3-9a9f-0b8ffa0ad1d6" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration_7a2aa3c9-98fc-49b3-9a9f-0b8ffa0ad1d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_908ee9dc-85c4-4c1e-ac90-2ee7d60cc053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_908ee9dc-85c4-4c1e-ac90-2ee7d60cc053" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_8a1cfef1-ff02-4565-be8a-0574a341f0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_8a1cfef1-ff02-4565-be8a-0574a341f0c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_436a2d4f-c9e3-48d6-998a-e72703786a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_436a2d4f-c9e3-48d6-998a-e72703786a78" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_00f4faf0-c566-4d4b-8796-cce5c59e1220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_00f4faf0-c566-4d4b-8796-cce5c59e1220" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_edfa1d76-df60-4277-9716-7a6c218877ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_edfa1d76-df60-4277-9716-7a6c218877ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_6f0be5b2-24e9-4c86-9907-8b466c22a710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_edfa1d76-df60-4277-9716-7a6c218877ec" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_6f0be5b2-24e9-4c86-9907-8b466c22a710" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_6f0be5b2-24e9-4c86-9907-8b466c22a710_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_6f0be5b2-24e9-4c86-9907-8b466c22a710" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_6f0be5b2-24e9-4c86-9907-8b466c22a710_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_8052342f-a13d-4537-bb66-e6c3f8acc3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_6f0be5b2-24e9-4c86-9907-8b466c22a710" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_8052342f-a13d-4537-bb66-e6c3f8acc3cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_63b1793f-332d-488d-a8b0-6d1034a22d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8052342f-a13d-4537-bb66-e6c3f8acc3cf" xlink:to="loc_us-gaap_DomesticCountryMember_63b1793f-332d-488d-a8b0-6d1034a22d22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_4afcf8df-7dd4-4907-aa82-f8e023bdbf03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8052342f-a13d-4537-bb66-e6c3f8acc3cf" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_4afcf8df-7dd4-4907-aa82-f8e023bdbf03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_a812161c-f2a1-4231-b901-4b2145d9cfec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8052342f-a13d-4537-bb66-e6c3f8acc3cf" xlink:to="loc_us-gaap_ForeignCountryMember_a812161c-f2a1-4231-b901-4b2145d9cfec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_2a3c0e7b-56c5-4f98-b729-a69c8a90e7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_edfa1d76-df60-4277-9716-7a6c218877ec" xlink:to="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_2a3c0e7b-56c5-4f98-b729-a69c8a90e7ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_2a3c0e7b-56c5-4f98-b729-a69c8a90e7ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_2a3c0e7b-56c5-4f98-b729-a69c8a90e7ed" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_2a3c0e7b-56c5-4f98-b729-a69c8a90e7ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_4f9559a1-f5ab-4621-aa74-9df9f5d748e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_2a3c0e7b-56c5-4f98-b729-a69c8a90e7ed" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_4f9559a1-f5ab-4621-aa74-9df9f5d748e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettlementWithTaxingAuthorityMember_d09c5102-232a-438d-8122-7ac31c7da6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettlementWithTaxingAuthorityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_4f9559a1-f5ab-4621-aa74-9df9f5d748e5" xlink:to="loc_us-gaap_SettlementWithTaxingAuthorityMember_d09c5102-232a-438d-8122-7ac31c7da6b5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/StockIncentivePlansNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#StockIncentivePlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/StockIncentivePlansNarrativeDetails" xlink:type="extended" id="ife9f118379084d7b8683fdc8c32a0a6c_StockIncentivePlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2035bf45-52f7-4e88-925d-50b89dc9d233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2035bf45-52f7-4e88-925d-50b89dc9d233" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3bc3f1b0-dd63-46e1-902e-da763d84a4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3bc3f1b0-dd63-46e1-902e-da763d84a4b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod_eeee2bd6-c784-4ecd-9880-b2b6baf467f2" xlink:href="cnc-20221231.xsd#cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod_eeee2bd6-c784-4ecd-9880-b2b6baf467f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a0b448f8-bf83-4a13-911f-453e9e6236d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a0b448f8-bf83-4a13-911f-453e9e6236d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_cf90b722-c96e-4650-83d6-2b24ad861e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_cf90b722-c96e-4650-83d6-2b24ad861e59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5ee9e2e0-ae12-4acd-8041-7069c37079b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5ee9e2e0-ae12-4acd-8041-7069c37079b5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e2c810f2-0a7e-4281-937e-0551a6d3bb21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e2c810f2-0a7e-4281-937e-0551a6d3bb21" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_cd45c3e3-fd6b-495e-8692-03cb062c9ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_cd45c3e3-fd6b-495e-8692-03cb062c9ad4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_abadfa5a-6ae4-4a58-983b-aa7648bf7e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_abadfa5a-6ae4-4a58-983b-aa7648bf7e1d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ceecd647-4040-48b9-bc6f-5f2448535579" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_StatementTable_ceecd647-4040-48b9-bc6f-5f2448535579" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_77ddfb72-592d-4c4e-9ea4-4ef308c86080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ceecd647-4040-48b9-bc6f-5f2448535579" xlink:to="loc_us-gaap_AwardTypeAxis_77ddfb72-592d-4c4e-9ea4-4ef308c86080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77ddfb72-592d-4c4e-9ea4-4ef308c86080_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_77ddfb72-592d-4c4e-9ea4-4ef308c86080" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77ddfb72-592d-4c4e-9ea4-4ef308c86080_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b93c72f3-7cc8-4ba7-9148-b063fc877b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_77ddfb72-592d-4c4e-9ea4-4ef308c86080" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b93c72f3-7cc8-4ba7-9148-b063fc877b8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_99da618c-abc5-4c80-bda3-c1bb28306caf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b93c72f3-7cc8-4ba7-9148-b063fc877b8c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_99da618c-abc5-4c80-bda3-c1bb28306caf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a18d6d8d-60a2-4235-90ab-f563b7d28d67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b93c72f3-7cc8-4ba7-9148-b063fc877b8c" xlink:to="loc_us-gaap_RestrictedStockMember_a18d6d8d-60a2-4235-90ab-f563b7d28d67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b7dfe683-7f69-4ea3-87d8-2f3b3d93f13e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b93c72f3-7cc8-4ba7-9148-b063fc877b8c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b7dfe683-7f69-4ea3-87d8-2f3b3d93f13e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cd84a811-20bc-4d77-ac1f-f17faa1c3c54" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ceecd647-4040-48b9-bc6f-5f2448535579" xlink:to="loc_srt_RangeAxis_cd84a811-20bc-4d77-ac1f-f17faa1c3c54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cd84a811-20bc-4d77-ac1f-f17faa1c3c54_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cd84a811-20bc-4d77-ac1f-f17faa1c3c54" xlink:to="loc_srt_RangeMember_cd84a811-20bc-4d77-ac1f-f17faa1c3c54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cf67e861-1b6d-4cf6-9a95-d05fb853010d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cd84a811-20bc-4d77-ac1f-f17faa1c3c54" xlink:to="loc_srt_RangeMember_cf67e861-1b6d-4cf6-9a95-d05fb853010d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e4b1647e-a578-4035-99d1-1dbb5e966e93" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cf67e861-1b6d-4cf6-9a95-d05fb853010d" xlink:to="loc_srt_MinimumMember_e4b1647e-a578-4035-99d1-1dbb5e966e93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9854a1d1-38f3-43d9-b60d-9359ed6ddcca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cf67e861-1b6d-4cf6-9a95-d05fb853010d" xlink:to="loc_srt_MaximumMember_9854a1d1-38f3-43d9-b60d-9359ed6ddcca" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/CommitmentsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#CommitmentsDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/CommitmentsDetails" xlink:type="extended" id="i1500af38cbf847c5acf8eab5ac59d370_CommitmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_5cf8ec57-1353-4628-b0ad-50b52f250529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:to="loc_us-gaap_OtherCommitment_5cf8ec57-1353-4628-b0ad-50b52f250529" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentTerm_e8bd733e-b5f9-4c9c-b0f6-d97718bf0965" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:to="loc_cnc_OtherCommitmentTerm_e8bd733e-b5f9-4c9c-b0f6-d97718bf0965" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentsPaid_18c64c88-ff5e-4917-9dd9-a18c95ca7201" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:to="loc_cnc_OtherCommitmentsPaid_18c64c88-ff5e-4917-9dd9-a18c95ca7201" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentEmployees_917a29b1-8067-4698-be68-bc383c1e76c6" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:to="loc_cnc_OtherCommitmentEmployees_917a29b1-8067-4698-be68-bc383c1e76c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentExpense_ab7859bb-f971-49b3-8edf-a1f280036576" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:to="loc_cnc_OtherCommitmentExpense_ab7859bb-f971-49b3-8edf-a1f280036576" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentToBePaidYearOneAndYearTwo_8206834f-bfdb-4ac6-98f2-05e2b14718f4" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentToBePaidYearOneAndYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:to="loc_cnc_OtherCommitmentToBePaidYearOneAndYearTwo_8206834f-bfdb-4ac6-98f2-05e2b14718f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_a0cd8d39-f2d6-46c7-a480-4f55a0fbebba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:to="loc_us-gaap_OtherCommitmentsTable_a0cd8d39-f2d6-46c7-a480-4f55a0fbebba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9e55bb75-1d33-423b-95a7-6c2adb90ba6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_a0cd8d39-f2d6-46c7-a480-4f55a0fbebba" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9e55bb75-1d33-423b-95a7-6c2adb90ba6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9e55bb75-1d33-423b-95a7-6c2adb90ba6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9e55bb75-1d33-423b-95a7-6c2adb90ba6e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9e55bb75-1d33-423b-95a7-6c2adb90ba6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5249e3f6-414d-4c7a-b185-f44da10fa6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9e55bb75-1d33-423b-95a7-6c2adb90ba6e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5249e3f6-414d-4c7a-b185-f44da10fa6d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanHealthMember_edadd2a9-57e5-4360-9af9-c80cb1ebe5c3" xlink:href="cnc-20221231.xsd#cnc_MagellanHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5249e3f6-414d-4c7a-b185-f44da10fa6d2" xlink:to="loc_cnc_MagellanHealthMember_edadd2a9-57e5-4360-9af9-c80cb1ebe5c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_6f9b7d0e-5008-40a4-a454-fab9c86b4f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_a0cd8d39-f2d6-46c7-a480-4f55a0fbebba" xlink:to="loc_us-gaap_OtherCommitmentsAxis_6f9b7d0e-5008-40a4-a454-fab9c86b4f0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_6f9b7d0e-5008-40a4-a454-fab9c86b4f0f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_6f9b7d0e-5008-40a4-a454-fab9c86b4f0f" xlink:to="loc_us-gaap_OtherCommitmentsDomain_6f9b7d0e-5008-40a4-a454-fab9c86b4f0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_6f9b7d0e-5008-40a4-a454-fab9c86b4f0f" xlink:to="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PurchaserBusinessGroupOnHealthMember_fe0cbf86-5928-4793-b59b-c596160d865d" xlink:href="cnc-20221231.xsd#cnc_PurchaserBusinessGroupOnHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:to="loc_cnc_PurchaserBusinessGroupOnHealthMember_fe0cbf86-5928-4793-b59b-c596160d865d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember_8adfb3bc-4015-4e4b-98e4-18f3d0e006ad" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:to="loc_cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember_8adfb3bc-4015-4e4b-98e4-18f3d0e006ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember_68aea105-7c9f-4c63-9739-c4e12500a0b5" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:to="loc_cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember_68aea105-7c9f-4c63-9739-c4e12500a0b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentServiceCenterinCaliforniaMember_1fb0d559-d598-4764-8459-e5b7160d8cd9" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentServiceCenterinCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:to="loc_cnc_LongTermInvestmentServiceCenterinCaliforniaMember_1fb0d559-d598-4764-8459-e5b7160d8cd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember_c0e8c571-8909-4462-a20b-247efa437699" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:to="loc_cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember_c0e8c571-8909-4462-a20b-247efa437699" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember_2874ac1c-6176-4e6c-910b-6b2ad1199cbb" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:to="loc_cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember_2874ac1c-6176-4e6c-910b-6b2ad1199cbb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1f3ef8ec-b97e-41e6-928d-c6ba89a8b951" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_a0cd8d39-f2d6-46c7-a480-4f55a0fbebba" xlink:to="loc_srt_RangeAxis_1f3ef8ec-b97e-41e6-928d-c6ba89a8b951" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1f3ef8ec-b97e-41e6-928d-c6ba89a8b951_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1f3ef8ec-b97e-41e6-928d-c6ba89a8b951" xlink:to="loc_srt_RangeMember_1f3ef8ec-b97e-41e6-928d-c6ba89a8b951_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1097746f-846f-45eb-becd-443e19a2f797" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1f3ef8ec-b97e-41e6-928d-c6ba89a8b951" xlink:to="loc_srt_RangeMember_1097746f-846f-45eb-becd-443e19a2f797" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_62dc44af-f0e7-49f4-a995-a552e5b335f2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1097746f-846f-45eb-becd-443e19a2f797" xlink:to="loc_srt_MinimumMember_62dc44af-f0e7-49f4-a995-a552e5b335f2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/ContingenciesDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#ContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/ContingenciesDetails" xlink:type="extended" id="i796c8e05e3b74034b96a272067d25103_ContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_802eb33c-77d6-4e12-ba79-27d7be836c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_11239d00-2b71-4e19-b87e-9fa3af1274e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_802eb33c-77d6-4e12-ba79-27d7be836c79" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_11239d00-2b71-4e19-b87e-9fa3af1274e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_3b485002-0c1b-4085-aea7-135e745bea85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_802eb33c-77d6-4e12-ba79-27d7be836c79" xlink:to="loc_us-gaap_LitigationReserve_3b485002-0c1b-4085-aea7-135e745bea85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_fdb387d8-4da1-4ac7-9225-f3bf19416ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_802eb33c-77d6-4e12-ba79-27d7be836c79" xlink:to="loc_us-gaap_LossContingenciesTable_fdb387d8-4da1-4ac7-9225-f3bf19416ddc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_98b52f65-7290-45eb-9a26-699f647c1c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_fdb387d8-4da1-4ac7-9225-f3bf19416ddc" xlink:to="loc_us-gaap_LitigationStatusAxis_98b52f65-7290-45eb-9a26-699f647c1c63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_98b52f65-7290-45eb-9a26-699f647c1c63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_98b52f65-7290-45eb-9a26-699f647c1c63" xlink:to="loc_us-gaap_LitigationStatusDomain_98b52f65-7290-45eb-9a26-699f647c1c63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d4f45763-27e8-4aae-8d5f-20aa8bc12f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_98b52f65-7290-45eb-9a26-699f647c1c63" xlink:to="loc_us-gaap_LitigationStatusDomain_d4f45763-27e8-4aae-8d5f-20aa8bc12f0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_3f851f8b-a093-4e8a-a0c7-18d00c3a4edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_d4f45763-27e8-4aae-8d5f-20aa8bc12f0d" xlink:to="loc_us-gaap_PendingLitigationMember_3f851f8b-a093-4e8a-a0c7-18d00c3a4edc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#SegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/SegmentInformationDetails" xlink:type="extended" id="i0e57a4c1565349d486a61c750474f5f6_SegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fa042183-2482-4cd8-943b-c740f9c5ac3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c03b5090-e444-4793-8bb6-46b331665859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fa042183-2482-4cd8-943b-c740f9c5ac3a" xlink:to="loc_us-gaap_Revenues_c03b5090-e444-4793-8bb6-46b331665859" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ca8d6bfd-a5fa-4922-8f6c-3b54db3f0942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fa042183-2482-4cd8-943b-c740f9c5ac3a" xlink:to="loc_us-gaap_OperatingIncomeLoss_ca8d6bfd-a5fa-4922-8f6c-3b54db3f0942" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c8f5190c-6ee4-4c4f-b54c-fc5377fd5add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_fa042183-2482-4cd8-943b-c740f9c5ac3a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c8f5190c-6ee4-4c4f-b54c-fc5377fd5add" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b131a079-06ca-429c-ab31-bf90485200cc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c8f5190c-6ee4-4c4f-b54c-fc5377fd5add" xlink:to="loc_srt_ConsolidationItemsAxis_b131a079-06ca-429c-ab31-bf90485200cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b131a079-06ca-429c-ab31-bf90485200cc_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_b131a079-06ca-429c-ab31-bf90485200cc" xlink:to="loc_srt_ConsolidationItemsDomain_b131a079-06ca-429c-ab31-bf90485200cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6f0153a6-a8f9-470f-9b7d-d3d951a801ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_b131a079-06ca-429c-ab31-bf90485200cc" xlink:to="loc_srt_ConsolidationItemsDomain_6f0153a6-a8f9-470f-9b7d-d3d951a801ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a3ad7e13-682a-454d-b81d-756cedb5f104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6f0153a6-a8f9-470f-9b7d-d3d951a801ea" xlink:to="loc_us-gaap_OperatingSegmentsMember_a3ad7e13-682a-454d-b81d-756cedb5f104" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_54d1765a-12c1-4d0a-98cd-18bd10eb7c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6f0153a6-a8f9-470f-9b7d-d3d951a801ea" xlink:to="loc_us-gaap_IntersegmentEliminationMember_54d1765a-12c1-4d0a-98cd-18bd10eb7c6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b0418f43-ea76-40fe-a348-19bd5a5c0b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c8f5190c-6ee4-4c4f-b54c-fc5377fd5add" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b0418f43-ea76-40fe-a348-19bd5a5c0b25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b0418f43-ea76-40fe-a348-19bd5a5c0b25_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b0418f43-ea76-40fe-a348-19bd5a5c0b25" xlink:to="loc_us-gaap_SegmentDomain_b0418f43-ea76-40fe-a348-19bd5a5c0b25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2c380312-a3f3-49ad-a18c-0536e8f6eb18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b0418f43-ea76-40fe-a348-19bd5a5c0b25" xlink:to="loc_us-gaap_SegmentDomain_2c380312-a3f3-49ad-a18c-0536e8f6eb18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ManagedCareMember_8557492e-69a1-4a4a-8545-eb01f24ee338" xlink:href="cnc-20221231.xsd#cnc_ManagedCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2c380312-a3f3-49ad-a18c-0536e8f6eb18" xlink:to="loc_cnc_ManagedCareMember_8557492e-69a1-4a4a-8545-eb01f24ee338" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SpecialtyServicesMember_818ee006-0662-4649-9e77-89e7dc10fe07" xlink:href="cnc-20221231.xsd#cnc_SpecialtyServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2c380312-a3f3-49ad-a18c-0536e8f6eb18" xlink:to="loc_cnc_SpecialtyServicesMember_818ee006-0662-4649-9e77-89e7dc10fe07" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" xlink:type="extended" id="ia7f3b8b2e8dd4c0886102fa973ea85a3_CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_024430e6-e99a-4899-93d6-ced643cf49f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9d777a9a-9ab7-4d58-ad55-9925e68bb64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_024430e6-e99a-4899-93d6-ced643cf49f1" xlink:to="loc_us-gaap_AssetsAbstract_9d777a9a-9ab7-4d58-ad55-9925e68bb64c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_aee78287-f774-4ce0-a018-41a723b58403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9d777a9a-9ab7-4d58-ad55-9925e68bb64c" xlink:to="loc_us-gaap_AssetsCurrentAbstract_aee78287-f774-4ce0-a018-41a723b58403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_62d18517-a109-40ac-b1c9-c967459afdc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aee78287-f774-4ce0-a018-41a723b58403" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_62d18517-a109-40ac-b1c9-c967459afdc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_2562c459-5025-479b-b88c-6fcede1e3d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aee78287-f774-4ce0-a018-41a723b58403" xlink:to="loc_us-gaap_ShortTermInvestments_2562c459-5025-479b-b88c-6fcede1e3d4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_f04d8a8b-cd1a-4e41-8a0c-43a9aa20c962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aee78287-f774-4ce0-a018-41a723b58403" xlink:to="loc_us-gaap_OtherAssetsCurrent_f04d8a8b-cd1a-4e41-8a0c-43a9aa20c962" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e3f52596-1fb4-4369-a10a-acb0ed774bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aee78287-f774-4ce0-a018-41a723b58403" xlink:to="loc_us-gaap_AssetsCurrent_e3f52596-1fb4-4369-a10a-acb0ed774bc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_b3ba077c-5bfb-4efd-b6bd-a53607727023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9d777a9a-9ab7-4d58-ad55-9925e68bb64c" xlink:to="loc_us-gaap_LongTermInvestments_b3ba077c-5bfb-4efd-b6bd-a53607727023" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_54576a7c-c29d-4051-8cfd-a79ba0c99991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9d777a9a-9ab7-4d58-ad55-9925e68bb64c" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_54576a7c-c29d-4051-8cfd-a79ba0c99991" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ce87a175-ff9a-4034-9ecf-3ef8d63a200c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9d777a9a-9ab7-4d58-ad55-9925e68bb64c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ce87a175-ff9a-4034-9ecf-3ef8d63a200c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c149cc1f-4123-41d5-9e2a-f6811a6bf57a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9d777a9a-9ab7-4d58-ad55-9925e68bb64c" xlink:to="loc_us-gaap_Assets_c149cc1f-4123-41d5-9e2a-f6811a6bf57a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_024430e6-e99a-4899-93d6-ced643cf49f1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_48b65152-049c-46e9-9b20-30b4f0f1eb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_48b65152-049c-46e9-9b20-30b4f0f1eb2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_b053ed3b-4b56-4862-8569-1373d67a930c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_48b65152-049c-46e9-9b20-30b4f0f1eb2e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_b053ed3b-4b56-4862-8569-1373d67a930c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_06a5004b-8709-4b14-b6cd-6c158caa338b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_48b65152-049c-46e9-9b20-30b4f0f1eb2e" xlink:to="loc_us-gaap_LongTermDebtCurrent_06a5004b-8709-4b14-b6cd-6c158caa338b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c4209ef4-6a69-49d5-94ea-e9f855a15c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_48b65152-049c-46e9-9b20-30b4f0f1eb2e" xlink:to="loc_us-gaap_LiabilitiesCurrent_c4209ef4-6a69-49d5-94ea-e9f855a15c7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7d3c4be6-de8b-45a8-923e-bbf4ed9f01cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_7d3c4be6-de8b-45a8-923e-bbf4ed9f01cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_42914307-b097-4743-b708-945532c2bd74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_42914307-b097-4743-b708-945532c2bd74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_50a31e24-8d68-4cc7-a2e7-6bb6b558989a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:to="loc_us-gaap_Liabilities_50a31e24-8d68-4cc7-a2e7-6bb6b558989a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_59dd8d92-3a09-4832-8b32-26195fdee8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_59dd8d92-3a09-4832-8b32-26195fdee8ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_128e6e95-b159-46f8-a5ac-ec82c1e91778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_PreferredStockValue_128e6e95-b159-46f8-a5ac-ec82c1e91778" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8dbcf6c8-aa22-47bf-aa5d-6cc17e933283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_CommonStockValue_8dbcf6c8-aa22-47bf-aa5d-6cc17e933283" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_80667310-27b6-4630-95b9-63ab5143e52a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_80667310-27b6-4630-95b9-63ab5143e52a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4e52a3c8-bd2d-4d6d-8a42-cfa181c2561e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4e52a3c8-bd2d-4d6d-8a42-cfa181c2561e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a1315628-85ec-4b14-8ba0-80b68e896646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a1315628-85ec-4b14-8ba0-80b68e896646" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_b7abd47c-d432-476a-a70c-3d9cae7c1ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_TreasuryStockShares_b7abd47c-d432-476a-a70c-3d9cae7c1ef8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_3e7ead5f-bbf1-4c0c-aa83-839d9c51562d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_TreasuryStockValue_3e7ead5f-bbf1-4c0c-aa83-839d9c51562d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a9dde714-21c6-470c-ac72-42c686af47ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_StockholdersEquity_a9dde714-21c6-470c-ac72-42c686af47ff" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_eb3ee9af-aa0e-4684-a569-a3fb1f135290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_MinorityInterest_eb3ee9af-aa0e-4684-a569-a3fb1f135290" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_314ba2a0-8f2e-4c1a-badd-d1c6c0d9811e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_314ba2a0-8f2e-4c1a-badd-d1c6c0d9811e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_efcbb865-8577-4ade-b607-b90ae48ad0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_efcbb865-8577-4ade-b607-b90ae48ad0e1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_11872c08-8f44-434e-b276-16f3c5d52a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_024430e6-e99a-4899-93d6-ced643cf49f1" xlink:to="loc_us-gaap_StatementTable_11872c08-8f44-434e-b276-16f3c5d52a8a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_730a6d6d-f679-42c2-b200-087cf7211eaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_11872c08-8f44-434e-b276-16f3c5d52a8a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_730a6d6d-f679-42c2-b200-087cf7211eaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_730a6d6d-f679-42c2-b200-087cf7211eaf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_730a6d6d-f679-42c2-b200-087cf7211eaf" xlink:to="loc_srt_ConsolidatedEntitiesDomain_730a6d6d-f679-42c2-b200-087cf7211eaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_87e71a7f-077d-488e-af8d-fbe1f45eb6f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_730a6d6d-f679-42c2-b200-087cf7211eaf" xlink:to="loc_srt_ConsolidatedEntitiesDomain_87e71a7f-077d-488e-af8d-fbe1f45eb6f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_cfe8bc38-c736-4736-b45e-f22b689ee3dc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_87e71a7f-077d-488e-af8d-fbe1f45eb6f4" xlink:to="loc_srt_ParentCompanyMember_cfe8bc38-c736-4736-b45e-f22b689ee3dc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails" xlink:type="extended" id="id214600219c64e8cabd078a35cf6248e_CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ff49f5c3-6a97-4451-b177-ce2b91d0804f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ff49f5c3-6a97-4451-b177-ce2b91d0804f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_94cbf7b9-5596-483d-8da0-7e1ad2361f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_94cbf7b9-5596-483d-8da0-7e1ad2361f78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_97cfcf8e-0353-4ba0-99a6-1b7b510e4740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_PreferredStockSharesIssued_97cfcf8e-0353-4ba0-99a6-1b7b510e4740" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_728e0437-f54c-43a1-ae54-14c6e5d8dbe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_728e0437-f54c-43a1-ae54-14c6e5d8dbe3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_cf4087fb-6fc0-4944-a304-c45e11544350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_cf4087fb-6fc0-4944-a304-c45e11544350" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4e1bdb98-6326-4f1e-9022-ba4dcbe94e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4e1bdb98-6326-4f1e-9022-ba4dcbe94e07" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_94044d0e-7747-4e3f-a58c-2f60bc2c99b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_CommonStockSharesIssued_94044d0e-7747-4e3f-a58c-2f60bc2c99b6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2096376a-631f-41e3-879e-620ad67c39f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2096376a-631f-41e3-879e-620ad67c39f0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_99dc59fc-ba9e-4678-a39d-58455ad4135c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_TreasuryStockShares_99dc59fc-ba9e-4678-a39d-58455ad4135c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e10e048e-28a9-408c-bdb7-a67ec2f4c7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_StatementTable_e10e048e-28a9-408c-bdb7-a67ec2f4c7f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_9e463489-dd46-4e21-b991-df8e8d813cb0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e10e048e-28a9-408c-bdb7-a67ec2f4c7f6" xlink:to="loc_srt_ConsolidatedEntitiesAxis_9e463489-dd46-4e21-b991-df8e8d813cb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_9e463489-dd46-4e21-b991-df8e8d813cb0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9e463489-dd46-4e21-b991-df8e8d813cb0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_9e463489-dd46-4e21-b991-df8e8d813cb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_de6e72f9-150e-4a35-bfab-e03118257246" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9e463489-dd46-4e21-b991-df8e8d813cb0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_de6e72f9-150e-4a35-bfab-e03118257246" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_fc5308e2-7f32-4734-9196-813cb645d61f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_de6e72f9-150e-4a35-bfab-e03118257246" xlink:to="loc_srt_ParentCompanyMember_fc5308e2-7f32-4734-9196-813cb645d61f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails" xlink:type="extended" id="i4294a49fb09d42bfbcb17661858c4824_CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_480441de-270b-433d-9526-63c1cb15b930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_OperatingExpensesAbstract_480441de-270b-433d-9526-63c1cb15b930" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_70eea1b4-8e59-449e-86e9-465a6bf65e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_480441de-270b-433d-9526-63c1cb15b930" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_70eea1b4-8e59-449e-86e9-465a6bf65e39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8d81d946-ce5a-4a57-a7d5-2619ae977f27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_480441de-270b-433d-9526-63c1cb15b930" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8d81d946-ce5a-4a57-a7d5-2619ae977f27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_11e3081e-9e73-4925-9e96-578cb90b0984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_480441de-270b-433d-9526-63c1cb15b930" xlink:to="loc_us-gaap_LitigationSettlementExpense_11e3081e-9e73-4925-9e96-578cb90b0984" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e4ee7582-4331-4afb-9410-413887e36aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e4ee7582-4331-4afb-9410-413887e36aca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_f060acd0-8573-4df8-8e26-b8efc2a60572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e4ee7582-4331-4afb-9410-413887e36aca" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_f060acd0-8573-4df8-8e26-b8efc2a60572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_983dcf34-db7c-4093-807e-b79c9d2b2775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e4ee7582-4331-4afb-9410-413887e36aca" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_983dcf34-db7c-4093-807e-b79c9d2b2775" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_61639f02-8bf7-4fc6-a3b4-bcb23c566297" xlink:href="cnc-20221231.xsd#cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e4ee7582-4331-4afb-9410-413887e36aca" xlink:to="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_61639f02-8bf7-4fc6-a3b4-bcb23c566297" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_089d6966-312b-421d-8050-50f52fabb086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e4ee7582-4331-4afb-9410-413887e36aca" xlink:to="loc_us-gaap_InterestExpense_089d6966-312b-421d-8050-50f52fabb086" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0a543829-a0e0-4bb5-bfa0-908276983901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0a543829-a0e0-4bb5-bfa0-908276983901" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9b8419e4-ed9e-4fe5-810c-1641ecda8c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9b8419e4-ed9e-4fe5-810c-1641ecda8c2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries_24d7c801-11f8-4048-8fa9-db7b8947cb58" xlink:href="cnc-20221231.xsd#cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries_24d7c801-11f8-4048-8fa9-db7b8947cb58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7c9551c8-3a32-4782-8f01-a381cb8986c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7c9551c8-3a32-4782-8f01-a381cb8986c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a116c467-98af-4f4d-ac7d-fc6bec7139b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_ProfitLoss_a116c467-98af-4f4d-ac7d-fc6bec7139b3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_36177287-d744-454f-9bb0-169bec706582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_36177287-d744-454f-9bb0-169bec706582" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a81c63e3-3607-40c9-80cc-d26346f1da6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_NetIncomeLoss_a81c63e3-3607-40c9-80cc-d26346f1da6a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_813cbcc7-eaf6-4cbc-877c-d1db70b61d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_EarningsPerShareAbstract_813cbcc7-eaf6-4cbc-877c-d1db70b61d1b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_77c63521-57ee-42fb-bb44-381af6b57f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_813cbcc7-eaf6-4cbc-877c-d1db70b61d1b" xlink:to="loc_us-gaap_EarningsPerShareBasic_77c63521-57ee-42fb-bb44-381af6b57f13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a9a1d134-db7c-4230-80f4-9d0ce04c8086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_813cbcc7-eaf6-4cbc-877c-d1db70b61d1b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a9a1d134-db7c-4230-80f4-9d0ce04c8086" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_87c6fc21-3942-4891-8d81-4016433c54a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_StatementTable_87c6fc21-3942-4891-8d81-4016433c54a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_d0321dfe-3cf5-4ebb-aba8-6dbbb80cae2f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_87c6fc21-3942-4891-8d81-4016433c54a3" xlink:to="loc_srt_ConsolidatedEntitiesAxis_d0321dfe-3cf5-4ebb-aba8-6dbbb80cae2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_d0321dfe-3cf5-4ebb-aba8-6dbbb80cae2f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d0321dfe-3cf5-4ebb-aba8-6dbbb80cae2f" xlink:to="loc_srt_ConsolidatedEntitiesDomain_d0321dfe-3cf5-4ebb-aba8-6dbbb80cae2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_615a4cba-bad2-4e8a-bb92-cbcfb9764c46" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d0321dfe-3cf5-4ebb-aba8-6dbbb80cae2f" xlink:to="loc_srt_ConsolidatedEntitiesDomain_615a4cba-bad2-4e8a-bb92-cbcfb9764c46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_bf2a8b24-2954-4dfd-b0b4-6ef8bfb10352" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_615a4cba-bad2-4e8a-bb92-cbcfb9764c46" xlink:to="loc_srt_ParentCompanyMember_bf2a8b24-2954-4dfd-b0b4-6ef8bfb10352" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"/>
  <link:definitionLink xlink:role="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="extended" id="ib3511d69b6d24121914a924d8ca9c562_CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_187c3d08-a314-4095-ad13-4ccc6fa3d88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_187c3d08-a314-4095-ad13-4ccc6fa3d88d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DividendsfromSubsidiariesOperatingActivities_33938a77-cac7-43c5-87e5-c3a22e875774" xlink:href="cnc-20221231.xsd#cnc_DividendsfromSubsidiariesOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_187c3d08-a314-4095-ad13-4ccc6fa3d88d" xlink:to="loc_cnc_DividendsfromSubsidiariesOperatingActivities_33938a77-cac7-43c5-87e5-c3a22e875774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_3238dd7d-f5dc-4e13-8240-157b72dbfd12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_187c3d08-a314-4095-ad13-4ccc6fa3d88d" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_3238dd7d-f5dc-4e13-8240-157b72dbfd12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_8e4ec998-c90f-480e-8a85-00541062f249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_187c3d08-a314-4095-ad13-4ccc6fa3d88d" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_8e4ec998-c90f-480e-8a85-00541062f249" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8eff686e-7a2a-4957-801a-9150756eb332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_187c3d08-a314-4095-ad13-4ccc6fa3d88d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8eff686e-7a2a-4957-801a-9150756eb332" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_CapitalContributionsToSubsidiaries_bf289b11-8b70-42bb-9ba4-24c15a6465f5" xlink:href="cnc-20221231.xsd#cnc_CapitalContributionsToSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_cnc_CapitalContributionsToSubsidiaries_bf289b11-8b70-42bb-9ba4-24c15a6465f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_117626b5-894f-4667-bece-a529a98d9b39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_117626b5-894f-4667-bece-a529a98d9b39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_5fe25837-53b7-4164-b61f-47a090671917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_5fe25837-53b7-4164-b61f-47a090671917" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompany_fcc19d7f-2136-4bcc-a90a-1ecb54c845cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDividendsPaidToParentCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompany_fcc19d7f-2136-4bcc-a90a-1ecb54c845cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_0c022b42-f4c9-460a-bb0b-f15c4897a042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_0c022b42-f4c9-460a-bb0b-f15c4897a042" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_d4d46d2e-8e31-4026-8672-630aea645792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_d4d46d2e-8e31-4026-8672-630aea645792" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ProceedsFromPaymentsForIntercompanyActivities_7b0374f2-d445-4df0-9cfd-6a9d3de25b0c" xlink:href="cnc-20221231.xsd#cnc_ProceedsFromPaymentsForIntercompanyActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_cnc_ProceedsFromPaymentsForIntercompanyActivities_7b0374f2-d445-4df0-9cfd-6a9d3de25b0c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e2255865-44fb-4b30-8506-e26d3eb75246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e2255865-44fb-4b30-8506-e26d3eb75246" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f131d0df-cec5-4a9b-ad7d-db12f4dfe9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f131d0df-cec5-4a9b-ad7d-db12f4dfe9d7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e2f27337-578b-4f00-98ae-8f4641e7b533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e2f27337-578b-4f00-98ae-8f4641e7b533" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b402e745-881c-4995-aafb-8f82a0b9cc52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b402e745-881c-4995-aafb-8f82a0b9cc52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2e89780b-2a00-45e7-a17a-939d363b3f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2e89780b-2a00-45e7-a17a-939d363b3f94" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_03632ea5-1bd1-4c88-8f33-c517b1af6683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_03632ea5-1bd1-4c88-8f33-c517b1af6683" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_cc43c9b0-d685-4773-a9fd-c915cf2719fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_cc43c9b0-d685-4773-a9fd-c915cf2719fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_98bfea8e-b819-4776-b963-eedee2f0d6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_98bfea8e-b819-4776-b963-eedee2f0d6ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5f22bfa2-91f3-4f3f-b2a3-3be83f7161bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5f22bfa2-91f3-4f3f-b2a3-3be83f7161bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_77832cab-2b5d-4e21-af95-92b4b54fe964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_77832cab-2b5d-4e21-af95-92b4b54fe964" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_15a2640f-447b-44d9-9794-5639269bf3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_15a2640f-447b-44d9-9794-5639269bf3d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6a6ba573-51e9-426e-8183-1f2149ef53ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6a6ba573-51e9-426e-8183-1f2149ef53ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45b73174-1f39-43e3-8f33-7454da4c6d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_15db0428-a0d9-4700-93eb-ec7d3654f1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:to="loc_us-gaap_StatementTable_15db0428-a0d9-4700-93eb-ec7d3654f1f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_ade9e5a6-fde2-4ccc-85a9-f795ab87be28" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_15db0428-a0d9-4700-93eb-ec7d3654f1f7" xlink:to="loc_srt_ConsolidatedEntitiesAxis_ade9e5a6-fde2-4ccc-85a9-f795ab87be28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ade9e5a6-fde2-4ccc-85a9-f795ab87be28_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ade9e5a6-fde2-4ccc-85a9-f795ab87be28" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ade9e5a6-fde2-4ccc-85a9-f795ab87be28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3b08e146-981a-4d13-827c-6eb76e7fe862" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ade9e5a6-fde2-4ccc-85a9-f795ab87be28" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3b08e146-981a-4d13-827c-6eb76e7fe862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_84c3ec31-5c0f-4033-8e21-9a4c35fb590d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_3b08e146-981a-4d13-827c-6eb76e7fe862" xlink:to="loc_srt_ParentCompanyMember_84c3ec31-5c0f-4033-8e21-9a4c35fb590d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cnc-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0b97e17d-6106-45f4-89d6-4fad8114f6eb,g:0be59ac2-4e57-4dab-9620-00ce2b3b169c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_d8fbf6f7-dcb5-47be-840d-bd2f72d0524a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_237fb09c-1c18-42b7-bcac-c73b92551fb1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_PremiumTaxExpense_05e473f2-f9ba-4d06-9626-fd7c50da1916_verboseLabel_en-US" xlink:label="lab_cnc_PremiumTaxExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium tax expense</link:label>
    <link:label id="lab_cnc_PremiumTaxExpense_label_en-US" xlink:label="lab_cnc_PremiumTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Tax Expense</link:label>
    <link:label id="lab_cnc_PremiumTaxExpense_documentation_en-US" xlink:label="lab_cnc_PremiumTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium tax expense, similar assessments and provider pass through payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PremiumTaxExpense" xlink:href="cnc-20221231.xsd#cnc_PremiumTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_PremiumTaxExpense" xlink:to="lab_cnc_PremiumTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss_3699d690-e4b8-40df-b533-4345e4e95579_verboseLabel_en-US" xlink:label="lab_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain</link:label>
    <link:label id="lab_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss_label_en-US" xlink:label="lab_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investment, Unrealized Gain/Loss</link:label>
    <link:label id="lab_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss_documentation_en-US" xlink:label="lab_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investment, Unrealized Gain/Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss" xlink:to="lab_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DebtTotalMember_c3fae6aa-6632-4d3d-8f86-bc9ab4e01ed0_terseLabel_en-US" xlink:label="lab_cnc_DebtTotalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Total</link:label>
    <link:label id="lab_cnc_DebtTotalMember_label_en-US" xlink:label="lab_cnc_DebtTotalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Total [Member]</link:label>
    <link:label id="lab_cnc_DebtTotalMember_documentation_en-US" xlink:label="lab_cnc_DebtTotalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtTotalMember" xlink:href="cnc-20221231.xsd#cnc_DebtTotalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DebtTotalMember" xlink:to="lab_cnc_DebtTotalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_TermLoanCreditAgreementMember_ca21e820-e8e6-468e-9fe9-260d1a46a0d2_terseLabel_en-US" xlink:label="lab_cnc_TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan credit facility</link:label>
    <link:label id="lab_cnc_TermLoanCreditAgreementMember_label_en-US" xlink:label="lab_cnc_TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Credit Agreement [Member]</link:label>
    <link:label id="lab_cnc_TermLoanCreditAgreementMember_documentation_en-US" xlink:label="lab_cnc_TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_TermLoanCreditAgreementMember" xlink:href="cnc-20221231.xsd#cnc_TermLoanCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_TermLoanCreditAgreementMember" xlink:to="lab_cnc_TermLoanCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_5b80fe46-3047-4845-9235-eeb58b8a8a49_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_6800bfaa-0a8a-47de-a6cd-959ade230a98_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_629d871e-6d41-4810-8ea9-b03703af8786_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_693d6e0d-ef3f-478a-8c4a-1902f900034b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts_778bbad8-aa96-4969-9430-6b27645eb46a_terseLabel_en-US" xlink:label="lab_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenues under contracts or subcontracts</link:label>
    <link:label id="lab_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts_label_en-US" xlink:label="lab_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Revenues Under Contracts Or Subcontracts</link:label>
    <link:label id="lab_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts_documentation_en-US" xlink:label="lab_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenues under contracts or subcontracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts" xlink:href="cnc-20221231.xsd#cnc_PercentageOfRevenuesUnderContractsOrSubcontracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts" xlink:to="lab_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_d82d7617-15ac-4eae-b5ab-77f67dce184e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair value of available-for-sale debt securities with gross unrealized losses by investment type in a continuous unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember_4ef294dc-0799-4007-9216-fb4acf9a5f19_terseLabel_en-US" xlink:label="lab_cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term investment, investment portfolio in vehicles supporting California&#8217;s health care infrastructure</link:label>
    <link:label id="lab_cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember_label_en-US" xlink:label="lab_cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investment, Vehicles Supporting California&#8217;s Health Care Infrastructure [Member]</link:label>
    <link:label id="lab_cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember_documentation_en-US" xlink:label="lab_cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investment, Vehicles Supporting California&#8217;s Health Care Infrastructure [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember" xlink:to="lab_cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember_1266e326-5775-4b38-8580-f2030bc33682_terseLabel_en-US" xlink:label="lab_cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Department Of Health, State Of New York</link:label>
    <link:label id="lab_cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember_label_en-US" xlink:label="lab_cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investment, Department Of Health, State Of New York [Member]</link:label>
    <link:label id="lab_cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember_documentation_en-US" xlink:label="lab_cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investment, Department of Health, State Of New York [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember" xlink:to="lab_cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_81e5b466-f507-48b3-8ca8-d4dc71528a29_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfAssumedDebt_87cd7cea-70c2-4c10-b0ef-c8fa8aa7f689_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payoff of assumed debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfAssumedDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Assumed Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAssumedDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfAssumedDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfAssumedDebt" xlink:to="lab_us-gaap_RepaymentsOfAssumedDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_25fad0b0-7801-4067-8d1d-cfc3a06d2670_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_c864ded7-f79d-42f5-9097-4da0db5c7be2_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation_a947bf27-faa3-4faf-b2b2-a74c6c16fbdc_terseLabel_en-US" xlink:label="lab_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share buybacks (in shares)</link:label>
    <link:label id="lab_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation_label_en-US" xlink:label="lab_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation</link:label>
    <link:label id="lab_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation_documentation_en-US" xlink:label="lab_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation" xlink:href="cnc-20221231.xsd#cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation" xlink:to="lab_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_3bf12aa4-c837-42b0-be8c-f914cc95366e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Change In Medical Claims Liability by Operating Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_7bcd1e2c-39b0-4f4d-b1c0-39c573045d44_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries_032b8374-d5dc-444c-9e55-c96f3f2776da_terseLabel_en-US" xlink:label="lab_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes for investments in subsidiaries</link:label>
    <link:label id="lab_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries_label_en-US" xlink:label="lab_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Taxes for Investment in Subsidiaries</link:label>
    <link:label id="lab_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries_documentation_en-US" xlink:label="lab_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Taxes for Investment in Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries" xlink:href="cnc-20221231.xsd#cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries" xlink:to="lab_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_7455ebb9-4abb-4a3e-bbe6-db051069525a_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, software and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_54369ce5-5b9f-4eb5-9704-e584bdeea50a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_394a7d4a-27de-436c-b1b0-d517119df242_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from interest rate swap terminations</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Derivative Instrument, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_e0877226-a171-49e0-bf99-1d5d5d92382e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_924e2427-b9f2-4cc1-93e2-e76c6b707f0d_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical claims liability</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_8ab85a1f-d33a-4298-b384-2a674a0da700_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, January 1</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_4ecb9cd2-c389-4705-8d84-a60541c98997_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, December 31</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_c455fa2a-5136-440e-9325-c0eecc027e56_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e41fac5c-c17c-4aaa-b201-6fa117ab4584_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_05e6d07c-3821-48b0-b70c-7edbb2fa0b5b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_1f1183fc-17ba-4aff-9f53-fec95f9bdbbe_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_3c51f6b1-1bf3-4a99-b60c-942370f28742_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_eedc6351-5430-46c4-8941-0c54d2f0410e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_ad8e0efd-0f12-4e3e-8ac4-2da93f4aadee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate stated, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_66e53adb-849f-4f7b-897a-082896b48aed_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DebtInstrumentExtensionTerm_44633f00-22f3-4b4b-881d-0012691415ac_terseLabel_en-US" xlink:label="lab_cnc_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extension term</link:label>
    <link:label id="lab_cnc_DebtInstrumentExtensionTerm_label_en-US" xlink:label="lab_cnc_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Term</link:label>
    <link:label id="lab_cnc_DebtInstrumentExtensionTerm_documentation_en-US" xlink:label="lab_cnc_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentExtensionTerm" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentExtensionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DebtInstrumentExtensionTerm" xlink:to="lab_cnc_DebtInstrumentExtensionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_556924b4-cd17-4166-a1c2-fbf7f2267d56_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued for acquisitions (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AffordableCareActReinsurancePayable_544cf00f-da8d-495e-883e-21fb053f2afc_negatedTerseLabel_en-US" xlink:label="lab_cnc_AffordableCareActReinsurancePayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk adjustment payable</link:label>
    <link:label id="lab_cnc_AffordableCareActReinsurancePayable_label_en-US" xlink:label="lab_cnc_AffordableCareActReinsurancePayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act Reinsurance Payable</link:label>
    <link:label id="lab_cnc_AffordableCareActReinsurancePayable_documentation_en-US" xlink:label="lab_cnc_AffordableCareActReinsurancePayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act Reinsurance, Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActReinsurancePayable" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActReinsurancePayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AffordableCareActReinsurancePayable" xlink:to="lab_cnc_AffordableCareActReinsurancePayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_02dc6fcc-4d94-48b9-99f8-14d3a9678e42_negatedNetLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_208ba03b-373d-42a0-a8bb-e12c5acc1a26_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_fdf35f88-2c53-4d6c-b99d-c8b9098421f5_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition resulting in noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_1527df57-4dc3-4f46-b4aa-0ea5217a877f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_7125de23-037d-4ae7-9f48-62ced164b830_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedIncomeStatementTableTextBlock_2d77cec9-e4ff-4d9a-a2a8-77b433d64c31_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statements Of Operations</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedIncomeStatementTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Income Statement [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_62731e5f-0d3d-4b4d-b1da-9628f67b68ea_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive stock options and restricted stock units excluded from the calculation of diluted earnings per common share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_dc1d8eda-4f85-4488-b7d3-2e9ed4c554d7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_73b031d6-9b51-4785-8b04-0b53d2889962_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ae3006a2-e204-4f95-98b5-111523f19066_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_722e9032-914d-4456-81e8-d5eeac72d9af_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_2528eea1-512d-48cf-be64-32de704af816_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_24067eac-c5cd-4cf5-bad1-0d19de50ae64_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_f8186b48-5d07-45fa-85f0-d19c4bdb6706_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_a27271c7-1645-43a5-a4ea-709d983f724a_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit_14475e9d-4b2a-436b-a6e8-51ce7f6d18eb_negatedLabel_en-US" xlink:label="lab_cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk adjustment pre-tax benefit</link:label>
    <link:label id="lab_cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit_label_en-US" xlink:label="lab_cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit)</link:label>
    <link:label id="lab_cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit_documentation_en-US" xlink:label="lab_cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit" xlink:to="lab_cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_c92d943a-58e5-40b4-9b88-bf9e5225d61b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability_fa2214b9-4786-4c98-a291-ca61c283112f_terseLabel_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical claims liability</link:label>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability_label_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Medical Claims Liability</link:label>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability_documentation_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Medical Claims Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability" xlink:to="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_02ea78e4-0e10-482b-bc7a-9b0a33ab0514_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_HealthSmartMember_618a4952-cfa8-48f5-aabb-87a817d245dc_terseLabel_en-US" xlink:label="lab_cnc_HealthSmartMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthSmart</link:label>
    <link:label id="lab_cnc_HealthSmartMember_label_en-US" xlink:label="lab_cnc_HealthSmartMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthSmart [Member]</link:label>
    <link:label id="lab_cnc_HealthSmartMember_documentation_en-US" xlink:label="lab_cnc_HealthSmartMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthSmart</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_HealthSmartMember" xlink:href="cnc-20221231.xsd#cnc_HealthSmartMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_HealthSmartMember" xlink:to="lab_cnc_HealthSmartMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_acd1b879-2621-486c-a546-7e740e341979_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_81933060-59a8-4550-b455-876fd1629123_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AffordableCareActRiskAdjustmentReceivable_7a3ab3f8-0cae-4267-bb36-46e566604359_terseLabel_en-US" xlink:label="lab_cnc_AffordableCareActRiskAdjustmentReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk adjustment receivable</link:label>
    <link:label id="lab_cnc_AffordableCareActRiskAdjustmentReceivable_label_en-US" xlink:label="lab_cnc_AffordableCareActRiskAdjustmentReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Risk Adjustment Receivable</link:label>
    <link:label id="lab_cnc_AffordableCareActRiskAdjustmentReceivable_documentation_en-US" xlink:label="lab_cnc_AffordableCareActRiskAdjustmentReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Risk Adjustment Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActRiskAdjustmentReceivable" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActRiskAdjustmentReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AffordableCareActRiskAdjustmentReceivable" xlink:to="lab_cnc_AffordableCareActRiskAdjustmentReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_db713068-185d-4b22-9f4d-b0af842f5bb1_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes_24c576e5-55eb-4699-b179-f321fa4b272b_terseLabel_en-US" xlink:label="lab_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share buybacks</link:label>
    <link:label id="lab_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes_label_en-US" xlink:label="lab_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes</link:label>
    <link:label id="lab_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes_documentation_en-US" xlink:label="lab_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes" xlink:href="cnc-20221231.xsd#cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes" xlink:to="lab_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SuretyBondMember_41064ae0-921f-4823-ad8f-10cd7418b3de_terseLabel_en-US" xlink:label="lab_us-gaap_SuretyBondMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surety Bond</link:label>
    <link:label id="lab_us-gaap_SuretyBondMember_label_en-US" xlink:label="lab_us-gaap_SuretyBondMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surety Bond [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuretyBondMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuretyBondMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SuretyBondMember" xlink:to="lab_us-gaap_SuretyBondMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_a0177ea3-0a55-4d43-b660-eccb36519be0_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_b79baa57-23fb-4388-aa46-db59b813d99f_netLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit agreement</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7df699f4-fa84-4a1e-8feb-7d950b0c90f6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_3a3a6992-66d6-476f-8714-18aeb5f20028_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification to non-redeemable</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_e0a52f6b-7daf-4842-b04d-795c1832ad52_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_86715fab-26b6-4bc7-ab36-8d8443365938_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_4fcf02f5-89c6-4d63-811f-5ab658854b56_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term (recorded within accounts payable and accrued expenses)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_d71dfea8-ef08-427e-a8b6-703b20325507_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestitures</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BridgeLoanMember_3341135c-8dea-4390-9b47-9b43936ac5a7_terseLabel_en-US" xlink:label="lab_us-gaap_BridgeLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swing Loan</link:label>
    <link:label id="lab_us-gaap_BridgeLoanMember_label_en-US" xlink:label="lab_us-gaap_BridgeLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridge Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BridgeLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BridgeLoanMember" xlink:to="lab_us-gaap_BridgeLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_bb5c3325-21d8-44ef-9fe7-5d595398ce1e_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DeferredTaxAssetPremiumAndTradeReceivables_4f027887-59b1-4c25-9363-351efc83a4dd_verboseLabel_en-US" xlink:label="lab_cnc_DeferredTaxAssetPremiumAndTradeReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium and trade receivables</link:label>
    <link:label id="lab_cnc_DeferredTaxAssetPremiumAndTradeReceivables_label_en-US" xlink:label="lab_cnc_DeferredTaxAssetPremiumAndTradeReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Premium And Trade Receivables</link:label>
    <link:label id="lab_cnc_DeferredTaxAssetPremiumAndTradeReceivables_documentation_en-US" xlink:label="lab_cnc_DeferredTaxAssetPremiumAndTradeReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Premium And Trade Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetPremiumAndTradeReceivables" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetPremiumAndTradeReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DeferredTaxAssetPremiumAndTradeReceivables" xlink:to="lab_cnc_DeferredTaxAssetPremiumAndTradeReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a3e6385a-fa6d-4be6-9f44-890c5b35aa53_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium and related receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_0a375128-2293-4f21-b16f-03a98918fe4a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_57dd1122-f8d9-4dc7-a7d6-7e9d4b6cd01d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, software and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_3eedd856-237f-485d-8a00-dcee7ecfa5c9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_8717c648-809e-4cbf-acf7-a797b745f19b_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_df8fb62d-8089-4832-ba1b-6850c1c67471_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_a62d7251-0d22-4d6a-bf1a-87e6c3521752_terseLabel_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term time deposits</link:label>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_label_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Time Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankTimeDepositsMember" xlink:to="lab_us-gaap_BankTimeDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c8cea605-40a0-43ec-974f-e88a9f71e0e9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c74917ba-5d3a-4346-b97d-08f4342ce249_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_736436f5-598b-4c24-83be-f7bf9de410b7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract_7c3df5c4-f4a2-488c-8483-1a396774760c_terseLabel_en-US" xlink:label="lab_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Capital Requirements And Dividend Restrictions [Abstract]</link:label>
    <link:label id="lab_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract_label_en-US" xlink:label="lab_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Capital Requirements And Dividend Restrictions [Abstract]</link:label>
    <link:label id="lab_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract_documentation_en-US" xlink:label="lab_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory capital requirements and dividend restrictions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract" xlink:href="cnc-20221231.xsd#cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract" xlink:to="lab_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayable_fa005154-2e1e-49b9-8506-be8e1a8de747_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction loan payable</link:label>
    <link:label id="lab_us-gaap_LoansPayable_label_en-US" xlink:label="lab_us-gaap_LoansPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayable" xlink:to="lab_us-gaap_LoansPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_A3500Million4625SeniorNotesDueDecember2029Member_be2480eb-53bd-4afc-976f-ab7e0c962cfa_terseLabel_en-US" xlink:label="lab_cnc_A3500Million4625SeniorNotesDueDecember2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$3,500 Million 4.625% Senior Notes due December 2029 [Member]</link:label>
    <link:label id="lab_cnc_A3500Million4625SeniorNotesDueDecember2029Member_label_en-US" xlink:label="lab_cnc_A3500Million4625SeniorNotesDueDecember2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$3,500 Million 4.625% Senior Notes due December 2029 [Member]</link:label>
    <link:label id="lab_cnc_A3500Million4625SeniorNotesDueDecember2029Member_documentation_en-US" xlink:label="lab_cnc_A3500Million4625SeniorNotesDueDecember2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$3,500 Million 4.625% Senior Notes due December 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A3500Million4625SeniorNotesDueDecember2029Member" xlink:href="cnc-20221231.xsd#cnc_A3500Million4625SeniorNotesDueDecember2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_A3500Million4625SeniorNotesDueDecember2029Member" xlink:to="lab_cnc_A3500Million4625SeniorNotesDueDecember2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_7a94bc6f-7159-49cf-af22-bdcb01c1b889_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DebtInstrumentAmortizationPaymentRatePercentage_a520d13f-fd40-4890-9c2c-f5db20beb481_terseLabel_en-US" xlink:label="lab_cnc_DebtInstrumentAmortizationPaymentRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization payment percentage</link:label>
    <link:label id="lab_cnc_DebtInstrumentAmortizationPaymentRatePercentage_label_en-US" xlink:label="lab_cnc_DebtInstrumentAmortizationPaymentRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Amortization Payment Rate, Percentage</link:label>
    <link:label id="lab_cnc_DebtInstrumentAmortizationPaymentRatePercentage_documentation_en-US" xlink:label="lab_cnc_DebtInstrumentAmortizationPaymentRatePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Amortization Payment Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentAmortizationPaymentRatePercentage" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentAmortizationPaymentRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DebtInstrumentAmortizationPaymentRatePercentage" xlink:to="lab_cnc_DebtInstrumentAmortizationPaymentRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_029965a9-24d3-48e2-bcec-c5048cb05a91_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claims Development [Table]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Claims Development [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1b557ee9-57c7-469f-926b-719b33ea873a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_0314dee4-b8d1-41d0-ab1b-09740ab5ebd7_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit agreement</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_368fcf1f-e5f1-405a-9bcd-4f0b555fe4ac_verboseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_3935c883-4217-4762-be3a-419a74288330_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_89069150-179b-433c-a17b-8a29a90eae67_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_88179931-f438-43d6-8725-c2c82614cd2e_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_a3ecf381-03a0-4afc-80af-62d3266b3e68_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation Period</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_WellCareHealthPlansIncMember_a7e4f38c-2280-49b7-8d25-29afae3a0042_terseLabel_en-US" xlink:label="lab_cnc_WellCareHealthPlansIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WellCare</link:label>
    <link:label id="lab_cnc_WellCareHealthPlansIncMember_label_en-US" xlink:label="lab_cnc_WellCareHealthPlansIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WellCare Health Plans, Inc [Member]</link:label>
    <link:label id="lab_cnc_WellCareHealthPlansIncMember_documentation_en-US" xlink:label="lab_cnc_WellCareHealthPlansIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WellCare Health Plans, Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_WellCareHealthPlansIncMember" xlink:href="cnc-20221231.xsd#cnc_WellCareHealthPlansIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_WellCareHealthPlansIncMember" xlink:to="lab_cnc_WellCareHealthPlansIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_83d0e5de-754e-4ece-aa43-c8ce77b1b8f4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889913a3-3a94-4fe4-9a69-28cb89070815_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c018543c-c7a1-4ae0-a626-57ed14b0b237_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_10223eb1-808b-4058-834d-2fac3f52308b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_b4349ac7-bc86-45d3-a386-5ca33a1aa71f_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList_8bbcb49a-faf7-4ac5-afc1-b11167350fd5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember_4e0aa390-ec8a-47e7-8bb3-eb05f0a4a92e_terseLabel_en-US" xlink:label="lab_cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term investment,improvement in enrollee health, locally based consumer assistance, and health care delivery system</link:label>
    <link:label id="lab_cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember_label_en-US" xlink:label="lab_cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investment, Improvement in Enrollee Health, Locally Based Consumer Assistance, and Health Care Delivery System [Member]</link:label>
    <link:label id="lab_cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember_documentation_en-US" xlink:label="lab_cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investment, Improvement in Enrollee Health, Locally Based Consumer Assistance, and Health Care Delivery System [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember" xlink:to="lab_cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_770da3a1-9739-4517-821b-5e51adeda885_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technologies</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount_9c25a9a3-0d39-43ff-bdf6-d19d959339f2_terseLabel_en-US" xlink:label="lab_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining amount available under the program</link:label>
    <link:label id="lab_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount_label_en-US" xlink:label="lab_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Repurchase Program, Remaining Amount Authorized to be Repurchased, Amount</link:label>
    <link:label id="lab_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount_documentation_en-US" xlink:label="lab_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Repurchase Program, Remaining Amount Authorized to be Repurchased, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount" xlink:href="cnc-20221231.xsd#cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount" xlink:to="lab_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DeferredTaxAssetOperatingLeaseLiability_9c90c0b2-b744-4fab-acab-9cc16b50e179_verboseLabel_en-US" xlink:label="lab_cnc_DeferredTaxAssetOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_cnc_DeferredTaxAssetOperatingLeaseLiability_label_en-US" xlink:label="lab_cnc_DeferredTaxAssetOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Operating Lease Liability</link:label>
    <link:label id="lab_cnc_DeferredTaxAssetOperatingLeaseLiability_documentation_en-US" xlink:label="lab_cnc_DeferredTaxAssetOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetOperatingLeaseLiability" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DeferredTaxAssetOperatingLeaseLiability" xlink:to="lab_cnc_DeferredTaxAssetOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_c89c8f6e-ae3a-4506-9f45-b84fdc1a0e5f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_0ddeba8b-ff4f-4a0c-b088-629d52b6bfde_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable net assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_A2000Million3375SeniorNotesDueFebruary2030Member_ca976373-3a2b-4966-bc1e-4bdb64fa20e5_terseLabel_en-US" xlink:label="lab_cnc_A2000Million3375SeniorNotesDueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,000 million 3.375% Senior Notes, due February 15, 2030</link:label>
    <link:label id="lab_cnc_A2000Million3375SeniorNotesDueFebruary2030Member_label_en-US" xlink:label="lab_cnc_A2000Million3375SeniorNotesDueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,000 Million 3.375% Senior Notes due February 2030 [Member]</link:label>
    <link:label id="lab_cnc_A2000Million3375SeniorNotesDueFebruary2030Member_documentation_en-US" xlink:label="lab_cnc_A2000Million3375SeniorNotesDueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,000 Million 3.375% Senior Notes due February 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2000Million3375SeniorNotesDueFebruary2030Member" xlink:href="cnc-20221231.xsd#cnc_A2000Million3375SeniorNotesDueFebruary2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_A2000Million3375SeniorNotesDueFebruary2030Member" xlink:to="lab_cnc_A2000Million3375SeniorNotesDueFebruary2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_372011e3-16de-44b4-97a9-bd16f6dad2a5_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal_19b5867b-a8f4-4b36-9579-97d4f9dc932b_terseLabel_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt assumed, aggregate principal</link:label>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal_label_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-term Debt, Principal</link:label>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal_documentation_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-term Debt, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal" xlink:to="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_561bc81a-5c71-437b-a5b9-bc1ffc8aca2a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_FixedAssetsLeasedRealEstateMember_68cbf324-3dbc-418d-b5ac-24d1cb2f0887_terseLabel_en-US" xlink:label="lab_cnc_FixedAssetsLeasedRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets, leased real estate</link:label>
    <link:label id="lab_cnc_FixedAssetsLeasedRealEstateMember_label_en-US" xlink:label="lab_cnc_FixedAssetsLeasedRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Assets, Leased Real Estate [Member]</link:label>
    <link:label id="lab_cnc_FixedAssetsLeasedRealEstateMember_documentation_en-US" xlink:label="lab_cnc_FixedAssetsLeasedRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Assets, Leased Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FixedAssetsLeasedRealEstateMember" xlink:href="cnc-20221231.xsd#cnc_FixedAssetsLeasedRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_FixedAssetsLeasedRealEstateMember" xlink:to="lab_cnc_FixedAssetsLeasedRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_0fcbeb4c-046c-4bf2-97ae-a8bc9b01a8e1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized gain (loss) on investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_741b458f-5d36-4255-9b40-02c0327009f3_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_db7cf899-775a-4410-b9b1-241f7863e2f3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_15b0c5d9-060b-4d30-b108-38ebbbb27453_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_2c19f3a3-d41f-45b6-9e32-db8c8af0ff1c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_f9437504-bd54-41a4-8287-64be75832259_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_3c24f213-78c5-448f-9ec9-23bc077f207d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_a96a3ca1-4a64-4fe4-b3a9-7a39506e4458_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_749ac1ca-ea95-4726-a8c3-53657beea318_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) on divestitures</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_7f9915ca-160e-4e00-b66e-1431bbb68b04_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on divestiture</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_c88e92e9-a29a-48cb-9b0e-f2fc9cb3f767_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MunicipalBondsMember_f95a8d2d-d1b8-42b2-9577-958d13f0f78b_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal securities</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_4273a4f6-7724-40c8-967e-afca4155a3b5_verboseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal securities</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_label_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalBondsMember" xlink:to="lab_us-gaap_MunicipalBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_f311362e-600c-4715-975c-2e7d1f516bf3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_ff06a3da-903d-4624-9682-7e65cb68beca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized gain (loss) on investments, tax effect</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_b667a9ef-3c04-4419-a429-87d5aa2356a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_e97e7ef0-b73f-4cde-b36c-cf948bf49728_terseLabel_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6bb57b0c-e5b0-4d58-b9ed-bfee65eca3e3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_b70e9d0f-318b-4d55-b7f5-d836425bb387_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_1a6bb8c4-0dd8-4e98-9bc8-0310a006c4b9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_78af37ff-a143-42c5-a28a-925307f14871_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f4e6bcfd-649a-47c9-acea-d6ed41a12564_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_b048816c-83e2-4997-8ec9-10dffe264466_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt redemption amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance_f8e6fdbd-21d8-46e0-bdfa-ee99f06dd816_negatedLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs of uncollectible receivables</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance" xlink:to="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_ae4dd558-ce32-4909-abe9-1b2a0709ccc8_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance contracts, number of reported claims</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Cumulative Number of Reported Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_6ddc56ce-ccae-47a0-9a1c-d6e6707966d6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit, Noncurrent</link:label>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_label_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLineOfCredit" xlink:to="lab_us-gaap_LongTermLineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_2a6c94d5-5ce4-49cd-836c-b6b1737deb5b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration insurance contracts, incurred claims and allocated claim adjustment expense, net</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsAndOtherReceivablesNet_36c3cecc-1934-4aea-a10e-92431053156d_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsAndOtherReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium and trade receivables</link:label>
    <link:label id="lab_us-gaap_PremiumsAndOtherReceivablesNet_label_en-US" xlink:label="lab_us-gaap_PremiumsAndOtherReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums and Other Receivables, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsAndOtherReceivablesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsAndOtherReceivablesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsAndOtherReceivablesNet" xlink:to="lab_us-gaap_PremiumsAndOtherReceivablesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_eb153c08-0a0e-4085-89bc-f73ff8d956cb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_066d2981-85cc-4967-8848-95f9c9827b3b_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_c27ae3a9-278b-4fc2-bbb9-5af7aae3585b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest_9506421e-8015-42e7-8df1-767b402000d2_terseLabel_en-US" xlink:label="lab_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings less noncontrolling interest before income tax expense</link:label>
    <link:label id="lab_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest_label_en-US" xlink:label="lab_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Less Noncontrolling Interest</link:label>
    <link:label id="lab_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest_documentation_en-US" xlink:label="lab_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Less Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest" xlink:href="cnc-20221231.xsd#cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest" xlink:to="lab_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_733dc39b-7f84-449e-891a-0672298f8ec6_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fdee15cb-51f6-44b2-92e1-d9b06d966cfc_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cc56fe55-a08b-471d-a06f-08004c982232_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b010b57d-545b-4c53-b047-5300612b5ee0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_2a848248-6cb1-42d1-b10b-548a320cc483_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_OtherCommitmentTerm_05711255-d6f4-4ad8-8814-9222b0152cb6_terseLabel_en-US" xlink:label="lab_cnc_OtherCommitmentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment to undertaking, term</link:label>
    <link:label id="lab_cnc_OtherCommitmentTerm_label_en-US" xlink:label="lab_cnc_OtherCommitmentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment, Term</link:label>
    <link:label id="lab_cnc_OtherCommitmentTerm_documentation_en-US" xlink:label="lab_cnc_OtherCommitmentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentTerm" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_OtherCommitmentTerm" xlink:to="lab_cnc_OtherCommitmentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f033632e-5681-44af-a680-2af5331be817_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_eb90e166-a750-4eaf-9f6d-6d958659818d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_ce0a844e-a3fb-41f1-971d-785b3a9e9ed4_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_8873b91f-0f1d-401e-a3c9-4d4dbabe422c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2a381247-2f71-46be-9bc0-b74005263778_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6635636c-0760-41bf-83a9-51436ae9749b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74296a16-985a-459b-a7b5-54610c14fb46_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_402bd1f9-78e8-478a-8c99-95108701147a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_217b9658-6d6a-49d0-b5fb-323f59d4b9a3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_089a972a-490b-4594-a791-609f4e8deed7_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_9597f4fd-e2b9-4de2-b8a4-7f68bbb7ca15_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_44c2f4fb-3b97-446c-b7ac-29a295bc0d9e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_eca8a858-c703-4274-8274-a3cc94eaba8f_negatedLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ace66050-b4ed-4f83-b61b-77bcee5d978c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_53c96ffd-b7ad-4f03-8df6-3dc919575e68_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_b65eb64d-6008-4cb2-9f5f-d89cae59f5ef_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b967e23b-7162-473b-b508-a8916d56ea1a_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_b5ce378b-f7b5-4ec0-8107-d9655b82207a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration insurance contracts, cumulative paid claims and allocated claim adjustment expense, net</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_c5cb5048-2c87-4f7d-94de-979280be9ba2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_8d759b8d-d204-4986-96bb-148b5994886c_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of total debt tied to variable rates</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b3a67d1e-2113-46de-a923-45437719a583_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_b5e0340c-2ff6-458b-9560-ba9442b9e921_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_237a1ed6-33af-459f-8d55-f14b5b634c17_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate of outstanding borrowings</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_a719c873-301b-41cb-998c-c6b9788146f8_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_70e65fd3-4b73-499f-b385-9ebe209b9cc0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per common share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5568feba-9d3d-4b24-89c2-f1524eeee28d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of restricted stock and restricted stock units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_4b29798c-715d-4b75-897b-e5ed4d3342ab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceDisclosureTextBlock_1813bda6-f80a-4b7d-900d-e3fbc598a300_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Claims Liability</link:label>
    <link:label id="lab_us-gaap_InsuranceDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InsuranceDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceDisclosureTextBlock" xlink:to="lab_us-gaap_InsuranceDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_ee218651-d1a8-43a1-944f-0fe6168fa317_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_A2300Million245SeniorNotesDueJuly2028Member_d294b671-f1e7-474a-9e9f-2d4ac62960af_terseLabel_en-US" xlink:label="lab_cnc_A2300Million245SeniorNotesDueJuly2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,300 Million 2.45% Senior Notes due July 2028 [Member]</link:label>
    <link:label id="lab_cnc_A2300Million245SeniorNotesDueJuly2028Member_label_en-US" xlink:label="lab_cnc_A2300Million245SeniorNotesDueJuly2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,300 Million 2.45% Senior Notes due July 2028 [Member]</link:label>
    <link:label id="lab_cnc_A2300Million245SeniorNotesDueJuly2028Member_documentation_en-US" xlink:label="lab_cnc_A2300Million245SeniorNotesDueJuly2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,300 Million 2.45% Senior Notes due July 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2300Million245SeniorNotesDueJuly2028Member" xlink:href="cnc-20221231.xsd#cnc_A2300Million245SeniorNotesDueJuly2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_A2300Million245SeniorNotesDueJuly2028Member" xlink:to="lab_cnc_A2300Million245SeniorNotesDueJuly2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DebtRepurchaseProgramAuthorizedAmount_97795b5a-5b63-476a-a1b7-5f3c11f57738_terseLabel_en-US" xlink:label="lab_cnc_DebtRepurchaseProgramAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_cnc_DebtRepurchaseProgramAuthorizedAmount_label_en-US" xlink:label="lab_cnc_DebtRepurchaseProgramAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_cnc_DebtRepurchaseProgramAuthorizedAmount_documentation_en-US" xlink:label="lab_cnc_DebtRepurchaseProgramAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtRepurchaseProgramAuthorizedAmount" xlink:href="cnc-20221231.xsd#cnc_DebtRepurchaseProgramAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DebtRepurchaseProgramAuthorizedAmount" xlink:to="lab_cnc_DebtRepurchaseProgramAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_25cc0231-97bb-4c57-af86-f348f442abc1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_dc0d0609-f818-47b4-93b5-ec7a8da2e213_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_dc155ae6-028d-47cd-8e17-b1b721474d6f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_da5a4b85-4c22-4d56-b4de-1a01727f7356_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_1ab29798-1372-4fd0-a16e-8515ff9334a9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest income</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableforsaleSecuritiesMember_3d6b4684-7254-4fbc-a154-4f3be3753b82_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_AvailableforsaleSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-Sale Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableforsaleSecuritiesMember" xlink:to="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_a6bccbc8-76a0-42e8-b160-28ccf4e4ac07_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_cfd08888-610d-46cc-a155-55f1e0e76cbd_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_55993fd9-1725-4420-add3-cebf5a3defa3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued for employee benefit plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_afda6121-d38f-4d1a-b1a8-06144ac64b1a_negatedNetLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_a38c0ced-ea08-40e0-a28e-e00392d5a198_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_1a648aef-2ba5-4f74-a0aa-cbd8304f0f4e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_83b807fb-988b-42d5-8064-c372b3d173ee_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_2b40feac-0f5a-4168-998a-12d229d07593_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_dfaa6bc9-86ee-4cbb-ab22-2d39522ae03a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumReceivableCreditLossExpenseReversal_5cf18dd5-352b-46c1-9577-3d9dd29f1b88_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumReceivableCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts charged to expense</link:label>
    <link:label id="lab_us-gaap_PremiumReceivableCreditLossExpenseReversal_label_en-US" xlink:label="lab_us-gaap_PremiumReceivableCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumReceivableCreditLossExpenseReversal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumReceivableCreditLossExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumReceivableCreditLossExpenseReversal" xlink:to="lab_us-gaap_PremiumReceivableCreditLossExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_6ed69cf6-0f77-4139-bfc6-2629be8e477b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reallocation</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5bd47519-a63d-4453-89dd-ac3279ac5d3e_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_f10bd6c2-e71a-4221-8a6b-b13fd69abfee_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_74e76efd-5550-4f15-951d-f489d49d0583_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net interest expense related to uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0bfc7170-8257-4184-be2c-5cc7f79c0c3f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_c63f42cc-a2f7-48cc-9852-40801397b06c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExternalCreditRatingByGroupingAxis_0d218470-320c-48b2-80ef-387f98d58317_terseLabel_en-US" xlink:label="lab_us-gaap_ExternalCreditRatingByGroupingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating by Grouping [Axis]</link:label>
    <link:label id="lab_us-gaap_ExternalCreditRatingByGroupingAxis_label_en-US" xlink:label="lab_us-gaap_ExternalCreditRatingByGroupingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating by Grouping [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingByGroupingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingByGroupingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExternalCreditRatingByGroupingAxis" xlink:to="lab_us-gaap_ExternalCreditRatingByGroupingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e38e6f21-66b9-418f-ad49-4fe269dc1ab2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease_78f23236-a578-4be8-8450-21ccae76620a_terseLabel_en-US" xlink:label="lab_cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk adjustment, net receivable increase</link:label>
    <link:label id="lab_cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease_label_en-US" xlink:label="lab_cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Risk Adjustment, Net Receivable Increase (Decrease)</link:label>
    <link:label id="lab_cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease_documentation_en-US" xlink:label="lab_cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Risk Adjustment, Net Receivable Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease" xlink:to="lab_cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ae7ebc29-bc3d-4c26-8439-691096bf1523_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less Than 12 Months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_cf94f5da-be9e-47fb-9637-52c2af56332c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fae0eccf-7471-4321-91e9-434e0e14b667_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f087a737-c23c-4d4a-be4a-27b80323e747_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration on divestiture</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_a0cfaf9f-f33b-4d64-b4b9-8cb165693a6e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_277000f1-2dfb-4bae-812b-c3493ce6c2b9_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheets</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodAxis_112fa629-cf05-4e0e-9a22-16fdd8b8973a_terseLabel_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Payment Period [Axis]</link:label>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodAxis_label_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Payment Period [Axis]</link:label>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodAxis_documentation_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodAxis" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DebtInstrumentPaymentPeriodAxis" xlink:to="lab_cnc_DebtInstrumentPaymentPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_545ffafc-7897-40f0-83db-24645235a5fb_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_fc4d0688-ffac-4d56-bee5-bcf32c8e5fa0_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current provision</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_f500553d-0b3b-4953-8823-ca91ce7af16c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_bdeb0cd5-c530-4719-9f65-1d9314e17a03_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of swap agreement</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_1e610663-3279-4882-b8a6-f213029f623b_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0abb3105-b6fe-41b7-9a77-254cae36758b_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation accruals</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_4c1ff17e-bab5-4ac1-a8e6-2004d9c2a8b8_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_5687f978-2b38-46e4-8cd5-33633a0b1f67_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_09dc62c9-4ebb-4241-aac6-0ec7941f9fad_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b9803f5b-9e0b-4292-be97-f667d68ee6be_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in subsidiaries</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AffordableCareActDisclosureTextBlock_3ccaf41c-2bec-4a23-84ad-303fc3731544_terseLabel_en-US" xlink:label="lab_cnc_AffordableCareActDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act</link:label>
    <link:label id="lab_cnc_AffordableCareActDisclosureTextBlock_label_en-US" xlink:label="lab_cnc_AffordableCareActDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act Disclosure [Text Block]</link:label>
    <link:label id="lab_cnc_AffordableCareActDisclosureTextBlock_documentation_en-US" xlink:label="lab_cnc_AffordableCareActDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActDisclosureTextBlock" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AffordableCareActDisclosureTextBlock" xlink:to="lab_cnc_AffordableCareActDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_7cc6352e-debf-4a86-9fca-2c7540c9724e_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_aebbed6b-c9c8-440c-87cf-206098ca3905_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_90cf01cc-8824-4e76-885c-f5757c2cb9b9_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_a8d876c8-5467-4ff3-844d-298cce3fcd69_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_8b1b6837-39ad-4cec-a76b-c2baea6e569b_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_92107832-8ee8-48c4-a0eb-87e74f9d1c2e_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_75befbfd-0a84-4398-a296-272723ee05d7_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_7180efdb-fd63-4608-99e8-7525e694d830_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_232ea65c-7f15-4121-8807-40d605e4e9eb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_78743173-b5d2-4d61-93e9-424ab32f9d03_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution from noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Subsidiary Equity Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_SeniorNotesTotal_6903e1fe-a9f8-4545-af4f-185749fdad2b_terseLabel_en-US" xlink:label="lab_cnc_SeniorNotesTotal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total senior notes</link:label>
    <link:label id="lab_cnc_SeniorNotesTotal_label_en-US" xlink:label="lab_cnc_SeniorNotesTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Total</link:label>
    <link:label id="lab_cnc_SeniorNotesTotal_documentation_en-US" xlink:label="lab_cnc_SeniorNotesTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SeniorNotesTotal" xlink:href="cnc-20221231.xsd#cnc_SeniorNotesTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_SeniorNotesTotal" xlink:to="lab_cnc_SeniorNotesTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0b188501-232c-4f00-8cac-48d1fa56d1ff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a67f025d-54e5-460e-ac7d-c49dec85ac91_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3026671b-e5e1-4248-8712-fe08d84359cb_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_6397a7c0-3462-43eb-ab9e-a0228af1a33c_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_bd2d5969-55a3-4429-9ddd-362f5e65d922_negatedNetLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_dc58dece-eab9-450f-91e2-26dd08bfde82_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestrictedAssetsNoncurrent_d0078e60-6b1e-4074-bbfc-6166b1015b36_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestrictedAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted deposits</link:label>
    <link:label id="lab_us-gaap_OtherRestrictedAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherRestrictedAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restricted Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestrictedAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestrictedAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestrictedAssetsNoncurrent" xlink:to="lab_us-gaap_OtherRestrictedAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_34884e6f-8b99-4ddc-8966-47453c3929af_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_RatedSecuritiesMember_fb004538-d7b2-45ae-9ad3-e28ea84aea97_terseLabel_en-US" xlink:label="lab_cnc_RatedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rated Securities</link:label>
    <link:label id="lab_cnc_RatedSecuritiesMember_label_en-US" xlink:label="lab_cnc_RatedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rated Securities [Member]</link:label>
    <link:label id="lab_cnc_RatedSecuritiesMember_documentation_en-US" xlink:label="lab_cnc_RatedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rated Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RatedSecuritiesMember" xlink:href="cnc-20221231.xsd#cnc_RatedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_RatedSecuritiesMember" xlink:to="lab_cnc_RatedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_d05845c5-8502-482c-b6d6-d47ad6ce0396_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses and Interest in Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_1bb7ec69-27ae-4cef-a7ba-1c1210af47d6_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember_3725fa06-64bb-4b63-b055-4a7919fa5dab_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider contracts</link:label>
    <link:label id="lab_us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember_label_en-US" xlink:label="lab_us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Contracts Acquired in Business Combination [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember" xlink:to="lab_us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodDomain_96bf6acc-c106-40fd-9b15-84bda9985e2b_terseLabel_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Payment Period [Domain]</link:label>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodDomain_label_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Payment Period [Domain]</link:label>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodDomain_documentation_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Payment Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodDomain" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DebtInstrumentPaymentPeriodDomain" xlink:to="lab_cnc_DebtInstrumentPaymentPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b3e043c1-edb0-4c4e-8c7e-e229dbcf8c4c_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_4a612770-ab80-4c68-8693-79bd93478df5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember_dfe7c7f8-d561-4a5f-92e8-73db102d5538_terseLabel_en-US" xlink:label="lab_cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) And Sterling Overnight Index Average (SONIA)</link:label>
    <link:label id="lab_cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember_label_en-US" xlink:label="lab_cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) And Sterling Overnight Index Average (SONIA) [Member]</link:label>
    <link:label id="lab_cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember_documentation_en-US" xlink:label="lab_cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) And Sterling Overnight Index Average (SONIA)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember" xlink:href="cnc-20221231.xsd#cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember" xlink:to="lab_cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_a3b902f8-e776-4400-8125-222988fd4684_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_97c19916-46e5-44d3-ae3a-bce4d88c0bba_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity issued in connection with acquisitions</link:label>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_label_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Significant Noncash Transaction, Value of Consideration Given</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:to="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_c1abb201-2c40-47d4-b28a-fab8d546750f_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_a3779089-ed02-4530-a1e1-e61c2b8a9b7d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December&#160;31, 2022, and 602,704 issued and 582,479 outstanding at December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_02883b7d-f3c6-4336-9f73-4a9d6ccb81f2_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December&#160;31, 2022, and 602,704 issued and 582,479 outstanding at December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod_4ea96a85-3c86-4d01-9b42-5f49df7ad740_terseLabel_en-US" xlink:label="lab_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated vesting period</link:label>
    <link:label id="lab_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod_label_en-US" xlink:label="lab_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Accelerated Vesting Period</link:label>
    <link:label id="lab_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod_documentation_en-US" xlink:label="lab_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Accelerated Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod" xlink:href="cnc-20221231.xsd#cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod" xlink:to="lab_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_b75e7100-9a7b-463e-85fc-39edfcf109c3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_8bb74f1a-eec4-45c1-9856-c44ab1c50d72_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_883162d7-574e-4baa-934c-179eaba860e6_verboseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_98ad863c-e406-4863-b505-a037c0057967_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue_9c87ffed-091f-4bf9-8931-7cc2482499c6_totalLabel_en-US" xlink:label="lab_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Fair Value</link:label>
    <link:label id="lab_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue_label_en-US" xlink:label="lab_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt Securities, Equity Securities And Other, Fair Value</link:label>
    <link:label id="lab_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue_documentation_en-US" xlink:label="lab_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt Securities, Equity Securities And Other, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue" xlink:href="cnc-20221231.xsd#cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue" xlink:to="lab_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitment_1226cb0a-f583-4cd2-ae51-73040c1146b5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment to undertaking</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_label_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_6c6f7080-3450-482c-85bd-d37822a94b9e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration_9dfa926a-3cff-43f9-b9c7-9996c1821da4_terseLabel_en-US" xlink:label="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards and tax credit carryforwards, subject to expiration</link:label>
    <link:label id="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards, Subject To Expiration</link:label>
    <link:label id="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration_documentation_en-US" xlink:label="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards, Subject To Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration" xlink:to="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_a7f8b87b-3e90-4ab4-b6b4-acbd68a9db84_verboseLabel_en-US" xlink:label="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss and tax credit carryforwards</link:label>
    <link:label id="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_label_en-US" xlink:label="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards</link:label>
    <link:label id="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_documentation_en-US" xlink:label="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:to="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_af0d02bc-c513-4064-a08c-c3c45513ff58_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a8c27fed-8807-422c-a33b-d599356d8734_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f3df1ad1-005e-4a93-9b73-b3a8247c1186_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents, and restricted cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredOtherTaxExpenseBenefit_2576c3ee-8ea2-44e6-bbf1-4a297a59b5b4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred provision</link:label>
    <link:label id="lab_us-gaap_DeferredOtherTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Other Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOtherTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_39b325fd-dbae-4847-a922-d6c2fe6f70db_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_506597eb-ab76-456b-8957-8ec8dc58a729_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_64708f80-09ed-4a76-a988-4d3af50dfa8e_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired_9b94d43e-b0f8-4cdf-9c65-952c05bbfa1e_verboseLabel_en-US" xlink:label="lab_cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired reserves</link:label>
    <link:label id="lab_cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired_label_en-US" xlink:label="lab_cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Reserves Acquired</link:label>
    <link:label id="lab_cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired_documentation_en-US" xlink:label="lab_cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Reserves Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired" xlink:href="cnc-20221231.xsd#cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired" xlink:to="lab_cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_e0437e3d-0385-4ee2-9ad0-55da5fbd0535_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Positions from which gross unrealized losses were generated</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_0054bba4-7f81-4006-b4c3-3b1b5f1086fa_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1ee46dbc-5298-4502-81d5-ba59e8ffa513_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e51c9634-23d4-49e4-9c60-4c3511262128_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average life in years</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4c0d8864-5fc2-4113-adce-1a15a07ae6b8_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_512af260-c986-4ab0-9aa3-e6d8f7f35488_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) earnings, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_b018a5d6-67af-49fd-89e7-a870e27ee0fd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of pre-existing payables and receivables prior to acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss_c504340e-ce95-484a-9cf1-e23b8ae0189c_terseLabel_en-US" xlink:label="lab_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss</link:label>
    <link:label id="lab_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss_label_en-US" xlink:label="lab_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Investment, Unrealized Gain/Loss</link:label>
    <link:label id="lab_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss_documentation_en-US" xlink:label="lab_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Investment, Unrealized Gain/Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss" xlink:to="lab_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_06dd06d4-8e7d-4d4c-98c2-4468e798d1ff_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and purchase accounting adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_31d843c9-1bb2-4ec4-ade6-1dc795f9127e_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cd6d66be-2141-43e0-aa62-daa44d3deaed_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d6027465-ab91-4345-b4a2-044b5d0a6a9c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fc62492b-50a2-4ef0-9e45-95465ab2a61e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_b2eccd80-5248-4b56-a6d0-a13f877c017c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_9c0eef0a-e2b3-418e-9baf-c15ba3ea973d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_cc1af1f9-af56-403a-baee-ecfcf18cdf7b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_22606dad-2f4b-40b7-815e-bdbddd993022_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid related to:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_9332b87f-805c-4890-acf8-6ea6f8b25772_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_4675f83f-e3e7-4276-a041-88cabeda7f70_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_39c5e488-33a8-44b0-b8a4-def82cf48db9_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther_fc88ec61-aefd-40fa-a0cc-fb29b1eecbe2_terseLabel_en-US" xlink:label="lab_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All outstanding liabilities prior to 2020, net of reinsurance</link:label>
    <link:label id="lab_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther_label_en-US" xlink:label="lab_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Other</link:label>
    <link:label id="lab_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther_documentation_en-US" xlink:label="lab_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther" xlink:href="cnc-20221231.xsd#cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther" xlink:to="lab_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_3ddcc876-f558-43d5-95b4-672d01753233_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement_2e52f0e7-bd3c-434a-b4ed-0a11c923c73a_verboseLabel_en-US" xlink:label="lab_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible PBM legal settlement</link:label>
    <link:label id="lab_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement_label_en-US" xlink:label="lab_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Litigation Settlement</link:label>
    <link:label id="lab_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement_documentation_en-US" xlink:label="lab_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement" xlink:href="cnc-20221231.xsd#cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement" xlink:to="lab_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_12b78f40-b5cf-4982-b9e4-1af3009dfb1f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical claims liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Health Care Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_OtherCommitmentExpense_9a5b46dd-4ba1-483b-8987-5931a5e6294b_terseLabel_en-US" xlink:label="lab_cnc_OtherCommitmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment to undertaking, expensed</link:label>
    <link:label id="lab_cnc_OtherCommitmentExpense_label_en-US" xlink:label="lab_cnc_OtherCommitmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment Expense</link:label>
    <link:label id="lab_cnc_OtherCommitmentExpense_documentation_en-US" xlink:label="lab_cnc_OtherCommitmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentExpense" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_OtherCommitmentExpense" xlink:to="lab_cnc_OtherCommitmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c459a400-0a84-436c-a34f-c53c458a6f04_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_ec0dd05d-d36a-4803-b31e-73c55365ef96_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0fe1ec36-a246-4f5b-a228-aa5f1979bda6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_36122b8a-e618-4dd4-b303-ad2049a939f8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities reduced by cash paid</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DeferredTaxLiabilitiesRightOfUseAssets_481d8c2f-759b-42ae-9424-a1d8d96a384a_verboseLabel_en-US" xlink:label="lab_cnc_DeferredTaxLiabilitiesRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_cnc_DeferredTaxLiabilitiesRightOfUseAssets_label_en-US" xlink:label="lab_cnc_DeferredTaxLiabilitiesRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Right Of Use Assets</link:label>
    <link:label id="lab_cnc_DeferredTaxLiabilitiesRightOfUseAssets_documentation_en-US" xlink:label="lab_cnc_DeferredTaxLiabilitiesRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxLiabilitiesRightOfUseAssets" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DeferredTaxLiabilitiesRightOfUseAssets" xlink:to="lab_cnc_DeferredTaxLiabilitiesRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_f1c52ec2-22d3-409b-9400-529744800fed_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments and repurchases of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_4c6a8c0d-df5a-410c-9a77-c11fbbfe4b8d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments and repurchases of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExternalCreditRatingByGroupingDomain_f9c2457a-4d6c-4d1e-9e89-c8aade60397b_terseLabel_en-US" xlink:label="lab_us-gaap_ExternalCreditRatingByGroupingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating by Grouping [Domain]</link:label>
    <link:label id="lab_us-gaap_ExternalCreditRatingByGroupingDomain_label_en-US" xlink:label="lab_us-gaap_ExternalCreditRatingByGroupingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating by Grouping [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingByGroupingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingByGroupingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExternalCreditRatingByGroupingDomain" xlink:to="lab_us-gaap_ExternalCreditRatingByGroupingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_91ab310f-c64c-4ec8-a499-537a8fa7cc7a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DeferredTaxAssetSoftwareDevelopmentCosts_82f17ef9-d2f1-498d-a789-2cb7498252ed_terseLabel_en-US" xlink:label="lab_cnc_DeferredTaxAssetSoftwareDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software development costs</link:label>
    <link:label id="lab_cnc_DeferredTaxAssetSoftwareDevelopmentCosts_label_en-US" xlink:label="lab_cnc_DeferredTaxAssetSoftwareDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Software Development Costs</link:label>
    <link:label id="lab_cnc_DeferredTaxAssetSoftwareDevelopmentCosts_documentation_en-US" xlink:label="lab_cnc_DeferredTaxAssetSoftwareDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Software Development Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetSoftwareDevelopmentCosts" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetSoftwareDevelopmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DeferredTaxAssetSoftwareDevelopmentCosts" xlink:to="lab_cnc_DeferredTaxAssetSoftwareDevelopmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_4830b918-66ac-410e-a6e7-8a9bd2ce8220_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost (57,093 and 20,225 shares, respectively)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_3191d298-34a5-46fe-88f7-46ef3421652d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost (57,093 and 20,225 shares, respectively)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_15b63547-cea1-4d08-b9cb-46cb319a5f26_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory capital and surplus</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus, Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_e9b94353-782f-4ef5-a4f5-e9382b2a8056_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9a903eac-797e-43ec-a7e4-8ce71e16d98a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_40ea65b4-8ab4-421b-8fd3-58470d11aa20_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram_afa98cdc-84a2-49a3-ab79-111792ac2414_terseLabel_en-US" xlink:label="lab_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of notional amount under ASR</link:label>
    <link:label id="lab_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram_label_en-US" xlink:label="lab_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value Acquired, Percentage Of Notional Amount Of Program</link:label>
    <link:label id="lab_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram_documentation_en-US" xlink:label="lab_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value Acquired, Percentage Of Notional Amount Of Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram" xlink:href="cnc-20221231.xsd#cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram" xlink:to="lab_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_67fb51a9-aea9-4b54-bb54-8126e1024ea2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets:</link:label>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsAbstract" xlink:to="lab_us-gaap_OtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_a84a652e-1595-4284-ad75-f8177904f073_terseLabel_en-US" xlink:label="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information of Registrant</link:label>
    <link:label id="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information of Parent Company Only Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:to="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_865cbe65-4799-4ad6-bf8f-0f83c230472f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation percentage</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_10cbf7e4-a11e-4130-89f3-2a7f4166ee72_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NY_ec14a566-1e2d-4fe6-b27f-5f98d732441b_terseLabel_en-US" xlink:label="lab_stpr_NY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK</link:label>
    <link:label id="lab_stpr_NY_label_en-US" xlink:label="lab_stpr_NY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NY" xlink:to="lab_stpr_NY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_c6768355-f323-4af6-8ccf-acb9d7a65659_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ac584acc-5d87-43ee-8f27-800bbbb33ce1_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_076ba99d-90e6-4224-ac7b-ac087b1c6b25_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_00a53611-61e7-4636-8272-2b756764bf53_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_843bf813-ab29-4e62-8709-05a9f7d3cfff_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_cdb05ee0-3b1e-4c1a-ab52-9296d00f764f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_e9bf2807-6496-43dc-a951-8e389894a993_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_fa8eb819-9ec0-43c0-9c06-3902d4d60a58_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_525bfc8d-0c14-42d4-b27e-669c71d63143_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_856ae726-6e49-4e33-aa38-f02e1292ac9d_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments_55c9dfc2-3db9-4b10-bb10-862df11210a7_terseLabel_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments_label_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Short-term Investments</link:label>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments_documentation_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments" xlink:to="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_SpecialtyServicesMember_97fcb023-c661-400b-8822-96b7869414d3_terseLabel_en-US" xlink:label="lab_cnc_SpecialtyServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Services</link:label>
    <link:label id="lab_cnc_SpecialtyServicesMember_label_en-US" xlink:label="lab_cnc_SpecialtyServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Services [Member]</link:label>
    <link:label id="lab_cnc_SpecialtyServicesMember_documentation_en-US" xlink:label="lab_cnc_SpecialtyServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SpecialtyServicesMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SpecialtyServicesMember" xlink:href="cnc-20221231.xsd#cnc_SpecialtyServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_SpecialtyServicesMember" xlink:to="lab_cnc_SpecialtyServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_8e25d11b-bea9-410e-a724-9ca42a6413dc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_CapitalContributionsToSubsidiaries_e2c65258-b7e8-45f7-8e25-d33c650bca05_negatedTerseLabel_en-US" xlink:label="lab_cnc_CapitalContributionsToSubsidiaries" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contributions to subsidiaries</link:label>
    <link:label id="lab_cnc_CapitalContributionsToSubsidiaries_label_en-US" xlink:label="lab_cnc_CapitalContributionsToSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Contributions to Subsidiaries</link:label>
    <link:label id="lab_cnc_CapitalContributionsToSubsidiaries_documentation_en-US" xlink:label="lab_cnc_CapitalContributionsToSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Contributions to Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_CapitalContributionsToSubsidiaries" xlink:href="cnc-20221231.xsd#cnc_CapitalContributionsToSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_CapitalContributionsToSubsidiaries" xlink:to="lab_cnc_CapitalContributionsToSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_c70debf1-65e9-4d78-b712-cded2a2f54ee_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ProviderContractsMember_63cbee29-d85d-4053-8433-eed57d48eddb_terseLabel_en-US" xlink:label="lab_cnc_ProviderContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider contracts</link:label>
    <link:label id="lab_cnc_ProviderContractsMember_label_en-US" xlink:label="lab_cnc_ProviderContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Contracts [Member]</link:label>
    <link:label id="lab_cnc_ProviderContractsMember_documentation_en-US" xlink:label="lab_cnc_ProviderContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ProviderContractsMember" xlink:href="cnc-20221231.xsd#cnc_ProviderContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ProviderContractsMember" xlink:to="lab_cnc_ProviderContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock_b44df38f-ff3f-41cb-b660-cb2e703c982c_terseLabel_en-US" xlink:label="lab_cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term and long-term investments and restricted deposits by investment type</link:label>
    <link:label id="lab_cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock_label_en-US" xlink:label="lab_cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term And Long Term Investments And Restricted Deposits By Investment Type [Table Text Block]</link:label>
    <link:label id="lab_cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock_documentation_en-US" xlink:label="lab_cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term and long-term investments and restricted deposits by investment type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock" xlink:href="cnc-20221231.xsd#cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock" xlink:to="lab_cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0884f0fb-2424-40cd-b228-495d9d782c47_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AcceleratedShareRepurchasesAgreementAmount_1f8d39c1-41ae-4b9f-8f5d-076990c21ad8_terseLabel_en-US" xlink:label="lab_cnc_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases agreement, amount</link:label>
    <link:label id="lab_cnc_AcceleratedShareRepurchasesAgreementAmount_label_en-US" xlink:label="lab_cnc_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases Agreement, Amount</link:label>
    <link:label id="lab_cnc_AcceleratedShareRepurchasesAgreementAmount_documentation_en-US" xlink:label="lab_cnc_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases Agreement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AcceleratedShareRepurchasesAgreementAmount" xlink:href="cnc-20221231.xsd#cnc_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AcceleratedShareRepurchasesAgreementAmount" xlink:to="lab_cnc_AcceleratedShareRepurchasesAgreementAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_17673fe5-152b-42db-aa16-c1b8be0850b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_fe515636-b22a-4074-8e82-e3f2533bb203_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less Than 12 Months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_a7635c05-fbcb-493b-b687-283a54082372_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_A2200Million250SeniorNotesDueMarch2031Member_6cdf304d-e114-4478-a4fc-6b23b29cece4_terseLabel_en-US" xlink:label="lab_cnc_A2200Million250SeniorNotesDueMarch2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,200 Million 2.50% Senior Notes due March 2031 [Member]</link:label>
    <link:label id="lab_cnc_A2200Million250SeniorNotesDueMarch2031Member_label_en-US" xlink:label="lab_cnc_A2200Million250SeniorNotesDueMarch2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,200 Million 2.50% Senior Notes due March 2031 [Member]</link:label>
    <link:label id="lab_cnc_A2200Million250SeniorNotesDueMarch2031Member_documentation_en-US" xlink:label="lab_cnc_A2200Million250SeniorNotesDueMarch2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,200 Million 2.50% Senior Notes due March 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2200Million250SeniorNotesDueMarch2031Member" xlink:href="cnc-20221231.xsd#cnc_A2200Million250SeniorNotesDueMarch2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_A2200Million250SeniorNotesDueMarch2031Member" xlink:to="lab_cnc_A2200Million250SeniorNotesDueMarch2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_b1d3604c-bdd4-4eb1-b2e2-e09ea608cfc0_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">12 Months or More</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_8b7e983c-39d1-498b-84fe-0584b4b80159_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ddf16bc5-b0cf-4dc3-a3ce-6f95e008b460_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_07940b8e-09cd-4392-a2e3-05480267077f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_e312f1a0-f285-4807-96af-8563d7d39290_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_1f92778f-b959-4f6f-b192-34cdb7122baf_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased contract rights</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_8c6ecdc4-0bc6-4f4a-9c56-03b14736327e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettlementWithTaxingAuthorityMember_ce8dfd7d-1dd2-4396-b3a7-bd1b45b57686_terseLabel_en-US" xlink:label="lab_us-gaap_SettlementWithTaxingAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration of Statues of Limitations and Projected Settlements</link:label>
    <link:label id="lab_us-gaap_SettlementWithTaxingAuthorityMember_label_en-US" xlink:label="lab_us-gaap_SettlementWithTaxingAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement with Taxing Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettlementWithTaxingAuthorityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettlementWithTaxingAuthorityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettlementWithTaxingAuthorityMember" xlink:to="lab_us-gaap_SettlementWithTaxingAuthorityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_RealEstateOwnedAndRelatedFixedAssetsMember_c4dd05c3-79a7-45d4-9e71-31e03c87fd03_terseLabel_en-US" xlink:label="lab_cnc_RealEstateOwnedAndRelatedFixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate owned and related fixed assets</link:label>
    <link:label id="lab_cnc_RealEstateOwnedAndRelatedFixedAssetsMember_label_en-US" xlink:label="lab_cnc_RealEstateOwnedAndRelatedFixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Owned and Related Fixed Assets [Member]</link:label>
    <link:label id="lab_cnc_RealEstateOwnedAndRelatedFixedAssetsMember_documentation_en-US" xlink:label="lab_cnc_RealEstateOwnedAndRelatedFixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Owned and Related Fixed Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RealEstateOwnedAndRelatedFixedAssetsMember" xlink:href="cnc-20221231.xsd#cnc_RealEstateOwnedAndRelatedFixedAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_RealEstateOwnedAndRelatedFixedAssetsMember" xlink:to="lab_cnc_RealEstateOwnedAndRelatedFixedAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_52709feb-b21c-4bdf-a9ae-79748c38d22f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from common stock issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c1be396e-31e7-41a4-a287-758a82a183ad_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3de49c2f-8a43-4dca-a37a-5ee62e60b191_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f66ef0b8-c906-4e76-960a-688b19c48e16_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DividendsfromSubsidiariesOperatingActivities_3ebdea57-09c6-4c44-8723-2bf1d51e58b0_verboseLabel_en-US" xlink:label="lab_cnc_DividendsfromSubsidiariesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends from subsidiaries, return on investment</link:label>
    <link:label id="lab_cnc_DividendsfromSubsidiariesOperatingActivities_label_en-US" xlink:label="lab_cnc_DividendsfromSubsidiariesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends from Subsidiaries, Operating Activities</link:label>
    <link:label id="lab_cnc_DividendsfromSubsidiariesOperatingActivities_documentation_en-US" xlink:label="lab_cnc_DividendsfromSubsidiariesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends from Subsidiaries, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DividendsfromSubsidiariesOperatingActivities" xlink:href="cnc-20221231.xsd#cnc_DividendsfromSubsidiariesOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DividendsfromSubsidiariesOperatingActivities" xlink:to="lab_cnc_DividendsfromSubsidiariesOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_b52837bd-e7ed-4bad-b41d-72f4fa013836_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_OtherCommitmentsPaid_f997d5d7-69f8-431c-ae4b-c91845b3f8ea_terseLabel_en-US" xlink:label="lab_cnc_OtherCommitmentsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments paid</link:label>
    <link:label id="lab_cnc_OtherCommitmentsPaid_label_en-US" xlink:label="lab_cnc_OtherCommitmentsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments, Paid</link:label>
    <link:label id="lab_cnc_OtherCommitmentsPaid_documentation_en-US" xlink:label="lab_cnc_OtherCommitmentsPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments, Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentsPaid" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_OtherCommitmentsPaid" xlink:to="lab_cnc_OtherCommitmentsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_faacc4a9-d0ea-4870-b95c-46eecdf28de1_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_802c5020-3279-44fa-bcc1-4f1bff1049b6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December&#160;31, 2022 and December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_d501cca9-c4b2-406d-a2bf-c89563025204_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December&#160;31, 2022 and December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e6dd3306-7757-481b-94e1-796e28f28649_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability_95af24b6-5b95-4755-bb79-9d3595328a92_terseLabel_en-US" xlink:label="lab_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease not yet commenced, liability</link:label>
    <link:label id="lab_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability_label_en-US" xlink:label="lab_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability</link:label>
    <link:label id="lab_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability_documentation_en-US" xlink:label="lab_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:href="cnc-20221231.xsd#cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:to="lab_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_af0fce68-bcb8-4793-bb4f-3063df3d0386_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_f12a916b-43ad-4e90-bb82-eb66b7cc3812_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_3a4028b2-3e2f-4b63-8b85-41c18111b136_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_9dcecbb6-144c-47cf-b8cd-714b152fe4fb_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_FederalServicesMember_c21ac92d-8159-4948-878c-2fcc4313c710_terseLabel_en-US" xlink:label="lab_cnc_FederalServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Services</link:label>
    <link:label id="lab_cnc_FederalServicesMember_label_en-US" xlink:label="lab_cnc_FederalServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Services [Member]</link:label>
    <link:label id="lab_cnc_FederalServicesMember_documentation_en-US" xlink:label="lab_cnc_FederalServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FederalServicesMember" xlink:href="cnc-20221231.xsd#cnc_FederalServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_FederalServicesMember" xlink:to="lab_cnc_FederalServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnRepurchaseOfDebtInstrument_93600368-642d-4368-b991-828689a82daf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnRepurchaseOfDebtInstrument" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on redemption of notes</link:label>
    <link:label id="lab_us-gaap_GainLossOnRepurchaseOfDebtInstrument_label_en-US" xlink:label="lab_us-gaap_GainLossOnRepurchaseOfDebtInstrument" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Repurchase of Debt Instrument</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnRepurchaseOfDebtInstrument" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnRepurchaseOfDebtInstrument"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnRepurchaseOfDebtInstrument" xlink:to="lab_us-gaap_GainLossOnRepurchaseOfDebtInstrument" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_009a6998-e622-48aa-90f3-4e64913e0e88_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_7b003b57-c0c1-4004-887d-ddc2058f2e05_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_f1253e07-1097-4e8c-b176-e56a8614ee6f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level III</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4c32cb76-10b6-435b-b0d1-6e23624cb0bb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0c86bab4-db3d-4c3f-afad-428c564e4961_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_aa3e56b9-a9b1-4dca-85e0-714cc748bb80_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_37aa9a04-8e5c-4dc4-8914-b1eed3b9fdbf_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_e1f11a3c-8728-4eb1-80c3-3776f5de71f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Effects Of Temporary Differences Which Give Rise To Deferred Tax Assets And Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AcceleratedShareRepurchasesDiscountPricePerShare_704c2b4b-333a-4c80-b7dd-7110e1f756d3_terseLabel_en-US" xlink:label="lab_cnc_AcceleratedShareRepurchasesDiscountPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR, discount (in usd per share)</link:label>
    <link:label id="lab_cnc_AcceleratedShareRepurchasesDiscountPricePerShare_label_en-US" xlink:label="lab_cnc_AcceleratedShareRepurchasesDiscountPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Discount, Price Per Share</link:label>
    <link:label id="lab_cnc_AcceleratedShareRepurchasesDiscountPricePerShare_documentation_en-US" xlink:label="lab_cnc_AcceleratedShareRepurchasesDiscountPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Discount, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AcceleratedShareRepurchasesDiscountPricePerShare" xlink:href="cnc-20221231.xsd#cnc_AcceleratedShareRepurchasesDiscountPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AcceleratedShareRepurchasesDiscountPricePerShare" xlink:to="lab_cnc_AcceleratedShareRepurchasesDiscountPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsByNatureAxis_458da5b6-90bd-4ab9-a50e-ce3c13d3aaf2_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsByNatureAxis_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis" xlink:to="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_c1a070cb-e132-4d64-9c8d-72d37ceeb43e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_e940c839-4e14-4ee3-bcd9-275fc73a9601_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_83030419-010a-440c-ab7b-c2ed162088f1_verboseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock equivalents (as determined by applying the treasury stock method) (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a2fc9308-f2e0-4993-b98f-87f800c374c4_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8741c16d-425b-4501-bb17-2514c67fe399_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_MagellanHealthMember_7b92d851-2227-46d7-bee9-f933d0206a12_terseLabel_en-US" xlink:label="lab_cnc_MagellanHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Health</link:label>
    <link:label id="lab_cnc_MagellanHealthMember_label_en-US" xlink:label="lab_cnc_MagellanHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Health [Member]</link:label>
    <link:label id="lab_cnc_MagellanHealthMember_documentation_en-US" xlink:label="lab_cnc_MagellanHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanHealthMember" xlink:href="cnc-20221231.xsd#cnc_MagellanHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_MagellanHealthMember" xlink:to="lab_cnc_MagellanHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerContractsMember_19f56ed9-1861-4e66-8586-42cac2024e5c_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased contract rights and customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerContractsMember_label_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerContractsMember" xlink:to="lab_us-gaap_CustomerContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_42ce067c-9552-4b9c-be06-21bfc7c272d5_negatedNetLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_883db2cd-c9ac-4dde-8d5d-e950d8ae8b16_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level II</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_0ab43839-26ab-4939-be68-02d14988da49_verboseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_SterlingOvernightIndexAverageSONIAMember_6e6ceb7f-3def-4b8e-8b36-ca99f5e7e2d6_terseLabel_en-US" xlink:label="lab_cnc_SterlingOvernightIndexAverageSONIAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterling Overnight Index Average (SONIA)</link:label>
    <link:label id="lab_cnc_SterlingOvernightIndexAverageSONIAMember_label_en-US" xlink:label="lab_cnc_SterlingOvernightIndexAverageSONIAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterling Overnight Index Average (SONIA) [Member]</link:label>
    <link:label id="lab_cnc_SterlingOvernightIndexAverageSONIAMember_documentation_en-US" xlink:label="lab_cnc_SterlingOvernightIndexAverageSONIAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterling Overnight Index Average (SONIA)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SterlingOvernightIndexAverageSONIAMember" xlink:href="cnc-20221231.xsd#cnc_SterlingOvernightIndexAverageSONIAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_SterlingOvernightIndexAverageSONIAMember" xlink:to="lab_cnc_SterlingOvernightIndexAverageSONIAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_bdd40e9b-bc04-48ad-a677-a1f26f182a9a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock_8f6804d9-92c8-4ccb-b7c8-dcb7ec626e40_terseLabel_en-US" xlink:label="lab_cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium and Trade Receivables and Unearned Revenue</link:label>
    <link:label id="lab_cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock_label_en-US" xlink:label="lab_cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium And Related Receivables And Unearned Revenue [Policy Text Block]</link:label>
    <link:label id="lab_cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock_documentation_en-US" xlink:label="lab_cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium And Related Receivables And Unearned Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock" xlink:href="cnc-20221231.xsd#cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock" xlink:to="lab_cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_03d73a46-6f32-496b-af69-400f5a098744_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_013e02b7-ea3d-4e91-8d47-328bd90f250a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_b191f422-c6d2-47ee-9e7b-192c695bc02c_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_ec0c0616-8da7-4c99-89e6-2fd4b74ff0f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ee4aaff6-2b70-4dff-9052-0d0e14bae9ba_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum_173c53d2-d194-483f-b2cf-ad6664ee1f9a_terseLabel_en-US" xlink:label="lab_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant, maximum net leverage ratio</link:label>
    <link:label id="lab_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum_label_en-US" xlink:label="lab_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Net Leverage Ratio, Maximum</link:label>
    <link:label id="lab_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum_documentation_en-US" xlink:label="lab_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Net Leverage Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentCovenantNetLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum" xlink:to="lab_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_24351712-69e4-472e-b60e-84b1fd071c70_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_21e4a5d9-d5bc-42f5-a986-9e36b98b6af8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_093911ae-8b25-465e-8686-425caab679ed_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_37b78dcd-fa29-4bde-91c4-a27244c3219f_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, January 1, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_a1c5cfdd-f548-46a9-8af8-6c4d35d2ff18_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, December 31, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_7b4640c9-5020-4988-bc8b-cf1b981c880d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Non-Vested Restricted Stock And Restricted Stock</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_LongTermInvestmentServiceCenterinCaliforniaMember_4fb21cda-001f-4314-b58f-4d7128ceb2df_terseLabel_en-US" xlink:label="lab_cnc_LongTermInvestmentServiceCenterinCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term investment, service center in California</link:label>
    <link:label id="lab_cnc_LongTermInvestmentServiceCenterinCaliforniaMember_label_en-US" xlink:label="lab_cnc_LongTermInvestmentServiceCenterinCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investment, Service Center in California [Member]</link:label>
    <link:label id="lab_cnc_LongTermInvestmentServiceCenterinCaliforniaMember_documentation_en-US" xlink:label="lab_cnc_LongTermInvestmentServiceCenterinCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investment, Service Center in California [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentServiceCenterinCaliforniaMember" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentServiceCenterinCaliforniaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_LongTermInvestmentServiceCenterinCaliforniaMember" xlink:to="lab_cnc_LongTermInvestmentServiceCenterinCaliforniaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_50a82ba9-e3cd-465c-911f-924c06353bb6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_e65298dc-b99e-49eb-9d5a-7bf6f39efdb2_verboseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_38229ecd-2151-4ae8-a8ad-d579ba44c945_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in computing per share amounts:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_110bff7d-7005-4f54-9855-88461f799aff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments_61768a70-0d44-4390-b407-d22a1c8270ce_terseLabel_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments_label_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Long-term Investments</link:label>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments_documentation_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments" xlink:to="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d5e9e618-71ef-4fae-a232-2cdc77f5595f_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount_74b5932b-9ff8-4bb2-800d-6afeb2f5070f_terseLabel_en-US" xlink:label="lab_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, increase to authorized amount</link:label>
    <link:label id="lab_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount_label_en-US" xlink:label="lab_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Increase, Authorized Amount</link:label>
    <link:label id="lab_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount_documentation_en-US" xlink:label="lab_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Increase, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount" xlink:href="cnc-20221231.xsd#cnc_StockRepurchaseProgramIncreaseAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount" xlink:to="lab_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_a757b273-1f17-49b8-8ead-53b5d000b615_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_10f809bd-a35e-438d-bf8a-17e031eaf446_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_56ce9acb-3cf8-4bf7-b9ba-a213003231b0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_791fb8cb-b5f5-4643-8ec7-08263ac08e9b_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_5de6df30-cd0b-4292-a0db-371a05879b85_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized gain (loss) on investments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_A2200Million475SeniorNotesDueJanuary2025Member_564e9f33-dcfd-42c0-b423-eac0124efd31_terseLabel_en-US" xlink:label="lab_cnc_A2200Million475SeniorNotesDueJanuary2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,200 Million 4.75% Senior Notes due January 2025</link:label>
    <link:label id="lab_cnc_A2200Million475SeniorNotesDueJanuary2025Member_label_en-US" xlink:label="lab_cnc_A2200Million475SeniorNotesDueJanuary2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,200 Million 4.75% Senior Notes due January 2025 [Member]</link:label>
    <link:label id="lab_cnc_A2200Million475SeniorNotesDueJanuary2025Member_documentation_en-US" xlink:label="lab_cnc_A2200Million475SeniorNotesDueJanuary2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,200 Million 4.75% Senior Notes due January 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2200Million475SeniorNotesDueJanuary2025Member" xlink:href="cnc-20221231.xsd#cnc_A2200Million475SeniorNotesDueJanuary2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_A2200Million475SeniorNotesDueJanuary2025Member" xlink:to="lab_cnc_A2200Million475SeniorNotesDueJanuary2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_76904fce-3a39-4fae-9583-e4cd4ccbe570_verboseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0b560b4c-f950-496f-ae0f-7373e90eaf33_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodTwoMember_3b955c5b-437a-473c-a08b-c7e0ca1e0262_terseLabel_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second year following closing</link:label>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodTwoMember_label_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Payment Period, Two [Member]</link:label>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodTwoMember_documentation_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Payment Period, Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodTwoMember" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DebtInstrumentPaymentPeriodTwoMember" xlink:to="lab_cnc_DebtInstrumentPaymentPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_d55218c9-4697-4e71-af90-36689c3268de_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_6a555d98-5b62-4a11-b718-a2effea4dd51_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AuditorInformationAbstract_5e6a8797-741f-4f6b-80e3-28ac40e6ff42_terseLabel_en-US" xlink:label="lab_cnc_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_cnc_AuditorInformationAbstract_label_en-US" xlink:label="lab_cnc_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_cnc_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_cnc_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AuditorInformationAbstract" xlink:href="cnc-20221231.xsd#cnc_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AuditorInformationAbstract" xlink:to="lab_cnc_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_75209062-2ff2-46da-b024-0ff241a972f3_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_029bfd28-368d-4cca-8f12-b62df195fde8_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax withholding (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_37d950d0-36f8-4f80-a077-f4e366bde9a0_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surety bonds outstanding</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_85145a89-fb22-4755-80b4-e372131ce816_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Tax Provision At The U.S. Federal Statutory Rate To Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_83c535a1-7465-492f-be72-8942d38f0178_verboseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal settlement</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_89100fa8-7c09-48de-8baa-30f521979b0e_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_6f25bb7d-0ad1-452d-9fe0-0d2b520e3f76_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_070c3b1d-5b9c-4642-bdb8-d7a02a31cd8a_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment and other income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNonoperating" xlink:to="lab_us-gaap_InvestmentIncomeNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_481e95c6-bfc7-455e-b202-9e611b7e55c5_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_7a7ef672-96c4-4ac4-b2b8-7d16ca8561e1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_83cca03c-c4d7-4ca1-b119-4a9414568380_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_ad4eb0ba-4f42-4bc5-aab7-d8e48d5659ee_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax withholding</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_498e9bdc-1362-4aa3-be53-c932a535eb34_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_737dc341-b5cf-4aa4-8716-8fee5fb9e0ac_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AffordableCareActCostSharingReductionsPayable_0a8cfdc3-98d4-4b14-9fa6-61981793add9_negatedTerseLabel_en-US" xlink:label="lab_cnc_AffordableCareActCostSharingReductionsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost sharing reduction payable</link:label>
    <link:label id="lab_cnc_AffordableCareActCostSharingReductionsPayable_label_en-US" xlink:label="lab_cnc_AffordableCareActCostSharingReductionsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act Cost Sharing Reductions, Payable</link:label>
    <link:label id="lab_cnc_AffordableCareActCostSharingReductionsPayable_documentation_en-US" xlink:label="lab_cnc_AffordableCareActCostSharingReductionsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act Cost Sharing Reductions, Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActCostSharingReductionsPayable" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActCostSharingReductionsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AffordableCareActCostSharingReductionsPayable" xlink:to="lab_cnc_AffordableCareActCostSharingReductionsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_4fbefd78-8c44-40bf-a269-83ca7262992e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_0821e389-3d2f-4cb2-b380-75d79188a08b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_2f8423f4-bd6f-4c92-8ebb-ddc0d72d2364_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_736eedf5-ae61-4be8-9fd0-9170b2f5b26d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_ed13f9be-5533-47c9-a7c3-3567d7aab02b_verboseLabel_en-US" xlink:label="lab_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment</link:label>
    <link:label id="lab_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_fa479a18-61e0-4014-aa1a-aa9a1c4f4950_terseLabel_en-US" xlink:label="lab_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment</link:label>
    <link:label id="lab_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_label_en-US" xlink:label="lab_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt , Including Cash Portion</link:label>
    <link:label id="lab_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_documentation_en-US" xlink:label="lab_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt , Including Cash Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion" xlink:href="cnc-20221231.xsd#cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion" xlink:to="lab_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxSettlements_1ab6ebc1-bc5f-45f5-9aaf-5f5a50be2a04_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit settlement</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxSettlements_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_9ce7a1e5-2735-4d4f-92bc-8858b3b300b9_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions_f5e00e8d-4ab8-4eb3-a2b7-aa308b35609c_terseLabel_en-US" xlink:label="lab_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investment positions</link:label>
    <link:label id="lab_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions_label_en-US" xlink:label="lab_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available -for-Sale, Number of Positions</link:label>
    <link:label id="lab_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions_documentation_en-US" xlink:label="lab_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available -for-Sale, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions" xlink:href="cnc-20221231.xsd#cnc_DebtSecuritiesAvailableForSaleNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions" xlink:to="lab_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_26bef322-9e0b-4a03-8805-2bfeee3d092c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_4996abc5-727f-4aba-be74-c65609ca4ea5_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ae18bb7b-3834-46aa-a1e4-9d2db3a345d2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_a916610c-90da-471b-a0ba-406ab133a66d_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of senior notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_ac752c15-b534-4d78-9bb1-b765b0432c73_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_3d6f0790-f190-48f2-baaf-0185bdc67889_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_b8df7b95-290a-4bd4-8ea6-51716aece2f8_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings from subsidiaries</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cdac6d4b-0120-4304-be98-6b7416de79ed_negatedNetLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_GrossIncreasesAbstract_7a202be8-5280-42cd-a927-e51537d61529_verboseLabel_en-US" xlink:label="lab_cnc_GrossIncreasesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross increases:</link:label>
    <link:label id="lab_cnc_GrossIncreasesAbstract_label_en-US" xlink:label="lab_cnc_GrossIncreasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Increases [Abstract]</link:label>
    <link:label id="lab_cnc_GrossIncreasesAbstract_documentation_en-US" xlink:label="lab_cnc_GrossIncreasesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Increases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GrossIncreasesAbstract" xlink:href="cnc-20221231.xsd#cnc_GrossIncreasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_GrossIncreasesAbstract" xlink:to="lab_cnc_GrossIncreasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ACAHealthInsurerFee_4ff1c426-27cf-4e7f-9357-21549c91095a_verboseLabel_en-US" xlink:label="lab_cnc_ACAHealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACA health insurer fee</link:label>
    <link:label id="lab_cnc_ACAHealthInsurerFee_label_en-US" xlink:label="lab_cnc_ACAHealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACA Health Insurer Fee</link:label>
    <link:label id="lab_cnc_ACAHealthInsurerFee_documentation_en-US" xlink:label="lab_cnc_ACAHealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACA Health Insurer Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ACAHealthInsurerFee" xlink:href="cnc-20221231.xsd#cnc_ACAHealthInsurerFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ACAHealthInsurerFee" xlink:to="lab_cnc_ACAHealthInsurerFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_cee23856-8744-4055-9cc3-4622962edc32_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_85dfcb35-af87-496e-9fd8-df4d2bd3f4a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Calculation Of Basic And Diluted Net Earnings Per Common Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3593a906-3d38-4fae-8fa5-d4995a4a5a7a_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0bc5dc4c-2239-453f-b50a-f1f959c1f3f5_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage_63181667-1348-4e20-b002-b042d9a04722_terseLabel_en-US" xlink:label="lab_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate percentage of principal outstanding</link:label>
    <link:label id="lab_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage_label_en-US" xlink:label="lab_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Accepted for Tender Offer, Principal Outstanding, Percentage</link:label>
    <link:label id="lab_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage_documentation_en-US" xlink:label="lab_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Accepted for Tender Offer, Principal Outstanding, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage" xlink:href="cnc-20221231.xsd#cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage" xlink:to="lab_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f1bd70e-3eed-434f-a45a-4faf51b131fa_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c60a03a8-7423-4e70-93a6-e2b675bd6d5e_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_35a385bb-ac0e-47b7-b7e8-fa0c44072a94_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_69b847e2-6d53-4586-a052-6a710c826a47_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5b37e2ae-d675-4599-a0bd-30c8fe50cccd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_OtherCommitmentEmployees_45a63eae-aa59-44ad-8db0-4a7d699b9dbc_terseLabel_en-US" xlink:label="lab_cnc_OtherCommitmentEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment to undertaking, by employing (people) (at least)</link:label>
    <link:label id="lab_cnc_OtherCommitmentEmployees_label_en-US" xlink:label="lab_cnc_OtherCommitmentEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment, Employees</link:label>
    <link:label id="lab_cnc_OtherCommitmentEmployees_documentation_en-US" xlink:label="lab_cnc_OtherCommitmentEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment, Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentEmployees" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_OtherCommitmentEmployees" xlink:to="lab_cnc_OtherCommitmentEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2a490296-0163-498c-ac96-dc034bde2b8c_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_a74d3925-2378-4677-9491-6dae4349ab9d_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_aecd94ec-cea1-48f2-8e5f-3c4bfbfabed0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_77983597-d832-4e0f-a8c6-41e2a8357f02_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_248cd7fb-178a-4ff2-a80c-1fb595883278_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_7fc9fc55-b212-48bc-9e71-802711917e1d_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_629ac7fa-02e7-4603-90ed-717ccda71544_negatedNetLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing activities, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2dfee2b0-af99-4f25-a7d4-62c891718838_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing activities, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_26d34682-f4d9-4e1b-822f-9c5503eb8458_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_FurnitureAndOfficeEquipmentMember_49b8f485-ad60-4545-95e8-d366f0a98c7b_terseLabel_en-US" xlink:label="lab_cnc_FurnitureAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and office equipment</link:label>
    <link:label id="lab_cnc_FurnitureAndOfficeEquipmentMember_label_en-US" xlink:label="lab_cnc_FurnitureAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture And Office Equipment [Member]</link:label>
    <link:label id="lab_cnc_FurnitureAndOfficeEquipmentMember_documentation_en-US" xlink:label="lab_cnc_FurnitureAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture And Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FurnitureAndOfficeEquipmentMember" xlink:href="cnc-20221231.xsd#cnc_FurnitureAndOfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_FurnitureAndOfficeEquipmentMember" xlink:to="lab_cnc_FurnitureAndOfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_11ec70e1-f2e8-4f43-9225-dd3166257d74_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_354aae3c-1ba4-4187-9581-fff1d7fd2ff6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statute of limitation lapses</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_a26cd3ad-2599-444c-bbd6-6f37b9eadf74_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_28bfc50d-02f9-489d-8746-54c297af7cec_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Reserve for Uncertain Tax Positions</link:label>
    <link:label id="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:to="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_0383eb69-21db-4169-b6d0-611d56967276_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_b7f384b0-701d-4d72-8a14-ec734cfd6548_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_c864a756-3e1d-4bb2-aa10-94e582daf4de_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to Centene Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_40df7bb8-66d9-4ae8-9c48-38ed18d755ff_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings attributable to Centene Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_ac5f0894-fff1-4ca0-8692-28fcc8aa770a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_22f7e0d7-c22f-409b-9a36-f8ee086da607_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Aggregate Maturities Of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_100d82fb-dc99-4d61-b802-aa83f4324010_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionLoanPayableMember_24f53a2b-f8ba-4ff6-8193-352a8a935b4a_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionLoanPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction loan payable</link:label>
    <link:label id="lab_us-gaap_ConstructionLoanPayableMember_label_en-US" xlink:label="lab_us-gaap_ConstructionLoanPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loan Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionLoanPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionLoanPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionLoanPayableMember" xlink:to="lab_us-gaap_ConstructionLoanPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_a11782ea-e6ae-4c89-8470-6032d22a7821_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_2781c1bf-b97a-4261-96e5-6769de3d292d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_25154b97-e4da-4c9e-9972-4db2ca3a1005_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_PremiumTaxRevenue_29d4f5e4-20b8-49c7-8827-2e33a18e4eb5_verboseLabel_en-US" xlink:label="lab_cnc_PremiumTaxRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium tax and health insurer fee</link:label>
    <link:label id="lab_cnc_PremiumTaxRevenue_label_en-US" xlink:label="lab_cnc_PremiumTaxRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Tax Revenue</link:label>
    <link:label id="lab_cnc_PremiumTaxRevenue_documentation_en-US" xlink:label="lab_cnc_PremiumTaxRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium tax revenue, similar assessments and provider pass through payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PremiumTaxRevenue" xlink:href="cnc-20221231.xsd#cnc_PremiumTaxRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_PremiumTaxRevenue" xlink:to="lab_cnc_PremiumTaxRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_45d92bea-532f-412d-bb62-3766bf7e0e2d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_acbfbd78-231e-428a-a0e2-50ad1985dcdb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease not yet commenced, term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AffordableCareActCostSharingReductionReceivable_da94b0e2-3106-4e8e-8a0c-ab98b8931e9c_terseLabel_en-US" xlink:label="lab_cnc_AffordableCareActCostSharingReductionReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost sharing reduction receivable</link:label>
    <link:label id="lab_cnc_AffordableCareActCostSharingReductionReceivable_label_en-US" xlink:label="lab_cnc_AffordableCareActCostSharingReductionReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Cost Sharing Reduction Receivable</link:label>
    <link:label id="lab_cnc_AffordableCareActCostSharingReductionReceivable_documentation_en-US" xlink:label="lab_cnc_AffordableCareActCostSharingReductionReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Cost Sharing Reduction Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActCostSharingReductionReceivable" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActCostSharingReductionReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AffordableCareActCostSharingReductionReceivable" xlink:to="lab_cnc_AffordableCareActCostSharingReductionReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_9784de61-58e0-40a5-afec-0243e835edd5_totalLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_4cef5fb2-8c6c-404c-a8fb-3cb4af5422f7_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_CenturionMember_2a160e01-2fb4-48ab-b7b1-c04be217d366_terseLabel_en-US" xlink:label="lab_cnc_CenturionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centurion</link:label>
    <link:label id="lab_cnc_CenturionMember_label_en-US" xlink:label="lab_cnc_CenturionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centurion [Member]</link:label>
    <link:label id="lab_cnc_CenturionMember_documentation_en-US" xlink:label="lab_cnc_CenturionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centurion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_CenturionMember" xlink:href="cnc-20221231.xsd#cnc_CenturionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_CenturionMember" xlink:to="lab_cnc_CenturionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForHedgeInvestingActivities_d25b7333-4b6e-466f-b676-8d0075729865_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for swap agreement</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForHedgeInvestingActivities" xlink:to="lab_us-gaap_PaymentsForHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_5aa6584d-35b5-45bd-8820-6d7635754ddb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_08494114-ca8f-4e44-b9c5-ff2574c54e83_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_a7296be0-7287-4160-bb9a-380fefa4bc2f_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_da14d81f-15c3-44bc-bf54-32a1a33b7dd2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_c649f1d5-c18c-4f9f-8dd1-e021107bd9a2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_19f67c82-95b2-4c7a-b7d3-90f6b50f0c9b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level I</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodOneMember_139be23d-a394-4fea-82c6-fc0771ac8b97_terseLabel_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First year</link:label>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodOneMember_label_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Payment Period, One [Member]</link:label>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodOneMember_documentation_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Payment Period, One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodOneMember" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DebtInstrumentPaymentPeriodOneMember" xlink:to="lab_cnc_DebtInstrumentPaymentPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1779d87a-ca54-4797-884c-8f7c432fbd01_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_4e9dd6e0-67da-4691-82c3-91bb463ed1f4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_0c213b56-6fa0-4415-a5ae-69373ef3fd0a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nontaxable divestiture (gains) losses</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_45bb2c98-4042-4556-ba3c-f89d61d79835_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claims Development</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Claims Development [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock_ca42c1de-9f83-446b-a8ee-c1d8236c53e7_verboseLabel_en-US" xlink:label="lab_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Capital Requirements and Dividend Restrictions</link:label>
    <link:label id="lab_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock_label_en-US" xlink:label="lab_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Capital Requirements And Dividend Restrictions [Text Block]</link:label>
    <link:label id="lab_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock_documentation_en-US" xlink:label="lab_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Capital Requirements And Dividend Restrictions [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock" xlink:href="cnc-20221231.xsd#cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock" xlink:to="lab_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_ea48eac9-84db-466e-9f97-0d93073d05b0_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_1068930f-e448-4fe0-9dab-c189ad6ce6bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recoveries</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Recovery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_00400065-17af-46bc-b7a8-107be06853c0_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_SignificantCustomersPolicyTextBlock_21c37ae8-d231-4bbd-b4e0-d4a74d2c5e39_terseLabel_en-US" xlink:label="lab_cnc_SignificantCustomersPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Customers</link:label>
    <link:label id="lab_cnc_SignificantCustomersPolicyTextBlock_label_en-US" xlink:label="lab_cnc_SignificantCustomersPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Customers [Policy Text Block]</link:label>
    <link:label id="lab_cnc_SignificantCustomersPolicyTextBlock_documentation_en-US" xlink:label="lab_cnc_SignificantCustomersPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Customers [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SignificantCustomersPolicyTextBlock" xlink:href="cnc-20221231.xsd#cnc_SignificantCustomersPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_SignificantCustomersPolicyTextBlock" xlink:to="lab_cnc_SignificantCustomersPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_665c6460-2cc0-4314-abd4-f949ec955b56_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ProceedsFromPaymentsForIntercompanyActivities_dac2785b-b04a-4f01-86bd-34e8c0c290f1_verboseLabel_en-US" xlink:label="lab_cnc_ProceedsFromPaymentsForIntercompanyActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany activities</link:label>
    <link:label id="lab_cnc_ProceedsFromPaymentsForIntercompanyActivities_label_en-US" xlink:label="lab_cnc_ProceedsFromPaymentsForIntercompanyActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From (Payments for) Intercompany Activities</link:label>
    <link:label id="lab_cnc_ProceedsFromPaymentsForIntercompanyActivities_documentation_en-US" xlink:label="lab_cnc_ProceedsFromPaymentsForIntercompanyActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From (Payments for) Intercompany Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ProceedsFromPaymentsForIntercompanyActivities" xlink:href="cnc-20221231.xsd#cnc_ProceedsFromPaymentsForIntercompanyActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ProceedsFromPaymentsForIntercompanyActivities" xlink:to="lab_cnc_ProceedsFromPaymentsForIntercompanyActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_bad87ee8-a09d-4e5b-b53f-9dcb82d736b1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of voting interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f98e0e8c-6dfe-478a-84f7-8fbd73fae8ae_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_b195ba59-83f6-472a-b48e-4e810bc00d9d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract_edbe12bd-e126-455d-b26b-79cc8ff7342f_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_b80f3ffc-612c-4230-a463-8ffecf5d9c3e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Software and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_8d8461bc-b7c0-4d5d-97e1-7aeee7af0c17_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine equity</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_bc1d2037-beec-449b-979f-329c0a036817_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DefinedContributionPlanMinimumAgeForCoverage_9ec6927f-58d7-4bca-b077-bd2c3e8c2914_terseLabel_en-US" xlink:label="lab_cnc_DefinedContributionPlanMinimumAgeForCoverage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan covered employee, age (at least)</link:label>
    <link:label id="lab_cnc_DefinedContributionPlanMinimumAgeForCoverage_label_en-US" xlink:label="lab_cnc_DefinedContributionPlanMinimumAgeForCoverage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Minimum Age For Coverage</link:label>
    <link:label id="lab_cnc_DefinedContributionPlanMinimumAgeForCoverage_documentation_en-US" xlink:label="lab_cnc_DefinedContributionPlanMinimumAgeForCoverage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Minimum Age For Coverage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DefinedContributionPlanMinimumAgeForCoverage" xlink:href="cnc-20221231.xsd#cnc_DefinedContributionPlanMinimumAgeForCoverage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DefinedContributionPlanMinimumAgeForCoverage" xlink:to="lab_cnc_DefinedContributionPlanMinimumAgeForCoverage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_10d17aeb-1414-43bf-8dbf-8caeee816f09_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_175dec68-760f-4dad-bd2b-29d16d4d634b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_cd7572e4-ad85-4008-a87e-dc1c917d55ca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_f821a7ea-fd2f-43b3-bd0b-3e09335cf035_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_bace3065-751f-45b4-8bc2-9adc0b0e0c39_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_d2993e82-0530-404d-a105-645d36abfc4e_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_29ae739a-9862-44d2-b959-46497a0461e9_negatedNetLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock_9c18e0fe-f0ab-42fa-91b9-65022a6e61ce_terseLabel_en-US" xlink:label="lab_cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense)</link:label>
    <link:label id="lab_cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock_label_en-US" xlink:label="lab_cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Policy Text Block] [Policy Text Block]</link:label>
    <link:label id="lab_cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock_documentation_en-US" xlink:label="lab_cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock" xlink:href="cnc-20221231.xsd#cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock" xlink:to="lab_cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ff5bb785-ed13-4585-ac56-f17d57a09f65_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued in business acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_33e52596-ca17-422c-9e57-4a8b84c8ac29_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_715cbde9-13cf-485e-9363-02c1f1a1b3aa_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_8e5042d2-5644-4803-a12d-4be6b2a6782b_verboseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_e3fa368e-47fe-41e4-b75b-eb17a7af0988_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_8d06e606-04d0-4171-846c-b10f374f7737_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_41d95d14-8470-481b-b916-4238df0077da_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_2b4184b0-9a22-4100-a827-947a05c447a6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_dd34f6de-404f-45a4-8f35-2b82659f34a7_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_17883357-117a-4693-bf5b-ea233817e839_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_89cf8e12-0db8-489b-b8a6-8b61b7ed557f_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture_ab7780f1-b321-4496-9bba-9c80c5bc3ffc_terseLabel_en-US" xlink:label="lab_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of unvested equity awards in connection with acquisition</link:label>
    <link:label id="lab_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture_label_en-US" xlink:label="lab_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:label id="lab_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture_documentation_en-US" xlink:label="lab_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture" xlink:href="cnc-20221231.xsd#cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture" xlink:to="lab_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_db57e56c-e1e2-46e1-be4e-267e17e393c5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings per common share attributable to Centene Corporation:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_fe094f47-00d2-44cb-b22f-c329eff53903_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings per common share attributable to Centene Corporation:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_MagellanRxMember_4abfd5f0-ac3b-4130-9e54-d57fe8b7a19a_terseLabel_en-US" xlink:label="lab_cnc_MagellanRxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Rx</link:label>
    <link:label id="lab_cnc_MagellanRxMember_label_en-US" xlink:label="lab_cnc_MagellanRxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Rx [Member]</link:label>
    <link:label id="lab_cnc_MagellanRxMember_documentation_en-US" xlink:label="lab_cnc_MagellanRxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Rx</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanRxMember" xlink:href="cnc-20221231.xsd#cnc_MagellanRxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_MagellanRxMember" xlink:to="lab_cnc_MagellanRxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_1f0a25c4-b446-43bb-9ffe-6eea46d6a298_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_a8afdfc5-d5c4-4390-b024-cbbd278597f4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency swap agreement</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AffordableCareActAbstract_61d51680-693a-49ba-b881-eb52e05ef6d3_terseLabel_en-US" xlink:label="lab_cnc_AffordableCareActAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act [Abstract]</link:label>
    <link:label id="lab_cnc_AffordableCareActAbstract_label_en-US" xlink:label="lab_cnc_AffordableCareActAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act [Abstract]</link:label>
    <link:label id="lab_cnc_AffordableCareActAbstract_documentation_en-US" xlink:label="lab_cnc_AffordableCareActAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActAbstract" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AffordableCareActAbstract" xlink:to="lab_cnc_AffordableCareActAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_16c1d45b-1f5e-404a-8935-8106268e286b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_9af8bfdd-cc2b-4242-87a1-5492df170596_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of outstanding debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_de6e9a84-61ab-4f33-a3e0-8d94fee77945_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_89b3ae9a-eb2c-43a1-9d79-f8659cecfb85_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program increase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_2ec5fbd1-bba4-40d3-bf28-26c80f077a85_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1918cb05-6efc-4598-8ac6-18774fc41388_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_efbeb953-ea9b-485f-a718-a267224d26cd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_2fff0c03-4794-4ef7-a2f5-599e765da7ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_4f455823-355e-43e2-a367-1ed12aa8e42c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_HealthInsurerFeeExpense_8e67cb92-32df-4d6f-90f2-492a73509079_terseLabel_en-US" xlink:label="lab_cnc_HealthInsurerFeeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurer fee expense</link:label>
    <link:label id="lab_cnc_HealthInsurerFeeExpense_label_en-US" xlink:label="lab_cnc_HealthInsurerFeeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee Expense</link:label>
    <link:label id="lab_cnc_HealthInsurerFeeExpense_documentation_en-US" xlink:label="lab_cnc_HealthInsurerFeeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_HealthInsurerFeeExpense" xlink:href="cnc-20221231.xsd#cnc_HealthInsurerFeeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_HealthInsurerFeeExpense" xlink:to="lab_cnc_HealthInsurerFeeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_7f0e1481-a25b-4833-9895-6e2f6e5e0900_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_EmployeeStockCompensationPlanMember_ee7800cc-79e6-4c98-bf70-24fb4bd59ebe_terseLabel_en-US" xlink:label="lab_cnc_EmployeeStockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Compensation Plan</link:label>
    <link:label id="lab_cnc_EmployeeStockCompensationPlanMember_label_en-US" xlink:label="lab_cnc_EmployeeStockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Compensation Plan [Member]</link:label>
    <link:label id="lab_cnc_EmployeeStockCompensationPlanMember_documentation_en-US" xlink:label="lab_cnc_EmployeeStockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Compensation Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EmployeeStockCompensationPlanMember" xlink:href="cnc-20221231.xsd#cnc_EmployeeStockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_EmployeeStockCompensationPlanMember" xlink:to="lab_cnc_EmployeeStockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_7677ddbe-404c-40c1-b427-0833c90faa48_periodStartLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: reinsurance recoverable</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_d4fd787e-61fd-40fb-8321-b80ca96ba05f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus: reinsurance recoverable</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:to="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_44916c89-0151-4ea2-b6d0-6170b8e5ffd7_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c705e7f1-685d-40b0-afd4-44c34dbebbbd_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_100abb68-2fae-4d41-81e1-214d8eab1dcd_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7b75c012-8aa0-4f54-b36d-8327bc74b886_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_c4f82c9f-4280-4080-8435-45615efa014e_negatedNetLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_bba25258-480d-4f89-b255-10daf3610279_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment costs</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_ee467bef-599e-42b8-9b34-14763709cbb3_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer hardware and software</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock_894f6f83-ac05-4d7d-b78d-59a797cd20a7_terseLabel_en-US" xlink:label="lab_cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Level Input And Input Definitions</link:label>
    <link:label id="lab_cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock_label_en-US" xlink:label="lab_cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Input Definitions [Table Text Block]</link:label>
    <link:label id="lab_cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock_documentation_en-US" xlink:label="lab_cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock" xlink:href="cnc-20221231.xsd#cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock" xlink:to="lab_cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost_3e97805f-ddbb-4c4e-b9aa-efd501f0b219_totalLabel_en-US" xlink:label="lab_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Amortized Cost</link:label>
    <link:label id="lab_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost_label_en-US" xlink:label="lab_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost</link:label>
    <link:label id="lab_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost_documentation_en-US" xlink:label="lab_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost" xlink:href="cnc-20221231.xsd#cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost" xlink:to="lab_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_f5fa6fbe-0840-4d00-89d7-8c92dd55062f_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_FinanceLeaseLiabilityAndOther_2f7e8133-8f5f-43b9-b930-155612dda175_terseLabel_en-US" xlink:label="lab_cnc_FinanceLeaseLiabilityAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases and other</link:label>
    <link:label id="lab_cnc_FinanceLeaseLiabilityAndOther_label_en-US" xlink:label="lab_cnc_FinanceLeaseLiabilityAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Liability And Other</link:label>
    <link:label id="lab_cnc_FinanceLeaseLiabilityAndOther_documentation_en-US" xlink:label="lab_cnc_FinanceLeaseLiabilityAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Liability And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FinanceLeaseLiabilityAndOther" xlink:href="cnc-20221231.xsd#cnc_FinanceLeaseLiabilityAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_FinanceLeaseLiabilityAndOther" xlink:to="lab_cnc_FinanceLeaseLiabilityAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d82b39d8-e1e3-4de9-ab23-285f8991e9c9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation impact</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_d58e40fb-6217-4476-a294-b34b7254f257_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2022</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_5f1feae9-2b23-4f49-a671-6a2a7e99de54_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_eaf1ee36-8c48-425e-aad9-014f8ac3e5d5_negatedLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture of noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:to="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_OtherCommitmentToBePaidYearOneAndYearTwo_5d9860d4-db8c-4350-bdf4-899670f7c9d2_terseLabel_en-US" xlink:label="lab_cnc_OtherCommitmentToBePaidYearOneAndYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment to be paid over 2023 and 2024</link:label>
    <link:label id="lab_cnc_OtherCommitmentToBePaidYearOneAndYearTwo_label_en-US" xlink:label="lab_cnc_OtherCommitmentToBePaidYearOneAndYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment To Be Paid Year One and Year Two</link:label>
    <link:label id="lab_cnc_OtherCommitmentToBePaidYearOneAndYearTwo_documentation_en-US" xlink:label="lab_cnc_OtherCommitmentToBePaidYearOneAndYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment To Be Paid Year One and Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentToBePaidYearOneAndYearTwo" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentToBePaidYearOneAndYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_OtherCommitmentToBePaidYearOneAndYearTwo" xlink:to="lab_cnc_OtherCommitmentToBePaidYearOneAndYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_51c1d80e-d0af-47da-aff0-adcf3ef1fa76_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_126e925d-1e86-4707-9605-0f34251c88af_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required minimum aggregate statutory capital and surplus</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus Required</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_e54207cc-f752-49d7-b326-82dabbbd9cbc_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_cbddbcc0-f035-47b7-a33b-20a8e1e876bc_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonredeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_5c6803aa-2556-4434-99be-aae81002d741_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember_3ef0d8b3-0451-4d7f-9f32-0f93bd27ed33_terseLabel_en-US" xlink:label="lab_cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term investment, California Organized Investment Network</link:label>
    <link:label id="lab_cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember_label_en-US" xlink:label="lab_cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investment, California Organized Investment Network [Member]</link:label>
    <link:label id="lab_cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember_documentation_en-US" xlink:label="lab_cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investment, California Organized Investment Network [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember" xlink:to="lab_cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClaimsDevelopmentLineItems_7b2d7462-ed1b-4ede-81b3-53d2fcad35c2_terseLabel_en-US" xlink:label="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Development [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClaimsDevelopmentLineItems_label_en-US" xlink:label="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Development [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems" xlink:to="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_153bc748-822f-4910-acdf-8ac75f3243b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_c723fc5c-62d8-4124-820c-9d713d5864af_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_8781f892-f2c2-49e2-b111-d729de0435aa_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit_b14cdb26-5799-41c7-9db1-ddd8f5bc340a_terseLabel_en-US" xlink:label="lab_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted option, to increase Credit Facility</link:label>
    <link:label id="lab_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit_label_en-US" xlink:label="lab_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:label id="lab_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit_documentation_en-US" xlink:label="lab_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit" xlink:href="cnc-20221231.xsd#cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit" xlink:to="lab_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_a0eade4f-1e58-455f-b926-4a5688a7b3f2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss and tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration_896256bf-3ce9-4a86-a5c8-36495821f42a_terseLabel_en-US" xlink:label="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards and tax credit carryforwards, not subject to expiration</link:label>
    <link:label id="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards, Not Subject To Expiration</link:label>
    <link:label id="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration_documentation_en-US" xlink:label="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards, Not Subject To Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration" xlink:to="lab_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue_70b48aaf-3102-49ad-b215-75f1fd6f33ca_terseLabel_en-US" xlink:label="lab_cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate carrying value which approximates fair value</link:label>
    <link:label id="lab_cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue_label_en-US" xlink:label="lab_cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Insurance Contracts And Equity Investments, Fair Value</link:label>
    <link:label id="lab_cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue_documentation_en-US" xlink:label="lab_cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Insurance Contracts And Equity Investments, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue" xlink:href="cnc-20221231.xsd#cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue" xlink:to="lab_cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AcceleratedShareRepurchaseAgreementMember_df1091da-f7fb-4e9e-9a64-550a630cf333_terseLabel_en-US" xlink:label="lab_cnc_AcceleratedShareRepurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Agreement</link:label>
    <link:label id="lab_cnc_AcceleratedShareRepurchaseAgreementMember_label_en-US" xlink:label="lab_cnc_AcceleratedShareRepurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Agreement [Member]</link:label>
    <link:label id="lab_cnc_AcceleratedShareRepurchaseAgreementMember_documentation_en-US" xlink:label="lab_cnc_AcceleratedShareRepurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AcceleratedShareRepurchaseAgreementMember" xlink:href="cnc-20221231.xsd#cnc_AcceleratedShareRepurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AcceleratedShareRepurchaseAgreementMember" xlink:to="lab_cnc_AcceleratedShareRepurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_8d6dca1b-8ae7-43e2-add8-c57a33e8bc16_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_bfff56a2-d2ac-4bd1-bab6-4e95dd9bc967_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_A2200Million250SeniorNotesDue2031Member_c1c27577-0b50-4064-a377-1cd4df7b1327_terseLabel_en-US" xlink:label="lab_cnc_A2200Million250SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,200 Million 2.50% Senior Notes due 2031</link:label>
    <link:label id="lab_cnc_A2200Million250SeniorNotesDue2031Member_label_en-US" xlink:label="lab_cnc_A2200Million250SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,200 Million 2.50% Senior Notes due 2031 [Member]</link:label>
    <link:label id="lab_cnc_A2200Million250SeniorNotesDue2031Member_documentation_en-US" xlink:label="lab_cnc_A2200Million250SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,200 Million 2.50% Senior Notes due 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2200Million250SeniorNotesDue2031Member" xlink:href="cnc-20221231.xsd#cnc_A2200Million250SeniorNotesDue2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_A2200Million250SeniorNotesDue2031Member" xlink:to="lab_cnc_A2200Million250SeniorNotesDue2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_14ddc287-3a69-4fe4-bdba-c1dcf442e6f6_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and cash equivalents, included in restricted deposits</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_626ad442-d6b7-47e9-9bfa-32ff86bd4002_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCarePremiumMember_777a94bc-b596-4b15-bf9b-6769e4a9f63b_verboseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePremiumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium</link:label>
    <link:label id="lab_us-gaap_HealthCarePremiumMember_label_en-US" xlink:label="lab_us-gaap_HealthCarePremiumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Premium [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePremiumMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCarePremiumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCarePremiumMember" xlink:to="lab_us-gaap_HealthCarePremiumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_dfda7d96-be75-409f-9ba3-48e8d28014fc_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ParentCompanyMember_2970b404-fc74-4bcc-a432-fcfc5a4c3492_terseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company</link:label>
    <link:label id="lab_srt_ParentCompanyMember_label_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ParentCompanyMember" xlink:to="lab_srt_ParentCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims_90a1bff6-dc32-4be2-9698-216ebf652e20_terseLabel_en-US" xlink:label="lab_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration insurance contracts, expected development on reported claims</link:label>
    <link:label id="lab_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims_label_en-US" xlink:label="lab_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Incurred but Not Reported and Expected Development on Reported Claims</link:label>
    <link:label id="lab_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims_documentation_en-US" xlink:label="lab_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Incurred but Not Reported Liabilities and Expected Development on Reported Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims" xlink:href="cnc-20221231.xsd#cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims" xlink:to="lab_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_8d997715-fa35-4dab-b364-55a69a2b18e2_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_1015201c-3d9b-4a81-b49c-06727e80d665_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_43b3b749-e130-4748-8faa-0500b51a137c_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_3fa5f7a6-9e52-4991-a7d3-ecabe71ce6f8_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term and Long-term Investments, Restricted Deposits</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_1b05fa5d-3eb7-42e7-a66b-5ac0d59f8399_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for debt extinguishment</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ComputerHardwareMember_152f31d3-81ee-4372-8190-5b253b95482f_terseLabel_en-US" xlink:label="lab_cnc_ComputerHardwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer hardware</link:label>
    <link:label id="lab_cnc_ComputerHardwareMember_label_en-US" xlink:label="lab_cnc_ComputerHardwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Hardware [Member]</link:label>
    <link:label id="lab_cnc_ComputerHardwareMember_documentation_en-US" xlink:label="lab_cnc_ComputerHardwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Hardware [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ComputerHardwareMember" xlink:href="cnc-20221231.xsd#cnc_ComputerHardwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ComputerHardwareMember" xlink:to="lab_cnc_ComputerHardwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_40a6bfb2-79b9-4878-8f4d-eaa94a3aa6db_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">12 Months or More</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_21383727-d94a-4557-acdd-ba805211b76d_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_6601c7e7-5be9-4338-be10-c2e20668ca5d_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_272d79b4-d701-4bbe-840e-92764f2f1853_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes In goodwill by operating segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_6921705b-48f1-42eb-8c09-c59dd25c2b8c_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b1b8fa4f-e696-4e2c-8c15-db795501a840_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandImprovementsMember_cc692aa9-8b83-4cf9-bb0e-b3a8487fedde_terseLabel_en-US" xlink:label="lab_us-gaap_LandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land improvements</link:label>
    <link:label id="lab_us-gaap_LandImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandImprovementsMember" xlink:to="lab_us-gaap_LandImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_787e9986-c69e-4ffa-af54-5e88049e5c1f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_ab5fe7dc-2b87-4d07-99e3-25726b1b4713_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Centene stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9426c367-d909-4e76-bef4-46c8bbb60216_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsMember_f99f6ce1-cc21-4208-a893-43105de30cd6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsMember_label_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsMember" xlink:to="lab_us-gaap_InvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_2176dc26-9379-4fc1-a9f0-73dbc928afec_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_7db23362-d41f-492c-8808-be17b4ae607d_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_c3cf6fc6-00be-4db0-8b8b-13419168b397_verboseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_d399d3e5-db5a-4a98-a53f-d83b52173ab5_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodThreeMember_4b225711-b401-4274-849a-d14a8d17a71d_terseLabel_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter until maturity</link:label>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodThreeMember_label_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Payment Period, Three [Member]</link:label>
    <link:label id="lab_cnc_DebtInstrumentPaymentPeriodThreeMember_documentation_en-US" xlink:label="lab_cnc_DebtInstrumentPaymentPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Payment Period, Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodThreeMember" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DebtInstrumentPaymentPeriodThreeMember" xlink:to="lab_cnc_DebtInstrumentPaymentPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f05c6dd5-10d5-4e2c-985d-f7cf0cc51009_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_42503685-d36e-4406-a521-b2c5e68eee5e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_54de43a0-2ba5-4e86-b434-b887e43b17f7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_7b21c2a6-6a55-46ec-a9db-a224fe67cead_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_2b1c7b9f-976c-4568-af99-7ec2e9acf19e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2021</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms_334f00de-fe4b-47be-8db2-628ceb0d290f_terseLabel_en-US" xlink:label="lab_cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs</link:label>
    <link:label id="lab_cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms_label_en-US" xlink:label="lab_cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs</link:label>
    <link:label id="lab_cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms_documentation_en-US" xlink:label="lab_cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms" xlink:href="cnc-20221231.xsd#cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms" xlink:to="lab_cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_85aa877f-ac3f-40a3-91db-b479f3d279f0_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_83f47685-2abc-4ad8-b368-c0788431d4b3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AssetImpairmentChargesNetOfTax_15f067a4-4910-492f-930c-84bae8850872_terseLabel_en-US" xlink:label="lab_cnc_AssetImpairmentChargesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge, net of tax</link:label>
    <link:label id="lab_cnc_AssetImpairmentChargesNetOfTax_label_en-US" xlink:label="lab_cnc_AssetImpairmentChargesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Net of Tax</link:label>
    <link:label id="lab_cnc_AssetImpairmentChargesNetOfTax_documentation_en-US" xlink:label="lab_cnc_AssetImpairmentChargesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AssetImpairmentChargesNetOfTax" xlink:href="cnc-20221231.xsd#cnc_AssetImpairmentChargesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AssetImpairmentChargesNetOfTax" xlink:to="lab_cnc_AssetImpairmentChargesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_6d3c6c77-aec5-41eb-b79e-4719b7e6e333_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_698253b9-ebf0-42ae-a06b-d7bd286a851e_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_31a719af-e708-48aa-b705-f310a5a8abef_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_58a4e4df-8131-4a0d-9c4c-71951f00ba3b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for future awards (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_3d5b20c8-00ab-474c-a7f8-cad11a568580_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_67e6489e-8e0a-4717-8d23-03e8c5319c6e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_46c50b25-4691-4a54-976e-c5b9d8f8be2d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium yield</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_9fa5227f-7257-4571-bacf-2f7b745cc2d7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued for acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_37b2021c-2e94-4289-ac80-c8bd5dcaba4b_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_c1b9ff74-0db7-43ce-bb6d-b1c2b02aaa30_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9c32c573-29ee-4a53-b98a-22f3b9bcfc6f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term (recorded within other long-term liabilities)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_6489eca7-2b73-445c-98c9-5894eb3fdb9d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_e703b1ff-057c-4ab6-8427-90b70bdce555_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan matching contribution expense</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_b5f8e179-f023-4169-bec0-72bebed1df52_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_RestrictedCertificatesOfDepositMember_a9564fc0-a2c1-4033-a849-4a051b66d803_terseLabel_en-US" xlink:label="lab_cnc_RestrictedCertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted certificates of deposit</link:label>
    <link:label id="lab_cnc_RestrictedCertificatesOfDepositMember_label_en-US" xlink:label="lab_cnc_RestrictedCertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Certificates Of Deposit [Member]</link:label>
    <link:label id="lab_cnc_RestrictedCertificatesOfDepositMember_documentation_en-US" xlink:label="lab_cnc_RestrictedCertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted certificates of deposit [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RestrictedCertificatesOfDepositMember" xlink:href="cnc-20221231.xsd#cnc_RestrictedCertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_RestrictedCertificatesOfDepositMember" xlink:to="lab_cnc_RestrictedCertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_db2d037b-fd5c-4c58-8d52-b2440d421ff2_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_45872a86-847f-4c7a-a9dc-a31d9e42af98_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_da597b89-7272-4061-a0aa-d435947ca745_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_f3d13154-1597-41ea-88d2-aed2ecf14b9d_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6e419158-8c0c-48cf-99aa-83d36b92c1c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_09bed6d7-efa4-4375-9889-9b9224c0ee09_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statements Of Cash Flows</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statement [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_88ec3cc0-9109-49d7-800e-11d830e8048a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating activities, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_ff04d65f-c093-4667-927a-a2561ba40031_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasury securities and obligations of U.S. government corporations and agencies</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_66c6512f-51ba-49ec-93ae-c1801fa2e899_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_fb141ecd-e2fd-4ea0-bd76-bd2b623ad78c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1_cc131589-ec26-4c85-8eab-096af5673275_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustment to stock based compensation associated with pre-combination service</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_LesseeOperatingLeaseLeasesCommencedLiability_a4822786-7acc-4b09-9ba6-8ea97cb8667c_terseLabel_en-US" xlink:label="lab_cnc_LesseeOperatingLeaseLeasesCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability for leases commenced</link:label>
    <link:label id="lab_cnc_LesseeOperatingLeaseLeasesCommencedLiability_label_en-US" xlink:label="lab_cnc_LesseeOperatingLeaseLeasesCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Leases Commenced, Liability</link:label>
    <link:label id="lab_cnc_LesseeOperatingLeaseLeasesCommencedLiability_documentation_en-US" xlink:label="lab_cnc_LesseeOperatingLeaseLeasesCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Leases Commenced, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LesseeOperatingLeaseLeasesCommencedLiability" xlink:href="cnc-20221231.xsd#cnc_LesseeOperatingLeaseLeasesCommencedLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_LesseeOperatingLeaseLeasesCommencedLiability" xlink:to="lab_cnc_LesseeOperatingLeaseLeasesCommencedLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_8243b914-0f0c-4803-9841-12ca2b875a20_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_33a0ac12-75d6-47d0-9c54-d2069f7b7cf7_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b5d30369-3e5a-496a-8b82-6ca71f46c0f7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5d648db9-890a-4b67-afd3-ef34a0917588_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_7dd98a37-6890-4e2c-998c-8da8e5caffd9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_b756cc52-6087-494a-a968-d83da390fba5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_af31f933-ec4c-4e32-8991-477ec888ef77_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_030b1afe-c5b8-432b-af38-af03d842aa1c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_9c631114-897c-446a-9ae5-37748e1b5946_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_626fc30d-fca7-4264-9ed7-9607e28602fa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets (recorded within other long-term assets)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4b444c87-713e-4ab5-8cac-ffccd70fddc8_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7e6cb5e8-a3b0-47dd-8ec4-042f0e3e5fe0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_2021e1db-7d75-4e50-8057-55f59f855396_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_97130a98-c684-432d-a7db-7499d13f94a0_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_f918ccbb-9bc1-4547-be48-6ca4862a1464_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bde18362-cd59-4980-92d5-aa5d0d60c255_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount_3f320ea1-6666-486f-9138-df99525b871c_terseLabel_en-US" xlink:label="lab_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life insurance contracts</link:label>
    <link:label id="lab_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount_label_en-US" xlink:label="lab_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Insurance, Corporate or Bank Owned, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LifeInsuranceCorporateOrBankOwnedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount" xlink:to="lab_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_db50d534-dad2-4197-9eea-79cc065f60a5_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c7e94702-5d5d-40c9-b30b-41c0a8be944e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c9cd4c70-f9a1-4df5-81ed-6f8acf2be266_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Guidance and Recent Accounting Guidance Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_A2200Million30SeniorNotesDueOctober2030Member_5b911994-795b-46e6-864c-081c6758e3f0_terseLabel_en-US" xlink:label="lab_cnc_A2200Million30SeniorNotesDueOctober2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,200 million 3.00% Senior Notes, due October 15, 2030</link:label>
    <link:label id="lab_cnc_A2200Million30SeniorNotesDueOctober2030Member_label_en-US" xlink:label="lab_cnc_A2200Million30SeniorNotesDueOctober2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,200 Million 3.0% Senior Notes due October 2030 [Member]</link:label>
    <link:label id="lab_cnc_A2200Million30SeniorNotesDueOctober2030Member_documentation_en-US" xlink:label="lab_cnc_A2200Million30SeniorNotesDueOctober2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,200 Million 3.0% Senior Notes due October 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2200Million30SeniorNotesDueOctober2030Member" xlink:href="cnc-20221231.xsd#cnc_A2200Million30SeniorNotesDueOctober2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_A2200Million30SeniorNotesDueOctober2030Member" xlink:to="lab_cnc_A2200Million30SeniorNotesDueOctober2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_3311d8ba-f74c-48d2-81ed-13093b9d2681_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_52c5761b-26cd-4a12-8d6d-cfdc96fd671c_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical claims liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e01e4685-4124-4857-9468-6e3c73089d8d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_c846d6c4-cc77-4019-a542-c246b0658c6c_verboseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ManagedCareMember_a31a1868-67e7-4a38-b55a-13f393817c2e_terseLabel_en-US" xlink:label="lab_cnc_ManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed&#160;Care&#160;</link:label>
    <link:label id="lab_cnc_ManagedCareMember_label_en-US" xlink:label="lab_cnc_ManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed Care [Member]</link:label>
    <link:label id="lab_cnc_ManagedCareMember_documentation_en-US" xlink:label="lab_cnc_ManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ManagedCareMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ManagedCareMember" xlink:href="cnc-20221231.xsd#cnc_ManagedCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ManagedCareMember" xlink:to="lab_cnc_ManagedCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8d03804e-a940-4ae2-a17a-172bc389b9d5_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_bf354f7b-d699-48b4-aaa2-cb3e1a2115e1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_c937045c-1caa-4198-a869-865b0ec3a8ee_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_087098b6-a433-4c01-ab60-ae6fe17ef850_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Software and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_e19b5cca-7cb6-46a8-ab28-2ac4d0432c81_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ce18aa80-ead3-4c74-81e2-9441778c2433_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_33777df0-256d-48eb-99b9-c6459740d79e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_aeb35407-4875-4858-931e-967156767e65_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_c5d9909a-741e-4797-9632-e0a05a7437b6_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_973b3e82-47ff-4ab4-9092-0556c62957c7_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings per common share attributable to Centene Corporation:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue_03ba20a4-1ee5-4dcb-910a-d16c6869af7a_terseLabel_en-US" xlink:label="lab_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Converted (usd per share)</link:label>
    <link:label id="lab_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="cnc-20221231.xsd#cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_a72d4c18-20dc-4229-9a34-978a91c91702_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Prepaid Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_528eb4df-bd7a-4535-8a36-3c1fc75e6275_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_eadde5d6-1932-44b4-bb09-18c204058316_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares and potential dilutive common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_GrossDecreasesAbstract_b2846e3e-d526-4e36-9631-02a7357dc01d_verboseLabel_en-US" xlink:label="lab_cnc_GrossDecreasesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross decreases:</link:label>
    <link:label id="lab_cnc_GrossDecreasesAbstract_label_en-US" xlink:label="lab_cnc_GrossDecreasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Decreases [Abstract]</link:label>
    <link:label id="lab_cnc_GrossDecreasesAbstract_documentation_en-US" xlink:label="lab_cnc_GrossDecreasesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Decreases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GrossDecreasesAbstract" xlink:href="cnc-20221231.xsd#cnc_GrossDecreasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_GrossDecreasesAbstract" xlink:to="lab_cnc_GrossDecreasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_AffordableCareActMinimumMedicalLossRatio_2139b651-8673-4cae-a939-8e8e91b851b1_negatedLabel_en-US" xlink:label="lab_cnc_AffordableCareActMinimumMedicalLossRatio" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum medical loss ratio</link:label>
    <link:label id="lab_cnc_AffordableCareActMinimumMedicalLossRatio_label_en-US" xlink:label="lab_cnc_AffordableCareActMinimumMedicalLossRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act Minimum Medical Loss Ratio</link:label>
    <link:label id="lab_cnc_AffordableCareActMinimumMedicalLossRatio_documentation_en-US" xlink:label="lab_cnc_AffordableCareActMinimumMedicalLossRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act, Minimum Medical Loss Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActMinimumMedicalLossRatio" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActMinimumMedicalLossRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_AffordableCareActMinimumMedicalLossRatio" xlink:to="lab_cnc_AffordableCareActMinimumMedicalLossRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_ad802559-164d-4a9c-8c01-9448afce82cc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_14d58fe2-659d-4300-a7eb-0fb37a87fbc1_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_A1800Million245SeniorNotesDueMarch2028Member_064e1b48-6730-4046-9541-543492daa62e_terseLabel_en-US" xlink:label="lab_cnc_A1800Million245SeniorNotesDueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,800 Million 2.45% Senior Notes due March 2028</link:label>
    <link:label id="lab_cnc_A1800Million245SeniorNotesDueMarch2028Member_label_en-US" xlink:label="lab_cnc_A1800Million245SeniorNotesDueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,800 Million 2.45% Senior Notes due March 2028 [Member]</link:label>
    <link:label id="lab_cnc_A1800Million245SeniorNotesDueMarch2028Member_documentation_en-US" xlink:label="lab_cnc_A1800Million245SeniorNotesDueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,800 Million 2.45% Senior Notes due March 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A1800Million245SeniorNotesDueMarch2028Member" xlink:href="cnc-20221231.xsd#cnc_A1800Million245SeniorNotesDueMarch2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_A1800Million245SeniorNotesDueMarch2028Member" xlink:to="lab_cnc_A1800Million245SeniorNotesDueMarch2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_95e83fcf-18b4-45a1-b9fc-7ba27da3f15e_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_85fc0f0b-f391-4139-98ef-907c9c72a30d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Investments And Restricted Deposits By Type [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_8d335989-4755-4445-964b-c4243fe378e3_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_31429ed5-b46b-476c-aade-9174a22e0eb4_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashDividendsPaidToParentCompany_32f73aa8-d5f7-48e0-b205-3a78b920b25c_verboseLabel_en-US" xlink:label="lab_us-gaap_CashDividendsPaidToParentCompany" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends from subsidiaries, return of investment</link:label>
    <link:label id="lab_us-gaap_CashDividendsPaidToParentCompany_label_en-US" xlink:label="lab_us-gaap_CashDividendsPaidToParentCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompany" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDividendsPaidToParentCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashDividendsPaidToParentCompany" xlink:to="lab_us-gaap_CashDividendsPaidToParentCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0d830338-5b3d-48ce-bc7a-035c2b483247_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c2864c10-bc9e-4884-82cb-2a9c0d7b9e05_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_90f71da6-c72d-4e09-b12c-7526f8137654_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_6aa593d0-4cd7-459c-bdd0-210b597d42c0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_955faf24-d9f2-4090-b093-58ecefd13aea_negatedNetLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) on acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_769d994c-c65f-4d1e-85d8-9fd2c0776c02_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_52ebc605-be95-4d89-91db-da97e8a6d444_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_6e3ee033-1a5e-4ca8-8e5d-9bf89662f630_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_10e70b04-6b3f-4974-9825-54607e1cea6e_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in unrecognized tax benefits is reasonably possible</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0eef55ba-aea1-420b-9a55-d6e4902c3f15_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1a1dc562-0b2a-4d20-9e7e-df6c9f21057d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2dbd5ef8-5817-4431-b604-90bf980a670f_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_41579533-7b12-4651-b6d8-92ea421aaeb2_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_4008a3aa-efc9-463c-989b-0e6dcb4db704_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_d0293839-d4e6-48a8-88ef-36fd5ee74c1c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private equity investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_09043805-cfad-4bf1-9952-7031946926b2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_9dfd3013-e9b7-4aad-b6bb-992a3b0d1b30_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_06f26ece-a423-4e17-8766-04b16b94a538_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_A1300Million2625SeniorNotesDueAugust2031Member_37f55ae7-0dd8-4fb9-8744-1a88acc229c9_terseLabel_en-US" xlink:label="lab_cnc_A1300Million2625SeniorNotesDueAugust2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,300 Million 2.625% Senior Notes due August 2031 [Member]</link:label>
    <link:label id="lab_cnc_A1300Million2625SeniorNotesDueAugust2031Member_label_en-US" xlink:label="lab_cnc_A1300Million2625SeniorNotesDueAugust2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,300 Million 2.625% Senior Notes due August 2031 [Member]</link:label>
    <link:label id="lab_cnc_A1300Million2625SeniorNotesDueAugust2031Member_documentation_en-US" xlink:label="lab_cnc_A1300Million2625SeniorNotesDueAugust2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,300 Million 2.625% Senior Notes due August 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A1300Million2625SeniorNotesDueAugust2031Member" xlink:href="cnc-20221231.xsd#cnc_A1300Million2625SeniorNotesDueAugust2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_A1300Million2625SeniorNotesDueAugust2031Member" xlink:to="lab_cnc_A1300Million2625SeniorNotesDueAugust2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_6fe629ed-2822-43d9-b5fc-981fda097858_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_990e527a-823a-4473-afb2-5288de05fbdc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_e3efc575-0f74-4e70-b98c-3737e02a341f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_06f3798a-9116-4ae3-8af1-2a9229dbc8e6_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill_d339aa96-fda4-439a-ba94-90204a6a45c7_verboseLabel_en-US" xlink:label="lab_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible goodwill</link:label>
    <link:label id="lab_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill_label_en-US" xlink:label="lab_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Nondeductible Expense, Goodwill</link:label>
    <link:label id="lab_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill_documentation_en-US" xlink:label="lab_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Nondeductible Expense, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill" xlink:href="cnc-20221231.xsd#cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill" xlink:to="lab_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_49a6411a-411d-48b3-ab62-deaa281db735_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2020</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_A2500Million425SeniorNotesDueDecember2027Member_fed50b3b-f561-47bb-be96-68a0ac7d6160_terseLabel_en-US" xlink:label="lab_cnc_A2500Million425SeniorNotesDueDecember2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,500 million 4.25% Senior Notes, due December 15, 2027</link:label>
    <link:label id="lab_cnc_A2500Million425SeniorNotesDueDecember2027Member_c4267ae0-ff6e-4636-96da-4693795dda70_verboseLabel_en-US" xlink:label="lab_cnc_A2500Million425SeniorNotesDueDecember2027Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,500 Million 4.25% Senior Notes due December 2027 [Member]</link:label>
    <link:label id="lab_cnc_A2500Million425SeniorNotesDueDecember2027Member_label_en-US" xlink:label="lab_cnc_A2500Million425SeniorNotesDueDecember2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,500 Million 4.25% Senior Notes due December 2027 [Member]</link:label>
    <link:label id="lab_cnc_A2500Million425SeniorNotesDueDecember2027Member_documentation_en-US" xlink:label="lab_cnc_A2500Million425SeniorNotesDueDecember2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2,500 Million 4.25% Senior Notes due December 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2500Million425SeniorNotesDueDecember2027Member" xlink:href="cnc-20221231.xsd#cnc_A2500Million425SeniorNotesDueDecember2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_A2500Million425SeniorNotesDueDecember2027Member" xlink:to="lab_cnc_A2500Million425SeniorNotesDueDecember2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_PANTHERxRareMember_bfab3e86-f708-4c24-b6db-772dbb9c755f_terseLabel_en-US" xlink:label="lab_cnc_PANTHERxRareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PANTHERx Rare</link:label>
    <link:label id="lab_cnc_PANTHERxRareMember_label_en-US" xlink:label="lab_cnc_PANTHERxRareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PANTHERx Rare [Member]</link:label>
    <link:label id="lab_cnc_PANTHERxRareMember_documentation_en-US" xlink:label="lab_cnc_PANTHERxRareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PANTHERx Rare</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PANTHERxRareMember" xlink:href="cnc-20221231.xsd#cnc_PANTHERxRareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_PANTHERxRareMember" xlink:to="lab_cnc_PANTHERxRareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_1c447e42-45d4-4165-b7b0-80a08e665780_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_22f42d96-a759-478f-94a0-dcc4bdc91290_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_3a2e5ade-00a1-43c3-ba07-c3e52eb82ff8_terseLabel_en-US" xlink:label="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Uncertainty [Axis]</link:label>
    <link:label id="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_label_en-US" xlink:label="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Uncertainty [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:to="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_87f44db1-4282-4a7b-9ecc-e093a59b1b69_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_b70738ee-98b2-4f1e-b467-08402792aed0_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_label_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_b6b056bc-2418-4ea7-bb4b-c53e0e4f7a79_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_231c5731-7a7a-4430-a128-4d77baf399e2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU asset impairments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_5b76affa-1fc7-4ed3-8374-2c90d0ae3666_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_f6ceeece-2a6b-439a-b7c2-3ba16faf61b1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_963bdac6-889d-4d83-af5a-4e4dab9d09c7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_720dbf29-17db-424e-bdae-d969eb5d5381_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7491a3c4-db0f-4f02-b2da-4359833eaf54_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_de6b602e-2fa3-4b9d-9c7d-2e42370dc03a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, software and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_564e99be-4c05-4dae-b6d3-e177228d0b30_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, software and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_352e8d93-e4c8-44d0-8850-f71ba565f6a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of amortization expense related to intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_60ca40a9-362c-4798-a028-93849da5fd45_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Values and Weighted Average Useful Lives for Identifiable Intangible Assets Acquired</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock_7c2678c5-4076-4f64-a50c-398a50ce10fc_terseLabel_en-US" xlink:label="lab_cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Allowance For Uncollectible Accounts</link:label>
    <link:label id="lab_cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock_label_en-US" xlink:label="lab_cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Allowance For Uncollectible Accounts [Table Text Block]</link:label>
    <link:label id="lab_cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock_documentation_en-US" xlink:label="lab_cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Allowance For Uncollectible Accounts [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock" xlink:href="cnc-20221231.xsd#cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock" xlink:to="lab_cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ac4119a2-7e2a-46ad-b806-c3bc0a979ce2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_36bae194-4a0e-4b77-8644-d935825e1433_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsNatureDomain_063b4056-0e90-4fd8-8428-fcdefd068810_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsNatureDomain_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain" xlink:to="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2b494405-01ff-4d08-bf9b-024279e4e4b4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive earnings (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_12a7c053-17cf-4e45-be61-66f908298e1b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Deposits</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_913206d4-bcfe-4ec5-bc37-1761114d3702_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_GainLossOnDispositionOfBusinessNetOfTax_fe0e0457-97d7-41e8-a32a-333e1b6aa8d3_terseLabel_en-US" xlink:label="lab_cnc_GainLossOnDispositionOfBusinessNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) on divestitures, net of tax</link:label>
    <link:label id="lab_cnc_GainLossOnDispositionOfBusinessNetOfTax_label_en-US" xlink:label="lab_cnc_GainLossOnDispositionOfBusinessNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business, Net of Tax</link:label>
    <link:label id="lab_cnc_GainLossOnDispositionOfBusinessNetOfTax_documentation_en-US" xlink:label="lab_cnc_GainLossOnDispositionOfBusinessNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GainLossOnDispositionOfBusinessNetOfTax" xlink:href="cnc-20221231.xsd#cnc_GainLossOnDispositionOfBusinessNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_GainLossOnDispositionOfBusinessNetOfTax" xlink:to="lab_cnc_GainLossOnDispositionOfBusinessNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_7b1eca59-5ec8-4bda-b81e-297d3f332178_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_82f7fecf-f778-4ece-ad45-d161a1396ca9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for legal settlement</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest_d9e53428-5f01-43f6-b5fa-e2c2357459f1_terseLabel_en-US" xlink:label="lab_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (earnings) attributable to flow through noncontrolling interest</link:label>
    <link:label id="lab_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest_label_en-US" xlink:label="lab_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (earnings) attributable to flow through noncontrolling interest</link:label>
    <link:label id="lab_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest_documentation_en-US" xlink:label="lab_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (earnings) attributable to flow through noncontrolling interest before tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest" xlink:href="cnc-20221231.xsd#cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest" xlink:to="lab_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_c302623c-774c-4925-bf0b-b81b172ad226_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_ffbc03e9-abf9-4d51-9e13-1250fb23192e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_0de5e438-58aa-465d-896d-f41d32e6eb52_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_943a90ea-af63-4a92-8179-d617f45c394a_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_b8db5e7c-12a5-4182-b6e8-9c2db99cd67d_terseLabel_en-US" xlink:label="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Claims Liability</link:label>
    <link:label id="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:to="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1e8bd273-ff59-480b-80e3-9acf951998a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_72ec36e6-4fe7-48cc-9231-cb3f4d5d78a7_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_bb8e2cfd-7d3e-4950-b2b3-f48ebc12dab5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the plans</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits_a2d527e0-6ef8-487b-a16e-81e59565abe6_terseLabel_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted deposits</link:label>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits_label_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Deposits</link:label>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits_documentation_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits" xlink:to="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_473ac87a-b26d-4ccc-8834-1c554a97439e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Software and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock_028daa58-2b87-41b9-8572-0d7984244f1e_terseLabel_en-US" xlink:label="lab_cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of receivables (payables) related to the Health Insurance Marketplace programs</link:label>
    <link:label id="lab_cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock_label_en-US" xlink:label="lab_cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Receivables (Payables) Related To The Affordable Care Act Programs [Table Text Block]</link:label>
    <link:label id="lab_cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock_documentation_en-US" xlink:label="lab_cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Receivables (Payables) Related to the Affordable Care Act Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock" xlink:href="cnc-20221231.xsd#cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock" xlink:to="lab_cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_91be43e6-3f80-4f4f-89d6-379de0096ac5_totalLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical claims liability, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_MagellanSpecialtyHealthMember_cbe3d39d-4b51-46ef-a5df-b104a478e1ae_terseLabel_en-US" xlink:label="lab_cnc_MagellanSpecialtyHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Specialty Health</link:label>
    <link:label id="lab_cnc_MagellanSpecialtyHealthMember_label_en-US" xlink:label="lab_cnc_MagellanSpecialtyHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Specialty Health [Member]</link:label>
    <link:label id="lab_cnc_MagellanSpecialtyHealthMember_documentation_en-US" xlink:label="lab_cnc_MagellanSpecialtyHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Magellan Specialty Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanSpecialtyHealthMember" xlink:href="cnc-20221231.xsd#cnc_MagellanSpecialtyHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_MagellanSpecialtyHealthMember" xlink:to="lab_cnc_MagellanSpecialtyHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable_26ac6c75-0834-44e3-a82d-1c5e59884dfa_terseLabel_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return of premium payable</link:label>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable_label_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Return Of Premium Payable</link:label>
    <link:label id="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable_documentation_en-US" xlink:label="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Return Of Premium Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable" xlink:to="lab_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_b266ecb0-6341-4a45-92ae-dd7af834c9ad_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_12773bb4-6974-4c51-8e96-ad273bdc02c4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_88a6bbe8-720d-4976-998d-df805969958b_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale, Maturity and Collection of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_1389e924-ac74-4208-a9c7-1ab73ab09606_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh_4816cb48-4115-450c-b40d-8f7cfb892507_terseLabel_en-US" xlink:label="lab_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, could receive (up to)</link:label>
    <link:label id="lab_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Consideration, Contingent Consideration, Range of Outcomes, Value High</link:label>
    <link:label id="lab_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh_documentation_en-US" xlink:label="lab_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Consideration, Contingent Consideration, Range of Outcomes, Value High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh" xlink:href="cnc-20221231.xsd#cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh" xlink:to="lab_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_34b7985f-1fca-4d1f-9f28-e029a52a2219_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_f8166746-5c09-47fe-9d49-dcd152bcb736_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_A750Million5375SeniorNotesDueJune2026Member_ccb0efec-4e9f-40f7-aed5-6ac8ae593cee_verboseLabel_en-US" xlink:label="lab_cnc_A750Million5375SeniorNotesDueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.375% Senior notes, due 2026</link:label>
    <link:label id="lab_cnc_A750Million5375SeniorNotesDueJune2026Member_label_en-US" xlink:label="lab_cnc_A750Million5375SeniorNotesDueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$750 Million 5.375% Senior Notes due June 2026 [Member]</link:label>
    <link:label id="lab_cnc_A750Million5375SeniorNotesDueJune2026Member_documentation_en-US" xlink:label="lab_cnc_A750Million5375SeniorNotesDueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$750 Million 5.375% Senior Notes due June 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A750Million5375SeniorNotesDueJune2026Member" xlink:href="cnc-20221231.xsd#cnc_A750Million5375SeniorNotesDueJune2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_A750Million5375SeniorNotesDueJune2026Member" xlink:to="lab_cnc_A750Million5375SeniorNotesDueJune2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_702b19cd-baed-4727-8746-0637fc1688fe_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued for employee benefit plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_4d225b6f-741f-4796-8cea-60ce4693276c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_8a8ebe17-bf7d-48c2-96f0-2049c639bc51_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_fcde47e7-b4d7-459e-8098-8379daa76893_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_77262f4a-d135-494b-aa3d-3b6f899bf6d2_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_f4405307-94b8-4073-ad9b-1285e7734c0b_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_9b3a1f55-4ede-4275-be43-8bdf1dd6b86b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_ffe35b49-133c-457f-b065-a437da7c9dd1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_7ef99577-1e15-4bf8-b89d-269b28816397_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_58a5bb6b-e4ee-455d-89ea-b933f993c24b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_CircleHealthMember_47dcaf02-0cbc-4d15-a1df-a8ddf3ecdc27_terseLabel_en-US" xlink:label="lab_cnc_CircleHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circle Health</link:label>
    <link:label id="lab_cnc_CircleHealthMember_label_en-US" xlink:label="lab_cnc_CircleHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circle Health [Member]</link:label>
    <link:label id="lab_cnc_CircleHealthMember_documentation_en-US" xlink:label="lab_cnc_CircleHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circle Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_CircleHealthMember" xlink:href="cnc-20221231.xsd#cnc_CircleHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_CircleHealthMember" xlink:to="lab_cnc_CircleHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_517bb2a8-c1c8-41c6-a7ee-050cb66cd75a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_e1f23a45-1bd7-4e36-9d32-76cf1a41695d_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_b1d36450-57ed-42bf-987a-088d79b45e14_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_RestrictedCashEquivalentsMember_6943e408-5bd9-4ff4-b606-691b8d188818_terseLabel_en-US" xlink:label="lab_cnc_RestrictedCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash equivalents</link:label>
    <link:label id="lab_cnc_RestrictedCashEquivalentsMember_label_en-US" xlink:label="lab_cnc_RestrictedCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents [Member]</link:label>
    <link:label id="lab_cnc_RestrictedCashEquivalentsMember_documentation_en-US" xlink:label="lab_cnc_RestrictedCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RestrictedCashEquivalentsMember" xlink:href="cnc-20221231.xsd#cnc_RestrictedCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_RestrictedCashEquivalentsMember" xlink:to="lab_cnc_RestrictedCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_RxAdvanceMember_90ef58f8-edc9-4388-8592-61ab3c5dd3c5_terseLabel_en-US" xlink:label="lab_cnc_RxAdvanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RxAdvance</link:label>
    <link:label id="lab_cnc_RxAdvanceMember_label_en-US" xlink:label="lab_cnc_RxAdvanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RxAdvance [Member]</link:label>
    <link:label id="lab_cnc_RxAdvanceMember_documentation_en-US" xlink:label="lab_cnc_RxAdvanceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RxAdvance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RxAdvanceMember" xlink:href="cnc-20221231.xsd#cnc_RxAdvanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_RxAdvanceMember" xlink:to="lab_cnc_RxAdvanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ac77638d-752c-42ae-a989-44b304074083_negatedNetLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries_6708d68f-8959-4815-b9c5-d51e396e781a_totalLabel_en-US" xlink:label="lab_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) before equity in subsidiaries</link:label>
    <link:label id="lab_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries_label_en-US" xlink:label="lab_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss), including portion attributable to noncontrolling interest before equity in earnings from subsidiaries</link:label>
    <link:label id="lab_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries_documentation_en-US" xlink:label="lab_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss), including portion attributable to noncontrolling interest before equity in earnings from subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries" xlink:href="cnc-20221231.xsd#cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries" xlink:to="lab_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_8813c364-8066-48be-ad03-6d12872113bc_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_0ba574e2-65df-4258-8ffe-d962a29751e5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual maturities of short-term and long-term investments and restricted deposits</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_df2b2865-b436-4f3c-99d5-9d4ccc7537c0_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_781ac21e-51ca-4a5a-b664-5550a3e87ee9_verboseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Operations</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignLineOfCreditMember_c79dac81-8d26-4184-a33c-3ba491bd2aae_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Line of Credit</link:label>
    <link:label id="lab_us-gaap_ForeignLineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_ForeignLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignLineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignLineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignLineOfCreditMember" xlink:to="lab_us-gaap_ForeignLineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExternalCreditRatingInvestmentGradeMember_1c019a19-5f9d-414c-87cf-9494f3c7ddfb_terseLabel_en-US" xlink:label="lab_us-gaap_ExternalCreditRatingInvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating, Investment Grade</link:label>
    <link:label id="lab_us-gaap_ExternalCreditRatingInvestmentGradeMember_label_en-US" xlink:label="lab_us-gaap_ExternalCreditRatingInvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating, Investment Grade [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingInvestmentGradeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingInvestmentGradeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExternalCreditRatingInvestmentGradeMember" xlink:to="lab_us-gaap_ExternalCreditRatingInvestmentGradeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_ffa8b4d8-43f8-49a4-82a7-629a6c45a2db_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7cee4b13-4321-4535-ac43-db393c5a34ed_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d286c148-1aa1-4c29-a8b5-4d405ef125d7_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_9ae1c610-c335-45b8-8eea-49edae6a6b2e_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_00417335-525b-4cc3-b403-c42b5834dd16_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_f8bed95d-5744-4128-aa5d-bda6c7bd7029_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_f1c3a2b0-4491-42c5-b80e-60f2b9d7c0a2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents reclassified (to) from held for sale</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f6374f25-9e6f-4ee3-b5b9-12f2ead0b617_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f0b2a5e1-a7e3-4190-9ba0-e580fcf5e477_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired finite-lived intangible assets, weighted average useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_61d59522-10eb-4728-8ff0-9b8f1c12cbba_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_d0c837ff-01bc-4b2e-a612-df2ff85d3f77_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_d9d25e71-012e-489a-b010-652e3807614c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock_26dcd14d-dae9-4934-b570-2691b2e907d2_terseLabel_en-US" xlink:label="lab_cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Property Software And Equipment Depreciation Periods</link:label>
    <link:label id="lab_cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock_label_en-US" xlink:label="lab_cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Property Software And Equipment Depreciation Periods [Table Text Block]</link:label>
    <link:label id="lab_cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock_documentation_en-US" xlink:label="lab_cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Property Software And Equipment Depreciation Periods [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock" xlink:href="cnc-20221231.xsd#cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock" xlink:to="lab_cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7459cdec-8ba8-4427-96ae-30fde46dac75_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_76280658-2ddc-4c4c-828e-47c65cac52be_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity value issued in business acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_1b2f8e4f-d662-423f-927c-0f7f09e03680_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_e5e395a9-ba2b-479a-b032-83bee6caf6d2_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_319e6153-6785-4458-9227-1d6ed0237cf9_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_0bb078db-f52d-4ad4-8951-cb333801d36f_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_2a55b288-7dd7-4a7d-9a72-9b30afb11f27_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_5dd5eaab-c834-4393-8ca7-c5aca053e8ca_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends_bc1e2095-b604-42e1-8268-c1dbc563761b_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital and surplus or net worth not available for dividends</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Retained Earnings Not Available for Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends" xlink:to="lab_us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c9a85460-8fec-4657-807c-d82f223745f7_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_64165e09-cb6c-4b63-a553-0eac09295ad2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_13ccae04-46f1-468a-917f-1e13d02f2674_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred related to:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_940a12c3-5e71-4e4a-909d-fa5dad6cbad9_periodStartLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, January 1</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_c18b7e66-5dff-479f-892b-ab03ad8236bc_periodEndLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, December 31</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditAvailabilityConcentrationRiskMember_d72cf89f-aafd-4788-a63a-9506803f6d2a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditAvailabilityConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Availability Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CreditAvailabilityConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CreditAvailabilityConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Availability Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditAvailabilityConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditAvailabilityConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditAvailabilityConcentrationRiskMember" xlink:to="lab_us-gaap_CreditAvailabilityConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_04889cee-c112-42cd-b3b7-a531667f6fec_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ReturnofPremiumPayable_68333553-8044-4348-a289-1e5e2c2e7e0d_terseLabel_en-US" xlink:label="lab_cnc_ReturnofPremiumPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return of premium payable</link:label>
    <link:label id="lab_cnc_ReturnofPremiumPayable_label_en-US" xlink:label="lab_cnc_ReturnofPremiumPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return of Premium Payable</link:label>
    <link:label id="lab_cnc_ReturnofPremiumPayable_documentation_en-US" xlink:label="lab_cnc_ReturnofPremiumPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return of Premium Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ReturnofPremiumPayable" xlink:href="cnc-20221231.xsd#cnc_ReturnofPremiumPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ReturnofPremiumPayable" xlink:to="lab_cnc_ReturnofPremiumPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_bf8c4c44-8ce2-48de-ad3f-323f28af14e1_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, redeemable noncontrolling interests and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_81e23dc9-3426-4661-9f0f-b1cba07b6785_terseLabel_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurance product line</link:label>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthInsuranceProductLineMember" xlink:to="lab_us-gaap_HealthInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_ed780461-3ccc-4745-9898-9255189b86d2_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_4c1fd0ae-010d-4117-8382-ea0c49b009f6_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsMember_ba2f3dc9-24f3-4553-973d-ebf33c7591d1_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Deposits</link:label>
    <link:label id="lab_us-gaap_DepositsMember_label_en-US" xlink:label="lab_us-gaap_DepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsMember" xlink:to="lab_us-gaap_DepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_93bd33f3-5c0d-4f6f-ba53-488edaeb2318_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_896caaac-095f-46d1-b9ac-64a3f3742ca8_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_5e062060-8613-4ecc-a458-87ab1cd7ba55_negatedNetLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_88d2b8e2-b47f-498f-bf6a-5a0fd5cff76f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_e0618f8b-49d5-4d6c-be60-2b83baf4aa96_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties for uncertain tax position</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1d8f8905-db8d-477f-a10b-19b5e98ae5c5_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_7dd69c13-d8ef-4b51-9fa7-d89ae5723043_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per common share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a081b845-1d6b-46f3-a7ad-6a85f9e23ec1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options, restricted stock and restricted stock unit awards vesting period, years</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_SpanishAndCentralEuropeanBusinessesMember_7b113e53-9653-40db-a27c-dc1bfc9e7254_terseLabel_en-US" xlink:label="lab_cnc_SpanishAndCentralEuropeanBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spanish and Central European Businesses</link:label>
    <link:label id="lab_cnc_SpanishAndCentralEuropeanBusinessesMember_label_en-US" xlink:label="lab_cnc_SpanishAndCentralEuropeanBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spanish and Central European Businesses [Member]</link:label>
    <link:label id="lab_cnc_SpanishAndCentralEuropeanBusinessesMember_documentation_en-US" xlink:label="lab_cnc_SpanishAndCentralEuropeanBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spanish and Central European Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SpanishAndCentralEuropeanBusinessesMember" xlink:href="cnc-20221231.xsd#cnc_SpanishAndCentralEuropeanBusinessesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_SpanishAndCentralEuropeanBusinessesMember" xlink:to="lab_cnc_SpanishAndCentralEuropeanBusinessesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_f5313833-4fd9-430e-b19d-173b2926fb69_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_05442402-3b9d-4da9-a5a3-9ae2b1980607_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_3cc9a6ce-4f8c-4518-8f3f-b7e6d54e10f0_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_8e740f9e-b317-43fd-bd2f-56fa1720c02d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_01a39a30-4fa2-421c-b5f7-981ebdce7c3a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Investments And Restricted Deposits By Type [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_328f7143-8db0-47f0-898a-65805ae7dc1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_e5913278-1257-4c36-bf1d-49025309fbbe_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits, January 1</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_d7ad374a-89b6-4264-95b3-9f12206f6508_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits, December 31</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_c74a67ab-41e7-47c9-bd19-cbbb26eff685_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_530c8cd1-58b5-4aac-b35b-ea1f41a8590e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining asset impairment charges</link:label>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetImpairmentCharges" xlink:to="lab_us-gaap_OtherAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_1101cc11-28e8-4006-b9b7-08129abcf1ff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_2b161dd6-d7a8-4b09-bd14-acc0cdeecbbc_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_d318f574-ae3e-410f-85a6-add53c0149dc_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f062cd49-bc64-43c7-91d4-03b82b1ec039_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ef8f4f52-b50d-44c8-bb38-deb73d04543a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_a03cbea7-2dae-4474-8eb7-db78c3eb81ef_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (loss), tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_6e61e97c-8456-4457-841a-76fef79bc3bd_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_b843abef-0fc1-498b-b12f-d8bd5029d192_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_3f0c35ab-3705-409e-9bdf-8b0c716219a8_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_ac99beae-f32e-42b5-882b-33e3e22d3bb8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_d9a939b0-55fa-4f18-8b5c-8968851b296b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_e21f6eb7-6e8d-4f5f-8831-f6a7a351fce6_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration_158a08c3-3d26-436c-bddb-6a66bac1c319_terseLabel_en-US" xlink:label="lab_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years)</link:label>
    <link:label id="lab_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration_label_en-US" xlink:label="lab_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration</link:label>
    <link:label id="lab_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration_documentation_en-US" xlink:label="lab_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration" xlink:href="cnc-20221231.xsd#cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration" xlink:to="lab_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_51646a1a-1538-4f3f-9de5-5808a47e27d1_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_InvestmentSecuritiesMember_2ba02a98-8181-4a29-8fa0-fee1cbed3b14_terseLabel_en-US" xlink:label="lab_cnc_InvestmentSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Securities</link:label>
    <link:label id="lab_cnc_InvestmentSecuritiesMember_label_en-US" xlink:label="lab_cnc_InvestmentSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Securities [Member]</link:label>
    <link:label id="lab_cnc_InvestmentSecuritiesMember_documentation_en-US" xlink:label="lab_cnc_InvestmentSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_InvestmentSecuritiesMember" xlink:href="cnc-20221231.xsd#cnc_InvestmentSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_InvestmentSecuritiesMember" xlink:to="lab_cnc_InvestmentSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_bfa49ccb-5996-4e2c-ad73-493f013dea63_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_97a6ba95-2364-4deb-85f9-49b7a031fce6_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term Assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_4d286115-53e3-48b1-a2b8-c7f1e831abec_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment on equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_fb06fd6f-7cdb-4470-ba9c-894b173f9136_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable_0b1a30e5-e26f-49c7-87fb-61cdaa26c81d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium and trade receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Premiums Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPremiumsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInPremiumsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_fa07ee1b-b127-4c94-95a6-1f6d2bd3daa3_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_7d3564d9-849e-4574-8991-c9f135ce9200_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock_57da0db7-9295-426b-ac84-83b73f5a195f_terseLabel_en-US" xlink:label="lab_cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Amortization Period For Intangible Assets</link:label>
    <link:label id="lab_cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Amortization Period For Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock_documentation_en-US" xlink:label="lab_cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Amortization Period For Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock" xlink:href="cnc-20221231.xsd#cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock" xlink:to="lab_cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_PurchaserBusinessGroupOnHealthMember_10160e06-b266-43d6-8d5e-44d215538d0a_terseLabel_en-US" xlink:label="lab_cnc_PurchaserBusinessGroupOnHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchaser Business Group on Health</link:label>
    <link:label id="lab_cnc_PurchaserBusinessGroupOnHealthMember_label_en-US" xlink:label="lab_cnc_PurchaserBusinessGroupOnHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchaser Business Group on Health [Member]</link:label>
    <link:label id="lab_cnc_PurchaserBusinessGroupOnHealthMember_documentation_en-US" xlink:label="lab_cnc_PurchaserBusinessGroupOnHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchaser Business Group on Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PurchaserBusinessGroupOnHealthMember" xlink:href="cnc-20221231.xsd#cnc_PurchaserBusinessGroupOnHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_PurchaserBusinessGroupOnHealthMember" xlink:to="lab_cnc_PurchaserBusinessGroupOnHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_870a74f1-1613-451e-92a6-a16c6a26f4dd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_b6674ffd-bac9-4308-8545-4e5b3f62dd54_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod_1ea91308-1988-4e52-ae9a-24bbc98ae9c4_terseLabel_en-US" xlink:label="lab_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Converted (in shares)</link:label>
    <link:label id="lab_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod_label_en-US" xlink:label="lab_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted Grants in Period</link:label>
    <link:label id="lab_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod_documentation_en-US" xlink:label="lab_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted Due to Acquisition, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod" xlink:href="cnc-20221231.xsd#cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod" xlink:to="lab_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_bc27339c-5c36-46cc-8d61-c1b36e6574ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_26c0efd9-a559-4dc0-9842-f630d17364e6_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated litigation reserve</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock_33eab1b4-1e09-4803-801c-40c4bab0e323_terseLabel_en-US" xlink:label="lab_cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affordable Care Act</link:label>
    <link:label id="lab_cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock_label_en-US" xlink:label="lab_cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Marketplace Disclosure [Policy Text Block]</link:label>
    <link:label id="lab_cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock_documentation_en-US" xlink:label="lab_cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Marketplace Disclosure [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock" xlink:href="cnc-20221231.xsd#cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock" xlink:to="lab_cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_e40a2cd4-5cf6-4ad5-b593-687da0ee347d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_25580aa7-1f07-4401-b53c-4229bf1fe917_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_6166ff5d-b036-4555-b5e6-7ec30b3d1246_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_1664ac34-cf7d-4262-86cd-7f6e5c2bf36f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_0cef8ba1-faae-4eb7-aae2-ae08b10a4856_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax provision at the U.S. federal statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_abc3cc4c-e563-4b17-8391-79ab83fb1807_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease_b4cfc075-95aa-477b-9d6a-8eb8eb83493f_terseLabel_en-US" xlink:label="lab_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of debt to EBITDA, may increase</link:label>
    <link:label id="lab_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease_label_en-US" xlink:label="lab_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Terms, Ratio Of Debt To Earnings Before Interest Taxes Depreciation And Amortization, Current Year, Other Increase</link:label>
    <link:label id="lab_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease_documentation_en-US" xlink:label="lab_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Terms, Ratio Of Debt To Earnings Before Interest Taxes Depreciation And Amortization, Current Year, Other Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease" xlink:href="cnc-20221231.xsd#cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease" xlink:to="lab_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_89ee17ff-097a-438f-b97e-df4486e241c6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_5fba0c6e-31e8-4419-8285-eba8f5b244f5_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_f9f44294-00ae-428e-a0dd-ff8df52bec54_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_86242237-7c2b-437f-9d5b-01f3eb3b1ed2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture proceeds, net of divested cash</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cnc-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0b97e17d-6106-45f4-89d6-4fad8114f6eb,g:0be59ac2-4e57-4dab-9620-00ce2b3b169c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.centene.com/role/Cover" xlink:type="simple" xlink:href="cnc-20221231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7d8a6fa1-eaed-4d44-93d6-b8b5572a5a78" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_DocumentType_7d8a6fa1-eaed-4d44-93d6-b8b5572a5a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_431019d7-b286-4af9-9b99-d4ca4061bb24" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_DocumentAnnualReport_431019d7-b286-4af9-9b99-d4ca4061bb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_fe7f9b69-fa8c-49e4-946c-17f281f7bb91" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_DocumentPeriodEndDate_fe7f9b69-fa8c-49e4-946c-17f281f7bb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_625873b2-ed38-44c8-b7c6-28d95a4bd053" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_CurrentFiscalYearEndDate_625873b2-ed38-44c8-b7c6-28d95a4bd053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_35e9d9b7-a4e1-4d2a-ad99-a718d535bb13" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_DocumentTransitionReport_35e9d9b7-a4e1-4d2a-ad99-a718d535bb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a36e7e45-040d-4671-b16a-6b2668d0a1f6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityFileNumber_a36e7e45-040d-4671-b16a-6b2668d0a1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c2252aa7-a36b-4ec1-be5b-80ba4bf83be9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityRegistrantName_c2252aa7-a36b-4ec1-be5b-80ba4bf83be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ae537350-823e-4854-b08e-91b203a3aade" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ae537350-823e-4854-b08e-91b203a3aade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e0c45fd8-0cbb-4a1e-a4b9-70c7719d37d2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityTaxIdentificationNumber_e0c45fd8-0cbb-4a1e-a4b9-70c7719d37d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7be39459-6919-498a-b909-92e09aa327e4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityAddressAddressLine1_7be39459-6919-498a-b909-92e09aa327e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_cdd5129e-33cd-4169-b7ef-e1d2ec871d89" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityAddressCityOrTown_cdd5129e-33cd-4169-b7ef-e1d2ec871d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f2df5417-eb12-4141-a1f8-e6dea8bfc460" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityAddressStateOrProvince_f2df5417-eb12-4141-a1f8-e6dea8bfc460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9c50d372-30a6-4473-94ec-825a080cfe82" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityAddressPostalZipCode_9c50d372-30a6-4473-94ec-825a080cfe82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fa2a5ad1-a20f-4734-abdd-e5e5f5da50b3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_CityAreaCode_fa2a5ad1-a20f-4734-abdd-e5e5f5da50b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_c4f2e0b6-4989-4b0a-86e1-2a62600d0fce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_LocalPhoneNumber_c4f2e0b6-4989-4b0a-86e1-2a62600d0fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_01653d59-d51a-47da-980b-4bf350693bb1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_Security12bTitle_01653d59-d51a-47da-980b-4bf350693bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c1207f1e-6a77-4c47-b4ec-950c1f9f3a55" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_TradingSymbol_c1207f1e-6a77-4c47-b4ec-950c1f9f3a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ae9375f2-7d25-47bc-8403-2543ae698fdb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_SecurityExchangeName_ae9375f2-7d25-47bc-8403-2543ae698fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_ac9b3d17-b54a-4ffc-b7fc-f9085a29b553" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_ac9b3d17-b54a-4ffc-b7fc-f9085a29b553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_71f6aff8-c561-4676-a47c-69bcf4147d82" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityVoluntaryFilers_71f6aff8-c561-4676-a47c-69bcf4147d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_aa98ac68-a8cb-449c-882b-6e8ffb52386b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityCurrentReportingStatus_aa98ac68-a8cb-449c-882b-6e8ffb52386b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_a0d88072-5abc-4609-9381-c4512bde3976" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityInteractiveDataCurrent_a0d88072-5abc-4609-9381-c4512bde3976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_3768c31f-3462-4f57-9bf9-be3a7a8f60fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityFilerCategory_3768c31f-3462-4f57-9bf9-be3a7a8f60fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_9a9ce405-4f48-4756-80e6-56b1233be801" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntitySmallBusiness_9a9ce405-4f48-4756-80e6-56b1233be801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_56060b4a-18ff-4fb2-9e38-7db3d48c0fbb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityEmergingGrowthCompany_56060b4a-18ff-4fb2-9e38-7db3d48c0fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_eb238aa3-ee61-40d1-b540-0b3f531de3e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityShellCompany_eb238aa3-ee61-40d1-b540-0b3f531de3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_213d07e2-ee63-4f06-9dee-f6033203e0f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityPublicFloat_213d07e2-ee63-4f06-9dee-f6033203e0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_651b93b4-d518-4402-8c7f-28fe115eb528" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_651b93b4-d518-4402-8c7f-28fe115eb528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_2fc50ecc-6d14-4262-9030-c8ca855600c7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_2fc50ecc-6d14-4262-9030-c8ca855600c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_9ea04fc2-c455-4137-a53d-08b00202a739" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_EntityCentralIndexKey_9ea04fc2-c455-4137-a53d-08b00202a739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_14b4040a-d64b-4fc8-87a1-179815c23c89" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_IcfrAuditorAttestationFlag_14b4040a-d64b-4fc8-87a1-179815c23c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_23220d7d-3191-492b-bfae-26153c8dd7d5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_DocumentFiscalYearFocus_23220d7d-3191-492b-bfae-26153c8dd7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_f32e6ccf-873f-4d2d-8c77-bcc66dff6596" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_f32e6ccf-873f-4d2d-8c77-bcc66dff6596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4a118a72-620f-4b37-87b3-1285f1656993" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_23bb3761-66fd-43e4-88d8-2cdf951c5bf0" xlink:to="loc_dei_AmendmentFlag_4a118a72-620f-4b37-87b3-1285f1656993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/AuditInformation" xlink:type="simple" xlink:href="cnc-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AuditorInformationAbstract_1be5c5bb-40e8-4568-823d-a0da5d907339" xlink:href="cnc-20221231.xsd#cnc_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_a7ca6e45-1ae8-4e69-9e77-65edc480f488" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_AuditorInformationAbstract_1be5c5bb-40e8-4568-823d-a0da5d907339" xlink:to="loc_dei_AuditorName_a7ca6e45-1ae8-4e69-9e77-65edc480f488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_c9c79b60-d6b7-44aa-879c-4fdc1ff270cb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_AuditorInformationAbstract_1be5c5bb-40e8-4568-823d-a0da5d907339" xlink:to="loc_dei_AuditorLocation_c9c79b60-d6b7-44aa-879c-4fdc1ff270cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_76e1152e-bd96-4bab-86b3-0eb91ea315b0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_AuditorInformationAbstract_1be5c5bb-40e8-4568-823d-a0da5d907339" xlink:to="loc_dei_AuditorFirmId_76e1152e-bd96-4bab-86b3-0eb91ea315b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="cnc-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1981ac0a-3bb2-4b03-9915-f3ff0a19eace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d4e8ff64-be51-4357-9c6f-ee1726386986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1981ac0a-3bb2-4b03-9915-f3ff0a19eace" xlink:to="loc_us-gaap_AssetsAbstract_d4e8ff64-be51-4357-9c6f-ee1726386986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_5666ef55-314f-41a1-9ab2-c949a1ea0ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d4e8ff64-be51-4357-9c6f-ee1726386986" xlink:to="loc_us-gaap_AssetsCurrentAbstract_5666ef55-314f-41a1-9ab2-c949a1ea0ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3cdfb3c6-f1fd-49b6-814c-77ecc4b5aabf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5666ef55-314f-41a1-9ab2-c949a1ea0ab6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3cdfb3c6-f1fd-49b6-814c-77ecc4b5aabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsAndOtherReceivablesNet_b10c4bd3-b1a2-484b-a1e8-f5a27c0ee3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsAndOtherReceivablesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5666ef55-314f-41a1-9ab2-c949a1ea0ab6" xlink:to="loc_us-gaap_PremiumsAndOtherReceivablesNet_b10c4bd3-b1a2-484b-a1e8-f5a27c0ee3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_e0cda752-2cab-4ea9-a466-78fd43f41558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5666ef55-314f-41a1-9ab2-c949a1ea0ab6" xlink:to="loc_us-gaap_ShortTermInvestments_e0cda752-2cab-4ea9-a466-78fd43f41558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_317ed5c9-0b8a-4efe-b3ee-276c7a3e4045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5666ef55-314f-41a1-9ab2-c949a1ea0ab6" xlink:to="loc_us-gaap_OtherAssetsCurrent_317ed5c9-0b8a-4efe-b3ee-276c7a3e4045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1346b3b5-abd7-4e17-b9e0-2a67f9a6361a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5666ef55-314f-41a1-9ab2-c949a1ea0ab6" xlink:to="loc_us-gaap_AssetsCurrent_1346b3b5-abd7-4e17-b9e0-2a67f9a6361a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_3e878443-1283-46a1-bf74-b59c280e13df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d4e8ff64-be51-4357-9c6f-ee1726386986" xlink:to="loc_us-gaap_LongTermInvestments_3e878443-1283-46a1-bf74-b59c280e13df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestrictedAssetsNoncurrent_cd9b00c3-133f-4b35-8aec-09b147f033c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestrictedAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d4e8ff64-be51-4357-9c6f-ee1726386986" xlink:to="loc_us-gaap_OtherRestrictedAssetsNoncurrent_cd9b00c3-133f-4b35-8aec-09b147f033c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_552e4756-2e24-47db-98b7-69334c9b7f57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d4e8ff64-be51-4357-9c6f-ee1726386986" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_552e4756-2e24-47db-98b7-69334c9b7f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6c3d1a40-2cff-4fcc-919d-9a4fea114292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d4e8ff64-be51-4357-9c6f-ee1726386986" xlink:to="loc_us-gaap_Goodwill_6c3d1a40-2cff-4fcc-919d-9a4fea114292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_02af3828-7b78-4286-a461-03c74341b090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d4e8ff64-be51-4357-9c6f-ee1726386986" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_02af3828-7b78-4286-a461-03c74341b090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9fee02b6-1eeb-4699-832a-1621cd4e8b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d4e8ff64-be51-4357-9c6f-ee1726386986" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9fee02b6-1eeb-4699-832a-1621cd4e8b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b9eb289f-d03e-4609-b231-d2658aab8e15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d4e8ff64-be51-4357-9c6f-ee1726386986" xlink:to="loc_us-gaap_Assets_b9eb289f-d03e-4609-b231-d2658aab8e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f4a0bcc0-4ae3-401c-8252-bff1d25e8c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1981ac0a-3bb2-4b03-9915-f3ff0a19eace" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f4a0bcc0-4ae3-401c-8252-bff1d25e8c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_fe0a7be3-696c-4ae5-88af-075c029c7227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f4a0bcc0-4ae3-401c-8252-bff1d25e8c2f" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_fe0a7be3-696c-4ae5-88af-075c029c7227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b953ce16-4fec-4fc0-ab55-e0ee8e71cb88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fe0a7be3-696c-4ae5-88af-075c029c7227" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b953ce16-4fec-4fc0-ab55-e0ee8e71cb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b01dc4ea-c0f6-4255-aa0a-0931d9f00bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fe0a7be3-696c-4ae5-88af-075c029c7227" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b01dc4ea-c0f6-4255-aa0a-0931d9f00bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ReturnofPremiumPayable_ea3bc129-3bfd-416c-bab8-371f1c1fc9ed" xlink:href="cnc-20221231.xsd#cnc_ReturnofPremiumPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fe0a7be3-696c-4ae5-88af-075c029c7227" xlink:to="loc_cnc_ReturnofPremiumPayable_ea3bc129-3bfd-416c-bab8-371f1c1fc9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ee46dbb6-e02c-405c-b229-352d5ca9f599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fe0a7be3-696c-4ae5-88af-075c029c7227" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ee46dbb6-e02c-405c-b229-352d5ca9f599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_b6909536-cb1f-4291-8d84-c8ee93c118b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fe0a7be3-696c-4ae5-88af-075c029c7227" xlink:to="loc_us-gaap_LongTermDebtCurrent_b6909536-cb1f-4291-8d84-c8ee93c118b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1f5fae2e-a9e2-4e5a-81da-b72dd487a688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fe0a7be3-696c-4ae5-88af-075c029c7227" xlink:to="loc_us-gaap_LiabilitiesCurrent_1f5fae2e-a9e2-4e5a-81da-b72dd487a688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6a95afa7-6e06-497b-94c1-19e81a96fc93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f4a0bcc0-4ae3-401c-8252-bff1d25e8c2f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6a95afa7-6e06-497b-94c1-19e81a96fc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a2189554-8410-471b-8cd9-2083986380c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f4a0bcc0-4ae3-401c-8252-bff1d25e8c2f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a2189554-8410-471b-8cd9-2083986380c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9d3b87a6-ed92-40f2-9d5a-4fc2f00788f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f4a0bcc0-4ae3-401c-8252-bff1d25e8c2f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9d3b87a6-ed92-40f2-9d5a-4fc2f00788f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_41fd7241-3a2e-4401-a83d-156650e9682e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f4a0bcc0-4ae3-401c-8252-bff1d25e8c2f" xlink:to="loc_us-gaap_Liabilities_41fd7241-3a2e-4401-a83d-156650e9682e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_843a9fb0-3de5-422e-a437-bd71a967164e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f4a0bcc0-4ae3-401c-8252-bff1d25e8c2f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_843a9fb0-3de5-422e-a437-bd71a967164e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_178cc972-fa68-4b0d-9cee-dcf5080352fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f4a0bcc0-4ae3-401c-8252-bff1d25e8c2f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_178cc972-fa68-4b0d-9cee-dcf5080352fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_91bcde10-bca6-4631-a519-6c65db3608a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f4a0bcc0-4ae3-401c-8252-bff1d25e8c2f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_91bcde10-bca6-4631-a519-6c65db3608a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ab5810a0-d2d8-410f-82f7-111613f78bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_91bcde10-bca6-4631-a519-6c65db3608a6" xlink:to="loc_us-gaap_PreferredStockValue_ab5810a0-d2d8-410f-82f7-111613f78bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_334e7537-f9db-41f8-8fd6-ee086d51e2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_91bcde10-bca6-4631-a519-6c65db3608a6" xlink:to="loc_us-gaap_CommonStockValue_334e7537-f9db-41f8-8fd6-ee086d51e2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a374a5d7-cc6f-4093-919e-11b0685a74c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_91bcde10-bca6-4631-a519-6c65db3608a6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a374a5d7-cc6f-4093-919e-11b0685a74c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_df1556fd-c6b8-4367-a6ec-a6dd4ada222d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_91bcde10-bca6-4631-a519-6c65db3608a6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_df1556fd-c6b8-4367-a6ec-a6dd4ada222d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d5b23b25-8e41-4a6f-9ca1-120af90200dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_91bcde10-bca6-4631-a519-6c65db3608a6" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d5b23b25-8e41-4a6f-9ca1-120af90200dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_ad126247-fa0d-4927-a238-8a9a52b272b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_91bcde10-bca6-4631-a519-6c65db3608a6" xlink:to="loc_us-gaap_TreasuryStockValue_ad126247-fa0d-4927-a238-8a9a52b272b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_27fb01a7-f708-4a7c-ba74-4c12254ff93e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_91bcde10-bca6-4631-a519-6c65db3608a6" xlink:to="loc_us-gaap_StockholdersEquity_27fb01a7-f708-4a7c-ba74-4c12254ff93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_03ef854c-df8a-486b-a1ce-8a5d49a3c1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_91bcde10-bca6-4631-a519-6c65db3608a6" xlink:to="loc_us-gaap_MinorityInterest_03ef854c-df8a-486b-a1ce-8a5d49a3c1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_98b5d4fb-6051-44ea-a4a0-3c99d8d1c4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_91bcde10-bca6-4631-a519-6c65db3608a6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_98b5d4fb-6051-44ea-a4a0-3c99d8d1c4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a09f9d71-adaf-4af8-9a7e-df23487d608c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f4a0bcc0-4ae3-401c-8252-bff1d25e8c2f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_a09f9d71-adaf-4af8-9a7e-df23487d608c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="cnc-20221231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_830f0fb1-b5d0-4bf6-adc7-beb430bbc693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7914077e-631e-43d8-aece-8b3138c6b3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_830f0fb1-b5d0-4bf6-adc7-beb430bbc693" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7914077e-631e-43d8-aece-8b3138c6b3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7b5963a2-04af-461a-8b8a-b730ea47ca98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7914077e-631e-43d8-aece-8b3138c6b3b6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7b5963a2-04af-461a-8b8a-b730ea47ca98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8bcde09d-4e47-4df7-a37e-cf7e63f2dca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7b5963a2-04af-461a-8b8a-b730ea47ca98" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8bcde09d-4e47-4df7-a37e-cf7e63f2dca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_0b1cc957-4b0a-4de9-bfc2-b88a893ee00d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7b5963a2-04af-461a-8b8a-b730ea47ca98" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_0b1cc957-4b0a-4de9-bfc2-b88a893ee00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_2745f09b-0552-4b83-997a-9a12db7749bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7b5963a2-04af-461a-8b8a-b730ea47ca98" xlink:to="loc_us-gaap_PreferredStockSharesIssued_2745f09b-0552-4b83-997a-9a12db7749bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_c356db7d-432b-4872-a1a0-dd56ad17247b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7b5963a2-04af-461a-8b8a-b730ea47ca98" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_c356db7d-432b-4872-a1a0-dd56ad17247b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_05077261-b50a-46f1-8b9e-ceee4df65146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7b5963a2-04af-461a-8b8a-b730ea47ca98" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_05077261-b50a-46f1-8b9e-ceee4df65146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_26fbc4d1-c845-4fb4-8143-57432c8a1dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7b5963a2-04af-461a-8b8a-b730ea47ca98" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_26fbc4d1-c845-4fb4-8143-57432c8a1dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_65b3b067-92ae-462c-bc58-f3bf8112e390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7b5963a2-04af-461a-8b8a-b730ea47ca98" xlink:to="loc_us-gaap_CommonStockSharesIssued_65b3b067-92ae-462c-bc58-f3bf8112e390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_83a0207d-c85a-49b9-b55f-2bc60f7477d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7b5963a2-04af-461a-8b8a-b730ea47ca98" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_83a0207d-c85a-49b9-b55f-2bc60f7477d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_492f8f6c-fb8d-477c-b531-5890c0df714a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7b5963a2-04af-461a-8b8a-b730ea47ca98" xlink:to="loc_us-gaap_TreasuryStockShares_492f8f6c-fb8d-477c-b531-5890c0df714a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="cnc-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_cccdb691-401c-463a-bddf-b800df670c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b75cdabc-51e6-4229-8f4c-5f7a4d0001ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cccdb691-401c-463a-bddf-b800df670c24" xlink:to="loc_us-gaap_StatementTable_b75cdabc-51e6-4229-8f4c-5f7a4d0001ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e6ec12a4-e866-47c7-88a5-04a0247d84f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b75cdabc-51e6-4229-8f4c-5f7a4d0001ce" xlink:to="loc_srt_ProductOrServiceAxis_e6ec12a4-e866-47c7-88a5-04a0247d84f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_785cbe7e-adde-4a60-8ba8-0758968d278f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e6ec12a4-e866-47c7-88a5-04a0247d84f3" xlink:to="loc_srt_ProductsAndServicesDomain_785cbe7e-adde-4a60-8ba8-0758968d278f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePremiumMember_1802c226-57d3-4f07-a1bc-8fd905aa876b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCarePremiumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_785cbe7e-adde-4a60-8ba8-0758968d278f" xlink:to="loc_us-gaap_HealthCarePremiumMember_1802c226-57d3-4f07-a1bc-8fd905aa876b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_1321326a-77fa-4572-a9c4-e62bedc2cffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_785cbe7e-adde-4a60-8ba8-0758968d278f" xlink:to="loc_us-gaap_ServiceMember_1321326a-77fa-4572-a9c4-e62bedc2cffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b75cdabc-51e6-4229-8f4c-5f7a4d0001ce" xlink:to="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_c408f964-8e29-436b-9b9f-84ab0102e4df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_RevenuesAbstract_c408f964-8e29-436b-9b9f-84ab0102e4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_81b31ff1-e964-4112-bf8b-4aaa4e2bb459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_c408f964-8e29-436b-9b9f-84ab0102e4df" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_81b31ff1-e964-4112-bf8b-4aaa4e2bb459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PremiumTaxRevenue_cb6adb1d-beb9-4dfa-9b66-b6472fe77c5b" xlink:href="cnc-20221231.xsd#cnc_PremiumTaxRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_c408f964-8e29-436b-9b9f-84ab0102e4df" xlink:to="loc_cnc_PremiumTaxRevenue_cb6adb1d-beb9-4dfa-9b66-b6472fe77c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a909284e-f707-4cee-90ea-46facfcb0f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_c408f964-8e29-436b-9b9f-84ab0102e4df" xlink:to="loc_us-gaap_Revenues_a909284e-f707-4cee-90ea-46facfcb0f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_74c93f7c-384a-49b1-bc6e-11dc843316f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_74c93f7c-384a-49b1-bc6e-11dc843316f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4c25f350-d951-4720-892c-1f6e88c28290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4c25f350-d951-4720-892c-1f6e88c28290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cb78768e-f7d1-4066-b94b-fc1e8cf1a802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cb78768e-f7d1-4066-b94b-fc1e8cf1a802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b95c95d5-b015-4bc5-9c4c-d4211150deb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_Depreciation_b95c95d5-b015-4bc5-9c4c-d4211150deb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0c433dc4-9a80-4930-8dee-4d9c9e325150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0c433dc4-9a80-4930-8dee-4d9c9e325150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PremiumTaxExpense_92f779a4-6dac-43c1-bbfd-a8845a5f2fd7" xlink:href="cnc-20221231.xsd#cnc_PremiumTaxExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_cnc_PremiumTaxExpense_92f779a4-6dac-43c1-bbfd-a8845a5f2fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_HealthInsurerFeeExpense_98bd8fb1-87f6-4e5d-a0d1-92ffee43b640" xlink:href="cnc-20221231.xsd#cnc_HealthInsurerFeeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_cnc_HealthInsurerFeeExpense_98bd8fb1-87f6-4e5d-a0d1-92ffee43b640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_53a7bd5e-cc9d-4574-99e4-ca881b3acf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_AssetImpairmentCharges_53a7bd5e-cc9d-4574-99e4-ca881b3acf2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_16eaf284-b1f3-46e4-8c77-1365a973c750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_LitigationSettlementExpense_16eaf284-b1f3-46e4-8c77-1365a973c750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e9ab4134-ea8a-451d-8aee-99a3329b99c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ee373bdf-6fcf-424f-b967-0259de6291f2" xlink:to="loc_us-gaap_CostsAndExpenses_e9ab4134-ea8a-451d-8aee-99a3329b99c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_33d0c352-ccc7-473e-989d-2894b5f6d2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_OperatingIncomeLoss_33d0c352-ccc7-473e-989d-2894b5f6d2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ef50329-cabb-4c6a-abc1-8aec313197f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ef50329-cabb-4c6a-abc1-8aec313197f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_6a63ebfc-7adf-4fce-b6d2-a5dd96d54aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ef50329-cabb-4c6a-abc1-8aec313197f7" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_6a63ebfc-7adf-4fce-b6d2-a5dd96d54aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_4171ca03-a55a-4258-b346-049858315e56" xlink:href="cnc-20221231.xsd#cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ef50329-cabb-4c6a-abc1-8aec313197f7" xlink:to="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_4171ca03-a55a-4258-b346-049858315e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_efee1e4c-f837-40e8-9465-8763127b2aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ef50329-cabb-4c6a-abc1-8aec313197f7" xlink:to="loc_us-gaap_InterestExpense_efee1e4c-f837-40e8-9465-8763127b2aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_18495b68-233f-45a9-8275-7a6b320ffd69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_18495b68-233f-45a9-8275-7a6b320ffd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e2312a55-e489-4107-b524-d8f06e5baa3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e2312a55-e489-4107-b524-d8f06e5baa3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ad747a46-44a7-4394-9a36-09626903508a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_ProfitLoss_ad747a46-44a7-4394-9a36-09626903508a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2e513cd0-9e9f-43e8-8a49-1ede21253815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2e513cd0-9e9f-43e8-8a49-1ede21253815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e82b17fe-93b1-4fe8-98fe-8a173ac780eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_NetIncomeLoss_e82b17fe-93b1-4fe8-98fe-8a173ac780eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8d0fbb2e-4258-4b54-bd78-07894e23ab54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8d0fbb2e-4258-4b54-bd78-07894e23ab54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ed0ef447-f772-45ba-b474-7bbee116a842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8d0fbb2e-4258-4b54-bd78-07894e23ab54" xlink:to="loc_us-gaap_EarningsPerShareBasic_ed0ef447-f772-45ba-b474-7bbee116a842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f9d93a60-626f-427c-b27c-47a9afbf4bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8d0fbb2e-4258-4b54-bd78-07894e23ab54" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f9d93a60-626f-427c-b27c-47a9afbf4bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_50077e3a-7794-4223-9066-9d17bfe3ab57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88416e55-6789-4e4c-8e38-3430f9a412ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_50077e3a-7794-4223-9066-9d17bfe3ab57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dfcdd056-bb8e-4d81-b3df-d2beb2487dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_50077e3a-7794-4223-9066-9d17bfe3ab57" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dfcdd056-bb8e-4d81-b3df-d2beb2487dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_340c1b6c-d724-4194-9d2f-6e8860c598ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_50077e3a-7794-4223-9066-9d17bfe3ab57" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_340c1b6c-d724-4194-9d2f-6e8860c598ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" xlink:type="simple" xlink:href="cnc-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b00ca00-68e3-4581-aa98-7f664b1a6288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ae197fc0-3a73-4984-8041-0531183408b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b00ca00-68e3-4581-aa98-7f664b1a6288" xlink:to="loc_us-gaap_ProfitLoss_ae197fc0-3a73-4984-8041-0531183408b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_2b8634dd-6106-4a4e-b070-f781deda10b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b00ca00-68e3-4581-aa98-7f664b1a6288" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_2b8634dd-6106-4a4e-b070-f781deda10b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_dfbc58c0-c0f1-46a5-97c4-3aff1c47242a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b00ca00-68e3-4581-aa98-7f664b1a6288" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_dfbc58c0-c0f1-46a5-97c4-3aff1c47242a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_5a4a2083-a40b-4223-b89f-c05f88da0fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b00ca00-68e3-4581-aa98-7f664b1a6288" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_5a4a2083-a40b-4223-b89f-c05f88da0fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_b4fa17f5-c919-47b5-b941-160658dfc01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b00ca00-68e3-4581-aa98-7f664b1a6288" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_b4fa17f5-c919-47b5-b941-160658dfc01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8c5152f2-c907-45c4-aa3e-09c32255b703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b00ca00-68e3-4581-aa98-7f664b1a6288" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8c5152f2-c907-45c4-aa3e-09c32255b703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_814680d4-3f57-4e7a-8b5b-ff64ddf3fc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b00ca00-68e3-4581-aa98-7f664b1a6288" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_814680d4-3f57-4e7a-8b5b-ff64ddf3fc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_564034b8-58ba-470c-bb82-4a81492efea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b00ca00-68e3-4581-aa98-7f664b1a6288" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_564034b8-58ba-470c-bb82-4a81492efea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_5d217a28-305c-4df7-a845-cab73426623a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b00ca00-68e3-4581-aa98-7f664b1a6288" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_5d217a28-305c-4df7-a845-cab73426623a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_40a81933-f982-40be-b93d-973db5577372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b00ca00-68e3-4581-aa98-7f664b1a6288" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_40a81933-f982-40be-b93d-973db5577372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="cnc-20221231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0ab348fb-4b05-4a49-9a71-d1b62775611d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7f6f0b8f-d44e-4f57-84a2-1eeb432f8943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0ab348fb-4b05-4a49-9a71-d1b62775611d" xlink:to="loc_us-gaap_StatementTable_7f6f0b8f-d44e-4f57-84a2-1eeb432f8943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8496e663-ce91-49e3-8103-29dd19a10da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7f6f0b8f-d44e-4f57-84a2-1eeb432f8943" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8496e663-ce91-49e3-8103-29dd19a10da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8496e663-ce91-49e3-8103-29dd19a10da9" xlink:to="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f220c8b2-4cfe-497d-bbcb-72f2156b2567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:to="loc_us-gaap_CommonStockMember_f220c8b2-4cfe-497d-bbcb-72f2156b2567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6f20569d-a3bb-4674-a488-80e57d4666f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6f20569d-a3bb-4674-a488-80e57d4666f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eaf4ac44-7e0b-460c-9ce2-714c9746f15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eaf4ac44-7e0b-460c-9ce2-714c9746f15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_69f4383b-d0b0-4db8-a060-bbe7fd5de898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:to="loc_us-gaap_RetainedEarningsMember_69f4383b-d0b0-4db8-a060-bbe7fd5de898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_e0d18262-52ff-47c1-a085-e384be1871a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:to="loc_us-gaap_TreasuryStockCommonMember_e0d18262-52ff-47c1-a085-e384be1871a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_79ba3862-52f4-47b9-968f-c45170c08ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5f535340-2b89-46c1-8931-4ca302a3a4e8" xlink:to="loc_us-gaap_NoncontrollingInterestMember_79ba3862-52f4-47b9-968f-c45170c08ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2bc58c2a-ee05-431f-a48b-370b67ee9d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7f6f0b8f-d44e-4f57-84a2-1eeb432f8943" xlink:to="loc_us-gaap_StatementLineItems_2bc58c2a-ee05-431f-a48b-370b67ee9d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2bc58c2a-ee05-431f-a48b-370b67ee9d83" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2f7b8fe0-2662-4e8c-9168-516772be45e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2f7b8fe0-2662-4e8c-9168-516772be45e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4073f571-8a7e-480b-9879-687a711ad50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4073f571-8a7e-480b-9879-687a711ad50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_67b626ad-e573-42c9-b8f7-d46c22353fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_TreasuryStockShares_67b626ad-e573-42c9-b8f7-d46c22353fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_73870193-b525-4b1c-992e-35264ec5b60c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_73870193-b525-4b1c-992e-35264ec5b60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_42450139-f91e-4447-acc0-66f2b4ca11fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_42450139-f91e-4447-acc0-66f2b4ca11fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_33345fb7-e9a8-44f4-be96-0e0ca1e31337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_33345fb7-e9a8-44f4-be96-0e0ca1e31337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_7b6bb52a-35c2-4374-89d9-75c50d4fd2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_7b6bb52a-35c2-4374-89d9-75c50d4fd2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_3b4ac966-ab85-43be-8886-de170860fef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_3b4ac966-ab85-43be-8886-de170860fef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_63601520-6720-46b2-96ac-f7348db07267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_63601520-6720-46b2-96ac-f7348db07267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture_bf7cdfeb-6643-4719-8bfb-79ab73da70d0" xlink:href="cnc-20221231.xsd#cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture_bf7cdfeb-6643-4719-8bfb-79ab73da70d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5dde1a94-101d-423f-9aac-5d48f8207754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5dde1a94-101d-423f-9aac-5d48f8207754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_d49736c8-4831-42e4-abe1-d9a38c597dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_d49736c8-4831-42e4-abe1-d9a38c597dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f9a7ea6a-d012-447f-8891-afd58a9264d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f9a7ea6a-d012-447f-8891-afd58a9264d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_2ecab748-431d-4d35-9c16-c9a8f33d79cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_2ecab748-431d-4d35-9c16-c9a8f33d79cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_aedfe33e-4c6c-4fb3-95f9-0d8fce5bb970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_aedfe33e-4c6c-4fb3-95f9-0d8fce5bb970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_945ccbb5-5246-4416-b9b6-86a474ab46c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_945ccbb5-5246-4416-b9b6-86a474ab46c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_9225d99e-a61e-4d29-8c2a-f400a157434a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_9225d99e-a61e-4d29-8c2a-f400a157434a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_82a48760-fcbb-4c5a-9669-2ac7fa7e5bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_82a48760-fcbb-4c5a-9669-2ac7fa7e5bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_bbc92d0a-65f0-4628-849c-6df220312377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_bbc92d0a-65f0-4628-849c-6df220312377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d428f44e-2582-4b68-8649-73175f1f0f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d428f44e-2582-4b68-8649-73175f1f0f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c6eeaece-09b6-4586-8ff2-8232afd37cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c6eeaece-09b6-4586-8ff2-8232afd37cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_8bb28a6a-32c4-4724-89f7-4839b292559a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b74a0f6c-f169-491b-b5b0-e5d4915a257d" xlink:to="loc_us-gaap_TreasuryStockShares_8bb28a6a-32c4-4724-89f7-4839b292559a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="simple" xlink:href="cnc-20221231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_744cb82a-8094-4d79-b987-eaa7b6320157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6d4af45d-31ec-4f3a-b342-c5e6d715125b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_744cb82a-8094-4d79-b987-eaa7b6320157" xlink:to="loc_us-gaap_StatementTable_6d4af45d-31ec-4f3a-b342-c5e6d715125b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_570cd374-0191-40c0-93d1-bf285b39200b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6d4af45d-31ec-4f3a-b342-c5e6d715125b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_570cd374-0191-40c0-93d1-bf285b39200b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fdd637db-a7f1-4132-b9c0-af3dc4430d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_570cd374-0191-40c0-93d1-bf285b39200b" xlink:to="loc_us-gaap_EquityComponentDomain_fdd637db-a7f1-4132-b9c0-af3dc4430d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f2c1ab2e-7f76-4906-b70f-639e863417f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fdd637db-a7f1-4132-b9c0-af3dc4430d47" xlink:to="loc_us-gaap_CommonStockMember_f2c1ab2e-7f76-4906-b70f-639e863417f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_a5fdd789-4e16-4f69-94a6-84c134a62ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fdd637db-a7f1-4132-b9c0-af3dc4430d47" xlink:to="loc_us-gaap_TreasuryStockCommonMember_a5fdd789-4e16-4f69-94a6-84c134a62ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2cb548de-95cd-4e06-b5e9-745b99f569be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6d4af45d-31ec-4f3a-b342-c5e6d715125b" xlink:to="loc_us-gaap_StatementLineItems_2cb548de-95cd-4e06-b5e9-745b99f569be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_714faf6c-492b-461c-9f26-4a7f5ecc7c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2cb548de-95cd-4e06-b5e9-745b99f569be" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_714faf6c-492b-461c-9f26-4a7f5ecc7c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_5f4d068b-c52c-42fe-8695-f3ae7f79bbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2cb548de-95cd-4e06-b5e9-745b99f569be" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_5f4d068b-c52c-42fe-8695-f3ae7f79bbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="cnc-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_18a338a0-6b06-4aa7-8876-bd9d1ef09c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b788ccb7-f542-4e9c-a195-3f83dbde3140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18a338a0-6b06-4aa7-8876-bd9d1ef09c76" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b788ccb7-f542-4e9c-a195-3f83dbde3140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d559010b-7063-4140-8c26-d716ad2ea31f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b788ccb7-f542-4e9c-a195-3f83dbde3140" xlink:to="loc_us-gaap_ProfitLoss_d559010b-7063-4140-8c26-d716ad2ea31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75534a0c-1c23-4cf3-ad23-05a64fbea8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b788ccb7-f542-4e9c-a195-3f83dbde3140" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75534a0c-1c23-4cf3-ad23-05a64fbea8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_1fd323fc-8786-454c-a701-f43e940ce211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75534a0c-1c23-4cf3-ad23-05a64fbea8c6" xlink:to="loc_us-gaap_DepreciationAndAmortization_1fd323fc-8786-454c-a701-f43e940ce211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ee90c144-7c05-4ff4-b1c8-00af4d63dfcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75534a0c-1c23-4cf3-ad23-05a64fbea8c6" xlink:to="loc_us-gaap_ShareBasedCompensation_ee90c144-7c05-4ff4-b1c8-00af4d63dfcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_3f81d20a-e047-462c-a905-98d6f139a35e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75534a0c-1c23-4cf3-ad23-05a64fbea8c6" xlink:to="loc_us-gaap_AssetImpairmentCharges_3f81d20a-e047-462c-a905-98d6f139a35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fd328851-9ad4-4390-b23a-89635977149f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75534a0c-1c23-4cf3-ad23-05a64fbea8c6" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fd328851-9ad4-4390-b23a-89635977149f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_3b2457ad-e74b-4e93-ab56-99cb1575ce98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75534a0c-1c23-4cf3-ad23-05a64fbea8c6" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_3b2457ad-e74b-4e93-ab56-99cb1575ce98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_077fc78c-e519-42b9-a2b5-1d368a541818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75534a0c-1c23-4cf3-ad23-05a64fbea8c6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_077fc78c-e519-42b9-a2b5-1d368a541818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_f3cf369e-be71-486d-858e-0082f5b7658a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75534a0c-1c23-4cf3-ad23-05a64fbea8c6" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_f3cf369e-be71-486d-858e-0082f5b7658a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_a2aab16d-bcff-4d75-8a3a-248fb2929474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75534a0c-1c23-4cf3-ad23-05a64fbea8c6" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_a2aab16d-bcff-4d75-8a3a-248fb2929474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_1907c9d6-ba88-4ff3-9038-430e23c4e80d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75534a0c-1c23-4cf3-ad23-05a64fbea8c6" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_1907c9d6-ba88-4ff3-9038-430e23c4e80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6191c282-ef15-4c4b-beb4-d3f7d38c7374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75534a0c-1c23-4cf3-ad23-05a64fbea8c6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6191c282-ef15-4c4b-beb4-d3f7d38c7374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_3e2ef68e-4643-420d-b3e4-91f423f55751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPremiumsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6191c282-ef15-4c4b-beb4-d3f7d38c7374" xlink:to="loc_us-gaap_IncreaseDecreaseInPremiumsReceivable_3e2ef68e-4643-420d-b3e4-91f423f55751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_4b6e47c0-0219-4c50-8968-4a7a46c246ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6191c282-ef15-4c4b-beb4-d3f7d38c7374" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_4b6e47c0-0219-4c50-8968-4a7a46c246ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_01acafbd-7caa-4a3b-a927-05cdc03d2d38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6191c282-ef15-4c4b-beb4-d3f7d38c7374" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_01acafbd-7caa-4a3b-a927-05cdc03d2d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8dcedfa2-1e9f-4cc5-9aa6-897bfcb0e587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6191c282-ef15-4c4b-beb4-d3f7d38c7374" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8dcedfa2-1e9f-4cc5-9aa6-897bfcb0e587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_974381bb-f2d0-403a-b3f2-880d1026134e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6191c282-ef15-4c4b-beb4-d3f7d38c7374" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_974381bb-f2d0-403a-b3f2-880d1026134e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2d7193cd-a292-4381-b28e-5328723422ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6191c282-ef15-4c4b-beb4-d3f7d38c7374" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2d7193cd-a292-4381-b28e-5328723422ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4edeb354-0d95-4a31-8cbd-2b617876f720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6191c282-ef15-4c4b-beb4-d3f7d38c7374" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4edeb354-0d95-4a31-8cbd-2b617876f720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6da2f07d-1c48-4118-b88f-f3dac449e576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b788ccb7-f542-4e9c-a195-3f83dbde3140" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6da2f07d-1c48-4118-b88f-f3dac449e576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a0ec621-691e-4f72-8864-ea9ad6a4e995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18a338a0-6b06-4aa7-8876-bd9d1ef09c76" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a0ec621-691e-4f72-8864-ea9ad6a4e995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_08601cf0-7c60-4156-9bc1-4d1fe9573409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a0ec621-691e-4f72-8864-ea9ad6a4e995" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_08601cf0-7c60-4156-9bc1-4d1fe9573409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_c25581e6-d64a-47d3-9371-a8d4a435350c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a0ec621-691e-4f72-8864-ea9ad6a4e995" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_c25581e6-d64a-47d3-9371-a8d4a435350c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_6b4fb4ea-61a9-4aef-b501-2486078fa882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a0ec621-691e-4f72-8864-ea9ad6a4e995" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_6b4fb4ea-61a9-4aef-b501-2486078fa882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2214e7d3-f785-4b10-b208-4d7bcefbcd6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a0ec621-691e-4f72-8864-ea9ad6a4e995" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2214e7d3-f785-4b10-b208-4d7bcefbcd6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_1c7dfa0e-9dbe-4ba2-a802-be9e7a4b7bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a0ec621-691e-4f72-8864-ea9ad6a4e995" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_1c7dfa0e-9dbe-4ba2-a802-be9e7a4b7bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6e0518bb-6e58-4105-97be-3a1ddeff50b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a0ec621-691e-4f72-8864-ea9ad6a4e995" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6e0518bb-6e58-4105-97be-3a1ddeff50b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cc80e3d8-e247-4942-87f0-21d12bfc1c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a0ec621-691e-4f72-8864-ea9ad6a4e995" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cc80e3d8-e247-4942-87f0-21d12bfc1c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410c6d18-8422-4787-b493-09b7f0c9d3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18a338a0-6b06-4aa7-8876-bd9d1ef09c76" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410c6d18-8422-4787-b493-09b7f0c9d3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_cf27de8a-c7d5-4c17-969c-9fb2e6519980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410c6d18-8422-4787-b493-09b7f0c9d3aa" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_cf27de8a-c7d5-4c17-969c-9fb2e6519980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_51d0dcf4-b613-4864-a723-527a73eb8f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410c6d18-8422-4787-b493-09b7f0c9d3aa" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_51d0dcf4-b613-4864-a723-527a73eb8f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e4341753-e17a-48eb-a8aa-02c83ec6fc26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410c6d18-8422-4787-b493-09b7f0c9d3aa" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e4341753-e17a-48eb-a8aa-02c83ec6fc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6be936d8-9dc8-4ff1-a892-565aac3884fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410c6d18-8422-4787-b493-09b7f0c9d3aa" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6be936d8-9dc8-4ff1-a892-565aac3884fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_29b97fcd-1e50-46b6-9a18-68b71f1670a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410c6d18-8422-4787-b493-09b7f0c9d3aa" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_29b97fcd-1e50-46b6-9a18-68b71f1670a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_77b94e1d-ac98-4f26-b13e-047769aa9c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410c6d18-8422-4787-b493-09b7f0c9d3aa" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_77b94e1d-ac98-4f26-b13e-047769aa9c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bc7f183b-a911-4c58-aea6-a2ca2e4ddc5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410c6d18-8422-4787-b493-09b7f0c9d3aa" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bc7f183b-a911-4c58-aea6-a2ca2e4ddc5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4dbc0b74-019f-42c6-9aed-e376752e1f22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410c6d18-8422-4787-b493-09b7f0c9d3aa" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4dbc0b74-019f-42c6-9aed-e376752e1f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4444da70-7c15-48fb-806e-83e5c7d089dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18a338a0-6b06-4aa7-8876-bd9d1ef09c76" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4444da70-7c15-48fb-806e-83e5c7d089dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2bb21865-a00b-486e-a727-cbb92855ff97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18a338a0-6b06-4aa7-8876-bd9d1ef09c76" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2bb21865-a00b-486e-a727-cbb92855ff97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_326a7d23-84b6-4b5e-9734-21f339f9209a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18a338a0-6b06-4aa7-8876-bd9d1ef09c76" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_326a7d23-84b6-4b5e-9734-21f339f9209a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f154ec9c-14dd-4def-bc12-cebbe322d647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18a338a0-6b06-4aa7-8876-bd9d1ef09c76" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f154ec9c-14dd-4def-bc12-cebbe322d647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_88f60489-49ab-494c-bb44-d4c9cb3e3141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18a338a0-6b06-4aa7-8876-bd9d1ef09c76" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_88f60489-49ab-494c-bb44-d4c9cb3e3141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_4ec4b3ad-342b-44f0-b035-69107d9a6fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18a338a0-6b06-4aa7-8876-bd9d1ef09c76" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_4ec4b3ad-342b-44f0-b035-69107d9a6fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_0a218db5-f1e6-4c8b-8b20-18f4ab0afc66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4ec4b3ad-342b-44f0-b035-69107d9a6fd4" xlink:to="loc_us-gaap_InterestPaidNet_0a218db5-f1e6-4c8b-8b20-18f4ab0afc66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_4fcd4822-810a-445d-a179-e61a1c872c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4ec4b3ad-342b-44f0-b035-69107d9a6fd4" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_4fcd4822-810a-445d-a179-e61a1c872c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_ecf5faf3-43ea-433f-9b62-309e17b65855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4ec4b3ad-342b-44f0-b035-69107d9a6fd4" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_ecf5faf3-43ea-433f-9b62-309e17b65855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f8344864-35de-460a-a454-200dbd4ebf60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_18a338a0-6b06-4aa7-8876-bd9d1ef09c76" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f8344864-35de-460a-a454-200dbd4ebf60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_98aa0abb-d06a-408a-8f49-df25ff4d8adf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f8344864-35de-460a-a454-200dbd4ebf60" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_98aa0abb-d06a-408a-8f49-df25ff4d8adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_8ef11ceb-d8e0-4037-88a9-3e63cf6878bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f8344864-35de-460a-a454-200dbd4ebf60" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_8ef11ceb-d8e0-4037-88a9-3e63cf6878bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5130c60f-6bfd-45f6-9ba2-628d293508b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f8344864-35de-460a-a454-200dbd4ebf60" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5130c60f-6bfd-45f6-9ba2-628d293508b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/OrganizationandOperations" xlink:type="simple" xlink:href="cnc-20221231.xsd#OrganizationandOperations"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/OrganizationandOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ca9b611a-59b5-4ea9-a219-c9698af75db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_39288909-bbfb-4fcd-b4ee-2925173966a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ca9b611a-59b5-4ea9-a219-c9698af75db3" xlink:to="loc_us-gaap_NatureOfOperations_39288909-bbfb-4fcd-b4ee-2925173966a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="cnc-20221231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_13df3add-afde-4915-81fb-dbb61c448613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_93f8bac6-47d4-4f04-89b2-49674b110f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_13df3add-afde-4915-81fb-dbb61c448613" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_93f8bac6-47d4-4f04-89b2-49674b110f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/AcquisitionsandDivestitures" xlink:type="simple" xlink:href="cnc-20221231.xsd#AcquisitionsandDivestitures"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/AcquisitionsandDivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6bdabb55-c670-44c9-b38a-81fafd018f21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_35493c63-7ffd-41f3-b825-8fbcf3e7ff11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6bdabb55-c670-44c9-b38a-81fafd018f21" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_35493c63-7ffd-41f3-b825-8fbcf3e7ff11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits" xlink:type="simple" xlink:href="cnc-20221231.xsd#ShorttermandLongtermInvestmentsRestrictedDeposits"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5c494430-97e9-42d5-9d36-327b6cc52eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_eebd688f-0440-44ea-97af-df0456c699d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5c494430-97e9-42d5-9d36-327b6cc52eab" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_eebd688f-0440-44ea-97af-df0456c699d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="cnc-20221231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c5d9c124-30ad-4c81-8734-9c1ffa99ca2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_b88c7dea-a404-4999-9459-abdb010b0b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c5d9c124-30ad-4c81-8734-9c1ffa99ca2c" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_b88c7dea-a404-4999-9459-abdb010b0b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/PropertySoftwareandEquipment" xlink:type="simple" xlink:href="cnc-20221231.xsd#PropertySoftwareandEquipment"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/PropertySoftwareandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1eed0e55-cf22-4a14-87b3-4ce95ea07237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_a264d695-4eab-4b6f-a86d-19890b7a642d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1eed0e55-cf22-4a14-87b3-4ce95ea07237" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_a264d695-4eab-4b6f-a86d-19890b7a642d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="cnc-20221231.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_591fc41b-463d-47f9-b190-0bf7b77b9d84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8b846c71-89dd-42ae-83ae-5555de5acd8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_591fc41b-463d-47f9-b190-0bf7b77b9d84" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8b846c71-89dd-42ae-83ae-5555de5acd8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/MedicalClaimsLiability" xlink:type="simple" xlink:href="cnc-20221231.xsd#MedicalClaimsLiability"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/MedicalClaimsLiability" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_baedb4ae-9862-452d-a304-27959b706a41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceDisclosureTextBlock_706102b6-17f1-4abe-91a8-1bcf7edaaa92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_baedb4ae-9862-452d-a304-27959b706a41" xlink:to="loc_us-gaap_InsuranceDisclosureTextBlock_706102b6-17f1-4abe-91a8-1bcf7edaaa92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/AffordableCareAct" xlink:type="simple" xlink:href="cnc-20221231.xsd#AffordableCareAct"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/AffordableCareAct" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActAbstract_6821ccfd-8adc-487b-afa6-8c708e9e94af" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActDisclosureTextBlock_339c8075-6519-4446-affc-83e066956f3f" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_AffordableCareActAbstract_6821ccfd-8adc-487b-afa6-8c708e9e94af" xlink:to="loc_cnc_AffordableCareActDisclosureTextBlock_339c8075-6519-4446-affc-83e066956f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/Debt" xlink:type="simple" xlink:href="cnc-20221231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2607e969-823e-4224-a9f3-eb52469b0c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_c16b2f75-e6b3-4edc-83b8-5f4767bdf27f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2607e969-823e-4224-a9f3-eb52469b0c52" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_c16b2f75-e6b3-4edc-83b8-5f4767bdf27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/Leases" xlink:type="simple" xlink:href="cnc-20221231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_80e34aad-0389-450c-9ae0-f816987bbf2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_0e9570fb-2e3f-4e17-8d37-202847f4f48f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_80e34aad-0389-450c-9ae0-f816987bbf2b" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_0e9570fb-2e3f-4e17-8d37-202847f4f48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/StockholdersEquity" xlink:type="simple" xlink:href="cnc-20221231.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d9946bdf-5040-44a8-b282-a6099ebfe6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0463ce68-9f45-4666-8c42-2518c6609084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d9946bdf-5040-44a8-b282-a6099ebfe6e6" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0463ce68-9f45-4666-8c42-2518c6609084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictions" xlink:type="simple" xlink:href="cnc-20221231.xsd#StatutoryCapitalRequirementsandDividendRestrictions"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract_5f9f3ad8-7db9-469a-b189-f7ff9d274cbe" xlink:href="cnc-20221231.xsd#cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock_07bb891b-eff4-4b1d-b0f8-034c69351b74" xlink:href="cnc-20221231.xsd#cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract_5f9f3ad8-7db9-469a-b189-f7ff9d274cbe" xlink:to="loc_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock_07bb891b-eff4-4b1d-b0f8-034c69351b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cnc-20221231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d19ac697-92d6-4006-880f-40c895789ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_0c844db1-fd4f-4e38-a4f5-67c82d15c9df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d19ac697-92d6-4006-880f-40c895789ee0" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_0c844db1-fd4f-4e38-a4f5-67c82d15c9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/StockIncentivePlans" xlink:type="simple" xlink:href="cnc-20221231.xsd#StockIncentivePlans"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/StockIncentivePlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3ec2e92-6fa9-405d-9069-9f5e90900f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_cf2bf7fe-e31e-4a53-8f96-c5d5798358d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3ec2e92-6fa9-405d-9069-9f5e90900f10" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_cf2bf7fe-e31e-4a53-8f96-c5d5798358d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/RetirementPlan" xlink:type="simple" xlink:href="cnc-20221231.xsd#RetirementPlan"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/RetirementPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ee9dc316-bb1f-479d-b8d7-2631939e882c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_c14d5c6c-5d5d-4102-bc8b-652ab32d5fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ee9dc316-bb1f-479d-b8d7-2631939e882c" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_c14d5c6c-5d5d-4102-bc8b-652ab32d5fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/Commitments" xlink:type="simple" xlink:href="cnc-20221231.xsd#Commitments"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/Commitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b05fd97b-0bd1-4cd9-89df-9990e3609599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_fae0980d-dd8e-4af9-9965-dfca567a7368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b05fd97b-0bd1-4cd9-89df-9990e3609599" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_fae0980d-dd8e-4af9-9965-dfca567a7368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/Contingencies" xlink:type="simple" xlink:href="cnc-20221231.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_34aca295-0462-4c76-bcb5-38437eed83b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1152d1ad-7c08-4a48-a315-0adf7bcb3107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_34aca295-0462-4c76-bcb5-38437eed83b0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1152d1ad-7c08-4a48-a315-0adf7bcb3107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/EarningsPerShare" xlink:type="simple" xlink:href="cnc-20221231.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_03375c60-8a62-403b-9533-87ba6c5e3095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_db79ac94-208d-4ed2-9741-cfcbbd15b271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_03375c60-8a62-403b-9533-87ba6c5e3095" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_db79ac94-208d-4ed2-9741-cfcbbd15b271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/SegmentInformation" xlink:type="simple" xlink:href="cnc-20221231.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ec2b9f0f-9a8a-4a4f-8a89-e1aaca618395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_d039fc52-3352-46c8-8241-bcfa15d48a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ec2b9f0f-9a8a-4a4f-8a89-e1aaca618395" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_d039fc52-3352-46c8-8241-bcfa15d48a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrant" xlink:type="simple" xlink:href="cnc-20221231.xsd#CondensedFinancialInformationofRegistrant"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/CondensedFinancialInformationofRegistrant" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_59fbedb3-cff6-4a94-bef5-1cd1c5a8bb08" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_e1b1c06e-67bf-4c15-a0b9-5ff15977d0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_59fbedb3-cff6-4a94-bef5-1cd1c5a8bb08" xlink:to="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_e1b1c06e-67bf-4c15-a0b9-5ff15977d0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cnc-20221231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_98bc3416-fcce-4cd1-b775-e01af521c283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_98bc3416-fcce-4cd1-b775-e01af521c283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_d44e6bb7-ec9e-47de-94c3-bccdcb46efed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_UseOfEstimates_d44e6bb7-ec9e-47de-94c3-bccdcb46efed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_0243deac-b021-4808-941a-ac6a7f47462d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_0243deac-b021-4808-941a-ac6a7f47462d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c7ad5593-7c5d-44fe-984f-7feb8aa41e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c7ad5593-7c5d-44fe-984f-7feb8aa41e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_e81944ea-1adc-4646-a67c-89e633b8c692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_e81944ea-1adc-4646-a67c-89e633b8c692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1b83cbf8-99d2-429c-a944-47b33785604b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1b83cbf8-99d2-429c-a944-47b33785604b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_6799726a-6e54-46fd-bd56-f67a92b70437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_6799726a-6e54-46fd-bd56-f67a92b70437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_775f4184-1151-4ba1-9e95-04ec90729e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_775f4184-1151-4ba1-9e95-04ec90729e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_7969efb2-272b-402a-9b4a-aed91dd11514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_7969efb2-272b-402a-9b4a-aed91dd11514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_b439dcde-ab98-4ae0-b249-c2ba301acc60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_b439dcde-ab98-4ae0-b249-c2ba301acc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_935df28d-a4a0-4103-a809-c818971cc809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_935df28d-a4a0-4103-a809-c818971cc809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock_72c30ad2-5620-4359-ab7d-0fb8b26c07b0" xlink:href="cnc-20221231.xsd#cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock_72c30ad2-5620-4359-ab7d-0fb8b26c07b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock_ab84d108-324b-42c2-baa5-6d1da1839e5f" xlink:href="cnc-20221231.xsd#cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock_ab84d108-324b-42c2-baa5-6d1da1839e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SignificantCustomersPolicyTextBlock_b4efd6f7-360c-4026-8a99-4b9d8f5bc3c5" xlink:href="cnc-20221231.xsd#cnc_SignificantCustomersPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_cnc_SignificantCustomersPolicyTextBlock_b4efd6f7-360c-4026-8a99-4b9d8f5bc3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock_cea86846-9811-47a9-9e77-9dd622047435" xlink:href="cnc-20221231.xsd#cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock_cea86846-9811-47a9-9e77-9dd622047435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_71391ae3-708b-494c-847d-e8e838670d36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_71391ae3-708b-494c-847d-e8e838670d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_50be4266-5114-4c08-8d2f-636260055381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_50be4266-5114-4c08-8d2f-636260055381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_209efc01-5c70-488a-afe9-9033e22ebe98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_209efc01-5c70-488a-afe9-9033e22ebe98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_4b5b1f40-ae90-434f-9ac5-78476ab9012e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_4b5b1f40-ae90-434f-9ac5-78476ab9012e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b6507874-6acf-4ade-899e-66ab4650e018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f8414d7-e618-4c2c-a26a-37dd76197570" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b6507874-6acf-4ade-899e-66ab4650e018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7e29e2dc-9936-4910-aae9-d8f539547b28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock_938fd169-ca66-4d9b-b73b-b93d8a83fb2c" xlink:href="cnc-20221231.xsd#cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7e29e2dc-9936-4910-aae9-d8f539547b28" xlink:to="loc_cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock_938fd169-ca66-4d9b-b73b-b93d8a83fb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock_7f979160-4f13-4aa6-98bc-097812a1c66f" xlink:href="cnc-20221231.xsd#cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7e29e2dc-9936-4910-aae9-d8f539547b28" xlink:to="loc_cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock_7f979160-4f13-4aa6-98bc-097812a1c66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock_0db1c9ee-d950-4f1f-a6a9-606c9c55ab31" xlink:href="cnc-20221231.xsd#cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7e29e2dc-9936-4910-aae9-d8f539547b28" xlink:to="loc_cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock_0db1c9ee-d950-4f1f-a6a9-606c9c55ab31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/AcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#AcquisitionsandDivestituresTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/AcquisitionsandDivestituresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f8cade3a-63c5-4722-ae9d-e0bc4dd8cbf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ad99e8bf-36d1-48c6-bc90-d0b022f06a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f8cade3a-63c5-4722-ae9d-e0bc4dd8cbf2" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ad99e8bf-36d1-48c6-bc90-d0b022f06a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_3d58e1d0-78f3-40aa-8345-37594b22023f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f8cade3a-63c5-4722-ae9d-e0bc4dd8cbf2" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_3d58e1d0-78f3-40aa-8345-37594b22023f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#ShorttermandLongtermInvestmentsRestrictedDepositsTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6fcba2b1-f84f-4b27-b95e-a67818367d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock_6b9a27b6-f785-42e0-81af-3bb94ac12c58" xlink:href="cnc-20221231.xsd#cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6fcba2b1-f84f-4b27-b95e-a67818367d21" xlink:to="loc_cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock_6b9a27b6-f785-42e0-81af-3bb94ac12c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_365200b2-c2e4-4233-bbf2-d9311bfb67c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6fcba2b1-f84f-4b27-b95e-a67818367d21" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_365200b2-c2e4-4233-bbf2-d9311bfb67c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_0cf04bb1-943b-4ae9-b08c-b505b1d59ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6fcba2b1-f84f-4b27-b95e-a67818367d21" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_0cf04bb1-943b-4ae9-b08c-b505b1d59ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ddbb4562-d78e-497e-899b-a204d0542704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock_61666ffc-a4fc-46ea-be15-4ef065bb3641" xlink:href="cnc-20221231.xsd#cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ddbb4562-d78e-497e-899b-a204d0542704" xlink:to="loc_cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock_61666ffc-a4fc-46ea-be15-4ef065bb3641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_15a77898-7ef7-450f-bbb9-e053073a10e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ddbb4562-d78e-497e-899b-a204d0542704" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_15a77898-7ef7-450f-bbb9-e053073a10e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/PropertySoftwareandEquipmentTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#PropertySoftwareandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/PropertySoftwareandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5bbf2717-e86a-4c40-a662-7f33bd1d552e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_e957c80a-342c-4d5f-8550-8c1a120712d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5bbf2717-e86a-4c40-a662-7f33bd1d552e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_e957c80a-342c-4d5f-8550-8c1a120712d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f5f5354-41ae-4f2f-a5cb-d507387589b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_cd499d51-83a5-493e-b572-b5f2006f7968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f5f5354-41ae-4f2f-a5cb-d507387589b9" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_cd499d51-83a5-493e-b572-b5f2006f7968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_730584e9-b80d-4a20-baac-968f6343eea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f5f5354-41ae-4f2f-a5cb-d507387589b9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_730584e9-b80d-4a20-baac-968f6343eea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a705e194-f367-40fe-9dba-6d0b01efda39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f5f5354-41ae-4f2f-a5cb-d507387589b9" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a705e194-f367-40fe-9dba-6d0b01efda39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/MedicalClaimsLiabilityTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#MedicalClaimsLiabilityTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/MedicalClaimsLiabilityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_028262b6-2082-477b-90ab-66cb5e321c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_b0b043b0-3fd3-4191-8bab-f8aaf149ab1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_028262b6-2082-477b-90ab-66cb5e321c86" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_b0b043b0-3fd3-4191-8bab-f8aaf149ab1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_d405be5e-dab3-476d-b04e-981b7d5611f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_028262b6-2082-477b-90ab-66cb5e321c86" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_d405be5e-dab3-476d-b04e-981b7d5611f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/AffordableCareActTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#AffordableCareActTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/AffordableCareActTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActAbstract_5616cb41-a62e-416d-b639-cd2d0d35b7bd" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock_4463c9cd-89ed-4b34-a460-8a56479ea309" xlink:href="cnc-20221231.xsd#cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_AffordableCareActAbstract_5616cb41-a62e-416d-b639-cd2d0d35b7bd" xlink:to="loc_cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock_4463c9cd-89ed-4b34-a460-8a56479ea309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fc8f5bb3-7d64-4516-a735-b073b8f28371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_024fd666-4317-4918-9259-9c1ba57abbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fc8f5bb3-7d64-4516-a735-b073b8f28371" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_024fd666-4317-4918-9259-9c1ba57abbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_70fe8b27-e8b8-42b5-a1f7-9762f7dd1963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fc8f5bb3-7d64-4516-a735-b073b8f28371" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_70fe8b27-e8b8-42b5-a1f7-9762f7dd1963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/LeasesTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f8f2e79c-4cb0-412a-b179-856bfc0e45a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_92f98743-2b93-4205-b395-d6452d90314c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f8f2e79c-4cb0-412a-b179-856bfc0e45a7" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_92f98743-2b93-4205-b395-d6452d90314c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_191d64cc-580e-41e0-9fc2-9a3a8bd151c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f8f2e79c-4cb0-412a-b179-856bfc0e45a7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_191d64cc-580e-41e0-9fc2-9a3a8bd151c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3fbcd301-824c-497d-b254-d065452bfdb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_bca008ef-f39b-4233-8621-5f3f851c2aab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3fbcd301-824c-497d-b254-d065452bfdb5" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_bca008ef-f39b-4233-8621-5f3f851c2aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a7788869-526a-4208-838d-65a217354bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_c3c128ae-ea1d-4fea-840e-b5a50c9ad1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a7788869-526a-4208-838d-65a217354bde" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_c3c128ae-ea1d-4fea-840e-b5a50c9ad1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_288901fe-046c-4410-8c70-5cf68aba6618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a7788869-526a-4208-838d-65a217354bde" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_288901fe-046c-4410-8c70-5cf68aba6618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3ac91bee-ffe4-4508-b7a1-77ac8f99bcd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a7788869-526a-4208-838d-65a217354bde" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3ac91bee-ffe4-4508-b7a1-77ac8f99bcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_e220c77a-d33d-4d43-89a8-fdada1cbdd76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a7788869-526a-4208-838d-65a217354bde" xlink:to="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_e220c77a-d33d-4d43-89a8-fdada1cbdd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/StockIncentivePlansTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#StockIncentivePlansTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/StockIncentivePlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1d245e48-3c68-4fa7-806e-8cffc1b26ada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_7e08cae0-3006-437b-80f2-b6f51b873c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1d245e48-3c68-4fa7-806e-8cffc1b26ada" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_7e08cae0-3006-437b-80f2-b6f51b873c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1d238dd1-1ab2-49b6-ab31-358eecd26fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5c1037bf-e0be-4361-9ce8-7565de9d2b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1d238dd1-1ab2-49b6-ab31-358eecd26fb1" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5c1037bf-e0be-4361-9ce8-7565de9d2b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_75bff6f2-e1db-4d32-a8fe-fc68ccd91302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5779b660-07cf-4a30-a193-5c42fccd1862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_75bff6f2-e1db-4d32-a8fe-fc68ccd91302" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5779b660-07cf-4a30-a193-5c42fccd1862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantTables" xlink:type="simple" xlink:href="cnc-20221231.xsd#CondensedFinancialInformationofRegistrantTables"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/CondensedFinancialInformationofRegistrantTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_f870462a-8919-4f73-889f-c9600325f828" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_a31665ac-1a81-450f-8c90-93cfad9ca668" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_f870462a-8919-4f73-889f-c9600325f828" xlink:to="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_a31665ac-1a81-450f-8c90-93cfad9ca668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedIncomeStatementTableTextBlock_3371b809-8585-4c41-94a2-188e4b977f65" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_f870462a-8919-4f73-889f-c9600325f828" xlink:to="loc_srt_ScheduleOfCondensedIncomeStatementTableTextBlock_3371b809-8585-4c41-94a2-188e4b977f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_7134a5be-bf37-4dd0-8d1b-77a1025d874f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_f870462a-8919-4f73-889f-c9600325f828" xlink:to="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_7134a5be-bf37-4dd0-8d1b-77a1025d874f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/OrganizationandOperationsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#OrganizationandOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/OrganizationandOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f95cde95-c3a1-4fb8-95c6-613ef3d0e458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_13ad67ab-5350-45d6-b21c-9d6b0ff8053c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f95cde95-c3a1-4fb8-95c6-613ef3d0e458" xlink:to="loc_us-gaap_NumberOfReportableSegments_13ad67ab-5350-45d6-b21c-9d6b0ff8053c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2d4ac22b-b8d2-4b07-bf31-3aa43f02cc08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d5e66f1c-88cb-4f60-ae4f-893473ba773e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2d4ac22b-b8d2-4b07-bf31-3aa43f02cc08" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d5e66f1c-88cb-4f60-ae4f-893473ba773e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_73f63f57-8be0-4f1d-8923-e5785f7c4b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d5e66f1c-88cb-4f60-ae4f-893473ba773e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_73f63f57-8be0-4f1d-8923-e5785f7c4b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_307f048c-8e5c-4b42-b378-32667e0811f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_73f63f57-8be0-4f1d-8923-e5785f7c4b48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_307f048c-8e5c-4b42-b378-32667e0811f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_0812de16-e138-4bc7-a12d-75ea13b0784b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_307f048c-8e5c-4b42-b378-32667e0811f6" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_0812de16-e138-4bc7-a12d-75ea13b0784b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_83612d5d-e726-4d70-88fd-357e53de076d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_307f048c-8e5c-4b42-b378-32667e0811f6" xlink:to="loc_us-gaap_ComputerEquipmentMember_83612d5d-e726-4d70-88fd-357e53de076d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_302d83a8-3634-40bf-8b09-d0ec5b709f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_307f048c-8e5c-4b42-b378-32667e0811f6" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_302d83a8-3634-40bf-8b09-d0ec5b709f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandImprovementsMember_fa94ad25-80f3-45e2-a0cc-1880b73812af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_307f048c-8e5c-4b42-b378-32667e0811f6" xlink:to="loc_us-gaap_LandImprovementsMember_fa94ad25-80f3-45e2-a0cc-1880b73812af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_a508fe0b-e1b0-46fd-8979-80a008c97475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_307f048c-8e5c-4b42-b378-32667e0811f6" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_a508fe0b-e1b0-46fd-8979-80a008c97475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_79c4b689-c974-4529-ac0f-03b5bef32223" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d5e66f1c-88cb-4f60-ae4f-893473ba773e" xlink:to="loc_srt_RangeAxis_79c4b689-c974-4529-ac0f-03b5bef32223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1a5fd33b-2b0b-49ed-88a2-01f5361ee23c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_79c4b689-c974-4529-ac0f-03b5bef32223" xlink:to="loc_srt_RangeMember_1a5fd33b-2b0b-49ed-88a2-01f5361ee23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0cba1058-b8d0-4ba7-877c-6b9104a8b264" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1a5fd33b-2b0b-49ed-88a2-01f5361ee23c" xlink:to="loc_srt_MinimumMember_0cba1058-b8d0-4ba7-877c-6b9104a8b264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_770d0dc8-c1f8-41cc-9681-47ca6c4b035c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1a5fd33b-2b0b-49ed-88a2-01f5361ee23c" xlink:to="loc_srt_MaximumMember_770d0dc8-c1f8-41cc-9681-47ca6c4b035c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7ba47fa-f46e-4de3-baf6-c8b49ddc64a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d5e66f1c-88cb-4f60-ae4f-893473ba773e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7ba47fa-f46e-4de3-baf6-c8b49ddc64a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_57d8a327-c5e3-4251-b6fb-0ab447582036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b7ba47fa-f46e-4de3-baf6-c8b49ddc64a2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_57d8a327-c5e3-4251-b6fb-0ab447582036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c0a49e24-4f1e-4b06-bd31-3f91ec93db19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4aa671e2-948f-4457-a58f-292d96507c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c0a49e24-4f1e-4b06-bd31-3f91ec93db19" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4aa671e2-948f-4457-a58f-292d96507c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ea113eee-0cd8-4b12-bd72-79ffea207bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4aa671e2-948f-4457-a58f-292d96507c74" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ea113eee-0cd8-4b12-bd72-79ffea207bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_781fd59e-3de0-4ab7-9c0e-e65d236a40f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ea113eee-0cd8-4b12-bd72-79ffea207bce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_781fd59e-3de0-4ab7-9c0e-e65d236a40f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_390148b2-7159-454d-b56c-418dd5ab7477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_781fd59e-3de0-4ab7-9c0e-e65d236a40f9" xlink:to="loc_us-gaap_CustomerContractsMember_390148b2-7159-454d-b56c-418dd5ab7477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ProviderContractsMember_42422bdc-fc66-4f70-abf2-e4d6836110d2" xlink:href="cnc-20221231.xsd#cnc_ProviderContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_781fd59e-3de0-4ab7-9c0e-e65d236a40f9" xlink:to="loc_cnc_ProviderContractsMember_42422bdc-fc66-4f70-abf2-e4d6836110d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_174d975e-9417-47b1-99cc-ecd23ea41f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_781fd59e-3de0-4ab7-9c0e-e65d236a40f9" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_174d975e-9417-47b1-99cc-ecd23ea41f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_994313e3-7906-41f5-b736-7e7ea6f7eac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_781fd59e-3de0-4ab7-9c0e-e65d236a40f9" xlink:to="loc_us-gaap_TradeNamesMember_994313e3-7906-41f5-b736-7e7ea6f7eac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_69e0f658-7969-4583-a8b3-b2acedf15cf3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4aa671e2-948f-4457-a58f-292d96507c74" xlink:to="loc_srt_RangeAxis_69e0f658-7969-4583-a8b3-b2acedf15cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_83ac12e9-6761-475e-9c5e-4ffc101ce828" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_69e0f658-7969-4583-a8b3-b2acedf15cf3" xlink:to="loc_srt_RangeMember_83ac12e9-6761-475e-9c5e-4ffc101ce828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6c6c2f7d-ffd6-4104-bc81-d350a51aa9f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_83ac12e9-6761-475e-9c5e-4ffc101ce828" xlink:to="loc_srt_MinimumMember_6c6c2f7d-ffd6-4104-bc81-d350a51aa9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4e54ae7d-3e27-47aa-a976-28837cdc47f5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_83ac12e9-6761-475e-9c5e-4ffc101ce828" xlink:to="loc_srt_MaximumMember_4e54ae7d-3e27-47aa-a976-28837cdc47f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_27892b36-5caa-4cb3-9256-5acb305cf3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4aa671e2-948f-4457-a58f-292d96507c74" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_27892b36-5caa-4cb3-9256-5acb305cf3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_761dd8cc-27d5-4ea4-8c74-70ec4334b214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_27892b36-5caa-4cb3-9256-5acb305cf3f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_761dd8cc-27d5-4ea4-8c74-70ec4334b214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAllowanceforUncollectibleAccountsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#SummaryofSignificantAccountingPoliciesScheduleofAllowanceforUncollectibleAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAllowanceforUncollectibleAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cf01af70-86a5-4e4e-8a07-b96805bbfe4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_148b65aa-ace8-471c-950b-12f6ff11d3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf01af70-86a5-4e4e-8a07-b96805bbfe4b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_148b65aa-ace8-471c-950b-12f6ff11d3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_7523770b-92ee-4f5f-8387-13e8bc797446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_148b65aa-ace8-471c-950b-12f6ff11d3d0" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_7523770b-92ee-4f5f-8387-13e8bc797446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumReceivableCreditLossExpenseReversal_3dd238de-d322-4948-8a68-fcfb223f2d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumReceivableCreditLossExpenseReversal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_148b65aa-ace8-471c-950b-12f6ff11d3d0" xlink:to="loc_us-gaap_PremiumReceivableCreditLossExpenseReversal_3dd238de-d322-4948-8a68-fcfb223f2d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_73adc561-4ff3-445a-a502-f308600d6e86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_148b65aa-ace8-471c-950b-12f6ff11d3d0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_73adc561-4ff3-445a-a502-f308600d6e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance_b1c6d94a-b0f0-4efe-a034-d0a25920eb16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_148b65aa-ace8-471c-950b-12f6ff11d3d0" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance_b1c6d94a-b0f0-4efe-a034-d0a25920eb16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_5ce53e53-cad4-448e-8853-496f359e378b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_148b65aa-ace8-471c-950b-12f6ff11d3d0" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_5ce53e53-cad4-448e-8853-496f359e378b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f6263471-3dfc-4202-ac13-7be67a642c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1496f09a-3dbc-4113-8f07-b8e02bbaa396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f6263471-3dfc-4202-ac13-7be67a642c49" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1496f09a-3dbc-4113-8f07-b8e02bbaa396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_51471c66-2cac-4b60-aafa-c902605f704b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1496f09a-3dbc-4113-8f07-b8e02bbaa396" xlink:to="loc_srt_StatementGeographicalAxis_51471c66-2cac-4b60-aafa-c902605f704b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c2a96c7c-b0e1-4ce2-9886-7d901d0ba780" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_51471c66-2cac-4b60-aafa-c902605f704b" xlink:to="loc_srt_SegmentGeographicalDomain_c2a96c7c-b0e1-4ce2-9886-7d901d0ba780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_2e0282a7-725e-4f52-8abf-b3cb19e54b2d" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c2a96c7c-b0e1-4ce2-9886-7d901d0ba780" xlink:to="loc_stpr_NY_2e0282a7-725e-4f52-8abf-b3cb19e54b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cc1699b7-e7ce-4e82-9d5d-f39214d241b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1496f09a-3dbc-4113-8f07-b8e02bbaa396" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_cc1699b7-e7ce-4e82-9d5d-f39214d241b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts_38a54aa4-afe6-42ef-9bec-2cffd2acf6b0" xlink:href="cnc-20221231.xsd#cnc_PercentageOfRevenuesUnderContractsOrSubcontracts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cc1699b7-e7ce-4e82-9d5d-f39214d241b6" xlink:to="loc_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts_38a54aa4-afe6-42ef-9bec-2cffd2acf6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#AcquisitionsandDivestituresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b63f662c-374d-48d5-b3e7-d47a2e8f706e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d5542af4-d488-4cf9-bcaa-9dadb63059cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b63f662c-374d-48d5-b3e7-d47a2e8f706e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d5542af4-d488-4cf9-bcaa-9dadb63059cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_09a8bdd8-1db7-4e5b-956e-f8e3ec5d763b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d5542af4-d488-4cf9-bcaa-9dadb63059cc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_09a8bdd8-1db7-4e5b-956e-f8e3ec5d763b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec64b8d4-31e3-4ff5-8597-aad70f600cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_09a8bdd8-1db7-4e5b-956e-f8e3ec5d763b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec64b8d4-31e3-4ff5-8597-aad70f600cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanHealthMember_09b6eaf0-a8bc-4c4e-b432-e480d099481b" xlink:href="cnc-20221231.xsd#cnc_MagellanHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec64b8d4-31e3-4ff5-8597-aad70f600cd9" xlink:to="loc_cnc_MagellanHealthMember_09b6eaf0-a8bc-4c4e-b432-e480d099481b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_318bef2d-96f7-48b1-b1a8-1c2f04f0a883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d5542af4-d488-4cf9-bcaa-9dadb63059cc" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_318bef2d-96f7-48b1-b1a8-1c2f04f0a883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ca8b6fb3-ac64-4568-86e8-156ec050abe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_318bef2d-96f7-48b1-b1a8-1c2f04f0a883" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ca8b6fb3-ac64-4568-86e8-156ec050abe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_182057e9-8145-43b6-b765-2d65c7522d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_318bef2d-96f7-48b1-b1a8-1c2f04f0a883" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_182057e9-8145-43b6-b765-2d65c7522d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_df16f041-ff95-482f-9b91-ceee676c417a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_318bef2d-96f7-48b1-b1a8-1c2f04f0a883" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_df16f041-ff95-482f-9b91-ceee676c417a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_089e46d5-afd1-47be-88d7-23e11e9a2d26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_318bef2d-96f7-48b1-b1a8-1c2f04f0a883" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_089e46d5-afd1-47be-88d7-23e11e9a2d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0709c4f4-c923-477e-ac12-cafb06a1b4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_318bef2d-96f7-48b1-b1a8-1c2f04f0a883" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0709c4f4-c923-477e-ac12-cafb06a1b4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_76b3624b-08fc-459f-b36c-b9cfe4940e86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1224aabf-46e6-488a-8a11-13a301fb0e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_76b3624b-08fc-459f-b36c-b9cfe4940e86" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1224aabf-46e6-488a-8a11-13a301fb0e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7a175100-d516-40f3-b374-fb46b8d9f85b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1224aabf-46e6-488a-8a11-13a301fb0e46" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7a175100-d516-40f3-b374-fb46b8d9f85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1634949a-3a86-48a8-b2e7-0481add06bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7a175100-d516-40f3-b374-fb46b8d9f85b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1634949a-3a86-48a8-b2e7-0481add06bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanHealthMember_dca2ae5c-43ac-409d-aa32-92b5fb4f0a9c" xlink:href="cnc-20221231.xsd#cnc_MagellanHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1634949a-3a86-48a8-b2e7-0481add06bc4" xlink:to="loc_cnc_MagellanHealthMember_dca2ae5c-43ac-409d-aa32-92b5fb4f0a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ef5ea39a-9992-4297-8122-02dcd2270a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1224aabf-46e6-488a-8a11-13a301fb0e46" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ef5ea39a-9992-4297-8122-02dcd2270a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ef5ea39a-9992-4297-8122-02dcd2270a2f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_08baf72f-4d73-4a2c-a172-008b1af06bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_08baf72f-4d73-4a2c-a172-008b1af06bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_ae63d09a-b8fb-467e-97f1-40dab5b1428b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_ae63d09a-b8fb-467e-97f1-40dab5b1428b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments_b35372a1-a9ff-4b4a-96ab-9b151732c55f" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments_b35372a1-a9ff-4b4a-96ab-9b151732c55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_361b0c1c-caf9-4692-baef-aaecd2cccfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_361b0c1c-caf9-4692-baef-aaecd2cccfb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments_34fbdf1b-2e3e-42e3-9e34-7457ca3a0aaa" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments_34fbdf1b-2e3e-42e3-9e34-7457ca3a0aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits_dda59bb4-fecf-4d72-9d68-d1696d7dd0d6" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits_dda59bb4-fecf-4d72-9d68-d1696d7dd0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_12d38dd0-ac19-4b08-824f-2a55035c8d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_12d38dd0-ac19-4b08-824f-2a55035c8d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5579c130-676f-4956-a550-9ad28eb83e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5579c130-676f-4956-a550-9ad28eb83e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_ede5842f-dd0f-4340-ae9c-ee9d53f5a1db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_ede5842f-dd0f-4340-ae9c-ee9d53f5a1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_86310566-9884-45ee-a51a-d1ef68684685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_86310566-9884-45ee-a51a-d1ef68684685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability_9efaa0a3-1197-4d50-8567-5e83ed32901e" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability_9efaa0a3-1197-4d50-8567-5e83ed32901e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1500b7f4-73ec-4e1d-9da4-3323ecf0623e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1500b7f4-73ec-4e1d-9da4-3323ecf0623e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable_8fabcea9-8608-4f98-b059-ad031f2ad3fb" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable_8fabcea9-8608-4f98-b059-ad031f2ad3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0a5321c0-01a4-441b-82c0-41343d9c7f74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0a5321c0-01a4-441b-82c0-41343d9c7f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_4d254d32-e3dc-45d6-81e7-521d0bec689d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_4d254d32-e3dc-45d6-81e7-521d0bec689d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_dc437926-c207-4d22-af44-48ff9920fd73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_dc437926-c207-4d22-af44-48ff9920fd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_cb832967-b028-496a-967e-081523ba48ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_cb832967-b028-496a-967e-081523ba48ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_1acab893-8dfd-4ec9-9fa2-44128d7a1c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_1acab893-8dfd-4ec9-9fa2-44128d7a1c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_10a88296-2235-4abd-ab10-de801f23b7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_10a88296-2235-4abd-ab10-de801f23b7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_4e4f5417-a91b-4dcb-9022-e7f4f6b8fe83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_4e4f5417-a91b-4dcb-9022-e7f4f6b8fe83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ece64b51-cd0b-4873-8d05-2a3c5a20feee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ece64b51-cd0b-4873-8d05-2a3c5a20feee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ec069703-294f-4541-b977-67f61a8a02ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_Goodwill_ec069703-294f-4541-b977-67f61a8a02ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9bbf317f-b1a3-4120-a4f4-11a147686895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9bbf317f-b1a3-4120-a4f4-11a147686895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_36ab6a72-4db0-4e72-b3e3-7f1469096526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_36ab6a72-4db0-4e72-b3e3-7f1469096526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal_bda0ca21-53eb-41c1-9276-d17b8d2c43ff" xlink:href="cnc-20221231.xsd#cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal_bda0ca21-53eb-41c1-9276-d17b8d2c43ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_bdeb821a-b149-4e04-9747-9ffd3b9ed924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_bdeb821a-b149-4e04-9747-9ffd3b9ed924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_12ed0ccb-7a72-4582-bcdd-3047329bad23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_a8ca56b9-f98a-434d-9530-cd76dbb69d33" xlink:to="loc_us-gaap_Goodwill_12ed0ccb-7a72-4582-bcdd-3047329bad23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_95ab623f-0032-4e0f-9395-5d7db9b79c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1cd11d32-b525-44da-99e3-a8475a235434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_95ab623f-0032-4e0f-9395-5d7db9b79c57" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1cd11d32-b525-44da-99e3-a8475a235434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a357d240-a860-4232-b8c2-8a485a76d3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1cd11d32-b525-44da-99e3-a8475a235434" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a357d240-a860-4232-b8c2-8a485a76d3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36363a6c-b249-4ba7-970a-c99b88c923d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a357d240-a860-4232-b8c2-8a485a76d3bc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36363a6c-b249-4ba7-970a-c99b88c923d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanHealthMember_7f10a451-c068-4efa-a68c-43be68700915" xlink:href="cnc-20221231.xsd#cnc_MagellanHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36363a6c-b249-4ba7-970a-c99b88c923d1" xlink:to="loc_cnc_MagellanHealthMember_7f10a451-c068-4efa-a68c-43be68700915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_589dff99-f28e-4d76-b3b9-95f9ae8e98c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1cd11d32-b525-44da-99e3-a8475a235434" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_589dff99-f28e-4d76-b3b9-95f9ae8e98c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_89973149-cb29-430b-8273-1aed6e25d9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_589dff99-f28e-4d76-b3b9-95f9ae8e98c8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_89973149-cb29-430b-8273-1aed6e25d9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_8df42708-0a7e-44a1-97b9-08c58475b4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_89973149-cb29-430b-8273-1aed6e25d9b6" xlink:to="loc_us-gaap_ContractualRightsMember_8df42708-0a7e-44a1-97b9-08c58475b4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember_dc45a051-2a37-4d27-bd6f-2a906999faba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_89973149-cb29-430b-8273-1aed6e25d9b6" xlink:to="loc_us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember_dc45a051-2a37-4d27-bd6f-2a906999faba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_4bc30fe2-21cd-4eec-85f5-fa2227e90fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_89973149-cb29-430b-8273-1aed6e25d9b6" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_4bc30fe2-21cd-4eec-85f5-fa2227e90fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ba412827-b53a-49e5-b415-5db5deb8b2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_89973149-cb29-430b-8273-1aed6e25d9b6" xlink:to="loc_us-gaap_TradeNamesMember_ba412827-b53a-49e5-b415-5db5deb8b2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_eb66cc4f-c2a4-4637-a164-3dc2eec0cecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1cd11d32-b525-44da-99e3-a8475a235434" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_eb66cc4f-c2a4-4637-a164-3dc2eec0cecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ee25715d-fdf4-4941-9863-e87ded28ea05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_eb66cc4f-c2a4-4637-a164-3dc2eec0cecd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ee25715d-fdf4-4941-9863-e87ded28ea05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e96b2f5e-5d57-488a-a9d1-9ae1c1e71925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_eb66cc4f-c2a4-4637-a164-3dc2eec0cecd" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e96b2f5e-5d57-488a-a9d1-9ae1c1e71925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#AcquisitionsandDivestituresDivestituresDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_66e6e0b0-7b81-493f-856d-1b714ed10f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_300338c4-202c-404a-a5a6-042ddd52b5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_66e6e0b0-7b81-493f-856d-1b714ed10f4c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_300338c4-202c-404a-a5a6-042ddd52b5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f309ad1d-726a-4e95-a758-0fe8674426f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_300338c4-202c-404a-a5a6-042ddd52b5f4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f309ad1d-726a-4e95-a758-0fe8674426f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f309ad1d-726a-4e95-a758-0fe8674426f9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PANTHERxRareMember_3876b294-e9f8-49f2-89ee-7e14179d32db" xlink:href="cnc-20221231.xsd#cnc_PANTHERxRareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:to="loc_cnc_PANTHERxRareMember_3876b294-e9f8-49f2-89ee-7e14179d32db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SpanishAndCentralEuropeanBusinessesMember_f63bdfa4-7391-48f3-a938-07b3002fc92c" xlink:href="cnc-20221231.xsd#cnc_SpanishAndCentralEuropeanBusinessesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:to="loc_cnc_SpanishAndCentralEuropeanBusinessesMember_f63bdfa4-7391-48f3-a938-07b3002fc92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanRxMember_f7e81b80-8d5a-458e-9a65-acb49313dcd4" xlink:href="cnc-20221231.xsd#cnc_MagellanRxMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:to="loc_cnc_MagellanRxMember_f7e81b80-8d5a-458e-9a65-acb49313dcd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanSpecialtyHealthMember_5b202339-8128-4380-845e-0759500efd42" xlink:href="cnc-20221231.xsd#cnc_MagellanSpecialtyHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:to="loc_cnc_MagellanSpecialtyHealthMember_5b202339-8128-4380-845e-0759500efd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_CenturionMember_dd3b9b46-997c-453c-87ce-ea0c26293e6f" xlink:href="cnc-20221231.xsd#cnc_CenturionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:to="loc_cnc_CenturionMember_dd3b9b46-997c-453c-87ce-ea0c26293e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_HealthSmartMember_80fca831-7f63-40b7-b963-60a37aee364b" xlink:href="cnc-20221231.xsd#cnc_HealthSmartMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ffe33415-a161-4435-be68-3b6ee233850d" xlink:to="loc_cnc_HealthSmartMember_80fca831-7f63-40b7-b963-60a37aee364b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3b03f909-233d-493e-b087-04c68fa4e544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_300338c4-202c-404a-a5a6-042ddd52b5f4" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3b03f909-233d-493e-b087-04c68fa4e544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b70ee1fe-9b3b-432a-92cf-f9c6d1d3afd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3b03f909-233d-493e-b087-04c68fa4e544" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b70ee1fe-9b3b-432a-92cf-f9c6d1d3afd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_c109d49c-fb2c-461b-b290-5232a13681b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b70ee1fe-9b3b-432a-92cf-f9c6d1d3afd8" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_c109d49c-fb2c-461b-b290-5232a13681b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_8848f655-2815-4e18-ac99-b8738c1e54be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b70ee1fe-9b3b-432a-92cf-f9c6d1d3afd8" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_8848f655-2815-4e18-ac99-b8738c1e54be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_bc1aa7b6-f754-4866-a5ba-9f7ac7545be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_300338c4-202c-404a-a5a6-042ddd52b5f4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_bc1aa7b6-f754-4866-a5ba-9f7ac7545be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3f703ff0-2f12-478a-ba9a-c4ce065cdf9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bc1aa7b6-f754-4866-a5ba-9f7ac7545be1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3f703ff0-2f12-478a-ba9a-c4ce065cdf9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1d56175b-01e3-4094-8761-1f5e11164b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3f703ff0-2f12-478a-ba9a-c4ce065cdf9d" xlink:to="loc_us-gaap_SubsequentEventMember_1d56175b-01e3-4094-8761-1f5e11164b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_744ca6a2-6c27-49ff-b15b-2bc37c4c76fa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_300338c4-202c-404a-a5a6-042ddd52b5f4" xlink:to="loc_srt_RangeAxis_744ca6a2-6c27-49ff-b15b-2bc37c4c76fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7c3e6676-e4c5-4de8-86b0-06571dfc3d7c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_744ca6a2-6c27-49ff-b15b-2bc37c4c76fa" xlink:to="loc_srt_RangeMember_7c3e6676-e4c5-4de8-86b0-06571dfc3d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_96bec48f-849c-442f-bd38-5718c80be8d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7c3e6676-e4c5-4de8-86b0-06571dfc3d7c" xlink:to="loc_srt_MinimumMember_96bec48f-849c-442f-bd38-5718c80be8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7ddbc12f-541b-470a-8fa0-817838919c27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7c3e6676-e4c5-4de8-86b0-06571dfc3d7c" xlink:to="loc_srt_MaximumMember_7ddbc12f-541b-470a-8fa0-817838919c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_300338c4-202c-404a-a5a6-042ddd52b5f4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_9de4694a-6640-400d-9b55-b828d55ed4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_9de4694a-6640-400d-9b55-b828d55ed4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_5f0354d9-5b2a-4ba3-bb97-cc5613e3ba77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_5f0354d9-5b2a-4ba3-bb97-cc5613e3ba77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GainLossOnDispositionOfBusinessNetOfTax_3e3eb985-d172-48aa-ae02-f440aa98bd79" xlink:href="cnc-20221231.xsd#cnc_GainLossOnDispositionOfBusinessNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_cnc_GainLossOnDispositionOfBusinessNetOfTax_3e3eb985-d172-48aa-ae02-f440aa98bd79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_8e26bb56-2432-4830-a5c5-8158dfecdaae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_us-gaap_AssetImpairmentCharges_8e26bb56-2432-4830-a5c5-8158dfecdaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AssetImpairmentChargesNetOfTax_ec612d94-f36b-4fb6-a61c-7cb81bdd2022" xlink:href="cnc-20221231.xsd#cnc_AssetImpairmentChargesNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_cnc_AssetImpairmentChargesNetOfTax_ec612d94-f36b-4fb6-a61c-7cb81bdd2022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_d5942aaa-a6a1-47cd-aa58-e91ea05ad67e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_d5942aaa-a6a1-47cd-aa58-e91ea05ad67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a8bddc7e-ec65-49db-aa49-27ccd2ef3ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a8bddc7e-ec65-49db-aa49-27ccd2ef3ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_830214e2-4938-4a57-8c0f-aaf4036de6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_830214e2-4938-4a57-8c0f-aaf4036de6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh_67e31e80-d735-415e-a869-8a16853de410" xlink:href="cnc-20221231.xsd#cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e771e868-52ab-4024-b896-6df9a966409c" xlink:to="loc_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh_67e31e80-d735-415e-a869-8a16853de410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_913db2a1-e33f-4f8e-8848-1982a9c613a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_a992e12d-a32c-4e33-9e4d-9630d127a529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_913db2a1-e33f-4f8e-8848-1982a9c613a4" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_a992e12d-a32c-4e33-9e4d-9630d127a529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1210be18-7a01-442a-a9f3-fa6ac2b6bd46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_a992e12d-a32c-4e33-9e4d-9630d127a529" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1210be18-7a01-442a-a9f3-fa6ac2b6bd46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1210be18-7a01-442a-a9f3-fa6ac2b6bd46" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_b0f47860-1dc9-4c47-9436-c507ebdc1020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_b0f47860-1dc9-4c47-9436-c507ebdc1020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_6ea92673-52f9-4f6e-9bbf-c3a891b7c70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_6ea92673-52f9-4f6e-9bbf-c3a891b7c70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RestrictedCertificatesOfDepositMember_a1514113-68da-4ae8-93f7-714182ff1f6a" xlink:href="cnc-20221231.xsd#cnc_RestrictedCertificatesOfDepositMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_cnc_RestrictedCertificatesOfDepositMember_a1514113-68da-4ae8-93f7-714182ff1f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RestrictedCashEquivalentsMember_786fee33-261b-4222-8975-654758061390" xlink:href="cnc-20221231.xsd#cnc_RestrictedCashEquivalentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_cnc_RestrictedCashEquivalentsMember_786fee33-261b-4222-8975-654758061390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_d1c454e1-b654-4bde-8cfc-f1a43acd840a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_us-gaap_BankTimeDepositsMember_d1c454e1-b654-4bde-8cfc-f1a43acd840a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_c3a5058a-ebb6-4efc-8ccd-d57abac35ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_us-gaap_MunicipalBondsMember_c3a5058a-ebb6-4efc-8ccd-d57abac35ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_0af7b84b-6069-4d99-bcc4-59af1862b555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_0af7b84b-6069-4d99-bcc4-59af1862b555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_4957a39f-57e5-4662-adc1-f91d2fbf290f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_4957a39f-57e5-4662-adc1-f91d2fbf290f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_db00583c-f4dd-464e-8416-12ef71a6e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a513ce0-0a48-4773-8176-835265dcea54" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_db00583c-f4dd-464e-8416-12ef71a6e7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_a992e12d-a32c-4e33-9e4d-9630d127a529" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_8a3aacab-c1cc-45fa-b784-85e4bc12a3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:to="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_8a3aacab-c1cc-45fa-b784-85e4bc12a3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_cd903330-38f0-4d05-8a2a-76d54437dd67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_8a3aacab-c1cc-45fa-b784-85e4bc12a3ab" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_cd903330-38f0-4d05-8a2a-76d54437dd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_33e8650f-23ac-4213-8eba-6e08f6e554b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_8a3aacab-c1cc-45fa-b784-85e4bc12a3ab" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_33e8650f-23ac-4213-8eba-6e08f6e554b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_08ecd24b-3b62-42cc-9292-5c1d000944fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_8a3aacab-c1cc-45fa-b784-85e4bc12a3ab" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_08ecd24b-3b62-42cc-9292-5c1d000944fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_3db88d46-c7b7-4b27-8c4e-6fb846faf79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_8a3aacab-c1cc-45fa-b784-85e4bc12a3ab" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_3db88d46-c7b7-4b27-8c4e-6fb846faf79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_1dbd4a69-4b69-464a-aab0-669ebcdd30b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_1dbd4a69-4b69-464a-aab0-669ebcdd30b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_c88b3cc7-0d7a-4f5c-9973-ed466ff80169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:to="loc_us-gaap_EquityMethodInvestments_c88b3cc7-0d7a-4f5c-9973-ed466ff80169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount_d64455ad-d50f-4c18-82e8-c87ebc20a176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LifeInsuranceCorporateOrBankOwnedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:to="loc_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount_d64455ad-d50f-4c18-82e8-c87ebc20a176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost_a28ef2df-d4f6-4d0c-a037-c7791a464d49" xlink:href="cnc-20221231.xsd#cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:to="loc_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost_a28ef2df-d4f6-4d0c-a037-c7791a464d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue_be025170-a70c-45b9-9159-89daae3df91f" xlink:href="cnc-20221231.xsd#cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cfee3888-a806-4f71-97a5-ca09e5664601" xlink:to="loc_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue_be025170-a70c-45b9-9159-89daae3df91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_57c1bb57-53a6-4dbc-8134-5d328eb28783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_57c1bb57-53a6-4dbc-8134-5d328eb28783" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8931f24-94f1-479d-8085-fa40d70439a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8931f24-94f1-479d-8085-fa40d70439a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f31771b7-6bfe-451f-8688-0cd518c218d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8931f24-94f1-479d-8085-fa40d70439a6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f31771b7-6bfe-451f-8688-0cd518c218d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RatedSecuritiesMember_26712c7b-e516-442f-ad76-adc30c3497e6" xlink:href="cnc-20221231.xsd#cnc_RatedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f31771b7-6bfe-451f-8688-0cd518c218d0" xlink:to="loc_cnc_RatedSecuritiesMember_26712c7b-e516-442f-ad76-adc30c3497e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingByGroupingAxis_2697ea78-ba80-46d6-a49e-054d7c0b71bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingByGroupingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:to="loc_us-gaap_ExternalCreditRatingByGroupingAxis_2697ea78-ba80-46d6-a49e-054d7c0b71bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingByGroupingDomain_a38ed24d-7347-4fbd-9676-1974ad998931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingByGroupingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExternalCreditRatingByGroupingAxis_2697ea78-ba80-46d6-a49e-054d7c0b71bc" xlink:to="loc_us-gaap_ExternalCreditRatingByGroupingDomain_a38ed24d-7347-4fbd-9676-1974ad998931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingInvestmentGradeMember_34ec6b5e-23e5-4277-b04b-ae3d6d47c753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingInvestmentGradeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExternalCreditRatingByGroupingDomain_a38ed24d-7347-4fbd-9676-1974ad998931" xlink:to="loc_us-gaap_ExternalCreditRatingInvestmentGradeMember_34ec6b5e-23e5-4277-b04b-ae3d6d47c753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e9b2567a-13e9-4cb2-8493-f870e9d4e5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e9b2567a-13e9-4cb2-8493-f870e9d4e5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ebdb7243-8c42-46c3-b77b-4f80d81c10de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e9b2567a-13e9-4cb2-8493-f870e9d4e5f5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ebdb7243-8c42-46c3-b77b-4f80d81c10de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_InvestmentSecuritiesMember_e846e7ef-9a2c-4615-8f0d-ddad0c35adee" xlink:href="cnc-20221231.xsd#cnc_InvestmentSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ebdb7243-8c42-46c3-b77b-4f80d81c10de" xlink:to="loc_cnc_InvestmentSecuritiesMember_e846e7ef-9a2c-4615-8f0d-ddad0c35adee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_81b7cf93-9b63-445b-ac3c-fd68ac47ee2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:to="loc_us-gaap_FinancialInstrumentAxis_81b7cf93-9b63-445b-ac3c-fd68ac47ee2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f18ce15f-86a1-48c7-b6af-903d9c2af5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_81b7cf93-9b63-445b-ac3c-fd68ac47ee2e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f18ce15f-86a1-48c7-b6af-903d9c2af5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_91abfea8-47af-46ed-a0a4-0f10a2cc7b10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f18ce15f-86a1-48c7-b6af-903d9c2af5d9" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_91abfea8-47af-46ed-a0a4-0f10a2cc7b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1d9d5617-b078-42b5-ab3b-9a1d0c8c7764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1d9d5617-b078-42b5-ab3b-9a1d0c8c7764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a94fb8e-b182-4ee5-87ab-d969471077e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d9d5617-b078-42b5-ab3b-9a1d0c8c7764" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a94fb8e-b182-4ee5-87ab-d969471077e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_CircleHealthMember_53f93718-8cee-429f-8e60-ad087f4341ad" xlink:href="cnc-20221231.xsd#cnc_CircleHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a94fb8e-b182-4ee5-87ab-d969471077e8" xlink:to="loc_cnc_CircleHealthMember_53f93718-8cee-429f-8e60-ad087f4341ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_21a9a477-cfe7-4dc9-a413-b034a99ab161" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_21a9a477-cfe7-4dc9-a413-b034a99ab161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_85453132-4bb6-439b-bcb6-715be327a869" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_21a9a477-cfe7-4dc9-a413-b034a99ab161" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_85453132-4bb6-439b-bcb6-715be327a869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RxAdvanceMember_9502c724-9c09-43c4-aee6-894aa11d1660" xlink:href="cnc-20221231.xsd#cnc_RxAdvanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_85453132-4bb6-439b-bcb6-715be327a869" xlink:to="loc_cnc_RxAdvanceMember_9502c724-9c09-43c4-aee6-894aa11d1660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9fb488e0-bd4c-4e83-a288-803e30f11491" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ebaec284-2da9-4d8d-8589-800e96b90428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ebaec284-2da9-4d8d-8589-800e96b90428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_abfd3bf3-4a2a-494f-be3d-913628345277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_abfd3bf3-4a2a-494f-be3d-913628345277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList_0120e057-caca-4b96-9876-5ee9f613f9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList_0120e057-caca-4b96-9876-5ee9f613f9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration_aa7d7f29-c953-4920-9081-481ad4bd480f" xlink:href="cnc-20221231.xsd#cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration_aa7d7f29-c953-4920-9081-481ad4bd480f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_9b8cab8a-88ca-4464-b64c-e004ff0230c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_9b8cab8a-88ca-4464-b64c-e004ff0230c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions_f017d87c-1fb1-4375-8ca5-f4555e8995f6" xlink:href="cnc-20221231.xsd#cnc_DebtSecuritiesAvailableForSaleNumberOfPositions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions_f017d87c-1fb1-4375-8ca5-f4555e8995f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_627750b3-94bf-47a0-bf5c-0997d416506e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_627750b3-94bf-47a0-bf5c-0997d416506e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_57be221c-6c3c-4ac1-b88b-82f7b1bb9996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_57be221c-6c3c-4ac1-b88b-82f7b1bb9996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_ed56760b-a3d7-40bd-9b01-c457a255c834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_ed56760b-a3d7-40bd-9b01-c457a255c834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_18e5b901-8f7e-45cb-99c0-0f5617f988cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_18e5b901-8f7e-45cb-99c0-0f5617f988cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_feb394e1-a4b0-42d7-a3a0-3112874a095c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a738dfc3-5b83-486a-b064-b8bff7bc9071" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_feb394e1-a4b0-42d7-a3a0-3112874a095c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_82a10daa-c615-4f07-8344-1c81550c173c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1e4618be-dd4e-4759-b19a-de67e14bd83c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_82a10daa-c615-4f07-8344-1c81550c173c" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1e4618be-dd4e-4759-b19a-de67e14bd83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6cb5ec2c-4022-46ac-95e9-5a2c0916599c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1e4618be-dd4e-4759-b19a-de67e14bd83c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6cb5ec2c-4022-46ac-95e9-5a2c0916599c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6cb5ec2c-4022-46ac-95e9-5a2c0916599c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_a399742b-64d9-456b-adce-66c82a8616d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_a399742b-64d9-456b-adce-66c82a8616d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_70c97b94-7e1b-42b7-b356-fb0deee83b77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_70c97b94-7e1b-42b7-b356-fb0deee83b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_8acabd8d-7a23-44d6-8193-f770450734fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:to="loc_us-gaap_MunicipalBondsMember_8acabd8d-7a23-44d6-8193-f770450734fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_2547186a-c295-4596-8582-7bfd9e42bdc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_2547186a-c295-4596-8582-7bfd9e42bdc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c5c35779-dcce-4bf6-8483-ba46f6206a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c5c35779-dcce-4bf6-8483-ba46f6206a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_605ed8b4-1d29-4713-bb64-6ce663f2bd96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_52612882-4a56-44aa-a531-5ff1cc5c4c67" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_605ed8b4-1d29-4713-bb64-6ce663f2bd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ab5ae346-6a68-4848-a422-342bbb209b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1e4618be-dd4e-4759-b19a-de67e14bd83c" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ab5ae346-6a68-4848-a422-342bbb209b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_c007ed29-33ad-486f-bd59-abdc4b8cd822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ab5ae346-6a68-4848-a422-342bbb209b51" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_c007ed29-33ad-486f-bd59-abdc4b8cd822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_9b0e8c5b-baf8-4687-a61a-e3ac685fc01e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_c007ed29-33ad-486f-bd59-abdc4b8cd822" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_9b0e8c5b-baf8-4687-a61a-e3ac685fc01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_ece22fb5-5b1e-4914-adba-9d55ecc9799a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_c007ed29-33ad-486f-bd59-abdc4b8cd822" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_ece22fb5-5b1e-4914-adba-9d55ecc9799a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract_7fc966dc-7491-4beb-9352-93fbaac79a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ab5ae346-6a68-4848-a422-342bbb209b51" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract_7fc966dc-7491-4beb-9352-93fbaac79a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_a6b6057d-4249-4a93-a6dc-b8dab606a291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract_7fc966dc-7491-4beb-9352-93fbaac79a8c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_a6b6057d-4249-4a93-a6dc-b8dab606a291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_ac748816-7332-40ad-bc03-e1a301ac3105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract_7fc966dc-7491-4beb-9352-93fbaac79a8c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_ac748816-7332-40ad-bc03-e1a301ac3105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_fcd4699b-0b6c-44e9-989b-aa82b8fd50f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_247871ec-ca57-4eab-8f95-444dfee152c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_fcd4699b-0b6c-44e9-989b-aa82b8fd50f4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_247871ec-ca57-4eab-8f95-444dfee152c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_a7142dd4-fc8b-4579-b137-c9fa76fcf19a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_247871ec-ca57-4eab-8f95-444dfee152c6" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_a7142dd4-fc8b-4579-b137-c9fa76fcf19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3efdc46-0c67-4e26-bda2-0263fa474c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_a7142dd4-fc8b-4579-b137-c9fa76fcf19a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3efdc46-0c67-4e26-bda2-0263fa474c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_d24d6105-1b18-48f9-be40-c33167277800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3efdc46-0c67-4e26-bda2-0263fa474c11" xlink:to="loc_us-gaap_InvestmentsMember_d24d6105-1b18-48f9-be40-c33167277800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsMember_20cce6f8-b00e-4ce3-af15-3e815ced9176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3efdc46-0c67-4e26-bda2-0263fa474c11" xlink:to="loc_us-gaap_DepositsMember_20cce6f8-b00e-4ce3-af15-3e815ced9176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_71ce1495-aaf5-4343-9ab7-638cc94220b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_247871ec-ca57-4eab-8f95-444dfee152c6" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_71ce1495-aaf5-4343-9ab7-638cc94220b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_71ce1495-aaf5-4343-9ab7-638cc94220b3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f028704a-864a-4a43-a957-829245717490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f028704a-864a-4a43-a957-829245717490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_032ded2e-b64e-4032-a238-35b9e72c1c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_032ded2e-b64e-4032-a238-35b9e72c1c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_6772f4e6-2592-4a96-8fb9-33dd5ce7debb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_6772f4e6-2592-4a96-8fb9-33dd5ce7debb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_c7460c1c-9502-4bbb-85c2-c808e841b810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_c7460c1c-9502-4bbb-85c2-c808e841b810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_d5db3793-6396-4c19-b8b7-d74eb7c5a346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_d5db3793-6396-4c19-b8b7-d74eb7c5a346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_d9e59f72-92f0-46de-9fe5-c3d9bfabde97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_7c7ca5c8-90ba-43ff-b3b8-483c7ba657ff" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_d9e59f72-92f0-46de-9fe5-c3d9bfabde97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_71ce1495-aaf5-4343-9ab7-638cc94220b3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0aa339e9-587b-4228-9649-cdccc0ab29d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0aa339e9-587b-4228-9649-cdccc0ab29d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_86fbab91-ddca-4b2f-8bdd-02ecfaa4b3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_86fbab91-ddca-4b2f-8bdd-02ecfaa4b3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_f983f8c0-6891-4da2-8ede-7c2abc8d5c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_f983f8c0-6891-4da2-8ede-7c2abc8d5c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_0d6a4889-be2d-407b-a11e-2b18fe64b5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_0d6a4889-be2d-407b-a11e-2b18fe64b5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_11397423-0729-4ed0-abb9-61df76b34a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_11397423-0729-4ed0-abb9-61df76b34a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_4e77f5cd-9794-428b-b2a1-96b34b7ef61c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d73266ce-e790-4d84-adc8-73fc139bfc73" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_4e77f5cd-9794-428b-b2a1-96b34b7ef61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5d980e58-bbce-4444-b9dc-e09d223f2acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_24c12f31-211b-4c84-b40e-bf3675ee5038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5d980e58-bbce-4444-b9dc-e09d223f2acc" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_24c12f31-211b-4c84-b40e-bf3675ee5038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_c0586a83-f2bb-4a71-a9bc-ac6047d7e706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_24c12f31-211b-4c84-b40e-bf3675ee5038" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_c0586a83-f2bb-4a71-a9bc-ac6047d7e706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3d82e4af-7282-44e5-95ec-af51cbfcb67c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_c0586a83-f2bb-4a71-a9bc-ac6047d7e706" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3d82e4af-7282-44e5-95ec-af51cbfcb67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_a87e459f-7fea-4f78-a732-101e07f951cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3d82e4af-7282-44e5-95ec-af51cbfcb67c" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_a87e459f-7fea-4f78-a732-101e07f951cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsMember_772e3b4f-1de1-4ca5-9400-08867a7e5cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3d82e4af-7282-44e5-95ec-af51cbfcb67c" xlink:to="loc_us-gaap_DepositsMember_772e3b4f-1de1-4ca5-9400-08867a7e5cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_2e5c2fb7-75ce-4a0c-9ed9-dad94bff1111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3d82e4af-7282-44e5-95ec-af51cbfcb67c" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_2e5c2fb7-75ce-4a0c-9ed9-dad94bff1111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8d2a1ed8-05f2-4249-b031-c99c20c7d879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_24c12f31-211b-4c84-b40e-bf3675ee5038" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8d2a1ed8-05f2-4249-b031-c99c20c7d879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c409662b-3f7a-4745-b1b2-63675845f8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8d2a1ed8-05f2-4249-b031-c99c20c7d879" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c409662b-3f7a-4745-b1b2-63675845f8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a5feceda-faba-4ea5-ae4b-35337debc481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c409662b-3f7a-4745-b1b2-63675845f8bb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a5feceda-faba-4ea5-ae4b-35337debc481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_13cbe9eb-8e99-4fa9-99a4-a72c6a3c2f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c409662b-3f7a-4745-b1b2-63675845f8bb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_13cbe9eb-8e99-4fa9-99a4-a72c6a3c2f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_654169a0-0237-4027-b37e-07e747f2fd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c409662b-3f7a-4745-b1b2-63675845f8bb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_654169a0-0237-4027-b37e-07e747f2fd1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d95da925-7043-4358-bf5a-34cdffd49097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_24c12f31-211b-4c84-b40e-bf3675ee5038" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d95da925-7043-4358-bf5a-34cdffd49097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d95da925-7043-4358-bf5a-34cdffd49097" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_613b8404-7346-4ac0-8202-049d8d498271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_613b8404-7346-4ac0-8202-049d8d498271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_f35628cc-8c82-4ecf-8fee-dd7c9b46359f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_f35628cc-8c82-4ecf-8fee-dd7c9b46359f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_e7b8f1a4-9f0b-40aa-8689-859313c938eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_MunicipalBondsMember_e7b8f1a4-9f0b-40aa-8689-859313c938eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_4aea29ec-f9a0-4b4c-a705-c3358a976a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_BankTimeDepositsMember_4aea29ec-f9a0-4b4c-a705-c3358a976a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_c0df14d0-3f25-4c54-b68c-084b69325041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_c0df14d0-3f25-4c54-b68c-084b69325041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_0d7aff49-cdee-4523-982e-4366aae4573f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_0d7aff49-cdee-4523-982e-4366aae4573f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d3f06b56-c115-4e44-8050-16ed790d0e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d3f06b56-c115-4e44-8050-16ed790d0e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_2c508144-ecf1-4fd9-9c8e-2ab57664e1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_2c508144-ecf1-4fd9-9c8e-2ab57664e1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_924e6a50-bcfe-463d-8865-f9d283c1b26e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_CertificatesOfDepositMember_924e6a50-bcfe-463d-8865-f9d283c1b26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5b50f94f-fd0a-4550-a826-96a890780c10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b99b35-4f03-41e7-9ac4-a63c1d2cb96a" xlink:to="loc_us-gaap_InterestRateSwapMember_5b50f94f-fd0a-4550-a826-96a890780c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b718daad-c33f-4ba8-8370-d31910195737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_24c12f31-211b-4c84-b40e-bf3675ee5038" xlink:to="loc_us-gaap_StatementLineItems_b718daad-c33f-4ba8-8370-d31910195737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_c4a23f42-58b5-4bde-803c-b51e0778d92a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b718daad-c33f-4ba8-8370-d31910195737" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_c4a23f42-58b5-4bde-803c-b51e0778d92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7cb3d760-e20e-49f4-a195-9d8e0ba0e0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_c4a23f42-58b5-4bde-803c-b51e0778d92a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7cb3d760-e20e-49f4-a195-9d8e0ba0e0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_5d0df84a-6f81-4c1d-9a85-a56ac54fbc84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_c4a23f42-58b5-4bde-803c-b51e0778d92a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_5d0df84a-6f81-4c1d-9a85-a56ac54fbc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_91fec213-6a6e-4979-96d7-48654154ae44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_5d0df84a-6f81-4c1d-9a85-a56ac54fbc84" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_91fec213-6a6e-4979-96d7-48654154ae44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_03f2fcb6-3b61-4f94-86ae-3a4cbf583e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_5d0df84a-6f81-4c1d-9a85-a56ac54fbc84" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_03f2fcb6-3b61-4f94-86ae-3a4cbf583e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_6f6e7cca-7e8e-46a3-bbba-87c1bd8dd575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_c4a23f42-58b5-4bde-803c-b51e0778d92a" xlink:to="loc_us-gaap_OtherAssetsAbstract_6f6e7cca-7e8e-46a3-bbba-87c1bd8dd575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_2f88c596-424b-4ddf-bfa7-e8b62b65e4be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_6f6e7cca-7e8e-46a3-bbba-87c1bd8dd575" xlink:to="loc_us-gaap_DerivativeAssets_2f88c596-424b-4ddf-bfa7-e8b62b65e4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_824ea3f8-a20e-411a-8ea8-61d97e79abdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b718daad-c33f-4ba8-8370-d31910195737" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_824ea3f8-a20e-411a-8ea8-61d97e79abdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_09fffc49-036a-4af3-a663-477b80ccd415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue_175dede7-ad00-4eee-8578-a60250561b0f" xlink:href="cnc-20221231.xsd#cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_09fffc49-036a-4af3-a663-477b80ccd415" xlink:to="loc_cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue_175dede7-ad00-4eee-8578-a60250561b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#PropertySoftwareandEquipmentComponentsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a4509d79-c940-46fb-ae9e-38e059f980de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_be26e390-ffb3-4f3f-a3e5-1e3a3caf72fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a4509d79-c940-46fb-ae9e-38e059f980de" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_be26e390-ffb3-4f3f-a3e5-1e3a3caf72fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a6ad83a9-5371-4fd2-b2ce-7585874c2634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_be26e390-ffb3-4f3f-a3e5-1e3a3caf72fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a6ad83a9-5371-4fd2-b2ce-7585874c2634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a6ad83a9-5371-4fd2-b2ce-7585874c2634" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_c45340ba-fe8d-4dfa-86a6-e7741313208d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_c45340ba-fe8d-4dfa-86a6-e7741313208d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_6299dc0a-b8ae-4c89-909e-f6920bec54d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:to="loc_us-gaap_BuildingMember_6299dc0a-b8ae-4c89-909e-f6920bec54d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ComputerHardwareMember_6a5153dc-55ae-4ce8-b855-2bfc352f8840" xlink:href="cnc-20221231.xsd#cnc_ComputerHardwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:to="loc_cnc_ComputerHardwareMember_6a5153dc-55ae-4ce8-b855-2bfc352f8840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_65a0f5fb-58ac-47a0-8317-fba2119c0651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_65a0f5fb-58ac-47a0-8317-fba2119c0651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FurnitureAndOfficeEquipmentMember_c1ebb6c1-1307-47c5-b0c3-215fc570bd25" xlink:href="cnc-20221231.xsd#cnc_FurnitureAndOfficeEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:to="loc_cnc_FurnitureAndOfficeEquipmentMember_c1ebb6c1-1307-47c5-b0c3-215fc570bd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_65eb7ca8-ab2c-4f6d-adcd-c8fe44eb3756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3cb61b56-199c-4b95-8bae-9e4ff00090b0" xlink:to="loc_us-gaap_LandMember_65eb7ca8-ab2c-4f6d-adcd-c8fe44eb3756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a5f8e167-4886-447b-a2d9-e7719188e7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_be26e390-ffb3-4f3f-a3e5-1e3a3caf72fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a5f8e167-4886-447b-a2d9-e7719188e7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ab79b961-9bf6-433e-bd78-20d821ab38a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a5f8e167-4886-447b-a2d9-e7719188e7df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ab79b961-9bf6-433e-bd78-20d821ab38a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_065ec495-f0cb-4f3c-96d3-760c9fb0d145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a5f8e167-4886-447b-a2d9-e7719188e7df" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_065ec495-f0cb-4f3c-96d3-760c9fb0d145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_92b88e4a-8ea6-4db3-b1cb-3f61216c4cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a5f8e167-4886-447b-a2d9-e7719188e7df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_92b88e4a-8ea6-4db3-b1cb-3f61216c4cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#PropertySoftwareandEquipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_598192e6-135c-484c-841b-b69d33eeedd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_17a28791-9a3a-4262-99d6-4f8ea5573862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_598192e6-135c-484c-841b-b69d33eeedd3" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_17a28791-9a3a-4262-99d6-4f8ea5573862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e85ba87-08f1-4e5e-bba1-50c5902e26f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_17a28791-9a3a-4262-99d6-4f8ea5573862" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e85ba87-08f1-4e5e-bba1-50c5902e26f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7da21ad-3b2e-4b21-ae5c-05eaa60fa0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2e85ba87-08f1-4e5e-bba1-50c5902e26f6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7da21ad-3b2e-4b21-ae5c-05eaa60fa0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_RealEstateOwnedAndRelatedFixedAssetsMember_ec8f617d-dba3-40df-8542-1e19622940b4" xlink:href="cnc-20221231.xsd#cnc_RealEstateOwnedAndRelatedFixedAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7da21ad-3b2e-4b21-ae5c-05eaa60fa0eb" xlink:to="loc_cnc_RealEstateOwnedAndRelatedFixedAssetsMember_ec8f617d-dba3-40df-8542-1e19622940b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FixedAssetsLeasedRealEstateMember_b89275ae-bca3-43b1-8b59-c2474a9b4c23" xlink:href="cnc-20221231.xsd#cnc_FixedAssetsLeasedRealEstateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c7da21ad-3b2e-4b21-ae5c-05eaa60fa0eb" xlink:to="loc_cnc_FixedAssetsLeasedRealEstateMember_b89275ae-bca3-43b1-8b59-c2474a9b4c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3b2b85c-562f-49cd-a334-67f6c05b7249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_17a28791-9a3a-4262-99d6-4f8ea5573862" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3b2b85c-562f-49cd-a334-67f6c05b7249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_823adbfb-1f7c-4c9c-8673-200093e268af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3b2b85c-562f-49cd-a334-67f6c05b7249" xlink:to="loc_us-gaap_Depreciation_823adbfb-1f7c-4c9c-8673-200093e268af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_7962fdfc-a6e6-49a5-8274-2375c5a53d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3b2b85c-562f-49cd-a334-67f6c05b7249" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_7962fdfc-a6e6-49a5-8274-2375c5a53d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_95b7d061-43f8-4af2-9bbe-27f5cdf13ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f3b2b85c-562f-49cd-a334-67f6c05b7249" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_95b7d061-43f8-4af2-9bbe-27f5cdf13ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3a6e564e-0c00-4499-a851-f24105f29089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_f7c56a0a-da71-4c41-9819-110f1d09ad22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3a6e564e-0c00-4499-a851-f24105f29089" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_f7c56a0a-da71-4c41-9819-110f1d09ad22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b7c86782-03d3-4579-af40-77482c515217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f7c56a0a-da71-4c41-9819-110f1d09ad22" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b7c86782-03d3-4579-af40-77482c515217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e532baf7-282e-472b-b717-2b66a9fc2c12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b7c86782-03d3-4579-af40-77482c515217" xlink:to="loc_us-gaap_SegmentDomain_e532baf7-282e-472b-b717-2b66a9fc2c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ManagedCareMember_1e602f85-b848-44a2-9675-9310ca740f76" xlink:href="cnc-20221231.xsd#cnc_ManagedCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e532baf7-282e-472b-b717-2b66a9fc2c12" xlink:to="loc_cnc_ManagedCareMember_1e602f85-b848-44a2-9675-9310ca740f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SpecialtyServicesMember_b74d6733-54bb-4b21-bedc-0d06a5708d00" xlink:href="cnc-20221231.xsd#cnc_SpecialtyServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e532baf7-282e-472b-b717-2b66a9fc2c12" xlink:to="loc_cnc_SpecialtyServicesMember_b74d6733-54bb-4b21-bedc-0d06a5708d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_ac5e17d8-e6a5-453b-86cc-e5f8ac8a6b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f7c56a0a-da71-4c41-9819-110f1d09ad22" xlink:to="loc_us-gaap_GoodwillLineItems_ac5e17d8-e6a5-453b-86cc-e5f8ac8a6b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_ac5e17d8-e6a5-453b-86cc-e5f8ac8a6b82" xlink:to="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_47c1884a-b40b-46da-b28f-69cb2a531f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:to="loc_us-gaap_Goodwill_47c1884a-b40b-46da-b28f-69cb2a531f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_fbfdc250-999e-4276-9281-ea93b5c2f7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_fbfdc250-999e-4276-9281-ea93b5c2f7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_b5828917-0376-4c25-80de-f863e0307e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_b5828917-0376-4c25-80de-f863e0307e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_0e08f416-8617-48f6-8496-275e6f280d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:to="loc_us-gaap_GoodwillTransfers_0e08f416-8617-48f6-8496-275e6f280d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2b605d79-2555-48d7-a534-7d780a48d6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2b605d79-2555-48d7-a534-7d780a48d6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_45913592-1475-4166-897f-704d07cc3a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_45913592-1475-4166-897f-704d07cc3a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7ed3da81-2a89-43e9-834f-a5e384de5d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f89798de-9588-48e5-a459-343c485433c4" xlink:to="loc_us-gaap_Goodwill_7ed3da81-2a89-43e9-834f-a5e384de5d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_092c7c15-0681-4ee1-95a4-e7ae73f7e9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_734ac086-0f43-4787-bada-e18593a1dc82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_092c7c15-0681-4ee1-95a4-e7ae73f7e9bb" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_734ac086-0f43-4787-bada-e18593a1dc82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_23afdca3-74d3-42b8-8845-527a1c0cc8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_734ac086-0f43-4787-bada-e18593a1dc82" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_23afdca3-74d3-42b8-8845-527a1c0cc8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_edbcba06-3ac0-4bce-80a2-b7bb79a09780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_23afdca3-74d3-42b8-8845-527a1c0cc8d7" xlink:to="loc_us-gaap_SegmentDomain_edbcba06-3ac0-4bce-80a2-b7bb79a09780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SpecialtyServicesMember_8aebdcbb-5e31-4859-9eef-59dcb93f4d65" xlink:href="cnc-20221231.xsd#cnc_SpecialtyServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_edbcba06-3ac0-4bce-80a2-b7bb79a09780" xlink:to="loc_cnc_SpecialtyServicesMember_8aebdcbb-5e31-4859-9eef-59dcb93f4d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_591574e7-6413-429e-a310-00bc2342f7af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_734ac086-0f43-4787-bada-e18593a1dc82" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_591574e7-6413-429e-a310-00bc2342f7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8d46ef2-3a59-497c-baca-18edaff66780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_591574e7-6413-429e-a310-00bc2342f7af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8d46ef2-3a59-497c-baca-18edaff66780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_CircleHealthMember_192ce6d2-297d-4c85-85a3-09d5e9304d4f" xlink:href="cnc-20221231.xsd#cnc_CircleHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8d46ef2-3a59-497c-baca-18edaff66780" xlink:to="loc_cnc_CircleHealthMember_192ce6d2-297d-4c85-85a3-09d5e9304d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_6a702f53-94e2-41ee-be55-24dce4501d60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_734ac086-0f43-4787-bada-e18593a1dc82" xlink:to="loc_us-gaap_SubsegmentsAxis_6a702f53-94e2-41ee-be55-24dce4501d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_28bdbcc6-0e27-4670-9267-54a678e919ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_6a702f53-94e2-41ee-be55-24dce4501d60" xlink:to="loc_us-gaap_SubsegmentsDomain_28bdbcc6-0e27-4670-9267-54a678e919ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FederalServicesMember_e5e1610c-3d18-47c6-a050-6d08d5ab9766" xlink:href="cnc-20221231.xsd#cnc_FederalServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_28bdbcc6-0e27-4670-9267-54a678e919ba" xlink:to="loc_cnc_FederalServicesMember_e5e1610c-3d18-47c6-a050-6d08d5ab9766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_bee27735-a363-447f-88d3-24c3f7279063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_734ac086-0f43-4787-bada-e18593a1dc82" xlink:to="loc_us-gaap_GoodwillLineItems_bee27735-a363-447f-88d3-24c3f7279063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_59c74531-1e24-48de-9f5d-490b45f4e05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_bee27735-a363-447f-88d3-24c3f7279063" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_59c74531-1e24-48de-9f5d-490b45f4e05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_83631ed3-bee9-4244-9dc7-09c105b7f07b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_bee27735-a363-447f-88d3-24c3f7279063" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_83631ed3-bee9-4244-9dc7-09c105b7f07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0d348c78-b586-47ef-8a6a-bc8732c80064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_bee27735-a363-447f-88d3-24c3f7279063" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0d348c78-b586-47ef-8a6a-bc8732c80064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_651b26d3-f212-4de2-a92e-b29fffca3afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4b8ed8d7-005f-42f2-a51c-0779e4aac482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_651b26d3-f212-4de2-a92e-b29fffca3afb" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4b8ed8d7-005f-42f2-a51c-0779e4aac482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_96b945ad-938c-46b5-9f42-e8ca60b691f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4b8ed8d7-005f-42f2-a51c-0779e4aac482" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_96b945ad-938c-46b5-9f42-e8ca60b691f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516cd007-9640-4399-be28-e1a9a1fef905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_96b945ad-938c-46b5-9f42-e8ca60b691f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516cd007-9640-4399-be28-e1a9a1fef905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_6a6b7ec2-b7c9-4249-9f86-ffed12333c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516cd007-9640-4399-be28-e1a9a1fef905" xlink:to="loc_us-gaap_CustomerContractsMember_6a6b7ec2-b7c9-4249-9f86-ffed12333c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_64d1e365-509d-4d9a-90e1-2f0ce28cc25c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516cd007-9640-4399-be28-e1a9a1fef905" xlink:to="loc_us-gaap_TradeNamesMember_64d1e365-509d-4d9a-90e1-2f0ce28cc25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ProviderContractsMember_3003a2f8-793d-4a39-a94a-9d8d3dfa5dec" xlink:href="cnc-20221231.xsd#cnc_ProviderContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516cd007-9640-4399-be28-e1a9a1fef905" xlink:to="loc_cnc_ProviderContractsMember_3003a2f8-793d-4a39-a94a-9d8d3dfa5dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_6a15ecf0-e2ba-41b2-a35b-de6cc29f2b14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516cd007-9640-4399-be28-e1a9a1fef905" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_6a15ecf0-e2ba-41b2-a35b-de6cc29f2b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_384e7b6f-b8a7-4d8d-bf42-7af6418623e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4b8ed8d7-005f-42f2-a51c-0779e4aac482" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_384e7b6f-b8a7-4d8d-bf42-7af6418623e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ece6bf2b-b01c-4414-9e96-482b3d11df58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_384e7b6f-b8a7-4d8d-bf42-7af6418623e1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ece6bf2b-b01c-4414-9e96-482b3d11df58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5f024df2-e2ca-4050-ab2a-00f22052ecec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_384e7b6f-b8a7-4d8d-bf42-7af6418623e1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5f024df2-e2ca-4050-ab2a-00f22052ecec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bd177848-e5a3-40e1-8801-095dbcce4d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_384e7b6f-b8a7-4d8d-bf42-7af6418623e1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bd177848-e5a3-40e1-8801-095dbcce4d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_43b446db-52e9-489a-b38f-8aa930062c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_384e7b6f-b8a7-4d8d-bf42-7af6418623e1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_43b446db-52e9-489a-b38f-8aa930062c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpensesDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2ea5d5af-165a-4bfc-bda5-1eb9ae633543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_14595192-fb22-45ea-921f-e6c9a8bc8149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2ea5d5af-165a-4bfc-bda5-1eb9ae633543" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_14595192-fb22-45ea-921f-e6c9a8bc8149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4d018ba0-7754-4cd1-b387-52969ad6c634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_14595192-fb22-45ea-921f-e6c9a8bc8149" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4d018ba0-7754-4cd1-b387-52969ad6c634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_46e3bae1-18ed-4d0e-9880-06b5b5fde6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_14595192-fb22-45ea-921f-e6c9a8bc8149" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_46e3bae1-18ed-4d0e-9880-06b5b5fde6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_81f3cdff-51a6-4b9f-a708-436f6cb1c7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_14595192-fb22-45ea-921f-e6c9a8bc8149" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_81f3cdff-51a6-4b9f-a708-436f6cb1c7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_19d7303c-77e6-4f5b-9965-596b3cf1cb35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_14595192-fb22-45ea-921f-e6c9a8bc8149" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_19d7303c-77e6-4f5b-9965-596b3cf1cb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5eff9493-d6ea-4547-a27d-23021ba4630f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_14595192-fb22-45ea-921f-e6c9a8bc8149" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5eff9493-d6ea-4547-a27d-23021ba4630f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_1c70a9d0-096c-4a02-a163-e5e30609123c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4a9a3535-362a-4888-9a66-cebc0722c275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_1c70a9d0-096c-4a02-a163-e5e30609123c" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4a9a3535-362a-4888-9a66-cebc0722c275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_7c24822a-4e86-4dfa-a73c-9d174b163d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4a9a3535-362a-4888-9a66-cebc0722c275" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_7c24822a-4e86-4dfa-a73c-9d174b163d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_c766bde3-20d2-4489-b44f-7cc8bb61a810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4a9a3535-362a-4888-9a66-cebc0722c275" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_c766bde3-20d2-4489-b44f-7cc8bb61a810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_5f04a3f6-8a36-46af-8195-5569ad78f93e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4a9a3535-362a-4888-9a66-cebc0722c275" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_5f04a3f6-8a36-46af-8195-5569ad78f93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_366e3827-0eee-460a-bdc2-29c7e1716078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4a9a3535-362a-4888-9a66-cebc0722c275" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_366e3827-0eee-460a-bdc2-29c7e1716078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_2929f66f-4993-449a-afeb-e51745be98ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4a9a3535-362a-4888-9a66-cebc0722c275" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_2929f66f-4993-449a-afeb-e51745be98ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_db317887-9c99-4ae5-baff-d437f5a49564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_2929f66f-4993-449a-afeb-e51745be98ce" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_db317887-9c99-4ae5-baff-d437f5a49564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_5f938086-ad1d-4ac3-a3aa-65e73679d801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_2929f66f-4993-449a-afeb-e51745be98ce" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_5f938086-ad1d-4ac3-a3aa-65e73679d801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_4bfb9c79-c64a-491b-bbdc-a6e5d32c1398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_2929f66f-4993-449a-afeb-e51745be98ce" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_4bfb9c79-c64a-491b-bbdc-a6e5d32c1398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d9404bf-caa5-452d-a331-dba952198f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4a9a3535-362a-4888-9a66-cebc0722c275" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d9404bf-caa5-452d-a331-dba952198f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_af4b8f3c-d279-4280-aeab-9e64cb5796c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d9404bf-caa5-452d-a331-dba952198f81" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_af4b8f3c-d279-4280-aeab-9e64cb5796c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_ca722ca0-6667-4d3a-8fc7-113ec5645b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d9404bf-caa5-452d-a331-dba952198f81" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_ca722ca0-6667-4d3a-8fc7-113ec5645b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f77ce1ed-0d9a-48da-b9dd-57baf2336d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_6d9404bf-caa5-452d-a331-dba952198f81" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f77ce1ed-0d9a-48da-b9dd-57baf2336d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_5357dd92-0c01-4fcc-9c0a-2e371f12e6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4a9a3535-362a-4888-9a66-cebc0722c275" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_5357dd92-0c01-4fcc-9c0a-2e371f12e6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ea87011a-8526-4f95-8f47-923922c68e85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4a9a3535-362a-4888-9a66-cebc0722c275" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ea87011a-8526-4f95-8f47-923922c68e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_27da5b31-702c-4c3b-8535-5d1bcf2fa9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4a9a3535-362a-4888-9a66-cebc0722c275" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_27da5b31-702c-4c3b-8535-5d1bcf2fa9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#MedicalClaimsLiabilityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_9994d073-781f-42fd-ae25-3e32d8d6db6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms_35aaa6d8-ebcc-49e1-95d3-9458bf7e877e" xlink:href="cnc-20221231.xsd#cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_9994d073-781f-42fd-ae25-3e32d8d6db6a" xlink:to="loc_cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms_35aaa6d8-ebcc-49e1-95d3-9458bf7e877e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_5ae5d37d-7171-44a9-bc59-2d44d0de8b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_0d77cad8-bb5e-4df1-a454-82760dc4458d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_5ae5d37d-7171-44a9-bc59-2d44d0de8b9d" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_0d77cad8-bb5e-4df1-a454-82760dc4458d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_6e1f68bd-1342-4607-af25-12899e689017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_0d77cad8-bb5e-4df1-a454-82760dc4458d" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_6e1f68bd-1342-4607-af25-12899e689017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0dfb5e88-3f99-4973-a2aa-fe0732dbc70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_6e1f68bd-1342-4607-af25-12899e689017" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0dfb5e88-3f99-4973-a2aa-fe0732dbc70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_cfc80f5e-449a-4eba-9091-bb18e7f885a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0dfb5e88-3f99-4973-a2aa-fe0732dbc70f" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_cfc80f5e-449a-4eba-9091-bb18e7f885a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_d9322c83-1ff7-4283-b63d-e8cd8d451231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0dfb5e88-3f99-4973-a2aa-fe0732dbc70f" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_d9322c83-1ff7-4283-b63d-e8cd8d451231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_a4c008db-0fff-4f90-a729-1feecde65868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0dfb5e88-3f99-4973-a2aa-fe0732dbc70f" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_a4c008db-0fff-4f90-a729-1feecde65868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d77e41a3-5b31-4ccd-b064-1c643f3e9347" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_0d77cad8-bb5e-4df1-a454-82760dc4458d" xlink:to="loc_srt_ProductOrServiceAxis_d77e41a3-5b31-4ccd-b064-1c643f3e9347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3861bb9c-5461-47ad-bbd2-06ddc0b36d8f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d77e41a3-5b31-4ccd-b064-1c643f3e9347" xlink:to="loc_srt_ProductsAndServicesDomain_3861bb9c-5461-47ad-bbd2-06ddc0b36d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_6282e86a-7c85-4029-93f9-7183b6dd6ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3861bb9c-5461-47ad-bbd2-06ddc0b36d8f" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_6282e86a-7c85-4029-93f9-7183b6dd6ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_5b62db88-1ae3-4f72-91d7-72a966242e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_0d77cad8-bb5e-4df1-a454-82760dc4458d" xlink:to="loc_us-gaap_ClaimsDevelopmentLineItems_5b62db88-1ae3-4f72-91d7-72a966242e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_14892645-a9f9-4aae-8df6-558bcf3e7c81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_5b62db88-1ae3-4f72-91d7-72a966242e63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_14892645-a9f9-4aae-8df6-558bcf3e7c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_f7c8af40-5626-443e-9feb-6deea3dc7bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_5b62db88-1ae3-4f72-91d7-72a966242e63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_f7c8af40-5626-443e-9feb-6deea3dc7bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther_862d5783-b337-4081-80b7-9a3eff0a6e83" xlink:href="cnc-20221231.xsd#cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_5b62db88-1ae3-4f72-91d7-72a966242e63" xlink:to="loc_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther_862d5783-b337-4081-80b7-9a3eff0a6e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_eff0aa96-4269-4b12-b285-65235ab0835a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_5b62db88-1ae3-4f72-91d7-72a966242e63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_eff0aa96-4269-4b12-b285-65235ab0835a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_b4e3b07a-ad71-4296-9583-ef42a0f5e705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_13fb6eba-3a53-426e-a419-3f98ca2e1605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_b4e3b07a-ad71-4296-9583-ef42a0f5e705" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_13fb6eba-3a53-426e-a419-3f98ca2e1605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_dba9bef2-772d-4318-a47d-f626893cf1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_13fb6eba-3a53-426e-a419-3f98ca2e1605" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_dba9bef2-772d-4318-a47d-f626893cf1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_de82ea26-1042-496c-a0c4-98fdbc1877db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_dba9bef2-772d-4318-a47d-f626893cf1c1" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_de82ea26-1042-496c-a0c4-98fdbc1877db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_82bff4d1-fcdc-4794-a7b7-0bfb719057e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_de82ea26-1042-496c-a0c4-98fdbc1877db" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_82bff4d1-fcdc-4794-a7b7-0bfb719057e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_c263993f-2d72-4ae8-b709-af513ef4eb75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_de82ea26-1042-496c-a0c4-98fdbc1877db" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_c263993f-2d72-4ae8-b709-af513ef4eb75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_63b5d202-7506-4c53-b537-6cdbcadc404b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_de82ea26-1042-496c-a0c4-98fdbc1877db" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_63b5d202-7506-4c53-b537-6cdbcadc404b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ca62c0cc-9597-44b8-a155-5e35e8882978" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_13fb6eba-3a53-426e-a419-3f98ca2e1605" xlink:to="loc_srt_ProductOrServiceAxis_ca62c0cc-9597-44b8-a155-5e35e8882978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cfe1b858-12d7-4617-9cad-a71d654e33fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ca62c0cc-9597-44b8-a155-5e35e8882978" xlink:to="loc_srt_ProductsAndServicesDomain_cfe1b858-12d7-4617-9cad-a71d654e33fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_4ed87648-a165-45bb-8e8b-ffb24c413689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cfe1b858-12d7-4617-9cad-a71d654e33fc" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_4ed87648-a165-45bb-8e8b-ffb24c413689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_e401f11d-a804-4d85-9163-9c69361481e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_13fb6eba-3a53-426e-a419-3f98ca2e1605" xlink:to="loc_us-gaap_ClaimsDevelopmentLineItems_e401f11d-a804-4d85-9163-9c69361481e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_678f3d65-b855-49df-b3d2-03c67e1e64a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e401f11d-a804-4d85-9163-9c69361481e0" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_678f3d65-b855-49df-b3d2-03c67e1e64a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims_90bca9d3-fa2b-400d-87b8-f86e4e3158ab" xlink:href="cnc-20221231.xsd#cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e401f11d-a804-4d85-9163-9c69361481e0" xlink:to="loc_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims_90bca9d3-fa2b-400d-87b8-f86e4e3158ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_b84788af-80a1-42ed-a66a-5509cabd08e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e401f11d-a804-4d85-9163-9c69361481e0" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims_b84788af-80a1-42ed-a66a-5509cabd08e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/AffordableCareActDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#AffordableCareActDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/AffordableCareActDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActAbstract_63ccf66b-3e6b-425a-85b6-e723532778e4" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActRiskAdjustmentReceivable_7eae6159-517c-4516-8468-47f18f8c6b5e" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActRiskAdjustmentReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_AffordableCareActAbstract_63ccf66b-3e6b-425a-85b6-e723532778e4" xlink:to="loc_cnc_AffordableCareActRiskAdjustmentReceivable_7eae6159-517c-4516-8468-47f18f8c6b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActReinsurancePayable_1b37e843-0f98-4d71-a916-2deb86e65757" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActReinsurancePayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_AffordableCareActAbstract_63ccf66b-3e6b-425a-85b6-e723532778e4" xlink:to="loc_cnc_AffordableCareActReinsurancePayable_1b37e843-0f98-4d71-a916-2deb86e65757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActMinimumMedicalLossRatio_51ed24c1-a51a-46a9-87ff-4482f43d637d" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActMinimumMedicalLossRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_AffordableCareActAbstract_63ccf66b-3e6b-425a-85b6-e723532778e4" xlink:to="loc_cnc_AffordableCareActMinimumMedicalLossRatio_51ed24c1-a51a-46a9-87ff-4482f43d637d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActCostSharingReductionReceivable_58150d8a-98a5-42ca-a91e-0adebab7b2ca" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActCostSharingReductionReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_AffordableCareActAbstract_63ccf66b-3e6b-425a-85b6-e723532778e4" xlink:to="loc_cnc_AffordableCareActCostSharingReductionReceivable_58150d8a-98a5-42ca-a91e-0adebab7b2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActCostSharingReductionsPayable_7c99b3dd-3874-4e82-a44c-5aecbf9033f1" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActCostSharingReductionsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_AffordableCareActAbstract_63ccf66b-3e6b-425a-85b6-e723532778e4" xlink:to="loc_cnc_AffordableCareActCostSharingReductionsPayable_7c99b3dd-3874-4e82-a44c-5aecbf9033f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease_611f58a0-4037-41ca-9bd8-1a3e788e7f5e" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_AffordableCareActAbstract_63ccf66b-3e6b-425a-85b6-e723532778e4" xlink:to="loc_cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease_611f58a0-4037-41ca-9bd8-1a3e788e7f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit_b59ee41b-9d47-451b-9cc7-7b9e80641383" xlink:href="cnc-20221231.xsd#cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_AffordableCareActAbstract_63ccf66b-3e6b-425a-85b6-e723532778e4" xlink:to="loc_cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit_b59ee41b-9d47-451b-9cc7-7b9e80641383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/DebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1b1475c5-ddc2-4e15-977b-cab64dcc4914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_31746410-8bff-4b75-823b-c0302929abc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1b1475c5-ddc2-4e15-977b-cab64dcc4914" xlink:to="loc_us-gaap_DebtInstrumentTable_31746410-8bff-4b75-823b-c0302929abc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_949ae3c7-af1d-4898-a2d8-1d08935a0a27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_31746410-8bff-4b75-823b-c0302929abc2" xlink:to="loc_us-gaap_DebtInstrumentAxis_949ae3c7-af1d-4898-a2d8-1d08935a0a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_949ae3c7-af1d-4898-a2d8-1d08935a0a27" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2500Million425SeniorNotesDueDecember2027Member_ed7641e6-2206-4b81-b4df-fc15a56b3dea" xlink:href="cnc-20221231.xsd#cnc_A2500Million425SeniorNotesDueDecember2027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:to="loc_cnc_A2500Million425SeniorNotesDueDecember2027Member_ed7641e6-2206-4b81-b4df-fc15a56b3dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2300Million245SeniorNotesDueJuly2028Member_44665001-9899-4f3c-8018-d2976ab77008" xlink:href="cnc-20221231.xsd#cnc_A2300Million245SeniorNotesDueJuly2028Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:to="loc_cnc_A2300Million245SeniorNotesDueJuly2028Member_44665001-9899-4f3c-8018-d2976ab77008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A3500Million4625SeniorNotesDueDecember2029Member_f2c69804-39fe-4296-b820-5bebf446b037" xlink:href="cnc-20221231.xsd#cnc_A3500Million4625SeniorNotesDueDecember2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:to="loc_cnc_A3500Million4625SeniorNotesDueDecember2029Member_f2c69804-39fe-4296-b820-5bebf446b037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2000Million3375SeniorNotesDueFebruary2030Member_9474b0a5-2a3f-4738-a755-21b6fd73c835" xlink:href="cnc-20221231.xsd#cnc_A2000Million3375SeniorNotesDueFebruary2030Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:to="loc_cnc_A2000Million3375SeniorNotesDueFebruary2030Member_9474b0a5-2a3f-4738-a755-21b6fd73c835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2200Million30SeniorNotesDueOctober2030Member_4df56441-0427-4402-80f4-1de8862f2362" xlink:href="cnc-20221231.xsd#cnc_A2200Million30SeniorNotesDueOctober2030Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:to="loc_cnc_A2200Million30SeniorNotesDueOctober2030Member_4df56441-0427-4402-80f4-1de8862f2362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2200Million250SeniorNotesDueMarch2031Member_0ccf2365-832f-468d-859d-7456f4f26143" xlink:href="cnc-20221231.xsd#cnc_A2200Million250SeniorNotesDueMarch2031Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:to="loc_cnc_A2200Million250SeniorNotesDueMarch2031Member_0ccf2365-832f-468d-859d-7456f4f26143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A1300Million2625SeniorNotesDueAugust2031Member_6227ee20-7355-4bf7-b604-9b3a6419d5e2" xlink:href="cnc-20221231.xsd#cnc_A1300Million2625SeniorNotesDueAugust2031Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860bcc09-4fb2-41fb-835f-755dd254bf24" xlink:to="loc_cnc_A1300Million2625SeniorNotesDueAugust2031Member_6227ee20-7355-4bf7-b604-9b3a6419d5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9aee1f7c-6494-400e-ac79-d1dadca6c1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_31746410-8bff-4b75-823b-c0302929abc2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9aee1f7c-6494-400e-ac79-d1dadca6c1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_787315dc-396c-4848-a3eb-eedfc4b97d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9aee1f7c-6494-400e-ac79-d1dadca6c1aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_787315dc-396c-4848-a3eb-eedfc4b97d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_70b654c0-c7da-4cf8-a49d-7acc64466b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787315dc-396c-4848-a3eb-eedfc4b97d65" xlink:to="loc_us-gaap_SeniorNotesMember_70b654c0-c7da-4cf8-a49d-7acc64466b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_TermLoanCreditAgreementMember_e589dbec-c225-4646-a975-d1f0b1452cbe" xlink:href="cnc-20221231.xsd#cnc_TermLoanCreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787315dc-396c-4848-a3eb-eedfc4b97d65" xlink:to="loc_cnc_TermLoanCreditAgreementMember_e589dbec-c225-4646-a975-d1f0b1452cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionLoanPayableMember_1d749489-b254-4173-b49d-02e59ea2de71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionLoanPayableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787315dc-396c-4848-a3eb-eedfc4b97d65" xlink:to="loc_us-gaap_ConstructionLoanPayableMember_1d749489-b254-4173-b49d-02e59ea2de71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8a2cb6aa-365e-448f-a0e7-fe732c46cfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_31746410-8bff-4b75-823b-c0302929abc2" xlink:to="loc_us-gaap_CreditFacilityAxis_8a2cb6aa-365e-448f-a0e7-fe732c46cfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_93da5574-2973-46a5-aade-991ea7881255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_8a2cb6aa-365e-448f-a0e7-fe732c46cfa3" xlink:to="loc_us-gaap_CreditFacilityDomain_93da5574-2973-46a5-aade-991ea7881255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3a17d4ad-7b0f-4606-bb49-df6d1d374c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_93da5574-2973-46a5-aade-991ea7881255" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3a17d4ad-7b0f-4606-bb49-df6d1d374c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_31746410-8bff-4b75-823b-c0302929abc2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_56eb7f8a-62f5-4dc8-81a3-7793cc557ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_56eb7f8a-62f5-4dc8-81a3-7793cc557ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6cfe111d-047e-4409-b3ca-a1c805615740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6cfe111d-047e-4409-b3ca-a1c805615740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_b0d675b5-835e-40fc-b218-ea5913b4a91d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_SeniorNotes_b0d675b5-835e-40fc-b218-ea5913b4a91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SeniorNotesTotal_81c23ff4-0bad-4098-9bd4-30f6ef21b1ff" xlink:href="cnc-20221231.xsd#cnc_SeniorNotesTotal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_cnc_SeniorNotesTotal_81c23ff4-0bad-4098-9bd4-30f6ef21b1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_f7596bb4-70f7-4653-8007-5f56e3525aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_LineOfCredit_f7596bb4-70f7-4653-8007-5f56e3525aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayable_6758da31-a42f-44af-9b83-714a64a968fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_LoansPayable_6758da31-a42f-44af-9b83-714a64a968fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_FinanceLeaseLiabilityAndOther_2909f132-c868-4af6-b539-198316ab2535" xlink:href="cnc-20221231.xsd#cnc_FinanceLeaseLiabilityAndOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_cnc_FinanceLeaseLiabilityAndOther_2909f132-c868-4af6-b539-198316ab2535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_9e9165af-7867-45f4-ad52-ebb26eae041f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_9e9165af-7867-45f4-ad52-ebb26eae041f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_42f5ddde-e082-4c8b-b3a2-9379b217931a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_42f5ddde-e082-4c8b-b3a2-9379b217931a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3a3c8151-d5fd-4511-a63e-86b4557e5c23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_LongTermDebtCurrent_3a3c8151-d5fd-4511-a63e-86b4557e5c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_42f25e07-3476-4d47-88a2-78ba3644ce31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d352499c-b43d-4d36-aa3f-b34d611ed68e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_42f25e07-3476-4d47-88a2-78ba3644ce31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtScheduleofDebtDetails_1" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtScheduleofDebtDetails_1"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/DebtScheduleofDebtDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.centene.com/role/DebtAdditionalInformationDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/DebtAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_290b2686-25aa-4a89-a8e8-6cf208991c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_60b3b5d6-e8f9-4851-9bea-24255a1e80e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_290b2686-25aa-4a89-a8e8-6cf208991c3a" xlink:to="loc_us-gaap_DebtInstrumentTable_60b3b5d6-e8f9-4851-9bea-24255a1e80e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_aede13ff-1544-42a2-98ca-ce74da89f8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_60b3b5d6-e8f9-4851-9bea-24255a1e80e4" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_aede13ff-1544-42a2-98ca-ce74da89f8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_48252a93-9a09-4ae5-a8bc-43a449b057f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_aede13ff-1544-42a2-98ca-ce74da89f8e5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_48252a93-9a09-4ae5-a8bc-43a449b057f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtTotalMember_329d97af-c270-4417-ae90-b99188361756" xlink:href="cnc-20221231.xsd#cnc_DebtTotalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_48252a93-9a09-4ae5-a8bc-43a449b057f2" xlink:to="loc_cnc_DebtTotalMember_329d97af-c270-4417-ae90-b99188361756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_f775631c-99eb-4bea-b7a8-357d7e788859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_60b3b5d6-e8f9-4851-9bea-24255a1e80e4" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_f775631c-99eb-4bea-b7a8-357d7e788859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6905fcb6-a823-4175-8bb5-c17abcc0c541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f775631c-99eb-4bea-b7a8-357d7e788859" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6905fcb6-a823-4175-8bb5-c17abcc0c541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditAvailabilityConcentrationRiskMember_d24908dc-e9df-4ef2-ad71-c06aceeed16d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditAvailabilityConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_6905fcb6-a823-4175-8bb5-c17abcc0c541" xlink:to="loc_us-gaap_CreditAvailabilityConcentrationRiskMember_d24908dc-e9df-4ef2-ad71-c06aceeed16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_fe9daab5-6649-4ff9-b1c6-c93611d15467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_60b3b5d6-e8f9-4851-9bea-24255a1e80e4" xlink:to="loc_us-gaap_VariableRateAxis_fe9daab5-6649-4ff9-b1c6-c93611d15467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_5187079d-6b71-45aa-bca6-c2b06f4815f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_fe9daab5-6649-4ff9-b1c6-c93611d15467" xlink:to="loc_us-gaap_VariableRateDomain_5187079d-6b71-45aa-bca6-c2b06f4815f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember_ff66ba80-765b-4418-9628-e464d7ddebfc" xlink:href="cnc-20221231.xsd#cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_5187079d-6b71-45aa-bca6-c2b06f4815f8" xlink:to="loc_cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember_ff66ba80-765b-4418-9628-e464d7ddebfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8afc38d1-2aab-4714-841f-45300ee2a469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_5187079d-6b71-45aa-bca6-c2b06f4815f8" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8afc38d1-2aab-4714-841f-45300ee2a469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SterlingOvernightIndexAverageSONIAMember_65fa1b64-c54a-4039-a6e0-1f82cff2d4db" xlink:href="cnc-20221231.xsd#cnc_SterlingOvernightIndexAverageSONIAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_5187079d-6b71-45aa-bca6-c2b06f4815f8" xlink:to="loc_cnc_SterlingOvernightIndexAverageSONIAMember_65fa1b64-c54a-4039-a6e0-1f82cff2d4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8f67c2c0-ca3d-4945-ae62-81578d62d1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_60b3b5d6-e8f9-4851-9bea-24255a1e80e4" xlink:to="loc_us-gaap_DebtInstrumentLineItems_8f67c2c0-ca3d-4945-ae62-81578d62d1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c41c9141-b528-4e68-b337-841a62801273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8f67c2c0-ca3d-4945-ae62-81578d62d1cd" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c41c9141-b528-4e68-b337-841a62801273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtSeniorNotesDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/DebtSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_204b7b61-dbb2-476f-872f-ac6bc719ac76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6950b109-08ef-4e71-abf4-fe4905e7cb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_204b7b61-dbb2-476f-872f-ac6bc719ac76" xlink:to="loc_us-gaap_DebtInstrumentTable_6950b109-08ef-4e71-abf4-fe4905e7cb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_414cc6af-914e-4fc3-9473-adee88304f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6950b109-08ef-4e71-abf4-fe4905e7cb0b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_414cc6af-914e-4fc3-9473-adee88304f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36340264-d296-4a7b-8dd0-7e31843241ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_414cc6af-914e-4fc3-9473-adee88304f77" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36340264-d296-4a7b-8dd0-7e31843241ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanHealthMember_36a524f3-0498-40cd-8262-d8c139320162" xlink:href="cnc-20221231.xsd#cnc_MagellanHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36340264-d296-4a7b-8dd0-7e31843241ff" xlink:to="loc_cnc_MagellanHealthMember_36a524f3-0498-40cd-8262-d8c139320162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_352716b8-f66c-417c-bb9b-d42d54f0cdda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6950b109-08ef-4e71-abf4-fe4905e7cb0b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_352716b8-f66c-417c-bb9b-d42d54f0cdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_66592332-7689-4343-b62f-e255e0393e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_352716b8-f66c-417c-bb9b-d42d54f0cdda" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_66592332-7689-4343-b62f-e255e0393e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_8bb2dfbf-9ae4-4bca-b5d0-f9d10b89994a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_66592332-7689-4343-b62f-e255e0393e4d" xlink:to="loc_us-gaap_SeniorNotesMember_8bb2dfbf-9ae4-4bca-b5d0-f9d10b89994a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_becf3e97-80bc-42f9-b987-844fe1a89bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6950b109-08ef-4e71-abf4-fe4905e7cb0b" xlink:to="loc_us-gaap_DebtInstrumentAxis_becf3e97-80bc-42f9-b987-844fe1a89bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_becf3e97-80bc-42f9-b987-844fe1a89bb0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A3500Million4625SeniorNotesDueDecember2029Member_43be0e11-288a-40a7-819b-bed59fdf659e" xlink:href="cnc-20221231.xsd#cnc_A3500Million4625SeniorNotesDueDecember2029Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:to="loc_cnc_A3500Million4625SeniorNotesDueDecember2029Member_43be0e11-288a-40a7-819b-bed59fdf659e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2500Million425SeniorNotesDueDecember2027Member_307563d7-c25a-4a97-a175-57a738372421" xlink:href="cnc-20221231.xsd#cnc_A2500Million425SeniorNotesDueDecember2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:to="loc_cnc_A2500Million425SeniorNotesDueDecember2027Member_307563d7-c25a-4a97-a175-57a738372421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2200Million250SeniorNotesDue2031Member_f3b19696-3cb1-4850-80df-48246943b9da" xlink:href="cnc-20221231.xsd#cnc_A2200Million250SeniorNotesDue2031Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:to="loc_cnc_A2200Million250SeniorNotesDue2031Member_f3b19696-3cb1-4850-80df-48246943b9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A2200Million475SeniorNotesDueJanuary2025Member_dd393233-517c-4592-83f4-c297eb9ba466" xlink:href="cnc-20221231.xsd#cnc_A2200Million475SeniorNotesDueJanuary2025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:to="loc_cnc_A2200Million475SeniorNotesDueJanuary2025Member_dd393233-517c-4592-83f4-c297eb9ba466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A1800Million245SeniorNotesDueMarch2028Member_e4a1c53b-f93d-4050-bd9b-a8f37adb8552" xlink:href="cnc-20221231.xsd#cnc_A1800Million245SeniorNotesDueMarch2028Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:to="loc_cnc_A1800Million245SeniorNotesDueMarch2028Member_e4a1c53b-f93d-4050-bd9b-a8f37adb8552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A1300Million2625SeniorNotesDueAugust2031Member_d951c7cb-b255-4caa-b235-ace223c0762b" xlink:href="cnc-20221231.xsd#cnc_A1300Million2625SeniorNotesDueAugust2031Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:to="loc_cnc_A1300Million2625SeniorNotesDueAugust2031Member_d951c7cb-b255-4caa-b235-ace223c0762b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_A750Million5375SeniorNotesDueJune2026Member_0964dd2c-4ba7-4881-9b70-642e4145f379" xlink:href="cnc-20221231.xsd#cnc_A750Million5375SeniorNotesDueJune2026Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_337b325b-e85a-4cb8-9b1f-175d665e518e" xlink:to="loc_cnc_A750Million5375SeniorNotesDueJune2026Member_0964dd2c-4ba7-4881-9b70-642e4145f379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6950b109-08ef-4e71-abf4-fe4905e7cb0b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAssumedDebt_75b67eb3-050e-490c-a4a9-2f93ac6d9a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfAssumedDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_RepaymentsOfAssumedDebt_75b67eb3-050e-490c-a4a9-2f93ac6d9a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_85992407-a9a9-42ae-a747-3b4ae6482f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_85992407-a9a9-42ae-a747-3b4ae6482f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_144f458e-4ba8-4f6a-999d-feace889fd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_144f458e-4ba8-4f6a-999d-feace889fd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnRepurchaseOfDebtInstrument_b37fa14e-ec65-4983-8896-7937bd5eef62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnRepurchaseOfDebtInstrument"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_GainLossOnRepurchaseOfDebtInstrument_b37fa14e-ec65-4983-8896-7937bd5eef62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_01fc7428-aa0e-4885-870f-90daa806e6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_01fc7428-aa0e-4885-870f-90daa806e6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage_71ea3b7a-bcc2-46ce-8ee7-1a6035aec483" xlink:href="cnc-20221231.xsd#cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage_71ea3b7a-bcc2-46ce-8ee7-1a6035aec483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e651aea3-0715-490a-8712-e00fc8e88d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e651aea3-0715-490a-8712-e00fc8e88d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c89d6d16-367f-4769-a4a4-9786a59c41ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f304ea67-9c3a-497d-9a4f-cd5feb920741" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c89d6d16-367f-4769-a4a4-9786a59c41ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_df041fe2-1b30-4e67-9250-90910e7678e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f8dd37a5-abd6-4081-abc6-7d898d4a1b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_df041fe2-1b30-4e67-9250-90910e7678e4" xlink:to="loc_us-gaap_DebtInstrumentTable_f8dd37a5-abd6-4081-abc6-7d898d4a1b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7d503429-611a-4ee2-a56c-5d8cc9fdce1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8dd37a5-abd6-4081-abc6-7d898d4a1b16" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7d503429-611a-4ee2-a56c-5d8cc9fdce1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9d15f702-f337-4eb5-b6f9-25bb77e1ca71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7d503429-611a-4ee2-a56c-5d8cc9fdce1a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9d15f702-f337-4eb5-b6f9-25bb77e1ca71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignLineOfCreditMember_752e7ced-19c7-4445-94a4-c6cb4516f389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignLineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9d15f702-f337-4eb5-b6f9-25bb77e1ca71" xlink:to="loc_us-gaap_ForeignLineOfCreditMember_752e7ced-19c7-4445-94a4-c6cb4516f389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1ec56084-6751-4a0c-bc9e-7fc983036da8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8dd37a5-abd6-4081-abc6-7d898d4a1b16" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1ec56084-6751-4a0c-bc9e-7fc983036da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5da2b08b-a403-4cbf-a30e-654e05ed56f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1ec56084-6751-4a0c-bc9e-7fc983036da8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5da2b08b-a403-4cbf-a30e-654e05ed56f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_b15b7307-cd4b-4cf6-84c3-3d8ac2b0b9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5da2b08b-a403-4cbf-a30e-654e05ed56f4" xlink:to="loc_us-gaap_CurrencySwapMember_b15b7307-cd4b-4cf6-84c3-3d8ac2b0b9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8dd37a5-abd6-4081-abc6-7d898d4a1b16" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_7a8068b8-7a16-4d2e-a91d-9634c2b08967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_us-gaap_DerivativeNotionalAmount_7a8068b8-7a16-4d2e-a91d-9634c2b08967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities_fc8fac10-193a-457b-98b6-24df24902d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_us-gaap_PaymentsForHedgeInvestingActivities_fc8fac10-193a-457b-98b6-24df24902d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_15f32900-3d48-44eb-adfe-03877c209a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_15f32900-3d48-44eb-adfe-03877c209a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_79d4caff-df77-4c82-a484-c83c081c6195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_79d4caff-df77-4c82-a484-c83c081c6195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c39c3a43-e994-406a-bb09-93b94f444c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c39c3a43-e994-406a-bb09-93b94f444c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_79896def-7f91-4120-a7bf-259fee4ceaab" xlink:href="cnc-20221231.xsd#cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_79896def-7f91-4120-a7bf-259fee4ceaab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_36491a72-6824-4289-aa5f-afc092bef562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d65b03f1-4bee-4751-9019-e6b959ef7540" xlink:to="loc_us-gaap_LongTermLineOfCredit_36491a72-6824-4289-aa5f-afc092bef562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtRevolvingCreditFacilityandTermLoanDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_50a3a8ec-95bd-4168-bdd5-c8359ad76127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_50a3a8ec-95bd-4168-bdd5-c8359ad76127" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_96b6192a-467a-484b-ac91-dbc75bc6b0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:to="loc_us-gaap_DebtInstrumentAxis_96b6192a-467a-484b-ac91-dbc75bc6b0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_df7881e1-0117-45b3-9bd0-c7825e14f5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_96b6192a-467a-484b-ac91-dbc75bc6b0c2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_df7881e1-0117-45b3-9bd0-c7825e14f5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_TermLoanCreditAgreementMember_c21f4e8f-237e-4ccf-9fec-3c2a45c57440" xlink:href="cnc-20221231.xsd#cnc_TermLoanCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_df7881e1-0117-45b3-9bd0-c7825e14f5a0" xlink:to="loc_cnc_TermLoanCreditAgreementMember_c21f4e8f-237e-4ccf-9fec-3c2a45c57440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d6affea2-4251-4dfc-85fb-633843f1ccd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:to="loc_us-gaap_CreditFacilityAxis_d6affea2-4251-4dfc-85fb-633843f1ccd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ad5cd5e4-681b-447b-8dbc-73beced8cea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_d6affea2-4251-4dfc-85fb-633843f1ccd0" xlink:to="loc_us-gaap_CreditFacilityDomain_ad5cd5e4-681b-447b-8dbc-73beced8cea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_297ff045-21ce-4413-85a0-3fc507d653ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_ad5cd5e4-681b-447b-8dbc-73beced8cea2" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_297ff045-21ce-4413-85a0-3fc507d653ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_d1fa87a1-de22-4ece-aff4-e73498d6e4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BridgeLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_ad5cd5e4-681b-447b-8dbc-73beced8cea2" xlink:to="loc_us-gaap_BridgeLoanMember_d1fa87a1-de22-4ece-aff4-e73498d6e4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_07d62e49-8a8f-455f-b3ff-c12039e0469b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_ad5cd5e4-681b-447b-8dbc-73beced8cea2" xlink:to="loc_us-gaap_LetterOfCreditMember_07d62e49-8a8f-455f-b3ff-c12039e0469b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_85f0d22b-e044-4217-bbfc-d4eaaaabf4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_85f0d22b-e044-4217-bbfc-d4eaaaabf4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2e346e3e-1d29-497c-9274-94f229edd813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_85f0d22b-e044-4217-bbfc-d4eaaaabf4c1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2e346e3e-1d29-497c-9274-94f229edd813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_ad4f9676-3414-418e-8245-dc1a47c8cfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2e346e3e-1d29-497c-9274-94f229edd813" xlink:to="loc_us-gaap_LineOfCreditMember_ad4f9676-3414-418e-8245-dc1a47c8cfb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_24d9aa11-1a96-4b0e-bdcd-8a280fb1f264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2e346e3e-1d29-497c-9274-94f229edd813" xlink:to="loc_us-gaap_UnsecuredDebtMember_24d9aa11-1a96-4b0e-bdcd-8a280fb1f264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_beff2754-bbed-45c1-a2bd-562e4a1950e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:to="loc_srt_RangeAxis_beff2754-bbed-45c1-a2bd-562e4a1950e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d865d281-293a-45a3-9df4-6163b674b1a3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_beff2754-bbed-45c1-a2bd-562e4a1950e5" xlink:to="loc_srt_RangeMember_d865d281-293a-45a3-9df4-6163b674b1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_886b7ab4-5814-4897-86c8-26205b9d5a59" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d865d281-293a-45a3-9df4-6163b674b1a3" xlink:to="loc_srt_MaximumMember_886b7ab4-5814-4897-86c8-26205b9d5a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2a2e3908-f4c3-4b27-9858-f2ede81a1d6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d865d281-293a-45a3-9df4-6163b674b1a3" xlink:to="loc_srt_MinimumMember_2a2e3908-f4c3-4b27-9858-f2ede81a1d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodAxis_54b64f88-c441-4fcd-9513-32cce161a783" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:to="loc_cnc_DebtInstrumentPaymentPeriodAxis_54b64f88-c441-4fcd-9513-32cce161a783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodDomain_c5cd2670-dd46-44aa-8533-deabece5324c" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_DebtInstrumentPaymentPeriodAxis_54b64f88-c441-4fcd-9513-32cce161a783" xlink:to="loc_cnc_DebtInstrumentPaymentPeriodDomain_c5cd2670-dd46-44aa-8533-deabece5324c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodOneMember_f97bbb8c-9900-4772-b686-4d6d5a892a84" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_DebtInstrumentPaymentPeriodDomain_c5cd2670-dd46-44aa-8533-deabece5324c" xlink:to="loc_cnc_DebtInstrumentPaymentPeriodOneMember_f97bbb8c-9900-4772-b686-4d6d5a892a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodTwoMember_e465dcfa-f903-43ef-94dc-85229c36df2b" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_DebtInstrumentPaymentPeriodDomain_c5cd2670-dd46-44aa-8533-deabece5324c" xlink:to="loc_cnc_DebtInstrumentPaymentPeriodTwoMember_e465dcfa-f903-43ef-94dc-85229c36df2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentPaymentPeriodThreeMember_ebf74f20-ba49-431f-94a0-aaf412b93817" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentPaymentPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_DebtInstrumentPaymentPeriodDomain_c5cd2670-dd46-44aa-8533-deabece5324c" xlink:to="loc_cnc_DebtInstrumentPaymentPeriodThreeMember_ebf74f20-ba49-431f-94a0-aaf412b93817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6edcdb1d-0407-453a-a980-c11bb1056eb4" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bcecb629-b13d-4b48-9faf-9ef56a82fbc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bcecb629-b13d-4b48-9faf-9ef56a82fbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0132fac4-0a69-4c21-9eb8-8d065b95d262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0132fac4-0a69-4c21-9eb8-8d065b95d262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum_16c2473c-b2f2-470d-9d2b-fea247796097" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentCovenantNetLeverageRatioMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum_16c2473c-b2f2-470d-9d2b-fea247796097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d459bbc0-ebfe-417a-be49-144a6f455017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d459bbc0-ebfe-417a-be49-144a6f455017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentAmortizationPaymentRatePercentage_a1255a13-5ec3-44be-8d66-0aa9546b747e" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentAmortizationPaymentRatePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_cnc_DebtInstrumentAmortizationPaymentRatePercentage_a1255a13-5ec3-44be-8d66-0aa9546b747e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit_73787d06-c0a0-44c5-ae02-637328240e65" xlink:href="cnc-20221231.xsd#cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit_73787d06-c0a0-44c5-ae02-637328240e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease_dd1a81bd-639a-4558-8f24-0f8cc25f3d5b" xlink:href="cnc-20221231.xsd#cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease_dd1a81bd-639a-4558-8f24-0f8cc25f3d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_c7243452-5206-4be1-a99d-3e66ca7d37eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_us-gaap_LineOfCredit_c7243452-5206-4be1-a99d-3e66ca7d37eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_4f237d2d-e381-4ab9-a328-1edb9ac25406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_d8272138-8b59-449f-9161-a0aea71d0940" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_4f237d2d-e381-4ab9-a328-1edb9ac25406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtConstructionLoanDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtConstructionLoanDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/DebtConstructionLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3de321bb-e290-4ddb-b86b-15edfbfc6716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b0cd38af-68ac-4d82-998d-2bba0e04f16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3de321bb-e290-4ddb-b86b-15edfbfc6716" xlink:to="loc_us-gaap_DebtInstrumentTable_b0cd38af-68ac-4d82-998d-2bba0e04f16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d817f307-ec27-477f-9fea-b0c00d623fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b0cd38af-68ac-4d82-998d-2bba0e04f16a" xlink:to="loc_us-gaap_VariableRateAxis_d817f307-ec27-477f-9fea-b0c00d623fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_60cff639-aa40-400f-9f83-3e826bce3b14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_d817f307-ec27-477f-9fea-b0c00d623fc1" xlink:to="loc_us-gaap_VariableRateDomain_60cff639-aa40-400f-9f83-3e826bce3b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2d1d94b5-781d-4e70-9415-bb6659ee4f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_60cff639-aa40-400f-9f83-3e826bce3b14" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2d1d94b5-781d-4e70-9415-bb6659ee4f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_f7f175f0-d1cb-4601-bf96-f2146c479439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_60cff639-aa40-400f-9f83-3e826bce3b14" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_f7f175f0-d1cb-4601-bf96-f2146c479439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5e318922-d1b7-48f2-8bb7-376196da667a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b0cd38af-68ac-4d82-998d-2bba0e04f16a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5e318922-d1b7-48f2-8bb7-376196da667a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b1a001c4-2e0f-481e-b60f-17a307d5b65d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5e318922-d1b7-48f2-8bb7-376196da667a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b1a001c4-2e0f-481e-b60f-17a307d5b65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionLoanPayableMember_6e333993-7764-4428-ab2b-dd3f8885514a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionLoanPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b1a001c4-2e0f-481e-b60f-17a307d5b65d" xlink:to="loc_us-gaap_ConstructionLoanPayableMember_6e333993-7764-4428-ab2b-dd3f8885514a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_014c78e1-ab06-46b7-8ea8-96e6b71f47d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b0cd38af-68ac-4d82-998d-2bba0e04f16a" xlink:to="loc_srt_RangeAxis_014c78e1-ab06-46b7-8ea8-96e6b71f47d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6b6354d1-a84a-45d5-a08b-be7ed13c9d12" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_014c78e1-ab06-46b7-8ea8-96e6b71f47d6" xlink:to="loc_srt_RangeMember_6b6354d1-a84a-45d5-a08b-be7ed13c9d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_16e20d9b-e236-4f39-9b4a-70bce8911d7e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6b6354d1-a84a-45d5-a08b-be7ed13c9d12" xlink:to="loc_srt_MaximumMember_16e20d9b-e236-4f39-9b4a-70bce8911d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_44b5b8c5-007c-4825-a0ab-8974e674231b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6b6354d1-a84a-45d5-a08b-be7ed13c9d12" xlink:to="loc_srt_MinimumMember_44b5b8c5-007c-4825-a0ab-8974e674231b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2f6a5b9b-327d-4aa2-9bc1-82ad44b1fe46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b0cd38af-68ac-4d82-998d-2bba0e04f16a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2f6a5b9b-327d-4aa2-9bc1-82ad44b1fe46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6875e053-c997-469d-8ce4-67cc86e611d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f6a5b9b-327d-4aa2-9bc1-82ad44b1fe46" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6875e053-c997-469d-8ce4-67cc86e611d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_efcc27b9-b248-4038-bde6-1a74a8b2caca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f6a5b9b-327d-4aa2-9bc1-82ad44b1fe46" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_efcc27b9-b248-4038-bde6-1a74a8b2caca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtInstrumentExtensionTerm_26ebf02b-491d-4ca0-92ec-69f0f6a5b6ac" xlink:href="cnc-20221231.xsd#cnc_DebtInstrumentExtensionTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f6a5b9b-327d-4aa2-9bc1-82ad44b1fe46" xlink:to="loc_cnc_DebtInstrumentExtensionTerm_26ebf02b-491d-4ca0-92ec-69f0f6a5b6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtDebtRepurchaseProgramDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtDebtRepurchaseProgramDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/DebtDebtRepurchaseProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2eea13aa-2e06-48a8-a97b-660d8a385176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtRepurchaseProgramAuthorizedAmount_48abf6b7-f58e-4403-b8f3-7924ec1e2001" xlink:href="cnc-20221231.xsd#cnc_DebtRepurchaseProgramAuthorizedAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2eea13aa-2e06-48a8-a97b-660d8a385176" xlink:to="loc_cnc_DebtRepurchaseProgramAuthorizedAmount_48abf6b7-f58e-4403-b8f3-7924ec1e2001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_09e870e5-10d4-4a36-8c2b-817d73d36a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2eea13aa-2e06-48a8-a97b-660d8a385176" xlink:to="loc_us-gaap_DebtInstrumentTable_09e870e5-10d4-4a36-8c2b-817d73d36a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6d29d585-7620-4d10-942d-8072291744c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09e870e5-10d4-4a36-8c2b-817d73d36a50" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6d29d585-7620-4d10-942d-8072291744c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_567d8f5c-64cc-4b22-bfa0-058550678b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6d29d585-7620-4d10-942d-8072291744c9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_567d8f5c-64cc-4b22-bfa0-058550678b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_04508d10-eed4-49d7-905e-249a08826d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_567d8f5c-64cc-4b22-bfa0-058550678b03" xlink:to="loc_us-gaap_SeniorNotesMember_04508d10-eed4-49d7-905e-249a08826d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_def34592-1dae-4f01-93c5-7b79fcb6beb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09e870e5-10d4-4a36-8c2b-817d73d36a50" xlink:to="loc_us-gaap_DebtInstrumentLineItems_def34592-1dae-4f01-93c5-7b79fcb6beb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_591072a1-e640-4281-af1c-564d162221cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_def34592-1dae-4f01-93c5-7b79fcb6beb1" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_591072a1-e640-4281-af1c-564d162221cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_39c29d68-c224-49df-a2dc-2723d6b9dd76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_def34592-1dae-4f01-93c5-7b79fcb6beb1" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_39c29d68-c224-49df-a2dc-2723d6b9dd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount_16416440-2e27-4b4a-861d-897da78f0e1e" xlink:href="cnc-20221231.xsd#cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_def34592-1dae-4f01-93c5-7b79fcb6beb1" xlink:to="loc_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount_16416440-2e27-4b4a-861d-897da78f0e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtLettersofCreditSuretyBondsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d809372d-f04b-45d4-8322-8087af98293a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9b2a909d-13ac-4b13-8665-9f183ca93999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d809372d-f04b-45d4-8322-8087af98293a" xlink:to="loc_us-gaap_DebtInstrumentTable_9b2a909d-13ac-4b13-8665-9f183ca93999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5c53ecf7-ac68-4e2f-8146-824af8cd5ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b2a909d-13ac-4b13-8665-9f183ca93999" xlink:to="loc_us-gaap_CreditFacilityAxis_5c53ecf7-ac68-4e2f-8146-824af8cd5ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5926e57c-b1c3-4b8e-99ce-a490b76bc74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_5c53ecf7-ac68-4e2f-8146-824af8cd5ca8" xlink:to="loc_us-gaap_CreditFacilityDomain_5926e57c-b1c3-4b8e-99ce-a490b76bc74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_a6f300ca-53be-4cb5-9af1-ff5ca28b5602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5926e57c-b1c3-4b8e-99ce-a490b76bc74e" xlink:to="loc_us-gaap_LetterOfCreditMember_a6f300ca-53be-4cb5-9af1-ff5ca28b5602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_00e8948e-0859-490b-8230-e80010209a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b2a909d-13ac-4b13-8665-9f183ca93999" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_00e8948e-0859-490b-8230-e80010209a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_359d1c51-7362-4d2f-ad36-35e80c860154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_00e8948e-0859-490b-8230-e80010209a88" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_359d1c51-7362-4d2f-ad36-35e80c860154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuretyBondMember_9bd7da5f-5c50-4c6a-8ac8-aaf386c691ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuretyBondMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_359d1c51-7362-4d2f-ad36-35e80c860154" xlink:to="loc_us-gaap_SuretyBondMember_9bd7da5f-5c50-4c6a-8ac8-aaf386c691ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_226a8c2a-6a0a-4f80-a563-4dac0c6204f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b2a909d-13ac-4b13-8665-9f183ca93999" xlink:to="loc_us-gaap_DebtInstrumentLineItems_226a8c2a-6a0a-4f80-a563-4dac0c6204f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_277a993e-fd7d-46f1-9064-4ae94d6e16e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_226a8c2a-6a0a-4f80-a563-4dac0c6204f0" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_277a993e-fd7d-46f1-9064-4ae94d6e16e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_c7719351-2c26-42f2-9b15-fa5734a880c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_226a8c2a-6a0a-4f80-a563-4dac0c6204f0" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_c7719351-2c26-42f2-9b15-fa5734a880c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_dfe99f1a-3725-4f9c-acf9-69fad614667d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_226a8c2a-6a0a-4f80-a563-4dac0c6204f0" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_dfe99f1a-3725-4f9c-acf9-69fad614667d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#DebtScheduleofAggregateMaturitiesofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_17e4cd92-03f8-4acd-a600-46f50565e596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_02562db0-e08c-4584-959c-4a8fcd5e946a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_17e4cd92-03f8-4acd-a600-46f50565e596" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_02562db0-e08c-4584-959c-4a8fcd5e946a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_cd576a45-7544-4248-8fdc-b8207c6f765d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_17e4cd92-03f8-4acd-a600-46f50565e596" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_cd576a45-7544-4248-8fdc-b8207c6f765d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_bd462320-d88d-4bbf-8615-5ba00196c3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_17e4cd92-03f8-4acd-a600-46f50565e596" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_bd462320-d88d-4bbf-8615-5ba00196c3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7b70076d-cced-40ae-87db-2fb9134e97c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_17e4cd92-03f8-4acd-a600-46f50565e596" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7b70076d-cced-40ae-87db-2fb9134e97c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a894c33c-543a-462b-8ff4-96f52e12d757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_17e4cd92-03f8-4acd-a600-46f50565e596" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a894c33c-543a-462b-8ff4-96f52e12d757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_3f5f97cd-61b9-4ce2-98c6-c1f9662b2b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_17e4cd92-03f8-4acd-a600-46f50565e596" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_3f5f97cd-61b9-4ce2-98c6-c1f9662b2b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e56881f8-36e7-4af4-8562-f3b053aaa1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_17e4cd92-03f8-4acd-a600-46f50565e596" xlink:to="loc_us-gaap_LongTermDebt_e56881f8-36e7-4af4-8562-f3b053aaa1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_8cbf83c6-16a9-4fdb-9071-739d2466e1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_17e4cd92-03f8-4acd-a600-46f50565e596" xlink:to="loc_us-gaap_LongTermDebtFairValue_8cbf83c6-16a9-4fdb-9071-739d2466e1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9deeaf41-ca0e-4236-9885-37b27a92b478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b22417c7-5b18-4eae-9206-6beb22b526fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9deeaf41-ca0e-4236-9885-37b27a92b478" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b22417c7-5b18-4eae-9206-6beb22b526fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_62fd2748-d40d-47b5-a72a-3414babda6a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b22417c7-5b18-4eae-9206-6beb22b526fe" xlink:to="loc_srt_RangeAxis_62fd2748-d40d-47b5-a72a-3414babda6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f7b10196-0ed8-469e-af29-7190b97f1301" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_62fd2748-d40d-47b5-a72a-3414babda6a7" xlink:to="loc_srt_RangeMember_f7b10196-0ed8-469e-af29-7190b97f1301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_51276634-09ba-4754-b38c-074fb048c5f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f7b10196-0ed8-469e-af29-7190b97f1301" xlink:to="loc_srt_MinimumMember_51276634-09ba-4754-b38c-074fb048c5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_008913c2-dd6c-4048-9988-6b89cc40c040" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f7b10196-0ed8-469e-af29-7190b97f1301" xlink:to="loc_srt_MaximumMember_008913c2-dd6c-4048-9988-6b89cc40c040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d09911d5-706f-43a6-b6c9-5d07a05cd3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b22417c7-5b18-4eae-9206-6beb22b526fe" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d09911d5-706f-43a6-b6c9-5d07a05cd3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28d40876-ddb8-40cd-a01b-79e0f52bdb52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d09911d5-706f-43a6-b6c9-5d07a05cd3b4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28d40876-ddb8-40cd-a01b-79e0f52bdb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanHealthMember_49e47045-a41e-4a3c-8ebb-62e269bb5926" xlink:href="cnc-20221231.xsd#cnc_MagellanHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28d40876-ddb8-40cd-a01b-79e0f52bdb52" xlink:to="loc_cnc_MagellanHealthMember_49e47045-a41e-4a3c-8ebb-62e269bb5926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b22417c7-5b18-4eae-9206-6beb22b526fe" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_47d2ba66-94e3-412a-9ad6-9b68dd0fd3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OperatingLeaseExpense_47d2ba66-94e3-412a-9ad6-9b68dd0fd3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_cba779ac-1f81-433e-83a6-5d56bb5391f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OperatingLeasePayments_cba779ac-1f81-433e-83a6-5d56bb5391f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4c7e14ce-311e-4d23-b6e4-1ca4fc866fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4c7e14ce-311e-4d23-b6e4-1ca4fc866fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LesseeOperatingLeaseLeasesCommencedLiability_6adc11f2-2352-4ee7-8e91-65f8df10491f" xlink:href="cnc-20221231.xsd#cnc_LesseeOperatingLeaseLeasesCommencedLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_cnc_LesseeOperatingLeaseLeasesCommencedLiability_6adc11f2-2352-4ee7-8e91-65f8df10491f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_449066f5-3510-4906-a014-e5f9348c930d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_449066f5-3510-4906-a014-e5f9348c930d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_fa69dd0d-289f-4b62-84a6-ee960cdedc67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OperatingLeaseLiability_fa69dd0d-289f-4b62-84a6-ee960cdedc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability_a6c18ff1-8e81-4032-b062-9e8b51de4100" xlink:href="cnc-20221231.xsd#cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability_a6c18ff1-8e81-4032-b062-9e8b51de4100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_b03c6961-ca13-400f-a81b-ab01ef68f219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_b03c6961-ca13-400f-a81b-ab01ef68f219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_47afce71-1582-4dea-98a8-cc488ab32247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_47afce71-1582-4dea-98a8-cc488ab32247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_fc4250b5-08bc-435f-aa15-141131397e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_fc4250b5-08bc-435f-aa15-141131397e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1e83a414-3e74-4476-95eb-c1b7c220b454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1e83a414-3e74-4476-95eb-c1b7c220b454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_11bf9449-e491-4bd8-adb3-ebc6f0506d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_80b58101-fc88-4c29-b85c-5c32a7a72550" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_11bf9449-e491-4bd8-adb3-ebc6f0506d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#LeasesROUAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0ddaaecc-993c-4c6e-a297-6dfc7374eaa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e7e7dcff-207d-4120-b84b-3ef5739b8378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0ddaaecc-993c-4c6e-a297-6dfc7374eaa3" xlink:to="loc_us-gaap_AssetsAbstract_e7e7dcff-207d-4120-b84b-3ef5739b8378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_443d44aa-acf6-4ef3-b205-db0e5a85260f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e7e7dcff-207d-4120-b84b-3ef5739b8378" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_443d44aa-acf6-4ef3-b205-db0e5a85260f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_9b10bd97-51f7-4451-b9d8-e506b34dd431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e7e7dcff-207d-4120-b84b-3ef5739b8378" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_9b10bd97-51f7-4451-b9d8-e506b34dd431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_4e1485fb-2715-4629-921b-4865170adcec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0ddaaecc-993c-4c6e-a297-6dfc7374eaa3" xlink:to="loc_us-gaap_LiabilitiesAbstract_4e1485fb-2715-4629-921b-4865170adcec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_125ae81f-708c-4643-8887-98a810bffdb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4e1485fb-2715-4629-921b-4865170adcec" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_125ae81f-708c-4643-8887-98a810bffdb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c583bd06-10fe-4b61-967c-2b6f563ef8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4e1485fb-2715-4629-921b-4865170adcec" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c583bd06-10fe-4b61-967c-2b6f563ef8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_657f4996-87ef-4ce0-9906-b39f09b202f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4e1485fb-2715-4629-921b-4865170adcec" xlink:to="loc_us-gaap_OperatingLeaseLiability_657f4996-87ef-4ce0-9906-b39f09b202f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_97df5f26-f7a5-4669-bd63-a8d5c07cc783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4e1485fb-2715-4629-921b-4865170adcec" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_97df5f26-f7a5-4669-bd63-a8d5c07cc783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_e2d6fec0-f0ac-4b5b-8c36-fd712d35c483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4e1485fb-2715-4629-921b-4865170adcec" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_e2d6fec0-f0ac-4b5b-8c36-fd712d35c483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#LeasesOperatingLeaseMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c84e1045-83c0-4bbf-b47b-6531b3742549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d47e7d5c-89a3-42f2-a972-59358e64b504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c84e1045-83c0-4bbf-b47b-6531b3742549" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d47e7d5c-89a3-42f2-a972-59358e64b504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_00b7df14-3755-422e-801a-599c6daa2770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c84e1045-83c0-4bbf-b47b-6531b3742549" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_00b7df14-3755-422e-801a-599c6daa2770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ff64190c-9db8-4f6c-923c-ff7b93f95edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c84e1045-83c0-4bbf-b47b-6531b3742549" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ff64190c-9db8-4f6c-923c-ff7b93f95edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d369906e-1fa4-4b5e-b0b7-8488574ae320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c84e1045-83c0-4bbf-b47b-6531b3742549" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d369906e-1fa4-4b5e-b0b7-8488574ae320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_638f3510-8617-4cf7-b295-a9b1708ae5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c84e1045-83c0-4bbf-b47b-6531b3742549" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_638f3510-8617-4cf7-b295-a9b1708ae5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b44ed8aa-a514-4b15-8652-2de46a8a8913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c84e1045-83c0-4bbf-b47b-6531b3742549" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b44ed8aa-a514-4b15-8652-2de46a8a8913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bc3c29e4-33ad-41bb-85d0-9145f26fd71a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c84e1045-83c0-4bbf-b47b-6531b3742549" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bc3c29e4-33ad-41bb-85d0-9145f26fd71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5bf73e29-63fe-49bb-b5c8-6a773f4bba57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c84e1045-83c0-4bbf-b47b-6531b3742549" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5bf73e29-63fe-49bb-b5c8-6a773f4bba57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_cbc40208-d2c0-4e69-9d08-9e1df0a0416c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c84e1045-83c0-4bbf-b47b-6531b3742549" xlink:to="loc_us-gaap_OperatingLeaseLiability_cbc40208-d2c0-4e69-9d08-9e1df0a0416c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="cnc-20221231.xsd#LeasesOperatingLeaseMaturityDetails_1"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.centene.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d15f7d03-95e9-44c6-93dc-7c012dbc7d79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_2fd2fb9b-80f1-4152-ad1b-c1c108dcc25b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d15f7d03-95e9-44c6-93dc-7c012dbc7d79" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_2fd2fb9b-80f1-4152-ad1b-c1c108dcc25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_cb623ffb-82e6-48b0-93be-0c63e92fe9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_2fd2fb9b-80f1-4152-ad1b-c1c108dcc25b" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_cb623ffb-82e6-48b0-93be-0c63e92fe9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_a16a1878-6c26-48aa-b136-2d6bf1ac47ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cb623ffb-82e6-48b0-93be-0c63e92fe9cb" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_a16a1878-6c26-48aa-b136-2d6bf1ac47ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AcceleratedShareRepurchaseAgreementMember_64a1645b-481d-4046-b8d3-47ae174277b8" xlink:href="cnc-20221231.xsd#cnc_AcceleratedShareRepurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_a16a1878-6c26-48aa-b136-2d6bf1ac47ea" xlink:to="loc_cnc_AcceleratedShareRepurchaseAgreementMember_64a1645b-481d-4046-b8d3-47ae174277b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_098dfd61-4fd3-4673-99ce-a3081b1b16f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_2fd2fb9b-80f1-4152-ad1b-c1c108dcc25b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_098dfd61-4fd3-4673-99ce-a3081b1b16f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cbab7291-78dd-4d8a-9b8c-b676f228cc3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_098dfd61-4fd3-4673-99ce-a3081b1b16f8" xlink:to="loc_us-gaap_ClassOfStockDomain_cbab7291-78dd-4d8a-9b8c-b676f228cc3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5d8f7c1a-597d-4996-9a2b-de1707899398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_cbab7291-78dd-4d8a-9b8c-b676f228cc3e" xlink:to="loc_us-gaap_CommonStockMember_5d8f7c1a-597d-4996-9a2b-de1707899398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_2c9f0a99-e502-41d7-8e88-228b25ed4660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_2fd2fb9b-80f1-4152-ad1b-c1c108dcc25b" xlink:to="loc_us-gaap_PlanNameAxis_2c9f0a99-e502-41d7-8e88-228b25ed4660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_941ea825-5038-41cd-817d-2af127aa1eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_2c9f0a99-e502-41d7-8e88-228b25ed4660" xlink:to="loc_us-gaap_PlanNameDomain_941ea825-5038-41cd-817d-2af127aa1eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EmployeeStockCompensationPlanMember_90b7cf7c-e75a-4c7b-9537-4c01f018a661" xlink:href="cnc-20221231.xsd#cnc_EmployeeStockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_941ea825-5038-41cd-817d-2af127aa1eed" xlink:to="loc_cnc_EmployeeStockCompensationPlanMember_90b7cf7c-e75a-4c7b-9537-4c01f018a661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_77c60466-7768-4c02-8b55-d57139283088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_2fd2fb9b-80f1-4152-ad1b-c1c108dcc25b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_77c60466-7768-4c02-8b55-d57139283088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_132dd06b-ed8f-4464-a505-dd13d4339404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_77c60466-7768-4c02-8b55-d57139283088" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_132dd06b-ed8f-4464-a505-dd13d4339404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_WellCareHealthPlansIncMember_bf070612-a97c-41b5-8ff6-22a5429a8828" xlink:href="cnc-20221231.xsd#cnc_WellCareHealthPlansIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_132dd06b-ed8f-4464-a505-dd13d4339404" xlink:to="loc_cnc_WellCareHealthPlansIncMember_bf070612-a97c-41b5-8ff6-22a5429a8828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_2fd2fb9b-80f1-4152-ad1b-c1c108dcc25b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount_6f3175cd-2d74-4744-a953-c727f20cb675" xlink:href="cnc-20221231.xsd#cnc_StockRepurchaseProgramIncreaseAuthorizedAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount_6f3175cd-2d74-4744-a953-c727f20cb675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_11be9548-dd59-42e7-a8cb-1d30a6568eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_11be9548-dd59-42e7-a8cb-1d30a6568eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AcceleratedShareRepurchasesAgreementAmount_06bc331f-855d-4422-960c-fad3e97a9cf6" xlink:href="cnc-20221231.xsd#cnc_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_cnc_AcceleratedShareRepurchasesAgreementAmount_06bc331f-855d-4422-960c-fad3e97a9cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_d5476a72-1010-405b-9c71-6ff9b5c5a342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_d5476a72-1010-405b-9c71-6ff9b5c5a342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram_5d2deced-9c40-4bd3-be87-216cf3a2241a" xlink:href="cnc-20221231.xsd#cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram_5d2deced-9c40-4bd3-be87-216cf3a2241a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_AcceleratedShareRepurchasesDiscountPricePerShare_4148f9bc-63ca-4b9f-9cba-66131e7b1fa0" xlink:href="cnc-20221231.xsd#cnc_AcceleratedShareRepurchasesDiscountPricePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_cnc_AcceleratedShareRepurchasesDiscountPricePerShare_4148f9bc-63ca-4b9f-9cba-66131e7b1fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_652cc6b9-de54-4eab-a3c7-21808ae16f33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_652cc6b9-de54-4eab-a3c7-21808ae16f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_25814a6c-f02f-4400-a89f-90891f1ee81f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_25814a6c-f02f-4400-a89f-90891f1ee81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_376b8912-63ec-48f0-a6d3-86b7950bf004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_376b8912-63ec-48f0-a6d3-86b7950bf004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f64f62df-016c-4ac5-9530-fc33b3c4c073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f64f62df-016c-4ac5-9530-fc33b3c4c073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_17ae36f3-b307-4025-accb-b4d6a2e11110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_17ae36f3-b307-4025-accb-b4d6a2e11110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_0f8f3887-3061-4fdd-9df3-2cb7f635eea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_0f8f3887-3061-4fdd-9df3-2cb7f635eea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_6a895f66-b383-48f0-886c-e53cd877847d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_aa44695e-386e-45d9-a6c5-b0112b416eaa" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_6a895f66-b383-48f0-886c-e53cd877847d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#StockholdersEquityShareRepurchaseActivityDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e98ef01d-b54c-4d29-a2ec-e9f1fe2546e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6367ea83-b3d0-4186-91eb-1471dfee9708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e98ef01d-b54c-4d29-a2ec-e9f1fe2546e8" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6367ea83-b3d0-4186-91eb-1471dfee9708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_26d8dc26-3bb2-471b-b06f-842105a62f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6367ea83-b3d0-4186-91eb-1471dfee9708" xlink:to="loc_us-gaap_StatementClassOfStockAxis_26d8dc26-3bb2-471b-b06f-842105a62f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3bdb6a9c-b00e-4a8e-9730-0470fc121f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_26d8dc26-3bb2-471b-b06f-842105a62f0d" xlink:to="loc_us-gaap_ClassOfStockDomain_3bdb6a9c-b00e-4a8e-9730-0470fc121f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_df6929e9-91cd-41af-8c6d-fbc6a5f420fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3bdb6a9c-b00e-4a8e-9730-0470fc121f3b" xlink:to="loc_us-gaap_CommonStockMember_df6929e9-91cd-41af-8c6d-fbc6a5f420fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_791eaa9e-07aa-4d03-aa8f-1a0505711ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6367ea83-b3d0-4186-91eb-1471dfee9708" xlink:to="loc_us-gaap_PlanNameAxis_791eaa9e-07aa-4d03-aa8f-1a0505711ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_aa1ad465-34ba-4430-a2b5-e8d16cbd03b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_791eaa9e-07aa-4d03-aa8f-1a0505711ba5" xlink:to="loc_us-gaap_PlanNameDomain_aa1ad465-34ba-4430-a2b5-e8d16cbd03b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EmployeeStockCompensationPlanMember_e0d07bb5-bede-4d88-9507-7093a9e8c5ef" xlink:href="cnc-20221231.xsd#cnc_EmployeeStockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_aa1ad465-34ba-4430-a2b5-e8d16cbd03b8" xlink:to="loc_cnc_EmployeeStockCompensationPlanMember_e0d07bb5-bede-4d88-9507-7093a9e8c5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6367ea83-b3d0-4186-91eb-1471dfee9708" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation_7c2d37ba-0399-45d1-a808-3164166efaa2" xlink:href="cnc-20221231.xsd#cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:to="loc_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation_7c2d37ba-0399-45d1-a808-3164166efaa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_6ee93fc7-42f0-4472-8d71-bc0900eb9a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_6ee93fc7-42f0-4472-8d71-bc0900eb9a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_c3b17ebd-28ef-4a66-9e2f-55bad8355d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_c3b17ebd-28ef-4a66-9e2f-55bad8355d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes_3348559a-306b-4855-9285-e0e3fb2b550a" xlink:href="cnc-20221231.xsd#cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:to="loc_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes_3348559a-306b-4855-9285-e0e3fb2b550a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_68a30207-18d8-455f-8466-064d4bd72286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_68a30207-18d8-455f-8466-064d4bd72286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_308f9747-6823-4cd2-a553-1c8250f6fdaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0f714b64-fddd-4f81-84fe-db334a398dc1" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_308f9747-6823-4cd2-a553-1c8250f6fdaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictionsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#StatutoryCapitalRequirementsandDividendRestrictionsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract_e327c66e-0aa7-4c72-84ed-badfee656087" xlink:href="cnc-20221231.xsd#cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_1753e974-b069-438a-a636-750c6df4c1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract_e327c66e-0aa7-4c72-84ed-badfee656087" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_1753e974-b069-438a-a636-750c6df4c1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_3440f518-9125-4e8e-bd9b-d54d4fa898c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract_e327c66e-0aa7-4c72-84ed-badfee656087" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_3440f518-9125-4e8e-bd9b-d54d4fa898c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends_754e98db-d358-415e-96a8-9d893dc304fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract_e327c66e-0aa7-4c72-84ed-badfee656087" xlink:to="loc_us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends_754e98db-d358-415e-96a8-9d893dc304fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#IncomeTaxesConsolidatedIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_12ff2355-d8fb-4664-8532-f43bce16823e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_843d41ee-8f3b-44a2-a1d5-9f22ea24741b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12ff2355-d8fb-4664-8532-f43bce16823e" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_843d41ee-8f3b-44a2-a1d5-9f22ea24741b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_6ee42efa-980e-4c7e-849f-3898d207b91b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12ff2355-d8fb-4664-8532-f43bce16823e" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_6ee42efa-980e-4c7e-849f-3898d207b91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c661e875-e681-4897-8c06-3c418a6fe608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12ff2355-d8fb-4664-8532-f43bce16823e" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c661e875-e681-4897-8c06-3c418a6fe608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4b78293f-f4cc-4a78-9186-5701a1d4790b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12ff2355-d8fb-4664-8532-f43bce16823e" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4b78293f-f4cc-4a78-9186-5701a1d4790b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOtherTaxExpenseBenefit_b6e76f0c-79ad-4bd3-9cde-a6eba49843c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOtherTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12ff2355-d8fb-4664-8532-f43bce16823e" xlink:to="loc_us-gaap_DeferredOtherTaxExpenseBenefit_b6e76f0c-79ad-4bd3-9cde-a6eba49843c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2e365f60-dd17-495e-9f01-679aa82981c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12ff2355-d8fb-4664-8532-f43bce16823e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2e365f60-dd17-495e-9f01-679aa82981c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fc645490-86ff-4435-b26f-bb1cc58a8e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fc645490-86ff-4435-b26f-bb1cc58a8e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest_764adfb0-77f2-4ff6-91ce-a22cbf5abe3c" xlink:href="cnc-20221231.xsd#cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest_764adfb0-77f2-4ff6-91ce-a22cbf5abe3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest_fc63ad9c-8178-4e1e-ae44-5cc89b3ecc3e" xlink:href="cnc-20221231.xsd#cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest_fc63ad9c-8178-4e1e-ae44-5cc89b3ecc3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_68bdc904-5e06-429a-a45d-c0cb146ab4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_68bdc904-5e06-429a-a45d-c0cb146ab4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_bccfeb0f-3b7a-44fb-8024-d0f8f182c5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_bccfeb0f-3b7a-44fb-8024-d0f8f182c5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_6ed9f5ae-2cdb-4954-8a32-8b507ea321c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_6ed9f5ae-2cdb-4954-8a32-8b507ea321c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement_f7f298d1-d067-44d9-a54c-d9d57afb842d" xlink:href="cnc-20221231.xsd#cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement_f7f298d1-d067-44d9-a54c-d9d57afb842d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_b2aa1ffc-783b-42df-afa1-003b5fbb4749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_b2aa1ffc-783b-42df-afa1-003b5fbb4749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries_e83a8c46-cf37-4ddc-a66b-b3c341238709" xlink:href="cnc-20221231.xsd#cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries_e83a8c46-cf37-4ddc-a66b-b3c341238709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ACAHealthInsurerFee_82e756ef-edef-4872-8375-71d38fc859c8" xlink:href="cnc-20221231.xsd#cnc_ACAHealthInsurerFee"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_cnc_ACAHealthInsurerFee_82e756ef-edef-4872-8375-71d38fc859c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_1840e496-26f3-4027-95f1-7e38e6de4c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_1840e496-26f3-4027-95f1-7e38e6de4c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4c95670d-7961-4acd-be8d-123a84e07122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4c95670d-7961-4acd-be8d-123a84e07122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill_b7edfaec-8b5a-4de4-aa14-718b8a294cde" xlink:href="cnc-20221231.xsd#cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill_b7edfaec-8b5a-4de4-aa14-718b8a294cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_9b1539f4-0152-48e3-8624-0203364f6acf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_9b1539f4-0152-48e3-8624-0203364f6acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bdfe1751-5491-4199-bca4-4d4ca5c91b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18c4075e-0b8d-4042-b095-7da129267831" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_bdfe1751-5491-4199-bca4-4d4ca5c91b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2b4fbebd-2dc0-4f60-ae99-eafe7f659e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_915682eb-37dd-4eb1-9782-1db8d95ed0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2b4fbebd-2dc0-4f60-ae99-eafe7f659e8b" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_915682eb-37dd-4eb1-9782-1db8d95ed0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_1a3f6afc-1cde-4d70-9d3b-4cf2d41bd7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_915682eb-37dd-4eb1-9782-1db8d95ed0e2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_1a3f6afc-1cde-4d70-9d3b-4cf2d41bd7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_43724b87-257a-40d9-8407-33314efe6805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_915682eb-37dd-4eb1-9782-1db8d95ed0e2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_43724b87-257a-40d9-8407-33314efe6805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_7c271bd3-1379-4920-8fa6-0fb15743f00b" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_915682eb-37dd-4eb1-9782-1db8d95ed0e2" xlink:to="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards_7c271bd3-1379-4920-8fa6-0fb15743f00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_b9ac9019-78f2-49c8-9e3c-8e0f8ef24093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_915682eb-37dd-4eb1-9782-1db8d95ed0e2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_b9ac9019-78f2-49c8-9e3c-8e0f8ef24093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetPremiumAndTradeReceivables_4cd40424-3db1-41da-a9fd-e1949d68d02b" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetPremiumAndTradeReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_915682eb-37dd-4eb1-9782-1db8d95ed0e2" xlink:to="loc_cnc_DeferredTaxAssetPremiumAndTradeReceivables_4cd40424-3db1-41da-a9fd-e1949d68d02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetOperatingLeaseLiability_38153240-6f0b-491a-a64e-322e62495e72" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_915682eb-37dd-4eb1-9782-1db8d95ed0e2" xlink:to="loc_cnc_DeferredTaxAssetOperatingLeaseLiability_38153240-6f0b-491a-a64e-322e62495e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss_b706bfc4-07ea-499b-b4a5-1e8bfd1d0f3c" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_915682eb-37dd-4eb1-9782-1db8d95ed0e2" xlink:to="loc_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss_b706bfc4-07ea-499b-b4a5-1e8bfd1d0f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetSoftwareDevelopmentCosts_fc56e507-af8f-4cf7-a653-ecb12fc86db6" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetSoftwareDevelopmentCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_915682eb-37dd-4eb1-9782-1db8d95ed0e2" xlink:to="loc_cnc_DeferredTaxAssetSoftwareDevelopmentCosts_fc56e507-af8f-4cf7-a653-ecb12fc86db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_5768abbf-61cd-4a52-a1ab-bb0e5b18eaf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_915682eb-37dd-4eb1-9782-1db8d95ed0e2" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_5768abbf-61cd-4a52-a1ab-bb0e5b18eaf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d79e139a-30b3-4df2-9dbc-26f721c4c03e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_915682eb-37dd-4eb1-9782-1db8d95ed0e2" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_d79e139a-30b3-4df2-9dbc-26f721c4c03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_cbe3f122-cfb2-4692-b6d0-fc394ebc392b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_915682eb-37dd-4eb1-9782-1db8d95ed0e2" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_cbe3f122-cfb2-4692-b6d0-fc394ebc392b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_f38f7f7b-f4d0-45aa-b66a-251cd1dfc6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_915682eb-37dd-4eb1-9782-1db8d95ed0e2" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_f38f7f7b-f4d0-45aa-b66a-251cd1dfc6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_53f22735-8e2d-401b-a0fe-b6d538e7efd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2b4fbebd-2dc0-4f60-ae99-eafe7f659e8b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_53f22735-8e2d-401b-a0fe-b6d538e7efd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_c2186d4c-16d3-44ae-aefe-a7f793f27ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_53f22735-8e2d-401b-a0fe-b6d538e7efd4" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_c2186d4c-16d3-44ae-aefe-a7f793f27ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_470678dc-2f7e-4e11-8906-14b6af9265ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_53f22735-8e2d-401b-a0fe-b6d538e7efd4" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_470678dc-2f7e-4e11-8906-14b6af9265ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_5c98ff34-76ea-4a7d-aeed-bb2eaff85eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_53f22735-8e2d-401b-a0fe-b6d538e7efd4" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_5c98ff34-76ea-4a7d-aeed-bb2eaff85eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxLiabilitiesRightOfUseAssets_6fa36c05-b435-4d8b-9f3f-ffeee2eea926" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_53f22735-8e2d-401b-a0fe-b6d538e7efd4" xlink:to="loc_cnc_DeferredTaxLiabilitiesRightOfUseAssets_6fa36c05-b435-4d8b-9f3f-ffeee2eea926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss_c4f4d9c9-4090-41cc-ad8b-083a96135747" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_53f22735-8e2d-401b-a0fe-b6d538e7efd4" xlink:to="loc_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss_c4f4d9c9-4090-41cc-ad8b-083a96135747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_79b7ffe8-b7ce-4ebf-a1a6-c233ed61bc90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_53f22735-8e2d-401b-a0fe-b6d538e7efd4" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_79b7ffe8-b7ce-4ebf-a1a6-c233ed61bc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_76c5a30b-84e3-4a70-9751-854e09fd5763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_53f22735-8e2d-401b-a0fe-b6d538e7efd4" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_76c5a30b-84e3-4a70-9751-854e09fd5763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_005a1154-6d72-4d79-8c0a-306e26a828b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2b4fbebd-2dc0-4f60-ae99-eafe7f659e8b" xlink:to="loc_us-gaap_DeferredTaxLiabilities_005a1154-6d72-4d79-8c0a-306e26a828b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0528b36b-57bf-404d-8f84-c82ca9e36e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_edfa1d76-df60-4277-9716-7a6c218877ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0528b36b-57bf-404d-8f84-c82ca9e36e16" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_edfa1d76-df60-4277-9716-7a6c218877ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_6f0be5b2-24e9-4c86-9907-8b466c22a710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_edfa1d76-df60-4277-9716-7a6c218877ec" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_6f0be5b2-24e9-4c86-9907-8b466c22a710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_8052342f-a13d-4537-bb66-e6c3f8acc3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_6f0be5b2-24e9-4c86-9907-8b466c22a710" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_8052342f-a13d-4537-bb66-e6c3f8acc3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_63b1793f-332d-488d-a8b0-6d1034a22d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8052342f-a13d-4537-bb66-e6c3f8acc3cf" xlink:to="loc_us-gaap_DomesticCountryMember_63b1793f-332d-488d-a8b0-6d1034a22d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_4afcf8df-7dd4-4907-aa82-f8e023bdbf03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8052342f-a13d-4537-bb66-e6c3f8acc3cf" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_4afcf8df-7dd4-4907-aa82-f8e023bdbf03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_a812161c-f2a1-4231-b901-4b2145d9cfec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8052342f-a13d-4537-bb66-e6c3f8acc3cf" xlink:to="loc_us-gaap_ForeignCountryMember_a812161c-f2a1-4231-b901-4b2145d9cfec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_2a3c0e7b-56c5-4f98-b729-a69c8a90e7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_edfa1d76-df60-4277-9716-7a6c218877ec" xlink:to="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_2a3c0e7b-56c5-4f98-b729-a69c8a90e7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_4f9559a1-f5ab-4621-aa74-9df9f5d748e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_2a3c0e7b-56c5-4f98-b729-a69c8a90e7ed" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_4f9559a1-f5ab-4621-aa74-9df9f5d748e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettlementWithTaxingAuthorityMember_d09c5102-232a-438d-8122-7ac31c7da6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettlementWithTaxingAuthorityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_4f9559a1-f5ab-4621-aa74-9df9f5d748e5" xlink:to="loc_us-gaap_SettlementWithTaxingAuthorityMember_d09c5102-232a-438d-8122-7ac31c7da6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_edfa1d76-df60-4277-9716-7a6c218877ec" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_97134f1f-f9e0-4fbe-8f09-4321108c58b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_us-gaap_OperatingLossCarryforwards_97134f1f-f9e0-4fbe-8f09-4321108c58b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration_0abec748-5027-435a-b10e-5ddb969c4cf4" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration_0abec748-5027-435a-b10e-5ddb969c4cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration_7a2aa3c9-98fc-49b3-9a9f-0b8ffa0ad1d6" xlink:href="cnc-20221231.xsd#cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration_7a2aa3c9-98fc-49b3-9a9f-0b8ffa0ad1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_908ee9dc-85c4-4c1e-ac90-2ee7d60cc053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_908ee9dc-85c4-4c1e-ac90-2ee7d60cc053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_8a1cfef1-ff02-4565-be8a-0574a341f0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_8a1cfef1-ff02-4565-be8a-0574a341f0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_436a2d4f-c9e3-48d6-998a-e72703786a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_436a2d4f-c9e3-48d6-998a-e72703786a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_00f4faf0-c566-4d4b-8796-cce5c59e1220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_3568be70-8a6e-43c3-bdfa-637690f75262" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_00f4faf0-c566-4d4b-8796-cce5c59e1220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_3c877ec3-ec12-4ce9-938b-c88cc86e96a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0528b36b-57bf-404d-8f84-c82ca9e36e16" xlink:to="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_3c877ec3-ec12-4ce9-938b-c88cc86e96a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries_9943490f-62df-45ca-be72-ad22a5c00913" xlink:href="cnc-20221231.xsd#cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_3c877ec3-ec12-4ce9-938b-c88cc86e96a9" xlink:to="loc_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries_9943490f-62df-45ca-be72-ad22a5c00913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_63c40cb4-cb52-48fa-b613-569da8f0ee39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_88e477dc-34d0-4bd1-b11f-0f03248ca766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_63c40cb4-cb52-48fa-b613-569da8f0ee39" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_88e477dc-34d0-4bd1-b11f-0f03248ca766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_9bcfa740-a3c8-4fcc-b76d-769be171ec9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_88e477dc-34d0-4bd1-b11f-0f03248ca766" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_9bcfa740-a3c8-4fcc-b76d-769be171ec9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GrossIncreasesAbstract_e8c37094-abd6-46fa-89e7-4441c2be2771" xlink:href="cnc-20221231.xsd#cnc_GrossIncreasesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_88e477dc-34d0-4bd1-b11f-0f03248ca766" xlink:to="loc_cnc_GrossIncreasesAbstract_e8c37094-abd6-46fa-89e7-4441c2be2771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_367540fb-1b3e-460d-a8e3-ce461ad74598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_GrossIncreasesAbstract_e8c37094-abd6-46fa-89e7-4441c2be2771" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_367540fb-1b3e-460d-a8e3-ce461ad74598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired_15e56c02-560f-481a-ab14-5613aa68e022" xlink:href="cnc-20221231.xsd#cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_GrossIncreasesAbstract_e8c37094-abd6-46fa-89e7-4441c2be2771" xlink:to="loc_cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired_15e56c02-560f-481a-ab14-5613aa68e022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_b3e05a09-e889-49f6-a553-d9a127d0290c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_GrossIncreasesAbstract_e8c37094-abd6-46fa-89e7-4441c2be2771" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_b3e05a09-e889-49f6-a553-d9a127d0290c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GrossDecreasesAbstract_ff56f463-7821-4a70-a7e8-36391f71c772" xlink:href="cnc-20221231.xsd#cnc_GrossDecreasesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_88e477dc-34d0-4bd1-b11f-0f03248ca766" xlink:to="loc_cnc_GrossDecreasesAbstract_ff56f463-7821-4a70-a7e8-36391f71c772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_1588c2b8-8e4d-42bd-8f27-2dae8fed4aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_GrossDecreasesAbstract_ff56f463-7821-4a70-a7e8-36391f71c772" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_1588c2b8-8e4d-42bd-8f27-2dae8fed4aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_077dc5f9-cf47-46ce-8597-9be6e4abdf42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_GrossDecreasesAbstract_ff56f463-7821-4a70-a7e8-36391f71c772" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_077dc5f9-cf47-46ce-8597-9be6e4abdf42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_db735480-061c-454a-b088-01589937cc23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnc_GrossDecreasesAbstract_ff56f463-7821-4a70-a7e8-36391f71c772" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_db735480-061c-454a-b088-01589937cc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_6c6143d1-5ff5-4d6d-9398-8144c7ac0003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_88e477dc-34d0-4bd1-b11f-0f03248ca766" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_6c6143d1-5ff5-4d6d-9398-8144c7ac0003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/StockIncentivePlansNarrativeDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#StockIncentivePlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/StockIncentivePlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_75dbb3fd-f114-41d5-95f8-efcbc7da3905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ceecd647-4040-48b9-bc6f-5f2448535579" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_75dbb3fd-f114-41d5-95f8-efcbc7da3905" xlink:to="loc_us-gaap_StatementTable_ceecd647-4040-48b9-bc6f-5f2448535579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_77ddfb72-592d-4c4e-9ea4-4ef308c86080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ceecd647-4040-48b9-bc6f-5f2448535579" xlink:to="loc_us-gaap_AwardTypeAxis_77ddfb72-592d-4c4e-9ea4-4ef308c86080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b93c72f3-7cc8-4ba7-9148-b063fc877b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_77ddfb72-592d-4c4e-9ea4-4ef308c86080" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b93c72f3-7cc8-4ba7-9148-b063fc877b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_99da618c-abc5-4c80-bda3-c1bb28306caf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b93c72f3-7cc8-4ba7-9148-b063fc877b8c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_99da618c-abc5-4c80-bda3-c1bb28306caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a18d6d8d-60a2-4235-90ab-f563b7d28d67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b93c72f3-7cc8-4ba7-9148-b063fc877b8c" xlink:to="loc_us-gaap_RestrictedStockMember_a18d6d8d-60a2-4235-90ab-f563b7d28d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b7dfe683-7f69-4ea3-87d8-2f3b3d93f13e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b93c72f3-7cc8-4ba7-9148-b063fc877b8c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b7dfe683-7f69-4ea3-87d8-2f3b3d93f13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cd84a811-20bc-4d77-ac1f-f17faa1c3c54" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ceecd647-4040-48b9-bc6f-5f2448535579" xlink:to="loc_srt_RangeAxis_cd84a811-20bc-4d77-ac1f-f17faa1c3c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cf67e861-1b6d-4cf6-9a95-d05fb853010d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cd84a811-20bc-4d77-ac1f-f17faa1c3c54" xlink:to="loc_srt_RangeMember_cf67e861-1b6d-4cf6-9a95-d05fb853010d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e4b1647e-a578-4035-99d1-1dbb5e966e93" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cf67e861-1b6d-4cf6-9a95-d05fb853010d" xlink:to="loc_srt_MinimumMember_e4b1647e-a578-4035-99d1-1dbb5e966e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9854a1d1-38f3-43d9-b60d-9359ed6ddcca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cf67e861-1b6d-4cf6-9a95-d05fb853010d" xlink:to="loc_srt_MaximumMember_9854a1d1-38f3-43d9-b60d-9359ed6ddcca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ceecd647-4040-48b9-bc6f-5f2448535579" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2035bf45-52f7-4e88-925d-50b89dc9d233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2035bf45-52f7-4e88-925d-50b89dc9d233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3bc3f1b0-dd63-46e1-902e-da763d84a4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3bc3f1b0-dd63-46e1-902e-da763d84a4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod_eeee2bd6-c784-4ecd-9880-b2b6baf467f2" xlink:href="cnc-20221231.xsd#cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod_eeee2bd6-c784-4ecd-9880-b2b6baf467f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a0b448f8-bf83-4a13-911f-453e9e6236d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a0b448f8-bf83-4a13-911f-453e9e6236d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_cf90b722-c96e-4650-83d6-2b24ad861e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_cf90b722-c96e-4650-83d6-2b24ad861e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5ee9e2e0-ae12-4acd-8041-7069c37079b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5ee9e2e0-ae12-4acd-8041-7069c37079b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e2c810f2-0a7e-4281-937e-0551a6d3bb21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e2c810f2-0a7e-4281-937e-0551a6d3bb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_cd45c3e3-fd6b-495e-8692-03cb062c9ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_cd45c3e3-fd6b-495e-8692-03cb062c9ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_abadfa5a-6ae4-4a58-983b-aa7648bf7e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0700a6bd-83eb-4845-bfc9-c35cfbc9a359" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_abadfa5a-6ae4-4a58-983b-aa7648bf7e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb9c8a9d-2c87-4a45-913b-618b32b10aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_e9bb8420-d246-4641-b3b6-66b3e8c17478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb9c8a9d-2c87-4a45-913b-618b32b10aeb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_e9bb8420-d246-4641-b3b6-66b3e8c17478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c672ab29-227f-4733-aaae-d153c097aabc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_e9bb8420-d246-4641-b3b6-66b3e8c17478" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c672ab29-227f-4733-aaae-d153c097aabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5f666700-0dcc-412b-9215-afd827feb9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_e9bb8420-d246-4641-b3b6-66b3e8c17478" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5f666700-0dcc-412b-9215-afd827feb9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod_0a66fa4a-bdef-4cda-83e0-649e7d7c61ef" xlink:href="cnc-20221231.xsd#cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_e9bb8420-d246-4641-b3b6-66b3e8c17478" xlink:to="loc_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod_0a66fa4a-bdef-4cda-83e0-649e7d7c61ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_430b6ba9-7bc5-4f3a-88ee-3025a4ffb8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_e9bb8420-d246-4641-b3b6-66b3e8c17478" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_430b6ba9-7bc5-4f3a-88ee-3025a4ffb8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_aef5c524-690f-4ad1-ae84-79d6423784f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_e9bb8420-d246-4641-b3b6-66b3e8c17478" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_aef5c524-690f-4ad1-ae84-79d6423784f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7a748f20-09a3-4c46-9848-27fa3e68448e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_e9bb8420-d246-4641-b3b6-66b3e8c17478" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7a748f20-09a3-4c46-9848-27fa3e68448e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9ccadf09-d069-4941-b0c4-a20c8db69408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb9c8a9d-2c87-4a45-913b-618b32b10aeb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9ccadf09-d069-4941-b0c4-a20c8db69408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_62cb8049-5c32-49c1-9c3f-b24f6be6578a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9ccadf09-d069-4941-b0c4-a20c8db69408" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_62cb8049-5c32-49c1-9c3f-b24f6be6578a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ccadbc37-eae4-43bb-8847-f8ddcde7947a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9ccadf09-d069-4941-b0c4-a20c8db69408" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ccadbc37-eae4-43bb-8847-f8ddcde7947a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue_7ad19e77-0a71-4dfb-b096-630986f05b7b" xlink:href="cnc-20221231.xsd#cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9ccadf09-d069-4941-b0c4-a20c8db69408" xlink:to="loc_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue_7ad19e77-0a71-4dfb-b096-630986f05b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_51af69ad-4f2e-4ab8-9590-80f79886f58b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9ccadf09-d069-4941-b0c4-a20c8db69408" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_51af69ad-4f2e-4ab8-9590-80f79886f58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_f438aa1f-33bd-4814-83da-54c8c1216c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9ccadf09-d069-4941-b0c4-a20c8db69408" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_f438aa1f-33bd-4814-83da-54c8c1216c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1635c818-a294-424a-acba-d122866d2901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9ccadf09-d069-4941-b0c4-a20c8db69408" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1635c818-a294-424a-acba-d122866d2901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/RetirementPlanDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#RetirementPlanDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/RetirementPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d511f4df-a060-4d07-be9f-8a9cf1fce7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DefinedContributionPlanMinimumAgeForCoverage_49b0307b-ebbb-485e-9e40-42ccd0618352" xlink:href="cnc-20221231.xsd#cnc_DefinedContributionPlanMinimumAgeForCoverage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d511f4df-a060-4d07-be9f-8a9cf1fce7c0" xlink:to="loc_cnc_DefinedContributionPlanMinimumAgeForCoverage_49b0307b-ebbb-485e-9e40-42ccd0618352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_917e8352-a849-4255-9946-8a55297a3b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d511f4df-a060-4d07-be9f-8a9cf1fce7c0" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_917e8352-a849-4255-9946-8a55297a3b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CommitmentsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#CommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/CommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e9345c2f-6fbf-4742-a83d-ca06cfbaa1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_a0cd8d39-f2d6-46c7-a480-4f55a0fbebba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e9345c2f-6fbf-4742-a83d-ca06cfbaa1d8" xlink:to="loc_us-gaap_OtherCommitmentsTable_a0cd8d39-f2d6-46c7-a480-4f55a0fbebba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9e55bb75-1d33-423b-95a7-6c2adb90ba6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_a0cd8d39-f2d6-46c7-a480-4f55a0fbebba" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9e55bb75-1d33-423b-95a7-6c2adb90ba6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5249e3f6-414d-4c7a-b185-f44da10fa6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9e55bb75-1d33-423b-95a7-6c2adb90ba6e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5249e3f6-414d-4c7a-b185-f44da10fa6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_MagellanHealthMember_edadd2a9-57e5-4360-9af9-c80cb1ebe5c3" xlink:href="cnc-20221231.xsd#cnc_MagellanHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5249e3f6-414d-4c7a-b185-f44da10fa6d2" xlink:to="loc_cnc_MagellanHealthMember_edadd2a9-57e5-4360-9af9-c80cb1ebe5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_6f9b7d0e-5008-40a4-a454-fab9c86b4f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_a0cd8d39-f2d6-46c7-a480-4f55a0fbebba" xlink:to="loc_us-gaap_OtherCommitmentsAxis_6f9b7d0e-5008-40a4-a454-fab9c86b4f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_6f9b7d0e-5008-40a4-a454-fab9c86b4f0f" xlink:to="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_PurchaserBusinessGroupOnHealthMember_fe0cbf86-5928-4793-b59b-c596160d865d" xlink:href="cnc-20221231.xsd#cnc_PurchaserBusinessGroupOnHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:to="loc_cnc_PurchaserBusinessGroupOnHealthMember_fe0cbf86-5928-4793-b59b-c596160d865d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember_8adfb3bc-4015-4e4b-98e4-18f3d0e006ad" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:to="loc_cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember_8adfb3bc-4015-4e4b-98e4-18f3d0e006ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember_68aea105-7c9f-4c63-9739-c4e12500a0b5" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:to="loc_cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember_68aea105-7c9f-4c63-9739-c4e12500a0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentServiceCenterinCaliforniaMember_1fb0d559-d598-4764-8459-e5b7160d8cd9" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentServiceCenterinCaliforniaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:to="loc_cnc_LongTermInvestmentServiceCenterinCaliforniaMember_1fb0d559-d598-4764-8459-e5b7160d8cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember_c0e8c571-8909-4462-a20b-247efa437699" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:to="loc_cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember_c0e8c571-8909-4462-a20b-247efa437699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember_2874ac1c-6176-4e6c-910b-6b2ad1199cbb" xlink:href="cnc-20221231.xsd#cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_2dd96e47-70cf-4b29-81ce-53c4bda47f8f" xlink:to="loc_cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember_2874ac1c-6176-4e6c-910b-6b2ad1199cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1f3ef8ec-b97e-41e6-928d-c6ba89a8b951" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_a0cd8d39-f2d6-46c7-a480-4f55a0fbebba" xlink:to="loc_srt_RangeAxis_1f3ef8ec-b97e-41e6-928d-c6ba89a8b951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1097746f-846f-45eb-becd-443e19a2f797" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1f3ef8ec-b97e-41e6-928d-c6ba89a8b951" xlink:to="loc_srt_RangeMember_1097746f-846f-45eb-becd-443e19a2f797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_62dc44af-f0e7-49f4-a995-a552e5b335f2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1097746f-846f-45eb-becd-443e19a2f797" xlink:to="loc_srt_MinimumMember_62dc44af-f0e7-49f4-a995-a552e5b335f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_a0cd8d39-f2d6-46c7-a480-4f55a0fbebba" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_5cf8ec57-1353-4628-b0ad-50b52f250529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:to="loc_us-gaap_OtherCommitment_5cf8ec57-1353-4628-b0ad-50b52f250529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentTerm_e8bd733e-b5f9-4c9c-b0f6-d97718bf0965" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:to="loc_cnc_OtherCommitmentTerm_e8bd733e-b5f9-4c9c-b0f6-d97718bf0965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentsPaid_18c64c88-ff5e-4917-9dd9-a18c95ca7201" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentsPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:to="loc_cnc_OtherCommitmentsPaid_18c64c88-ff5e-4917-9dd9-a18c95ca7201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentEmployees_917a29b1-8067-4698-be68-bc383c1e76c6" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:to="loc_cnc_OtherCommitmentEmployees_917a29b1-8067-4698-be68-bc383c1e76c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentExpense_ab7859bb-f971-49b3-8edf-a1f280036576" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:to="loc_cnc_OtherCommitmentExpense_ab7859bb-f971-49b3-8edf-a1f280036576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_OtherCommitmentToBePaidYearOneAndYearTwo_8206834f-bfdb-4ac6-98f2-05e2b14718f4" xlink:href="cnc-20221231.xsd#cnc_OtherCommitmentToBePaidYearOneAndYearTwo"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f314516e-ca98-44b6-aea6-e9c7e2032285" xlink:to="loc_cnc_OtherCommitmentToBePaidYearOneAndYearTwo_8206834f-bfdb-4ac6-98f2-05e2b14718f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/ContingenciesDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#ContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/ContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7241db05-d94e-474d-8c81-53e9fd0c03ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_fdb387d8-4da1-4ac7-9225-f3bf19416ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7241db05-d94e-474d-8c81-53e9fd0c03ff" xlink:to="loc_us-gaap_LossContingenciesTable_fdb387d8-4da1-4ac7-9225-f3bf19416ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_98b52f65-7290-45eb-9a26-699f647c1c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_fdb387d8-4da1-4ac7-9225-f3bf19416ddc" xlink:to="loc_us-gaap_LitigationStatusAxis_98b52f65-7290-45eb-9a26-699f647c1c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d4f45763-27e8-4aae-8d5f-20aa8bc12f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_98b52f65-7290-45eb-9a26-699f647c1c63" xlink:to="loc_us-gaap_LitigationStatusDomain_d4f45763-27e8-4aae-8d5f-20aa8bc12f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_3f851f8b-a093-4e8a-a0c7-18d00c3a4edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_d4f45763-27e8-4aae-8d5f-20aa8bc12f0d" xlink:to="loc_us-gaap_PendingLitigationMember_3f851f8b-a093-4e8a-a0c7-18d00c3a4edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_802eb33c-77d6-4e12-ba79-27d7be836c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_fdb387d8-4da1-4ac7-9225-f3bf19416ddc" xlink:to="loc_us-gaap_LossContingenciesLineItems_802eb33c-77d6-4e12-ba79-27d7be836c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_11239d00-2b71-4e19-b87e-9fa3af1274e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_802eb33c-77d6-4e12-ba79-27d7be836c79" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_11239d00-2b71-4e19-b87e-9fa3af1274e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_3b485002-0c1b-4085-aea7-135e745bea85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_802eb33c-77d6-4e12-ba79-27d7be836c79" xlink:to="loc_us-gaap_LitigationReserve_3b485002-0c1b-4085-aea7-135e745bea85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#EarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d554225f-df24-49be-afea-e7635fd4a951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_f590c7e7-f2c7-4011-8227-6ebcbd15b093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d554225f-df24-49be-afea-e7635fd4a951" xlink:to="loc_us-gaap_NetIncomeLossAbstract_f590c7e7-f2c7-4011-8227-6ebcbd15b093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ba64be27-fbb0-46e7-a46d-f26f9fcd66de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_f590c7e7-f2c7-4011-8227-6ebcbd15b093" xlink:to="loc_us-gaap_NetIncomeLoss_ba64be27-fbb0-46e7-a46d-f26f9fcd66de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_6e6af401-eda2-4584-b099-450ceeba3d76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d554225f-df24-49be-afea-e7635fd4a951" xlink:to="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_6e6af401-eda2-4584-b099-450ceeba3d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fbcd15cc-b241-4f63-8c14-e8639462a101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_6e6af401-eda2-4584-b099-450ceeba3d76" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fbcd15cc-b241-4f63-8c14-e8639462a101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_06a9c4da-daa5-4310-84c8-fde8e2efa06b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_6e6af401-eda2-4584-b099-450ceeba3d76" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_06a9c4da-daa5-4310-84c8-fde8e2efa06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0882d67a-ba4e-4adf-be5c-0c106646ce27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_6e6af401-eda2-4584-b099-450ceeba3d76" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0882d67a-ba4e-4adf-be5c-0c106646ce27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_58972949-7901-446b-a5d8-f71f79a314bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d554225f-df24-49be-afea-e7635fd4a951" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_58972949-7901-446b-a5d8-f71f79a314bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1a111993-f739-4d9d-9f81-d634d175f70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_58972949-7901-446b-a5d8-f71f79a314bc" xlink:to="loc_us-gaap_EarningsPerShareBasic_1a111993-f739-4d9d-9f81-d634d175f70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_528287d6-e1c5-4b9b-b470-8db85f749df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_58972949-7901-446b-a5d8-f71f79a314bc" xlink:to="loc_us-gaap_EarningsPerShareDiluted_528287d6-e1c5-4b9b-b470-8db85f749df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bed5fe02-8c14-44a6-ba19-414baf73ec5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d554225f-df24-49be-afea-e7635fd4a951" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bed5fe02-8c14-44a6-ba19-414baf73ec5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#SegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_47868c7b-1053-4fe1-b989-281dd59e7edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_7119ceb4-46e3-4855-a102-18526482cad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_47868c7b-1053-4fe1-b989-281dd59e7edb" xlink:to="loc_us-gaap_NumberOfOperatingSegments_7119ceb4-46e3-4855-a102-18526482cad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c8f5190c-6ee4-4c4f-b54c-fc5377fd5add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_47868c7b-1053-4fe1-b989-281dd59e7edb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c8f5190c-6ee4-4c4f-b54c-fc5377fd5add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b131a079-06ca-429c-ab31-bf90485200cc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c8f5190c-6ee4-4c4f-b54c-fc5377fd5add" xlink:to="loc_srt_ConsolidationItemsAxis_b131a079-06ca-429c-ab31-bf90485200cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6f0153a6-a8f9-470f-9b7d-d3d951a801ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_b131a079-06ca-429c-ab31-bf90485200cc" xlink:to="loc_srt_ConsolidationItemsDomain_6f0153a6-a8f9-470f-9b7d-d3d951a801ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a3ad7e13-682a-454d-b81d-756cedb5f104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6f0153a6-a8f9-470f-9b7d-d3d951a801ea" xlink:to="loc_us-gaap_OperatingSegmentsMember_a3ad7e13-682a-454d-b81d-756cedb5f104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_54d1765a-12c1-4d0a-98cd-18bd10eb7c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6f0153a6-a8f9-470f-9b7d-d3d951a801ea" xlink:to="loc_us-gaap_IntersegmentEliminationMember_54d1765a-12c1-4d0a-98cd-18bd10eb7c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b0418f43-ea76-40fe-a348-19bd5a5c0b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c8f5190c-6ee4-4c4f-b54c-fc5377fd5add" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b0418f43-ea76-40fe-a348-19bd5a5c0b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2c380312-a3f3-49ad-a18c-0536e8f6eb18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b0418f43-ea76-40fe-a348-19bd5a5c0b25" xlink:to="loc_us-gaap_SegmentDomain_2c380312-a3f3-49ad-a18c-0536e8f6eb18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ManagedCareMember_8557492e-69a1-4a4a-8545-eb01f24ee338" xlink:href="cnc-20221231.xsd#cnc_ManagedCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2c380312-a3f3-49ad-a18c-0536e8f6eb18" xlink:to="loc_cnc_ManagedCareMember_8557492e-69a1-4a4a-8545-eb01f24ee338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_SpecialtyServicesMember_818ee006-0662-4649-9e77-89e7dc10fe07" xlink:href="cnc-20221231.xsd#cnc_SpecialtyServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2c380312-a3f3-49ad-a18c-0536e8f6eb18" xlink:to="loc_cnc_SpecialtyServicesMember_818ee006-0662-4649-9e77-89e7dc10fe07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fa042183-2482-4cd8-943b-c740f9c5ac3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c8f5190c-6ee4-4c4f-b54c-fc5377fd5add" xlink:to="loc_us-gaap_StatementLineItems_fa042183-2482-4cd8-943b-c740f9c5ac3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c03b5090-e444-4793-8bb6-46b331665859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fa042183-2482-4cd8-943b-c740f9c5ac3a" xlink:to="loc_us-gaap_Revenues_c03b5090-e444-4793-8bb6-46b331665859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ca8d6bfd-a5fa-4922-8f6c-3b54db3f0942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fa042183-2482-4cd8-943b-c740f9c5ac3a" xlink:to="loc_us-gaap_OperatingIncomeLoss_ca8d6bfd-a5fa-4922-8f6c-3b54db3f0942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_0564b9a8-67e9-4458-83f6-fa7b6d7dd1ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_acba0f48-d0f4-44ce-9d28-dff61e980a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_0564b9a8-67e9-4458-83f6-fa7b6d7dd1ba" xlink:to="loc_us-gaap_StatementOfFinancialPositionAbstract_acba0f48-d0f4-44ce-9d28-dff61e980a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_11872c08-8f44-434e-b276-16f3c5d52a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_acba0f48-d0f4-44ce-9d28-dff61e980a4e" xlink:to="loc_us-gaap_StatementTable_11872c08-8f44-434e-b276-16f3c5d52a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_730a6d6d-f679-42c2-b200-087cf7211eaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_11872c08-8f44-434e-b276-16f3c5d52a8a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_730a6d6d-f679-42c2-b200-087cf7211eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_87e71a7f-077d-488e-af8d-fbe1f45eb6f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_730a6d6d-f679-42c2-b200-087cf7211eaf" xlink:to="loc_srt_ConsolidatedEntitiesDomain_87e71a7f-077d-488e-af8d-fbe1f45eb6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_cfe8bc38-c736-4736-b45e-f22b689ee3dc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_87e71a7f-077d-488e-af8d-fbe1f45eb6f4" xlink:to="loc_srt_ParentCompanyMember_cfe8bc38-c736-4736-b45e-f22b689ee3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_024430e6-e99a-4899-93d6-ced643cf49f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_11872c08-8f44-434e-b276-16f3c5d52a8a" xlink:to="loc_us-gaap_StatementLineItems_024430e6-e99a-4899-93d6-ced643cf49f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9d777a9a-9ab7-4d58-ad55-9925e68bb64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_024430e6-e99a-4899-93d6-ced643cf49f1" xlink:to="loc_us-gaap_AssetsAbstract_9d777a9a-9ab7-4d58-ad55-9925e68bb64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_aee78287-f774-4ce0-a018-41a723b58403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9d777a9a-9ab7-4d58-ad55-9925e68bb64c" xlink:to="loc_us-gaap_AssetsCurrentAbstract_aee78287-f774-4ce0-a018-41a723b58403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_62d18517-a109-40ac-b1c9-c967459afdc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aee78287-f774-4ce0-a018-41a723b58403" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_62d18517-a109-40ac-b1c9-c967459afdc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_2562c459-5025-479b-b88c-6fcede1e3d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aee78287-f774-4ce0-a018-41a723b58403" xlink:to="loc_us-gaap_ShortTermInvestments_2562c459-5025-479b-b88c-6fcede1e3d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_f04d8a8b-cd1a-4e41-8a0c-43a9aa20c962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aee78287-f774-4ce0-a018-41a723b58403" xlink:to="loc_us-gaap_OtherAssetsCurrent_f04d8a8b-cd1a-4e41-8a0c-43a9aa20c962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e3f52596-1fb4-4369-a10a-acb0ed774bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aee78287-f774-4ce0-a018-41a723b58403" xlink:to="loc_us-gaap_AssetsCurrent_e3f52596-1fb4-4369-a10a-acb0ed774bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_b3ba077c-5bfb-4efd-b6bd-a53607727023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9d777a9a-9ab7-4d58-ad55-9925e68bb64c" xlink:to="loc_us-gaap_LongTermInvestments_b3ba077c-5bfb-4efd-b6bd-a53607727023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_54576a7c-c29d-4051-8cfd-a79ba0c99991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9d777a9a-9ab7-4d58-ad55-9925e68bb64c" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_54576a7c-c29d-4051-8cfd-a79ba0c99991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ce87a175-ff9a-4034-9ecf-3ef8d63a200c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9d777a9a-9ab7-4d58-ad55-9925e68bb64c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ce87a175-ff9a-4034-9ecf-3ef8d63a200c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c149cc1f-4123-41d5-9e2a-f6811a6bf57a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9d777a9a-9ab7-4d58-ad55-9925e68bb64c" xlink:to="loc_us-gaap_Assets_c149cc1f-4123-41d5-9e2a-f6811a6bf57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_024430e6-e99a-4899-93d6-ced643cf49f1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_48b65152-049c-46e9-9b20-30b4f0f1eb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_48b65152-049c-46e9-9b20-30b4f0f1eb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_b053ed3b-4b56-4862-8569-1373d67a930c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_48b65152-049c-46e9-9b20-30b4f0f1eb2e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_b053ed3b-4b56-4862-8569-1373d67a930c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_06a5004b-8709-4b14-b6cd-6c158caa338b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_48b65152-049c-46e9-9b20-30b4f0f1eb2e" xlink:to="loc_us-gaap_LongTermDebtCurrent_06a5004b-8709-4b14-b6cd-6c158caa338b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c4209ef4-6a69-49d5-94ea-e9f855a15c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_48b65152-049c-46e9-9b20-30b4f0f1eb2e" xlink:to="loc_us-gaap_LiabilitiesCurrent_c4209ef4-6a69-49d5-94ea-e9f855a15c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7d3c4be6-de8b-45a8-923e-bbf4ed9f01cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_7d3c4be6-de8b-45a8-923e-bbf4ed9f01cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_42914307-b097-4743-b708-945532c2bd74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_42914307-b097-4743-b708-945532c2bd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_50a31e24-8d68-4cc7-a2e7-6bb6b558989a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:to="loc_us-gaap_Liabilities_50a31e24-8d68-4cc7-a2e7-6bb6b558989a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_59dd8d92-3a09-4832-8b32-26195fdee8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_59dd8d92-3a09-4832-8b32-26195fdee8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_128e6e95-b159-46f8-a5ac-ec82c1e91778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_PreferredStockValue_128e6e95-b159-46f8-a5ac-ec82c1e91778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8dbcf6c8-aa22-47bf-aa5d-6cc17e933283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_CommonStockValue_8dbcf6c8-aa22-47bf-aa5d-6cc17e933283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_80667310-27b6-4630-95b9-63ab5143e52a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_80667310-27b6-4630-95b9-63ab5143e52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4e52a3c8-bd2d-4d6d-8a42-cfa181c2561e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4e52a3c8-bd2d-4d6d-8a42-cfa181c2561e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a1315628-85ec-4b14-8ba0-80b68e896646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a1315628-85ec-4b14-8ba0-80b68e896646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_b7abd47c-d432-476a-a70c-3d9cae7c1ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_TreasuryStockShares_b7abd47c-d432-476a-a70c-3d9cae7c1ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_3e7ead5f-bbf1-4c0c-aa83-839d9c51562d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_TreasuryStockValue_3e7ead5f-bbf1-4c0c-aa83-839d9c51562d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a9dde714-21c6-470c-ac72-42c686af47ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_StockholdersEquity_a9dde714-21c6-470c-ac72-42c686af47ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_eb3ee9af-aa0e-4684-a569-a3fb1f135290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_MinorityInterest_eb3ee9af-aa0e-4684-a569-a3fb1f135290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_314ba2a0-8f2e-4c1a-badd-d1c6c0d9811e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3f38d395-e714-4531-b3b5-2eac7065acb5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_314ba2a0-8f2e-4c1a-badd-d1c6c0d9811e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_efcbb865-8577-4ade-b607-b90ae48ad0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e90dbd19-e1c1-484f-9c3f-d357b154be75" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_efcbb865-8577-4ade-b607-b90ae48ad0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_4c8a000a-a0d8-4880-801d-03c7721af865" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_247d770a-a200-4d93-b1a9-1d23ba9f66b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_4c8a000a-a0d8-4880-801d-03c7721af865" xlink:to="loc_us-gaap_StatementOfFinancialPositionAbstract_247d770a-a200-4d93-b1a9-1d23ba9f66b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e10e048e-28a9-408c-bdb7-a67ec2f4c7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_247d770a-a200-4d93-b1a9-1d23ba9f66b6" xlink:to="loc_us-gaap_StatementTable_e10e048e-28a9-408c-bdb7-a67ec2f4c7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_9e463489-dd46-4e21-b991-df8e8d813cb0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e10e048e-28a9-408c-bdb7-a67ec2f4c7f6" xlink:to="loc_srt_ConsolidatedEntitiesAxis_9e463489-dd46-4e21-b991-df8e8d813cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_de6e72f9-150e-4a35-bfab-e03118257246" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9e463489-dd46-4e21-b991-df8e8d813cb0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_de6e72f9-150e-4a35-bfab-e03118257246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_fc5308e2-7f32-4734-9196-813cb645d61f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_de6e72f9-150e-4a35-bfab-e03118257246" xlink:to="loc_srt_ParentCompanyMember_fc5308e2-7f32-4734-9196-813cb645d61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e10e048e-28a9-408c-bdb7-a67ec2f4c7f6" xlink:to="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ff49f5c3-6a97-4451-b177-ce2b91d0804f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ff49f5c3-6a97-4451-b177-ce2b91d0804f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_94cbf7b9-5596-483d-8da0-7e1ad2361f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_94cbf7b9-5596-483d-8da0-7e1ad2361f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_97cfcf8e-0353-4ba0-99a6-1b7b510e4740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_PreferredStockSharesIssued_97cfcf8e-0353-4ba0-99a6-1b7b510e4740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_728e0437-f54c-43a1-ae54-14c6e5d8dbe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_728e0437-f54c-43a1-ae54-14c6e5d8dbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_cf4087fb-6fc0-4944-a304-c45e11544350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_cf4087fb-6fc0-4944-a304-c45e11544350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4e1bdb98-6326-4f1e-9022-ba4dcbe94e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4e1bdb98-6326-4f1e-9022-ba4dcbe94e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_94044d0e-7747-4e3f-a58c-2f60bc2c99b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_CommonStockSharesIssued_94044d0e-7747-4e3f-a58c-2f60bc2c99b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2096376a-631f-41e3-879e-620ad67c39f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2096376a-631f-41e3-879e-620ad67c39f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_99dc59fc-ba9e-4678-a39d-58455ad4135c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6b22034f-5690-45ed-abb0-7ceefe48a142" xlink:to="loc_us-gaap_TreasuryStockShares_99dc59fc-ba9e-4678-a39d-58455ad4135c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_8c330615-0220-458f-90ab-c68b70b1292a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_948891c4-ce9a-4b69-8b0c-30d3f49081be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_8c330615-0220-458f-90ab-c68b70b1292a" xlink:to="loc_us-gaap_IncomeStatementAbstract_948891c4-ce9a-4b69-8b0c-30d3f49081be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_87c6fc21-3942-4891-8d81-4016433c54a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_948891c4-ce9a-4b69-8b0c-30d3f49081be" xlink:to="loc_us-gaap_StatementTable_87c6fc21-3942-4891-8d81-4016433c54a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_d0321dfe-3cf5-4ebb-aba8-6dbbb80cae2f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_87c6fc21-3942-4891-8d81-4016433c54a3" xlink:to="loc_srt_ConsolidatedEntitiesAxis_d0321dfe-3cf5-4ebb-aba8-6dbbb80cae2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_615a4cba-bad2-4e8a-bb92-cbcfb9764c46" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d0321dfe-3cf5-4ebb-aba8-6dbbb80cae2f" xlink:to="loc_srt_ConsolidatedEntitiesDomain_615a4cba-bad2-4e8a-bb92-cbcfb9764c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_bf2a8b24-2954-4dfd-b0b4-6ef8bfb10352" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_615a4cba-bad2-4e8a-bb92-cbcfb9764c46" xlink:to="loc_srt_ParentCompanyMember_bf2a8b24-2954-4dfd-b0b4-6ef8bfb10352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_87c6fc21-3942-4891-8d81-4016433c54a3" xlink:to="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_480441de-270b-433d-9526-63c1cb15b930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_OperatingExpensesAbstract_480441de-270b-433d-9526-63c1cb15b930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_70eea1b4-8e59-449e-86e9-465a6bf65e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_480441de-270b-433d-9526-63c1cb15b930" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_70eea1b4-8e59-449e-86e9-465a6bf65e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8d81d946-ce5a-4a57-a7d5-2619ae977f27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_480441de-270b-433d-9526-63c1cb15b930" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8d81d946-ce5a-4a57-a7d5-2619ae977f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_11e3081e-9e73-4925-9e96-578cb90b0984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_480441de-270b-433d-9526-63c1cb15b930" xlink:to="loc_us-gaap_LitigationSettlementExpense_11e3081e-9e73-4925-9e96-578cb90b0984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e4ee7582-4331-4afb-9410-413887e36aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e4ee7582-4331-4afb-9410-413887e36aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_f060acd0-8573-4df8-8e26-b8efc2a60572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e4ee7582-4331-4afb-9410-413887e36aca" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_f060acd0-8573-4df8-8e26-b8efc2a60572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_983dcf34-db7c-4093-807e-b79c9d2b2775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e4ee7582-4331-4afb-9410-413887e36aca" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_983dcf34-db7c-4093-807e-b79c9d2b2775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_61639f02-8bf7-4fc6-a3b4-bcb23c566297" xlink:href="cnc-20221231.xsd#cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e4ee7582-4331-4afb-9410-413887e36aca" xlink:to="loc_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion_61639f02-8bf7-4fc6-a3b4-bcb23c566297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_089d6966-312b-421d-8050-50f52fabb086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e4ee7582-4331-4afb-9410-413887e36aca" xlink:to="loc_us-gaap_InterestExpense_089d6966-312b-421d-8050-50f52fabb086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0a543829-a0e0-4bb5-bfa0-908276983901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0a543829-a0e0-4bb5-bfa0-908276983901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9b8419e4-ed9e-4fe5-810c-1641ecda8c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9b8419e4-ed9e-4fe5-810c-1641ecda8c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries_24d7c801-11f8-4048-8fa9-db7b8947cb58" xlink:href="cnc-20221231.xsd#cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries_24d7c801-11f8-4048-8fa9-db7b8947cb58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7c9551c8-3a32-4782-8f01-a381cb8986c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7c9551c8-3a32-4782-8f01-a381cb8986c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a116c467-98af-4f4d-ac7d-fc6bec7139b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_ProfitLoss_a116c467-98af-4f4d-ac7d-fc6bec7139b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_36177287-d744-454f-9bb0-169bec706582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_36177287-d744-454f-9bb0-169bec706582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a81c63e3-3607-40c9-80cc-d26346f1da6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_NetIncomeLoss_a81c63e3-3607-40c9-80cc-d26346f1da6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_813cbcc7-eaf6-4cbc-877c-d1db70b61d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5808ab5a-3a24-472c-94f7-4980d1975ec4" xlink:to="loc_us-gaap_EarningsPerShareAbstract_813cbcc7-eaf6-4cbc-877c-d1db70b61d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_77c63521-57ee-42fb-bb44-381af6b57f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_813cbcc7-eaf6-4cbc-877c-d1db70b61d1b" xlink:to="loc_us-gaap_EarningsPerShareBasic_77c63521-57ee-42fb-bb44-381af6b57f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a9a1d134-db7c-4230-80f4-9d0ce04c8086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_813cbcc7-eaf6-4cbc-877c-d1db70b61d1b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a9a1d134-db7c-4230-80f4-9d0ce04c8086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="cnc-20221231.xsd#CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"/>
  <link:presentationLink xlink:role="http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_1d899d67-6fc2-423c-bba2-653fc856bdc2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_38bbfed2-b145-4672-9de7-78dbbe0854b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_1d899d67-6fc2-423c-bba2-653fc856bdc2" xlink:to="loc_us-gaap_StatementOfCashFlowsAbstract_38bbfed2-b145-4672-9de7-78dbbe0854b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_15db0428-a0d9-4700-93eb-ec7d3654f1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_38bbfed2-b145-4672-9de7-78dbbe0854b8" xlink:to="loc_us-gaap_StatementTable_15db0428-a0d9-4700-93eb-ec7d3654f1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_ade9e5a6-fde2-4ccc-85a9-f795ab87be28" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_15db0428-a0d9-4700-93eb-ec7d3654f1f7" xlink:to="loc_srt_ConsolidatedEntitiesAxis_ade9e5a6-fde2-4ccc-85a9-f795ab87be28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3b08e146-981a-4d13-827c-6eb76e7fe862" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ade9e5a6-fde2-4ccc-85a9-f795ab87be28" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3b08e146-981a-4d13-827c-6eb76e7fe862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_84c3ec31-5c0f-4033-8e21-9a4c35fb590d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_3b08e146-981a-4d13-827c-6eb76e7fe862" xlink:to="loc_srt_ParentCompanyMember_84c3ec31-5c0f-4033-8e21-9a4c35fb590d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_15db0428-a0d9-4700-93eb-ec7d3654f1f7" xlink:to="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_187c3d08-a314-4095-ad13-4ccc6fa3d88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_187c3d08-a314-4095-ad13-4ccc6fa3d88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_DividendsfromSubsidiariesOperatingActivities_33938a77-cac7-43c5-87e5-c3a22e875774" xlink:href="cnc-20221231.xsd#cnc_DividendsfromSubsidiariesOperatingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_187c3d08-a314-4095-ad13-4ccc6fa3d88d" xlink:to="loc_cnc_DividendsfromSubsidiariesOperatingActivities_33938a77-cac7-43c5-87e5-c3a22e875774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_3238dd7d-f5dc-4e13-8240-157b72dbfd12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_187c3d08-a314-4095-ad13-4ccc6fa3d88d" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_3238dd7d-f5dc-4e13-8240-157b72dbfd12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_8e4ec998-c90f-480e-8a85-00541062f249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_187c3d08-a314-4095-ad13-4ccc6fa3d88d" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_8e4ec998-c90f-480e-8a85-00541062f249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8eff686e-7a2a-4957-801a-9150756eb332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_187c3d08-a314-4095-ad13-4ccc6fa3d88d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8eff686e-7a2a-4957-801a-9150756eb332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_CapitalContributionsToSubsidiaries_bf289b11-8b70-42bb-9ba4-24c15a6465f5" xlink:href="cnc-20221231.xsd#cnc_CapitalContributionsToSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_cnc_CapitalContributionsToSubsidiaries_bf289b11-8b70-42bb-9ba4-24c15a6465f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_117626b5-894f-4667-bece-a529a98d9b39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_117626b5-894f-4667-bece-a529a98d9b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_5fe25837-53b7-4164-b61f-47a090671917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_5fe25837-53b7-4164-b61f-47a090671917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompany_fcc19d7f-2136-4bcc-a90a-1ecb54c845cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDividendsPaidToParentCompany"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompany_fcc19d7f-2136-4bcc-a90a-1ecb54c845cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_0c022b42-f4c9-460a-bb0b-f15c4897a042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_0c022b42-f4c9-460a-bb0b-f15c4897a042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_d4d46d2e-8e31-4026-8672-630aea645792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_d4d46d2e-8e31-4026-8672-630aea645792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnc_ProceedsFromPaymentsForIntercompanyActivities_7b0374f2-d445-4df0-9cfd-6a9d3de25b0c" xlink:href="cnc-20221231.xsd#cnc_ProceedsFromPaymentsForIntercompanyActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_cnc_ProceedsFromPaymentsForIntercompanyActivities_7b0374f2-d445-4df0-9cfd-6a9d3de25b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e2255865-44fb-4b30-8506-e26d3eb75246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e2255865-44fb-4b30-8506-e26d3eb75246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f131d0df-cec5-4a9b-ad7d-db12f4dfe9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a8c0178-bfad-4786-905f-0efeb2a887b1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f131d0df-cec5-4a9b-ad7d-db12f4dfe9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e2f27337-578b-4f00-98ae-8f4641e7b533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e2f27337-578b-4f00-98ae-8f4641e7b533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b402e745-881c-4995-aafb-8f82a0b9cc52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b402e745-881c-4995-aafb-8f82a0b9cc52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2e89780b-2a00-45e7-a17a-939d363b3f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2e89780b-2a00-45e7-a17a-939d363b3f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_03632ea5-1bd1-4c88-8f33-c517b1af6683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_03632ea5-1bd1-4c88-8f33-c517b1af6683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_cc43c9b0-d685-4773-a9fd-c915cf2719fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_cc43c9b0-d685-4773-a9fd-c915cf2719fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_98bfea8e-b819-4776-b963-eedee2f0d6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_98bfea8e-b819-4776-b963-eedee2f0d6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5f22bfa2-91f3-4f3f-b2a3-3be83f7161bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5f22bfa2-91f3-4f3f-b2a3-3be83f7161bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_77832cab-2b5d-4e21-af95-92b4b54fe964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c3f73ad-b162-4d09-990d-0264e58d2173" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_77832cab-2b5d-4e21-af95-92b4b54fe964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_15a2640f-447b-44d9-9794-5639269bf3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_15a2640f-447b-44d9-9794-5639269bf3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6a6ba573-51e9-426e-8183-1f2149ef53ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6a6ba573-51e9-426e-8183-1f2149ef53ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45b73174-1f39-43e3-8f33-7454da4c6d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9a36d897-2940-4361-9b9b-d10a15066b23" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45b73174-1f39-43e3-8f33-7454da4c6d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>7
<FILENAME>a2022123110-kexhibit41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ibf1f1eefec474287abf3a5241c167729_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT 4.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESCRIPTION OF CENTENE COMMON STOCK</font></div><div id="ibf1f1eefec474287abf3a5241c167729_4"></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Authorized Capital Stock of Centene</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Centene amended and restated certificate of incorporation provides that the total number of shares of capital stock which may be issued by Centene is 810,000,000, consisting of 800,000,000 shares of common stock, par value $0.001 per share, and 10,000,000 shares of preferred stock, par value $0.001 per share.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Voting Rights</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The holders of Centene common stock are entitled to one vote on each matter submitted for their vote at any meeting of Centene stockholders for each share of Centene common stock held as of the record date for the meeting, including the election of directors. Holders of Centene common stock do not have cumulative voting rights.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generally, the affirmative vote of the holders of a majority of the total number of votes cast of Centene capital stock represented at a meeting and entitled to vote on a matter is required in order to approve such matter.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liquidation Rights</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event that Centene is liquidated, dissolved or wound up, the holders of Centene common stock will be entitled to share ratably in all assets remaining after the payment of liabilities, subject to any rights of holders of Centene preferred stock prior to distribution.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dividends</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to any preference rights of holders of Centene preferred stock, the holders of Centene common stock are entitled to receive dividends and other distributions in cash, stock or property, if any, declared from time to time by the Centene Board out of legally available funds.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fully Paid and Non-Assessable</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All outstanding shares of Centene common stock are fully paid and non-assessable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">No Preemptive Rights or Conversion Rights</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Centene common stock has no preemptive or conversion rights or other subscription rights.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">No Redemption Rights or Sinking Fund</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No redemption or sinking fund provisions apply to the Centene common stock.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NYSE Listing</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene common stock is listed on the NYSE under the symbol &#34;CNC.&#34;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Transfer Agent and Registrar</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The transfer agent and registrar for the Centene common stock is Broadridge Corporate Issuer Solutions, Inc.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-takeover Provisions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Some of the provisions in the Centene amended and restated certificate of incorporation, the Centene amended and restated by-laws and the General Corporation Law of the State of Delaware (&#34;DGCL&#34;) could have the following effects, among others&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">delaying, deferring or preventing a change in control of Centene&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">delaying, deferring or preventing the removal of Centene's existing management or directors&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">deterring potential acquirers from making an offer to the Centene stockholders&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">limiting the Centene stockholders' opportunity to realize premiums over prevailing market prices of Centene common stock in connection with offers by potential acquirers.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following is a summary of some of the provisions in the Centene amended and restated certificate of incorporation and the Centene amended and restated by-laws that could have the effects described above. Centene believes that the benefits of increased protection of its potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure Centene outweigh the disadvantages of discouraging takeover or acquisition proposals because negotiation of these proposals could result in an improvement of their terms.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Delaware Business Combination Statute</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene must comply with Section 203 of the DGCL, an anti-takeover law. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a &#34;business combination&#34; with an &#34;interested stockholder&#34; for a period of three years following the date the person became an interested stockholder, unless the business combination or the transaction in which the person became an interested stockholder is approved in a prescribed manner or certain other exceptions are met. Generally, a &#34;business combination&#34; includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to an interested stockholder. An &#34;interested stockholder&#34; includes a person who, together with affiliates and associates, owns, or did own within three years prior to the determination of interested stockholder status, 15% or more of the corporation&#8217;s voting stock. The existence of this provision generally will have an anti-takeover effect for transactions not approved in advance by the Centene Board, including discouraging attempts that might result in a premium over the market price for the shares of common stock held by stockholders.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actions at Meetings of Stockholders&#59; Special Meetings</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene&#8217;s amended and restated certificate of incorporation and amended and restated by-laws provide that a special meetings of stockholders may be called at any time by either (i) the Chairman of the Board of Directors, if there be one, (ii) the Chief Executive Officer, (iii) the Board of Directors or (iv) subject to certain terms and conditions, a stockholder, or a group of stockholders, holding at least 10% of the outstanding shares of Centene's common stock. The business transacted at a special meeting shall be limited to the purpose or purposes stated in the notice of the meeting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Action by Written Consent</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene&#8217;s amended and restated certificate of incorporation and amended and restated by-laws require that any action required or permitted to be taken by stockholders at an annual or special meeting may be taken by written consent, but only if such action is taken in accordance with the DGCL and Centene's amended and restated certificate of incorporation and amended and restated by-laws. Any stockholder seeking to have the stockholders take an action by written consent must request that a record date be fixed for such purpose by submitted a written notice signed by stockholders holding at least 10% of the voting power of the shares of capital stock entitled to vote on such action.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Board of Directors</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene&#8217;s amended and restated certificate of incorporation and amended and restated by-laws provide that the term of office of all directors serving as of September 27, 2022 will expire at the 2023 annual of meeting of stockholders and each person elected as a director after September 27, 2022, whether to succeed a person whose term of office as a director has expired or to full any vacancy, will be elected for a term expiring at the next annual meeting of stockholders.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Directors, and Not Stockholders, Fix the Size of the Centene Board</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene&#8217;s amended and restated certificate of incorporation and amended and restated by-laws provide that the number of directors will be fixed from time to time exclusively pursuant to a resolution adopted by a majority of the Centene Board, but in no event will it consist of less than five nor more than 14 directors.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Board Vacancies to Be Filled by Remaining Directors and Not Stockholders</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under Centene&#8217;s amended and restated certificate of incorporation and amended and restated by-laws, any vacancy on the Centene Board created by any reason prior to the expiration of the term in which the vacancy occurs will be filled by a majority of the remaining directors, even if less than a quorum. A director elected to fill a vacancy will be elected for the unexpired term of his or her predecessor.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Advance Notice for Stockholder Proposals</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene&#8217;s amended and restated by-laws contain provisions requiring that advance notice be delivered to Centene of any business to be brought by a stockholder before an annual meeting and providing for procedures to be followed by Centene stockholders in nominating persons for election to the Centene Board. Ordinarily, the stockholder must give notice not less than 120 days nor more than 150 days prior to the anniversary date of the immediately preceding annual meeting&#59; provided, however, that in the event that the date of the meeting is not within 30 days before or 70 days after such date, notice by the stockholder must be received no earlier than 120 days prior to such meeting and no later than the later of 70 days prior to the meeting or the 10th day following the day on which public disclosure of the date of the annual meeting was first made by Centene. The notice must include a description of the proposal, the reasons for the proposal, and other specified matters. The Centene Board may reject any proposals that have not followed these procedures.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Limitation on Liability of Directors&#59; Indemnification</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene&#8217;s amended and restated certificate of incorporation provides that no director shall be personally liable to Centene or any of its stockholders for monetary damages for breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under the DGCL as the same exists or may hereafter be amended. If the DGCL is amended hereafter to authorize the further elimination or limitation of the liability of directors, then the liability of directors shall be eliminated or limited to the fullest extent authorized by the DGCL, as so amended. Centene&#8217;s amended and restated certificate of incorporation further provides that any repeal or modification of this limitation of liability by the Centene stockholders shall not adversely affect any right or protection of a director of Centene existing at the time of such repeal or modification with respect to acts or omissions occurring prior to such repeal or modification.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene&#8217;s amended and restated certificate of incorporation requires that Centene indemnify its directors and officers to the fullest extent authorized or permitted by law, as now or hereafter in effect, and that such right to indemnification shall continue as to a person who has ceased to be a director or officer and shall inure to the benefit of his or her heirs, executors and personal and legal representatives. Except for proceedings to enforce rights to indemnification, however, Centene shall not be obligated to indemnify in connection with a proceeding (or part thereof) if such director, officer or successor in interest initiated such proceeding (or part thereof) unless such proceeding was authorized or consented to by the Centene Board. The right to indemnification includes the right to be paid the expenses incurred in defending or otherwise participating in any proceeding in advance of its final disposition. Any repeal or modification by the stockholders of indemnification or advancement rights shall not adversely affect any rights to indemnification and to the advancement of expenses of a director or officer of Centene existing at the time of such repeal or modification with respect to any acts or omissions occurring prior to such repeal or modification.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Centene Board may in its discretion provide rights to indemnification and to the advancement of expenses to employees and agents of Centene similar to those described above.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The inclusion of these provisions in the Centene amended and restated certificate of incorporation and amended and restated by-laws may have the effect of reducing the likelihood of derivative litigation against Centene&#8217;s directors and may discourage or deter Centene or its stockholders from bringing a lawsuit against Centene&#8217;s directors for breach of their duty of care, even though such an action, if successful, might otherwise have benefited Centene and its stockholders.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Provisions Related to Centene Preferred Stock</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following is a description of general terms and provisions of the Centene preferred stock. All of the terms of the Centene preferred stock are, or will be contained in Centene&#8217;s amended and restated certificate of incorporation, or in one or more certificates of designation relating to each series of the preferred stock.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Centene Board is authorized, without further stockholder approval but subject to applicable rules of the NYSE and any limitations prescribed by law, to issue up to ten million shares of preferred stock from time to time. The Centene Board has the discretion to provide for the issuance of all or any shares of preferred stock in one or more classes or series, and to fix for each such class or series such voting powers, full or limited, or no voting powers, and such designations, preferences and relative, participating, optional or other special rights and such qualifications, limitations or restrictions thereof, as shall be stated and expressed in the resolution or resolutions adopted by the board of directors providing for the issuance of such class or series, including, without limitation, the authority to provide that any such class or series may be&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">subject to redemption at such time or times and at such price or prices&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">entitled to receive dividends (which may be cumulative or non-cumulative) at such rates, on such conditions, and at such times, and payable in preference to, or in such relation to, the dividends payable on any other class or classes or any other series&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">entitled to such rights upon the dissolution of Centene or upon any distribution of Centene&#8217;s assets&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">convertible into, or exchangeable for, shares of any other class or classes of stock or of any other series of the same or any other class or classes of stock of Centene at such price or prices or at such rates of exchange and with such adjustments as the board may determine.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The purpose of authorizing the Centene Board to issue preferred stock and determine its rights and preferences is to eliminate delays associated with a stockholder vote on specific issuances. The issuance of preferred stock may provide desirable flexibility in connection with possible acquisitions and other corporate purposes, but could have the effect of making it more difficult for a third party to acquire, or could discourage a third party from acquiring, a majority of Centene&#8217;s outstanding voting stock.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Certain Effects of Authorized but Unissued Stock</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene may issue additional shares of common stock or preferred stock without stockholder approval, subject to applicable rules of the NYSE and Delaware law, for a variety of corporate purposes, including future public or private offerings to raise additional capital, corporate acquisitions, and employee benefit plans and equity grants. The existence of unissued and unreserved common and preferred stock may enable Centene to issue shares to persons who are friendly to current management, which could discourage an attempt to obtain control of Centene by means of a proxy contest, tender offer, merger or otherwise. Centene will not solicit approval of its stockholders for issuance of common and preferred stock unless the Centene Board believes that approval is advisable or is required by applicable rules of the NYSE or Delaware law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>8
<FILENAME>a2022123110-kexhibit105.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if28e03aaf1824a889521e6e3e87d05dc_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT 10.5</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Sixth Amendment and Restatement of the</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Centene Corporation Voluntary</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Nonqualified Deferred Compensation Plan</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">ARTICLE I</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PURPOSE AND EFFECTIVE DATE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The purpose of the Centene Corporation Voluntary Nonqualified Deferred Compensation Plan (&#34;Plan&#34;) is to aid Centene Corporation and its subsidiaries in retaining and attracting executive employees by providing them with tax deferred savings opportunities.  The Plan provides a select group of management and highly compensated employees within the meaning of Sections 201(2), 301(a)(3) and 401(a)(1) of the Employee Retirement Income Security Act of 1974, as amended (ERISA), of Centene Corporation with the opportunity to elect to defer receipt of specified portions of compensation, and to have these deferred amounts treated as if invested in specified hypothetical investment benchmarks.  The Plan is intended to conform to the requirements of Code &#167;409A.  A Participant's Account that was earned and vested prior to January 1, 2005, plus subsequent earnings thereon, shall not be subject to the terms of this Plan but shall be subject to the terms of the prior plan dated June 1, 2002.  The Plan has been amended and restated on five previous occasions. The Sixth Amendment and Restatement of the Plan shall be effective January 1, 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">ARTICLE II</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">DEFINITIONS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">For the purposes of this Plan, the following words and phrases shall have the meanings indicated, unless the context clearly indicates otherwise&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.01</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Administrative Committee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  &#34;Administrative Committee&#34; or &#34;Committee&#34; means the Company&#8217;s Head of Human Resources officer or other individuals to whom the Compensation Committee has delegated the authority to take action under the Plan.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.02</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Base Salary.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Base Salary&#34; means the base rate of cash compensation paid by the Company to or for the benefit of a Participant for services rendered or labor performed while a Participant is employed by the Company, including base pay a Participant could have received in cash in lieu of (A) deferrals pursuant to Section 4.02 and (B) contributions made on their behalf to any qualified plan maintained by the Company or to any cafeteria plan under Code Section 125 maintained by the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.03</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Base Salary Deferral.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Base Salary Deferral&#34; means the amount of a Participant's Base Salary which the Participant elects to have withheld on a pre-tax basis from their Base Salary and credited to their Deferral Account pursuant to Section 4.02.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.04</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Beneficiary.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Beneficiary&#34; means the person, persons or entity designated by the Participant to receive any benefits payable under the Plan pursuant to Article VIII.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.05</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Board.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Board&#34; means the Board of Directors of Centene Corporation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.06</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Annual Bonus Compensation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">   &#34;Annual Bonus Compensation&#34; or &#34;Bonus Compensation&#34; means the bonus plan that is eligible for payment once per year, based on funding approval by the Board, and is determined by established metrics. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.07</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Cash Long-Term Incentive Plan Deferral.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Cash Long-Term Incentive Plan Deferral&#34; means the amount of a Participant's Cash Long-Term Incentive Plan compensation (Cash LTIP) which the Participant elects to have withheld on a pre-tax basis from their Cash LTIP Compensation and credited to their account pursuant to Section 4.02.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.08</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Change of Control.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  For purposes of this Plan, a &#34;Change in Control&#34; shall be deemed to have occurred if any of the events set forth in any one of the following clauses shall occur&#58; (A) any Person (as defined in section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the &#34;Exchange Act&#34;), and as such term is modified in sections 13(d) and 14(d) of the Exchange Act), excluding a group of persons including Executive, is or becomes the &#34;beneficial owner&#34; (as defined in Rule 13(d)(3) under the Exchange Act), directly or indirectly, of securities of the Company representing forty percent (40%) or more of the  combined voting power  of  the Company's then outstanding securities&#59; (B) individuals who, as of the date of this Agreement, constitute the Board of Directors (the &#34;Incumbent Board&#34;), cease for any reason to constitute a majority thereof (provided, however, that an individual becoming a Director subsequent to the date of this Agreement whose election, or nomination for election by the Company's stockholders, was approved by at least a majority of the directors then comprising the Incumbent Board shall be included within the definition of Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual election contest (or such terms used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board)&#59; or (C) the stockholders of the Company consummate a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent (50%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation.  In order to qualify as Change in Control, the event or events must also qualify as a change in ownership or effective control of the Company or in the ownership of a substantial portion of the assets of the Company within the meaning of Code Section 409A.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.09</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Code.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Code&#34; shall mean the Internal Revenue Code of 1986, as amended. References to any provision of the Code or regulation (including a proposed regulation) thereunder shall include any successor provisions or regulations.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.10</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Company&#34; means Centene Corporation, its successors, any subsidiary or affiliated organizations authorized by the Board or the Compensation Committee to participate in the Plan and any organization into which or with which Centene Corporation may merge or consolidate or to which all or substantially all of its assets may be transferred.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.11</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Compensation Committee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Compensation Committee&#34; means the Compensation Committee of the Board of Directors.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.12</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Deferral Account.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Deferral Account&#34; means the account maintained by the Administrative Committee for each Participant pursuant to Article VI.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.13</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Deferral Period.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Deferral Period&#34; means the period after which payment of the Deferred Amount is to be made or begin to be made.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.14</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Deferred Amount.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Deferred Amount&#34; means the amount of Eligible Compensation for the Plan Year or performance period to which the Participation Agreement relates that is to be deferred under the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.15</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Designee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Designee&#34; shall mean the Company's senior Human Resources officer or other individuals to whom the Committee has delegated the authority to take action under the Plan.  Wherever Committee is referenced in the Plan, it shall be deemed to also refer to Designee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.16</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Disability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Disability&#34; means eligibility for long term disability benefits under the terms of the Company's Long-Term Disability Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.17</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Eligible Compensation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Eligible Compensation&#34; means any Base Salary, Annual Bonus Compensation, Incentive Compensation, and&#47;or Cash Long-Term Incentive Plan compensation otherwise payable with respect to a Plan Year. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.18</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">ERISA.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;ERISA&#34; means the Employee Retirement Income Security Act of 1974, as amended.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.19</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Form of Payment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Form of Payment&#34; means payment in one lump sum or in substantially equal annual installments of two (2) to fifteen (15) years.  If the Form of Payment is substantially equal annual installments, each installment shall constitute a separate payment for purposes of Code Section 409A.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.20</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Hardship Withdrawal.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Hardship Withdrawal&#34; means the early payment of all or part of the balance in a Deferral Account(s) in the event of an Unforeseeable Emergency, as defined in Code section 409A(a)(2)(B)(ii), pursuant to Section 7.08.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.21</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Hypothetical Investment Benchmark.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Hypothetical Investment Benchmark&#34; shall mean the phantom investment benchmarks which are used to measure the return credited to a Participant's Deferral Account.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.22</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Incentive Compensation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Incentive Compensation&#34; means the amount awarded to a Participant for a Plan Year under any incentive plan maintained by the Company, such as commission or other sales based compensation plans, as approved in the sole discretion of the Committee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.23</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Specified Employee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Specified Employee&#34; means a &#34;specified employee&#34; within the meaning of Code Section 409A(2)(8).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.24</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Matching Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.  &#34;Matching Contribution&#34; means the amount of any matching contribution that the Company will make to the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.25</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Participant.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Participant&#34; means any individual who is eligible or makes an election to participate in this Plan and who elects to participate by submitting a Participation Agreement as provided in Article IV.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.26</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Participation Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Participation Agreement&#34; means an agreement submitted by a Participant in accordance with Article IV.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.27</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Plan Year.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Plan Year&#34; means a twelve-month period beginning January 1 and ending the following December 31.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.28</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Qualified Retirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  For participants hired on or after January 1, 2019, &#34;Qualified Retirement&#34; means retirement of a Participant from the Company after attaining age 55 with at least ten (10) years of service.  For Participants hired prior to January 1, 2019, &#34;Qualified Retirement&#34; is defined as 65 or age 55 with at least five (5) years of service. Years of service will be calculated in accordance with the method adopted by the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.29</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Qualified Retiree.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#34;Qualified Retiree&#34; means a Participant who has experienced a Qualified Retirement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.30</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Separation from Service.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Separation from Service&#34; means a reduction in a Participant&#8217;s services (regardless whether performed as an employee or independent contractor) to a rate that is reasonably anticipated to be a permanent reduction in services to 20 percent or less of the average rate of services performed prior to such reduction.  If a Participant ceases or reduces services under a bona fide leave of absence, a Separation from Service occurs after the close of the six (6)-month anniversary of such leave, provided however that the Separation from Service shall be delayed to the extent that the Participant has a statutory or contractual right to reemployment.  Determination of whether a Separation from Service occurs shall be made in a manner that is consistent with the principles in Reg. 1.409A-1(h).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.31</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Unforeseeable Emergency.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Unforeseeable Emergency&#34; means severe financial hardship to the Participant resulting from a sudden and unexpected illness or accident of the Participant or a dependent of the Participant, loss of the Participant's property due to casualty, or other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the control of the Participant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.32</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Valuation Date.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  &#34;Valuation Date&#34; means the last day of the calendar month during which a Participant&#8217;s last deferral occurs or such other date as the Committee in its sole discretion may determine.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 2.33</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Signing Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.  &#34;Signing Bonus&#34; means the bonus offered to selected Participants in connection with an acquisition of another entity by the Company. The decision whether a Signing Bonus shall be eligible for deferral pursuant to the terms of this Plan shall be made in the sole discretion of the Committee prior to the Signing Bonus being presented in an offer letter or employment agreement with the Participant.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">ARTICLE Ill</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">ADMINISTRATION Section 3.01</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 3.01</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Administrative Committee Duties.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The Committee shall be responsible for the administration of this Plan and shall have all powers necessary to administer this Plan, including discretionary authority to determine eligibility for benefits and to decide claims under the terms of this Plan, except to the extent that any such powers are vested in any other person administering this Plan by the Committee.  The Committee may from time to time establish rules for the administration of this Plan, and it shall have the exclusive right to interpret this Plan and to decide any matters arising in connection with the administration and operation of this Plan.  All rules, interpretations and decisions of the Committee shall be conclusive and binding on the Company, Participants and Beneficiaries.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The Committee may delegate responsibility for performing certain administrative functions under this Plan to certain employees of the Company or outside third parties. The Committee shall be responsible for determining issues related to eligibility, Hypothetical Investment Benchmarks, distribution of Deferred Amounts, determination of account balances, crediting of hypothetical earnings and debiting of hypothetical losses and of distributions, inservice withdrawals, deferral elections and any other duties concerning the day-to-day operation of this Plan.  The Committee may designate one of its members as a Chairperson and may retain and supervise outside providers, third party administrators, record keepers and professionals (including in-house professionals) to perform any or all of the duties delegated to it hereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Neither the Committee nor a member of the Board shall be liable for any act or action hereunder, whether of omission or commission, by any other member or employee or by any agent to whom duties in connection with the administration of this Plan have been delegated or for anything done or omitted to be done in connection with this Plan.  The Committee shall keep records of all of their respective proceedings and the Committee shall keep records of all payments made to Participants or Beneficiaries and payments made for expenses or otherwise.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The Company shall, to the fullest extent permitted by law, indemnify each Director, officer or employee of the Company (including the heirs, executors, administrators and other personal representatives of such person), each member of the Committee against expenses (including attorneys' fees), judgments, fines, amounts paid in settlement, actually and reasonably incurred by such person in connection with any threatened, pending or actual suit, action or proceeding (whether civil, criminal, administrative or investigative in nature or otherwise) in which such person may be involved by reason of the fact that he or she is or was serving this Plan in any capacity at the request of the Company or the Committee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Any expense incurred by the Company or the Committee relative to the administration of this Plan shall be paid by the Company and&#47;or may be deducted from the Deferral Accounts of the Participants as determined by the Committee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 3.02</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Claim Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.  If a Participant or Beneficiary makes a written request alleging a right to receive payments under this Plan or alleging a right to receive an adjustment in benefits being paid under this Plan, such actions shall be treated as a claim for benefits.  All claims for benefits under this Plan shall be sent to the Committee.  If the Committee determines that any individual who has claimed a right to receive benefits, or different benefits, under this Plan is not entitled to receive all or any part of the benefits claimed, the Committee shall inform the claimant in writing of such determination and the reasons therefore in terms calculated to be understood by the claimant. The notice shall be sent within 90 days of the claim unless the Committee determines that additional time, not exceeding 90 days, is needed and so notifies the Participant.  The notice shall make specific reference to the pertinent Plan provisions on which the denial is based, and shall describe any additional material or information that is necessary. Such notice shall, in addition, inform the claimant of the procedure that the claimant should follow to take advantage of the review procedures set forth below in the event the claimant desires to contest the denial of the claim.  The claimant may within 90 days thereafter submit in writing to the Committee a notice that the claimant contests the denial of their claim and desires a further review by the Committee.  The Committee shall within 60 days thereafter review the claim and authorize the claimant to review pertinent documents and submit issues and comments relating to the claim to the Committee.  The Committee will render a final decision on behalf of the Company with specific reasons therefor in writing and will transmit it to the claimant within 60 days of the written request for review, unless the Chairperson of the Committee determines that additional time, not exceeding 60 days, is needed, and so notifies the Participant.  If the Committee fails to respond to a claim submitted in accordance with the foregoing within 60 days or any such extended period, the Company shall be deemed to have denied the claim.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">ARTICLE IV PARTICIPATION</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 4.01</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Participation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Participation in the Plan shall be limited to executives who (i) meet such eligibility criteria as the Committee shall establish from time to time, and (ii) elect to participate in this Plan by submitting a Participation Agreement via the third party administrator&#8217;s website during the defined Open Enrollment period.  A Participation Agreement must be submitted prior to the December 31st immediately preceding the Plan Year for which it is effective.  The Committee shall have the discretion to establish special deadlines regarding the submission of Participation Agreements for Participants if it determines that such deadlines conform to the requirements of Code Section 409A.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 4.02</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Contents of Participation Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Subject to Article VII, each Participation Agreement shall set forth&#58; (i) the amount of Eligible Compensation for the Plan Year or performance period to which the Participation Agreement relates that is to be deferred under the Plan (the &#34;Deferred Amount&#34;), expressed as a percentage of the Base Salary, Annual Bonus or Cash LTIP. for such Plan Year or performance period&#59; provided, that the minimum Deferred Amount for any Plan Year or performance period shall not be less than one percent (1%) and the maximum Deferred Amount shall not exceed eighty percent (80%)&#59; (ii) the period after which payment of the Deferred Amount is to be made or begin to be made (the &#34;Deferral Period&#34;), which shall be the earlier of (A) a number of full years, not less than three, and (B) the period ending upon the Qualified Retirement or prior termination of employment of the Participant, and (iii) the form in which payments are to be made, which may be a lump sum or in substantially equal annual installments of two (2) to fifteen (15) years. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 4.03</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Modification or Revocation of Election by Participant.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  A Participant may not change the amount of their Base Salary Deferrals during a Plan Year.  However, a Participant may discontinue a Base Salary Deferral election at any time by submitting, on such forms and subject to such limitations and restrictions as the Committee may prescribe in its discretion, a revised Participation Agreement with the third party administrator.  If approved by the Committee, revocation shall take effect as of the first payroll period next following its submission.  If a Participant discontinues a Base Salary Deferral election during a Plan Year, they will not be permitted to elect new Deferrals of eligible compensation again until the first day of the Plan Year which immediately follows twelve (12) months from the date of discontinuance.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">In addition, the Deferral Period may be extended if an amended Participation Agreement is submitted to the Committee at least one full calendar year before the Deferral Period (as in effect before such amendment) ends.  As described in Section 7.11, an extension on a Deferral Period must result in a delay of payment for a minimum of five (5) years from the initial deferral period and otherwise satisfy the requirements of Code Section 409A.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">4.04 Deferral of Signing Bonuses </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Notwithstanding any provision to the contrary, the deferral of a Signing Bonus offered to selected Participants in connection with an acquisition shall be governed exclusively by this Section 4.04.  The decision whether to offer the deferral opportunity with respect to all or any portion of a Signing Bonus shall be made in the sole discretion of the Committee.  In the event the Committee decides to offer such deferral option to a Participant, the election to defer shall be included in the offer letter or employment agreement presented to such Participant.  In the event a deferral option is offered with respect to a Signing Bonus, any such deferrals shall not be eligible for Matching Contributions described in Section 7.02.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">ARTICLE V </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">DEFERRED COMPENSATION</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 5.01</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Elective Deferred Compensation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  The Deferred Amount of a Participant with respect to each Plan Year of participation in the Plan shall be credited by the Committee, or designee, to the Participant's Deferral Account as and when such Deferred Amount would otherwise have been paid to the Participant.  To the extent that the Company is required to withhold any taxes or other amounts from the Deferred Amount pursuant to any state, Federal or local law, such amounts shall be taken out of other compensation eligible to be paid to the Participant that is not deferred under this Plan.  However, if the Participant elects to defer a large percentage of Eligible Compensation and the election does not allow enough remaining compensation for required withholdings or deductions, the withholdings and deductions will be subtracted from the eligible compensation first, followed by deferral of the remaining eligible compensation. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 5.02</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Vesting of Deferral Account.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Except as provided in Section 7.03, a Participant shall be 100% vested in their Deferral Account at all times.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">ARTICLE VI</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">MAINTENANCE AND INVESTMENT OF ACCOUNTS Section 6.01</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 6.01</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Maintenance of Accounts.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Separate Deferral Accounts shall be maintained for each Participant.  More than one Deferral Account may be maintained for a Participant as necessary to reflect (a) various Hypothetical Investment Benchmarks and&#47;or (b) separate Participation Agreements specifying different Deferral Periods and&#47;or forms of payment.  A Participant's Deferral Account(s) shall be utilized solely as a device for the measurement and determination of the amounts to be paid to the Participant pursuant to this Plan, and shall not constitute or be treated as a trust fund of any kind.  The Committee, or Designee, shall determine the balance of each Deferral Account, as of each Valuation Date, by adjusting the balance of such Deferral Account as of the immediately preceding Valuation Date to reflect changes in the value of the deemed investments thereof, credits and debits pursuant to Section 5.01 and Section 6.02 and distributions pursuant to Article VII that conform to Code Section 409A with respect to such Deferral Account since the preceding Valuation Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 6.02</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Hypothetical Investment Benchmarks.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Each Participant shall be entitled to direct the manner in which their Deferral Accounts will be deemed to be invested, selecting among the Hypothetical Investment Benchmarks specified in Appendix A hereto, as amended by the Centene Corporation Voluntary Nonqualified Deferred Compensation Plan Committee from time to time, and in accordance with such rules, regulations and procedures as the Centene Corporation Voluntary Nonqualified Deferred Compensation Plan Committee may establish from time to time. Notwithstanding anything to the contrary herein, earnings and losses based on a Participant's investment elections shall begin to accrue as of the date such Participant's Deferral Amounts are credited to their Deferral Accounts.</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 6.03</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Statement of Accounts.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Participants will have the ability to access account information via a web site provided by the designated third party administrator.  Participants may also receive an account statement upon a written request to the Committee.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">ARTICLE VII BENEFITS</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 7.01</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Time and Form of Payment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  At the end of the Deferral Period for each Deferral Account, the Company shall pay to the Participant the balance of such Deferral Account at the time or times elected by the Participant in the applicable Participation Agreement&#59; provided that if the Participant has elected to receive payments from a Deferral Account in a lump sum, the Company shall pay the balance in such Deferral Account (determined as of the most recent Valuation Date preceding the end of the Deferral Period) in a lump sum in cash as soon as practicable after the end of the Deferral Period.  If the Participant has elected to receive payments from a Deferral Account in installments, the Company shall make annual cash only payments from such Deferral Account, each of which shall consist of an amount equal to (i) the balance of such Deferral Account as of the most recent Valuation Date preceding the payment date times (ii) a fraction, the numerator of which is one and the denominator of which is the number of remaining installments (including the installment being paid).  The first such installment shall be paid as soon as practicable after the end of the Deferral Period and each subsequent installment shall be paid on or about the anniversary of such first payment.  Each such installment shall be deemed to be made on a pro rata basis from each of the different deemed investments of the Deferral Account (if there is more than one such deemed investment).</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 7.02</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Matching Contribution.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Each Participant who elects to make deferrals of Eligible Compensation to the Plan will be eligible to receive a Matching Contribution equal to fifty percent (50%) of the first six percent (6%) of the Participant's Eligible Compensation being deferred to the Plan for such Plan Year (excluding deferrals to the Plan from the Participant&#8217;s Cash Long-Term Incentive Plan and stock based compensation), reduced by any matching contributions made by the Company to the Centene Management Corporation Retirement Plan (401k Plan) for such Plan Year. When due, Matching Contributions shall be credited to a Participant&#8217;s account in conjunction with the Company&#8217;s regular payroll schedule.  </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 7.03</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Matching Contribution Vesting.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Participants will vest in Matching Contributions as set forth under the Participant's 401(k) plan. The vesting schedule is&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:30.608%"><tr><td style="width:1.0%"></td><td style="width:63.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Less than 1 year</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">0%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">1 year</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">10%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">2 years</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">30%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">3 years</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">60%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">4 years</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">80%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">5 years</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">100%</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Section 7.04</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Separation from Service and Qualified Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.  Subject to Section 7.01 and Section 7.07 hereof, if a Participant has elected to have the balance of his or her Deferral Account distributed upon Qualified Retirement or other Separation from Service, the account balance of the Participant (determined as of the Valuation Date immediately following the Participant&#8217;s last deferral after such Qualified Retirement or other Separation from Service) shall be distributed as soon as practicable following the Qualified Retirement or other Separation from Service in installments or a lump sum in accordance with the Plan and as elected in the applicable Participation Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">For these purposes, a Participant who elects to have his or her Deferral Account distributed upon Qualified Retirement may choose between a lump sum or annual installments which do not exceed fifteen (15) years.  Participants who terminate employment and who experience a Separation from Service but do not satisfy the Qualified Retirement definition shall choose between a lump sum or annual installments not to exceed five (5) years.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Deferral elections applicable to future Annual Bonus and&#47;or Cash LTIP payments will be honored for Participants who had a Qualified Retirement or a Separation from Service.  In addition, a Participant who experiences a Qualified Retirement or Separation from Service will be allowed to defer Annual Bonus and&#47;or Cash LTIP payments that are paid after such Qualified Retirement or Separation from Service.  However, if a Participant who experiences a Qualified Retirement or Separation from Service has received a full distribution and has a zero-account balance at the time of the Annual Bonus or Cash LTIP payment, no deferral will be taken from such Annual Bonus or Cash LTIP payment.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 7.05</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">In-Service Distributions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Subject to Section 7.01 and Section 7.07 hereof, if a Participant has elected to defer Eligible Compensation under the Plan for a stated number of years, the account balance of the Participant (determined as of the most recent Valuation Date immediately following such Deferral Period) shall be distributed in installments or a lump sum in accordance with the Plan and as elected in the Participation Agreement.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 7.06</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.  Notwithstanding the provisions of Section 7.04 and Section 7.05 hereof and any Participation Agreement, if a Participant dies or experiences a Disability prior to Qualified Retirement and prior to receiving full payment of his or her Deferral Account(s), the Company shall pay the remaining balance (determined as of the Valuation Date immediately following such event) to the Participant or the Participant's Beneficiary or Beneficiaries (as the case may be) in a lump sum in cash only (notwithstanding Section 7.01 hereof) as soon as practicable following the occurrence of such event. Subject to Section 6.02 hereof, the amount distributable under the preceding sentence of this Section 7.06 shall be based on the Participant's investment selections.  If a Participant who terminates employment due to death or disability, makes a Base Salary or Incentive Deferral from the final paycheck, and the final paycheck is paid after the Valuation Date, any distributions will be valued on the Valuation Date immediately following the final Base Salary or Incentive Deferral.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 7.07</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Delay for Specified Employees.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Notwithstanding this Article VII, if a Deferral Period ceases upon Separation from Service (other than for death or Disability), payments to a Participant who is a Specified Employee shall not be made until the close of the six (6) month anniversary of such Separation from Service.  If during such six (6) month delay a Participant dies, payments shall be made pursuant to Section 7.06.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 7.08</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Hardship Withdrawals.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Notwithstanding the provisions of Section 7.01 and any Participation Agreement, a Participant shall be entitled to early payment of all or part of the balance in their Deferral Account(s) in the event of an Unforeseeable Emergency, in accordance with this Section 7.08.  A distribution pursuant to this Section 7.08 may only be made to the extent reasonably needed to satisfy the Unforeseeable Emergency need, and may not be made if such need is or may be relieved (i) through reimbursement or compensation by insurance or otherwise, (ii) by liquidation of the Participant's assets to the extent such liquidation would not itself cause severe financial hardship, or (iii) by cessation of participation in the Plan.  An application for an early payment under this Section 7.08 shall be made to the Committee in such form and in accordance with such procedures as the Committee shall determine from time to time.  The determination of whether and in what amount and form a distribution will be permitted pursuant to this Section 7.08 shall be made solely by the Committee.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 7.09</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Change of Control Election.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  In the event of a Separation from Service as a result of a Change of Control, the participant's account balance will be paid out as specified in their Change in Control election.  This is a separate election from the Form of Payment election and this election applies to all Plan Years.  The Participant can elect to have the same distribution schedule as previously elected, a lump sum payment or installments over two (2) to fifteen (15) years.  The first such installment shall be paid as soon as practicable after the Change in Control and each subsequent installment shall be paid on or about the anniversary of such first payment.  If there is no Change in Control election at the time a Change in Control occurs, the Participant&#8217;s previous elections will be the default and will be followed.  The Participant can change their Change in Control election by making a written request to the Committee.  The Committee will inform the claimant in writing of the determination of the request within 90 days of the receipt of the request.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 7.10</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Withholding of Taxes.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Notwithstanding any other provision of this Plan, the Company shall withhold from payments made hereunder any amounts required to be so withheld by any applicable law or regulation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 7.11</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Changes in Payment Elections.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  A Participant may modify the time or the form of payment elections made on his or her Participation Agreement under the following circumstances&#58; (i) any such election to modify may not take effect until at least twelve (12) months following the date of such election&#59; (ii) if the election relates to a payment based on a Separation from Service, which includes a Qualified Retirement, or on a Change of Control or if the payment is at a specified time or pursuant to a fixed schedule, the election must result in payment being made not earlier than five (5) years following the date upon which the payment would otherwise would have been made&#59; and (iii) if the election is related to payment at a specified time or pursuant to a fixed schedule, the Participant must make the election not less than twelve (12) months prior to the date the payment is scheduled to be made.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">ARTICLE VIII</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">BENEFICIARY DESIGNATION</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 8.01</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Beneficiary Designation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Each Participant shall have the right, at any time, to designate any person, persons or entity as their Beneficiary or Beneficiaries.  A Beneficiary designation shall be made, and may be amended, by the Participant by accessing the web site of the third party administrator and making such changes. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 8.02</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">No Beneficiary Designation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  If a Participant fails to designate a Beneficiary as provided above, or if all designated Beneficiaries predecease the Participant, then the Participant's Beneficiary shall be deemed to be the Participant's estate.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">ARTICLE IX</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">AMENDMENT AND TERMINATION OF PLAN </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 9.01</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Amendment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  The Board or the Committee may at any time amend this Plan in whole or in part, provided, however, that no amendment shall be effective to decrease the balance in any Deferral Account as accrued at the time of such amendment, nor shall any amendment otherwise have a retroactive effect. Interpretation of the Plan by the Board or the Committee shall be made in a manner that is consistent with the intent that the Plan conform to the requirements of Code Section 409A.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 9.02</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Company's Right to Terminate.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  The Board or the Committee may at any time terminate the Plan with respect to future Participation Agreements.  The Board or the Committee may also terminate the Plan in its entirety at any time for any reason, including without limitation if, in its judgment, the continuance of the Plan, the tax, accounting, or other effects thereof, or potential payments thereunder would not be in the best interests of the Company, and upon any such termination, the Company shall immediately pay to each Participant in a lump sum the accrued balance in their Deferral Account (determined as of the most recent Valuation Date preceding the termination date). Such termination, however, shall be made in a manner that conforms to the requirements of Code Section 409A.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">ARTICLE X MISCELLANEOUS</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 10.01</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Unfunded Plan.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  This Plan is intended to be an unfunded plan maintained primarily for the purpose of providing deferred compensation for a select group of management or highly compensated employees, within the meaning of Sections 201, 301 and 401 of ERISA.  All payments pursuant to the Plan shall be made from the general funds of the Company and no special or separate fund shall be established or other segregation of assets made to assure payment.  No Participant or other person shall have under any circumstances any interest in any particular property or assets of the Company as a result of participating in the Plan.  Notwithstanding the foregoing, the Company may (but shall not be obligated to) create one or more grantor trusts, the assets of which are subject to the claims of the Company's creditors, to assist it in accumulating funds to pay its obligations under the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 10.02</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">No Assignability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Except as specifically set forth in the Plan with respect to the designation of Beneficiaries, neither a Participant nor any other person shall have any right to commute, sell, assign, transfer, pledge, anticipate, mortgage or otherwise encumber, transfer, hypothecate or convey in advance of actual receipt the amounts, if any, payable hereunder, or any part thereof, which are, and all rights to which are, expressly declared to be unassignable and non-transferable. No part of the amounts payable shall, prior to actual payment, be subject to seizure or sequestration for the payment of any debts, judgments, alimony or separate maintenance owed by a Participant or any other person, nor be transferable by operation of law in the event of a Participant's or any other person's bankruptcy or insolvency.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 10.03</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Hypothetical Investment Benchmarks.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  (a) Each Participant shall be entitled to direct the manner in which their Deferral Accounts will be deemed to be invested, selecting among the Hypothetical Investment Benchmarks specified in Appendix A hereto, as amended by the Committee from time to time, and in accordance with such rules, regulations and procedures as the Committee may establish from time to time. Notwithstanding anything to the contrary herein, earnings and losses based on a Participant's investment elections shall begin to accrue as of the date such Participant's Deferral Amounts are credited to their Deferral Accounts.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 10.04</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Validity and Severability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  The invalidity or unenforceability of any provision of this Plan shall not affect the validity or enforceability of any other provision of this Plan, which shall remain in full force and effect, and any prohibition or unenforceability in any jurisdiction, shall not invalidate or render unenforceable such provision in any other jurisdiction.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 10.05</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Governing Law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  The validity, interpretation, construction and performance of this Plan shall in all respects be governed by the laws of the State of Missouri, without reference to principles of conflict of law, except to the extent preempted by federal law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 10.06</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Employment Status.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  This Plan does not constitute a contract of employment or impose on the Participant or the Company any obligation for the Participant to remain an employee of the Company or change the status of the Participant's employment or the policies of the Company and its affiliates regarding termination of employment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 10.07</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Underlying Incentive Plans and Programs.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Nothing in this Plan shall prevent the Company from modifying, amending or terminating any Eligible Compensation arrangement or the incentive plans and programs pursuant to which cash awards are earned and which are deferred under this Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Section 10.08</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Section 409A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">  Notwithstanding any other provisions of the Plan or any Participation Agreement to the contrary, no payment shall be granted, deferred, accelerated, extended, made or modified under this Plan in a manner that would result in the imposition of an additional tax under Code Section 409A upon a Participant. In the event that it is reasonably determined by the Committee that, as a result of Code Section 409A, payments under the Plan may not be made at the time contemplated by the terms of the Plan or the relevant Participation Agreement, as the case may be, without causing the Participant receiving such payment to be subject to taxation under Code Section 409A, the Company will make such payment on the first day that would not result in the Participant incurring any tax liability under Code Section 409A&#59; which, if the Participant is a Specified Employee within the meaning of the Code Section 409A, shall be the first day following the six-month period beginning on the date of Participant&#8217;s termination of employment. The Company shall use commercially reasonable efforts to implement the provisions of this Section 10.09 in good faith&#59; provided that neither the Company, the Committee nor any of the Company&#8217;s employees, directors or representatives shall have any liability to a Participant with respect to this Section 10.09.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="if28e03aaf1824a889521e6e3e87d05dc_65"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, the Company has caused this Amendment and Restatement of the Plan to be executed by its duly authorized officer or representative.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">CENTENE CORPORATION</font></div><div style="margin-top:24pt;padding-left:252pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.538%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;  &#47;s&#47; Christopher A. Koster                </font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Christopher A. Koster</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Executive Vice President, Secretary and General Counsel</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="if28e03aaf1824a889521e6e3e87d05dc_72"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">APPENDIX A</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Centene Corporation Common Stock (CNC)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">MainStay VP U.S. Government Money Market - Initial Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">MFS&#174; Value Series - Initial Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Fidelity&#174; VIP Index 500 Portfolio - Initial Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Fidelity&#174; VIP Growth Portfolio - Initial Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Fidelity&#174; VIP Contrafund&#174; Portfolio - Initial Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Janus Henderson VIT Enterprise Portfolio - Institutional Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">T. Rowe Price New America Growth Portfolio</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">T. Rowe Price International Stock Portfolio</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">PIMCO VIT Total Return Portfolio-Administrative Class Shares</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Janus Henderson VIT Enterprise Portfolio - Institutional Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">T. Rowe Price Blue Chip Growth Portfolio</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Lord Abbett Series - Mid-Cap Stock Portfolio - Class VC</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">VOYA Russell Mid Cap Index Portfolio - Initial Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Delaware VIP&#174; Small Cap Value Series-Standard Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">MainStay VP Eagle Small Cap Growth Portfolio - Initial Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">MainStay VP Small Cap Core - Initial Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">LVIP Baron Growth Opportunities Fund - Service Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">MainStay VP Emerging Markets Equity - Initial Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Moody's Corporate Bond Average</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Fidelity VIP Freedom 2010 Portfolio - Initial Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Fidelity VIP Freedom 2020 Portfolio - Initial Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Fidelity&#174; VIP Freedom 2030 Portfolio - Initial Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Fidelity&#174; VIP Freedom 2040 Portfolio - Initial Class</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Fidelity&#174; VIP Freedom 2050 Portfolio - Initial Class</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>9
<FILENAME>a2022123110-kexhibit1013.htm
<DESCRIPTION>EX-10.13
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie7794a98abbe4ab4922e2ccf2fc2f7c4_38"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT 10.13</font></div></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CENTENE CORPORATION</font></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Nonstatutory Stock Option Agreement Granted Under<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">2012 Stock Incentive Plan</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Grant of Option</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:23.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This agreement evidences the grant by Centene Corporation, a Delaware corporation (the &#8220;Company&#8221;), on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">______ </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(the &#8220;Grant Date&#8221;) to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">______,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Company (the &#8220;Participant&#8221;), of an option to purchase, in whole or in part, on the terms provided herein and in the Company&#8217;s 2012 Stock Incentive Plan (the &#8220;Plan&#8221;), a total of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">______</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shares (the &#8220;Shares&#8221;) of common stock, $0.001 par value per share, of the Company (&#8220;Common Stock&#8221;) at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">______ </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">per Share.  Unless earlier terminated, this option shall expire at 3&#58;00 p.m., Central time, on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">______</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (the &#8220;Final Exercise Date&#8221;).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:23.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the &#8220;Code&#8221;).  Except as otherwise indicated by the context, the term &#8220;Participant,&#8221; as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Vesting Schedule</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:23.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This option will become exercisable (&#8220;vest&#8221;) as to ___% of the original number of Shares on the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">______ </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">anniversary of the Grant Date and as to an additional ___% of the original number of Shares at the end of each successive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> ______ </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">period following the first anniversary of the Grant Date until the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">______</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> anniversary of the Grant Date.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The right of exercise shall be cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of this option under Section 3 hereof or the Plan.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event of a &#8220;Change in Control&#8221; of the Company, all of the Shares that (but for the application of this clause) are not vested at the time of the occurrence of such Change in Control event shall vest.  A &#8220;Change in Control&#8221; shall be deemed to have occurred if any of the events set forth in any one of the following clauses shall occur&#58;  (i) any Person (as defined in section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and as such term is modified in sections 13(d) and 14(d) of the Exchange Act), excluding a group of persons including the Participant, is or becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13(d)(3) under the Exchange Act), directly or indirectly, of securities representing forty percent or more of the combined voting power of the Company&#8217;s then outstanding securities&#59; (ii) individuals who, as of the Grant Date, constitute the Board of Directors of the Company (the &#8220;Incumbent Board&#8221;), cease for any reason to constitute a majority thereof (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that an individual becoming a director subsequent to the Grant Date whose election, or nomination for election by the Company&#8217;s stockholders, was approved by at least a majority of the directors then comprising the Incumbent Board shall be included within the definition of Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual election contest (or such terms used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board of Directors of the Company)&#59; or (iii) the stockholders of the Company consummate a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Exercise of Option</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Form of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Each election to exercise this option shall be in writing, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan.  Common Stock purchased upon the exercise of this option shall be paid for as follows&#58;</font></div><div style="text-indent:41.75pt"><font><br></font></div><div style="margin-bottom:11pt;padding-left:72pt;text-align:justify;text-indent:-28.37pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18pt">in cash or by check, payable to the order of the Company&#59;</font></div><div style="margin-bottom:11pt;padding-left:72pt;text-align:justify;text-indent:-31.42pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18pt">by (i) delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price and any required tax withholding or (ii) delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price and any required tax withholding&#59;</font></div><div style="margin-bottom:11pt;padding-left:72pt;text-align:justify;text-indent:-34.47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18pt">when the Common Stock is registered under the Securities and Exchange Act of 1934, as amended, by delivery of shares of Common Stock owned by the Participant valued at their fair market value as determined by (or in a manner approved by) the board of directors of the Company (the &#8220;Board&#8221;) in good faith (&#8220;Fair Market Value&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (i)&#160;such method of payment is then permitted under applicable law and (ii) such Common Stock, if acquired directly from the Company was owned by the Participant at least six months prior to such delivery&#59;</font></div><div style="margin-bottom:11pt;padding-left:72pt;text-align:justify;text-indent:-33.87pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18pt">to the extent permitted under applicable law and permitted by the Board, in its sole discretion, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that at least an amount equal to the par value of the Common Stock being purchased shall be paid in cash&#59; or</font></div><div style="margin-bottom:11pt;padding-left:72pt;text-align:justify;text-indent:-30.82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18pt">by any combination of the above permitted forms of payment.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for any fractional share or for fewer than ten whole shares.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Continuous Relationship with the Company Required</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except as otherwise provided in this Section&#160;3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, a director of, or consultant or advisor to, the Company or any other entity the directors, consultants or advisors of which are eligible to receive option grants under the Plan (an &#8220;Eligible Participant&#8221;).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Termination of Relationship with the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs&#160;(d) and (e) below, the right to exercise this option shall terminate 30 days after such cessation (but in no event after the Final Exercise Date), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation.  Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality provisions of any consulting, advisory, nondisclosure, non-competition or other agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon such violation.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Exercise Period Upon Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If the Participant dies or becomes disabled (within the meaning of Section&#160;22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for &#8220;cause&#8221; as specified in paragraph (e) below, this option shall be exercisable, within the period of 90 days following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">further provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this option shall not be exercisable after the Final Exercise Date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Discharge for Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If the Participant, prior to the Final Exercise Date, is discharged by the Company for &#8220;cause&#8221; (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such discharge.  &#8220;Cause&#8221; shall include acts or omissions that the Company&#160;determines in writing, after affording the Participant an opportunity to be heard, are  (i) criminal, dishonest or fraudulent or constitute  misconduct that reflect negatively on the reputation of the Company (including any parent, subsidiary, affiliate or division of the Company)&#59; (ii) acts or omissions that could expose the Company or any parent, subsidiary, affiliate or division of the Company to claims of illegal harassment or discrimination in employment&#59;(iii) material breaches of this Agreement&#59; or (iv) continued and repeated failure to perform substantially the duties of his&#47;her employment.  The Participant shall be considered to have been discharged for &#8220;cause&#8221; if the Company determines, within 30 days after the Participant&#8217;s resignation, that discharge for cause was warranted.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Withholding</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Non-transferability of Option</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Provisions of the Plan</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This option is subject to the provisions of the Plan, a copy of which is furnished to the Participant with this option.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:23.75pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In Witness Whereof, the Company has caused this option to be executed under its corporate seal by its duly authorized officer.  This option shall take effect as a sealed instrument.</font></div><div style="margin-bottom:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Centene Corporation</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">PARTICIPANT&#8217;S ACCEPTANCE</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof.  The undersigned hereby acknowledges receipt of a copy of the Company&#8217;s 2012 Stock Incentive Plan.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participant&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;Director Name&#93;</font></td></tr></table></div><div style="padding-left:234pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14
<SEQUENCE>10
<FILENAME>a2022123110-kexhibit1014.htm
<DESCRIPTION>EX-10.14
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i74f36bd100f74197ba22fff903bf1617_38"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT 10.14</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CENTENE CORPORATION</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Restricted Stock Agreement Granted Under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2012 Stock Incentive Plan</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the &#8220;Company&#8221;), and the undersigned </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Company (hereinafter the &#8220;Participant&#8221;).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Company desires to align the long-term interests of its directors with those of the Company by providing the ownership interest granted herein&#59;</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the foregoing and the mutual agreements herein contained, the parties hereto hereby agree as follows&#58;</font></div><div style="margin-bottom:11pt;padding-left:4.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.25pt;text-decoration:underline">Issuance of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company is issuing to the Participant as of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">______</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, subject to the terms and conditions set forth in this Agreement and in the Company&#8217;s 2012 Stock Incentive Plan (the &#8220;Plan&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">______ </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shares (the &#8220;Shares&#8221;) of common stock, $.001 par value, of the Company (&#8220;Common Stock&#8221;). The Participant agrees that the Shares shall be subject to the purchase option set forth in Section&#160;2 of this Agreement and the restrictions on transfer set forth in Section&#160;4 of this Agreement.</font></div><div style="margin-bottom:11pt;padding-left:4.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.25pt;text-decoration:underline">Purchase Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company shall have the right and option (the &#8220;Purchase Option&#8221;) to purchase some or all of the Shares from the Participant for a sum of $.001 per Share (the &#8220;Option Price&#8221;), subject to the following&#58;</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Company may not exercise the Purchase Option until such time, if any, as the Participant ceases to be a director of the Company for a reason other than the Participant&#8217;s death or &#8220;permanent and total disability&#8221; (as defined in the first sentence of Section 22(e)(3), or any successor provision, of the Internal Revenue Code of 1986, as amended from time to time).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">It is understood and expected that the Participant will attend all or substantially all Board events in person or by telephone.  If, as determined by the Board, the Participant is absent from a significant number of Board events, the Company may exercise the Purchase Option.  While not limiting the discretion of the Board, it is understood and expected that absences are more likely to be excused if they result from a family or personal emergency such as death, illness or similar unexpected event.  Also, while not limiting Board discretion, it is understood and expected that absences are less likely to be excused if they result from business conflicts or emergencies.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Subject to the first sentence of Section 3(c), the Company may not exercise the Purchase Option upon or after the earliest to occur of (i) the date of the first annual meeting of stockholders of the Company (or any special meeting held in lieu of such annual meeting) to occur after the date of this Agreement, (ii) the occurrence of a Change in Control (as defined below) and (iii) the death of the Participant.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of clarity (and without limiting the foregoing), if the Participant is not absent from any of the specified Board events and continues to serve as a director of the Company until the date of the first annual meeting of stockholders of the Company (or any special meeting held in lieu of such annual meeting) to occur after the date of this Agreement, the Company shall never be entitled to exercise the Purchase Option with respect to any of the SharesA &#8220;Change in Control&#8221; shall be deemed to have occurred if any of the events set forth in any one of the following clauses shall occur&#58;  (i) any Person (as defined in section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and as such term is modified in sections 13(d) and 14(d) of the Exchange Act), excluding a group of persons including the Participant, is or becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13(d)(3) under the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exchange Act), directly or indirectly, of securities of the Company representing forty percent or more of the combined voting power of the Company&#8217;s then-outstanding securities&#59; (ii) individuals who, as of the date of this Agreement, constitute the Board of Directors of the Company (the &#8220;Incumbent Board&#8221;), cease for any reason to constitute a majority thereof (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that an individual becoming a director subsequent to the date of this Agreement whose election, or nomination for election by the Company&#8217;s stockholders, was approved by at least a majority of the directors then comprising the Incumbent Board shall be included within the definition of Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual election contest (or such terms used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board of Directors of the Company)&#59; or (iii)&#160;the stockholders of the Company consummate a merger or consolidation of the Company with any other corporation, other than a merger or consolidation that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation.</font></div><div style="margin-bottom:11pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.25pt;text-decoration:underline">Exercise of Purchase Option and Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Company may exercise the Purchase Option under Section 2(a) by delivering or mailing to the Participant (or his or her estate) a written notice of exercise, within 90 days after the date on which the Participant ceases to be a director of the Company (regardless of the deadlines specified in Section 2(c)).   The Company may exercise the Purchase Option under Section 2(b) by delivering or mailing to the Participant prior to the date of the first annual meeting of stockholders of the Company (or any special meeting held in lieu of such annual meeting) to occur after the date of this Agreement, a written notice of exercise of the Purchase Option.  Any notice to exercise the Purchase Option under Section 2(a) or 2(b) shall specify the number of Shares to be purchased.  If and to the extent the Purchase Option under Section 2(a) or 2(b) is not so exercised by the giving of such a notice, the Purchase Option shall automatically expire and terminate.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Within 10 days after delivery to the Participant of the Company&#8217;s notice of the exercise of the Purchase Option pursuant to subsection&#160;(a) above, the Participant (or his or her estate) shall, pursuant to the provisions of the Joint Escrow Instructions referred to in Section&#160;5 below, tender to the Company at its principal offices the certificate or certificates representing the Shares which the Company has elected to purchase in accordance with the terms of this Agreement, duly endorsed in blank or with duly endorsed stock powers attached thereto, all in form suitable for the transfer of such Shares to the Company.  Promptly following its receipt of such certificate or certificates, the Company shall pay to the Participant the aggregate Option Price for such Shares (provided that any delay in making such payment shall not invalidate the Company&#8217;s exercise of the Purchase Option with respect to such Shares).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">After the time at which any Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection&#160;(b) above, the Company shall not pay any dividend to the Participant on account of such Shares or permit the Participant to exercise any of the privileges or rights of a stockholder with respect to such Shares, but shall, in so far as permitted by law, treat the Company as the owner of such Shares.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The Option Price is payable in cash (by check).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Company shall not purchase any fraction of a Share upon exercise of the Purchase Option, and any fraction of a Share resulting from a computation made pursuant to Section&#160;2 of this Agreement shall be rounded to the nearest whole Share (with any one-half Share being rounded upward).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">The Company may assign its Purchase Option to one or more persons or entities.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:11pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.25pt;text-decoration:underline">Restrictions on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Participant shall not sell, assign, transfer, pledge, hypothecate or otherwise dispose of, by operation of law or otherwise (collectively &#8220;transfer&#8221;) any Shares, or any interest therein, that are subject to the Purchase Option, except that the Participant may transfer such Shares (i) to or for the benefit of any spouse, children, parents, uncles, aunts, siblings, grandchildren and any other relatives approved by the Board of Directors (collectively, &#8220;Approved Relatives&#8221;) or to a trust established solely for the benefit of the Participant and&#47;or Approved Relatives, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Shares shall remain subject to this Agreement (including without limitation the restrictions on transfer set forth in this Section 4 and the Purchase Option) and such permitted transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of this Agreement or (ii) as part of the sale of all or substantially all of the shares of capital stock of the Company (including pursuant to a merger or consolidation), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, in accordance with the Plan, the securities or other property received by the Participant in connection with such transaction shall remain subject to this Agreement.</font></div><div style="margin-bottom:11pt;padding-left:4.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.25pt;text-decoration:underline">Escrow</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant shall, upon the execution of this Agreement, execute Joint Escrow Instructions in the form attached to this Agreement as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Joint Escrow Instructions shall be delivered to the Secretary of the Company, as escrow agent thereunder.  The Participant shall deliver to such escrow agent a stock assignment duly endorsed in blank, in the form attached to this Agreement as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and hereby instructs the Company to deliver to such escrow agent, on behalf of the Participant, the certificate(s) evidencing the Shares issued hereunder.  Such materials shall be held by such escrow agent pursuant to the terms of such Joint Escrow Instructions.</font></div><div style="margin-bottom:11pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.25pt;text-decoration:underline">Restrictive Legends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All certificates representing Shares shall have affixed thereto legends in substantially the following form, in addition to any other legends that may be required under federal or state securities laws&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;The shares of stock represented by this certificate are subject to restrictions on transfer and an option to purchase set forth in a certain Restricted Stock Agreement between the corporation and the registered owner of these shares (or his predecessor in interest), and such Agreement is available for inspection without charge at the office of the Secretary of the corporation.&#8221;</font></div><div style="margin-bottom:11pt;padding-left:4.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.25pt;text-decoration:underline">Provisions of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">This Agreement is subject to the provisions of the Plan, a copy of which is furnished to the Participant with this Agreement.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">As provided in the Plan, upon the occurrence of a Reorganization Event (as defined in the Plan), the repurchase and other rights of the Company hereunder shall inure to the benefit of the Company&#8217;s successor and shall apply to the cash, securities or other property which the Shares were converted into or exchanged for pursuant to such Reorganization Event in the same manner and to the same extent as they applied to the Shares under this Agreement.  If, in connection with a Reorganization Event, a portion of the cash, securities and&#47;or other property received upon the conversion or exchange of the Shares is to be placed into escrow to secure indemnification or similar obligations, the mix between the vested and unvested portion of such cash, securities and&#47;or other property that is placed into escrow shall be the same as the mix between the vested and unvested portion of such cash, securities and&#47;or other property that is not subject to escrow.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:11pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.25pt;text-decoration:underline">Withholding Taxes&#59; Section 83(b) Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Participant acknowledges and agrees that the Company has the right to deduct from payments of any kind otherwise due to the Participant any federal, state or local taxes of any kind required by law to be withheld with respect to the purchase of the Shares by the Participant or the lapse of the Purchase Option.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The Participant has reviewed with the Participant&#8217;s own tax advisors the federal, state, local and foreign tax consequences of this investment and the transactions contemplated by this Agreement.  The Participant is relying solely on such advisors and not on any statements or representations of the Company or any of its agents.  The Participant understands that the Participant (and not the Company) shall be responsible for the Participant&#8217;s own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement.  The Participant understands that it may be beneficial in many circumstances to elect to be taxed at the time the Shares are purchased rather than when and as the Company&#8217;s Purchase Option expires by filing an election under Section 83(b) of the Internal Revenue Code of 1986 with the I.R.S. within 30 days from the date of purchase.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">THE PARTICIPANT ACKNOWLEDGES THAT IT IS THE PARTICIPANT&#8217;S SOLE RESPONSIBILITY AND NOT THE COMPANY&#8217;S TO FILE TIMELY THE ELECTION UNDER SECTION 83(b), EVEN IF THE PARTICIPANT REQUESTS THE COMPANY OR ITS REPRESENTATIVES TO MAKE THIS FILING ON THE PARTICIPANT&#8217;S BEHALF.</font></div><div style="margin-bottom:11pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.25pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board of Directors of the Company.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Binding Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs, executors, administrators, legal representatives, successors and assigns, subject to the restrictions on transfer set forth in Section&#160;4 of this Agreement. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All notices required or permitted hereunder shall be in writing and deemed effectively given upon personal delivery or five days after deposit in the United States Post Office, by registered or certified mail, postage prepaid, addressed to the other party hereto at the address shown beneath his or her or its respective signature to this Agreement, or at such other address or addresses as either party shall designate to the other in accordance with this Section&#160;9(d).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Pronouns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Whenever the context may require, any pronouns used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns and pronouns shall include the plural, and vice&#160;versa.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement and the Plan constitute the entire agreement between the parties, and supersedes all prior agreements and understandings, relating to the subject matter of this Agreement.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement may be amended or modified only by a written instrument executed by both the Company and the Participant.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement shall be construed, interpreted and enforced in accordance with the internal laws of the State of Delaware without regard to any applicable conflicts of laws.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Participant&#8217;s Acknowledgments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant acknowledges that he or she&#58; (i) has read this Agreement&#59; (ii) has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of the Participant&#8217;s own choice or has voluntarily declined to seek such counsel&#59; (iii) understands the terms and consequences of this Agreement&#59; (iv) is fully aware of the legal and binding effect of this Agreement&#59; and (v) understands that the law firm of Bryan Cave LLP, is acting as counsel to the Company in connection with the transactions contemplated by the Agreement, and is not acting as counsel for the Participant.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CENTENE CORPORATION</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______________________________</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;  </font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">________________________________</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;Director Name&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.22A
<SEQUENCE>11
<FILENAME>a2022123110-kexhibit1022a.htm
<DESCRIPTION>EX-10.22A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="idb7e1bc9a93f4de9b23266bcaf99f80a_58"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT 10.22a</font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AMENDMENT OF EXECUTIVE EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">THIS AMENDMENT OF EXECUTIVE EMPLOYMENT AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is entered into as of February 20, 2023, by and between Centene Corporation, a Delaware corporation, together with its successors and assigns permitted under this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and Sarah M. London (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the parties entered into that certain Executive Employment Agreement dated as of April 27, 2022 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the parties desire to amend the Agreement in order to reflect a change in the Executive&#8217;s long-term incentive compensation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NOW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> THEREFORE,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in consideration of the premises and mutual covenants herein contained, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">Section 3.3 is amended in its entirety to read as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Executive shall be eligible for annual grants of long-term cash and equity compensation awards at the Company&#8217;s good faith discretion, based upon the Compensation Committee&#8217;s evaluation of her performance and peer company compensation practices (each, a &#8220;Long-Term Award&#8221;). The Long-Term Awards may consist of, among others, (a) a cash-based long-term incentive awards (the &#8220;Cash Awards&#8221;) under the Company&#8217;s 2007 Long-Term Incentive Plan, as amended, or successor-plan (the &#8220;LTIP&#8221;), and (b) service-based restricted stock units, performance-based restricted stock units and performance-based stock options (the &#8220;Equity Awards&#8221;) issued under the Company&#8217;s 2012 Stock Incentive Plan, as amended, or successor plan (the &#8220;Stock Plan&#8221;). Each Cash Award shall be subject to the terms of the LTIP and an award agreement to be executed by Executive and the Company, and each Equity Award shall be subject to the terms of the Stock Plan and award agreements to be executed by Executive and the Company&#59; provided, that the terms of such awards shall be no less favorable than provided to other senior executives of the Company generally. In 2022, the Executive&#8217;s annual target Long-Term Awards shall be $12,500,000. The amount and type of the Executive&#8217;s future Long-Term Awards shall be annually determined by the Compensation Committee in its sole discretion&#59; provided that Executive shall be treated no less favorably than senior executives of the Company generally, with respect to the type of her future Long-Term Awards. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">Section 5.1(f)(ii) is hereby amended in its entirety to read as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">upon or following a Change in Control, a reduction in Executive&#8217;s Salary or Annual Bonus potential from those in effect immediately prior to the Change in Control </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">Section 5.1(f)(iv) is hereby amended in its entirety to read as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a material breach by the Company or any of its affiliates of this Agreement (including without limitation, Section 3.1 and Section 3.2 hereof) or any material compensation agreement</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">Section 5.5(a) is hereby amended to replace the reference to &#8220;three (3) times&#8221; with &#8220;2.99 times.&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">Section 7.4 is hereby amended to replace the second sentence of such section in its entirety and replace it with the following&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company hereby agrees to engage the Accountant to do an independent valuation of the Non-Compete Provision as part of an analysis of Executive&#8217;s post-Change in Control reasonable compensation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">General Terms and Conditions. All other terms and conditions of the Agreement not amended hereunder shall remain in full force and effect, as applicable. This Amendment shall be governed by and construed in accordance with the laws of the State of Missouri, without regard to principles of conflict of laws that would cause the application of laws of another jurisdiction. This Amendment may be executed in any number of counterparts, each of which will be an original, but such counterparts will together constitute but one and the same Amendment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><div id="idb7e1bc9a93f4de9b23266bcaf99f80a_61"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the parties hereto have signed their names as of the date and year first above written.</font></div><div style="margin-top:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CENTENE CORPORATION<br><br><br></font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.538%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;  &#47;s&#47; Christopher Koster                </font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Christopher Koster</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Executive Vice President, Secretary and General Counsel</font></div></td></tr></table></div><div style="margin-top:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXECUTIVE</font></div><div style="margin-top:24pt;padding-left:252pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.538%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;  &#47;s&#47; Sarah London                  </font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SARAH LONDON</font></td></tr></table></div><div style="margin-top:24pt"><font><br></font></div><div style="margin-top:24pt"><font><br></font></div><div style="margin-top:24pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.23A
<SEQUENCE>12
<FILENAME>a2022123110-kexhibit1023a.htm
<DESCRIPTION>EX-10.23A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if056e6944b5248428ec1d4c8dae36e9e_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT 10.23a</font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AMENDMENT OF EXECUTIVE EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">THIS AMENDMENT OF EXECUTIVE EMPLOYMENT AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is entered into as of February 20, 2023, by and between Centene Corporation, a Delaware corporation, together with its successors and assigns permitted under this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and Andrew Asher (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the parties entered into that certain Executive Employment Agreement dated as of April 28, 2022 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the parties desire to amend the Agreement in order to reflect a change in the Executive&#8217;s long-term incentive compensation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NOW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> THEREFORE,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in consideration of the premises and mutual covenants herein contained, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">Section 3(g) is amended in its entirety to read as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In 2022, the total target level of compensation for the Executive will be $8,900,000. In future calendar years, the Executive&#8217;s actual total target level of compensation shall be annually determined by the Compensation Committee in its sole discretion. The Compensation Committee shall determine in its sole discretion, consistent with the principles set forth in (d) and (e) above, the specific components of the Executive&#8217;s total compensation for 2023 and 2024 and for any future calendar years in the Employment Term.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">Section 3(h) is deleted in its entirety. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">Section 14(h)(i) is amended in its entirety to read as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) a reduction in the Executive&#8217;s (x) Base Salary, (y) Target Bonus or (z) aggregate compensation opportunity, in each case, from the prior year&#8217;s amounts,</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">General Terms and Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. All other terms and conditions of the Agreement not amended hereunder shall remain in full force and effect, as applicable. This Amendment shall be governed by and construed in accordance with the laws of the State of Missouri, without regard to principles of conflict of laws that would cause the application of laws of another jurisdiction. This Amendment may be executed in any number of counterparts, each of which will be an original, but such counterparts will together constitute but one and the same Amendment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="if056e6944b5248428ec1d4c8dae36e9e_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the parties hereto have signed their names as of the date and year first above written.</font></div><div style="margin-top:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CENTENE CORPORATION<br><br><br></font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.538%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">By&#58;  &#47;s&#47; Sarah M. London                  </font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Name&#58; Sarah M. London</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Title&#58; Chief Executive Officer</font></td></tr></table></div><div style="margin-top:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXECUTIVE</font></div><div style="margin-bottom:10pt;margin-top:24pt;padding-left:252pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.538%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">By&#58;  &#47;s&#47; Andrew Asher      </font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">ANDREW ASHER</font></td></tr></table></div><div style="margin-top:24pt"><font><br></font></div><div style="margin-top:24pt"><font><br></font></div><div style="margin-top:24pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.24
<SEQUENCE>13
<FILENAME>a2022123110-kexhibit1024.htm
<DESCRIPTION>EX-10.24
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if701299ef2314ab58413da27a4c43221_38"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT 10.24</font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTIVE EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In this Executive Employment Agreement, dated as of February 20, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), Centene Corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and Kenneth Fasola (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), intending to be legally bound and for good and valuable consideration, agree as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">The Executive&#8217;s employment hereunder shall begin effective on the date above and shall continue until terminated by either party in accordance with Section 5 of this Agreement. The period during which the Executive is employed by the Company hereunder is hereby referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employment Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Position and Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During the Employment Term, the Executive shall serve as the President of the Company, reporting solely and directly to the Company&#8217;s Chief Executive Officer. In such position, the Executive shall have the duties, authority, and responsibilities consistent with industry norms for the President role, as shall be determined from time to time by the Chief Executive Officer, which duties, authority, and responsibilities shall include, without limitation, operating accountability for the revenue generating operations of the Company, subject to standard oversight of the Board and Chief Executive Officer.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During the Employment Term, the Executive shall devote substantially all of the Executive&#8217;s business time and attention to the performance of the Executive&#8217;s duties hereunder and shall not engage in any other business, profession, or occupation for compensation or otherwise which would conflict or interfere with the performance of such services either directly or indirectly without the prior written consent of the Board of Directors (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Executive may serve on trade, civic or charitable boards and, subject to prior approval by the Board, the board of directors of one (1) other for-profit company, that does not compete as described in Section 11(d), of the Executive&#8217;s choice, and may manage personal investments and affairs to the extent such activities do not materially interfere with the performance of the Executive&#8217;s duties and responsibilities hereunder.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Travel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Executive&#8217;s principal business location shall be in Texas.  The Executive acknowledges and agrees that the Executive may be required to travel on Company business, as reasonably needed to meet the Company&#8217;s objectives, during the Employment Term.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Effective January 1, 2023, the Company shall pay the Executive an annual base salary of $1,100,000 in periodic installments in accordance with the Company&#8217;s customary payroll practices and applicable wage payment laws, but no less frequently than monthly. The Executive&#8217;s base salary shall be reviewed at least annually by the Compensation Committee of the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and the Compensation Committee may, but shall not be required to, increase the base salary during the Employment Term. However, the Executive&#8217;s base salary may not be decreased during the Employment Term other than as part of an across-the-board salary reduction that applies in the same manner to all senior executives generally, subject to Section 13(h). The Executive&#8217;s annual base salary, as in effect from time to time, is hereinafter referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221; Any unpaid portion of Base Salary from January 1, 2023 through the date of execution of this Agreement shall be paid in a lump sum in accordance with the Company&#8217;s customary payroll practices on March 3, 2023. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During the Employment Term (effective beginning with the 2023 calendar year), the Executive shall be eligible to receive an annual bonus based on the achievement of performance goals established and evaluated by the Compensation Committee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Executive&#8217;s annual target bonus opportunity shall be equal to 125% of the Executive&#8217;s Base Salary (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Target Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Annual Bonus, if any, shall be paid within two and a half (2 1&#47;2) months after the end of the year during which the Annual Bonus is earned.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Signing Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Upon the execution of this Agreement the Executive shall be paid a one-time $1,000,000 cash award. In the event the Executive&#8217;s employment is terminated by the Company for Cause or by the Executive without Good Reason within 18 months following the date of this Agreement and prior to a Change in Control, the Executive shall repay to the Company the full amount of such cash award within thirty (30) days following such termination of employment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Long-Term Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the first quarter of 2023, the Executive shall be entitled to receive an equity award under the Company&#8217;s 2012 Stock Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Stock Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) with an aggregate annual grant date target value equal to $6,025,000 (subject to any delay required by applicable securities law). Following 2023, the amount of the Executive&#8217;s annual long term incentive grants shall be determined in the discretion of the Compensation Committee (taking into account individual and Company performance and market compensation levels for similarly-situated senior executives). The allocation of long-term incentive compensation awards amongst types of awards, and any applicable performance measures, shall be determined by the Compensation Committee in its sole discretion, but shall be consistent with the percentages and performance targets assigned to awards granted in the same performance cycle to similarly situated senior executives of the Company. Under the equity program in effect as of the date of this Agreement, 35% of the long-term incentive compensation awards will be in the form of restricted stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and 65% will be in the form of performance share units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). Under the current program, all RSUs are subject to three-year graded vesting, and all PSUs are subject to three-year cliff vesting (in each case, with settlement upon vesting). All RSUs and PSUs shall be subject to the terms of the Stock Plan and award agreements to be executed by the Executive and the Company. Except as set forth in the following sentence, the award agreements shall be in the same form applicable to similarly situated senior executives of the Company, and shall provide that units shall be settled as soon as practicable following the applicable vesting date. Upon the Executive&#8217;s termination of employment by the Company or by the Executive for any reason whether voluntary or involuntary (other than a termination of employment by the Company for Cause), all long-term incentive compensation awards granted after the date of this Agreement will continue to vest according to their terms (disregarding any ongoing service requirements), without pro-ration, and with PSUs eligible to be earned based upon the attainment of the applicable performance metrics. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Legacy Company Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in that certain Agreement and Plan of Merger between the Company and Magellan Health Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transaction Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), 50% of the remaining unvested Executive Company Equity Awards (as defined in the Transaction Agreement) that were converted into corresponding awards of the Company (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Legacy Company Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) will vest on the second anniversary of the Closing Date (as defined in the Transaction Agreement), and the remaining 50% will vest on the thirty (30) month anniversary following the Closing Date, subject to continued employment with the Company or one of its affiliates through each vesting date. Such Legacy Company Equity Awards shall be settled on the vesting date or as soon as practicable thereafter (but not more than five business days thereafter). For the avoidance of doubt, in the event the Executive&#8217;s employment is terminated without Cause or by the Executive with Good Reason on or prior to the thirty (30) month anniversary of the Closing Date, the Legacy Company Equity Awards will vest on the date of the Executive&#8217;s termination. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Executive and&#47;or the Executive&#8217;s dependents, as the case may be, shall participate in employee and executive retirement, medical, dental, vision, disability, group and&#47;or executive life, accidental death and travel accident insurance, and similar benefit plans and programs of the Company, subject to the terms and conditions thereof, as in effect from time to time with respect generally to senior executives employed by the Company. The Executive shall be entitled to be paid these benefits upon termination in accordance with the terms of the applicable employee benefit plans, or, if not governed by ERISA, pursuant to the policies and practices of the Company as in effect from time to time with respect to senior executives employed by the Company. In addition, the Executive shall be entitled to personal use of the Company&#8217;s corporate aircraft in accordance with the policies of the Company in effect from time to time, up to a maximum of 20 hours per year.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Severance Pay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Employment Term and the Executive&#8217;s employment hereunder may be terminated by either the Company or the Executive at any time and for any reason&#59; provided that, unless otherwise provided herein, (i) the Executive shall be required to give the Company at least ninety (90) days&#8217; advance written notice of the Executive&#8217;s intent to retire or otherwise terminate his employment, and (ii) the Company shall be required to give the Executive at least sixty (60) days&#8217; advance written notice of the termination of the Executive&#8217;s employment for any reason other than for Cause. Should the Executive&#8217;s employment with the Company be terminated due to a Qualifying Termination that is not a Change in Control Termination, in addition to the Accrued Obligations, the Company agrees to pay or provide the following compensation and benefits during the severance period and the Executive shall have no further rights to any compensation or any other benefits from the Company&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">Severance pay to the Executive in the form of a cash lump sum payment equal to the Executive&#8217;s annual Base Salary determined using the Executive&#8217;s then-current Base Salary (disregarding any reduction constituting Good Reason or any reduction made in the preceding six (6) month period), with such amount payable to the Executive on the sixtieth (60th) day after the termination date.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">A prorated Annual Bonus for the year in which the Executive&#8217;s date of termination occurs based on the degree of achievement of goals under the bonus program in effect at the time of termination and the portion of the year elapsed as of the date of termination. The degree of achievement of goals shall be determined in accordance with the bonus program, except that should any goals be of a subjective nature, the degree of achievement therefore shall be determined by the Company in its sole discretion. Any such bonus amount shall be paid in a single, lump sum payment at the same time as Annual Bonuses for the year are paid to the Company&#8217;s officers generally. The Executive shall also receive any prior Annual Bonus which has been achieved and accrued, but not paid at the time of termination. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">Subject to Section 11, during the twelve (12) month period of salary continuation described in (a) above, the Company shall pay for a portion of the health, dental, prescription drug and vision insurance continuation coverage (collectively &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medical Coverage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to which the Executive is entitled under the Consolidated Omnibus Budget Reconciliation Act of 1985 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) on behalf of the Executive, and as applicable, the Executive&#8217;s spouse and dependents, subject to the Executive&#8217;s timely election of COBRA healthcare continuation coverage. For such twelve (12) month period, the terminated the Executive shall be responsible to pay contributions for Medical Coverage provided under this Section 5(c) in the same amount as is charged to similar active employees for similar coverage, rather than the full COBRA premium amount, and the Company shall pay the remainder of the COBRA premium amount.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The Executive&#8217;s then-outstanding RSUs, PSUs or other equity-based or long-term cash incentive awards (including, but not limited to, any Company equity-based or long-term cash incentive awards granted in calendar year 2022), if any, shall remain subject to the vesting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and forfeiture terms set forth in their award agreements (or the letter agreement dated January 4, 2021, by and between the Company and the Executive, as applicable (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;))&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, however, that awards granted following the date of this Agreement shall continue to vest consistent with the terms of Section 3(d)&#59; and provided further, that with respect to any equity-based or long-term cash incentive award outstanding on the date of the Qualifying Termination, the Executive will receive no less than an additional 12 months of service credit. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">For a period of up to six (6) months from the date of the Qualifying Termination, the Company shall provide outplacement services to the Executive that are comparable to other executives at this level who have terminated. Outplacement services shall be provided by an entity selected by the Company. The Executive shall use best efforts, consistent with the terms of Section 11, to become gainfully employed during the period the Executive is receiving benefits under this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.01pt">Notwithstanding the foregoing, should the Executive&#8217;s employment with the Company be terminated prior to May 31, 2024 due to a Qualifying Termination that is not a Change in Control Termination, in lieu of the cash severance payable under Section 5(a) of this Agreement but in addition to the other payments and benefits under Sections 5(b)-(e) of this Agreement, the Executive shall be entitled to severance pay in a cash lump sum payment equal to the product of (x) the sum of (i) the Executive&#8217;s Base Salary, plus (ii) the Annual Bonus paid to the Executive in the calendar year prior to the year in which the Qualifying Termination occurs, multiplied by (y) 2.5, with such amount payable to the Executive on the sixtieth (60</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) day after the termination date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, however, that in no event shall the amount payable under this section 5(f) exceed the maximum amount payable under the Company&#8217;s Executive Officer Cash Severance Policy. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">If amounts are payable under this Section 5, no additional amounts shall be payable under Section 7 of this Agreement (unless Section 6(a)(ii) becomes applicable), nor any other agreement between the parties, which shall include, and not be limited to, any Executive Severance and Change in Control Agreement as well as any severance pay plan generally maintained by the Company for its employees. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company shall pay to the Executive the severance described in Section 7 if the Executive experiences a Qualifying Termination that occurred under the circumstances described below (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Control Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">On the day of, or within twenty-four (24) months after, the occurrence of a Change in Control&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Prior to a Change in Control but at the request of any third party participating in or causing the Change in Control or during the one hundred twenty (120) day period prior to a Change in Control.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Change in Control Severance Pay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the event of a Change in Control Termination, in addition to the Accrued Obligations, the Company agrees to provide the Executive the following&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">Severance pay equal to the product of (x) the sum of (i) the Executive&#8217;s Base Salary, plus (ii) the average of the last two (2) Annual Bonuses paid to the Executive during the two (2) most recently completed full fiscal years of the Company, multiplied by (y) two (2). Such amount shall be paid in an undiscounted lump sum on the sixtieth (60th) day after the termination date. For purposes of calculating the amount of severance in this Section 7(a) and Section 7(b) due as a result of a Change in Control Termination, the Executive&#8217;s Base Salary shall be based on the highest amount of such Base Salary during the two (2) year period ending on the date of termination.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">A prorated Target Bonus for the year in which such termination occurs, paid in an undiscounted lump sum on the sixtieth (60</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) day after the termination date.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">During the eighteen (18) month period following the Change in Control Termination, the Company shall pay for the Executive&#8217;s entire Medical Coverage to which the Executive is entitled under COBRA. If the Company purchased a life insurance policy for the benefit of the Executive&#8217;s beneficiaries prior to the Change in Control, the Company shall continue to maintain and pay all expenses associated with the corporate-owned life insurance policy for the remainder of the Executive&#8217;s life. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Any RSUs, PSUs or other equity-based awards that were outstanding immediately prior to the Change in Control Termination shall, to the extent not then vested, fully vest and become exercisable as of the date of the Change in Control Termination and the Executive shall have the right to exercise any such stock option or stock appreciation right until the earlier to occur of (i) one (1) year from the date of the Change in Control Termination and (ii) the expiration date of such stock option or stock appreciation right or other equity-based award as set forth in the agreement evidencing such award. Any PSUs that were outstanding immediately prior to the Change in Control Termination shall vest at the greater of the actual performance level at the time of the Change in Control event or at target performance level, in each case, without pro-ration.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">If amounts are payable under this Section 7, no amounts shall be payable under Section 5 of this Agreement, nor any other agreement between the parties, which shall include, and not be limited to, any Executive Severance and Change in Control Agreement as well as any severance pay plan generally maintained by the Company for its employees. Notwithstanding the foregoing, the amounts payable pursuant to this Section 7 shall be reduced by any amounts previously paid to the Executive pursuant to Section 5 and no duplication of payments shall occur.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If, for any reason, any part or all of the amounts payable to the Executive under this Agreement (or otherwise, if such amounts are in the nature of compensation paid or payable by the Company or any of its subsidiaries after there has been a Change in Control) (collectively &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Total Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) are deemed to be &#8220;excess parachute payments&#8221; within the meaning of Section 280G(b)(1) of the Code or any successor or similar provision, and would be subject to the excise tax imposed by Section 4999 of the Code or any successor or similar provision, such Total Payments shall be reduced to the extent necessary such that no amounts paid or payable to the Executive shall be deemed excess parachute payments subject to excise tax under Section 4999 of the Code&#59; provided, however, that no such reduction shall occur if (i) the net amount of such Total Payments as so reduced (and after subtracting the net amount of federal, state and local income taxes on such reduced Total Payments) is less than (ii) the net amount of such Total Payments without such reduction (but after subtracting the net amount of federal, state and local income taxes on such unreduced Total Payments and the amount of excise taxes to which the Executive would be subject in respect of such unreduced Total Payments). All determinations required to be made under this Section 8 and the assumptions to be utilized in arriving at such determination shall be made by an independent, nationally recognized accounting firm designated by the Company prior to the Change in Control (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Auditor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Auditor shall provide detailed supporting calculations to both the Company and the Executive within fifteen (15) business days of the receipt of notice from the Executive or the Company that there has been a payment, or such earlier time as is requested by the Company. All fees and expenses of the Auditor shall be paid by the Company. All determinations made by the Auditor shall be binding upon the Company and the Executive.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The parties agree that certain matters in which the Executive shall be involved during the Employment Term may necessitate the Executive&#8217;s cooperation in the future. Accordingly, during the 24-month period following the termination of the Executive&#8217;s employment for any reason, to the extent reasonably requested by the Board, the Executive shall cooperate with the Company to provide truthful information in connection with matters arising out of the Executive&#8217;s service to the Company&#59; provided that, such cooperation shall be subject to the Executive&#8217;s personal and business commitments, the Company shall make reasonable efforts to minimize disruption of the Executive&#8217;s other activities and the Executive shall receive reasonable compensation, as to be agreed by the parties, for the Executive&#8217;s cooperation in excess of eight (8) hours per month. The Company shall reimburse Executive for all reasonable expenses incurred in connection with cooperation including travel costs, and if determined in good faith to be reasonably appropriate by the Executive, the reasonable fees incurred by independent counsel for the Executive (subject to the good faith prior approval of the Company&#8217;s general counsel). The Executive shall not be required to cooperate against his own legal interests or those of a subsequent employer or business partner.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any payments or benefits made or provided pursuant to this Agreement are subject to the Executive&#8217;s&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-42.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">compliance in all material respects with the provisions of Section 11 hereof (provided, that, the Company shall provide the Executive with written notice of any such failure to comply and not less than thirty (30) days to cure, if curable)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-45.66pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">with respect to payments under Sections 5, 7 and the last sentence of 3(d), delivery to the Company, within 45 days following the Executive&#8217;s termination date, of an executed full and complete release of claims, in the form attached hereto as Exhibit A, with such terms as needed under then applicable law to give full effect to its intent and purpose (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-48.99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">delivery to the Company of a resignation from all offices, directorships and fiduciary positions with the Company, its affiliates and employee benefit plans.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the due date of any post-employment payments, any amounts due under this Agreement shall not be due until after the expiration of any revocation period applicable to the Release. Nevertheless, upon any termination of the Executive&#8217;s employment, the Executive shall be entitled to receive the Accrued Obligations, payable within thirty (30) days after the date of termination or in accordance with the applicable plan, program or policy.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Executive&#8217;s Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Executive acknowledges that the above consideration, absent this Agreement, is beyond what the Company is obligated to pay. In consideration for the Executive&#8217;s employment, the opportunity for the payments and benefits specified in this Agreement, and the Company allowing the Executive to have access (or continue to have access) to the Company&#8217;s or its Affiliates&#8217; Confidential Information, the Executive agrees to the following, which shall continue to apply in the event the Executive&#8217;s employment is terminated by either party for any reason, whether voluntary or involuntary and whether with or without Cause or with or without Good Reason. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. As used in this Section 11, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Company&#8217;s and the Affiliates&#8217; trade secrets and other non-public proprietary information relating to the Company and the Affiliates or the business of the Company and the Affiliates, including, but not limited to, information relating to financial statements, customer lists and customer information, employee skills and compensation, employee data, supplier lists and supplier information, vendor lists and vendor information, acquisition targets, servicing methods, equipment, programs, strategies and information, analyses, marketing plans and strategies, new and proposed product plans&#59; pricing, profit margins, financial, promotional, marketing, training or operational information, customer lists and customer information, and other information developed or used by the Company that is not known generally to the public or the industry. Confidential Information shall not include any information that is in the public domain or becomes known in the public domain through no wrongful act on the part of the Executive.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Executive agrees that the Confidential Information is a valuable, special and unique asset of the Company&#8217;s business, that such Confidential Information is important to the Company and the effective operation of the Company&#8217;s business. As such and in addition to the other restrictions contained in this Section 11, the Executive shall not, either during the Executive&#8217;s employment with the Company and at all times thereafter, directly or indirectly use, disclose, divulge or communicate in any fashion, form or manner to any person, firm, partnership, corporation or other entity, or use for the Executive&#8217;s own benefit, any trade secrets (whether patentable or not) or any Confidential Information except to the limited extent that such disclosure or use is both authorized and reasonably required in connection with the Executive&#8217;s employment. Notwithstanding the foregoing provisions of Section 11(b), the Executive may disclose information if required by applicable law or a court order or subpoena requested by a governmental or self-regulatory organization or as reasonably necessary in connection with any legal process between Executive and the Company or any of its subsidiaries or Affiliates, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">except that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (i) in the case of disclosure required by law, court order or subpoena, to the extent legally permitted, the Executive shall inform the Company immediately upon becoming aware of the requirement to disclose or, if applicable, upon receipt of the court order or subpoena, and, to the extent legally permitted, shall not disclose until the Company has had a reasonable opportunity to review and object to such disclosure&#59; and (ii) in the case of disclosure in connection with any legal process, the Executive shall only be permitted to disclose to the parties to the legal process, and then only as may be consistent with any confidentiality stipulation or protective order as may be in effect in such legal process. The Company shall reimburse the Executive for all reasonable legal costs incurred in complying with the foregoing sentence. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-42.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:36pt">Defend Trade Secrets Act Notice to Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding the foregoing and any other terms of this Agreement, the Executive will not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that&#58; (A) is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, and (ii) solely for the purpose of reporting or investigating a suspected violation of law&#59; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, if the Executive files a lawsuit for retaliation by the Company or any of its Affiliates for reporting a suspected violation of law, the Executive may disclose the trade secret to Employee&#8217;s attorney and use the trade secret information in the court proceeding if the Executive files any document containing the trade secret under seal and does not disclose the trade secret except pursuant to court order.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Property of Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any Confidential Information, and all other business information or documents, shall be and remain solely and exclusively the property of the Company and&#47;or its Affiliates. During his or her employment, the Executive shall not remove from the property or premises of the Company or its Affiliates any Confidential Information or any other documents or data relating to the business, work, services or sales of the Company and&#47;or its Affiliates, or copies thereof, unless authorized by the Company and&#47;or its Affiliates and required for the Executive to perform his or her employment duties. Upon the termination of the Executive&#8217;s employment regardless of whether such termination is with or without Cause or with or without Good Reason, or at any other time requested by the Company or its Affiliates, the Executive shall promptly deliver all documents, files, devices and other items (whether maintained in electronic or hard copy format) obtained in the course of his or her employment, whether or not the Executive believes such items constitute or contain Confidential Information, and without retaining any copies, notes, or excerpts thereof. Notwithstanding the foregoing, the Executive may retain the Executive&#8217;s contacts, calendars, personal correspondence, and all information and documentation reasonably needed for the Executive&#8217;s personal tax return preparation purposes.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Non-Competition&#59; Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-42.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">During the Employment Term and for twelve (12) months after the termination of the Executive&#8217;s employment with the Company (including any parent, subsidiary, Affiliate or division of the Company) for any reason whatsoever, whether voluntary or involuntary and whether with or without Cause or with or without Good Reason, the Executive shall not directly or indirectly counsel, advise, consult, be employed or otherwise engaged, in each case, in a strategic, managerial or executive role, by or with any entity or enterprise (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Competitor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) that competes, or that intends or plans to compete with (A) any area of business in which the Company or any Affiliate is engaged, and in which the Executive was engaged, participated in or about which the Executive learned Confidential Information during the Executive&#8217;s last thirty-six (36) months of employment, or (B) any other area of business for which the Company or any Affiliate has taken substantial steps towards becoming engaged, and in which the Executive was engaged, participated in or about which the Executive learned Confidential Information during the Executive&#8217;s last 36 months of employment. Because the Company and its Affiliates engage in business nationwide, the obligations under this Section 11(d) shall apply nationwide (anywhere in the United States). Notwithstanding the foregoing, Executive shall not violate this provision by providing services to a unit, division, subsidiary or affiliate of a Competitor which otherwise engages in activities competitive with the business activities of the Company if such unit, division, subsidiary or affiliate for which Executive provides services does not engage in such business activities. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-45.66pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">During the Employment Term and for the period of twelve (12) months immediately after the termination of the Executive&#8217;s employment with the Company (or any parent, subsidiary, affiliate or division of the Company) for any reason whatsoever, and whether voluntary or involuntary, and whether with or without Cause or with or without Good Reason (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Executive shall not, either directly or indirectly, either for the Executive or for any other person, firm, company or corporation, call upon, solicit, divert, or take away, or attempt to solicit, divert or take away any of the customers, prospective customers, business, providers, vendors or suppliers of the Company or any Affiliate that (at any time during the last three years of the Executive&#8217;s employment) the Executive had dealings with, or responsibility for, or about which the Executive had access to the Company&#8217;s (or any Affiliate&#8217;s) Confidential Information or such customers&#8217;, providers&#8217;, vendors&#8217; or suppliers&#8217; confidential information. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-48.99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">The Executive shall not, at any time during the Restricted Period, without the prior written consent of the Company, (1) directly or indirectly, solicit, recruit, divert from the Company, hire, or employ (whether as an employee, officer, director, agent, consultant or independent contractor) any person who was or is at any time during the previous six (6) months an employee, representative, officer or director of the Company or any Affiliate&#59; or (2) take any action to encourage or induce any employee, representative, officer or director of the Company or any Affiliate to cease their relationship with the Company or any Affiliate for any reason. Notwithstanding the foregoing, the Executive shall not violate this covenant by advertising not specifically targeted at any of the Company&#8217;s employees and serving as a reference upon request.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Non-Disparagement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During and after the Employment Term, the Executive agrees not to make any statement that criticizes, ridicules, disparages, or is otherwise derogatory of the Company&#59; provided, however, that nothing in this Agreement shall restrict the Executive from making truthful statements (a) when required by law, subpoena, court order or the like&#59; (b) when requested by a governmental, regulatory, or similar body or entity&#59; (c) in confidence to a professional advisor for the purpose of securing professional advice&#59; (d) in the course of performing the Executive&#8217;s duties during the Employment Term&#59; (e) pursuant to legal process between the Executive and the Company&#59; or (f) as reasonably necessary to correct false or misleading statements made by the Company about the Executive. In addition, the Company will instruct its executive officers and the Board not to disparage the Executive, directly or indirectly, to any person or entity.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.01pt;text-decoration:underline">Enforcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If any of the provisions or subparts of this Section 11 shall be held to be invalid or unenforceable by a court or arbitrator, the remaining provisions or subparts thereof shall nevertheless continue to be valid and enforceable according to their terms. Further, if any restriction contained in the provisions or subparts of this Section 11 is held to be overbroad or unreasonable as written (for example, in scope of activities restricted, duration, or geographic reach), the parties agree that such court or arbitrator shall modify such provisions in a manner to reflect the maximum period, scope or geographical area deemed reasonable and enforceable by the court or arbitrator, and such provisions, as modified, shall be fully enforceable as though set forth herein. Any such modification shall not affect the other provisions or clauses of this Agreement in any respect.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Remedies for Breach</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-42.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">Because the Executive&#8217;s services are unique and because the Executive has access to the Company&#8217;s and its Affiliates&#8217; Confidential Information, the parties agree that any breach or threatened breach of this Section 11 shall cause irreparable harm to the Company and&#47;or its Affiliates and that money damages alone would be an inadequate remedy. The parties therefore agree that, in the event of any breach or threatened breach of this Section 11, and in addition to all other rights and remedies available to it under this Agreement or otherwise, and whether in equity or at law, the Company and&#47;or its Affiliates may apply for specific performance and&#47;or injunctive or other relief, without a bond, in order to enforce or prevent any violations of the provisions of this Section 11. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-45.66pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">The Executive acknowledges and understands that, but for agreeing to be bound to the provisions of this Section 11, the Executive would not be entitled to receive the benefits and payments promised by the Company pursuant to Section 5, including all subparts thereto. The Executive agrees that any breach of this Section 11 during the twelve (12) month period following a Qualifying Termination would constitute a material breach of this Agreement and subjects the Executive to the forfeiture of all the aggregate after-tax proceeds of payments made pursuant to Section 5 of this Agreement (taking into account all amounts of tax that would be recoverable upon a claim of loss for payment of such proceeds in the year of repayment). The Company expressly reserves the right to pursue all other legal and equitable remedies available to it by virtue of any breach of this Section 11, including without limitation injunctive relief as provided in Section 11(g)(i) above. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-48.99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">The Executive acknowledges and agrees that the remedies provided for in this Section 11(g) are cumulative and not exclusive of any and other remedies available under this Agreement or otherwise, and whether in equity or at law, including other remedies provided under agreements related to bonuses and equity and equity-based awards. In that regard, the Executive acknowledges and agrees that, while the forfeiture of payments and benefits referenced in Section 11(g) is appropriate in the event of a breach of Section 11, injunctive relief to prevent a continuing breach would still be necessary to give the Company an adequate remedy.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The provisions of this Section 11 shall survive and continue in full force in accordance with their terms notwithstanding any termination of this Agreement or any termination of the Executive&#8217;s employment for any reason (whether voluntary or involuntary). </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Dispute Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except with respect to any claims by either Party for or concerning temporary and&#47;or preliminary injunctive relief as it relates to the specific performance of the restrictions set forth in Section 11(a) through 11(f) of this Agreement, any disputes under this Agreement shall, at the election of the Executive or the Company, be settled by arbitration in St. Louis, Missouri, in accordance with the Arbitration Rules of the American Arbitration Association for employment disputes, as modified herein, as determined by a panel of St. Louis arbitrators. Unless otherwise agreed, the arbitration shall be conducted within sixty (60) days of submission to arbitration and a decision shall be rendered within thirty (30) days of the conclusion of the arbitration hearing. Otherwise, any such dispute shall be resolved by a state court sitting in St. Louis County, Missouri or a Federal court sitting in St. Louis, Missouri, as described in Section 16. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. For purposes of this Agreement, the following terms shall have the definitions as set forth below&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean each and every direct or indirect parent or subsidiary of the Company, as well as any entity that is under common control with the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accrued Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean, as of the date of termination, the sum of (A) the Executive&#8217;s then-current Base Salary (disregarding any reduction constituting Good Reason) through the date of termination to the extent not theretofore paid, (B) any vacation pay, sick pay and expense reimbursements earned and accrued by the Executive as of the date of termination to the extent not theretofore paid, (C) any rights, entitlements or benefits to which the Executive is or becomes (or the Executive&#8217;s dependents are or become) entitled in accordance with the terms of any Company employee benefit plan or program. and (D) any accrued but unpaid Annual Bonus in respect of any prior completed fiscal year. For the purpose of this definition of &#8220;Accrued Obligations,&#8221; except as provided in the applicable plan, program or policy, amounts shall be deemed to accrue ratably over the period during which they are earned, but no discretionary compensation shall be deemed earned or accrued until it is specifically approved by the Board or a designee in accordance with the applicable plan, program or policy. In no event shall Accrued Obligations include any RSUs or PSUs outstanding. For the avoidance of doubt, if the Executive is terminated for any reason other than a Qualifying Termination the Executive shall only be entitled to Accrued Obligations, plus the benefits set forth in the last sentence of Section 3(d) to the extent applicable.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean acts or omissions that are (i) criminal, dishonest or fraudulent or constitute willful misconduct that adversely affects the reputation of the Company (including any parent, subsidiary, Affiliate or division of the Company), other than Limited Vicarious Liability (as defined below)&#59; (ii) acts or omissions that could reasonably be expected to expose the Company or any parent, subsidiary, Affiliate or division of the Company to liability for illegal harassment or discrimination in employment&#59; (iii) material breaches of this Agreement, which breaches if curable are not cured within thirty (30) days following written notice from the Company&#59; or (iv) willful and repeated refusal to perform, or willful and repeated failure to undertake good faith efforts to perform, substantially the duties of the Executive&#8217;s employment, which non-performance has continued for thirty (30) days following the Executive&#8217;s receipt of written notice from the Chief Executive Officer or the Board of such non-performance&#59; provided, that, poor performance shall not in and of itself constitute Cause. No action or inaction shall be treated as willful unless done or not done in bad faith and without an objectively reasonable belief it was in the best interests of the Company or any parent, subsidiary, Affiliate or division of the Company. Poor performance shall not in and of itself constitute Cause. Cause shall not occur as a result of actions or inactions based upon directions from the Board or advice of counsel to the Company. The Executive shall not be terminated for Cause absent a resolution by the Board and the opportunity to be heard (with his counsel present if he so elects) before the Board. For purposes of this Section 13(c), &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Limited Vicarious Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean any liability which is (A) based on acts of the Company for which the Executive is responsible solely as a result of his office(s) with the Company and (B) provided that (1) he was not directly involved in such acts and either had no prior knowledge of such intended actions or promptly acted reasonably and in good faith to attempt to prevent the acts causing such liability or (2) he did not have a reasonable basis to believe that a law was being violated by such acts.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the first to occur of any of the following&#59; provided, that for any distribution that is subject to Section 409A of the Code, a Change in Control under this Agreement shall be deemed to occur only if such event also satisfies the requirements under Treas. Regs. Section 1.409A-3(i)(5)&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-42.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">any Person (as defined in section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and as such term is modified in sections 13(d) and 14(d) of the Exchange Act), excluding a group of persons including the Executive , is or becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13(d)(3) under the Exchange Act), directly or indirectly, of securities of the Company representing forty percent (40%) or more of the combined voting power of the Company&#8217;s then-outstanding securities&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-45.66pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">individuals who, as of January 1, 2023, constituted the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incumbent Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), cease for any reason to constitute a majority thereof (provided, however, that an individual becoming a director subsequent to January 1, 2023 whose election, or nomination for election by the Company&#8217;s stockholders, was approved by at least a majority of the directors then comprising the Incumbent Board shall be included within the definition of Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual election contest (or such terms used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board)&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-48.99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">the stockholders of the Company consummate a merger or consolidation of the Company with any other corporation, other than a merger or consolidation that would result in (x) the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity (i.e., the ultimate parent entity if one exists)) at least fifty percent (50%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation and (y) the members of the board of directors of the Company as of the time of the Board&#8217;s approval of the execution of the initial agreement providing for such merger or consolidation continuing to represent a majority of the board of directors of the Company or such surviving entity (i.e., the ultimate parent entity if one exists) immediately after such merger or consolidation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the disability of the Executive as defined in Section 409A(a)(2)(C) of the Code.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Employee Retirement Income Security Act of 1974, as amended.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean without the Executive&#8217;s express written consent (i) a reduction in the Executive&#8217;s Base Salary or Annual Bonus or aggregate annual compensation opportunity, as compared to such amounts in the prior calendar year (or during the first calendar year of the Employment Term as compared to 2023), other than, prior to a Change in Control, any reduction solely to Base Salary that is also applicable in a substantially similar manner and proportion to the other senior executives of the Company generally, that is not in excess of an aggregate 10%, (ii) a material adverse change in the Executive&#8217;s title or position with the Company or the nature or scope of the Executive&#8217;s duties during the Employment Term, as in place immediately following the execution of this Agreement, or the Executive no longer reports solely and directly to the Chief Executive Officer, (iii) a demand by the Company during the Employment Term, as defined in Section 1, that the Executive relocate outside of the location at which the Executive was primarily working at the time of such demand, or (iv) a material breach by the Company or its Affiliates of this Agreement or any material compensation agreement. In order to effectuate a resignation with Good Reason, the Executive must provide written notice to the Company of the existence of Good Reason no later than ninety (90) days after the Executive&#8217;s knowledge of its initial existence, the Company shall have a period of thirty (30) days following its receipt of such written notice during which it may remedy in all material respects the Good Reason condition identified in such written notice. If the Company fails to remedy in all material respects such Good Reason condition, the Executive shall be permitted to terminate with Good Reason during the thirty (30) day period following the foregoing cure period.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean a termination of the Executive&#8217;s employment (a) by the Company without Cause, (b) by the Executive for Good Reason, or (c) due to death or Disability.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">No Mitigation&#59; Limited Offset</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In no event shall the Executive be obligated to seek other employment or take other action by way of mitigation of the amounts payable to the Executive hereunder, and such amounts shall not be reduced regardless whether the Executive obtains other employment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Reformation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as otherwise set forth in Section 11 of this Agreement, if any provision(s) of this Agreement shall be found invalid, illegal, or unenforceable, in whole or in part, then such provision(s) shall be deemed to be modified or restricted to the extent and in the manner necessary to render the same valid and enforceable or shall be deemed excised from this Agreement, as the case may require, and this Agreement shall be construed and enforced to the maximum extent permitted by law, as if such provision(s) had been originally incorporated herein as so modified or restricted or as if such provision(s) had not been originally incorporated herein, as the case may be.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Governing Law&#59; Venue for Disputes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement shall be governed under the internal laws of the State of Missouri, without regard to its conflict of law principles. The Executive agrees that, except as otherwise set forth in Section 12 above, the exclusive venue and jurisdiction for any litigation concerning the enforcement or enforceability of the terms of this Agreement, or for any litigation that in any way arises out of this Agreement or the Executive&#8217;s employment with the Company or any Affiliate, shall be the St. Louis County Circuit Court, in the State of Missouri or, if the federal court has subject matter jurisdiction (and at the option of the party pursuing the claim), in the United States District Court for the Eastern District of Missouri, and the Executive hereby&#58; (a) submits to the personal jurisdiction of such courts&#59; (b) consents to the service of process in connection with any action, suit, or proceeding against the Executive&#59; and (c) waives any other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction, venue or service of process.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Conflict</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If any provision of this Agreement conflicts with any other agreement, policy, plan, practice or other the Company document, then the provisions of this Agreement shall control. This Agreement shall supersede any prior agreement, including any Executive Severance and Change in Control Agreement, between the Executive and the Company with respect to the subject matter contained herein and may be amended only by a writing signed by an officer of the Company and the Executive.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent applicable, it is intended that the payment of the benefits, severance, incentive compensation and&#47;or equity compensation provided under this Agreement shall comply with or be exempt from the provisions of Section 409A of the Code, and this Agreement shall be construed and applied in a manner consistent with this intent. In the event any payment or benefit under this Agreement is determined by the Company to be in the nature of deferred compensation, the Company and the Executive hereby agree to take such actions, not otherwise provided herein, as may be mutually agreed between the parties to ensure that such payments remain exempt from or in compliance with the applicable provisions of Section 409A of the Code and the Treasury Regulations thereunder. Notwithstanding any provision of this Agreement to the contrary, if the Executive is a &#8220;specified employee&#8221; within the meaning of Section 409A, any payments due upon a termination of the Executive&#8217;s employment under any arrangement that constitutes a &#8220;deferral of compensation&#8221; within the meaning of Section 409A and which does not otherwise qualify under the exemptions under Treasury Regulation Section 1.409A-1 (including without limitation, the short-term deferral exemption or the permitted payments under Treasury Regulation Section 1.409A-1(b)(9)(iii)(A)), shall be delayed and paid or provided on the earlier of (i) the date which is six months after the Executive&#8217;s &#8220;separation from service&#8221; (as such term is defined in Section 409A and the Regulations and the other published guidance thereunder) for any reason other than death, and (ii) the date of the Executive&#8217;s death. To the extent that any payment or benefit under this Agreement is modified by reason of this Section 19, it shall be modified in a manner that complies with Section 409A and preserves to the maximum possible extent the economic costs or value thereof (as applies) to the respective parties (determined on a pre-tax basis).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company shall have the right to withhold from any amount payable hereunder any Federal, state, and local taxes in order that the Company satisfies any required withholding tax obligation it may have under any applicable law or regulation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement shall be binding upon and inure to the benefit of the Company and any successor or assign of the Company, including (without limitation) any corporation or other entity that may acquire all or substantially all of the assets of the Company, or with or into which the Company may be merged or consolidated, and any such successor or assign shall be deemed substituted for Employer under the provisions hereof&#59; provided, that, if the Company assigns this Agreement to an Affiliate it shall remain secondarily liable . The Executive further hereby consents to the assignment of this Agreement by the Company and waives any assertion or claim that the Executive&#8217;s contemporaneous consent for such an assignment is needed for the assignment to be effective. The Executive shall not be permitted to assign the Executive&#8217;s rights or obligations under this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Third-Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Executive acknowledges and agrees that, if the Executive provides any material services to, or receives any material confidential information concerning, any Affiliate of the Company, such other Affiliate(s) of the Company shall be deemed a third-party beneficiary of the Executive&#8217;s obligations under Section 11(a) of this Agreement and shall be permitted to enforce Section 11(a) of this Agreement against the Executive as if such Affiliate(s) were the Company hereunder.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as otherwise referenced herein, this Agreement constitutes the entire agreement of the parties and is the complete, final, and exclusive embodiment of their agreement with regard to this subject matter, and will supersede all prior agreements, understandings, discussions, negotiations and undertakings, whether written or oral, between the parties with respect to the subject matter hereof, including (i) the employment agreement, dated October 31, 2019, by and between Magellan Health Inc. and the Executive, and (ii) the Letter Agreement. No modification, amendment, or waiver of any of the provisions of this Agreement shall be effective or binding unless set forth in a writing signed by the parties hereto and specifically referring to this Agreement. Unless otherwise specifically agreed by the Executive and the Company in writing following the date hereof, the definitions of Cause, Good Reason and Disability set forth herein shall replace the definitions of those terms applicable to the Executive in any other agreement between the Company and the Executive or any Company plan applicable to the Executive and the restrictive covenants set forth in Section 11 herein shall replace the restrictive covenants applicable to the Executive with respect to any Company equity award or other plan or agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement may be executed in one or more counterparts, which together shall constitute a valid and binding agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div style="text-align:justify"><font><br></font></div></div></div><div id="if701299ef2314ab58413da27a4c43221_41"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Executive and the Company, by its duly authorized representatives, have executed this Agreement effective as of the date set forth below.</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXECUTIVE</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CENTENE CORPORATION</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Kenneth Fasola</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  &#47;s&#47; Sarah M. London                  </font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Kenneth Fasola</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Sarah M. London</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Chief Executive Officer</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">February 20, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">February 20, 2023</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div style="text-align:justify"><font><br></font></div></div></div><div id="if701299ef2314ab58413da27a4c43221_44"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A<br><br>FORM OF GENERAL RELEASE OF ALL CLAIMS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIS GENERAL RELEASE OF ALL CLAIMS (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">General Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), dated as of ________, is made by and between Kenneth Fasola (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and Centene Corporation (together with its successors and assigns, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Company and Executive are parties to that certain Employment Agreement, dated as of &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">DATE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, Executive&#8217;s employment with the Company has been terminated and Executive is entitled to receive severance and other benefits, as set forth in Section 5 of the Employment Agreement subject to the execution of this General Release&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, in consideration for Executive&#8217;s signing of this General Release, the Company will provide Executive with such severance and benefits pursuant to the Employment Agreement&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, except as otherwise expressly set forth herein, the parties hereto intend that this General Release shall effect a full satisfaction and release of the obligations described herein owed to Executive by the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the premises, the mutual covenants of the parties hereinafter set forth and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby covenant and agree as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Executive, for Executive, Executive&#8217;s spouse, heirs, administrators, children, representatives, executors, successors, assigns, and all other individuals and entities claiming through Executive, if any (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive Releasers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), does hereby release, waive, and forever discharge the Company and each of its respective agents, subsidiaries, parents, affiliates, related organizations, employees, officers, directors, attorneys, successors, and assigns in their capacities as such (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employer Releasees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) from, and does fully waive any obligations of Employer Releasees to Executive Releasers for, any and all liability, actions, charges, causes of action, demands, damages, or claims for relief, remuneration, sums of money, accounts or expenses (including attorneys&#8217; fees and costs) of any kind whatsoever, whether known or unknown or contingent or absolute, which heretofore has been or which hereafter may be suffered or sustained, directly or indirectly, by Executive Releasers in consequence of, arising out of, or in any way relating to&#58; (a) Executive&#8217;s employment with the Company&#59; (b) the termination of Executive&#8217;s employment with the Company&#59; (c) the Employment Agreement&#59; or (d) any events relating to Executive&#8217;s employment occurring on or prior to the date of this General Release. The foregoing release, discharge and waiver includes, but is not limited to, all waivable claims and any obligations or causes of action arising from such claims, under common law including wrongful or retaliatory discharge, breach of contract (including but not limited to any claims under the Employment Agreement other than claims for unpaid severance benefits, bonus or salary earned thereunder) and any action arising in tort including libel, slander, defamation or intentional infliction of emotional distress, and claims under any federal, state or local statute including the Age Discrimination in Employment Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1866 and 1871 (42 U.S.C. &#167; 1981), the National Labor Relations Act, the Fair Labor Standards Act, the Employee Retirement Income Security Act, the Americans with Disabilities Act of 1990, the Rehabilitation Act of 1973, or the discrimination or employment laws of any state or municipality, and&#47;or any claims under any express or implied contract which Executive Releasers may claim existed with Employer </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Releasees. This also includes a release of any claims for wrongful discharge and all other claims for alleged physical or personal injury, emotional distress relating to or arising out of Executive&#8217;s employment with the Company or any of its subsidiaries or affiliates or the termination of that employment&#59; and any claims under the WARN Act or any similar law, which requires, among other things, that advance notice be given of certain work force reductions. Notwithstanding anything contained in this Section 1 above to the contrary, nothing contained in herein shall constitute a release by any Executive Releaser of any of his, her or its rights or remedies available to him, her or it, at law or in equity, related to, on account of, in connection with or in any way pertaining to the enforcement of&#58; (i) any right to indemnification, advancement of legal fees or directors and officers liability insurance coverage existing under the constituent documents of the Company or applicable state corporate, limited liability company and partnership statutes or pursuant to any agreement, plan or arrangement&#59; (ii) any rights to the receipt of health, welfare or qualified retirement benefits which vested on or prior to the date of this General Release&#59; (iii) the right to continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act&#59; (iv) the right to receive worker&#8217;s compensation, or (v) this General Release or any of its terms or conditions.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Excluded from this General Release and waiver are any claims which cannot be waived by applicable law, including but not limited to the right to participate in an investigation conducted by certain government agencies. Executive does, however, waive Executive&#8217;s right to any monetary recovery should any government agency (such as the Equal Employment Opportunity Commission) pursue any claims on Executive&#8217;s behalf. Executive represents and warrants that Executive has not filed any complaint, charge, or lawsuit against the Employer Releasees with any government agency or any court.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Executive agrees never to seek personal recovery from any Employer Releasee in any forum for any claim covered by the above waiver and release language, except that Executive may bring a claim under the ADEA to challenge this General Release. If Executive violates this General Release by suing an Employer Releasee, then Executive shall be liable to the Employer Releasee so sued for such Employer Releasee&#8217;s reasonable attorneys&#8217; fees and other litigation costs incurred in defending against such a suit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">except that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> to the extent such suit includes claims under the ADEA or other claims that are excluded from the release set forth in Section 1 hereof, the Executive shall not be liable for paying for the attorneys&#8217; fees and costs associated with such ADEA or other excluded claims. Nothing in this General Release is intended to reflect any party&#8217;s belief that Executive&#8217;s waiver of claims under ADEA is invalid or unenforceable, it being the intent of the parties that such claims are waived.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Each party agrees that neither this General Release, nor the furnishing of the consideration for this General Release, shall be deemed or construed at any time to be an admission by any party of any improper or unlawful conduct.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Each party acknowledges and recites that he or it has&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i. executed this General Release knowingly and voluntarily&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii. had a reasonable opportunity to consider this General Release&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii. read and understands this General Release in its entirety&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv. been advised and directed orally and in writing (and this subparagraph (d) constitutes such written direction) to seek legal counsel and any other advice such party wishes with respect to the terms of this General Release before executing it&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v. relied solely on such party&#8217;s own judgment, belief and knowledge, and such advice as such party may have received from such party&#8217;s legal counsel.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Section 12 of the Employment Agreement, which shall survive the expiration of the Employment Agreement for this purpose, shall apply to any dispute with regard to this General Release.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Executive acknowledges and agrees that (a) Executive&#8217;s execution of this General Release has not been forced by any employee or agent of the Company, and Executive has had an opportunity to negotiate the terms of this General Release&#59; and (b) Executive has been offered twenty-one (21) calendar days after receipt of this General Release to consider its terms before executing it. Executive shall have seven (7) calendar days from the date he executes this General Release to revoke Executive&#8217;s waiver of any ADEA claims by providing written notice of the revocation to the Company. Such notice shall not be effective unless it is received by the Company within such seven-day period, and provided by the Executive (i) by personal delivery to the CEO or such other individual as may be identified by the Company at the time of Executive&#8217;s termination, or (ii) by FedEx or other nationally recognized overnight delivery service, or by first class mail with charges or postage prepaid and return receipt requested, in each case properly addressed to the Company at its principal office, or (iii) by such other method as may be designated by the Company at the time of Executive&#8217;s termination (for example, DocuSign or pdf attachment to email).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Capitalized terms used but not defined in this General Release have the meanings ascribed to such terms in the Employment Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">This General Release may be executed by the parties in one or more counterparts, each of which shall be an original and all of which shall together constitute one and the same instrument. Each counterpart may be delivered by facsimile transmission or e-mail (as a .pdf, .tif or similar un-editable attachment), which transmission shall be deemed delivery of an originally executed counterpart hereof.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this General Release as of the day and year first above written.</font></div><div style="margin-top:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CENTENE CORPORATION<br><br><br></font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.538%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="margin-top:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXECUTIVE</font></div><div style="margin-bottom:10pt;margin-top:24pt;padding-left:252pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.538%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Kenneth Fasola</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.25
<SEQUENCE>14
<FILENAME>a2022123110-kexhibit1025.htm
<DESCRIPTION>EX-10.25
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i226cbbfece9c4b02860fb5645f9be722_38"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT 10.25</font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTIVE EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In this Executive Employment Agreement, dated as of February 20, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), Centene Corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and James E. Murray (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), intending to be legally bound and for good and valuable consideration, agree as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">The Executive&#8217;s employment hereunder shall begin effective on the date above and shall continue until terminated by either party in accordance with Section 5 of this Agreement. The period during which the Executive is employed by the Company hereunder is hereby referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employment Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Position and Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During the Employment Term, the Executive shall serve as the Chief Operating Officer of the Company, reporting solely and directly to the Company&#8217;s President and shall continue to be a member of the &#8220;Office of the CEO&#8221; or similar c-suite executive leadership committee. The Executive shall have the duties, authority, and responsibilities as shall be determined from time to time by the President, which duties, authority, and responsibilities are consistent with the Executive&#8217;s position.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During the Employment Term, the Executive shall devote substantially all of the Executive&#8217;s business time and attention to the performance of the Executive&#8217;s duties hereunder and shall not engage in any other business, profession, or occupation for compensation or otherwise which would conflict or interfere with the performance of such services either directly or indirectly without the prior written consent of the Board of Directors (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Executive may serve on trade, civic or charitable boards and, subject to prior approval by the Board, the board of directors of one (1) other for-profit company, that does not compete as described in Section 11(d), of the Executive&#8217;s choice, and may manage personal investments and affairs to the extent such activities do not materially interfere with the performance of the Executive&#8217;s duties and responsibilities hereunder.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Travel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Executive&#8217;s principal business location shall be in Texas. The Executive acknowledges and agrees that the Executive may be required to travel on Company business, as reasonably needed to meet the Company&#8217;s objectives, during the Employment Term.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Effective January 1, 2023, the Company shall pay the Executive an annual base salary of $750,000 in periodic installments in accordance with the Company&#8217;s customary payroll practices and applicable wage payment laws, but no less frequently than monthly. The Executive&#8217;s base salary shall be reviewed at least annually by the Compensation Committee of the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and the Compensation Committee may, but shall not be required to, increase the base salary during the Employment Term. However, the Executive&#8217;s base salary may not be decreased during the Employment Term other than as part of an across-the-board salary reduction that applies in the same manner to all senior executives generally, subject to Section 13(h). The Executive&#8217;s annual base salary, as in effect from time to time, is hereinafter referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221; Any unpaid portion of Base Salary from January 1, 2023 through the date of execution of this Agreement shall be paid in a lump sum in accordance with the Company&#8217;s customary payroll practices on March 3, 2023.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During the Employment Term (effective beginning with the 2023 calendar year), the Executive shall be eligible to receive an annual bonus based on the achievement of performance goals established and evaluated by the Compensation Committee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Executive&#8217;s annual target bonus opportunity shall be equal to 100% of the Executive&#8217;s Base Salary (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Target Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Annual Bonus, if any, shall be paid within two and a half (2 1&#47;2) months after the end of the year during which the Annual Bonus is earned.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Long-Term Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the first quarter of 2023, the Executive shall be entitled to receive an equity award under the Company&#8217;s 2012 Stock Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Stock Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) with an aggregate annual grant date target value equal to $4,250,000 (subject to any delay required by applicable securities law). Following 2023, the amount of the Executive&#8217;s annual long term incentive grants shall be determined in the discretion of the Compensation Committee (taking into account individual and Company performance and market compensation levels for similarly-situated senior executives). The allocation of long-term incentive compensation awards amongst types of awards, and any applicable performance measures, shall be determined by the Compensation Committee in its sole discretion, but shall be consistent with the percentages and performance targets assigned to awards granted in the same performance cycle to similarly situated senior executives of the Company. Under the equity program in effect as of the date of this Agreement, 35% of the long-term incentive compensation awards will be in the form of restricted stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and 65% will be in the form of performance share units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). Under the current program, all RSUs are subject to three-year graded vesting, and all PSUs are subject to three-year cliff vesting (in each case, with settlement upon vesting). All RSUs and PSUs shall be subject to the terms of the Stock Plan and award agreements to be executed by the Executive and the Company. Except as set forth in the following sentence, the award agreements shall be in the same form applicable to similarly situated senior executives of the Company, and shall provide that units shall be settled as soon as practicable following the applicable vesting date. Upon the Executive&#8217;s termination of employment by the Company or by the Executive for any reason whether voluntary or involuntary (other than a termination of employment by the Company for Cause), all long-term incentive compensation awards granted after the date of this Agreement will continue to vest according to their terms (disregarding any ongoing service requirements), without pro-ration, and with PSUs eligible to be earned based upon the attainment of the applicable performance metrics.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Legacy Company Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in that certain Agreement and Plan of Merger between the Company and Magellan Health Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transaction Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the remaining unvested 50% of the Executive&#8217;s Company Equity Awards (as defined in the Transaction Agreement) that were converted into corresponding awards of the Company (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Legacy Company Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) (other than the Company Stock Options (as defined in the Transaction Agreement) will vest on the second anniversary of the Closing Date (as defined in the Transaction Agreement), subject to continued employment with the Company or one of its affiliates through the vesting date. Such Legacy Company Equity Awards shall be settled on the vesting date or as soon as practicable thereafter (but not more than five business days thereafter). For the avoidance of doubt, in the event the Executive&#8217;s employment is terminated without Cause or by the Executive with Good Reason on or prior to the second anniversary of the Closing Date, the Legacy Company Equity Awards will vest on the date of the Executive&#8217;s termination. Company Stock Options shall continue to vest on their normal vesting schedules.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Executive and&#47;or the Executive&#8217;s dependents, as the case may be, shall participate in employee and executive retirement, medical, dental, vision, disability, group and&#47;or executive life, accidental death and travel accident insurance, and similar benefit plans and programs of the Company, subject to the terms and conditions thereof, as in effect from time to time with respect generally to senior executives employed by the Company. The Executive shall be entitled to be paid these benefits upon termination in accordance with the terms of the applicable employee benefit plans, or, if not governed by ERISA, pursuant to the policies and practices of the Company as in effect from time to time with respect to senior executives employed by the Company. In addition, the Executive shall be entitled to personal use of the Company&#8217;s corporate aircraft in accordance with the policies of the Company in effect from time to time, up to a maximum of 20 hours per year.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Severance Pay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Employment Term and the Executive&#8217;s employment hereunder may be terminated by either the Company or the Executive at any time and for any reason&#59; provided that, unless otherwise provided herein, (i) the Executive shall be required to give the Company at least ninety (90) days&#8217; advance written notice of the Executive&#8217;s intent to retire or otherwise terminate his employment, and (ii) the Company shall be required to give the Executive at least sixty (60) days&#8217; advance written notice of the termination of the Executive&#8217;s employment for any reason other than for Cause. Should the Executive&#8217;s employment with the Company be terminated due to a Qualifying Termination that is not a Change in Control Termination, in addition to the Accrued Obligations, the Company agrees to pay or provide the following compensation and benefits during the severance period and the Executive shall have no further rights to any compensation or any other benefits from the Company&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">Severance pay to the Executive in the form of a cash lump sum payment equal to the Executive&#8217;s annual Base Salary determined using the Executive&#8217;s then-current Base Salary (disregarding any reduction constituting Good Reason or any reduction made in the preceding six (6) month period), with such amount payable to the Executive on the sixtieth (60th) day after the termination date.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">A prorated Annual Bonus for the year in which the Executive&#8217;s date of termination occurs based on the degree of achievement of goals under the bonus program in effect at the time of termination and the portion of the year elapsed as of the date of termination. The degree of achievement of goals shall be determined in accordance with the bonus program, except that should any goals be of a subjective nature, the degree of achievement therefore shall be determined by the Company in its sole discretion. Any such bonus amount shall be paid in a single, lump sum payment at the same time as Annual Bonuses for the year are paid to the Company&#8217;s officers generally. The Executive shall also receive any prior Annual Bonus which has been achieved and accrued, but not paid at the time of termination. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">Subject to Section 11, during the twelve (12) month period of salary continuation described in (a) above, the Company shall pay for a portion of the health, dental, prescription drug and vision insurance continuation coverage (collectively &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medical Coverage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to which the Executive is entitled under the Consolidated Omnibus Budget Reconciliation Act of 1985 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) on behalf of the Executive, and as applicable, the Executive&#8217;s spouse and dependents, subject to the Executive&#8217;s timely election of COBRA healthcare continuation coverage. For such twelve (12) month period, the terminated the Executive shall be responsible to pay contributions for Medical Coverage provided under this Section 5(c) in the same amount as is charged to similar active employees for similar coverage, rather than the full COBRA premium amount, and the Company shall pay the remainder of the COBRA premium amount.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The Executive&#8217;s then-outstanding RSUs, PSUs or other equity-based or long-term cash incentive awards (including, but not limited to, any Company equity-based or long-term cash incentive awards granted in calendar year 2022), if any, shall remain subject to the vesting and forfeiture terms set forth in their award agreements (or the letter agreement dated June 9, 2021, by and between the Company and the Executive, as applicable (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;))&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, however, that awards granted following the date of this Agreement shall continue to vest consistent with the terms of Section 3(c)&#59; and provided further, that with respect to any equity-based or long-term cash incentive award outstanding on the date of the Qualifying Termination, the Executive will receive no less than an additional 12 months of service credit. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">For a period of up to six (6) months from the date of the Qualifying Termination, the Company shall provide outplacement services to the Executive that are comparable to other executives at this level who have terminated. Outplacement services shall be provided by an entity selected by the Company. The Executive shall use best efforts, consistent with the terms of Section 11, to become gainfully employed during the period the Executive is receiving benefits under this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.01pt">Notwithstanding the foregoing, should the Executive&#8217;s employment with the Company be terminated prior to May 31, 2024 due to a Qualifying Termination that is not a Change in Control Termination, in lieu of the cash severance payable under Section 5(a) of this Agreement but in addition to the other payments and benefits under Sections 5(b)-(e) of this Agreement, the Executive shall be entitled to severance pay in a cash lump sum payment equal to the product of (x) the sum of (i) the Executive&#8217;s Base Salary, plus (ii) the Annual Bonus paid to the Executive in the calendar year prior to the year in which the Qualifying Termination occurs, multiplied by (y) 2.5, with such amount payable to the Executive on the sixtieth (60</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) day after the termination date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, however, that in no event shall the amount payable under this section 5(f) exceed the maximum amount payable under the Company&#8217;s Executive Officer Cash Severance Policy. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">If amounts are payable under this Section 5, no additional amounts shall be payable under Section 7 of this Agreement (unless Section 6(a)(ii) becomes applicable), nor any other agreement between the parties, which shall include, and not be limited to, any Executive Severance and Change in Control Agreement as well as any severance pay plan generally maintained by the Company for its employees. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company shall pay to the Executive the severance described in Section 7 if the Executive experiences a Qualifying Termination that occurred under the circumstances described below (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Control Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">On the day of, or within twenty-four (24) months after, the occurrence of a Change in Control&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Prior to a Change in Control but at the request of any third party participating in or causing the Change in Control or during the one hundred twenty (120) day period prior to a Change in Control.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Change in Control Severance Pay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the event of a Change in Control Termination, in addition to the Accrued Obligations, the Company agrees to provide the Executive the following&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">Severance pay equal to the product of (x) the sum of (i) the Executive&#8217;s Base Salary, plus (ii) the average of the last two (2) Annual Bonuses paid to the Executive during the two (2) most recently completed full fiscal years of the Company, multiplied by (y) two (2). Such amount shall be paid in an undiscounted lump sum on the sixtieth (60th) day after the termination date. For purposes of calculating the amount of severance in this Section 7(a) and Section 7(b) due as a result of a Change in Control Termination, the Executive&#8217;s Base Salary shall be based on the highest amount of such Base Salary during the two (2) year period ending on the date of termination.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">A prorated Target Bonus for the year in which such termination occurs, paid in an undiscounted lump sum on the sixtieth (60th) day after the termination date.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">During the eighteen (18) month period following the Change in Control Termination, the Company shall pay for the Executive&#8217;s entire Medical Coverage to which the Executive is entitled under COBRA. If the Company purchased a life insurance policy for the benefit of the Executive&#8217;s beneficiaries prior to the Change in Control, the Company shall continue to maintain and pay all expenses associated with the corporate-owned life insurance policy for the remainder of the Executive&#8217;s life. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Any RSUs, PSUs or other equity-based awards that were outstanding immediately prior to the Change in Control Termination shall, to the extent not then vested, fully vest and become exercisable as of the date of the Change in Control Termination and the Executive shall have the right to exercise any such stock option or stock appreciation right until the earlier to occur of (i) one (1) year from the date of the Change in Control Termination and (ii) the expiration date of such stock option or stock appreciation right or other equity-based award as set forth in the agreement evidencing such award. Any PSUs that were outstanding immediately prior to the Change in Control Termination shall vest at the greater of the actual performance level at the time of the Change in Control event or at target performance level, in each case, without pro-ration.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">If amounts are payable under this Section 7, no amounts shall be payable under Section 5 of this Agreement, nor any other agreement between the parties, which shall include, and not be limited to, any Executive Severance and Change in Control Agreement as well as any severance pay plan generally maintained by the Company for its employees. Notwithstanding the foregoing, the amounts payable pursuant to this Section 7 shall be reduced by any amounts previously paid to the Executive pursuant to Section 5 and no duplication of payments shall occur.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If, for any reason, any part or all of the amounts payable to the Executive under this Agreement (or otherwise, if such amounts are in the nature of compensation paid or payable by the Company or any of its subsidiaries after there has been a Change in Control) (collectively &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Total Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) are deemed to be &#8220;excess parachute payments&#8221; within the meaning of Section 280G(b)(1) of the Code or any successor or similar provision, and would be subject to the excise tax imposed by Section 4999 of the Code or any successor or similar provision, such Total Payments shall be reduced to the extent necessary such that no amounts paid or payable to the Executive shall be deemed excess parachute payments subject to excise tax under Section 4999 of the Code&#59; provided, however, that no such reduction shall occur if (i) the net amount of such Total Payments as so reduced (and after subtracting the net amount of federal, state and local income taxes on such reduced Total Payments) is less than (ii) the net amount of such Total Payments without such reduction (but after subtracting the net amount of federal, state and local income taxes on such unreduced Total Payments and the amount of excise </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">taxes to which the Executive would be subject in respect of such unreduced Total Payments). All determinations required to be made under this Section 8 and the assumptions to be utilized in arriving at such determination shall be made by an independent, nationally recognized accounting firm designated by the Company prior to the Change in Control (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Auditor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Auditor shall provide detailed supporting calculations to both the Company and the Executive within fifteen (15) business days of the receipt of notice from the Executive or the Company that there has been a payment, or such earlier time as is requested by the Company. All fees and expenses of the Auditor shall be paid by the Company. All determinations made by the Auditor shall be binding upon the Company and the Executive.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The parties agree that certain matters in which the Executive shall be involved during the Employment Term may necessitate the Executive&#8217;s cooperation in the future. Accordingly, during the 24-month period following the termination of the Executive&#8217;s employment for any reason, to the extent reasonably requested by the Board, the Executive shall cooperate with the Company to provide truthful information in connection with matters arising out of the Executive&#8217;s service to the Company&#59; provided that, such cooperation shall be subject to the Executive&#8217;s personal and business commitments, the Company shall make reasonable efforts to minimize disruption of the Executive&#8217;s other activities and the Executive shall receive reasonable compensation, as to be agreed by the parties, for the Executive&#8217;s cooperation in excess of eight (8) hours per month. The Company shall reimburse Executive for all reasonable expenses incurred in connection with cooperation including travel costs, and if determined in good faith to be reasonably appropriate by the Executive, the reasonable fees incurred by independent counsel for the Executive (subject to the good faith prior approval of the Company&#8217;s general counsel). The Executive shall not be required to cooperate against his own legal interests or those of a subsequent employer or business partner.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any payments or benefits made or provided pursuant to this Agreement are subject to the Executive&#8217;s&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-42.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">compliance in all material respects with the provisions of Section 11 hereof (provided, that, the Company shall provide the Executive with written notice of any such failure to comply and not less than thirty (30) days to cure, if curable)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-45.66pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">with respect to payments under Sections 5, 7 and the last sentence of 3(c), delivery to the Company, within 45 days following the Executive&#8217;s termination date, of an executed full and complete release of claims, in the form attached hereto as Exhibit A, with such terms as needed under then applicable law to give full effect to its intent and purpose (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-48.99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">delivery to the Company of a resignation from all offices, directorships and fiduciary positions with the Company, its affiliates and employee benefit plans.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the due date of any post-employment payments, any amounts due under this Agreement shall not be due until after the expiration of any revocation period applicable to the Release. Nevertheless, upon any termination of the Executive&#8217;s employment, the Executive shall be entitled to receive the Accrued Obligations, payable within thirty (30) days after the date of termination or in accordance with the applicable plan, program or policy.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Executive&#8217;s Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Executive acknowledges that the above consideration, absent this Agreement, is beyond what the Company is obligated to pay. In consideration for the Executive&#8217;s employment, the opportunity for the payments and benefits specified in this Agreement, and the Company allowing the Executive to have access (or continue to have access) to the Company&#8217;s or its Affiliates&#8217; Confidential Information, the Executive agrees to the following, which shall continue to apply in the event the Executive&#8217;s employment is terminated by either party for any reason, whether voluntary or involuntary and whether with or without Cause or with or without Good Reason.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. As used in this Section 11, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Company&#8217;s and the Affiliates&#8217; trade secrets and other non-public proprietary information relating to the Company and the Affiliates or the business of the Company and the Affiliates, including, but not limited to, information relating to financial statements, customer lists and customer information, employee skills and compensation, employee data, supplier lists and supplier information, vendor lists and vendor information, acquisition targets, servicing methods, equipment, programs, strategies and information, analyses, marketing plans and strategies, new and proposed product plans&#59; pricing, profit margins, financial, promotional, marketing, training or operational information, customer lists and customer information, and other information developed or used by the Company that is not known generally to the public or the industry. Confidential Information shall not include any information that is in the public domain or becomes known in the public domain through no wrongful act on the part of the Executive.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Executive agrees that the Confidential Information is a valuable, special and unique asset of the Company&#8217;s business, that such Confidential Information is important to the Company and the effective operation of the Company&#8217;s business. As such and in addition to the other restrictions contained in this Section 11, the Executive shall not, either during the Executive&#8217;s employment with the Company and at all times thereafter, directly or indirectly use, disclose, divulge or communicate in any fashion, form or manner to any person, firm, partnership, corporation or other entity, or use for the Executive&#8217;s own benefit, any trade secrets (whether patentable or not) or any Confidential Information except to the limited extent that such disclosure or use is both authorized and reasonably required in connection with the Executive&#8217;s employment. Notwithstanding the foregoing provisions of Section 11(b), the Executive may disclose information if required by applicable law or a court order or subpoena requested by a governmental or self-regulatory organization or as reasonably necessary in connection with any legal process between Executive and the Company or any of its subsidiaries or Affiliates, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">except that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (i) in the case of disclosure required by law, court order or subpoena, to the extent legally permitted, the Executive shall inform the Company immediately upon becoming aware of the requirement to disclose or, if applicable, upon receipt of the court order or subpoena, and, to the extent legally permitted, shall not disclose until the Company has had a reasonable opportunity to review and object to such disclosure&#59; and (ii) in the case of disclosure in connection with any legal process, the Executive shall only be permitted to disclose to the parties to the legal process, and then only as may be consistent with any confidentiality stipulation or protective order as may be in effect in such legal process. The Company shall reimburse the Executive for all reasonable legal costs incurred in complying with the foregoing sentence. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-42.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:36pt">Defend Trade Secrets Act Notice to Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding the foregoing and any other terms of this Agreement, the Executive will not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that&#58; (A) is made (i) in confidence to a Federal, State, or </font></div><div style="padding-left:108pt;text-align:justify;text-indent:-44.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:36pt">local government official, either directly or indirectly, or to an attorney, and (ii) solely for the purpose of reporting or investigating a suspected violation of law&#59; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, if the Executive files a lawsuit for retaliation by the Company or any of its Affiliates for reporting a suspected violation of law, the Executive may disclose the trade secret to Employee&#8217;s attorney and use the trade secret information in the court proceeding if the Executive files any document containing the trade secret under seal and does not disclose the trade secret except pursuant to court order.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Property of Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any Confidential Information, and all other business information or documents, shall be and remain solely and exclusively the property of the Company and&#47;or its Affiliates. During his or her employment, the Executive shall not remove from the property or premises of the Company or its Affiliates any Confidential Information or any other documents or data relating to the business, work, services or sales of the Company and&#47;or its Affiliates, or copies thereof, unless authorized by the Company and&#47;or its Affiliates and required for the Executive to perform his or her employment duties. Upon the termination of the Executive&#8217;s employment regardless of whether such termination is with or without Cause or with or without Good Reason, or at any other time requested by the Company or its Affiliates, the Executive shall promptly deliver all documents, files, devices and other items (whether maintained in electronic or hard copy format) obtained in the course of his or her employment, whether or not the Executive believes such items constitute or contain Confidential Information, and without retaining any copies, notes, or excerpts thereof. Notwithstanding the foregoing, the Executive may retain the Executive&#8217;s contacts, calendars, personal correspondence, and all information and documentation reasonably needed for the Executive&#8217;s personal tax return preparation purposes.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Non-Competition&#59; Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-42.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">During the Employment Term and for twelve (12) months after the termination of the Executive&#8217;s employment with the Company (including any parent, subsidiary, Affiliate or division of the Company) for any reason whatsoever, whether voluntary or involuntary and whether with or without Cause or with or without Good Reason, the Executive shall not directly or indirectly counsel, advise, consult, be employed or otherwise engaged, in each case, in a strategic, managerial or executive role, by or with any entity or enterprise (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Competitor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) that competes, or that intends or plans to compete with (A) any area of business in which the Company or any Affiliate is engaged, and in which the Executive was engaged, participated in or about which the Executive learned Confidential Information during the Executive&#8217;s last thirty-six (36) months of employment, or (B) any other area of business for which the Company or any Affiliate has taken substantial steps towards becoming engaged, and in which the Executive was engaged, participated in or about which the Executive learned Confidential Information during the Executive&#8217;s last 36 </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">months of employment. Because the Company and its Affiliates engage in business nationwide, the obligations under this Section 11(d) shall apply nationwide (anywhere in the United States). Notwithstanding the foregoing, Executive shall not violate this provision by providing services to a unit, division, subsidiary or affiliate of a Competitor which otherwise engages in activities competitive with the business activities of the Company if such unit, division, subsidiary or affiliate for which Executive provides services does not engage in such business activities. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-45.66pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">During the Employment Term and for the period of twelve (12) months immediately after the termination of the Executive&#8217;s employment with the Company (or any parent, subsidiary, affiliate or division of the Company) for any reason whatsoever, and whether voluntary or involuntary, and whether with or without Cause or with or without Good Reason (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Executive shall not, either directly or indirectly, either for the Executive or for any other person, firm, company or corporation, call upon, solicit, divert, or take away, or attempt to solicit, divert or take away any of the customers, prospective customers, business, providers, vendors or suppliers of the Company or any Affiliate that (at any time during the last three years of the Executive&#8217;s employment) the Executive had dealings with, or responsibility for, or about which the Executive had access to the Company&#8217;s (or any Affiliate&#8217;s) Confidential Information or such customers&#8217;, providers&#8217;, vendors&#8217; or suppliers&#8217; confidential information. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-48.99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">The Executive shall not, at any time during the Restricted Period, without the prior written consent of the Company, (1) directly or indirectly, solicit, recruit, divert from the Company, hire, or employ (whether as an employee, officer, director, agent, consultant or independent contractor) any person who was or is at any time during the previous six (6) months an employee, representative, officer or director of the Company or any Affiliate&#59; or (2) take any action to encourage or induce any employee, representative, officer or director of the Company or any Affiliate to cease their relationship with the Company or any Affiliate for any reason. Notwithstanding the foregoing, the Executive shall not violate this covenant by advertising not specifically targeted at any of the Company&#8217;s employees and serving as a reference upon request.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-48.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">The Executive hereby confirms that prior to the date hereof Executive has informed eHealth that the Executive will not serve on the board of directors of eHealth and the Executive confirms and agrees that the Executive has not since June 8, 2021, and will not in the future, participate in any committee or other meetings of the board of directors of eHealth as an observer or otherwise or hold himself out in any way as a current or future member of the board of directors of eHealth. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt;text-decoration:underline">Non-Disparagement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During and after the Employment Term, the Executive agrees not to make any statement that criticizes, ridicules, disparages, or is otherwise derogatory of the Company&#59; provided, however, that nothing in this Agreement shall restrict the Executive from making truthful statements (a) when required by law, subpoena, court order or the like&#59; (b) when requested by a governmental, regulatory, or similar body or entity&#59; (c) in confidence to a professional advisor for the purpose of securing professional advice&#59; (d) in the course of performing the Executive&#8217;s duties during the Employment Term&#59; (e) pursuant to legal process between the Executive and the Company&#59; or (f) as reasonably necessary to correct false or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">misleading statements made by the Company about the Executive. In addition, the Company will instruct its executive officers and the Board not to disparage the Executive, directly or indirectly, to any person or entity.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.01pt;text-decoration:underline">Enforcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If any of the provisions or subparts of this Section 11 shall be held to be invalid or unenforceable by a court or arbitrator, the remaining provisions or subparts thereof shall nevertheless continue to be valid and enforceable according to their terms. Further, if any restriction contained in the provisions or subparts of this Section 11 is held to be overbroad or unreasonable as written (for example, in scope of activities restricted, duration, or geographic reach), the parties agree that such court or arbitrator shall modify such provisions in a manner to reflect the maximum period, scope or geographical area deemed reasonable and enforceable by the court or arbitrator, and such provisions, as modified, shall be fully enforceable as though set forth herein. Any such modification shall not affect the other provisions or clauses of this Agreement in any respect.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Remedies for Breach</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-42.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">Because the Executive&#8217;s services are unique and because the Executive has access to the Company&#8217;s and its Affiliates&#8217; Confidential Information, the parties agree that any breach or threatened breach of this Section 11 shall cause irreparable harm to the Company and&#47;or its Affiliates and that money damages alone would be an inadequate remedy. The parties therefore agree that, in the event of any breach or threatened breach of this Section 11, and in addition to all other rights and remedies available to it under this Agreement or otherwise, and whether in equity or at law, the Company and&#47;or its Affiliates may apply for specific performance and&#47;or injunctive or other relief, without a bond, in order to enforce or prevent any violations of the provisions of this Section 11. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-45.66pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">The Executive acknowledges and understands that, but for agreeing to be bound to the provisions of this Section 11, the Executive would not be entitled to receive the benefits and payments promised by the Company pursuant to Section 5, including all subparts thereto. The Executive agrees that any breach of this Section 11 during the twelve (12) month period following a Qualifying Termination would constitute a material breach of this Agreement and subjects the Executive to the forfeiture of all the aggregate after-tax proceeds of payments made pursuant to Section 5 of this Agreement (taking into account all amounts of tax that would be recoverable upon a claim of loss for payment of such proceeds in the year of repayment). The Company expressly reserves the right to pursue all other legal and equitable remedies available to it by virtue of any breach of this Section 11, including without limitation injunctive relief as provided in Section 11(g)(i) above. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-48.99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">The Executive acknowledges and agrees that the remedies provided for in this Section 11(g) are cumulative and not exclusive of any and other remedies available under this Agreement or otherwise, and whether in equity or at law, including other remedies provided under agreements related to bonuses and equity and equity-based awards. In that regard, the Executive acknowledges and agrees that, while the forfeiture of payments and benefits referenced in Section 11(g) is appropriate in the event of a breach of Section 11, injunctive relief to prevent a continuing breach would still be necessary to give the Company an adequate remedy.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The provisions of this Section 11 shall survive and continue in full force in accordance with their terms notwithstanding any termination of this Agreement or any termination of the Executive&#8217;s employment for any reason (whether voluntary or involuntary). </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Dispute Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except with respect to any claims by either Party for or concerning temporary and&#47;or preliminary injunctive relief as it relates to the specific performance of the restrictions set forth in Section 11(a) through 11(f) of this Agreement, any disputes under this Agreement shall, at the election of the Executive or the Company, be settled by arbitration in St. Louis, Missouri, in accordance with the Arbitration Rules of the American Arbitration Association for employment disputes, as modified herein, as determined by a panel of St. Louis arbitrators. Unless otherwise agreed, the arbitration shall be conducted within sixty (60) days of submission to arbitration and a decision shall be rendered within thirty (30) days of the conclusion of the arbitration hearing. Otherwise, any such dispute shall be resolved by a state court sitting in St. Louis County, Missouri or a Federal court sitting in St. Louis, Missouri, as described in Section 16. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. For purposes of this Agreement, the following terms shall have the definitions as set forth below&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean each and every direct or indirect parent or subsidiary of the Company, as well as any entity that is under common control with the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accrued Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean, as of the date of termination, the sum of (A) the Executive&#8217;s then-current Base Salary (disregarding any reduction constituting Good Reason) through the date of termination to the extent not theretofore paid, (B) any vacation pay, sick pay and expense reimbursements earned and accrued by the Executive as of the date of termination to the extent not theretofore paid, (C) any rights, entitlements or benefits to which the Executive is or becomes (or the Executive&#8217;s dependents are or become) entitled in accordance with the terms of any Company employee benefit plan or program. and (D) any accrued but unpaid Annual Bonus in respect of any prior completed fiscal year. For the purpose of this definition of &#8220;Accrued Obligations,&#8221; except as provided in the applicable plan, program or policy, amounts shall be deemed to accrue ratably over the period during which they are earned, but no discretionary compensation shall be deemed earned or accrued until it is specifically approved by the Board or a designee in accordance with the applicable plan, program or policy. In no event shall Accrued Obligations include any RSUs or PSUs outstanding. For the avoidance of doubt, if the Executive is terminated for any reason other than a Qualifying Termination the Executive shall only be entitled to Accrued Obligations, plus the benefits set forth in the last sentence of Section 3(c) to the extent applicable.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean acts or omissions that are (i) criminal, dishonest or fraudulent or constitute willful misconduct that adversely affects the reputation of the Company (including any parent, subsidiary, Affiliate or division of the Company), other than Limited Vicarious Liability (as defined below)&#59; (ii) acts or omissions that could reasonably be expected to expose the Company or any parent, subsidiary, Affiliate or division of the Company to liability for illegal harassment or discrimination in employment&#59; (iii) material breaches of this Agreement, which breaches if curable are not cured within thirty (30) days following written notice from the Company&#59; or (iv) willful and repeated refusal to perform, or willful and repeated failure to undertake good faith efforts to perform, substantially the duties of the Executive&#8217;s employment, which non-performance has continued for thirty (30) days following the Executive&#8217;s receipt of written notice from the Chief Executive Officer or the Board of such non-performance&#59; provided, that, poor performance shall not in and of itself constitute Cause. No action or inaction shall be treated as willful unless done or not done in bad faith and without an objectively reasonable belief it was in the best interests of the Company or any parent, subsidiary, Affiliate or division of the Company. Poor performance shall not in and of itself constitute Cause. Cause shall not </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">occur as a result of actions or inactions based upon directions from the Board or advice of counsel to the Company. The Executive shall not be terminated for Cause absent a resolution by the Board and the opportunity to be heard (with his counsel present if he so elects) before the Board. For purposes of this Section 13(c), &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Limited Vicarious Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean any liability which is (A) based on acts of the Company for which the Executive is responsible solely as a result of his office(s) with the Company and (B) provided that (1) he was not directly involved in such acts and either had no prior knowledge of such intended actions or promptly acted reasonably and in good faith to attempt to prevent the acts causing such liability or (2) he did not have a reasonable basis to believe that a law was being violated by such acts.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the first to occur of any of the following&#59; provided, that for any distribution that is subject to Section 409A of the Code, a Change in Control under this Agreement shall be deemed to occur only if such event also satisfies the requirements under Treas. Regs. Section 1.409A-3(i)(5)&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-42.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">any Person (as defined in section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and as such term is modified in sections 13(d) and 14(d) of the Exchange Act), excluding a group of persons including the Executive , is or becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13(d)(3) under the Exchange Act), directly or indirectly, of securities of the Company representing forty percent (40%) or more of the combined voting power of the Company&#8217;s then-outstanding securities&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-45.66pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">individuals who, as of January 1, 2023, constituted the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incumbent Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), cease for any reason to constitute a majority thereof (provided, however, that an individual becoming a director subsequent to January 1, 2023 whose election, or nomination for election by the Company&#8217;s stockholders, was approved by at least a majority of the directors then comprising the Incumbent Board shall be included within the definition of Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual election contest (or such terms used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board)&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-48.99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:36pt">the stockholders of the Company consummate a merger or consolidation of the Company with any other corporation, other than a merger or consolidation that would result in (x) the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity (i.e., the ultimate parent entity if one exists)) at least fifty percent (50%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation and (y) the members of the board of directors of the Company as of the time of the Board&#8217;s approval of the execution of the initial agreement providing for such merger or consolidation continuing to represent a majority of the board of directors of the Company or such surviving entity (i.e., the ultimate parent entity if one exists) immediately after such merger or consolidation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Internal Revenue Code of 1986, as amended.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the disability of the Executive as defined in Section 409A(a)(2)(C) of the Code.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Employee Retirement Income Security Act of 1974, as amended.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean without the Executive&#8217;s express written consent (i) a reduction in the Executive&#8217;s Base Salary or Annual Bonus or aggregate compensation opportunity, as compared to such amounts in the prior calendar year (or during the first calendar year of the Employment Term as compared to 2023), other than, prior to a Change in Control, any reduction solely to Base Salary that is also applicable in a substantially similar manner and proportion to the other senior executives of the Company generally, that is not in excess of an aggregate 10%, (ii) a material adverse change in the Executive&#8217;s title or position with the Company or the nature or scope of the Executive&#8217;s duties during the Employment Term, as in place immediately following the execution of this Agreement, or the Executive no longer reports solely and directly to the President, (iii) a demand by the Company during the Employment Term, as defined in Section 1, that the Executive relocate outside of the location at which the Executive was primarily working at the time of such demand, or (iv) a material breach by the Company or its Affiliates of this Agreement or any material compensation agreement. In order to effectuate a resignation with Good Reason, the Executive must provide written notice to the Company of the existence of Good Reason no later than ninety (90) days after the Executive&#8217;s knowledge of its initial existence, the Company shall have a period of thirty (30) days following its receipt of such written notice during which it may remedy in all material respects the Good Reason condition identified in such written notice. If the Company fails to remedy in all material respects such Good Reason condition, the Executive shall be permitted to terminate with Good Reason during the thirty (30) day period following the foregoing cure period.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean a termination of the Executive&#8217;s employment (a) by the Company without Cause, (b) by the Executive for Good Reason, or (c) due to death or Disability.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">No Mitigation&#59; Limited Offset</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In no event shall the Executive be obligated to seek other employment or take other action by way of mitigation of the amounts payable to the Executive hereunder, and such amounts shall not be reduced regardless whether the Executive obtains other employment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Reformation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as otherwise set forth in Section 11 of this Agreement, if any provision(s) of this Agreement shall be found invalid, illegal, or unenforceable, in whole or in part, then such provision(s) shall be deemed to be modified or restricted to the extent and in the manner necessary to render the same valid and enforceable or shall be deemed excised from this Agreement, as the case may require, and this Agreement shall be construed and enforced to the maximum extent permitted by law, as if such provision(s) had been originally incorporated herein as so modified or restricted or as if such provision(s) had not been originally incorporated herein, as the case may be.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Governing Law&#59; Venue for Disputes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement shall be governed under the internal laws of the State of Missouri, without regard to its conflict of law principles. The Executive agrees that, except as otherwise set forth in Section 12 above, the exclusive venue and jurisdiction for any litigation concerning the enforcement or enforceability of the terms of this Agreement, or for any litigation that in any way arises out of this Agreement or the Executive&#8217;s employment with the Company or any Affiliate, shall be the St. Louis County Circuit Court, in the State of Missouri or, if the federal court has subject matter jurisdiction (and at the option of the party pursuing the claim), in the United States District Court for the Eastern District of Missouri, and the Executive hereby&#58; (a) submits to the personal jurisdiction of such courts&#59; (b) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">consents to the service of process in connection with any action, suit, or proceeding against the Executive&#59; and (c) waives any other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction, venue or service of process.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Conflict</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If any provision of this Agreement conflicts with any other agreement, policy, plan, practice or other the Company document, then the provisions of this Agreement shall control. This Agreement shall supersede any prior agreement, including any Executive Severance and Change in Control Agreement, between the Executive and the Company with respect to the subject matter contained herein and may be amended only by a writing signed by an officer of the Company and the Executive.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent applicable, it is intended that the payment of the benefits, severance, incentive compensation and&#47;or equity compensation provided under this Agreement shall comply with or be exempt from the provisions of Section 409A of the Code, and this Agreement shall be construed and applied in a manner consistent with this intent. In the event any payment or benefit under this Agreement is determined by the Company to be in the nature of deferred compensation, the Company and the Executive hereby agree to take such actions, not otherwise provided herein, as may be mutually agreed between the parties to ensure that such payments remain exempt from or in compliance with the applicable provisions of Section 409A of the Code and the Treasury Regulations thereunder. Notwithstanding any provision of this Agreement to the contrary, if the Executive is a &#8220;specified employee&#8221; within the meaning of Section 409A, any payments due upon a termination of the Executive&#8217;s employment under any arrangement that constitutes a &#8220;deferral of compensation&#8221; within the meaning of Section 409A and which does not otherwise qualify under the exemptions under Treasury Regulation Section 1.409A-1 (including without limitation, the short-term deferral exemption or the permitted payments under Treasury Regulation Section 1.409A-1(b)(9)(iii)(A)), shall be delayed and paid or provided on the earlier of (i) the date which is six months after the Executive&#8217;s &#8220;separation from service&#8221; (as such term is defined in Section 409A and the Regulations and the other published guidance thereunder) for any reason other than death, and (ii) the date of the Executive&#8217;s death. To the extent that any payment or benefit under this Agreement is modified by reason of this Section 19, it shall be modified in a manner that complies with Section 409A and preserves to the maximum possible extent the economic costs or value thereof (as applies) to the respective parties (determined on a pre-tax basis).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company shall have the right to withhold from any amount payable hereunder any Federal, state, and local taxes in order that the Company satisfies any required withholding tax obligation it may have under any applicable law or regulation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement shall be binding upon and inure to the benefit of the Company and any successor or assign of the Company, including (without limitation) any corporation or other entity that may acquire all or substantially all of the assets of the Company, or with or into which the Company may be merged or consolidated, and any such successor or assign shall be deemed substituted for Employer under the provisions hereof&#59; provided, that, if the Company assigns this Agreement to an Affiliate it shall remain secondarily liable . The Executive further hereby consents to the assignment of this Agreement by the Company and waives any assertion or claim that the Executive&#8217;s contemporaneous consent for such an assignment is needed for the assignment to be effective. The Executive shall not be permitted to assign the Executive&#8217;s rights or obligations under this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Third-Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Executive acknowledges and agrees that, if the Executive provides any material services to, or receives any material confidential information concerning, any Affiliate of the Company, such other Affiliate(s) of the Company shall be deemed a third-party beneficiary of the Executive&#8217;s obligations under Section 11(a) of this Agreement and shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">be permitted to enforce Section 11(a) of this Agreement against the Executive as if such Affiliate(s) were the Company hereunder.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as otherwise referenced herein, this Agreement constitutes the entire agreement of the parties and is the complete, final, and exclusive embodiment of their agreement with regard to this subject matter, and will supersede all prior agreements, understandings, discussions, negotiations and undertakings, whether written or oral, between the parties with respect to the subject matter hereof, including (i) the employment agreement, dated December 3, 2019, by and between Magellan Health Inc. and the Executive, and (ii) the Letter Agreement. No modification, amendment, or waiver of any of the provisions of this Agreement shall be effective or binding unless set forth in a writing signed by the parties hereto and specifically referring to this Agreement. Unless otherwise specifically agreed by the Executive and the Company in writing following the date hereof, the definitions of Cause, Good Reason and Disability set forth herein shall replace the definitions of those terms applicable to the Executive in any other agreement between the Company and the Executive or any Company plan applicable to the Executive and the restrictive covenants set forth in Section 11 herein shall replace the restrictive covenants applicable to the Executive with respect to any Company equity award or other plan or agreement. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement may be executed in one or more counterparts, which together shall constitute a valid and binding agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div style="text-align:justify"><font><br></font></div></div></div><div id="i226cbbfece9c4b02860fb5645f9be722_41"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Executive and the Company, by its duly authorized representatives, have executed this Agreement effective as of the date set forth below.</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXECUTIVE</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CENTENE CORPORATION</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; James E. Murray</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  &#47;s&#47; Sarah M. London</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">James E. Murray</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Sarah M. London</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Chief Executive Officer</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">February 20, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">February 20, 2023</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div style="text-align:justify"><font><br></font></div></div></div><div id="i226cbbfece9c4b02860fb5645f9be722_44"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A<br><br>FORM OF GENERAL RELEASE OF ALL CLAIMS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIS GENERAL RELEASE OF ALL CLAIMS (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">General Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), dated as of ________, is made by and between James E. Murray (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and Centene Corporation (together with its successors and assigns, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Company and Executive are parties to that certain Employment Agreement, dated as of &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">DATE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, Executive&#8217;s employment with the Company has been terminated and Executive is entitled to receive severance and other benefits, as set forth in Section 5 of the Employment Agreement subject to the execution of this General Release&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, in consideration for Executive&#8217;s signing of this General Release, the Company will provide Executive with such severance and benefits pursuant to the Employment Agreement&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, except as otherwise expressly set forth herein, the parties hereto intend that this General Release shall effect a full satisfaction and release of the obligations described herein owed to Executive by the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the premises, the mutual covenants of the parties hereinafter set forth and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby covenant and agree as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Executive, for Executive, Executive&#8217;s spouse, heirs, administrators, children, representatives, executors, successors, assigns, and all other individuals and entities claiming through Executive, if any (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive Releasers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), does hereby release, waive, and forever discharge the Company and each of its respective agents, subsidiaries, parents, affiliates, related organizations, employees, officers, directors, attorneys, successors, and assigns in their capacities as such (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employer Releasees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) from, and does fully waive any obligations of Employer Releasees to Executive Releasers for, any and all liability, actions, charges, causes of action, demands, damages, or claims for relief, remuneration, sums of money, accounts or expenses (including attorneys&#8217; fees and costs) of any kind whatsoever, whether known or unknown or contingent or absolute, which heretofore has been or which hereafter may be suffered or sustained, directly or indirectly, by Executive Releasers in consequence of, arising out of, or in any way relating to&#58; (a) Executive&#8217;s employment with the Company&#59; (b) the termination of Executive&#8217;s employment with the Company&#59; (c) the Employment Agreement&#59; or (d) any events relating to Executive&#8217;s employment occurring on or prior to the date of this General Release. The foregoing release, discharge and waiver includes, but is not limited to, all waivable claims and any obligations or causes of action arising from such claims, under common law including wrongful or retaliatory discharge, breach of contract (including but not limited to any claims under the Employment Agreement other than claims for unpaid severance benefits, bonus or salary earned thereunder) and any action arising in tort including libel, slander, defamation or intentional infliction of emotional distress, and claims under any federal, state or local statute including the Age Discrimination in Employment Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1866 and 1871 (42 U.S.C. &#167; 1981), the National Labor Relations Act, the Fair Labor Standards Act, the Employee Retirement Income Security Act, the Americans with Disabilities Act of 1990, the Rehabilitation Act of 1973, or the discrimination or employment laws of any state or municipality, and&#47;or any claims under any express or implied contract which Executive Releasers may claim existed with Employer </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Releasees. This also includes a release of any claims for wrongful discharge and all other claims for alleged physical or personal injury, emotional distress relating to or arising out of Executive&#8217;s employment with the Company or any of its subsidiaries or affiliates or the termination of that employment&#59; and any claims under the WARN Act or any similar law, which requires, among other things, that advance notice be given of certain work force reductions. Notwithstanding anything contained in this Section 1 above to the contrary, nothing contained in herein shall constitute a release by any Executive Releaser of any of his, her or its rights or remedies available to him, her or it, at law or in equity, related to, on account of, in connection with or in any way pertaining to the enforcement of&#58; (i) any right to indemnification, advancement of legal fees or directors and officers liability insurance coverage existing under the constituent documents of the Company or applicable state corporate, limited liability company and partnership statutes or pursuant to any agreement, plan or arrangement&#59; (ii) any rights to the receipt of health, welfare or qualified retirement benefits which vested on or prior to the date of this General Release&#59; (iii) the right to continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act&#59; (iv) the right to receive worker&#8217;s compensation, or (v) this General Release or any of its terms or conditions.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Excluded from this General Release and waiver are any claims which cannot be waived by applicable law, including but not limited to the right to participate in an investigation conducted by certain government agencies. Executive does, however, waive Executive&#8217;s right to any monetary recovery should any government agency (such as the Equal Employment Opportunity Commission) pursue any claims on Executive&#8217;s behalf. Executive represents and warrants that Executive has not filed any complaint, charge, or lawsuit against the Employer Releasees with any government agency or any court.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Executive agrees never to seek personal recovery from any Employer Releasee in any forum for any claim covered by the above waiver and release language, except that Executive may bring a claim under the ADEA to challenge this General Release. If Executive violates this General Release by suing an Employer Releasee, then Executive shall be liable to the Employer Releasee so sued for such Employer Releasee&#8217;s reasonable attorneys&#8217; fees and other litigation costs incurred in defending against such a suit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">except that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> to the extent such suit includes claims under the ADEA or other claims that are excluded from the release set forth in Section 1 hereof, the Executive shall not be liable for paying for the attorneys&#8217; fees and costs associated with such ADEA or other excluded claims. Nothing in this General Release is intended to reflect any party&#8217;s belief that Executive&#8217;s waiver of claims under ADEA is invalid or unenforceable, it being the intent of the parties that such claims are waived.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Each party agrees that neither this General Release, nor the furnishing of the consideration for this General Release, shall be deemed or construed at any time to be an admission by any party of any improper or unlawful conduct.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Each party acknowledges and recites that he or it has&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i. executed this General Release knowingly and voluntarily&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii. had a reasonable opportunity to consider this General Release&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii. read and understands this General Release in its entirety&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv. been advised and directed orally and in writing (and this subparagraph (d) constitutes such written direction) to seek legal counsel and any other advice such party wishes with respect to the terms of this General Release before executing it&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v. relied solely on such party&#8217;s own judgment, belief and knowledge, and such advice as such party may have received from such party&#8217;s legal counsel.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Section 12 of the Employment Agreement, which shall survive the expiration of the Employment Agreement for this purpose, shall apply to any dispute with regard to this General Release.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Executive acknowledges and agrees that (a) Executive&#8217;s execution of this General Release has not been forced by any employee or agent of the Company, and Executive has had an opportunity to negotiate the terms of this General Release&#59; and (b) Executive has been offered twenty-one (21) calendar days after receipt of this General Release to consider its terms before executing it. Executive shall have seven (7) calendar days from the date he executes this General Release to revoke Executive&#8217;s waiver of any ADEA claims by providing written notice of the revocation to the Company. Such notice shall not be effective unless it is received by the Company within such seven-day period, and provided by the Executive (i) by personal delivery to the CEO or such other individual as may be identified by the Company at the time of Executive&#8217;s termination, or (ii) by FedEx or other nationally recognized overnight delivery service, or by first class mail with charges or postage prepaid and return receipt requested, in each case properly addressed to the Company at its principal office, or (iii) by such other method as may be designated by the Company at the time of Executive&#8217;s termination (for example, DocuSign or pdf attachment to email).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Capitalized terms used but not defined in this General Release have the meanings ascribed to such terms in the Employment Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">This General Release may be executed by the parties in one or more counterparts, each of which shall be an original and all of which shall together constitute one and the same instrument. Each counterpart may be delivered by facsimile transmission or e-mail (as a .pdf, .tif or similar un-editable attachment), which transmission shall be deemed delivery of an originally executed counterpart hereof.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this General Release as of the day and year first above written.</font></div><div style="margin-top:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CENTENE CORPORATION<br><br><br></font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.538%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="margin-top:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXECUTIVE</font></div><div style="margin-bottom:10pt;margin-top:24pt;padding-left:252pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.538%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">James E. Murray</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.31
<SEQUENCE>15
<FILENAME>a2022123110-kexhibit1031.htm
<DESCRIPTION>EX-10.31
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6b6216d45b044f52bf4ada1eea581332_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT 10.31</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CENTENE CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTIVE OFFICER CASH SEVERANCE POLICY</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Purpose</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The purpose of this Policy is to limit the Cash Severance Benefits that Centene Corporation (the &#8220;Company&#8221;) may pay to Executive Officers upon termination.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Definitions</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of this Policy, the following definitions shall apply&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.7pt">&#8220;Base Salary&#8221; means the amount an Executive Officer is entitled to receive as wages or salary on an annualized basis, excluding all bonus, overtime, health additive and incentive compensation, payable by the Company as consideration for the Executive Officer&#8217;s services.</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.02pt">&#8220;Board&#8221; means the Centene Corporation Board of Directors.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.7pt">&#8220;Cash Severance Benefits&#8221; means the present value of cash payments&#58; (i) in respect of the termination of the Executive Officer&#8217;s employment&#894; and (ii) to secure an agreement not to compete with the Company. For the avoidance of doubt, &#8220;Cash Severance Benefits&#8221; do not include (A) the payment, vesting, acceleration or other handling of long term incentive awards granted under the Company&#8217;s stockholder-approved plans, (B) payment of deferred compensation, earned retirement benefits or other vested employee benefits, in each case consistent with normal practices, provided under the Company&#8217;s retirement or employee benefit plans, (C) the provision of perquisites, insurance, disability, health and welfare plan coverage and other non-cash benefits generally available to similarly-situated employees, (D) any interest required to be paid pursuant to the terms of any Company plan or policy between the termination date and the payment date, (E) any unpaid bonus for any previously completed performance period required to by paid pursuant to the terms of any Company plan or policy, (F) accrued but unpaid Base Salary or vacation pay through the termination date and reimbursement for any expenses validly incurred prior to the termination date, (G) any payment in respect of the Executive Officer&#8217;s Target Bonus for the year of termination (prorated based on the Executive Officer&#8217;s days of service during the annual performance period), or (H) payments resulting from a determination made in good faith by the Board to enter into a reasonable settlement of a claim made against the Company by the Executive Officer.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.02pt">&#8220;Committee&#8221; means the Compensation and Talent Committee of the Centene Corporation Board of Directors. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.7pt">&#8220;Executive Officer&#8221; means those persons who are designated by the Board as &#8220;executive officers&#8221; for purposes of Rule 3b-7 under the Exchange Act.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:6.03pt">&#8220;Target Bonus&#8221; means the Executive Officer&#8217;s target bonus under the Company&#8217;s annual incentive plan applicable to the Executive Officer for the year of termination, provided that if no target bonus has been established for such year under such plan, the year immediately preceding the year of termination.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitation on Severance Benefits</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company will not enter into any new employment agreement, or severance agreement with any Executive Officer of the Company or establish any new severance plan or policy covering any Executive Officer of the Company, in each case that provides for Cash Severance Benefits in an amount that exceeds 2.99 times the sum of the Executive Officer&#8217;s Base Salary plus the greater of Target Bonus or the average of the Executive Officer&#8217;s two most recent annual bonuses, without seeking stockholder ratification of such agreement, plan or policy. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of this Policy, the present value of any Cash Severance Benefits shall be calculated using the applicable methodology set forth in Sections 280G and 4999 (or any successor provisions) of the U.S. Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Board shall make all determinations regarding the application and operation of this Policy in its sole discretion, taking into account the recommendation of the Committee, and all such determinations shall be final and binding. Further, the exercise by the Board of any rights pursuant to this Policy shall be without prejudice to any other rights that the Company, the Board, or the Committee may have with respect to any Executive Officer subject to this policy. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>16
<FILENAME>a2022123110-kexhibit21.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia9f30fd75225400f9e120c485ffd4377_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT 21</font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">List of Subsidiaries</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ABC Network &#38; Collaborative Health Systems Joint Venture, LLC, an Arizona LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Absolute Total Care, Inc, a South Carolina corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AcariaHealth Pharmacy #11, Inc, a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AcariaHealth Pharmacy #12, Inc, a New York corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AcariaHealth Pharmacy #13, Inc, a California corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AcariaHealth Pharmacy #14, Inc, a California corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AcariaHealth Pharmacy #26, Inc, a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AcariaHealth Pharmacy, Inc, a California corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AcariaHealth Solutions, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AcariaHealth, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Acquisition, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Florida City, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Hialeah, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Kendall, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Lakeland, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Lauderdale Lakes, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Margate, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Miami, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of North Miami Beach, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Opa-Locka, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Pembroke Pines, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Perrine, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Riverview, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Tampa II, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Tampa III, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Tampa, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Access Medical Group of Westchester, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition Direct Contracting, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Community Health Centers II, LLC, a Texas LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Elite Providers II, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Elite Providers, III, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Elite Providers IV, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Elite Providers IX, LLC, an Illinois LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Elite Providers LLC, a Hawaii LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Elite Providers VII, LLC, an Arizona LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Elite Providers VIII, LLC, an Illinois LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Elite Providers X, LLC, an Illinois LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Elite Providers XI, LLC, an Illinois LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Georgia, LLC, a Georgia LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Maryland, LLC, a Maryland LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Northeast Georgia, LLC, a Georgia LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Northeast Partners, LLC, a Pennsylvania LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Northwest Florida, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Prime Health, LLC, an Oregon LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Quality Health II, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Quality Health III, LLC, a Delaware LLC</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Quality Health, LLC, an Oregon LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Southeast Partners, LLC, a Georgia LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Southeast Physician Partners, LLC, a South Carolina LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Southeast Texas, Inc., a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Southeast Wisconsin, LLC, a Wisconsin LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Tennessee, LLC, a Tennessee LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accountable Care Coalition of Texas, Inc., a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agate Resources, Inc., an Oregon corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ambetter of Magnolia, Inc, a Mississippi corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ambetter of North Carolina, Inc., a North Carolina corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ambetter of Peach State Inc., a Georgia corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">American Progressive Life and Health Insurance Company of New York, a New York corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">America's 1st Choice California Holdings, LLC, a Florida corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Apixio, Inc, a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Arizona Biodyne, Inc., an Arizona corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Arkansas Health &#38; Wellness Health Plan, Inc., an Arkansas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Arkansas Total Care Holding Company, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Arkansas Total Care, Inc., an Arkansas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Armed Forces Services Corporation, a Virginia corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AT Learning Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AT Medics Holdings LLP, an English and Welsh LLP</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AT Medics Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AT Technology (Private) Limited, a Pakistan private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AT Technology Services Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aurelia Health, LLC, an Arizona corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bankers Reserve Life Insurance Company of Wisconsin, a Wisconsin corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bishopswood SPV Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BMI Imaging Clinic Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BMI Southend Private Hospital Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BMI Syon Clinic Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bridgeway Health Solutions of Arizona, Inc., an Arizona corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bridgeway Health Solutions, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buckeye Community Health Plan, Inc, an Ohio corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buckeye Health Plan Community Solutions, Inc., an Ohio corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">California Health and Wellness Plan, a California corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cantina Laredo Clayton, LP, a Delaware limited partnership</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Care 1st Health Plan Administrative Services, Inc., an Arizona corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Care 1st Health Plan of Arizona, Inc., an Arizona corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carolina Complete Health Holding Company Partnership, a Delaware partnership</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carolina Complete Health, Inc., a North Carolina corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CCTX Holdings, LLC, a Texas LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CEF Holding Company Limited, a limited liability Malta company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Celtic Group, Inc, a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Celtic Insurance Company, an Illinois corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CeltiCare Health Plan Holdings LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CeltiCare Health Plan of Massachusetts, Inc., a Massachusetts corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cenpatico Behavioral Health, LLC, a California LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Center I, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Center II, LLC, a Delaware LLC</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Center LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Company of Texas, LP, a Texas limited partnership</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Europe Finance Company Limited, a limited liability Malta company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Health Plan Holdings, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Institute for Advanced Health Education, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene International Financing Company Limited, a limited liability Malta company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene International Ventures, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Management Company LLC, a Wisconsin LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Pharmacy Services, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Venture Company Alabama Health Plan, Inc., an Alabama corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Venture Company Florida, Inc., a Florida corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Venture Company Illinois, Inc., an Illinois corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Venture Company Indiana, Inc., an Indiana corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Venture Company Kansas, Inc., a Kansas corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Venture Company Michigan, Inc., a Michigan corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Venture Company Tennessee, Inc., a Tennessee corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centene Venture Insurance Company Texas, Inc., a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centurion Detention Health Services, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centurion LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centurion of Delaware, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centurion of Florida, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centurion of Idaho, LLC, an Idaho LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centurion of Indiana, LLC, an Indiana LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centurion of Kansas, LLC, a Kansas LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centurion of Minnesota, LLC, a Minnesota LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centurion of Missouri, LLC, a Missouri LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centurion of New Hampshire, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centurion of Pennsylvania, LLC, a Pennsylvania LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centurion of Tennessee, LLC, a Tennessee LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centurion of West Virginia, LLC, a West Virginia LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centurion of Wyoming, LLC, a Wyoming LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHG Management Services Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Birmingham Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Clinical Services Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Decontamination Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Harmony Health Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Harmony Health Limited, a Hong Kong private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Health 1 Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Health 2 Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Health 3 Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Health 4 Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Health Group Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Health Holdings Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Health MyWay Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Holdings Limited, a Jersey private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Hospital (Reading) Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle International PLC, an English and Welsh PLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Nottingham Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Circle Rehabilitation Services, an English and Welsh private company</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CMC Real Estate Company, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cobalt Therapeutics, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collaborative Choice Healthcare Accountable Care, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collaborative Choice Healthcare, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collaborative Health Systems IPA, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collaborative Health Systems, LLC, a New York LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collaborative Health Systems of Maryland, LLC, a Maryland LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collaborative Health Systems of New Mexico, LLC, a New Mexico LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collaborative Health Systems of Virginia, LLC, a Virginia LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Community Medical Holdings Corp, a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive Health Management, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continiuum Behavioral Care, LLC, a Rhode Island LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Coordinated Care Corporation, an Indiana corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Coordinated Care of Washington, Inc, a Washington corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Delaware First Health Complete, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Delaware First Health, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">District Community Care Inc., a Washington D.C. corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve Benefits Options, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve Dental, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve Dental IPA of New York, Inc., a New York corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve Dental of Florida, Inc., a Florida corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve Dental of Texas, Inc., a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve Holdings, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve Optical, Inc. a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve PeopleCare, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve Pharmacy IPA, LLC, a New York LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve Total Vision, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve Vision Benefits, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve Vision, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve Vision IPA of New York, Inc., a New York corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve Vision of Florida, Inc., a Florida corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Envolve Vision of Texas, Inc., a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Essential Care Partners, LLC, a Texas LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forensic Health Services, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foundation Care, LLC, a Missouri LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General Healthcare Group Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General Healthcare Holdings 2 Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General Healthcare Holdings 3 Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Generale de Sante International Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GHG (DB) Pension Trustees, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GHG Healthcare Holdings Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GHG Intermediate Holdings Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GHG Leasing Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GHG Mount Alvernia Hospital Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Golden Triangle Physician Alliance, a Texas not-for-profit corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granite State Health Plan, Inc, a New Hampshire corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hallmark Life Insurance Co, an Arizona corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Harmony Health Management, Inc., a New Jersey corporation</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Harmony Health Plan, Inc., an Illinois corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Harmony Health Systems Inc., a New Jersey corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Care Enterprises, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Net Access, Inc., an Arizona corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Net Community Solutions, Inc., a California corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Net Community Solutions of Arizona, Inc., an Arizona corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Net Federal Services, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Net Health Plan of Oregon, Inc., an Oregon corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Net Life Insurance Company, a California corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Net Life Reinsurance Company, a Cayman Islands corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Net, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Net of Arizona, Inc., an Arizona corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Net of California, Inc., a California corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Plan Real Estate Holdings, Inc., a Missouri corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HealthPeaksMD, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HealthSmart Benefit Solutions, Inc., an Illinois corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HealthSmart Benefits Management, LLC, a Texas LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HealthSmart Care Management Solutions, LP, a Texas partnership</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HealthSmart Information Systems, Inc., a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HealthSmart Preferred Care II, LP, a Texas partnership</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HealthSmart Preferred Network II, Inc, a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HealthSmart Primary Care Clinics, LP, a Texas partnership</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HealthSmart Rx Solutions, Inc., an Ohio corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Louisiana Holdings LLC, a Delaware LLC </font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Missouri Holdings, Inc, a Missouri corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Washington Holdings, Inc, a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Heritage Health Systems, Inc., a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Heritage Health Systems of Texas, Inc., a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Heritage Physician Networks, a Texas not-for-profit corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HHS Texas Management, Inc., a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HHS Texas Management, LP, a Texas limited partnership</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HLM Strategic Investment Fund, L.P., a Delaware limited partnership</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Home State Health Plan, Inc, a Missouri corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HomeScripts.com, LLC, a Michigan LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Human Affairs International of California, a California corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Illinois Health Practice Alliance, LLC, a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Integrated Mental Health Services, a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interpreta Holdings, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interpreta, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Iowa Total Care, Inc, an Iowa corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Justin M. Bayless and Associates, LLC, an Arizona LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LifeShare Management Group, LLC, a New Hampshire LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Louisiana Healthcare Connections, Inc, a Louisiana corporation </font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Behavioral Care of Iowa, Inc., an Iowa corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Behavioral Health of Florida, Inc., a Florida corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Behavioral Health of New Jersey, LLC, a New Jersey LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Behavioral Health of Pennsylvania, Inc., a Pennsylvania corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Behavioral Health Systems, LLC, a Utah LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Behavioral of Michigan, Inc., a Michigan corporation</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Capital, LLC, a Nevada LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care of Louisiana, Inc., a Louisiana corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Complete Care of Pennsylvania, Inc., a Pennsylvania corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Financial Capital, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Health QI0, LLC, a Nebraska LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Health Services of Arizona, Inc., an Arizona corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Health Services of California, Inc. - Employer Services, a California corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Health Services of New Mexico, Inc., a New Mexico corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Health, Inc, a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Healthcare Provider Group, Inc., a Maryland corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Healthcare, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan HRSC, Inc., an Ohio corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Life Insurance Company, a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan of Idaho, LLC, an Idaho LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan of Maryland, LLC, a Maryland LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan of Ohio, Inc., an Ohio corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Pharmacy Services, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magellan Providers of Texas, Inc., a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magnolia Health Plan, Inc, a Mississippi corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Magnolia Joint Venture Holding Company, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Managed Health Network, a California corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Managed Health Network, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Managed Health Services Insurance Corporation, a Wisconsin corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Maryland Collaborative Care Transformation Organization, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mauli Ola Health and Wellness, Inc., a Hawaii corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MBC of North Carolina, LLC, a North Carolina LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Meriden Hospital Advanced Imaging Centre Ltd., an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Meridian Health Plan of Illinois, Inc., an Illinois corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Meridian Health Plan of Michigan, Inc., a Michigan corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Meridian Management Company, LLC (a&#47;k&#47;a Meridian Administration Company, LLC), a Michigan LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Meridian Network Services, LLC, a Michigan LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MeridianRx IPA, LLC, a New York LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MeridianRx, LLC, a Michigan LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MeridianRx of Indiana, LLC, a Michigan LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Merit Behavioral Care Corporation, a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MH Services International Holdings (UK) Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MHM Correctional Services, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MHM Health Professionals, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MHM Services, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MHM Services of California, LLC, a California LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MHM Solutions, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MHN Government Services LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MHN Services, LLC, a California LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MHS Consulting, International, Inc, a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MHS Travel &#38; Charter, Inc, a Wisconsin corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael B. Bayless and Associates, LLC, an Arizona LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mid-Atlantic Collaborative Care, LLC, a Maryland LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mount Alvernia PET CT Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">National Imaging Associates, Inc., a Delaware corporation</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nations Healthcare Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nebraska Total Care, Inc., a Nebraska corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Network Providers, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New York Quality Healthcare Corporation, a New York corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Next Door Neighbors, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Next Door Neighbors, LLC., a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NIA IPA of New York, Inc., a New York corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North West Cancer Clinic Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Novasys Health, Inc, a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ohana Health Plan, Inc., a Hawaii corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oklahoma Complete Health Holding Company, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oklahoma Complete Health Inc., an Oklahoma corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One Care by Care 1st Health Plans of Arizona, Inc., an Arizona corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operose Health (Group) Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operose Health (Group) UK Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operose Health Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">P.P.C., Inc., a Missouri corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Parker LP, LLC, a Nevada LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Peach State Health Plan, Inc, a Georgia corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Penn Marketing America, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pennsylvania Health and Wellness, Inc., a Pennsylvania corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PPC Group, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premier Marketing Group, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Primary Care Partners Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">QCA Healthplan, Inc., an Arkansas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Qualchoice Life and Health Insurance Company, an Arkansas company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quincy Coverage Corporation, a New York corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rhythm Health Tennessee, Inc., a Tennessee corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RI Health &#38; Wellness, Inc., a Rhode Island corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Runnymeade SPV Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rural Community Health Services Accountable Care, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rural Community HealthServices, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Salus Administrative Services, Inc., a New York corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Salus IPA, LLC, a New York LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SelectCare of Texas, Inc., a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shanghai Circle Harmony Hospital Management, a Chinese private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SilverSummit Healthplan, Inc., a Nevada corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skylight &#38; Collaborative Health Systems Joint Venture IPA, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skylight Joint Venture, LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Social Health Bridge Trust, a Delaware trust</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Social Health Bridge, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Specialty Therapeutic Care Holdings, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Specialty Therapeutic Care, GP, LLC, a Texas LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Specialty Therapeutic Care, LP, a Texas limited partnership</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State of Franklin Collaborative Care, LLC, a Tennessee LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sunflower State Health Plan, Inc, a Kansas corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sunshine Health Community Solutions, Inc., a Florida corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sunshine Health Holding LLC, a Florida LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sunshine State Health Plan, Inc, a Florida corporation</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Superior Health Management Advisors, LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Superior HealthPlan, Inc, a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Pavilion Clinic Ltd, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Practice Properties Limited, an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The WellCare Management Group, Inc., a New York corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Shires Hospital LP, an English and Welsh limited partnership</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">TKH Holding Ltd., an English and Welsh private company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transplant Health Solutions IPA, Inc., a New York corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trillium Community Health Plan, Inc., an Oregon corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. IPA Providers, Inc., a New York corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">UAM Agent Services Corp., an Iowa corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Universal American Corp., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Universal American Financial Services, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Universal American Holdings, LLC, a Delaware LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WCG Health Management, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance Company of America, an Arkansas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance Company of Kentucky, Inc., a Kentucky corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance Company of Louisiana, Inc., a Louisiana corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance Company of Nevada, Inc., a Nevada corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance Company of New Hampshire, Inc., a New Hampshire corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance Company of New Jersey, Inc., a New Jersey corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance Company of Oklahoma, Inc., an Oklahoma corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance Company of Washington, Inc., a Washington corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance of Arizona, Inc., an Arizona corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance of Connecticut, Inc., a Connecticut corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance of Hawaii, Inc., a Hawaii corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance of New York, Inc., a New York corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance of North Carolina, Inc., a North Carolina corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance of Southwest, Inc., an Arizona corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Insurance of Tennessee, Inc., a Tennessee corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Plans, Inc., a Delaware corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Plans of Kentucky, Inc., a Kentucky corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Plans of Massachusetts, Inc, a Massachusetts corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Plans of Missouri, Inc., a Missouri corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Plans of New Jersey, Inc., a New Jersey corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Plans of Rhode Island, Inc., a Rhode Island corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Health Plans of Vermont, Inc., a Vermont corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare National Health Insurance Company, a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of Alabama, Inc., an Alabama corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of California, Inc., a California corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of Connecticut, Inc., a Connecticut corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of Georgia, Inc., a Georgia corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of Illinois, Inc., an Illinois corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of Indiana, Inc., an Indiana corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of Maine, Inc., a Maine corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of Michigan Holding Company, a Michigan corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of Mississippi, Inc., a Mississippi corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of Missouri Health Insurance Company, Inc., a Missouri corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of New Hampshire, Inc., a New Hampshire corporation</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of North Carolina, Inc., a North Carolina corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of Oklahoma, Inc., an Oklahoma corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of Pennsylvania, Inc., a Pennsylvania corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of South Carolina, Inc., a South Carolina corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of Texas, Inc., a Texas corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of Virginia, Inc., a Virginia corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare of Washington, Inc., a Washington corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WellCare Prescription Insurance, Inc., an Arizona corporation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Western Sky Community Care, Inc., a New Mexico corporation</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Worlco Management Services, Inc., a New York corporation</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>17
<FILENAME>a2022123110-kexhibit23.htm
<DESCRIPTION>EX-23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0111aa0d676b493084b69fb037b98f50_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT 23</font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the registration statements Nos. 333-261993, 333-255735, 333-238597, 333-236036, 333-217634, 333-210376, 333-197737, 333-180976, 333-108467, and 333-90976 on Form S-8 and in the registration statement No. 333-238050 on Form S-3 of our reports dated February&#160;21, 2023, with respect to the consolidated financial statements of Centene Corporation and the effectiveness of internal control over financial reporting.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; KPMG LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">St.&#160;Louis, Missouri</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;21, 2023</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>18
<FILENAME>a2022123110-kexhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="icdd5a5c41fc2420aa6bbeb0522211c07_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Sarah M. London, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Annual Report on Form 10-K of Centene Corporation&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;SARAH M. LONDON</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer<br>(principal executive officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>19
<FILENAME>a2022123110-kexhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id978b3d5d33443d090a11edd3c14950f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div></div><div style="text-align:right"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Andrew L. Asher, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Annual Report on Form 10-K of Centene Corporation&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter&#160;(the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.362%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; ANDREW L. ASHER</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive&#160;Vice President, Chief Financial Officer<br>(principal&#160;financial officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>20
<FILENAME>a2022123110-kexhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0e8668480de3499d95f4176a3ffeb54d_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div></div><div style="text-align:right"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C.&#160;&#160;SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of Centene Corporation (the Company) for the period ended December&#160;31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Sarah M. London, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;SARAH M. LONDON</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer<br>(principal executive officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>21
<FILENAME>a2022123110-kexhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4a2cc157ee474f73911f2a3c805d03c6_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div></div><div style="text-align:right"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C.&#160;&#160;SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of Centene Corporation (the Company) for the period ended December&#160;31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Andrew L. Asher, Executive Vice President and Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; ANDREW L. ASHER</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive&#160;Vice President, Chief Financial Officer<br>(principal&#160;financial officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>cnc-20221231_g1.jpg
<TEXT>
begin 644 cnc-20221231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $@ 2 # 2(  A$! Q$!_\0
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MJOV*[).29(P &/NRE6^K&OR_C++U>&.@O[LOT?Z?<?NWAKF[:JY55>WO1_\
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M\$[X8U^#NNSA<2OKTJ,WJ!;VY _\>/YU]2U\F_\ !.G5EF^&GB?31C=;ZO\
M:#ZXDAC4?^BC7UE7XOG2:S"M?O\ H?T9PZT\IP]NWZL_(3XM7SZA\5O&=TXP
MTVM7DA&<XS.YQ7/:?';W%];174YM;5Y%66<(7,:$@,VT=<#)QWQ77_'G2WT7
MXU^.;1X_) UFZD1 , (\K.F!Z;6%<*K8K]EP[4J$''LOR/YVQD7'$U%):J3_
M #/UT^#W_")1_#G1;?P1=6]YX<MX1';RP'DGJQ<8!$A))8$ Y)R!79U^>?[
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MI??K\T?0_P"PUJUEHWQL>XU"\M[&W_LNX7S;F58UR6CP,L0,U^@O_"P/"_\
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MI?6J:]Z._FO^!^5S\^5;%2 YJ!6IZMBOT8_*VB8&G@U$#FG U1FT3*U2*U0
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9L3H"BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>cnc-20221231_g2.jpg
<TEXT>
begin 644 cnc-20221231_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $@ 2 # 2(  A$! Q$!_\0
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MMU\RQ1117&>D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^W?_ $N)\F*V:>K8JNK8J56S7[D?RNT6%:I%:JRMBI5:K,6B=6KT3X"^-/\
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M@]J0&OU$_'6B8&GJU1*V:<#5&;1,K8J16J!6IZMBF9-$U/5JB5J=5&;1]+_
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MV/.Q&783%ZUJ:;[]?O6I^:?B?_@FK\1-+9WT76M#UR =%:22VF/_  %E*_\
MC]>9:Y^QK\9?#Y;S_ ]Y<H.0UC-#<Y'/01N3VZ8S7Z\T5[5/B+&0^)*7R_R/
MGZO"N!J:P<H_/_-,_%>^^!WQ'TN3;=> ?$T') +Z1<8..N#LP?PK*_X0'Q0K
M%6\-ZNK X(-C+_\ $U^WM%=L>)JBWI+[SSI<'TGM6?W+_,_$NU^&?C"^W?9O
M"FN7&W&[RM.F;&>F<+[5TND_LX_%/6&"V_P^\1+GHUQITD"GC.<R!17['T4I
M<35?LTU]["/!U#[=9OY)?YGY7^'_ -A'XPZTR^?H-KH\;?\ +34-0A _[YC9
MV'Y5ZWX3_P"":&I2%'\3>-+6V P7@TFU:;/J!)(4Q]=AK[UHK@J\0XZII%J/
MHO\ .YZ5'A7+:3O).7J_\K'@/@;]AWX4^"VBFFT>;Q'=QX(FUJ<RKGO^Z4+&
M1]5->Z:;I=EHMC%9Z?9P6%G$-L=O;1+'&@] J@ 5:HKPZV)K8AWK3<O5GTF'
EP>'PBM0IJ/H@HHHKF.P**** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>cnc-20221231_g3.jpg
<TEXT>
begin 644 cnc-20221231_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $@ 2 # 2(  A$! Q$!_\0
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M0;]A'5)K_P""UU!*^Y++5YX(ES]U#'%)C_OJ1C^-?$<68:,\+'$?:B[?)_\
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M/9;W3Y$<Z#)\J7';).&ZC/<<5[E173A\15PM55J+M)''B\)1QU&6'Q$;Q?\
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M-J=L-B9]Y17W)_YA7Y*_MP:"=!_:8\6\ 0WIM[R/WWP)N_\ 'P]?K57YT_\
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M--71^!2BXNS)0:D5JA5J<#5&31.#3E:HE:G@U1DT3 TY6J%6J0&F9M$ZMFG
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FX/\ W>FH^BU^_<****XSO"BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>cnc-20221231_g4.jpg
<TEXT>
begin 644 cnc-20221231_g4.jpg
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M 0 "$0,1 #\ _?RBBB@ HK\]/VV/^"@7QV\=_M"?'7]C/]F?XB:3\/Y?@?\
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MB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\
M@,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_
M (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_
M .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-
M_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V**
M ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
M@,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\
MZ#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_
M .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH
MQ_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'
M_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
MQ_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H
M-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >%_M8?\EL^!
M_P#V/<O_ *3-7NE>%_M8?\EL^!__ &/<O_I,U>Z4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'A?[6'_);/@?\ ]CW+_P"DS5[I7A?[6'_)
M;/@?_P!CW+_Z3-7NE !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!X7^UA_R6SX'_ /8]R_\ I,U>Z5X7^UA_R6SX'_\ 8]R_^DS5[I0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 >%_M8?\EL^!_P#V/<O_
M *3-7NE>%_M8?\EL^!__ &/<O_I,U>Z4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 45QG[1/QU\#?LR? SQ5\?_B5>>3HGA/19M0O<, TNQ?DA3/621RL:#NS
MJ.]?F5_P;X_\%8/'/[3GQS^)OP _:'\2^=K?BS6KOQCX-\V8E8M[#[7IL.[I
M'&@CDB0=%2<]JYJF*I4J\*4MY?U^)WX?+L1B<'4Q,%[L+7^?;TW9^M%%%%=)
MP!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'A?[6'_ "6SX'_]CW+_ .DS5[I7A?[6'_);/@?_ -CW+_Z3-7NE !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_8]R_P#I,U>Z5X7^UA_R6SX'_P#8]R_^DS5[I0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MLFNM4T6T:VL_$VA7\"W%AJD4#NYADV-Y5Q$'=4E *MB0(OU!7YB_ %=3OO\
M@[ ^.EYHX8Z;8?LNZ7;:TR?<%X]YI4D ;'\7E"0C/8&OTZH ***\O^*WQY^)
M7P^\7/X<\+_LR^*/%-HL"2#5M)GA6%F8<IASG([T <W^UA_R6SX'_P#8]R_^
MDS5[I7R%\7?C=\0_'_QR^#T7B?\ 9S\2^%UL_&A>!]5FA871:$J538>H!W'/
M85]2_P#"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_W
MTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H
M7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\
M?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%
M[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_W
MTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H
M7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\
M?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%
M[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_W
MTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H
M7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\
M?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%
M[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_W
MTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H
M7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\
M?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%
M[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_W
MTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H
M7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\
M?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%
M[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_W
MTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H
M7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\
M?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%
M[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_W
MTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H
M7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\
M?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%
M[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_W
MTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H
M7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\
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M1Y(0$\LS.[>V445O"$:<5&*LD<56K4KU'4F[MA1115&84444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >%_
MM8?\EL^!_P#V/<O_ *3-7NE>%_M8?\EL^!__ &/<O_I,U>Z4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"_VL/^2V?
M_P#['N7_ -)FKW2O"_VL/^2V? __ +'N7_TF:O=* "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5+17>.KZ+X>K/3S#A?)\OP<Z\YS]U=XZOHOAZL_:FBBBOS$_/@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"_VL/\
MDMGP/_['N7_TF:O=*\+_ &L/^2V? _\ ['N7_P!)FKW2@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[LM!TBV^59;I\R7$F,B*&-<O-(<'"(">">@)KYD_L_\ :\_X*8_/K8UOX)_
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M;XQ](_L\?LS_  4_97\ Q?#GX(>![;1[ $/=S+\]S?38YFN)F^>:0\\L>!P
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M?)/@W]O;XI?LV^)[+X._\%*_ UMX8GNIA;:'\6M!1Y/#>M-T7SFQFQF.,E7
M7[S8C4#/UAIVI:=K&GP:MI%_#=6MS$LMM<VTH>.6-AE75E)#*0001P0:X\3@
MZ^$:YUH]FM8OT?Z;KJD<V(PM;#-<RT>S6J?H_P"FNI-1117*<P4444 %%%%
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M=^S)^S-\'OV0_@OH_P !O@9X732]!T>'"@D--=S-_K+F>3 ,LTC?,SGV  4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^!__ &/<O_I,U>Z4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$UH%O$?Q&\42>?J5ZY W*A8G[/#Q@1H?NA0S/M!KVVBBO/KXBMBJCJ597?\
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MC>NY,\9SD#UNO.K4*V'J.G5BXR71G#5I5:%1PJ*S71A11161F%%%% !1110
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MU"Q_X.&?V_$\7AAJLMEX+ETXRCYFL3I_R%?50GV<<>@':OKWX9_LU?'7Q_\
M%'PK^T!^V]XV\(ZOX@\#QW+^"O"G@'2;FWT?1[ZY@:WGU%Y;N5Y[RZ,#RPQN
M1#'%%<3 1L[^8,7XR_L3>.M'_;>T[_@HE^RGJ7A^W\<7'@J3PAX]\+^*9Y[;
M3?%.E"99[:0W-O'*]I=V\J#;-Y,P>)C$54!6 !\O? %=3OO^#L#XZ7FCACIM
MA^R[I=MK3)]P7CWFE20!L?Q>4)",]@:_3JOGK]BO]A^?]G?XD?%+]I[XL^*K
M'Q)\6OC3KMKJ'C;6M-LV@LK*TM(!;:?I5FDC,_V>VA&WS'.^9RSL%RJ)]"T
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M@#'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EK8HH Q_^$EU?_H4+W_OI:/\
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M)=7_ .A0O?\ OI:/^$EU?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\
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M\^UEKI?V8/V*O#OP/\53_&_XIQ:U\2/BOJ2?\37Q_P")0C2PY!!ALH<E+.$
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MNKKS1^@O_"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2U^#/_  ^T_P""G7_1S/\
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M%[_WTM'_  DNK_\ 0H7O_?2UL44 9=GKVI7-TD$WAFZA5FPTKLN%]S6I110
M4444 %%%% !1110 4444 %%%% !1110 4444 >%_M8?\EL^!_P#V/<O_ *3-
M7NE>%_M8?\EL^!__ &/<O_I,U>Z4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X7^UA_R6SX'_\
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M2%%%% !1110 5Y-^U]^VE\#OV*/AY'XY^+^MS27FH3?9?#7A?28?M&J:]>'
M6VM+<'=(Q9E!;A5W#<1D9X']LO\ X*'6'P.\86G[,_[./@63XF_''7X<Z+X%
MTR7]UIL9 Q>ZG,"%M+=00Q#%68$<JI\P4OV0?^">-_X!^(<G[7'[8_CJ/XF?
M'#4X<-KL\7_$N\,PG/\ H6DP, ((UW%3+@.^6.$WN&]2C@J5&DL1B[J+^&*^
M*?\ E'^\_P#MU/IY5?&U:U5X?!V<E\4G\,/_ )*7:*_[>:TOPGPP_8T^/'[>
MWCS3/VG/^"G.E)IWAW3KD7OP_P#V>K>X\S3]*_YYW6KG@7EWM/\ JV&Q,D$
M,T*_;L$$%K EM;0I''&@6.-% 55 P  .@ IU%<V+QM7%R7-91CI&*VBO)?FW
M=O=MG3A,%2P<7RW<I:RD_BD_-_DE9+9)!1117(=@4444 %%%% !1110 445\
MM_\ #Z3_ ()H?]'*?^6=K/\ \AUQ8O,<OR_E^M5H4^:]N:2C>V]KM7M=7]3.
M=6E2^.27J['U)17RW_P^D_X)H?\ 1RG_ )9VL_\ R'7J7[-7[:7[,_[7_P#;
M7_#.WQ*_X2'_ (1[[-_;'_$FO;3[/Y_F^5_Q\PQ[]WDR_=SC;SC(SCA\ZR;%
MUE2H8FG.;V49Q;=M=$G?;4F.(H3ERQFF_5'J5%%%>F;!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% %37M#T?Q/H=[X:\0Z=%>:?J-I);7U
MI.FZ.>&12CHP[JRD@CT-?*O_  3*_P"":.C_ +!^N?$3Q+?7<5_J'B#Q!+;>
M';O=NDM]!C;?;HQ[2NS9D X)BC]*^M:*ZJ6-Q-##5*$)6C.W,N]G='32Q=>C
MAYT8.T9VNO38****Y3F"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** /"_VL/^2V? __ +'N7_TF:O=*\+_:P_Y+9\#_
M /L>Y?\ TF:O=* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJ7B3Q%H7A#P[?^+?%&
MJPV&F:792W>HWUR^V.W@C0O)(Y[*JJ23V HV!)MV1=HKXD_X)$_\%;M"_P""
MD?B+XI>$M0L8=,U/PQXGEN_"UCMV27/AN5]EM(X[S1LI$I' ,T7K7NO[37_!
M0K]C#]CZ!T_:"_:#\/Z)J"J#'H$5P;O4Y<_=VV=N'G(/ #;-O/)%80Q%&I2]
MJI>[W.RK@,71Q+P\H/G71:[ZGLU!( R3@#J37Q+_ ,/!?V]_VI?]#_8%_P""
M?NI:3H]QQ!\2?CU<-HNGA3TEBT^(FZN8SU#H1P.5YH'_  2K^.O[29_M#_@I
M'^WEXQ\=64WS3_#KX?G_ (1OPX >L,JP?OKQ1SAW,;\]?6?K#G_"BWY[+[W^
MB9I]1C2_WBHH>7Q2^Y:+_MYH]&_:$_X*W?L)_L[ZY_P@NI_&%/%WB]Y#%:^"
M/AW:-KFJSS#_ )8^7;;DBDX^[*Z5YS_PT/\ \%>_VM/W/[.?[*.@? ?PQ<?<
M\8?&B\-UK+QG^.'2;;_42CCY+C<IYY]/I3]GS]D/]F+]E+0O^$>_9U^!GAOP
ME"T82>;2=-1;FY Z>=<-F68\#F1V/%>C4>SKU/CE;RC_ )O7[K!]8P='^%3Y
MGWGK_P"2K3[W(^+]$_X(R^!?BAJUOXS_ ."@_P"TGX_^/VL0RB9-,\0ZHVF>
M'[>4<[H-+LV5(^>H+LI  *U]7?#'X1_"OX*>%HO _P 'OAOH7A;1X/\ 5:7X
M?TJ&S@!QC.R)5!/J3R>]=%16E.A2I.\5KWZ_?N85L7B<0DJDKI=-DO1+1?)!
M1116IS!1110 451\2>)_#?@[19_$GB[Q#8Z5IUJF^ZO]2NT@AA7U9W(51[DU
M\V>,?^"KOP"NM?G\!?LQ^$?%7QI\2Q':UA\/-'>XLX&/0S7K@0I'_P!-$,@%
M=.'P6*Q=_90;2W?1>KV7S9T4,)B<3?V46[;OHO5[+YGU#7-?%#XR?";X)^'F
M\5_%_P")&B>&=.7.+O6]2CME<C^%-Y&]O]E<D]A7SA_PC'_!5W]IGYO%7C+P
ME^S]X<G^]IWA^-=>\0%#U1[A\6\9(Z/%AE.>*Z3X7_\ !*[]D[P3XA7X@?$?
M0]6^*/BTX,WBCXH:J^KSNPYR(Y/W*X/(_=[AQSQ75]3P6'_WBM=_RP]Y_.6D
M?FG+T.GZKA*'\>K=]H>]_P"3:1^YR]#G[S_@J(OQ:NY=!_83_9E\:?%VY$AC
M'B$6AT?0(W!P=U]=J,D')V[!N X;O4?_  S7_P %&_VDOW_[2W[6=G\--"G_
M -9X/^#%J8[LH?X9-3N,R(X'!\L,A)..U?6%G9VFG6D5AI]K'!!#&$AAA0*D
M:@8"J!P !V%24_[0I4/]UI*/G+WY?BN5?**?F'UVG1_W>FH^;]Z7XJR^44_,
M\1^ W_!.K]C_ /9VU >)/ _P>LK[Q 9/-F\4^)7;4M2DE[R^?<%C&Q[^6$'M
M7MU%%<-?$5\3/GK2<GW;N<=:O6Q$^:K)R?F[A1116)D%%%% !1110 4444 %
M%%8WQ#^(G@7X3>"=2^(_Q,\6V&A:#H]JUQJ>K:G<K%!;QC^)F;CK@ =22 ,D
M@4XQE*2C%7;%*481<I.R1LDA068@ #DFOBOXT?MR_&G]K?XDZG^R1_P2[DM+
MFZTZ;[+\0/CE>0^=HGA13PT-F?NWU]C.U5RBG'4;GBYJ[\4?M(?\%D;R71/A
MQ>:]\*_V83*T6H>*/+:UU_XBQ X>*T5AFTL&Y!D(W2 X(;+QQ_:'P7^"?PI_
M9W^&VF?"+X*^!K#P[X=TB'R['3-/BVJO]YV)RTDC'EI&)9B26))S7L>RH95K
M62G6Z1WC'_'WE_=V7VOY3QO:XC-M*#<*/66TI_X.T?[^[^S_ #'!?L:?L,_!
MC]BGP==Z7X"BO-8\2Z[-]J\9>//$$WVC5O$%V26::XF;+;=Q8K&#M7)/+%F;
MV:BBO+KUZV)JNI5E>3W;/5H4*.&I*E2BHQ6R04445D:A1110 4444 %%%% !
M117+_%?XV?"#X%>&F\8?&7XF:'X7TQ<XO-<U*.W60C^%-Y!=O15R3V%3.<*<
M'*;LEU>PFTE=G45_+?7[JW7_  5)USXVW4F@_P#!/O\ 94\8?%>3>8QXNOX#
MH?AR)LX+?:[H!I2O)*!%+ ?*>:_"JOQ+Q1QV%QOU3V$N9+VFJ3Y7\&TK6EYV
M;L?/YQ4A4Y.77?\ 0*_4C_@VL_YK1_W+G_N4K\MZ^Z_^"*NC?MLW/_"R_$'[
M&GC+P);3Z?\ V-_;WA_Q]I]P]MJP;[=Y.R>W_>0,FR8<<-YHS]VOD^!JKH<4
MX>:BY6Y]%J_@EZ;;_D<.72Y<9%VOO^3/VEHKY%_X>$?M4_!3_1_VP?\ @G7X
MUL+2+B7Q3\+[J+Q'8%>\SQ1E9;>/_?+,/3FO1O@I_P %+OV&?C].FF?#_P#:
M-\/QZFS;#HNO3-IEZ),X,8ANQ&SL#P=@8<=:_HFEFV7U9\CGRR_EDG"7W22;
M^1]4J])NU[/ST_,]THI%974.C @C((/!%+7I&H4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 >%_M8?\EL^!__ &/<O_I,U>Z5
MX7^UA_R6SX'_ /8]R_\ I,U>Z4 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !114&IZGINBZ?-JVL:A!
M:6EM$9+BYN91''$@&2S,Q 4 =2>* W)Z*^2OBS_P6;_9#\+>*Y?A7^S_ /\
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M3/DI1<GV2N_P-*5&M7GR4XN3[)7/8J;++%;Q-//*J(BEG=VP% ZDGL*^3?\
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M_P"&@?\ @M5X..?$G_!/?X9>,@GWAX1^+"Z=YG^[]N0X_&C_ (>0_MG>%?\
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M?&WQ$\1R>?JVOW1.YGEE8DI'NR5B4[5ZG<Q9V[WX$_ 3X0_LS_#'3?@[\#?
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MN445Z-"A0PU-4Z,5&*Z)67X&L8Q@K15D%%%%:E!1110 4444 %%%% !1110
M4444 %%%% !1110!PWQC_9D_9X_:$L38?&[X*>&?%"[-D<VL:/%--$/^F<I7
MS(S[JP-> S_\$C_ OPWG?5/V-?VE/B;\')]Q>+2]"\1R:AHY8G.9+*[+B3GM
MO Y-?6]%<.(RS 8J?/4IKF_F6DOE)6:^\SE1I3=VM?Q^\^11=?\ !9#X ?\
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MI^HZ?JUC%J>E7T-S;3H'@N+>4.DBGH58<$>XJ:O3331L%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 >%_M8?\ );/@?_V/<O\ Z3-7NE>%_M8?\EL^!_\ V/<O_I,U>Z4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M11]>P4OCPL?DYK\Y-?@'U#&Q^#%3^<8/\HI_B?''_#\3]C_0^/BK\/\ XO\
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M'YA!SB1<[95/='#*PX((I/VB/@SXN_9X^.OBWX'^.[&:#5?"^O7.GW*S*09
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M^-GA#X1:#(/WGPZ_9@\)6^A H>J3ZN\?VN;(^5T(93SAN<U]6_LP_P#!._\
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M=3KWJR76;O;TCI%?**.Q4(7O+5^?]6([2TM;"UCLK&VCAAA0)%#$@544# 4
M<  =A4E%%>IL;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^"?\
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MI+X,-4?RBO\ TJ43W?;-[0?X?JT?6E%?)G_#OW]L+Q!Q\0?^"L'Q+N0WW_\
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M= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/^"2WP1@'PQ_9Z\30:U/%_J/"OPA^'MU<*V.!L%M;I;GT&'KOOA9_P $;_\
M@F+\'Y$N/"_[&_A&]G1MWVGQ1!)K4C/UWDW[S?-GG(Q@],5]"^$O _@OP!I*
MZ#X$\(:7HEBF-EEI&GQVT2_1(U 'Y5RXC&YOC?XU73LVY6]-DON.O#8+A_ ?
MP*3;[I1A?UTDW]Y\A?\ #S_]K/XG?)^S#_P2'^,>L+)Q!>?$F\LO",+#L_\
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M;2=A<:C.HCC4\?.H=>>M4O\ A47_  59_:A_>?&/X[>'?@3X;G^_X;^&MO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPGJ_QI^#?[-O[+_@N%[CQ'X^_:H\.0:?;1#+K;Q6U]]HN..B1"2-F;HJDDX
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MK7U+]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\
M 8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\
MT&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_
M -!NR_\  8_XT 9OQQ^#W@_]H#X0>(_@MX]M?-TGQ)I4ME=X4%H]P^65,]'1
MPKJ>S(#VK^8*1&B<QMU!K^H_[%XW_P"@W9?^ Q_QK^6;5/%.D?\ "7CPFLG^
ME_9/.;GCK]WZXY^E>_PGQ0\JXFP^4U/X>)52S[3AR<ORDFX^<N5'UG"&8U:.
M9_4[7C44GZ.-M?1IV];%FOM[_@BE\:/V+_V8?'_C?]H[]K/XOZ-X7OM$TJUL
MO"4>ILSRS_:3/]KE@@C5I9'1(8XR44X6X(/WA7PQK&JVNB:7/JUZV(K>,NWO
MCL/<GC\:]^_X)U_LR?%?XW-XE^+W[._[(/P]^+TNEI83:MI_Q CCN1;^?]H\
MORH;BZAC?/DR!E!)&Q0!SS]IQYGV'P%.CERK1C4KMZ/FO*"BVTG&,K.Z6ZUB
MI)=6OK.)\13IX!4)5?9NH[7Y6[VU:T:M?UVOH?H#\9O^#H/]CSPY?-X<_9T^
M$/C7XD:HSE+4K;KIMK<-V",XDG/3H8!7EFK_ /!3#_@O+^UB\UE^SC^Q9K?@
M/3)U_P")=JEIX!>1Y,]C>:R\5O@=-RP\?E6[X?\ ^"D/[9G[&-A)I_C3_@E=
MH/@/3H$Q)+X;\%W6D63@=EE@@FA(X_O$#BN]^&O_  <"6WC>&!]2^ $\4L^-
MEGHOB_3+VY8^BP2/!*Q]MN:_-Z6(BY\E"KA^;MSPE/\ \!J3?_IM'YC+*\+5
M=O:.IY>VA#[E#DJ+_P #9XD/^"5/_!87]J>XCU+]J&\TBZBEPUUI?Q?^,.H:
MI:P-G.;>ST)88$.>=K.5KW[X(?\ !$'X_> (8Q>_MX6G@>(KMDL_@G\*-+T&
MZ08P1_:A#W<OIND)(KU*R_X*X> [:UCOOB%\&OB_X0@D4,+GQ%\++@1%?[P:
M!Y R^XK;\,?\%<?V&_%4HMK7]K70;*8'#PZSH%_8E#Z$SPH/UQ77B,#Q#B:=
MJOM9P[*_)]T+1_ VHY35P<O:8;!1B_YE#GE_X'+GE_Y,8%A_P0G_ &(-;O8]
M6_: UGXF_%^^B8.+SXG?$O4+UB_]XK \*-]"I'/2O</A1^P-^Q)\#O*D^$_[
M)_P_T2XAQLO[7PK:FZXZ9G9#*WXL:B\)_M=_L_\ CK:O@[]KGX9ZD[](;3Q-
M9O(/8H)=P/L17H.FW'B36;1;_2/%FEW<#_<FMHQ(C?0J2#7CO QPTO>I\K\U
M9_B3B,3F+7+6E*W9W2^[8WU544(B@ #  ' %+6/]B\;_ /0;LO\ P&/^-'V+
MQO\ ]!NR_P# 8_XU1PFQ16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT
M ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_
M ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR
M_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&
M_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+
MQO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!
ML45C&S\;*"S:Y9 #J3;'_&OF_P",/_!2;PAX3\92?!S]G^"Z^,/Q !*_\(QX
M!LOM$5JV<;KN\YAMT!X8Y8H?O*.M=&'PN(Q<^6E&]M^R\V]DO-V1O0PU?$RY
M:4;_ )+U>R7FSZIZ=:^<OC5_P4P^"G@7Q=)\'_@?HFK?%WXA<JGA'P!%]J%N
MP.";JZ&8;9 >&)+,G\2@5P=S^R)^W1^V';B\_;8^.\'@[PM<<M\*?AM<M$LT
M9_Y9W]^/GFST:-"8SU4J:^@?@K^SGX-_9T\(IX%^"'A#P[X:TQ<%X--TW:T[
M 8#RR$EYGQ_&[,WO79[++\'_ !9>UEVB[17K+=^D5;M(ZO9X'"_Q)>TEVCI'
MYRW?_;O_ ($>$_\ #*_[;?[9/^G_ +:_QH_X5_X/N.?^%3_"Z]*2SQG_ )9Z
MAJ7+2Y'#QQ9C;JI0U]%? _\ 9V^"'[-GA)? _P #/AEI7AO3@!YL>GV^)+A@
M,!YI6S),^/XI&9O>MS[%XW_Z#=E_X#'_ !H^Q>-_^@W9?^ Q_P :PQ&/Q&(A
M[/2,/Y8Z1^[J_-W?F8U\;7KPY/AA_*M%]W5^;N_,V**Q_L7C?_H-V7_@,?\
M&C[%XW_Z#=E_X#'_ !KB.0V**\!_:'_;W_9W_9<F;2OB[^T1X=M]9#!(_#6F
M0-?:G(YX5!:V^^12QX!<*N>]>7V/[6'_  4G_:7;R?V4_P!DN+P7H4_$7CCX
MUYL,J?XX]-A+3MD?,KDE3QD"O.K9K@J-1TU+GG_+%.4OFE>WJ[(RE6IQ=KW?
M9:GV7<7%O:0/=74Z111(7DDD8*J*!DDD\  =Z^;_ (N_\%7/V0/AOXB/P]\#
M^*=2^)OB]B5@\(_"W2WUJ[D8<%2\/[E2#@$&0,/3BN'F_P""6?Q%^.5S'K/[
M>/[7?B?XGY8._A*QE?1?#Z'.0OV2T93(5X <LI(ZCFOH?X1?L]^#O@%X='A/
MX*^"/"OA?3\#?;Z)H:6_FD?Q2,H#2-_M,23ZUE[3-\5\$52CWE[TO_ 8OE7_
M (%+T)O7GLN5>>K^[;\6>"?\)E_P5L_:D^7P1\/_  G^SQX9N/NZMXID77O$
M31GI)':IBWB..L<V&!QSWK6\%_\ !)#]GZ[\10?$+]J;QCXK^-_BB$[TO_B-
MK#SV5NQZK!8H1"D9_P">;B0"OI'[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
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MQ16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\
M 8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_
M  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_
M -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;
M_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%
M%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !
MC_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\
M 8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\
MT&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_
M -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45
MC_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/
M^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !
MC_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0
M;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\
MT&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/
M]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_X
MT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/
M^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!N
MR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0
M;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V
M+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1
M]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_X
MT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+
M_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!N
MR_\  8_XT ;%%9=G:>+4ND>^U:U>(-^\1+<@D>QK4H **** "BBB@#Y7_:I_
MX)=>$?C9K'Q%^)?P<^-WCGX=>,?B;864'C"71=>6?2M9>TAAM[>6XL+R*X@2
M1((8XQ) D3D(,L>2?5_V;_V0?@_^S#>>)_$_@E-5U7Q5XYU&*_\ ''C?Q/J3
M7NKZ]/%'Y4)GF( 6.*/Y(H(ECAB4D)&NYL^HT4 ?._Q@_P"";/PF^-?[6/A+
M]M7Q3\6/B#:^/O -O=V_@B]TO6;:&VT:"ZC:.XBCMS;-%*LB.RL9ED9AC).T
M8];^.7P,^%'[2OPAUWX#_'/P7:>(_"GB6P-GK6D7P(2XC)# AD(:-U95=)$*
MLCJK*5901UM% 'B7PO\ V#_A;X!^*^A_''QIX[\9_$7Q9X2T>;2O!.M?$+6H
M[V3PY9S*J3K:+%%$@FE1$22ZD62ZD10KS,I(.M\>?V/?AE\=_B!X:^-#ZWKW
MA+Q_X/M[FU\.>//!]W%!J-M:7 'VBS<3Q307-O(51C#/%(BNBNH5P&KU>B@#
MSS]G#]E[X1?LL>%=3\-?"O2;K[1K^MSZUXIU[5[Y[O4M>U.?'G7MY<2$M+*V
MU5'1$151%1%51Z'110 4444 >%_M8?\ );/@?_V/<O\ Z3-7NE>%_M8?\EL^
M!_\ V/<O_I,U>Z4 %%%% !1110 4444 %%%% !7X[R?\&H.K2^+#XP;_ (*%
M_P"E&Z\[_DE''7[O_(5Z8^7Z5^Q%%85,-1J5X5I+WX?"[M-:IZ6\TON.S!9A
MB\NJ.>'ERMJU[)Z?-,_#OX,_\&[GQI_:@TOQ=I/Q1^./_"MXO#'B^?1[7/A!
MM2_MKR/O7*9NK?9 2R%&^;?S]W;S^@/_  22_P""45Y_P2WT?QQHLW[0W_">
MQ>,)=.>'/A3^RS8?9?M61_Q]S^8'-SG^';L/WMW'V'17=FU99SFBQ^(C^\5K
M;Z63CHMMF_O9V9CGF/S.+A5:Y;II66C79VOWZ]>P5YS\5?V0/V5OCAYLGQ;_
M &=_!NOSRYW7NH^'K=[D9ZD3;?,4^X85Z-17)5HTJ\>6I%279J_YGC.,9*S1
M\FWO_!&O]E+0+N35?V?_ !?\2OA+>NY<W'PZ^(%Y;*7]2D[2KCU4 #''%8GB
M;]A']OWP_%Y?@?\ ;D\.?$*Q08AT'XS_  TM+T$#L]["#,V>A^45]FT5YZR?
M 4WS48NF_P"Y*4/PBTOO1DJ%.+O#W?1M?D?G-XL_9_\ C]X>W?\ "^/^"+?P
M/^(4(_X^];^$.JVVF2D=W6"YC6>4^P8'WKS^^L?^"07A&^^U?&[]C7XW? #4
M<A9M5U+3];MK<'/!CEMIYD9<GAA&*_5FDDC25&BE0,K AE89!'H:[:=;B'"J
MV&Q]2W:?O+_R7D;^;9V0QF:4=*>(FEV;;7Z'Y^?"KX0_L5?$ORA^R_\ \%BO
MB?I]Q)C[/HL?QABD^F;*[C$I_$>U>L+^QY_P4+\,*)/AU_P5-U*XA REIXK^
M&6G7_F#MF;<''U KT[XJ?L!_L4_&OS9/B7^R]X+U"XFSYM_'H45O=-G_ *;P
M!)?_ !ZO)V_X(^_!?P2QN/V9?C_\7_A.R$F"S\(>/KA[$'L'@NO-\Q?]DL*T
M_MSB>G_%A3JKTC?[IPDO_)R_[5S-?'RS]8Q?_I47^9;_ .$;_P""S?@\?\2G
MXD_ /QC$GWO[<T?5-/G<?[/V8E ?KQ1_PT#_ ,%7O"'_ ",W_!/WP=XK5/\
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M1]6RR7PUVO\ %!K_ -)E(/89?+X:S7^*%OR<CZKHKY4_X9>_X*>^$OF\'?\
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M:'I5JN;G4M8OX[:WB'JTDA"K^)KYD\3_ /!6WX/^)M<N/ O['/PI\9?'+Q#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'A?[
M6'_);/@?_P!CW+_Z3-7NE>%_M8?\EL^!_P#V/<O_ *3-7NE !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 0ZCING:O92:;J
MUA#=6TR[9K>XB#HX]"K @CZUXA\5/^"9/[ ?QF,LGCK]E+P@9YLF6[T?3O[,
MG<G^(RV9B<GW)S7NM%85\+AL5'EK04EYI/\ ,F4(35I*Y\D?\.G-+\ ?OOV8
M?VS_ (T_#GR_^/?2K7Q>VHZ4GIFUNE;=CW?I1_PK#_@LC\)#GP;^TQ\*/BO:
M1=8O'?A&;1;N1/16T\E-_;+\=S7UO17#_8V#A_!YJ?\ AE)+_P !OR_@9?5Z
M:^&Z]&_RV/DC_AN?]NKX7#9^T+_P2^\67-M%_K-6^%GB6TU[SAW9+0;)5^C-
MFK_AS_@LI^PO=ZHGAOXE>,?$/PZUA_\ F$?$+PC>Z=*OKN?RVB7'N]?5%4/$
MGA7PQXQTM]#\7^'+#5;*7_66>I6:3Q/]4<$'\J/JF9TOX6(YO\<$_P 8<GZC
MY*T=IW]5_E8P/AI\?O@7\9[<77PB^,GA;Q0A7=_Q(-?M[L@=\B)V(([@\BNN
MKYV^)?\ P2<_X)Y_%.X.H:U^R_X?TN\W;X[WPKYNCR1O_?'V)XE+9YY!YZUR
M/_#L#XA_#H^;^S#_ ,%$_C+X."?\>^F:_JL7B'38,= EM=*N!Z@L<T?6,WI?
M'0C-?W)Z_=)17_DPN:O'>-_1_P"=OS/K>BODC^P_^"T'PD_Y!WCKX,?%RPB^
M_P#VOIEUH.IS?[OD$VRD]\T?\/$_VH/AD-G[2W_!,#XGZ7''_KM0^'=Y:^*(
M /\ GH1 T;(O<YR0/6C^UZ$/XT)T_6#:_P# H\T?Q#V\5\2:^7ZJZ/C+_@M3
M^TK^P+^V3\.O#_Q"^!7QKBU+QYX7NC;"R/AK4K9K_39CET\R:V1-T4F)%#,!
MAY<9+ 'X'^!/A[X:>*OC#X<T+XS>,_\ A'O"<^JQ?\)'K M9IVM[-3NEV) C
MNSLH*+A3AF!. "1ED C!'!J&TM!;ECW)X^E>1PSX[U\%P=C:6+C%8JG;V"2E
MRRYW9WO)OW'[SU5T[*Q[&3<<SP>0UZ-2WM8_P]]>;?\ \!>OGL?T<_LF_M;?
MLH?M+Z'?>&OV5?',6JZ?X-M+*VNK2#1+RRCL(9%D2W11<PQ[EVV[@!<X"<XR
M,^MSSPVT+W-S,L<<:EI)'8!54#)))Z"OQ:_X(LZ_^VO:?\+*\+?L:^ ?!EW<
MZK_8W]N^*/'&IR1VFAJGVX18MX?WMP\F^4C;\J&'Y@=XK[K@_P""7?BOXXS)
MK'_!0/\ :X\9?%#<P>3P=H\YT+PZG.=AM;4AYMO02%U8CJ,FHX?XBS+.LHIX
MET+U)<UW\--6DTM9.4GHE?E4M;[;'@8;%UL304^6[=_);^=W^9UGQ@_X*L?L
M>_##Q"?A_P"$?%]_\2?%[$K;^$/A?IK:U>RN."NZ']RA!P"K2!AZ5R'_  G7
M_!6G]J/Y/A_\-?"G[/?AFX^[K/B^5=<\0M&>DD=G'B"%O6.;D>OK](_!_P"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >%_
MM8?\EL^!_P#V/<O_ *3-7NE>%_M8?\EL^!__ &/<O_I,U>Z4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% '\M]%?O9_PY;_X)H?]&U_^7CK/_P F4?\ #EO_ ()H?]&U
M_P#EXZS_ /)E?@7_ !"OB'_G[2_\"G_\@?,_V-BN\?Q_R/EO_@VL_P":T?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH \+_:P_Y+9\#_ /L>Y?\ TF:O=*\+_:P_Y+9\#_\
ML>Y?_29J]TH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"_
MVL/^2V? _P#['N7_ -)FKW2O"_VL/^2V? __ +'N7_TF:O=* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#PO]K#_DMGP/\ ^Q[E_P#29J]T
MKPO]K#_DMGP/_P"Q[E_])FKW2@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH \+_:P_Y+9\#_ /L>Y?\ TF:O=*\+_:P_Y+9\#_\ L>Y?_29J
M]TH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"_VL/^2V?
M_P#['N7_ -)FKW2O"_VL/^2V? __ +'N7_TF:O=* "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#PO]K#_DMGP/\ ^Q[E_P#29J]TKPO]K#_D
MMGP/_P"Q[E_])FKW2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI^#KM;[Q%X!\<?%N6*R-RZ,H-[I#6D,PM_-8N@#F%FC"[I%5E/I^H_%W4?\
M@H'_ ,%H/'O[#?B+7=4C^$?[/?P\L+_Q/X=TK59[2/Q+XGU/RI8/MLD#HT]K
M;VKMMMB=AG!=PVQ0H!^@E%?"7_!/O]H;QA\+?^"E_P"T!_P2@\9>*]3US0O!
M6EZ9XW^$5]K>HRWE[9Z%?1P"[TR2>9FDEAM;N=$@9V=Q')L+81 /NV@ HHHH
M \+_ &L/^2V? _\ ['N7_P!)FKW2O"_VL/\ DMGP/_['N7_TF:O=* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *S?&/B[P[X \(ZKX\\7ZD+/2=$TV>_U2\:-G$%O#&TDDFU
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M&GPZCY']H)9&+3C&Z?:O,VK"L;QIYJOZ5^TS_P $SOV9_P!ICX#>"OV=Y_\
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M[^M=M_PK[_@H?_T<%X$_\)=ZV_V*? OB[X??"?4M$\::#/IUW-XPU2ZC@N
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MA_\ T<%X$_\ "7>C_A7W_!0__HX+P)_X2[U[U10!X+_PK[_@H?\ ]'!>!/\
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M_"OO^"A__1P7@3_PEWKWJB@#P7_A7W_!0_\ Z."\"?\ A+O1_P *^_X*'_\
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M_"OO^"A__1P7@3_PEWH_X5]_P4/_ .C@O G_ (2[U[U10!X+_P *^_X*'_\
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MPCU+Q[)^QEX8U?P+!;:CXH;X8V4VC1ZO<,L-S?\ ]G(T0GD&6"-+MW-UP2:
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M_?!O_@HK\+D^"7[0WBGQ8OA#[9!>7.@>'=7CL8[JXA??%+)(L1F)1L$*'"9
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MM[2ZN;:YN[EBR[Y+J>6T@,DI;YMAP!N8FE^UW^PAX'_; \2^#?&^L_&_XJ>
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M5ZM0 4444 %%%% !1110 4444 %%%% 'Q1_P<7?\H5/C]_V*]K_Z<K2OIO\
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M +/OC/X\:S8/>1>$_#EWJ4>GP_ZR^FCB8PVL8')DEDV1(!R6D4#K7"?MW?\
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M\K:'H7B+4X[Q=,,L\L\WDR^4LN'EF=RKNR@GY0N3D ]EHHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC'X'ZAXJT'6;[P1++)H,JWKVZSW2M>,=0>/R<(L36T;-<J70K$=[/V]?#7Q
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MP\-:9I.O69T^]M-;L]+@@E6"27$99MCB&X5C&'9"64JP7XK^.'PT_:Q^*O\
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M;9#Y:Q&65][>;&H"GSG]G#_@I'^U_P#$;P=^U'^R?\0KKP/I?[0O[,JRR_\
M"1S>&KB;1/%&ER6LMS8:A]A2[BD@DEBC7S$$Q2,S1N P)C&3^S+\)?CG_P $
MG_\ @HU^T)JGB+X(^-/&OP/_ &A_%G_"<^'?%W@#PY/K5QX=UZ5Y7OK&^L;1
M7N4CD>8F.=(VC"Q1@D%G\O5^%G[*WQ0\-^*?VSO^"C_Q%^#WB*Q\2_M Z1;Z
M-X#^'=II_P!KU>'2M/T;^SK-IXK<NL-Q>2A96C9L0((_-9&\Q4 /%8/VZ_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;NTC):[HH0-G 2:8,&!W#I7TS0 4444 %%%% !1110 445\R6W_!2G1_B_\
M&#Q1\$OV)?@7KWQ@OO NHMIOC?Q5IVJ6FF>&]%U!1EM/;4+E\W-TH*[XK6*<
M1Y D9#Q0!]-T5\X:-_P4-6P_:C\"?L;_ !C_ &9_''@GQMX^34I]&N-0-I=Z
M-=6UC9R7,\MO?VLSK*PVHA@=8IE\S>R!-K/]'T %%%% !1110 4444 %%%%
M!17E7[-GQQ^-OQB\4?$K1/B]^RQJ_P -[+P=X[N=%\(ZIJ>N07B>+]-C ,>K
M0K&JF".3/$;;L9 WE@ZIZ-X<\4^'/%]C-J?A?6[74+>WO[FQFFM)@ZI<VT[P
M3Q$CH\<T<D;#JK(P/(H OT444 %%?)E[_P %7=%LO^"B,'_!,R3]D_XBMX^N
M?#!\1PZBMWH_]E-I(++]K\[[=Y@7>C1[#'YF[^''-?6= !117F/[9/[1UY^R
M-^S-XR_:2M_A'K7C6#P7X?O-9U'1="O+2";[);6\D\TI>ZEC78B1L2$WR'C;
M&YXH ].HKS']BS]I!/VP?V2OAU^U-'X./AY?B!X0L==70VU#[4;$7$2R>3YW
MEQ^9MW8W;%SZ"O3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6UK&@^T16ES-,6D;YW43RS!&<9,BKM/@/_!%G]JCXB_L@?\ !ON/^"C/Q_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS,\]S>7#A5#2RS2.[;55%W;45$547JZ** "BBB@ HHHH **\)_X*/_MKW/\
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M>TZVAUSXKS6B>(!X=LK]9(HKD:]#JSZ9!*Q".ZPQM&"#L><L5)5@38_X*/\
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M ,/;OPG9WUA<V-I=SVULFMS3!KAIKIK=F9K26!8$F0!961B_FK_\%ZY?'_\
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MU^&W@FSTZP^"?B.ZMM&NU\;ZI-923SS7/V]9F>-)O*@2U@6"5\MB1F&!P_\
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M%UO2[HS0JD[ PR+*L;JKJ["-I8S(%'!];_9*_P""@_\ P5$_:H31/@1\1_\
M@F!XS^#OB^WF@A^(GQ,\3W$"^'K"")E^U7&F*X9[Z>959(8E#Q1/*KO)(D;;
MP#IOCQ\8OVU1\6?C???$?XZ:;^SK\-/!-CIMC\%?$]U;:-=+XWU6>SDGN);G
M[>LS-%'-Y4"6L"P2N2V)&;@>5_\ #:7CS_@H9_P:[_$']KWXHZ'IVG>(O%?P
M"\:1ZU;:3&R6QN;(:C8/+&K,Q19#:^9MR=N_&3BHOA1!^VW\/O\ @J!^T3?_
M !S_ &&_&?Q*U;Q7=Q6_P ^*$5S9KX<\/>&S RFP:ZGESI2[BKW MX99YW5V
M,4I6+?YA^Q;\%_VPOAI_P;->-_V$/B7^Q?X^T;Q[:^"/%OA70-&>SBN+G7=0
MU2]U6=)(HH'<PVL:74(-Q<&)68.%!7RWE .8_P""D[_&73?^#8[]FG6OAQ\;
M+WPSI#?#OX96'B/1M/TZ-FUN*XM-.18Y9V.Y(48!S&@'F$!6)7*GU_\ X+Y>
M'/C)X"_9L_98T_QK\1H/B!XGA_;@\$S65_=:9%H\5RWE:D8H'$ D6)=PP9 K
M$!L[3C!SOVN?V6?VGOCY_P &VOPY_9S^&GP!\32_$WX;^%O EOK/@#4]/-G?
MSW.C+8I>10>;A)_EC=T:-F5PI527&RNA_P""N=]^TM^V9\%OV;-:^'_[#?Q2
MLM0\.?M-^%_'VL^&KK2(9]0TSP_I\=TLTUW]GEDMX;AI)CLM4FEE\L*SB-F,
M:@'9>)OVG/\ @H7^R)_P57^ _P"SY^TA\=O!GC_X>_M'6_B2UMM'T'P%_9#^
M#]1TRS2[58)C<32W<3^9''NF;)^=MJ85:]&\!?M&?'/]O?\ :*^-7PK_ &>?
MC2WPS\%_!/Q&GA"7Q)I?A^SU+4]<\2BW6>\W+?))#!9VWF11>6L9EF?>PEB5
M0K>5_P#!1[1/BG\3O^"GW[%GQV^&7[/_ ,0]>\(?"K6/$NH>/M<L?!EX$TJ#
M5-.M(;8F.2-997!5C)'$CO'M*L _RUYQI-I^W=_P1V_X*.?'+QGX$_8B\=?'
M?X%_M$>*QXPTZY^&44=QJGAO7Y0?M<4]N[+B-W<Y=RJ;$A97W"1  >ZZ)\=?
M^"UNG?\ !-DZMXU_9/\ #)_:07QK%X;2'3]0M9]-?3'O(X3XC,"76W"PL[FW
M\X?,F\JJ$QC \"?MY_%/X:_\%AO _P#P3^B_:OTGXT>#O'O@+5[O4KR>QTM-
M4\*Z[IJM+) TNEQ0PF.2-?\ CWEC,T9927Q][(_X*<:9_P %2OC)_P $Y[3Q
MEX3^"^KKK>L_%S2-7\?_  4\(:]&^K+X!C79<Z$M[ 5\^YG:.*6X\DG N9X$
M:6./,G#^.?#?[4OB7_@J9^R=^U?\%_\ @F!XW\,?#'PGX&\2^&[/P].=*TZY
MT,W5J(X9+ZU@G>#2[16=< 223%$EVP;U2*0 U-!_:6_X+*_M'_MW?M9?L&_!
MO]H#X3>&]1^$=AX5N/"?C&?X?2_9;?\ M"R>]%N;62YN)#+,LD:/<.\T<0M7
M*6^9AY?I^J_MS_%_XC_'WQG^R,OQ=\3>$]0^#_AS0;+QYXV^%OP0U/Q3)K'B
MF]L%NYD@5+&]M[&RA1HR8Y5:>5IRJO$(&:7 _8.\.?%_PU_P6T_:X^.OB_\
M9X\?Z+X%^,-GX.B\!^+=6\+SPVEY)H^D_9+D2 CS+8,Y9HVF5 P7DAF53Q'Q
MQTW]OW_@E;_P5+^)_P"V%\ OV/\ Q-\>?@E^T+:Z1<>+O#_@-EDUOPSKEA:B
MU6:. @F2.1 [$X"'S0&=#"HD /HK_@D/^U?^V7^T=\/_ !]X*_;>^"'B'P_X
MF^'GC>XT?1_&NI_#W4?#=GXZTG<XM=6M[2^C1XV=8R9(UX3=&<(7V#+_ .#A
M_P#Y0M_M ?\ 8H0_^E]M7N'['WQ#_:7^,_A74?C)^T3\(9_AK#K<L*^%/AOJ
M%Y!=:AI5E&K9N;^6$;5NKAW)-NK,L,<4(SYC2UXQ_P %Y?"WQ)^+G_!,7XG_
M +.WP3^$?BGQIXS\<Z+%8Z#H_AO19;@%EO+=Y'EFP(8%5%9OG=6;!"AB#@ \
M?_:/_:>_:A_8M_X-P_AU^U1^RIXJ\+Z9KG@_X$>"IKE?$GAN34#-%/::;:_N
M"MQ&D,J>>9 TL<Z-LVE!G<*?[7O[8W_!3W]CC1_@'^VAXX^,W@+5/A_X^^(?
MAKPMXQ^$&F^"L26EIJD;9O5U=Y?,GNE*EBJPP0AG50C*A9\S]LGP%\=?C%_P
M;;V7[''@7]F;XC7'Q4?X5^$O"LO@F7PE<1W$-_8-IOVHM*RB PJMO*PE$A5\
M!1\V5%S_ (*X^#_C?^T-_P $\O@!\.O@I^S/\1_$'B?0?B3X.U_Q!X>@\(W$
M,^F6FF(XN_.:8)'O5P$55=B^0R[D^>@#Z(^,O[7?Q,^*G_!1?3O^"9W[-WC&
M'PO=:+\/F\;_ !5\=C3H;R[TRQ>X2VL]-L(KA7@%W,[^:TL\<L<<*C$;LXV?
M,W[(6A_%_P"'W_!RQ\:=)^/'Q5M?%C6'[+M@^D>)WTJ&PN)],_M:V=/MD< 6
M#SXW,R,\21HZQHWEH216A^T;X _:D_8Q_P""PME_P5E^!W[-'C;XL_"OXM?#
M&V\)_$SPUX0T=F\1^'KB%XFM[Q-.F\N61=MO "N 5S.&VDQ[K'P+\-_M-?$_
M_@NYXU_:D\4?L)_$O0/A=XX_9SL?"2:WX@&G6KV<AOUFWW*-=_+E$ES#"9IX
MPT7F1(694 *.O?\ !23]KK]J+]C;7/VU/V0/'?C[1=>E@U+5/A9\+],_9FUO
M7=*U^PM9I5MK6^U%=/?S;J]2'/F6MS!#;M<+&?,,32MTW[9?[5W_  5<O?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX 7.^3&1#LPN-N3FOKBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%D\*?^%#;?\ Q='_  O;X(?]%D\*?^%#;?\ Q=>5?\.K_P#@GG_T:=X4_P#
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M[@^']/:20:=I3RQ%DEE@BD<NZ$IOE95+!0S 'V#1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5\@?M;_\$M/!_P"TO^W+\-_V
MG;N&T72=*_Y'[3Y ,ZG]E DL?E_CW/\ NI,]8D4#I7U_175@\;B<!5=2A*S:
M:^35O^"O.S.G"XNO@ZCG1=FTU\FK?UYA1117*<P4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
)10 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967462846864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 17, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-31826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Centene Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">42-1406317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7700 Forsyth Boulevard<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">St. Louis,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">63105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">725-4477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CNC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">551,264,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the Proxy Statement for the registrant's 2023 annual meeting of stockholders are incorporated by reference in Part III, Items 10, 11, 12, 13 and 14.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001071739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967462723920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">KPMG LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">St. Louis, MO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">185<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditor Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967464010256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 12,074<span></span>
</td>
<td class="nump">$ 13,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsAndOtherReceivablesNet', window );">Premium and trade receivables</a></td>
<td class="nump">13,272<span></span>
</td>
<td class="nump">12,238<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">2,321<span></span>
</td>
<td class="nump">1,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">2,461<span></span>
</td>
<td class="nump">1,602<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">30,128<span></span>
</td>
<td class="nump">28,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">14,684<span></span>
</td>
<td class="nump">14,043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherRestrictedAssetsNoncurrent', window );">Restricted deposits</a></td>
<td class="nump">1,217<span></span>
</td>
<td class="nump">1,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, software and equipment, net</a></td>
<td class="nump">2,432<span></span>
</td>
<td class="nump">3,391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">18,812<span></span>
</td>
<td class="nump">19,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">6,911<span></span>
</td>
<td class="nump">7,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">2,686<span></span>
</td>
<td class="nump">3,781<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">76,870<span></span>
</td>
<td class="nump">78,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical claims liability</a></td>
<td class="nump">16,745<span></span>
</td>
<td class="nump">14,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">9,525<span></span>
</td>
<td class="nump">8,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_ReturnofPremiumPayable', window );">Return of premium payable</a></td>
<td class="nump">1,634<span></span>
</td>
<td class="nump">2,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Unearned revenue</a></td>
<td class="nump">478<span></span>
</td>
<td class="nump">434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">28,464<span></span>
</td>
<td class="nump">25,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">17,938<span></span>
</td>
<td class="nump">18,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">615<span></span>
</td>
<td class="nump">1,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">5,616<span></span>
</td>
<td class="nump">5,610<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">52,633<span></span>
</td>
<td class="nump">51,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December&#160;31, 2022 and December&#160;31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December&#160;31, 2022, and 602,704 issued and 582,479 outstanding at December&#160;31, 2021</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">20,060<span></span>
</td>
<td class="nump">19,672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive earnings (loss)</a></td>
<td class="num">(1,132)<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">9,341<span></span>
</td>
<td class="nump">8,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost (57,093 and 20,225 shares, respectively)</a></td>
<td class="num">(4,213)<span></span>
</td>
<td class="num">(1,094)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Centene stockholders' equity</a></td>
<td class="nump">24,057<span></span>
</td>
<td class="nump">26,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Nonredeemable noncontrolling interest</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">24,181<span></span>
</td>
<td class="nump">26,940<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interests and stockholders' equity</a></td>
<td class="nump">$ 76,870<span></span>
</td>
<td class="nump">$ 78,375<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_ReturnofPremiumPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Return of Premium Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_ReturnofPremiumPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestrictedAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets that are pledged or subject to withdrawal restrictions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestrictedAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsAndOtherReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date, net of allowance for doubtful accounts, of all premiums and other types of receivables due from other persons or entities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsAndOtherReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967455850272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">607,847<span></span>
</td>
<td class="nump">602,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">550,754<span></span>
</td>
<td class="nump">582,479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, at cost (in shares)</a></td>
<td class="nump">57,093<span></span>
</td>
<td class="nump">20,225<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967463863488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 135,479<span></span>
</td>
<td class="nump">$ 117,983<span></span>
</td>
<td class="nump">$ 103,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_PremiumTaxRevenue', window );">Premium tax and health insurer fee</a></td>
<td class="nump">9,068<span></span>
</td>
<td class="nump">7,999<span></span>
</td>
<td class="nump">7,315<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">144,547<span></span>
</td>
<td class="nump">125,982<span></span>
</td>
<td class="nump">111,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Medical costs</a></td>
<td class="nump">111,529<span></span>
</td>
<td class="nump">98,602<span></span>
</td>
<td class="nump">86,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of services</a></td>
<td class="nump">7,032<span></span>
</td>
<td class="nump">4,894<span></span>
</td>
<td class="nump">3,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">11,589<span></span>
</td>
<td class="nump">9,601<span></span>
</td>
<td class="nump">9,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">614<span></span>
</td>
<td class="nump">565<span></span>
</td>
<td class="nump">487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">817<span></span>
</td>
<td class="nump">770<span></span>
</td>
<td class="nump">719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_PremiumTaxExpense', window );">Premium tax expense</a></td>
<td class="nump">9,330<span></span>
</td>
<td class="nump">8,287<span></span>
</td>
<td class="nump">6,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_HealthInsurerFeeExpense', window );">Health insurer fee expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment</a></td>
<td class="nump">2,318<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Legal settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">143,229<span></span>
</td>
<td class="nump">124,198<span></span>
</td>
<td class="nump">108,033<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">1,318<span></span>
</td>
<td class="nump">1,784<span></span>
</td>
<td class="nump">3,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNonoperating', window );">Investment and other income</a></td>
<td class="nump">1,279<span></span>
</td>
<td class="nump">819<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion', window );">Debt extinguishment</a></td>
<td class="nump">30<span></span>
</td>
<td class="num">(125)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(665)<span></span>
</td>
<td class="num">(665)<span></span>
</td>
<td class="num">(728)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income tax</a></td>
<td class="nump">1,962<span></span>
</td>
<td class="nump">1,813<span></span>
</td>
<td class="nump">2,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">760<span></span>
</td>
<td class="nump">477<span></span>
</td>
<td class="nump">979<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">1,202<span></span>
</td>
<td class="nump">1,336<span></span>
</td>
<td class="nump">1,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Loss attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Centene Corporation</a></td>
<td class="nump">$ 1,202<span></span>
</td>
<td class="nump">$ 1,347<span></span>
</td>
<td class="nump">$ 1,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net earnings per common share attributable to Centene Corporation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in usd per share)</a></td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 2.31<span></span>
</td>
<td class="nump">$ 3.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in usd per share)</a></td>
<td class="nump">$ 2.07<span></span>
</td>
<td class="nump">$ 2.28<span></span>
</td>
<td class="nump">$ 3.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted average number of common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">575,191<span></span>
</td>
<td class="nump">582,832<span></span>
</td>
<td class="nump">570,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">582,040<span></span>
</td>
<td class="nump">590,516<span></span>
</td>
<td class="nump">579,135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePremiumMember', window );">Premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 127,131<span></span>
</td>
<td class="nump">$ 112,319<span></span>
</td>
<td class="nump">$ 100,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 8,348<span></span>
</td>
<td class="nump">$ 5,664<span></span>
</td>
<td class="nump">$ 3,745<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Extinguishment of Debt , Including Cash Portion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_HealthInsurerFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Health Insurer Fee Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_HealthInsurerFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_PremiumTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Premium tax expense, similar assessments and provider pass through payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_PremiumTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_PremiumTaxRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Premium tax revenue, similar assessments and provider pass through payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_PremiumTaxRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePremiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePremiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967463832480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 1,202<span></span>
</td>
<td class="nump">$ 1,336<span></span>
</td>
<td class="nump">$ 1,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Change in unrealized gain (loss) on investments</a></td>
<td class="num">(1,475)<span></span>
</td>
<td class="num">(296)<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Change in unrealized gain (loss) on investments, tax effect</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="num">(60)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Change in unrealized gain (loss) on investments, net of tax</a></td>
<td class="num">(1,126)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Reclassification adjustment, net of tax</a></td>
<td class="nump">11<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments, net of tax</a></td>
<td class="num">(94)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (loss)</a></td>
<td class="num">(1,209)<span></span>
</td>
<td class="num">(260)<span></span>
</td>
<td class="nump">203<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive earnings (loss)</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">1,076<span></span>
</td>
<td class="nump">1,997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive loss attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss attributable to noncontrolling interests</a></td>
<td class="num">$ (7)<span></span>
</td>
<td class="nump">$ 1,087<span></span>
</td>
<td class="nump">$ 2,011<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967460096096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Earnings (Loss)</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">421,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 12,659<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 7,647<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">$ 4,984<span></span>
</td>
<td class="num">$ (214)<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance Treasury stock (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (loss)</a></td>
<td class="nump">1,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) earnings, net of tax</a></td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Common stock issued for acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Common stock issued for acquisitions</a></td>
<td class="nump">11,527<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">11,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock issued for employee benefit plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued for employee benefit plans</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="num">(626)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (602)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,310)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation expense</a></td>
<td class="nump">281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Contribution from noncontrolling interest</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">598,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">25,885<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">19,459<span></span>
</td>
<td class="nump">337<span></span>
</td>
<td class="nump">6,792<span></span>
</td>
<td class="num">$ (816)<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance Treasury stock (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (loss)</a></td>
<td class="nump">1,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) earnings, net of tax</a></td>
<td class="num">(260)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(260)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock issued for employee benefit plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued for employee benefit plans</a></td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="num">(297)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (278)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(326)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation expense</a></td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Contribution from noncontrolling interest</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation', window );">Divestiture of noncontrolling interest</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisition resulting in noncontrolling interest</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">582,479<span></span>
</td>
<td class="nump">602,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 26,940<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">19,672<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">8,139<span></span>
</td>
<td class="num">$ (1,094)<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance Treasury stock (in shares) at Dec. 31, 2021</a></td>
<td class="nump">20,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (loss)</a></td>
<td class="nump">$ 1,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) earnings, net of tax</a></td>
<td class="num">(1,209)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,209)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock issued for employee benefit plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued for employee benefit plans</a></td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture', window );">Fair value of unvested equity awards in connection with acquisition</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="num">(3,096)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,119)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,868)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation expense</a></td>
<td class="nump">234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Reclassification to non-redeemable</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation', window );">Divestiture of noncontrolling interest</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Dividend to noncontrolling interest</a></td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of noncontrolling interest</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">550,754<span></span>
</td>
<td class="nump">607,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 24,181<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 20,060<span></span>
</td>
<td class="num">$ (1,132)<span></span>
</td>
<td class="nump">$ 9,341<span></span>
</td>
<td class="num">$ (4,213)<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance Treasury stock (in shares) at Dec. 31, 2022</a></td>
<td class="nump">57,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967463831568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Other comprehensive earnings (loss), tax</a></td>
<td class="nump">$ 349<span></span>
</td>
<td class="num">$ (75)<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967464313360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 1,202<span></span>
</td>
<td class="nump">$ 1,336<span></span>
</td>
<td class="nump">$ 1,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,553<span></span>
</td>
<td class="nump">1,476<span></span>
</td>
<td class="nump">1,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment</a></td>
<td class="nump">2,318<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">(Gain) loss on debt extinguishment</a></td>
<td class="num">(25)<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">(Gain) on acquisition</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(309)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(631)<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) on divestitures</a></td>
<td class="num">(772)<span></span>
</td>
<td class="num">(88)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of equipment</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other adjustments, net</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPremiumsReceivable', window );">Premium and trade receivables</a></td>
<td class="num">(1,627)<span></span>
</td>
<td class="num">(2,453)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">128<span></span>
</td>
<td class="num">(99)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities', window );">Medical claims liabilities</a></td>
<td class="nump">2,397<span></span>
</td>
<td class="nump">1,802<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Unearned revenue</a></td>
<td class="nump">31<span></span>
</td>
<td class="num">(109)<span></span>
</td>
<td class="num">(528)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
<td class="nump">585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="nump">842<span></span>
</td>
<td class="nump">1,093<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other operating activities, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">6,261<span></span>
</td>
<td class="nump">4,205<span></span>
</td>
<td class="nump">5,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(1,004)<span></span>
</td>
<td class="num">(910)<span></span>
</td>
<td class="num">(869)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(6,736)<span></span>
</td>
<td class="num">(7,400)<span></span>
</td>
<td class="num">(7,402)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Sales and maturities of investments</a></td>
<td class="nump">3,802<span></span>
</td>
<td class="nump">5,458<span></span>
</td>
<td class="nump">4,921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="num">(1,460)<span></span>
</td>
<td class="num">(534)<span></span>
</td>
<td class="num">(4,049)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Divestiture proceeds, net of divested cash</a></td>
<td class="nump">2,477<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) investing activities</a></td>
<td class="num">(2,921)<span></span>
</td>
<td class="num">(3,299)<span></span>
</td>
<td class="num">(6,955)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt</a></td>
<td class="nump">360<span></span>
</td>
<td class="nump">9,267<span></span>
</td>
<td class="nump">5,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments and repurchases of long-term debt</a></td>
<td class="num">(1,490)<span></span>
</td>
<td class="num">(7,434)<span></span>
</td>
<td class="num">(4,067)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock repurchases</a></td>
<td class="num">(3,096)<span></span>
</td>
<td class="num">(297)<span></span>
</td>
<td class="num">(626)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from common stock issuances</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishment</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(157)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="num">(120)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="num">(27)<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(4,197)<span></span>
</td>
<td class="nump">1,362<span></span>
</td>
<td class="nump">260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents</a></td>
<td class="num">(868)<span></span>
</td>
<td class="nump">2,257<span></span>
</td>
<td class="num">(1,174)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations', window );">Cash and cash equivalents reclassified (to) from held for sale</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period</a></td>
<td class="nump">13,214<span></span>
</td>
<td class="nump">10,957<span></span>
</td>
<td class="nump">12,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash and cash equivalents, end of period</a></td>
<td class="nump">12,330<span></span>
</td>
<td class="nump">13,214<span></span>
</td>
<td class="nump">10,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">657<span></span>
</td>
<td class="nump">658<span></span>
</td>
<td class="nump">725<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="nump">1,222<span></span>
</td>
<td class="nump">678<span></span>
</td>
<td class="nump">1,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1', window );">Equity issued in connection with acquisitions</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">12,074<span></span>
</td>
<td class="nump">13,118<span></span>
</td>
<td class="nump">10,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and cash equivalents, included in restricted deposits</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash and cash equivalents</a></td>
<td class="nump">$ 12,330<span></span>
</td>
<td class="nump">$ 13,214<span></span>
</td>
<td class="nump">$ 10,957<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in health care insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPremiumsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in the premium receivable balance on the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPremiumsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967467072928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Organization and Operations</a></td>
<td class="text">Organization and Operations Centene Corporation, or the Company, is a leading healthcare enterprise, committed to helping people live healthier lives, with an established expertise in lower-income and medically complex populations. The Company provides access to high-quality healthcare, innovative programs, and a wide range of health solutions that help families and individuals get well, stay well, and be well. During 2022, the Company operated in two segments: Managed Care and Specialty Services. The Managed Care segment provided health plan coverage to individuals through government subsidized programs, including Medicaid, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare, the Supplemental Security Income Program, also known as the Aged, Blind, or Disabled Program (ABD), Medicare (including Medicare Prescription Drug Plans), and the Health Insurance Marketplace. The Company also offered a variety of individual, small group, and large group commercial healthcare products, both to employers and directly to members in the Managed Care segment. The Specialty Services segment consisted of the Company's specialty companies offering auxiliary healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations, as well as to the Company's own subsidiaries. The Specialty Services segment also included the government contracts business, including the Company's government-sponsored Managed Care Support Contract with the U.S. Department of Defense (DoD) under the TRICARE program and other healthcare related government contracts.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967461931504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of Centene Corporation and all majority owned subsidiaries and subsidiaries over which the Company exercises the power and control to direct activities significantly impacting financial performance. All material intercompany balances and transactions have been eliminated. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the consolidated financial statements and notes have been reclassified to conform to the 2022 presentation. Beginning in 2022, the Company has included a separate line item for depreciation expense on the Consolidated Statement of Operations, which was previously included in selling, general and administrative (SG&amp;A) expenses. Prior period SG&amp;A expense ratios have also been conformed to the current presentation. These reclassifications have no effect on net earnings, cash flow, or stockholders' equity as previously reported.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 2022, the Company acquired all of the issued and outstanding shares of Magellan Health, Inc. (Magellan). The acquisition was accounted for as a business combination. Additionally, during 2022 the Company completed the divestitures of PANTHERx Rare (PANTHERx), its Spanish and Central European businesses, and Magellan Rx. See Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further details.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Future events and their effects cannot be predicted with certainty; accordingly, the accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes. The Company evaluates and updates its assumptions and estimates on an ongoing basis and may employ outside experts to assist in its evaluation, as considered necessary. Actual results could differ from those estimates. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business combinations are accounted for using the acquisition method of accounting. The Company allocates the fair value of purchase consideration to the assets acquired and liabilities assumed based on their fair values at the acquisition date. The excess of the fair value of consideration transferred over the fair value of the net assets acquired is recorded as goodwill. Goodwill is generally attributable to the value of the synergies between the combined companies and the value of the acquired assembled workforce, neither of which qualifies for recognition as an intangible asset. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses its best estimates and assumptions to value assets acquired and liabilities assumed at the acquisition date; however, these estimates are sometimes preliminary and, in some instances, all information required to value the assets acquired and liabilities assumed may not be available or final as of the end of a reporting period subsequent to the business combination. If the accounting for the business combination is incomplete, provisional amounts are recorded. The provisional amounts are updated during the period determined, up to one year from the acquisition date. The Company includes the results of operations of acquired businesses in the Company's consolidated results prospectively from the date of acquisition. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition related expenses and post-acquisition restructuring costs are recognized separately from the business combination and are expensed as incurred.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments with original maturities of three months or less are considered to be cash equivalents. Cash equivalents consist of money market funds, bank certificates of deposit, and savings accounts. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains amounts on deposit with various financial institutions, which may exceed federally insured limits. However, management periodically evaluates the credit-worthiness of those institutions, and the Company has not experienced any losses on such deposits.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments include securities with maturities greater than three months to one year. Long-term investments include securities with maturities greater than one year. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term and long-term investments are generally classified as available-for-sale and are carried at fair value. Certain equity investments are recorded using the fair value or equity method. The Company monitors the difference between the carrying value and fair value of its available-for-sale debt investments and whether declines in fair value are credit related. Unrealized gains and losses on debt investments available-for-sale are excluded from earnings and reported in accumulated other comprehensive earnings (loss), a separate component of stockholders' equity, net of income tax effects. If a loss is deemed to be credit related, the Company recognizes an allowance through earnings. For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes.&#160;If the security meets this criterion, the decline in fair value is recorded in earnings through investment and other income. Premiums and discounts are amortized or accreted over the life of the related security using the effective interest method. To calculate realized gains and losses on the sale of investments, the Company uses the specific amortized cost of each investment sold. Realized gains and losses are recorded in investment and other income. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the equity method to account for investments in entities that it does not control but has the ability to exercise significant influence over operating and financial policies. Generally, under the equity method, original investments in these entities are recorded at cost and subsequently adjusted by the Company's share of equity in income or losses after the date of acquisition&#160;as well as capital contributions to and distributions from these companies. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Deposits </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted deposits consist of investments required by various state statutes to be deposited or pledged to state agencies. These investments are classified as long-term, regardless of the contractual maturity date, due to the nature of the states' requirements. The Company is required to annually adjust the amount of the deposit pledged to certain states.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value&#160;Measurements</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company invests in various financial assets and&#160;incurs various financial liabilities. Fair values are disclosed for all financial instruments, whether or not such values are recognized in the Consolidated Balance Sheets. Management obtains quoted market prices and other observable inputs for these disclosures. The carrying amounts reported in the Consolidated Balance Sheets for cash and cash equivalents, premium and&#160;trade receivables, medical claims liability, accounts payable and accrued expenses, unearned revenue, and certain other current assets and liabilities are carried at cost, which approximates fair value because of their short-term nature. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used to estimate the fair value of each financial instrument: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Available-for-sale investments and restricted deposits: The carrying amount is stated at fair value, based on quoted market prices, where available. For securities not actively traded, fair values were estimated using values obtained from independent pricing services or quoted market prices of comparable instruments.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Senior unsecured notes: Estimated based on third-party quoted market prices for the same or similar issues.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Variable rate debt: The carrying amount of the Company's floating rate debt approximates fair value since the interest rates adjust based on market rate adjustments.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency swap: Estimated based on Great British Pound to US Dollar foreign exchange rates.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Contingent consideration: Estimated based on expected achievement of metrics included in the acquisition agreement considering circumstances that exist as of the acquisition date.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Software and Equipment </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, software and equipment are stated at cost less accumulated depreciation. Computer hardware and software includes certain costs incurred in the development of internal-use software, including external direct costs of materials and services and payroll costs of employees devoted to specific software development. Depreciation is calculated principally by the straight-line method over estimated useful lives. Leasehold improvements are depreciated using the straight-line method over the shorter of the expected useful life or the remaining term of the lease. Property, software and equipment are depreciated over the following periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"/><td style="width:67.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.941%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed Asset</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation Period</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;5 - 40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;3 - 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;10 - 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;1 - 20 years</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of all long-lived assets are evaluated to determine if adjustment to the depreciation and amortization period or to the unamortized balance is warranted. Such evaluation is based principally on the expected utilization of the long-lived assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company retains fully depreciated assets in property and accumulated depreciation accounts until it removes them from service. In the case of sale, retirement, or disposal, the asset cost and related accumulated depreciation balance is removed from the respective account, and the resulting net amount, less any proceeds, is included as a component of earnings from operations in the Consolidated Statements of Operations. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets represent assets acquired in purchase transactions and consist primarily of purchased contract rights and customer relationships, provider contracts, trade names, developed technologies, and goodwill. Intangible assets are amortized using the straight-line method over the following periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"/><td style="width:67.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.941%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Asset</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights and customer relationships</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 21 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 - 15 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 - 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 7 years</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests for impairment of intangible assets, as well as long-lived assets, whenever events or changes in circumstances indicate that the carrying value of an asset or asset group (hereinafter referred to as "asset group") may not be recoverable by comparing the sum of the estimated undiscounted future cash flows expected to result from use of the asset group and its eventual disposition to the carrying value. Such factors include, but are not limited to, significant changes in membership, state funding, state contracts, and provider networks and contracts. If the sum of the estimated undiscounted future cash flows is less than the carrying value, an impairment determination is required. The amount of impairment is calculated by subtracting the fair value of the asset group from the carrying value of the asset group. An impairment charge, if any, is recognized within earnings from operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill for impairment using a fair value approach. The Company is required to test for impairment at least annually, absent a triggering event, which could include a significant decline in operating performance that would require an impairment assessment. Absent any impairment indicators, the Company performs its goodwill impairment testing during the fourth quarter of each year. The Company recognizes an impairment charge for any amount by which the carrying amount of goodwill exceeds its fair value. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company first assesses qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. The Company generally does not calculate the fair value of a reporting unit unless it determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the quantitative test is deemed necessary, the Company determines an appropriate valuation technique to estimate a reporting unit's fair value as of the testing date. The Company utilizes either the income approach or the market approach, whichever is most appropriate for the respective reporting unit. The income approach is based on an internally developed discounted cash flow model that includes many assumptions related to future growth rates, discount factors, future tax rates, and other various assumptions. The market approach is based on financial multiples of comparable companies derived from current market data. The Company then compares the fair value of the reporting unit calculated using the income approach or market approach with its carrying amount and recognizes an impairment charge for the amount by which the carrying amount exceeds fair value. The impairment charge is limited to the total amount of goodwill allocated to the reporting unit. Changes in economic and operating conditions impacting assumptions used in the Company's analyses could result in goodwill impairment in future periods.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Claims Liability</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical claims liability includes claims reported but not yet paid, or inventory, estimates for claims incurred but not reported, or IBNR, and estimates for the costs necessary to process unpaid claims at the end of each period.&#160;The Company estimates its medical claims liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice.&#160;These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actuarial Standards of Practice generally require that the medical claims liability estimates be adequate to cover obligations under moderately adverse conditions.&#160;Moderately adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of estimate.&#160;In many situations, the claims amounts ultimately settled will be different than the estimate that satisfies the Actuarial Standards of Practice. The Company includes in its IBNR an estimate for medical claims liability under moderately adverse conditions which represents the risk of adverse deviation of the estimates in its actuarial method of reserving.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses its judgment to determine the assumptions to be used in the calculation of the required estimates. The assumptions it considers when estimating IBNR include, without limitation, claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, healthcare service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known outbreaks of disease or increased incidence of illness such as influenza or COVID-19, provider contract changes, changes to fee schedules, and the incidence of high-dollar or catastrophic claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's development of the medical claims liability estimate is a continuous process which it monitors and refines on a monthly basis as additional claims receipts and payment information becomes available. As more complete claims information becomes available, the Company adjusts the amount of the estimates, and includes the changes in estimates in medical costs in the period in which the changes are identified. In every reporting period, the operating results include the effects of more completely developed medical claims liability estimates associated with previously reported periods. The Company consistently applies its reserving methodology from period to period. As additional information becomes known, it adjusts the actuarial model accordingly to establish medical claims liability estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement, and maintenance costs. For purposes of determining premium deficiencies, contracts are grouped in a manner consistent with the method of acquiring, servicing, and measuring the profitability of such contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's health plans generate revenues primarily from premiums received from the states in which it operates health plans, premiums received from its members and the Centers for Medicare and Medicaid Services (CMS) for its Medicare product, and premiums from members of its commercial health plans. In addition to member premium payments, its Marketplace contracts also generate revenues from subsidies received from CMS. The Company generally receives a fixed premium per member per month pursuant to its contracts and recognizes premium revenues during the period in which it is obligated to provide services to its members at the amount reasonably estimable. In some instances, the Company's base premiums are subject to an adjustment factor, in the form of a risk score or risk adjustment, based on the acuity of its membership. Generally, the risk score or risk adjustment is determined by the state or CMS analyzing submissions of processed claims and medical record data to determine the acuity of the Company's membership, often relative to the respective program's membership. The Company estimates the amount of risk score and risk adjustment based upon the processed claims and medical record data submitted and expected to be submitted to CMS and records revenues on a risk adjusted basis. Some contracts allow for additional premiums related to certain supplemental services provided such as maternity deliveries.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts with states may require it to maintain a minimum health benefits ratio (HBR) or may require it to share cost-savings in excess of certain levels. In certain circumstances, including commercial plans, its plans may be required to return premium to the state or policyholders in the event costs are below established levels. The Company estimates the effect of these programs and recognizes reductions in revenue in the current period. Other states may require us to meet certain performance and quality metrics in order to receive additional or full contractual revenue. For performance-based contracts, the Company does not recognize revenue subject to refund until data is sufficient to measure performance.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recorded based on membership and eligibility data provided by the states or CMS, which is adjusted on a monthly basis by the states or CMS for retroactive additions or deletions to membership data. These eligibility adjustments are estimated monthly and subsequent adjustments are made in the period known. The Company reviews and updates those estimates as new information becomes available.&#160;It is possible that new information could require us to make additional adjustments, which could be significant, to these estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Medicare Advantage contracts are with CMS. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model pays more for members whose medical history would indicate that they are expected to have higher medical costs. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis data from hospital inpatient, hospital outpatient, physician treatment settings as well as prescription drug events. The Company and the healthcare providers collect, compile, and submit the necessary and available diagnosis data to CMS within prescribed deadlines. The Company estimates risk adjustment revenues based upon the diagnosis data submitted and expected to be submitted to CMS and records revenues on a risk adjusted basis.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For qualifying low-income prescription drug benefit members, CMS pays for some, or all, of the member's monthly premium. The Company receives certain Part D prospective subsidy payments from CMS for these members as a fixed monthly per member amount, based on the estimated costs of providing prescription drug benefits over the plan year, as reflected in its bids. Approximately nine to ten months subsequent to the end of the plan year, or later in the case of the coverage gap discount subsidy, a settlement payment is made between CMS and the Company's plans based on the difference between the prospective payments and actual claims experience. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's specialty services generate revenues under contracts with state and federal programs, healthcare organizations, and other commercial organizations, as well as from its own subsidiaries. Revenues are recognized when the related services are provided, when inventory is shipped, or as ratably earned over the covered period of services. The Company recognizes revenue related to administrative services under the TRICARE government-sponsored Managed Care Support Contract for the DoD's TRICARE program on a straight-line basis over the option period, when the fees become fixed and determinable. The TRICARE contract includes various performance-based measures.&#160;For each of the measures, an estimate of the amount that has been earned is made at each interim date, and revenue is recognized accordingly. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states enact premium taxes, similar assessments, and provider pass-through payments, collectively premium taxes, and these taxes are recorded as a separate component of both revenues and operating expenses. Additionally, the Company's insurance subsidiaries were previously subject to the Affordable Care Act (ACA) annual health insurer fee (HIF). Beginning in 2021, the HIF was permanently repealed. This revenue was recorded as premium tax and health insurer fee revenue in the Consolidated Statements of Operations. For certain products, premium taxes, state assessments, and the HIF are not pass-through payments and are recorded as premium revenue and premium tax expense or health insurer fee expense in the Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states require state directed payments that have minimal risk, but are administered as a premium adjustment.&#160;These payments are recorded as premium revenue and medical costs at close to a 100% HBR. In many instances, the Company has little visibility to the timing of these payments until they are paid by the state. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Affordable Care Act</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established risk spreading premium stabilization programs as well as minimum medical loss ratio (MLR) and cost sharing reductions (CSRs). The Company's accounting policies for the programs are as follows: </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Risk Adjustment </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The permanent risk adjustment program established by the ACA transfers funds from qualified individual and small group insurance plans with below average risk scores to those plans with above average risk scores within each state. The Company estimates the receivable or payable under the risk adjustment program based on its estimated risk score compared to the state average risk score. The Company may record a receivable or payable as an adjustment to premium revenues to reflect the year-to-date impact of the risk adjustment based on its best estimate. The Company refines its estimate as new information becomes available. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Minimum Medical Loss Ratio</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the ACA established a minimum MLR for the Health Insurance Marketplace. The risk adjustment program described above is taken into consideration to determine if the Company's estimated annual medical costs are less than the minimum MLR and require an adjustment to premium revenues to meet the minimum MLR. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Cost Sharing Reductions</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA directs issuers to reduce the Company's members' cost sharing for essential health benefits for individuals with Federal Poverty Levels (FPLs) between 100% and 250% who are enrolled in a silver tier product; eliminate cost sharing for Indians/Alaska Natives with a FPL less than 300% and eliminate cost sharing for Indians/Alaska Natives regardless of FPL when services are provided by an Indian Health Service. In order to compensate issuers for reduced cost sharing provided to enrollees, CMS pays an advance CSR payment to the Company each month based on the Company's certification data provided at the time of the qualified health plan application. In October 2017, the Trump Administration issued an executive order that immediately ceased payments of CSRs to issuers, and beginning in 2018 premium rates for Health Insurance Marketplace were set without factoring in the cost sharing subsidy payments from the federal government.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Premium and Trade Receivables and Unearned Revenue</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium and service revenues collected in advance are recorded as unearned revenue. For performance-based contracts, the Company does not recognize revenue subject to refund until data is sufficient to measure performance. Premiums and service revenues due to the Company are recorded as premium and trade receivables and are recorded net of an allowance based on historical trends and management's judgment on the collectability of these accounts. As the Company generally receives payments during the month in which services are provided, the allowance is typically not significant in comparison to total revenues and does not have a material impact on the presentation of the financial condition or results of operations. Amounts receivable under federal contracts are comprised primarily of contractually defined billings, accrued contract incentives under the terms of the contract, and amounts related to change orders for services not originally specified in the contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity in the allowance for uncollectible accounts is summarized below ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts charged to expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of uncollectible receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Customers </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company receives the majority of its revenues under contracts or subcontracts with state Medicaid managed care programs. Customers where the aggregate annual contract revenues exceeded 10% of total annual revenues included the state of New York, where the percentage of the Company's total revenue was 10% and 11% for the years ended December 31, 2021 and 2020. None of the Company's customers exceeded 10% of total annual revenues for the year ended December 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense) </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense) consists routinely of investment income, interest expense, and equity method earnings from investments. Investment income is derived from the Company's cash, cash equivalents, restricted deposits and investments. Interest expense relates to borrowings under the senior notes, credit facilities, mortgage and construction loans, and capital leases. Further, other income (expense) includes gains or losses on sales of investments, divestitures, and acquisitions as well as debt extinguishment costs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recorded for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law or tax rates is recognized in income in the period that includes the enactment date. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowances are provided when it is considered more likely than not that deferred tax assets will not be realized. In determining if a deductible temporary difference or net operating loss can be realized, the Company considers future reversals of existing taxable temporary differences, future taxable income, taxable income in prior carryback periods, and tax planning strategies.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accrues for loss contingencies associated with outstanding litigation, claims, and assessments for which it has determined it is probable that a loss contingency exists and the amount of loss can be reasonably estimated. The Company expenses professional fees associated with litigation claims and assessments as incurred.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Based Compensation</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock based compensation expense is recognized at grant date fair value over the period during which an employee is required to provide service in exchange for the award. Excess tax benefits related to stock compensation are presented as a cash inflow from operating activities. The Company accounts for forfeitures when they occur.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to foreign currency exchange risk through its international subsidiaries whose functional currencies include the Euro and Great British Pound. The assets and liabilities of the Company's subsidiaries are translated into United States dollars at the balance sheet date. The Company translates its proportionate share of earnings using average rates during the year. The resulting foreign currency translation adjustments are recorded as a separate component of accumulated other comprehensive earnings (loss). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial condition, results of operations, or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967468024480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Acquisitions and Divestitures</a></td>
<td class="text">Acquisitions and Divestitures<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Magellan Acquisition </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On&#160;January&#160;4, 2022, the Company acquired all of the issued and outstanding shares of Magellan. Total consideration for the acquisition was $2,491 million, consisting of $2,431 million in cash and $60 million related to the fair value of replacement equity awards associated with pre-combination service. The purchase price has been adjusted to reflect the net effective settlement of preexisting relationships between the Company and Magellan of $70&#160;million. The Company recognized $106 million of acquisition related expenses related to Magellan for the year ended December 31, 2022.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Magellan acquisition was accounted for as a business combination using the acquisition method of accounting that requires assets acquired and liabilities assumed to be recognized at fair value as of the acquisition date. The valuation of all assets acquired and liabilities assumed was finalized in the fourth quarter of 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's allocation of the fair value of assets acquired and liabilities assumed as of the acquisition date of January&#160;4, 2022 is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"><tr><td style="width:1.0%"/><td style="width:71.342%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and related receivables</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims liability</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return of premium payable</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired and liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,491&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant fair value adjustments are noted as follows:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The identifiable intangible assets acquired are to be measured at fair value as of the completion of the acquisition. The fair value of intangible assets is determined primarily using variations of the income approach, which is based on the present value of the future after-tax cash flows attributable to each identified intangible asset. Other valuation methods, including the market approach and cost approach, were also considered in estimating the fair value. The identifiable intangible assets include purchased contract rights, provider contracts, developed technologies, and trade names. The Company has estimated the fair value of intangible assets to be $889 million with a weighted average life of 12 years.</span></div><div style="padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values and weighted average useful lives for identifiable intangible assets acquired are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.736%"><tr><td style="width:1.0%"/><td style="width:43.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.848%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.524%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.848%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Useful Life in Years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Debt is required to be measured at fair value under the acquisition method of accounting. The fair value of Magellan's&#160;Senior Notes and Credit Agreement assumed in the acquisition was&#160;$535 million. In January 2022, the Company paid off Magellan's debt acquired in the transaction using Magellan's cash on hand.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The deferred tax liabilities are presented net of $102 million of deferred tax assets.</span></div><div style="padding-left:9pt;text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The acquisition resulted in $905 million of goodwill primarily related to synergies expected from the acquisition and the assembled workforce of Magellan. All of the goodwill was assigned to the Specialty segment. The majority of the goodwill is not deductible for income tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PANTHERx Rare Divestiture</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;14, 2022, the Company completed the divestiture of PANTHERx for $1,373 million. The Company recognized a gain of $490&#160;million, or $382 million after-tax, which is included in investment and other income on the Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Spanish and Central European Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;16, 2022, as part of the Company's review of strategic alternatives for its international portfolio, the Company completed the divestiture of its ownership stakes in its Spanish and Central European businesses, including Ribera Salud, Torrej&#243;n Salud, and Pro Diagnostics Group.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Company recorded an impairment charge primarily related to intangible assets and goodwill associated with the divestiture of $163 million, or $140 million after-tax.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Magellan Rx Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;2, 2022, the Company completed the divestiture of Magellan Rx for $1,337 million. The Company recognized a gain of $269&#160;million, or $99&#160;million after-tax, which is included in investment and other income on the Consolidated Statements of Operations and is subject to a final working capital adjustment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Magellan Specialty Health Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;17, 2022, the Company signed a definitive agreement to divest Magellan Specialty Health. As of December&#160;31, 2022, the assets and liabilities of Magellan Specialty Health were considered held for sale, resulting in $645&#160;million of assets held for sale in other current assets and $87&#160;million of liabilities held for sale in accounts payable and accrued expenses on the Consolidated Balance Sheet. The majority of the of held for sale assets were previously reported as goodwill and intangible assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;20, 2023, the Company completed the divestiture for approximately $646&#160;million in cash and stock, including an estimated working capital adjustment. The Company estimates that it will recognize an initial pre-tax gain of approximately $85 million to $95 million. The Company could also receive up to an additional $150&#160;million in cash and stock in 2024 based on certain 2023 performance metrics. The Company will recognize the appropriate amount of contingent consideration related to the $150&#160;million when realized or realizable.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Centurion Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;10, 2023, the Company signed and closed a definitive agreement to divest Centurion, its prison healthcare business. As of December&#160;31, 2022, the assets and liabilities of Centurion were considered held for sale resulting in $236&#160;million of assets held for sale in other current assets and $198&#160;million of liabilities held for sale in accounts payable and accrued expenses on the Consolidated Balance Sheet. The majority of the held for sale assets were previously reported as premium and trade receivables. The majority of the liabilities were previously reported as medical claims liability and accounts payable and accrued liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company recorded an impairment charge related to goodwill and other current assets associated with the divestiture of $259 million, or $181 million after-tax.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HealthSmart Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;1, 2022, the Company signed a definitive agreement to divest HealthSmart, its third party health plan administration business. The divestiture was completed on January&#160;5, 2023. As of December&#160;31, 2022, the assets and liabilities of HealthSmart were considered held for sale resulting in $66 million of assets held for sale in other current assets and $34 million of liabilities held for sale in accounts payable and accrued expenses on the Consolidated Balance Sheet. The majority of the held for sale assets were previously reported as cash and cash equivalents, premium and trade receivables, and goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company recorded an impairment charge related to goodwill associated with the divestiture of $36 million, or $27 million after-tax.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967547146864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term and Long-term Investments, Restricted Deposits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Short-term and Long-term Investments, Restricted Deposits</a></td>
<td class="text">Short-term and Long-term Investments, Restricted Deposits <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.458%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.320%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,566&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,364)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,222&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,521&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:10.8pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments in equity securities as of December&#160;31, 2021 primarily consisted of exchange traded funds in fixed income securities.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments, and life insurance contracts.&#160;The Company's investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with a focus on high credit quality securities.&#160;The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of December&#160;31, 2022, 98% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations.&#160;At December&#160;31, 2022, the Company held certificates of deposit, equity securities, private equity investments, and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzEwNTE_c9c93204-9871-484c-a20b-e44dba7e3ac9">132&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzEwNTg_296f7fee-e19d-4aef-8f1c-7793183430b5">96&#160;million</span> at December 31, 2022 and 2021, respectively, and is included in other current assets on the Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association, or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AAA and a weighted average duration of 4 years at December&#160;31, 2022.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:19.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.584%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,400</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,075&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(744)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,747&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,602&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the gross unrealized losses were generated from 6,423 positions out of a total of 6,854 positions.&#160;The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual, or regulatory purposes.&#160;If the security meets this criterion, the decline in fair value is recorded in earnings.&#160;The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates, and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit related loss may include rating agency actions, adverse conditions specifically related to the security, or failure of the issuer of the security to make scheduled payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company acquired the remaining 60% interest of Circle Health for $705&#160;million. As a result of the acquisition, the Company recorded a non-cash gain of $309&#160;million on its original investment in the year ended December&#160;31, 2021. The gain was included in investment and other income on the Consolidated Statement of Operations. Beginning in July 2021, the Company consolidates 100% of Circle Health.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company recorded a $229 million impairment of its equity method investment in RxAdvance, a pharmacy benefit manager. The impairment was the result of the Company&#8217;s focus on simplification of its pharmacy operations. The impairment was based on the Company's estimate of RxAdvance's future cash flows and other market indicators of fair value. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.136%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.738%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year or less</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,396&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,581&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,483&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from contractual maturities due to call or prepayment options.&#160;Equity securities, private equity investments, and life insurance contracts are excluded from the table above because they do not have a contractual maturity.&#160;The Company has an option to redeem substantially all of the securities included in the greater than ten years category listed above at amortized cost.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967562888480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value.&#160;Level inputs are as follows:&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;Input:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Input Definition:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level&#160;I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level&#160;II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level&#160;III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at December&#160;31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,074&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,074&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,307&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,007&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,591&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,598&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at December&#160;31, 2021, for assets and liabilities measured at fair value on a recurring basis ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,809&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency swap agreement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes matrix pricing services to estimate fair value for securities which are not actively traded on the measurement date.&#160;The Company designates these securities as Level II fair value measurements.&#160;In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $698 million and $773 million as of December&#160;31, 2022, and December&#160;31, 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967547146864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Software and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Software and Equipment</a></td>
<td class="text">Property, Software and Equipment<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, software and equipment consist of the following ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,224&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,498&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,291&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,066)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,900)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,432&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the years ended December 31, 2022, 2021, and 2020 was $614 million, $565 million, and $487 million, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2022, in connection with the adoption of a more modern, flexible work environment, the Company undertook a real estate optimization initiative to evaluate future real estate needs and downsize its real estate footprint for owned and leased properties. As a result of this evaluation, the Company substantially changed the use or abandoned various properties and assessed for impairment. The Company engaged a third-party real estate specialist to determine the fair value of its owned properties. The valuation primarily considered comparable properties in each market as well as future cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the optimization, the Company recognized impairment charges related to owned real estate of $808 million for the year ended December 31, 2022. The Company also recognized impairment on fixed assets related to leased real estate of $242 million for the year ended December 31, 2022. These impairments are primarily related to the Managed Care segment. The remainder of the $1,627 million charge relates to right-of-use (ROU) asset impairments, which is included within other long-term assets on the Consolidated Balance Sheet, refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Leases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967461873952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">Goodwill and Intangible Assets<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in goodwill by operating segment ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.840%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Managed&#160;Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,974&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,652&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reallocation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,771&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and purchase accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reallocation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,315&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in the Specialty Services segment goodwill in 2022 was primarily driven by the ongoing portfolio review divestiture related activity during the year as discussed in Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, divestiture related reductions to goodwill included the completed divestitures of PANTHERx and Magellan Rx, as well as goodwill reclassified to other current assets associated with the divestiture of Magellan Specialty Health, which was considered held for sale as of December&#160;31, 2022. The acquired goodwill in 2022 represents goodwill associated with the Magellan acquisition.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Specialty Services segment impairments in 2022 was primarily the result of the impairment of Federal Services business, which included $216 million of goodwill, in conjunction with the December 2022 announcement from the DoD that the Company was not awarded a TRICARE Managed Care Support Contract. The Managed Care segment impairment was the result of the divestiture of the Spanish and Central European businesses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the increase in the Managed Care segment goodwill in 2021 was related to the acquisition of the remaining 60% interest in Circle Health.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets at December 31, consist of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:49.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.684%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average&#160;Life in Years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights and customer relationships</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,850&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,068&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,835&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,036&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights and customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,924)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,212)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,911&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,824&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described above, the decrease in intangible assets in 2022 was primarily driven by divestiture related activity, which included related impairments, during the year as discussed with goodwill above and in Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $817 million, $770 million, and $719 million for the years ended December 31, 2022, 2021, and 2020, respectively. Estimated total amortization expense related to the December&#160;31, 2022 intangible assets for each of the five succeeding fiscal years is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"/><td style="width:67.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.941%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Total Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967547056752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Claims Liability<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceDisclosureTextBlock', window );">Medical Claims Liability</a></td>
<td class="text">Medical Claims Liability<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,243&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,438&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,473&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,453&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,783)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,745&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,243&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,438&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. The impact from COVID-19 on healthcare utilization and medical claims submission patterns provided increased estimation uncertainty on the IBNR liability. Additionally, as a result of minimum HBR and other return of premium programs, the Company recorded approximately $198 million, $492 million, and $86 million of the "Incurred related to: Prior years" as a reduction to premium revenues in 2022, 2021, and 2020, respectively. Further, claims processing initiatives yielded increased claim payment recoveries and coordination of benefits related to prior year dates of service.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in medical utilization and cost trends and the effect of population health management initiatives may also contribute to changes in medical claim liability estimates.&#160;While the Company has evidence that population health management initiatives are effective on a case by case basis, population health management initiatives primarily focus on events and behaviors prior to the incurrence of the medical event and generation of a claim. Accordingly, any change in behavior, leveling of care, or coordination of treatment occurs prior to claim generation and as a result, the costs prior to the population health management initiative are not known by the Company. Additionally, certain population health management initiatives are focused on member and provider education with the intent of influencing behavior to appropriately align the medical services provided with the member's acuity. In these cases, determining whether the population health management initiative changed the behavior cannot be determined. Because of the complexity of its business, the number of states in which it operates, and the volume of claims that it processes, the Company is unable to practically quantify the impact of these initiatives on its changes in estimates of IBNR. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement, and maintenance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Specialty Services segment has an insignificant amount of medical claims liability and, therefore, disclosures related to medical claims liabilities have been aggregated and are presented on a consolidated basis. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about incurred and paid claims development as of December&#160;31, 2022 is included in the table below. The claims development information for all periods preceding the most recent reporting period is considered required supplementary information. Incurred and paid claims development as of December&#160;31, 2022 is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:23.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.354%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance</span></td></tr><tr><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Claim Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 (unaudited)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 (unaudited)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,206&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,502&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,433&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,896&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred claims</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance</span></td></tr><tr><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Claim Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 (unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 (unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,722&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,593&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,021&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total payment of incurred claims</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All outstanding liabilities prior to 2020, net of reinsurance</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims liability, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,719&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incurred claims and allocated claim adjustment expenses, net of reinsurance, total IBNR plus expected development on reported claims and cumulative claims data as of December&#160;31, 2022 are included in the following table. For claims frequency information summarized below, a claim is defined as the financial settlement of a single medical event in which remuneration was paid to the servicing provider. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims, and estimates for the costs necessary to process unpaid claims at the end of each period.&#160;The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice.&#160;These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.&#160;Information is summarized as follows (in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.535%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative Paid Claims</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,433&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,896&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,081&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI https://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967547056752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affordable Care Act<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AffordableCareActAbstract', window );"><strong>Affordable Care Act [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AffordableCareActDisclosureTextBlock', window );">Affordable Care Act</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Affordable Care Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established risk spreading premium stabilization programs as well as a minimum annual MLR and cost sharing reductions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's net receivables (payables) for each of the programs are as follows ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment receivable</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum medical loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>In June 2022, CMS announced the final risk adjustment transfers for the 2021 benefit year. As a result of the announcement, the Company increased its risk adjustment net receivables by $403 million from December&#160;31, 2021. After consideration of minimum MLR and other related impacts, the net pre-tax benefit recognized was approximately $368 million for the year ended December&#160;31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AffordableCareActAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affordable Care Act [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AffordableCareActAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AffordableCareActDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affordable Care Act Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AffordableCareActDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967461677648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,500 million 4.25% Senior Notes, due December 15, 2027</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,484&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,300 million 2.45% Senior Notes, due July 15, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,500 million 4.625% Senior Notes, due December 15, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 3.375% Senior Notes, due February 15, 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 3.00% Senior Notes, due October 15, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 2.50% Senior Notes, due March 1, 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,300 million 2.625% Senior Notes, due August 1, 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction loan payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,938&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,571&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the Company's total debt, approximately 13% is variable rate debt. Approximately 12% uses the London Interbank Offered Rate (LIBOR) as a reference rate pursuant to the terms of the Company Credit Facility and approximately 1% uses the Sterling Overnight Index Average (SONIA) as a reference rate. The Company believes that the credit agreement will allow Secured Overnight Financing Rate (SOFR) to be used as the new reference rate upon LIBOR's discontinuance. The debt agreements that may be impacted by the discontinuation of LIBOR have provisions included that are sufficient for the Company to transition from the existing LIBOR rates to the prevailing successor market rates as necessary. The document governing the Company Credit Facility includes provisions to convert from LIBOR to SOFR at the time LIBOR ceases to be published.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Magellan acquisition in January 2022, the Company paid off Magellan's debt of $535 million acquired in the transaction using Magellan's cash on hand. Specifically, the Company redeemed Magellan's existing outstanding 4.4% Senior Notes due 2024 and paid off the existing Credit Agreement. The Company recognized an immaterial net pre-tax gain on extinguishment including related fees and expenses and the write-off of the unamortized premium.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company utilized a portion of the proceeds from the PANTHERx divestiture to repurchase $95 million of its par value Senior Notes due 2027 and $223 million of its par value Senior Notes due 2029 through the Company's senior note debt repurchase program. The Company recognized a $14 million gain on the redemptions of the notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company issued $2,200 million 2.50% Senior Notes due 2031 (the 2031 Notes). In conjunction with the 2031 Notes offering, the Company completed a tender offer (the Tender Offer) to purchase for cash, subject to certain conditions, any and all of the outstanding aggregate principal amount of the $2,200 million 4.75% Senior Notes due 2025 (the 2025 Notes). The Company used the net proceeds from the 2031 Notes, together with available cash on hand, to fund the purchase price for the 2025 Notes accepted for purchase in the Tender Offer (approximately 36% of the aggregate principal amount outstanding) and used the remaining proceeds to redeem any of the 2025 Notes that remained outstanding following the Tender Offer, including all premiums and accrued interest. The Company recognized a pre-tax loss on extinguishment of $46&#160;million on the redemption of the 2025 Notes, including the call premium, the write-off of the unamortized premium and debt issuance costs, and expenses related to the redemption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company issued $1,800&#160;million 2.45% Senior Notes due 2028 (the 2028 Notes). The Company used the net proceeds from the offering of the 2028 Notes to finance a portion of the cash consideration payable in connection with the acquisition of Magellan Health Inc., which closed in January 2022, and to pay related fees and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company issued $1,800&#160;million aggregate principal amount of Senior Notes which included $500&#160;million aggregate principal amount of additional 2028 Notes at a premium to yield 2.31% and $1,300&#160;million aggregate principal amount of new 2.625% Senior Notes due 2031. The Company used the net proceeds of the offering, together with cash on hand and term loan facility borrowings, to redeem all of its outstanding 5.375% Senior Notes due 2026 and WellCare Health Plans, Inc.'s outstanding 5.375% Senior Notes due 2026 (together the 2026 Notes), including all premiums and accrued interest. The Company recognized a pre-tax loss on extinguishment of $79&#160;million on the redemptions of the 2026 Notes, including the call premium, the write-off of the unamortized premium and debt issuance costs, and expenses related to the redemptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indentures governing the senior notes listed in the table above contain restrictive covenants of Centene Corporation. At December&#160;31, 2022, the Company was in compliance with all covenants.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Swap</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to manage the foreign exchange risk associated with an intercompany note receivable related to the Circle Health acquisition, the Company entered into a foreign currency swap agreement for a notional amount of $705&#160;million, to purchase &#163;509&#160;million. The swap agreement was formally designated and qualified as a fair value hedge. All gains and losses due to changes in the fair value of the foreign currency swap completely offset changes in the remeasurement of the intercompany note receivable within investment and other income in the Consolidated Statement of Operations, resulting in no net impact to the Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the swap agreement as of December&#160;31, 2021 was $15&#160;million, which was recorded in other current assets in the Consolidated Balance Sheet. The offsetting changes in fair value of the foreign currency swap and the remeasurement on the underlying intercompany note receivable were both recognized in investment and other income in the Consolidated Statements of Operations. The Company does not hold or issue any derivative instruments for trading or speculative purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2022, the foreign currency swap settled in connection with its expiration, and the Company received cash proceeds of $35 million. The Company does not hold or issue any derivative instruments for trading or speculative purposes.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Circle Health Debt Refinancing</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company refinanced certain debt agreements for its Circle Health subsidiary with a new &#163;250 million credit facility maturing in May 2025. The Company recognized a $13 million pre-tax gain on the extinguishment of the existing debt. As of December&#160;31, 2022, &#163;160&#160;million was drawn on the facility, which is included within Finance leases and other in the table above. The new facility is guaranteed by the Company and has similar borrowing rates and covenants to the Company's Revolving Credit Agreement, except it uses the SONIA as the reference rate for the interest rate payable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revolving Credit Facility and Term Loan Credit Facility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company amended and restated its existing credit agreement to, among other things, (i) extend the various maturities under the existing Credit Agreement until 2026, (ii) increase the aggregate principal amount of the U.S. dollar unsecured term loan facility under the existing Credit Agreement from $1,450 million to $2,200 million, (iii) increase the maximum total net leverage ratio permitted under the total debt to EBITDA financial covenant from 3.5 to 1.0 to 4.0 to 1.0, (iv) reduce the applicable margin with respect to borrowings to between 1.50% to 1.125%, based on the total debt to EBITDA ratio and type of borrowing and (v) include scheduled amortization payments with respect to the term loan facility equal to 0% for the first year following closing, 2.5% for the second year following closing and 5% thereafter until maturity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has (i) unsecured $2,000 million multi-currency revolving credit facility (the Revolving Credit Facility), which includes a $300 million sub-limit for letters of credit and a $200 million sub-limit for swingline loans and (ii) a $2,200 million unsecured delayed-draw term loan facility (the Term Loan Facility, and, together with the Revolving Credit Facility, the Company Credit Facility). Borrowings under the Revolving Credit Facility bear interest, at the Company's option, at LIBOR, EURIBOR, CDOR, BBR, or base rates plus, in each case, an applicable margin between 1.50% to 1.125%, based on the total debt to EBITDA ratio and type of borrowing. Borrowings under the Term Loan Facility bear interest, at the Company's option, at LIBOR or base rates plus, in each case, an applicable margin based on the total debt to EBITDA ratio. The Company has an uncommitted option to increase its Company Credit Facility by an additional $500 million plus certain additional amounts based on its total debt to EBITDA ratio. The Company believes that the credit agreement will allow SOFR to be used as the new reference rate upon LIBOR's discontinuance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company Credit Facility contains financial covenants including maintenance of a minimum fixed charge coverage ratio and a restriction on the Company's maximum total debt to EBITDA ratio not to exceed 4.0 to 1.0. It also contains certain non-financial covenants including: limitations on incurrence of additional indebtedness; restrictions on incurrence of liens; restrictions on dividends and other restricted payments; restrictions on investments, mergers, consolidations, and asset sales; and limitations on transactions with affiliates. As of December&#160;31, 2022, the Company was in compliance with all financial and non-financial covenants under the Company Credit Facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had $58 million of borrowings outstanding under the Revolving Credit Facility, with a weighted average interest rate of 4.80%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility and the Term Loan Facility will mature on August&#160;16, 2026.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Construction Loan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, the Company executed a $200 million non-recourse construction loan to fund the expansion of the Company's corporate headquarters. Until final completion of the project, which occurred in July 2021, the loan bore interest based on the one month LIBOR plus 2.70%, which reduced to LIBOR plus 2.00%&#160;at the time construction completed. The agreement contains financial and non-financial covenants similar to those contained in the Company Credit Facility. The Company guaranteed completion of the construction project associated with the loan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, the Company extended the term of the loan for an additional one year. The extension reduced interest on the loan to SOFR plus 1.85% and matures in April 2023. In December 2022, the Company paid off the outstanding balance of the construction loan.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Note Debt Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company's Board of Directors authorized a new $1,000 million senior note debt repurchase program in preparation for future debt reductions as part of the Company's strategic value creation initiatives. During the year ended December 31, 2022, the Company repurchased $318 million of its par value senior notes, as described above, for $300 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $700 million available under the senior note debt repurchase program.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit &amp; Surety Bonds</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had outstanding letters of credit of $217 million as of December&#160;31, 2022, which were not part of the Revolving Credit Facility.&#160;The letters of credit bore interest at 0.6% as of December&#160;31, 2022. The Company had outstanding surety bonds of $1,292 million as of December&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate maturities for the Company's debt for the years ending December 31, are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"/><td style="width:67.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.941%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Maturities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,179&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of outstanding debt was approximately $15,791 million and $19,256 million at December 31, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967461844496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records ROU assets and lease liabilities for non-cancelable operating leases primarily for real estate and equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet. Expense related to leases is recorded on a straight-line basis over the lease term, including rent holidays. The Company recognized operating lease expense of $429 million and $390&#160;million during the years ended December 31, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers the existence of options to extend or terminate leases in its analysis of the lease term for the purposes of measuring its ROU assets and lease liabilities. The renewal options are not included in the measurement of the ROU assets and lease liabilities unless the Company is reasonably certain to exercise the optional renewal periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the ROU assets and lease liabilities ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets (recorded within other long-term assets)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMS0xLTEtMzU0MDE4_199e3251-c3e9-421e-aaf9-eda971b806fd">2,554</span>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMy0xLTEtMzU0MDE4_25d5eafe-3f10-47e5-a022-23bca263c61e">3,566</span>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term (recorded within accounts payable and accrued expenses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMS0xLTEtMzU0MDE4_53c5f53c-16be-4589-801c-7882d412dd63">180</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMy0xLTEtMzU0MDE4_ca13f2de-0327-4128-b4b7-a1cf2eacc73a">204</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term (recorded within other long-term liabilities)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMS0xLTEtMzU0MDE4_f7d03d1c-fd2a-4fb1-b8d2-c6a9e69f4553">3,133</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMy0xLTEtMzU0MDE4_83602f08-9569-4028-8eb3-50c7d80f55b9">3,619</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,823&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities, recorded as operating cash flows in the Consolidated Statements of Cash Flows, was $440 million and $385&#160;million during the years ended December 31, 2022 and 2021, respectively. New operating leases commenced resulting in the recognition of ROU assets and lease liabilities of $60 million and $177&#160;million during the years ended December 31, 2022 and 2021, respectively. In connection with the acquisition of Magellan in January 2022, the Company acquired $30 million of ROU assets and lease liabilities. As of December&#160;31, 2022, the Company had additional operating leases that have not yet commenced of $8 million. These operating leases will commence in 2023 with lease terms ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzE1ODI_9a1af50d-4299-45b3-b023-ef6bb807076b">one</span> to eight years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the real estate optimization initiative as described in Note 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Property, Software and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company vacated and abandoned various domestic leased properties. As a result, the Company assessed the ROU assets for impairment. The Company engaged a third-party real estate specialist to determine the recoverability of the leased properties. The valuation primarily considered comparable leased properties in each market and the assessment of potential future rental income that could be generated by the ROU assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the optimization, the Company recognized $577 million of ROU asset impairments in the year ended December 31, 2022, primarily related to the Managed Care segment. The remainder of the $1,627 million charge was recorded within Property, Software and Equipment, refer to Note 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Property, Software and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term of the Company's operating leases was 20.5</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 21.1 years as of December 31, 2022 and 2021, respectively. The lease liabilities reflect a weighted average discount rate of 5.7% and 5.7% as of December 31, 2022 and 2021, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease payments over the next five years and thereafter are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"/><td style="width:67.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.941%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Payments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,240&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,927)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967461873952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders' Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Board of Directors has authorized a stock repurchase program of the Company's common stock from time to time on the open market or through privately negotiated transactions. In 2022, in preparation for the closing of divestitures as well as planning for the future, the Company's Board of Directors authorized increases under the program including $3,000 million in June 2022 and an additional $2,000 million in December 2022. With these increases, the Company is authorized to repurchase up to $6,000 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company entered into an accelerated share repurchase (ASR) agreement with Bank of America to purchase $1,000 million of the Company's common stock in aggregate under the Company's stock repurchase program. In July 2022, 8.6 million shares were delivered to the Company, representing 80% of the notional amount under the ASR. In October 2022, an additional 3.0 million shares were delivered upon settlement of the ASR based upon the volume-weighted average price (VWAP) over the term of the agreement, less a discount, of $86.21. In total, 11.6 million shares were purchased through the $1,000 million ASR. In addition, the Company purchased additional shares throughout the year through open market repurchases, including repurchase plans designed to comply with Rule 10b5-1.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share repurchases in 2022, 2021, and 2020 were primarily funded through divestiture proceeds. The following represents the Company's share repurchase activity ($ in millions, shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share buybacks</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,655&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,994&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,402&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,672&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax withholding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share repurchases</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,868&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,096&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,781&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,717&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased for income tax withholding are shares withheld in connection with employee stock plans to meet applicable tax withholding requirements. These shares are typically included in the Company's treasury stock, except for the vesting of certain shares assumed in connection with the WellCare acquisition in 2020 and 2021, which were withheld rather than repurchased. Although these shares are not issued, they are treated as common stock repurchases as they reduce the number of shares that would have been issued upon vesting. Shares withheld were 326&#160;thousand shares at an aggregate cost of $19 million, and 407&#160;thousand at an aggregate cost of $24 million, for the years ended December 31, 2021 and 2020, respectively. No shares were withheld under this method in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had a remaining amount of $2,806 million available under the Company's stock repurchase program. No duration has been placed on the repurchase program. The Company reserves the right to discontinue the repurchase program at any time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shares Issued for Acquisition</span></div>In January 2020, the Company issued 171&#160;million shares of Centene common stock with a fair value of $11,431&#160;million and paid $6,079&#160;million in cash in exchange for all the outstanding shares of WellCare common stock. In addition, the Company recorded $95&#160;million related to the fair value of replacement equity awards associated with pre-combination service.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967547056752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statutory Capital Requirements and Dividend Restrictions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract', window );"><strong>Statutory Capital Requirements And Dividend Restrictions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock', window );">Statutory Capital Requirements and Dividend Restrictions</a></td>
<td class="text">Statutory Capital Requirements and Dividend Restrictions&#160;Various state laws require Centene's regulated subsidiaries to maintain minimum capital levels specified by each state and restrict the amount of dividends that may be paid without prior regulatory approval. At December 31, 2022 and 2021, Centene's subsidiaries had aggregate statutory capital and surplus of $16,436 million and $14,039 million, respectively, compared with the required minimum aggregate statutory capital and surplus of $7,979 million and $6,706 million, respectively. As of December&#160;31, 2022, the amount of capital and surplus or net worth that was unavailable for the payment of dividends or return of capital to the Company was $7,979 million in the aggregate.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Statutory capital requirements and dividend restrictions [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Statutory Capital Requirements And Dividend Restrictions [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967547146864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated income tax expense consists of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current provision</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(649)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the tax provision at the U.S. federal statutory rate to income tax expense is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income tax expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,962&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,773&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (earnings) attributable to flow through noncontrolling interest </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings less noncontrolling interest before income tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,782&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at the U.S. federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible PBM legal settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nontaxable divestiture (gains) losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes for investments in subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACA health insurer fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to recognize deferred tax assets and liabilities for consolidated subsidiaries that are determined to be held for sale as of December 31, 2022. The Company established a net deferred tax liability of $84 million for these investments in subsidiaries.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences which give rise to deferred tax assets and liabilities are presented below ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims liability</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and trade receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,407)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had not historically provided for deferred income taxes on the undistributed earnings of foreign subsidiaries as they were considered indefinitely reinvested outside the U.S. During the fourth quarter of 2022, as part of the Company's review of strategic alternatives for its international portfolio, the Company evaluated its assertion regarding its ability and intent to indefinitely reinvest undistributed earnings of the foreign subsidiaries. Upon evaluating the assertion, the Company determined that any historical or future undistributed earnings of foreign subsidiaries are no longer considered to be indefinitely reinvested. There is no deferred tax liability associated with these earnings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase to the unrealized loss deferred tax asset reflects the change in the fair market value of the Company's investment portfolio. Decreases to the fixed assets and ROU asset deferred tax liabilities are primarily related to the impairments recorded as part of the Company's real estate optimization initiative.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowances are provided when it is considered more likely than not that deferred tax assets will not be realized. The valuation allowances primarily relate to future tax benefits on certain federal, state, and foreign net operating loss, federal and state capital loss, and tax credit carryforwards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal net operating loss and credit carryforwards of $69 million expire beginning in 2023 through 2043. State net operating loss and tax credit carryforwards of $51 million expire beginning in 2023 through 2042, while the remaining $15 million have indefinite carryforward periods. Substantially all the non-U.S. tax loss carryforwards of $206 million have indefinite carryforward periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a reserve for uncertain tax positions that may be challenged by a tax authority. A rollforward of the beginning and ending amount of uncertain tax positions, exclusive of related interest and penalties, is as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, January 1</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitation lapses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, $303 million of unrecognized tax benefits would impact the Company's effective tax rate in future periods, if recognized.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table above excludes interest and penalties, net of related tax benefits, which are treated as income tax expense (benefit) under the Company's accounting policy. The Company recognized net interest expense and penalties related to uncertain positions of $23 million and $1 million expense for the years ended December 31, 2022 and 2021, respectively. The Company had $66 million and $43 million of accrued interest and penalties for uncertain tax positions as of December 31, 2022 and 2021, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files federal tax returns as well as returns for numerous state and international tax jurisdictions and is engaged in multiple audit proceedings for its state and foreign filings. Generally, no further state or foreign audit activity is expected for years prior to 2015. As of December&#160;31, 2022, the Company's tax returns are under federal examination for the tax years 2014 through 2017, only with respect to Internal Revenue Service (IRS) proposed adjustments relating to the Company's claims to the Domestic Production Activities Deduction for these years. The Company has appealed the IRS adjustments and the appeals process is expected to be conducted within the next 12 months. The Company believes it is reasonably possible that its liability for unrecognized tax benefits will decrease by approximately $124 million within the next 12 months if the Company reaches a satisfactory agreement with the IRS during the appeals process and an additional $3&#160;million decrease as a result of the expiration of statutes of limitations and projected audit settlements in certain jurisdictions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967463907152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Incentive Plans</a></td>
<td class="text">Stock Incentive Plans<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's stock incentive plans allow for the granting of restricted stock or restricted stock unit awards and options to purchase common stock. Both incentive stock options and nonqualified stock options can be awarded under the plans. However, an immaterial amount of options were granted, exercised, or outstanding in 2022. The plans have 17 million shares available for future awards. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for stock options and restricted stock unit awards is recognized on a straight-line basis over the vesting period, generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTA_555f768d-bd53-493d-899f-ffdf3d5a60f0">three</span> to five years for stock options and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTg_0f5667b6-1669-434f-8a62-05af54a230a9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTg_d969fa16-d3ae-4cf3-a934-197b9b0e25e4">one</span></span> to three years for restricted stock or restricted stock unit awards. Vesting is accelerated by one year for individuals who qualify under the Company's retirement eligible provisions. The fair value of restricted stock and restricted stock units is determined using the previous day's market close price at the time of grant. The fair value of stock options is determined based on the Black-Scholes option-pricing model. Forfeitures for all stock awards are recognized as they occur. Certain restricted stock unit awards contain performance-based as well as service-based provisions. Certain awards provide for accelerated vesting if there is a change in control as defined in the plans. The total compensation cost that has been charged against income for the stock incentive plans was $234 million, $203 million, and $281 million for the years ended December 31, 2022, 2021, and 2020, respectively. The total income tax benefit recognized in the Statements of Operations for stock-based compensation arrangements was $48 million, $35 million, and $34 million for the years ended December 31, 2022, 2021, and 2020, respectively. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the&#160;Company's non-vested&#160;restricted stock and restricted stock unit shares as of December&#160;31, 2022, and changes during the year ended December&#160;31, 2022, is presented below (shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested balance, December 31, 2021</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,142&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Converted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,553)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(877)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested balance, December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Magellan awards converted in connection with the acquisition.</span></div></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of restricted stock and restricted stock units vested during the years ended December 31, 2022, 2021, and 2020, was $298 million, $264 million, and $364 million, respectively.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $249 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the plans; that cost is expected to be recognized over a weighted-average period of 1.8 years. </span></div>The Company maintains an employee stock purchase plan and issued 449 thousand shares, 516 thousand shares, and 487 thousand shares in 2022, 2021, and 2020, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967462779968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Retirement Plan</a></td>
<td class="text">Retirement Plan &#160;Centene has a defined contribution plan which covers substantially all employees who are at least 21 years of age. Under the plan, eligible employees may contribute a percentage of their base salary, subject to certain limitations. Centene may elect to match a portion of the employee's contribution. Company expense related to matching contributions to the plan was $133&#160;million, $105 million, and $91 million during the years ended December 31, 2022, 2021, and 2020, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI https://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI https://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967463907152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Commitments</a></td>
<td class="text">Commitments <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with obtaining regulatory approval of the Magellan Health acquisition, the Company entered into certain undertakings with the Department of Managed Health Care in 2022. These undertakings contain various commitments by the Company effective upon completion of the Magellan Health acquisition. As part of the undertaking, the Company shall contribute $10&#160;million to the Purchaser Business Group on Health (PBGH) to be paid over a five-year period for initiatives consistent with the Company's mission of implementing and spreading innovative programs and best practices to increase health care value. As a result of the closing of the Magellan acquisition, the $10 million contribution to PBGH was expensed during 2022. As of December&#160;31, 2022, the Company has paid $1.5 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with obtaining regulatory approval of the Fidelis Care acquisition, the Company entered into certain undertakings with the New York State Department of Health in 2018. These undertakings contain various commitments by the Company effective upon completion of the Fidelis Care acquisition. One of the undertakings includes a $340&#160;million contribution by the Company to the State of New York to be paid over a five-year period for initiatives consistent with the Company's mission of providing high-quality healthcare to vulnerable populations within New York State. The Company has fulfilled this undertaking as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also committed to certain undertakings with the California Department of Insurance and the California Department of Managed Health Care in connection with obtaining regulatory approval of the Health Net acquisition in 2016. The Health Net commitments related to the undertakings are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">invest an additional $30 million through the California Organized Investment Network over the five years following completion of the acquisition; the Company fulfilled this undertaking in 2020;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">build a service center in an economically distressed community in California, investing $200 million over 10 years and employing at least 300 people, of which the Company has incurred $109 million through 2022;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contribute $65 million to improve enrollee health outcomes, support locally-based consumer assistance programs, and strengthen the healthcare delivery system, of which the Company has contributed $49 million through 2022 with remaining $16 million scheduled to be paid equally over 2023 and 2024; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">invest $75 million of its investment portfolio in vehicles supporting California's healthcare infrastructure, and the Company fulfilled this undertaking in 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459961040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text">Contingencies <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, submissions to CMS for risk adjustment payments, or the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, cybersecurity issues, including those related to the Company's or the Company's third-party vendors' information systems, and the Health Insurance Portability and Accountability Act of 1996 and other federal and state fraud, waste and abuse laws;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property, and employment-related claims; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions, and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups, and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, these matters may result in awards of damages, fines, or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as described below with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company&#8217;s pharmacy benefits management (PBM) subsidiary. It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow, and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings, including as described below. Except for the proceedings discussed below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow, or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">California</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 20, 2015, the Company's California subsidiary, Health Net of California, Inc. (Health Net California), was named as a defendant in a California taxpayer action filed in Los Angeles County Superior Court, captioned as Michael D. Myers v. State Board of Equalization, Dave Jones, Insurance Commissioner of the State of California, Betty T. Yee, Controller of the State of California, et al., Los Angeles Superior Court Case No. BS158655. This action is brought under a California statute that permits an individual taxpayer to sue a governmental agency when the taxpayer believes the agency has failed to enforce governing law. Plaintiff contends that Health Net California, a California licensed Health Care Service Plan (HCSP), is an "insurer" for purposes of taxation despite acknowledging it is not an "insurer" under regulatory law. Under California law, "insurers" must pay a gross premiums tax (GPT), calculated as 2.35% on gross premiums. As a licensed HCSP, Health Net California has paid the California Corporate Franchise Tax (CFT), the tax generally paid by California businesses. Plaintiff contends that Health Net California must pay the GPT rather than the CFT. Plaintiff seeks a writ of mandate directing the California taxing agencies to collect the GPT, and seeks an order requiring Health Net California to pay GPT, interest, and penalties for a period dating to eight years prior to the October 2015 filing of the complaint. This lawsuit is being coordinated with similar lawsuits filed against other entities (collectively, Related Actions). In March 2018, the Court overruled the Company's demurrer seeking to dismiss the complaint and denied the Company's motion to strike allegations seeking retroactive relief. In August 2018, the trial court stayed all the Related Actions pending determination of a writ of mandate by the California Court of Appeals in two of the Related Actions. In March 2019, the California Court of Appeals denied the writ of mandate. The defendants in those Related Actions sought review by the California Supreme Court, which declined to review the matter. Upon the return of the matter to the Los Angeles County Superior Court, motions for summary judgment were scheduled. Health Net California's motion for summary judgment was heard by the Court in March 2020. In March 2020, the Court granted Health Net California's motion for summary judgment. In September 2020, the plaintiff appealed the Court's decision. The Company intends to continue its vigorous defense against these claims; however, this matter is subject to many uncertainties, and an adverse outcome in this matter could potentially have a materially adverse impact on the Company's financial condition, results of operations, and cash flows.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in April 2021, several lawsuits have been filed against the Company and its subsidiaries, alleging that the defendants failed to prevent Health Net members' personal and health data from being exposed in connection with a data breach involving Accellion's File Transfer Appliance. The Company denies any wrongdoing and is seeking indemnification from Accellion for these claims. In December 2021, the plaintiffs in three of the pending actions filed a motion for preliminary approval of a settlement with the Company and its subsidiaries, which, if approved by the court, should resolve most or all of the pending litigation. In addition, claims related to these lawsuits are anticipated to be covered in part by the Company's insurance carrier. As a result, while these matters are subject to many uncertainties, the Company does not believe that an adverse outcome in these matters is likely to have a materially adverse impact on the Company's financial condition, results of operations, and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Benefits Management Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2021, the State of Ohio filed a civil action against the Company and the Company's subsidiaries, Buckeye Health Plan Community Solutions, Inc. and Envolve, in Franklin County Court of Common Pleas, captioned as Ohio Department of Medicaid, et al. v. Centene Corporation, et al. The complaint alleged breaches of contract with the Ohio Department of Medicaid relating to the provision of PBM services and violations of Ohio law relating to such contracts, including among other things, by (i) seeking payment for services already reimbursed, (ii) not accurately disclosing to the Ohio Department of Medicaid the true cost of the PBM services and (iii) inflating dispensing fees for prescription drugs. The plaintiffs sought an undisclosed sum of money in damages, penalties, and possible termination of the contract with Buckeye Health Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has reached no-fault agreements with the Attorney Generals, including Ohio, to resolve claims and/or allegations made by the states related to services previously provided by Envolve. As a result of the settlement, the Ohio Attorney General's litigation against the Company was dismissed. Additionally, the Company is in discussions to bring final resolution to similar concerns in other affected states. Consistent with those discussions, the Company recorded a reserve estimate of $1,250&#160;million in the second quarter of 2021 related to this issue, inclusive of the above settlements and rebates that the Company determined in the course of the matter are payable across products. Additional claims, reviews, or investigations relating to the Company's historical PBM business across products may be brought by other states, the federal government, or shareholder litigants, and there is no guarantee the Company will have the ability to settle such claims with other states within the reserve estimate the Company has recorded and on other acceptable terms, or at all. This matter is subject to many uncertainties, and an adverse outcome in this matter could have an adverse impact on the Company's financial condition, results of operations, and cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967462779968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:61.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to Centene Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,808&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing per share amounts:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents (as determined by applying the treasury stock method)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares and potential dilutive common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,516&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.09&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted earnings per common share for 2022, 2021, and 2020 excludes the impact of 187&#160;thousand shares, 44&#160;thousand shares, and 398&#160;thousand shares, respectively, related to anti-dilutive stock options and restricted stock units.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967462779968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Centene operates in two segments: Managed Care and Specialty Services. The Managed Care segment consists of Centene's health plans, including all of the functions needed to operate them. The Specialty Services segment consists of Centene's specialty companies offering auxiliary healthcare services and products. Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams, and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In early 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company has revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. The Company will begin reporting under this new segment structure in 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not report total assets by segment since this is not a metric used to allocate resources or evaluate segment performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further discussed in Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as part of the Company's ongoing portfolio review various divestitures were pending or completed during the year ended December&#160;31, 2022. The Spanish and Central European businesses were included in the Managed Care segment. The PANTHERx, Magellan Rx, Magellan Specialty Health, Centurion, and HealthSmart businesses were included in the Specialty Services segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the year ended December&#160;31, 2022, follows ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.566%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Managed&#160;Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,055&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,492&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,547&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,281)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,063&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,765&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,281)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,547&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,913&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(595)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the year ended December&#160;31, 2021, follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.566%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Managed&#160;Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,119&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,863&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,982&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,795)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,652&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,795)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,982&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the year ended December&#160;31, 2020, follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.566%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Managed&#160;Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,862&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,253&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,115&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,746)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,867&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,994&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,746)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,031&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459961040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of Registrant<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock', window );">Condensed Financial Information of Registrant</a></td>
<td class="text">Condensed Financial Information of Registrant<div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Centene Corporation (Parent Company Only)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except shares in thousands and per share data in dollars)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December&#160;31, 2022 and December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December&#160;31, 2022, and 602,704 issued and 582,479 outstanding at December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive earnings (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost (57,093 and 20,225 shares, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,094)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Centene stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,057&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,795&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,181&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,940&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, redeemable noncontrolling interests and stockholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed financial information of registrant.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Centene Corporation (Parent Company Only)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share data in dollars)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(641)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,735)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(687)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) before equity in subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,427)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings from subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,336&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,794&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to Centene Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,808&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed financial information of registrant.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Centene Corporation (Parent Company Only)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:71.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends from subsidiaries, return on investment</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,706&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for legal settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contributions to subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and maturities of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends from subsidiaries, return of investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investing activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,363)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,256)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and repurchases of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,207)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,875)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,096)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(626)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,456)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(659)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,589)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> beginning of period</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,257&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed financial information of registrant.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Information of Registrant</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note A - Basis of Presentation and Significant Accounting Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parent company only financial statements should be read in conjunction with Centene Corporation's audited consolidated financial statements and the notes to consolidated financial statements included in this Form 10-K.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parent company's investment in subsidiaries is stated at cost plus equity in undistributed earnings of the subsidiaries. The parent company's share of net income of its unconsolidated subsidiaries is included in income using the equity method of accounting. Certain unrestricted subsidiaries receive monthly management fees from the Company's restricted subsidiaries. The management and service fees received by its unrestricted subsidiaries are associated with all of the functions required to manage the restricted subsidiaries including but not limited to salaries and wages for all personnel, rent, utilities, population health management, provider contracting, compliance, member services, claims processing, information technology, cash management, finance and accounting, and other services. The management fees are based either on a percentage of the restricted subsidiaries' revenue or a cost basis reimbursement.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the Company's centralized cash management function, cash flows generated by its unrestricted subsidiaries are utilized by the parent company to the extent required, primarily to repay borrowings on the parent company's credit facilities, repurchase the parent company's common stock, make acquisitions, fund capital contributions to subsidiaries, and fund its operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts presented in the parent company only financial statements are eliminated in the consolidated financial statements of Centene Corporation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.5-04(Schedule I))<br> -URI https://asc.fasb.org/extlink&amp;oid=126898705&amp;loc=d3e5864-122674<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=d3e5283-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967460021840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of Centene Corporation and all majority owned subsidiaries and subsidiaries over which the Company exercises the power and control to direct activities significantly impacting financial performance. All material intercompany balances and transactions have been eliminated. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the consolidated financial statements and notes have been reclassified to conform to the 2022 presentation. Beginning in 2022, the Company has included a separate line item for depreciation expense on the Consolidated Statement of Operations, which was previously included in selling, general and administrative (SG&amp;A) expenses. Prior period SG&amp;A expense ratios have also been conformed to the current presentation. These reclassifications have no effect on net earnings, cash flow, or stockholders' equity as previously reported.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 2022, the Company acquired all of the issued and outstanding shares of Magellan Health, Inc. (Magellan). The acquisition was accounted for as a business combination. Additionally, during 2022 the Company completed the divestitures of PANTHERx Rare (PANTHERx), its Spanish and Central European businesses, and Magellan Rx. See Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further details.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>The preparation of financial statements in conformity with generally accepted accounting principles in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Future events and their effects cannot be predicted with certainty; accordingly, the accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes. The Company evaluates and updates its assumptions and estimates on an ongoing basis and may employ outside experts to assist in its evaluation, as considered necessary. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business combinations are accounted for using the acquisition method of accounting. The Company allocates the fair value of purchase consideration to the assets acquired and liabilities assumed based on their fair values at the acquisition date. The excess of the fair value of consideration transferred over the fair value of the net assets acquired is recorded as goodwill. Goodwill is generally attributable to the value of the synergies between the combined companies and the value of the acquired assembled workforce, neither of which qualifies for recognition as an intangible asset. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses its best estimates and assumptions to value assets acquired and liabilities assumed at the acquisition date; however, these estimates are sometimes preliminary and, in some instances, all information required to value the assets acquired and liabilities assumed may not be available or final as of the end of a reporting period subsequent to the business combination. If the accounting for the business combination is incomplete, provisional amounts are recorded. The provisional amounts are updated during the period determined, up to one year from the acquisition date. The Company includes the results of operations of acquired businesses in the Company's consolidated results prospectively from the date of acquisition. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition related expenses and post-acquisition restructuring costs are recognized separately from the business combination and are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments with original maturities of three months or less are considered to be cash equivalents. Cash equivalents consist of money market funds, bank certificates of deposit, and savings accounts. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains amounts on deposit with various financial institutions, which may exceed federally insured limits. However, management periodically evaluates the credit-worthiness of those institutions, and the Company has not experienced any losses on such deposits.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments include securities with maturities greater than three months to one year. Long-term investments include securities with maturities greater than one year. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term and long-term investments are generally classified as available-for-sale and are carried at fair value. Certain equity investments are recorded using the fair value or equity method. The Company monitors the difference between the carrying value and fair value of its available-for-sale debt investments and whether declines in fair value are credit related. Unrealized gains and losses on debt investments available-for-sale are excluded from earnings and reported in accumulated other comprehensive earnings (loss), a separate component of stockholders' equity, net of income tax effects. If a loss is deemed to be credit related, the Company recognizes an allowance through earnings. For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes.&#160;If the security meets this criterion, the decline in fair value is recorded in earnings through investment and other income. Premiums and discounts are amortized or accreted over the life of the related security using the effective interest method. To calculate realized gains and losses on the sale of investments, the Company uses the specific amortized cost of each investment sold. Realized gains and losses are recorded in investment and other income. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>The Company uses the equity method to account for investments in entities that it does not control but has the ability to exercise significant influence over operating and financial policies. Generally, under the equity method, original investments in these entities are recorded at cost and subsequently adjusted by the Company's share of equity in income or losses after the date of acquisition&#160;as well as capital contributions to and distributions from these companies.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Deposits</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Deposits </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted deposits consist of investments required by various state statutes to be deposited or pledged to state agencies. These investments are classified as long-term, regardless of the contractual maturity date, due to the nature of the states' requirements. The Company is required to annually adjust the amount of the deposit pledged to certain states.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value&#160;Measurements</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company invests in various financial assets and&#160;incurs various financial liabilities. Fair values are disclosed for all financial instruments, whether or not such values are recognized in the Consolidated Balance Sheets. Management obtains quoted market prices and other observable inputs for these disclosures. The carrying amounts reported in the Consolidated Balance Sheets for cash and cash equivalents, premium and&#160;trade receivables, medical claims liability, accounts payable and accrued expenses, unearned revenue, and certain other current assets and liabilities are carried at cost, which approximates fair value because of their short-term nature. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used to estimate the fair value of each financial instrument: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Available-for-sale investments and restricted deposits: The carrying amount is stated at fair value, based on quoted market prices, where available. For securities not actively traded, fair values were estimated using values obtained from independent pricing services or quoted market prices of comparable instruments.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Senior unsecured notes: Estimated based on third-party quoted market prices for the same or similar issues.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Variable rate debt: The carrying amount of the Company's floating rate debt approximates fair value since the interest rates adjust based on market rate adjustments.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency swap: Estimated based on Great British Pound to US Dollar foreign exchange rates.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Contingent consideration: Estimated based on expected achievement of metrics included in the acquisition agreement considering circumstances that exist as of the acquisition date.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Software and Equipment</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Software and Equipment </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, software and equipment are stated at cost less accumulated depreciation. Computer hardware and software includes certain costs incurred in the development of internal-use software, including external direct costs of materials and services and payroll costs of employees devoted to specific software development. Depreciation is calculated principally by the straight-line method over estimated useful lives. Leasehold improvements are depreciated using the straight-line method over the shorter of the expected useful life or the remaining term of the lease. Property, software and equipment are depreciated over the following periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"/><td style="width:67.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.941%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed Asset</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation Period</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;5 - 40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;3 - 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;10 - 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;1 - 20 years</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of all long-lived assets are evaluated to determine if adjustment to the depreciation and amortization period or to the unamortized balance is warranted. Such evaluation is based principally on the expected utilization of the long-lived assets.</span></div>The Company retains fully depreciated assets in property and accumulated depreciation accounts until it removes them from service. In the case of sale, retirement, or disposal, the asset cost and related accumulated depreciation balance is removed from the respective account, and the resulting net amount, less any proceeds, is included as a component of earnings from operations in the Consolidated Statements of Operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets represent assets acquired in purchase transactions and consist primarily of purchased contract rights and customer relationships, provider contracts, trade names, developed technologies, and goodwill. Intangible assets are amortized using the straight-line method over the following periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"/><td style="width:67.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.941%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Asset</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights and customer relationships</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 21 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 - 15 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 - 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 7 years</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests for impairment of intangible assets, as well as long-lived assets, whenever events or changes in circumstances indicate that the carrying value of an asset or asset group (hereinafter referred to as "asset group") may not be recoverable by comparing the sum of the estimated undiscounted future cash flows expected to result from use of the asset group and its eventual disposition to the carrying value. Such factors include, but are not limited to, significant changes in membership, state funding, state contracts, and provider networks and contracts. If the sum of the estimated undiscounted future cash flows is less than the carrying value, an impairment determination is required. The amount of impairment is calculated by subtracting the fair value of the asset group from the carrying value of the asset group. An impairment charge, if any, is recognized within earnings from operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill for impairment using a fair value approach. The Company is required to test for impairment at least annually, absent a triggering event, which could include a significant decline in operating performance that would require an impairment assessment. Absent any impairment indicators, the Company performs its goodwill impairment testing during the fourth quarter of each year. The Company recognizes an impairment charge for any amount by which the carrying amount of goodwill exceeds its fair value. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company first assesses qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. The Company generally does not calculate the fair value of a reporting unit unless it determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the quantitative test is deemed necessary, the Company determines an appropriate valuation technique to estimate a reporting unit's fair value as of the testing date. The Company utilizes either the income approach or the market approach, whichever is most appropriate for the respective reporting unit. The income approach is based on an internally developed discounted cash flow model that includes many assumptions related to future growth rates, discount factors, future tax rates, and other various assumptions. The market approach is based on financial multiples of comparable companies derived from current market data. The Company then compares the fair value of the reporting unit calculated using the income approach or market approach with its carrying amount and recognizes an impairment charge for the amount by which the carrying amount exceeds fair value. The impairment charge is limited to the total amount of goodwill allocated to the reporting unit. Changes in economic and operating conditions impacting assumptions used in the Company's analyses could result in goodwill impairment in future periods.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy', window );">Medical Claims Liability</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Claims Liability</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical claims liability includes claims reported but not yet paid, or inventory, estimates for claims incurred but not reported, or IBNR, and estimates for the costs necessary to process unpaid claims at the end of each period.&#160;The Company estimates its medical claims liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice.&#160;These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actuarial Standards of Practice generally require that the medical claims liability estimates be adequate to cover obligations under moderately adverse conditions.&#160;Moderately adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of estimate.&#160;In many situations, the claims amounts ultimately settled will be different than the estimate that satisfies the Actuarial Standards of Practice. The Company includes in its IBNR an estimate for medical claims liability under moderately adverse conditions which represents the risk of adverse deviation of the estimates in its actuarial method of reserving.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses its judgment to determine the assumptions to be used in the calculation of the required estimates. The assumptions it considers when estimating IBNR include, without limitation, claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, healthcare service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known outbreaks of disease or increased incidence of illness such as influenza or COVID-19, provider contract changes, changes to fee schedules, and the incidence of high-dollar or catastrophic claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's development of the medical claims liability estimate is a continuous process which it monitors and refines on a monthly basis as additional claims receipts and payment information becomes available. As more complete claims information becomes available, the Company adjusts the amount of the estimates, and includes the changes in estimates in medical costs in the period in which the changes are identified. In every reporting period, the operating results include the effects of more completely developed medical claims liability estimates associated with previously reported periods. The Company consistently applies its reserving methodology from period to period. As additional information becomes known, it adjusts the actuarial model accordingly to establish medical claims liability estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement, and maintenance costs. For purposes of determining premium deficiencies, contracts are grouped in a manner consistent with the method of acquiring, servicing, and measuring the profitability of such contracts.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's health plans generate revenues primarily from premiums received from the states in which it operates health plans, premiums received from its members and the Centers for Medicare and Medicaid Services (CMS) for its Medicare product, and premiums from members of its commercial health plans. In addition to member premium payments, its Marketplace contracts also generate revenues from subsidies received from CMS. The Company generally receives a fixed premium per member per month pursuant to its contracts and recognizes premium revenues during the period in which it is obligated to provide services to its members at the amount reasonably estimable. In some instances, the Company's base premiums are subject to an adjustment factor, in the form of a risk score or risk adjustment, based on the acuity of its membership. Generally, the risk score or risk adjustment is determined by the state or CMS analyzing submissions of processed claims and medical record data to determine the acuity of the Company's membership, often relative to the respective program's membership. The Company estimates the amount of risk score and risk adjustment based upon the processed claims and medical record data submitted and expected to be submitted to CMS and records revenues on a risk adjusted basis. Some contracts allow for additional premiums related to certain supplemental services provided such as maternity deliveries.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts with states may require it to maintain a minimum health benefits ratio (HBR) or may require it to share cost-savings in excess of certain levels. In certain circumstances, including commercial plans, its plans may be required to return premium to the state or policyholders in the event costs are below established levels. The Company estimates the effect of these programs and recognizes reductions in revenue in the current period. Other states may require us to meet certain performance and quality metrics in order to receive additional or full contractual revenue. For performance-based contracts, the Company does not recognize revenue subject to refund until data is sufficient to measure performance.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recorded based on membership and eligibility data provided by the states or CMS, which is adjusted on a monthly basis by the states or CMS for retroactive additions or deletions to membership data. These eligibility adjustments are estimated monthly and subsequent adjustments are made in the period known. The Company reviews and updates those estimates as new information becomes available.&#160;It is possible that new information could require us to make additional adjustments, which could be significant, to these estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Medicare Advantage contracts are with CMS. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model pays more for members whose medical history would indicate that they are expected to have higher medical costs. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis data from hospital inpatient, hospital outpatient, physician treatment settings as well as prescription drug events. The Company and the healthcare providers collect, compile, and submit the necessary and available diagnosis data to CMS within prescribed deadlines. The Company estimates risk adjustment revenues based upon the diagnosis data submitted and expected to be submitted to CMS and records revenues on a risk adjusted basis.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For qualifying low-income prescription drug benefit members, CMS pays for some, or all, of the member's monthly premium. The Company receives certain Part D prospective subsidy payments from CMS for these members as a fixed monthly per member amount, based on the estimated costs of providing prescription drug benefits over the plan year, as reflected in its bids. Approximately nine to ten months subsequent to the end of the plan year, or later in the case of the coverage gap discount subsidy, a settlement payment is made between CMS and the Company's plans based on the difference between the prospective payments and actual claims experience. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's specialty services generate revenues under contracts with state and federal programs, healthcare organizations, and other commercial organizations, as well as from its own subsidiaries. Revenues are recognized when the related services are provided, when inventory is shipped, or as ratably earned over the covered period of services. The Company recognizes revenue related to administrative services under the TRICARE government-sponsored Managed Care Support Contract for the DoD's TRICARE program on a straight-line basis over the option period, when the fees become fixed and determinable. The TRICARE contract includes various performance-based measures.&#160;For each of the measures, an estimate of the amount that has been earned is made at each interim date, and revenue is recognized accordingly. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states enact premium taxes, similar assessments, and provider pass-through payments, collectively premium taxes, and these taxes are recorded as a separate component of both revenues and operating expenses. Additionally, the Company's insurance subsidiaries were previously subject to the Affordable Care Act (ACA) annual health insurer fee (HIF). Beginning in 2021, the HIF was permanently repealed. This revenue was recorded as premium tax and health insurer fee revenue in the Consolidated Statements of Operations. For certain products, premium taxes, state assessments, and the HIF are not pass-through payments and are recorded as premium revenue and premium tax expense or health insurer fee expense in the Consolidated Statements of Operations.</span></div>Some states require state directed payments that have minimal risk, but are administered as a premium adjustment.&#160;These payments are recorded as premium revenue and medical costs at close to a 100% HBR. In many instances, the Company has little visibility to the timing of these payments until they are paid by the state.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock', window );">Affordable Care Act</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Affordable Care Act</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established risk spreading premium stabilization programs as well as minimum medical loss ratio (MLR) and cost sharing reductions (CSRs). The Company's accounting policies for the programs are as follows: </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Risk Adjustment </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The permanent risk adjustment program established by the ACA transfers funds from qualified individual and small group insurance plans with below average risk scores to those plans with above average risk scores within each state. The Company estimates the receivable or payable under the risk adjustment program based on its estimated risk score compared to the state average risk score. The Company may record a receivable or payable as an adjustment to premium revenues to reflect the year-to-date impact of the risk adjustment based on its best estimate. The Company refines its estimate as new information becomes available. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Minimum Medical Loss Ratio</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the ACA established a minimum MLR for the Health Insurance Marketplace. The risk adjustment program described above is taken into consideration to determine if the Company's estimated annual medical costs are less than the minimum MLR and require an adjustment to premium revenues to meet the minimum MLR. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Cost Sharing Reductions</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA directs issuers to reduce the Company's members' cost sharing for essential health benefits for individuals with Federal Poverty Levels (FPLs) between 100% and 250% who are enrolled in a silver tier product; eliminate cost sharing for Indians/Alaska Natives with a FPL less than 300% and eliminate cost sharing for Indians/Alaska Natives regardless of FPL when services are provided by an Indian Health Service. In order to compensate issuers for reduced cost sharing provided to enrollees, CMS pays an advance CSR payment to the Company each month based on the Company's certification data provided at the time of the qualified health plan application. In October 2017, the Trump Administration issued an executive order that immediately ceased payments of CSRs to issuers, and beginning in 2018 premium rates for Health Insurance Marketplace were set without factoring in the cost sharing subsidy payments from the federal government.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock', window );">Premium and Trade Receivables and Unearned Revenue</a></td>
<td class="text">Premium and Trade Receivables and Unearned RevenuePremium and service revenues collected in advance are recorded as unearned revenue. For performance-based contracts, the Company does not recognize revenue subject to refund until data is sufficient to measure performance. Premiums and service revenues due to the Company are recorded as premium and trade receivables and are recorded net of an allowance based on historical trends and management's judgment on the collectability of these accounts. As the Company generally receives payments during the month in which services are provided, the allowance is typically not significant in comparison to total revenues and does not have a material impact on the presentation of the financial condition or results of operations. Amounts receivable under federal contracts are comprised primarily of contractually defined billings, accrued contract incentives under the terms of the contract, and amounts related to change orders for services not originally specified in the contract.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_SignificantCustomersPolicyTextBlock', window );">Significant Customers</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Customers </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company receives the majority of its revenues under contracts or subcontracts with state Medicaid managed care programs. Customers where the aggregate annual contract revenues exceeded 10% of total annual revenues included the state of New York, where the percentage of the Company's total revenue was 10% and 11% for the years ended December 31, 2021 and 2020. None of the Company's customers exceeded 10% of total annual revenues for the year ended December 31, 2022.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock', window );">Other Income (Expense)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense) </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>Other income (expense) consists routinely of investment income, interest expense, and equity method earnings from investments. Investment income is derived from the Company's cash, cash equivalents, restricted deposits and investments. Interest expense relates to borrowings under the senior notes, credit facilities, mortgage and construction loans, and capital leases. Further, other income (expense) includes gains or losses on sales of investments, divestitures, and acquisitions as well as debt extinguishment costs.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recorded for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law or tax rates is recognized in income in the period that includes the enactment date. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowances are provided when it is considered more likely than not that deferred tax assets will not be realized. In determining if a deductible temporary difference or net operating loss can be realized, the Company considers future reversals of existing taxable temporary differences, future taxable income, taxable income in prior carryback periods, and tax planning strategies.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accrues for loss contingencies associated with outstanding litigation, claims, and assessments for which it has determined it is probable that a loss contingency exists and the amount of loss can be reasonably estimated. The Company expenses professional fees associated with litigation claims and assessments as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock Based Compensation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Based Compensation</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock based compensation expense is recognized at grant date fair value over the period during which an employee is required to provide service in exchange for the award. Excess tax benefits related to stock compensation are presented as a cash inflow from operating activities. The Company accounts for forfeitures when they occur.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>The Company is exposed to foreign currency exchange risk through its international subsidiaries whose functional currencies include the Euro and Great British Pound. The assets and liabilities of the Company's subsidiaries are translated into United States dollars at the balance sheet date. The Company translates its proportionate share of earnings using average rates during the year. The resulting foreign currency translation adjustments are recorded as a separate component of accumulated other comprehensive earnings (loss).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Guidance and Recent Accounting Guidance Not Yet Adopted</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial condition, results of operations, or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Health Insurance Marketplace Disclosure [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Income and Other Expense Disclosure [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Premium And Related Receivables And Unearned Revenue [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_SignificantCustomersPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant Customers [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_SignificantCustomersPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14754-158437<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14784-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967462698272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock', window );">Schedule Of Property Software And Equipment Depreciation Periods</a></td>
<td class="text">Property, software and equipment are depreciated over the following periods:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"/><td style="width:67.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.941%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed Asset</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation Period</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;5 - 40 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;3 - 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;10 - 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;1 - 20 years</span></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock', window );">Schedule Of Amortization Period For Intangible Assets</a></td>
<td class="text">Intangible assets are amortized using the straight-line method over the following periods:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"/><td style="width:67.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.941%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Asset</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights and customer relationships</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 21 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 - 15 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 - 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 7 years</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock', window );">Schedule Of Allowance For Uncollectible Accounts</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity in the allowance for uncollectible accounts is summarized below ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts charged to expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of uncollectible receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Allowance For Uncollectible Accounts [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Amortization Period For Intangible Assets [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Property Software And Equipment Depreciation Periods [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967461847136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's allocation of the fair value of assets acquired and liabilities assumed as of the acquisition date of January&#160;4, 2022 is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"><tr><td style="width:1.0%"/><td style="width:71.342%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and related receivables</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims liability</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return of premium payable</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired and liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,491&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of Fair Values and Weighted Average Useful Lives for Identifiable Intangible Assets Acquired</a></td>
<td class="text"><div style="padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values and weighted average useful lives for identifiable intangible assets acquired are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.736%"><tr><td style="width:1.0%"/><td style="width:43.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.848%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.524%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.848%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Useful Life in Years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967455849824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term and Long-term Investments, Restricted Deposits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock', window );">Short-term and long-term investments and restricted deposits by investment type</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.458%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.320%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,566&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,364)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,222&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,521&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:10.8pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments in equity securities as of December&#160;31, 2021 primarily consisted of exchange traded funds in fixed income securities.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of Fair value of available-for-sale debt securities with gross unrealized losses by investment type in a continuous unrealized loss position</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:19.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.584%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized <br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,400</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,075&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(744)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,747&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,602&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Contractual maturities of short-term and long-term investments and restricted deposits</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.136%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.738%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year or less</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,396&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,581&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,483&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-term and long-term investments and restricted deposits by investment type</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967461647600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock', window );">Fair Value Level Input And Input Definitions</a></td>
<td class="text">Level inputs are as follows:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;Input:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Input Definition:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level&#160;I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level&#160;II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level&#160;III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at December&#160;31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,074&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,074&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,307&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,007&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,591&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,598&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at December&#160;31, 2021, for assets and liabilities measured at fair value on a recurring basis ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,809&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency swap agreement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967461655600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Software and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Software and Equipment</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, software and equipment consist of the following ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,224&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,498&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,291&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,066)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,900)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, software and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,432&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967467113392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of changes In goodwill by operating segment</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in goodwill by operating segment ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.840%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Managed&#160;Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,974&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,652&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reallocation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,771&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and purchase accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reallocation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,315&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of intangible assets</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets at December 31, consist of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:49.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.684%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average&#160;Life in Years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights and customer relationships</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,850&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,068&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,835&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,036&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased contract rights and customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,924)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,212)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,911&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,824&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of amortization expense related to intangible assets</a></td>
<td class="text">Estimated total amortization expense related to the December&#160;31, 2022 intangible assets for each of the five succeeding fiscal years is as follows ($ in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"/><td style="width:67.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.941%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Total Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967463986800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Claims Liability (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule Of Change In Medical Claims Liability by Operating Segment</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,243&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,438&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,473&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,453&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,783)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,745&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,243&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,438&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock', window );">Short-duration Insurance Contracts, Claims Development</a></td>
<td class="text">Incurred and paid claims development as of December&#160;31, 2022 is as follows ($ in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:23.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.354%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance</span></td></tr><tr><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Claim Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 (unaudited)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 (unaudited)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,206&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,502&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,433&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,896&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred claims</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance</span></td></tr><tr><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Claim Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 (unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 (unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,722&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,593&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,021&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total payment of incurred claims</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All outstanding liabilities prior to 2020, net of reinsurance</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims liability, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,719&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>Information is summarized as follows (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.535%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total IBNR Plus Expected Development on Reported Claims</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative Paid Claims</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,433&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,896&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,081&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967461037648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affordable Care Act (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AffordableCareActAbstract', window );"><strong>Affordable Care Act [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock', window );">Schedule of receivables (payables) related to the Health Insurance Marketplace programs</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's net receivables (payables) for each of the programs are as follows ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment receivable</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum medical loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AffordableCareActAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affordable Care Act [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AffordableCareActAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Receivables (Payables) Related to the Affordable Care Act Programs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967463821680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule Of Debt</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,500 million 4.25% Senior Notes, due December 15, 2027</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,484&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,300 million 2.45% Senior Notes, due July 15, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,500 million 4.625% Senior Notes, due December 15, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 3.375% Senior Notes, due February 15, 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 3.00% Senior Notes, due October 15, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 2.50% Senior Notes, due March 1, 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,300 million 2.625% Senior Notes, due August 1, 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction loan payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,938&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,571&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule Of Aggregate Maturities Of Debt</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate maturities for the Company's debt for the years ending December 31, are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"/><td style="width:67.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.941%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Maturities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,179&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967458194208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">ROU Assets and Liabilities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the ROU assets and lease liabilities ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets (recorded within other long-term assets)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMS0xLTEtMzU0MDE4_199e3251-c3e9-421e-aaf9-eda971b806fd">2,554</span>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMy0xLTEtMzU0MDE4_25d5eafe-3f10-47e5-a022-23bca263c61e">3,566</span>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term (recorded within accounts payable and accrued expenses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMS0xLTEtMzU0MDE4_53c5f53c-16be-4589-801c-7882d412dd63">180</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMy0xLTEtMzU0MDE4_ca13f2de-0327-4128-b4b7-a1cf2eacc73a">204</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term (recorded within other long-term liabilities)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMS0xLTEtMzU0MDE4_f7d03d1c-fd2a-4fb1-b8d2-c6a9e69f4553">3,133</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMy0xLTEtMzU0MDE4_83602f08-9569-4028-8eb3-50c7d80f55b9">3,619</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,823&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Operating Lease Maturity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease payments over the next five years and thereafter are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"><tr><td style="width:1.0%"/><td style="width:67.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.941%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Payments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,240&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,927)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967461891840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Share Repurchase Activity</a></td>
<td class="text">The following represents the Company's share repurchase activity ($ in millions, shares in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share buybacks</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,655&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,994&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,402&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,672&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax withholding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share repurchases</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,868&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,096&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,781&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,717&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967455860464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Consolidated Income Tax Expense</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated income tax expense consists of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current provision</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(649)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation Of Tax Provision At The U.S. Federal Statutory Rate To Income Tax Expense</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the tax provision at the U.S. federal statutory rate to income tax expense is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income tax expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,962&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,773&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (earnings) attributable to flow through noncontrolling interest </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings less noncontrolling interest before income tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,782&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at the U.S. federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible PBM legal settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nontaxable divestiture (gains) losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes for investments in subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACA health insurer fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Tax Effects Of Temporary Differences Which Give Rise To Deferred Tax Assets And Liabilities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences which give rise to deferred tax assets and liabilities are presented below ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical claims liability</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and trade receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,407)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock', window );">Summary of Reserve for Uncertain Tax Positions</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a reserve for uncertain tax positions that may be challenged by a tax authority. A rollforward of the beginning and ending amount of uncertain tax positions, exclusive of related interest and penalties, is as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, January 1</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitation lapses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967547042944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of Non-Vested Restricted Stock And Restricted Stock</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the&#160;Company's non-vested&#160;restricted stock and restricted stock unit shares as of December&#160;31, 2022, and changes during the year ended December&#160;31, 2022, is presented below (shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested balance, December 31, 2021</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,142&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Converted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,553)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(877)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested balance, December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Magellan awards converted in connection with the acquisition.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967461979072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Calculation Of Basic And Diluted Net Earnings Per Common Share</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:61.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to Centene Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,808&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing per share amounts:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents (as determined by applying the treasury stock method)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares and potential dilutive common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,516&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.09&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967547040064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the year ended December&#160;31, 2022, follows ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.566%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Managed&#160;Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,055&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,492&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,547&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,281)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,063&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,765&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,281)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,547&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,913&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(595)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the year ended December&#160;31, 2021, follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.566%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Managed&#160;Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,119&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,863&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,982&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,795)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,652&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,795)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,982&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the year ended December&#160;31, 2020, follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.566%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Managed&#160;Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from external customers</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,862&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,253&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,115&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from internal customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,746)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,867&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,994&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,746)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,031&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459810880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of Registrant (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">Condensed Balance Sheets</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Centene Corporation (Parent Company Only)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except shares in thousands and per share data in dollars)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December&#160;31, 2022 and December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December&#160;31, 2022, and 602,704 issued and 582,479 outstanding at December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive earnings (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost (57,093 and 20,225 shares, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,094)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Centene stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,057&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,795&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,181&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,940&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, redeemable noncontrolling interests and stockholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock', window );">Condensed Statements Of Operations</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Centene Corporation (Parent Company Only)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share data in dollars)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(641)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,735)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(687)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) before equity in subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,427)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings from subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,336&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,794&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to Centene Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,808&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock', window );">Condensed Statements Of Cash Flows</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Centene Corporation (Parent Company Only)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:71.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends from subsidiaries, return on investment</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,706&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for legal settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contributions to subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and maturities of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends from subsidiaries, return of investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investing activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,363)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,256)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and repurchases of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,207)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,875)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,096)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(626)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,456)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(659)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,589)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> beginning of period</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,257&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph (a)<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph (a)<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedCashFlowStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph (a)<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedIncomeStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967461883680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Operations (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967464067968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Property, Software and Equipment Depreciation Periods (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciation Period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciation Period</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer hardware and software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciation Period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer hardware and software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciation Period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciation Period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciation Period</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember', window );">Land improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciation Period</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember', window );">Land improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciation Period</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciation Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciation Period</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967462918016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Amortization Period for Intangible Assets (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization Period</a></td>
<td class="text">13 years 4 months 24 days<span></span>
</td>
<td class="text">13 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Purchased contract rights and customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization Period</a></td>
<td class="text">13 years 4 months 24 days<span></span>
</td>
<td class="text">13 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Purchased contract rights and customer relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization Period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Purchased contract rights and customer relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization Period</a></td>
<td class="text">21 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnc_ProviderContractsMember', window );">Provider contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization Period</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">13 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnc_ProviderContractsMember', window );">Provider contracts | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization Period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnc_ProviderContractsMember', window );">Provider contracts | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization Period</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization Period</a></td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technologies | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization Period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technologies | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization Period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization Period</a></td>
<td class="text">15 years 4 months 24 days<span></span>
</td>
<td class="text">13 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization Period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization Period</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnc_ProviderContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnc_ProviderContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967460229584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Allowance for Uncollectible Accounts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts', window );">Balance, January 1</a></td>
<td class="nump">$ 139<span></span>
</td>
<td class="nump">$ 243<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumReceivableCreditLossExpenseReversal', window );">Amounts charged to expense</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries', window );">Recoveries</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance', window );">Write-offs of uncollectible receivables</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts', window );">Balance, December 31</a></td>
<td class="nump">$ 130<span></span>
</td>
<td class="nump">$ 139<span></span>
</td>
<td class="nump">$ 243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in allowance for credit loss on accounts receivable, from recovery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumReceivableCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on premium receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumReceivableCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross premiums receivable to net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of writeoff of premium receivable, charged against allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967464077456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Significant Customers (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts', window );">Percentage of revenues under contracts or subcontracts</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NY', window );">NEW YORK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts', window );">Percentage of revenues under contracts or subcontracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_PercentageOfRevenuesUnderContractsOrSubcontracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenues under contracts or subcontracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_PercentageOfRevenuesUnderContractsOrSubcontracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967460179072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Narrative (Details) - Magellan Health - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 04, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 2,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments to acquire business</a></td>
<td class="nump">2,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredOther1', window );">Fair value adjustment to stock based compensation associated with pre-combination service</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts', window );">Settlement of pre-existing payables and receivables prior to acquisition</a></td>
<td class="num">$ (70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredOther1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredOther1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967458439936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 04, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract', window );"><strong>Assets acquired and liabilities assumed</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,812<span></span>
</td>
<td class="nump">$ 19,771<span></span>
</td>
<td class="nump">$ 18,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,812<span></span>
</td>
<td class="nump">$ 19,771<span></span>
</td>
<td class="nump">$ 18,652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember', window );">Magellan Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract', window );"><strong>Assets acquired and liabilities assumed</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Premium and related receivables</a></td>
<td class="nump">791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments', window );">Short-term investments</a></td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments', window );">Long-term investments</a></td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits', window );">Restricted deposits</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, software and equipment</a></td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangibles assets</a></td>
<td class="nump">889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">3,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability', window );">Medical claims liability</a></td>
<td class="nump">194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable', window );">Return of premium payable</a></td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Unearned revenue</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt', window );">Current portion of long-term debt</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Long-term debt</a></td>
<td class="nump">542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">1,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Mezzanine equity</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total identifiable net assets</a></td>
<td class="nump">1,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total assets acquired and liabilities assumed</a></td>
<td class="nump">$ 2,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal', window );">Debt assumed, aggregate principal</a></td>
<td class="nump">$ 535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Deposits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Return Of Premium Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Long-term Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Short-term Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Medical Claims Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-term Debt, Principal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967463026192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Identifiable Intangible Assets (Details) - Magellan Health<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 04, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangibles assets</a></td>
<td class="nump">$ 889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life</a></td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember', window );">Purchased contract rights</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangibles assets</a></td>
<td class="nump">$ 581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life</a></td>
<td class="text">13 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember', window );">Provider contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangibles assets</a></td>
<td class="nump">$ 120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember', window );">Developed technologies</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangibles assets</a></td>
<td class="nump">$ 101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangibles assets</a></td>
<td class="nump">$ 87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life</a></td>
<td class="text">17 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459446944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Divestitures (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 20, 2023</div></th>
<th class="th"><div>Dec. 02, 2022</div></th>
<th class="th"><div>Jul. 14, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) on divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (772)<span></span>
</td>
<td class="num">$ (88)<span></span>
</td>
<td class="num">$ (104)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,318<span></span>
</td>
<td class="nump">$ 229<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_PANTHERxRareMember', window );">PANTHERx Rare | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) on divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(490)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_GainLossOnDispositionOfBusinessNetOfTax', window );">(Gain) on divestitures, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_SpanishAndCentralEuropeanBusinessesMember', window );">Spanish and Central European Businesses | Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AssetImpairmentChargesNetOfTax', window );">Impairment charge, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_MagellanRxMember', window );">Magellan Rx | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) on divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_GainLossOnDispositionOfBusinessNetOfTax', window );">(Gain) on divestitures, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (99)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_MagellanSpecialtyHealthMember', window );">Magellan Specialty Health | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Consideration on divestiture</a></td>
<td class="nump">$ 646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh', window );">Contingent consideration, could receive (up to)</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_MagellanSpecialtyHealthMember', window );">Magellan Specialty Health | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Subsequent Event | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) on divestitures</a></td>
<td class="num">(85)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_MagellanSpecialtyHealthMember', window );">Magellan Specialty Health | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Subsequent Event | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) on divestitures</a></td>
<td class="num">$ (95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_MagellanSpecialtyHealthMember', window );">Magellan Specialty Health | Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 645<span></span>
</td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_CenturionMember', window );">Centurion | Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AssetImpairmentChargesNetOfTax', window );">Impairment charge, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_HealthSmartMember', window );">HealthSmart | Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AssetImpairmentChargesNetOfTax', window );">Impairment charge, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AssetImpairmentChargesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment Charges, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AssetImpairmentChargesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Consideration, Contingent Consideration, Range of Outcomes, Value High</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_GainLossOnDispositionOfBusinessNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Disposition of Business, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_GainLossOnDispositionOfBusinessNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_PANTHERxRareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_PANTHERxRareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_SpanishAndCentralEuropeanBusinessesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_SpanishAndCentralEuropeanBusinessesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_MagellanRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_MagellanRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_MagellanSpecialtyHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_MagellanSpecialtyHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_CenturionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_CenturionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_HealthSmartMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cnc_HealthSmartMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459578960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,364)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Private equity investments</a></td>
<td class="nump">529<span></span>
</td>
<td class="nump">587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount', window );">Life insurance contracts</a></td>
<td class="nump">169<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost', window );">Total, Amortized Cost</a></td>
<td class="nump">19,566<span></span>
</td>
<td class="nump">16,521<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue', window );">Total, Fair Value</a></td>
<td class="nump">18,222<span></span>
</td>
<td class="nump">16,650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Treasury securities and obligations of U.S. government corporations and agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">695<span></span>
</td>
<td class="nump">642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">679<span></span>
</td>
<td class="nump">640<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">10,127<span></span>
</td>
<td class="nump">8,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(778)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">9,361<span></span>
</td>
<td class="nump">8,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cnc_RestrictedCertificatesOfDepositMember', window );">Restricted certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cnc_RestrictedCashEquivalentsMember', window );">Restricted cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember', window );">Short-term time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember', window );">Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">4,055<span></span>
</td>
<td class="nump">3,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(280)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">3,781<span></span>
</td>
<td class="nump">3,468<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">1,396<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">1,326<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">1,165<span></span>
</td>
<td class="nump">850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(121)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">961<span></span>
</td>
<td class="nump">870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(99)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">$ 862<span></span>
</td>
<td class="nump">$ 873<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments, Debt Securities, Equity Securities And Other, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeInsuranceCorporateOrBankOwnedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the amount that could be realized under a life insurance contract or contracts owned by the Entity as of the date of the statement of financial position. Such Entity-owned life insurance policies are commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -SubTopic 30<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6384206&amp;loc=d3e41899-111602<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeInsuranceCorporateOrBankOwnedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cnc_RestrictedCertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cnc_RestrictedCertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cnc_RestrictedCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cnc_RestrictedCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459539840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>position</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss', window );">Accrued interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList', window );">Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other Assets, Current<span></span>
</td>
<td class="text">Other Assets, Current<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Positions from which gross unrealized losses were generated | position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions', window );">Total investment positions | position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Gain on acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (309)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cnc_RxAdvanceMember', window );">RxAdvance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment on equity method investment</a></td>
<td class="nump">$ 229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnc_CircleHealthMember', window );">Circle Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Gain on acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (309)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage', window );">Consolidation percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration', window );">Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=cnc_RatedSecuritiesMember', window );">Rated Securities | External Credit Rating, Investment Grade | Investment Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DebtSecuritiesAvailableForSaleNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available -for-Sale, Number of Positions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DebtSecuritiesAvailableForSaleNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267853-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL121698322-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267856-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes accrued interest, after allowance for credit loss, on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267853-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI https://asc.fasb.org/extlink&amp;oid=126903467&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cnc_RxAdvanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cnc_RxAdvanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cnc_CircleHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cnc_CircleHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=cnc_RatedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=cnc_RatedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExternalCreditRatingByGroupingAxis=us-gaap_ExternalCreditRatingInvestmentGradeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExternalCreditRatingByGroupingAxis=us-gaap_ExternalCreditRatingInvestmentGradeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=cnc_InvestmentSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=cnc_InvestmentSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967460097056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-for-Sale Investments in a Continuous Unrealized Loss Position (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months</a></td>
<td class="num">$ (620)<span></span>
</td>
<td class="num">$ (102)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or More</a></td>
<td class="num">(744)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months</a></td>
<td class="nump">10,075<span></span>
</td>
<td class="nump">7,602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or More</a></td>
<td class="nump">5,747<span></span>
</td>
<td class="nump">331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Treasury securities and obligations of U.S. government corporations and agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or More</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or More</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months</a></td>
<td class="num">(340)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or More</a></td>
<td class="num">(438)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months</a></td>
<td class="nump">5,368<span></span>
</td>
<td class="nump">4,209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or More</a></td>
<td class="nump">3,400<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember', window );">Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months</a></td>
<td class="num">(142)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or More</a></td>
<td class="num">(138)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months</a></td>
<td class="nump">2,437<span></span>
</td>
<td class="nump">1,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or More</a></td>
<td class="nump">995<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or More</a></td>
<td class="num">(41)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months</a></td>
<td class="nump">786<span></span>
</td>
<td class="nump">770<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or More</a></td>
<td class="nump">486<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or More</a></td>
<td class="num">(66)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months</a></td>
<td class="nump">629<span></span>
</td>
<td class="nump">472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or More</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months</a></td>
<td class="num">(49)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or More</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months</a></td>
<td class="nump">513<span></span>
</td>
<td class="nump">380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or More</a></td>
<td class="nump">$ 330<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459349120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_InvestmentsMember', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">One year or less</a></td>
<td class="nump">$ 2,207<span></span>
</td>
<td class="nump">$ 1,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">One year through five years</a></td>
<td class="nump">7,651<span></span>
</td>
<td class="nump">6,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">Five years through ten years</a></td>
<td class="nump">4,066<span></span>
</td>
<td class="nump">3,647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost', window );">Greater than ten years</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Asset-backed securities</a></td>
<td class="nump">3,522<span></span>
</td>
<td class="nump">3,028<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">17,581<span></span>
</td>
<td class="nump">14,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">One year or less</a></td>
<td class="nump">2,179<span></span>
</td>
<td class="nump">1,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">One year through five years</a></td>
<td class="nump">7,147<span></span>
</td>
<td class="nump">6,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Five years through ten years</a></td>
<td class="nump">3,613<span></span>
</td>
<td class="nump">3,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than ten years</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Asset-backed securities</a></td>
<td class="nump">3,234<span></span>
</td>
<td class="nump">3,034<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">16,302<span></span>
</td>
<td class="nump">14,483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">One year or less</a></td>
<td class="nump">534<span></span>
</td>
<td class="nump">368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">One year through five years</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">Five years through ten years</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost', window );">Greater than ten years</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Asset-backed securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">1,282<span></span>
</td>
<td class="nump">1,072<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">One year or less</a></td>
<td class="nump">532<span></span>
</td>
<td class="nump">368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">One year through five years</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Five years through ten years</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than ten years</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Asset-backed securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">$ 1,217<span></span>
</td>
<td class="nump">$ 1,068<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_InvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_InvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967453425376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 12,074<span></span>
</td>
<td class="nump">$ 13,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other long-term assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">29,598<span></span>
</td>
<td class="nump">29,010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Treasury securities and obligations of U.S. government corporations and agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">679<span></span>
</td>
<td class="nump">640<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">9,361<span></span>
</td>
<td class="nump">8,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember', window );">Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">3,781<span></span>
</td>
<td class="nump">3,468<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember', window );">Short-term time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">1,326<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">862<span></span>
</td>
<td class="nump">873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">12,074<span></span>
</td>
<td class="nump">13,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other long-term assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">13,007<span></span>
</td>
<td class="nump">14,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other long-term assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">16,591<span></span>
</td>
<td class="nump">14,832<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other long-term assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">16,307<span></span>
</td>
<td class="nump">14,809<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | U.S. Treasury securities and obligations of U.S. government corporations and agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">9,328<span></span>
</td>
<td class="nump">8,170<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">3,165<span></span>
</td>
<td class="nump">2,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Short-term time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">1,326<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">862<span></span>
</td>
<td class="nump">873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">369<span></span>
</td>
<td class="nump">495<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level I | U.S. Treasury securities and obligations of U.S. government corporations and agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">366<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level I | Corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level I | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level I | Short-term time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level I | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level I | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level I | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">15,938<span></span>
</td>
<td class="nump">14,314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level II | U.S. Treasury securities and obligations of U.S. government corporations and agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level II | Corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">9,328<span></span>
</td>
<td class="nump">8,170<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level II | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">3,165<span></span>
</td>
<td class="nump">2,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level II | Short-term time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level II | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">1,326<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level II | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level II | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">862<span></span>
</td>
<td class="nump">873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level III | U.S. Treasury securities and obligations of U.S. government corporations and agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level III | Corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level III | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level III | Short-term time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level III | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level III | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Investments | Level III | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">1,217<span></span>
</td>
<td class="nump">1,068<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | U.S. Treasury securities and obligations of U.S. government corporations and agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">308<span></span>
</td>
<td class="nump">469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">616<span></span>
</td>
<td class="nump">469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">564<span></span>
</td>
<td class="nump">565<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level I | U.S. Treasury securities and obligations of U.S. government corporations and agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">308<span></span>
</td>
<td class="nump">469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level I | Corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level I | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level I | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level I | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">653<span></span>
</td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level II | U.S. Treasury securities and obligations of U.S. government corporations and agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level II | Corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level II | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">616<span></span>
</td>
<td class="nump">469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level II | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level II | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level III | U.S. Treasury securities and obligations of U.S. government corporations and agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level III | Corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level III | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level III | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember', window );">Restricted Deposits | Level III | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other long-term Assets | Foreign currency swap agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other long-term assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other long-term Assets | Level I | Foreign currency swap agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other long-term assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other long-term Assets | Level II | Foreign currency swap agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other long-term assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other long-term Assets | Level III | Foreign currency swap agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other long-term assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_AvailableforsaleSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_DepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967466603088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue', window );">Aggregate carrying value which approximates fair value</a></td>
<td class="nump">$ 698<span></span>
</td>
<td class="nump">$ 773<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Insurance Contracts And Equity Investments, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967458300832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Software and Equipment - Components (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, software and equipment, gross</a></td>
<td class="nump">$ 4,498<span></span>
</td>
<td class="nump">$ 5,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(2,066)<span></span>
</td>
<td class="num">(1,900)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, software and equipment, net</a></td>
<td class="nump">2,432<span></span>
</td>
<td class="nump">3,391<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, software and equipment, gross</a></td>
<td class="nump">2,224<span></span>
</td>
<td class="nump">1,825<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, software and equipment, gross</a></td>
<td class="nump">659<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cnc_ComputerHardwareMember', window );">Computer hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, software and equipment, gross</a></td>
<td class="nump">604<span></span>
</td>
<td class="nump">617<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, software and equipment, gross</a></td>
<td class="nump">467<span></span>
</td>
<td class="nump">732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cnc_FurnitureAndOfficeEquipmentMember', window );">Furniture and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, software and equipment, gross</a></td>
<td class="nump">366<span></span>
</td>
<td class="nump">753<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, software and equipment, gross</a></td>
<td class="nump">$ 178<span></span>
</td>
<td class="nump">$ 248<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cnc_ComputerHardwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cnc_ComputerHardwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cnc_FurnitureAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cnc_FurnitureAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967458426336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Software and Equipment - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 614<span></span>
</td>
<td class="nump">$ 565<span></span>
</td>
<td class="nump">$ 487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Remaining asset impairment charges</a></td>
<td class="nump">1,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cnc_RealEstateOwnedAndRelatedFixedAssetsMember', window );">Real estate owned and related fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cnc_FixedAssetsLeasedRealEstateMember', window );">Fixed assets, leased real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">$ 242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cnc_RealEstateOwnedAndRelatedFixedAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cnc_RealEstateOwnedAndRelatedFixedAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cnc_FixedAssetsLeasedRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cnc_FixedAssetsLeasedRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967458449152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Schedule of Changes in Goodwill by Operating Segment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance beginning of period</a></td>
<td class="nump">$ 19,771<span></span>
</td>
<td class="nump">$ 18,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition and purchase accounting adjustments</a></td>
<td class="nump">1,077<span></span>
</td>
<td class="nump">1,168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="num">(1,533)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Reallocation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="num">(370)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Translation impact</a></td>
<td class="num">(133)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance end of period</a></td>
<td class="nump">18,812<span></span>
</td>
<td class="nump">19,771<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cnc_ManagedCareMember', window );">Managed&#160;Care&#160;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance beginning of period</a></td>
<td class="nump">18,338<span></span>
</td>
<td class="nump">16,974<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition and purchase accounting adjustments</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">1,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Reallocation</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="num">(66)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Translation impact</a></td>
<td class="num">(133)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance end of period</a></td>
<td class="nump">18,315<span></span>
</td>
<td class="nump">18,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cnc_SpecialtyServicesMember', window );">Specialty Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance beginning of period</a></td>
<td class="nump">1,433<span></span>
</td>
<td class="nump">1,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition and purchase accounting adjustments</a></td>
<td class="nump">905<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="num">(1,533)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Reallocation</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="num">(304)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Translation impact</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance end of period</a></td>
<td class="nump">$ 497<span></span>
</td>
<td class="nump">$ 1,433<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cnc_ManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cnc_ManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cnc_SpecialtyServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cnc_SpecialtyServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967464390832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">817<span></span>
</td>
<td class="nump">$ 770<span></span>
</td>
<td class="nump">$ 719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnc_CircleHealthMember', window );">Circle Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cnc_SpecialtyServicesMember', window );">Specialty Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cnc_SpecialtyServicesMember', window );">Specialty Services | Federal Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cnc_CircleHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cnc_CircleHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cnc_SpecialtyServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cnc_SpecialtyServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cnc_FederalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cnc_FederalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967458415568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets</a></td>
<td class="nump">$ 9,835<span></span>
</td>
<td class="nump">$ 10,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Total accumulated amortization</a></td>
<td class="num">(2,924)<span></span>
</td>
<td class="num">(2,212)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 6,911<span></span>
</td>
<td class="nump">$ 7,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average life in years</a></td>
<td class="text">13 years 4 months 24 days<span></span>
</td>
<td class="text">13 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Purchased contract rights and customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets</a></td>
<td class="nump">$ 7,850<span></span>
</td>
<td class="nump">$ 8,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Total accumulated amortization</a></td>
<td class="num">$ (2,193)<span></span>
</td>
<td class="num">$ (1,642)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average life in years</a></td>
<td class="text">13 years 4 months 24 days<span></span>
</td>
<td class="text">13 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets</a></td>
<td class="nump">$ 983<span></span>
</td>
<td class="nump">$ 1,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Total accumulated amortization</a></td>
<td class="num">$ (263)<span></span>
</td>
<td class="num">$ (206)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average life in years</a></td>
<td class="text">15 years 4 months 24 days<span></span>
</td>
<td class="text">13 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnc_ProviderContractsMember', window );">Provider contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets</a></td>
<td class="nump">$ 612<span></span>
</td>
<td class="nump">$ 492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Total accumulated amortization</a></td>
<td class="num">$ (183)<span></span>
</td>
<td class="num">$ (139)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average life in years</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">13 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets</a></td>
<td class="nump">$ 390<span></span>
</td>
<td class="nump">$ 369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Total accumulated amortization</a></td>
<td class="num">$ (285)<span></span>
</td>
<td class="num">$ (225)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average life in years</a></td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnc_ProviderContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnc_ProviderContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967466617936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Schedule of Future Amortization Expenses (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">$ 678<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967464395968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Balance, January 1</a></td>
<td class="nump">$ 14,243<span></span>
</td>
<td class="nump">$ 12,438<span></span>
</td>
<td class="nump">$ 7,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Less: reinsurance recoverable</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Balance, January 1, net</a></td>
<td class="nump">14,220<span></span>
</td>
<td class="nump">12,415<span></span>
</td>
<td class="nump">7,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquisitions and divestitures</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Incurred related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">112,896<span></span>
</td>
<td class="nump">100,385<span></span>
</td>
<td class="nump">86,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(1,367)<span></span>
</td>
<td class="num">(1,783)<span></span>
</td>
<td class="num">(501)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred</a></td>
<td class="nump">111,529<span></span>
</td>
<td class="nump">98,602<span></span>
</td>
<td class="nump">86,264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Paid related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="nump">97,799<span></span>
</td>
<td class="nump">87,427<span></span>
</td>
<td class="nump">78,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="nump">11,336<span></span>
</td>
<td class="nump">9,370<span></span>
</td>
<td class="nump">6,320<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total paid</a></td>
<td class="nump">109,135<span></span>
</td>
<td class="nump">96,797<span></span>
</td>
<td class="nump">85,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Balance, December 31, net</a></td>
<td class="nump">16,719<span></span>
</td>
<td class="nump">14,220<span></span>
</td>
<td class="nump">12,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Plus: reinsurance recoverable</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Balance, December 31</a></td>
<td class="nump">$ 16,745<span></span>
</td>
<td class="nump">$ 14,243<span></span>
</td>
<td class="nump">$ 12,438<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967461678176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Claims Liability - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms', window );">Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs</a></td>
<td class="nump">$ 198<span></span>
</td>
<td class="nump">$ 492<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967463918608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Medical Claims Liability - Cumulative Incurred and Paid Claims (Details) - Health insurance product line - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration insurance contracts, incurred claims and allocated claim adjustment expense, net</a></td>
<td class="nump">$ 298,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration insurance contracts, cumulative paid claims and allocated claim adjustment expense, net</a></td>
<td class="nump">281,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther', window );">All outstanding liabilities prior to 2020, net of reinsurance</a></td>
<td class="nump">147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented', window );">Medical claims liability, net of reinsurance</a></td>
<td class="nump">16,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member', window );">Short-Duration Insurance Contract, Accident Year 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration insurance contracts, incurred claims and allocated claim adjustment expense, net</a></td>
<td class="nump">86,433<span></span>
</td>
<td class="nump">$ 86,502<span></span>
</td>
<td class="nump">$ 88,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration insurance contracts, cumulative paid claims and allocated claim adjustment expense, net</a></td>
<td class="nump">86,021<span></span>
</td>
<td class="nump">85,593<span></span>
</td>
<td class="nump">$ 76,722<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member', window );">Short-Duration Insurance Contract, Accident Year 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration insurance contracts, incurred claims and allocated claim adjustment expense, net</a></td>
<td class="nump">99,087<span></span>
</td>
<td class="nump">100,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration insurance contracts, cumulative paid claims and allocated claim adjustment expense, net</a></td>
<td class="nump">98,024<span></span>
</td>
<td class="nump">$ 87,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member', window );">Short-Duration Insurance Contract, Accident Year 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration insurance contracts, incurred claims and allocated claim adjustment expense, net</a></td>
<td class="nump">112,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration insurance contracts, cumulative paid claims and allocated claim adjustment expense, net</a></td>
<td class="nump">$ 97,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClaimsDevelopmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClaimsDevelopmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts for accident years not separately presented in claim development information. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967466338880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Medical Claims Liability - Incurred Claims and Allocated Claims Adjustment Expenses (Details) - Health insurance product line<br> claim in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration insurance contracts, incurred claims and allocated claim adjustment expense, net</a></td>
<td class="nump">$ 298,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member', window );">Short-Duration Insurance Contract, Accident Year 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration insurance contracts, incurred claims and allocated claim adjustment expense, net</a></td>
<td class="nump">86,433<span></span>
</td>
<td class="nump">$ 86,502<span></span>
</td>
<td class="nump">$ 88,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims', window );">Short-duration insurance contracts, expected development on reported claims</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims', window );">Short-duration Insurance contracts, number of reported claims | claim</a></td>
<td class="nump">568.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member', window );">Short-Duration Insurance Contract, Accident Year 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration insurance contracts, incurred claims and allocated claim adjustment expense, net</a></td>
<td class="nump">$ 99,087<span></span>
</td>
<td class="nump">$ 100,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims', window );">Short-duration insurance contracts, expected development on reported claims</a></td>
<td class="nump">$ 273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims', window );">Short-duration Insurance contracts, number of reported claims | claim</a></td>
<td class="nump">623.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member', window );">Short-Duration Insurance Contract, Accident Year 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration insurance contracts, incurred claims and allocated claim adjustment expense, net</a></td>
<td class="nump">$ 112,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims', window );">Short-duration insurance contracts, expected development on reported claims</a></td>
<td class="nump">$ 11,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims', window );">Short-duration Insurance contracts, number of reported claims | claim</a></td>
<td class="nump">608.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-duration Insurance Contracts, Incurred but Not Reported Liabilities and Expected Development on Reported Claims</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClaimsDevelopmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClaimsDevelopmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative number of reported claims for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671317-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967464000640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affordable Care Act (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AffordableCareActAbstract', window );"><strong>Affordable Care Act [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AffordableCareActRiskAdjustmentReceivable', window );">Risk adjustment receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 838<span></span>
</td>
<td class="nump">$ 522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AffordableCareActReinsurancePayable', window );">Risk adjustment payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(780)<span></span>
</td>
<td class="num">(536)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AffordableCareActMinimumMedicalLossRatio', window );">Minimum medical loss ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="num">(196)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AffordableCareActCostSharingReductionReceivable', window );">Cost sharing reduction receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AffordableCareActCostSharingReductionsPayable', window );">Cost sharing reduction payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(99)<span></span>
</td>
<td class="num">$ (42)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease', window );">Risk adjustment, net receivable increase</a></td>
<td class="nump">$ 403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit', window );">Risk adjustment pre-tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AffordableCareActAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affordable Care Act [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AffordableCareActAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AffordableCareActCostSharingReductionReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affordable Care Act, Cost Sharing Reduction Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AffordableCareActCostSharingReductionReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AffordableCareActCostSharingReductionsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affordable Care Act Cost Sharing Reductions, Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AffordableCareActCostSharingReductionsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AffordableCareActMinimumMedicalLossRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affordable Care Act, Minimum Medical Loss Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AffordableCareActMinimumMedicalLossRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AffordableCareActReinsurancePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affordable Care Act Reinsurance, Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AffordableCareActReinsurancePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affordable Care Act, Risk Adjustment, Net Receivable Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AffordableCareActRiskAdjustmentReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affordable Care Act, Risk Adjustment Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AffordableCareActRiskAdjustmentReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967455657344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Debt (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_SeniorNotesTotal', window );">Total senior notes</a></td>
<td class="nump">$ 15,673,000,000<span></span>
</td>
<td class="nump">$ 15,988,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_FinanceLeaseLiabilityAndOther', window );">Finance leases and other</a></td>
<td class="nump">253,000,000<span></span>
</td>
<td class="nump">493,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Debt issuance costs</a></td>
<td class="num">(147,000,000)<span></span>
</td>
<td class="num">(171,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="nump">18,020,000,000<span></span>
</td>
<td class="nump">18,838,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion</a></td>
<td class="num">(82,000,000)<span></span>
</td>
<td class="num">(267,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">17,938,000,000<span></span>
</td>
<td class="nump">18,571,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Credit facility</a></td>
<td class="nump">58,000,000<span></span>
</td>
<td class="nump">149,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=cnc_TermLoanCreditAgreementMember', window );">Term loan credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Credit facility</a></td>
<td class="nump">2,183,000,000<span></span>
</td>
<td class="nump">2,195,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConstructionLoanPayableMember', window );">Construction loan payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Construction loan payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">184,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cnc_A2500Million425SeniorNotesDueDecember2027Member', window );">$2,500 million 4.25% Senior Notes, due December 15, 2027 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 2,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 2,393,000,000<span></span>
</td>
<td class="nump">2,484,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cnc_A2300Million245SeniorNotesDueJuly2028Member', window );">$2,300 Million 2.45% Senior Notes due July 2028 [Member] | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 2,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="nump">2.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 2,303,000,000<span></span>
</td>
<td class="nump">2,304,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cnc_A3500Million4625SeniorNotesDueDecember2029Member', window );">$3,500 Million 4.625% Senior Notes due December 2029 [Member] | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 3,277,000,000<span></span>
</td>
<td class="nump">3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cnc_A2000Million3375SeniorNotesDueFebruary2030Member', window );">$2,000 million 3.375% Senior Notes, due February 15, 2030 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cnc_A2200Million30SeniorNotesDueOctober2030Member', window );">$2,200 million 3.00% Senior Notes, due October 15, 2030 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 2,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 2,200,000,000<span></span>
</td>
<td class="nump">2,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cnc_A2200Million250SeniorNotesDueMarch2031Member', window );">$2,200 Million 2.50% Senior Notes due March 2031 [Member] | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 2,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 2,200,000,000<span></span>
</td>
<td class="nump">2,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cnc_A1300Million2625SeniorNotesDueAugust2031Member', window );">$1,300 Million 2.625% Senior Notes due August 2031 [Member] | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_FinanceLeaseLiabilityAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Liability And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_FinanceLeaseLiabilityAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_SeniorNotesTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Senior Notes, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_SeniorNotesTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=cnc_TermLoanCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=cnc_TermLoanCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConstructionLoanPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConstructionLoanPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_A2500Million425SeniorNotesDueDecember2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_A2500Million425SeniorNotesDueDecember2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_A2300Million245SeniorNotesDueJuly2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_A2300Million245SeniorNotesDueJuly2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_A3500Million4625SeniorNotesDueDecember2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_A3500Million4625SeniorNotesDueDecember2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_A2000Million3375SeniorNotesDueFebruary2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_A2000Million3375SeniorNotesDueFebruary2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_A2200Million30SeniorNotesDueOctober2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_A2200Million30SeniorNotesDueOctober2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_A2200Million250SeniorNotesDueMarch2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_A2200Million250SeniorNotesDueMarch2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_A1300Million2625SeniorNotesDueAugust2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_A1300Million2625SeniorNotesDueAugust2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967466334400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Additional Information (Details) - Debt Total - Credit Availability Concentration Risk<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=cnc_DebtTotalMember', window );">London Interbank Offered Rate (LIBOR) And Sterling Overnight Index Average (SONIA)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total debt tied to variable rates</a></td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=cnc_DebtTotalMember', window );">LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total debt tied to variable rates</a></td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=cnc_DebtTotalMember', window );">Sterling Overnight Index Average (SONIA)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total debt tied to variable rates</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=cnc_DebtTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=cnc_DebtTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditAvailabilityConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditAvailabilityConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=cnc_SterlingOvernightIndexAverageSONIAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=cnc_SterlingOvernightIndexAverageSONIAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967455512960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Senior Notes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (25,000,000)<span></span>
</td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="nump">$ 57,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">318,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnRepurchaseOfDebtInstrument', window );">Gain on redemption of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | $3,500 Million 4.625% Senior Notes due December 2029 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | $2,500 Million 4.25% Senior Notes due December 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | $2,200 Million 2.50% Senior Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | $2,200 Million 4.75% Senior Notes due January 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage', window );">Aggregate percentage of principal outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | $1,800 Million 2.45% Senior Notes due March 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.45%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Premium yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.31%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | $1,300 Million 2.625% Senior Notes due August 2031 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.375% Senior notes, due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember', window );">Magellan Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfAssumedDebt', window );">Payoff of assumed debt</a></td>
<td class="nump">$ 535,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate stated, percentage</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Accepted for Tender Offer, Principal Outstanding, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnRepurchaseOfDebtInstrument">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the repurchase price of a debt instrument initially issued by the entity and the net carrying amount of the debt at the time of its repurchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnRepurchaseOfDebtInstrument</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfAssumedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayments of a long-term debt originally issued by another party but is assumed by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfAssumedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_A3500Million4625SeniorNotesDueDecember2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_A3500Million4625SeniorNotesDueDecember2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_A2500Million425SeniorNotesDueDecember2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_A2500Million425SeniorNotesDueDecember2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_A2200Million250SeniorNotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_A2200Million250SeniorNotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_A2200Million475SeniorNotesDueJanuary2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_A2200Million475SeniorNotesDueJanuary2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_A1800Million245SeniorNotesDueMarch2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_A1800Million245SeniorNotesDueMarch2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_A1300Million2625SeniorNotesDueAugust2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_A1300Million2625SeniorNotesDueAugust2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_A750Million5375SeniorNotesDueJune2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_A750Million5375SeniorNotesDueJune2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967458249296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Foreign Currency Swaps and Circle Health Debt Refinancing (Details)<br> &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion', window );">Debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="num">$ (125)<span></span>
</td>
<td class="num">$ (61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeInvestingActivities', window );">Payment for swap agreement | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair value of swap agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities', window );">Proceeds from interest rate swap terminations</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ForeignLineOfCreditMember', window );">Foreign Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion', window );">Debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Long-Term Line of Credit, Noncurrent | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Extinguishment of Debt , Including Cash Portion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1314-112600<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow provided by derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3505-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ForeignLineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ForeignLineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459508368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Revolving Credit Facility and Term Loan (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease', window );">Ratio of debt to EBITDA, may increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DebtInstrumentPaymentPeriodAxis=cnc_DebtInstrumentPaymentPeriodOneMember', window );">First year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DebtInstrumentAmortizationPaymentRatePercentage', window );">Amortization payment percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DebtInstrumentPaymentPeriodAxis=cnc_DebtInstrumentPaymentPeriodTwoMember', window );">Second year following closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DebtInstrumentAmortizationPaymentRatePercentage', window );">Amortization payment percentage</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DebtInstrumentPaymentPeriodAxis=cnc_DebtInstrumentPaymentPeriodThreeMember', window );">Thereafter until maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DebtInstrumentAmortizationPaymentRatePercentage', window );">Amortization payment percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit', window );">Uncommitted option, to increase Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Revolving credit agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate of outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_BridgeLoanMember', window );">Swing Loan | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate of outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cnc_TermLoanCreditAgreementMember', window );">Term loan credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility</a></td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="nump">$ 1,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum', window );">Covenant, maximum net leverage ratio</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cnc_TermLoanCreditAgreementMember', window );">Term loan credit facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cnc_TermLoanCreditAgreementMember', window );">Term loan credit facility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cnc_TermLoanCreditAgreementMember', window );">Term loan credit facility | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DebtInstrumentAmortizationPaymentRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Amortization Payment Rate, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DebtInstrumentAmortizationPaymentRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DebtInstrumentCovenantNetLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Net Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DebtInstrumentCovenantNetLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Covenant Terms, Ratio Of Debt To Earnings Before Interest Taxes Depreciation And Amortization, Current Year, Other Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Accordion Feature, Increase Limit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DebtInstrumentPaymentPeriodAxis=cnc_DebtInstrumentPaymentPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DebtInstrumentPaymentPeriodAxis=cnc_DebtInstrumentPaymentPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DebtInstrumentPaymentPeriodAxis=cnc_DebtInstrumentPaymentPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DebtInstrumentPaymentPeriodAxis=cnc_DebtInstrumentPaymentPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DebtInstrumentPaymentPeriodAxis=cnc_DebtInstrumentPaymentPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DebtInstrumentPaymentPeriodAxis=cnc_DebtInstrumentPaymentPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_BridgeLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_BridgeLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnc_TermLoanCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnc_TermLoanCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967462675040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Construction Loan (Details) - Construction loan payable - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DebtInstrumentExtensionTerm', window );">Extension term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">LIBOR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember', window );">SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="nump">1.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DebtInstrumentExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DebtInstrumentExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConstructionLoanPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConstructionLoanPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967466529984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Debt Repurchase Program (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DebtRepurchaseProgramAuthorizedAmount', window );">Debt Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount', window );">Remaining amount available under the program</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt redemption amount</a></td>
<td class="nump">318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repurchase of senior notes</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DebtRepurchaseProgramAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Repurchase Program, Authorized Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DebtRepurchaseProgramAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Repurchase Program, Remaining Amount Authorized to be Repurchased, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459810112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Letters of Credit &amp; Surety Bonds (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_SuretyBondMember', window );">Surety Bond</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Surety bonds outstanding</a></td>
<td class="nump">$ 1,292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="nump">$ 217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate of outstanding borrowings</a></td>
<td class="nump">0.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_SuretyBondMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_SuretyBondMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967466283888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Aggregate Maturities of Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">1,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">2,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">13,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt, Total</a></td>
<td class="nump">18,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of outstanding debt</a></td>
<td class="nump">$ 15,791<span></span>
</td>
<td class="nump">$ 19,256<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459911488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 429<span></span>
</td>
<td class="nump">$ 390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Lease liabilities reduced by cash paid</a></td>
<td class="nump">440<span></span>
</td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liability</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_LesseeOperatingLeaseLeasesCommencedLiability', window );">Lease liability for leases commenced</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets</a></td>
<td class="nump">2,554<span></span>
</td>
<td class="nump">3,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">3,313<span></span>
</td>
<td class="nump">$ 3,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability', window );">Operating lease not yet commenced, liability</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">ROU asset impairments</a></td>
<td class="nump">577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Remaining asset impairment charges</a></td>
<td class="nump">$ 1,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">20 years 6 months<span></span>
</td>
<td class="text">21 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate for operating leases</a></td>
<td class="nump">5.70%<span></span>
</td>
<td class="nump">5.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember', window );">Magellan Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Operating lease not yet commenced, term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Operating lease not yet commenced, term</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_LesseeOperatingLeaseLeasesCommencedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Leases Commenced, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_LesseeOperatingLeaseLeasesCommencedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967466187632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - ROU Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets (recorded within other long-term assets)</a></td>
<td class="nump">$ 2,554<span></span>
</td>
<td class="nump">$ 3,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other long-term assets<span></span>
</td>
<td class="text">Other long-term assets<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Short-term (recorded within accounts payable and accrued expenses)</a></td>
<td class="nump">$ 180<span></span>
</td>
<td class="nump">$ 204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term (recorded within other long-term liabilities)</a></td>
<td class="nump">3,133<span></span>
</td>
<td class="nump">3,619<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 3,313<span></span>
</td>
<td class="nump">$ 3,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Accounts Payable and Accrued Liabilities, Current<span></span>
</td>
<td class="text">Accounts Payable and Accrued Liabilities, Current<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967458426560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Operating Lease Maturity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">4,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">6,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(2,927)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 3,313<span></span>
</td>
<td class="nump">$ 3,823<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459758304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 23, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount', window );">Stock repurchase program, increase to authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program increase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,096<span></span>
</td>
<td class="nump">$ 297<span></span>
</td>
<td class="nump">$ 626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnc_WellCareHealthPlansIncMember', window );">WellCare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued in business acquisition (in shares)</a></td>
<td class="nump">171,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Equity value issued in business acquisition</a></td>
<td class="nump">$ 11,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments to acquire business</a></td>
<td class="nump">6,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredOther1', window );">Fair value adjustment to stock based compensation associated with pre-combination service</a></td>
<td class="nump">$ 95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cnc_EmployeeStockCompensationPlanMember', window );">Employee Stock Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Income tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
<td class="nump">1,379<span></span>
</td>
<td class="nump">2,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cnc_EmployeeStockCompensationPlanMember', window );">Employee Stock Compensation Plan | WellCare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Income tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,868<span></span>
</td>
<td class="nump">3,781<span></span>
</td>
<td class="nump">10,717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,096<span></span>
</td>
<td class="nump">$ 297<span></span>
</td>
<td class="nump">$ 626<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cnc_AcceleratedShareRepurchaseAgreementMember', window );">Accelerated Share Repurchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AcceleratedShareRepurchasesDiscountPricePerShare', window );">ASR, discount (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cnc_AcceleratedShareRepurchaseAgreementMember', window );">Accelerated Share Repurchase Agreement | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_AcceleratedShareRepurchasesAgreementAmount', window );">Accelerated share repurchases agreement, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">8,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram', window );">Percentage of notional amount under ASR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AcceleratedShareRepurchasesAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases Agreement, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AcceleratedShareRepurchasesAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_AcceleratedShareRepurchasesDiscountPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Discount, Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_AcceleratedShareRepurchasesDiscountPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_StockRepurchaseProgramIncreaseAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Increase, Authorized Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_StockRepurchaseProgramIncreaseAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value Acquired, Percentage Of Notional Amount Of Program</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredOther1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredOther1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cnc_WellCareHealthPlansIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cnc_WellCareHealthPlansIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cnc_EmployeeStockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cnc_EmployeeStockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cnc_AcceleratedShareRepurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cnc_AcceleratedShareRepurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459770544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity -Share Repurchase Activity (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="nump">$ 3,096<span></span>
</td>
<td class="nump">$ 297<span></span>
</td>
<td class="nump">$ 626<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cnc_EmployeeStockCompensationPlanMember', window );">Employee Stock Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Income tax withholding (in shares)</a></td>
<td class="nump">1,213<span></span>
</td>
<td class="nump">1,379<span></span>
</td>
<td class="nump">2,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Income tax withholding</a></td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation', window );">Share buybacks (in shares)</a></td>
<td class="nump">35,655<span></span>
</td>
<td class="nump">2,402<span></span>
</td>
<td class="nump">8,672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchases (in shares)</a></td>
<td class="nump">36,868<span></span>
</td>
<td class="nump">3,781<span></span>
</td>
<td class="nump">10,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes', window );">Share buybacks</a></td>
<td class="nump">$ 2,994<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="nump">$ 3,096<span></span>
</td>
<td class="nump">$ 297<span></span>
</td>
<td class="nump">$ 626<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cnc_EmployeeStockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cnc_EmployeeStockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967458227936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statutory Capital Requirements and Dividend Restrictions (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract', window );"><strong>Statutory Capital Requirements And Dividend Restrictions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance', window );">Statutory capital and surplus</a></td>
<td class="nump">$ 16,436<span></span>
</td>
<td class="nump">$ 14,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired', window );">Required minimum aggregate statutory capital and surplus</a></td>
<td class="nump">7,979<span></span>
</td>
<td class="nump">$ 6,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends', window );">Capital and surplus or net worth not available for dividends</a></td>
<td class="nump">$ 7,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Statutory capital requirements and dividend restrictions [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of retained earnings as of the balance sheet date that cannot be distributed to stockholders pursuant to statutory rules and regulations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967458408112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Consolidated Income Tax Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 1,144<span></span>
</td>
<td class="nump">$ 507<span></span>
</td>
<td class="nump">$ 959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">International</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current provision</a></td>
<td class="nump">1,409<span></span>
</td>
<td class="nump">628<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOtherTaxExpenseBenefit', window );">Deferred provision</a></td>
<td class="num">(649)<span></span>
</td>
<td class="num">(151)<span></span>
</td>
<td class="num">(136)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 760<span></span>
</td>
<td class="nump">$ 477<span></span>
</td>
<td class="nump">$ 979<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967458423200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of the Tax Provision at the U.S. Federal Statutory Rate to the Provision for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income tax</a></td>
<td class="nump">$ 1,962<span></span>
</td>
<td class="nump">$ 1,813<span></span>
</td>
<td class="nump">$ 2,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest', window );">Loss (earnings) attributable to flow through noncontrolling interest</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest', window );">Earnings less noncontrolling interest before income tax expense</a></td>
<td class="nump">1,956<span></span>
</td>
<td class="nump">1,815<span></span>
</td>
<td class="nump">2,782<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Tax provision at the U.S. federal statutory rate</a></td>
<td class="nump">411<span></span>
</td>
<td class="nump">381<span></span>
</td>
<td class="nump">584<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal income tax benefit</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Nondeductible compensation</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement', window );">Nondeductible PBM legal settlement</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness', window );">Nontaxable divestiture (gains) losses</a></td>
<td class="nump">111<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries', window );">Deferred taxes for investments in subsidiaries</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_ACAHealthInsurerFee', window );">ACA health insurer fee</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxSettlements', window );">Audit settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill', window );">Nondeductible goodwill</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other, net</a></td>
<td class="nump">8<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 760<span></span>
</td>
<td class="nump">$ 477<span></span>
</td>
<td class="nump">$ 979<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_ACAHealthInsurerFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ACA Health Insurer Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_ACAHealthInsurerFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deferred Taxes for Investment in Subsidiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Litigation Settlement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Nondeductible Expense, Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Less Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss (earnings) attributable to flow through noncontrolling interest before tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967455747984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Tax Effects of Temporary Differences Which Give Rise to Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Medical claims liability</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Nondeductible liabilities</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards', window );">Net operating loss and tax credit carryforwards</a></td>
<td class="nump">341<span></span>
</td>
<td class="nump">357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Compensation accruals</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DeferredTaxAssetPremiumAndTradeReceivables', window );">Premium and trade receivables</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DeferredTaxAssetOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">397<span></span>
</td>
<td class="nump">445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss', window );">Unrealized loss</a></td>
<td class="nump">320<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DeferredTaxAssetSoftwareDevelopmentCosts', window );">Software development costs</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">1,873<span></span>
</td>
<td class="nump">1,597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(205)<span></span>
</td>
<td class="num">(212)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">1,668<span></span>
</td>
<td class="nump">1,385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Goodwill and intangible assets</a></td>
<td class="nump">1,724<span></span>
</td>
<td class="nump">1,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Prepaid assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DeferredTaxLiabilitiesRightOfUseAssets', window );">Right-of-use asset</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss', window );">Unrealized gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">2,283<span></span>
</td>
<td class="nump">2,792<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred tax liabilities, net</a></td>
<td class="num">$ (615)<span></span>
</td>
<td class="num">$ (1,407)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DeferredTaxAssetOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DeferredTaxAssetOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DeferredTaxAssetPremiumAndTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Premium And Trade Receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DeferredTaxAssetPremiumAndTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DeferredTaxAssetSoftwareDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Software Development Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DeferredTaxAssetSoftwareDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Investment, Unrealized Gain/Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Investment, Unrealized Gain/Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DeferredTaxLiabilitiesRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Right Of Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DeferredTaxLiabilitiesRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459706368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration', window );">Operating loss carryforwards and tax credit carryforwards, not subject to expiration</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Net interest expense related to uncertain tax positions</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties for uncertain tax position</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Decrease in unrecognized tax benefits is reasonably possible</a></td>
<td class="nump">124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries', window );">Deferred taxes for investments in subsidiaries</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=us-gaap_SettlementWithTaxingAuthorityMember', window );">Expiration of Statues of Limitations and Projected Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Decrease in unrecognized tax benefits is reasonably possible</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss and tax credit carryforwards</a></td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration', window );">Operating loss carryforwards and tax credit carryforwards, subject to expiration</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss and tax credit carryforwards</a></td>
<td class="nump">$ 206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards, Not Subject To Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards, Subject To Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deferred Taxes for Investment in Subsidiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=us-gaap_SettlementWithTaxingAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=us-gaap_SettlementWithTaxingAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967460075296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Reserve for Uncertain Tax Positions That May be Challenged (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits, January 1</a></td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">$ 354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_GrossIncreasesAbstract', window );"><strong>Gross increases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Current year tax positions</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired', window );">Acquired reserves</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Prior year tax positions</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_GrossDecreasesAbstract', window );"><strong>Gross decreases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Prior year tax positions</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Statute of limitation lapses</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits, December 31</a></td>
<td class="nump">$ 410<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_GrossDecreasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross Decreases [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_GrossDecreasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_GrossIncreasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross Increases [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_GrossIncreasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Increase Resulting from Reserves Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967455318080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Narrative (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Available for future awards (in shares)</a></td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod', window );">Accelerated vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation expense</a></td>
<td class="nump">$ 234<span></span>
</td>
<td class="nump">$ 203<span></span>
</td>
<td class="nump">$ 281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit recognized</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of restricted stock and restricted stock units</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
<td class="nump">$ 364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the plans</a></td>
<td class="nump">$ 249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period</a></td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan issued (in shares)</a></td>
<td class="nump">449<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="nump">487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock options, restricted stock and restricted stock unit awards vesting period, years</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock options, restricted stock and restricted stock unit awards vesting period, years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock options, restricted stock and restricted stock unit awards vesting period, years</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock options, restricted stock and restricted stock unit awards vesting period, years</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units Awards | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock options, restricted stock and restricted stock unit awards vesting period, years</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units Awards | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock options, restricted stock and restricted stock unit awards vesting period, years</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Award Accelerated Vesting Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967466291216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Non-Vested Restricted Stock and Restricted Stock (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance, beginning of period (in shares) | shares</a></td>
<td class="nump">7,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">2,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod', window );">Converted (in shares) | shares</a></td>
<td class="nump">917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(3,553)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(877)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance, end of period (in shares) | shares</a></td>
<td class="nump">6,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance, beginning of period (usd per share) | $ / shares</a></td>
<td class="nump">$ 65.30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (usd per share) | $ / shares</a></td>
<td class="nump">84.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Converted (usd per share) | $ / shares</a></td>
<td class="nump">82.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (usd per share) | $ / shares</a></td>
<td class="nump">67.70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (usd per share) | $ / shares</a></td>
<td class="nump">70.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance, end of period (usd per share) | $ / shares</a></td>
<td class="nump">$ 74.20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted Due to Acquisition, Grants in Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted, Grants in Period, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967468043968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DefinedContributionPlanMinimumAgeForCoverage', window );">Defined contribution plan covered employee, age (at least)</a></td>
<td class="text">21 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined contribution plan matching contribution expense</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DefinedContributionPlanMinimumAgeForCoverage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan, Minimum Age For Coverage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DefinedContributionPlanMinimumAgeForCoverage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967460121168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">84 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($) </div>
<div>newEmployee</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 04, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember', window );">Department Of Health, State Of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Commitment to undertaking</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 340.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_OtherCommitmentTerm', window );">Commitment to undertaking, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember', window );">Long term investment, California Organized Investment Network</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Commitment to undertaking</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_OtherCommitmentTerm', window );">Commitment to undertaking, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentServiceCenterinCaliforniaMember', window );">Long term investment, service center in California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Commitment to undertaking</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_OtherCommitmentTerm', window );">Commitment to undertaking, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_OtherCommitmentExpense', window );">Commitment to undertaking, expensed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentServiceCenterinCaliforniaMember', window );">Long term investment, service center in California | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_OtherCommitmentEmployees', window );">Commitment to undertaking, by employing (people) (at least) | newEmployee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember', window );">Long term investment,improvement in enrollee health, locally based consumer assistance, and health care delivery system</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Commitment to undertaking</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_OtherCommitmentExpense', window );">Commitment to undertaking, expensed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_OtherCommitmentToBePaidYearOneAndYearTwo', window );">Commitment to be paid over 2023 and 2024</a></td>
<td class="nump">$ 16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember', window );">Long term investment, investment portfolio in vehicles supporting California&#8217;s health care infrastructure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Commitment to undertaking</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember', window );">Magellan Health | Purchaser Business Group on Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Commitment to undertaking</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_OtherCommitmentTerm', window );">Commitment to undertaking, term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_OtherCommitmentsPaid', window );">Commitments paid</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_OtherCommitmentExpense', window );">Commitment to undertaking, expensed</a></td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_OtherCommitmentEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Commitment, Employees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_OtherCommitmentEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_OtherCommitmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Commitment Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_OtherCommitmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_OtherCommitmentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Commitment, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_OtherCommitmentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_OtherCommitmentToBePaidYearOneAndYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Commitment To Be Paid Year One and Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_OtherCommitmentToBePaidYearOneAndYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_OtherCommitmentsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Commitments, Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_OtherCommitmentsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentServiceCenterinCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentServiceCenterinCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cnc_MagellanHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=cnc_PurchaserBusinessGroupOnHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=cnc_PurchaserBusinessGroupOnHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967458194208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Details) - Pending Litigation<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>claim</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims | claim</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated litigation reserve | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967462675712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Net Income (Loss) Attributable to Parent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Earnings attributable to Centene Corporation</a></td>
<td class="nump">$ 1,202<span></span>
</td>
<td class="nump">$ 1,347<span></span>
</td>
<td class="nump">$ 1,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract', window );"><strong>Shares used in computing per share amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding (in shares)</a></td>
<td class="nump">575,191<span></span>
</td>
<td class="nump">582,832<span></span>
</td>
<td class="nump">570,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Common stock equivalents (as determined by applying the treasury stock method) (in shares)</a></td>
<td class="nump">6,849<span></span>
</td>
<td class="nump">7,684<span></span>
</td>
<td class="nump">8,413<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares and potential dilutive common shares outstanding (in shares)</a></td>
<td class="nump">582,040<span></span>
</td>
<td class="nump">590,516<span></span>
</td>
<td class="nump">579,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Net earnings per common share attributable to Centene Corporation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in usd per share)</a></td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 2.31<span></span>
</td>
<td class="nump">$ 3.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in usd per share)</a></td>
<td class="nump">$ 2.07<span></span>
</td>
<td class="nump">$ 2.28<span></span>
</td>
<td class="nump">$ 3.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive stock options and restricted stock units excluded from the calculation of diluted earnings per common share (in shares)</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">398<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967464357456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 144,547<span></span>
</td>
<td class="nump">$ 125,982<span></span>
</td>
<td class="nump">$ 111,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings (loss) from operations</a></td>
<td class="nump">1,318<span></span>
</td>
<td class="nump">1,784<span></span>
</td>
<td class="nump">3,082<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cnc_ManagedCareMember', window );">Managed&#160;Care&#160;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">135,063<span></span>
</td>
<td class="nump">120,125<span></span>
</td>
<td class="nump">106,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings (loss) from operations</a></td>
<td class="nump">1,913<span></span>
</td>
<td class="nump">1,789<span></span>
</td>
<td class="nump">3,031<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cnc_SpecialtyServicesMember', window );">Specialty Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">22,765<span></span>
</td>
<td class="nump">18,652<span></span>
</td>
<td class="nump">14,994<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings (loss) from operations</a></td>
<td class="num">(595)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Managed&#160;Care&#160;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">135,055<span></span>
</td>
<td class="nump">120,119<span></span>
</td>
<td class="nump">106,862<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Specialty Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">9,492<span></span>
</td>
<td class="nump">5,863<span></span>
</td>
<td class="nump">4,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="num">(13,281)<span></span>
</td>
<td class="num">(12,795)<span></span>
</td>
<td class="num">(10,746)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Eliminations | Managed&#160;Care&#160;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Eliminations | Specialty Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 13,273<span></span>
</td>
<td class="nump">$ 12,789<span></span>
</td>
<td class="nump">$ 10,741<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cnc_ManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cnc_ManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cnc_SpecialtyServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cnc_SpecialtyServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967458600000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Financial Information of Registrant - Condensed Balance Sheets (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 12,074<span></span>
</td>
<td class="nump">$ 13,118<span></span>
</td>
<td class="nump">$ 10,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">2,321<span></span>
</td>
<td class="nump">1,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">2,461<span></span>
</td>
<td class="nump">1,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">30,128<span></span>
</td>
<td class="nump">28,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">14,684<span></span>
</td>
<td class="nump">14,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">2,686<span></span>
</td>
<td class="nump">3,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">76,870<span></span>
</td>
<td class="nump">78,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">28,464<span></span>
</td>
<td class="nump">25,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">17,938<span></span>
</td>
<td class="nump">18,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">5,616<span></span>
</td>
<td class="nump">5,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">52,633<span></span>
</td>
<td class="nump">51,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December&#160;31, 2022 and December&#160;31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December&#160;31, 2022, and 602,704 issued and 582,479 outstanding at December&#160;31, 2021</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">20,060<span></span>
</td>
<td class="nump">19,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive earnings (loss)</a></td>
<td class="num">(1,132)<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">$ 9,341<span></span>
</td>
<td class="nump">$ 8,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">57,093<span></span>
</td>
<td class="nump">20,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost (57,093 and 20,225 shares, respectively)</a></td>
<td class="num">$ (4,213)<span></span>
</td>
<td class="num">$ (1,094)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Centene stockholders' equity</a></td>
<td class="nump">24,057<span></span>
</td>
<td class="nump">26,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Nonredeemable noncontrolling interest</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">24,181<span></span>
</td>
<td class="nump">26,940<span></span>
</td>
<td class="nump">$ 25,885<span></span>
</td>
<td class="nump">$ 12,659<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interests and stockholders' equity</a></td>
<td class="nump">76,870<span></span>
</td>
<td class="nump">78,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in subsidiaries</a></td>
<td class="nump">42,306<span></span>
</td>
<td class="nump">45,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">422<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">42,812<span></span>
</td>
<td class="nump">46,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">534<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">603<span></span>
</td>
<td class="nump">633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">17,699<span></span>
</td>
<td class="nump">18,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">273<span></span>
</td>
<td class="nump">461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">18,575<span></span>
</td>
<td class="nump">19,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December&#160;31, 2022 and December&#160;31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December&#160;31, 2022, and 602,704 issued and 582,479 outstanding at December&#160;31, 2021</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">20,060<span></span>
</td>
<td class="nump">19,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive earnings (loss)</a></td>
<td class="num">(1,132)<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">$ 9,341<span></span>
</td>
<td class="nump">$ 8,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">57,093<span></span>
</td>
<td class="nump">20,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost (57,093 and 20,225 shares, respectively)</a></td>
<td class="num">$ (4,213)<span></span>
</td>
<td class="num">$ (1,094)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Centene stockholders' equity</a></td>
<td class="nump">24,057<span></span>
</td>
<td class="nump">26,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Nonredeemable noncontrolling interest</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">24,181<span></span>
</td>
<td class="nump">26,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interests and stockholders' equity</a></td>
<td class="nump">$ 42,812<span></span>
</td>
<td class="nump">$ 46,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459917952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Financial Information of Registrant - Condensed Balance Sheets Additional (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">607,847,000<span></span>
</td>
<td class="nump">602,704,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">550,754,000<span></span>
</td>
<td class="nump">582,479,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, at cost (in shares)</a></td>
<td class="nump">57,093,000<span></span>
</td>
<td class="nump">20,225,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">607,847,000<span></span>
</td>
<td class="nump">602,704,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">550,754,000<span></span>
</td>
<td class="nump">582,479,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, at cost (in shares)</a></td>
<td class="nump">57,093,000<span></span>
</td>
<td class="nump">20,225,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967459736288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of Registrant - Condensed Statements of Operations (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">$ 11,589<span></span>
</td>
<td class="nump">$ 9,601<span></span>
</td>
<td class="nump">$ 9,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Legal settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNonoperating', window );">Investment and other income</a></td>
<td class="nump">1,279<span></span>
</td>
<td class="nump">819<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on divestiture</a></td>
<td class="nump">772<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion', window );">Debt extinguishment</a></td>
<td class="nump">30<span></span>
</td>
<td class="num">(125)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(665)<span></span>
</td>
<td class="num">(665)<span></span>
</td>
<td class="num">(728)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">760<span></span>
</td>
<td class="nump">477<span></span>
</td>
<td class="nump">979<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">1,202<span></span>
</td>
<td class="nump">1,336<span></span>
</td>
<td class="nump">1,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Loss attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Centene Corporation</a></td>
<td class="nump">$ 1,202<span></span>
</td>
<td class="nump">$ 1,347<span></span>
</td>
<td class="nump">$ 1,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net earnings per common share attributable to Centene Corporation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in usd per share)</a></td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 2.31<span></span>
</td>
<td class="nump">$ 3.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in usd per share)</a></td>
<td class="nump">$ 2.07<span></span>
</td>
<td class="nump">$ 2.28<span></span>
</td>
<td class="nump">$ 3.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Legal settlement</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNonoperating', window );">Investment and other income</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on divestiture</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion', window );">Debt extinguishment</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(125)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(643)<span></span>
</td>
<td class="num">(641)<span></span>
</td>
<td class="num">(723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">(Loss) before income taxes</a></td>
<td class="num">(615)<span></span>
</td>
<td class="num">(1,735)<span></span>
</td>
<td class="num">(687)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(208)<span></span>
</td>
<td class="num">(308)<span></span>
</td>
<td class="num">(331)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries', window );">Net (loss) before equity in subsidiaries</a></td>
<td class="num">(407)<span></span>
</td>
<td class="num">(1,427)<span></span>
</td>
<td class="num">(356)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings from subsidiaries</a></td>
<td class="nump">1,609<span></span>
</td>
<td class="nump">2,763<span></span>
</td>
<td class="nump">2,150<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">1,202<span></span>
</td>
<td class="nump">1,336<span></span>
</td>
<td class="nump">1,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Loss attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Centene Corporation</a></td>
<td class="nump">$ 1,202<span></span>
</td>
<td class="nump">$ 1,347<span></span>
</td>
<td class="nump">$ 1,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net earnings per common share attributable to Centene Corporation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in usd per share)</a></td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 2.31<span></span>
</td>
<td class="nump">$ 3.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in usd per share)</a></td>
<td class="nump">$ 2.07<span></span>
</td>
<td class="nump">$ 2.28<span></span>
</td>
<td class="nump">$ 3.12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Extinguishment of Debt , Including Cash Portion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net income (loss), including portion attributable to noncontrolling interest before equity in earnings from subsidiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139967455349328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other operating activities, net</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">6,261<span></span>
</td>
<td class="nump">4,205<span></span>
</td>
<td class="nump">5,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(6,736)<span></span>
</td>
<td class="num">(7,400)<span></span>
</td>
<td class="num">(7,402)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Sales and maturities of investments</a></td>
<td class="nump">3,802<span></span>
</td>
<td class="nump">5,458<span></span>
</td>
<td class="nump">4,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) investing activities</a></td>
<td class="num">(2,921)<span></span>
</td>
<td class="num">(3,299)<span></span>
</td>
<td class="num">(6,955)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from common stock issuances</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt</a></td>
<td class="nump">360<span></span>
</td>
<td class="nump">9,267<span></span>
</td>
<td class="nump">5,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments and repurchases of long-term debt</a></td>
<td class="num">(1,490)<span></span>
</td>
<td class="num">(7,434)<span></span>
</td>
<td class="num">(4,067)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock repurchases</a></td>
<td class="num">(3,096)<span></span>
</td>
<td class="num">(297)<span></span>
</td>
<td class="num">(626)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishment</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(157)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="num">(120)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="num">(27)<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(4,197)<span></span>
</td>
<td class="nump">1,362<span></span>
</td>
<td class="nump">260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period</a></td>
<td class="nump">13,214<span></span>
</td>
<td class="nump">10,957<span></span>
</td>
<td class="nump">12,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash and cash equivalents, end of period</a></td>
<td class="nump">12,330<span></span>
</td>
<td class="nump">13,214<span></span>
</td>
<td class="nump">10,957<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_DividendsfromSubsidiariesOperatingActivities', window );">Dividends from subsidiaries, return on investment</a></td>
<td class="nump">1,706<span></span>
</td>
<td class="nump">2,194<span></span>
</td>
<td class="nump">739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlement</a></td>
<td class="num">(282)<span></span>
</td>
<td class="num">(298)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other operating activities, net</a></td>
<td class="num">(450)<span></span>
</td>
<td class="num">(582)<span></span>
</td>
<td class="num">(287)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">974<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_CapitalContributionsToSubsidiaries', window );">Capital contributions to subsidiaries</a></td>
<td class="num">(880)<span></span>
</td>
<td class="num">(1,217)<span></span>
</td>
<td class="num">(761)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(723)<span></span>
</td>
<td class="num">(111)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Sales and maturities of investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashDividendsPaidToParentCompany', window );">Dividends from subsidiaries, return of investment</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates', window );">Investments in acquisitions</a></td>
<td class="num">(2,431)<span></span>
</td>
<td class="num">(151)<span></span>
</td>
<td class="num">(7,188)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnc_ProceedsFromPaymentsForIntercompanyActivities', window );">Intercompany activities</a></td>
<td class="nump">5,785<span></span>
</td>
<td class="num">(1,709)<span></span>
</td>
<td class="nump">1,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities, net</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) investing activities</a></td>
<td class="nump">2,485<span></span>
</td>
<td class="num">(3,363)<span></span>
</td>
<td class="num">(6,256)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from common stock issuances</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">9,066<span></span>
</td>
<td class="nump">4,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments and repurchases of long-term debt</a></td>
<td class="num">(491)<span></span>
</td>
<td class="num">(7,207)<span></span>
</td>
<td class="num">(3,875)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock repurchases</a></td>
<td class="num">(3,096)<span></span>
</td>
<td class="num">(297)<span></span>
</td>
<td class="num">(626)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishment</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(157)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="num">(120)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(3,456)<span></span>
</td>
<td class="nump">1,390<span></span>
</td>
<td class="nump">215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(659)<span></span>
</td>
<td class="num">(5,589)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">668<span></span>
</td>
<td class="nump">6,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash and cash equivalents, end of period</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 668<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_CapitalContributionsToSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Contributions to Subsidiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_CapitalContributionsToSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_DividendsfromSubsidiariesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividends from Subsidiaries, Operating Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_DividendsfromSubsidiariesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnc_ProceedsFromPaymentsForIntercompanyActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From (Payments for) Intercompany Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnc_ProceedsFromPaymentsForIntercompanyActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDividendsPaidToParentCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents disclosure of the total aggregate cash dividends paid to the entity by consolidated subsidiaries, by unconsolidated subsidiaries, and by 50 percent or less owned persons accounted for using the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDividendsPaidToParentCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>cnc-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cnc="http://www.centene.com/20221231"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cnc-20221231.xsd" xlink:type="simple"/>
    <context id="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i04652939d67241d39001577da981b842_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie567ad4d3dfb4202acf278d4fe91232a_I20230217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
        </entity>
        <period>
            <instant>2023-02-17</instant>
        </period>
    </context>
    <context id="ida2e74d548f94bb09ac682a12b3f2b23_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2eadcd3758bd48558b2055d1213fc6f5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7c83c53bcfae4452bc7f79564bebc856_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i85fbc70041964c1a8bd77082880bf5c5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib80ff9d53361464b80c69f222a08fd78_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i28166a0649364f7486e28e0475aa1937_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7ba97cd7426845cea3497f057312fa44_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if74f20f9672c42969aaf06d880b02823_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id53035e323dd4a8a8791395cc30ffafe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iefd78604c8af4b3eb7e7763dd317e282_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b6ce4061fae4dd2bf7bfef4711d6df6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i205075141d20449391c609023aa905f8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i116b2020b2da4f3ea027f5a137798310_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22a603f1ec5a4ed6ac95d0033583c8ae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0a00c10b57c34ba7b04e400d6d51804c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i677e18bc38214dc8aa867bdadeb3507e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i007f9f25b89a4328b4843c47ad28463f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i463620403a104db8bdb4789fd3025d04_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaab02486f5a340caa2b7a035d3d61cfd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i89efa37b183c4c618c28149ddb506553_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4325cafc5d4145589b2f8c8a9708b14d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i65cbc7d56bfd4ffb861729ca1b540ab1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i70228d9f45fe464887fc03a805d9f728_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icbc613d20c5e4995abeaccfb2d2a2ffd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b2f9a41ae484e65bfe6464f3b6bcc36_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if18a7a7ccfa44c02a607ea5b90c04d27_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iddfa338597904f0eba0c96789f0d0ed5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2fe5e0012c04cccb9b042e45cdf6198_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75d4d36b1dce42f98b2a5b7237c1773e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43b316ad31204bf786dbb981cb93be17_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2185a9a104a3441390ac2f06aefa122a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2e696a8243e449cea4c408643b0c8316_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ied7399d5bbf14198bf9416f0242b68b1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if228d12dc7ec48dbabc207800e70e561_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia4141bf74d4f4cf2a006bd905970e699_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia335774c94194c9e9df1cee6eca206c1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i87039d6a8fdd4824bbf66cc17f0022f6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i59eb9977480d4e3891765c8703b4e646_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d8aca346cdc405eb8ae3ab1bb1a0e8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i253a5454e6f34367b12d67c6674b4320_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i831e8980ca404c60aa04c6cee3dd1a38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07517ae73bdd457783095996579e8053_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic2d17142024e44a0b55466c586719466_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i00ea1fbc2e9c4c9f8ef3db694f5e19cb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6fe2f9326b88400aa8db63ee38c9dc25_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifad2424f092c43c5aef13a515b9bf557_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0e9d6d9ad10d41afb05597363822ad5c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idda5d167ac1a435ba11ce095d9bf8926_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic1d80c4c83dd418ebc09acf400b5608c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0b68b2bcce604d8997c874bfd621f1fd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4ff8138305244a25baa6cc2d532766f2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id7f45234b97a4a8db9cc70838a92e915_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2359cd8d83d04e01929e44fe25fcb92f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4607d979606c4f7fa36ae2f1b825cb49_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i35e17c2ca0f64a168f7fe15e237ef8d1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i34c5f25db0f84955937399bdc59bc0f8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib42047c8782d4d33831b521cdbbe8d2f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib9cb6bb95198406b9dc757a3fe689c48_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i39698c8d4f5741c2bd5f7bb1c215d1c2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib0e7605c14854f1298823da0004e7bcd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i67e4e863732140539a2d0c4798909e31_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i74119b927bec4965b1fd97a0689f4f10_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7f0027dbc67f4fcfb5bb6efed06c4909_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if4d49678d798431db2da34d388ffc987_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnc:ProviderContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iae0603c3ac604874a3f063c971cb1131_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnc:ProviderContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifcdf168f01c14287ab8225cc4e5ac2a2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id7c90459707d4aa69df99c5cbc3d379b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5054b3e6c71b40e494d1cacca5fded80_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i77c71d30602b434bb2aa3deac20d8334_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if6cdbd424736484b93b773b56ebf2191_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if869d22d0f044d3d9bfb60d75bc74fbe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i906fa59240054e0ca347d7e3ce1f9812_D20220104-20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-04</startDate>
            <endDate>2022-01-04</endDate>
        </period>
    </context>
    <context id="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-04</instant>
        </period>
    </context>
    <context id="i3799e2d4c58049f4bac2714882700574_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8fd457add58740c084e97e1c414ce9f9_I20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-04</instant>
        </period>
    </context>
    <context id="iea27c4aa651545eaa7d30d7a626031a7_D20220104-20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-04</startDate>
            <endDate>2022-01-04</endDate>
        </period>
    </context>
    <context id="id1b54f2cbfd746b8a13ac300eb5f594d_I20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InsuranceContractsAcquiredInBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-04</instant>
        </period>
    </context>
    <context id="ic898092fd2d349718cfc66201cf1e5db_D20220104-20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InsuranceContractsAcquiredInBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-04</startDate>
            <endDate>2022-01-04</endDate>
        </period>
    </context>
    <context id="i9adcef2d77d24557bc8ed47f59f80d11_I20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-04</instant>
        </period>
    </context>
    <context id="idb157bc574b24e8ea7212ed38cddbc14_D20220104-20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-04</startDate>
            <endDate>2022-01-04</endDate>
        </period>
    </context>
    <context id="i68d8c947320f402488ed555c813a0394_I20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-04</instant>
        </period>
    </context>
    <context id="ie2f7de6d3ba44de9a27dfe4b0d2086cd_D20220104-20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-04</startDate>
            <endDate>2022-01-04</endDate>
        </period>
    </context>
    <context id="i8676d1a500a445dfbdfe2ed3255b473a_D20220714-20220714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:PANTHERxRareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-14</startDate>
            <endDate>2022-07-14</endDate>
        </period>
    </context>
    <context id="i3fad3c7a923b4e3ea96e190945650528_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:SpanishAndCentralEuropeanBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6a752c4a069849f8a31ceb9055f487f2_D20221202-20221202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:MagellanRxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-02</startDate>
            <endDate>2022-12-02</endDate>
        </period>
    </context>
    <context id="i40a749aec9b14d808f4fa50726eaa259_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:MagellanSpecialtyHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4727fabbef274d23a97b2b7195f75143_I20230120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:MagellanSpecialtyHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-20</instant>
        </period>
    </context>
    <context id="i1032a3c41f4546a19e08100bbd31888f_D20230120-20230120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:MagellanSpecialtyHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-20</startDate>
            <endDate>2023-01-20</endDate>
        </period>
    </context>
    <context id="ie93c74b491b34072ae22f37b005de9da_D20230120-20230120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:MagellanSpecialtyHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-20</startDate>
            <endDate>2023-01-20</endDate>
        </period>
    </context>
    <context id="ided6cdd3afac49e7905a2933ce43623e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:CenturionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0fc78fa9a34b400587dbebfb3ac1f1e0_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:CenturionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i86423bee35dc4d99be0b3b984e6903db_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:HealthSmartMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie6bd664dd1964db0a6890c587570d306_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cnc:HealthSmartMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i499a3149a68f43d197206136874ec7aa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i486a37f6a0154762895b4f1f4cd9ca74_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf473a0753b24a40bd69716fc04aff8f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5313c9c8ef254fd3990dc4af6888052c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iecda6a96704c4e55abf2859375ea8c57_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cnc:RestrictedCertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie5a4abd7dcb44577b824de2cb64ccc35_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cnc:RestrictedCertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6eb00ce8440f4809aea66ea9110d64fa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cnc:RestrictedCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3fbea513469f43a3b9e290efb35c514f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cnc:RestrictedCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if9983f6fb6634358b6dacbf534d64ca5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i26daba9ff8ae466cb9021364a5170509_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0f21479b9405481aaa26f40d779ddb4e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icbcf20613be2440d8fe8fbcdc3292971_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i62cd5054218c428380088f2fb37a4a38_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8a80b9a6c7ea417db21376c703ac065f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i20374a9ab1a44d948a3ce54237e30bae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifff1bb111f3d44fbbc41cd705208898f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51d11822d99c47479c5a2eb3e89364a4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04e2a006b9ac457da4ba57b86f6e47ed_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">cnc:RatedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">cnc:InvestmentSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExternalCreditRatingByGroupingAxis">us-gaap:ExternalCreditRatingInvestmentGradeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idb1c5e81b8794292b604efa3e3607763_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i556fc29a81414ce8a1faff7d6b5ca940_I20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:CircleHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="i4603a3c3a78b4cf6befa775abe6f9136_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:CircleHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i90289acf8f4c42b891561c01ab371852_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:CircleHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i06e20193ad1d4a6dbe47803672976cf0_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cnc:RxAdvanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6dfd24ddae8241599cc88560c625724a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0c52ea456a784db98386d3d5e55fe44a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f801e952ab24058bc3bbd7e74346274_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d47874d2cff447d94764455a4adb274_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibe885a414a174f139a113b8c48656f0c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ide98fb1c086841bba65730c9e9d0e5c3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5739f0204cdd40bba7cfc286758eb99d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iedfc351c3aa441b898074cff9cb2f90d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i825be3c8cf254b448365fca017922b84_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8356e0b9cfbd4b0db5eae0058bb52f71_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i127bbbf2926f42efa993800b43144c0b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i27d15395c0854bfc84fc70f257308756_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i97902e8b6d3543a38beee90270b3e1ff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2d86972bd8ff440db8e9af798cbcff0d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a7ebe084b2d42bd9909a9b07d2e00f6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia09367fbf6484c039eeb488ad6dcf554_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idadbc4c70fb443308a1c36faac206d9d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if05e29f0742c42d1ac24bff7df962924_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6425ad722cf84deabeab468c2d10b6a0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia457c3f6b68a498ba18886372c07c24a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i194a19a31fe840fdb6c8c759266afa3b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6634f441212f425fbe5da6bca4e48783_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i153a782b2ac745db920b4785f8268200_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5e9cd9d12c3f43ec9d70ee7e0d8076c1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6477b8c63c58454499074d398a80a373_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0f9e3a31c01942a391fbfab0d89c3f8a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icb29efff83384a97be4e90505f07645f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic16bff1ee9254c80a89f582ee2e9b3d3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic86ea1d5b6dc44f2af63bb7d314c17d5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1bf59ef98b1545adac077505ac7e83d0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib5c115dbb53c47ffa08fb896b39bd7b6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i39665844725c4209a15066dc801d7fe6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8282158849cc4f238ec41de28faa2d35_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ied071109707642119601cf0ea5c86d13_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i82eb3754c9b94d449778e6b6e63c6591_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifd47e5c8ab1d4ffa93389f360a448165_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a73e4388fe442ff84fc2ffc6a2c6266_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e0d2df27c5e4c51a64b0329476580fc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id72eb9f8ac6f4c728bdaa099f9836385_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia1cff2bd501f465094c089dec54779c4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i426b68aa333f427d93dad8edc44dcfab_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id30239d3660e4d4e85eea70a9128120a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib614a9b3d9dd414cadb853523d634e9c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if285b05be18e4ded8654557403239a51_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i249d2de894e0473fb963ddd614601836_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i245f71d6b43543a69ba7ea32da0f2548_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1fa6f8785ba04ad2bb2c6f69131c343b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i74784b40d1ef48b4a3940d2a5c85d9da_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2d30f208873344438005137cb7dcd673_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i463216755f0b40bd89cd2299509f861d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2cd578a7ae594d1eb11c60355e3eda18_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i100fd78a36ac4838b8fdcf17fc398935_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3a41716be165442ebf2bc3d198eeae9e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibcb39c9bd51e4ed3982382b5190d3215_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i35ee59d0ad594d20a7367f83c5d42181_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib6f446cc848c4d8fa4602eaa87f92478_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib02b7ea5d28e49ecba973f7748fd0c3a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i59b0c1e5f1b94a69a226785725883c7b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0768ba92b27244339b1a4a4e64b0bd8a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iedd975f60e2e4f52bb7a01b3588ba5d8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i187b2a05bec94d17b6890569f214fb4e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id146c5c9a6ff4458bb147ee4d06bcceb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if6480f6a8b344d4da26190ba7e2b134a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idca2cbb365924fe08d1fca9331f9da1f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1d9e0273ef794fc09e5b2df846ddc972_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2aed0c146004449ae3c852aea7d1b98_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4826ba2c9157409bba218177c880c8c0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d7b7c7689844e74893cf79348121605_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32d48e9a7c194db7a29153a53ba29a2a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b3b2780690e461ca82dd12d2d5dea77_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia002a77fe35d43898743d9977eabc858_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7e5d0bc94d8549d38b7acb1bb04d6f9f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie109b7ada8cc4654be6dcb72b936b2df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1fb9a57293054024a366990a739e6596_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3597245e7cf440a7a7ae6ac45addecab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id22add844f974bf8b07a30cbc2cefe30_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaf8cebd612ae46269efac158f2dd98f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic527e2e72ab14196892caa07ca0316e6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i71fd9e78e4214b78976cc93ea78ffce2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d746bbdd1cd469ea1b06db720fb369c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if17efe1115fb48509286959669ffc628_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i625be35b035e4450b7053b827871d006_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33f404899e1b4c598c4445ab4bd72151_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04c7968a4f2a40c6a44dabd77d8b77e6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2c93ff1086147fe9a512996471b4758_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9816bbb59837427d84449a8fd8eb65cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia8115e874d4641dbae3a0cd214707412_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i38d0ee4467e84cb3835ebbfe019c4b73_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb9927142500410bb4d9ae681347e21a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30c71d0c43ce416697a4a799bd7c4d1f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf8c88bbd7e141e7b68274a9caaec1aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5950552df0e54a939965751bc3cd51fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i130febd9b4734349a2f8f9936469e9c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie8bae7a6f996464ba2b7a6100620166e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d506e3cd8b44e8ea7ee6f72aa813850_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2a87d5a6e486446c962961764c10fbe0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9edce9fba80c47b48d09fea184945683_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5dd964793f9f461fac181d8ef8a81d1b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5ef9ed30634649e4b045916294d297c9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30cf143adc074a69bb21722cf2cc8d97_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i367faaa9b8c24d72b8fa062cc2dd99ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifcd5875603574767bf2ff59bc4998ce3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifaf506fcaacf4a9c9bf01628e13c738c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2df834d688e1427a96aae1a432497373_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9a410191f824e1d812f6139c4125641_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0ac8c808851e491b96fe0b5a20350edd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8600bfef99244855ad7eb86ab1559616_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6bdb686a074e4acf9ab3712cd681a240_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia685ebb6c459475f8ad0e6a8307326bd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02f6517e534d4e87a32cacd9b1d43a6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ife540dc14d1e40cab44feeb7eef313d4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic50a20d112914cc4ab63d1807d98ab0a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i961947f6659e41f1bea8348eb926b5a0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib15d07215a9d4d18aff3f2e340e78ee3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if8802b984efc41ec94e160ab0bbca2fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i118155f938754467a285e3cd573f13ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia00f1e5c743a40a290330dfdc47180cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i984f2728edad403096ab760c7297e528_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec7c0676d1274e64a619cdde89d6aa4f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1f91cce64b3471488b001aaa80a426d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i36b0789820344a6381068e7895a8cc6b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia19da1ea96814ca79e2518469b123c9c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65e7424994e04f29bb2b11d17ca82c2d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i216cffbfe6cc49fea999c1a173ee7d01_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i48bf1c0bd1314a1c90835a095147262c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ife87f5c217a845f2a51cd1c4a41ade32_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f2e4216a4ce40698cac894107c3c948_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8b936995e0d14a0e9066d6970142374e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i11d6455065c14916bedcc4b31887f1f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cnc:ComputerHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if190281df1454b0d9f5770396612743e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cnc:ComputerHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b6b990671ab4dd8acf8fa985ca2d4e4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i100a54adfd364d5fb0858e40985a6181_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73c2a614f2d145f98965ad96053b0c7e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cnc:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if22e34d79ca74c90b70c889d03c57bff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cnc:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i06f29161405549d4ac55bc80cc166ac5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib38956abc3fb4d8e8499d7bb2fe5d94d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29be61bb7bd449499dfb1c0c4a885854_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cnc:RealEstateOwnedAndRelatedFixedAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie3a179811ece4f09918f2e0f0934aad0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cnc:FixedAssetsLeasedRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibe9c3a7c196249c9a9c9c18973bfaf0c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3600301874b74a97849c262419053cdf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6447d75d16c04ef5b131401dd27e366b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id2bebbc40fd54b4b8b61324fc370f6f6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i92213e6837f747a4af84a01d94d1a0e5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ebf3857ac8d4d779658871d0f01e499_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1a0d132e8b0f4c5e9eabdf2f63c857e9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i181e950b83264a488f15aa5b9518e0ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7849ad351f3a4c2c85f3c60fa5e30c67_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cnc:FederalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i328ddde551924916887c2898ccb4dd3b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1d16b33d8c444b8481c9b42434c97635_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03902f10bd8f4acb93c88c3d43810400_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i58a9fd19cada4c13b08e45b396931905_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9b18a16cf3a0445a91bf4830e4787fa6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i16afdebec9994bc7a8b3f04e5c78b0d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e59224fa1b1425dae4c36a43f5ca733_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib287146fc44b4771b7ffa29552be6cfb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia1efb4143fcd4b1aaef7a1ba3c72805f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnc:ProviderContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4cf15dae4e23403b853ee515df157fa4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnc:ProviderContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i77a6398252454629906ae6fadb232df2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnc:ProviderContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i49909ff543254622b7916b96f58bad77_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnc:ProviderContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7e453e9028df40d18c170e5c715a855a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if1db28c738ca41c9b8de3081714dc705_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia59410e42a404d6697fe2e242a44ea5a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i46026d8e014347bd85d04fc8a7960c3c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i73627a9d2f3f4c7890caac11b561d45e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id73d46c1711b4b3da426964338d0f2df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i19d7002bf5504374ba94620ad1f9d850_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifa9b52eb00894da485bfb964ba7dce6c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic0bdad4169ab4f599480c131c7206ae1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7d2f58523cb7466b8aecbc8fdbe138a8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i41b58c91b23541a8a008f29061d225c8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieedd2924db2741fca6d7ee512adc93cd_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if59e715c4ba4443c81f2e83328a8a425_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2500Million425SeniorNotesDueDecember2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if498067e62854af781939df76fc7b035_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2500Million425SeniorNotesDueDecember2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id75e90133d6e4c55b389cae1596db986_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2300Million245SeniorNotesDueJuly2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2b3779cadebd4a4a8a5ddcba3d40c0d3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2300Million245SeniorNotesDueJuly2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i250c45b9e6554e22b18804fe0e46eccf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A3500Million4625SeniorNotesDueDecember2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i93f572be795842d992415254cf1b1974_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A3500Million4625SeniorNotesDueDecember2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd89fe164f074e05acdf55f863fcc0a3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2000Million3375SeniorNotesDueFebruary2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iae25ea5bc64c484ebad2cc5c1bc36113_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2000Million3375SeniorNotesDueFebruary2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i078d28b9b7034dd79780964d934280a4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2200Million30SeniorNotesDueOctober2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1f64aca31038437e9b59b40bd0c68e62_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2200Million30SeniorNotesDueOctober2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id1b9e385a1ff409aa6196f98517e19f0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2200Million250SeniorNotesDueMarch2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia0e4077697e84a6aacad32e78a712191_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2200Million250SeniorNotesDueMarch2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i78293ad1cf844c17be18714b5b518d0d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A1300Million2625SeniorNotesDueAugust2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b35f9af5214457fa8305485b8f5f80b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A1300Million2625SeniorNotesDueAugust2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3889e7dc9b3e43e2a89701b5ac996351_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0c97fc5b57a3422fa0bc98e9660b7eae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i86309d5b4d1e4ad9b29778c622cf58d4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic251ef2ec19d480a85766f384559792b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if6e2a887cb3d462b82d112eb5f97f89a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoanPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifffd6515bcf049398572bfc7345e86dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoanPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7582e6a18d214d5683a70f95e9969290_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">cnc:DebtTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditAvailabilityConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">cnc:LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i197f99f81f0748d8ba59ab12609ea196_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">cnc:DebtTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditAvailabilityConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7fded93a3db84d59b9c64760d9785611_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">cnc:DebtTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditAvailabilityConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">cnc:SterlingOvernightIndexAverageSONIAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i71b9b8cb331c423a90a34a1f496e8463_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i474329559a594a6db005b911431a9b0d_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i15f1c30fc6e14d85b699a2ed36b96775_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibc4208797a9b45e58c4c6d017a4605de_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2200Million250SeniorNotesDue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="i5b0acc9d6b8245e5961cda862a186a59_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2200Million475SeniorNotesDueJanuary2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="iaf49d7094f0e45829152639ae4685492_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A2200Million475SeniorNotesDueJanuary2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i055c199b26fc4eaaae9f9b983763a177_I20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A1800Million245SeniorNotesDueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="ic5a2e2fdf251412ca928d6700728fd1c_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i6f91eaa1ade34d99a4b37902e16b46fb_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A1800Million245SeniorNotesDueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i9a76b04856c549278fbebee384e77959_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A1300Million2625SeniorNotesDueAugust2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i2af47f4133f54a42b12356bc6030758a_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A750Million5375SeniorNotesDueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i5cf2b5d34cdd49e092806cd5c281dddf_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:A750Million5375SeniorNotesDueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i628d01f64b184de1b7b5efff1732a9d8_I20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="ie7b1ceee886645d6a8088bd5d3047f69_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i9533de2ead4446adb1c44eb2cb595111_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i512923a399a94c85a9f81f1c02440f82_D20220331-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaf8926fc8ce441d596b2ad6011782776_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ForeignLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i300c0cc925174961aa324cbb7cf6b0ad_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ForeignLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i7421b87407a64ef3a02518501627c5ff_I20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="id87680544d5e40f493d0ad0a03ad37db_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="iec2cac8396b94542a2646f54a9d68328_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i2a40221e9a2a4afc802c9416ad92a8cf_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i6b51f86196b74c5d81b9dbbe890e9cd5_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i68f6f5e3a4564d01bf741fa247876509_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="icaf48712843846db970ca72f1062bb57_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cnc:DebtInstrumentPaymentPeriodAxis">cnc:DebtInstrumentPaymentPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i0ced5abd56064636b901e0fb233dc37e_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cnc:DebtInstrumentPaymentPeriodAxis">cnc:DebtInstrumentPaymentPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i09c848e42b694dbdb1f15b4c4e6aa8d2_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cnc:DebtInstrumentPaymentPeriodAxis">cnc:DebtInstrumentPaymentPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i177a913a1fb447848f07559f4f84f998_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9b3d244dd3854164a91cb86ed9b12891_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i07f12668f2cd4f52a84d59666eb6d3ce_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnc:TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6086520b355b4f8cbc019750e6f19c0d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ieb5e31256d79442d9db9f7a1fd150824_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib9edeffc055d4939acb82ad908f07cbe_I20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoanPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-31</instant>
        </period>
    </context>
    <context id="i7a8103ddaf8e4f1baaddc98a488f091f_D20171001-20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoanPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-10-31</endDate>
        </period>
    </context>
    <context id="i1aefa7ec1d0042b6a41fc0a03595d12d_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoanPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i96f3204307ae4fdfb13dc11441d5072d_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoanPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i1e6dc3e560e84de0a5d2f02722587893_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoanPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i7ca911cb3026492eb537e47263364487_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i68ee5cfa5b3041a9aa1e9d4f1e223aa1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0b502a06d63b40bebe5407d59dadc678_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:SuretyBondMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibdb10359bdf9470da1ce1cc23be870ee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2972405604564d108b785acc0e0173ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icd22c4115d4947d6878c9e6781a372d1_D20220601-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7b616f4f2341472dbd385786d0a01c38_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ief504e0f21434c29b6eea0887f48d0e5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cnc:AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i29cb5a3f49f1494e8f6826eff1bd9010_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cnc:AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="ia6584fae5af246acaeeca245d13601b3_D20221001-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cnc:AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ide855c65da574e12a7000a0c1c5d15dd_D20221001-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cnc:AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i798439eca4864894a14ab00bbc412860_D20220701-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cnc:AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i7b5a6df0e62840ec938274ece6e23cb2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2cf082093f37453aa852faade614d285_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5bc71fec53d748409f78d934b69f1f56_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if8a8cf81a11c41a893d0995455479cd6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cnc:EmployeeStockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic9f4a1f99a204f11946360404ec006fb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cnc:EmployeeStockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2e3759b9cf8a44728c767939b67b86ae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cnc:EmployeeStockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5dd496b069e94c7f84fc2916ec5f8a53_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:WellCareHealthPlansIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cnc:EmployeeStockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i411fcfa45e664b36954eea6f3adec1d3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:WellCareHealthPlansIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cnc:EmployeeStockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i544615d6498841d8b5bd747233c5fb23_D20200123-20200123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:WellCareHealthPlansIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-23</startDate>
            <endDate>2020-01-23</endDate>
        </period>
    </context>
    <context id="ie0934fe54808484a9ec9bca372c35cb2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie1d6506c5c5d40a788e453632be65da8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i10545d0936824fd6b5972c4e49790df4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i565504036a2e459fa252e3436ba28dea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">us-gaap:SettlementWithTaxingAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i710e1a1e967847a5bfd25febe427afbe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i660d37afc2d64a069401dc54b4c69ba9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id4e35ffd327d45e280e358485568b79f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia2c6097d9fc34e458585987bbb311fea_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i96654801b9964ae2b8f134e8859eac41_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7772399e744a48908f193c434d6d6a34_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4e6ac045f07846a0a20f759b986b78a4_I20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:PurchaserBusinessGroupOnHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-04</instant>
        </period>
    </context>
    <context id="ic47ddeb6bff94082ad9cbbcb46104c2d_D20220104-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnc:MagellanHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:PurchaserBusinessGroupOnHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-04</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i56eac86dba6e4053a7ca2c5c5581989e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6b9698336fd64b6e87b61c763e298e1d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iddb3faf7d44a4e5c8ad7bb4b13280732_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="if0872678e89e4daeb40637a4f74959f1_D20160101-20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="if0c316f54cfe4b9fa7a39964c5a1d5f0_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentServiceCenterinCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="ib82f610c9738480cb8bbbc7d5b5a8247_D20160101-20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentServiceCenterinCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="i892f84f1e688414fa51beaf4c47f0a87_D20160101-20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentServiceCenterinCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="ib2a9aa63979e4693b2198d2bf9cbd715_D20160101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentServiceCenterinCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie8e887f935d34e8aa8685f28daf85a31_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i422ca41ca2bc487dab910fa58cd7b380_D20160101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i87ea845a685c481cb90b1ac715f64443_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie4d87dee1a254093b133d2780a8d3d4f_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">cnc:LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="ie10b1c36a39645fd98b8f6652a9ea7aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1408e06a90864ff9b0dadeb355581288_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id1c2cca7f4f74960a51897309069b67d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0679197c607142fab0cde5bfadf6106e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5edc68c239804a80814acb778ec0cec8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i81fb523ea67d40f5940533702a20d4a3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6897fe7f407348408f329013f91d65d4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i597b4c195cb04959abb207f4c5a9d77b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibdc35ca45e39441388aa8777389f4f17_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibfc51f1798d2493e9397d897df02b75d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8c52c3388e80478599272c3d556863c1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i73a2cbaeddfd400e90e0ac804c3f053d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i08f2668a7ad14973b713bb5cfbcf8727_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6991fd72507b46dc832dd05186288635_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3fd30ab791664c4f9c22d79dbf638763_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7155450c86684d8ba820c2c57095f767_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i06642903404e4397841d66d835b14359_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if516d478048c4636bd145efe65e63d37_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i51a6cef996834ef6bafb08a049d5359c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cnc:SpecialtyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0152a1872d414c68a590ec9403c7ff34_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0033f462240348c2a7b3d5fe00b22f47_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4f75ea8b064c4d4a8f2d206bf5351a9c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i41f276fba4a64c09ba22940633f73652_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001071739</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>cnc:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="position">
        <measure>cnc:position</measure>
    </unit>
    <unit id="claim">
        <measure>cnc:claim</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="newemployee">
        <measure>cnc:newEmployee</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl80L2ZyYWc6YTRjOTIxYWI2NzgyNDE0YWEyZjdjMTZlNWI2NDE0MGIvdGFibGU6MTU1MTlkNTFlMzhlNDI5MTkzOWRjZjlkOTU3MDBhZWUvdGFibGVyYW5nZToxNTUxOWQ1MWUzOGU0MjkxOTM5ZGNmOWQ5NTcwMGFlZV80LTEtMS0xLTM1NDAxOA_9966e243-dea5-4284-88f3-579d4dc2eafa">0001071739</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl80L2ZyYWc6YTRjOTIxYWI2NzgyNDE0YWEyZjdjMTZlNWI2NDE0MGIvdGFibGU6MTU1MTlkNTFlMzhlNDI5MTkzOWRjZjlkOTU3MDBhZWUvdGFibGVyYW5nZToxNTUxOWQ1MWUzOGU0MjkxOTM5ZGNmOWQ5NTcwMGFlZV85LTEtMS0xLTM1NDAxOA_db508322-3c6f-4768-a48d-0c9e032b38c8">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl80L2ZyYWc6YTRjOTIxYWI2NzgyNDE0YWEyZjdjMTZlNWI2NDE0MGIvdGFibGU6MTU1MTlkNTFlMzhlNDI5MTkzOWRjZjlkOTU3MDBhZWUvdGFibGVyYW5nZToxNTUxOWQ1MWUzOGU0MjkxOTM5ZGNmOWQ5NTcwMGFlZV8xMC0xLTEtMS0zNTQwMTg_5daf5fd1-f1fb-4b7a-986f-0741227dcc2e">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl80L2ZyYWc6YTRjOTIxYWI2NzgyNDE0YWEyZjdjMTZlNWI2NDE0MGIvdGFibGU6MTU1MTlkNTFlMzhlNDI5MTkzOWRjZjlkOTU3MDBhZWUvdGFibGVyYW5nZToxNTUxOWQ1MWUzOGU0MjkxOTM5ZGNmOWQ5NTcwMGFlZV8xMS0xLTEtMS0zNTQwMTg_57ab3229-b9fd-4e80-b708-b1d0d0b38969">false</dei:AmendmentFlag>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzEwNTE_c9c93204-9871-484c-a20b-e44dba7e3ac9">http://fasb.org/us-gaap/2022#OtherAssetsCurrent</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzEwNTg_296f7fee-e19d-4aef-8f1c-7793183430b5">http://fasb.org/us-gaap/2022#OtherAssetsCurrent</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMS0xLTEtMzU0MDE4_199e3251-c3e9-421e-aaf9-eda971b806fd">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMy0xLTEtMzU0MDE4_25d5eafe-3f10-47e5-a022-23bca263c61e">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMS0xLTEtMzU0MDE4_53c5f53c-16be-4589-801c-7882d412dd63">http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMy0xLTEtMzU0MDE4_ca13f2de-0327-4128-b4b7-a1cf2eacc73a">http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMS0xLTEtMzU0MDE4_f7d03d1c-fd2a-4fb1-b8d2-c6a9e69f4553">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMy0xLTEtMzU0MDE4_83602f08-9569-4028-8eb3-50c7d80f55b9">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="ibdb10359bdf9470da1ce1cc23be870ee_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzE1ODI_9a1af50d-4299-45b3-b023-ef6bb807076b">P1Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i710e1a1e967847a5bfd25febe427afbe_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTA_555f768d-bd53-493d-899f-ffdf3d5a60f0">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id4e35ffd327d45e280e358485568b79f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTg_0f5667b6-1669-434f-8a62-05af54a230a9">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia2c6097d9fc34e458585987bbb311fea_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTg_d969fa16-d3ae-4cf3-a934-197b9b0e25e4">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTk3_02b56393-aaf6-479b-8dbb-38d35f8329ac">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTkw_5eba0293-94e1-4147-963c-f42791f79b1d">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV80OTQ3ODAyMzI4MjEy_ff1f2b71-f00c-4f9f-8e44-13138fd9a50f">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV80OTQ3ODAyMzI4MjEy_1b8204dd-3708-44d5-a7ac-84bad9f8c5ee">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTk5_023e7351-ba4a-4860-83f4-10ac7357905e">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTkx_6af76cbc-1c1c-407c-ae41-243cf08cd895">001-31826</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTg2_99cae993-dc5e-4468-9dd5-d5a212d3407d">Centene Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NjlmMGRmYTAxOGM5NDBiN2FjYmJjZWM5YWUwNDlkNDUvdGFibGVyYW5nZTo2OWYwZGZhMDE4Yzk0MGI3YWNiYmNlYzlhZTA0OWQ0NV8wLTAtMS0xLTM1NDAxOA_e8f4d215-6eb0-4df8-8aae-06b7f20d224d">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NjlmMGRmYTAxOGM5NDBiN2FjYmJjZWM5YWUwNDlkNDUvdGFibGVyYW5nZTo2OWYwZGZhMDE4Yzk0MGI3YWNiYmNlYzlhZTA0OWQ0NV8wLTItMS0xLTM1NDAxOA_0a143143-0cba-4b38-bdb2-9d716540dca5">42-1406317</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NjlmMGRmYTAxOGM5NDBiN2FjYmJjZWM5YWUwNDlkNDUvdGFibGVyYW5nZTo2OWYwZGZhMDE4Yzk0MGI3YWNiYmNlYzlhZTA0OWQ0NV8zLTAtMS0xLTM1NDAxOA_680fed11-f4c4-4a75-a059-88e645121efd">7700 Forsyth Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NjlmMGRmYTAxOGM5NDBiN2FjYmJjZWM5YWUwNDlkNDUvdGFibGVyYW5nZTo2OWYwZGZhMDE4Yzk0MGI3YWNiYmNlYzlhZTA0OWQ0NV80LTAtMS0xLTM1NDAxOA_0925f4e3-47ab-40e2-938d-aa286de01e56">St. Louis,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NjlmMGRmYTAxOGM5NDBiN2FjYmJjZWM5YWUwNDlkNDUvdGFibGVyYW5nZTo2OWYwZGZhMDE4Yzk0MGI3YWNiYmNlYzlhZTA0OWQ0NV80LTEtMS0xLTM1NDAxOA_024df02d-b75a-4156-8de7-9baef248ab15">MO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NjlmMGRmYTAxOGM5NDBiN2FjYmJjZWM5YWUwNDlkNDUvdGFibGVyYW5nZTo2OWYwZGZhMDE4Yzk0MGI3YWNiYmNlYzlhZTA0OWQ0NV80LTItMS0xLTM1NDAxOA_de074009-d796-47c6-94f1-0bbd3c8ac5f4">63105</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTg3_5cf55909-4be2-4345-8edb-9bcfbaad2be5">314</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTk4_a1718823-8299-41ae-821f-5a3622cc6f64">725-4477</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NzVhOWE1ZDcxYzVmNGU2NDkzYjM0NGU3MDk4ODc5Y2YvdGFibGVyYW5nZTo3NWE5YTVkNzFjNWY0ZTY0OTNiMzQ0ZTcwOTg4NzljZl8xLTAtMS0xLTM1NDAxOA_bc65cfc7-206e-4051-8b98-1a03a76f51b5">Common Stock, $0.001 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NzVhOWE1ZDcxYzVmNGU2NDkzYjM0NGU3MDk4ODc5Y2YvdGFibGVyYW5nZTo3NWE5YTVkNzFjNWY0ZTY0OTNiMzQ0ZTcwOTg4NzljZl8xLTEtMS0xLTM1NDAxOA_255a4c80-7859-4d8a-a40b-2f143968fa9c">CNC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NzVhOWE1ZDcxYzVmNGU2NDkzYjM0NGU3MDk4ODc5Y2YvdGFibGVyYW5nZTo3NWE5YTVkNzFjNWY0ZTY0OTNiMzQ0ZTcwOTg4NzljZl8xLTItMS0xLTM1NDAxOA_b946111c-3a6f-46b4-9308-9e641d4923cb">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTk0_d558ec85-3a18-41a5-9f68-e1e8aa1a3b55">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTky_208e0884-4fef-496d-a0fc-ee52d969c78b">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTg4_6800e6d5-9143-4c72-ab50-b218809e0944">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTk1_5d036af5-9bd4-4d05-92a2-4a3b91c1f48b">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NzRmZjBlYzA1ZDliNGM5NGJlMDg1NzM2ZmU1ZGJlOTEvdGFibGVyYW5nZTo3NGZmMGVjMDVkOWI0Yzk0YmUwODU3MzZmZTVkYmU5MV8wLTAtMS0xLTM1NDAxOA_db932fc5-9696-4490-8b84-a6e3773661ad">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NzRmZjBlYzA1ZDliNGM5NGJlMDg1NzM2ZmU1ZGJlOTEvdGFibGVyYW5nZTo3NGZmMGVjMDVkOWI0Yzk0YmUwODU3MzZmZTVkYmU5MV8xLTMtMS0xLTM1NDAxOA_5d87eb1b-a4a6-46d5-9cac-012d5791289c">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGFibGU6NzRmZjBlYzA1ZDliNGM5NGJlMDg1NzM2ZmU1ZGJlOTEvdGFibGVyYW5nZTo3NGZmMGVjMDVkOWI0Yzk0YmUwODU3MzZmZTVkYmU5MV8yLTMtMS0xLTM1NDAxOA_63979e36-5292-40ae-9b79-65718680518c">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTg5_e71b648d-8ba6-48c6-ac45-bc6a0724aaff">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTkz_02e73f11-45d2-4727-81d9-50fd8708d54d">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i04652939d67241d39001577da981b842_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8yOTA2_010aec79-74d5-43aa-80da-a0d8e0154f3f"
      unitRef="usd">49200000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ie567ad4d3dfb4202acf278d4fe91232a_I20230217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8yOTQw_fe1430e8-01a5-4726-8bd3-e26e5f04fe9a"
      unitRef="shares">551264559</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xL2ZyYWc6ZWQ4Y2NkMTVmNjZiNDhiMjhhZDkyOTkxZDE0M2RjOWEvdGV4dHJlZ2lvbjplZDhjY2QxNWY2NmI0OGIyOGFkOTI5OTFkMTQzZGM5YV8zMTk2_52468cec-0222-453e-bc22-2228e74b8beb">Portions of the Proxy Statement for the registrant's 2023 annual meeting of stockholders are incorporated by reference in Part III, Items 10, 11, 12, 13 and 14.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMy0xLTEtMS0zNTQwMTg_fc7e1b1e-d49e-40ff-bbf6-c25bf6799ee8"
      unitRef="usd">12074000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMy0zLTEtMS0zNTQwMTg_966465b2-f6b3-46b9-8b08-298df70b6666"
      unitRef="usd">13118000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PremiumsAndOtherReceivablesNet
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNC0xLTEtMS0zNTQwMTg_e5dca235-26c4-4963-a75c-3b115d607459"
      unitRef="usd">13272000000</us-gaap:PremiumsAndOtherReceivablesNet>
    <us-gaap:PremiumsAndOtherReceivablesNet
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNC0zLTEtMS0zNTQwMTg_a5dbce99-b9ba-4dee-b0b4-054623bb49cb"
      unitRef="usd">12238000000</us-gaap:PremiumsAndOtherReceivablesNet>
    <us-gaap:ShortTermInvestments
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNS0xLTEtMS0zNTQwMTg_07d895a1-baf8-47a7-86f4-92ead7960fcf"
      unitRef="usd">2321000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNS0zLTEtMS0zNTQwMTg_266de068-cb56-4ee6-9f9d-511a1e3ea62c"
      unitRef="usd">1539000000</us-gaap:ShortTermInvestments>
    <us-gaap:OtherAssetsCurrent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNi0xLTEtMS0zNTQwMTg_c4be5939-595e-4046-accf-4012d0767bb6"
      unitRef="usd">2461000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNi0zLTEtMS0zNTQwMTg_4b812ef4-d98e-4938-83dd-2c5013cf606a"
      unitRef="usd">1602000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNy0xLTEtMS0zNTQwMTg_0264682a-0c49-40bb-bf0d-81f111cfd490"
      unitRef="usd">30128000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNy0zLTEtMS0zNTQwMTg_8fb20643-1ad6-4f39-9df9-66288ec7061d"
      unitRef="usd">28497000000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfOC0xLTEtMS0zNTQwMTg_3e7f6820-ea42-4454-89dd-c5618dcdb946"
      unitRef="usd">14684000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfOC0zLTEtMS0zNTQwMTg_c3f493e0-99af-465c-a8ea-850a1e289590"
      unitRef="usd">14043000000</us-gaap:LongTermInvestments>
    <us-gaap:OtherRestrictedAssetsNoncurrent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfOS0xLTEtMS0zNTQwMTg_70a52387-7725-4221-8033-8137b45fea4a"
      unitRef="usd">1217000000</us-gaap:OtherRestrictedAssetsNoncurrent>
    <us-gaap:OtherRestrictedAssetsNoncurrent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfOS0zLTEtMS0zNTQwMTg_9df4bc5e-a89e-4d2a-bc8a-d85982ed73fe"
      unitRef="usd">1068000000</us-gaap:OtherRestrictedAssetsNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTAtMS0xLTEtMzU0MDE4_fa050f43-66ab-4b25-8423-c3a5c5eab270"
      unitRef="usd">2432000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTAtMy0xLTEtMzU0MDE4_afefffee-0279-411b-b92e-dae86e55499f"
      unitRef="usd">3391000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTEtMS0xLTEtMzU0MDE4_e6c488e1-91cd-44f3-b7c0-0eb659685ca3"
      unitRef="usd">18812000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTEtMy0xLTEtMzU0MDE4_fbee738f-1b49-4012-aa0a-5f3f9fd7bec8"
      unitRef="usd">19771000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTItMS0xLTEtMzU0MDE4_6f4e55e4-6c62-4b3b-a52b-581230c6d739"
      unitRef="usd">6911000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTItMy0xLTEtMzU0MDE4_7f3090d3-c86d-47f0-8a99-73ade2a78832"
      unitRef="usd">7824000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTMtMS0xLTEtMzU0MDE4_d7823b54-939f-4bc6-b377-e5b39c2bf329"
      unitRef="usd">2686000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTMtMy0xLTEtMzU0MDE4_fe0abc4e-26e5-4fed-b796-7be7d513ad3e"
      unitRef="usd">3781000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTQtMS0xLTEtMzU0MDE4_a243075a-b462-4363-8761-8fedb8c97f94"
      unitRef="usd">76870000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTQtMy0xLTEtMzU0MDE4_ee1413c6-8a3c-4a09-a5af-269358a32bb9"
      unitRef="usd">78375000000</us-gaap:Assets>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTctMS0xLTEtMzU0MDE4_aa7ecf64-35bf-4cf2-b13a-77197b8f71f6"
      unitRef="usd">16745000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTctMy0xLTEtMzU0MDE4_4b83a123-cc41-49f7-8f84-2068c5a33b21"
      unitRef="usd">14243000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTgtMS0xLTEtMzU0MDE4_94432841-77aa-49f8-a280-24a3289dc7a7"
      unitRef="usd">9525000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTgtMy0xLTEtMzU0MDE4_c62503f7-9b66-40f3-aecb-798f6277e31a"
      unitRef="usd">8493000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <cnc:ReturnofPremiumPayable
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTktMS0xLTEtMzU0MDE4_0d727a6a-ca29-4c30-a435-c6b9ea2fe57a"
      unitRef="usd">1634000000</cnc:ReturnofPremiumPayable>
    <cnc:ReturnofPremiumPayable
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMTktMy0xLTEtMzU0MDE4_08e66756-f12f-43ff-b636-cb652faa8255"
      unitRef="usd">2328000000</cnc:ReturnofPremiumPayable>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjAtMS0xLTEtMzU0MDE4_a58e2cab-795a-42e1-8018-97116944b03e"
      unitRef="usd">478000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjAtMy0xLTEtMzU0MDE4_de3a47fa-1d4d-4263-9ba5-9980cd0739ba"
      unitRef="usd">434000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjEtMS0xLTEtMzU0MDE4_11979356-d22b-4115-a38f-5ed94bf89824"
      unitRef="usd">82000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjEtMy0xLTEtMzU0MDE4_18123ac6-1fbc-4826-b2ea-63812ed3c362"
      unitRef="usd">267000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjItMS0xLTEtMzU0MDE4_216e2fd4-14be-45bc-89bb-39e4516f6107"
      unitRef="usd">28464000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjItMy0xLTEtMzU0MDE4_a53162eb-61e2-4e97-a29e-ba2d9e9d39e5"
      unitRef="usd">25765000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjMtMS0xLTEtMzU0MDE4_d899c840-54d4-404b-bc1e-3164866c6e2a"
      unitRef="usd">17938000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjMtMy0xLTEtMzU0MDE4_6b4878db-609e-437a-a670-1e7552d82304"
      unitRef="usd">18571000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjQtMS0xLTEtMzU0MDE4_740233b3-dd92-405d-a9eb-f7d11621c6e0"
      unitRef="usd">615000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjQtMy0xLTEtMzU0MDE4_b8564e27-4485-4caf-8f2a-be0120407316"
      unitRef="usd">1407000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjUtMS0xLTEtMzU0MDE4_00fc0593-ed49-4067-b199-ec8fc880fa18"
      unitRef="usd">5616000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjUtMy0xLTEtMzU0MDE4_3f9c3d61-f7a4-4d58-98c3-bf30b3ef511c"
      unitRef="usd">5610000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjYtMS0xLTEtMzU0MDE4_dfbd19b9-d99a-4118-b0b6-dd5a2c1bc88e"
      unitRef="usd">52633000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjYtMy0xLTEtMzU0MDE4_23ad92e8-c687-4990-a0bd-df9db9c0ab93"
      unitRef="usd">51353000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjctMS0xLTEtMzU0MDE4_1543b5d7-5c5e-46ad-b20a-a86a05cbe12a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjctMy0xLTEtMzU0MDE4_ddf8b36d-6bdc-4ac6-8b8c-ae699be4f50b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjgtMS0xLTEtMzU0MDE4_dddaec5a-0f5a-4e37-b05c-9da4808c4fe2"
      unitRef="usd">56000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMjgtMy0xLTEtMzU0MDE4_c5907aa3-acca-4222-96e1-1d7b0a91304e"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfMjI_888445f4-32a0-4368-92ef-364ca80825cf"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfMjI_e820cdef-5285-4e72-9468-fd6a17fde4fd"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfNDc_af888ec6-5db5-442e-9f92-f8d728a1ffdc"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfNDc_b12a205a-7dc0-459d-8857-b4fae54b6e45"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfNTg_2490bed5-fc3d-41a6-ae7e-39558272797b"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfNTg_455f80f2-805d-4cb8-9abc-597b4406a6a7"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfNTg_74c00518-70b5-4303-85d0-e80437186398"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MmMxMTBlZTNjOTMxNGQ2NGIwMjAxZWJlNDQ1MjFhMmJfNTg_98b64db9-b964-4baa-ba6a-152066191454"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMS0xLTEtMzU0MDE4_497010cc-80dc-4165-af9c-ae435c650976"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzEtMy0xLTEtMzU0MDE4_4d9e9eff-76f4-4fbc-9935-b989c5a655b5"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfMTk_05f69653-cfe2-4b83-9829-ecc85109f483"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfMTk_60c9f3e0-badf-442d-80db-f820211af5e3"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfNDQ_bc438f08-de75-4463-b6f4-2c76e330ad2e"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfNDQ_f04f5f32-19b7-425e-97e5-de239bcc26fd"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfNTU_802c9535-cce7-4983-8245-44435714c993"
      unitRef="shares">607847000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfNjk_21480e59-a1cf-4661-a8eb-866bcf1f85aa"
      unitRef="shares">550754000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfOTU_9305475e-e4df-4fa5-ba31-86667d9f4f48"
      unitRef="shares">602704000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246OWY3ZTdiZjQ5OWZlNGZlYWEwOGQzMmEzNzBmY2Q3NGNfMTA5_223a113d-e4c4-4d18-b3aa-cbc78d2419f0"
      unitRef="shares">582479000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMS0xLTEtMzU0MDE4_f0d2bf76-836e-4f3e-bb5c-fd557be0f0c7"
      unitRef="usd">1000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzItMy0xLTEtMzU0MDE4_c190e523-aa71-4618-88a0-e9e330a2730d"
      unitRef="usd">1000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzMtMS0xLTEtMzU0MDE4_74097a93-81f9-4023-9af0-9684ab2b1d3e"
      unitRef="usd">20060000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzMtMy0xLTEtMzU0MDE4_f697e4b6-9753-4f8b-9402-7dd9346fe6ba"
      unitRef="usd">19672000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzUtMS0xLTEtMzU0MDE4_b2c0d15d-de89-4585-bd25-e1426e4159ae"
      unitRef="usd">-1132000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzUtMy0xLTEtMzU0MDE4_094ecc08-f901-457f-ae7a-3430b6027130"
      unitRef="usd">77000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzYtMS0xLTEtMzU0MDE4_e2e5d530-9dc9-4678-a7ef-f2e96e77a2c5"
      unitRef="usd">9341000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzYtMy0xLTEtMzU0MDE4_9264d546-987c-44b2-87d2-551f0f415a6a"
      unitRef="usd">8139000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzctMC0xLTEtMzU0MDE4L3RleHRyZWdpb246ZGNjZjY2YjIwNTU4NDMwZWFhNmFmMGQ3ODI4OTk0NTFfMjk_6680628e-f434-4f05-a5ed-db1656a9f2a0"
      unitRef="shares">57093000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzctMC0xLTEtMzU0MDE4L3RleHRyZWdpb246ZGNjZjY2YjIwNTU4NDMwZWFhNmFmMGQ3ODI4OTk0NTFfMzY_58df2bcc-f393-4f37-beb0-cdeb06fb226d"
      unitRef="shares">20225000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzctMS0xLTEtMzU0MDE4_27d734eb-8579-4ae8-94dc-ba79f0339962"
      unitRef="usd">4213000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzctMy0xLTEtMzU0MDE4_a77ba4d2-62b6-465a-aac5-2978567704ec"
      unitRef="usd">1094000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzgtMS0xLTEtMzU0MDE4_1ed1a698-271b-4bfa-8ca3-7ddea7ce81c4"
      unitRef="usd">24057000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzgtMy0xLTEtMzU0MDE4_b724af7a-5a7d-4c1d-af4d-cfe1b218a578"
      unitRef="usd">26795000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzktMS0xLTEtMzU0MDE4_d6d50c50-90a5-40ce-8d68-daa7898a2360"
      unitRef="usd">124000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfMzktMy0xLTEtMzU0MDE4_9333f1b2-cab0-4d35-8a79-29fb736c081b"
      unitRef="usd">145000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNDAtMS0xLTEtMzU0MDE4_a3cfd6f4-5aaa-4081-8d13-1891dbb65dce"
      unitRef="usd">24181000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNDAtMy0xLTEtMzU0MDE4_ea33028b-c236-4c3a-b5b5-8d39d5445a78"
      unitRef="usd">26940000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNDEtMS0xLTEtMzU0MDE4_678312d3-c796-43e2-8266-4eadacf1d4a4"
      unitRef="usd">76870000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84Mi9mcmFnOmI4MzcwMTAwY2I4NTRkM2JiYTU1ZDY0NTBlMWQxNDcxL3RhYmxlOjY1MmM5NWU0YmI0YzRkNDQ5ODZiZDI3YjliNGE1MTgxL3RhYmxlcmFuZ2U6NjUyYzk1ZTRiYjRjNGQ0NDk4NmJkMjdiOWI0YTUxODFfNDEtMy0xLTEtMzU0MDE4_f42e36c1-3eb6-41bf-8956-7892798ae096"
      unitRef="usd">78375000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2eadcd3758bd48558b2055d1213fc6f5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMy0xLTEtMS0zNTQwMTg_4fe26460-903e-4672-9b95-ff675c671c9f"
      unitRef="usd">127131000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c83c53bcfae4452bc7f79564bebc856_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMy0zLTEtMS0zNTQwMTg_fd45b889-46f6-485c-8d6f-89d91d1a65f2"
      unitRef="usd">112319000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i85fbc70041964c1a8bd77082880bf5c5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMy01LTEtMS0zNTQwMTg_f6fd8ca1-10af-452f-ba0b-37b420fa5bc8"
      unitRef="usd">100055000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib80ff9d53361464b80c69f222a08fd78_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNC0xLTEtMS0zNTQwMTg_45f17ad2-ee65-46e0-bba0-929ca33dbcd2"
      unitRef="usd">8348000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28166a0649364f7486e28e0475aa1937_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNC0zLTEtMS0zNTQwMTg_73bacd6c-2a1e-4759-a903-f33b04d7bb8d"
      unitRef="usd">5664000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ba97cd7426845cea3497f057312fa44_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNC01LTEtMS0zNTQwMTg_f4b98192-9ca2-433a-bfe1-0801dfd9f89b"
      unitRef="usd">3745000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNS0xLTEtMS0zNTQwMTg_fc9f13b7-5490-4501-b153-04162b36a667"
      unitRef="usd">135479000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNS0zLTEtMS0zNTQwMTg_c61de2a6-5fed-40df-9cf8-bff6ae440022"
      unitRef="usd">117983000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNS01LTEtMS0zNTQwMTg_d799ace2-8642-4732-82ab-af000c1ab102"
      unitRef="usd">103800000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <cnc:PremiumTaxRevenue
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNi0xLTEtMS0zNTQwMTg_5299c610-50a6-4f6a-b354-b1d490d2bc15"
      unitRef="usd">9068000000</cnc:PremiumTaxRevenue>
    <cnc:PremiumTaxRevenue
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNi0zLTEtMS0zNTQwMTg_59e2a63c-5be7-48c9-9605-41e4d15e4cfd"
      unitRef="usd">7999000000</cnc:PremiumTaxRevenue>
    <cnc:PremiumTaxRevenue
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNi01LTEtMS0zNTQwMTg_368d9998-39d5-40ed-b257-0d07842e7e1f"
      unitRef="usd">7315000000</cnc:PremiumTaxRevenue>
    <us-gaap:Revenues
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNy0xLTEtMS0zNTQwMTg_4e206f2f-1b9c-4345-af73-0502b0bc4736"
      unitRef="usd">144547000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNy0zLTEtMS0zNTQwMTg_84f02b63-b0fc-42f3-8b1a-093327739ecd"
      unitRef="usd">125982000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNy01LTEtMS0zNTQwMTg_1863c9b5-33a6-40e2-8772-e259533a83c0"
      unitRef="usd">111115000000</us-gaap:Revenues>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfOS0xLTEtMS0zNTQwMTg_9af3e218-7f50-4031-b63c-3dc14565a0f0"
      unitRef="usd">111529000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfOS0zLTEtMS0zNTQwMTg_aa791694-e8af-49bc-86c6-4de4c5af00fd"
      unitRef="usd">98602000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfOS01LTEtMS0zNTQwMTg_ee777d47-af03-4053-8c70-2bd1daa814b8"
      unitRef="usd">86264000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTAtMS0xLTEtMzU0MDE4_36ad99ca-526f-4374-9ceb-362de60b0d19"
      unitRef="usd">7032000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTAtMy0xLTEtMzU0MDE4_f2f9476e-dfcc-4513-a569-3c33ed0a09be"
      unitRef="usd">4894000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTAtNS0xLTEtMzU0MDE4_cbb3a01d-ab8c-4dbd-a573-40ed23eb285e"
      unitRef="usd">3303000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTEtMS0xLTEtMzU0MDE4_9c37e260-29dd-4ef7-be7b-be6b3a508f29"
      unitRef="usd">11589000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTEtMy0xLTEtMzU0MDE4_1d77f7d6-c6e6-4a86-9a20-a9bf1ae18a7d"
      unitRef="usd">9601000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTEtNS0xLTEtMzU0MDE4_fff865b4-2002-4975-93e9-70632388c848"
      unitRef="usd">9380000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:Depreciation
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTItMS0xLTEtMzU0MDE4_057f95d2-590a-4085-85e1-2e2e770d3d0b"
      unitRef="usd">614000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTItMy0xLTEtMzU0MDE4_392fab8d-2abd-49fd-b519-86932b3e03b7"
      unitRef="usd">565000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTItNS0xLTEtMzU0MDE4_581b83c2-5279-4e59-840a-8046a985511c"
      unitRef="usd">487000000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTMtMS0xLTEtMzU0MDE4_372c5b98-5131-4d26-8a96-4250b69c3d7e"
      unitRef="usd">817000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTMtMy0xLTEtMzU0MDE4_98500083-244c-4788-9627-2b132aa943a4"
      unitRef="usd">770000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTMtNS0xLTEtMzU0MDE4_c09f4550-0212-4315-b1e4-570e7ca2f6cb"
      unitRef="usd">719000000</us-gaap:AmortizationOfIntangibleAssets>
    <cnc:PremiumTaxExpense
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTQtMS0xLTEtMzU0MDE4_74beaccb-3aee-4324-b260-a34b56b5a8c1"
      unitRef="usd">9330000000</cnc:PremiumTaxExpense>
    <cnc:PremiumTaxExpense
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTQtMy0xLTEtMzU0MDE4_9fd2b2aa-7a80-4173-9a18-78e065ca8693"
      unitRef="usd">8287000000</cnc:PremiumTaxExpense>
    <cnc:PremiumTaxExpense
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTQtNS0xLTEtMzU0MDE4_55e38905-1564-4d3e-8293-ce262aa1284a"
      unitRef="usd">6332000000</cnc:PremiumTaxExpense>
    <cnc:HealthInsurerFeeExpense
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTUtMS0xLTEtMzU0MDE4_96ee9d3a-1160-4480-b4fa-5c986a9fb71b"
      unitRef="usd">0</cnc:HealthInsurerFeeExpense>
    <cnc:HealthInsurerFeeExpense
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTUtMy0xLTEtMzU0MDE4_ad0ce2d2-9379-45d4-9b0d-e901086989a7"
      unitRef="usd">0</cnc:HealthInsurerFeeExpense>
    <cnc:HealthInsurerFeeExpense
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTUtNS0xLTEtMzU0MDE4_bb2b050b-070c-4533-922b-52e775217ff6"
      unitRef="usd">1476000000</cnc:HealthInsurerFeeExpense>
    <us-gaap:AssetImpairmentCharges
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTYtMS0xLTEtMzU0MDE4_cb6f9798-5979-4749-9210-5b3e4a06d550"
      unitRef="usd">2318000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTYtMy0xLTEtMzU0MDE4_cfda68bc-3e44-46dc-8bc5-c01ccb41f2b0"
      unitRef="usd">229000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTYtNS0xLTEtMzU0MDE4_a8ef76a7-38ba-430d-ab85-3c12ec136988"
      unitRef="usd">72000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:LitigationSettlementExpense
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTctMS0xLTEtMzU0MDE4_98979f25-2020-4e34-a7ed-1dd822a8c21d"
      unitRef="usd">0</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTctMy0xLTEtMzU0MDE4_d3a6eaf2-f448-45ff-bd63-2151f2211734"
      unitRef="usd">1250000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTctNS0xLTEtMzU0MDE4_8d0c2601-ffc4-44eb-a7aa-5cfa10fdf1e8"
      unitRef="usd">0</us-gaap:LitigationSettlementExpense>
    <us-gaap:CostsAndExpenses
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTgtMS0xLTEtMzU0MDE4_fa406dfc-21a6-46b8-b2a2-08753c7cf451"
      unitRef="usd">143229000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTgtMy0xLTEtMzU0MDE4_a499b5f5-35f9-4f6c-95f6-350bf70ad39e"
      unitRef="usd">124198000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTgtNS0xLTEtMzU0MDE4_aa0df5d5-d64e-45ba-914b-1af6ba64201c"
      unitRef="usd">108033000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTktMS0xLTEtMzU0MDE4_f087b011-d793-491f-a74f-657e14e6b960"
      unitRef="usd">1318000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTktMy0xLTEtMzU0MDE4_0e4f89d8-15bd-4d7b-905b-b11ea8da7eb0"
      unitRef="usd">1784000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMTktNS0xLTEtMzU0MDE4_8c8bb7d8-9781-4734-b778-2eaa8a03b687"
      unitRef="usd">3082000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjEtMS0xLTEtMzU0MDE4_3457e954-9b91-4a06-ac84-826cc462a472"
      unitRef="usd">1279000000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjEtMy0xLTEtMzU0MDE4_755b36c1-ec6e-4ee1-b45b-3fcd555151de"
      unitRef="usd">819000000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjEtNS0xLTEtMzU0MDE4_888c5387-222d-4a64-9d83-9a465390b55e"
      unitRef="usd">480000000</us-gaap:InvestmentIncomeNonoperating>
    <cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjItMS0xLTEtMzU0MDE4_aecbade8-f080-4bda-bc09-920215e11d83"
      unitRef="usd">30000000</cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion>
    <cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjItMy0xLTEtMzU0MDE4_59639112-e7cd-4147-aaf7-2d659dcd8e47"
      unitRef="usd">-125000000</cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion>
    <cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjItNS0xLTEtMzU0MDE4_36f9faab-3e74-4436-a00a-6cf1d93f7be1"
      unitRef="usd">-61000000</cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion>
    <us-gaap:InterestExpense
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjMtMS0xLTEtMzU0MDE4_942cf900-1803-4762-a1d4-6b5189371cdd"
      unitRef="usd">665000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjMtMy0xLTEtMzU0MDE4_7968da6f-0fdb-4fb0-b45d-ccf6e14f25b5"
      unitRef="usd">665000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjMtNS0xLTEtMzU0MDE4_19fcb8bf-4ab7-487a-a1b3-c444c58ef728"
      unitRef="usd">728000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjQtMS0xLTEtMzU0MDE4_9055478a-5e65-419f-befa-dbf1c8701ceb"
      unitRef="usd">1962000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjQtMy0xLTEtMzU0MDE4_d923b2d0-2084-4384-a2e3-84bde3943012"
      unitRef="usd">1813000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjQtNS0xLTEtMzU0MDE4_46775a47-5839-4a41-b495-280591e7d6e1"
      unitRef="usd">2773000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjUtMS0xLTEtMzU0MDE4_285a1714-0a9c-4bcb-831b-5fefd403e65a"
      unitRef="usd">760000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjUtMy0xLTEtMzU0MDE4_6bf85bf6-f717-4082-8db2-a88786dbd5fa"
      unitRef="usd">477000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjUtNS0xLTEtMzU0MDE4_b6857440-689d-47fd-901e-f82277f1a604"
      unitRef="usd">979000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjgtMS0xLTEtMzU0MDE4_de1e1989-69d6-49fd-93cc-d799750b10dc"
      unitRef="usd">1202000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjgtMy0xLTEtMzU0MDE4_9517b3b7-aa7c-4092-a48f-1b2f5ad80e70"
      unitRef="usd">1336000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjgtNS0xLTEtMzU0MDE4_2b945164-3ada-4308-9e65-23aaf5a34404"
      unitRef="usd">1794000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjktMS0xLTEtMzU0MDE4_6303e2cc-cf0f-437d-ba45-124996013355"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjktMy0xLTEtMzU0MDE4_0455846e-b49f-44bd-b085-7a008fc60100"
      unitRef="usd">-11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMjktNS0xLTEtMzU0MDE4_c55c6166-b432-4d6d-bfec-551c1444c3c1"
      unitRef="usd">-14000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMzAtMS0xLTEtMzU0MDE4_954bb2c4-2be6-4ead-be7a-5d7bfa61481e"
      unitRef="usd">1202000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMzAtMy0xLTEtMzU0MDE4_62b97976-d84f-4719-9019-59c9b8bb8671"
      unitRef="usd">1347000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfMzAtNS0xLTEtMzU0MDE4_4531b261-2b00-4708-ad40-84293a688437"
      unitRef="usd">1808000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDEtMS0xLTEtMzU0MDE4_729a3f95-6681-4bed-8e32-ee0eee59d62a"
      unitRef="usdPerShare">2.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDEtMy0xLTEtMzU0MDE4_30f13cb9-d4ed-410f-bd06-95c09fed3284"
      unitRef="usdPerShare">2.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDEtNS0xLTEtMzU0MDE4_9ccfdcb5-ff9e-4d71-b824-9a07cdbadecb"
      unitRef="usdPerShare">3.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDYtMS0xLTEtMzU0MDE4_59d5d2ab-21e1-44f8-9985-cb7204f42679"
      unitRef="usdPerShare">2.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDYtMy0xLTEtMzU0MDE4_6c04aca9-fb3d-45d7-b51c-eccd6bc73962"
      unitRef="usdPerShare">2.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDYtNS0xLTEtMzU0MDE4_8639590c-df0b-498a-812b-460d082b30f1"
      unitRef="usdPerShare">3.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDktMS0xLTEtMzU0MDE4_c31e101d-9980-474f-aa78-ef684ff9bdef"
      unitRef="shares">575191000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDktMy0xLTEtMzU0MDE4_870077c9-642a-4309-a112-b8788461d6cf"
      unitRef="shares">582832000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNDktNS0xLTEtMzU0MDE4_b979288c-8772-456a-b695-f16fdc3d0088"
      unitRef="shares">570722000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNTAtMS0xLTEtMzU0MDE4_51bce433-df28-408a-bccd-d3fc6e25aa4b"
      unitRef="shares">582040000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNTAtMy0xLTEtMzU0MDE4_fb4a005d-129f-4fb8-986a-58b78402e6ae"
      unitRef="shares">590516000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84NS9mcmFnOmE4MDQyZWIyOWYyNTQ0MjBiNjEzOTQ5M2ViNzE0YjFmL3RhYmxlOjE2YjY1YmM5NWQ1ZDQwODFiYjIwOGM4MGJjNWUxZGU3L3RhYmxlcmFuZ2U6MTZiNjViYzk1ZDVkNDA4MWJiMjA4YzgwYmM1ZTFkZTdfNTAtNS0xLTEtMzU0MDE4_a5d9540a-31eb-4a99-847e-d49eb7169e53"
      unitRef="shares">579135000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfMi0xLTEtMS0zNTQwMTg_929cf6d2-3919-4684-ad88-7e0bf7373fbb"
      unitRef="usd">1202000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfMi0zLTEtMS0zNTQwMTg_93e84156-93c5-40a9-96a8-371cc78c156c"
      unitRef="usd">1336000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfMi01LTEtMS0zNTQwMTg_d3e6cd1d-591c-4755-a2f5-d9c553e714d5"
      unitRef="usd">1794000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNC0xLTEtMS00Nzk2ODc_348a2a02-e023-47ac-9230-0033577ca30d"
      unitRef="usd">-1475000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNC0zLTEtMS00Nzk2OTQ_f623fe30-98bc-426d-bdda-2ea53f2d2cf9"
      unitRef="usd">-296000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNC01LTEtMS00Nzk3MDI_9a1e0d3b-1938-41c3-bb6a-8a933c6b8216"
      unitRef="usd">251000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNS0xLTEtMS00Nzk2ODc_8141ac93-f6c0-4375-b7e2-fbe716059d03"
      unitRef="usd">-349000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNS0zLTEtMS00Nzk2OTQ_a52f9bdb-aaa4-4038-82fa-d4ebd2475f04"
      unitRef="usd">-75000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNS01LTEtMS00Nzk3MDI_fa54c984-5d94-4f28-8169-0d4a304f8d64"
      unitRef="usd">60000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNC0xLTEtMS0zNTQwMTg_0514c0bb-1e64-4ee1-8e25-dc750271fb45"
      unitRef="usd">-1126000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNC0zLTEtMS0zNTQwMTg_dfe992c4-ca77-48b1-af5f-418e8fa6eff6"
      unitRef="usd">-221000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNC01LTEtMS0zNTQwMTg_85c76833-0bec-425b-93c1-963930b05f51"
      unitRef="usd">191000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOC0xLTEtMS00Nzk3MTk_ad72ec94-692b-4995-9967-2885f716e14e"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOC0zLTEtMS00Nzk3MTk_80beb991-d061-4dc9-885d-874ae91fb0bc"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOC01LTEtMS00Nzk3MTk_a11aa378-f417-42fa-8e26-bdedb8161b6a"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNi0xLTEtMS0zNTQwMTg_749a033b-372e-4846-b567-f08e59431010"
      unitRef="usd">-94000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNi0zLTEtMS0zNTQwMTg_51143a76-dc82-46a7-80df-1fbbd02a4c51"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNi01LTEtMS0zNTQwMTg_80dbf900-671f-423d-bdff-31a2aedcef35"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNy0xLTEtMS0zNTQwMTg_a9725b45-a740-4b3f-a0bb-baf4177e3c57"
      unitRef="usd">-1209000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNy0zLTEtMS0zNTQwMTg_604d7d62-d096-40ed-9931-a0e6c72f0c96"
      unitRef="usd">-260000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfNy01LTEtMS0zNTQwMTg_793a66f6-916d-4c78-9828-0b5d273a18fd"
      unitRef="usd">203000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOC0xLTEtMS0zNTQwMTg_43f7ec4b-d5f3-42e4-8a06-b9e093dcec20"
      unitRef="usd">-7000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOC0zLTEtMS0zNTQwMTg_f6d9376a-e3b3-45fe-9c3a-4412d111f4e4"
      unitRef="usd">1076000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOC01LTEtMS0zNTQwMTg_58bc6092-db22-49f1-b350-eaca826c8a6f"
      unitRef="usd">1997000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOS0xLTEtMS0zNTQwMTg_89f6c5b2-e49f-4ef9-8cd2-2f36dbded412"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOS0zLTEtMS0zNTQwMTg_1a223f47-9b45-41f9-bea5-e2492fba60c8"
      unitRef="usd">-11000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfOS01LTEtMS0zNTQwMTg_aaa5a083-42af-4ed9-8b47-ff17777be082"
      unitRef="usd">-14000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfMTAtMS0xLTEtMzU0MDE4_c79db779-37ea-484a-8410-289033a11c82"
      unitRef="usd">-7000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfMTAtMy0xLTEtMzU0MDE4_6b44fb42-9c68-4be4-a170-d666fc35b520"
      unitRef="usd">1087000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl84OC9mcmFnOjRkNzYwZDlkMGRjMzQ3MDU4OWUwZGNjZTQ1YTIyZWRhL3RhYmxlOmY5MDM3YmJhYmFlYzRhODE4MGEzNzAzNTFhMWNmNmVkL3RhYmxlcmFuZ2U6ZjkwMzdiYmFiYWVjNGE4MTgwYTM3MDM1MWExY2Y2ZWRfMTAtNS0xLTEtMzU0MDE4_3bd00b5d-115e-4da7-ae5f-9a30f5cd2b4a"
      unitRef="usd">2011000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if74f20f9672c42969aaf06d880b02823_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xLTEtMS0zNTQwMTgvdGV4dHJlZ2lvbjo5NzAwMzc0MDE3YWU0OWVmOWNjYjgyYzRjZGMzOWUyZl80_9c817287-1159-4b60-87ed-a703324f5094"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="id53035e323dd4a8a8791395cc30ffafe_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xLTEtMS0zNTQwMTgvdGV4dHJlZ2lvbjo5NzAwMzc0MDE3YWU0OWVmOWNjYjgyYzRjZGMzOWUyZl80_b3f4b1a1-decd-4274-89bc-7fedc43aff0f"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iefd78604c8af4b3eb7e7763dd317e282_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xLTEtMS0zNTQwMTgvdGV4dHJlZ2lvbjo5NzAwMzc0MDE3YWU0OWVmOWNjYjgyYzRjZGMzOWUyZl80_d4ef21a7-10cd-4e17-91cf-b5977e797052"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4b6ce4061fae4dd2bf7bfef4711d6df6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xLTEtMS0zNTQwMTgvdGV4dHJlZ2lvbjo5NzAwMzc0MDE3YWU0OWVmOWNjYjgyYzRjZGMzOWUyZl80_de6dd1d9-3691-4796-a5cd-5f7b9c82c474"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i205075141d20449391c609023aa905f8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xMS0xLTEtMzU0MDE4L3RleHRyZWdpb246MDliMjcxYjgxNjcxNDNjZmI5MzMyZTU4OWYxZmViYzlfNA_03d04c9c-45d4-440a-a8de-e7b836061d76"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i116b2020b2da4f3ea027f5a137798310_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xMS0xLTEtMzU0MDE4L3RleHRyZWdpb246MDliMjcxYjgxNjcxNDNjZmI5MzMyZTU4OWYxZmViYzlfNA_2384c785-e1e8-4367-883b-5e2f62d61616"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i22a603f1ec5a4ed6ac95d0033583c8ae_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xMS0xLTEtMzU0MDE4L3RleHRyZWdpb246MDliMjcxYjgxNjcxNDNjZmI5MzMyZTU4OWYxZmViYzlfNA_4d344090-617e-4574-aca6-39fc98420c37"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0a00c10b57c34ba7b04e400d6d51804c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMi0xMS0xLTEtMzU0MDE4L3RleHRyZWdpb246MDliMjcxYjgxNjcxNDNjZmI5MzMyZTU4OWYxZmViYzlfNA_6dfd5fcb-e166-408a-a30f-4f6f5a8d6b72"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id53035e323dd4a8a8791395cc30ffafe_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy0xLTEtMS0zNTQwMTg_95f5fbb6-f461-4257-9b36-41de3cc57163"
      unitRef="shares">421508000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id53035e323dd4a8a8791395cc30ffafe_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy0zLTEtMS0zNTQwMTg_2f79b47c-ec5e-432a-bac2-3e0ccc15382d"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i677e18bc38214dc8aa867bdadeb3507e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy01LTEtMS0zNTQwMTg_6be74d03-1be2-413f-8e7d-8936b34ebf52"
      unitRef="usd">7647000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i007f9f25b89a4328b4843c47ad28463f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy03LTEtMS0zNTQwMTg_4bd212d7-24a8-408b-be41-f763e8533b40"
      unitRef="usd">134000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i463620403a104db8bdb4789fd3025d04_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy05LTEtMS0zNTQwMTg_a77e1702-9c18-446d-b57f-8445ba8a1bee"
      unitRef="usd">4984000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i205075141d20449391c609023aa905f8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy0xMS0xLTEtMzU0MDE4_9df4ae77-c6b8-4177-9146-1ea2370f0b49"
      unitRef="shares">6460000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i205075141d20449391c609023aa905f8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy0xMy0xLTEtMzU0MDE4_d44ad7cc-8b86-4651-8dcf-88ac5213a90d"
      unitRef="usd">-214000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaab02486f5a340caa2b7a035d3d61cfd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy0xNS0xLTEtMzU0MDE4_1473ebbb-7e75-4055-94e2-0d1557afdc4d"
      unitRef="usd">108000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i89efa37b183c4c618c28149ddb506553_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMy0xNy0xLTEtMzU0MDE4_b1e19d55-d039-4b76-b626-dc8f52843917"
      unitRef="usd">12659000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i4325cafc5d4145589b2f8c8a9708b14d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNC05LTEtMS0zNTQwMTg_ee9d4b02-bc49-4e0e-847e-d79909d1a594"
      unitRef="usd">1808000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i65cbc7d56bfd4ffb861729ca1b540ab1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNC0xNS0xLTEtMzU0MDE4_78a93d30-069d-4c7c-961b-e7b74b179d9e"
      unitRef="usd">-24000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNC0xNy0xLTEtMzU0MDE4_57b35c85-e5e0-4939-bed7-2115ba35eefb"
      unitRef="usd">1784000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNS0wLTEtMS0zNTQwMTgvdGV4dHJlZ2lvbjplMDY0ODc1MzM2NTc0ODkwYTVmMDVjOTViN2EwNGNmZV80MQ_9d9e3539-fb15-4fd4-af8d-ecf57c292b0f"
      unitRef="usd">60000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i70228d9f45fe464887fc03a805d9f728_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNS03LTEtMS0zNTQwMTg_769f73be-03d1-400e-a075-62f2bcbee142"
      unitRef="usd">203000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNS0xNy0xLTEtMzU0MDE4_28c1db7a-2465-4e72-9554-2f108be5b3de"
      unitRef="usd">203000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="icbc613d20c5e4995abeaccfb2d2a2ffd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNi0xLTEtMS0zNTQwMTg_3c2aeace-b3ab-42d9-9f26-812e2aeb10f1"
      unitRef="shares">171225000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="icbc613d20c5e4995abeaccfb2d2a2ffd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNi0zLTEtMS0zNTQwMTg_62701d31-5d64-49cb-9898-696cbaaf9eb8"
      unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i6b2f9a41ae484e65bfe6464f3b6bcc36_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNi01LTEtMS0zNTQwMTg_5dff4120-4f6b-4665-9948-1a54ecc9069c"
      unitRef="usd">11526000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNi0xNy0xLTEtMzU0MDE4_3199d03c-3bc9-4f0b-a8cc-e7b2f95a670c"
      unitRef="usd">11527000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="icbc613d20c5e4995abeaccfb2d2a2ffd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNy0xLTEtMS0zNTQwMTg_7a38f437-d3f3-46fb-b24a-26f58e4f93ea"
      unitRef="shares">5923000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6b2f9a41ae484e65bfe6464f3b6bcc36_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNy01LTEtMS0zNTQwMTg_bdca7777-e4a1-4e94-a4e4-19395250d62b"
      unitRef="usd">29000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfNy0xNy0xLTEtMzU0MDE4_6a5ff2aa-1e60-4ffa-9873-3b8a8439eeb4"
      unitRef="usd">29000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="icbc613d20c5e4995abeaccfb2d2a2ffd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfOC0xLTEtMS0zNTQwMTg_afe9b4fc-1c9a-40d5-b76d-357b58806fa4"
      unitRef="shares">407000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i6b2f9a41ae484e65bfe6464f3b6bcc36_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfOC01LTEtMS0zNTQwMTg_ea92c279-1002-4092-a986-4582182aab95"
      unitRef="usd">24000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="if18a7a7ccfa44c02a607ea5b90c04d27_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfOC0xMS0xLTEtMzU0MDE4_e5cf048e-3c08-4752-92d9-0c0133eebc51"
      unitRef="shares">10310000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if18a7a7ccfa44c02a607ea5b90c04d27_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfOC0xMy0xLTEtMzU0MDE4_518adc38-bf37-493c-994e-5468211b9fae"
      unitRef="usd">602000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfOC0xNy0xLTEtMzU0MDE4_482b3367-df94-474e-a25b-3f1a4ec2a553"
      unitRef="usd">626000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6b2f9a41ae484e65bfe6464f3b6bcc36_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfOS01LTEtMS0zNTQwMTg_8cff3017-235e-42d8-9290-e305fe9c3499"
      unitRef="usd">281000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfOS0xNy0xLTEtMzU0MDE4_d4ad71d9-02db-4cf4-9740-76e96ea9fad7"
      unitRef="usd">281000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i65cbc7d56bfd4ffb861729ca1b540ab1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTAtMTUtMS0xLTM1NDAxOA_73a4c834-2ced-4e06-9400-c16ef0cc3f61"
      unitRef="usd">28000000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTAtMTctMS0xLTM1NDAxOA_ac8825bb-58ae-4712-8653-651011ae6168"
      unitRef="usd">28000000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4b6ce4061fae4dd2bf7bfef4711d6df6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItMS0xLTEtMzU0MDE4_0dff45a5-3068-4910-b6f7-db8c97eea00c"
      unitRef="shares">598249000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4b6ce4061fae4dd2bf7bfef4711d6df6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItMy0xLTEtMzU0MDE4_e3f52be4-6284-44b1-971c-6b4122510c88"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iddfa338597904f0eba0c96789f0d0ed5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItNS0xLTEtMzU0MDE4_1febaea9-05f6-4a00-9ca7-65373fc490fc"
      unitRef="usd">19459000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib2fe5e0012c04cccb9b042e45cdf6198_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItNy0xLTEtMzU0MDE4_e1add0cb-c958-4aac-8c95-d1b96aea6d6e"
      unitRef="usd">337000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i75d4d36b1dce42f98b2a5b7237c1773e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItOS0xLTEtMzU0MDE4_dc66cd8b-21b5-4391-86e3-0d1420ab292b"
      unitRef="usd">6792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i0a00c10b57c34ba7b04e400d6d51804c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItMTEtMS0xLTM1NDAxOA_d286f3fb-a0b4-47f6-9774-0105402f5387"
      unitRef="shares">16770000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0a00c10b57c34ba7b04e400d6d51804c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItMTMtMS0xLTM1NDAxOA_e4cee386-a1da-443b-85f3-15f9c57772b1"
      unitRef="usd">-816000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i43b316ad31204bf786dbb981cb93be17_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItMTUtMS0xLTM1NDAxOA_d59b86b8-96dc-4644-b611-9fa58ce628b3"
      unitRef="usd">112000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTItMTctMS0xLTM1NDAxOA_ed239121-df25-4fd5-8a20-56a2821e11b7"
      unitRef="usd">25885000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i2e696a8243e449cea4c408643b0c8316_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTMtOS0xLTEtMzU0MDE4_0a889766-65a4-4fa9-b230-4496b13f3e78"
      unitRef="usd">1347000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ied7399d5bbf14198bf9416f0242b68b1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTMtMTUtMS0xLTM1NDAxOA_bdfa5713-d26b-4e1a-8f52-7a34e0ec2214"
      unitRef="usd">-21000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTMtMTctMS0xLTM1NDAxOA_7058d249-d47e-4f89-a024-b9d72b83ba6a"
      unitRef="usd">1326000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTQtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246ZWI0ODNjZmZhMWY3NDQxNjljMDhhZTYzZTk3NmM4YzRfMzc_55b249c7-e99c-407d-b6af-694177bd1fc4"
      unitRef="usd">-75000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if228d12dc7ec48dbabc207800e70e561_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTQtNy0xLTEtMzU0MDE4_ff6495f2-1500-4a50-ac48-92fd1a92352c"
      unitRef="usd">-260000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTQtMTctMS0xLTM1NDAxOA_1cef3a91-6a69-465c-989e-d2688201e95a"
      unitRef="usd">-260000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia4141bf74d4f4cf2a006bd905970e699_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTUtMS0xLTEtMzU0MDE4_1b5dfc23-6787-499d-9aa4-b500c6957ccb"
      unitRef="shares">4781000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia335774c94194c9e9df1cee6eca206c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTUtNS0xLTEtMzU0MDE4_c308bbea-7bb2-4992-95a1-0d7634f24799"
      unitRef="usd">38000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTUtMTctMS0xLTM1NDAxOA_f3346fe2-0284-47f0-897b-8d555b4f8d72"
      unitRef="usd">38000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ia4141bf74d4f4cf2a006bd905970e699_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTYtMS0xLTEtMzU0MDE4_6c8d0d34-6c94-4845-a9b1-a72acd9c8612"
      unitRef="shares">326000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ia335774c94194c9e9df1cee6eca206c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTYtNS0xLTEtMzU0MDE4_b4f9f781-d87b-4ad7-a5dc-01e401298da4"
      unitRef="usd">19000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i87039d6a8fdd4824bbf66cc17f0022f6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTYtMTEtMS0xLTM1NDAxOA_327b73e9-8d4f-4698-823d-7e4ba2d09528"
      unitRef="shares">3455000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i87039d6a8fdd4824bbf66cc17f0022f6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTYtMTMtMS0xLTM1NDAxOA_98b11b55-8a30-4ca7-b377-53388931132b"
      unitRef="usd">278000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTYtMTctMS0xLTM1NDAxOA_a0671963-886a-45ea-925f-bcbe61353c94"
      unitRef="usd">297000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia335774c94194c9e9df1cee6eca206c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTctNS0xLTEtMzU0MDE4_c832c11d-5387-497a-941c-4ad4b8045552"
      unitRef="usd">203000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTctMTctMS0xLTM1NDAxOA_c9bd1bcf-e3ea-4e14-84dd-2c56cd9e3b6a"
      unitRef="usd">203000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="ied7399d5bbf14198bf9416f0242b68b1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTgtMTUtMS0xLTM1NDAxOA_7403c134-d30d-4b3f-9898-3ceedb0da226"
      unitRef="usd">46000000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTgtMTctMS0xLTM1NDAxOA_8db3e82d-1616-4934-8b79-2c52780a9e56"
      unitRef="usd">46000000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="ia335774c94194c9e9df1cee6eca206c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTktNS0xLTEtMzU0MDE4_1ab0ffe7-485b-4dc4-b686-0286495629a7"
      unitRef="usd">9000000</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="ied7399d5bbf14198bf9416f0242b68b1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTktMTUtMS0xLTM1NDAxOA_659ff3e7-6130-410e-8cfd-1f39ee2df487"
      unitRef="usd">-5000000</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMTktMTctMS0xLTM1NDAxOA_5715978c-b86b-4a10-ad0d-2c711fbd8ddd"
      unitRef="usd">4000000</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="ied7399d5bbf14198bf9416f0242b68b1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjAtMTUtMS0xLTM1NDAxOA_b2383a9a-06db-4831-9e4d-4884e4d16d08"
      unitRef="usd">3000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjAtMTctMS0xLTM1NDAxOA_e79cfea9-d238-469d-8e99-92ea3896caaa"
      unitRef="usd">3000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iefd78604c8af4b3eb7e7763dd317e282_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtMS0xLTEtMzU0MDE4_b0d21700-7afe-46b1-8ad5-9aaed55755a8"
      unitRef="shares">602704000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iefd78604c8af4b3eb7e7763dd317e282_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtMy0xLTEtMzU0MDE4_65cda9f6-e7ee-461a-9ece-1f2d09f8f92f"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i59eb9977480d4e3891765c8703b4e646_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtNS0xLTEtMzU0MDE4_dc879232-a6b5-43e7-9ff0-6e2f797f57b4"
      unitRef="usd">19672000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d8aca346cdc405eb8ae3ab1bb1a0e8a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtNy0xLTEtMzU0MDE4_04f03ecb-fe32-4419-b76d-3a68d55eb822"
      unitRef="usd">77000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i253a5454e6f34367b12d67c6674b4320_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtOS0xLTEtMzU0MDE4_88d6d07e-3b46-43cf-812e-b67a6c26c062"
      unitRef="usd">8139000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i116b2020b2da4f3ea027f5a137798310_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtMTEtMS0xLTM1NDAxOA_302d8159-6b09-405c-84ad-cd89cf9d4646"
      unitRef="shares">20225000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i116b2020b2da4f3ea027f5a137798310_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtMTMtMS0xLTM1NDAxOA_dd0c2b73-04f4-4108-b41d-9f6df6beebc0"
      unitRef="usd">-1094000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i831e8980ca404c60aa04c6cee3dd1a38_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtMTUtMS0xLTM1NDAxOA_b48ce77c-d327-4eb8-8c1f-c6ef57446c6a"
      unitRef="usd">145000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjEtMTctMS0xLTM1NDAxOA_3516850b-7658-435e-be74-79459019c41d"
      unitRef="usd">26940000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i07517ae73bdd457783095996579e8053_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjItOS0xLTEtMzU0MDE4_39f14de8-ecb0-4709-9e7a-f2dab08fecc7"
      unitRef="usd">1202000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ic2d17142024e44a0b55466c586719466_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjItMTUtMS0xLTM1NDAxOA_a1be528c-aabc-4663-b7c9-665471124fc6"
      unitRef="usd">-13000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjItMTctMS0xLTM1NDAxOA_96d32110-c87c-41ae-b3ba-c7dd0f464bcd"
      unitRef="usd">1189000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjMtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246ZDBmMmQ0MDM0ZTE1NDg0ZjkwZGNhZmJmMjFmMjdhNmFfMjE5OTAyMzI1NTU3NA_bcd1ad08-661f-4270-a746-e9752b74b75d"
      unitRef="usd">349000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i00ea1fbc2e9c4c9f8ef3db694f5e19cb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjMtNy0xLTEtMzU0MDE4_e5058ed7-0906-41b7-b45e-1ee89bd29d15"
      unitRef="usd">-1209000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjMtMTctMS0xLTM1NDAxOA_70ea14c3-d185-42da-b1ed-8c1d919ce9dd"
      unitRef="usd">-1209000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i6fe2f9326b88400aa8db63ee38c9dc25_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjYtMS0xLTEtMzU0MDE4_051ff82a-cfa6-4382-8cdc-180f5b5aeb62"
      unitRef="shares">5143000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifad2424f092c43c5aef13a515b9bf557_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjYtNS0xLTEtMzU0MDE4_87acd8d0-7712-4182-8b26-3b7a4edfc69a"
      unitRef="usd">71000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjYtMTctMS0xLTM1NDAxOA_6721d955-cbbf-4719-baf4-5810cd42ecba"
      unitRef="usd">71000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <cnc:SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture
      contextRef="ifad2424f092c43c5aef13a515b9bf557_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjctNS0xLTEtMzgwNzA4_66e6a60c-9c46-418a-a597-c7e7e8c15663"
      unitRef="usd">60000000</cnc:SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture>
    <cnc:SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjctMTctMS0xLTM4MDcwOA_c79ad9c3-433d-49fc-b522-32d4a1069c63"
      unitRef="usd">60000000</cnc:SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ifad2424f092c43c5aef13a515b9bf557_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjctNS0xLTEtMzU0MDE4_1210425c-03fb-464e-a832-b88ac46e8e4f"
      unitRef="usd">-23000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0e9d6d9ad10d41afb05597363822ad5c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjctMTEtMS0xLTM1NDAxOA_7a018293-780d-4fb1-b428-22cf98c28960"
      unitRef="shares">36868000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0e9d6d9ad10d41afb05597363822ad5c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjctMTMtMS0xLTM1NDAxOA_1076f708-7f4f-4746-a548-aa49edeff59f"
      unitRef="usd">3119000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjctMTctMS0xLTM1NDAxOA_c20f2b89-2260-4c39-950d-93e27723775d"
      unitRef="usd">3096000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifad2424f092c43c5aef13a515b9bf557_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjgtNS0xLTEtMzU0MDE4_99ca5cb8-6cc1-409c-9f80-2a0a34e09c16"
      unitRef="usd">234000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMjgtMTctMS0xLTM1NDAxOA_a7823f16-2c3f-4ae9-932b-21d11f770b32"
      unitRef="usd">234000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="ic2d17142024e44a0b55466c586719466_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzMtMTUtMS0xLTQ2NDExNQ_07b1b937-f974-4793-93bf-818aaf8e51db"
      unitRef="usd">17000000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzMtMTctMS0xLTQ2NDEyNA_0f793a2a-28ea-4aa2-9e7b-5d38cca7e172"
      unitRef="usd">17000000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="ic2d17142024e44a0b55466c586719466_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzItMTUtMS0xLTM1NDAxOA_09962603-b424-4a9c-88b6-ec580135becd"
      unitRef="usd">14000000</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzItMTctMS0xLTM1NDAxOA_c510235a-b138-4baa-bcde-0438cbf9e90b"
      unitRef="usd">14000000</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ic2d17142024e44a0b55466c586719466_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzMtMTUtMS0xLTM1NDAxOA_77f06ed7-e522-47ad-a07b-d14a4096c81c"
      unitRef="usd">10000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzMtMTctMS0xLTM1NDAxOA_13346a73-937e-4475-84aa-c5c2c4471ce7"
      unitRef="usd">10000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ic2d17142024e44a0b55466c586719466_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzQtMTUtMS0xLTM1NDAxOA_ca2a3881-488b-421d-a6d2-a60c6f19d5ab"
      unitRef="usd">-1000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzQtMTctMS0xLTM1NDAxOA_d8d91bc1-ac54-4fe3-b926-14ff94ae148f"
      unitRef="usd">-1000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if74f20f9672c42969aaf06d880b02823_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtMS0xLTEtMzU0MDE4_1079ca24-9a9f-4ddb-a152-ee0cb918a16f"
      unitRef="shares">607847000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if74f20f9672c42969aaf06d880b02823_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtMy0xLTEtMzU0MDE4_f3552c89-5412-4454-bf90-7d3602b78a22"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idda5d167ac1a435ba11ce095d9bf8926_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtNS0xLTEtMzU0MDE4_cb2efd0b-dabf-41e4-ab95-6a259e21f427"
      unitRef="usd">20060000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic1d80c4c83dd418ebc09acf400b5608c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtNy0xLTEtMzU0MDE4_8ee19fea-5064-4177-9b63-1dceb302b2dc"
      unitRef="usd">-1132000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b68b2bcce604d8997c874bfd621f1fd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtOS0xLTEtMzU0MDE4_21b6551e-bd44-4d42-a9a3-a2dbfaf036bb"
      unitRef="usd">9341000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i22a603f1ec5a4ed6ac95d0033583c8ae_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtMTEtMS0xLTM1NDAxOA_09ffd22d-4e4e-41c8-a227-81e01be5abbe"
      unitRef="shares">57093000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22a603f1ec5a4ed6ac95d0033583c8ae_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtMTMtMS0xLTM1NDAxOA_cd3c27b4-2a7a-41e6-bd6a-671172e8886d"
      unitRef="usd">-4213000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4ff8138305244a25baa6cc2d532766f2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtMTUtMS0xLTM1NDAxOA_83002638-0ffe-49c6-a9c0-e87f13d89749"
      unitRef="usd">124000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85MS9mcmFnOjMwZDhkNzlhZTJlNjQ1MTU5ZjAzNjM1N2ZhOTk0MDg2L3RhYmxlOmUyYWY5NTU4ODE0NjQxNzc5YTFlNjA0NTdkZWVjMDQ0L3RhYmxlcmFuZ2U6ZTJhZjk1NTg4MTQ2NDE3NzlhMWU2MDQ1N2RlZWMwNDRfMzYtMTctMS0xLTM1NDAxOA_55b34b65-31a8-4edf-98d7-ba9fbd2ca710"
      unitRef="usd">24181000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMy0xLTEtMS0zNTQwMTg_de1e1989-69d6-49fd-93cc-d799750b10dc"
      unitRef="usd">1202000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMy0zLTEtMS0zNTQwMTg_9517b3b7-aa7c-4092-a48f-1b2f5ad80e70"
      unitRef="usd">1336000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMy01LTEtMS0zNTQwMTg_2b945164-3ada-4308-9e65-23aaf5a34404"
      unitRef="usd">1794000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNS0xLTEtMS0zNTQwMTg_d8e84042-5cfe-4840-84b6-32ce0e21d57d"
      unitRef="usd">1553000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNS0zLTEtMS0zNTQwMTg_63d914bb-c04c-422a-b4b9-1facc3b8191b"
      unitRef="usd">1476000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNS01LTEtMS0zNTQwMTg_b2cee311-0d34-427d-8280-80c2c0f0bd06"
      unitRef="usd">1259000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNi0xLTEtMS0zNTQwMTg_453d3e18-83e8-4b4b-b017-461be75e6448"
      unitRef="usd">234000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNi0zLTEtMS0zNTQwMTg_aca2c84d-21c6-428d-a981-ded026c8aea0"
      unitRef="usd">203000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNi01LTEtMS0zNTQwMTg_21caf962-e566-490a-9d46-6dc432f962dc"
      unitRef="usd">281000000</us-gaap:ShareBasedCompensation>
    <us-gaap:AssetImpairmentCharges
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNy0xLTEtMS0zNTQwMTg_32e1f8ec-9c77-487c-b28d-dd1ed915848d"
      unitRef="usd">2318000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNy0zLTEtMS0zNTQwMTg_51183f18-fde4-4216-99bd-3b4eb3864e4b"
      unitRef="usd">229000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNy01LTEtMS0zNTQwMTg_e4be244c-7288-48de-b6c3-51a07816487a"
      unitRef="usd">72000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfOC0xLTEtMS0zNTQwMTg_e239d3e5-dbb9-4315-8a2e-d09b059f573e"
      unitRef="usd">25000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfOC0zLTEtMS0zNTQwMTg_e76b4d7f-9e17-4a71-8daf-d429c1d51dd2"
      unitRef="usd">-125000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfOC01LTEtMS0zNTQwMTg_38c487de-149b-4303-9b9e-3adfd387d234"
      unitRef="usd">-57000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfOS0xLTEtMS0zNTQwMTg_13cb3ed5-3afb-4c6f-a663-7608a02411aa"
      unitRef="usd">2000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfOS0zLTEtMS0zNTQwMTg_d3dbfda0-1d95-4bce-b2e7-7dd208dd0c64"
      unitRef="usd">309000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfOS01LTEtMS0zNTQwMTg_d37fbd5f-8204-466c-a1a0-63d886ff3d88"
      unitRef="usd">0</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTAtMS0xLTEtMzU0MDE4_8cc602d8-065c-4e0a-9136-6677ffd191ab"
      unitRef="usd">-631000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTAtMy0xLTEtMzU0MDE4_28da490b-5950-41ca-8031-6c0a86d86370"
      unitRef="usd">-132000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTAtNS0xLTEtMzU0MDE4_d59515c3-a165-4586-8806-815b259698e6"
      unitRef="usd">-51000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTEtMS0xLTEtMzU0MDE4_a4fcd3ad-c2b3-4d5d-bc59-d167be4e7b9f"
      unitRef="usd">772000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTEtMy0xLTEtMzU0MDE4_e32c5383-49d6-486b-8bf4-4a84139c076d"
      unitRef="usd">88000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTEtNS0xLTEtMzU0MDE4_8274ffa3-d2e4-481e-a433-426008def5ca"
      unitRef="usd">104000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTItMS0xLTEtNDM0NjE3_edd9cebe-896e-4650-a349-875146763684"
      unitRef="usd">-221000000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTItMy0xLTEtNDM0NjE3_2b607e30-9411-4e2a-a37d-139036039046"
      unitRef="usd">-12000000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTItNS0xLTEtNDM0NjE3_7bb21f5a-78f3-479e-ba04-2e3fd09e035b"
      unitRef="usd">-5000000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTItMS0xLTEtMzU0MDE4_5b7e1160-7249-43aa-98c1-36b02f853c8c"
      unitRef="usd">31000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTItMy0xLTEtMzU0MDE4_613cfcba-aa16-492d-84bb-1c36084b697d"
      unitRef="usd">23000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTItNS0xLTEtMzU0MDE4_a7c4025d-1a17-4b06-b579-03ff39a67de6"
      unitRef="usd">5000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInPremiumsReceivable
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTQtMS0xLTEtMzU0MDE4_dd6a2f49-52a4-49e0-89f9-305b6dba6f8f"
      unitRef="usd">1627000000</us-gaap:IncreaseDecreaseInPremiumsReceivable>
    <us-gaap:IncreaseDecreaseInPremiumsReceivable
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTQtMy0xLTEtMzU0MDE4_4cf84721-603d-481d-abce-a2d84ffb532d"
      unitRef="usd">2453000000</us-gaap:IncreaseDecreaseInPremiumsReceivable>
    <us-gaap:IncreaseDecreaseInPremiumsReceivable
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTQtNS0xLTEtMzU0MDE4_12864fc7-3651-4088-b367-7aea0afa5072"
      unitRef="usd">52000000</us-gaap:IncreaseDecreaseInPremiumsReceivable>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTUtMS0xLTEtMzU0MDE4_eaeea676-c406-48d4-a35b-a462e801391e"
      unitRef="usd">-128000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTUtMy0xLTEtMzU0MDE4_dfafa58a-9950-4c67-a394-0a3f95684ae9"
      unitRef="usd">99000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTUtNS0xLTEtMzU0MDE4_24001106-8c59-4577-874c-ac33fbf5a050"
      unitRef="usd">30000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTYtMS0xLTEtMzU0MDE4_1b54f475-4e8e-41cd-95f4-4407fbac405e"
      unitRef="usd">2397000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTYtMy0xLTEtMzU0MDE4_314c7445-f403-4460-8797-25dc71d76edc"
      unitRef="usd">1802000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTYtNS0xLTEtMzU0MDE4_91fdbaf0-6132-472a-99ab-c19f9306bb7b"
      unitRef="usd">1117000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTctMS0xLTEtMzU0MDE4_edb8f9f6-47b0-40c0-b885-a6768dd41772"
      unitRef="usd">31000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTctMy0xLTEtMzU0MDE4_3f4a0c70-0070-4639-b9f4-ac87a655d28b"
      unitRef="usd">-109000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTctNS0xLTEtMzU0MDE4_acb122bb-7287-4e01-b5bf-8b6de66ed2f4"
      unitRef="usd">-528000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTgtMS0xLTEtMzU0MDE4_2566105e-bb32-4a0a-994c-0fbcff9dea9d"
      unitRef="usd">421000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTgtMy0xLTEtMzU0MDE4_f5a31b88-a504-4285-979b-ef4e652e6bf7"
      unitRef="usd">1141000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTgtNS0xLTEtMzU0MDE4_8ea298d6-b98e-4396-ba35-cfcd5a34ab2c"
      unitRef="usd">585000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTktMS0xLTEtMzU0MDE4_6dcc3148-fbd8-4d19-a8b6-467b32684f28"
      unitRef="usd">842000000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTktMy0xLTEtMzU0MDE4_3d590c4e-44ff-467e-91c4-9440668aac9b"
      unitRef="usd">1093000000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMTktNS0xLTEtMzU0MDE4_6bd7ae28-f778-4536-ac4b-65282cd0fec5"
      unitRef="usd">1078000000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjAtMS0xLTEtMzU0MDE4_221bb6e4-314c-467d-b6e4-16f9bdd46825"
      unitRef="usd">2000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjAtMy0xLTEtMzU0MDE4_9f670433-e3b5-4832-9a95-585ceeb956ab"
      unitRef="usd">1000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjAtNS0xLTEtMzU0MDE4_e4700adc-938c-4d6c-b964-c64c621c014e"
      unitRef="usd">25000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjEtMS0xLTEtMzU0MDE4_855b71fd-4b86-4d9b-aaeb-338d3981bff2"
      unitRef="usd">6261000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjEtMy0xLTEtMzU0MDE4_c9b055d7-5ff7-4855-b4b3-0139c64f9152"
      unitRef="usd">4205000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjEtNS0xLTEtMzU0MDE4_f154dac8-332d-4d88-b55d-2960d50008a1"
      unitRef="usd">5503000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjMtMS0xLTEtMzU0MDE4_d352f4c4-af91-444a-8977-5c8be143f6bc"
      unitRef="usd">1004000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjMtMy0xLTEtMzU0MDE4_347588da-0af8-47d5-948c-6686b53f7cff"
      unitRef="usd">910000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjMtNS0xLTEtMzU0MDE4_cc614661-6569-40cb-8d21-1ee7b7714006"
      unitRef="usd">869000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjQtMS0xLTEtMzU0MDE4_e2c7d32f-7723-4eab-a63e-d5cc7fd76890"
      unitRef="usd">6736000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjQtMy0xLTEtMzU0MDE4_4f8ccea8-3e92-43dc-b9b4-a1dcfd886bad"
      unitRef="usd">7400000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjQtNS0xLTEtMzU0MDE4_4cf1a3c5-9b59-4f1d-8cad-f55a2cc68a5a"
      unitRef="usd">7402000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjUtMS0xLTEtMzU0MDE4_06077a94-a88e-468c-a38f-7ed96aebe6e6"
      unitRef="usd">3802000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjUtMy0xLTEtMzU0MDE4_8862bdc5-25f5-44be-bf16-1e44ee8fcbe1"
      unitRef="usd">5458000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjUtNS0xLTEtMzU0MDE4_64312e1f-b1fb-443a-a31c-77b8db9f7e91"
      unitRef="usd">4921000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjYtMS0xLTEtMzU0MDE4_ae83aeef-bb65-4210-a4de-a5632060cd34"
      unitRef="usd">1460000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjYtMy0xLTEtMzU0MDE4_02268597-f23a-4956-bf49-1906373ea31c"
      unitRef="usd">534000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjYtNS0xLTEtMzU0MDE4_776b031a-9500-4040-9f6a-6eca7795504e"
      unitRef="usd">4049000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjctMS0xLTEtMzU0MDE4_2a593c9d-9a20-46f3-b5d4-e5d30b80aa6e"
      unitRef="usd">2477000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjctMy0xLTEtMzU0MDE4_409ad41c-e059-4154-b4e6-18dbc6164a03"
      unitRef="usd">68000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjctNS0xLTEtMzU0MDE4_1d6d96dd-b0e8-4456-b5f3-bce14da2b02f"
      unitRef="usd">466000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjktMS0xLTEtMzU0MDE4_2d006898-8fc6-4945-a1f7-9b0b939b27e0"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjktMy0xLTEtMzU0MDE4_1b77edc6-0d08-49dd-83d7-98651c6042ec"
      unitRef="usd">-19000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMjktNS0xLTEtMzU0MDE4_6b936579-30b5-4b23-af30-249149c5c8fc"
      unitRef="usd">22000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzAtMS0xLTEtMzU0MDE4_a233e675-dbd3-48d5-9391-4672b71a5513"
      unitRef="usd">-2921000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzAtMy0xLTEtMzU0MDE4_1895fa85-5ecd-4a00-b691-462b3ab65996"
      unitRef="usd">-3299000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzAtNS0xLTEtMzU0MDE4_6a858e43-eada-49fd-b776-21b34fc305ee"
      unitRef="usd">-6955000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzMtMS0xLTEtMzU0MDE4_9b583097-f111-44fe-a5bb-97edc0dfa308"
      unitRef="usd">360000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzMtMy0xLTEtMzU0MDE4_ad75ca11-b7bd-4502-8e64-06c7b0d99b07"
      unitRef="usd">9267000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzMtNS0xLTEtMzU0MDE4_033d6d34-367a-4e84-9a11-c262902fbbef"
      unitRef="usd">5107000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzQtMS0xLTEtMzU0MDE4_232966c8-7db2-472e-8ea2-fb7016f41bab"
      unitRef="usd">1490000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzQtMy0xLTEtMzU0MDE4_b6050072-2acb-4ddb-925f-edf464c2d597"
      unitRef="usd">7434000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzQtNS0xLTEtMzU0MDE4_ebd02234-ffb9-4258-a554-c8de09fa9185"
      unitRef="usd">4067000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzUtMS0xLTEtMzU0MDE4_5286a65e-efa4-41ae-99d5-ebe55eaeeee6"
      unitRef="usd">3096000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzUtMy0xLTEtMzU0MDE4_2f25edac-2b29-4027-a77d-6fc48128b3d1"
      unitRef="usd">297000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzUtNS0xLTEtMzU0MDE4_6ce2db13-4fb3-4f78-bec0-92d3cd97cfed"
      unitRef="usd">626000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzctMS0xLTEtMzU0MDE4_e2e90832-718e-48d2-9bad-3e053cd7ca3f"
      unitRef="usd">70000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzctMy0xLTEtMzU0MDE4_376e5b00-f5b0-4dd4-8eea-a17a63da4042"
      unitRef="usd">35000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzctNS0xLTEtMzU0MDE4_568a8341-046f-42d9-8401-cf627b6793b2"
      unitRef="usd">28000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzgtMS0xLTEtMzU0MDE4_7eac91d3-7402-4fbc-85f3-802ec250f198"
      unitRef="usd">14000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzgtMy0xLTEtMzU0MDE4_e0e51804-c068-498c-958e-58a7c7afd86d"
      unitRef="usd">157000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzgtNS0xLTEtMzU0MDE4_38df86d8-21bb-4289-b5a4-aa2232c02c92"
      unitRef="usd">81000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzktMS0xLTEtMzU0MDE4_0c3b6f47-6792-4ee7-ab61-e58e8f40802c"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzktMy0xLTEtMzU0MDE4_f309388a-31a3-4769-a553-68041c0cb0fd"
      unitRef="usd">72000000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfMzktNS0xLTEtMzU0MDE4_c44b05be-847f-482d-a60e-b597c1e8541b"
      unitRef="usd">120000000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDAtMS0xLTEtMzU0MDE4_13ab4497-9581-424b-9685-716e75f2f1bb"
      unitRef="usd">-27000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDAtMy0xLTEtMzU0MDE4_ebc1d9d4-a026-4e04-a19b-87366d634529"
      unitRef="usd">20000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDAtNS0xLTEtMzU0MDE4_1a51c3d3-f0b1-41ac-8e54-fee161edb390"
      unitRef="usd">19000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDEtMS0xLTEtMzU0MDE4_284d235e-e160-4b6e-ba95-8914fde6a753"
      unitRef="usd">-4197000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDEtMy0xLTEtMzU0MDE4_cd619336-c86f-477c-8d3d-899818f611ee"
      unitRef="usd">1362000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDEtNS0xLTEtMzU0MDE4_bd23fe30-aa1c-48e9-b355-28637add4f5d"
      unitRef="usd">260000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDItMS0xLTEtMzU0MDE4_ee04e25e-a334-4d2a-9c53-75204c3b807c"
      unitRef="usd">-11000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDItMy0xLTEtMzU0MDE4_bcd0aadd-5cce-40e1-beb2-b63e2d9f553f"
      unitRef="usd">-11000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDItNS0xLTEtMzU0MDE4_2e810325-e5d1-4f95-bf73-f5a01c992e3a"
      unitRef="usd">18000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDMtMS0xLTEtMzU0MDE4_4ad69000-d602-4338-b414-c5216c634edc"
      unitRef="usd">-868000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDMtMy0xLTEtMzU0MDE4_4bcd7845-7851-426f-83b5-4f6815f6038e"
      unitRef="usd">2257000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDMtNS0xLTEtMzU0MDE4_8dd9932c-70aa-4a54-81da-5ceb7c6add57"
      unitRef="usd">-1174000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDQtMS0xLTEtNDMwMDc1_eb33a5f3-7163-4aeb-bc69-24db553ab875"
      unitRef="usd">16000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDQtMy0xLTEtNDU4MzA2_12b93574-9983-44e0-9ac3-9bbb6d8d2ace"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDQtNS0xLTEtNDU4MzI5_3a6ee163-12fb-4a7e-8c5e-02bac8ceb720"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDQtMS0xLTEtMzU0MDE4_5b99291a-b2a4-4b99-8ce1-7fb1de6e7ba7"
      unitRef="usd">13214000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDQtMy0xLTEtMzU0MDE4_1b74efa6-74e8-472e-bdd5-661a4a35fd96"
      unitRef="usd">10957000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i89efa37b183c4c618c28149ddb506553_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDQtNS0xLTEtMzU0MDE4_72054d52-b2fb-4a1c-90cc-998c3d891385"
      unitRef="usd">12131000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDUtMS0xLTEtMzU0MDE4_895a6bc5-9b2c-4817-8e06-96abdf97ed87"
      unitRef="usd">12330000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDUtMy0xLTEtMzU0MDE4_992c09d9-10e3-4177-bf85-ec5e7295847c"
      unitRef="usd">13214000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDUtNS0xLTEtMzU0MDE4_645d7c59-8d7f-4b59-8255-7cf55cd443bb"
      unitRef="usd">10957000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDctMS0xLTEtMzU0MDE4_f330c377-23ab-4406-8780-e2584baf844c"
      unitRef="usd">657000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDctMy0xLTEtMzU0MDE4_837c153a-af21-4ce2-a84f-79ef67d08602"
      unitRef="usd">658000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDctNS0xLTEtMzU0MDE4_6b3d2d27-7e2b-4e0e-a6fa-ee626f40d6f3"
      unitRef="usd">725000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDgtMS0xLTEtMzU0MDE4_0c540800-7eb7-4224-8121-0ea3a41fa119"
      unitRef="usd">1222000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDgtMy0xLTEtMzU0MDE4_90cc6a0b-2fed-4ae0-bb6d-7d07cab70503"
      unitRef="usd">678000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDgtNS0xLTEtMzU0MDE4_c34a19f7-b501-4652-b200-36f00bb0213e"
      unitRef="usd">1191000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDktMS0xLTEtMzU0MDE4_34bb22a3-d8c1-4fbf-8c04-1c68f7126732"
      unitRef="usd">60000000</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDktMy0xLTEtMzU0MDE4_d16fbf4f-7398-4c3b-ab43-5f96219bdf93"
      unitRef="usd">0</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNDktNS0xLTEtMzU0MDE4_dbb6fcae-8a82-4739-8ea9-5893faaadfbe"
      unitRef="usd">11526000000</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTItMS0xLTEtMzU0MDE4_2e78bb03-004d-4fa6-8545-0cebc9f66c69"
      unitRef="usd">12074000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTItMy0xLTEtMzU0MDE4_725a1b4d-f4e3-4ceb-a4cc-99696b93b823"
      unitRef="usd">13118000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTItNS0xLTEtMzU0MDE4_4ac72f0a-92e9-4dab-8012-8ad73ce6124b"
      unitRef="usd">10800000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTMtMS0xLTEtMzU0MDE4_3d096c24-72e9-47d2-bb22-9f7e15b115bb"
      unitRef="usd">256000000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTMtMy0xLTEtMzU0MDE4_db0280aa-394e-4a7f-a24a-ce2a3d8ce82d"
      unitRef="usd">96000000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTMtNS0xLTEtMzU0MDE4_334c64f4-9bf7-4af4-bf7b-ce902038d5b3"
      unitRef="usd">157000000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTQtMS0xLTEtMzU0MDE4_b427e373-6a99-4d99-93b0-8f682eddcb11"
      unitRef="usd">12330000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTQtMy0xLTEtMzU0MDE4_45fd8d5f-d624-41dc-b756-173ad86cc357"
      unitRef="usd">13214000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl85NC9mcmFnOmYxZGJiNjg4N2IwYzQ3YjY4ZDhiZmI1ZmMyZGZkNjcxL3RhYmxlOjM2OTNkNGZiZjYwZTRkZjg5YWJkOTQ5MzJmMzQwY2U0L3RhYmxlcmFuZ2U6MzY5M2Q0ZmJmNjBlNGRmODlhYmQ5NDkzMmYzNDBjZTRfNTQtNS0xLTEtMzU0MDE4_25f48d69-8dc6-4690-b520-ca774cf38a69"
      unitRef="usd">10957000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NatureOfOperations
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDAvZnJhZzo1ZDE3MjUyZDg1ODA0ZGUyYTlmMGJkZTRiZWZhNGEyYy90ZXh0cmVnaW9uOjVkMTcyNTJkODU4MDRkZTJhOWYwYmRlNGJlZmE0YTJjXzE3NzQ_d340688a-3772-40fe-ad1a-3e4d3c96ed79">Organization and Operations Centene Corporation, or the Company, is a leading healthcare enterprise, committed to helping people live healthier lives, with an established expertise in lower-income and medically complex populations. The Company provides access to high-quality healthcare, innovative programs, and a wide range of health solutions that help families and individuals get well, stay well, and be well. During 2022, the Company operated in two segments: Managed Care and Specialty Services. The Managed Care segment provided health plan coverage to individuals through government subsidized programs, including Medicaid, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare, the Supplemental Security Income Program, also known as the Aged, Blind, or Disabled Program (ABD), Medicare (including Medicare Prescription Drug Plans), and the Health Insurance Marketplace. The Company also offered a variety of individual, small group, and large group commercial healthcare products, both to employers and directly to members in the Managed Care segment. The Specialty Services segment consisted of the Company's specialty companies offering auxiliary healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations, as well as to the Company's own subsidiaries. The Specialty Services segment also included the government contracts business, including the Company's government-sponsored Managed Care Support Contract with the U.S. Department of Defense (DoD) under the TRICARE program and other healthcare related government contracts.</us-gaap:NatureOfOperations>
    <us-gaap:NumberOfReportableSegments
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDAvZnJhZzo1ZDE3MjUyZDg1ODA0ZGUyYTlmMGJkZTRiZWZhNGEyYy90ZXh0cmVnaW9uOjVkMTcyNTJkODU4MDRkZTJhOWYwYmRlNGJlZmE0YTJjXzQyNg_82a453be-e967-4ba2-bd68-10f6c488b7c1"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjQy_be58bd1a-8c25-4060-9fb1-c6e04369f261">Summary of Significant Accounting Policies &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements include the accounts of Centene Corporation and all majority owned subsidiaries and subsidiaries over which the Company exercises the power and control to direct activities significantly impacting financial performance. All material intercompany balances and transactions have been eliminated. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts in the consolidated financial statements and notes have been reclassified to conform to the 2022 presentation. Beginning in 2022, the Company has included a separate line item for depreciation expense on the Consolidated Statement of Operations, which was previously included in selling, general and administrative (SG&amp;amp;A) expenses. Prior period SG&amp;amp;A expense ratios have also been conformed to the current presentation. These reclassifications have no effect on net earnings, cash flow, or stockholders' equity as previously reported.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 2022, the Company acquired all of the issued and outstanding shares of Magellan Health, Inc. (Magellan). The acquisition was accounted for as a business combination. Additionally, during 2022 the Company completed the divestitures of PANTHERx Rare (PANTHERx), its Spanish and Central European businesses, and Magellan Rx. See Note 3. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with generally accepted accounting principles in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Future events and their effects cannot be predicted with certainty; accordingly, the accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes. The Company evaluates and updates its assumptions and estimates on an ongoing basis and may employ outside experts to assist in its evaluation, as considered necessary. Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Business combinations are accounted for using the acquisition method of accounting. The Company allocates the fair value of purchase consideration to the assets acquired and liabilities assumed based on their fair values at the acquisition date. The excess of the fair value of consideration transferred over the fair value of the net assets acquired is recorded as goodwill. Goodwill is generally attributable to the value of the synergies between the combined companies and the value of the acquired assembled workforce, neither of which qualifies for recognition as an intangible asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses its best estimates and assumptions to value assets acquired and liabilities assumed at the acquisition date; however, these estimates are sometimes preliminary and, in some instances, all information required to value the assets acquired and liabilities assumed may not be available or final as of the end of a reporting period subsequent to the business combination. If the accounting for the business combination is incomplete, provisional amounts are recorded. The provisional amounts are updated during the period determined, up to one year from the acquisition date. The Company includes the results of operations of acquired businesses in the Company's consolidated results prospectively from the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquisition related expenses and post-acquisition restructuring costs are recognized separately from the business combination and are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments with original maturities of three months or less are considered to be cash equivalents. Cash equivalents consist of money market funds, bank certificates of deposit, and savings accounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains amounts on deposit with various financial institutions, which may exceed federally insured limits. However, management periodically evaluates the credit-worthiness of those institutions, and the Company has not experienced any losses on such deposits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments include securities with maturities greater than three months to one year. Long-term investments include securities with maturities greater than one year. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term and long-term investments are generally classified as available-for-sale and are carried at fair value. Certain equity investments are recorded using the fair value or equity method. The Company monitors the difference between the carrying value and fair value of its available-for-sale debt investments and whether declines in fair value are credit related. Unrealized gains and losses on debt investments available-for-sale are excluded from earnings and reported in accumulated other comprehensive earnings (loss), a separate component of stockholders' equity, net of income tax effects. If a loss is deemed to be credit related, the Company recognizes an allowance through earnings. For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes.&#160;If the security meets this criterion, the decline in fair value is recorded in earnings through investment and other income. Premiums and discounts are amortized or accreted over the life of the related security using the effective interest method. To calculate realized gains and losses on the sale of investments, the Company uses the specific amortized cost of each investment sold. Realized gains and losses are recorded in investment and other income. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the equity method to account for investments in entities that it does not control but has the ability to exercise significant influence over operating and financial policies. Generally, under the equity method, original investments in these entities are recorded at cost and subsequently adjusted by the Company's share of equity in income or losses after the date of acquisition&#160;as well as capital contributions to and distributions from these companies. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Deposits &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted deposits consist of investments required by various state statutes to be deposited or pledged to state agencies. These investments are classified as long-term, regardless of the contractual maturity date, due to the nature of the states' requirements. The Company is required to annually adjust the amount of the deposit pledged to certain states.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value&#160;Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company invests in various financial assets and&#160;incurs various financial liabilities. Fair values are disclosed for all financial instruments, whether or not such values are recognized in the Consolidated Balance Sheets. Management obtains quoted market prices and other observable inputs for these disclosures. The carrying amounts reported in the Consolidated Balance Sheets for cash and cash equivalents, premium and&#160;trade receivables, medical claims liability, accounts payable and accrued expenses, unearned revenue, and certain other current assets and liabilities are carried at cost, which approximates fair value because of their short-term nature. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following methods and assumptions were used to estimate the fair value of each financial instrument: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Available-for-sale investments and restricted deposits: The carrying amount is stated at fair value, based on quoted market prices, where available. For securities not actively traded, fair values were estimated using values obtained from independent pricing services or quoted market prices of comparable instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Senior unsecured notes: Estimated based on third-party quoted market prices for the same or similar issues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Variable rate debt: The carrying amount of the Company's floating rate debt approximates fair value since the interest rates adjust based on market rate adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign currency swap: Estimated based on Great British Pound to US Dollar foreign exchange rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Contingent consideration: Estimated based on expected achievement of metrics included in the acquisition agreement considering circumstances that exist as of the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Software and Equipment &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, software and equipment are stated at cost less accumulated depreciation. Computer hardware and software includes certain costs incurred in the development of internal-use software, including external direct costs of materials and services and payroll costs of employees devoted to specific software development. Depreciation is calculated principally by the straight-line method over estimated useful lives. Leasehold improvements are depreciated using the straight-line method over the shorter of the expected useful life or the remaining term of the lease. Property, software and equipment are depreciated over the following periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fixed Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;5 - 40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;3 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;10 - 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;1 - 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of all long-lived assets are evaluated to determine if adjustment to the depreciation and amortization period or to the unamortized balance is warranted. Such evaluation is based principally on the expected utilization of the long-lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company retains fully depreciated assets in property and accumulated depreciation accounts until it removes them from service. In the case of sale, retirement, or disposal, the asset cost and related accumulated depreciation balance is removed from the respective account, and the resulting net amount, less any proceeds, is included as a component of earnings from operations in the Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets represent assets acquired in purchase transactions and consist primarily of purchased contract rights and customer relationships, provider contracts, trade names, developed technologies, and goodwill. Intangible assets are amortized using the straight-line method over the following periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased contract rights and customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 21 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 - 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 - 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 - 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests for impairment of intangible assets, as well as long-lived assets, whenever events or changes in circumstances indicate that the carrying value of an asset or asset group (hereinafter referred to as "asset group") may not be recoverable by comparing the sum of the estimated undiscounted future cash flows expected to result from use of the asset group and its eventual disposition to the carrying value. Such factors include, but are not limited to, significant changes in membership, state funding, state contracts, and provider networks and contracts. If the sum of the estimated undiscounted future cash flows is less than the carrying value, an impairment determination is required. The amount of impairment is calculated by subtracting the fair value of the asset group from the carrying value of the asset group. An impairment charge, if any, is recognized within earnings from operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests goodwill for impairment using a fair value approach. The Company is required to test for impairment at least annually, absent a triggering event, which could include a significant decline in operating performance that would require an impairment assessment. Absent any impairment indicators, the Company performs its goodwill impairment testing during the fourth quarter of each year. The Company recognizes an impairment charge for any amount by which the carrying amount of goodwill exceeds its fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company first assesses qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. The Company generally does not calculate the fair value of a reporting unit unless it determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the quantitative test is deemed necessary, the Company determines an appropriate valuation technique to estimate a reporting unit's fair value as of the testing date. The Company utilizes either the income approach or the market approach, whichever is most appropriate for the respective reporting unit. The income approach is based on an internally developed discounted cash flow model that includes many assumptions related to future growth rates, discount factors, future tax rates, and other various assumptions. The market approach is based on financial multiples of comparable companies derived from current market data. The Company then compares the fair value of the reporting unit calculated using the income approach or market approach with its carrying amount and recognizes an impairment charge for the amount by which the carrying amount exceeds fair value. The impairment charge is limited to the total amount of goodwill allocated to the reporting unit. Changes in economic and operating conditions impacting assumptions used in the Company's analyses could result in goodwill impairment in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medical Claims Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical claims liability includes claims reported but not yet paid, or inventory, estimates for claims incurred but not reported, or IBNR, and estimates for the costs necessary to process unpaid claims at the end of each period.&#160;The Company estimates its medical claims liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice.&#160;These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Actuarial Standards of Practice generally require that the medical claims liability estimates be adequate to cover obligations under moderately adverse conditions.&#160;Moderately adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of estimate.&#160;In many situations, the claims amounts ultimately settled will be different than the estimate that satisfies the Actuarial Standards of Practice. The Company includes in its IBNR an estimate for medical claims liability under moderately adverse conditions which represents the risk of adverse deviation of the estimates in its actuarial method of reserving.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses its judgment to determine the assumptions to be used in the calculation of the required estimates. The assumptions it considers when estimating IBNR include, without limitation, claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, healthcare service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known outbreaks of disease or increased incidence of illness such as influenza or COVID-19, provider contract changes, changes to fee schedules, and the incidence of high-dollar or catastrophic claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's development of the medical claims liability estimate is a continuous process which it monitors and refines on a monthly basis as additional claims receipts and payment information becomes available. As more complete claims information becomes available, the Company adjusts the amount of the estimates, and includes the changes in estimates in medical costs in the period in which the changes are identified. In every reporting period, the operating results include the effects of more completely developed medical claims liability estimates associated with previously reported periods. The Company consistently applies its reserving methodology from period to period. As additional information becomes known, it adjusts the actuarial model accordingly to establish medical claims liability estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement, and maintenance costs. For purposes of determining premium deficiencies, contracts are grouped in a manner consistent with the method of acquiring, servicing, and measuring the profitability of such contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's health plans generate revenues primarily from premiums received from the states in which it operates health plans, premiums received from its members and the Centers for Medicare and Medicaid Services (CMS) for its Medicare product, and premiums from members of its commercial health plans. In addition to member premium payments, its Marketplace contracts also generate revenues from subsidies received from CMS. The Company generally receives a fixed premium per member per month pursuant to its contracts and recognizes premium revenues during the period in which it is obligated to provide services to its members at the amount reasonably estimable. In some instances, the Company's base premiums are subject to an adjustment factor, in the form of a risk score or risk adjustment, based on the acuity of its membership. Generally, the risk score or risk adjustment is determined by the state or CMS analyzing submissions of processed claims and medical record data to determine the acuity of the Company's membership, often relative to the respective program's membership. The Company estimates the amount of risk score and risk adjustment based upon the processed claims and medical record data submitted and expected to be submitted to CMS and records revenues on a risk adjusted basis. Some contracts allow for additional premiums related to certain supplemental services provided such as maternity deliveries.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's contracts with states may require it to maintain a minimum health benefits ratio (HBR) or may require it to share cost-savings in excess of certain levels. In certain circumstances, including commercial plans, its plans may be required to return premium to the state or policyholders in the event costs are below established levels. The Company estimates the effect of these programs and recognizes reductions in revenue in the current period. Other states may require us to meet certain performance and quality metrics in order to receive additional or full contractual revenue. For performance-based contracts, the Company does not recognize revenue subject to refund until data is sufficient to measure performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recorded based on membership and eligibility data provided by the states or CMS, which is adjusted on a monthly basis by the states or CMS for retroactive additions or deletions to membership data. These eligibility adjustments are estimated monthly and subsequent adjustments are made in the period known. The Company reviews and updates those estimates as new information becomes available.&#160;It is possible that new information could require us to make additional adjustments, which could be significant, to these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's Medicare Advantage contracts are with CMS. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model pays more for members whose medical history would indicate that they are expected to have higher medical costs. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis data from hospital inpatient, hospital outpatient, physician treatment settings as well as prescription drug events. The Company and the healthcare providers collect, compile, and submit the necessary and available diagnosis data to CMS within prescribed deadlines. The Company estimates risk adjustment revenues based upon the diagnosis data submitted and expected to be submitted to CMS and records revenues on a risk adjusted basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For qualifying low-income prescription drug benefit members, CMS pays for some, or all, of the member's monthly premium. The Company receives certain Part D prospective subsidy payments from CMS for these members as a fixed monthly per member amount, based on the estimated costs of providing prescription drug benefits over the plan year, as reflected in its bids. Approximately nine to ten months subsequent to the end of the plan year, or later in the case of the coverage gap discount subsidy, a settlement payment is made between CMS and the Company's plans based on the difference between the prospective payments and actual claims experience. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's specialty services generate revenues under contracts with state and federal programs, healthcare organizations, and other commercial organizations, as well as from its own subsidiaries. Revenues are recognized when the related services are provided, when inventory is shipped, or as ratably earned over the covered period of services. The Company recognizes revenue related to administrative services under the TRICARE government-sponsored Managed Care Support Contract for the DoD's TRICARE program on a straight-line basis over the option period, when the fees become fixed and determinable. The TRICARE contract includes various performance-based measures.&#160;For each of the measures, an estimate of the amount that has been earned is made at each interim date, and revenue is recognized accordingly. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some states enact premium taxes, similar assessments, and provider pass-through payments, collectively premium taxes, and these taxes are recorded as a separate component of both revenues and operating expenses. Additionally, the Company's insurance subsidiaries were previously subject to the Affordable Care Act (ACA) annual health insurer fee (HIF). Beginning in 2021, the HIF was permanently repealed. This revenue was recorded as premium tax and health insurer fee revenue in the Consolidated Statements of Operations. For certain products, premium taxes, state assessments, and the HIF are not pass-through payments and are recorded as premium revenue and premium tax expense or health insurer fee expense in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some states require state directed payments that have minimal risk, but are administered as a premium adjustment.&#160;These payments are recorded as premium revenue and medical costs at close to a 100% HBR. In many instances, the Company has little visibility to the timing of these payments until they are paid by the state. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Affordable Care Act&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established risk spreading premium stabilization programs as well as minimum medical loss ratio (MLR) and cost sharing reductions (CSRs). The Company's accounting policies for the programs are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Risk Adjustment &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The permanent risk adjustment program established by the ACA transfers funds from qualified individual and small group insurance plans with below average risk scores to those plans with above average risk scores within each state. The Company estimates the receivable or payable under the risk adjustment program based on its estimated risk score compared to the state average risk score. The Company may record a receivable or payable as an adjustment to premium revenues to reflect the year-to-date impact of the risk adjustment based on its best estimate. The Company refines its estimate as new information becomes available. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Minimum Medical Loss Ratio&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, the ACA established a minimum MLR for the Health Insurance Marketplace. The risk adjustment program described above is taken into consideration to determine if the Company's estimated annual medical costs are less than the minimum MLR and require an adjustment to premium revenues to meet the minimum MLR. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Cost Sharing Reductions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA directs issuers to reduce the Company's members' cost sharing for essential health benefits for individuals with Federal Poverty Levels (FPLs) between 100% and 250% who are enrolled in a silver tier product; eliminate cost sharing for Indians/Alaska Natives with a FPL less than 300% and eliminate cost sharing for Indians/Alaska Natives regardless of FPL when services are provided by an Indian Health Service. In order to compensate issuers for reduced cost sharing provided to enrollees, CMS pays an advance CSR payment to the Company each month based on the Company's certification data provided at the time of the qualified health plan application. In October 2017, the Trump Administration issued an executive order that immediately ceased payments of CSRs to issuers, and beginning in 2018 premium rates for Health Insurance Marketplace were set without factoring in the cost sharing subsidy payments from the federal government.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Premium and Trade Receivables and Unearned Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium and service revenues collected in advance are recorded as unearned revenue. For performance-based contracts, the Company does not recognize revenue subject to refund until data is sufficient to measure performance. Premiums and service revenues due to the Company are recorded as premium and trade receivables and are recorded net of an allowance based on historical trends and management's judgment on the collectability of these accounts. As the Company generally receives payments during the month in which services are provided, the allowance is typically not significant in comparison to total revenues and does not have a material impact on the presentation of the financial condition or results of operations. Amounts receivable under federal contracts are comprised primarily of contractually defined billings, accrued contract incentives under the terms of the contract, and amounts related to change orders for services not originally specified in the contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity in the allowance for uncollectible accounts is summarized below ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts charged to expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs of uncollectible receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Customers &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company receives the majority of its revenues under contracts or subcontracts with state Medicaid managed care programs. Customers where the aggregate annual contract revenues exceeded 10% of total annual revenues included the state of New York, where the percentage of the Company's total revenue was 10% and 11% for the years ended December 31, 2021 and 2020. None of the Company's customers exceeded 10% of total annual revenues for the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Income (Expense) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income (expense) consists routinely of investment income, interest expense, and equity method earnings from investments. Investment income is derived from the Company's cash, cash equivalents, restricted deposits and investments. Interest expense relates to borrowings under the senior notes, credit facilities, mortgage and construction loans, and capital leases. Further, other income (expense) includes gains or losses on sales of investments, divestitures, and acquisitions as well as debt extinguishment costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities are recorded for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law or tax rates is recognized in income in the period that includes the enactment date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation allowances are provided when it is considered more likely than not that deferred tax assets will not be realized. In determining if a deductible temporary difference or net operating loss can be realized, the Company considers future reversals of existing taxable temporary differences, future taxable income, taxable income in prior carryback periods, and tax planning strategies.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accrues for loss contingencies associated with outstanding litigation, claims, and assessments for which it has determined it is probable that a loss contingency exists and the amount of loss can be reasonably estimated. The Company expenses professional fees associated with litigation claims and assessments as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock based compensation expense is recognized at grant date fair value over the period during which an employee is required to provide service in exchange for the award. Excess tax benefits related to stock compensation are presented as a cash inflow from operating activities. The Company accounts for forfeitures when they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to foreign currency exchange risk through its international subsidiaries whose functional currencies include the Euro and Great British Pound. The assets and liabilities of the Company's subsidiaries are translated into United States dollars at the balance sheet date. The Company translates its proportionate share of earnings using average rates during the year. The resulting foreign currency translation adjustments are recorded as a separate component of accumulated other comprehensive earnings (loss). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Guidance Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial condition, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjk2_7c5661f0-91b4-4dd1-9389-bd91c486d29f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements include the accounts of Centene Corporation and all majority owned subsidiaries and subsidiaries over which the Company exercises the power and control to direct activities significantly impacting financial performance. All material intercompany balances and transactions have been eliminated. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts in the consolidated financial statements and notes have been reclassified to conform to the 2022 presentation. Beginning in 2022, the Company has included a separate line item for depreciation expense on the Consolidated Statement of Operations, which was previously included in selling, general and administrative (SG&amp;amp;A) expenses. Prior period SG&amp;amp;A expense ratios have also been conformed to the current presentation. These reclassifications have no effect on net earnings, cash flow, or stockholders' equity as previously reported.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 2022, the Company acquired all of the issued and outstanding shares of Magellan Health, Inc. (Magellan). The acquisition was accounted for as a business combination. Additionally, during 2022 the Company completed the divestitures of PANTHERx Rare (PANTHERx), its Spanish and Central European businesses, and Magellan Rx. See Note 3. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjU3_ece4cb61-1c16-4d0d-abf9-80df25839286">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;The preparation of financial statements in conformity with generally accepted accounting principles in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Future events and their effects cannot be predicted with certainty; accordingly, the accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes. The Company evaluates and updates its assumptions and estimates on an ongoing basis and may employ outside experts to assist in its evaluation, as considered necessary. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTQ5_cf946741-1c14-44b0-95d7-02b3a8ef47a6">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Business combinations are accounted for using the acquisition method of accounting. The Company allocates the fair value of purchase consideration to the assets acquired and liabilities assumed based on their fair values at the acquisition date. The excess of the fair value of consideration transferred over the fair value of the net assets acquired is recorded as goodwill. Goodwill is generally attributable to the value of the synergies between the combined companies and the value of the acquired assembled workforce, neither of which qualifies for recognition as an intangible asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses its best estimates and assumptions to value assets acquired and liabilities assumed at the acquisition date; however, these estimates are sometimes preliminary and, in some instances, all information required to value the assets acquired and liabilities assumed may not be available or final as of the end of a reporting period subsequent to the business combination. If the accounting for the business combination is incomplete, provisional amounts are recorded. The provisional amounts are updated during the period determined, up to one year from the acquisition date. The Company includes the results of operations of acquired businesses in the Company's consolidated results prospectively from the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquisition related expenses and post-acquisition restructuring costs are recognized separately from the business combination and are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjQ2_b544eb5c-2d9a-439f-8b0f-43cf37d3e5de">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments with original maturities of three months or less are considered to be cash equivalents. Cash equivalents consist of money market funds, bank certificates of deposit, and savings accounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains amounts on deposit with various financial institutions, which may exceed federally insured limits. However, management periodically evaluates the credit-worthiness of those institutions, and the Company has not experienced any losses on such deposits.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMzI1_334ce47d-9322-46da-afd5-74b9c501f698">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments include securities with maturities greater than three months to one year. Long-term investments include securities with maturities greater than one year. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term and long-term investments are generally classified as available-for-sale and are carried at fair value. Certain equity investments are recorded using the fair value or equity method. The Company monitors the difference between the carrying value and fair value of its available-for-sale debt investments and whether declines in fair value are credit related. Unrealized gains and losses on debt investments available-for-sale are excluded from earnings and reported in accumulated other comprehensive earnings (loss), a separate component of stockholders' equity, net of income tax effects. If a loss is deemed to be credit related, the Company recognizes an allowance through earnings. For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes.&#160;If the security meets this criterion, the decline in fair value is recorded in earnings through investment and other income. Premiums and discounts are amortized or accreted over the life of the related security using the effective interest method. To calculate realized gains and losses on the sale of investments, the Company uses the specific amortized cost of each investment sold. Realized gains and losses are recorded in investment and other income. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;The Company uses the equity method to account for investments in entities that it does not control but has the ability to exercise significant influence over operating and financial policies. Generally, under the equity method, original investments in these entities are recorded at cost and subsequently adjusted by the Company's share of equity in income or losses after the date of acquisition&#160;as well as capital contributions to and distributions from these companies.</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTIy_5960163e-040b-462e-97e9-0148f4fa5fa3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Deposits &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted deposits consist of investments required by various state statutes to be deposited or pledged to state agencies. These investments are classified as long-term, regardless of the contractual maturity date, due to the nature of the states' requirements. The Company is required to annually adjust the amount of the deposit pledged to certain states.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjc3_db7f2064-a928-48bf-af79-7890e5f022ef">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value&#160;Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company invests in various financial assets and&#160;incurs various financial liabilities. Fair values are disclosed for all financial instruments, whether or not such values are recognized in the Consolidated Balance Sheets. Management obtains quoted market prices and other observable inputs for these disclosures. The carrying amounts reported in the Consolidated Balance Sheets for cash and cash equivalents, premium and&#160;trade receivables, medical claims liability, accounts payable and accrued expenses, unearned revenue, and certain other current assets and liabilities are carried at cost, which approximates fair value because of their short-term nature. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following methods and assumptions were used to estimate the fair value of each financial instrument: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Available-for-sale investments and restricted deposits: The carrying amount is stated at fair value, based on quoted market prices, where available. For securities not actively traded, fair values were estimated using values obtained from independent pricing services or quoted market prices of comparable instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Senior unsecured notes: Estimated based on third-party quoted market prices for the same or similar issues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Variable rate debt: The carrying amount of the Company's floating rate debt approximates fair value since the interest rates adjust based on market rate adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign currency swap: Estimated based on Great British Pound to US Dollar foreign exchange rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Contingent consideration: Estimated based on expected achievement of metrics included in the acquisition agreement considering circumstances that exist as of the acquisition date.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMzIx_869bbf32-aeec-4d99-bada-d7b6dee53cb9">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Software and Equipment &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, software and equipment are stated at cost less accumulated depreciation. Computer hardware and software includes certain costs incurred in the development of internal-use software, including external direct costs of materials and services and payroll costs of employees devoted to specific software development. Depreciation is calculated principally by the straight-line method over estimated useful lives. Leasehold improvements are depreciated using the straight-line method over the shorter of the expected useful life or the remaining term of the lease. Property, software and equipment are depreciated over the following periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fixed Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;5 - 40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;3 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;10 - 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;1 - 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of all long-lived assets are evaluated to determine if adjustment to the depreciation and amortization period or to the unamortized balance is warranted. Such evaluation is based principally on the expected utilization of the long-lived assets.&lt;/span&gt;&lt;/div&gt;The Company retains fully depreciated assets in property and accumulated depreciation accounts until it removes them from service. In the case of sale, retirement, or disposal, the asset cost and related accumulated depreciation balance is removed from the respective account, and the resulting net amount, less any proceeds, is included as a component of earnings from operations in the Consolidated Statements of Operations.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <cnc:ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjQ4_f29c2841-8557-48e1-be97-af44b5669150">Property, software and equipment are depreciated over the following periods:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fixed Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;5 - 40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;3 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;10 - 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;1 - 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cnc:ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id7f45234b97a4a8db9cc70838a92e915_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzEtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YjM4YWUzYjQ1YWQxNDdiODhmODVjNjhjMTMzNzk2YTZfNQ_48a4b1e0-4f3d-4336-9998-023c1033e933">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2359cd8d83d04e01929e44fe25fcb92f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzEtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YjM4YWUzYjQ1YWQxNDdiODhmODVjNjhjMTMzNzk2YTZfMTA_c8988613-fed8-4859-88b5-ad8c4298056c">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i4607d979606c4f7fa36ae2f1b825cb49_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzItMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YTI4OTAzZGM2OTU2NDhjYjkyNWFhMDA1MmU2YTNiMzlfNA_08bbeb03-196c-41b8-9051-680323b32f36">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i35e17c2ca0f64a168f7fe15e237ef8d1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzItMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YTI4OTAzZGM2OTU2NDhjYjkyNWFhMDA1MmU2YTNiMzlfOQ_d32a22c1-a639-4a9e-a7eb-4b4185864335">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i34c5f25db0f84955937399bdc59bc0f8_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzMtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246NGM0MmEyYmVmMzMzNDI0YTlmMmZiZmZhMzA1ZDM1OWFfNQ_10d0614b-7e3d-4101-b75a-861969a6cc81">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib42047c8782d4d33831b521cdbbe8d2f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzMtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246NGM0MmEyYmVmMzMzNDI0YTlmMmZiZmZhMzA1ZDM1OWFfMTA_c0323480-d5fb-4e39-9b84-9ca20edf2c9d">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib9cb6bb95198406b9dc757a3fe689c48_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzQtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YzA0NzgwNzQyMzQ1NGM3NWJjNjM5NmIzNjlhYTk4NDRfNQ_021fe84c-dd50-445b-9fe1-e52eb6f47a57">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i39698c8d4f5741c2bd5f7bb1c215d1c2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzQtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YzA0NzgwNzQyMzQ1NGM3NWJjNjM5NmIzNjlhYTk4NDRfMTA_83d100cc-2c22-4994-abb1-f7f491db53be">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib0e7605c14854f1298823da0004e7bcd_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzUtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246ZTRiZjg3NDgyODYxNDg5N2EzY2U5YTBhZTE3MTA4NjhfNQ_e9986e9c-813d-421a-bed5-76f8884f4268">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i67e4e863732140539a2d0c4798909e31_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo4OGJkNTdmMzNjNjM0MTQzOTFmMzBmNzE4OThhYjNiZS90YWJsZXJhbmdlOjg4YmQ1N2YzM2M2MzQxNDM5MWYzMGY3MTg5OGFiM2JlXzUtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246ZTRiZjg3NDgyODYxNDg5N2EzY2U5YTBhZTE3MTA4NjhfMTA_1ceb520f-cc88-40b7-8d13-3636da161601">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjQw_f2bd426a-a567-4b39-9696-d329770a1395">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets represent assets acquired in purchase transactions and consist primarily of purchased contract rights and customer relationships, provider contracts, trade names, developed technologies, and goodwill. Intangible assets are amortized using the straight-line method over the following periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased contract rights and customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 21 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 - 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 - 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 - 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests for impairment of intangible assets, as well as long-lived assets, whenever events or changes in circumstances indicate that the carrying value of an asset or asset group (hereinafter referred to as "asset group") may not be recoverable by comparing the sum of the estimated undiscounted future cash flows expected to result from use of the asset group and its eventual disposition to the carrying value. Such factors include, but are not limited to, significant changes in membership, state funding, state contracts, and provider networks and contracts. If the sum of the estimated undiscounted future cash flows is less than the carrying value, an impairment determination is required. The amount of impairment is calculated by subtracting the fair value of the asset group from the carrying value of the asset group. An impairment charge, if any, is recognized within earnings from operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests goodwill for impairment using a fair value approach. The Company is required to test for impairment at least annually, absent a triggering event, which could include a significant decline in operating performance that would require an impairment assessment. Absent any impairment indicators, the Company performs its goodwill impairment testing during the fourth quarter of each year. The Company recognizes an impairment charge for any amount by which the carrying amount of goodwill exceeds its fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company first assesses qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. The Company generally does not calculate the fair value of a reporting unit unless it determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the quantitative test is deemed necessary, the Company determines an appropriate valuation technique to estimate a reporting unit's fair value as of the testing date. The Company utilizes either the income approach or the market approach, whichever is most appropriate for the respective reporting unit. The income approach is based on an internally developed discounted cash flow model that includes many assumptions related to future growth rates, discount factors, future tax rates, and other various assumptions. The market approach is based on financial multiples of comparable companies derived from current market data. The Company then compares the fair value of the reporting unit calculated using the income approach or market approach with its carrying amount and recognizes an impairment charge for the amount by which the carrying amount exceeds fair value. The impairment charge is limited to the total amount of goodwill allocated to the reporting unit. Changes in economic and operating conditions impacting assumptions used in the Company's analyses could result in goodwill impairment in future periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <cnc:ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTUz_8d94bb01-aaad-4e89-a49f-b7ceefdc19f5">Intangible assets are amortized using the straight-line method over the following periods:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased contract rights and customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 21 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 - 15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 - 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 - 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</cnc:ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i74119b927bec4965b1fd97a0689f4f10_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzEtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246ZTI3ZGRjNmYxMDRhNDYxNTgxMTBmNmZkMWE3OTliNzFfNA_42b8c2bd-bbc5-46e4-a840-86525538933f">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7f0027dbc67f4fcfb5bb6efed06c4909_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzEtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246ZTI3ZGRjNmYxMDRhNDYxNTgxMTBmNmZkMWE3OTliNzFfOQ_d0058679-3902-4a52-a19b-83ed7cdf32b3">P21Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if4d49678d798431db2da34d388ffc987_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzItMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YzAwNjc2MjIzMWNmNGE3OWIzZTVmZDc4NjViYjJiNzBfNA_ef8f4dfc-4ff4-4501-a4aa-99237f5d5f12">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iae0603c3ac604874a3f063c971cb1131_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzItMi0xLTEtMzU0MDE4L3RleHRyZWdpb246YzAwNjc2MjIzMWNmNGE3OWIzZTVmZDc4NjViYjJiNzBfOQ_5efc8bf4-5a8a-4440-bce3-35f2e16463cc">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ifcdf168f01c14287ab8225cc4e5ac2a2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzMtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246ZmZmODJhZTMxMzgwNGI3YmEwYzc5ZjdkNDMxZDU3YzhfNA_11f2e390-4419-481d-9c43-296f6e9dba48">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id7c90459707d4aa69df99c5cbc3d379b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzMtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246ZmZmODJhZTMxMzgwNGI3YmEwYzc5ZjdkNDMxZDU3YzhfOQ_e1322719-1f84-44b9-b5a0-4c876bb02c75">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5054b3e6c71b40e494d1cacca5fded80_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzQtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246NDNmNzYyM2EyZWY1NDcxNDlmMmQ3NTJmNGM3MGUxN2ZfNA_d9a21936-3278-4172-a2d1-f014d0ce1b1f">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i77c71d30602b434bb2aa3deac20d8334_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZTo3M2FhMTIxYmQ3ZDE0YjY2YmRlNTRmMzYyOTI4OWI2Yy90YWJsZXJhbmdlOjczYWExMjFiZDdkMTRiNjZiZGU1NGYzNjI5Mjg5YjZjXzQtMi0xLTEtMzU0MDE4L3RleHRyZWdpb246NDNmNzYyM2EyZWY1NDcxNDlmMmQ3NTJmNGM3MGUxN2ZfOQ_1ba70ff2-8ca1-43f9-8ec6-d83a236490e5">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjA0_80303528-e009-412d-a180-e387dada3bbc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medical Claims Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical claims liability includes claims reported but not yet paid, or inventory, estimates for claims incurred but not reported, or IBNR, and estimates for the costs necessary to process unpaid claims at the end of each period.&#160;The Company estimates its medical claims liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice.&#160;These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Actuarial Standards of Practice generally require that the medical claims liability estimates be adequate to cover obligations under moderately adverse conditions.&#160;Moderately adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of estimate.&#160;In many situations, the claims amounts ultimately settled will be different than the estimate that satisfies the Actuarial Standards of Practice. The Company includes in its IBNR an estimate for medical claims liability under moderately adverse conditions which represents the risk of adverse deviation of the estimates in its actuarial method of reserving.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses its judgment to determine the assumptions to be used in the calculation of the required estimates. The assumptions it considers when estimating IBNR include, without limitation, claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, healthcare service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known outbreaks of disease or increased incidence of illness such as influenza or COVID-19, provider contract changes, changes to fee schedules, and the incidence of high-dollar or catastrophic claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's development of the medical claims liability estimate is a continuous process which it monitors and refines on a monthly basis as additional claims receipts and payment information becomes available. As more complete claims information becomes available, the Company adjusts the amount of the estimates, and includes the changes in estimates in medical costs in the period in which the changes are identified. In every reporting period, the operating results include the effects of more completely developed medical claims liability estimates associated with previously reported periods. The Company consistently applies its reserving methodology from period to period. As additional information becomes known, it adjusts the actuarial model accordingly to establish medical claims liability estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement, and maintenance costs. For purposes of determining premium deficiencies, contracts are grouped in a manner consistent with the method of acquiring, servicing, and measuring the profitability of such contracts.&lt;/span&gt;&lt;/div&gt;</us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjUx_2116e564-2245-464c-a1b9-2bd66908565e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's health plans generate revenues primarily from premiums received from the states in which it operates health plans, premiums received from its members and the Centers for Medicare and Medicaid Services (CMS) for its Medicare product, and premiums from members of its commercial health plans. In addition to member premium payments, its Marketplace contracts also generate revenues from subsidies received from CMS. The Company generally receives a fixed premium per member per month pursuant to its contracts and recognizes premium revenues during the period in which it is obligated to provide services to its members at the amount reasonably estimable. In some instances, the Company's base premiums are subject to an adjustment factor, in the form of a risk score or risk adjustment, based on the acuity of its membership. Generally, the risk score or risk adjustment is determined by the state or CMS analyzing submissions of processed claims and medical record data to determine the acuity of the Company's membership, often relative to the respective program's membership. The Company estimates the amount of risk score and risk adjustment based upon the processed claims and medical record data submitted and expected to be submitted to CMS and records revenues on a risk adjusted basis. Some contracts allow for additional premiums related to certain supplemental services provided such as maternity deliveries.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's contracts with states may require it to maintain a minimum health benefits ratio (HBR) or may require it to share cost-savings in excess of certain levels. In certain circumstances, including commercial plans, its plans may be required to return premium to the state or policyholders in the event costs are below established levels. The Company estimates the effect of these programs and recognizes reductions in revenue in the current period. Other states may require us to meet certain performance and quality metrics in order to receive additional or full contractual revenue. For performance-based contracts, the Company does not recognize revenue subject to refund until data is sufficient to measure performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recorded based on membership and eligibility data provided by the states or CMS, which is adjusted on a monthly basis by the states or CMS for retroactive additions or deletions to membership data. These eligibility adjustments are estimated monthly and subsequent adjustments are made in the period known. The Company reviews and updates those estimates as new information becomes available.&#160;It is possible that new information could require us to make additional adjustments, which could be significant, to these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's Medicare Advantage contracts are with CMS. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model pays more for members whose medical history would indicate that they are expected to have higher medical costs. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis data from hospital inpatient, hospital outpatient, physician treatment settings as well as prescription drug events. The Company and the healthcare providers collect, compile, and submit the necessary and available diagnosis data to CMS within prescribed deadlines. The Company estimates risk adjustment revenues based upon the diagnosis data submitted and expected to be submitted to CMS and records revenues on a risk adjusted basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For qualifying low-income prescription drug benefit members, CMS pays for some, or all, of the member's monthly premium. The Company receives certain Part D prospective subsidy payments from CMS for these members as a fixed monthly per member amount, based on the estimated costs of providing prescription drug benefits over the plan year, as reflected in its bids. Approximately nine to ten months subsequent to the end of the plan year, or later in the case of the coverage gap discount subsidy, a settlement payment is made between CMS and the Company's plans based on the difference between the prospective payments and actual claims experience. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's specialty services generate revenues under contracts with state and federal programs, healthcare organizations, and other commercial organizations, as well as from its own subsidiaries. Revenues are recognized when the related services are provided, when inventory is shipped, or as ratably earned over the covered period of services. The Company recognizes revenue related to administrative services under the TRICARE government-sponsored Managed Care Support Contract for the DoD's TRICARE program on a straight-line basis over the option period, when the fees become fixed and determinable. The TRICARE contract includes various performance-based measures.&#160;For each of the measures, an estimate of the amount that has been earned is made at each interim date, and revenue is recognized accordingly. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some states enact premium taxes, similar assessments, and provider pass-through payments, collectively premium taxes, and these taxes are recorded as a separate component of both revenues and operating expenses. Additionally, the Company's insurance subsidiaries were previously subject to the Affordable Care Act (ACA) annual health insurer fee (HIF). Beginning in 2021, the HIF was permanently repealed. This revenue was recorded as premium tax and health insurer fee revenue in the Consolidated Statements of Operations. For certain products, premium taxes, state assessments, and the HIF are not pass-through payments and are recorded as premium revenue and premium tax expense or health insurer fee expense in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;Some states require state directed payments that have minimal risk, but are administered as a premium adjustment.&#160;These payments are recorded as premium revenue and medical costs at close to a 100% HBR. In many instances, the Company has little visibility to the timing of these payments until they are paid by the state.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <cnc:HealthInsuranceMarketplaceDisclosurePolicyTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTc0_bc56e995-837f-47b5-bd15-3a2f31be4980">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Affordable Care Act&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established risk spreading premium stabilization programs as well as minimum medical loss ratio (MLR) and cost sharing reductions (CSRs). The Company's accounting policies for the programs are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Risk Adjustment &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The permanent risk adjustment program established by the ACA transfers funds from qualified individual and small group insurance plans with below average risk scores to those plans with above average risk scores within each state. The Company estimates the receivable or payable under the risk adjustment program based on its estimated risk score compared to the state average risk score. The Company may record a receivable or payable as an adjustment to premium revenues to reflect the year-to-date impact of the risk adjustment based on its best estimate. The Company refines its estimate as new information becomes available. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Minimum Medical Loss Ratio&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, the ACA established a minimum MLR for the Health Insurance Marketplace. The risk adjustment program described above is taken into consideration to determine if the Company's estimated annual medical costs are less than the minimum MLR and require an adjustment to premium revenues to meet the minimum MLR. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Cost Sharing Reductions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA directs issuers to reduce the Company's members' cost sharing for essential health benefits for individuals with Federal Poverty Levels (FPLs) between 100% and 250% who are enrolled in a silver tier product; eliminate cost sharing for Indians/Alaska Natives with a FPL less than 300% and eliminate cost sharing for Indians/Alaska Natives regardless of FPL when services are provided by an Indian Health Service. In order to compensate issuers for reduced cost sharing provided to enrollees, CMS pays an advance CSR payment to the Company each month based on the Company's certification data provided at the time of the qualified health plan application. In October 2017, the Trump Administration issued an executive order that immediately ceased payments of CSRs to issuers, and beginning in 2018 premium rates for Health Insurance Marketplace were set without factoring in the cost sharing subsidy payments from the federal government.&lt;/span&gt;&lt;/div&gt;</cnc:HealthInsuranceMarketplaceDisclosurePolicyTextBlock>
    <cnc:PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTU5_4c7d8e53-40c9-4660-98df-881eb7c468ad">Premium and Trade Receivables and Unearned RevenuePremium and service revenues collected in advance are recorded as unearned revenue. For performance-based contracts, the Company does not recognize revenue subject to refund until data is sufficient to measure performance. Premiums and service revenues due to the Company are recorded as premium and trade receivables and are recorded net of an allowance based on historical trends and management's judgment on the collectability of these accounts. As the Company generally receives payments during the month in which services are provided, the allowance is typically not significant in comparison to total revenues and does not have a material impact on the presentation of the financial condition or results of operations. Amounts receivable under federal contracts are comprised primarily of contractually defined billings, accrued contract incentives under the terms of the contract, and amounts related to change orders for services not originally specified in the contract.</cnc:PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock>
    <cnc:ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjMz_77140b51-55f1-49e2-aed7-cc9e73fee8ea">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity in the allowance for uncollectible accounts is summarized below ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts charged to expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs of uncollectible receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cnc:ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock>
    <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzEtMS0xLTEtMzU0MDE4_ad9580c6-1591-4206-99fe-c1f33d6b50a5"
      unitRef="usd">139000000</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts>
    <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzEtMy0xLTEtMzU0MDE4_281d9424-869d-4906-898c-1f8dc07368ed"
      unitRef="usd">243000000</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts>
    <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts
      contextRef="i89efa37b183c4c618c28149ddb506553_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzEtNS0xLTEtMzU0MDE4_9c2417f5-ae79-4cb6-95d7-c44ad6a6baf1"
      unitRef="usd">157000000</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts>
    <us-gaap:PremiumReceivableCreditLossExpenseReversal
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzMtMS0xLTEtMzU0MDE4_2f4d9a8c-eeb0-4681-83c6-bc253e173cb2"
      unitRef="usd">70000000</us-gaap:PremiumReceivableCreditLossExpenseReversal>
    <us-gaap:PremiumReceivableCreditLossExpenseReversal
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzMtMy0xLTEtMzU0MDE4_0e4ac23a-012b-41f9-9e37-6cca934967c1"
      unitRef="usd">62000000</us-gaap:PremiumReceivableCreditLossExpenseReversal>
    <us-gaap:PremiumReceivableCreditLossExpenseReversal
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzMtNS0xLTEtMzU0MDE4_6f20597e-f120-4ea7-80de-3466b5deefbe"
      unitRef="usd">121000000</us-gaap:PremiumReceivableCreditLossExpenseReversal>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzQtMS0xLTEtMzU0MDE4_76130f8a-745c-4161-bbb8-37a17453722f"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzQtMy0xLTEtMzU0MDE4_1c9d84be-7b1e-4334-aa05-50c9d83042ff"
      unitRef="usd">43000000</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzQtNS0xLTEtMzU0MDE4_dce4c10a-9b55-43eb-a1fb-3de60b77383f"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzUtMS0xLTEtMzU0MDE4_4d8658c5-6038-46b4-b92c-f733177975b8"
      unitRef="usd">79000000</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance>
    <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzUtMy0xLTEtMzU0MDE4_892c7d80-6aed-48ef-9ceb-b79db18a305f"
      unitRef="usd">123000000</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance>
    <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzUtNS0xLTEtMzU0MDE4_694a8382-edda-4680-820e-2ff228e412eb"
      unitRef="usd">35000000</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance>
    <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzYtMS0xLTEtMzU0MDE4_e479aa52-1ab0-464e-b1ee-4b4e1796c2d7"
      unitRef="usd">130000000</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts>
    <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzYtMy0xLTEtMzU0MDE4_9b26a00a-7bbf-461d-99e6-48fcfa96b3c5"
      unitRef="usd">139000000</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts>
    <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90YWJsZToyNjQ3MDRlYTcwOTg0ZWQyOTZhMDg0ODk5ZGI0ODI3NC90YWJsZXJhbmdlOjI2NDcwNGVhNzA5ODRlZDI5NmEwODQ4OTlkYjQ4Mjc0XzYtNS0xLTEtMzU0MDE4_f594cd13-7a97-4414-a01b-ac4f848e81ce"
      unitRef="usd">243000000</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts>
    <cnc:SignificantCustomersPolicyTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTY1_b0852979-8538-445a-af70-10fea6a5191c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Customers &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company receives the majority of its revenues under contracts or subcontracts with state Medicaid managed care programs. Customers where the aggregate annual contract revenues exceeded 10% of total annual revenues included the state of New York, where the percentage of the Company's total revenue was 10% and 11% for the years ended December 31, 2021 and 2020. None of the Company's customers exceeded 10% of total annual revenues for the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;</cnc:SignificantCustomersPolicyTextBlock>
    <cnc:PercentageOfRevenuesUnderContractsOrSubcontracts
      contextRef="if6cdbd424736484b93b773b56ebf2191_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzI2Mjg2_1356ed16-26e5-4f34-8139-b7a8f696e74a"
      unitRef="number">0.10</cnc:PercentageOfRevenuesUnderContractsOrSubcontracts>
    <cnc:PercentageOfRevenuesUnderContractsOrSubcontracts
      contextRef="if869d22d0f044d3d9bfb60d75bc74fbe_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzI2Mjk0_658252a8-e3dd-4cc7-97ff-fff9227598f8"
      unitRef="number">0.11</cnc:PercentageOfRevenuesUnderContractsOrSubcontracts>
    <cnc:PercentageOfRevenuesUnderContractsOrSubcontracts
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzQ5NDc4MDIzNjA0NzQ_b3fddb06-0d28-4f9a-8473-728611f57ffc"
      unitRef="number">0</cnc:PercentageOfRevenuesUnderContractsOrSubcontracts>
    <cnc:OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTcx_f38a8b90-1c06-4a53-89b2-0efaddc782e4">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Income (Expense) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;Other income (expense) consists routinely of investment income, interest expense, and equity method earnings from investments. Investment income is derived from the Company's cash, cash equivalents, restricted deposits and investments. Interest expense relates to borrowings under the senior notes, credit facilities, mortgage and construction loans, and capital leases. Further, other income (expense) includes gains or losses on sales of investments, divestitures, and acquisitions as well as debt extinguishment costs.</cnc:OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTE5_fb1343fb-953c-4703-bdc9-e2562af5420d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities are recorded for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law or tax rates is recognized in income in the period that includes the enactment date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation allowances are provided when it is considered more likely than not that deferred tax assets will not be realized. In determining if a deductible temporary difference or net operating loss can be realized, the Company considers future reversals of existing taxable temporary differences, future taxable income, taxable income in prior carryback periods, and tax planning strategies.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTg1_fe3065ed-4565-4f9c-94ec-2c858b306056">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accrues for loss contingencies associated with outstanding litigation, claims, and assessments for which it has determined it is probable that a loss contingency exists and the amount of loss can be reasonably estimated. The Company expenses professional fees associated with litigation claims and assessments as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMTMz_8d8ffc21-ac5d-4422-8281-1506284a65b9">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock based compensation expense is recognized at grant date fair value over the period during which an employee is required to provide service in exchange for the award. Excess tax benefits related to stock compensation are presented as a cash inflow from operating activities. The Company accounts for forfeitures when they occur.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMzIz_54959396-1a17-4fd2-b244-4698d3289b13">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;The Company is exposed to foreign currency exchange risk through its international subsidiaries whose functional currencies include the Euro and Great British Pound. The assets and liabilities of the Company's subsidiaries are translated into United States dollars at the balance sheet date. The Company translates its proportionate share of earnings using average rates during the year. The resulting foreign currency translation adjustments are recorded as a separate component of accumulated other comprehensive earnings (loss).</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDMvZnJhZzplNjcyYWFiNWRiZGQ0Y2Y3YmU3MTVhODA5MjdkMjE4Yi90ZXh0cmVnaW9uOmU2NzJhYWI1ZGJkZDRjZjdiZTcxNWE4MDkyN2QyMThiXzMwMjI4_9cf3b29a-656a-4b3d-b3c5-9402c5322911">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Guidance Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial condition, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzQ2MTE_005d8826-2441-4ece-9b2c-5df158a9049d">Acquisitions and Divestitures&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Magellan Acquisition &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On&#160;January&#160;4, 2022, the Company acquired all of the issued and outstanding shares of Magellan. Total consideration for the acquisition was $2,491 million, consisting of $2,431 million in cash and $60 million related to the fair value of replacement equity awards associated with pre-combination service. The purchase price has been adjusted to reflect the net effective settlement of preexisting relationships between the Company and Magellan of $70&#160;million. The Company recognized $106 million of acquisition related expenses related to Magellan for the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Magellan acquisition was accounted for as a business combination using the acquisition method of accounting that requires assets acquired and liabilities assumed to be recognized at fair value as of the acquisition date. The valuation of all assets acquired and liabilities assumed was finalized in the fourth quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's allocation of the fair value of assets acquired and liabilities assumed as of the acquisition date of January&#160;4, 2022 is as follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium and related receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted deposits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, software and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical claims liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return of premium payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mezzanine equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant fair value adjustments are noted as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The identifiable intangible assets acquired are to be measured at fair value as of the completion of the acquisition. The fair value of intangible assets is determined primarily using variations of the income approach, which is based on the present value of the future after-tax cash flows attributable to each identified intangible asset. Other valuation methods, including the market approach and cost approach, were also considered in estimating the fair value. The identifiable intangible assets include purchased contract rights, provider contracts, developed technologies, and trade names. The Company has estimated the fair value of intangible assets to be $889 million with a weighted average life of 12 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values and weighted average useful lives for identifiable intangible assets acquired are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Useful Life in Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased contract rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  Debt is required to be measured at fair value under the acquisition method of accounting. The fair value of Magellan's&#160;Senior Notes and Credit Agreement assumed in the acquisition was&#160;$535 million. In January 2022, the Company paid off Magellan's debt acquired in the transaction using Magellan's cash on hand.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The deferred tax liabilities are presented net of $102 million of deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The acquisition resulted in $905 million of goodwill primarily related to synergies expected from the acquisition and the assembled workforce of Magellan. All of the goodwill was assigned to the Specialty segment. The majority of the goodwill is not deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PANTHERx Rare Divestiture&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July&#160;14, 2022, the Company completed the divestiture of PANTHERx for $1,373 million. The Company recognized a gain of $490&#160;million, or $382 million after-tax, which is included in investment and other income on the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Spanish and Central European Divestiture&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November&#160;16, 2022, as part of the Company's review of strategic alternatives for its international portfolio, the Company completed the divestiture of its ownership stakes in its Spanish and Central European businesses, including Ribera Salud, Torrej&#xf3;n Salud, and Pro Diagnostics Group.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2022, the Company recorded an impairment charge primarily related to intangible assets and goodwill associated with the divestiture of $163 million, or $140 million after-tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Magellan Rx Divestiture&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December&#160;2, 2022, the Company completed the divestiture of Magellan Rx for $1,337 million. The Company recognized a gain of $269&#160;million, or $99&#160;million after-tax, which is included in investment and other income on the Consolidated Statements of Operations and is subject to a final working capital adjustment. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Magellan Specialty Health Divestiture&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November&#160;17, 2022, the Company signed a definitive agreement to divest Magellan Specialty Health. As of December&#160;31, 2022, the assets and liabilities of Magellan Specialty Health were considered held for sale, resulting in $645&#160;million of assets held for sale in other current assets and $87&#160;million of liabilities held for sale in accounts payable and accrued expenses on the Consolidated Balance Sheet. The majority of the of held for sale assets were previously reported as goodwill and intangible assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;20, 2023, the Company completed the divestiture for approximately $646&#160;million in cash and stock, including an estimated working capital adjustment. The Company estimates that it will recognize an initial pre-tax gain of approximately $85 million to $95 million. The Company could also receive up to an additional $150&#160;million in cash and stock in 2024 based on certain 2023 performance metrics. The Company will recognize the appropriate amount of contingent consideration related to the $150&#160;million when realized or realizable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Centurion Divestiture&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;10, 2023, the Company signed and closed a definitive agreement to divest Centurion, its prison healthcare business. As of December&#160;31, 2022, the assets and liabilities of Centurion were considered held for sale resulting in $236&#160;million of assets held for sale in other current assets and $198&#160;million of liabilities held for sale in accounts payable and accrued expenses on the Consolidated Balance Sheet. The majority of the held for sale assets were previously reported as premium and trade receivables. The majority of the liabilities were previously reported as medical claims liability and accounts payable and accrued liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2022, the Company recorded an impairment charge related to goodwill and other current assets associated with the divestiture of $259 million, or $181 million after-tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;HealthSmart Divestiture&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November&#160;1, 2022, the Company signed a definitive agreement to divest HealthSmart, its third party health plan administration business. The divestiture was completed on January&#160;5, 2023. As of December&#160;31, 2022, the assets and liabilities of HealthSmart were considered held for sale resulting in $66 million of assets held for sale in other current assets and $34 million of liabilities held for sale in accounts payable and accrued expenses on the Consolidated Balance Sheet. The majority of the held for sale assets were previously reported as cash and cash equivalents, premium and trade receivables, and goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2022, the Company recorded an impairment charge related to goodwill associated with the divestiture of $36 million, or $27 million after-tax.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i906fa59240054e0ca347d7e3ce1f9812_D20220104-20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzE1Mw_bc00fc9d-83e5-4a05-bdae-d750c29c000e"
      unitRef="usd">2491000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i906fa59240054e0ca347d7e3ce1f9812_D20220104-20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzE3MQ_bdd6600b-3579-4455-9c15-4ab34e5df7e0"
      unitRef="usd">2431000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1
      contextRef="i906fa59240054e0ca347d7e3ce1f9812_D20220104-20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzE4Ng_d38aa1e1-04db-4485-9da9-03de225bcf81"
      unitRef="usd">60000000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzQyNw_91ada634-a844-4a13-b14e-0d5ba9288784"
      unitRef="usd">70000000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i3799e2d4c58049f4bac2714882700574_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzQ1NA_e46ba8e7-db13-47e4-ab34-5ac372ffdf58"
      unitRef="usd">106000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzQ2MTM_b5400c05-38ce-4cf2-89af-9bc2c7cf783b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's allocation of the fair value of assets acquired and liabilities assumed as of the acquisition date of January&#160;4, 2022 is as follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium and related receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted deposits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, software and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical claims liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return of premium payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mezzanine equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzEtMi0xLTEtMzU0MDE4_64a8620d-7c06-4c3b-a14c-a3fc23b430c5"
      unitRef="usd">995000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzItMi0xLTEtMzU0MDE4_4f242bf0-9ca1-4af8-9edd-a73962893811"
      unitRef="usd">791000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzMtMi0xLTEtMzU0MDE4_0f275883-335e-4e9e-a0a9-efe098e1aa8d"
      unitRef="usd">144000000</cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzQtMi0xLTEtMzU0MDE4_d60fffc0-5e8f-4a05-9300-07c7159db819"
      unitRef="usd">145000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzUtMi0xLTEtMzU0MDE4_4b8b752d-961d-47d0-9185-fe514eb4cb9d"
      unitRef="usd">43000000</cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments>
    <cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzYtMi0xLTEtMzU0MDE4_f44f4e66-64c0-427a-9e72-2be9a89f152f"
      unitRef="usd">7000000</cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzctMi0xLTEtMzU0MDE4_f8f7cc1f-fd77-4e35-ae27-d3eb045235fd"
      unitRef="usd">72000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzgtMi0xLTEtMzU0MDE4_7a35e091-def5-4331-82bf-0e3c8cc76ac3"
      unitRef="usd">889000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzktMi0xLTEtMzU0MDE4_0f6623a5-500a-4198-aa00-dfd7d4c4cf11"
      unitRef="usd">50000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzEwLTItMS0xLTM1NDAxOA_758b9d07-32cf-4878-a09f-45c2cb361d84"
      unitRef="usd">3136000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzEyLTItMS0xLTM1NDAxOA_47bf8134-e0d5-4aae-bac5-f4b8aec8bf2f"
      unitRef="usd">194000000</cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzEzLTItMS0xLTM1NDAxOA_3408bc42-2a49-4a29-ba52-b707df8e0730"
      unitRef="usd">495000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzE0LTItMS0xLTM1NDAxOA_16fcc353-9fa9-4025-8e1e-e0450945e1c1"
      unitRef="usd">53000000</cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzE1LTItMS0xLTM1NDAxOA_578d6728-47b0-4d26-a418-03d5d3606bfe"
      unitRef="usd">8000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzE2LTItMS0xLTM1NDAxOA_ddc58ac4-c28c-4d69-a3fa-c3270fa26ea6"
      unitRef="usd">5000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzE3LTItMS0xLTM1NDAxOA_85974fca-29ac-4b82-8de5-0a362cb06dfc"
      unitRef="usd">542000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzE4LTItMS0xLTM1NDAxOA_83813743-f146-41c3-9f02-329084453531"
      unitRef="usd">157000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzE5LTItMS0xLTM1NDAxOA_1284801f-6405-4ae1-b110-6daf32341a82"
      unitRef="usd">64000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzIwLTItMS0xLTM1NDAxOA_d31b42e9-ede6-45c2-b9d2-51094a8ffc37"
      unitRef="usd">1518000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzIxLTItMS0xLTM1NDAxOA_04884c64-cee1-4e33-be06-1c8a3ad5f7d5"
      unitRef="usd">32000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzIyLTItMS0xLTM1NDAxOA_bfade448-8b20-4d08-b669-c8d3c5f76d79"
      unitRef="usd">1586000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzIzLTItMS0xLTM1NDAxOA_eb0ff89d-0deb-43da-958b-58205997b3bd"
      unitRef="usd">905000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTpmMzBhMGYwMDU2N2Q0MTkzYjZjNWI0M2MyZDY3NGJmYy90YWJsZXJhbmdlOmYzMGEwZjAwNTY3ZDQxOTNiNmM1YjQzYzJkNjc0YmZjXzI0LTItMS0xLTM1NDAxOA_48d7d481-3c3b-48d5-9eea-5f561b6d2d64"
      unitRef="usd">2491000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzIxODM_7a35e091-def5-4331-82bf-0e3c8cc76ac3"
      unitRef="usd">889000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i906fa59240054e0ca347d7e3ce1f9812_D20220104-20220104"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzIyMTg_3877498e-de8c-4aef-aa23-54c01814ffba">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzQ2MTU_9dfab382-b5b5-4434-9b08-8cedc300749c">&lt;div style="padding-left:22.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values and weighted average useful lives for identifiable intangible assets acquired are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Useful Life in Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased contract rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i8fd457add58740c084e97e1c414ce9f9_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzEtMi0xLTEtMzU0MDE4_b02c1ddb-3c10-4537-95be-1d452443ee1d"
      unitRef="usd">581000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iea27c4aa651545eaa7d30d7a626031a7_D20220104-20220104"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzEtNC0xLTEtMzU0MDE4_289d5da8-4833-4ea1-b871-654453ce2b32">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id1b54f2cbfd746b8a13ac300eb5f594d_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzItMi0xLTEtMzU0MDE4_fdb06423-1dd6-4e93-8985-85b554d2ba72"
      unitRef="usd">120000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ic898092fd2d349718cfc66201cf1e5db_D20220104-20220104"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzItNC0xLTEtMzU0MDE4_908bd728-686d-47f9-8167-0192b6906f8f">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9adcef2d77d24557bc8ed47f59f80d11_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzMtMi0xLTEtNDY5MDUy_8990ab36-0c6e-47ae-9bc9-82588edb34aa"
      unitRef="usd">101000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="idb157bc574b24e8ea7212ed38cddbc14_D20220104-20220104"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzMtNC0xLTEtNDY5MDUy_14f4c0a3-e27f-4f0d-a211-f13cb3352c88">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i68d8c947320f402488ed555c813a0394_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzMtMi0xLTEtMzU0MDE4_93c3189c-0afb-4ce9-a47f-68711a9b8744"
      unitRef="usd">87000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ie2f7de6d3ba44de9a27dfe4b0d2086cd_D20220104-20220104"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzMtNC0xLTEtMzU0MDE4_9bc603aa-01ab-4474-9b7b-de46b9aab215">P17Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzUtMi0xLTEtMzU0MDE4_28f24c3f-5df3-4b4c-bee3-cdbad05b9e11"
      unitRef="usd">889000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i906fa59240054e0ca347d7e3ce1f9812_D20220104-20220104"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90YWJsZTo0MjAxMGU2NTgzZDI0ZjNhOTA1NjQ2ZGM3MmRiMTFjYS90YWJsZXJhbmdlOjQyMDEwZTY1ODNkMjRmM2E5MDU2NDZkYzcyZGIxMWNhXzUtNC0xLTEtMzU0MDE4_3877498e-de8c-4aef-aa23-54c01814ffba">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzI4MjY_a0bd4420-76fa-4eb7-8732-7a6446dbb4e6"
      unitRef="usd">535000000</cnc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzI5OTg_eafba6f3-227e-4be3-9af6-7ef5ef8dee74"
      unitRef="usd">102000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:Goodwill
      contextRef="ib9e33ae8c26e4bee80e6c7f1321df430_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzMwNTg_eb0ff89d-0deb-43da-958b-58205997b3bd"
      unitRef="usd">905000000</us-gaap:Goodwill>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i8676d1a500a445dfbdfe2ed3255b473a_D20220714-20220714"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzM0NDc_8736b330-551b-4f8f-9d1f-5147a0d7f76e"
      unitRef="usd">1373000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i8676d1a500a445dfbdfe2ed3255b473a_D20220714-20220714"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzM0ODQ_d1a9872b-a471-4e8b-bab5-4cb8c60a55fc"
      unitRef="usd">490000000</us-gaap:GainLossOnSaleOfBusiness>
    <cnc:GainLossOnDispositionOfBusinessNetOfTax
      contextRef="i8676d1a500a445dfbdfe2ed3255b473a_D20220714-20220714"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzM0OTE_2f0a578b-dab9-4e97-a9cd-b5027859b8c6"
      unitRef="usd">382000000</cnc:GainLossOnDispositionOfBusinessNetOfTax>
    <us-gaap:AssetImpairmentCharges
      contextRef="i3fad3c7a923b4e3ea96e190945650528_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgyMDYwMg_93f4c5ec-8881-449a-a158-f690577702d2"
      unitRef="usd">163000000</us-gaap:AssetImpairmentCharges>
    <cnc:AssetImpairmentChargesNetOfTax
      contextRef="i3fad3c7a923b4e3ea96e190945650528_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzOTYxMQ_fc68b0a6-39d5-4adb-9940-83301eb59cf4"
      unitRef="usd">140000000</cnc:AssetImpairmentChargesNetOfTax>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i6a752c4a069849f8a31ceb9055f487f2_D20221202-20221202"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNzUyNg_12793293-43a3-425c-9507-8725e74a51d7"
      unitRef="usd">1337000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i6a752c4a069849f8a31ceb9055f487f2_D20221202-20221202"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNzU2NA_c0bdc307-f5b6-41a6-adb6-d2e445ff5246"
      unitRef="usd">269000000</us-gaap:GainLossOnSaleOfBusiness>
    <cnc:GainLossOnDispositionOfBusinessNetOfTax
      contextRef="i6a752c4a069849f8a31ceb9055f487f2_D20221202-20221202"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNzU3Mg_8d355370-1790-4000-8fb8-9986922f7294"
      unitRef="usd">-99000000</cnc:GainLossOnDispositionOfBusinessNetOfTax>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i40a749aec9b14d808f4fa50726eaa259_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzMyOTg1MzQ4OTcxODM_04ba49a8-a5fe-4b56-af6b-3155ee7f6234"
      unitRef="usd">645000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i40a749aec9b14d808f4fa50726eaa259_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzMyOTg1MzQ4OTcxOTg_0bdf16cf-9da1-410f-aa75-86536d3621fa"
      unitRef="usd">87000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i4727fabbef274d23a97b2b7195f75143_I20230120"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzMyOTg1MzQ4OTcyNDg_a52bbb99-b1a9-45e5-a4cb-640fe8618170"
      unitRef="usd">646000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i1032a3c41f4546a19e08100bbd31888f_D20230120-20230120"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNzM5Mg_4aa3d40d-838e-4098-a9f2-b1da9d9cc100"
      unitRef="usd">85000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ie93c74b491b34072ae22f37b005de9da_D20230120-20230120"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNzQyMQ_8d613845-76b0-4270-a9b2-9a863ba4e084"
      unitRef="usd">95000000</us-gaap:GainLossOnSaleOfBusiness>
    <cnc:DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh
      contextRef="i4727fabbef274d23a97b2b7195f75143_I20230120"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzEwOTk1MTE2NTUxNDA_c0e9267b-0617-4200-8f7a-0d2277865459"
      unitRef="usd">150000000</cnc:DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh>
    <cnc:DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh
      contextRef="i4727fabbef274d23a97b2b7195f75143_I20230120"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzEwOTk1MTE2NTUxNDg_c0e9267b-0617-4200-8f7a-0d2277865459"
      unitRef="usd">150000000</cnc:DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ided6cdd3afac49e7905a2933ce43623e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNDE1Mg_44e20e58-84a9-4d6b-a2ee-4785b5e6ab47"
      unitRef="usd">236000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ided6cdd3afac49e7905a2933ce43623e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNDE1OQ_943cf08e-767a-41b8-9ebe-2f1bbbe34dbc"
      unitRef="usd">198000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetImpairmentCharges
      contextRef="i0fc78fa9a34b400587dbebfb3ac1f1e0_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNDE4OA_8b695447-0d19-4bf9-98ac-9c4de1f2d87d"
      unitRef="usd">259000000</us-gaap:AssetImpairmentCharges>
    <cnc:AssetImpairmentChargesNetOfTax
      contextRef="i0fc78fa9a34b400587dbebfb3ac1f1e0_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNDE5Ng_56469b9f-0e7b-465d-bd53-4cd9d159bd3b"
      unitRef="usd">181000000</cnc:AssetImpairmentChargesNetOfTax>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i86423bee35dc4d99be0b3b984e6903db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzOTA2Nw_d8b09dbe-a787-4ec0-8e5e-fdcd87ce11a1"
      unitRef="usd">66000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i86423bee35dc4d99be0b3b984e6903db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzOTA3NQ_8dd7f2fa-2198-411a-a141-6611d2b0ddbd"
      unitRef="usd">34000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetImpairmentCharges
      contextRef="ie6bd664dd1964db0a6890c587570d306_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNDE3MA_eee37834-ccc7-4772-875f-b3e50c2b91c6"
      unitRef="usd">36000000</us-gaap:AssetImpairmentCharges>
    <cnc:AssetImpairmentChargesNetOfTax
      contextRef="ie6bd664dd1964db0a6890c587570d306_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMDYvZnJhZzoxYWMyMzlmYmY4MjE0YzM2YjkxNDFjYjY2N2MxNGNiOS90ZXh0cmVnaW9uOjFhYzIzOWZiZjgyMTRjMzZiOTE0MWNiNjY3YzE0Y2I5XzU0OTc1NTgzNDE3OQ_cdc97b0a-e98e-4902-a023-b12b4fd04c24"
      unitRef="usd">27000000</cnc:AssetImpairmentChargesNetOfTax>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzQ5MzQ_f0c3d40b-508c-4937-8487-d774801cb117">Short-term and Long-term Investments, Restricted Deposits &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities and obligations of U.S. government corporations and agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term time deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,364)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:10.8pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investments in equity securities as of December&#160;31, 2021 primarily consisted of exchange traded funds in fixed income securities.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments, and life insurance contracts.&#160;The Company's investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with a focus on high credit quality securities.&#160;The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of December&#160;31, 2022, 98% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations.&#160;At December&#160;31, 2022, the Company held certificates of deposit, equity securities, private equity investments, and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzEwNTE_c9c93204-9871-484c-a20b-e44dba7e3ac9"&gt;132&#160;million&lt;/span&gt; and $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzEwNTg_296f7fee-e19d-4aef-8f1c-7793183430b5"&gt;96&#160;million&lt;/span&gt; at December 31, 2022 and 2021, respectively, and is included in other current assets on the Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association, or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AAA and a weighted average duration of 4 years at December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less Than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;12 Months or More&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less Than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;12 Months or More&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities and obligations of U.S. government corporations and agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,400&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the gross unrealized losses were generated from 6,423 positions out of a total of 6,854 positions.&#160;The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual, or regulatory purposes.&#160;If the security meets this criterion, the decline in fair value is recorded in earnings.&#160;The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates, and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit related loss may include rating agency actions, adverse conditions specifically related to the security, or failure of the issuer of the security to make scheduled payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the Company acquired the remaining 60% interest of Circle Health for $705&#160;million. As a result of the acquisition, the Company recorded a non-cash gain of $309&#160;million on its original investment in the year ended December&#160;31, 2021. The gain was included in investment and other income on the Consolidated Statement of Operations. Beginning in July 2021, the Company consolidates 100% of Circle Health.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, the Company recorded a $229 million impairment of its equity method investment in RxAdvance, a pharmacy benefit manager. The impairment was the result of the Company&#x2019;s focus on simplification of its pharmacy operations. The impairment was based on the Company's estimate of RxAdvance's future cash flows and other market indicators of fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Deposits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Actual maturities may differ from contractual maturities due to call or prepayment options.&#160;Equity securities, private equity investments, and life insurance contracts are excluded from the table above because they do not have a contractual maturity.&#160;The Company has an option to redeem substantially all of the securities included in the greater than ten years category listed above at amortized cost.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzQ5MjQ_107d43f5-388f-4619-a2f0-6b0c8feb8b40">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities and obligations of U.S. government corporations and agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term time deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,364)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:10.8pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investments in equity securities as of December&#160;31, 2021 primarily consisted of exchange traded funds in fixed income securities.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i499a3149a68f43d197206136874ec7aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtMS0xLTEtMzU0MDE4_fcf7de4f-d908-4b0b-9bb1-6ea441382b5d"
      unitRef="usd">695000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i499a3149a68f43d197206136874ec7aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtMy0xLTEtMzU0MDE4_1fbd8486-efba-4098-b0e6-0fca3fc7e039"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i499a3149a68f43d197206136874ec7aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtNS0xLTEtMzU0MDE4_56445113-4a3d-44bb-884c-8dc3c0649dfe"
      unitRef="usd">16000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i499a3149a68f43d197206136874ec7aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtNy0xLTEtMzU0MDE4_6c59218c-a6f4-4a29-94cf-1b6e06335a19"
      unitRef="usd">679000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtOS0xLTEtMzU0MDE4_462e1326-0b7e-4b9d-b840-249c5a55e0ab"
      unitRef="usd">642000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtMTEtMS0xLTM1NDAxOA_da3197ee-b335-4add-bdd0-09f148a70bf0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtMTMtMS0xLTM1NDAxOA_8593895d-9c97-41fc-afda-62267e94f7c6"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzMtMTUtMS0xLTM1NDAxOA_f6392a75-5781-4f28-b9ee-6361c071009c"
      unitRef="usd">640000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtMS0xLTEtMzU0MDE4_5b5ca197-6e95-4b4a-af54-9ba2fba75799"
      unitRef="usd">10127000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtMy0xLTEtMzU0MDE4_055b8c05-294b-4075-a1fd-876d7373e4b1"
      unitRef="usd">12000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtNS0xLTEtMzU0MDE4_46d073fc-1f25-43ab-a081-eea25e9fc1c8"
      unitRef="usd">778000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtNy0xLTEtMzU0MDE4_3449de7d-040e-4a4b-821b-940f0bf61a55"
      unitRef="usd">9361000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtOS0xLTEtMzU0MDE4_a254d2ef-37e2-467e-9d98-46b3a9690346"
      unitRef="usd">8145000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtMTEtMS0xLTM1NDAxOA_b30bb79f-f422-45c3-8171-11150b8913a5"
      unitRef="usd">130000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtMTMtMS0xLTM1NDAxOA_bacd3def-4ad8-4481-a48b-7848e15ef769"
      unitRef="usd">75000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzQtMTUtMS0xLTM1NDAxOA_8607d01f-842f-43cc-9412-87039d46cfee"
      unitRef="usd">8200000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="iecda6a96704c4e55abf2859375ea8c57_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtMS0xLTEtMzU0MDE4_92a769e8-6b4e-4f73-a259-1caf1302e975"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iecda6a96704c4e55abf2859375ea8c57_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtMy0xLTEtMzU0MDE4_ad063a0e-1926-45d6-847c-8fb9414d1682"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iecda6a96704c4e55abf2859375ea8c57_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtNS0xLTEtMzU0MDE4_6b35fe43-394b-4324-8c93-51658130070c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iecda6a96704c4e55abf2859375ea8c57_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtNy0xLTEtMzU0MDE4_a100163a-7ddb-4154-a892-3a646551b224"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ie5a4abd7dcb44577b824de2cb64ccc35_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtOS0xLTEtMzU0MDE4_76241005-0333-424d-b076-2c06c38334f7"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie5a4abd7dcb44577b824de2cb64ccc35_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtMTEtMS0xLTM1NDAxOA_6bc1a74b-645d-4ec1-9487-bbbc00575d63"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie5a4abd7dcb44577b824de2cb64ccc35_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtMTMtMS0xLTM1NDAxOA_1dfd98c4-cb1c-4e44-ac2a-e3eb19e500e5"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ie5a4abd7dcb44577b824de2cb64ccc35_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzUtMTUtMS0xLTM1NDAxOA_35c46f33-57be-4cd7-af8a-75ae83c78d80"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i6eb00ce8440f4809aea66ea9110d64fa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtMS0xLTEtMzU0MDE4_de85da8b-a91b-44bf-8fb0-cbfce44b3370"
      unitRef="usd">256000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6eb00ce8440f4809aea66ea9110d64fa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtMy0xLTEtMzU0MDE4_cd76ccd1-10b8-4104-9840-c99409a1ee32"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6eb00ce8440f4809aea66ea9110d64fa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtNS0xLTEtMzU0MDE4_70f895a3-2ded-41b3-9393-81ad7381fe6f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6eb00ce8440f4809aea66ea9110d64fa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtNy0xLTEtMzU0MDE4_88ef0aef-ab38-4fd4-9580-77c019502fa7"
      unitRef="usd">256000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i3fbea513469f43a3b9e290efb35c514f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtOS0xLTEtMzU0MDE4_8e19484f-7aa8-436d-b4c1-0b3944309097"
      unitRef="usd">96000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3fbea513469f43a3b9e290efb35c514f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtMTEtMS0xLTM1NDAxOA_41ad8841-d4ad-4287-8469-2e7f33f01554"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3fbea513469f43a3b9e290efb35c514f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtMTMtMS0xLTM1NDAxOA_72dab587-ad58-408d-9d17-65e6bd77323d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3fbea513469f43a3b9e290efb35c514f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzYtMTUtMS0xLTM1NDAxOA_173b05c6-4918-490c-90b4-1bf6cf592f40"
      unitRef="usd">96000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="if9983f6fb6634358b6dacbf534d64ca5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctMS0xLTEtMzU0MDE4_83d785ac-136f-471d-8b9a-0c79755e1a48"
      unitRef="usd">204000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if9983f6fb6634358b6dacbf534d64ca5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctMy0xLTEtMzU0MDE4_e2a39ad2-30ff-4764-b946-8b2c0b335d12"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if9983f6fb6634358b6dacbf534d64ca5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctNS0xLTEtMzU0MDE4_467040d1-0189-4d88-a82b-82a7d2cc3fb3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if9983f6fb6634358b6dacbf534d64ca5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctNy0xLTEtMzU0MDE4_6fe0c34e-dcd7-4ca2-8535-11b69cc4889a"
      unitRef="usd">204000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i26daba9ff8ae466cb9021364a5170509_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctOS0xLTEtMzU0MDE4_d19d7156-4752-429b-bfe6-30b615eb2a1b"
      unitRef="usd">109000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i26daba9ff8ae466cb9021364a5170509_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctMTEtMS0xLTM1NDAxOA_c9f7f4aa-f947-41c0-b065-d86f71c1bc87"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i26daba9ff8ae466cb9021364a5170509_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctMTMtMS0xLTM1NDAxOA_37542acf-f664-4d5e-9ff0-abbe55558cc5"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i26daba9ff8ae466cb9021364a5170509_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzctMTUtMS0xLTM1NDAxOA_eb5db183-2512-4764-92a7-e0de2a02860b"
      unitRef="usd">109000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtMS0xLTEtMzU0MDE4_01307fb9-7a56-4bc6-ba5d-4e8364a9ff4f"
      unitRef="usd">4055000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtMy0xLTEtMzU0MDE4_c7af5ddd-c497-4990-bea2-858218ff413a"
      unitRef="usd">6000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtNS0xLTEtMzU0MDE4_079547d2-37bb-4c45-8012-012dbf171719"
      unitRef="usd">280000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtNy0xLTEtMzU0MDE4_fe9ffbbc-19e3-4ca0-a3b3-cbd11210906c"
      unitRef="usd">3781000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtOS0xLTEtMzU0MDE4_5fb68c13-f6c1-4b05-9b0f-cacd0c07fa3a"
      unitRef="usd">3398000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtMTEtMS0xLTM1NDAxOA_41ad260a-6762-41bb-a0bd-88490e92c1c9"
      unitRef="usd">85000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtMTMtMS0xLTM1NDAxOA_cd39d4d6-af80-4229-a4b0-cfc4dc5b8696"
      unitRef="usd">15000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzgtMTUtMS0xLTM1NDAxOA_d75f1f62-a373-42cb-b6dc-3e462ef35e30"
      unitRef="usd">3468000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktMS0xLTEtMzU0MDE4_5a108be0-7c9f-42c4-911e-57893be7bea4"
      unitRef="usd">1396000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktMy0xLTEtMzU0MDE4_bd1f9e1c-59eb-4652-b603-725b0b3d4bab"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktNS0xLTEtMzU0MDE4_6a0d6acd-be9d-43d7-9f92-7c8aedbd5bed"
      unitRef="usd">70000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktNy0xLTEtMzU0MDE4_3ec48d9a-430c-4ae4-a222-1e04635831d4"
      unitRef="usd">1326000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktOS0xLTEtMzU0MDE4_f5cf815d-8cd9-407a-8615-367904e874ee"
      unitRef="usd">1308000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktMTEtMS0xLTM1NDAxOA_148de718-0e0c-403a-8f81-eb20528a42e4"
      unitRef="usd">5000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktMTMtMS0xLTM1NDAxOA_622466b0-644f-4230-9508-93cdbd84b311"
      unitRef="usd">5000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzktMTUtMS0xLTM1NDAxOA_695d15ad-df5c-47f7-95a7-7f8a54007f7e"
      unitRef="usd">1308000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTEtMS0xLTM1NDAxOA_af759a4b-4a25-462b-80eb-b0bfcfee6c91"
      unitRef="usd">1165000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTMtMS0xLTM1NDAxOA_cbcac26d-4211-45ad-84ea-6d003d038b58"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTUtMS0xLTM1NDAxOA_43112baf-18f8-43d8-b611-6c7b8c5a2467"
      unitRef="usd">121000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTctMS0xLTM1NDAxOA_214c1432-749c-4373-883e-b2abe064ff35"
      unitRef="usd">1046000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTktMS0xLTM1NDAxOA_232d4179-f10b-4e09-ac27-1fe4cdb93c44"
      unitRef="usd">850000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTExLTEtMS0zNTQwMTg_d7fe76b1-9810-40fb-872c-861b239d6798"
      unitRef="usd">10000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTEzLTEtMS0zNTQwMTg_d1976e19-e255-4dab-b69c-7d184ecf6431"
      unitRef="usd">7000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEwLTE1LTEtMS0zNTQwMTg_f153cc2c-ea11-44a5-98d7-90f515e1ac7c"
      unitRef="usd">853000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTEtMS0xLTM1NDAxOA_5d73e797-52a9-47b0-97e4-dce4626cb6f9"
      unitRef="usd">961000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTMtMS0xLTM1NDAxOA_02f249c9-4a4a-471f-bd75-2840063d92a6"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTUtMS0xLTM1NDAxOA_d40d209e-d9e4-48b8-8c1f-c0cdf4d723d9"
      unitRef="usd">99000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTctMS0xLTM1NDAxOA_7a70c5e0-e82c-44ab-a84a-b88cab289e5d"
      unitRef="usd">862000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTktMS0xLTM1NDAxOA_45230a13-41e9-4cd7-9e7c-2f15809b6fab"
      unitRef="usd">870000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTExLTEtMS0zNTQwMTg_b597020f-64e2-4d6d-bfc4-4b56e3ba8f79"
      unitRef="usd">13000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTEzLTEtMS0zNTQwMTg_e1e1f3ea-c937-40f8-aa45-230c2716ec9b"
      unitRef="usd">10000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzExLTE1LTEtMS0zNTQwMTg_12fe7752-75b6-4945-9ab3-5e9dff4b4404"
      unitRef="usd">873000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEyLTEtMS0xLTM1NDAxOA_942d5ffa-8b4c-4dde-bc08-8fdb64e005bd"
      unitRef="usd">5000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEyLTctMS0xLTM1NDAxOA_0ad2a03e-734b-49dc-b558-c73cb256e8d5"
      unitRef="usd">5000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEyLTktMS0xLTM1NDAxOA_59d3ba88-e65f-4c51-8955-2014c8b2dd8a"
      unitRef="usd">326000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEyLTE1LTEtMS0zNTQwMTg_290fb0b3-0b8a-4445-bdc9-b863839cf278"
      unitRef="usd">326000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquityMethodInvestments
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEzLTEtMS0xLTM1NDAxOA_e0a376cf-65ea-4efa-b097-1af8d156716c"
      unitRef="usd">529000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEzLTctMS0xLTM1NDAxOA_54214210-45fe-4fde-a365-f20d79cb2716"
      unitRef="usd">529000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEzLTktMS0xLTM1NDAxOA_0ce97741-ccd6-4e6f-a3fe-7d3c6139c1c4"
      unitRef="usd">587000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzEzLTE1LTEtMS0zNTQwMTg_2fbbb4d0-c479-4676-a959-c525218d3b28"
      unitRef="usd">587000000</us-gaap:EquityMethodInvestments>
    <us-gaap:LifeInsuranceCorporateOrBankOwnedAmount
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE0LTEtMS0xLTM1NDAxOA_da2e6e3a-96a3-4635-a05f-ac37ba667239"
      unitRef="usd">169000000</us-gaap:LifeInsuranceCorporateOrBankOwnedAmount>
    <us-gaap:LifeInsuranceCorporateOrBankOwnedAmount
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE0LTctMS0xLTM1NDAxOA_e1020206-e7f1-447a-91c6-9abd7a12e85e"
      unitRef="usd">169000000</us-gaap:LifeInsuranceCorporateOrBankOwnedAmount>
    <us-gaap:LifeInsuranceCorporateOrBankOwnedAmount
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE0LTktMS0xLTM1NDAxOA_e820b163-229e-4834-8d96-d0e374a668a9"
      unitRef="usd">186000000</us-gaap:LifeInsuranceCorporateOrBankOwnedAmount>
    <us-gaap:LifeInsuranceCorporateOrBankOwnedAmount
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE0LTE1LTEtMS0zNTQwMTg_a4a007dc-cadf-49e9-bdb2-af70eb19749d"
      unitRef="usd">186000000</us-gaap:LifeInsuranceCorporateOrBankOwnedAmount>
    <cnc:InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTEtMS0xLTM1NDAxOA_5d1f5230-c356-495d-871e-42ecca7cc91d"
      unitRef="usd">19566000000</cnc:InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTMtMS0xLTM1NDAxOA_c991eb75-6e23-448e-ad9b-f5bc486e05fb"
      unitRef="usd">20000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTUtMS0xLTM1NDAxOA_7326b098-5e3c-47e6-8568-d99235db2ea4"
      unitRef="usd">1364000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <cnc:InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTctMS0xLTM1NDAxOA_11389d32-4396-469d-b01a-a5e38c35a654"
      unitRef="usd">18222000000</cnc:InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue>
    <cnc:InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTktMS0xLTM1NDAxOA_15c60902-2385-49a4-9ad7-98a12ff9af3b"
      unitRef="usd">16521000000</cnc:InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTExLTEtMS0zNTQwMTg_ddd11df5-3fbd-451e-9c01-edcb376241fa"
      unitRef="usd">243000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTEzLTEtMS0zNTQwMTg_e399d43c-dc5c-4995-9186-672fcfbece30"
      unitRef="usd">114000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <cnc:InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTo4NDQ4M2IxMWQzYjk0MmRiOTE5M2FkNDcwNmQ3N2ZlOC90YWJsZXJhbmdlOjg0NDgzYjExZDNiOTQyZGI5MTkzYWQ0NzA2ZDc3ZmU4XzE1LTE1LTEtMS0zNTQwMTg_dadca3da-1472-4302-8325-43baf0cf2826"
      unitRef="usd">16650000000</cnc:InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i04e2a006b9ac457da4ba57b86f6e47ed_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzY3OA_9d9844a0-541f-4a18-9cca-ce4a86eae2c9"
      unitRef="number">0.98</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzEwNTE_91196d18-aa01-41c3-b373-1f306cf7c4f0"
      unitRef="usd">132000000</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzEwNTg_c92529a9-214b-4718-8b8e-a77ef9bd9131"
      unitRef="usd">96000000</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss>
    <cnc:InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration
      contextRef="idb1c5e81b8794292b604efa3e3607763_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzIxOTkwMjMyNjA5OTA_bdc5b43f-7780-4ec8-a65c-022060789c13">P4Y</cnc:InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzQ5Mzg_da2f34dc-f98a-45b6-afa8-373ae2a01517">&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less Than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;12 Months or More&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less Than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;12 Months or More&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities and obligations of U.S. government corporations and agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,400&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i499a3149a68f43d197206136874ec7aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtMS0xLTEtMzU0MDE4_00f0fe44-d26e-4f02-b8be-2148c1e73e9a"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i499a3149a68f43d197206136874ec7aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtMy0xLTEtMzU0MDE4_47aca917-5ec2-4360-907d-a67ed2709dd1"
      unitRef="usd">342000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i499a3149a68f43d197206136874ec7aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtNS0xLTEtMzU0MDE4_f1ed3119-d1b7-42d3-a26a-a24d1bc1f6d3"
      unitRef="usd">11000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i499a3149a68f43d197206136874ec7aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtNy0xLTEtMzU0MDE4_117811f6-3be3-4a4d-8f9d-5c7aa9c08b4b"
      unitRef="usd">184000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtOS0xLTEtMzU0MDE4_5b86d0b3-44ff-4659-924f-e45c820ac0c5"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtMTEtMS0xLTM1NDAxOA_5a34a00a-7b06-433d-9377-1247ac78f372"
      unitRef="usd">598000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtMTMtMS0xLTM1NDAxOA_7ca55d4b-83f8-4d2e-826e-30e4f89f0198"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i486a37f6a0154762895b4f1f4cd9ca74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzMtMTUtMS0xLTM1NDAxOA_97f78cd4-dfcf-4198-b657-ec1663e4a02d"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtMS0xLTEtMzU0MDE4_685f3a6d-517f-4bb5-beee-d19a305fff6d"
      unitRef="usd">340000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtMy0xLTEtMzU0MDE4_168e15ef-225d-4ac7-9b93-413386b2c0aa"
      unitRef="usd">5368000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtNS0xLTEtMzU0MDE4_562bf30b-8df7-4db3-b824-fa773676051a"
      unitRef="usd">438000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="icf473a0753b24a40bd69716fc04aff8f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtNy0xLTEtMzU0MDE4_70c74f2f-bab2-4a76-81d4-259eca2d04f4"
      unitRef="usd">3400000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtOS0xLTEtMzU0MDE4_93912a90-10da-4bbd-be7a-7d4b596f02c7"
      unitRef="usd">66000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtMTEtMS0xLTM1NDAxOA_fd6c9367-8e21-4559-9193-05adad12e9c3"
      unitRef="usd">4209000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtMTMtMS0xLTM1NDAxOA_dc31d997-0e4c-4f6c-931c-ec11b8df6876"
      unitRef="usd">9000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i5313c9c8ef254fd3990dc4af6888052c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzQtMTUtMS0xLTM1NDAxOA_da7aefd9-90e0-4fb0-b0f0-59cbab6c2c75"
      unitRef="usd">209000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtMS0xLTEtMzU0MDE4_c84495a2-7114-4712-906f-8bc6311fcc2c"
      unitRef="usd">142000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtMy0xLTEtMzU0MDE4_05ea4670-bf8a-4477-b391-169d1b315fd7"
      unitRef="usd">2437000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtNS0xLTEtMzU0MDE4_03ad2736-6968-4c14-bec8-d3d1b6e77c18"
      unitRef="usd">138000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i0f21479b9405481aaa26f40d779ddb4e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtNy0xLTEtMzU0MDE4_4ba18bcb-e305-439d-a540-a8f387fc08a4"
      unitRef="usd">995000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtOS0xLTEtMzU0MDE4_1ea6ef4a-0015-4f45-8601-aa05bf38728f"
      unitRef="usd">14000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtMTEtMS0xLTM1NDAxOA_f61584c9-f8cb-444f-8516-2a01268e6268"
      unitRef="usd">1173000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtMTMtMS0xLTM1NDAxOA_6bcb77f7-d283-4f6c-a498-0c9ea79ab463"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="icbcf20613be2440d8fe8fbcdc3292971_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzUtMTUtMS0xLTM1NDAxOA_595238f2-4e06-489c-9424-0d196e72aee0"
      unitRef="usd">39000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtMS0xLTEtMzU0MDE4_913e4f33-2b2f-46b4-b469-fa771119fd7e"
      unitRef="usd">29000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtMy0xLTEtMzU0MDE4_5f53206c-dd52-410c-89f5-be5c99544a5b"
      unitRef="usd">786000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtNS0xLTEtMzU0MDE4_6c6e6677-e047-4972-bc6a-716b65206638"
      unitRef="usd">41000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i62cd5054218c428380088f2fb37a4a38_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtNy0xLTEtMzU0MDE4_2d54e3fa-8abb-4e4b-882b-0f632bafeba3"
      unitRef="usd">486000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtOS0xLTEtMzU0MDE4_7ed624a3-4e14-48a5-924d-2677261d5bf9"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtMTEtMS0xLTM1NDAxOA_7da23a7b-9551-4a25-8c78-f304162cade1"
      unitRef="usd">770000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtMTMtMS0xLTM1NDAxOA_6a9da86b-0b6f-42c5-8756-6b51a76132ad"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i530c9e7c7b664f33a25dfb73541c7b7a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzYtMTUtMS0xLTM1NDAxOA_0342cef2-16a1-42cc-976f-21939777f487"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctMS0xLTEtMzU0MDE4_d7a135da-a701-45cc-86b9-c27f2e289bf7"
      unitRef="usd">55000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctMy0xLTEtMzU0MDE4_ef10ace9-2e85-49d5-9460-c1e48877882e"
      unitRef="usd">629000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctNS0xLTEtMzU0MDE4_3aa28e9b-87b0-4c5d-8caa-75b5baf2916a"
      unitRef="usd">66000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i8a80b9a6c7ea417db21376c703ac065f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctNy0xLTEtMzU0MDE4_83a40527-5921-4c0d-8090-4593b455bb63"
      unitRef="usd">352000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctOS0xLTEtMzU0MDE4_75d7685a-101a-4c93-9517-cd90702c589a"
      unitRef="usd">7000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctMTEtMS0xLTM1NDAxOA_dfe253b1-99a5-4afa-a013-542013452de0"
      unitRef="usd">472000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctMTMtMS0xLTM1NDAxOA_38937dcb-59df-4be7-9d11-c8c7fd6f755b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i20374a9ab1a44d948a3ce54237e30bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzctMTUtMS0xLTM1NDAxOA_bab33c01-5c41-47cb-a460-f372480fc810"
      unitRef="usd">15000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtMS0xLTEtMzU0MDE4_ab4856d7-7fe1-4283-a8a0-7c79d8a72776"
      unitRef="usd">49000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtMy0xLTEtMzU0MDE4_ccb38573-3fce-42ab-a401-0245ba9622b4"
      unitRef="usd">513000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtNS0xLTEtMzU0MDE4_5c97840b-7f21-49f0-adec-2bd70f165aad"
      unitRef="usd">50000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ifff1bb111f3d44fbbc41cd705208898f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtNy0xLTEtMzU0MDE4_9a7b85ae-3fc3-42a9-8b5c-337abce5469a"
      unitRef="usd">330000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtOS0xLTEtMzU0MDE4_92e1c9c6-e737-4247-b55d-ac76a3859957"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtMTEtMS0xLTM1NDAxOA_3c027ed4-5157-4c7a-a036-5f63e7ada0d6"
      unitRef="usd">380000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtMTMtMS0xLTM1NDAxOA_2ebbcc8f-2a66-4910-9b7e-0a72aea3d6e4"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i51d11822d99c47479c5a2eb3e89364a4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzgtMTUtMS0xLTM1NDAxOA_36ffc634-305e-4fb5-9fcc-05907c4579ca"
      unitRef="usd">32000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTEtMS0xLTM1NDAxOA_46bcaf88-5a87-4736-b16d-2b22a81a2276"
      unitRef="usd">620000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTMtMS0xLTM1NDAxOA_d048a28b-fbd6-43ce-ae2b-304dd4e89da7"
      unitRef="usd">10075000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTUtMS0xLTM1NDAxOA_74255d22-45a4-4901-a3bb-d476ca4906d9"
      unitRef="usd">744000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTctMS0xLTM1NDAxOA_9e7875ca-752c-4ab9-88a2-153b012736fe"
      unitRef="usd">5747000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTktMS0xLTM1NDAxOA_db3efd62-a57e-4369-aeb3-5584360a5656"
      unitRef="usd">102000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTExLTEtMS0zNTQwMTg_8c7d274a-e578-4573-952f-8039ff2374b3"
      unitRef="usd">7602000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTEzLTEtMS0zNTQwMTg_3dfa7456-9670-4512-973b-de6a8596bcf6"
      unitRef="usd">12000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZTpjNTVlOWU3MjY5Nzk0YzcxODFkNGM5YTg0YjU2MTU0My90YWJsZXJhbmdlOmM1NWU5ZTcyNjk3OTRjNzE4MWQ0YzlhODRiNTYxNTQzXzEwLTE1LTEtMS0zNTQwMTg_985f24c3-c661-4c1b-8f64-b250939f0372"
      unitRef="usd">331000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzE4OTM_ce77e06d-7165-4e08-93da-35eea1cb369a"
      unitRef="position">6423</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <cnc:DebtSecuritiesAvailableForSaleNumberOfPositions
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzE5MjQ_bfefcea7-42f4-4e05-a95d-7af0b009e82f"
      unitRef="position">6854</cnc:DebtSecuritiesAvailableForSaleNumberOfPositions>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i556fc29a81414ce8a1faff7d6b5ca940_I20210731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzM1MzI_5fe1bd4d-cddb-441c-b476-87a88054e1ba"
      unitRef="number">0.60</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i4603a3c3a78b4cf6befa775abe6f9136_D20210701-20210731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzM1NjU_194b626f-745d-4cd3-87db-e3e4c0803398"
      unitRef="usd">705000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i90289acf8f4c42b891561c01ab371852_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzM2NDE_45104b51-e1d8-4944-b2a4-cdab2c81b0fd"
      unitRef="usd">309000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage
      contextRef="i556fc29a81414ce8a1faff7d6b5ca940_I20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzM4NDk_de21115a-3319-4456-bf8b-3cd7f3ceb0c9"
      unitRef="number">1</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i06e20193ad1d4a6dbe47803672976cf0_D20210901-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzIxOTkwMjMyNjEwMjM_901b8230-f9a7-4c2b-97e2-c3742c11f27e"
      unitRef="usd">229000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90ZXh0cmVnaW9uOjhiNmNmNWEyMjI3NzRmMDFhOTJhYTJlNmRkYTQ5ZWZlXzQ5NDE_0c745c43-ac8c-46e1-bb1d-86e266eb1b16">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Deposits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtMS0xLTEtMzU0MDE4_69cb3bf5-0087-4226-a041-1d1d96505971"
      unitRef="usd">2207000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtMy0xLTEtMzU0MDE4_075ec188-ff08-463f-af93-e1f4ac6f6e68"
      unitRef="usd">2179000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtNS0xLTEtMzU0MDE4_376f39ec-d9f9-41f0-bea9-de194ff82194"
      unitRef="usd">534000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtNy0xLTEtMzU0MDE4_18778fb1-481d-4264-82e0-57f4a9d2eb8e"
      unitRef="usd">532000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtOS0xLTEtMzU0MDE4_017beecb-6cd9-48fe-b5d6-b3964d183597"
      unitRef="usd">1390000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtMTEtMS0xLTM1NDAxOA_fa1d97c7-8b7b-4eb5-94e3-de052fd896d4"
      unitRef="usd">1396000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i5d47874d2cff447d94764455a4adb274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtMTMtMS0xLTM1NDAxOA_5a3cb30d-46bc-47f5-b20e-9392a27a0987"
      unitRef="usd">368000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i5d47874d2cff447d94764455a4adb274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzMtMTUtMS0xLTM1NDAxOA_6e7c39db-8045-4af6-bc7b-668ca0b1afb2"
      unitRef="usd">368000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtMS0xLTEtMzU0MDE4_2a3afd38-1270-46dd-a53d-5cfa2dd3b709"
      unitRef="usd">7651000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtMy0xLTEtMzU0MDE4_1b0af060-3665-454e-8e15-264ad87aaaaa"
      unitRef="usd">7147000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtNS0xLTEtMzU0MDE4_f6602eb4-990f-48b3-9429-10f988624d03"
      unitRef="usd">524000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtNy0xLTEtMzU0MDE4_0c0ab080-86fd-4eb8-90a7-edbdf78833a2"
      unitRef="usd">490000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtOS0xLTEtMzU0MDE4_9ee2689f-f97d-46a8-a6fd-b4b9baf8a2a6"
      unitRef="usd">6212000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtMTEtMS0xLTM1NDAxOA_875ec686-9bd9-443a-ba30-ab96271bc3c3"
      unitRef="usd">6294000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i5d47874d2cff447d94764455a4adb274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtMTMtMS0xLTM1NDAxOA_3c6136e5-c06e-4b94-915a-f9dfb4d82c15"
      unitRef="usd">460000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i5d47874d2cff447d94764455a4adb274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzQtMTUtMS0xLTM1NDAxOA_61549372-da6d-4a52-9914-046acea6ece1"
      unitRef="usd">457000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtMS0xLTEtMzU0MDE4_2c3861b7-8b43-46e2-af7c-730a15739905"
      unitRef="usd">4066000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtMy0xLTEtMzU0MDE4_e679d113-add3-4c2a-a269-161b64ac65bc"
      unitRef="usd">3613000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtNS0xLTEtMzU0MDE4_3d847194-bebf-4d9a-91b2-a2d3f92894b7"
      unitRef="usd">224000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtNy0xLTEtMzU0MDE4_74cd5626-2177-4c47-a664-31924517b7e7"
      unitRef="usd">195000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtOS0xLTEtMzU0MDE4_e95d8fd5-2073-458c-8bb3-a02de3a30994"
      unitRef="usd">3647000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtMTEtMS0xLTM1NDAxOA_a48bc79f-aea1-48ac-b55b-3f84d8d6a1d5"
      unitRef="usd">3681000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="i5d47874d2cff447d94764455a4adb274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtMTMtMS0xLTM1NDAxOA_f998d57f-6696-4f72-8d0e-c07c89b9e884"
      unitRef="usd">244000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i5d47874d2cff447d94764455a4adb274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzUtMTUtMS0xLTM1NDAxOA_49c0bed7-2acb-447d-b5f9-ba701f41a9ad"
      unitRef="usd">243000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtMS0xLTEtMzU0MDE4_137481e8-0f34-4e32-8833-914f2056890a"
      unitRef="usd">135000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtMy0xLTEtMzU0MDE4_9fcc60fd-5da2-42e5-955c-d9e859541969"
      unitRef="usd">129000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtNS0xLTEtMzU0MDE4_01a68b74-3645-45ff-97a4-5180f10d6a08"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtNy0xLTEtMzU0MDE4_dea06ab7-dc0b-45e2-8396-78d16efb0a21"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtOS0xLTEtMzU0MDE4_0defc8f8-4fe2-48df-8dd1-5ed28456724e"
      unitRef="usd">73000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtMTEtMS0xLTM1NDAxOA_e7edaa7b-ad67-4801-8598-289b12653fe4"
      unitRef="usd">78000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="i5d47874d2cff447d94764455a4adb274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtMTMtMS0xLTM1NDAxOA_fbc32575-c08c-46e6-9e99-0fa441c28e37"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i5d47874d2cff447d94764455a4adb274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzYtMTUtMS0xLTM1NDAxOA_da21f2c5-a11d-47c5-9e8b-17145bcad4a6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctMS0xLTEtMzU0MDE4_2aea5e5b-50f2-438f-9f93-1657ce5bc755"
      unitRef="usd">3522000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctMy0xLTEtMzU0MDE4_ae97dbd3-d7a7-4acb-80d0-91d9ccd307a3"
      unitRef="usd">3234000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctNS0xLTEtMzU0MDE4_603fa85f-abe6-4c31-9bf6-c1273a07809d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctNy0xLTEtMzU0MDE4_6ff40d69-4e2c-41a2-9201-a2141822243a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctOS0xLTEtMzU0MDE4_44c8d82d-ccb7-4664-b854-b56a24d0e0e4"
      unitRef="usd">3028000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctMTEtMS0xLTM1NDAxOA_01732d49-ddcc-487c-a9da-351dcdbc4e6a"
      unitRef="usd">3034000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="i5d47874d2cff447d94764455a4adb274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctMTMtMS0xLTM1NDAxOA_8d6ba074-31fc-41e7-b78d-128b768ee39f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i5d47874d2cff447d94764455a4adb274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzctMTUtMS0xLTM1NDAxOA_437ab1dc-5ecd-4efa-8f85-52ec11c22ea4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtMS0xLTEtMzU0MDE4_d1de1524-97b8-43fd-aef7-87af99e3c008"
      unitRef="usd">17581000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6dfd24ddae8241599cc88560c625724a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtMy0xLTEtMzU0MDE4_f2db2724-523b-4814-b9d2-7e84d3fe7f9e"
      unitRef="usd">16302000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtNS0xLTEtMzU0MDE4_2f211b80-3aae-4b0b-ba87-9feb4b6ec25d"
      unitRef="usd">1282000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtNy0xLTEtMzU0MDE4_84e5dde7-3870-4b45-9d97-32c8a3e33f29"
      unitRef="usd">1217000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtOS0xLTEtMzU0MDE4_c7a32e82-7073-4fb1-a3b9-326a8f4a03b7"
      unitRef="usd">14350000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6f801e952ab24058bc3bbd7e74346274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtMTEtMS0xLTM1NDAxOA_83bed815-a861-41d0-bbd0-dbfc5694ad09"
      unitRef="usd">14483000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i5d47874d2cff447d94764455a4adb274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtMTMtMS0xLTM1NDAxOA_daca9aaa-d3f7-4ec9-a0fb-798e37f2adf0"
      unitRef="usd">1072000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5d47874d2cff447d94764455a4adb274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTIvZnJhZzo4YjZjZjVhMjIyNzc0ZjAxYTkyYWEyZTZkZGE0OWVmZS90YWJsZToxMjZjZTBlMzJmZjg0MWEyODM5ZjA4YjJiOTUxMDA1NS90YWJsZXJhbmdlOjEyNmNlMGUzMmZmODQxYTI4MzlmMDhiMmI5NTEwMDU1XzgtMTUtMS0xLTM1NDAxOA_81f9879c-7360-4020-a118-04256f8cf00c"
      unitRef="usd">1068000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90ZXh0cmVnaW9uOjFlYjAzNTk3YTE0OTRjNTJiM2Y4N2Y2ZWU4OWNhZDc4Xzk1MA_ec4c7e59-dbf5-4bf0-a77a-7d0c087cefc5">Fair Value Measurements&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value.&#160;Level inputs are as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;Input:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Input Definition:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level&#160;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level&#160;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level&#160;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes fair value measurements by level at December&#160;31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities and obligations of U.S. government corporations and agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term time deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted deposits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities and obligations of U.S. government corporations and agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restricted deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes fair value measurements by level at December&#160;31, 2021, for assets and liabilities measured at fair value on a recurring basis ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities and obligations of U.S. government corporations and agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term time deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted deposits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities and obligations of U.S. government corporations and agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restricted deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency swap agreement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes matrix pricing services to estimate fair value for securities which are not actively traded on the measurement date.&#160;The Company designates these securities as Level II fair value measurements.&#160;In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $698 million and $773 million as of December&#160;31, 2022, and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <cnc:FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90ZXh0cmVnaW9uOjFlYjAzNTk3YTE0OTRjNTJiM2Y4N2Y2ZWU4OWNhZDc4Xzk1Mw_8b3a7b28-09c3-46b1-931f-53336f00ea67">Level inputs are as follows:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;Input:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Input Definition:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level&#160;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level&#160;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level&#160;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cnc:FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90ZXh0cmVnaW9uOjFlYjAzNTk3YTE0OTRjNTJiM2Y4N2Y2ZWU4OWNhZDc4Xzk2MA_8b07e5c2-dd80-407f-8d3b-ca4b4ca63704">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes fair value measurements by level at December&#160;31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities and obligations of U.S. government corporations and agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term time deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted deposits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities and obligations of U.S. government corporations and agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restricted deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes fair value measurements by level at December&#160;31, 2021, for assets and liabilities measured at fair value on a recurring basis ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities and obligations of U.S. government corporations and agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term time deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted deposits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities and obligations of U.S. government corporations and agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restricted deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency swap agreement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ibe885a414a174f139a113b8c48656f0c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzItMS0xLTEtMzU0MDE4_eb357ec5-afc7-4916-bad1-58948c8d941a"
      unitRef="usd">12074000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ide98fb1c086841bba65730c9e9d0e5c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzItMy0xLTEtMzU0MDE4_260d962a-7ffd-4f7a-b3ff-6725a8cf8441"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5739f0204cdd40bba7cfc286758eb99d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzItNS0xLTEtMzU0MDE4_ab0e99ea-c0b3-42da-82c6-e62dd096ce71"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzItNy0xLTEtMzU0MDE4_54565b57-76be-498b-a144-25773d84cf0c"
      unitRef="usd">12074000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iedfc351c3aa441b898074cff9cb2f90d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzQtMS0xLTEtMzU0MDE4_bcfde046-20cc-448f-a979-a9fb38c12deb"
      unitRef="usd">366000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i825be3c8cf254b448365fca017922b84_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzQtMy0xLTEtMzU0MDE4_a488e3ec-2cb2-4184-8bc2-276997bdbd7e"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8356e0b9cfbd4b0db5eae0058bb52f71_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzQtNS0xLTEtMzU0MDE4_9c681e39-8ca6-4f85-8307-5f3fc995d7ce"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i127bbbf2926f42efa993800b43144c0b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzQtNy0xLTEtMzU0MDE4_e9f6ede4-578d-4d6d-b911-7154b45fa333"
      unitRef="usd">371000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i27d15395c0854bfc84fc70f257308756_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzUtMS0xLTEtMzU0MDE4_5807cd81-092c-4ff7-ad7e-dae9d2d366cc"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i97902e8b6d3543a38beee90270b3e1ff_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzUtMy0xLTEtMzU0MDE4_70154977-4863-4a41-9e9a-457e289dc424"
      unitRef="usd">9328000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2d86972bd8ff440db8e9af798cbcff0d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzUtNS0xLTEtMzU0MDE4_33bff37c-8243-4485-9a16-923b88a44196"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6a7ebe084b2d42bd9909a9b07d2e00f6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzUtNy0xLTEtMzU0MDE4_eaf29216-5cc8-446a-91d9-dd2f3db1df0d"
      unitRef="usd">9328000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia09367fbf6484c039eeb488ad6dcf554_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzYtMS0xLTEtMzU0MDE4_17f00b37-a94f-484b-b8a7-60425cac5448"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="idadbc4c70fb443308a1c36faac206d9d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzYtMy0xLTEtMzU0MDE4_353b2ef2-191f-4d74-8642-240d359c0651"
      unitRef="usd">3165000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if05e29f0742c42d1ac24bff7df962924_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzYtNS0xLTEtMzU0MDE4_45cde25c-b451-4f14-b1c1-9b051f379924"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6425ad722cf84deabeab468c2d10b6a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzYtNy0xLTEtMzU0MDE4_24873339-36ff-454f-b89e-4003b175988f"
      unitRef="usd">3165000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia457c3f6b68a498ba18886372c07c24a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzctMS0xLTEtMzU0MDE4_c4dd10c5-fcb6-44b7-b434-9ed263e0ee95"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i194a19a31fe840fdb6c8c759266afa3b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzctMy0xLTEtMzU0MDE4_d9506ac1-d668-4e3b-9942-5cf4e6eddec7"
      unitRef="usd">204000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6634f441212f425fbe5da6bca4e48783_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzctNS0xLTEtMzU0MDE4_f17615c6-1e0f-4aea-9727-b956eaeb5025"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i153a782b2ac745db920b4785f8268200_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzctNy0xLTEtMzU0MDE4_44de2326-923f-48aa-8d2d-90fabf5444a2"
      unitRef="usd">204000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5e9cd9d12c3f43ec9d70ee7e0d8076c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzgtMS0xLTEtMzU0MDE4_fb70556f-4405-4aa3-b0b5-fabc133ea81f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6477b8c63c58454499074d398a80a373_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzgtMy0xLTEtMzU0MDE4_05fbef92-29bb-4a9b-bb19-718916149c46"
      unitRef="usd">1326000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0f9e3a31c01942a391fbfab0d89c3f8a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzgtNS0xLTEtMzU0MDE4_faf160c9-1b07-4067-96c4-d1c703effe8a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="icb29efff83384a97be4e90505f07645f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzgtNy0xLTEtMzU0MDE4_203897bc-0d1b-4822-8e1c-c13ff33dc52a"
      unitRef="usd">1326000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ic16bff1ee9254c80a89f582ee2e9b3d3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzktMS0xLTEtMzU0MDE4_ea97f121-61ab-4ac6-ae17-84ff82535756"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ic86ea1d5b6dc44f2af63bb7d314c17d5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzktMy0xLTEtMzU0MDE4_a10570ce-d866-44e1-b879-affcd2627d24"
      unitRef="usd">1046000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i1bf59ef98b1545adac077505ac7e83d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzktNS0xLTEtMzU0MDE4_e4379b1d-da75-4e8b-943a-cc4d0eb3bc14"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib5c115dbb53c47ffa08fb896b39bd7b6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzktNy0xLTEtMzU0MDE4_de137a78-6990-4684-a328-f417ff31df76"
      unitRef="usd">1046000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i39665844725c4209a15066dc801d7fe6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEwLTEtMS0xLTM1NDAxOA_2ebe79f3-1caa-40c4-95cc-b0a64114bd9f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8282158849cc4f238ec41de28faa2d35_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEwLTMtMS0xLTM1NDAxOA_8e561d96-ac1b-4058-b861-26a0c8dab78b"
      unitRef="usd">862000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ied071109707642119601cf0ea5c86d13_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEwLTUtMS0xLTM1NDAxOA_eaec4a92-63b5-4def-ae67-13343449ce27"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i82eb3754c9b94d449778e6b6e63c6591_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEwLTctMS0xLTM1NDAxOA_27fe246f-913b-42b5-8273-908cca2c047b"
      unitRef="usd">862000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ibe885a414a174f139a113b8c48656f0c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzExLTEtMS0xLTM1NDAxOA_2c90fcd3-44b6-4ed6-8d3e-c2f2e89e8f8f"
      unitRef="usd">3000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ide98fb1c086841bba65730c9e9d0e5c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzExLTMtMS0xLTM1NDAxOA_5747516b-2236-422c-b206-05a5f64b867e"
      unitRef="usd">2000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5739f0204cdd40bba7cfc286758eb99d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzExLTUtMS0xLTM1NDAxOA_3c4c71c9-ff42-426b-9ba6-3c51707b004b"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzExLTctMS0xLTM1NDAxOA_096a97da-ffa6-43f4-86fc-73381fd91ae7"
      unitRef="usd">5000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ifd47e5c8ab1d4ffa93389f360a448165_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEyLTEtMS0xLTM1NDAxOA_91cacc05-e235-44d6-9b9d-e653ded97100"
      unitRef="usd">369000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6a73e4388fe442ff84fc2ffc6a2c6266_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEyLTMtMS0xLTM1NDAxOA_b3ec6cd5-e509-48c8-b6bd-2ceb669b1ac7"
      unitRef="usd">15938000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i9e0d2df27c5e4c51a64b0329476580fc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEyLTUtMS0xLTM1NDAxOA_b5809bec-ba3a-4d6a-b76b-784d3ee35895"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="id72eb9f8ac6f4c728bdaa099f9836385_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzEyLTctMS0xLTM1NDAxOA_c933ee17-07d3-4d60-831f-72ed0425d8c9"
      unitRef="usd">16307000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia1cff2bd501f465094c089dec54779c4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE0LTEtMS0xLTM1NDAxOA_2d907fdd-7273-437b-9ad6-e2ecbd7129b0"
      unitRef="usd">256000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i426b68aa333f427d93dad8edc44dcfab_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE0LTMtMS0xLTM1NDAxOA_393369c3-015e-471f-a957-f05c569db6f5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="id30239d3660e4d4e85eea70a9128120a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE0LTUtMS0xLTM1NDAxOA_28b0cc3b-ff80-4ff7-865f-755884c5893d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib614a9b3d9dd414cadb853523d634e9c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE0LTctMS0xLTM1NDAxOA_5c6be021-93f0-4773-a2a6-c30ab31732ca"
      unitRef="usd">256000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if285b05be18e4ded8654557403239a51_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTEtMS0xLTQ5NjUxNQ_d1557f69-8412-495c-b49c-2a252bab86ea"
      unitRef="usd">308000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i249d2de894e0473fb963ddd614601836_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTMtMS0xLTQ5NjUxNQ_c3197e8d-8167-41d2-a3a7-a3117f92cde9"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i245f71d6b43543a69ba7ea32da0f2548_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTUtMS0xLTQ5NjUxNQ_561c1584-0158-4119-b136-57018f759358"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i1fa6f8785ba04ad2bb2c6f69131c343b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTctMS0xLTQ5NjUxNQ_9cc6a767-98d0-4936-834d-2aa67b2fc2f8"
      unitRef="usd">308000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i74784b40d1ef48b4a3940d2a5c85d9da_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE2LTEtMS0xLTQ5NjUyMA_8d9c328b-75e9-4468-9e85-daae10b02fbd"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2d30f208873344438005137cb7dcd673_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE2LTMtMS0xLTQ5NjUyMA_c4a79319-b0e9-4f95-9f7c-607b3be639f6"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i463216755f0b40bd89cd2299509f861d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE2LTUtMS0xLTQ5NjUyMA_cf91beb3-2bab-4385-966b-118db8e792e2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2cd578a7ae594d1eb11c60355e3eda18_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE2LTctMS0xLTQ5NjUyMA_5ada1579-3bee-4a99-8749-4e3591161413"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i100fd78a36ac4838b8fdcf17fc398935_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTEtMS0xLTM1NDAxOA_501ab44b-0a24-42f1-a7e3-7b65928720cf"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3a41716be165442ebf2bc3d198eeae9e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTMtMS0xLTM1NDAxOA_e1bfacbe-30d6-48e9-bb08-4e8516572cb8"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ibcb39c9bd51e4ed3982382b5190d3215_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTUtMS0xLTM1NDAxOA_0517e9d9-993e-480f-b57c-aeacb98b463f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i35ee59d0ad594d20a7367f83c5d42181_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE1LTctMS0xLTM1NDAxOA_1fa767df-028f-4749-a6bd-8359d44ccefc"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib6f446cc848c4d8fa4602eaa87f92478_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE3LTEtMS0xLTM1NDAxOA_38a18814-53ee-4e6c-b6f9-9cca8aa0cb04"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib02b7ea5d28e49ecba973f7748fd0c3a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE3LTMtMS0xLTM1NDAxOA_2f16f407-2ddf-4c17-b92a-9b7d92d0b490"
      unitRef="usd">616000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i59b0c1e5f1b94a69a226785725883c7b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE3LTUtMS0xLTM1NDAxOA_e6057db8-5d6b-4c6f-a067-8537657bd7f4"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0768ba92b27244339b1a4a4e64b0bd8a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE3LTctMS0xLTM1NDAxOA_46a462a9-c0e2-4d42-8033-4cc45ceade2d"
      unitRef="usd">616000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iedd975f60e2e4f52bb7a01b3588ba5d8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE5LTEtMS0xLTM1NDAxOA_0a26319a-fb0f-4653-8127-9b519b9b98c2"
      unitRef="usd">564000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i187b2a05bec94d17b6890569f214fb4e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE5LTMtMS0xLTM1NDAxOA_685ffb03-61a6-4932-9bfc-9afd905d774e"
      unitRef="usd">653000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="id146c5c9a6ff4458bb147ee4d06bcceb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE5LTUtMS0xLTM1NDAxOA_b3a88f1f-1f3c-4998-b5e9-89f24d829a27"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0c52ea456a784db98386d3d5e55fe44a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzE5LTctMS0xLTM1NDAxOA_0e9a25b8-40a5-477d-9d04-2b2314b38907"
      unitRef="usd">1217000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibe885a414a174f139a113b8c48656f0c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzIyLTEtMS0xLTM1NDAxOA_402245fb-df66-4e88-82b8-fd0eb40abbee"
      unitRef="usd">13007000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ide98fb1c086841bba65730c9e9d0e5c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzIyLTMtMS0xLTM1NDAxOA_3c2ec3a3-c6f2-48da-a10f-1cdd3ff57046"
      unitRef="usd">16591000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5739f0204cdd40bba7cfc286758eb99d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzIyLTUtMS0xLTM1NDAxOA_127c628a-5edf-45a6-840c-c98ad1029332"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZTpiNTc1MjkzNmM2YmU0Zjk4Yjk4ZDVlMWQ0NTIxYTNmNC90YWJsZXJhbmdlOmI1NzUyOTM2YzZiZTRmOThiOThkNWUxZDQ1MjFhM2Y0XzIyLTctMS0xLTM1NDAxOA_5286397c-7073-4b5c-98d4-5b144106beb2"
      unitRef="usd">29598000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if6480f6a8b344d4da26190ba7e2b134a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzItMS0xLTEtMzU0MDE4_d6f7cb40-6843-47e7-b47f-6d27799738a1"
      unitRef="usd">13118000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="idca2cbb365924fe08d1fca9331f9da1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzItMy0xLTEtMzU0MDE4_bf01a9de-50a8-4bda-9246-5b5ddbfea5b4"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i1d9e0273ef794fc09e5b2df846ddc972_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzItNS0xLTEtMzU0MDE4_116dbcb9-0941-4dbf-9611-e9f5dd6b1956"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzItNy0xLTEtMzU0MDE4_53a47496-d812-4b58-bd97-afea7bdd84f8"
      unitRef="usd">13118000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ie2aed0c146004449ae3c852aea7d1b98_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzQtMS0xLTEtMzU0MDE4_4b57c865-5cbc-41e1-bb20-245437d099d7"
      unitRef="usd">171000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i4826ba2c9157409bba218177c880c8c0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzQtMy0xLTEtMzU0MDE4_ad962fa2-da15-43de-8985-66290e160c99"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6d7b7c7689844e74893cf79348121605_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzQtNS0xLTEtMzU0MDE4_8038e7bc-eee8-43fd-bf91-cdf7c7c7b23c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i32d48e9a7c194db7a29153a53ba29a2a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzQtNy0xLTEtMzU0MDE4_de841fb7-5702-4893-8a88-ec95693880b0"
      unitRef="usd">171000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6b3b2780690e461ca82dd12d2d5dea77_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzUtMS0xLTEtMzU0MDE4_76010ff6-54b1-4ffa-9163-6c4861afcc2f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia002a77fe35d43898743d9977eabc858_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzUtMy0xLTEtMzU0MDE4_7ec0710d-d7c5-4f1d-9847-33772117e4bc"
      unitRef="usd">8170000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i7e5d0bc94d8549d38b7acb1bb04d6f9f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzUtNS0xLTEtMzU0MDE4_653e313d-a362-47d6-881d-56bf4b144c27"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ie109b7ada8cc4654be6dcb72b936b2df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzUtNy0xLTEtMzU0MDE4_98944521-4cc9-4779-90d5-fb2cb31626c5"
      unitRef="usd">8170000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i1fb9a57293054024a366990a739e6596_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzYtMS0xLTEtMzU0MDE4_0c9a8642-c132-41f8-aeaf-15995706af02"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3597245e7cf440a7a7ae6ac45addecab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzYtMy0xLTEtMzU0MDE4_a8632064-1d26-4584-b25d-b530ccd36cfe"
      unitRef="usd">2999000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="id22add844f974bf8b07a30cbc2cefe30_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzYtNS0xLTEtMzU0MDE4_2eb4777e-2343-4a0b-bf86-e39dca8aaf5e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iaf8cebd612ae46269efac158f2dd98f3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzYtNy0xLTEtMzU0MDE4_b6dd5b35-dc79-497e-adca-d328ebead4fb"
      unitRef="usd">2999000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ic527e2e72ab14196892caa07ca0316e6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzctMS0xLTEtMzU0MDE4_cb793abe-d28f-401f-acc5-8719824de50a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i71fd9e78e4214b78976cc93ea78ffce2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzctMy0xLTEtMzU0MDE4_bf4b9274-2b4b-4c8a-8dd9-d0facba38818"
      unitRef="usd">109000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5d746bbdd1cd469ea1b06db720fb369c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzctNS0xLTEtMzU0MDE4_2deed20d-8482-4581-aade-1e7fddc23337"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if17efe1115fb48509286959669ffc628_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzctNy0xLTEtMzU0MDE4_1e85e2b2-e65d-40b9-a5bd-c0cb6b1e604d"
      unitRef="usd">109000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i625be35b035e4450b7053b827871d006_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzgtMS0xLTEtMzU0MDE4_149130b3-3f44-44ec-92da-076503227673"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i33f404899e1b4c598c4445ab4bd72151_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzgtMy0xLTEtMzU0MDE4_30bd7d08-ed5c-410b-ae08-5b08fc68b08a"
      unitRef="usd">1308000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i04c7968a4f2a40c6a44dabd77d8b77e6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzgtNS0xLTEtMzU0MDE4_5ebd28cf-ef8e-4e89-83e8-f042c8523b07"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia2c93ff1086147fe9a512996471b4758_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzgtNy0xLTEtMzU0MDE4_6af01bc8-3f83-435c-a31b-72470785c996"
      unitRef="usd">1308000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i9816bbb59837427d84449a8fd8eb65cc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzktMS0xLTEtMzU0MDE4_59915613-c2e9-4420-9119-4098a5d2eb6e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia8115e874d4641dbae3a0cd214707412_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzktMy0xLTEtMzU0MDE4_1689a3b5-1f53-4d64-acd4-701ec78e2310"
      unitRef="usd">853000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i38d0ee4467e84cb3835ebbfe019c4b73_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzktNS0xLTEtMzU0MDE4_3e9110af-6250-4dee-a832-972442ee1ea7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="idb9927142500410bb4d9ae681347e21a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzktNy0xLTEtMzU0MDE4_696722a6-ed1e-4ac1-b46f-c714419668af"
      unitRef="usd">853000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i30c71d0c43ce416697a4a799bd7c4d1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEwLTEtMS0xLTM1NDAxOA_d9c1a597-0816-445c-8360-2040582c3803"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="icf8c88bbd7e141e7b68274a9caaec1aa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEwLTMtMS0xLTM1NDAxOA_fb03f939-0f2a-4b9c-8149-2fd4a436cfc8"
      unitRef="usd">873000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5950552df0e54a939965751bc3cd51fc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEwLTUtMS0xLTM1NDAxOA_4b4b2637-472a-42f3-9613-8db12ea9597e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i130febd9b4734349a2f8f9936469e9c1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEwLTctMS0xLTM1NDAxOA_6260ee74-2a3f-443d-b6d8-c8d05ba89a06"
      unitRef="usd">873000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if6480f6a8b344d4da26190ba7e2b134a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzExLTEtMS0xLTM1NDAxOA_c0271f89-76db-4deb-b00f-a0825f7cb032"
      unitRef="usd">324000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="idca2cbb365924fe08d1fca9331f9da1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzExLTMtMS0xLTM1NDAxOA_a5067548-ffdf-4bb1-9f06-290cecc4b028"
      unitRef="usd">2000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1d9e0273ef794fc09e5b2df846ddc972_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzExLTUtMS0xLTM1NDAxOA_7a0456a4-196e-4fb8-856e-6fc73644731e"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzExLTctMS0xLTM1NDAxOA_e95c9004-e536-46e6-94ea-0e7d98323acd"
      unitRef="usd">326000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ie8bae7a6f996464ba2b7a6100620166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEyLTEtMS0xLTM1NDAxOA_047dc2a1-ef55-4272-9861-1a6de7376cb3"
      unitRef="usd">495000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3d506e3cd8b44e8ea7ee6f72aa813850_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEyLTMtMS0xLTM1NDAxOA_fa4b1091-1dd7-4db3-8fd8-2bb2b237c09e"
      unitRef="usd">14314000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2a87d5a6e486446c962961764c10fbe0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEyLTUtMS0xLTM1NDAxOA_7c25e015-0fb7-4bea-a7b9-feaf4c6331ec"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i9edce9fba80c47b48d09fea184945683_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzEyLTctMS0xLTM1NDAxOA_95f966b7-0340-4c1c-b828-b747fc289dff"
      unitRef="usd">14809000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5dd964793f9f461fac181d8ef8a81d1b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE0LTEtMS0xLTM1NDAxOA_9e6b0b69-7db5-4783-8402-4c6b519de629"
      unitRef="usd">96000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5ef9ed30634649e4b045916294d297c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE0LTMtMS0xLTM1NDAxOA_6d704d7b-bc41-428e-99b9-7eef18d6d80a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i30cf143adc074a69bb21722cf2cc8d97_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE0LTUtMS0xLTM1NDAxOA_39cafe68-c84b-435b-b46e-900765dfdde0"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i367faaa9b8c24d72b8fa062cc2dd99ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE0LTctMS0xLTM1NDAxOA_97d9d38f-7714-4499-b717-9e4a50559c4d"
      unitRef="usd">96000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ifcd5875603574767bf2ff59bc4998ce3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTEtMS0xLTQ5NjUyNw_62d8077b-8bef-48fb-8166-90670d868f74"
      unitRef="usd">469000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ifaf506fcaacf4a9c9bf01628e13c738c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTMtMS0xLTQ5NjUyNw_ed887455-44dc-4200-aff8-176a724ad97c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2df834d688e1427a96aae1a432497373_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTUtMS0xLTQ5NjUyNw_a5b6e5f7-bfe9-40bb-82ae-f4d2066d66b3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="id9a410191f824e1d812f6139c4125641_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTctMS0xLTQ5NjUyNw_98753907-ee1b-446d-8d1a-b5e880938463"
      unitRef="usd">469000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0ac8c808851e491b96fe0b5a20350edd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE2LTEtMS0xLTQ5NjUzMA_fa42b426-7dc5-483c-9b5e-e9757b5cbb42"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8600bfef99244855ad7eb86ab1559616_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE2LTMtMS0xLTQ5NjUzMA_4858d4b3-e2f7-4b1a-875d-6818ca072d10"
      unitRef="usd">30000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6bdb686a074e4acf9ab3712cd681a240_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE2LTUtMS0xLTQ5NjUzMA_216002b6-435b-4775-9ba2-7a4a1f4f92d6"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia685ebb6c459475f8ad0e6a8307326bd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE2LTctMS0xLTQ5NjUzMA_e28f09b7-844a-41ca-bc06-ac93d3bfc905"
      unitRef="usd">30000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i02f6517e534d4e87a32cacd9b1d43a6f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTEtMS0xLTM1NDAxOA_a10d60c6-fcd2-462e-a0b9-0b3b7c6e9138"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ife540dc14d1e40cab44feeb7eef313d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTMtMS0xLTM1NDAxOA_6c1074e7-b82f-4855-852a-749bb1e5a663"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ic50a20d112914cc4ab63d1807d98ab0a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTUtMS0xLTM1NDAxOA_290c55b7-1205-43ab-af66-cf0553c58c55"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i961947f6659e41f1bea8348eb926b5a0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE1LTctMS0xLTM1NDAxOA_2358b983-1abf-41fc-babd-3de0b75ff3ca"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib15d07215a9d4d18aff3f2e340e78ee3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE3LTEtMS0xLTM1NDAxOA_46777d71-672e-40f4-a56b-0c49526622fe"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if8802b984efc41ec94e160ab0bbca2fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE3LTMtMS0xLTM1NDAxOA_7d794848-a9a5-4840-b272-7e2e5171cf23"
      unitRef="usd">469000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i118155f938754467a285e3cd573f13ce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE3LTUtMS0xLTM1NDAxOA_9b748cf6-44ab-4987-a962-3381b67a2ba8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia00f1e5c743a40a290330dfdc47180cd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE3LTctMS0xLTM1NDAxOA_0a14ad1c-d8c4-4b2d-b025-a6f00135066f"
      unitRef="usd">469000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i984f2728edad403096ab760c7297e528_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE5LTEtMS0xLTM1NDAxOA_888f7281-22ef-499b-868b-50f0811d4294"
      unitRef="usd">565000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iec7c0676d1274e64a619cdde89d6aa4f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE5LTMtMS0xLTM1NDAxOA_1c0e24d8-429e-44cc-9b26-780fee2c6a06"
      unitRef="usd">503000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia1f91cce64b3471488b001aaa80a426d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE5LTUtMS0xLTM1NDAxOA_99632a16-5144-4ff1-a36c-9bc51bee33e8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5d47874d2cff447d94764455a4adb274_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzE5LTctMS0xLTM1NDAxOA_e2fc2852-fddc-4d88-b2bb-e8be64733e28"
      unitRef="usd">1068000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DerivativeAssets
      contextRef="i36b0789820344a6381068e7895a8cc6b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIxLTEtMS0xLTM1NDAxOA_56d68c91-c648-4fc6-b306-81a5bffc2977"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ia19da1ea96814ca79e2518469b123c9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIxLTMtMS0xLTM1NDAxOA_e0c94ba9-9ca7-491f-bdde-97b2a87ad046"
      unitRef="usd">15000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i65e7424994e04f29bb2b11d17ca82c2d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIxLTUtMS0xLTM1NDAxOA_c6ac0885-4514-4dfc-9324-9450eca268b8"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i216cffbfe6cc49fea999c1a173ee7d01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIxLTctMS0xLTM1NDAxOA_d3a20be9-f4b8-49b4-a16e-fd750f634b4b"
      unitRef="usd">15000000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if6480f6a8b344d4da26190ba7e2b134a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIyLTEtMS0xLTM1NDAxOA_12f3904e-7268-4dbd-8356-f1d4acc26a0a"
      unitRef="usd">14178000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idca2cbb365924fe08d1fca9331f9da1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIyLTMtMS0xLTM1NDAxOA_4b216f36-a231-4c2f-99a5-74fe32cbc1ea"
      unitRef="usd">14832000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1d9e0273ef794fc09e5b2df846ddc972_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIyLTUtMS0xLTM1NDAxOA_a2e700a5-e9b8-4b8f-ada3-838d1d2a97a4"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90YWJsZToyNDkwM2QzNDk1NzM0OGNkYTA3YjlhMjBiODA0ZjNiOS90YWJsZXJhbmdlOjI0OTAzZDM0OTU3MzQ4Y2RhMDdiOWEyMGI4MDRmM2I5XzIyLTctMS0xLTM1NDAxOA_85be5982-44cf-4356-9649-21a0222944c7"
      unitRef="usd">29010000000</us-gaap:AssetsFairValueDisclosure>
    <cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90ZXh0cmVnaW9uOjFlYjAzNTk3YTE0OTRjNTJiM2Y4N2Y2ZWU4OWNhZDc4XzkwOA_3d4f1c77-354e-483a-a4b8-bd795571df91"
      unitRef="usd">698000000</cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue>
    <cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTUvZnJhZzoxZWIwMzU5N2ExNDk0YzUyYjNmODdmNmVlODljYWQ3OC90ZXh0cmVnaW9uOjFlYjAzNTk3YTE0OTRjNTJiM2Y4N2Y2ZWU4OWNhZDc4XzkxNQ_ea4cd90f-b951-4cba-88e4-24a631114a38"
      unitRef="usd">773000000</cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzY4Mw_79dfce97-4785-433b-9c36-bcd94839c25d">Property, Software and Equipment&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, software and equipment consist of the following ($ in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, software and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, software and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense for the years ended December 31, 2022, 2021, and 2020 was $614 million, $565 million, and $487 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2022, in connection with the adoption of a more modern, flexible work environment, the Company undertook a real estate optimization initiative to evaluate future real estate needs and downsize its real estate footprint for owned and leased properties. As a result of this evaluation, the Company substantially changed the use or abandoned various properties and assessed for impairment. The Company engaged a third-party real estate specialist to determine the fair value of its owned properties. The valuation primarily considered comparable properties in each market as well as future cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the optimization, the Company recognized impairment charges related to owned real estate of $808 million for the year ended December 31, 2022. The Company also recognized impairment on fixed assets related to leased real estate of $242 million for the year ended December 31, 2022. These impairments are primarily related to the Managed Care segment. The remainder of the $1,627 million charge relates to right-of-use (ROU) asset impairments, which is included within other long-term assets on the Consolidated Balance Sheet, refer to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Note 11.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzY4Ng_512c75a5-d8b1-41c4-8313-42ef1ac14bdc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, software and equipment consist of the following ($ in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, software and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, software and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i48bf1c0bd1314a1c90835a095147262c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzEtMS0xLTEtMzU0MDE4_202e228d-c3c7-4d28-9545-fd5d6634638c"
      unitRef="usd">2224000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ife87f5c217a845f2a51cd1c4a41ade32_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzEtMy0xLTEtMzU0MDE4_f60c2ac9-1c6a-4d7e-a3eb-07d903f46bcf"
      unitRef="usd">1825000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6f2e4216a4ce40698cac894107c3c948_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzItMS0xLTEtMzU0MDE4_61c5f47d-ec4f-48b6-b806-bfb8fc318f2a"
      unitRef="usd">659000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8b936995e0d14a0e9066d6970142374e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzItMy0xLTEtMzU0MDE4_e8e2b5bb-48ab-4f76-ac57-af0e475e57b1"
      unitRef="usd">1116000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i11d6455065c14916bedcc4b31887f1f5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzMtMS0xLTEtMzU0MDE4_e02c57b7-e72a-4865-8778-5b0e6a20d0f0"
      unitRef="usd">604000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if190281df1454b0d9f5770396612743e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzMtMy0xLTEtMzU0MDE4_9ef0a2ce-2493-460a-a08c-684e85ba698d"
      unitRef="usd">617000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6b6b990671ab4dd8acf8fa985ca2d4e4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzQtMS0xLTEtMzU0MDE4_7746b15c-c94f-4aec-ab73-7eedb2029ede"
      unitRef="usd">467000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i100a54adfd364d5fb0858e40985a6181_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzQtMy0xLTEtMzU0MDE4_c3bfae58-481f-4b54-bc8a-2432a1574348"
      unitRef="usd">732000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i73c2a614f2d145f98965ad96053b0c7e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzUtMS0xLTEtMzU0MDE4_811ec73f-b828-406a-b438-e4d4fb55315c"
      unitRef="usd">366000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if22e34d79ca74c90b70c889d03c57bff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzUtMy0xLTEtMzU0MDE4_e338cba9-cc4f-40be-bfe0-e55eb70aee0c"
      unitRef="usd">753000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i06f29161405549d4ac55bc80cc166ac5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzYtMS0xLTEtMzU0MDE4_dc7414a9-6f13-49e7-bbf0-15988c2990f1"
      unitRef="usd">178000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib38956abc3fb4d8e8499d7bb2fe5d94d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzYtMy0xLTEtMzU0MDE4_383450c1-092a-4d57-9648-51b483e52134"
      unitRef="usd">248000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzctMS0xLTEtMzU0MDE4_ebd17917-3d55-427a-9045-58a544ff4534"
      unitRef="usd">4498000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzctMy0xLTEtMzU0MDE4_74e69062-ece2-4468-acd8-6bfd1ed29066"
      unitRef="usd">5291000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzgtMS0xLTEtMzU0MDE4_83674609-8417-4143-abbc-710ae966a8b0"
      unitRef="usd">2066000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzgtMy0xLTEtMzU0MDE4_8ee1bc4f-4d59-45e4-917f-1a73a6683580"
      unitRef="usd">1900000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzktMS0xLTEtMzU0MDE4_0d905f9a-045b-47c2-9b42-e101a1f4a844"
      unitRef="usd">2432000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90YWJsZTo1OWJlZTg3ZGE0OTI0ZWM0YTc0NWIzY2MwY2FlNjljZi90YWJsZXJhbmdlOjU5YmVlODdkYTQ5MjRlYzRhNzQ1YjNjYzBjYWU2OWNmXzktMy0xLTEtMzU0MDE4_112ef29b-1668-4d0c-8e3c-b5fbb707da06"
      unitRef="usd">3391000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzE2MA_7726d180-f3f4-4c7b-ad6f-9529bd7da18f"
      unitRef="usd">614000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzE2NA_a23119d8-0fca-4cce-897a-a69753555ee8"
      unitRef="usd">565000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzE3Mg_caa5e1fb-f859-4a11-a593-5d2eeb81a4eb"
      unitRef="usd">487000000</us-gaap:Depreciation>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i29be61bb7bd449499dfb1c0c4a885854_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzMxNQ_8d6221c8-163f-487e-ac57-ffce3d552aba"
      unitRef="usd">808000000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="ie3a179811ece4f09918f2e0f0934aad0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzQxOA_56147880-39ad-4b8b-8d6c-4899f963d387"
      unitRef="usd">242000000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMTgvZnJhZzo4ODUxN2MyM2MyODg0MjhmYjc2Y2JkYzZjY2IzZjgwNi90ZXh0cmVnaW9uOjg4NTE3YzIzYzI4ODQyOGZiNzZjYmRjNmNjYjNmODA2XzUyMw_ad7f4024-c9b7-4483-8d4e-50e5a081db52"
      unitRef="usd">1627000000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzc3MQ_defc027e-2dfa-4719-8e1d-62346a801b8d">Goodwill and Intangible Assets&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in goodwill by operating segment ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;Managed&#160;Care&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reallocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reallocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The decrease in the Specialty Services segment goodwill in 2022 was primarily driven by the ongoing portfolio review divestiture related activity during the year as discussed in Note 3. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2022, divestiture related reductions to goodwill included the completed divestitures of PANTHERx and Magellan Rx, as well as goodwill reclassified to other current assets associated with the divestiture of Magellan Specialty Health, which was considered held for sale as of December&#160;31, 2022. The acquired goodwill in 2022 represents goodwill associated with the Magellan acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's Specialty Services segment impairments in 2022 was primarily the result of the impairment of Federal Services business, which included $216 million of goodwill, in conjunction with the December 2022 announcement from the DoD that the Company was not awarded a TRICARE Managed Care Support Contract. The Managed Care segment impairment was the result of the divestiture of the Spanish and Central European businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the increase in the Managed Care segment goodwill in 2021 was related to the acquisition of the remaining 60% interest in Circle Health.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets at December 31, consist of the following ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&#160;Life in Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased contract rights and customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased contract rights and customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described above, the decrease in intangible assets in 2022 was primarily driven by divestiture related activity, which included related impairments, during the year as discussed with goodwill above and in Note 3. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense was $817 million, $770 million, and $719 million for the years ended December 31, 2022, 2021, and 2020, respectively. Estimated total amortization expense related to the December&#160;31, 2022 intangible assets for each of the five succeeding fiscal years is as follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated Total Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzc3MA_44c1d5d7-832b-42c3-8d1a-0e48f6a3059c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in goodwill by operating segment ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;Managed&#160;Care&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reallocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reallocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ibe9c3a7c196249c9a9c9c18973bfaf0c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEtMS0xLTEtMzU0MDE4_5f2fdbde-f569-4728-8bc6-92e0aa478687"
      unitRef="usd">16974000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3600301874b74a97849c262419053cdf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEtMy0xLTEtMzU0MDE4_d4d4973e-dd80-4aff-9078-12d39b0f8ff7"
      unitRef="usd">1678000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEtNS0xLTEtMzU0MDE4_4d065499-d32a-4a97-ac2b-a27808241bba"
      unitRef="usd">18652000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i6447d75d16c04ef5b131401dd27e366b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzItMS0xLTEtMzU0MDE4_227e589a-f125-4751-9aec-834117af1ddb"
      unitRef="usd">1139000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id2bebbc40fd54b4b8b61324fc370f6f6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzItMy0xLTEtMzU0MDE4_6375a28c-b0e4-4a48-8a62-c430fac42c20"
      unitRef="usd">29000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzItNS0xLTEtMzU0MDE4_f78049dc-6d0a-4ba8-9d1c-ac1eed57dbfb"
      unitRef="usd">1168000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i6447d75d16c04ef5b131401dd27e366b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzMtMS0xLTEtMzU0MDE4_077abdd0-0148-4ecc-b1fb-e70654aef5af"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="id2bebbc40fd54b4b8b61324fc370f6f6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzMtMy0xLTEtMzU0MDE4_1bdabdae-edef-406b-99d5-96908d5a174f"
      unitRef="usd">24000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzMtNS0xLTEtMzU0MDE4_070c12b7-65fb-4ae7-a680-0c74af95581e"
      unitRef="usd">24000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillTransfers
      contextRef="i6447d75d16c04ef5b131401dd27e366b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzQtMS0xLTEtMzU0MDE4_7afc1bec-d4fa-4fd3-8869-bcf4542770eb"
      unitRef="usd">250000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="id2bebbc40fd54b4b8b61324fc370f6f6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzQtMy0xLTEtMzU0MDE4_643f834b-fb7e-4851-a6f3-3dba31941c2c"
      unitRef="usd">-250000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzQtNS0xLTEtMzU0MDE4_59f788b9-d1d3-421f-a732-8600b0bf4974"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i6447d75d16c04ef5b131401dd27e366b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzYtMS0xLTEtMzU0MDE4_981cd506-9798-448c-bd02-3f99ac9bc608"
      unitRef="usd">-25000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="id2bebbc40fd54b4b8b61324fc370f6f6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzYtMy0xLTEtMzU0MDE4_3ccccaea-27e9-40b1-92a5-9f4e05590a01"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzYtNS0xLTEtMzU0MDE4_4d754b16-86ef-447f-b355-74690cacb224"
      unitRef="usd">-25000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i92213e6837f747a4af84a01d94d1a0e5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzctMS0xLTEtMzU0MDE4_17c75a40-c7c6-4511-aabe-86921d2a68af"
      unitRef="usd">18338000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6ebf3857ac8d4d779658871d0f01e499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzctMy0xLTEtMzU0MDE4_159aa213-3e83-453d-9909-bbaf4f49984b"
      unitRef="usd">1433000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzctNS0xLTEtMzU0MDE4_55500557-7adb-49f7-9188-c5a6eb0f7c2b"
      unitRef="usd">19771000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzgtMS0xLTEtMzU0MDE4_3a03dc67-015b-405b-9c28-d0e797710cbe"
      unitRef="usd">172000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzgtMy0xLTEtMzU0MDE4_34ceb36b-3e1b-459a-a867-86c26625d784"
      unitRef="usd">905000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzgtNS0xLTEtMzU0MDE4_e5d18122-38ff-4dce-afca-1db366fb0bd1"
      unitRef="usd">1077000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzktMS0xLTEtMzU0MDE4_22801c25-e576-40ea-a1e9-ee39aa7846da"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzktMy0xLTEtMzU0MDE4_858e2955-c705-40dc-bcf1-fa0d088bf373"
      unitRef="usd">1533000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzktNS0xLTEtMzU0MDE4_45200633-e6ef-43bf-b8f8-891f9d51cce1"
      unitRef="usd">1533000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillTransfers
      contextRef="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEwLTEtMS0xLTM1NDAxOA_507ab6b2-914e-40b8-b4d4-ac6717e5af8a"
      unitRef="usd">4000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEwLTMtMS0xLTM1NDAxOA_5fa3d343-7241-4178-ac0d-4efa02638145"
      unitRef="usd">-4000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEwLTUtMS0xLTM1NDAxOA_290e5b0a-add1-4f3c-95f4-0dd7d4a984e2"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzExLTEtMS0xLTM1NDAxOA_f8795d12-a882-4435-9197-36fcb77311f6"
      unitRef="usd">66000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzExLTMtMS0xLTM1NDAxOA_73682e81-3e77-4842-813b-10666be8ff8f"
      unitRef="usd">304000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzExLTUtMS0xLTM1NDAxOA_2edf7e17-cfa7-4ea3-8730-1f242d0c30ec"
      unitRef="usd">370000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEyLTEtMS0xLTM1NDAxOA_4f965d34-37fd-4803-a324-50d93ddad397"
      unitRef="usd">-133000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEyLTMtMS0xLTM1NDAxOA_34a360f9-ba88-48d7-bbcb-8776ebec40a3"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEyLTUtMS0xLTM1NDAxOA_25750b95-aa73-474a-80ff-b13d03699758"
      unitRef="usd">-133000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i1a0d132e8b0f4c5e9eabdf2f63c857e9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEzLTEtMS0xLTM1NDAxOA_3824454b-c777-4b78-a214-c7700d62e575"
      unitRef="usd">18315000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i181e950b83264a488f15aa5b9518e0ac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEzLTMtMS0xLTM1NDAxOA_8f73a2a0-fcd9-4c49-a5c1-15252ab56d18"
      unitRef="usd">497000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo0NTY4YTE1YzAwNTQ0ZGQ3YTAxMGJkNTdkNTM0MGI4My90YWJsZXJhbmdlOjQ1NjhhMTVjMDA1NDRkZDdhMDEwYmQ1N2Q1MzQwYjgzXzEzLTUtMS0xLTM1NDAxOA_a73f6854-7799-479e-8e94-6b988bfd0f1d"
      unitRef="usd">18812000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7849ad351f3a4c2c85f3c60fa5e30c67_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzE2NDkyNjc0NDU3NzA_e77f8043-8981-43bc-ad35-43d9d1b7ddd5"
      unitRef="usd">216000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i556fc29a81414ce8a1faff7d6b5ca940_I20210731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzQxNw_5fe1bd4d-cddb-441c-b476-87a88054e1ba"
      unitRef="number">0.60</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzc3Mw_407df1b5-6be9-4d31-9d21-21c1264f9b64">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets at December 31, consist of the following ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&#160;Life in Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased contract rights and customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased contract rights and customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i328ddde551924916887c2898ccb4dd3b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzItMS0xLTEtMzU0MDE4_b7b36f7f-714d-43dc-ae1f-cdcde1dab784"
      unitRef="usd">7850000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1d16b33d8c444b8481c9b42434c97635_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzItMy0xLTEtMzU0MDE4_069d7ae9-8444-464a-a12e-4265aff644d9"
      unitRef="usd">8068000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i03902f10bd8f4acb93c88c3d43810400_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzItNS0xLTEtMzU0MDE4_bc5247e6-93c3-4679-868c-6b1adaa138ea">P13Y4M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i58a9fd19cada4c13b08e45b396931905_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzItNy0xLTEtMzU0MDE4_3f87f43f-5667-477b-981e-3e64ba52165a">P13Y6M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9b18a16cf3a0445a91bf4830e4787fa6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzMtMS0xLTEtMzU0MDE4_913a43d4-c46c-4150-aef2-443a06f94895"
      unitRef="usd">983000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i16afdebec9994bc7a8b3f04e5c78b0d5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzMtMy0xLTEtMzU0MDE4_76a3535d-52b1-4d7b-903a-3d311286e51c"
      unitRef="usd">1107000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i9e59224fa1b1425dae4c36a43f5ca733_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzMtNS0xLTEtMzU0MDE4_7e7fc661-e4f9-4e13-84c8-a9efa28eef5e">P15Y4M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib287146fc44b4771b7ffa29552be6cfb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzMtNy0xLTEtMzU0MDE4_acdb8fae-4cf9-49d7-ac2a-d0acb1580326">P13Y3M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia1efb4143fcd4b1aaef7a1ba3c72805f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzQtMS0xLTEtMzU0MDE4_3af74e13-c328-4dd5-92ef-e1a8c04d5ca6"
      unitRef="usd">612000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4cf15dae4e23403b853ee515df157fa4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzQtMy0xLTEtMzU0MDE4_819f931c-5278-4e58-9f75-baec7742b0cc"
      unitRef="usd">492000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i77a6398252454629906ae6fadb232df2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzQtNS0xLTEtMzU0MDE4_c3f0b3e6-786c-4ded-b181-0368b5a2bcc5">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i49909ff543254622b7916b96f58bad77_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzQtNy0xLTEtMzU0MDE4_797cec03-f7c3-4e4f-add0-5552866a8110">P13Y9M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7e453e9028df40d18c170e5c715a855a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzUtMS0xLTEtMzU0MDE4_179f76ee-7313-4a4d-bdf4-132b1c49a019"
      unitRef="usd">390000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if1db28c738ca41c9b8de3081714dc705_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzUtMy0xLTEtMzU0MDE4_a842b1e7-894f-48cc-bd33-386af9ad121c"
      unitRef="usd">369000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ia59410e42a404d6697fe2e242a44ea5a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzUtNS0xLTEtMzU0MDE4_6500a2db-f77d-43b8-8f61-9b34d543eb6d">P5Y3M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i46026d8e014347bd85d04fc8a7960c3c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzUtNy0xLTEtMzU0MDE4_bd278d44-541a-4bf3-a7bd-9eff9a326676">P5Y4M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzctMS0xLTEtMzU0MDE4_444d4287-5e28-445c-94f4-f4195a1ad4fb"
      unitRef="usd">9835000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzctMy0xLTEtMzU0MDE4_885f3a4b-3774-4f64-ab80-519a9f261206"
      unitRef="usd">10036000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzctNS0xLTEtMzU0MDE4_b558490b-852b-4cd4-b7d8-74bb29df68cf">P13Y4M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzctNy0xLTEtMzU0MDE4_1df30582-2181-4376-9c09-5ef71dc4f094">P13Y2M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i328ddde551924916887c2898ccb4dd3b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzktMS0xLTEtMzU0MDE4_cb8fd0d9-806f-4e80-b655-ccf677465dba"
      unitRef="usd">2193000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1d16b33d8c444b8481c9b42434c97635_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzktMy0xLTEtMzU0MDE4_6b09a8c1-607f-4b6f-9fc2-cfac8d388089"
      unitRef="usd">1642000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9b18a16cf3a0445a91bf4830e4787fa6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzEwLTEtMS0xLTM1NDAxOA_14ce355b-54db-4ae1-b6dc-67ea90433a48"
      unitRef="usd">263000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i16afdebec9994bc7a8b3f04e5c78b0d5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzEwLTMtMS0xLTM1NDAxOA_1eef8040-5b5d-40e1-ba89-e745c5fa01a1"
      unitRef="usd">206000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia1efb4143fcd4b1aaef7a1ba3c72805f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzExLTEtMS0xLTM1NDAxOA_a58bcc80-ab24-419c-92e3-5472f9daff35"
      unitRef="usd">183000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4cf15dae4e23403b853ee515df157fa4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzExLTMtMS0xLTM1NDAxOA_209238eb-900a-4a95-b394-0fabe0d121eb"
      unitRef="usd">139000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7e453e9028df40d18c170e5c715a855a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzEyLTEtMS0xLTM1NDAxOA_7edc2b6e-284c-4225-8c7f-6a2654a96f88"
      unitRef="usd">285000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if1db28c738ca41c9b8de3081714dc705_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzEyLTMtMS0xLTM1NDAxOA_6152e0cf-8820-4b1d-987e-3156a9fd6cc9"
      unitRef="usd">225000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzE0LTEtMS0xLTM1NDAxOA_97e5aa17-2861-4a3f-847f-a322f459d3da"
      unitRef="usd">2924000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzE0LTMtMS0xLTM1NDAxOA_e4499c10-40b8-4843-b0bf-5e175dc2615e"
      unitRef="usd">2212000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzE1LTEtMS0xLTM1NDAxOA_fa136916-1904-41e7-85f2-b4f68af9ad70"
      unitRef="usd">6911000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZToxZTFjNjAxYWZiZjM0NTg2YWJlNmRiZWI1M2QxNmU2OS90YWJsZXJhbmdlOjFlMWM2MDFhZmJmMzQ1ODZhYmU2ZGJlYjUzZDE2ZTY5XzE1LTMtMS0xLTM1NDAxOA_4465af9e-17fa-44fe-8f39-d23a59476538"
      unitRef="usd">7824000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzU1MQ_372c5b98-5131-4d26-8a96-4250b69c3d7e"
      unitRef="usd">817000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzU1NQ_98500083-244c-4788-9627-2b132aa943a4"
      unitRef="usd">770000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzU2Mw_c09f4550-0212-4315-b1e4-570e7ca2f6cb"
      unitRef="usd">719000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90ZXh0cmVnaW9uOmViOWU3MmYyZjNmMjQyMTFiMWMxZWM4NzE5NGMzMWQxXzc1NA_4f6c047d-4568-447a-bb5b-a3cb21a40341">Estimated total amortization expense related to the December&#160;31, 2022 intangible assets for each of the five succeeding fiscal years is as follows ($ in millions):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated Total Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo5N2Q2ZjRkYTRiZGE0YzllYWM3YzNiMTRlODQwNDlhMy90YWJsZXJhbmdlOjk3ZDZmNGRhNGJkYTRjOWVhYzdjM2IxNGU4NDA0OWEzXzEtMi0xLTEtMzU0MDE4_7c4c82f7-e2fb-4b91-805b-7ed4b6cdef9b"
      unitRef="usd">723000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo5N2Q2ZjRkYTRiZGE0YzllYWM3YzNiMTRlODQwNDlhMy90YWJsZXJhbmdlOjk3ZDZmNGRhNGJkYTRjOWVhYzdjM2IxNGU4NDA0OWEzXzItMi0xLTEtMzU0MDE4_c8145a6f-aee9-434a-9952-400dd78f5069"
      unitRef="usd">707000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo5N2Q2ZjRkYTRiZGE0YzllYWM3YzNiMTRlODQwNDlhMy90YWJsZXJhbmdlOjk3ZDZmNGRhNGJkYTRjOWVhYzdjM2IxNGU4NDA0OWEzXzMtMi0xLTEtMzU0MDE4_0fd35e90-6574-455c-bab8-364f231e5327"
      unitRef="usd">706000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo5N2Q2ZjRkYTRiZGE0YzllYWM3YzNiMTRlODQwNDlhMy90YWJsZXJhbmdlOjk3ZDZmNGRhNGJkYTRjOWVhYzdjM2IxNGU4NDA0OWEzXzQtMi0xLTEtMzU0MDE4_632fe723-2508-4deb-9f03-ac653ec179c8"
      unitRef="usd">689000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjEvZnJhZzplYjllNzJmMmYzZjI0MjExYjFjMWVjODcxOTRjMzFkMS90YWJsZTo5N2Q2ZjRkYTRiZGE0YzllYWM3YzNiMTRlODQwNDlhMy90YWJsZXJhbmdlOjk3ZDZmNGRhNGJkYTRjOWVhYzdjM2IxNGU4NDA0OWEzXzUtMi0xLTEtMzU0MDE4_0a43619e-72c8-40ce-bdcc-f56409070f9a"
      unitRef="usd">678000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:InsuranceDisclosureTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90ZXh0cmVnaW9uOjYwNDVlNWRlYTVkZDQ4NDVhZDk3MTllMDZlOTNmNmUxXzQyOTg_4abcf009-ef58-4817-8bf9-72bf60ad0e14">Medical Claims Liability&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the change in medical claims liability ($ in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, January 1, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions and divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incurred related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paid related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. The impact from COVID-19 on healthcare utilization and medical claims submission patterns provided increased estimation uncertainty on the IBNR liability. Additionally, as a result of minimum HBR and other return of premium programs, the Company recorded approximately $198 million, $492 million, and $86 million of the "Incurred related to: Prior years" as a reduction to premium revenues in 2022, 2021, and 2020, respectively. Further, claims processing initiatives yielded increased claim payment recoveries and coordination of benefits related to prior year dates of service.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in medical utilization and cost trends and the effect of population health management initiatives may also contribute to changes in medical claim liability estimates.&#160;While the Company has evidence that population health management initiatives are effective on a case by case basis, population health management initiatives primarily focus on events and behaviors prior to the incurrence of the medical event and generation of a claim. Accordingly, any change in behavior, leveling of care, or coordination of treatment occurs prior to claim generation and as a result, the costs prior to the population health management initiative are not known by the Company. Additionally, certain population health management initiatives are focused on member and provider education with the intent of influencing behavior to appropriately align the medical services provided with the member's acuity. In these cases, determining whether the population health management initiative changed the behavior cannot be determined. Because of the complexity of its business, the number of states in which it operates, and the volume of claims that it processes, the Company is unable to practically quantify the impact of these initiatives on its changes in estimates of IBNR. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement, and maintenance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Specialty Services segment has an insignificant amount of medical claims liability and, therefore, disclosures related to medical claims liabilities have been aggregated and are presented on a consolidated basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information about incurred and paid claims development as of December&#160;31, 2022 is included in the table below. The claims development information for all periods preceding the most recent reporting period is considered required supplementary information. Incurred and paid claims development as of December&#160;31, 2022 is as follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Claim Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020 (unaudited)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021 (unaudited)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Claim Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total payment of incurred claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All outstanding liabilities prior to 2020, net of reinsurance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical claims liability, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incurred claims and allocated claim adjustment expenses, net of reinsurance, total IBNR plus expected development on reported claims and cumulative claims data as of December&#160;31, 2022 are included in the following table. For claims frequency information summarized below, a claim is defined as the financial settlement of a single medical event in which remuneration was paid to the servicing provider. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims, and estimates for the costs necessary to process unpaid claims at the end of each period.&#160;The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice.&#160;These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.&#160;Information is summarized as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total IBNR Plus Expected Development on Reported Claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative Paid Claims&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InsuranceDisclosureTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90ZXh0cmVnaW9uOjYwNDVlNWRlYTVkZDQ4NDVhZDk3MTllMDZlOTNmNmUxXzQzMDY_3207c522-7cc2-4650-9b74-9935131eeb3a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the change in medical claims liability ($ in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, January 1, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions and divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incurred related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paid related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzItMi0xLTEtMzU0MDE4_63098723-4d5a-4698-ad59-29d616ced2e0"
      unitRef="usd">14243000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzItNC0xLTEtMzU0MDE4_fe9306df-6caa-4221-9233-8358a8388489"
      unitRef="usd">12438000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i89efa37b183c4c618c28149ddb506553_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzItNi0xLTEtMzU0MDE4_b74e4006-81c6-4acf-a22f-dcb4ac6feca1"
      unitRef="usd">7473000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzMtMi0xLTEtMzU0MDE4_6b4a2947-9610-47c8-82ce-ea05739e4e2a"
      unitRef="usd">23000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzMtNC0xLTEtMzU0MDE4_d8498ec4-146e-4188-8961-0c56d58a6a3b"
      unitRef="usd">23000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i89efa37b183c4c618c28149ddb506553_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzMtNi0xLTEtMzU0MDE4_8dbda97b-5b64-409c-90c5-bcd1c5ca049e"
      unitRef="usd">20000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzQtMi0xLTEtMzU0MDE4_97e68326-07cd-48f1-b55a-3a57bba948b9"
      unitRef="usd">14220000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzQtNC0xLTEtMzU0MDE4_100adefd-45a2-4e07-b456-927bb40fa125"
      unitRef="usd">12415000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i89efa37b183c4c618c28149ddb506553_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzQtNi0xLTEtMzU0MDE4_41b83665-5c84-4a53-8a29-18622655d1cc"
      unitRef="usd">7453000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzUtMi0xLTEtMzU0MDE4_2877b5e3-7a13-4342-8d3c-a9f5e0671c00"
      unitRef="usd">105000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzUtNC0xLTEtMzU0MDE4_607819bf-c0c3-433a-950a-30a17a759b42"
      unitRef="usd">0</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzUtNi0xLTEtMzU0MDE4_67a5d0f5-0e66-4fa8-b86a-15aa488879d1"
      unitRef="usd">3856000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzgtMi0xLTEtMzU0MDE4_3d133d35-2aff-4868-9279-482c54053d73"
      unitRef="usd">112896000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzgtNC0xLTEtMzU0MDE4_cc888a85-7e66-4b89-b592-a4c03059f8a4"
      unitRef="usd">100385000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzgtNi0xLTEtMzU0MDE4_afbe9f80-c434-4b20-9fc7-0d8410cd107d"
      unitRef="usd">86765000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzktMi0xLTEtMzU0MDE4_99ba2c45-2ee0-4946-917e-644bd009c136"
      unitRef="usd">-1367000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzktNC0xLTEtMzU0MDE4_c4af01d1-9194-4355-bf05-7202fc95e02f"
      unitRef="usd">-1783000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzktNi0xLTEtMzU0MDE4_65611967-a878-4d9b-b585-59155f7895b0"
      unitRef="usd">-501000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEwLTItMS0xLTM1NDAxOA_3bc4fb72-f251-4fa6-b569-591cf385f975"
      unitRef="usd">111529000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEwLTQtMS0xLTM1NDAxOA_b2808b73-a418-498f-99fb-39398395b22a"
      unitRef="usd">98602000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEwLTYtMS0xLTM1NDAxOA_3f2ecc8a-23b2-4b74-8689-85489d959c5f"
      unitRef="usd">86264000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEyLTItMS0xLTM1NDAxOA_b3321ceb-855c-4a22-92d1-af7f999ae891"
      unitRef="usd">97799000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEyLTQtMS0xLTM1NDAxOA_0c4d0033-e245-4117-bb06-c90f589ac7f5"
      unitRef="usd">87427000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEyLTYtMS0xLTM1NDAxOA_714713d3-3fcc-4718-b747-50172abe7097"
      unitRef="usd">78838000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEzLTItMS0xLTM1NDAxOA_e2527aa7-bfd2-4f06-bb4d-08094468201c"
      unitRef="usd">11336000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEzLTQtMS0xLTM1NDAxOA_56bfebff-5a87-4b18-b389-79b9704029ae"
      unitRef="usd">9370000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzEzLTYtMS0xLTM1NDAxOA_e7ad4240-7881-4ab5-b27c-664ae7c16ff6"
      unitRef="usd">6320000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE0LTItMS0xLTM1NDAxOA_1629ec19-e6ac-4f49-a4bf-15638255aae3"
      unitRef="usd">109135000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE0LTQtMS0xLTM1NDAxOA_0e748bfd-ced4-4d56-bed5-2696d82c1696"
      unitRef="usd">96797000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE0LTYtMS0xLTM1NDAxOA_a4353bc6-a4f9-4bdd-a34c-76772bb28bd8"
      unitRef="usd">85158000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE1LTItMS0xLTM1NDAxOA_3638a909-8632-4b13-a411-7e08c9cba949"
      unitRef="usd">16719000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE1LTQtMS0xLTM1NDAxOA_ada72253-b16c-4b3a-9bec-e2b61613ddd8"
      unitRef="usd">14220000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE1LTYtMS0xLTM1NDAxOA_1b463992-a3f6-4cc4-9ac7-d271cf6d9c13"
      unitRef="usd">12415000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE2LTItMS0xLTM1NDAxOA_938c2489-3c35-4ed8-ac57-3a97f3fc33a8"
      unitRef="usd">26000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE2LTQtMS0xLTM1NDAxOA_cc593e49-59bc-4b33-8bf7-767365d365c9"
      unitRef="usd">23000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE2LTYtMS0xLTM1NDAxOA_f97e8924-95a2-4dab-9f45-45dbbd08ea8c"
      unitRef="usd">23000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE3LTItMS0xLTM1NDAxOA_016b6629-386b-48a5-a4f2-db51f8050994"
      unitRef="usd">16745000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE3LTQtMS0xLTM1NDAxOA_c15308ec-0a8f-4f9d-9fcc-a8aa9afdadd9"
      unitRef="usd">14243000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTpmOGFlMWYxZGEyNmQ0ODkxYWQ3MTAwNTA3YzQ1YjU0MS90YWJsZXJhbmdlOmY4YWUxZjFkYTI2ZDQ4OTFhZDcxMDA1MDdjNDViNTQxXzE3LTYtMS0xLTM1NDAxOA_f0c5391e-e39d-4673-a3bf-a3d6ddd76081"
      unitRef="usd">12438000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <cnc:AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90ZXh0cmVnaW9uOjYwNDVlNWRlYTVkZDQ4NDVhZDk3MTllMDZlOTNmNmUxXzE2NDkyNjc0NDYwMzQ_0e8bbaef-e49a-4ce3-b900-e645aac21523"
      unitRef="usd">198000000</cnc:AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms>
    <cnc:AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90ZXh0cmVnaW9uOjYwNDVlNWRlYTVkZDQ4NDVhZDk3MTllMDZlOTNmNmUxXzE2NDkyNjc0NDYwMTk_a866c4f2-ed5e-4385-9b81-73298289518b"
      unitRef="usd">492000000</cnc:AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms>
    <cnc:AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90ZXh0cmVnaW9uOjYwNDVlNWRlYTVkZDQ4NDVhZDk3MTllMDZlOTNmNmUxXzE2NDkyNjc0NDYwMjY_d0265cfb-ae55-47fd-b1c6-39a285505713"
      unitRef="usd">86000000</cnc:AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms>
    <us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90ZXh0cmVnaW9uOjYwNDVlNWRlYTVkZDQ4NDVhZDk3MTllMDZlOTNmNmUxXzQzMTI_14ffbad8-74f4-4458-8e90-626dc4beeca8">Incurred and paid claims development as of December&#160;31, 2022 is as follows ($ in millions):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Claim Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020 (unaudited)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021 (unaudited)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Claim Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total payment of incurred claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All outstanding liabilities prior to 2020, net of reinsurance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical claims liability, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;Information is summarized as follows (in millions):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total IBNR Plus Expected Development on Reported Claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative Paid Claims&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i73627a9d2f3f4c7890caac11b561d45e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzQtMi0xLTEtMzU0MDE4_8aa0c581-0090-410f-ac21-94b775d7b485"
      unitRef="usd">88206000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="id73d46c1711b4b3da426964338d0f2df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzQtNC0xLTEtMzU0MDE4_f7f5eb05-8252-47b3-b4ae-814216a411bf"
      unitRef="usd">86502000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i19d7002bf5504374ba94620ad1f9d850_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzQtNi0xLTEtMzU0MDE4_b3f52128-9b7e-4674-b5d0-60856dae4783"
      unitRef="usd">86433000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ifa9b52eb00894da485bfb964ba7dce6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzUtNC0xLTEtMzU0MDE4_6b126bb1-8dc9-46d1-a899-7c119ae90b65"
      unitRef="usd">100385000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ic0bdad4169ab4f599480c131c7206ae1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzUtNi0xLTEtMzU0MDE4_bf40d89e-bb56-4758-89b6-ed154a84d6ad"
      unitRef="usd">99087000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i7d2f58523cb7466b8aecbc8fdbe138a8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzYtNi0xLTEtMzU0MDE4_d9245ab3-e739-4e72-8c85-fcd79c6181ed"
      unitRef="usd">112896000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i41b58c91b23541a8a008f29061d225c8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzctNi0xLTEtMzU0MDE4_5e584a43-862e-4f59-886e-e4ff657ce0e2"
      unitRef="usd">298416000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i73627a9d2f3f4c7890caac11b561d45e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzEzLTItMS0xLTM1NDAxOA_be2f6a60-4ce1-42a2-a114-f3f5a447f55a"
      unitRef="usd">76722000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="id73d46c1711b4b3da426964338d0f2df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzEzLTQtMS0xLTM1NDAxOA_89cb0d34-f049-4879-aed5-9c341c2078a3"
      unitRef="usd">85593000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i19d7002bf5504374ba94620ad1f9d850_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzEzLTYtMS0xLTM1NDAxOA_4c954364-aefc-4f30-a43c-11d21ca77d8b"
      unitRef="usd">86021000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ifa9b52eb00894da485bfb964ba7dce6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzE0LTQtMS0xLTM1NDAxOA_8343dd38-94a4-4375-9730-d501002f94be"
      unitRef="usd">87427000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ic0bdad4169ab4f599480c131c7206ae1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzE0LTYtMS0xLTM1NDAxOA_f579b31a-f2b8-40e4-b9f1-271b8a75e9a4"
      unitRef="usd">98024000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i7d2f58523cb7466b8aecbc8fdbe138a8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzE1LTYtMS0xLTM1NDAxOA_b96ccdc6-3401-4d8c-a5f9-3a19c08cf18c"
      unitRef="usd">97799000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i41b58c91b23541a8a008f29061d225c8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzE2LTYtMS0xLTM1NDAxOA_b8eec6e0-7691-47f0-b74e-8680fdd362f5"
      unitRef="usd">281844000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <cnc:ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther
      contextRef="i41b58c91b23541a8a008f29061d225c8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzE3LTYtMS0xLTM1NDAxOA_5e69c351-c387-4eca-bc8c-595709f61034"
      unitRef="usd">147000000</cnc:ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented
      contextRef="i41b58c91b23541a8a008f29061d225c8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZToyYWI4MTEyMTcxMWM0Yzk1YWYwNjRhNGRkZTMxMmRhMi90YWJsZXJhbmdlOjJhYjgxMTIxNzExYzRjOTVhZjA2NGE0ZGRlMzEyZGEyXzE4LTYtMS0xLTM1NDAxOA_a5acdc4d-ed3d-4050-9765-825e18d13b13"
      unitRef="usd">16719000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i19d7002bf5504374ba94620ad1f9d850_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzQtMS0xLTEtMzU0MDE4_c3367d78-0135-44b5-9ae2-f1059147c412"
      unitRef="usd">86433000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <cnc:ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims
      contextRef="i19d7002bf5504374ba94620ad1f9d850_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzQtMy0xLTEtMzU0MDE4_7f30e1e2-6287-4309-8de7-8e485a4b4583"
      unitRef="usd">0</cnc:ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims>
    <us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims
      contextRef="i19d7002bf5504374ba94620ad1f9d850_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzQtNS0xLTEtMzU0MDE4_3a834325-9875-4bd9-b886-48681ba78280"
      unitRef="claim">568800000</us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ic0bdad4169ab4f599480c131c7206ae1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzUtMS0xLTEtMzU0MDE4_88ca6e13-2f2b-4d08-807a-bb2abb3645f1"
      unitRef="usd">99087000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <cnc:ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims
      contextRef="ic0bdad4169ab4f599480c131c7206ae1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzUtMy0xLTEtMzU0MDE4_252144d3-0248-484b-bce8-7911fa7cc7c5"
      unitRef="usd">273000000</cnc:ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims>
    <us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims
      contextRef="ic0bdad4169ab4f599480c131c7206ae1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzUtNS0xLTEtMzU0MDE4_2c2f2905-f569-4845-8e80-17845c0aa4f2"
      unitRef="claim">623200000</us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i7d2f58523cb7466b8aecbc8fdbe138a8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzYtMS0xLTEtMzU0MDE4_c0e083d2-5021-43f9-b97f-232db9e98f2b"
      unitRef="usd">112896000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <cnc:ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims
      contextRef="i7d2f58523cb7466b8aecbc8fdbe138a8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzYtMy0xLTEtMzU0MDE4_8f74f033-930d-473c-a4cc-9eb6e98b5bbd"
      unitRef="usd">11081000000</cnc:ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims>
    <us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims
      contextRef="i7d2f58523cb7466b8aecbc8fdbe138a8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjQvZnJhZzo2MDQ1ZTVkZWE1ZGQ0ODQ1YWQ5NzE5ZTA2ZTkzZjZlMS90YWJsZTozNGRkODQwY2FiNjA0YmYwOGYzOTkxZTk1M2U2YzExMy90YWJsZXJhbmdlOjM0ZGQ4NDBjYWI2MDRiZjA4ZjM5OTFlOTUzZTZjMTEzXzYtNS0xLTEtMzU0MDE4_7c6204bf-e29e-4a9e-866b-0b057214cbf1"
      unitRef="claim">608100000</us-gaap:ShortdurationInsuranceContractsNumberOfReportedClaims>
    <cnc:AffordableCareActDisclosureTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90ZXh0cmVnaW9uOjY2OTA5Zjc1YmY4ZjQ4ZjhhMzI5MzA3MzU1OThhY2VmXzU3OA_7f18e56c-4a6a-4df2-a6f9-7ddab6a57696">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Affordable Care Act&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established risk spreading premium stabilization programs as well as a minimum annual MLR and cost sharing reductions. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's net receivables (payables) for each of the programs are as follows ($ in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk adjustment receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk adjustment payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Minimum medical loss ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost sharing reduction receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost sharing reduction payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;In June 2022, CMS announced the final risk adjustment transfers for the 2021 benefit year. As a result of the announcement, the Company increased its risk adjustment net receivables by $403 million from December&#160;31, 2021. After consideration of minimum MLR and other related impacts, the net pre-tax benefit recognized was approximately $368 million for the year ended December&#160;31, 2022.</cnc:AffordableCareActDisclosureTextBlock>
    <cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90ZXh0cmVnaW9uOjY2OTA5Zjc1YmY4ZjQ4ZjhhMzI5MzA3MzU1OThhY2VmXzU4NA_cc1a34ff-eb8c-4667-bee4-e281f496f881">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's net receivables (payables) for each of the programs are as follows ($ in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk adjustment receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk adjustment payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Minimum medical loss ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost sharing reduction receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost sharing reduction payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock>
    <cnc:AffordableCareActRiskAdjustmentReceivable
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzEtMS0xLTEtMzU0MDE4_475fd411-802d-4749-b810-fc15bfb8ca7a"
      unitRef="usd">838000000</cnc:AffordableCareActRiskAdjustmentReceivable>
    <cnc:AffordableCareActRiskAdjustmentReceivable
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzEtMy0xLTEtMzU0MDE4_02ace0eb-78f5-4a2a-889f-7155563c2b23"
      unitRef="usd">522000000</cnc:AffordableCareActRiskAdjustmentReceivable>
    <cnc:AffordableCareActReinsurancePayable
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzItMS0xLTEtMzU0MDE4_5d58bb36-2bb2-400b-a7d7-ff4db8c063cd"
      unitRef="usd">780000000</cnc:AffordableCareActReinsurancePayable>
    <cnc:AffordableCareActReinsurancePayable
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzItMy0xLTEtMzU0MDE4_eb2a0396-f0d4-4b1d-badf-120c038fafda"
      unitRef="usd">536000000</cnc:AffordableCareActReinsurancePayable>
    <cnc:AffordableCareActMinimumMedicalLossRatio
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzQtMS0xLTEtMzU0MDE4_e1da6955-3c76-4987-bc1b-de4510d2d601"
      unitRef="usd">103000000</cnc:AffordableCareActMinimumMedicalLossRatio>
    <cnc:AffordableCareActMinimumMedicalLossRatio
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzQtMy0xLTEtMzU0MDE4_d580ee06-5b5d-4234-b111-f3ac9efa3b1c"
      unitRef="usd">196000000</cnc:AffordableCareActMinimumMedicalLossRatio>
    <cnc:AffordableCareActCostSharingReductionReceivable
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzUtMy0xLTEtMzU0MDE4_b2199ed0-51f4-4c76-a6d4-92b33b4c7199"
      unitRef="usd">69000000</cnc:AffordableCareActCostSharingReductionReceivable>
    <cnc:AffordableCareActCostSharingReductionsPayable
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzYtMS0xLTEtMzU0MDE4_33de4cd4-5799-4c6f-8708-488e8a922bbc"
      unitRef="usd">99000000</cnc:AffordableCareActCostSharingReductionsPayable>
    <cnc:AffordableCareActCostSharingReductionsPayable
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90YWJsZTo1NzNiNDY4Mjk5NDE0OGE2OWQxMjUwY2U3ZDkwNDM0ZS90YWJsZXJhbmdlOjU3M2I0NjgyOTk0MTQ4YTY5ZDEyNTBjZTdkOTA0MzRlXzYtMy0xLTEtMzU0MDE4_8451ea4c-b504-47e9-ac32-848e557d0f0c"
      unitRef="usd">42000000</cnc:AffordableCareActCostSharingReductionsPayable>
    <cnc:AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease
      contextRef="ieedd2924db2741fca6d7ee512adc93cd_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90ZXh0cmVnaW9uOjY2OTA5Zjc1YmY4ZjQ4ZjhhMzI5MzA3MzU1OThhY2VmXzQzNg_4ae9c886-9ebc-4d8f-807f-2015239663f9"
      unitRef="usd">403000000</cnc:AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease>
    <cnc:AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMjcvZnJhZzo2NjkwOWY3NWJmOGY0OGY4YTMyOTMwNzM1NTk4YWNlZi90ZXh0cmVnaW9uOjY2OTA5Zjc1YmY4ZjQ4ZjhhMzI5MzA3MzU1OThhY2VmXzU2Mw_ccdf547e-8d7d-486c-a431-e04f31773813"
      unitRef="usd">-368000000</cnc:AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzk5MDU_cb411c95-1f0d-4add-ab99-2f4502b4da74">Debt &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt consists of the following ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,500 million 4.25% Senior Notes, due December 15, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,300 million 2.45% Senior Notes, due July 15, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3,500 million 4.625% Senior Notes, due December 15, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,000 million 3.375% Senior Notes, due February 15, 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,200 million 3.00% Senior Notes, due October 15, 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,200 million 2.50% Senior Notes, due March 1, 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,300 million 2.625% Senior Notes, due August 1, 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan credit facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving credit agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction loan payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the Company's total debt, approximately 13% is variable rate debt. Approximately 12% uses the London Interbank Offered Rate (LIBOR) as a reference rate pursuant to the terms of the Company Credit Facility and approximately 1% uses the Sterling Overnight Index Average (SONIA) as a reference rate. The Company believes that the credit agreement will allow Secured Overnight Financing Rate (SOFR) to be used as the new reference rate upon LIBOR's discontinuance. The debt agreements that may be impacted by the discontinuation of LIBOR have provisions included that are sufficient for the Company to transition from the existing LIBOR rates to the prevailing successor market rates as necessary. The document governing the Company Credit Facility includes provisions to convert from LIBOR to SOFR at the time LIBOR ceases to be published.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Magellan acquisition in January 2022, the Company paid off Magellan's debt of $535 million acquired in the transaction using Magellan's cash on hand. Specifically, the Company redeemed Magellan's existing outstanding 4.4% Senior Notes due 2024 and paid off the existing Credit Agreement. The Company recognized an immaterial net pre-tax gain on extinguishment including related fees and expenses and the write-off of the unamortized premium.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, the Company utilized a portion of the proceeds from the PANTHERx divestiture to repurchase $95 million of its par value Senior Notes due 2027 and $223 million of its par value Senior Notes due 2029 through the Company's senior note debt repurchase program. The Company recognized a $14 million gain on the redemptions of the notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company issued $2,200 million 2.50% Senior Notes due 2031 (the 2031 Notes). In conjunction with the 2031 Notes offering, the Company completed a tender offer (the Tender Offer) to purchase for cash, subject to certain conditions, any and all of the outstanding aggregate principal amount of the $2,200 million 4.75% Senior Notes due 2025 (the 2025 Notes). The Company used the net proceeds from the 2031 Notes, together with available cash on hand, to fund the purchase price for the 2025 Notes accepted for purchase in the Tender Offer (approximately 36% of the aggregate principal amount outstanding) and used the remaining proceeds to redeem any of the 2025 Notes that remained outstanding following the Tender Offer, including all premiums and accrued interest. The Company recognized a pre-tax loss on extinguishment of $46&#160;million on the redemption of the 2025 Notes, including the call premium, the write-off of the unamortized premium and debt issuance costs, and expenses related to the redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the Company issued $1,800&#160;million 2.45% Senior Notes due 2028 (the 2028 Notes). The Company used the net proceeds from the offering of the 2028 Notes to finance a portion of the cash consideration payable in connection with the acquisition of Magellan Health Inc., which closed in January 2022, and to pay related fees and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, the Company issued $1,800&#160;million aggregate principal amount of Senior Notes which included $500&#160;million aggregate principal amount of additional 2028 Notes at a premium to yield 2.31% and $1,300&#160;million aggregate principal amount of new 2.625% Senior Notes due 2031. The Company used the net proceeds of the offering, together with cash on hand and term loan facility borrowings, to redeem all of its outstanding 5.375% Senior Notes due 2026 and WellCare Health Plans, Inc.'s outstanding 5.375% Senior Notes due 2026 (together the 2026 Notes), including all premiums and accrued interest. The Company recognized a pre-tax loss on extinguishment of $79&#160;million on the redemptions of the 2026 Notes, including the call premium, the write-off of the unamortized premium and debt issuance costs, and expenses related to the redemptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The indentures governing the senior notes listed in the table above contain restrictive covenants of Centene Corporation. At December&#160;31, 2022, the Company was in compliance with all covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Swap&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In order to manage the foreign exchange risk associated with an intercompany note receivable related to the Circle Health acquisition, the Company entered into a foreign currency swap agreement for a notional amount of $705&#160;million, to purchase &#xa3;509&#160;million. The swap agreement was formally designated and qualified as a fair value hedge. All gains and losses due to changes in the fair value of the foreign currency swap completely offset changes in the remeasurement of the intercompany note receivable within investment and other income in the Consolidated Statement of Operations, resulting in no net impact to the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the swap agreement as of December&#160;31, 2021 was $15&#160;million, which was recorded in other current assets in the Consolidated Balance Sheet. The offsetting changes in fair value of the foreign currency swap and the remeasurement on the underlying intercompany note receivable were both recognized in investment and other income in the Consolidated Statements of Operations. The Company does not hold or issue any derivative instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 31, 2022, the foreign currency swap settled in connection with its expiration, and the Company received cash proceeds of $35 million. The Company does not hold or issue any derivative instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Circle Health Debt Refinancing&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, the Company refinanced certain debt agreements for its Circle Health subsidiary with a new &#xa3;250 million credit facility maturing in May 2025. The Company recognized a $13 million pre-tax gain on the extinguishment of the existing debt. As of December&#160;31, 2022, &#xa3;160&#160;million was drawn on the facility, which is included within Finance leases and other in the table above. The new facility is guaranteed by the Company and has similar borrowing rates and covenants to the Company's Revolving Credit Agreement, except it uses the SONIA as the reference rate for the interest rate payable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revolving Credit Facility and Term Loan Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, the Company amended and restated its existing credit agreement to, among other things, (i) extend the various maturities under the existing Credit Agreement until 2026, (ii) increase the aggregate principal amount of the U.S. dollar unsecured term loan facility under the existing Credit Agreement from $1,450 million to $2,200 million, (iii) increase the maximum total net leverage ratio permitted under the total debt to EBITDA financial covenant from 3.5 to 1.0 to 4.0 to 1.0, (iv) reduce the applicable margin with respect to borrowings to between 1.50% to 1.125%, based on the total debt to EBITDA ratio and type of borrowing and (v) include scheduled amortization payments with respect to the term loan facility equal to 0% for the first year following closing, 2.5% for the second year following closing and 5% thereafter until maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has (i) unsecured $2,000 million multi-currency revolving credit facility (the Revolving Credit Facility), which includes a $300 million sub-limit for letters of credit and a $200 million sub-limit for swingline loans and (ii) a $2,200 million unsecured delayed-draw term loan facility (the Term Loan Facility, and, together with the Revolving Credit Facility, the Company Credit Facility). Borrowings under the Revolving Credit Facility bear interest, at the Company's option, at LIBOR, EURIBOR, CDOR, BBR, or base rates plus, in each case, an applicable margin between 1.50% to 1.125%, based on the total debt to EBITDA ratio and type of borrowing. Borrowings under the Term Loan Facility bear interest, at the Company's option, at LIBOR or base rates plus, in each case, an applicable margin based on the total debt to EBITDA ratio. The Company has an uncommitted option to increase its Company Credit Facility by an additional $500 million plus certain additional amounts based on its total debt to EBITDA ratio. The Company believes that the credit agreement will allow SOFR to be used as the new reference rate upon LIBOR's discontinuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company Credit Facility contains financial covenants including maintenance of a minimum fixed charge coverage ratio and a restriction on the Company's maximum total debt to EBITDA ratio not to exceed 4.0 to 1.0. It also contains certain non-financial covenants including: limitations on incurrence of additional indebtedness; restrictions on incurrence of liens; restrictions on dividends and other restricted payments; restrictions on investments, mergers, consolidations, and asset sales; and limitations on transactions with affiliates. As of December&#160;31, 2022, the Company was in compliance with all financial and non-financial covenants under the Company Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company had $58 million of borrowings outstanding under the Revolving Credit Facility, with a weighted average interest rate of 4.80%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Credit Facility and the Term Loan Facility will mature on August&#160;16, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Construction Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2017, the Company executed a $200 million non-recourse construction loan to fund the expansion of the Company's corporate headquarters. Until final completion of the project, which occurred in July 2021, the loan bore interest based on the one month LIBOR plus 2.70%, which reduced to LIBOR plus 2.00%&#160;at the time construction completed. The agreement contains financial and non-financial covenants similar to those contained in the Company Credit Facility. The Company guaranteed completion of the construction project associated with the loan. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2022, the Company extended the term of the loan for an additional one year. The extension reduced interest on the loan to SOFR plus 1.85% and matures in April 2023. In December 2022, the Company paid off the outstanding balance of the construction loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Note Debt Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Company's Board of Directors authorized a new $1,000 million senior note debt repurchase program in preparation for future debt reductions as part of the Company's strategic value creation initiatives. During the year ended December 31, 2022, the Company repurchased $318 million of its par value senior notes, as described above, for $300 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, there was $700 million available under the senior note debt repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Letters of Credit &amp;amp; Surety Bonds&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had outstanding letters of credit of $217 million as of December&#160;31, 2022, which were not part of the Revolving Credit Facility.&#160;The letters of credit bore interest at 0.6% as of December&#160;31, 2022. The Company had outstanding surety bonds of $1,292 million as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate maturities for the Company's debt for the years ending December 31, are as follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate Maturities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of outstanding debt was approximately $15,791 million and $19,256 million at December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzk4ODY_f8a1472f-c4a0-4feb-85cf-6a0900152bd1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt consists of the following ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,500 million 4.25% Senior Notes, due December 15, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,300 million 2.45% Senior Notes, due July 15, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3,500 million 4.625% Senior Notes, due December 15, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,000 million 3.375% Senior Notes, due February 15, 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,200 million 3.00% Senior Notes, due October 15, 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2,200 million 2.50% Senior Notes, due March 1, 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,300 million 2.625% Senior Notes, due August 1, 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan credit facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving credit agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction loan payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if59e715c4ba4443c81f2e83328a8a425_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246ZTE4MTM2MjlkMmExNGQ1MjhhZmM1YzZiMTk2NGZlZjZfNA_3c8a67d3-8a20-4eea-9852-e1505b98e07c"
      unitRef="usd">2500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if59e715c4ba4443c81f2e83328a8a425_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246ZTE4MTM2MjlkMmExNGQ1MjhhZmM1YzZiMTk2NGZlZjZfNw_11f44b94-94cb-4515-b6bf-4c4399117149"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="if59e715c4ba4443c81f2e83328a8a425_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEtMS0xLTEtMzU0MDE4_a7f3cef0-fc9d-4121-8116-aaf1f8547986"
      unitRef="usd">2393000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="if498067e62854af781939df76fc7b035_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEtMy0xLTEtMzU0MDE4_4543c3e2-0b01-40af-9823-93efcb1115b7"
      unitRef="usd">2484000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id75e90133d6e4c55b389cae1596db986_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MzgxNzQ0NTUyNWM1NDFkODgxOTJjZTQ1ZTIyYTE3N2ZfNA_55f47f6c-4733-4c06-95c8-7b32f05bf8ce"
      unitRef="usd">2300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id75e90133d6e4c55b389cae1596db986_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzItMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MzgxNzQ0NTUyNWM1NDFkODgxOTJjZTQ1ZTIyYTE3N2ZfNw_4f2310df-7c5e-41e6-b1ac-fcd2883fdaad"
      unitRef="number">0.0245</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="id75e90133d6e4c55b389cae1596db986_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzItMS0xLTEtMzU0MDE4_211169c2-c6b9-4e78-8556-d44d1264ccb4"
      unitRef="usd">2303000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i2b3779cadebd4a4a8a5ddcba3d40c0d3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzItMy0xLTEtMzU0MDE4_a9d085ca-caac-444d-9606-5c4f3b7c71f4"
      unitRef="usd">2304000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i250c45b9e6554e22b18804fe0e46eccf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzMtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246NjEyMDZmOTQ5ZGM2NGY1MTgzNjI5OWFlMzQ0ZTYwYWVfNA_2b6d04c5-386e-44c2-963d-e45c1e7b3f45"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i250c45b9e6554e22b18804fe0e46eccf_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzMtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246NjEyMDZmOTQ5ZGM2NGY1MTgzNjI5OWFlMzQ0ZTYwYWVfNw_f016fcd3-f123-4bc4-91d7-15c250d21822"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i250c45b9e6554e22b18804fe0e46eccf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzMtMS0xLTEtMzU0MDE4_95d9aab2-a5a3-469a-8d15-35e278fa8376"
      unitRef="usd">3277000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i93f572be795842d992415254cf1b1974_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzMtMy0xLTEtMzU0MDE4_191f5a45-844d-4f62-a40b-babe1efb0eac"
      unitRef="usd">3500000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ifd89fe164f074e05acdf55f863fcc0a3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzQtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MWUxZmE2NzEwODI3NGNhZTkyZGE1M2NmMmM4MzVhYzRfNA_65b47058-4500-4535-befe-da02bcd0a6fe"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifd89fe164f074e05acdf55f863fcc0a3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzQtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MWUxZmE2NzEwODI3NGNhZTkyZGE1M2NmMmM4MzVhYzRfNw_26c8549f-844b-41c8-8caa-1fe12271d9d9"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="ifd89fe164f074e05acdf55f863fcc0a3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzQtMS0xLTEtMzU0MDE4_a8442df6-6b7a-4426-945b-7e84877c3501"
      unitRef="usd">2000000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="iae25ea5bc64c484ebad2cc5c1bc36113_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzQtMy0xLTEtMzU0MDE4_aabfb514-7a6a-43cb-a40a-50794d68c33d"
      unitRef="usd">2000000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i078d28b9b7034dd79780964d934280a4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzUtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246NGEyYTI4MjA0ZmEyNGZhYmIyOTVjOTNlMDJjZjkzNmJfNA_625b6036-16bd-4315-90f1-799cdb194d5b"
      unitRef="usd">2200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i078d28b9b7034dd79780964d934280a4_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzUtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246NGEyYTI4MjA0ZmEyNGZhYmIyOTVjOTNlMDJjZjkzNmJfNw_da4a5179-8de3-4274-8acf-f3682e80f67f"
      unitRef="number">0.0300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i078d28b9b7034dd79780964d934280a4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzUtMS0xLTEtMzU0MDE4_2dcd69ca-e646-439c-ab1c-93583cc63d62"
      unitRef="usd">2200000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i1f64aca31038437e9b59b40bd0c68e62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzUtMy0xLTEtMzU0MDE4_d11fdaf0-829a-47fd-a235-5e79c13a7d96"
      unitRef="usd">2200000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id1b9e385a1ff409aa6196f98517e19f0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzYtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246NzY1OGFmZGIxMjQyNDFjMmI0ODIxZmQ4NTgzMzQ2MDdfNA_0a5c082c-0114-4c8d-baa6-e6fa3c7aff99"
      unitRef="usd">2200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id1b9e385a1ff409aa6196f98517e19f0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzYtMC0xLTEtMzU0MDE4L3RleHRyZWdpb246NzY1OGFmZGIxMjQyNDFjMmI0ODIxZmQ4NTgzMzQ2MDdfNw_f20315a9-0405-4484-bf34-31153d10360d"
      unitRef="number">0.0250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="id1b9e385a1ff409aa6196f98517e19f0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzYtMS0xLTEtMzU0MDE4_74a54676-03a6-44ea-98ce-50ebbd9ea8b8"
      unitRef="usd">2200000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="ia0e4077697e84a6aacad32e78a712191_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzYtMy0xLTEtMzU0MDE4_68d1dbd2-5ac4-4810-b603-9cf42c2d9aa9"
      unitRef="usd">2200000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i78293ad1cf844c17be18714b5b518d0d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzctMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MjMyNWU3Y2YwNTY3NDIzZGFmNjNmOGExMmMwNzY2MjJfNA_a10e094e-d1c2-40f6-a599-83498386fe1a"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i78293ad1cf844c17be18714b5b518d0d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzctMC0xLTEtMzU0MDE4L3RleHRyZWdpb246MjMyNWU3Y2YwNTY3NDIzZGFmNjNmOGExMmMwNzY2MjJfNw_7febd840-5330-4c8d-a508-63aa3d15cdb1"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i78293ad1cf844c17be18714b5b518d0d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzctMS0xLTEtMzU0MDE4_ecef0cb8-12c9-485a-8db9-1dc2e75feed6"
      unitRef="usd">1300000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i6b35f9af5214457fa8305485b8f5f80b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzctMy0xLTEtMzU0MDE4_e6519d2c-41e6-4d92-b447-34cfcf98a432"
      unitRef="usd">1300000000</us-gaap:SeniorNotes>
    <cnc:SeniorNotesTotal
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzgtMS0xLTEtMzU0MDE4_b7052d89-6738-4af1-943d-971df308e579"
      unitRef="usd">15673000000</cnc:SeniorNotesTotal>
    <cnc:SeniorNotesTotal
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzgtMy0xLTEtMzU0MDE4_7fb14bed-d5ae-4ff9-9b18-c8edd4b333a8"
      unitRef="usd">15988000000</cnc:SeniorNotesTotal>
    <us-gaap:LineOfCredit
      contextRef="i3889e7dc9b3e43e2a89701b5ac996351_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzktMS0xLTEtMzU0MDE4_a3b7adf0-c044-4293-9fe0-b5089716b596"
      unitRef="usd">2183000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i0c97fc5b57a3422fa0bc98e9660b7eae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzktMy0xLTEtMzU0MDE4_57b05038-5dd4-4a07-823c-9793aec9ab27"
      unitRef="usd">2195000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i86309d5b4d1e4ad9b29778c622cf58d4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEwLTEtMS0xLTM1NDAxOA_51f1b6c0-f5e5-4103-b308-16ed907d9c3a"
      unitRef="usd">58000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ic251ef2ec19d480a85766f384559792b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEwLTMtMS0xLTM1NDAxOA_ad7f1ca6-a5f2-47db-a3a9-6f9b94c2b559"
      unitRef="usd">149000000</us-gaap:LineOfCredit>
    <us-gaap:LoansPayable
      contextRef="if6e2a887cb3d462b82d112eb5f97f89a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzExLTEtMS0xLTM1NDAxOA_afda1018-e6a9-4862-a774-39cb45f3db84"
      unitRef="usd">0</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="ifffd6515bcf049398572bfc7345e86dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzExLTMtMS0xLTM1NDAxOA_da12eaf4-8296-435e-9746-cada9b82014c"
      unitRef="usd">184000000</us-gaap:LoansPayable>
    <cnc:FinanceLeaseLiabilityAndOther
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEyLTEtMS0xLTM1NDAxOA_2cc985e3-7da8-4d77-b7f6-ea826f85f1e9"
      unitRef="usd">253000000</cnc:FinanceLeaseLiabilityAndOther>
    <cnc:FinanceLeaseLiabilityAndOther
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEyLTMtMS0xLTM1NDAxOA_595f40aa-95b6-4b0d-932c-f2569ad0a0e9"
      unitRef="usd">493000000</cnc:FinanceLeaseLiabilityAndOther>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEzLTEtMS0xLTM1NDAxOA_9f494ada-cae2-43ae-b76c-d9fca7c67dfd"
      unitRef="usd">147000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzEzLTMtMS0xLTM1NDAxOA_1ccc8d73-1c57-4bca-8c53-2a53897b6b92"
      unitRef="usd">171000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzE0LTEtMS0xLTM1NDAxOA_f01fef6e-4c13-4913-ad06-af032c298678"
      unitRef="usd">18020000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzE0LTMtMS0xLTM1NDAxOA_cfa9c96f-b4e1-40e6-938f-b203ea5dc6ef"
      unitRef="usd">18838000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtCurrent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzE1LTEtMS0xLTM1NDAxOA_b138b3da-12ec-46a0-a543-8ad58c0b3c5d"
      unitRef="usd">82000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzE1LTMtMS0xLTM1NDAxOA_6452fd53-7fc9-47f0-85b4-aae569724854"
      unitRef="usd">267000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzE2LTEtMS0xLTM1NDAxOA_c8a282c7-6a5f-4c48-9b35-acef6c026b2c"
      unitRef="usd">17938000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZToyYmYyNDhlM2VjYjc0ZTBkYWIzYjljNDgxNzU2Yzg3NS90YWJsZXJhbmdlOjJiZjI0OGUzZWNiNzRlMGRhYjNiOWM0ODE3NTZjODc1XzE2LTMtMS0xLTM1NDAxOA_c55a89b5-297f-435b-842a-38012712b0c3"
      unitRef="usd">18571000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7582e6a18d214d5683a70f95e9969290_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc2OTA_7fc57c58-e879-4384-be24-1b767ae02b6f"
      unitRef="number">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i197f99f81f0748d8ba59ab12609ea196_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzU0OTc1NTgyOTQ4NA_f6674250-42ef-4c6c-afed-34db874186dc"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7fded93a3db84d59b9c64760d9785611_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzU0OTc1NTgzMDEzOQ_93177b71-a7d5-46ac-994f-6c0199997aa7"
      unitRef="number">0.01</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RepaymentsOfAssumedDebt
      contextRef="i71b9b8cb331c423a90a34a1f496e8463_D20220101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzU0OTc1NTgzNDU5NA_52552038-4bf9-4028-91b0-3faf46ca8718"
      unitRef="usd">535000000</us-gaap:RepaymentsOfAssumedDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i474329559a594a6db005b911431a9b0d_I20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc2OTY_70e4530e-2c6f-4bb7-af8f-d5ec70d8bde4"
      unitRef="number">0.044</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="if59e715c4ba4443c81f2e83328a8a425_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzkwNQ_4c21a6b1-e2b1-4167-be38-9cba3e1f714a"
      unitRef="usd">95000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i250c45b9e6554e22b18804fe0e46eccf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzk0OQ_8abd4e6c-de1b-42a0-b5cb-640b9d624216"
      unitRef="usd">223000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:GainLossOnRepurchaseOfDebtInstrument
      contextRef="i15f1c30fc6e14d85b699a2ed36b96775_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzM4NDgyOTA3MDc0ODg_a39dade1-d077-458f-89e4-c75772beef48"
      unitRef="usd">14000000</us-gaap:GainLossOnRepurchaseOfDebtInstrument>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ibc4208797a9b45e58c4c6d017a4605de_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzExNDY_4e7af662-d783-4909-9e2a-57407619880b"
      unitRef="usd">2200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibc4208797a9b45e58c4c6d017a4605de_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzExNDk_4807fdfa-9029-46cf-a787-c6486b540fc6"
      unitRef="number">0.0250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5b0acc9d6b8245e5961cda862a186a59_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzE0MTE_9100433b-804c-4af1-be4b-79699ec5fd75"
      unitRef="usd">2200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5b0acc9d6b8245e5961cda862a186a59_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzE0MTQ_51dd015a-50c9-48fc-8bc1-3b78e3255db1"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <cnc:NotesAcceptedForTenderOfferPrincipalOutstandingPercentage
      contextRef="i5b0acc9d6b8245e5961cda862a186a59_I20210228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzE2NTM_fd4f31a6-f792-427a-98f4-37671cfa67cd"
      unitRef="number">0.36</cnc:NotesAcceptedForTenderOfferPrincipalOutstandingPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iaf49d7094f0e45829152639ae4685492_D20210201-20210228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzE5MjU_da5894c8-0bf3-4c57-81a7-f9cd74091145"
      unitRef="usd">-46000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i055c199b26fc4eaaae9f9b983763a177_I20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzIxMzM_9de71288-13d3-47c1-8152-22738c9c2042"
      unitRef="usd">1800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i055c199b26fc4eaaae9f9b983763a177_I20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzIxMzY_13b8b6d1-5cc4-4e74-9bd1-1b7ac8225fd8"
      unitRef="number">0.0245</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic5a2e2fdf251412ca928d6700728fd1c_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzI1ODc_adc0e8b7-9117-49e1-abbb-4edb1b9a3f5d"
      unitRef="usd">1800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6f91eaa1ade34d99a4b37902e16b46fb_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzI2NDg_c7a7b4ae-eaf4-463c-b7a4-bd260459d016"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i6f91eaa1ade34d99a4b37902e16b46fb_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzI3MjU_d6e935fc-8c5d-46ad-97c5-96cf141b8a0d"
      unitRef="number">0.0231</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9a76b04856c549278fbebee384e77959_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzI3MzI_10940e6a-63ac-4e99-a611-f6649af08c2c"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9a76b04856c549278fbebee384e77959_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzI3Njk_c3142a2b-5cf8-419d-ba7f-6bb1745fc7bc"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2af47f4133f54a42b12356bc6030758a_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzI5NDE_3a87e41e-6e05-4094-984f-b1ac11b2f01e"
      unitRef="number">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2af47f4133f54a42b12356bc6030758a_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzMwMTI_3a87e41e-6e05-4094-984f-b1ac11b2f01e"
      unitRef="number">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5cf2b5d34cdd49e092806cd5c281dddf_D20210801-20210831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzMxNjg_726eb0bc-7209-4e07-915d-6772f580a767"
      unitRef="usd">-79000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i628d01f64b184de1b7b5efff1732a9d8_I20210731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzM3Njc_4eb990c0-7bf5-4b9d-a901-fb53979a0987"
      unitRef="usd">705000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:PaymentsForHedgeInvestingActivities
      contextRef="ie7b1ceee886645d6a8088bd5d3047f69_D20210701-20210731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzM3ODM_1dde2514-b86d-4cb8-8c12-c1b07d4ca442"
      unitRef="gbp">509000000</us-gaap:PaymentsForHedgeInvestingActivities>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i9533de2ead4446adb1c44eb2cb595111_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzQyMzY_0c1a5381-97f0-4da3-887d-b4933b42c181"
      unitRef="usd">15000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="i512923a399a94c85a9f81f1c02440f82_D20220331-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzQ3Nzg_a081fc3e-0513-458f-bc97-89d89bedafbb"
      unitRef="usd">35000000</us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iaf8926fc8ce441d596b2ad6011782776_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzUwMTg_53eb8f53-f60a-4a94-afec-9895f4306aa4"
      unitRef="gbp">250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion
      contextRef="i300c0cc925174961aa324cbb7cf6b0ad_D20220501-20220531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzUwODQ_a55c04dd-ab48-406b-9d48-3821189d8b20"
      unitRef="usd">13000000</cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion>
    <us-gaap:LongTermLineOfCredit
      contextRef="iaf8926fc8ce441d596b2ad6011782776_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzUxNTQ_c86eef19-5d1f-4076-aa22-d9505a011309"
      unitRef="gbp">160000000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7421b87407a64ef3a02518501627c5ff_I20210731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4MzY_1a7892c7-7226-4bb3-bdac-1e4cb11c7e9a"
      unitRef="usd">1450000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id87680544d5e40f493d0ad0a03ad37db_I20210831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4NDE_3d2f3245-60be-474d-a8f4-1d102210907a"
      unitRef="usd">2200000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <cnc:DebtInstrumentCovenantNetLeverageRatioMaximum
      contextRef="iec2cac8396b94542a2646f54a9d68328_D20210701-20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4NDY_f09ff0a6-b014-454d-9805-d1a3654e6cfc"
      unitRef="number">3.5</cnc:DebtInstrumentCovenantNetLeverageRatioMaximum>
    <cnc:DebtInstrumentCovenantNetLeverageRatioMaximum
      contextRef="i2a40221e9a2a4afc802c9416ad92a8cf_D20210801-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4NTA_5380737d-93c7-4645-a36b-45094046993c"
      unitRef="number">4.0</cnc:DebtInstrumentCovenantNetLeverageRatioMaximum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i6b51f86196b74c5d81b9dbbe890e9cd5_D20210801-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc5MTc_11b13112-a962-44e7-afad-e67cba81a5a2"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i68f6f5e3a4564d01bf741fa247876509_D20210801-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc5MjI_510d66d7-2cba-4d0a-9154-f70ac0135ca2"
      unitRef="number">0.01125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <cnc:DebtInstrumentAmortizationPaymentRatePercentage
      contextRef="icaf48712843846db970ca72f1062bb57_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4NTQ_61174a85-1aa0-437c-9922-9eb47e21a533"
      unitRef="number">0</cnc:DebtInstrumentAmortizationPaymentRatePercentage>
    <cnc:DebtInstrumentAmortizationPaymentRatePercentage
      contextRef="i0ced5abd56064636b901e0fb233dc37e_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4NTg_8a216d9d-81bc-4a6f-a4cd-a949d3c6459b"
      unitRef="number">0.025</cnc:DebtInstrumentAmortizationPaymentRatePercentage>
    <cnc:DebtInstrumentAmortizationPaymentRatePercentage
      contextRef="i09c848e42b694dbdb1f15b4c4e6aa8d2_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4NjM_f1a80393-2eaa-4a2c-8edf-3ddb0c2f1ab3"
      unitRef="number">0.05</cnc:DebtInstrumentAmortizationPaymentRatePercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i86309d5b4d1e4ad9b29778c622cf58d4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4Njc_1f291d17-5c42-4836-9a12-57f87a5fb621"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i177a913a1fb447848f07559f4f84f998_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4NzI_9f7bb082-11ef-453c-aa56-ded64ffa9e4a"
      unitRef="usd">300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9b3d244dd3854164a91cb86ed9b12891_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4Nzc_c287a5b8-a260-4358-b98b-15500b86e2e1"
      unitRef="usd">200000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i07f12668f2cd4f52a84d59666eb6d3ce_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4ODI_810d1d72-32da-4b82-b91d-f47ee93fb05b"
      unitRef="usd">2200000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i6086520b355b4f8cbc019750e6f19c0d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzU0OTc1NTgyNDEzNg_dd591db3-7872-4009-a081-4352ad01845b"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ieb5e31256d79442d9db9f7a1fd150824_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzU0OTc1NTgyNDE0MQ_47dff6a1-8770-43ab-a822-9ffe9c21fd67"
      unitRef="number">0.01125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <cnc:LineofCreditFacilityAccordionFeatureIncreaseLimit
      contextRef="i86309d5b4d1e4ad9b29778c622cf58d4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc4OTU_1f491cef-41e1-4c5f-8b04-3301b779e09d"
      unitRef="usd">500000000</cnc:LineofCreditFacilityAccordionFeatureIncreaseLimit>
    <cnc:LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc5MDA_91d68d8b-4adb-43af-bf2b-d9f4945004ac"
      unitRef="number">4.0</cnc:LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease>
    <us-gaap:LineOfCredit
      contextRef="i86309d5b4d1e4ad9b29778c622cf58d4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzc5MzE_51f1b6c0-f5e5-4103-b308-16ed907d9c3a"
      unitRef="usd">58000000</us-gaap:LineOfCredit>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i86309d5b4d1e4ad9b29778c622cf58d4_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzgwMzg_0a517624-c96e-460e-883f-e0965923d42c"
      unitRef="number">0.0480</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib9edeffc055d4939acb82ad908f07cbe_I20171031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzgxNzk_5e68a29a-5549-4997-b9dd-afb12a53760e"
      unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7a8103ddaf8e4f1baaddc98a488f091f_D20171001-20171031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzg0MDE_77b2cc20-ba9a-427a-8c22-89ccbd94c154"
      unitRef="number">0.0270</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i1aefa7ec1d0042b6a41fc0a03595d12d_D20210701-20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzg0MzM_69194960-030d-46b7-989d-3e5abd47b83f"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <cnc:DebtInstrumentExtensionTerm
      contextRef="i96f3204307ae4fdfb13dc11441d5072d_D20220401-20220430"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzg4ODc_cf566631-4289-443e-b0f6-e5d524fbac3e">P1Y</cnc:DebtInstrumentExtensionTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i1e6dc3e560e84de0a5d2f02722587893_D20220401-20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzg5NDc_f87d008e-c820-4b2d-b336-a47f53a37776"
      unitRef="number">0.0185</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <cnc:DebtRepurchaseProgramAuthorizedAmount
      contextRef="i04652939d67241d39001577da981b842_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzkwNjA_3ab872bd-8a0b-4e41-8939-ea03e6079b1c"
      unitRef="usd">1000000000</cnc:DebtRepurchaseProgramAuthorizedAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i7ca911cb3026492eb537e47263364487_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzkyMzE_8cc8a1d2-ac29-47a8-ab46-ec38b3f5e9b8"
      unitRef="usd">318000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i15f1c30fc6e14d85b699a2ed36b96775_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzkyODk_dbbf28de-0daf-4259-b46c-f7074d62c75e"
      unitRef="usd">300000000</us-gaap:RepaymentsOfSeniorDebt>
    <cnc:DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzkzMTQ_6f9773db-ad0b-4b43-ad7c-23dabebeca6d"
      unitRef="usd">700000000</cnc:DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i68ee5cfa5b3041a9aa1e9d4f1e223aa1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzk1Mjg_574b4fa6-e75b-4a4f-b2db-c25debe9d51d"
      unitRef="usd">217000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i68ee5cfa5b3041a9aa1e9d4f1e223aa1_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzk2MzQ_68311675-3eff-4ca1-a8ba-4e1372794fa6"
      unitRef="number">0.006</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="i0b502a06d63b40bebe5407d59dadc678_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzk2OTE_d317327c-4618-4da2-9894-694240e0588a"
      unitRef="usd">1292000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4Xzk4OTQ_61644d20-c8e6-4b82-b55f-a9edc963c0ae">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate maturities for the Company's debt for the years ending December 31, are as follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate Maturities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZTo4MGZjZjEzMDY3YWU0ODEzOTk5YjczYzBkNTEwYmQ2NS90YWJsZXJhbmdlOjgwZmNmMTMwNjdhZTQ4MTM5OTliNzNjMGQ1MTBiZDY1XzAtMi0xLTEtMzU0MDE4_1e1d9cb5-c6f3-4368-82b5-78be61308ab0"
      unitRef="usd">82000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZTo4MGZjZjEzMDY3YWU0ODEzOTk5YjczYzBkNTEwYmQ2NS90YWJsZXJhbmdlOjgwZmNmMTMwNjdhZTQ4MTM5OTliNzNjMGQ1MTBiZDY1XzEtMi0xLTEtMzU0MDE4_2b9c5c19-7f66-412f-91de-9832188abded"
      unitRef="usd">122000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZTo4MGZjZjEzMDY3YWU0ODEzOTk5YjczYzBkNTEwYmQ2NS90YWJsZXJhbmdlOjgwZmNmMTMwNjdhZTQ4MTM5OTliNzNjMGQ1MTBiZDY1XzItMi0xLTEtMzU0MDE4_dd1912c9-6578-4eed-ae3c-d37584a3a9ac"
      unitRef="usd">313000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZTo4MGZjZjEzMDY3YWU0ODEzOTk5YjczYzBkNTEwYmQ2NS90YWJsZXJhbmdlOjgwZmNmMTMwNjdhZTQ4MTM5OTliNzNjMGQ1MTBiZDY1XzMtMi0xLTEtMzU0MDE4_4236b0fe-be9e-4fe7-8c06-c2a5d15033cc"
      unitRef="usd">1963000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZTo4MGZjZjEzMDY3YWU0ODEzOTk5YjczYzBkNTEwYmQ2NS90YWJsZXJhbmdlOjgwZmNmMTMwNjdhZTQ4MTM5OTliNzNjMGQ1MTBiZDY1XzQtMi0xLTEtMzU0MDE4_4e36f807-3a50-4b02-9d15-82124a121c57"
      unitRef="usd">2413000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZTo4MGZjZjEzMDY3YWU0ODEzOTk5YjczYzBkNTEwYmQ2NS90YWJsZXJhbmdlOjgwZmNmMTMwNjdhZTQ4MTM5OTliNzNjMGQ1MTBiZDY1XzUtMi0xLTEtMzU0MDE4_ee9fa6e9-cc3d-4bdf-9bd9-eea67ad7e85f"
      unitRef="usd">13286000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LongTermDebt
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90YWJsZTo4MGZjZjEzMDY3YWU0ODEzOTk5YjczYzBkNTEwYmQ2NS90YWJsZXJhbmdlOjgwZmNmMTMwNjdhZTQ4MTM5OTliNzNjMGQ1MTBiZDY1XzYtMi0xLTEtMzU0MDE4_c38a3b61-5aeb-4bff-bdd8-a3a2379b8fa2"
      unitRef="usd">18179000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtFairValue
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc5MjY_66ede9c7-bf5c-4644-8078-9f01134fca6e"
      unitRef="usd">15791000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzAvZnJhZzoyZmE0ZTJkOTBkOWY0NTA2Yjk1OWFhNWUyMjVlNzdkOC90ZXh0cmVnaW9uOjJmYTRlMmQ5MGQ5ZjQ1MDZiOTU5YWE1ZTIyNWU3N2Q4XzEwOTk1MTE2Mzc5MzE_3f908b96-0e7b-477d-8ad6-85e554fe976f"
      unitRef="usd">19256000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzI4ODA_a468222b-11c4-4d20-8881-99c7928bf770">Leases&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records ROU assets and lease liabilities for non-cancelable operating leases primarily for real estate and equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet. Expense related to leases is recorded on a straight-line basis over the lease term, including rent holidays. The Company recognized operating lease expense of $429 million and $390&#160;million during the years ended December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers the existence of options to extend or terminate leases in its analysis of the lease term for the purposes of measuring its ROU assets and lease liabilities. The renewal options are not included in the measurement of the ROU assets and lease liabilities unless the Company is reasonably certain to exercise the optional renewal periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the ROU assets and lease liabilities ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets (recorded within other long-term assets)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMS0xLTEtMzU0MDE4_199e3251-c3e9-421e-aaf9-eda971b806fd"&gt;2,554&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMy0xLTEtMzU0MDE4_25d5eafe-3f10-47e5-a022-23bca263c61e"&gt;3,566&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term (recorded within accounts payable and accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMS0xLTEtMzU0MDE4_53c5f53c-16be-4589-801c-7882d412dd63"&gt;180&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMy0xLTEtMzU0MDE4_ca13f2de-0327-4128-b4b7-a1cf2eacc73a"&gt;204&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term (recorded within other long-term liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMS0xLTEtMzU0MDE4_f7d03d1c-fd2a-4fb1-b8d2-c6a9e69f4553"&gt;3,133&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMy0xLTEtMzU0MDE4_83602f08-9569-4028-8eb3-50c7d80f55b9"&gt;3,619&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities, recorded as operating cash flows in the Consolidated Statements of Cash Flows, was $440 million and $385&#160;million during the years ended December 31, 2022 and 2021, respectively. New operating leases commenced resulting in the recognition of ROU assets and lease liabilities of $60 million and $177&#160;million during the years ended December 31, 2022 and 2021, respectively. In connection with the acquisition of Magellan in January 2022, the Company acquired $30 million of ROU assets and lease liabilities. As of December&#160;31, 2022, the Company had additional operating leases that have not yet commenced of $8 million. These operating leases will commence in 2023 with lease terms ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzE1ODI_9a1af50d-4299-45b3-b023-ef6bb807076b"&gt;one&lt;/span&gt; to eight years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the real estate optimization initiative as described in Note 6.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Property, Software and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company vacated and abandoned various domestic leased properties. As a result, the Company assessed the ROU assets for impairment. The Company engaged a third-party real estate specialist to determine the recoverability of the leased properties. The valuation primarily considered comparable leased properties in each market and the assessment of potential future rental income that could be generated by the ROU assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the optimization, the Company recognized $577 million of ROU asset impairments in the year ended December 31, 2022, primarily related to the Managed Care segment. The remainder of the $1,627 million charge was recorded within Property, Software and Equipment, refer to Note 6.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Property, Software and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term of the Company's operating leases was 20.5&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and 21.1 years as of December 31, 2022 and 2021, respectively. The lease liabilities reflect a weighted average discount rate of 5.7% and 5.7% as of December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease payments over the next five years and thereafter are as follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzM4NA_169109b9-9d71-4378-9a27-513dad95fcfd"
      unitRef="usd">429000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzM5MQ_ac09f9e5-c10d-4844-a97b-92ffad91c9a1"
      unitRef="usd">390000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzI4ODc_a8a762ad-2a51-4558-98a8-95e45748f28e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the ROU assets and lease liabilities ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets (recorded within other long-term assets)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMS0xLTEtMzU0MDE4_199e3251-c3e9-421e-aaf9-eda971b806fd"&gt;2,554&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMy0xLTEtMzU0MDE4_25d5eafe-3f10-47e5-a022-23bca263c61e"&gt;3,566&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term (recorded within accounts payable and accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMS0xLTEtMzU0MDE4_53c5f53c-16be-4589-801c-7882d412dd63"&gt;180&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMy0xLTEtMzU0MDE4_ca13f2de-0327-4128-b4b7-a1cf2eacc73a"&gt;204&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term (recorded within other long-term liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMS0xLTEtMzU0MDE4_f7d03d1c-fd2a-4fb1-b8d2-c6a9e69f4553"&gt;3,133&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMy0xLTEtMzU0MDE4_83602f08-9569-4028-8eb3-50c7d80f55b9"&gt;3,619&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMS0xLTEtMzU0MDE4_31b01a93-63b2-42a7-b255-f63bcda90095"
      unitRef="usd">2554000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzMtMy0xLTEtMzU0MDE4_71aa30b6-3897-4664-aa63-818c8312aeaa"
      unitRef="usd">3566000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMS0xLTEtMzU0MDE4_b3e6e229-f943-4c27-9e9b-bccf4bf71782"
      unitRef="usd">180000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzYtMy0xLTEtMzU0MDE4_2fce69ad-63d0-4431-a5dd-11e87b3b649d"
      unitRef="usd">204000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMS0xLTEtMzU0MDE4_dab10104-cd44-418e-9a11-6e263e3a80d5"
      unitRef="usd">3133000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzctMy0xLTEtMzU0MDE4_ab207255-0e9c-4af8-ab9a-28a7a6f7b0fe"
      unitRef="usd">3619000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzgtMS0xLTEtMzU0MDE4_e16bc598-df39-462b-9af0-b0db225e7887"
      unitRef="usd">3313000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTozNjFkZjAzY2UyOTE0Mzk2ODEzODNmZjllOGNiODk3OC90YWJsZXJhbmdlOjM2MWRmMDNjZTI5MTQzOTY4MTM4M2ZmOWU4Y2I4OTc4XzgtMy0xLTEtMzU0MDE4_a7c8ef64-b7f4-4fb4-b285-5ea9616b486a"
      unitRef="usd">3823000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeasePayments
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzEwNDU_2515f0d4-87af-44b3-99f5-00b10ea06904"
      unitRef="usd">440000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzEwNTI_ab720119-48ec-4f95-a4a1-bc7b5d9e7e7f"
      unitRef="usd">385000000</us-gaap:OperatingLeasePayments>
    <cnc:LesseeOperatingLeaseLeasesCommencedLiability
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzExODM_a5a40299-aa3c-44ed-8508-f63632f3c2ba"
      unitRef="usd">60000000</cnc:LesseeOperatingLeaseLeasesCommencedLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzExODM_ce78ba41-bb72-4e9f-8e47-e9347daeae1f"
      unitRef="usd">60000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzExOTA_a645593b-60a2-45bd-aa53-7b381a303edf"
      unitRef="usd">177000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <cnc:LesseeOperatingLeaseLeasesCommencedLiability
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzExOTA_d2fb3237-f185-47ac-b2f8-01b26dd88081"
      unitRef="usd">177000000</cnc:LesseeOperatingLeaseLeasesCommencedLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i474329559a594a6db005b911431a9b0d_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzM4NDgyOTA3MDA5NDQ_73bb1ea2-c19e-4f75-84ce-ce6965aeb180"
      unitRef="usd">30000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i474329559a594a6db005b911431a9b0d_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzM4NDgyOTA3MDA5NDQ_bdec1e70-5bfe-4215-bc5a-f13c524479b3"
      unitRef="usd">30000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <cnc:LesseeOperatingLeaseLeaseNotYetCommencedLiability
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzE1MDU_87c03c18-697a-4a78-b09a-57b28f254a2c"
      unitRef="usd">8000000</cnc:LesseeOperatingLeaseLeaseNotYetCommencedLiability>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="i2972405604564d108b785acc0e0173ac_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzU0OTc1NTgxNzcwOQ_2f74d039-b261-48a3-90b1-ab22d3beacc6">P8Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzIxNTY_c094cd7a-822b-49a4-afe7-59eb97703a64"
      unitRef="usd">577000000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzIyNjM_ad7f4024-c9b7-4483-8d4e-50e5a081db52"
      unitRef="usd">1627000000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzI2NTA_b2f61139-749c-48fb-bc0a-eea98e865983">P20Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzI2NTc_b363d31e-9992-46cd-8667-949032102288">P21Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzI3NTY_28d2001b-9ce7-4cfb-87bd-5de1666da67f"
      unitRef="number">0.057</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzI3NjM_2781eb3a-e018-47ab-ac45-8aeaa061ece2"
      unitRef="number">0.057</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90ZXh0cmVnaW9uOjdiNGYzZDJkYWMwNTRiMGY5NjAxNTgxMzNkNWIxYTUyXzI4ODQ_0e7d68af-bcdd-4207-9ae6-541556c4c278">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease payments over the next five years and thereafter are as follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.266%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzItMS0xLTEtMzU0MDE4_e578d17a-abc0-4735-9043-dc1c07f39d32"
      unitRef="usd">343000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzMtMS0xLTEtMzU0MDE4_db6e4a29-8c66-4e63-b18d-eb7e058a0dfc"
      unitRef="usd">350000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzQtMS0xLTEtMzU0MDE4_169333ce-5f19-407c-80a1-b43f75b67882"
      unitRef="usd">325000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzUtMS0xLTEtMzU0MDE4_34b039db-1c82-498e-9aed-919de501ca57"
      unitRef="usd">302000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzYtMS0xLTEtMzU0MDE4_759e5571-dd37-4878-b95e-a1b8d4d7e8d9"
      unitRef="usd">287000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzctMS0xLTEtMzU0MDE4_9435411d-37e6-4d96-82d8-6f28533bc21c"
      unitRef="usd">4633000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzgtMS0xLTEtMzU0MDE4_73088d55-717f-428d-8163-3580b419808a"
      unitRef="usd">6240000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzktMS0xLTEtMzU0MDE4_a5b19039-88c1-46f6-be46-58450a47f703"
      unitRef="usd">2927000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzMvZnJhZzo3YjRmM2QyZGFjMDU0YjBmOTYwMTU4MTMzZDViMWE1Mi90YWJsZTo4OGUxNTk3NmIyNTU0MDZiYTM5ZmEzZThhNzQ4YjU1Yi90YWJsZXJhbmdlOjg4ZTE1OTc2YjI1NTQwNmJhMzlmYTNlOGE3NDhiNTViXzEwLTEtMS0xLTM1NDAxOA_77df39f0-556a-4ae6-b64e-9e2a4cc033dc"
      unitRef="usd">3313000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzM1NDY_e976d6ab-3d52-459a-a8e2-d27013083981">Stockholders' Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's Board of Directors has authorized a stock repurchase program of the Company's common stock from time to time on the open market or through privately negotiated transactions. In 2022, in preparation for the closing of divestitures as well as planning for the future, the Company's Board of Directors authorized increases under the program including $3,000 million in June 2022 and an additional $2,000 million in December 2022. With these increases, the Company is authorized to repurchase up to $6,000 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2022, the Company entered into an accelerated share repurchase (ASR) agreement with Bank of America to purchase $1,000 million of the Company's common stock in aggregate under the Company's stock repurchase program. In July 2022, 8.6 million shares were delivered to the Company, representing 80% of the notional amount under the ASR. In October 2022, an additional 3.0 million shares were delivered upon settlement of the ASR based upon the volume-weighted average price (VWAP) over the term of the agreement, less a discount, of $86.21. In total, 11.6 million shares were purchased through the $1,000 million ASR. In addition, the Company purchased additional shares throughout the year through open market repurchases, including repurchase plans designed to comply with Rule 10b5-1.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share repurchases in 2022, 2021, and 2020 were primarily funded through divestiture proceeds. The following represents the Company's share repurchase activity ($ in millions, shares in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share buybacks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax withholding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares repurchased for income tax withholding are shares withheld in connection with employee stock plans to meet applicable tax withholding requirements. These shares are typically included in the Company's treasury stock, except for the vesting of certain shares assumed in connection with the WellCare acquisition in 2020 and 2021, which were withheld rather than repurchased. Although these shares are not issued, they are treated as common stock repurchases as they reduce the number of shares that would have been issued upon vesting. Shares withheld were 326&#160;thousand shares at an aggregate cost of $19 million, and 407&#160;thousand at an aggregate cost of $24 million, for the years ended December 31, 2021 and 2020, respectively. No shares were withheld under this method in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company had a remaining amount of $2,806 million available under the Company's stock repurchase program. No duration has been placed on the repurchase program. The Company reserves the right to discontinue the repurchase program at any time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shares Issued for Acquisition&lt;/span&gt;&lt;/div&gt;In January 2020, the Company issued 171&#160;million shares of Centene common stock with a fair value of $11,431&#160;million and paid $6,079&#160;million in cash in exchange for all the outstanding shares of WellCare common stock. In addition, the Company recorded $95&#160;million related to the fair value of replacement equity awards associated with pre-combination service.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <cnc:StockRepurchaseProgramIncreaseAuthorizedAmount
      contextRef="icd22c4115d4947d6878c9e6781a372d1_D20220601-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzEwMzg_be03d111-68b1-4ee0-a027-d40951662d23"
      unitRef="usd">3000000000</cnc:StockRepurchaseProgramIncreaseAuthorizedAmount>
    <cnc:StockRepurchaseProgramIncreaseAuthorizedAmount
      contextRef="i7b616f4f2341472dbd385786d0a01c38_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzc2OTY1ODE0MDUyOTM_3612a3ea-be42-4963-a7e8-bf79ce8fb0ed"
      unitRef="usd">2000000000</cnc:StockRepurchaseProgramIncreaseAuthorizedAmount>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzc2OTY1ODE0MDUzNTE_1ece062c-79ab-4474-bd5f-2e267bdf9989"
      unitRef="usd">6000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <cnc:AcceleratedShareRepurchasesAgreementAmount
      contextRef="ief504e0f21434c29b6eea0887f48d0e5_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzEzODA_73900b91-3fb1-4f63-b770-d9a7214d0a95"
      unitRef="usd">1000000000</cnc:AcceleratedShareRepurchasesAgreementAmount>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i29cb5a3f49f1494e8f6826eff1bd9010_D20220701-20220731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzE0Nzk_bd822d3c-de2f-4c62-b55f-a00b979676eb"
      unitRef="shares">8600000</us-gaap:TreasuryStockSharesAcquired>
    <cnc:TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram
      contextRef="i29cb5a3f49f1494e8f6826eff1bd9010_D20220701-20220731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzE1MzM_51299f5c-5d6c-44b6-8ebd-06038feb25f2"
      unitRef="number">0.80</cnc:TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ia6584fae5af246acaeeca245d13601b3_D20221001-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzE2MDU_9d27d4bc-11d8-435a-ba62-73c4cd74cb52"
      unitRef="shares">3000000</us-gaap:TreasuryStockSharesAcquired>
    <cnc:AcceleratedShareRepurchasesDiscountPricePerShare
      contextRef="ide855c65da574e12a7000a0c1c5d15dd_D20221001-20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzU0OTc1NTgzNTEwMA_b8abb12c-ebce-42c5-afbf-f97d6480cbd2"
      unitRef="usdPerShare">86.21</cnc:AcceleratedShareRepurchasesDiscountPricePerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i798439eca4864894a14ab00bbc412860_D20220701-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzE3Njg_0694c1f7-8cc4-4466-81c9-590efe0c1829"
      unitRef="shares">11600000</us-gaap:TreasuryStockSharesAcquired>
    <cnc:AcceleratedShareRepurchasesAgreementAmount
      contextRef="ief504e0f21434c29b6eea0887f48d0e5_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzE4MDU_73900b91-3fb1-4f63-b770-d9a7214d0a95"
      unitRef="usd">1000000000</cnc:AcceleratedShareRepurchasesAgreementAmount>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzQ5NDc4MDIzNDU1ODI_fa2ee556-a95f-4649-8615-e22fc2ea5d1c">The following represents the Company's share repurchase activity ($ in millions, shares in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share buybacks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax withholding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <cnc:TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation
      contextRef="i7b5a6df0e62840ec938274ece6e23cb2_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzItMC0xLTEtNDE1ODYx_814f7968-3e48-429e-8e31-9f0d8a7fff64"
      unitRef="shares">35655000</cnc:TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation>
    <cnc:TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes
      contextRef="i7b5a6df0e62840ec938274ece6e23cb2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzItMS0xLTEtNDE1ODIy_4ef7cda5-80c4-4a44-89e2-d7d403e04479"
      unitRef="usd">2994000000</cnc:TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes>
    <cnc:TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation
      contextRef="i2cf082093f37453aa852faade614d285_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzItMy0xLTEtNDE1ODc1_62ef6e79-ef7f-44ac-9342-dd9b2afffef4"
      unitRef="shares">2402000</cnc:TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation>
    <cnc:TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes
      contextRef="i2cf082093f37453aa852faade614d285_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzItMy0xLTEtNDE1ODIy_0458d6c8-94d2-47fc-9b99-0d119e2304c5"
      unitRef="usd">200000000</cnc:TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes>
    <cnc:TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation
      contextRef="i5bc71fec53d748409f78d934b69f1f56_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzItNS0xLTEtNDE1ODIy_d91da177-ec14-460c-9971-28a327ee495d"
      unitRef="shares">8672000</cnc:TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation>
    <cnc:TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes
      contextRef="i5bc71fec53d748409f78d934b69f1f56_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzItOC0xLTEtNDU4NjUx_91fde2bc-cc24-4968-ba85-3183d1a47d94"
      unitRef="usd">500000000</cnc:TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="if8a8cf81a11c41a893d0995455479cd6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzMtMS0xLTEtNDE5MTQy_ca7faa7c-6e44-40fc-97c6-1107062449db"
      unitRef="shares">1213000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if8a8cf81a11c41a893d0995455479cd6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzMtMi0xLTEtNDE5MTUw_5733b9ed-aba2-4668-8b45-70231ea937aa"
      unitRef="usd">102000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ic9f4a1f99a204f11946360404ec006fb_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzMtNC0xLTEtNDE2MDA4_0c924332-396e-4ea3-ae05-3623429d74ae"
      unitRef="shares">1379000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ic9f4a1f99a204f11946360404ec006fb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzMtNS0xLTEtNDE2MTE3_88d680d9-7022-4e1a-b984-02d20384287a"
      unitRef="usd">97000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i2e3759b9cf8a44728c767939b67b86ae_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzMtNy0xLTEtNDE2MTI1_e9b305cf-ac0a-4bf9-8f64-4b05ed953467"
      unitRef="shares">2045000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2e3759b9cf8a44728c767939b67b86ae_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzMtOC0xLTEtNDE2MTA5_86e889ef-ade4-460b-81b6-470bde7454f9"
      unitRef="usd">126000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i7b5a6df0e62840ec938274ece6e23cb2_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzQtMS0xLTEtNDU4NjQx_879bee59-b805-465b-877d-316799a76257"
      unitRef="shares">36868000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i7b5a6df0e62840ec938274ece6e23cb2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzQtMi0xLTEtNDU4NjQx_9bee2e37-4f86-4b34-bac1-393c264a3a1f"
      unitRef="usd">3096000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2cf082093f37453aa852faade614d285_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzQtNC0xLTEtNDU4NjQ1_205746af-4fcc-4e09-9542-352241713cea"
      unitRef="shares">3781000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2cf082093f37453aa852faade614d285_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzQtNS0xLTEtNDU4NjQ1_60b72d02-1085-484d-bba2-59142ecf2b07"
      unitRef="usd">297000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i5bc71fec53d748409f78d934b69f1f56_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzQtNy0xLTEtNDU4NjQ4_a466e2ca-7165-42d2-bd0c-673230368e67"
      unitRef="shares">10717000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5bc71fec53d748409f78d934b69f1f56_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90YWJsZTo5YzhkNTAxMzNmNDE0MGE5OWYyMWQzMjNhMzhiZTc3MS90YWJsZXJhbmdlOjljOGQ1MDEzM2Y0MTQwYTk5ZjIxZDMyM2EzOGJlNzcxXzQtOC0xLTEtNDU4NjUx_15d11977-4d61-4f3f-b211-28807b626749"
      unitRef="usd">626000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i5dd496b069e94c7f84fc2916ec5f8a53_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzU0OTc1NTgzNDY3MQ_45cf442f-539a-4040-a6af-9c31babc9b0d"
      unitRef="shares">326000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5dd496b069e94c7f84fc2916ec5f8a53_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzEwOTk1MTE2MzE0MTI_853982eb-215a-48c1-b532-f5bd73a5dac5"
      unitRef="usd">19000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i411fcfa45e664b36954eea6f3adec1d3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzU0OTc1NTgzNDY2Mg_836a4b07-a024-4a9c-a696-9d21ed3c4eb6"
      unitRef="shares">407000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i411fcfa45e664b36954eea6f3adec1d3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzc2OTY1ODE0MDk2NDQ_6d238a50-ef85-4b8b-98fe-8cf3893e8b76"
      unitRef="usd">24000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzc2OTY1ODE0MTAyMjg_349b5243-c51c-4fed-8973-5db4a0366e94"
      unitRef="usd">2806000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i544615d6498841d8b5bd747233c5fb23_D20200123-20200123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzU0OTc1NTgzMjcyMw_63d1dc70-507f-49e7-8ef7-02f76792e357"
      unitRef="shares">171000000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i544615d6498841d8b5bd747233c5fb23_D20200123-20200123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzU0OTc1NTgzMjczNg_c446dd35-5601-4ba8-8883-bf53192bef2f"
      unitRef="usd">11431000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i544615d6498841d8b5bd747233c5fb23_D20200123-20200123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzU0OTc1NTgzMjgxMQ_89dcb334-90f1-401e-8f2f-ef07e087398f"
      unitRef="usd">6079000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1
      contextRef="i544615d6498841d8b5bd747233c5fb23_D20200123-20200123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzYvZnJhZzoxM2MxMjgxM2FkMGE0OGQzYjM1M2FkZjgxNjkwZmQwMS90ZXh0cmVnaW9uOjEzYzEyODEzYWQwYTQ4ZDNiMzUzYWRmODE2OTBmZDAxXzU0OTc1NTgzMjgyNw_9cfd0069-8711-42df-b296-d4ad3e4ef240"
      unitRef="usd">95000000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <cnc:StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzkvZnJhZzowNGRhNjg1NWEzNTM0OTAyYjVkMDNlZTM0NDQwZDk2OC90ZXh0cmVnaW9uOjA0ZGE2ODU1YTM1MzQ5MDJiNWQwM2VlMzQ0NDBkOTY4XzU5OQ_07faf2a4-61ac-4509-8d14-12e4672f2b57">Statutory Capital Requirements and Dividend Restrictions&#160;Various state laws require Centene's regulated subsidiaries to maintain minimum capital levels specified by each state and restrict the amount of dividends that may be paid without prior regulatory approval. At December 31, 2022 and 2021, Centene's subsidiaries had aggregate statutory capital and surplus of $16,436 million and $14,039 million, respectively, compared with the required minimum aggregate statutory capital and surplus of $7,979 million and $6,706 million, respectively. As of December&#160;31, 2022, the amount of capital and surplus or net worth that was unavailable for the payment of dividends or return of capital to the Company was $7,979 million in the aggregate.</cnc:StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzkvZnJhZzowNGRhNjg1NWEzNTM0OTAyYjVkMDNlZTM0NDQwZDk2OC90ZXh0cmVnaW9uOjA0ZGE2ODU1YTM1MzQ5MDJiNWQwM2VlMzQ0NDBkOTY4XzE2NDkyNjc0NDIyODg_0794e11b-5b4a-4dbb-b2e4-600c8d40f026"
      unitRef="usd">16436000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzkvZnJhZzowNGRhNjg1NWEzNTM0OTAyYjVkMDNlZTM0NDQwZDk2OC90ZXh0cmVnaW9uOjA0ZGE2ODU1YTM1MzQ5MDJiNWQwM2VlMzQ0NDBkOTY4XzMwNg_86fcd4e1-1df1-4968-a3cc-7f1da1083fef"
      unitRef="usd">14039000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzkvZnJhZzowNGRhNjg1NWEzNTM0OTAyYjVkMDNlZTM0NDQwZDk2OC90ZXh0cmVnaW9uOjA0ZGE2ODU1YTM1MzQ5MDJiNWQwM2VlMzQ0NDBkOTY4XzE2NDkyNjc0NDIyNzc_217b7051-c2a4-4214-8812-77dd7f65532e"
      unitRef="usd">7979000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzkvZnJhZzowNGRhNjg1NWEzNTM0OTAyYjVkMDNlZTM0NDQwZDk2OC90ZXh0cmVnaW9uOjA0ZGE2ODU1YTM1MzQ5MDJiNWQwM2VlMzQ0NDBkOTY4XzQwOQ_f1280621-dcd0-4c5a-8bb1-b8cacb128055"
      unitRef="usd">6706000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired>
    <us-gaap:StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xMzkvZnJhZzowNGRhNjg1NWEzNTM0OTAyYjVkMDNlZTM0NDQwZDk2OC90ZXh0cmVnaW9uOjA0ZGE2ODU1YTM1MzQ5MDJiNWQwM2VlMzQ0NDBkOTY4XzEwOTk1MTE2Mjg1MjY_e8d58213-e5c6-4da9-a187-bfbbe37745bd"
      unitRef="usd">7979000000</us-gaap:StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzMyMDQ_ff8fdd80-97e7-40f9-84cc-6e80283671b8">Income Taxes&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated income tax expense consists of the following ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the tax provision at the U.S. federal statutory rate to income tax expense is as follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss (earnings) attributable to flow through noncontrolling interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings less noncontrolling interest before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision at the U.S. federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible PBM legal settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nontaxable divestiture (gains) losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred taxes for investments in subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ACA health insurer fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Audit settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to recognize deferred tax assets and liabilities for consolidated subsidiaries that are determined to be held for sale as of December 31, 2022. The Company established a net deferred tax liability of $84 million for these investments in subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences which give rise to deferred tax assets and liabilities are presented below ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical claims liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium and trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had not historically provided for deferred income taxes on the undistributed earnings of foreign subsidiaries as they were considered indefinitely reinvested outside the U.S. During the fourth quarter of 2022, as part of the Company's review of strategic alternatives for its international portfolio, the Company evaluated its assertion regarding its ability and intent to indefinitely reinvest undistributed earnings of the foreign subsidiaries. Upon evaluating the assertion, the Company determined that any historical or future undistributed earnings of foreign subsidiaries are no longer considered to be indefinitely reinvested. There is no deferred tax liability associated with these earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The increase to the unrealized loss deferred tax asset reflects the change in the fair market value of the Company's investment portfolio. Decreases to the fixed assets and ROU asset deferred tax liabilities are primarily related to the impairments recorded as part of the Company's real estate optimization initiative.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation allowances are provided when it is considered more likely than not that deferred tax assets will not be realized. The valuation allowances primarily relate to future tax benefits on certain federal, state, and foreign net operating loss, federal and state capital loss, and tax credit carryforwards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal net operating loss and credit carryforwards of $69 million expire beginning in 2023 through 2043. State net operating loss and tax credit carryforwards of $51 million expire beginning in 2023 through 2042, while the remaining $15 million have indefinite carryforward periods. Substantially all the non-U.S. tax loss carryforwards of $206 million have indefinite carryforward periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a reserve for uncertain tax positions that may be challenged by a tax authority. A rollforward of the beginning and ending amount of uncertain tax positions, exclusive of related interest and penalties, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statute of limitation lapses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, $303 million of unrecognized tax benefits would impact the Company's effective tax rate in future periods, if recognized.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table above excludes interest and penalties, net of related tax benefits, which are treated as income tax expense (benefit) under the Company's accounting policy. The Company recognized net interest expense and penalties related to uncertain positions of $23 million and $1 million expense for the years ended December 31, 2022 and 2021, respectively. The Company had $66 million and $43 million of accrued interest and penalties for uncertain tax positions as of December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files federal tax returns as well as returns for numerous state and international tax jurisdictions and is engaged in multiple audit proceedings for its state and foreign filings. Generally, no further state or foreign audit activity is expected for years prior to 2015. As of December&#160;31, 2022, the Company's tax returns are under federal examination for the tax years 2014 through 2017, only with respect to Internal Revenue Service (IRS) proposed adjustments relating to the Company's claims to the Domestic Production Activities Deduction for these years. The Company has appealed the IRS adjustments and the appeals process is expected to be conducted within the next 12 months. The Company believes it is reasonably possible that its liability for unrecognized tax benefits will decrease by approximately $124 million within the next 12 months if the Company reaches a satisfactory agreement with the IRS during the appeals process and an additional $3&#160;million decrease as a result of the expiration of statutes of limitations and projected audit settlements in certain jurisdictions.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzMyMDc_44554983-0563-439e-97d1-e9db5cbcb111">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated income tax expense consists of the following ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzItMS0xLTEtMzU0MDE4_dff5119c-2d12-4767-939f-92c38708f862"
      unitRef="usd">1144000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzItMy0xLTEtMzU0MDE4_6b856126-4acc-4428-abb7-b5b1c76aa034"
      unitRef="usd">507000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzItNS0xLTEtMzU0MDE4_3f2c7e2b-25a9-46f0-b109-2f80ff2459ea"
      unitRef="usd">959000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzMtMS0xLTEtMzU0MDE4_bbf39fa4-b1ea-4995-96fd-911fc99b031a"
      unitRef="usd">261000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzMtMy0xLTEtMzU0MDE4_092b87fd-dcd0-449d-973e-9a945f49f9d2"
      unitRef="usd">114000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzMtNS0xLTEtMzU0MDE4_9df79cf8-d0f8-4a28-a4ee-9ff9cda94641"
      unitRef="usd">152000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzQtMS0xLTEtMzU0MDE4_4537055a-3d6c-46b3-a9ed-82b3d3d29f0a"
      unitRef="usd">4000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzQtMy0xLTEtMzU0MDE4_c580241c-5c07-4cff-a7ad-6986a4dfeebd"
      unitRef="usd">7000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzQtNS0xLTEtMzU0MDE4_9d490541-a92d-4470-a374-fbc62e25837f"
      unitRef="usd">4000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzUtMS0xLTEtMzU0MDE4_29972638-d8f7-4f18-9fb3-f5fa56e13acd"
      unitRef="usd">1409000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzUtMy0xLTEtMzU0MDE4_64a4569e-42b6-413d-9436-ed9c094c723e"
      unitRef="usd">628000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzUtNS0xLTEtMzU0MDE4_f0e62f4a-b256-4371-9f25-287c9567d233"
      unitRef="usd">1115000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredOtherTaxExpenseBenefit
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzYtMS0xLTEtMzU0MDE4_ef84e7af-c138-4a3e-8686-88b24609700c"
      unitRef="usd">-649000000</us-gaap:DeferredOtherTaxExpenseBenefit>
    <us-gaap:DeferredOtherTaxExpenseBenefit
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzYtMy0xLTEtMzU0MDE4_d1554389-1f63-48a8-92f6-d9b7f339ae94"
      unitRef="usd">-151000000</us-gaap:DeferredOtherTaxExpenseBenefit>
    <us-gaap:DeferredOtherTaxExpenseBenefit
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzYtNS0xLTEtMzU0MDE4_f249e89f-71f5-4c32-b862-5021ad16f338"
      unitRef="usd">-136000000</us-gaap:DeferredOtherTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzctMS0xLTEtMzU0MDE4_d07ab67e-899f-4bec-8268-c354b34b686a"
      unitRef="usd">760000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzctMy0xLTEtMzU0MDE4_8cba08bf-096b-4404-a9eb-8ea2a2550f71"
      unitRef="usd">477000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTo3ZmYwZWEyZjQxM2E0ODM5YTk1ZWQzMTlhNDYzNDAzNy90YWJsZXJhbmdlOjdmZjBlYTJmNDEzYTQ4MzlhOTVlZDMxOWE0NjM0MDM3XzctNS0xLTEtMzU0MDE4_f3fae0fb-c6ba-4be8-a4f0-a9f2a4ea62eb"
      unitRef="usd">979000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzMxOTc_321cc3f5-899c-40fd-8784-8992f0add984">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the tax provision at the U.S. federal statutory rate to income tax expense is as follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss (earnings) attributable to flow through noncontrolling interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings less noncontrolling interest before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision at the U.S. federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible PBM legal settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nontaxable divestiture (gains) losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred taxes for investments in subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ACA health insurer fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Audit settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEtMS0xLTEtMzU0MDE4_e90ac4ad-654a-4de0-b347-4a2ef02a7964"
      unitRef="usd">1962000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEtMy0xLTEtMzU0MDE4_a547819b-1aad-421e-8275-535369c2f8db"
      unitRef="usd">1813000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEtNS0xLTEtMzU0MDE4_b24362dc-2dde-4ae6-85e0-64d22927709e"
      unitRef="usd">2773000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <cnc:LossEarningsAttributableToFlowThroughNoncontrollingInterest
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzItMS0xLTEtMzU0MDE4_ee47bcdf-f4ef-4b91-ae8b-29bb0d85d032"
      unitRef="usd">-6000000</cnc:LossEarningsAttributableToFlowThroughNoncontrollingInterest>
    <cnc:LossEarningsAttributableToFlowThroughNoncontrollingInterest
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzItMy0xLTEtMzU0MDE4_117668f6-657b-42e3-a4d9-c5ea9316ae9f"
      unitRef="usd">2000000</cnc:LossEarningsAttributableToFlowThroughNoncontrollingInterest>
    <cnc:LossEarningsAttributableToFlowThroughNoncontrollingInterest
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzItNS0xLTEtMzU0MDE4_daabe39b-63d8-4b4a-ba7c-9857e77a1335"
      unitRef="usd">9000000</cnc:LossEarningsAttributableToFlowThroughNoncontrollingInterest>
    <cnc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzMtMS0xLTEtMzU0MDE4_b40ab06f-b5c1-438c-bf79-d391bebe55be"
      unitRef="usd">1956000000</cnc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest>
    <cnc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzMtMy0xLTEtMzU0MDE4_70f68aef-1ecd-4960-8f59-124500745244"
      unitRef="usd">1815000000</cnc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest>
    <cnc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzMtNS0xLTEtMzU0MDE4_3395eac4-d356-4011-b9c1-2c90bbd5f78a"
      unitRef="usd">2782000000</cnc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzUtMS0xLTEtMzU0MDE4_81404979-e2d9-4d2c-bcbb-84c2e7b091e5"
      unitRef="usd">411000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzUtMy0xLTEtMzU0MDE4_1c7ca898-a562-4318-b826-cda1187b19ed"
      unitRef="usd">381000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzUtNS0xLTEtMzU0MDE4_a084ab24-4d55-49f7-bacf-04602f35bff5"
      unitRef="usd">584000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzYtMS0xLTEtMzU0MDE4_36326f99-3d6b-4613-a76f-ac179aee6eaf"
      unitRef="usd">50000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzYtMy0xLTEtMzU0MDE4_2cceb63f-2ea1-48d0-a8e0-afbea7345e3d"
      unitRef="usd">63000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzYtNS0xLTEtMzU0MDE4_81464548-576f-4bac-b38e-e31ce9bc43fb"
      unitRef="usd">106000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzctMS0xLTEtMzU0MDE4_e98ad38c-a818-4b96-86e3-cf505c8fb9b8"
      unitRef="usd">49000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzctMy0xLTEtMzU0MDE4_b870e3f8-eb4f-40b3-9142-6e1732a0e087"
      unitRef="usd">40000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzctNS0xLTEtMzU0MDE4_930b9d61-f02e-4659-b1bc-620e69d0376a"
      unitRef="usd">54000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <cnc:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzgtMS0xLTEtMzU0MDE4_5371329f-c580-481a-ba06-44d5dc8770b0"
      unitRef="usd">-5000000</cnc:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement>
    <cnc:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzgtMy0xLTEtMzU0MDE4_b1ef5801-44a3-4460-92a4-e35b9154839a"
      unitRef="usd">78000000</cnc:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement>
    <cnc:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzgtNS0xLTEtMzU0MDE4_e00de318-5fd0-4734-931b-1165055110d3"
      unitRef="usd">0</cnc:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzktMS0xLTEtMzU0MDE4_28a03aad-dbd6-4f3a-9833-be64f7fc749a"
      unitRef="usd">111000000</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzktMy0xLTEtMzU0MDE4_dab8a6c9-0ed7-40ab-b4e2-c854f3db871e"
      unitRef="usd">-95000000</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzktNS0xLTEtMzU0MDE4_337e3a29-817d-4489-8238-7565d2d420e8"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <cnc:EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEwLTEtMS0xLTQ1NjY4Ng_5729b3bb-febe-4720-949f-18838a6a6472"
      unitRef="usd">84000000</cnc:EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries>
    <cnc:EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEwLTMtMS0xLTQ1NjY4Ng_9122ad7e-13c2-43d9-969f-96e320f0a2c1"
      unitRef="usd">0</cnc:EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries>
    <cnc:EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEwLTUtMS0xLTQ1NjY4Ng_8c68f43e-1908-423c-998b-7d933cffea49"
      unitRef="usd">0</cnc:EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries>
    <cnc:ACAHealthInsurerFee
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEwLTEtMS0xLTM1NDAxOA_2212d813-dd6e-4b4e-8d99-56bd51b1b05e"
      unitRef="usd">0</cnc:ACAHealthInsurerFee>
    <cnc:ACAHealthInsurerFee
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEwLTMtMS0xLTM1NDAxOA_0a46910e-a5ab-4afb-b4a9-00eee95dd3dc"
      unitRef="usd">0</cnc:ACAHealthInsurerFee>
    <cnc:ACAHealthInsurerFee
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEwLTUtMS0xLTM1NDAxOA_d1963700-8b40-4e6b-8d2d-8b1e8b552a1c"
      unitRef="usd">316000000</cnc:ACAHealthInsurerFee>
    <us-gaap:IncomeTaxReconciliationTaxSettlements
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzExLTEtMS0xLTM1NDAxOA_e3f9d140-f642-4e28-b723-d6b52a7cceb0"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationTaxSettlements>
    <us-gaap:IncomeTaxReconciliationTaxSettlements
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzExLTMtMS0xLTM1NDAxOA_41e6b045-6507-4187-b399-4d4b4a503e31"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationTaxSettlements>
    <us-gaap:IncomeTaxReconciliationTaxSettlements
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzExLTUtMS0xLTM1NDAxOA_8bf7a3aa-7566-408e-9ff2-f39dfcabfcf5"
      unitRef="usd">-71000000</us-gaap:IncomeTaxReconciliationTaxSettlements>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEyLTEtMS0xLTM1NDAxOA_11e32193-1e5c-453c-a490-56cd095c65b0"
      unitRef="usd">-17000000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEyLTMtMS0xLTM1NDAxOA_1f6033da-f9a3-4d40-bf87-5b053fc24854"
      unitRef="usd">29000000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEyLTUtMS0xLTM1NDAxOA_59ab1c82-a1ca-416a-9ef3-dfdbf8ba2477"
      unitRef="usd">-11000000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <cnc:EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEzLTEtMS0xLTM1NDAxOA_cc6938a8-0895-4f77-89a5-2b90e7e98610"
      unitRef="usd">69000000</cnc:EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill>
    <cnc:EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEzLTMtMS0xLTM1NDAxOA_3d1a4ce7-6393-4322-9e99-5ff90a1fa435"
      unitRef="usd">0</cnc:EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill>
    <cnc:EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzEzLTUtMS0xLTM1NDAxOA_64b8ba28-845f-4374-b7c7-758aecc723ee"
      unitRef="usd">16000000</cnc:EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzE0LTEtMS0xLTM1NDAxOA_b1830715-3830-40a0-ac24-afc2d6c1b988"
      unitRef="usd">8000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzE0LTMtMS0xLTM1NDAxOA_2f694697-a8ad-466c-ad11-ccaff21f5ca3"
      unitRef="usd">-19000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzE0LTUtMS0xLTM1NDAxOA_89c94742-d93d-4331-baaf-9a1c3b90e192"
      unitRef="usd">-15000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzE1LTEtMS0xLTM1NDAxOA_ed934b14-f678-46bf-bec4-7a1e0337a0c4"
      unitRef="usd">760000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzE1LTMtMS0xLTM1NDAxOA_cd51e405-77ad-422b-b02f-46b075483125"
      unitRef="usd">477000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpjOTU0YTdhZDNhMjM0MmZhODBmZGExYzNlMzA3NTg1My90YWJsZXJhbmdlOmM5NTRhN2FkM2EyMzQyZmE4MGZkYTFjM2UzMDc1ODUzXzE1LTUtMS0xLTM1NDAxOA_e5e1c0a1-a6bd-4e81-8b31-214b9e79b6b2"
      unitRef="usd">979000000</us-gaap:IncomeTaxExpenseBenefit>
    <cnc:EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzI3NDg3NzkwNzMzODA_b2960c23-debd-4e81-b67b-a0249179444d"
      unitRef="usd">84000000</cnc:EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzMyMDE_83314a86-0442-4e55-be5f-87bd4330afc0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences which give rise to deferred tax assets and liabilities are presented below ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical claims liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium and trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzItMS0xLTEtMzU0MDE4_21d62185-8212-49e6-848a-b1c538da9ee1"
      unitRef="usd">132000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzItMy0xLTEtMzU0MDE4_18a5c8f7-7fa1-4673-ab67-7510ab37fcc2"
      unitRef="usd">120000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzMtMS0xLTEtMzU0MDE4_2f937111-ad0f-4b97-923f-aa7aa9d1362f"
      unitRef="usd">202000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzMtMy0xLTEtMzU0MDE4_2680c5a0-0b55-4cf9-acc0-8af2e760b2e2"
      unitRef="usd">215000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <cnc:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzQtMS0xLTEtMzU0MDE4_a869689e-94cb-4350-8036-37469662a879"
      unitRef="usd">341000000</cnc:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards>
    <cnc:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzQtMy0xLTEtMzU0MDE4_018b6f72-174e-46e3-a5da-41e30973a347"
      unitRef="usd">357000000</cnc:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzUtMS0xLTEtMzU0MDE4_5d54cbe7-8c23-4ae6-a1b3-3d3b99b01482"
      unitRef="usd">96000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzUtMy0xLTEtMzU0MDE4_62f63c74-5768-4939-9c56-39fa637ca7dd"
      unitRef="usd">205000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <cnc:DeferredTaxAssetPremiumAndTradeReceivables
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzctMS0xLTEtMzU0MDE4_996b6cf4-809c-4475-b483-c8f8965f6fae"
      unitRef="usd">91000000</cnc:DeferredTaxAssetPremiumAndTradeReceivables>
    <cnc:DeferredTaxAssetPremiumAndTradeReceivables
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzctMy0xLTEtMzU0MDE4_12ec304a-0ed3-4091-be24-f8c7553b8c01"
      unitRef="usd">143000000</cnc:DeferredTaxAssetPremiumAndTradeReceivables>
    <cnc:DeferredTaxAssetOperatingLeaseLiability
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzgtMS0xLTEtMzU0MDE4_a7dd9672-72b4-4b1f-a9ba-83b397a26730"
      unitRef="usd">397000000</cnc:DeferredTaxAssetOperatingLeaseLiability>
    <cnc:DeferredTaxAssetOperatingLeaseLiability
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzgtMy0xLTEtMzU0MDE4_de7f9a8d-2390-49b4-901b-9be1f639b810"
      unitRef="usd">445000000</cnc:DeferredTaxAssetOperatingLeaseLiability>
    <cnc:DeferredTaxAssetsInvestmentUnrealizedGainLoss
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEwLTEtMS0xLTQ1Njc5Nw_4bc2699f-f413-4ee4-baea-113e4b2ec931"
      unitRef="usd">320000000</cnc:DeferredTaxAssetsInvestmentUnrealizedGainLoss>
    <cnc:DeferredTaxAssetsInvestmentUnrealizedGainLoss
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEwLTMtMS0xLTQ1Njc5Nw_7dd62dd0-db32-42a7-b48a-80e1919e83d8"
      unitRef="usd">0</cnc:DeferredTaxAssetsInvestmentUnrealizedGainLoss>
    <cnc:DeferredTaxAssetSoftwareDevelopmentCosts
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzExLTEtMS0xLTQ1Njc5Nw_e2352b35-b51e-4218-95d4-e79f4a6676f8"
      unitRef="usd">209000000</cnc:DeferredTaxAssetSoftwareDevelopmentCosts>
    <cnc:DeferredTaxAssetSoftwareDevelopmentCosts
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzExLTMtMS0xLTQ1Njc5Nw_12dacaf1-1ec6-4f4c-a375-d0543817b40a"
      unitRef="usd">0</cnc:DeferredTaxAssetSoftwareDevelopmentCosts>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEwLTEtMS0xLTM1NDAxOA_f561ba4b-3088-4604-83ba-b785df630ac3"
      unitRef="usd">85000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEwLTMtMS0xLTM1NDAxOA_ee784317-92f9-4087-88c8-e171766cd8a4"
      unitRef="usd">112000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzExLTEtMS0xLTM1NDAxOA_d1f68aa7-cb18-405e-9f78-2135e971cf71"
      unitRef="usd">1873000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzExLTMtMS0xLTM1NDAxOA_6eb44412-1913-4e58-9366-7816fcc6be61"
      unitRef="usd">1597000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEyLTEtMS0xLTM1NDAxOA_3dfb2216-6bcc-48c4-bef6-3330b9bb7e3e"
      unitRef="usd">205000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEyLTMtMS0xLTM1NDAxOA_e0522c38-8e4b-4661-b7ed-e3b5add9d09d"
      unitRef="usd">212000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEzLTEtMS0xLTM1NDAxOA_5d66c894-9df9-482d-8deb-1ed52a40665f"
      unitRef="usd">1668000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzEzLTMtMS0xLTM1NDAxOA_fa731b5d-11e2-42b4-9d33-21ff7bdf192d"
      unitRef="usd">1385000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzE2LTEtMS0xLTM1NDAxOA_3d94161e-fb1f-4584-959f-bd6d71cb3098"
      unitRef="usd">1724000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzE2LTMtMS0xLTM1NDAxOA_cdac2cbf-b525-4aa6-95d6-5c0f48a30775"
      unitRef="usd">1794000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzE3LTEtMS0xLTM1NDAxOA_4e3c49b1-becc-4539-8609-48fc0a5f15ac"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzE3LTMtMS0xLTM1NDAxOA_c3d9cd35-6936-4377-bbe3-974f72ef288c"
      unitRef="usd">46000000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzE4LTEtMS0xLTM1NDAxOA_c6294929-9d55-4139-8d08-f06f674b8c64"
      unitRef="usd">111000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzE4LTMtMS0xLTM1NDAxOA_0960f349-adfa-4421-971d-53f7b5d93662"
      unitRef="usd">409000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <cnc:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzIxLTEtMS0xLTM1NDAxOA_fca7deb6-4e9e-4f52-b735-a1b1c751255d"
      unitRef="usd">285000000</cnc:DeferredTaxLiabilitiesRightOfUseAssets>
    <cnc:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzIxLTMtMS0xLTM1NDAxOA_501208b1-7b2f-4105-b0fc-e045f241ba20"
      unitRef="usd">444000000</cnc:DeferredTaxLiabilitiesRightOfUseAssets>
    <cnc:DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzIyLTEtMS0xLTM1NDAxOA_8bca62a8-d959-48b2-a482-4fc4e06435f7"
      unitRef="usd">0</cnc:DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss>
    <cnc:DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzIyLTMtMS0xLTM1NDAxOA_f2d6efd3-de6c-40c0-88b0-e24084d90d32"
      unitRef="usd">29000000</cnc:DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzIzLTEtMS0xLTM1NDAxOA_449baf26-e75c-46eb-a7c0-48652e3c8349"
      unitRef="usd">163000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzIzLTMtMS0xLTM1NDAxOA_d91f887c-6182-4f49-93eb-ea8bb4a593cd"
      unitRef="usd">70000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzI0LTEtMS0xLTM1NDAxOA_9a22f3ff-4855-4d95-be4d-d59456bfb5b5"
      unitRef="usd">2283000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzI0LTMtMS0xLTM1NDAxOA_4699b93c-ce01-4b78-8e76-3c65bd991baa"
      unitRef="usd">2792000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzI1LTEtMS0xLTM1NDAxOA_8172d483-5a33-43f7-8f12-77a2b34f1f16"
      unitRef="usd">615000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTozNmI0ZjNjNzdmMDM0NTFhYmEzN2FmMDU0YTlhMDRjYS90YWJsZXJhbmdlOjM2YjRmM2M3N2YwMzQ1MWFiYTM3YWYwNTRhOWEwNGNhXzI1LTMtMS0xLTM1NDAxOA_5d72970a-b2b0-4f6d-ae68-37bef91116ed"
      unitRef="usd">1407000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ie0934fe54808484a9ec9bca372c35cb2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzE1MjQ_04873f95-6f0a-4600-94f5-c0d6a052230e"
      unitRef="usd">69000000</us-gaap:OperatingLossCarryforwards>
    <cnc:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration
      contextRef="ie1d6506c5c5d40a788e453632be65da8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzE2MTk_92630e77-eda3-47a2-ada3-84452b9e1f1a"
      unitRef="usd">51000000</cnc:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration>
    <cnc:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzI3NDg3NzkwNzM0OTU_a8a2e6f9-ba57-4565-b928-7c7a664aaaa3"
      unitRef="usd">15000000</cnc:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i10545d0936824fd6b5972c4e49790df4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzE3MTQ_54c4f3df-7c13-4ba2-9069-8439ecbd3682"
      unitRef="usd">206000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzMyMTY_e002b175-4120-4f87-89fc-c3e99d5ca2dd">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a reserve for uncertain tax positions that may be challenged by a tax authority. A rollforward of the beginning and ending amount of uncertain tax positions, exclusive of related interest and penalties, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statute of limitation lapses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzItMS0xLTEtMzU0MDE4_dfd1c96a-c86d-4ada-be92-3b0dc78be83a"
      unitRef="usd">355000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i2185a9a104a3441390ac2f06aefa122a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzItMy0xLTEtMzU0MDE4_c990cbe0-e7f2-4135-848f-1d7c3c923873"
      unitRef="usd">354000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzQtMS0xLTEtMzU0MDE4_152e16b4-e946-489c-aafa-6952ca21ab69"
      unitRef="usd">52000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzQtMy0xLTEtMzU0MDE4_0ad888ff-7e4b-47db-8638-bd207d0c234d"
      unitRef="usd">9000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <cnc:UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzUtMS0xLTEtMzU0MDE4_b7816d8c-26a0-4c3c-9bef-aec9271e5372"
      unitRef="usd">7000000</cnc:UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired>
    <cnc:UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzUtMy0xLTEtMzU0MDE4_c2e73fb1-7c4e-4e0e-8aff-87346a38b2be"
      unitRef="usd">0</cnc:UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzYtMS0xLTEtMzU0MDE4_9ae8a4aa-3a5f-4ca3-b9e6-3bf5c7bedd70"
      unitRef="usd">20000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzYtMy0xLTEtMzU0MDE4_1653d63f-487f-452e-9663-c6129e42b97f"
      unitRef="usd">12000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzgtMS0xLTEtMzU0MDE4_b3c1507f-aff9-40b1-a6a5-921aeacc0676"
      unitRef="usd">17000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzgtMy0xLTEtMzU0MDE4_0478eaeb-3a76-4f3e-b3dd-5dc53b52eb2d"
      unitRef="usd">13000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzktMS0xLTEtMzU0MDE4_4ed8c1b0-da6c-4900-a17a-f7a8bbe97f1f"
      unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzktMy0xLTEtMzU0MDE4_5260b15d-caae-4a50-8e8e-dff180edd690"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzEwLTEtMS0xLTM1NDAxOA_44bc1873-59aa-4661-8e53-4e3dd0a6a85e"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzEwLTMtMS0xLTM1NDAxOA_83379521-1d44-405f-a063-c6fd757b4536"
      unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzExLTEtMS0xLTM1NDAxOA_55d27a64-a065-44ed-b957-34dbd841bd6e"
      unitRef="usd">410000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90YWJsZTpiOWM2OTNjMTY5NzQ0NjYyYjBhNjU5NDVmMmNlZGRiMS90YWJsZXJhbmdlOmI5YzY5M2MxNjk3NDQ2NjJiMGE2NTk0NWYyY2VkZGIxXzExLTMtMS0xLTM1NDAxOA_7e1e81a9-9947-464c-ba38-8be6905fa826"
      unitRef="usd">355000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzEwOTk1MTE2MzEwMDM_581f414f-aacc-407f-a0be-80ecb450268d"
      unitRef="usd">303000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzEwOTk1MTE2MzEwMTc_b451ddf6-c59c-455e-b347-685f5e86f057"
      unitRef="usd">23000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzEwOTk1MTE2MzEwNDU_7edebb66-de45-4432-99d4-2ea48f3a7c50"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzEwOTk1MTE2MzEwNjA_75c551be-29f2-4344-a73c-83ecebbcdb90"
      unitRef="usd">66000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzEwOTk1MTE2MzEwNTE_5758c6cd-6596-40c7-b58d-83b17eb63a4c"
      unitRef="usd">43000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzU0OTc1NTgzMzg5Mg_7e751620-62cc-46c2-a333-02d859638d1b"
      unitRef="usd">124000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i565504036a2e459fa252e3436ba28dea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDIvZnJhZzo1MDc2NzliNDUxZWI0ZjgzOTIwOGU3OTVhNDEzYjJkOS90ZXh0cmVnaW9uOjUwNzY3OWI0NTFlYjRmODM5MjA4ZTc5NWE0MTNiMmQ5XzI0NDU5_d089477c-942e-49ca-abe1-079b162c4980"
      unitRef="usd">3000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzE5Mzc_12bdbe1b-1e62-48ea-b8da-ed0e21550690">Stock Incentive Plans&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's stock incentive plans allow for the granting of restricted stock or restricted stock unit awards and options to purchase common stock. Both incentive stock options and nonqualified stock options can be awarded under the plans. However, an immaterial amount of options were granted, exercised, or outstanding in 2022. The plans have 17 million shares available for future awards. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense for stock options and restricted stock unit awards is recognized on a straight-line basis over the vesting period, generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTA_555f768d-bd53-493d-899f-ffdf3d5a60f0"&gt;three&lt;/span&gt; to five years for stock options and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTg_0f5667b6-1669-434f-8a62-05af54a230a9"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTg_d969fa16-d3ae-4cf3-a934-197b9b0e25e4"&gt;one&lt;/span&gt;&lt;/span&gt; to three years for restricted stock or restricted stock unit awards. Vesting is accelerated by one year for individuals who qualify under the Company's retirement eligible provisions. The fair value of restricted stock and restricted stock units is determined using the previous day's market close price at the time of grant. The fair value of stock options is determined based on the Black-Scholes option-pricing model. Forfeitures for all stock awards are recognized as they occur. Certain restricted stock unit awards contain performance-based as well as service-based provisions. Certain awards provide for accelerated vesting if there is a change in control as defined in the plans. The total compensation cost that has been charged against income for the stock incentive plans was $234 million, $203 million, and $281 million for the years ended December 31, 2022, 2021, and 2020, respectively. The total income tax benefit recognized in the Statements of Operations for stock-based compensation arrangements was $48 million, $35 million, and $34 million for the years ended December 31, 2022, 2021, and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the&#160;Company's non-vested&#160;restricted stock and restricted stock unit shares as of December&#160;31, 2022, and changes during the year ended December&#160;31, 2022, is presented below (shares in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Converted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Magellan awards converted in connection with the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of restricted stock and restricted stock units vested during the years ended December 31, 2022, 2021, and 2020, was $298 million, $264 million, and $364 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, there was $249 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the plans; that cost is expected to be recognized over a weighted-average period of 1.8 years. &lt;/span&gt;&lt;/div&gt;The Company maintains an employee stock purchase plan and issued 449 thousand shares, 516 thousand shares, and 487 thousand shares in 2022, 2021, and 2020, respectively.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5NjM_c700c600-d4ed-4ef5-acd9-93b70de7de35"
      unitRef="shares">17000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i660d37afc2d64a069401dc54b4c69ba9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2Mjk5OTQ_8eaee3e8-7a99-46be-a330-2dbd698475fb">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i96654801b9964ae2b8f134e8859eac41_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwMDI_a5384e49-cebc-4288-81da-9b82faf15b2d">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7772399e744a48908f193c434d6d6a34_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwMDI_ab9f5486-7383-429b-afdd-01e82e42d763">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <cnc:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwMDY_7261f157-22ba-41f8-9190-d00b1b088fd5">P1Y</cnc:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwMTk_c848a451-d5fa-4560-b921-f63e23854d69"
      unitRef="usd">234000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwMjQ_85bf6146-d495-4584-8c32-185b9207fe36"
      unitRef="usd">203000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwMjk_facc71a7-51f9-4f95-9705-8825c9c3c10a"
      unitRef="usd">281000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwNTk_ecd62e81-e6b4-447f-b6c8-b6bfe8c6ef6d"
      unitRef="usd">48000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwNjQ_a6fcd3d9-58ee-4246-8492-06d2d3d91d6a"
      unitRef="usd">35000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwNjk_a89fa84a-eda3-4717-a0c4-9f3f8079a0a9"
      unitRef="usd">34000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzE5NjU_372b476b-0a8f-494d-97d0-c72f978d2a96">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the&#160;Company's non-vested&#160;restricted stock and restricted stock unit shares as of December&#160;31, 2022, and changes during the year ended December&#160;31, 2022, is presented below (shares in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Converted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Magellan awards converted in connection with the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzEtMS0xLTEtMzU0MDE4_3367386d-0f96-47ee-9ba8-4182d7e0f3ee"
      unitRef="shares">7142000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzEtMy0xLTEtMzU0MDE4_aa59af3d-5ce8-42f0-9401-159204aaae4d"
      unitRef="usdPerShare">65.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzItMS0xLTEtMzU0MDE4_f1056f09-19c0-4886-94b9-da85b2c7a3d4"
      unitRef="shares">2944000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzItMy0xLTEtMzU0MDE4_f1cf821b-974f-4527-b2fd-31a1290cc390"
      unitRef="usdPerShare">84.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <cnc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzMtMS0xLTEtMzU0MDE4_bf47b2ea-7f60-4064-b38c-b95b4a0fcdfc"
      unitRef="shares">917000</cnc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod>
    <cnc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzMtMy0xLTEtMzU0MDE4_126fef5b-39db-4a1f-a4a1-1ff7eb638af2"
      unitRef="usdPerShare">82.65</cnc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzQtMS0xLTEtMzU0MDE4_39c247a2-3b9e-44fa-a5b3-9a181e200d79"
      unitRef="shares">3553000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzQtMy0xLTEtMzU0MDE4_e066fe26-599e-415b-aec6-61a0200d3056"
      unitRef="usdPerShare">67.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzUtMS0xLTEtMzU0MDE4_c207236f-8827-458c-b1c3-8178abdf359d"
      unitRef="shares">877000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzUtMy0xLTEtMzU0MDE4_2c5da2c8-b624-4bd8-8e89-5e2be5f9bb98"
      unitRef="usdPerShare">70.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzYtMS0xLTEtMzU0MDE4_74147599-410f-4431-b183-d8058825c62b"
      unitRef="shares">6573000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90YWJsZTozN2ViOGZlN2I2ZWE0NjEzYmFjNDYxMjkzMGQzYTAwZi90YWJsZXJhbmdlOjM3ZWI4ZmU3YjZlYTQ2MTNiYWM0NjEyOTMwZDNhMDBmXzYtMy0xLTEtMzU0MDE4_4f0f6bde-d713-4bd5-b643-193d1f8e1474"
      unitRef="usdPerShare">74.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAwNzQ_46e027a8-3dd3-495a-9679-94c0dc5fa8f5"
      unitRef="usd">298000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAxMDM_9656d99e-a771-40c7-b997-b80bae46afdc"
      unitRef="usd">264000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAxMDg_529350de-dfe4-49c0-8bf1-188a8d490fa6"
      unitRef="usd">364000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ida2e74d548f94bb09ac682a12b3f2b23_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAxMTM_296f7cba-ca06-4f33-88d3-5ad9bb6e5666"
      unitRef="usd">249000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAxMzQ_2e22dcfe-3152-4aea-854e-4c0a3c8d6ea8">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAxNDk_658f1462-2caf-4e00-a22b-8fbf28376f8b"
      unitRef="shares">449000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAxNjY_34f265fe-7d4e-44fa-b9e6-c0131a1aa0b2"
      unitRef="shares">516000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNDUvZnJhZzoyYjEwNjg5MWJkMjY0NDFkYWY1ODUxYzFkMzhlMTY0Ny90ZXh0cmVnaW9uOjJiMTA2ODkxYmQyNjQ0MWRhZjU4NTFjMWQzOGUxNjQ3XzEwOTk1MTE2MzAxODI_c14b7249-945c-4a90-88b5-70d0d88a29b4"
      unitRef="shares">487000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTEvZnJhZzplNjU2OTMyYmFiY2E0MjZjODFmOWY4MTkzNDFiZTIxOS90ZXh0cmVnaW9uOmU2NTY5MzJiYWJjYTQyNmM4MWY5ZjgxOTM0MWJlMjE5XzQzOQ_55c3d581-b7b5-4503-8201-f5e364d6f967">Retirement Plan &#160;Centene has a defined contribution plan which covers substantially all employees who are at least 21 years of age. Under the plan, eligible employees may contribute a percentage of their base salary, subject to certain limitations. Centene may elect to match a portion of the employee's contribution. Company expense related to matching contributions to the plan was $133&#160;million, $105 million, and $91 million during the years ended December 31, 2022, 2021, and 2020, respectively.</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <cnc:DefinedContributionPlanMinimumAgeForCoverage
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTEvZnJhZzplNjU2OTMyYmFiY2E0MjZjODFmOWY4MTkzNDFiZTIxOS90ZXh0cmVnaW9uOmU2NTY5MzJiYWJjYTQyNmM4MWY5ZjgxOTM0MWJlMjE5XzExMw_84e85050-b460-4201-86f9-2fdf60a4b5df">P21Y</cnc:DefinedContributionPlanMinimumAgeForCoverage>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTEvZnJhZzplNjU2OTMyYmFiY2E0MjZjODFmOWY4MTkzNDFiZTIxOS90ZXh0cmVnaW9uOmU2NTY5MzJiYWJjYTQyNmM4MWY5ZjgxOTM0MWJlMjE5XzEwOTk1MTE2MjgyNTk_24f125ac-ce1e-4b8f-9310-24cc67d65673"
      unitRef="usd">133000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTEvZnJhZzplNjU2OTMyYmFiY2E0MjZjODFmOWY4MTkzNDFiZTIxOS90ZXh0cmVnaW9uOmU2NTY5MzJiYWJjYTQyNmM4MWY5ZjgxOTM0MWJlMjE5XzM4Ng_339a84b8-9e53-400c-b754-5eb54052d893"
      unitRef="usd">105000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTEvZnJhZzplNjU2OTMyYmFiY2E0MjZjODFmOWY4MTkzNDFiZTIxOS90ZXh0cmVnaW9uOmU2NTY5MzJiYWJjYTQyNmM4MWY5ZjgxOTM0MWJlMjE5XzM5NA_12da5400-1366-46b6-90df-00024bb16361"
      unitRef="usd">91000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:CommitmentsDisclosureTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNjQwOA_123d7745-f1c2-450c-907e-7e442d8f93e9">Commitments &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with obtaining regulatory approval of the Magellan Health acquisition, the Company entered into certain undertakings with the Department of Managed Health Care in 2022. These undertakings contain various commitments by the Company effective upon completion of the Magellan Health acquisition. As part of the undertaking, the Company shall contribute $10&#160;million to the Purchaser Business Group on Health (PBGH) to be paid over a five-year period for initiatives consistent with the Company's mission of implementing and spreading innovative programs and best practices to increase health care value. As a result of the closing of the Magellan acquisition, the $10 million contribution to PBGH was expensed during 2022. As of December&#160;31, 2022, the Company has paid $1.5 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with obtaining regulatory approval of the Fidelis Care acquisition, the Company entered into certain undertakings with the New York State Department of Health in 2018. These undertakings contain various commitments by the Company effective upon completion of the Fidelis Care acquisition. One of the undertakings includes a $340&#160;million contribution by the Company to the State of New York to be paid over a five-year period for initiatives consistent with the Company's mission of providing high-quality healthcare to vulnerable populations within New York State. The Company has fulfilled this undertaking as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also committed to certain undertakings with the California Department of Insurance and the California Department of Managed Health Care in connection with obtaining regulatory approval of the Health Net acquisition in 2016. The Health Net commitments related to the undertakings are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;invest an additional $30 million through the California Organized Investment Network over the five years following completion of the acquisition; the Company fulfilled this undertaking in 2020;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;build a service center in an economically distressed community in California, investing $200 million over 10 years and employing at least 300 people, of which the Company has incurred $109 million through 2022;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;contribute $65 million to improve enrollee health outcomes, support locally-based consumer assistance programs, and strengthen the healthcare delivery system, of which the Company has contributed $49 million through 2022 with remaining $16 million scheduled to be paid equally over 2023 and 2024; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;invest $75 million of its investment portfolio in vehicles supporting California's healthcare infrastructure, and the Company fulfilled this undertaking in 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:OtherCommitment
      contextRef="i4e6ac045f07846a0a20f759b986b78a4_I20220104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzQ5NDc4MDIzMzQzMTk_5e8f44c8-882e-425c-ab68-7e76a1668d8d"
      unitRef="usd">10000000</us-gaap:OtherCommitment>
    <cnc:OtherCommitmentTerm
      contextRef="ic47ddeb6bff94082ad9cbbcb46104c2d_D20220104-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzQ5NDc4MDIzMzQ0Nzg_973c6013-ebff-4bfd-b84a-b326037a2c31">P5Y</cnc:OtherCommitmentTerm>
    <cnc:OtherCommitmentExpense
      contextRef="ic47ddeb6bff94082ad9cbbcb46104c2d_D20220104-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxOTEzMg_c87857dc-7f5e-41d1-b556-ee150ded8790"
      unitRef="usd">10000000</cnc:OtherCommitmentExpense>
    <cnc:OtherCommitmentsPaid
      contextRef="ic47ddeb6bff94082ad9cbbcb46104c2d_D20220104-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxOTIxNA_0a9d2051-2cd9-4b65-92b1-0a605d8490f8"
      unitRef="usd">1500000</cnc:OtherCommitmentsPaid>
    <us-gaap:OtherCommitment
      contextRef="i56eac86dba6e4053a7ca2c5c5581989e_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNjU3NA_78b6503d-00b8-44ca-916b-b156372f86a8"
      unitRef="usd">340000000</us-gaap:OtherCommitment>
    <cnc:OtherCommitmentTerm
      contextRef="i6b9698336fd64b6e87b61c763e298e1d_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzQ5NDc4MDIzMzQ0Nzc_39b43e4f-0178-4bdb-abcb-384769fc627f">P5Y</cnc:OtherCommitmentTerm>
    <us-gaap:OtherCommitment
      contextRef="iddb3faf7d44a4e5c8ad7bb4b13280732_I20161231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNTg5MQ_4e2fbe22-d407-4544-9618-dee351e80efa"
      unitRef="usd">30000000</us-gaap:OtherCommitment>
    <cnc:OtherCommitmentTerm
      contextRef="if0872678e89e4daeb40637a4f74959f1_D20160101-20161231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNTg4Mw_9833e343-4fc0-49ee-8a6c-f54c17e29307">P5Y</cnc:OtherCommitmentTerm>
    <us-gaap:OtherCommitment
      contextRef="if0c316f54cfe4b9fa7a39964c5a1d5f0_I20161231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNTkwMA_0b142828-68a3-4a9e-bbf3-9449993e7279"
      unitRef="usd">200000000</us-gaap:OtherCommitment>
    <cnc:OtherCommitmentTerm
      contextRef="ib82f610c9738480cb8bbbc7d5b5a8247_D20160101-20161231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNTkwOA_d061e0ea-b674-48ad-a1fc-f4ea18d7993f">P10Y</cnc:OtherCommitmentTerm>
    <cnc:OtherCommitmentEmployees
      contextRef="i892f84f1e688414fa51beaf4c47f0a87_D20160101-20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNjA5OA_00eab40e-c4c6-4a1a-8d4a-06222c9394e7"
      unitRef="newemployee">300</cnc:OtherCommitmentEmployees>
    <cnc:OtherCommitmentExpense
      contextRef="ib2a9aa63979e4693b2198d2bf9cbd715_D20160101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNTkxNA_69e4872a-70bd-4281-a97e-a9ad1e36b8c1"
      unitRef="usd">109000000</cnc:OtherCommitmentExpense>
    <us-gaap:OtherCommitment
      contextRef="ie8e887f935d34e8aa8685f28daf85a31_I20161231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNjEwNQ_bd63c9fe-724c-4b1b-8e18-3dda12eebe81"
      unitRef="usd">65000000</us-gaap:OtherCommitment>
    <cnc:OtherCommitmentExpense
      contextRef="i422ca41ca2bc487dab910fa58cd7b380_D20160101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzIxOTkwMjMyNTg0ODY_e53739c7-96a6-4081-bf7a-274d1fbb78ed"
      unitRef="usd">49000000</cnc:OtherCommitmentExpense>
    <cnc:OtherCommitmentToBePaidYearOneAndYearTwo
      contextRef="i87ea845a685c481cb90b1ac715f64443_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzIxOTkwMjMyNTg3MjU_45a79ab1-fe05-46ef-82fe-ac4e7b859369"
      unitRef="usd">16000000</cnc:OtherCommitmentToBePaidYearOneAndYearTwo>
    <us-gaap:OtherCommitment
      contextRef="ie4d87dee1a254093b133d2780a8d3d4f_I20161231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTQvZnJhZzpjNjU4NzZiNzQ4ZTQ0MmUwYTUyODNlMWMyN2ExYWRiNS90ZXh0cmVnaW9uOmM2NTg3NmI3NDhlNDQyZTBhNTI4M2UxYzI3YTFhZGI1XzU0OTc1NTgxNjQxMA_66c6b8c9-6bfc-4a2f-a93a-d863d36a359f"
      unitRef="usd">75000000</us-gaap:OtherCommitment>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTcvZnJhZzpjYTY3ZDJjNjM1ODU0YjI1ODMyM2NiMTFhNjY0ODFhOC90ZXh0cmVnaW9uOmNhNjdkMmM2MzU4NTRiMjU4MzIzY2IxMWE2NjQ4MWE4XzEwMjU1_92f2b3a0-652e-4a44-9536-7b2f7ecb5f56">Contingencies &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, submissions to CMS for risk adjustment payments, or the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, cybersecurity issues, including those related to the Company's or the Company's third-party vendors' information systems, and the Health Insurance Portability and Accountability Act of 1996 and other federal and state fraud, waste and abuse laws;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property, and employment-related claims; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions, and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups, and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Among other things, these matters may result in awards of damages, fines, or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as described below with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company&#x2019;s pharmacy benefits management (PBM) subsidiary. It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow, and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings, including as described below. Except for the proceedings discussed below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow, or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;California&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 20, 2015, the Company's California subsidiary, Health Net of California, Inc. (Health Net California), was named as a defendant in a California taxpayer action filed in Los Angeles County Superior Court, captioned as Michael D. Myers v. State Board of Equalization, Dave Jones, Insurance Commissioner of the State of California, Betty T. Yee, Controller of the State of California, et al., Los Angeles Superior Court Case No. BS158655. This action is brought under a California statute that permits an individual taxpayer to sue a governmental agency when the taxpayer believes the agency has failed to enforce governing law. Plaintiff contends that Health Net California, a California licensed Health Care Service Plan (HCSP), is an "insurer" for purposes of taxation despite acknowledging it is not an "insurer" under regulatory law. Under California law, "insurers" must pay a gross premiums tax (GPT), calculated as 2.35% on gross premiums. As a licensed HCSP, Health Net California has paid the California Corporate Franchise Tax (CFT), the tax generally paid by California businesses. Plaintiff contends that Health Net California must pay the GPT rather than the CFT. Plaintiff seeks a writ of mandate directing the California taxing agencies to collect the GPT, and seeks an order requiring Health Net California to pay GPT, interest, and penalties for a period dating to eight years prior to the October 2015 filing of the complaint. This lawsuit is being coordinated with similar lawsuits filed against other entities (collectively, Related Actions). In March 2018, the Court overruled the Company's demurrer seeking to dismiss the complaint and denied the Company's motion to strike allegations seeking retroactive relief. In August 2018, the trial court stayed all the Related Actions pending determination of a writ of mandate by the California Court of Appeals in two of the Related Actions. In March 2019, the California Court of Appeals denied the writ of mandate. The defendants in those Related Actions sought review by the California Supreme Court, which declined to review the matter. Upon the return of the matter to the Los Angeles County Superior Court, motions for summary judgment were scheduled. Health Net California's motion for summary judgment was heard by the Court in March 2020. In March 2020, the Court granted Health Net California's motion for summary judgment. In September 2020, the plaintiff appealed the Court's decision. The Company intends to continue its vigorous defense against these claims; however, this matter is subject to many uncertainties, and an adverse outcome in this matter could potentially have a materially adverse impact on the Company's financial condition, results of operations, and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in April 2021, several lawsuits have been filed against the Company and its subsidiaries, alleging that the defendants failed to prevent Health Net members' personal and health data from being exposed in connection with a data breach involving Accellion's File Transfer Appliance. The Company denies any wrongdoing and is seeking indemnification from Accellion for these claims. In December 2021, the plaintiffs in three of the pending actions filed a motion for preliminary approval of a settlement with the Company and its subsidiaries, which, if approved by the court, should resolve most or all of the pending litigation. In addition, claims related to these lawsuits are anticipated to be covered in part by the Company's insurance carrier. As a result, while these matters are subject to many uncertainties, the Company does not believe that an adverse outcome in these matters is likely to have a materially adverse impact on the Company's financial condition, results of operations, and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pharmacy Benefits Management Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 11, 2021, the State of Ohio filed a civil action against the Company and the Company's subsidiaries, Buckeye Health Plan Community Solutions, Inc. and Envolve, in Franklin County Court of Common Pleas, captioned as Ohio Department of Medicaid, et al. v. Centene Corporation, et al. The complaint alleged breaches of contract with the Ohio Department of Medicaid relating to the provision of PBM services and violations of Ohio law relating to such contracts, including among other things, by (i) seeking payment for services already reimbursed, (ii) not accurately disclosing to the Ohio Department of Medicaid the true cost of the PBM services and (iii) inflating dispensing fees for prescription drugs. The plaintiffs sought an undisclosed sum of money in damages, penalties, and possible termination of the contract with Buckeye Health Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has reached no-fault agreements with the Attorney Generals, including Ohio, to resolve claims and/or allegations made by the states related to services previously provided by Envolve. As a result of the settlement, the Ohio Attorney General's litigation against the Company was dismissed. Additionally, the Company is in discussions to bring final resolution to similar concerns in other affected states. Consistent with those discussions, the Company recorded a reserve estimate of $1,250&#160;million in the second quarter of 2021 related to this issue, inclusive of the above settlements and rebates that the Company determined in the course of the matter are payable across products. Additional claims, reviews, or investigations relating to the Company's historical PBM business across products may be brought by other states, the federal government, or shareholder litigants, and there is no guarantee the Company will have the ability to settle such claims with other states within the reserve estimate the Company has recorded and on other acceptable terms, or at all. This matter is subject to many uncertainties, and an adverse outcome in this matter could have an adverse impact on the Company's financial condition, results of operations, and cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ie10b1c36a39645fd98b8f6652a9ea7aa_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTcvZnJhZzpjYTY3ZDJjNjM1ODU0YjI1ODMyM2NiMTFhNjY0ODFhOC90ZXh0cmVnaW9uOmNhNjdkMmM2MzU4NTRiMjU4MzIzY2IxMWE2NjQ4MWE4Xzc0NzQ_a760215f-1df7-45b2-9a87-f14e4446d8c5"
      unitRef="claim">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LitigationReserve
      contextRef="i1408e06a90864ff9b0dadeb355581288_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNTcvZnJhZzpjYTY3ZDJjNjM1ODU0YjI1ODMyM2NiMTFhNjY0ODFhOC90ZXh0cmVnaW9uOmNhNjdkMmM2MzU4NTRiMjU4MzIzY2IxMWE2NjQ4MWE4Xzk0ODU_f52f81ce-03d4-495c-a29f-8dd22606e992"
      unitRef="usd">1250000000</us-gaap:LitigationReserve>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90ZXh0cmVnaW9uOjExOGI3NzU5NzE2YjQwMzNiOGUzYTk2YjdmYzdhMjEwXzQ0Nw_5045b4e8-4b03-4bea-b23b-5946460d6f87">Earnings Per Share&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings attributable to Centene Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in computing per share amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock equivalents (as determined by applying the treasury stock method)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares and potential dilutive common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings per common share attributable to Centene Corporation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of diluted earnings per common share for 2022, 2021, and 2020 excludes the impact of 187&#160;thousand shares, 44&#160;thousand shares, and 398&#160;thousand shares, respectively, related to anti-dilutive stock options and restricted stock units.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90ZXh0cmVnaW9uOjExOGI3NzU5NzE2YjQwMzNiOGUzYTk2YjdmYzdhMjEwXzQ1Ng_ead9ece3-5866-46d0-b296-13f905dfbd78">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings attributable to Centene Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in computing per share amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock equivalents (as determined by applying the treasury stock method)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares and potential dilutive common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings per common share attributable to Centene Corporation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzQtMS0xLTEtMzU0MDE4_957647bc-d0c4-4830-8b7f-d46cdd591de1"
      unitRef="usd">1202000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzQtMy0xLTEtMzU0MDE4_ac7d6950-e2e2-44c8-ad38-cad7eac014a3"
      unitRef="usd">1347000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzQtNS0xLTEtMzU0MDE4_27773c3f-51b5-406a-a23c-20309812ea71"
      unitRef="usd">1808000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzctMS0xLTEtMzU0MDE4_c31e101d-9980-474f-aa78-ef684ff9bdef"
      unitRef="shares">575191000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzctMy0xLTEtMzU0MDE4_870077c9-642a-4309-a112-b8788461d6cf"
      unitRef="shares">582832000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzctNS0xLTEtMzU0MDE4_b979288c-8772-456a-b695-f16fdc3d0088"
      unitRef="shares">570722000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzgtMS0xLTEtMzU0MDE4_1b1b5ab5-c654-4d9d-bc7b-175d25506d6f"
      unitRef="shares">6849000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzgtMy0xLTEtMzU0MDE4_9c88e954-aff9-48bc-920a-5b236b270c78"
      unitRef="shares">7684000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzgtNS0xLTEtMzU0MDE4_edc0e40b-7a8b-4e5d-9b0c-be86d305dd37"
      unitRef="shares">8413000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzktMS0xLTEtMzU0MDE4_51bce433-df28-408a-bccd-d3fc6e25aa4b"
      unitRef="shares">582040000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzktMy0xLTEtMzU0MDE4_fb4a005d-129f-4fb8-986a-58b78402e6ae"
      unitRef="shares">590516000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzktNS0xLTEtMzU0MDE4_a5d9540a-31eb-4a99-847e-d49eb7169e53"
      unitRef="shares">579135000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzE1LTEtMS0xLTM1NDAxOA_729a3f95-6681-4bed-8e32-ee0eee59d62a"
      unitRef="usdPerShare">2.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzE1LTMtMS0xLTM1NDAxOA_30f13cb9-d4ed-410f-bd06-95c09fed3284"
      unitRef="usdPerShare">2.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzE1LTUtMS0xLTM1NDAxOA_9ccfdcb5-ff9e-4d71-b824-9a07cdbadecb"
      unitRef="usdPerShare">3.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzIwLTEtMS0xLTM1NDAxOA_59d5d2ab-21e1-44f8-9985-cb7204f42679"
      unitRef="usdPerShare">2.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzIwLTMtMS0xLTM1NDAxOA_6c04aca9-fb3d-45d7-b51c-eccd6bc73962"
      unitRef="usdPerShare">2.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90YWJsZTplYmFiMzAyNzM3NGQ0ZDkxOTI3NWUzZjIwMDliNzMxNi90YWJsZXJhbmdlOmViYWIzMDI3Mzc0ZDRkOTE5Mjc1ZTNmMjAwOWI3MzE2XzIwLTUtMS0xLTM1NDAxOA_8639590c-df0b-498a-812b-460d082b30f1"
      unitRef="usdPerShare">3.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90ZXh0cmVnaW9uOjExOGI3NzU5NzE2YjQwMzNiOGUzYTk2YjdmYzdhMjEwXzMwMw_b5a9a63f-470b-4ee4-a13d-daaaf7150bea"
      unitRef="shares">187000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90ZXh0cmVnaW9uOjExOGI3NzU5NzE2YjQwMzNiOGUzYTk2YjdmYzdhMjEwXzMxNA_b2807e15-e244-44f9-9a1c-1b453859de08"
      unitRef="shares">44000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjAvZnJhZzoxMThiNzc1OTcxNmI0MDMzYjhlM2E5NmI3ZmM3YTIxMC90ZXh0cmVnaW9uOjExOGI3NzU5NzE2YjQwMzNiOGUzYTk2YjdmYzdhMjEwXzMyOQ_bce14f0b-63c8-4b88-8f95-16b1a31aebb7"
      unitRef="shares">398000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90ZXh0cmVnaW9uOjBkYmMxODAwNzgyMjQwMTE4Njg3NjRmYmMxOGJmYTU0XzEwODQ_407e8fd1-7ba6-4fff-9589-3d571af421f0">Segment Information&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Centene operates in two segments: Managed Care and Specialty Services. The Managed Care segment consists of Centene's health plans, including all of the functions needed to operate them. The Specialty Services segment consists of Centene's specialty companies offering auxiliary healthcare services and products. Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams, and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In early 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company has revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. The Company will begin reporting under this new segment structure in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not report total assets by segment since this is not a metric used to allocate resources or evaluate segment performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As further discussed in Note 3. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Divestitures,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as part of the Company's ongoing portfolio review various divestitures were pending or completed during the year ended December&#160;31, 2022. The Spanish and Central European businesses were included in the Managed Care segment. The PANTHERx, Magellan Rx, Magellan Specialty Health, Centurion, and HealthSmart businesses were included in the Specialty Services segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment information for the year ended December&#160;31, 2022, follows ($ in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Managed&#160;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Specialty Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues from internal customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment information for the year ended December&#160;31, 2021, follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Managed&#160;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Specialty Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues from internal customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,795)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,795)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment information for the year ended December&#160;31, 2020, follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Managed&#160;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Specialty Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues from internal customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,746)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,746)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90ZXh0cmVnaW9uOjBkYmMxODAwNzgyMjQwMTE4Njg3NjRmYmMxOGJmYTU0XzMz_4452ea48-2a41-44f0-837e-805fc7536a6f"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90ZXh0cmVnaW9uOjBkYmMxODAwNzgyMjQwMTE4Njg3NjRmYmMxOGJmYTU0XzEwODY_ce05f7db-5de0-4cc9-97bd-5a7d368cf912">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment information for the year ended December&#160;31, 2022, follows ($ in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Managed&#160;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Specialty Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues from internal customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment information for the year ended December&#160;31, 2021, follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Managed&#160;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Specialty Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues from internal customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,795)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,795)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment information for the year ended December&#160;31, 2020, follows ($ in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Managed&#160;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Specialty Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues from internal customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,746)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,746)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="id1c2cca7f4f74960a51897309069b67d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzEtMS0xLTEtMzU0MDE4_97852315-d6cb-4421-9483-a33e17139db7"
      unitRef="usd">135055000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0679197c607142fab0cde5bfadf6106e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzEtMy0xLTEtMzU0MDE4_02859d1c-1e3f-49fc-9888-bc66393707ea"
      unitRef="usd">9492000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzEtNy0xLTEtMzU0MDE4_99a34df3-4926-46ef-823c-fbcece135ad0"
      unitRef="usd">144547000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5edc68c239804a80814acb778ec0cec8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzItMS0xLTEtMzU0MDE4_a6edc92a-cf82-47e0-a558-44a8749aebae"
      unitRef="usd">8000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i81fb523ea67d40f5940533702a20d4a3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzItMy0xLTEtMzU0MDE4_d228915f-0fc1-4ada-a317-1a3808749e9d"
      unitRef="usd">13273000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6897fe7f407348408f329013f91d65d4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzItNS0xLTEtMzU0MDE4_6c346441-feb5-48c7-bc03-2e1a2204d1a5"
      unitRef="usd">-13281000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzMtMS0xLTEtMzU0MDE4_ab31190d-a233-46fd-826d-cfec40d38c4e"
      unitRef="usd">135063000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzMtMy0xLTEtMzU0MDE4_ebe5ba0b-2fd1-4957-aa4f-aa70ac1e8aab"
      unitRef="usd">22765000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6897fe7f407348408f329013f91d65d4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzMtNS0xLTEtMzU0MDE4_203d529e-1b16-44b4-bca2-323cdc07d014"
      unitRef="usd">-13281000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzMtNy0xLTEtMzU0MDE4_f69a6fd8-8ee9-462c-8fff-421fdf80e639"
      unitRef="usd">144547000000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia377c479d63741a3b7a2348b5a1387cb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzQtMS0xLTEtMzU0MDE4_90689bc9-6a41-4a48-bc64-f0b6a21d3492"
      unitRef="usd">1913000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib8430a9fce0646c293c7fcb15249d06f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzQtMy0xLTEtMzU0MDE4_a4ddaba9-60e6-43e4-ad70-4b92702b27ba"
      unitRef="usd">-595000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTplODg2MTgwZTlhNDE0ZDA1YjUwOWVmMDdiOThjZmE4Mi90YWJsZXJhbmdlOmU4ODYxODBlOWE0MTRkMDViNTA5ZWYwN2I5OGNmYTgyXzQtNy0xLTEtMzU0MDE4_d3afd85e-9537-4a33-bb37-748af136f888"
      unitRef="usd">1318000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:Revenues
      contextRef="i597b4c195cb04959abb207f4c5a9d77b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzEtMS0xLTEtMzU0MDE4_59003bca-c756-48e3-a38a-4e78e5b59e82"
      unitRef="usd">120119000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibdc35ca45e39441388aa8777389f4f17_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzEtMy0xLTEtMzU0MDE4_fe938f82-43cf-4ead-8e7c-5eaf927812cf"
      unitRef="usd">5863000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzEtNy0xLTEtMzU0MDE4_9ad14f77-9e17-4c63-bbca-2f208bacc437"
      unitRef="usd">125982000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibfc51f1798d2493e9397d897df02b75d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzItMS0xLTEtMzU0MDE4_e8507963-0eb5-46cb-9422-781ef917c65b"
      unitRef="usd">6000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8c52c3388e80478599272c3d556863c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzItMy0xLTEtMzU0MDE4_f5d49aef-9351-462d-8404-4469b67370da"
      unitRef="usd">12789000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i73a2cbaeddfd400e90e0ac804c3f053d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzItNS0xLTEtMzU0MDE4_9f6ff25c-5ae0-45d2-8d42-c5d542954b37"
      unitRef="usd">-12795000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6447d75d16c04ef5b131401dd27e366b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzMtMS0xLTEtMzU0MDE4_ba31abbf-a5cc-4fda-a581-c525874d2233"
      unitRef="usd">120125000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id2bebbc40fd54b4b8b61324fc370f6f6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzMtMy0xLTEtMzU0MDE4_9b7a8f15-d9c4-40fb-b7ac-a856eca4a8a1"
      unitRef="usd">18652000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i73a2cbaeddfd400e90e0ac804c3f053d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzMtNS0xLTEtMzU0MDE4_11364768-7b12-4471-818f-90ec015cbf4b"
      unitRef="usd">-12795000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzMtNy0xLTEtMzU0MDE4_49eb350e-c6d7-49cd-8286-d5b7bf1fb212"
      unitRef="usd">125982000000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6447d75d16c04ef5b131401dd27e366b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzQtMS0xLTEtMzU0MDE4_70ab40a1-962b-4de9-85fa-ad314f69d897"
      unitRef="usd">1789000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id2bebbc40fd54b4b8b61324fc370f6f6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzQtMy0xLTEtMzU0MDE4_32f078b3-acaa-4017-af3e-50ff8804cbd3"
      unitRef="usd">-5000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i61abc519fa6040798a5c67717a2ffe4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTphNmI3MTFmZjMyOWQ0ZWFhYTUyYmVjNDFhNTU4NDI5Yy90YWJsZXJhbmdlOmE2YjcxMWZmMzI5ZDRlYWFhNTJiZWM0MWE1NTg0MjljXzQtNy0xLTEtMzU0MDE4_b343c6ce-15fa-4214-93b8-2d8075af6219"
      unitRef="usd">1784000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:Revenues
      contextRef="i08f2668a7ad14973b713bb5cfbcf8727_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzEtMS0xLTEtMzU0MDE4_41194d22-3a6c-4311-ad1a-d521e8058ddf"
      unitRef="usd">106862000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6991fd72507b46dc832dd05186288635_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzEtMy0xLTEtMzU0MDE4_808f8178-4eb4-4176-a308-dfdb69bc844f"
      unitRef="usd">4253000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzEtNy0xLTEtMzU0MDE4_e6512739-a6b9-42c0-8bcf-55921ec9091e"
      unitRef="usd">111115000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fd30ab791664c4f9c22d79dbf638763_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzItMS0xLTEtMzU0MDE4_086991b1-15ad-4a82-9798-de28534773ce"
      unitRef="usd">5000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7155450c86684d8ba820c2c57095f767_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzItMy0xLTEtMzU0MDE4_63a7d35e-7f40-429e-99a8-0f3e75f2ce49"
      unitRef="usd">10741000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i06642903404e4397841d66d835b14359_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzItNS0xLTEtMzU0MDE4_e9cce9fa-bbe9-428c-9d36-7a4a3be0160f"
      unitRef="usd">-10746000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if516d478048c4636bd145efe65e63d37_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzMtMS0xLTEtMzU0MDE4_6cb63afb-fc9a-4f02-94d5-4b42369d54ee"
      unitRef="usd">106867000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i51a6cef996834ef6bafb08a049d5359c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzMtMy0xLTEtMzU0MDE4_ca707b9f-da41-47c2-b393-0c7b717ecde0"
      unitRef="usd">14994000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i06642903404e4397841d66d835b14359_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzMtNS0xLTEtMzU0MDE4_e356de78-5566-4b22-ae0d-3a8082287cbd"
      unitRef="usd">-10746000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzMtNy0xLTEtMzU0MDE4_cf1bad82-c67d-4000-b2b6-f9cb4bb82d34"
      unitRef="usd">111115000000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="if516d478048c4636bd145efe65e63d37_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzQtMS0xLTEtMzU0MDE4_a8d44026-5843-4dd2-bf4d-a216662cc5f7"
      unitRef="usd">3031000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i51a6cef996834ef6bafb08a049d5359c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzQtMy0xLTEtMzU0MDE4_b1421f07-975c-441a-bc9d-0f9add7cb4d5"
      unitRef="usd">51000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6e356f77d08c491b8673fa8a21946ccc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjMvZnJhZzowZGJjMTgwMDc4MjI0MDExODY4NzY0ZmJjMThiZmE1NC90YWJsZTo5MDIxYmIyZWI2ZjI0MjVjOGQyNzlmOWU3YTA4ZDEyNC90YWJsZXJhbmdlOjkwMjFiYjJlYjZmMjQyNWM4ZDI3OWY5ZTdhMDhkMTI0XzQtNy0xLTEtMzU0MDE4_a787a6a7-ef4c-418d-b1a9-73e0ce0a9327"
      unitRef="usd">3082000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90ZXh0cmVnaW9uOjM4ZGM4YjEwODJmMTRkNjA4MGYzZDIwYzEyNWVlY2U3XzIzMzk_795f9640-6fea-48e9-817d-b00aefa40b54">Condensed Financial Information of Registrant&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Centene Corporation (Parent Company Only)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(In millions, except shares in thousands and per share data in dollars)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stockholders' equity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December&#160;31, 2022 and December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock, $0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December&#160;31, 2022, and 602,704 issued and 582,479 outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive earnings (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Treasury stock, at cost (57,093 and 20,225 shares, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Centene stockholders' equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders' equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities, redeemable noncontrolling interests and stockholders' equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See notes to condensed financial information of registrant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Centene Corporation (Parent Company Only)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(In millions, except per share data in dollars)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on divestiture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt extinguishment &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(687)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) before equity in subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings from subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net earnings attributable to Centene Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net earnings per common share attributable to Centene Corporation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See notes to condensed financial information of registrant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Centene Corporation (Parent Company Only)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends from subsidiaries, return on investment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for legal settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating activities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash provided by operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flows from investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital contributions to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and maturities of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends from subsidiaries, return of investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intercompany activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investing activities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash (used in) provided by investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flows from financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from common stock issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments and repurchases of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,096)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for debt extinguishment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other financing activities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash (used in) provided by financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase (decrease) in cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,589)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; beginning of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; end of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See notes to condensed financial information of registrant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Notes to Condensed Financial Information of Registrant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note A - Basis of Presentation and Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The parent company only financial statements should be read in conjunction with Centene Corporation's audited consolidated financial statements and the notes to consolidated financial statements included in this Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The parent company's investment in subsidiaries is stated at cost plus equity in undistributed earnings of the subsidiaries. The parent company's share of net income of its unconsolidated subsidiaries is included in income using the equity method of accounting. Certain unrestricted subsidiaries receive monthly management fees from the Company's restricted subsidiaries. The management and service fees received by its unrestricted subsidiaries are associated with all of the functions required to manage the restricted subsidiaries including but not limited to salaries and wages for all personnel, rent, utilities, population health management, provider contracting, compliance, member services, claims processing, information technology, cash management, finance and accounting, and other services. The management fees are based either on a percentage of the restricted subsidiaries' revenue or a cost basis reimbursement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the Company's centralized cash management function, cash flows generated by its unrestricted subsidiaries are utilized by the parent company to the extent required, primarily to repay borrowings on the parent company's credit facilities, repurchase the parent company's common stock, make acquisitions, fund capital contributions to subsidiaries, and fund its operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts presented in the parent company only financial statements are eliminated in the consolidated financial statements of Centene Corporation.&lt;/span&gt;&lt;/div&gt;</us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90ZXh0cmVnaW9uOjM4ZGM4YjEwODJmMTRkNjA4MGYzZDIwYzEyNWVlY2U3XzIzNjg_f48ddfef-41d4-46a2-ad0c-21e519ffda56">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Centene Corporation (Parent Company Only)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(In millions, except shares in thousands and per share data in dollars)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stockholders' equity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December&#160;31, 2022 and December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock, $0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December&#160;31, 2022, and 602,704 issued and 582,479 outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive earnings (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Treasury stock, at cost (57,093 and 20,225 shares, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Centene stockholders' equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders' equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities, redeemable noncontrolling interests and stockholders' equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzQtMS0xLTEtMzU0MDE4_4fc2e473-7742-4995-9505-bbff8c818d2e"
      unitRef="usd">12000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzQtMy0xLTEtMzU0MDE4_103b93cf-ee88-4273-9903-c78756de7fa4"
      unitRef="usd">9000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzYtMS0xLTEtMzU0MDE4_729d2e6e-8c09-41fb-83c6-eb84ff895151"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzYtMy0xLTEtMzU0MDE4_67f19abe-7b07-44db-a3e1-9d143369cbac"
      unitRef="usd">1000000</us-gaap:ShortTermInvestments>
    <us-gaap:OtherAssetsCurrent
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzctMS0xLTEtMzU0MDE4_0858c48e-6575-46c0-9116-3828667e243d"
      unitRef="usd">6000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzctMy0xLTEtMzU0MDE4_e2376f98-ec03-448a-9a42-4246ae3e41f7"
      unitRef="usd">738000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzgtMS0xLTEtMzU0MDE4_8e001c2d-8ce7-4ab5-843b-f0cbf93b2056"
      unitRef="usd">18000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzgtMy0xLTEtMzU0MDE4_20ca6dfd-fde9-411c-bf13-2ebb04c64955"
      unitRef="usd">748000000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzktMS0xLTEtMzU0MDE4_f8d82d33-a5f1-439a-8e99-38baf17619c8"
      unitRef="usd">66000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzktMy0xLTEtMzU0MDE4_b819ce2c-8909-4b19-99c6-08f4bb96f51f"
      unitRef="usd">128000000</us-gaap:LongTermInvestments>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzEwLTEtMS0xLTM1NDAxOA_be9e1670-7aa5-4d19-b4d4-3c7caefc56fe"
      unitRef="usd">42306000000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzEwLTMtMS0xLTM1NDAxOA_285540b7-d1e2-4fde-9398-d82a696d453f"
      unitRef="usd">45117000000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzExLTEtMS0xLTM1NDAxOA_d8af4035-4db8-49d7-906c-ecb30e1e9b68"
      unitRef="usd">422000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzExLTMtMS0xLTM1NDAxOA_a0234864-9ca2-4816-9055-2197db3247a7"
      unitRef="usd">271000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzEyLTEtMS0xLTM1NDAxOA_0333f312-6767-4a52-b247-b3d98a7d9e80"
      unitRef="usd">42812000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzEyLTMtMS0xLTM1NDAxOA_7e7d54d7-65b4-40eb-8617-c31c93f8b97d"
      unitRef="usd">46264000000</us-gaap:Assets>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE1LTEtMS0xLTM1NDAxOA_510f5587-493c-445e-9961-75238770b308"
      unitRef="usd">534000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE1LTMtMS0xLTM1NDAxOA_0acc6c7e-2b0a-472f-84cb-d7c129be3397"
      unitRef="usd">619000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE2LTEtMS0xLTM1NDAxOA_751befdd-8818-40e1-9624-c2581568728f"
      unitRef="usd">69000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE2LTMtMS0xLTM1NDAxOA_8fee6d44-1962-4978-b04d-fada5c328dfc"
      unitRef="usd">14000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE3LTEtMS0xLTM1NDAxOA_ac8d825d-9c81-4907-b5df-0f2121de299d"
      unitRef="usd">603000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE3LTMtMS0xLTM1NDAxOA_2fc07091-0aad-4cc0-b6cb-1f3012d3a8ae"
      unitRef="usd">633000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE4LTEtMS0xLTM1NDAxOA_c0393305-9c01-416c-a12a-77c467ec7b44"
      unitRef="usd">17699000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE4LTMtMS0xLTM1NDAxOA_bfb5a560-e259-4618-9537-2edfcd986e2b"
      unitRef="usd">18148000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE5LTEtMS0xLTM1NDAxOA_2669802f-5cb4-4ec8-bd08-1fea011808a0"
      unitRef="usd">273000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzE5LTMtMS0xLTM1NDAxOA_74ef2dcb-3dbc-44db-adc2-5080ef455e47"
      unitRef="usd">461000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIwLTEtMS0xLTM1NDAxOA_9cab9656-7ab0-4b45-8e34-1d1ab45062ff"
      unitRef="usd">18575000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIwLTMtMS0xLTM1NDAxOA_9006840c-ce7c-4df1-aaa9-3666f5ae951c"
      unitRef="usd">19242000000</us-gaap:Liabilities>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIxLTEtMS0xLTM1NDAxOA_704bae8f-1b9c-44ee-8715-fa9a73db4de7"
      unitRef="usd">56000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIxLTMtMS0xLTM1NDAxOA_4bc88b70-81f8-455a-9b9b-c7f51e7d8a3f"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3NjU_87ba514a-d080-469a-b12e-16332cab8b43"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3NjU_c0187be6-e296-4579-ac86-281e8b461680"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3Njk_1d5c4135-9606-46c7-98bb-eb7d35385d9d"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3Njk_37312559-4fd0-48d2-9f88-c666db353b3d"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3NzM_28259bf0-6ce3-4186-a6d6-79ba24f1b613"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3NzM_37a0db18-79da-464c-8b0d-36905899c946"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3NzM_58f01dbc-03ef-41b4-853c-d7850c371485"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmIyZjcyMDI1YjdmMjRhNzc4YmZkMjQwYjI3ZjdmYmRlXzE2NDkyNjc0NDE3NzM_9bfc78a4-d0eb-4604-8217-b34aff47ed72"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTEtMS0xLTM1NDAxOA_dde18463-ea3d-4480-9fc1-e30936acdcee"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzIzLTMtMS0xLTM1NDAxOA_fd8f7c77-3958-4bd2-8e73-3ec4062b630d"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE3OTM_2153c91f-b98a-4124-88ca-a288a0af61e9"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE3OTM_7e7927ec-4525-4118-937e-e0e1aee34432"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE3OTc_02dab9bc-b035-4f4d-880c-520dfad50e47"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE3OTc_bfe0fce6-fd53-4856-9fad-14b9417e9136"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE4MDA_9c8c0bc2-1978-4298-8ed4-60c22dee937c"
      unitRef="shares">607847000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE4MDQ_0aef50c6-2876-4683-bc68-afaf580854e8"
      unitRef="shares">550754000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE4MDk_d42cf621-44de-46b5-9765-2eeb8d55a063"
      unitRef="shares">602704000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOmI1OWZiMzI4MWQ2ZDQ0MDA5NzNjMzliNmE4OGFiNmQ5XzE2NDkyNjc0NDE4MTI_6f4e7f72-0e38-464a-b548-c10952696003"
      unitRef="shares">582479000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTEtMS0xLTM1NDAxOA_96d2947f-cde7-4e19-aa4f-e2eabd3ef1d8"
      unitRef="usd">1000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI0LTMtMS0xLTM1NDAxOA_7e2f8b6c-514f-4647-8729-e93a81a7f832"
      unitRef="usd">1000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI1LTEtMS0xLTM1NDAxOA_adf284b3-fca7-40ce-816a-9b753d8f571f"
      unitRef="usd">20060000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI1LTMtMS0xLTM1NDAxOA_ad1b6517-62d6-404e-8f08-5fb834be0110"
      unitRef="usd">19672000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI2LTEtMS0xLTM1NDAxOA_bf9eed49-042e-471b-847b-1eab9bae2787"
      unitRef="usd">-1132000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI2LTMtMS0xLTM1NDAxOA_9e50b810-d60d-4223-bdc8-375391547611"
      unitRef="usd">77000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI3LTEtMS0xLTM1NDAxOA_22228499-0d25-4cef-847b-d3cdc69b7dd5"
      unitRef="usd">9341000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI3LTMtMS0xLTM1NDAxOA_d96ebb29-af8d-4365-93e3-46671ccd9693"
      unitRef="usd">8139000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI4LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOjYzMTU4ZTI5YzhkNDQ0MTFiMWY5NWEwMTlhOWRlZDRiXzE2NDkyNjc0NDE3MjQ_a3f32649-9cbf-4d6e-b530-22d11dc5dfbe"
      unitRef="shares">57093000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI4LTAtMS0xLTM1NDAxOC90ZXh0cmVnaW9uOjYzMTU4ZTI5YzhkNDQ0MTFiMWY5NWEwMTlhOWRlZDRiXzE2NDkyNjc0NDE3Mjg_b1a17f34-4a51-4f6f-8e22-9b0ce1fcdb5e"
      unitRef="shares">20225000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI4LTEtMS0xLTM1NDAxOA_826d29ed-28f6-4484-a23c-a97e13be29fd"
      unitRef="usd">4213000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI4LTMtMS0xLTM1NDAxOA_0dfb6cbf-9ee5-4c38-9bef-9d8eba600d8a"
      unitRef="usd">1094000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI5LTEtMS0xLTM1NDAxOA_ae498483-cc01-4188-808a-ea12f11f5605"
      unitRef="usd">24057000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzI5LTMtMS0xLTM1NDAxOA_82e7218e-63a8-46bb-963c-af1d2308ebb8"
      unitRef="usd">26795000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzMwLTEtMS0xLTM1NDAxOA_2d0a1240-ac9b-486e-a2d1-1a514ec62aa4"
      unitRef="usd">124000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzMwLTMtMS0xLTM1NDAxOA_e641a641-6835-4cfc-8239-58c49636ec4c"
      unitRef="usd">145000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzMxLTEtMS0xLTM1NDAxOA_625ab23f-4ef9-43f8-b3ab-3cff56e99c31"
      unitRef="usd">24181000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzMxLTMtMS0xLTM1NDAxOA_a9e4fdad-48b3-49a0-9f22-6c1a6451c850"
      unitRef="usd">26940000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzMyLTEtMS0xLTM1NDAxOA_83aaf67f-d96a-4ba0-9147-f71d3f6c20e9"
      unitRef="usd">42812000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTpmYWQxMzc1NjJhYmM0ZDlkOTc0MTJmNTg2ZTNmY2EyOS90YWJsZXJhbmdlOmZhZDEzNzU2MmFiYzRkOWQ5NzQxMmY1ODZlM2ZjYTI5XzMyLTMtMS0xLTM1NDAxOA_094161be-1064-4385-9a07-ef1ff5df5e54"
      unitRef="usd">46264000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <srt:ScheduleOfCondensedIncomeStatementTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90ZXh0cmVnaW9uOjM4ZGM4YjEwODJmMTRkNjA4MGYzZDIwYzEyNWVlY2U3XzIzNTE_a514c37d-c623-40aa-8f8b-8267a7f9ddcd">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Centene Corporation (Parent Company Only)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(In millions, except per share data in dollars)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on divestiture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt extinguishment &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(687)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) before equity in subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings from subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net earnings attributable to Centene Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net earnings per common share attributable to Centene Corporation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfCondensedIncomeStatementTableTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzMtMS0xLTEtMzU0MDE4_c4e0f18f-4f42-4f7e-b082-c88f155b09d6"
      unitRef="usd">21000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzMtMy0xLTEtMzU0MDE4_540c152a-bc8a-4777-b17d-70049e920b52"
      unitRef="usd">9000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzMtNS0xLTEtMzU0MDE4_400df855-a868-4b6b-90e0-701d201efff7"
      unitRef="usd">13000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzQtMS0xLTEtMzU0MDE4_233844f4-618e-4f7b-b533-e5f4eef16262"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzQtMy0xLTEtMzU0MDE4_558dfb41-32f3-4dd4-9e92-55590602ddd8"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzQtNS0xLTEtMzU0MDE4_aa3d60d5-9af2-4929-bea5-e632ca29ec23"
      unitRef="usd">-1000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:LitigationSettlementExpense
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzUtMS0xLTEtMzU0MDE4_76faa319-9398-4acd-900b-3c3bbb4c9f36"
      unitRef="usd">33000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzUtMy0xLTEtMzU0MDE4_d20f9fc5-44a5-4d65-83df-bb9a011b319b"
      unitRef="usd">1116000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzUtNS0xLTEtMzU0MDE4_ac89a3f9-7d5c-4243-8b04-3d56625d1bd5"
      unitRef="usd">0</us-gaap:LitigationSettlementExpense>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzctMS0xLTEtMzU0MDE4_8215b0a7-cd42-466e-a941-73c35f0a7fa7"
      unitRef="usd">55000000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzctMy0xLTEtMzU0MDE4_e5678f12-7f82-4a6f-b04c-d2f88e5ad4d4"
      unitRef="usd">38000000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzctNS0xLTEtMzU0MDE4_295da1c7-9b32-41cc-94d7-209dc4eb1fe3"
      unitRef="usd">5000000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzgtMS0xLTEtMzU0MDE4_e7c8fd16-9869-462f-87ba-b70b18002012"
      unitRef="usd">13000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzgtMy0xLTEtMzU0MDE4_59da2b92-9338-415e-95f6-39d06c4a7d3d"
      unitRef="usd">118000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzgtNS0xLTEtMzU0MDE4_fea4cf40-8f31-4412-8d6e-5907e39636e0"
      unitRef="usd">104000000</us-gaap:GainLossOnSaleOfBusiness>
    <cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzktMS0xLTEtMzU0MDE4_57c62a12-e1e1-4fb4-88d7-c7d45f763379"
      unitRef="usd">14000000</cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion>
    <cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzktMy0xLTEtMzU0MDE4_8334dc8a-5233-4db0-bac8-03b4f1290dc9"
      unitRef="usd">-125000000</cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion>
    <cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzktNS0xLTEtMzU0MDE4_d736078f-4925-4d0e-95bd-c032e215099b"
      unitRef="usd">-61000000</cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion>
    <us-gaap:InterestExpense
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEwLTEtMS0xLTM1NDAxOA_3733cb89-674a-44a3-bdc4-12faf9a037a1"
      unitRef="usd">643000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEwLTMtMS0xLTM1NDAxOA_3b6aa16e-f94c-4b90-97e4-2ef26d2570cc"
      unitRef="usd">641000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEwLTUtMS0xLTM1NDAxOA_462d0a2e-795c-4bf4-acc9-58e985976262"
      unitRef="usd">723000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzExLTEtMS0xLTM1NDAxOA_febe222b-e0c8-4b8a-abfd-3ca742863c61"
      unitRef="usd">-615000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzExLTMtMS0xLTM1NDAxOA_e13c7a48-9c2b-49c4-a45f-5a657b878746"
      unitRef="usd">-1735000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzExLTUtMS0xLTM1NDAxOA_1b9ced90-f90f-40c1-8d6a-447b82ee2ea4"
      unitRef="usd">-687000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEyLTEtMS0xLTM1NDAxOA_11e85a09-7cee-497e-9631-0271bf0407fa"
      unitRef="usd">-208000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEyLTMtMS0xLTM1NDAxOA_274a95ee-8dea-4862-b1f0-f35546da7eb0"
      unitRef="usd">-308000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEyLTUtMS0xLTM1NDAxOA_fb54a069-72b1-43cc-a333-d418d4139ea5"
      unitRef="usd">-331000000</us-gaap:IncomeTaxExpenseBenefit>
    <cnc:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEzLTEtMS0xLTM1NDAxOA_42ed97ae-5a46-45dc-9fc1-24135f69fa0d"
      unitRef="usd">-407000000</cnc:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries>
    <cnc:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEzLTMtMS0xLTM1NDAxOA_46b64e2c-b847-4044-a9a5-1a56ee636647"
      unitRef="usd">-1427000000</cnc:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries>
    <cnc:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzEzLTUtMS0xLTM1NDAxOA_b53f8cef-227b-48c9-b3aa-c56e80bed8e8"
      unitRef="usd">-356000000</cnc:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE0LTEtMS0xLTM1NDAxOA_8313e08d-42af-44f9-8d87-496c73965c4e"
      unitRef="usd">1609000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE0LTMtMS0xLTM1NDAxOA_e90cea97-c70c-44ce-ad3c-660fa00ac869"
      unitRef="usd">2763000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE0LTUtMS0xLTM1NDAxOA_2dfbaaaf-a7f8-432b-876a-26716f75c335"
      unitRef="usd">2150000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE1LTEtMS0xLTM1NDAxOA_b7e1dce3-c864-4688-9ad9-a63fc31d7a00"
      unitRef="usd">1202000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE1LTMtMS0xLTM1NDAxOA_d919c025-45cb-403a-92cb-4f0ae5b98a43"
      unitRef="usd">1336000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE1LTUtMS0xLTM1NDAxOA_7b5875f6-4107-49ea-8377-7aa66c35e25e"
      unitRef="usd">1794000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE2LTEtMS0xLTM1NDAxOA_058cdcc0-742c-446b-b749-ef7845ab5bcc"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE2LTMtMS0xLTM1NDAxOA_0028de76-1637-4cab-975f-334a3ea97287"
      unitRef="usd">-11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE2LTUtMS0xLTM1NDAxOA_a8d6e37c-4b77-4321-939b-c6820e959068"
      unitRef="usd">-14000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE3LTEtMS0xLTM1NDAxOA_63ef2351-a819-4263-944d-c4751192b59b"
      unitRef="usd">1202000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE3LTMtMS0xLTM1NDAxOA_f858fa28-678a-4d21-a1a5-3e4ed9303835"
      unitRef="usd">1347000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzE3LTUtMS0xLTM1NDAxOA_942fa478-7d39-48c9-b540-3ed42b3cca85"
      unitRef="usd">1808000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzIwLTEtMS0xLTM1NDAxOA_842187c0-ddb5-4d63-9ac5-d4faa4ba8301"
      unitRef="usdPerShare">2.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzIwLTMtMS0xLTM1NDAxOA_5504dca2-c389-4a08-9e0d-5b7b4cc362ce"
      unitRef="usdPerShare">2.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzIwLTUtMS0xLTM1NDAxOA_a2479d1c-2db9-4192-8f55-dfb1020210ce"
      unitRef="usdPerShare">3.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzIxLTEtMS0xLTM1NDAxOA_271b4d31-a623-4d21-b55f-6ca2c2a2341a"
      unitRef="usdPerShare">2.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzIxLTMtMS0xLTM1NDAxOA_66cf7384-5f46-45b3-bc63-4e1fe77b7fbe"
      unitRef="usdPerShare">2.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZToyMWI3NGJkMGM0ZmU0MGZiYjI4MDk3MGU3NTg2Mjk4NS90YWJsZXJhbmdlOjIxYjc0YmQwYzRmZTQwZmJiMjgwOTcwZTc1ODYyOTg1XzIxLTUtMS0xLTM1NDAxOA_f9abafd7-bb0f-45f5-87dc-055c09bbf57d"
      unitRef="usdPerShare">3.12</us-gaap:EarningsPerShareDiluted>
    <srt:ScheduleOfCondensedCashFlowStatementTableTextBlock
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90ZXh0cmVnaW9uOjM4ZGM4YjEwODJmMTRkNjA4MGYzZDIwYzEyNWVlY2U3XzIzMzc_13eeeec4-993b-432f-b242-c7f44d7115da">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Centene Corporation (Parent Company Only)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends from subsidiaries, return on investment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for legal settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating activities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash provided by operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flows from investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital contributions to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and maturities of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends from subsidiaries, return of investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intercompany activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investing activities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash (used in) provided by investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flows from financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from common stock issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments and repurchases of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,096)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for debt extinguishment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other financing activities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash (used in) provided by financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase (decrease) in cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,589)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; beginning of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; end of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfCondensedCashFlowStatementTableTextBlock>
    <cnc:DividendsfromSubsidiariesOperatingActivities
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMtMS0xLTEtMzU0MDE4_ebe618b1-2078-4ba0-902c-ed38dc7f8251"
      unitRef="usd">1706000000</cnc:DividendsfromSubsidiariesOperatingActivities>
    <cnc:DividendsfromSubsidiariesOperatingActivities
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMtMy0xLTEtMzU0MDE4_83280e76-643e-4fda-94cb-045d70e3f72b"
      unitRef="usd">2194000000</cnc:DividendsfromSubsidiariesOperatingActivities>
    <cnc:DividendsfromSubsidiariesOperatingActivities
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMtNS0xLTEtMzU0MDE4_7d4100ff-498c-46af-bf5d-e87b400bf230"
      unitRef="usd">739000000</cnc:DividendsfromSubsidiariesOperatingActivities>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzQtMS0xLTEtMzU0MDE4_f1aa7227-c77f-407c-8f8b-233dac1508c6"
      unitRef="usd">282000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzQtMy0xLTEtMzU0MDE4_9b977d59-0cb8-49ca-9352-bcc24bb2e982"
      unitRef="usd">298000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzQtNS0xLTEtMzU0MDE4_b639c3d9-d2cd-4ded-97cc-9d640b30c79f"
      unitRef="usd">0</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzUtMS0xLTEtMzU0MDE4_2d4eb085-094c-43ed-a33e-1c730a908fdc"
      unitRef="usd">-450000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzUtMy0xLTEtMzU0MDE4_7ea68c85-ae3e-4607-b754-f7983d4e191c"
      unitRef="usd">-582000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzUtNS0xLTEtMzU0MDE4_5f97705d-2321-4706-a525-c34cb7cae872"
      unitRef="usd">-287000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzYtMS0xLTEtMzU0MDE4_10b4fcc3-b653-496e-b926-9cdc89d97a1b"
      unitRef="usd">974000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzYtMy0xLTEtMzU0MDE4_fd5b5a0d-5ef4-42f8-9bd6-41f6d6e1bad5"
      unitRef="usd">1314000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzYtNS0xLTEtMzU0MDE4_566eaac0-0561-47c5-a54d-792394c835ba"
      unitRef="usd">452000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <cnc:CapitalContributionsToSubsidiaries
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzgtMS0xLTEtMzU0MDE4_ec8f2344-591e-4a37-82d5-3a9e0e69f8e1"
      unitRef="usd">880000000</cnc:CapitalContributionsToSubsidiaries>
    <cnc:CapitalContributionsToSubsidiaries
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzgtMy0xLTEtMzU0MDE4_0f9a53d9-d1f8-46c8-9115-7ebcbf447e46"
      unitRef="usd">1217000000</cnc:CapitalContributionsToSubsidiaries>
    <cnc:CapitalContributionsToSubsidiaries
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzgtNS0xLTEtMzU0MDE4_dba937ee-37bb-4456-8391-3e3ac200d0c8"
      unitRef="usd">761000000</cnc:CapitalContributionsToSubsidiaries>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzktMS0xLTEtMzU0MDE4_a8894d01-e490-4f5f-908e-49ca2a137c4a"
      unitRef="usd">2000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzktMy0xLTEtMzU0MDE4_00d9e5d2-36f0-4791-b950-0a066880f89c"
      unitRef="usd">723000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzktNS0xLTEtMzU0MDE4_37e1430d-6ac6-47bf-a247-df56d0ca61b3"
      unitRef="usd">111000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEwLTEtMS0xLTM1NDAxOA_af65c466-0539-4e4d-a466-86b73b1c6845"
      unitRef="usd">0</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEwLTMtMS0xLTM1NDAxOA_dd17a15b-e663-4807-8f39-f5f83976538a"
      unitRef="usd">66000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEwLTUtMS0xLTM1NDAxOA_52e2a3bb-1a02-45d4-9a53-5608bd216ad5"
      unitRef="usd">11000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:CashDividendsPaidToParentCompany
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzExLTEtMS0xLTM1NDAxOA_4b156c8c-918e-4b6d-80e5-bd0aec3d3afc"
      unitRef="usd">10000000</us-gaap:CashDividendsPaidToParentCompany>
    <us-gaap:CashDividendsPaidToParentCompany
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzExLTMtMS0xLTM1NDAxOA_26a3c2dd-a780-4b88-99db-8156edfbf46a"
      unitRef="usd">241000000</us-gaap:CashDividendsPaidToParentCompany>
    <us-gaap:CashDividendsPaidToParentCompany
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzExLTUtMS0xLTM1NDAxOA_e1a5aaa8-9401-4d2a-a93c-284848b65553"
      unitRef="usd">87000000</us-gaap:CashDividendsPaidToParentCompany>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEyLTEtMS0xLTM1NDAxOA_d760cf05-1af6-424c-befa-dfdb13a1f1f7"
      unitRef="usd">2431000000</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEyLTMtMS0xLTM1NDAxOA_59cfab72-8745-4951-9ed6-63513af17138"
      unitRef="usd">151000000</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEyLTUtMS0xLTM1NDAxOA_365af0f4-e597-4d16-806d-d82a066ea86f"
      unitRef="usd">7188000000</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEzLTEtMS0xLTM1NDAxOA_6d04d3d7-a850-4103-a813-24dc609f2903"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEzLTMtMS0xLTM1NDAxOA_70f3d456-c1fb-4603-8269-60d34acb2a24"
      unitRef="usd">130000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzEzLTUtMS0xLTM1NDAxOA_6836db80-2fce-4896-bb3b-0ee8cd890426"
      unitRef="usd">533000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <cnc:ProceedsFromPaymentsForIntercompanyActivities
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE0LTEtMS0xLTM1NDAxOA_ea3f13f9-0946-41e3-b59a-f52466ed08e1"
      unitRef="usd">5785000000</cnc:ProceedsFromPaymentsForIntercompanyActivities>
    <cnc:ProceedsFromPaymentsForIntercompanyActivities
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE0LTMtMS0xLTM1NDAxOA_2ec6750a-a6cc-43a7-9cdb-dfd93dc2147b"
      unitRef="usd">-1709000000</cnc:ProceedsFromPaymentsForIntercompanyActivities>
    <cnc:ProceedsFromPaymentsForIntercompanyActivities
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE0LTUtMS0xLTM1NDAxOA_6c555001-489d-408f-b2c7-0c9b7dd2fe43"
      unitRef="usd">1185000000</cnc:ProceedsFromPaymentsForIntercompanyActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE1LTEtMS0xLTM1NDAxOA_5f1b803d-78db-4422-8ece-6d258b4be0bf"
      unitRef="usd">-3000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE1LTMtMS0xLTM1NDAxOA_54603a0a-5729-460c-a7e9-50b5f4bda23b"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE1LTUtMS0xLTM1NDAxOA_deb2d349-ef87-4e7a-a15a-16821ec45e05"
      unitRef="usd">12000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE2LTEtMS0xLTM1NDAxOA_bb20eedc-de80-4296-94c8-b357fa8a9983"
      unitRef="usd">2485000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE2LTMtMS0xLTM1NDAxOA_138049d1-24c6-4e9e-bf5c-392387fcf9b4"
      unitRef="usd">-3363000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE2LTUtMS0xLTM1NDAxOA_8c39e3d2-8de3-4c0d-a914-14050097e156"
      unitRef="usd">-6256000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE4LTEtMS0xLTM1NDAxOA_ab13e2ee-da1a-4d84-88f5-1c6f1efc133b"
      unitRef="usd">70000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE4LTMtMS0xLTM1NDAxOA_7962772e-00c2-4c3d-ae40-db2f32414e5c"
      unitRef="usd">35000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE4LTUtMS0xLTM1NDAxOA_11e07253-c9c0-4072-bd73-f26369314dd0"
      unitRef="usd">28000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE5LTEtMS0xLTM1NDAxOA_44de5993-6f44-4d9d-a8fa-7dbcb39555ee"
      unitRef="usd">75000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE5LTMtMS0xLTM1NDAxOA_b13538c6-66b8-4323-bd6b-d74f9adbeb5d"
      unitRef="usd">9066000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzE5LTUtMS0xLTM1NDAxOA_e851e791-c307-4506-bd5e-411f5a06f2b3"
      unitRef="usd">4870000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIwLTEtMS0xLTM1NDAxOA_f3222756-021f-4269-883e-4d72baa6a744"
      unitRef="usd">491000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIwLTMtMS0xLTM1NDAxOA_8087aa12-35f4-480e-8be9-7fca69bd2a91"
      unitRef="usd">7207000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIwLTUtMS0xLTM1NDAxOA_3e5ce4d8-4cf8-4dfc-acbc-9e4e845dd0e9"
      unitRef="usd">3875000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIxLTEtMS0xLTM1NDAxOA_387a9068-f1c5-44f5-b2bb-3272c87847ca"
      unitRef="usd">3096000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIxLTMtMS0xLTM1NDAxOA_1ac3a2c6-a6e4-4e24-bed0-c1709598ae4e"
      unitRef="usd">297000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIxLTUtMS0xLTM1NDAxOA_658ced1f-32b8-4b33-ba30-d63e373d23b8"
      unitRef="usd">626000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIzLTEtMS0xLTM1NDAxOA_f5f39ab5-efaa-425a-96d9-646dbc6f2110"
      unitRef="usd">14000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIzLTMtMS0xLTM1NDAxOA_d95bb1e2-9eb4-4e01-8644-b0ca6475d536"
      unitRef="usd">157000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzIzLTUtMS0xLTM1NDAxOA_7cc340a2-9472-4b69-958e-3210329a8e20"
      unitRef="usd">81000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI0LTEtMS0xLTM1NDAxOA_5a4d543b-a234-457c-9e2f-af624c66ac38"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI0LTMtMS0xLTM1NDAxOA_0a870ba4-0a6a-4f6b-b886-1b4fe6d2d249"
      unitRef="usd">72000000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI0LTUtMS0xLTM1NDAxOA_cda662d5-9ee9-4bf5-b10b-7f476e410345"
      unitRef="usd">120000000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI2LTEtMS0xLTM1NDAxOA_d0a72f51-bcd6-46f2-ae8f-9b4b81889c88"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI2LTMtMS0xLTM1NDAxOA_89df214a-7748-472d-8142-d6791e2943da"
      unitRef="usd">22000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI2LTUtMS0xLTM1NDAxOA_00340182-1bbe-4799-a89a-38634f2c5b48"
      unitRef="usd">19000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI3LTEtMS0xLTM1NDAxOA_095b95d1-1816-4152-a95c-319d534480d0"
      unitRef="usd">-3456000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI3LTMtMS0xLTM1NDAxOA_6d512e99-b487-4b45-8431-f7300420a1c8"
      unitRef="usd">1390000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI3LTUtMS0xLTM1NDAxOA_02b91e74-fe55-472c-930e-a0a577b7c61c"
      unitRef="usd">215000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI5LTEtMS0xLTM1NDAxOA_aa54e01a-6c85-4df9-9f3c-28bd10999b89"
      unitRef="usd">3000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i5fdcf6fdaf2c4222a0be81a153559154_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI5LTMtMS0xLTM1NDAxOA_94e6c74c-9ebb-4870-a9ba-968956acac87"
      unitRef="usd">-659000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i7d88210ce78545d0b26ea0acb51858e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzI5LTUtMS0xLTM1NDAxOA_81b777f7-f395-4463-8750-6d5ae50ac29d"
      unitRef="usd">-5589000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMwLTEtMS0xLTM1NDAxOA_877c6cf3-c071-4c04-af8e-f2f3b1040ab0"
      unitRef="usd">9000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4f75ea8b064c4d4a8f2d206bf5351a9c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMwLTMtMS0xLTM1NDAxOA_42cf9bfe-9cb6-4ef9-9eff-aae41b024b8e"
      unitRef="usd">668000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i41f276fba4a64c09ba22940633f73652_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMwLTUtMS0xLTM1NDAxOA_429b34b5-6c9b-4235-8739-7148f1b6a17e"
      unitRef="usd">6257000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0152a1872d414c68a590ec9403c7ff34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMxLTEtMS0xLTM1NDAxOA_24a52da7-5446-4f1a-b83e-17b3e8fcbe0c"
      unitRef="usd">12000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0033f462240348c2a7b3d5fe00b22f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMxLTMtMS0xLTM1NDAxOA_d37625f8-8ac9-4e04-975c-b46c0088605a"
      unitRef="usd">9000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4f75ea8b064c4d4a8f2d206bf5351a9c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8xNjkvZnJhZzozOGRjOGIxMDgyZjE0ZDYwODBmM2QyMGMxMjVlZWNlNy90YWJsZTo5ZDRhZDlkYmY0OWQ0MTA0ODg4OTVhMjFiMTNiY2NmNC90YWJsZXJhbmdlOjlkNGFkOWRiZjQ5ZDQxMDQ4ODg5NWEyMWIxM2JjY2Y0XzMxLTUtMS0xLTM1NDAxOA_52d81a78-c4de-4f36-9fb4-c51352b03ea2"
      unitRef="usd">668000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <dei:AuditorName
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8yMDUvZnJhZzphMzY3YTg1MDU0NWE0ZTExYWU0NThkNjJiNDE5OGE3ZC90ZXh0cmVnaW9uOmEzNjdhODUwNTQ1YTRlMTFhZTQ1OGQ2MmI0MTk4YTdkXzQ3NQ_d48a3930-781b-4977-ad87-6e5c377d6849">KPMG LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8yMDUvZnJhZzphMzY3YTg1MDU0NWE0ZTExYWU0NThkNjJiNDE5OGE3ZC90ZXh0cmVnaW9uOmEzNjdhODUwNTQ1YTRlMTFhZTQ1OGQ2MmI0MTk4YTdkXzQ3Ng_b04ad614-1848-4cb1-a89b-2e03929d92ac">St. Louis, MO</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlkZWU1NzBjZmJkMDQzZDZhMTcwMDI5OGMxNGIyNDQ2L3NlYzo5ZGVlNTcwY2ZiZDA0M2Q2YTE3MDAyOThjMTRiMjQ0Nl8yMDUvZnJhZzphMzY3YTg1MDU0NWE0ZTExYWU0NThkNjJiNDE5OGE3ZC90ZXh0cmVnaW9uOmEzNjdhODUwNTQ1YTRlMTFhZTQ1OGQ2MmI0MTk4YTdkXzE1Ng_19b45f8e-86a1-40b1-bd37-f46081cea788">185</dei:AuditorFirmId>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>131
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M\UDDLO_H>7ULJU5#?BHDBS?!< 5QF*P_R<L&Q%[ N7,@ &\"\)L ]] 9O$V
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M^D8\_L&W 4767RXJU?U%CUO;8(+R5FE1;P<;!'79;/ZS[]M$' S X<@ LAU
M3AU MP-H%^@&61?6%=-L?B[%(Y+6VGBS%UUNNM$FFK*QTWBKI7E:FG%ZOOC\
MZ?;SA_=7EU_>7:&WEQ\N/RW>H=L_WKW[<HO.T-?;*_3RQ:_H!2H;]+&L*I-Y
M=3[3YL5V^"S?ON3MYB5DY"57/'^%*)XB$A "#%^</AP?#Y^9</<QDWW,I/-'
MQV)NI>2-1DPIKM5K*)Z-@Q!V8$OKM5JQG%],3.TH+M=\,O_Y)QP';Z#H?I"S
MHUCI/E;J\SY?,+5$K"E0;B_XWVVY9I4)'IS%C:ND<V7K?SW')$C"\]GZ,!S
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MK=S06"_C1'+UE*H\Z0X?[B</=[?7@^GH&ET-[@;WPQ&:W(Q&TPGZ,B8<8AF
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M41\GGI=7>4.R)*M0GIA4]4YV&ZB2%+@.4,]GC,E50Q<]99'K_@502P,$%
M  @ HX-55B*K]?J !P  A28  !@   !X;"]W;W)K<VAE971S+W-H965T-2YX
M;6RM6FU3VS@0_BN:7.>FG6F))3E^X8 9B.F4F5*8AEX_FT1)/+6MG*4 =[_^
MY!?L6%H+F)H/)':>7>O9U6H?V3YYY,4OL65,HJ<LS<7I9"OE[G@Z%<LMRV)Q
MQ'<L5[^L>9'%4AT6FZG8%2Q>5499.B6.XTVS.,DG9R?5N=OB[(3O99KD[+9
M8I]E<?'O!4OYX^D$3YY/?$\V6UF>F)Z=[.(-6S#Y8W=;J*-IZV659"P7"<]1
MP=:GDW-\'-&P-*@0?R?L41Q\1R65>\Y_E0=7J].)4XZ(I6PI2Q>Q^GA@<Y:F
MI2<UCG\:IY/VFJ7AX?=G[Y\K\HK,?2S8G*<_DY7<GDZ""5JQ=;Q/Y7?^^(4U
MA&:EOR5/1?4?/3989X*6>R%YUABK$61)7G_&3TT@#@RP-V! &@.B&[@#!K0Q
MH*\U<!L#MXI,3:6*0Q3+^.RDX(^H*-'*6_FE"F9EK>@G>9GWA2S4KXFRDV?S
MFV^+FZ]7T?G=9806=^KC^O+;W0+=?$8WMY??S^^N% !]0C\6$7K_[@,2V[A@
M B4YNMORO8CSE?B(WI7'UTF:JDR*DZE4XRJ]3Y?-&"[J,9"!,6""KGDNMP)=
MYBNVZCN8*D(M*_+,ZH)8/49L>80H_HB(0P@PH/GKS3%@'KW>W+&PH6V.:.6/
M#OC[SAY8OF?B& IM;>K"IN6J<2QV\9*=3M2R(%CQP"9G?_Z!/><O*"QC.HM&
M<M8+F=N&S+5Y;T,&1:RV]"O+<EE\.,-TYOKAR?3A,!8 #/MA0/NP"( Y-'"<
M%M8;_ZP=_\PZ_MN"9<D^0S)^0JK&T);%J=RJ,A/[@A5HS1C$K/;I'8PE=+Q
MXV6"_##4R$< B.(9S,EK.7E63G=<QJGJ%<.9\8RK8M=5J=$8 # R"P.B<0!@
MY=\ "[]EX5N+\?))M5PQ4(S^F,4XIK-H)&>]D 5MR )KXJ_9*EFJU"^YD&#>
M RA3,Z)7I D+ \_1TVZB H]X+ISUL*406BG,U= 17Z,R-,D2GKVA63,.U48W
M-T%N$+H:!1-$J4-A!MCI.KUCY;!0XBK)-Q_1AN6L4/DH%Y9XI41%(F01E_H+
ML69V@TW< =(T"_0L ;#0<[!&$4*I97. XX&:P5:.$5/S=YG$E:9LR(!<L'%Y
M#[LZ$Q,T\V8Z$1/D!OX #]+Q(%8>YQDO9/)?S4/-NWCYSSXIV$IU !GGF^0^
M92@6@L'UU#COU0#65U$ Y/N.S@X X7" 7:=GL+7W][J;+4D4F"/4T7F8J( $
MOD[$1'GTH#K[3#J9@>TZXXO1EZV$7&,0!IL7(1$ P:[O#5#I% >V2XZK;!<G
MA=K227#HIB(@%.O: D+IRW@$@/RA1'3: MO%Q5>V42N:*@B9LD$.IB(PP@]J
M"R,#-D=] IVLP-86W*@CM9\O5^)\8U^)?6 &4"/2<PA'7!P&.A\ YP0.'6HY
M7>/']LY_&1>Y(B/0NN#9,[FA/2*@ H 9!J#\0&^@ (HZP= DZT0 #JW:[T9N
M59$G^9)G#+UO,O0!5(+8JB?>*@5']1:-Y:V_->]T"+'KD*O\@0E9%FFE0/A!
M4*%($D!V$&.W!J "K*\\ ,@=TARDTQSD)<UQ+U6YEE6[3\1V:/4AIE P>AF
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M,@N'[C*&T@(H+832&)06F6NJJYW6N:9FYWHN9N=EE52;@M?S\3["4?W1H?S
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MG4#\_S[/JQ]OZF^'VG\%VM7_ 5!+ P04    " "C@U569F>RV3$#  "1#
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MX5D#G"TD2](.[Y%)[!?3J8_?#,"5 3Z?,B9?%^H%Q5=([P]02P,$%     @
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MF[PGWYN\DL3\ ).3G9QY<JR=21U U[E*93$-'+%9R HL_*-)E\1>%?HFV/%
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M *$/=K(G\@P&KO[6.B$K51LB6$DVCA;V-*]?URKX/X5 CTMW]7H#V!B2.RP
M8CS-81\_+45^B =ID7#MW[%AI^-)O]=9N#!A<0%LRD]R=8=I>GJK(=2VVRV9
MW*I5]RLM<5^Z3&:;9DS@"?Y/<F?C[62B.B9HN'(L8!%BB!$;7&_HT&Y4MUMO
MDP0AO7+U?K"$!,.?W+ YP_<P/M(X7ID..5^<\MJ#1T['U\AE,*$)(LEC09&)
M$A,\GRB%]GQ3LAQIEWTBC8R0HBA:DCA9UR'.L"C>M=U#BVLXR]Z5[Z3FN,;<
M3G34"G5N?%0KV@K7%9';WC1<Q&L258N._BCQS(M??GOU\N+J;S,AP;BL80S&
MH2,4D'%;C8U+*H"S!2$F+BK)$W*1P4"^+YF_1.MZCAE)?N:G^:M/DI=\G4JO
MP8TP-DUK"D\1VD))J]A>:W8DV 'B\F#DF>264W85*Z<TGY%:>J]BZ6 ,^C1G
M?J-^DUU+B,;!!QZ;%%=RTL+/5.($WEI8'4R\5I"0="8; A(U:\B#-<^1B7Z;
M@'..R,QSD1++9\<%EM-K'0)U-/OL-D)Z%]UN_'$)?8*6S&7Y!+U(8J33? >;
MUS,7=J,AF,HZ#9AK)=M^W]0J^X)L5'F)Z*W>7E#LB!?/QM7-R9MZ=I;,EK@D
MFQ]?%,KL@267&M57I>-'>OWC*)A&2>[15,/T-2=\Z,20;[(+'2H/U><)YOR1
M'3X/!ZCER*B407()B2N#*N*H5<UU!-JCP7-8[J-065@Z3<PS9:',\9"5^ S=
M1J(L?/!,O9HY"79&=%=]@$WO9VI0VH]K@72(9M6'IE*QZQ=J;$AP1.Y"<J%S
M*;AE+*%.Q@J%Y0Z(J%+1(!-,<0HE9AI*@7O<:\$Y;*%6)+#2;=QW>E\1VE9"
MRZPJ^*.8X"B_"S>8^HYV8;04++(88KZ5RBOZ/UZ/R^6RFOS[IFSMKA_7 >NE
MX)B($M8QY$NE6)K,DUK!*'.(541VN'R1Q:E)Q)=A;1VOG:"_12^>E+AYFJ"6
M/\ASNK,"AK,7K^_.)2Q+$X7!JJ,M)*\K\X*VF-YJ@#>$ EZB[!1>EI F'?@.
M.#\63EX5AY<;]*\Y6$ /KEQ*!6B'<(Q<R<5*&PXW10=MYU3,4 =".:ZY4B#
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M0$O$J<I]@")Z!A!,+@#UCA1S&V20$F)@$3$<](:5L31GTY(;JTLT3DL,F2H
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MQ-4ABR.9)[-(1"."]"W+0[T!8 HPML_^(AI$@+Z/K0/$[%1$IS4"'=;FB(L
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M(4H;\'YAC*\_$(/F)R/G_P%02P,$%     @ HX-55II(1BC7"P  [2   !D
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M-?BU#?9J[A$DH(G-<FSGB;Z (H]L"C(K[0EP5%1(TEA#0UK95D..NMN$A4?
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M,.<)RDI:H]MTL":7@= ;: BC]70-D#Y=4PK0>4HYL-U*?FG3(XEXSM0*P1O
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M+<#SE3&^O:$#NE^W+OX-4$L#!!0    ( *.#55:AC2#SW@(  ',&   9
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M-3D]ZT94*F'$U8K351@K*^UH2 6QI!I"XPWH?*VUNU=\@.8_,_D-4$L#!!0
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M6_Y(.5X9>@"_KS($F?^#-JC^Z>;=_P)02P,$%     @ HX-55@+*/!##!@
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MQ9W0+3-<PH6F#?B^5,JV#V2@N]:?_0M02P,$%     @ HX-55F>%=-8Z P
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M7.CPUL,6ZAY9[<)[[;P39B4\UJ],@335Y5J<GV$](JXHD#SNXJ7XMY(VN%G
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MQ##*<6"Q5+!GD?-F)Z&A9$!]DJFCGIQP&9RO4;MS(5GMGH"-5 ]$Z@QNK.&
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M![U7AQWAJIM6]1)L$6\W,QMP5XJ/ (@\>0%^GUL;-B\<H+GN3O\#4$L#!!0
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M'G:8"=^5X<;ITG_+S;1#:OSETK\7T08\GVN<>_4-.6@_[L_^!U!+ P04
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M6R<U ^(:_H$E#0!?Y[]CC6-;MFVWI? !!ONJD++!?5$S=%ZI %SR(%$[2H!
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M\65/T27B.FP"J[K$*>4<G"%&N,=TG28,4@T@I-PX,O9W9"@PC"((1+%K#CP
MZE*YAQ'(1/X9;4C#0U/^B_Y8=>VP-8\0D4/<L.R)@=(B@"D$;TZ2!T\>IR5@
M22<2)EWL!#,'&1B"!T@\5:,).03H YG3T,GDHWV F;F@R2@^1E$9U61L@2O$
MG(%<N=<<;.BZRG@@YFH)6X^Y>X$6$+ ,[']P8529(AIF:4=?ROB-VRQ<AP(V
MD]00EMZHM8S_F2@:X0:5N\;UU!<=>PFM9K _EV=@;PE?235GO.(9]3=$*53W
M$(RU)HRD1RN$$,D[.4B!G?;#@BB?JIKL;U,H ^_+X^C1N;G,B 66=RM$;2BY
M@!PD+RQ)$:P[I=EAFB?6T><3*JG&;*R;;+IL5E#!" EBA*,9-AQU/);M"?+T
M(?T&6[!@^P]6MUJM.&H@H=44 FQO78;:FLWD+DF1R^+8<FHC*>O[/8T@M(WV
MG"L0C#XOA91FE^TPVP[0B3Q1)M-P^TM@7O(B,@#I25HEEBTVN6'/C>)&2DMP
M$3#E95Z V=MVSIYA 85E$N0N]NE.Q+R!/*XY,\UI-3"=>UEUOH^E&6H0ZKD#
M5(U#AJ72VHT'-<:.*VR[@8>$1T06C .AJ QTB%\Y);':6;:2^X@EA'WE2EMJ
M!@"D\!]2_RJJMO-)!L9F:XN2,&.Q.5IEHN_]J# 3C0TEW/-]")8L8P1I22S-
M!>[ELA;))S>%Z@?8![D0P25YW^H/SI"'1-B8)U]D-,<H/ CK7E<.XU&863K'
M. %"E4:U QKD2.)#/Q8-)B=-G/1]1OLRQ$;:EC,BE@D93Q90-*'T$,VBE 0H
MDKB%X ^ @-+5LG<:.&^D#!GRB5K< B:*0P'S>P]*2XF561A9=6&FCV'959Z)
M:61-CR<S\*)&K,H6%;.4&W#SU;;>R[O%%D#,L]QI1D_SM#(X[*4=6?HU=5_C
M.)/-FKP;F0XEWBV"V(G]'R^(.A\FU$#2J)\V;TE%YJAY4Y,V-F?[HZ*&!@##
M4M_VH;\MLY/:T1J>' OF540\L):FW6 !$K<]N"'XM)1^YWC<(94T2EKO=:Y9
M$.4=VMU"O!9!/7ALRF1B:9BE3\*%HX%A/)9S?O0<S?-W4E2XXJ+"6RTJ3(:$
MGS>4>7>@<)'DM/B;4$M!((K&=X?I85N5U-V/"?H&2^RSI!642BK\=DB%Z=LZ
M'+W]YL7/-ZRN^<M<AD14E+NSKJ5VXJ'!^74*B2BDKY,<.N]&KGMQ!M2*0W4;
MA5M8_J3#+UKW(+/%77&;3=O4.Y8?4(TU'2S@[C$"/?*R).:PP<!<AO%N\8B"
M[4HY@H1R63BMVNY/J\G<X/JU[6$- 7C;T1K0SA#;MG;'36JV1YN,1S'0YO>=
MH^8[8%\Y0&2ZJ3Y",$!M%)9K5:.<!Z^HH'2IY!A3HPHFVMW9:(+GGUI> B04
M!89 \.!&Q/W"CMX2WB/4@8=^[JA 6%<KZ4J%, 0^0?<BW9VVA$>XYUULP-R\
M._8UIX:K?I 10;&CQ9-:N(I;Y[)@$*A;0Z@?F]8<L^F^\FFH%&P\;6 NNM@R
M3;(K3V,^@SUC)(D!B;XGJ3=T3QM>$P0J/?6:2].-]GWUD:RD.@<3>QC74^,Y
M?O<0 =UO%*X8::$:HR,)$Z P'M:P3^^6,#^DIZ0EN?(?"&?*\P WJBQ/EZ@X
M$S;6)WR0.Q;WSE"$3OK?AW*E6<D(LB4:3!OJ%RYS(>JH$WI".!8(DT@V&:B*
M!1MJPPI<1#-$C V9 '3I[2!9 ,O=7,%(%Z[:]EH)(/IC.ZEYA)\C%HKB+;4@
M?>3Q[% 2(20(8/MJBN]$)D D]PU%9DK4\#S0"FWI*)L=8)5=8HU4D*(I6H Y
M658A[3$S'YKVOL$#8(O.V0_<5%SAV(Y]5(%-8[15!2P%.8)9A+JF+EVUJ%6S
M!!5M_K3XSM4OO[UY>7K^SXD,99Q6.898U0$+ &N70^V2%M]L0C03IR77#:GI
MH(=0'- XR+KL8R:27_AQX>A!]A)AEB5BJV9 [*M>DW4*V!;Z0QD*+BFNH7B,
M>FVQP$/==MC7&HZWC23-9Z*6GN)8.,2F/JVA7TH8IX<@(C@X\MJH4Y&J!7ZB
M3RCHUDS[8N(AAD2D,]L0F"CE.GI8"@R9Z=<!J-B'E7IJH2+[[*A;<7R(A*F.
M*%3//J2'A:4YE'OD$[9D$=0#_"*8D58*4H3V)TY4!ER:V3K)WSLZ"PP10UV)
M[0NV4>PE)I/EK(1PAY,*!*XN,_&8VDM22SS%F&]?-,H4$&*C3(<9RGHGH3-L
M/Y;;/\V"<=+F#B\P4']-%238,2STZ/$1L8<2@H7H8B\LF*8#I64/5/)#?.2)
M.H5*T*BBHKX"Z8[WE"7\)%6:)4\+]219>#9_E[7\].V*DSZT\22]4L@)."-&
MSS[0YAD>2([<#TNFM(^PZMA08G;]3, &YVH(XUKJ&K;,6^(2]LUHURT?\F!7
MRAYDQ"FJZ,3"AV6ZAZUT;R,6:M@"B]S&=:>G(]';<J:;7 7]R1 <V_'">:FN
MA56H+ 5$%C+>QT*X>%?!^?%;!FZXF\O<Q -]D]';7QYEY"$D^-C6MM$SCM3>
M2^_YI$+'2JQBP#ULFK>('9S1^H'2LA5S^22S0X-P5$6X(9YPP:L0.H[I.."4
M&C7_ V*X6^UA>'3U[O8QYZMAH/"PH 6M5<C,-*%.)H<5,"[#BQ% QU)ZR5:K
MG4(YY]>"#(H+\WS8^AUE4>#%PJ7RB"?G]YE+5,B-#6[,#EC.H62J/(AN>DG-
M H$6Q,5"'D'D!E<Q=!XSEDB[]!$K67DF1T<)].V?$4QW%R_!X!B*[9W@G-A5
M(O.%/<V:=+D+'VR?6F-R]&_V#WGFV17,L<5M)-PX+'[''A?J"4Z; CBXG*EW
MICPV)YDQ#/ %>DYL\L=_Q==FV5%EL F#*'FR%("U<_.C;L<LQA:'!N4$L1ZO
MC.TO='"QPZWFM-&?U,(W+#:5]WI<4M"7B^F*)CIW;G;G 'X_W BTYSQ,P7F[
M[)T<D*1LMB;+0D(7IE]U=O-%OOCIO$B.K1*.D*"-6,)L'K;"Z <OD]C34PM6
M4XX#Z?@E_)O96LK;/LHU0=6$'FZAJT#5;U'X4KW%M#/5:B)02<Q7R#2'QO(!
MP!#YM23>4,TH0Z1 ;5@-M<4[+(IWE=N#[I$*<E5B7K%"K2F0BH1>3S2BEP/O
MN $%%O.E[I8O\3"/?GIQ\Y@SO>,QZ+8+<KRG>GRR:I*S][J\&M$E6\30L);6
MZ=,>M,2<BMU'4MC/( 6C<SV= XC0!!LD@AA4A"&,')Q2E:8R8W)2=X'W9260
MJ@P$'Y97O8-D*;WA(N][QA'('(H0_(HHA=!=KS\19/L+0:N)+1L\>Q#7!P:F
MU4Z<DTM:NZ1GT^!YEHZ91(8_E4:Z>(/:]N*A"Z%.,%0<_W21=9B,ZJ&A1!=6
M'9:9V%@(]["'%<^M2^(0.Z4S(,AHR>47 MVH\F5G=&++;3 NK-;@5RH!6#1)
M4*'4=GHQGEIIKGQ4Z(EP=.I5.1'68\VC3UE+#X!VNI"N24@,A1G,T"6D)LW"
MG.8+V3NE1.]HDFL"QB]LL$<G#R<I!CH0I^!&T'E^E.4VOTT!4]_WGPJLWY!K
M HSMJ7&'PH;Q:T56?1<)MA\R*4S6D9?]T2;'>O],]#JE=&SW G*[+#%';%=N
M!.S)'!(ZPOTK'7:I^MR@DX/AX# <8\ H&W<RF&\J 2!JJ'/ %^-)_%:^\1BM
MTQ8GARM*MT%C0?F7D,JFU0!AT^0 6I1<!J<X&1K=T^:IM^/,_$[:'O9:GW9[
M&62Z3TERR*-8\U?*E=+IQ#V"8H0^(XI#I3#)E@9]&L%=*7.4E5TU+2H7UQ 0
MN,):ME5/$3U$J!5AJO!9._3AP^UZY\%J6,KS63GA!X$A][;&WC$,)XNNVG*'
M>3=(?\G(K&O(D*04-?.&SK3&*PUG%+A7M1R28;1 ;\4R$<77X?Z/T0(%54AW
MCA"VH*YO6]+1Y4.^9LS] $9&.&@TX?\IVGE-AT3P^ABJQX+S/)7"\#[+-64J
M(LL20]*,@HR@G0IRH$RSF&G$1Q$YBO$3&=KKE.%@1K7JVG:]>9E>]B$QTB[$
M6B%"2@YUA3 CAD5AWA@6,3P=@?QHID/S.XN.Y!JF6>%CUR?:#6H"HIY'<)$U
M;Y-4$185)M NX[$4H*DAE(Y=5HW>4+!_?8R4)$=3X!4;= E!*!S$%D)N6@2;
MN;+;V.H@_.-CZ9IYB<E7SWY'C_>K).51 ]O&C&\'K@9(=R[L&!]>2^M@,7$U
M=@%TR "T>!<A]'[PS%6@*93,EQ'PK1P!SV6UAK9;V48J!%EE,@&MXV>B/0K9
M"JP9I!<N3J <;>=;"V_BT6L]>A'M5,D]L;$D3M *\,96JMV6H#S'S'SF+T@@
M[7M(UU)22F8XV)>FX"X)8T;W!08B!_$BSKR_>7-U>?/*K'"^!K?VU&_Q<"1.
MSJ<T\2896-3M0#Z7#C!1U4/K\B_;E[#'.I#L#UNIO+>:45M88KM-VOAGD:5+
M1R5>LENL]W0X7GM!">>\3T@/99B0Z=<FGWVH+% VO2<A&#?^9I;5+>/= T,C
M769X.0M?:LE;IMJ&"5H^WHY'<C9R0)HMN 0764=HDN66.%6 K&MP,2%PLA^1
M*#UG%YOBQNVZ6_CJ5"\=B$DL\91\/G$TJ!@%[_B#',J3W9V^]&+18OM54(VL
MRR9>1)G?A)@;G]@;D5UP2F<EDZI%$J=037H)VUF2'R>1O(2O'EU>73Z6]M6L
M\P);))R#*/G-Z\?[UWZ>,T7P)5_"Z5!,N/[1N2T,PTW&552K>YO?*I?PDE@P
M,?<HJIR^&=3G5X.R9(9@DK.=R;%CE0<VC&-IT#5I?_BD4(2;:*:6HS0GZ56^
MP$1O.>VF5JK?_J65'LNKQQLESX]?*3DA$Y-Y];\\"MD8$*XL_\ Y,+KZ.ZU;
M>*X>Z,&DD'*(/D93.0KGZ0X6R>.\>WOS6)KL?4^Y&RX4A@3%HZO;&_]X[%63
MZ^:V>EFSVN1(0D=-I7R,Q7]K;G !EQ&VON? E(5_#]2J,4]9(%$W<D:O:/1\
MFQ<[4KV_D",=L$U:Y/(;C,RXS3[J/\,0<O:<[K$">&*ZT;/^8TB5/&T7+8;W
M$T^'7OM" ,2Q?%$\O&^X88K^C [R$$L"<*)#'0%P)DG2<4U15':/X/&%9CM-
MC]H#Q/$]D/EQN;U</Z=V:K*>:[[6ZK1O3^EN/6Y_#$TIDXE<65EVC>08>G"C
M0,J !Z8IWHDV:,_A6]2&&]*&?:\QUL&8%P7%"1+/M_F:-T&PDLH-TWUH)\L0
M]+%(@<WO[0?";7RC='Y+:G9F,?=J40S$'^5M!:B+^?&7="&,%,*1B$]O+V4=
M1Z/@ 678L%NQ(3?1AJ@UXQ/$G@_L=R(G\)2;+BI\D1LEY#9F]<'L1'<;XB<J
MU@6E%SU]+<#]&H$?A !O*85K'KV^?NL?ASCC_.SL[\2"BV?PQ_VZY:1(@T>8
MM>CKJYJP8T75.G*,W\6KQ?<)?0.D@+EX<EE;_\&:GPD$J_4P,'^R&T]U_K\^
M7GYA#@Y+4'8R(D#K";/Q2"JS4O*D-'Q(#:/U )?*_3N\59S:Q+T:N8HP.G8I
M,,M<&M&3.-V15H G"7&BV*5@%]%><HDQBPJ3$D:XIU'N!DCRN*/.1?P[>H(D
M'<?M)87>G-J87XJ^Q4C^XNS\:U;X]]VPV8(AB+$+G?Z2>[WQNOMBH'A&F$7G
M!S:H:QR*%]S;%> .7L$/#I3JE\Q*!DN+'!.>?Q/5+#0>'S,K#%?Q0)@VXG'2
M4$;LUR,9FLYZ<,C#.A*CL*/@*-YA?7[\]NGKY*X:/B]Z$^^JH4]_U=MF)-*=
MQ$[_VY.D;VB;8+!L$K"(THO8CM'J^)*<_U>ED>Q2M[WU)5=FA53G 2P^><70
M/GJ7VP:SBP&#!B=MX=QP*?TY>O_2%TF#:ZM"2SN0-,3TTHRN-[!>^HS^B4Z&
M(.-)SP';EM!R<"!E0O%V6 <ZX]U6KE>EBZ>2TX:5GIVIO!RBI>,C660:MII_
M\B#Y$0L!09KC2G[[0V\G#\=^0B,RWR(X<1'R'$^!RU53 ;,QBE3ESJL>=-]D
M)7</Q$/S2=F/NO^6W&# G;9^%NZ+2I,>Z(WOLJP.(I2]Z]MF>H6"D!F+W7Q1
M#5E32?_JUB#C])9@C,?YMI"DQUG&/FJNXB7(Y\>O+DY_?.=*CLA/7WOP&>-,
M)ZE)+L-OL"REZ?% 2A(Y,RPF4Y2A?VDC.3,M6% 8-D_(X NE2,I7*\0.E. D
MN!BO"E *^"P5#'<.\ 3WD\]'\>/AJ7 -4%)B7YJ? 8?_J^T^S)(I05Y17#
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M%5Z@$,X1P?C6^@RZD,YP^WGC_://G7)9,(,72GSAF2U.@TD &>:L%O96K?_
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MH_2]63-FR;=,2'/66UN;SP8#DZQ91LV)RIF$*TNE,VIAJ%<#DVM&4[<H$X/
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M0,67K*O-G7S\F??^. -+66OWA$>_-\7-9:>-;'IAM* 1K7^S;WT<=@3R\(
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M^PCAFM4V4P'\PMH.VP80. $2!S2.[( &<93C( OB+(+W7.MS[!5B3+#BI7S
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M&38BY2^F_L/(C;L,+J3!JZ4;KO$NSY7=@.M+*<WP816,_PYF_P)02P,$%
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MO^EU'5#-V&D<(\NZU9?2T."HS8PF-2H;0.<K*<W!L0G:V3_Y"U!+ P04
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M GB^TMKM_["![B/.Y?\ 4$L#!!0    ( *.#559!AP*^(@,  - &   9
M>&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;(U5VV[;, S]%<(;M@;(?$^<=4F
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MOQQ4UH&^;Z4TQXTEZ']B\]]02P,$%     @ HX-55MXG9QMZ P  [@<  !D
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M(*.R!K2_E70H_<0&.#[QRY]02P,$%     @ HX-55EWE#NM; P  <0D  !D
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MOI7V3NW^A#Z?S.&52AK_);O.EA4!*;?&JKIW1@:U:+J6/_1U.'#(XU<<6._
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MD2PPH"@!-X04N'U]*$.N\:.DJ+A%CZ_*<ME_-=Q#LT7SE58U@0<+NL'I[B"
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M%AI/WEUCI,(>!</(UL]N+HW=!'^L[:\'E NP]WLIS=%P"<:?6?874$L#!!0
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M/X)UVM6N-%H+PVX/>Z9@^X\%&VSY7<6M*V&G8;RB8-UYGZ'7UI6PVY:^29(
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M)2TJ _']BC'^?%$==3_^:\/B7U!+ P04    " "C@U56!S@5_;X&  !M+0
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M@]@F*;T<J>P5E._I:/'G'S *_C+%YTFL$RUNH\4N]<57JGKWVR8I 43@6@V
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M0& TA*L:SOWQ;+"R.WBT9G:2;W&]*[,TVR;Y"Y75+7/VPOEWX!AI'"/L8:?
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MXI3AL43_@W-6K"4)+F]ZV5DQD"1^86T]824<7-[T,!7A2(@*AU=]7=A[H*O
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M=O\HRVTTNJQF%/4$T.<5A$ OBL=7?=C')^J?]E5J.T!>6.2!O2I>X6 V=T;
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M-([5JHBY+14I#6V')8&[(P%TAL ]"6^ "Z\ <A RI*]^/QVVTVTE1:4'JO1
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MQ"2&JDW "\0++[FV%DX<;'<=WYZSDX6DR\(JA3>M[?A^]OTOY_AF.R%_J@V
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MLJR\W6.48JX!ZO\M8_+E00_0G&$M_@=02P,$%     @ HX-55J4\+IRM @
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M#=3Y!6-ROZ,_"=3?C&9_ U!+ P04    " "C@U56LR7175$$  "=&@  &0
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M"6CGSA12<A\F6.%X(/@6"=-;LYE";F:.UO(),^O^H(3^2C1.Q:.YWCLIGE%
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M;"]W;W)K<VAE971S+W-H965T-S<N>&ULK9I;;^(X&(;_BI4=K6:DMCEP*AU
MFI+C:KJJVIW=B]5>N,& -4G,V@9::7_\.H<&0E.72-\-),;OXT->;,>?)WO&
M?XHU(1(]ITDFIL9:RLV-:8IX35(LKMB&9.J7)>,IENJ6KTRQX00O"E&:F(YE
M#<T4T\R838JT>SZ;L*U,:$;N.1+;-,7\Y98D;#\U;.,UX8&NUC)/,&>3#5Z1
M1R)_;.ZYNC-KRH*F)!.498B3Y=3X9M]$]B 7%#G^I&0OCJY1WI0GQG[F-]%B
M:EAYC4A"8IDCL/K:D3E)DIRDZO%O!37J,G/A\?4KW2\:KQKSA 69L^0ONI#K
MJ7%MH 59XFTB']@^)%6#B@K&+!'%)]I7>2T#Q5LA65J)50U2FI7?^+GJB".!
MX[PC<"J!<RJPWQ'T*D'OW!+ZE:!_KF!0"0;G"H:58'BN8%0)1N<*KBO!];F"
M<248%W8HGU_Q\%TL\6S"V1[Q/+>BY1>%@PJU>N8TR\W^*+GZE2J=G+GD2:)+
MI(RC;)&A^99SDL4OZ'&/-P+A;('FE,<)02'!B5RC(O\#6=(,9S'-5NBS2R2F
MB?B"?OW%'O:^(IJA.YHDRLGB GTZOIV84M4X+]>,J]K-R]HY[]3.1G<LDVN!
MO&Q!%BUZ[P.]HP&8JJOJ_G)>^^O6T1+O,+]"/?L".9;CH!^/+OK\Z4M;PS["
MO)Q#<?64W[9)71D;!;?WZ'/Y$-I8GI[EDOBLAOGG8VP-)C@?8VDP89=&?=!!
M49?.;JU2PU&]^A_8*[@]W3\PRH3D6S6)2/3W=Y4!19*DXI^66MZ6M'X[+9\;
M;\0&QV1JJ,E/$+XCQBQOL_6US:60,!<2YD'"?$A8  D+(6$1$*QAXWYMX[Z.
M7MJ8/$LU)VRI6.=6;G.O%M+5O9 P%Q+FE;!1 <O7F[M9SYJ8NV-/OLUR:3N#
M9J:@)=/0;N8)(2L> <$:%AK4%AIH+=18?+291ROO:AY(F L)\R!A/B0L@(2%
MD+ ("-;P[;#V[1!T!A]"VA@2YD+"/$B8#PD+(&$A)"P"@C5L/*IM//I@!N=T
MA_.]APN4L7PK B<(IVS;/I-K85U=# ES(6$>),R'A 60L! 2%HW>K%I&UF%E
MTS#G=6W.:ZTY[_%+,;8N&4="+0\07G%"BJ3_JIV'-I-JH5U-"@ES2YC=/^JD
M@35N+NT\R!)]2%@ "0LA81$0K.'2<>W2L=:E/J8<[7"R)8@M3WS:9D\MK:L]
M(6$N),R#A/GC-X.+??K6!%E>" F+@& -<]K68:_7T@^BG,6$+ 1:<I8BFDFB
M2I&(8TE*LZJ$E&98OK-;>UOQ&^^U)YT_U]>AJP]!:1XHS0>E!:"T$)060=&:
MOCV*4=CZ8;6*3A3O56I@G7.RH*T#JA[4=40%I;F@- ^4YH/2 E!:"$J+H&A-
M*SL'*SN@>P45#LK0D#07E.:!TGQ06@!*"T%I$12M:>A#],K61A5F#V3'DET>
M"8Z+41DM<4P3*E^T[V5Z:&=;@X:Q0&D>*,T'I06@M+"B-5YIG<%)V"."*K-I
MUT.4R@8)4^DIG?WY-HQC]YK]XH*6Z('2?%!: $H+06D1%*WISD, S-9'P+ZS
M;'7YAWH).UGJ7J#?6187X3']?I>>W]FWH#$R4)H'2O-!:0$H+:QHC7%5Y3T=
M5T$C8.;1B;*4\%5Q'%&@. \&E$=;ZM3ZR..WXJ#?2?K<OG'MEG3/O@G* XT'
M?'F^\@[S%<T$2LA2%65=C53#>'EDL;R1;%.<9WMB4K*TN%P3O" \SZ!^7S(F
M7V_R NJ#H[/_ 5!+ P04    " "C@U56)$\*A8\'  !A2@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970W."YX;6RUG.]OVC@8Q_\5BYM.F[0KY >EW;5(+?9T
M/:W2U*ZW%Z=[D8*!:$G,)8:NI_WQYX0TQB&X9/KF36D@_AB>)W[P)PZY>!+I
MMVS)N23?XRC)+GM+*5<?^OULNN1QD)V(%4_4*W.1QH%4F^FBGZU2'LR*1G'4
M=P>#TWX<A$EO?%$\]SD=7XBUC,*$?TY)MH[C('V^YI%XNNPYO9<G[L+%4N9/
M],<7JV#![[E\6'U.U5:_HLS"F"=9*!*2\OEE[\KYP/Q1WJ#8XZ^0/V4[_Y/\
MHSP*\2W?N)E=]@;Y.^(1G\H<$:B'#9_P*,I)ZGW\6T)[59]YP]W_7^@?BP^O
M/LQCD/&)B+Z&,[F\[)WUR(S/@W4D[\33'[S\0,.<-Q515OPE3]M]1ZK'Z3J3
M(BX;J^TX3+:/P?<R$#L-7/=  [=LX![;P"L;>,<V\,L&_K$-AF6#XJ/WMY^]
M"!P-9#"^2,432?.]%2W_IXA^T5K%*TSR ^5>INK54+638\H?)?F-W/&-B#9A
MLB"3E,]"23X&TS *Y3,)DAGYPM.8?!)!0MY2+H,PRMZ1-R1,R&T812K=V45?
MJO>2$_O3LM_K;;_N@7X=<BL2N<P(2V9\UM">OM+>M0#Z*@A5)-R72%R[5N+5
M>G%"/.<]<0>N0Q[N*7G[YEW#&YO8,7^NHZ,PU(ZA?%IA7 N&'8\Y\&Z,8'G5
M8>,57.\ ]Y/:)F*^=[3\7;QP(WF<_=-T4&RI?C,U+XH?LE4PY9<]5?4RGFYX
M;_SK+\[IX/>F1"!A% EC()B1&K]*C6^CC^\"58'SW,SRH2T%8=<W7^C5>U4U
MGM68G:JODXPWY<:*;9L;)(QN8:<%+/_FVXS]B_YF-^"@[HR #ZN #ZT!_QBF
MF23//$B;HFIMVS:J2!A%PA@(9B3@M$K :2?%Z!29&B2,(F$,!#-2,ZI2,[*.
MC:M8I#+\+R@FA:O@64TQ)5GQ=*H>U3RT*2M;H#/8&>T#<[1/K'VVC342QD P
M(]9G5:S/K+&^YU.A)FMY(2)S$2D%R.=STTADZK$ITE9<V^,?":-(& /!C)R<
M5SDY[Z0TG2-3@X11)(R!8$9JG(%6GP&Z.)5$Q]VM3B<#=UBK4/:>V\8<2F,H
MFAGU'>%TK%'_LN1J"CJ7/"7K1(:1FI?*=:H&16.\K:RV P%*HU :0]',K+@Z
M*VXGA:K$HA*$I%$HC:%H9H*T<#M6:?RI8N4U3*5.!GNU"NK14!I#T<R@:Y5V
M7G'IZK38=#LNYN6X: PW5*"A- JE,13-S(KV;6?83:V"NCB41J$TAJ*9"=(^
M[EB=LN6P@6HXE$9+VFBG@+J#04U'&:I/,]I:L1V[8S\D4Q''H91\1L0J_WYX
MGY_V>SG55Q\FC3E 2O $2J,E;??LWW _!5V(MZ/-V[&K]]X!'RQ2SO.OZ,9H
M0\4;2J,E;?>('Y[5@[V_C^.?5SN9,=2F[%AM;_RU6--3QW"PX:F:T:@#6#D"
MSR1) UG4>[&6F0R261[G1Y&FQ0F.YK4GJ#]#:;2DU172WXMR%W+L:CEV[7)\
ML(:3'^0V^![&Z[@I\G9JV\A#:11*8RB:F1^MT:[3R23(A1HUE$:A-(:BF0G2
M1NU:A7!\LUN^&C,!56<HC9:T>I%R:N[(4+V:,=92[-JEV%JDPN1@D8(N0T-I
M%$IC*)J9'^W/KM]-D8*J-)1&H32&HID)TBKMVM>N7R]24&>&TFA)<[Q:D7+J
MI^,9JE\SRMJ'7;L/WQ<K<<4%5#^(.28:8PXU8BB-0FD,13/SHLW9'753GJ"Z
M#*51*(VA:&:"M%>[+;W:=B+)SFJ=%:A6N_O*[.Z=Q$!U:09;"[AK%_!/7.:+
M<O;2!!5K*(U":0Q%,R^OU/KM#3HI31[4OZ$T"J4Q%,U,D/9OS[Z,C3Q=9>^J
M==*@3E[2ZB8X.*T5+U2O9CJT;7MVVZX7KZ,F6G9FZ[A##1Q*8RB:F9V=J\4[
MNEP<>[TX]H)Q[!7C78BZIT7= RYTVUFMLP*U\Y*V.]'R]B9:J"[-8&OI]NS2
M7?R<)LIM\)A@0P4<2J-0&D/1S*QH2?>ZN8K<@]HZE$:A-(:BF0G2MN[9U[G;
MU:C1OG#M&=>D82_''];VHO;WU3J*72BUIY7:LROU1&QX$B0R_SU0L8I'$BY)
MQ,M9;)I?8-88T+.]97B_'LWM+HZS6WQ/AO5H0B_N1M',:&IG]NS.?+"4VU=)
M[=36-0.JT5 :0]',G\)IC?:[T6@?JM%0&H72&(IF)DAKM&_7Z%<7(/QF_ZRO
M1$[L_;2.,70E&D4S8ZS=V+>[L;5('5XEM5-;CP&H'4-I#$4S\Z/MV._&CGVH
M'4-I%$IC*)J9H)U?5-OM^/4BY1^Y$CFQ]]0ZRM"U:!3-C++68O\GM5B5J8<D
MX].U>IKD-ZQH3 '4DZ$T"J4Q%,U,D_9DOQM/]J&>#*51*(VA:&:"M"?[0$^V
MLUIG!;J4[1_C\ S5YS;:_9U;Z<0\713W,,K(5*P3N;V73/5L=9^DJ^+N0+7G
MKYT/D^W=CC1F>_.EVR!=A$FFG'NND(.3D1K/Z?9^1ML-*5;%#7L>A90B+OY=
M\F#&TWP']?I<"/FRD7=0W55J_#]02P,$%     @ HX-55HI*"QJ! P  RQ(
M !D   !X;"]W;W)K<VAE971S+W-H965T-SDN>&ULK9A=;]HP%(;_BI554RMM
MY -:V@XB%=)J3$6M6G6[F'9AX !1'3NS36FE_?C93@BD2KVB^0;BC_>QSVN.
M<=Q;,_XHE@ 2/6>$BKZWE#(_]WTQ74*&18OE0%7+G/$,2U7D"U_D'/#,B#+B
M1T%PXF<XI5[<,W6W/.ZQE20IA5N.Q"K+,'\9 &'KOA=ZFXJ[=+&4NL*/>SE>
MP#W(A_R6JY)?469I!E2DC"(.\[YW$9XG84<+3(_O*:S%SC/2H4P8>]2%T:SO
M!7I&0& J-0*KKR<8 B&:I.;QNX1ZU9A:N/N\H5^9X%4P$RQ@R,B/=":7?>_4
M0S.8XQ61=VS]%<J CC5ORH@PGVA=]@T\-%T)R;)2K&:0I;3XQL^E$3L"Q6D6
M1*4@>BWHO"%HEX+V>P6=4F"L]HM0C \)ECCN<;9&7/=6-/U@S#1J%7Y*];K?
M2ZY:4Z63<0(3B3ZC(:-"\E6Q%M<,4W28@,0I$4>O6XENS?$+GA!0;0_W"3H\
M.$('**5HG!*B^HB>+]7<] C^M)S'H)A'],8\0C1F5"X%NJ0SF-7UOHJI"BS:
M!#:(K,"+G+=0._B$HB"*&N8SM,N_K8B2AT8>-L@3N_QF*C?RL&N)IETM4]OP
MVK9E&IE54$DGT<]KU0&-)&3B5Y/9!:W33--[R;G(\13ZGMHL!/ G\.*/'\*3
MX$N34RYAB2-8S<5.Y6+'1H^O%!CAC*VH;#+-*M[7-)>PI(!U#4SOY$^QVM=[
M_E.#%\>5%\=6+RZ?9;E[2^!9DQUV?8A> /.FR*VZ?2-W!*M9=%)9=&(-\7HT
MN+E#?] 8/Z?9JM$C*V#?GXQ+6.((5C.N6QG7=;I;=5VZZ!*6.(+57#RM7#RU
M_OQ&5&4F"(DXEM!DFU6^KVTN84D!"Z.=#2MH!5&W><LZJPPY>U\^IO2M?+0"
M]K7$)2QQ!*L9%P;;4U[@-"-+G",CG=(25[2ZE3L'YO#_TM*NW]N[\OP>O,JE
M*I5*4QP-6C<EVIH264VYO[FZ:_3"*MO;"Y>TQ!6M;MGV1!^Z/=*'3L_T3FF)
M*UK=RNVQ/K2?Z_^=DIW&/Z3P]+B>1D/[0'O;XHA6V.+OO.5GP!?FMD2@J7Z=
M*=Z+J]KJ1N;"W$.\JA_HFQIS>[#%%-<\8\P7*16(P%PA@U97';]Y<7-2%"3+
MS5W"A$G),O.X!#P#KCNH]CEC<E/0 U3W5_%?4$L#!!0    ( *.#55:.35%-
M' ,  "@+   9    >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;*U6;4_;,!#^
M*Z<,34QBY*7T!=9&*G33F,:$6K%]0/O@)M?&(K$SVVG9?OUL)X06TB!0OR2V
MX^>Y>^[LRPW77-S)!%'!?98R.7(2I?(SUY51@AF1QSQ'IK\LN,B(TE.Q=&4N
MD,06E*5NX'D]-R.4.>'0KEV+<,@+E5*&UP)DD65$_#W'E*]'CN\\+$SI,E%F
MP0V'.5GB#-5-?BWTS*U98IHADY0S$+@8.6/_[,+W#,#N^$EQ+3?&8*3,.;\S
MD\MXY'C&(TPQ4H:"Z-<*+S!-#9/VXT]%ZM0V#7!S_,#^Q8K78N9$X@5/?]%8
M)2-GX$","U*D:LK77[$2U#5\$4^E?<*ZW-OK.A 54O&L FL/,LK*-[FO K$!
M\'L[ $$%")X"3G8 .A6@8X66GEE9$Z)(.!1\#<+LUFQF8&-CT5H-92:-,R7T
M5ZIQ*IS@7,%'L*\IYH6($AT4N!9\*4@&AQ-4A*;R@]YS,YO X<$'. #*X(JF
MJ4Z#'+I*>V&XW*BR>%Y:#'98] .XXDPE$CZS&.-M E>[7VL('C2<!ZV,$XR.
MH>,?0> %08-#%^WP;P73<*\)ON5.IPYIQ_)UVD(ZH3)*N2P$PNUX+I70Y_5W
M4[!*KI-F+G.)SV1.(APY^I9*%"MTPO?O_)[WJ4GHGLBV9)_4LD_:V,,=1^@(
MQH5*N*#_,(9QQ@NFFL+0ROW:,)1D?4MFZM@J]#W/&[JK!GG=6E[WY:Q>,IW)
M0E<Q!;??]0:X5)C)QKQV]REH3V1;PGNU\%YK7J=H_@:4+8'8[ %9Z8I YBE"
MH2^P )4@Y&6RFP+1>Y:,_D8N2GVM'KQ17[_6UV_5-T-&N8 ?7&%C-6M%OS:1
M>R+;$CJHA0[V>H('^Q2^)[(MX:>U\-.7*Y/ &+.\;!UV5J&2I[=Q5CO^X,E9
M;;7U1B6^]_B[]EZXC76!Y0N0Y=EEN\YN1;9Y^3K/+E^[Q=<J<C=ZD0S%TK9H
M$B(3\K(MJ5?K-G!LFQ_W<7O90UX1L:1,0HH+#?6.^[H,BK(M*R>*Y[:SF7.E
M^R0[3'0KB\)LT-\77 >FFA@#=7,<_@=02P,$%     @ HX-55INDABZ, @
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M[/")YH2&"L]GD4C_HD/6=@0]^GLA69P'PWT<)ME_\IP+<1+@C,\$X#P UP)
MF?: ?A[0K_=P+F"0!Z126QF55 >/2#*?<G9 7+4&-'61BIE& _TP4>_]07+X
M-80X.?]"032!KM%?A'.BW@%Z[U%)PDA\@*>/#QYZ_^X#>H?"!"W#*()W)::6
MA)Y5O.7GO=QEO> SO3@8+5DBMP+]G@0TJ )8D'*1-W[)^PYK$3WJWZ"^<X6P
MC7%+0HNWASLMX9X^_$^2G.N]PJ9?O(5^BM<_^Q:$H/0*I6_C"GE4^#S<I1/C
MGR_0%GV6-!;_M@F? 0_:@=6J<2MVQ*>S'BP+@O(GVIO_^HOCVK^UB682S#,$
M5A%T4 @ZT*'/O^ZH&LW)!D5*4D2?8:$4M$W #&B4 JE5\FD^P).I]72J2[--
M?V)7VWC:A"ZD.RSH#K5TTW&#HI"LPBB4(4QH3H.]3P.T.B*?B"W:D3!H8Y_A
MNJ?L!S5FBV:;_GA88Z_-[T+V;L'>U;)/-ZMKMK[>@P@$9I(4B*U@#4M  %BW
MZ+._)<F&(M@F$:N-C!?1CFWJN WF;EV<9A-G-*J)HTW_0G%&A3BC#D/CF&H0
M98N^SV+8P?WZ>IQ1'[U.O=FD25V;W(74QP7UL7Y<?'W,AT,;P7$C>SP<#FH4
MFXWZ0]>M<=1F<2''2<%QTFFATP[G29--W^G7*$^::]T8UQIYVJ0NI.S8I6>Q
M.Y%.F$1'\,C%@+[2ZY##GPHQKJF@SZ#K5F@*K:K7B<=SWC814!C#1L!!I/8Y
MD>.<"C.L3^F%OK/.TAA"JTJ#2VFP7AJJBB,UE.H"(=@T^(:VZX0;D\1Q<4,H
M;=>=A3*$5A6J=*B.UJ_-OZ<5%&RHY DF'VRFO% NFX22\KA5*STNMF'J$BZ0
MB^*T1&CSI:]A.#F&DV$ 5D".;4B>'NE2%4M;ZNA]:4/%(!0^V\-H@P6MU:"T
MC[^L%P>?#$#[QAXV1N#;VGGZK"]5I72OCMZ^+D&)*"()^D1))+>MC T9S%P7
MDVB>*;2J>J7[==R?53PZAIQIKJI)-,\46E75TC8[>M^L-X_ZX,["F43S<K2*
M@RNM>U6.TDH[>B_=R6?JL3JK8Q+-R]'>I$YIPAV]"U_"1ACOV[<_0U8YU\(D
MFF<*K?H%K[3QV/Y9"Q<V:<\71M$\4VA554NSC_5F_PW%T3FK]@IRYK):!31:
M$IA"JPI8E@187Q(LR?.YR:R/[#SLC-8'IM"JJI7U ?YIG["QT6_81M$\4VA5
M5<MZ 7?[CMUE,NN1QUG)U*J@H6H@5]!H;6&=''7%%.IS=62H/F5"#96='A5/
MBV/)C^EA7.WYG7.[R X72YCLK',)97^8"%!\#9#VS0CL/<^.#[,;R7;I@=J*
M2<GB]')+24"Y:@"_KQF3+S>J@^(0=_X_4$L#!!0    ( *.#55:\*4[M9@,
M  L,   9    >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;+56;6_;-A#^*X16
M# F01&^VXF2V -=9T0'I:L3+^J'8!UH^6T0I4B/I./GW.TJR*L>,T[7N%TND
M[AX^S_'N?,.-5%]T#F#(8\&%'GFY,>6U[^LLAX+J"UF"P"]+J0IJ<*E6OBX5
MT$7E5' _"H+$+R@37CJL]J8J'<JUX4S 5!&]+@JJGMX"EYN1%WK;C3NVRHW=
M\--A25<P W-?3A6N_!9EP0H0FDE!%"Q'WCB\GH2!=:@L_F:PT9UW8J7,I?QB
M%W\L1EY@&0&'S%@(BH\'F #G%@EY_-N >NV9UK'[OD5_5XE',7.J82+Y)[8P
M^<@;>&0!2[KFYDYNWD,CJ&_Q,LEU]4LVC6W@D6RMC2P:9V10,%$_Z6,3B(Y#
M_R6'J'&(OM4A;ASB2FC-K))U0PU-ATINB++6B&9?JMA4WJB&"7N-,Z/P*T,_
MD]X"QD"3<W+W\9Z,M0:C"14+<LOHG'%F&'X\N0%#&=>G:'8_NR$G;T[)&\($
M^< XQ[O00]\@%0OH9\VQ;^MCHQ>.O8'L@L3A&8F"*'*X3[[=/=QU]S$ ;12B
M-@I1A1>_@-<(_SR>:Z,PL_YQ*:HA>FX(6V[7NJ09C#RL)PWJ ;STUU_")/C-
MI>](8#MJXU9M? @]M5=-:\4G"C*I%K# M#,Y7JDT.2C"I5B=&U!%8W?JBD=]
MR&5UB.T6#VG4[_>&_D-7Y[Y1W$^2UFB'?Z_EWSO(_V,)BAHF5J3*WC-2-9]S
MN3R_UU G\1F9&6H ^XTA<DG>,4%%QB@G4ZE9U3\^__YH;#>:<\!DU^XK?X6'
M,U:NV_YQG)U ]=M ]0^F=;>(#^=V_YBY?22P'<E)*SDY&,M9+I6IP[B7VS3+
MY%I@UI?TB=I[MXT.-]4:;> 1_QFQ%3I3/=G+XG 0/,OT?9LHZ+D3_;(5<WE0
MS&V;$J_6*?]ZU4X%]4%)MP[#.'XFP6&4A%=N#8-6P^"@AK^DP;+CME"[)%T<
M!_N] DD^X^@P&D2QF^-5R_'J_S64;>$\G9')6BGL(D=J*(=YC+<).NTDZ+A)
MT$XQMZQ<U?=3C]@);QA\'3*"[P[PGU)D1XWQ:UQ>KASG('(DM#IR?F=2LV/R
M!ZI63&BLCR7"!Q>7V#M5/7G6"R/+:GB;2X.C8/6:X[0.RAK@]Z649KNP\V [
M_Z?_ 5!+ P04    " "C@U566[U3XNX"  #W"@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970X-2YX;6RMEEU/VS 4AO^*E:$)I-%\-OU8&PE:39L$&H*Q74R[
M<-O3UL*),]MMX=_OV"FAM"%%T6YHG)SW]?,Z,<>#C9 /:@F@R6/*,S5TEEKG
M?==5TR6D5+5$#AD^F0N94HU#N7!5+H'.K"CE;N!YL9M2ECG)P-Z[D<E K#1G
M&=Q(HE9I2N73)7"Q&3J^\WSCEBV6VMQPDT%.%W '^CZ_D3AR2Y<92R%33&1$
MPGSH7/C]D6\%MN(G@XW:N28FRD2(!S/X-ALZGB$"#E-M+"C^K&$$G!LGY/B[
M-77*.8UP]_K9_8L-CV$F5,%(\%]LII=#I^N0&<SIBNM;L?D*VT!MXS<57-F_
M9%/4QE@\72DMTJT8"5*6%;_T<;L0.P(_>D,0; 7!>P7A5A#:H 69C36FFB8#
M*39$FFIT,Q=V;:P:T[#,O,8[+?$I0YU.K@#70)%S\CT'237+%L3>(M=4KR33
M3^1T#)HRKLZPZ/YN3$Y/SL@)81FY9ISCFU #5R.(L7.GVTDOBTF#-R8=P[1%
M0O\3";P@J)"/WB_W7\M=C%^N05"N06#]POHU^'TQ45KB=_6G*E%A$55;F,W6
M5SF=PM#!W:1 KL%)/G[P8^]S5;[_9/8J;5BF#>O<$URTL"I@H>I8E=G\ZR2,
ML'"]RUWKW) [*KFC8]Q1%7>ABG>YV]X>=ZUS0^YVR=T^QMVNXFX?<IO"5]RU
MS@VYXY([/L8=5W''A]Q>L,==Z]R0NU-R=XYQ=ZJX.P?<0;>SQUWKW)"[6W)W
M:[E_+ '[\%R#K*+O'M!'<;B_/6LG:(C?*_%[]?A"4TZX[1TY?<).KRL[0^\@
M2!Q$^_NU=JJ&07SOI25ZM5&N0*D^86F^TC##3H>O!)2N;'/>09KSH!?L?U;U
M\S7-L]/B_7>_&L[HA'&F&53W;?^P"X3^_G=65=4-7JH*3G?G5&*.A-=4+EBF
M$&2.,J_5P?]NLCAE%0,M<GM0F0B-QQY[N<23*4A3@,_G0NCG@3G[E&?=Y!]0
M2P,$%     @ HX-55C*0NWE0"0  -6L  !D   !X;"]W;W)K<VAE971S+W-H
M965T.#8N>&ULM=UK<]K*&0?PK[)#,VTRXV-TX>K:S#CHKJ;UV$W/BTY?K,7:
MJ-&%:(6==,Z'[^IBA$ L<,[?>1&#V.<G"?9!*^E!NGY-LV]\R5A.?L11PF]Z
MRSQ?7?7[/%BRF/++=,42\<I3FL4T%T^SYSY?98PNRJ XZFN*,NK'-$QZL^MR
MVETVNT[7>10F["XC?!W'-/OYF47IZTU/[;U-N ^?EWDQH3^[7M%G]L#RKZN[
M3#SK;Y1%&+.$AVE",O9TT[M5KWQ=*P+*%O\*V2O?>DR*57E,TV_%$W=QTU.*
M)6(1"_*"H.+/"YNS*"HDL1S?:[2WF6<1N/WX3;?*E1<K\T@YFZ?1K^$B7][T
M)CVR8$]T'>7WZ:O#ZA4:%EZ01KS\G[S6;94>"=8\3^,Z6"Q!'";57_JC?B.V
M M3!@0"M#M!V X8' O0Z0#]U#H,Z8'!JP+ .&)X:,*H#1J>NP[@.&)\:,*D#
M)KL!HP,!TSI@>NHZJ,K;)Z><'++YL*M.5_62LHL9-*>SZRQ])5G17GC%@[*?
MEO&B9X5)D5(/>29>#45</GO(T^#;,HT6+.-_(>;W=9C_)+^0O],LHT5G)Q\-
MEM,PXI_$U*\/!OGXX1/Y0/J$+VG&. D3\C4)<WZQ->&?RW3-:;(0$S\4S[^$
M4232AU_W<['$Q7S[0;UT\VKIM -+IY(O:9(O.3&3!5MTQ-OR>/U8O"./'QR+
M=X\LOR8!^N*CVGQ>VMOG]5F3BAY-+HFF7Q!-T92N-U0>;K#@DNAJ&:YUA!OR
M\'\$N33</++PZT@:;AT+%^NN*P?#;7GX UM)PYT_MN[N'WOGO=/#U8YP__1P
M1=(-]<W7AEYZ^J'W<OW(PT4H-L(7Y(%&C*1/I/PJ(?_^FVA*W)S%_#\=R_FY
M<@?=;C& N.(K&K";GA@A<):]L-[LSW]21\I?NSH[$C.0F(G$+"1F(S$'B;E(
MS$-B/@AKI=I@DVH#F5YMH<7H=;7.@J48/))5ECYG-+X0F]9 C*+%E#PE=)TO
MTRS\'UL0&J?K)._*/>F,SLV]"AN76#%P?YF)8;SX;GG9SBGD'$TD9NTOOKZW
M^#9RC@X2<Y&8A\1\$-;*E>$F5X:_*U>:5#F<'%+YW.2HL-%6[QKM)P=RCB82
MLY"8C<0<).8.][X#]C\E#SE''X2UDF.T28Z1-#GF:1RG">$[.=*U6_99*IV;
M#$C,0&(F$K.0F(W$'"3FCO:^VG1E.MI)FM'^X& Z;K?Q]]N,M,9I=?'QIHN/
MI5W\GA5'$</D>7L\M+4Y./SM+W7/[?#C_;6?*#MOD8&<HXG$+"1F(S$'B;FG
M?$H><HX^"&NEQF23&A-I:OS*HFA.,];5^:61YW9^)&8@,1.)64C,1F(.$G.1
MF(?$?!#62J;I)IFF[W3X:XI,-21F(#$3B5E(S$9B#A)SD9B'Q'P0UDHU56G.
M4"GRG?KZQ!+G:S&:"Q/RN.:B">>$!M_7(0_+<[,?Q0O5*:A/77E7SV-[V*J.
MU;V]O;E\6<[-*:AF0C4+JME0S8%J+E3SH)J/TMJYM77V5Y7F5GW"]X5&:W8D
MPSJS2MT;0ZOJ0%=WDTJZ$&<G%5(SH9H%U6RHYD U%ZIY4,U':>VDTIJDTN0'
MVBA?DA7]&;,DY^7)F2*+,K9)J\Y4TCH.&8^GNYDDG?/9F8343*AF034;JCE0
MS85J'E3S45H[DYHJ U5Z9G5FT3"K-TYT\=\USXN4*C*J.HA=U-(M2)#&*Y9P
M6I7H<9X&(<W%]-<P%VF8L5]$@\<PJ5XOEC$,.H^"U,NRO3&;#G?S#UIQ -5,
MJ&9!-1NJ.5#-A6H>5/-16CO_FM(#55Y[8,:K*/W)6'UP8[Z=:7<1[1X30JL,
MH)H!U4RH9D$U&ZHY4,V%:AY4\U%:.^&:^@5U^$X'%E5H_0)4,Z":"=4LJ&9#
M-0>JN5#-@VH^2FNG75,9H<I+(]Q$C!$9R>F/<M18U,,7)Y&/'5.$5DE -0.J
MF5#-@FHV5'.@FJON%TNHFJKOG&/N:J7O[OK[':TT93#L+IA0FXH)55XR<6R(
M1WXCLE/'<OWL'$!J!E0SH9H%U6RHYD U%ZIY4,U':>W<:THRU,E[C?:@)1M0
MS8!J)E2SH)H-U1RHYD(U#ZKY**V==DWQABH]8?U[1WO0T@VH9D U$ZI94,V&
M:@Y4<Z&:5VNM0EMMM#LHW&\T4,;=8T*MJ;C0Y!47YU2*RZESTP*J&5#-A&H6
M5+.AF@/57*CFU5JKY&!W5ZFCC38XD!1-J80F+Y6HDZ(<GW4F O(4]ARJ&5#-
MA&H65+.AF@/57*CF034?I;63JRF9T+1WVA/2D.>[YU#-@&HF5+.@F@W5'*CF
M0C4/JODHK9UV37V%)J^O.#30.[8O)&?/3CIH4054,Z&:!=5LJ.9 -;?66GLO
MH\EHLG/HNZO9>*+NCN?V6ZG*6#VTG].4-VCR\H:S]G.@90U0S8!J)E2SH)H-
MU1RHYM9:^Y(2>[^,[6BU_]/8CD8'?QNK-<4%FOSJ"+=!P"*6E<5QY8\JR'WS
MT]C;YXRQHKRNL_-#BPN@F@'53*AF034;JCE0S85J'E3S45H[[9KB FWT7OLV
MT (#J&9 -1.J65#-AFH.5'.AF@?5?)363KNFL$&3%S;</MQ?D$7(@^*2#^4.
MS9HOR(IEU8Y-]WX-M)H!JAFU-MT:$TQ&EYHRW?K7'D:8T 6PH)H-U1RHYD(U
M#ZKY**V=54W)@B:_C,1I8TCR&SEZN!Q:P0#5#*AF0C4+JME0S8%J+E3SH)J/
MTMI9V%0P:.]U_0D-6L4 U0RH9D(U"ZK94,V!:BY4\Z":C]+:USQNZB)T>5W$
M]L:O'$2VCIG3MZW?A>0Z8_(YG)M_4,V :B94LZ":K7<4$>Q="\2!SM.%:AY4
M\U%:.Z^:T@K]I-**LT]#R=FSDPE:<E%K[>LD[G8QLZ/59+3;RH(NF0W5G(XU
M4-6]57"A,_6@FH_2VKV_J7W0Y9>+N&-9(+8:]+D<QB5I\=,+&M7;$+).%BPC
MMP_WG0D +7Z :@94,VNMN%S.II\IEY/=1($6-4 U!ZJY4,V#:CY*J_*IOW5S
MFYAES^7]ES@I#^M5-ZS83-W<X^FVO+/1SO2Y>F6I'=-=]<JO;J;3\-4-I;[0
M[#E,.(G8DYB5<CD>]DA6W:.I>I*GJ_+6.H]IGJ=Q^7#)J$C8HH%X_2E-\[<G
MQ0PV=\J:_1]02P,$%     @ HX-55C5G(A;> P  O1   !D   !X;"]W;W)K
M<VAE971S+W-H965T.#<N>&ULM5A1;Z,X$/XK%K>Z:Z5NP2:!I)<@M:6KJW25
MJN9V]^%T#PXX 15PUC9-^^_/-I0$<++9%?O28//-A[^Q9SS3V9:R9YX0(L!K
MGA5\;B5";*YLFT<)R3&_I!M2R#<KRG(LY)"M;;YA!,?:*,]LY#B>G>.TL(*9
MGGMDP8R6(DL+\L@ +_,<L[<;DM'MW(+6^\13NDZ$FK"#V0:OR8*(SYM')D=V
MPQ*G.2EX2@O R&IN7<.K$(Z4@49\2<F6[ST#)65)Z;,:W,=SRU$K(AF)A*+
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M2ZB)=/D:F'ZRY*(F2@_%RI-K :1HC.K*"WP_\6I"F9/-FKE[D<WX1E64P;U
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M/\:VP)KXXVT[PP@&2#3>,#W3OL_I>TK/I#NIGG0)8- S9T*/<&E,-0P"G9?
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M>I!+^3PI6C056K^ '04'K^9T[=I;PI#O261]4)C!P'/ET:TR<\+0&:$ :C-
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MP-6((Y@#\( A05 ^![>>1U[]G/+6_TZ/_@!02P,$%     @ HX-55I>*NQS
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M-+FLV;7JWVS/.E@!P IHL9;KNW1]<WVY>%A=LG\O;A9WRQ5+OZQ6#ZD#& +
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MV0^I[/&,%]F]8>U#=Z\@BML=;MNF*);VV%K=:)Z__*O%RS]R?/X34$L#!!0
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MU3L!]$ZJ=P+HG53O!- [J=X)H'=J#IL ]$ZJ=P+HG53O!- [J=X)H'=6O3-
M[ZQZ9X#>6?7. +VSZIT!>F?5.P/TSJIW!NB=5>\,T#LWAP4!>F?5.P/TSJIW
M!NA=5.\"T+NHW@6@=U&]"T#OHGH7@-Y%]2X O8OJ70!Z%]6[ /0NJG<!Z%V:
MP]X O8OJ70!Z5]6[ O2NJG<%Z%U5[PK0NZK>%:!W5;TK0.^J>E> WE7UK@"]
MJ^I= 7I7U;L"]*[-L Y ;VO:<1V W]8T SL&(+@US<B. 1AN33.T8P"*6].,
M[9CO='R</G;#>"WZ6C<!WZGV=/GL</W^S^77Q?8N_H2ZO\T8'_\"4$L#!!0
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M2P$"% ,4    " "C@U56>PBNO>\    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "C@U56F5R<(Q &  "<)P
M$P              @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( *.#558-*ZSE<P<  -XN   8              " @0X(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "C@U568,>*HC$"  "K!0
M&               @(&W#P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L!
M A0#%     @ HX-55O1Y 4 D!P  =AX  !@              ("!'A(  'AL
M+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( *.#559VPN/@'P,
M / *   8              " @7@9  !X;"]W;W)K<VAE971S+W-H965T-"YX
M;6Q02P$"% ,4    " "C@U56(JOU^H '  "%)@  &               @('-
M'   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ HX-55A[B
M4&T=!   FPX  !@              ("!@R0  'AL+W=O<FMS:&5E=',O<VAE
M970V+GAM;%!+ 0(4 Q0    ( *.#55;]$!J]/ L   YM   8
M  " @=8H  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "C
M@U569F>RV3$#  "1#   &               @(%(-   >&PO=V]R:W-H965T
M<R]S:&5E=#@N>&UL4$L! A0#%     @ HX-55@!P'SOK"0  )#,  !@
M         ("!KS<  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0
M   ( *.#559?IVW#*P4  -$+   9              " @=!!  !X;"]W;W)K
M<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ HX-55HM QH79)P  ,WL
M !D              ("!,D<  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q0
M2P$"% ,4    " "C@U5696K80O *   ^(@  &0              @(%";P
M>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( *.#55::2$8H
MUPL  .T@   9              " @6EZ  !X;"]W;W)K<VAE971S+W-H965T
M,3,N>&UL4$L! A0#%     @ HX-55B:;W64Y!@  8!,  !D
M ("!=X8  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "C
M@U56%^C#;A %  "Y"P  &0              @('GC   >&PO=V]R:W-H965T
M<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( *.#558B(?H=T08   <1   9
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M970R,"YX;6Q02P$"% ,4    " "C@U56YOASIX4&  #B#P  &0
M    @('"O@  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (
M *.#559GA736.@,  .X'   9              " @7[%  !X;"]W;W)K<VAE
M971S+W-H965T,C(N>&UL4$L! A0#%     @ HX-55B_S@U5K"P  _!T  !D
M             ("![\@  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"
M% ,4    " "C@U56VSHIC9T$  "X"@  &0              @(&1U   >&PO
M=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( *.#55;9F_E^[0(
M (@&   9              " @679  !X;"]W;W)K<VAE971S+W-H965T,C4N
M>&UL4$L! A0#%     @ HX-55@I<4>BB!0  ^@X  !D              ("!
MB=P  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "C@U56
MQSBRCK$0   H+0  &0              @(%BX@  >&PO=V]R:W-H965T<R]S
M:&5E=#(W+GAM;%!+ 0(4 Q0    ( *.#55;UE7U)MP,  *X(   9
M      " @4KS  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%
M  @ HX-55OC"#/ #!@  Z \  !D              ("!./<  'AL+W=O<FMS
M:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " "C@U56XGQH0NH*  #G'
M&0              @(%R_0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+
M 0(4 Q0    ( *.#55;J^T]QV20  .IW   9              " @9,( 0!X
M;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ HX-55N-OCRH,
M!   TPD  !D              ("!HRT! 'AL+W=O<FMS:&5E=',O<VAE970S
M,BYX;6Q02P$"% ,4    " "C@U56\ICK0X@$  "-"@  &0
M@('F,0$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( *.#
M55:)\ 0@IP8  -L2   9              " @:4V 0!X;"]W;W)K<VAE971S
M+W-H965T,S0N>&UL4$L! A0#%     @ HX-55E7<V\^$!0  T1$  !D
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M=#,Y+GAM;%!+ 0(4 Q0    ( *.#558R,=+'_0,  ( )   9
M  " @6]3 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @
MHX-55E?'&I5" P  RP<  !D              ("!HU<! 'AL+W=O<FMS:&5E
M=',O<VAE970T,2YX;6Q02P$"% ,4    " "C@U56SJF:Y<T"   '!@  &0
M            @($<6P$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4
M Q0    ( *.#55:F^"PI%0<  - 1   9              " @2!> 0!X;"]W
M;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ HX-55D&' KXB P
MT 8  !D              ("!;&4! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX
M;6Q02P$"% ,4    " "C@U56WB=G&WH#  #N!P  &0              @('%
M: $ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( *.#559=
MY0[K6P,  '$)   9              " @79L 0!X;"]W;W)K<VAE971S+W-H
M965T-#8N>&UL4$L! A0#%     @ HX-55L"/6]B>"   6A8  !D
M     ("!"' ! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *.#559MZD48V0(  *\*   9              "
M@6Z( 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ HX-5
M5E>69BQ! P  C@D  !D              ("!?HL! 'AL+W=O<FMS:&5E=',O
M<VAE970U,RYX;6Q02P$"% ,4    " "C@U56#SVE!,T&  #J,0  &0
M        @('VC@$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0
M   ( *.#55;PBP^D<P,  -0/   9              " @?J5 0!X;"]W;W)K
M<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ HX-55E?. L]X"0   W,
M !D              ("!I)D! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q0
M2P$"% ,4    " "C@U56UW>^3E4'  #F,   &0              @(%3HP$
M>&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( *.#558'.!7]
MO@8  &TM   9              " @=^J 0!X;"]W;W)K<VAE971S+W-H965T
M-3@N>&UL4$L! A0#%     @ HX-55BT"1#PG!@  B2@  !D
M ("!U+$! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " "C
M@U56Q4B7-=@$  #(&   &0              @($RN $ >&PO=V]R:W-H965T
M<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( *.#55;VVCP!EQ(  //*   9
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M970V-2YX;6Q02P$"% ,4    " "C@U56RD7H?=P#  "?%@  &0
M    @(%MWP$ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    (
M *.#558*L?=[N@0  $89   9              " @8#C 0!X;"]W;W)K<VAE
M971S+W-H965T-C<N>&UL4$L! A0#%     @ HX-55F789=9Y @  )P8  !D
M             ("!<>@! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"
M% ,4    " "C@U56:]"$ZZ $  #/$@  &0              @($AZP$ >&PO
M=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( *.#55:E/"Z<K0(
M -\&   9              " @?CO 0!X;"]W;W)K<VAE971S+W-H965T-S N
M>&UL4$L! A0#%     @ HX-55E8>P5]M!   /QH  !D              ("!
MW/(! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"% ,4    " "C@U56
MLR7175$$  "=&@  &0              @(& ]P$ >&PO=V]R:W-H965T<R]S
M:&5E=#<R+GAM;%!+ 0(4 Q0    ( *.#559>$4+$4 ,  "0-   9
M      " @0C\ 0!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%
M  @ HX-55N^@KO*G"   ^%0  !D              ("!C_\! 'AL+W=O<FMS
M:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    " "C@U56GR#-?_$"  "I"0
M&0              @(%M" ( >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+
M 0(4 Q0    ( *.#55:I[#S\.@D   EQ   9              " @94+ @!X
M;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%     @ HX-55EIR:_HX
M!0  1"H  !D              ("!!A4" 'AL+W=O<FMS:&5E=',O<VAE970W
M-RYX;6Q02P$"% ,4    " "C@U56)$\*A8\'  !A2@  &0
M@(%U&@( >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( *.#
M55:*2@L:@0,  ,L2   9              " @3LB @!X;"]W;W)K<VAE971S
M+W-H965T-SDN>&UL4$L! A0#%     @ HX-55HY-44T< P  * L  !D
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M=#@T+GAM;%!+ 0(4 Q0    ( *.#559;O5/B[@(  /<*   9
M  " @20X @!X;"]W;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @
MHX-55C*0NWE0"0  -6L  !D              ("!23L" 'AL+W=O<FMS:&5E
M=',O<VAE970X-BYX;6Q02P$"% ,4    " "C@U56-6<B%MX#  "]$   &0
M            @('01 ( >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4
M Q0    ( *.#558K)O@ DP(   D'   9              " @>5( @!X;"]W
M;W)K<VAE971S+W-H965T.#@N>&UL4$L! A0#%     @ HX-55NU6^=$Q P
M5 H  !D              ("!KTL" 'AL+W=O<FMS:&5E=',O<VAE970X.2YX
M;6Q02P$"% ,4    " "C@U56(NIZ$_4$  !R$@  &0              @($7
M3P( >&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;%!+ 0(4 Q0    ( *.#559^
M9]1MK@0  %T2   9              " @4-4 @!X;"]W;W)K<VAE971S+W-H
M965T.3$N>&UL4$L! A0#%     @ HX-55MS?%A=#!0  I1T  !D
M     ("!*%D" 'AL+W=O<FMS:&5E=',O<VAE970Y,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *.#559;):@"T@8  *(]   9              "
M@2-O @!X;"]W;W)K<VAE971S+W-H965T.3<N>&UL4$L! A0#%     @ HX-5
M5A$_+?U5 @  #@8  !D              ("!+'8" 'AL+W=O<FMS:&5E=',O
M<VAE970Y."YX;6Q02P$"% ,4    " "C@U56"U@UZ60$  #*#P  &0
M        @(&X> ( >&PO=V]R:W-H965T<R]S:&5E=#DY+GAM;%!+ 0(4 Q0
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M965T,3 S+GAM;%!+ 0(4 Q0    ( *.#55:=<)5-? @  "4P   :
M      " @5N7 @!X;"]W;W)K<VAE971S+W-H965T,3 T+GAM;%!+ 0(4 Q0
M   ( *.#55;KF0"T9P,  *H6   -              "  0^@ @!X;"]S='EL
M97,N>&UL4$L! A0#%     @ HX-55I>*NQS     $P(   L
M ( !H:," %]R96QS+RYR96QS4$L! A0#%     @ HX-55N!K7\YG!P  %40
M  \              ( !BJ0" 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M *.#55;Q"++Y\@(  !L]   :              "  1ZL @!X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( *.#559E4>EO9@(  .LZ   3
M              "  4BO @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !P
- '  S!X  -^Q @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>427</ContextCount>
  <ElementCount>540</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>123</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Organization and Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/OrganizationandOperations</Role>
      <ShortName>Organization and Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Acquisitions and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/AcquisitionsandDivestitures</Role>
      <ShortName>Acquisitions and Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Short-term and Long-term Investments, Restricted Deposits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits</Role>
      <ShortName>Short-term and Long-term Investments, Restricted Deposits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Property, Software and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/PropertySoftwareandEquipment</Role>
      <ShortName>Property, Software and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Medical Claims Liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/MedicalClaimsLiability</Role>
      <ShortName>Medical Claims Liability</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Affordable Care Act</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/AffordableCareAct</Role>
      <ShortName>Affordable Care Act</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Statutory Capital Requirements and Dividend Restrictions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictions</Role>
      <ShortName>Statutory Capital Requirements and Dividend Restrictions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Stock Incentive Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/StockIncentivePlans</Role>
      <ShortName>Stock Incentive Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Retirement Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/RetirementPlan</Role>
      <ShortName>Retirement Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/Commitments</Role>
      <ShortName>Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Condensed Financial Information of Registrant</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/CondensedFinancialInformationofRegistrant</Role>
      <ShortName>Condensed Financial Information of Registrant</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.centene.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Acquisitions and Divestitures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/AcquisitionsandDivestituresTables</Role>
      <ShortName>Acquisitions and Divestitures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/AcquisitionsandDivestitures</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables</Role>
      <ShortName>Short-term and Long-term Investments, Restricted Deposits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/FairValueMeasurements</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Property, Software and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/PropertySoftwareandEquipmentTables</Role>
      <ShortName>Property, Software and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/PropertySoftwareandEquipment</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Medical Claims Liability (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/MedicalClaimsLiabilityTables</Role>
      <ShortName>Medical Claims Liability (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/MedicalClaimsLiability</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Affordable Care Act (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/AffordableCareActTables</Role>
      <ShortName>Affordable Care Act (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/AffordableCareAct</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/Debt</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/Leases</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/StockholdersEquity</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/IncomeTaxes</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Stock Incentive Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/StockIncentivePlansTables</Role>
      <ShortName>Stock Incentive Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/StockIncentivePlans</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/EarningsPerShare</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/SegmentInformation</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Condensed Financial Information of Registrant (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/CondensedFinancialInformationofRegistrantTables</Role>
      <ShortName>Condensed Financial Information of Registrant (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.centene.com/role/CondensedFinancialInformationofRegistrant</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Organization and Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/OrganizationandOperationsDetails</Role>
      <ShortName>Organization and Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.centene.com/role/OrganizationandOperations</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property, Software and Equipment Depreciation Periods (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Property, Software and Equipment Depreciation Periods (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Summary of Significant Accounting Policies - Schedule of Amortization Period for Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Amortization Period for Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Summary of Significant Accounting Policies - Schedule of Allowance for Uncollectible Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAllowanceforUncollectibleAccountsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Allowance for Uncollectible Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Summary of Significant Accounting Policies - Significant Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Significant Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Acquisitions and Divestitures - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails</Role>
      <ShortName>Acquisitions and Divestitures - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Acquisitions and Divestitures - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisitions and Divestitures - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Acquisitions and Divestitures - Identifiable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>Acquisitions and Divestitures - Identifiable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Acquisitions and Divestitures - Divestitures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails</Role>
      <ShortName>Acquisitions and Divestitures - Divestitures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails</Role>
      <ShortName>Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails</Role>
      <ShortName>Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-for-Sale Investments in a Continuous Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails</Role>
      <ShortName>Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-for-Sale Investments in a Continuous Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails</Role>
      <ShortName>Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Property, Software and Equipment - Components (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails</Role>
      <ShortName>Property, Software and Equipment - Components (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Property, Software and Equipment - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails</Role>
      <ShortName>Property, Software and Equipment - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Goodwill and Intangible Assets - Schedule of Changes in Goodwill by Operating Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Schedule of Changes in Goodwill by Operating Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Goodwill and Intangible Assets - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Goodwill and Intangible Assets - Schedule of Future Amortization Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpensesDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Schedule of Future Amortization Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails</Role>
      <ShortName>Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Medical Claims Liability - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails</Role>
      <ShortName>Medical Claims Liability - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Medical Claims Liability - Cumulative Incurred and Paid Claims (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails</Role>
      <ShortName>Medical Claims Liability - Cumulative Incurred and Paid Claims (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Medical Claims Liability - Incurred Claims and Allocated Claims Adjustment Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails</Role>
      <ShortName>Medical Claims Liability - Incurred Claims and Allocated Claims Adjustment Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Affordable Care Act (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/AffordableCareActDetails</Role>
      <ShortName>Affordable Care Act (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.centene.com/role/AffordableCareActTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Debt - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/DebtScheduleofDebtDetails</Role>
      <ShortName>Debt - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Debt - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/DebtAdditionalInformationDetails</Role>
      <ShortName>Debt - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Debt - Senior Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.centene.com/role/DebtSeniorNotesDetails</Role>
      <ShortName>Debt - Senior Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Debt - Foreign Currency Swaps and Circle Health Debt Refinancing (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails</Role>
      <ShortName>Debt - Foreign Currency Swaps and Circle Health Debt Refinancing (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Debt - Revolving Credit Facility and Term Loan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails</Role>
      <ShortName>Debt - Revolving Credit Facility and Term Loan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Debt - Construction Loan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/DebtConstructionLoanDetails</Role>
      <ShortName>Debt - Construction Loan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Debt - Debt Repurchase Program (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/DebtDebtRepurchaseProgramDetails</Role>
      <ShortName>Debt - Debt Repurchase Program (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Debt - Letters of Credit &amp; Surety Bonds (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails</Role>
      <ShortName>Debt - Letters of Credit &amp; Surety Bonds (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Debt - Schedule of Aggregate Maturities of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails</Role>
      <ShortName>Debt - Schedule of Aggregate Maturities of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Leases - ROU Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails</Role>
      <ShortName>Leases - ROU Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Leases - Operating Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails</Role>
      <ShortName>Leases - Operating Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - Stockholders' Equity -Share Repurchase Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails</Role>
      <ShortName>Stockholders' Equity -Share Repurchase Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Statutory Capital Requirements and Dividend Restrictions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictionsDetails</Role>
      <ShortName>Statutory Capital Requirements and Dividend Restrictions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictions</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - Income Taxes - Consolidated Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes - Consolidated Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - Income Taxes - Reconciliation of the Tax Provision at the U.S. Federal Statutory Rate to the Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Reconciliation of the Tax Provision at the U.S. Federal Statutory Rate to the Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0000091 - Disclosure - Income Taxes - Tax Effects of Temporary Differences Which Give Rise to Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Tax Effects of Temporary Differences Which Give Rise to Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0000092 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0000093 - Disclosure - Income Taxes - Schedule of Reserve for Uncertain Tax Positions That May be Challenged (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails</Role>
      <ShortName>Income Taxes - Schedule of Reserve for Uncertain Tax Positions That May be Challenged (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0000094 - Disclosure - Stock Incentive Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/StockIncentivePlansNarrativeDetails</Role>
      <ShortName>Stock Incentive Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0000095 - Disclosure - Stock Incentive Plans - Non-Vested Restricted Stock and Restricted Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails</Role>
      <ShortName>Stock Incentive Plans - Non-Vested Restricted Stock and Restricted Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0000096 - Disclosure - Retirement Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/RetirementPlanDetails</Role>
      <ShortName>Retirement Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.centene.com/role/RetirementPlan</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0000097 - Disclosure - Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/CommitmentsDetails</Role>
      <ShortName>Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.centene.com/role/Commitments</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0000098 - Disclosure - Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/ContingenciesDetails</Role>
      <ShortName>Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.centene.com/role/Contingencies</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0000099 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.centene.com/role/EarningsPerShareTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0000100 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.centene.com/role/SegmentInformationTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>0000101 - Disclosure - Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails</Role>
      <ShortName>Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>0000102 - Disclosure - Condensed Financial Information of Registrant - Condensed Balance Sheets Additional (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails</Role>
      <ShortName>Condensed Financial Information of Registrant - Condensed Balance Sheets Additional (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>0000103 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails</Role>
      <ShortName>Condensed Financial Information of Registrant - Condensed Statements of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="cnc-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>0000104 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails</Role>
      <ShortName>Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 4 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 -  cnc-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="cnc-20221231.htm">cnc-20221231.htm</File>
    <File>a2022123110-kexhibit1013.htm</File>
    <File>a2022123110-kexhibit1014.htm</File>
    <File>a2022123110-kexhibit1022a.htm</File>
    <File>a2022123110-kexhibit1023a.htm</File>
    <File>a2022123110-kexhibit1024.htm</File>
    <File>a2022123110-kexhibit1025.htm</File>
    <File>a2022123110-kexhibit1031.htm</File>
    <File>a2022123110-kexhibit105.htm</File>
    <File>a2022123110-kexhibit21.htm</File>
    <File>a2022123110-kexhibit23.htm</File>
    <File>a2022123110-kexhibit311.htm</File>
    <File>a2022123110-kexhibit312.htm</File>
    <File>a2022123110-kexhibit321.htm</File>
    <File>a2022123110-kexhibit322.htm</File>
    <File>a2022123110-kexhibit41.htm</File>
    <File>cnc-20221231.xsd</File>
    <File>cnc-20221231_cal.xml</File>
    <File>cnc-20221231_def.xml</File>
    <File>cnc-20221231_lab.xml</File>
    <File>cnc-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cnc-20221231_g1.jpg</File>
    <File>cnc-20221231_g2.jpg</File>
    <File>cnc-20221231_g3.jpg</File>
    <File>cnc-20221231_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="1620">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>137
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cnc-20221231.htm": {
   "axisCustom": 1,
   "axisStandard": 36,
   "baseTaxonomies": {
    "http://fasb.org/srt/2022": 3,
    "http://fasb.org/us-gaap/2022": 1620,
    "http://xbrl.sec.gov/dei/2022": 37
   },
   "contextCount": 427,
   "dts": {
    "calculationLink": {
     "local": [
      "cnc-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cnc-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cnc-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cnc-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cnc-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cnc-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 843,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 12,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 16
   },
   "keyCustom": 90,
   "keyStandard": 450,
   "memberCustom": 48,
   "memberStandard": 73,
   "nsprefix": "cnc",
   "nsuri": "http://www.centene.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.centene.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Organization and Operations",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.centene.com/role/OrganizationandOperations",
     "shortName": "Organization and Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - Segment Information (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://www.centene.com/role/SegmentInformationDetails",
     "shortName": "Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000101 - Disclosure - Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
     "shortName": "Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i0152a1872d414c68a590ec9403c7ff34_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000102 - Disclosure - Condensed Financial Information of Registrant - Condensed Balance Sheets Additional (Details)",
     "menuCat": "Details",
     "order": "102",
     "role": "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails",
     "shortName": "Condensed Financial Information of Registrant - Condensed Balance Sheets Additional (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i0152a1872d414c68a590ec9403c7ff34_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000103 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Operations (Details)",
     "menuCat": "Details",
     "order": "103",
     "role": "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
     "shortName": "Condensed Financial Information of Registrant - Condensed Statements of Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherOperatingActivitiesCashFlowStatement",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000104 - Disclosure - Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)",
     "menuCat": "Details",
     "order": "104",
     "role": "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
     "shortName": "Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedCashFlowStatementTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i02b1234883664159a2ff344e54fcb3d5_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cnc:DividendsfromSubsidiariesOperatingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.centene.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Acquisitions and Divestitures",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.centene.com/role/AcquisitionsandDivestitures",
     "shortName": "Acquisitions and Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Short-term and Long-term Investments, Restricted Deposits",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits",
     "shortName": "Short-term and Long-term Investments, Restricted Deposits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.centene.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Property, Software and Equipment",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.centene.com/role/PropertySoftwareandEquipment",
     "shortName": "Property, Software and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Goodwill and Intangible Assets",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.centene.com/role/GoodwillandIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Medical Claims Liability",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.centene.com/role/MedicalClaimsLiability",
     "shortName": "Medical Claims Liability",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnc:AffordableCareActDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Affordable Care Act",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.centene.com/role/AffordableCareAct",
     "shortName": "Affordable Care Act",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnc:AffordableCareActDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Debt",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.centene.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.centene.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.centene.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Stockholders' Equity",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.centene.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnc:StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Statutory Capital Requirements and Dividend Restrictions",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictions",
     "shortName": "Statutory Capital Requirements and Dividend Restrictions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnc:StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.centene.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Stock Incentive Plans",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.centene.com/role/StockIncentivePlans",
     "shortName": "Stock Incentive Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Retirement Plan",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.centene.com/role/RetirementPlan",
     "shortName": "Retirement Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Commitments",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.centene.com/role/Commitments",
     "shortName": "Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Contingencies",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.centene.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Earnings Per Share",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://www.centene.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Segment Information",
     "menuCat": "Notes",
     "order": "29",
     "role": "http://www.centene.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PremiumsAndOtherReceivablesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Condensed Financial Information of Registrant",
     "menuCat": "Notes",
     "order": "30",
     "role": "http://www.centene.com/role/CondensedFinancialInformationofRegistrant",
     "shortName": "Condensed Financial Information of Registrant",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "31",
     "role": "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnc:ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnc:ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Acquisitions and Divestitures (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.centene.com/role/AcquisitionsandDivestituresTables",
     "shortName": "Acquisitions and Divestitures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables",
     "shortName": "Short-term and Long-term Investments, Restricted Deposits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnc:FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.centene.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnc:FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Property, Software and Equipment (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.centene.com/role/PropertySoftwareandEquipmentTables",
     "shortName": "Property, Software and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.centene.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Medical Claims Liability (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.centene.com/role/MedicalClaimsLiabilityTables",
     "shortName": "Medical Claims Liability (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Affordable Care Act (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.centene.com/role/AffordableCareActTables",
     "shortName": "Affordable Care Act (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Debt (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.centene.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.centene.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Stockholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.centene.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://www.centene.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Stock Incentive Plans (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://www.centene.com/role/StockIncentivePlansTables",
     "shortName": "Stock Incentive Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Earnings Per Share (Tables)",
     "menuCat": "Tables",
     "order": "45",
     "role": "http://www.centene.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Segment Information (Tables)",
     "menuCat": "Tables",
     "order": "46",
     "role": "http://www.centene.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Condensed Financial Information of Registrant (Tables)",
     "menuCat": "Tables",
     "order": "47",
     "role": "http://www.centene.com/role/CondensedFinancialInformationofRegistrantTables",
     "shortName": "Condensed Financial Information of Registrant (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Organization and Operations (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.centene.com/role/OrganizationandOperationsDetails",
     "shortName": "Organization and Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "id7f45234b97a4a8db9cc70838a92e915_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property, Software and Equipment Depreciation Periods (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Property, Software and Equipment Depreciation Periods (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "id7f45234b97a4a8db9cc70838a92e915_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Summary of Significant Accounting Policies - Schedule of Amortization Period for Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Amortization Period for Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i74119b927bec4965b1fd97a0689f4f10_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cnc:ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Summary of Significant Accounting Policies - Schedule of Allowance for Uncollectible Accounts (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAllowanceforUncollectibleAccountsDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Allowance for Uncollectible Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cnc:ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i89efa37b183c4c618c28149ddb506553_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "cnc:SignificantCustomersPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "cnc:PercentageOfRevenuesUnderContractsOrSubcontracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Summary of Significant Accounting Policies - Significant Customers (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails",
     "shortName": "Summary of Significant Accounting Policies - Significant Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "cnc:SignificantCustomersPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "cnc:PercentageOfRevenuesUnderContractsOrSubcontracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i906fa59240054e0ca347d7e3ce1f9812_D20220104-20220104",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Acquisitions and Divestitures - Narrative (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails",
     "shortName": "Acquisitions and Divestitures - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i906fa59240054e0ca347d7e3ce1f9812_D20220104-20220104",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Acquisitions and Divestitures - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "Acquisitions and Divestitures - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ib9e33ae8c26e4bee80e6c7f1321df430_I20220104",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ib9e33ae8c26e4bee80e6c7f1321df430_I20220104",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Acquisitions and Divestitures - Identifiable Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails",
     "shortName": "Acquisitions and Divestitures - Identifiable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i8fd457add58740c084e97e1c414ce9f9_I20220104",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfBusiness",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Acquisitions and Divestitures - Divestitures (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails",
     "shortName": "Acquisitions and Divestitures - Divestitures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i8676d1a500a445dfbdfe2ed3255b473a_D20220714-20220714",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails",
     "shortName": "Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails",
     "shortName": "Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-for-Sale Investments in a Continuous Unrealized Loss Position (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails",
     "shortName": "Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-for-Sale Investments in a Continuous Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i6dfd24ddae8241599cc88560c625724a_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails",
     "shortName": "Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i6dfd24ddae8241599cc88560c625724a_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.centene.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Property, Software and Equipment - Components (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails",
     "shortName": "Property, Software and Equipment - Components (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Property, Software and Equipment - Narrative (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails",
     "shortName": "Property, Software and Equipment - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i29be61bb7bd449499dfb1c0c4a885854_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:TangibleAssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Goodwill and Intangible Assets - Schedule of Changes in Goodwill by Operating Segment (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails",
     "shortName": "Goodwill and Intangible Assets - Schedule of Changes in Goodwill by Operating Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i7849ad351f3a4c2c85f3c60fa5e30c67_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Goodwill and Intangible Assets - Schedule of Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets - Schedule of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Goodwill and Intangible Assets - Schedule of Future Amortization Expenses (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpensesDetails",
     "shortName": "Goodwill and Intangible Assets - Schedule of Future Amortization Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails",
     "shortName": "Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i89efa37b183c4c618c28149ddb506553_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "id53035e323dd4a8a8791395cc30ffafe_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "id53035e323dd4a8a8791395cc30ffafe_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Medical Claims Liability - Narrative (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails",
     "shortName": "Medical Claims Liability - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i41b58c91b23541a8a008f29061d225c8_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Medical Claims Liability - Cumulative Incurred and Paid Claims (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails",
     "shortName": "Medical Claims Liability - Cumulative Incurred and Paid Claims (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i41b58c91b23541a8a008f29061d225c8_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i41b58c91b23541a8a008f29061d225c8_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Medical Claims Liability - Incurred Claims and Allocated Claims Adjustment Expenses (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails",
     "shortName": "Medical Claims Liability - Incurred Claims and Allocated Claims Adjustment Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i19d7002bf5504374ba94620ad1f9d850_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cnc:ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:AffordableCareActRiskAdjustmentReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Affordable Care Act (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.centene.com/role/AffordableCareActDetails",
     "shortName": "Affordable Care Act (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:AffordableCareActRiskAdjustmentReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:SeniorNotesTotal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Debt - Schedule of Debt (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.centene.com/role/DebtScheduleofDebtDetails",
     "shortName": "Debt - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:SeniorNotesTotal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i7582e6a18d214d5683a70f95e9969290_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Debt - Additional Information (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.centene.com/role/DebtAdditionalInformationDetails",
     "shortName": "Debt - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i7582e6a18d214d5683a70f95e9969290_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Debt - Senior Notes (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.centene.com/role/DebtSeniorNotesDetails",
     "shortName": "Debt - Senior Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i15f1c30fc6e14d85b699a2ed36b96775_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GainLossOnRepurchaseOfDebtInstrument",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:GainLossOnExtinguishmentOfDebtIncludingCashPortion",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Debt - Foreign Currency Swaps and Circle Health Debt Refinancing (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails",
     "shortName": "Debt - Foreign Currency Swaps and Circle Health Debt Refinancing (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i628d01f64b184de1b7b5efff1732a9d8_I20210731",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cnc:LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Debt - Revolving Credit Facility and Term Loan (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
     "shortName": "Debt - Revolving Credit Facility and Term Loan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cnc:LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ib9edeffc055d4939acb82ad908f07cbe_I20171031",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Debt - Construction Loan (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.centene.com/role/DebtConstructionLoanDetails",
     "shortName": "Debt - Construction Loan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i96f3204307ae4fdfb13dc11441d5072d_D20220401-20220430",
      "decimals": null,
      "lang": "en-US",
      "name": "cnc:DebtInstrumentExtensionTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i04652939d67241d39001577da981b842_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:DebtRepurchaseProgramAuthorizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Debt - Debt Repurchase Program (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.centene.com/role/DebtDebtRepurchaseProgramDetails",
     "shortName": "Debt - Debt Repurchase Program (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i04652939d67241d39001577da981b842_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:DebtRepurchaseProgramAuthorizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i0b502a06d63b40bebe5407d59dadc678_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Debt - Letters of Credit & Surety Bonds (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails",
     "shortName": "Debt - Letters of Credit & Surety Bonds (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i0b502a06d63b40bebe5407d59dadc678_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Debt - Schedule of Aggregate Maturities of Debt (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails",
     "shortName": "Debt - Schedule of Aggregate Maturities of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.centene.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Leases - ROU Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails",
     "shortName": "Leases - ROU Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Leases - Operating Lease Maturity (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails",
     "shortName": "Leases - Operating Lease Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i7b616f4f2341472dbd385786d0a01c38_D20221201-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:StockRepurchaseProgramIncreaseAuthorizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.centene.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i7b616f4f2341472dbd385786d0a01c38_D20221201-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:StockRepurchaseProgramIncreaseAuthorizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Stockholders' Equity -Share Repurchase Activity (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails",
     "shortName": "Stockholders' Equity -Share Repurchase Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "if8a8cf81a11c41a893d0995455479cd6_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Statutory Capital Requirements and Dividend Restrictions (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictionsDetails",
     "shortName": "Statutory Capital Requirements and Dividend Restrictions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - Income Taxes - Consolidated Income Tax Expense (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails",
     "shortName": "Income Taxes - Consolidated Income Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - Income Taxes - Reconciliation of the Tax Provision at the U.S. Federal Statutory Rate to the Provision for Income Taxes (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes - Reconciliation of the Tax Provision at the U.S. Federal Statutory Rate to the Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cnc:LossEarningsAttributableToFlowThroughNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - Income Taxes - Tax Effects of Temporary Differences Which Give Rise to Deferred Tax Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Tax Effects of Temporary Differences Which Give Rise to Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.centene.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnc:DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - Income Taxes - Schedule of Reserve for Uncertain Tax Positions That May be Challenged (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails",
     "shortName": "Income Taxes - Schedule of Reserve for Uncertain Tax Positions That May be Challenged (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i2185a9a104a3441390ac2f06aefa122a_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - Stock Incentive Plans - Narrative (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://www.centene.com/role/StockIncentivePlansNarrativeDetails",
     "shortName": "Stock Incentive Plans - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ida2e74d548f94bb09ac682a12b3f2b23_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - Stock Incentive Plans - Non-Vested Restricted Stock and Restricted Stock (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails",
     "shortName": "Stock Incentive Plans - Non-Vested Restricted Stock and Restricted Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i6b3b1ee2d45c48b5841dfb1bcb1f71c5_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnc:DefinedContributionPlanMinimumAgeForCoverage",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - Retirement Plan (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://www.centene.com/role/RetirementPlanDetails",
     "shortName": "Retirement Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnc:DefinedContributionPlanMinimumAgeForCoverage",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i56eac86dba6e4053a7ca2c5c5581989e_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCommitment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - Commitments (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://www.centene.com/role/CommitmentsDetails",
     "shortName": "Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "i56eac86dba6e4053a7ca2c5c5581989e_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCommitment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ie10b1c36a39645fd98b8f6652a9ea7aa_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - Contingencies (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://www.centene.com/role/ContingenciesDetails",
     "shortName": "Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ie10b1c36a39645fd98b8f6652a9ea7aa_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - Earnings Per Share (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://www.centene.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnc-20221231.htm",
      "contextRef": "ibbe8935085c442c8aa0b990f7fb9fde5_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 123,
   "tag": {
    "cnc_A1300Million2625SeniorNotesDueAugust2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$1,300 Million 2.625% Senior Notes due August 2031",
        "label": "$1,300 Million 2.625% Senior Notes due August 2031 [Member]",
        "terseLabel": "$1,300 Million 2.625% Senior Notes due August 2031 [Member]"
       }
      }
     },
     "localname": "A1300Million2625SeniorNotesDueAugust2031Member",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofDebtDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_A1800Million245SeniorNotesDueMarch2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$1,800 Million 2.45% Senior Notes due March 2028",
        "label": "$1,800 Million 2.45% Senior Notes due March 2028 [Member]",
        "terseLabel": "$1,800 Million 2.45% Senior Notes due March 2028"
       }
      }
     },
     "localname": "A1800Million245SeniorNotesDueMarch2028Member",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_A2000Million3375SeniorNotesDueFebruary2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$2,000 Million 3.375% Senior Notes due February 2030 [Member]",
        "label": "$2,000 Million 3.375% Senior Notes due February 2030 [Member]",
        "terseLabel": "$2,000 million 3.375% Senior Notes, due February 15, 2030"
       }
      }
     },
     "localname": "A2000Million3375SeniorNotesDueFebruary2030Member",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_A2200Million250SeniorNotesDue2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$2,200 Million 2.50% Senior Notes due 2031",
        "label": "$2,200 Million 2.50% Senior Notes due 2031 [Member]",
        "terseLabel": "$2,200 Million 2.50% Senior Notes due 2031"
       }
      }
     },
     "localname": "A2200Million250SeniorNotesDue2031Member",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_A2200Million250SeniorNotesDueMarch2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$2,200 Million 2.50% Senior Notes due March 2031",
        "label": "$2,200 Million 2.50% Senior Notes due March 2031 [Member]",
        "terseLabel": "$2,200 Million 2.50% Senior Notes due March 2031 [Member]"
       }
      }
     },
     "localname": "A2200Million250SeniorNotesDueMarch2031Member",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_A2200Million30SeniorNotesDueOctober2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$2,200 Million 3.0% Senior Notes due October 2030",
        "label": "$2,200 Million 3.0% Senior Notes due October 2030 [Member]",
        "terseLabel": "$2,200 million 3.00% Senior Notes, due October 15, 2030"
       }
      }
     },
     "localname": "A2200Million30SeniorNotesDueOctober2030Member",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_A2200Million475SeniorNotesDueJanuary2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$2,200 Million 4.75% Senior Notes due January 2025",
        "label": "$2,200 Million 4.75% Senior Notes due January 2025 [Member]",
        "terseLabel": "$2,200 Million 4.75% Senior Notes due January 2025"
       }
      }
     },
     "localname": "A2200Million475SeniorNotesDueJanuary2025Member",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_A2300Million245SeniorNotesDueJuly2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$2,300 Million 2.45% Senior Notes due July 2028",
        "label": "$2,300 Million 2.45% Senior Notes due July 2028 [Member]",
        "terseLabel": "$2,300 Million 2.45% Senior Notes due July 2028 [Member]"
       }
      }
     },
     "localname": "A2300Million245SeniorNotesDueJuly2028Member",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_A2500Million425SeniorNotesDueDecember2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$2,500 Million 4.25% Senior Notes due December 2027 [Member]",
        "label": "$2,500 Million 4.25% Senior Notes due December 2027 [Member]",
        "terseLabel": "$2,500 million 4.25% Senior Notes, due December 15, 2027",
        "verboseLabel": "$2,500 Million 4.25% Senior Notes due December 2027 [Member]"
       }
      }
     },
     "localname": "A2500Million425SeniorNotesDueDecember2027Member",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofDebtDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_A3500Million4625SeniorNotesDueDecember2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$3,500 Million 4.625% Senior Notes due December 2029",
        "label": "$3,500 Million 4.625% Senior Notes due December 2029 [Member]",
        "terseLabel": "$3,500 Million 4.625% Senior Notes due December 2029 [Member]"
       }
      }
     },
     "localname": "A3500Million4625SeniorNotesDueDecember2029Member",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofDebtDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_A750Million5375SeniorNotesDueJune2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$750 Million 5.375% Senior Notes due June 2026 [Member]",
        "label": "$750 Million 5.375% Senior Notes due June 2026 [Member]",
        "verboseLabel": "5.375% Senior notes, due 2026"
       }
      }
     },
     "localname": "A750Million5375SeniorNotesDueJune2026Member",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_ACAHealthInsurerFee": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ACA Health Insurer Fee",
        "label": "ACA Health Insurer Fee",
        "verboseLabel": "ACA health insurer fee"
       }
      }
     },
     "localname": "ACAHealthInsurerFee",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_AcceleratedShareRepurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase Agreement",
        "label": "Accelerated Share Repurchase Agreement [Member]",
        "terseLabel": "Accelerated Share Repurchase Agreement"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseAgreementMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_AcceleratedShareRepurchasesAgreementAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases Agreement, Amount",
        "label": "Accelerated Share Repurchases Agreement, Amount",
        "terseLabel": "Accelerated share repurchases agreement, amount"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesAgreementAmount",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_AcceleratedShareRepurchasesDiscountPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Discount, Price Per Share",
        "label": "Accelerated Share Repurchases, Discount, Price Per Share",
        "terseLabel": "ASR, discount (in usd per share)"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDiscountPricePerShare",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cnc_AffordableCareActAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affordable Care Act [Abstract]",
        "label": "Affordable Care Act [Abstract]",
        "terseLabel": "Affordable Care Act [Abstract]"
       }
      }
     },
     "localname": "AffordableCareActAbstract",
     "nsuri": "http://www.centene.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cnc_AffordableCareActCostSharingReductionReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affordable Care Act, Cost Sharing Reduction Receivable",
        "label": "Affordable Care Act, Cost Sharing Reduction Receivable",
        "terseLabel": "Cost sharing reduction receivable"
       }
      }
     },
     "localname": "AffordableCareActCostSharingReductionReceivable",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AffordableCareActDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_AffordableCareActCostSharingReductionsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affordable Care Act Cost Sharing Reductions, Payable",
        "label": "Affordable Care Act Cost Sharing Reductions, Payable",
        "negatedTerseLabel": "Cost sharing reduction payable"
       }
      }
     },
     "localname": "AffordableCareActCostSharingReductionsPayable",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AffordableCareActDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_AffordableCareActDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affordable Care Act Disclosure [Text Block]",
        "label": "Affordable Care Act Disclosure [Text Block]",
        "terseLabel": "Affordable Care Act"
       }
      }
     },
     "localname": "AffordableCareActDisclosureTextBlock",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AffordableCareAct"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cnc_AffordableCareActMinimumMedicalLossRatio": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affordable Care Act, Minimum Medical Loss Ratio",
        "label": "Affordable Care Act Minimum Medical Loss Ratio",
        "negatedLabel": "Minimum medical loss ratio"
       }
      }
     },
     "localname": "AffordableCareActMinimumMedicalLossRatio",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AffordableCareActDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_AffordableCareActReinsurancePayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affordable Care Act Reinsurance, Payable",
        "label": "Affordable Care Act Reinsurance Payable",
        "negatedTerseLabel": "Risk adjustment payable"
       }
      }
     },
     "localname": "AffordableCareActReinsurancePayable",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AffordableCareActDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit)",
        "label": "Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit)",
        "negatedLabel": "Risk adjustment pre-tax benefit"
       }
      }
     },
     "localname": "AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AffordableCareActDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affordable Care Act, Risk Adjustment, Net Receivable Increase (Decrease)",
        "label": "Affordable Care Act, Risk Adjustment, Net Receivable Increase (Decrease)",
        "terseLabel": "Risk adjustment, net receivable increase"
       }
      }
     },
     "localname": "AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AffordableCareActDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_AffordableCareActRiskAdjustmentReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affordable Care Act, Risk Adjustment Receivable",
        "label": "Affordable Care Act, Risk Adjustment Receivable",
        "terseLabel": "Risk adjustment receivable"
       }
      }
     },
     "localname": "AffordableCareActRiskAdjustmentReceivable",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AffordableCareActDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs",
        "label": "Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs",
        "terseLabel": "Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs"
       }
      }
     },
     "localname": "AmountsrecordedasanadjustmenttopremiumrevenuesrelatedtominimumHBRandreturnofpremiumprograms",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_AssetImpairmentChargesNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment Charges, Net of Tax",
        "label": "Asset Impairment Charges, Net of Tax",
        "terseLabel": "Impairment charge, net of tax"
       }
      }
     },
     "localname": "AssetImpairmentChargesNetOfTax",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_AuditorInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor Information",
        "label": "Auditor Information [Abstract]",
        "terseLabel": "Auditor Information [Abstract]"
       }
      }
     },
     "localname": "AuditorInformationAbstract",
     "nsuri": "http://www.centene.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Deposits",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Deposits",
        "terseLabel": "Restricted deposits"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedDeposits",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Return Of Premium Payable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Return Of Premium Payable",
        "terseLabel": "Return of premium payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReturnOfPremiumPayable",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Long-term Investments",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Long-term Investments",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsLongtermInvestments",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Short-term Investments",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Short-term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsShorttermInvestments",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Medical Claims Liability",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Medical Claims Liability",
        "terseLabel": "Medical claims liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesMedicalClaimsLiability",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-term Debt, Principal",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-term Debt, Principal",
        "terseLabel": "Debt assumed, aggregate principal"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtPrincipal",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_CapitalContributionsToSubsidiaries": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Contributions to Subsidiaries",
        "label": "Capital Contributions to Subsidiaries",
        "negatedTerseLabel": "Capital contributions to subsidiaries"
       }
      }
     },
     "localname": "CapitalContributionsToSubsidiaries",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_CenturionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Centurion",
        "label": "Centurion [Member]",
        "terseLabel": "Centurion"
       }
      }
     },
     "localname": "CenturionMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_CircleHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Circle Health",
        "label": "Circle Health [Member]",
        "terseLabel": "Circle Health"
       }
      }
     },
     "localname": "CircleHealthMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_ComputerHardwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer Hardware [Member]",
        "label": "Computer Hardware [Member]",
        "terseLabel": "Computer hardware"
       }
      }
     },
     "localname": "ComputerHardwareMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_DebtInstrumentAmortizationPaymentRatePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Amortization Payment Rate, Percentage",
        "label": "Debt Instrument, Amortization Payment Rate, Percentage",
        "terseLabel": "Amortization payment percentage"
       }
      }
     },
     "localname": "DebtInstrumentAmortizationPaymentRatePercentage",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cnc_DebtInstrumentCovenantNetLeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Net Leverage Ratio, Maximum",
        "label": "Debt Instrument, Covenant, Net Leverage Ratio, Maximum",
        "terseLabel": "Covenant, maximum net leverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantNetLeverageRatioMaximum",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "cnc_DebtInstrumentExtensionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Extension Term",
        "label": "Debt Instrument, Extension Term",
        "terseLabel": "Extension term"
       }
      }
     },
     "localname": "DebtInstrumentExtensionTerm",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtConstructionLoanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cnc_DebtInstrumentPaymentPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Payment Period",
        "label": "Debt Instrument, Payment Period [Axis]",
        "terseLabel": "Debt Instrument, Payment Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentPaymentPeriodAxis",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cnc_DebtInstrumentPaymentPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Payment Period [Domain]",
        "label": "Debt Instrument, Payment Period [Domain]",
        "terseLabel": "Debt Instrument, Payment Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentPaymentPeriodDomain",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_DebtInstrumentPaymentPeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Payment Period, One",
        "label": "Debt Instrument, Payment Period, One [Member]",
        "terseLabel": "First year"
       }
      }
     },
     "localname": "DebtInstrumentPaymentPeriodOneMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_DebtInstrumentPaymentPeriodThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Payment Period, Three",
        "label": "Debt Instrument, Payment Period, Three [Member]",
        "terseLabel": "Thereafter until maturity"
       }
      }
     },
     "localname": "DebtInstrumentPaymentPeriodThreeMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_DebtInstrumentPaymentPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Payment Period, Two",
        "label": "Debt Instrument, Payment Period, Two [Member]",
        "terseLabel": "Second year following closing"
       }
      }
     },
     "localname": "DebtInstrumentPaymentPeriodTwoMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_DebtRepurchaseProgramAuthorizedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Repurchase Program, Authorized Amount",
        "label": "Debt Repurchase Program, Authorized Amount",
        "terseLabel": "Debt Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "DebtRepurchaseProgramAuthorizedAmount",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtDebtRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Repurchase Program, Remaining Amount Authorized to be Repurchased, Amount",
        "label": "Debt Repurchase Program, Remaining Amount Authorized to be Repurchased, Amount",
        "terseLabel": "Remaining amount available under the program"
       }
      }
     },
     "localname": "DebtRepurchaseProgramRemainingAmountAuthorizedToBeRepurchasedAmount",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtDebtRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_DebtSecuritiesAvailableForSaleNumberOfPositions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available -for-Sale, Number of Positions",
        "label": "Debt Securities, Available -for-Sale, Number of Positions",
        "terseLabel": "Total investment positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleNumberOfPositions",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cnc_DebtTotalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Total",
        "label": "Debt Total [Member]",
        "terseLabel": "Debt Total"
       }
      }
     },
     "localname": "DebtTotalMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_DeferredTaxAssetOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Operating Lease Liability",
        "label": "Deferred Tax Asset, Operating Lease Liability",
        "verboseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetOperatingLeaseLiability",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_DeferredTaxAssetPremiumAndTradeReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Premium And Trade Receivables",
        "label": "Deferred Tax Asset, Premium And Trade Receivables",
        "verboseLabel": "Premium and trade receivables"
       }
      }
     },
     "localname": "DeferredTaxAssetPremiumAndTradeReceivables",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_DeferredTaxAssetSoftwareDevelopmentCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Software Development Costs",
        "label": "Deferred Tax Asset, Software Development Costs",
        "terseLabel": "Software development costs"
       }
      }
     },
     "localname": "DeferredTaxAssetSoftwareDevelopmentCosts",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_DeferredTaxAssetsInvestmentUnrealizedGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Investment, Unrealized Gain/Loss",
        "label": "Deferred Tax Assets, Investment, Unrealized Gain/Loss",
        "terseLabel": "Unrealized loss"
       }
      }
     },
     "localname": "DeferredTaxAssetsInvestmentUnrealizedGainLoss",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards",
        "verboseLabel": "Net operating loss and tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards, Not Subject To Expiration",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards, Not Subject To Expiration",
        "terseLabel": "Operating loss carryforwards and tax credit carryforwards, not subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards, Subject To Expiration",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards And Tax Credit Carryforwards, Subject To Expiration",
        "terseLabel": "Operating loss carryforwards and tax credit carryforwards, subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwardsSubjectToExpiration",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Investment, Unrealized Gain/Loss",
        "label": "Deferred Tax Liabilities, Investment, Unrealized Gain/Loss",
        "verboseLabel": "Unrealized gain"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesInvestmentUnrealizedGainLoss",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_DeferredTaxLiabilitiesRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Right Of Use Assets",
        "label": "Deferred Tax Liabilities, Right Of Use Assets",
        "verboseLabel": "Right-of-use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRightOfUseAssets",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_DefinedContributionPlanMinimumAgeForCoverage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan, Minimum Age For Coverage",
        "label": "Defined Contribution Plan, Minimum Age For Coverage",
        "terseLabel": "Defined contribution plan covered employee, age (at least)"
       }
      }
     },
     "localname": "DefinedContributionPlanMinimumAgeForCoverage",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/RetirementPlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Consideration, Contingent Consideration, Range of Outcomes, Value High",
        "label": "Disposal Group, Including Discontinued Operations, Consideration, Contingent Consideration, Range of Outcomes, Value High",
        "terseLabel": "Contingent consideration, could receive (up to)"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_DividendsfromSubsidiariesOperatingActivities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends from Subsidiaries, Operating Activities",
        "label": "Dividends from Subsidiaries, Operating Activities",
        "verboseLabel": "Dividends from subsidiaries, return on investment"
       }
      }
     },
     "localname": "DividendsfromSubsidiariesOperatingActivities",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Deferred Taxes for Investment in Subsidiaries",
        "label": "Effective Income Tax Rate Reconciliation, Deferred Taxes for Investment in Subsidiaries",
        "terseLabel": "Deferred taxes for investments in subsidiaries"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeferredTaxesForInvestmentInSubsidiaries",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails",
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Litigation Settlement",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Litigation Settlement",
        "verboseLabel": "Nondeductible PBM legal settlement"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLitigationSettlement",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Nondeductible Expense, Goodwill",
        "label": "Effective Income Tax Reconciliation, Nondeductible Expense, Goodwill",
        "verboseLabel": "Nondeductible goodwill"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationNondeductibleExpenseGoodwill",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_EmployeeStockCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Compensation Plan",
        "label": "Employee Stock Compensation Plan [Member]",
        "terseLabel": "Employee Stock Compensation Plan"
       }
      }
     },
     "localname": "EmployeeStockCompensationPlanMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions",
        "label": "Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Input Definitions [Table Text Block]",
        "terseLabel": "Fair Value Level Input And Input Definitions"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cnc_FederalServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Services",
        "label": "Federal Services [Member]",
        "terseLabel": "Federal Services"
       }
      }
     },
     "localname": "FederalServicesMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_FinanceLeaseLiabilityAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/DebtScheduleofDebtDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Liability And Other",
        "label": "Finance Lease Liability And Other",
        "terseLabel": "Finance leases and other"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityAndOther",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_FixedAssetsLeasedRealEstateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Assets, Leased Real Estate",
        "label": "Fixed Assets, Leased Real Estate [Member]",
        "terseLabel": "Fixed assets, leased real estate"
       }
      }
     },
     "localname": "FixedAssetsLeasedRealEstateMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_FurnitureAndOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Furniture And Office Equipment [Member]",
        "label": "Furniture And Office Equipment [Member]",
        "terseLabel": "Furniture and office equipment"
       }
      }
     },
     "localname": "FurnitureAndOfficeEquipmentMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_GainLossOnDispositionOfBusinessNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Disposition of Business, Net of Tax",
        "label": "Gain (Loss) on Disposition of Business, Net of Tax",
        "terseLabel": "(Gain) on divestitures, net of tax"
       }
      }
     },
     "localname": "GainLossOnDispositionOfBusinessNetOfTax",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Extinguishment of Debt , Including Cash Portion",
        "label": "Gain (Loss) on Extinguishment of Debt , Including Cash Portion",
        "terseLabel": "Debt extinguishment",
        "verboseLabel": "Debt extinguishment"
       }
      }
     },
     "localname": "GainLossOnExtinguishmentOfDebtIncludingCashPortion",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_GrossDecreasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Decreases [Abstract]",
        "label": "Gross Decreases [Abstract]",
        "verboseLabel": "Gross decreases:"
       }
      }
     },
     "localname": "GrossDecreasesAbstract",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cnc_GrossIncreasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Increases [Abstract]",
        "label": "Gross Increases [Abstract]",
        "verboseLabel": "Gross increases:"
       }
      }
     },
     "localname": "GrossIncreasesAbstract",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Insurance Marketplace Disclosure [Policy Text Block]",
        "label": "Health Insurance Marketplace Disclosure [Policy Text Block]",
        "terseLabel": "Affordable Care Act"
       }
      }
     },
     "localname": "HealthInsuranceMarketplaceDisclosurePolicyTextBlock",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cnc_HealthInsurerFeeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Insurer Fee Expense",
        "label": "Health Insurer Fee Expense",
        "terseLabel": "Health insurer fee expense"
       }
      }
     },
     "localname": "HealthInsurerFeeExpense",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_HealthSmartMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HealthSmart",
        "label": "HealthSmart [Member]",
        "terseLabel": "HealthSmart"
       }
      }
     },
     "localname": "HealthSmartMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Less Noncontrolling Interest",
        "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Less Noncontrolling Interest",
        "terseLabel": "Earnings less noncontrolling interest before income tax expense"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_InvestmentSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Securities",
        "label": "Investment Securities [Member]",
        "terseLabel": "Investment Securities"
       }
      }
     },
     "localname": "InvestmentSecuritiesMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost",
        "label": "Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost",
        "totalLabel": "Total, Amortized Cost"
       }
      }
     },
     "localname": "InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments, Debt Securities, Equity Securities And Other, Fair Value",
        "label": "Investments, Debt Securities, Equity Securities And Other, Fair Value",
        "totalLabel": "Total, Fair Value"
       }
      }
     },
     "localname": "InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration",
        "label": "Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration",
        "terseLabel": "Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years)"
       }
      }
     },
     "localname": "InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cnc_LesseeOperatingLeaseLeaseNotYetCommencedLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability",
        "terseLabel": "Operating lease not yet commenced, liability"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiability",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_LesseeOperatingLeaseLeasesCommencedLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Leases Commenced, Liability",
        "label": "Lessee, Operating Lease, Leases Commenced, Liability",
        "terseLabel": "Lease liability for leases commenced"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeasesCommencedLiability",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Life Insurance Contracts And Equity Investments, Fair Value",
        "label": "Life Insurance Contracts And Equity Investments, Fair Value",
        "terseLabel": "Aggregate carrying value which approximates fair value"
       }
      }
     },
     "localname": "LifeInsuranceContractsAndEquityInvestmentsFairValue",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Covenant Terms, Ratio Of Debt To Earnings Before Interest Taxes Depreciation And Amortization, Current Year, Other Increase",
        "label": "Line of Credit Facility, Covenant Terms, Ratio Of Debt To Earnings Before Interest Taxes Depreciation And Amortization, Current Year, Other Increase",
        "terseLabel": "Ratio of debt to EBITDA, may increase"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationAndAmortizationCurrentYearOtherIncrease",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "cnc_LineofCreditFacilityAccordionFeatureIncreaseLimit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Accordion Feature, Increase Limit",
        "label": "Line of Credit Facility, Accordion Feature, Increase Limit",
        "terseLabel": "Uncommitted option, to increase Credit Facility"
       }
      }
     },
     "localname": "LineofCreditFacilityAccordionFeatureIncreaseLimit",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "London Interbank Offered Rate (LIBOR) And Sterling Overnight Index Average (SONIA)",
        "label": "London Interbank Offered Rate (LIBOR) And Sterling Overnight Index Average (SONIA) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR) And Sterling Overnight Index Average (SONIA)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Investment, California Organized Investment Network [Member]",
        "label": "Long Term Investment, California Organized Investment Network [Member]",
        "terseLabel": "Long term investment, California Organized Investment Network"
       }
      }
     },
     "localname": "LongTermInvestmentCaliforniaOrganizedInvestmentNetworkMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Investment, Department of Health, State Of New York [Member]",
        "label": "Long Term Investment, Department Of Health, State Of New York [Member]",
        "terseLabel": "Department Of Health, State Of New York"
       }
      }
     },
     "localname": "LongTermInvestmentDepartmentOfHealthStateOfNewYorkMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Investment, Improvement in Enrollee Health, Locally Based Consumer Assistance, and Health Care Delivery System [Member]",
        "label": "Long Term Investment, Improvement in Enrollee Health, Locally Based Consumer Assistance, and Health Care Delivery System [Member]",
        "terseLabel": "Long term investment,improvement in enrollee health, locally based consumer assistance, and health care delivery system"
       }
      }
     },
     "localname": "LongTermInvestmentImprovementinEnrolleeHealthLocallyBasedConsumerAssistanceandHealthCareDeliverySystemMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_LongTermInvestmentServiceCenterinCaliforniaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Investment, Service Center in California [Member]",
        "label": "Long Term Investment, Service Center in California [Member]",
        "terseLabel": "Long term investment, service center in California"
       }
      }
     },
     "localname": "LongTermInvestmentServiceCenterinCaliforniaMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Investment, Vehicles Supporting California\u2019s Health Care Infrastructure [Member]",
        "label": "Long Term Investment, Vehicles Supporting California\u2019s Health Care Infrastructure [Member]",
        "terseLabel": "Long term investment, investment portfolio in vehicles supporting California\u2019s health care infrastructure"
       }
      }
     },
     "localname": "LongTermInvestmentVehiclesSupportingCaliforniasHealthCareInfrastructureMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_LossEarningsAttributableToFlowThroughNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss (earnings) attributable to flow through noncontrolling interest before tax",
        "label": "Loss (earnings) attributable to flow through noncontrolling interest",
        "terseLabel": "Loss (earnings) attributable to flow through noncontrolling interest"
       }
      }
     },
     "localname": "LossEarningsAttributableToFlowThroughNoncontrollingInterest",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_MagellanHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Magellan Health",
        "label": "Magellan Health [Member]",
        "terseLabel": "Magellan Health"
       }
      }
     },
     "localname": "MagellanHealthMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails",
      "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.centene.com/role/CommitmentsDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails",
      "http://www.centene.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_MagellanRxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Magellan Rx",
        "label": "Magellan Rx [Member]",
        "terseLabel": "Magellan Rx"
       }
      }
     },
     "localname": "MagellanRxMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_MagellanSpecialtyHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Magellan Specialty Health",
        "label": "Magellan Specialty Health [Member]",
        "terseLabel": "Magellan Specialty Health"
       }
      }
     },
     "localname": "MagellanSpecialtyHealthMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_ManagedCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ManagedCareMember",
        "label": "Managed Care [Member]",
        "terseLabel": "Managed\u00a0Care"
       }
      }
     },
     "localname": "ManagedCareMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails",
      "http://www.centene.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net income (loss), including portion attributable to noncontrolling interest before equity in earnings from subsidiaries",
        "label": "Net income (loss), including portion attributable to noncontrolling interest before equity in earnings from subsidiaries",
        "totalLabel": "Net (loss) before equity in subsidiaries"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_NotesAcceptedForTenderOfferPrincipalOutstandingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Accepted for Tender Offer, Principal Outstanding, Percentage",
        "label": "Notes Accepted for Tender Offer, Principal Outstanding, Percentage",
        "terseLabel": "Aggregate percentage of principal outstanding"
       }
      }
     },
     "localname": "NotesAcceptedForTenderOfferPrincipalOutstandingPercentage",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cnc_OtherCommitmentEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Commitment, Employees",
        "label": "Other Commitment, Employees",
        "terseLabel": "Commitment to undertaking, by employing (people) (at least)"
       }
      }
     },
     "localname": "OtherCommitmentEmployees",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cnc_OtherCommitmentExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Commitment Expense",
        "label": "Other Commitment Expense",
        "terseLabel": "Commitment to undertaking, expensed"
       }
      }
     },
     "localname": "OtherCommitmentExpense",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_OtherCommitmentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Commitment, Term",
        "label": "Other Commitment, Term",
        "terseLabel": "Commitment to undertaking, term"
       }
      }
     },
     "localname": "OtherCommitmentTerm",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cnc_OtherCommitmentToBePaidYearOneAndYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Commitment To Be Paid Year One and Year Two",
        "label": "Other Commitment To Be Paid Year One and Year Two",
        "terseLabel": "Commitment to be paid over 2023 and 2024"
       }
      }
     },
     "localname": "OtherCommitmentToBePaidYearOneAndYearTwo",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_OtherCommitmentsPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Commitments, Paid",
        "label": "Other Commitments, Paid",
        "terseLabel": "Commitments paid"
       }
      }
     },
     "localname": "OtherCommitmentsPaid",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Income and Other Expense Disclosure [Policy Text Block]",
        "label": "Other Income and Other Expense Disclosure [Policy Text Block] [Policy Text Block]",
        "terseLabel": "Other Income (Expense)"
       }
      }
     },
     "localname": "OtherIncomeandOtherExpenseDisclosurePolicyTextBlockPolicyTextBlock",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cnc_PANTHERxRareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PANTHERx Rare",
        "label": "PANTHERx Rare [Member]",
        "terseLabel": "PANTHERx Rare"
       }
      }
     },
     "localname": "PANTHERxRareMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_PercentageOfRevenuesUnderContractsOrSubcontracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of revenues under contracts or subcontracts.",
        "label": "Percentage Of Revenues Under Contracts Or Subcontracts",
        "terseLabel": "Percentage of revenues under contracts or subcontracts"
       }
      }
     },
     "localname": "PercentageOfRevenuesUnderContractsOrSubcontracts",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premium And Related Receivables And Unearned Revenue [Policy Text Block]",
        "label": "Premium And Related Receivables And Unearned Revenue [Policy Text Block]",
        "terseLabel": "Premium and Trade Receivables and Unearned Revenue"
       }
      }
     },
     "localname": "PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cnc_PremiumTaxExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premium tax expense, similar assessments and provider pass through payments.",
        "label": "Premium Tax Expense",
        "verboseLabel": "Premium tax expense"
       }
      }
     },
     "localname": "PremiumTaxExpense",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_PremiumTaxRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premium tax revenue, similar assessments and provider pass through payments.",
        "label": "Premium Tax Revenue",
        "verboseLabel": "Premium tax and health insurer fee"
       }
      }
     },
     "localname": "PremiumTaxRevenue",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_ProceedsFromPaymentsForIntercompanyActivities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From (Payments for) Intercompany Activities",
        "label": "Proceeds From (Payments for) Intercompany Activities",
        "verboseLabel": "Intercompany activities"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForIntercompanyActivities",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_ProviderContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provider Contracts [Member]",
        "label": "Provider Contracts [Member]",
        "terseLabel": "Provider contracts"
       }
      }
     },
     "localname": "ProviderContractsMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_PurchaserBusinessGroupOnHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchaser Business Group on Health",
        "label": "Purchaser Business Group on Health [Member]",
        "terseLabel": "Purchaser Business Group on Health"
       }
      }
     },
     "localname": "PurchaserBusinessGroupOnHealthMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_RatedSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rated Securities [Member]",
        "label": "Rated Securities [Member]",
        "terseLabel": "Rated Securities"
       }
      }
     },
     "localname": "RatedSecuritiesMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_RealEstateOwnedAndRelatedFixedAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Estate Owned and Related Fixed Assets",
        "label": "Real Estate Owned and Related Fixed Assets [Member]",
        "terseLabel": "Real estate owned and related fixed assets"
       }
      }
     },
     "localname": "RealEstateOwnedAndRelatedFixedAssetsMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_RestrictedCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Cash Equivalents [Member]",
        "label": "Restricted Cash Equivalents [Member]",
        "terseLabel": "Restricted cash equivalents"
       }
      }
     },
     "localname": "RestrictedCashEquivalentsMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_RestrictedCertificatesOfDepositMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted certificates of deposit [member]",
        "label": "Restricted Certificates Of Deposit [Member]",
        "terseLabel": "Restricted certificates of deposit"
       }
      }
     },
     "localname": "RestrictedCertificatesOfDepositMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_ReturnofPremiumPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Return of Premium Payable",
        "label": "Return of Premium Payable",
        "terseLabel": "Return of premium payable"
       }
      }
     },
     "localname": "ReturnofPremiumPayable",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_RxAdvanceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RxAdvance",
        "label": "RxAdvance [Member]",
        "terseLabel": "RxAdvance"
       }
      }
     },
     "localname": "RxAdvanceMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Allowance For Uncollectible Accounts [Table Text Block]",
        "label": "Schedule Of Allowance For Uncollectible Accounts [Table Text Block]",
        "terseLabel": "Schedule Of Allowance For Uncollectible Accounts"
       }
      }
     },
     "localname": "ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Amortization Period For Intangible Assets [Table Text Block]",
        "label": "Schedule Of Amortization Period For Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule Of Amortization Period For Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Property Software And Equipment Depreciation Periods [Table Text Block]",
        "label": "Schedule Of Property Software And Equipment Depreciation Periods [Table Text Block]",
        "terseLabel": "Schedule Of Property Software And Equipment Depreciation Periods"
       }
      }
     },
     "localname": "ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Receivables (Payables) Related to the Affordable Care Act Programs",
        "label": "Schedule Of Receivables (Payables) Related To The Affordable Care Act Programs [Table Text Block]",
        "terseLabel": "Schedule of receivables (payables) related to the Health Insurance Marketplace programs"
       }
      }
     },
     "localname": "ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AffordableCareActTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cnc_SeniorNotesTotal": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/DebtScheduleofDebtDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, Total",
        "label": "Senior Notes, Total",
        "terseLabel": "Total senior notes"
       }
      }
     },
     "localname": "SeniorNotesTotal",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted Due to Acquisition, Grants in Period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted Grants in Period",
        "terseLabel": "Converted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriod",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cnc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted, Grants in Period, Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Converted (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cnc_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Award Accelerated Vesting Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Accelerated Vesting Period",
        "terseLabel": "Accelerated vesting period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardAwardAcceleratedVestingPeriod",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture",
        "label": "Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Fair value of unvested equity awards in connection with acquisition"
       }
      }
     },
     "localname": "SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Other",
        "label": "Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Other",
        "terseLabel": "All outstanding liabilities prior to 2020, net of reinsurance"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetOther",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term and long-term investments and restricted deposits by investment type",
        "label": "Short Term And Long Term Investments And Restricted Deposits By Investment Type [Table Text Block]",
        "terseLabel": "Short-term and long-term investments and restricted deposits by investment type"
       }
      }
     },
     "localname": "ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cnc_ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-duration Insurance Contracts, Incurred but Not Reported Liabilities and Expected Development on Reported Claims",
        "label": "Short-duration Insurance Contracts, Incurred but Not Reported and Expected Development on Reported Claims",
        "terseLabel": "Short-duration insurance contracts, expected development on reported claims"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredbutNotReportedandExpectedDevelopmentonReportedClaims",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_SignificantCustomersPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Customers [Policy Text Block]",
        "label": "Significant Customers [Policy Text Block]",
        "terseLabel": "Significant Customers"
       }
      }
     },
     "localname": "SignificantCustomersPolicyTextBlock",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cnc_SpanishAndCentralEuropeanBusinessesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Spanish and Central European Businesses",
        "label": "Spanish and Central European Businesses [Member]",
        "terseLabel": "Spanish and Central European Businesses"
       }
      }
     },
     "localname": "SpanishAndCentralEuropeanBusinessesMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_SpecialtyServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SpecialtyServicesMember",
        "label": "Specialty Services [Member]",
        "terseLabel": "Specialty Services"
       }
      }
     },
     "localname": "SpecialtyServicesMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails",
      "http://www.centene.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statutory capital requirements and dividend restrictions [Abstract]",
        "label": "Statutory Capital Requirements And Dividend Restrictions [Abstract]",
        "terseLabel": "Statutory Capital Requirements And Dividend Restrictions [Abstract]"
       }
      }
     },
     "localname": "StatutoryCapitalRequirementsAndDividendRestrictionsAbstract",
     "nsuri": "http://www.centene.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cnc_StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statutory Capital Requirements And Dividend Restrictions [Text Block]",
        "label": "Statutory Capital Requirements And Dividend Restrictions [Text Block]",
        "verboseLabel": "Statutory Capital Requirements and Dividend Restrictions"
       }
      }
     },
     "localname": "StatutoryCapitalRequirementsAndDividendRestrictionsTextBlock",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cnc_SterlingOvernightIndexAverageSONIAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sterling Overnight Index Average (SONIA)",
        "label": "Sterling Overnight Index Average (SONIA) [Member]",
        "terseLabel": "Sterling Overnight Index Average (SONIA)"
       }
      }
     },
     "localname": "SterlingOvernightIndexAverageSONIAMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_StockRepurchaseProgramIncreaseAuthorizedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Increase, Authorized Amount",
        "label": "Stock Repurchase Program, Increase, Authorized Amount",
        "terseLabel": "Stock repurchase program, increase to authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramIncreaseAuthorizedAmount",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_TermLoanCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Credit Agreement [Member]",
        "label": "Term Loan Credit Agreement [Member]",
        "terseLabel": "Term loan credit facility"
       }
      }
     },
     "localname": "TermLoanCreditAgreementMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation",
        "label": "Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation",
        "terseLabel": "Share buybacks (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes",
        "label": "Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes",
        "terseLabel": "Share buybacks"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value Acquired, Percentage Of Notional Amount Of Program",
        "label": "Treasury Stock, Value Acquired, Percentage Of Notional Amount Of Program",
        "terseLabel": "Percentage of notional amount under ASR"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cnc_UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Increase Resulting from Reserves Acquired",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Reserves Acquired",
        "verboseLabel": "Acquired reserves"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreaseResultingFromReservesAcquired",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnc_WellCareHealthPlansIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "WellCare Health Plans, Inc [Member]",
        "label": "WellCare Health Plans, Inc [Member]",
        "terseLabel": "WellCare"
       }
      }
     },
     "localname": "WellCareHealthPlansIncMember",
     "nsuri": "http://www.centene.com/20221231",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r861"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.centene.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Information Disclosure [Abstract]",
        "terseLabel": "Condensed Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract",
     "nsuri": "http://fasb.org/srt/2022",
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r363",
      "r660",
      "r661",
      "r665",
      "r666",
      "r704",
      "r793",
      "r799",
      "r927",
      "r930",
      "r931",
      "r1001",
      "r1004",
      "r1005"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r363",
      "r660",
      "r661",
      "r665",
      "r666",
      "r704",
      "r793",
      "r799",
      "r927",
      "r930",
      "r931",
      "r1001",
      "r1004",
      "r1005"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r363",
      "r406",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r424",
      "r428",
      "r495",
      "r496",
      "r497",
      "r498",
      "r500",
      "r501",
      "r503",
      "r505",
      "r506",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r928",
      "r929",
      "r1002",
      "r1003"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r363",
      "r406",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r424",
      "r428",
      "r495",
      "r496",
      "r497",
      "r498",
      "r500",
      "r501",
      "r503",
      "r505",
      "r506",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r928",
      "r929",
      "r1002",
      "r1003"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r491",
      "r492",
      "r493",
      "r494",
      "r575",
      "r736",
      "r767",
      "r794",
      "r795",
      "r834",
      "r842",
      "r852",
      "r932",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.centene.com/role/DebtConstructionLoanDetails",
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
      "http://www.centene.com/role/LeasesNarrativeDetails",
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r491",
      "r492",
      "r493",
      "r494",
      "r575",
      "r736",
      "r767",
      "r794",
      "r795",
      "r834",
      "r842",
      "r852",
      "r932",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.centene.com/role/CommitmentsDetails",
      "http://www.centene.com/role/DebtConstructionLoanDetails",
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
      "http://www.centene.com/role/LeasesNarrativeDetails",
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ParentCompanyMember": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The registrant that controls, directly or indirectly, another entity (or entities). The usual condition for control is ownership of a majority (over 50 percent) of the outstanding voting stock. The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders or by court decree.",
        "label": "Parent Company [Member]",
        "terseLabel": "Parent Company"
       }
      }
     },
     "localname": "ParentCompanyMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r430",
      "r738",
      "r835",
      "r850",
      "r924",
      "r925",
      "r934",
      "r989"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails",
      "http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r430",
      "r738",
      "r835",
      "r850",
      "r924",
      "r925",
      "r934",
      "r989"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails",
      "http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r491",
      "r492",
      "r493",
      "r494",
      "r567",
      "r575",
      "r604",
      "r605",
      "r606",
      "r712",
      "r736",
      "r767",
      "r794",
      "r795",
      "r834",
      "r842",
      "r852",
      "r920",
      "r932",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.centene.com/role/CommitmentsDetails",
      "http://www.centene.com/role/DebtConstructionLoanDetails",
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
      "http://www.centene.com/role/LeasesNarrativeDetails",
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r491",
      "r492",
      "r493",
      "r494",
      "r567",
      "r575",
      "r604",
      "r605",
      "r606",
      "r712",
      "r736",
      "r767",
      "r794",
      "r795",
      "r834",
      "r842",
      "r852",
      "r920",
      "r932",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.centene.com/role/CommitmentsDetails",
      "http://www.centene.com/role/DebtConstructionLoanDetails",
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
      "http://www.centene.com/role/LeasesNarrativeDetails",
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r882",
      "r1000"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.",
        "label": "Condensed Balance Sheet [Table Text Block]",
        "terseLabel": "Condensed Balance Sheets"
       }
      }
     },
     "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_ScheduleOfCondensedCashFlowStatementTableTextBlock": {
     "auth_ref": [
      "r882",
      "r1000"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.",
        "label": "Condensed Cash Flow Statement [Table Text Block]",
        "terseLabel": "Condensed Statements Of Cash Flows"
       }
      }
     },
     "localname": "ScheduleOfCondensedCashFlowStatementTableTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": {
     "auth_ref": [
      "r882",
      "r1000"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.",
        "label": "Condensed Income Statement [Table Text Block]",
        "terseLabel": "Condensed Statements Of Operations"
       }
      }
     },
     "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r431",
      "r432",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r798",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r836",
      "r851",
      "r934"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r431",
      "r432",
      "r775",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r798",
      "r800",
      "r836",
      "r851",
      "r934"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "stpr_NY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK",
        "terseLabel": "NEW YORK"
       }
      }
     },
     "localname": "NY",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "verboseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r129",
      "r315"
     ],
     "calculation": {
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r42",
      "r44",
      "r45",
      "r325",
      "r756",
      "r772",
      "r773"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive earnings (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r41",
      "r45",
      "r221",
      "r703",
      "r768",
      "r769",
      "r869",
      "r870",
      "r871",
      "r884",
      "r885",
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Earnings (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired finite-lived intangible assets, weighted average useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails",
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r613",
      "r614",
      "r615",
      "r884",
      "r885",
      "r886",
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "terseLabel": "Income tax withholding"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r173",
      "r174",
      "r576"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Stock compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r608"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Allocated share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Recovery",
        "negatedTerseLabel": "Recoveries"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAllowanceforUncollectibleAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAllowanceforUncollectibleAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r71",
      "r113",
      "r120"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Anti-dilutive stock options and restricted stock units excluded from the calculation of diluted earnings per common share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r837",
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-Backed Securities [Member]",
        "terseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r71",
      "r124"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment charge",
        "verboseLabel": "Impairment"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r245",
      "r273",
      "r319",
      "r360",
      "r414",
      "r420",
      "r426",
      "r452",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r502",
      "r504",
      "r506",
      "r507",
      "r660",
      "r665",
      "r679",
      "r849",
      "r928",
      "r929",
      "r978"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS",
        "verboseLabel": "Assets [Abstract]"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r310",
      "r327",
      "r360",
      "r452",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r502",
      "r504",
      "r506",
      "r507",
      "r660",
      "r665",
      "r679",
      "r849",
      "r928",
      "r929",
      "r978"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r230"
     ],
     "calculation": {
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets at fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r126",
      "r132",
      "r308",
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": {
       "order": 1.0,
       "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": {
       "order": 2.0,
       "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Abstract]",
        "terseLabel": "Investments:"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r95",
      "r439",
      "r751"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r95",
      "r438",
      "r750"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r95",
      "r440",
      "r752"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "One year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r95",
      "r437",
      "r749"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "One year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [
      "r441"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r101",
      "r753"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableforsaleSecuritiesMember": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available-for-Sale Securities [Member]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "AvailableforsaleSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r579",
      "r580",
      "r581",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BankTimeDepositsMember": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest.",
        "label": "Bank Time Deposits [Member]",
        "terseLabel": "Short-term time deposits"
       }
      }
     },
     "localname": "BankTimeDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BridgeLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing which is expected to be replaced by a medium to long-term loan. The loan \"bridges\" the gap in time when otherwise no financing would be in place.",
        "label": "Bridge Loan [Member]",
        "terseLabel": "Swing Loan"
       }
      }
     },
     "localname": "BridgeLoanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r656",
      "r840",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails",
      "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.centene.com/role/CommitmentsDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails",
      "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.centene.com/role/LeasesNarrativeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r195",
      "r196",
      "r656",
      "r840",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails",
      "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.centene.com/role/CommitmentsDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails",
      "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.centene.com/role/LeasesNarrativeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Shares issued in business acquisition (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of voting interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r191"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r205",
      "r206",
      "r207"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "totalLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r205",
      "r206"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Equity value issued in business acquisition"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredOther1": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.",
        "label": "Business Combination, Consideration Transferred, Other",
        "terseLabel": "Fair value adjustment to stock based compensation associated with pre-combination service"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredOther1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r658",
      "r876"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Premium and related receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "terseLabel": "Unearned revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r197",
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangibles assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails",
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r197",
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Total identifiable net assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]",
        "terseLabel": "Assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r197",
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, software and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts": {
     "auth_ref": [
      "r193"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs.",
        "label": "Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Costs",
        "negatedTerseLabel": "Settlement of pre-existing payables and receivables prior to acquisition"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage",
        "terseLabel": "Consolidation percentage"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r194"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "negatedNetLabel": "(Gain) on acquisition",
        "negatedTerseLabel": "Gain on acquisition"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r73",
      "r312",
      "r818"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r74",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Deposits"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r67",
      "r73",
      "r79"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash and cash equivalents, end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period",
        "totalLabel": "Total cash, cash equivalents, and restricted cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations": {
     "auth_ref": [
      "r67",
      "r73",
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations",
        "negatedTerseLabel": "Cash and cash equivalents reclassified (to) from held for sale"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r67",
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "terseLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r67",
      "r237"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashDividendsPaidToParentCompany": {
     "auth_ref": [
      "r883"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents disclosure of the total aggregate cash dividends paid to the entity by consolidated subsidiaries, by unconsolidated subsidiaries, and by 50 percent or less owned persons accounted for using the equity method.",
        "label": "SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees",
        "verboseLabel": "Dividends from subsidiaries, return of investment"
       }
      }
     },
     "localname": "CashDividendsPaidToParentCompany",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClaimsDevelopmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Claims Development [Line Items]",
        "terseLabel": "Claims Development [Line Items]"
       }
      }
     },
     "localname": "ClaimsDevelopmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails",
      "http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r360",
      "r379",
      "r383",
      "r385",
      "r387",
      "r394",
      "r395",
      "r452",
      "r495",
      "r498",
      "r499",
      "r500",
      "r506",
      "r507",
      "r537",
      "r538",
      "r540",
      "r544",
      "r551",
      "r679",
      "r796",
      "r863",
      "r878",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r101",
      "r936"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by commercial real estate mortgage loans.",
        "label": "Commercial Mortgage-Backed Securities [Member]",
        "terseLabel": "Commercial mortgage-backed securities",
        "verboseLabel": "Commercial mortgage-backed securities"
       }
      }
     },
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r35",
      "r255",
      "r281"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r136",
      "r488",
      "r489",
      "r779",
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r142",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "Commitments Disclosure [Text Block]",
        "terseLabel": "Commitments"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/Commitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r884",
      "r885",
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical",
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in usd per share)",
        "verboseLabel": "Common stock, par value (in usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r21",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "verboseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r21",
      "r849"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December\u00a031, 2022, and 602,704 issued and 582,479 outstanding at December\u00a031, 2021",
        "verboseLabel": "Common stock, $0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December\u00a031, 2022, and 602,704 issued and 582,479 outstanding at December\u00a031, 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "Retirement Plan"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/RetirementPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r47",
      "r336",
      "r338",
      "r348",
      "r745",
      "r760"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r214",
      "r215",
      "r224",
      "r336",
      "r338",
      "r347",
      "r744",
      "r759"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedLabel": "Comprehensive loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r213",
      "r224",
      "r336",
      "r338",
      "r346",
      "r743",
      "r758"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive earnings (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer hardware and software"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r844",
      "r917",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Computer software"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r83",
      "r84",
      "r235",
      "r236",
      "r434",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtAdditionalInformationDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r83",
      "r84",
      "r235",
      "r236",
      "r434",
      "r774",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtAdditionalInformationDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r83",
      "r84",
      "r235",
      "r236",
      "r434",
      "r778",
      "r992"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtAdditionalInformationDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r83",
      "r84",
      "r235",
      "r236",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations",
        "verboseLabel": "Percentage of total debt tied to variable rates"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtAdditionalInformationDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r83",
      "r84",
      "r235",
      "r236",
      "r434",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtAdditionalInformationDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock": {
     "auth_ref": [
      "r306",
      "r363",
      "r864"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.",
        "label": "Condensed Financial Information of Parent Company Only Disclosure [Text Block]",
        "terseLabel": "Condensed Financial Information of Registrant"
       }
      }
     },
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrant"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionLoanPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A real estate loan to finance building costs. The funds are disbursed as needed or in accordance with a prearranged plan; generally, a portion of the funds is disbursed at inception and the remainder as construction progresses. The money is repaid on completion of the project (generally one to seven years), usually from the proceeds of a mortgage loan.",
        "label": "Construction Loan Payable [Member]",
        "terseLabel": "Construction loan payable"
       }
      }
     },
     "localname": "ConstructionLoanPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtConstructionLoanDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r553",
      "r554",
      "r565"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "verboseLabel": "Unearned revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Purchased contract rights"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r837",
      "r839",
      "r991"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate securities",
        "verboseLabel": "Corporate securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r53",
      "r738"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "verboseLabel": "Cost of services"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditAvailabilityConcentrationRiskMember": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that borrowing or credit line availability under commitments from one or more lenders is to a selected benchmark, such as total debt, segment debt. Risk is the materially adverse effects that funds which may be needed for operations or for a specific purpose will not be available on terms that are acceptable to an entity, if at all.",
        "label": "Credit Availability Concentration Risk [Member]",
        "terseLabel": "Credit Availability Concentration Risk"
       }
      }
     },
     "localname": "CreditAvailabilityConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails",
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails",
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r881",
      "r966",
      "r967"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r881",
      "r966"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r189",
      "r640",
      "r648",
      "r881"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current provision"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r881",
      "r966",
      "r967"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State and local"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerContractsMember": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's established relationships with its customers through contracts.",
        "label": "Customer Contracts [Member]",
        "terseLabel": "Purchased contract rights and customer relationships"
       }
      }
     },
     "localname": "CustomerContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r253",
      "r283"
     ],
     "calculation": {
      "http://www.centene.com/role/DebtScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.centene.com/role/DebtScheduleofDebtDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r149",
      "r358",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r524",
      "r531",
      "r532",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r15",
      "r16",
      "r17",
      "r246",
      "r248",
      "r271",
      "r363",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r514",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r691",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r879"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtConstructionLoanDetails",
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r239",
      "r241",
      "r508",
      "r691",
      "r830",
      "r831"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount",
        "verboseLabel": "Face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtConstructionLoanDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r32",
      "r239",
      "r536",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Premium yield"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r32",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate stated, percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtAdditionalInformationDetails",
      "http://www.centene.com/role/DebtConstructionLoanDetails",
      "http://www.centene.com/role/DebtDebtRepurchaseProgramDetails",
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails",
      "http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r33",
      "r363",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r514",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r691",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r879"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt redemption amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtDebtRepurchaseProgramDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r33",
      "r156",
      "r157",
      "r158",
      "r159",
      "r238",
      "r239",
      "r241",
      "r266",
      "r363",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r514",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r533",
      "r691",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r879"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtAdditionalInformationDetails",
      "http://www.centene.com/role/DebtConstructionLoanDetails",
      "http://www.centene.com/role/DebtDebtRepurchaseProgramDetails",
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails",
      "http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r436",
      "r460",
      "r461",
      "r462"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss",
        "terseLabel": "Accrued interest income"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes accrued interest, after allowance for credit loss, on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": {
       "order": 3.0,
       "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost",
       "weight": 1.0
      },
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r446",
      "r465",
      "r826"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "12 Months or More"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r446",
      "r465"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedLabel": "12 Months or More"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r446",
      "r465",
      "r826"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Less Than 12 Months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r446",
      "r465"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedLabel": "Less Than 12 Months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      },
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest",
        "terseLabel": "Fair Value",
        "totalLabel": "Fair Value",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r444",
      "r826",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Fair value of available-for-sale debt securities with gross unrealized losses by investment type in a continuous unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r445",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Positions from which gross unrealized losses were generated"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost [Abstract]",
        "terseLabel": "Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted average interest rate of outstanding borrowings"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails",
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r180"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Decrease in unrecognized tax benefits is reasonably possible"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r71",
      "r189",
      "r641",
      "r647",
      "r648",
      "r881"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "verboseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r18",
      "r19",
      "r247",
      "r269",
      "r635"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "totalLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r621",
      "r622"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOtherTaxExpenseBenefit": {
     "auth_ref": [
      "r186",
      "r188",
      "r881"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.",
        "label": "Deferred Other Tax Expense (Benefit)",
        "terseLabel": "Deferred provision"
       }
      }
     },
     "localname": "DeferredOtherTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r636"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r964"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r185",
      "r965"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r185",
      "r965"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "verboseLabel": "Compensation accruals"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "auth_ref": [
      "r185",
      "r965"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "verboseLabel": "Nondeductible liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r185",
      "r965"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "verboseLabel": "Medical claims liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r637"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedNetLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r176",
      "r964"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Deferred tax liabilities, net"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r185",
      "r965"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "verboseLabel": "Goodwill and intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r185",
      "r965"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.",
        "label": "Deferred Tax Liabilities, Prepaid Expenses",
        "verboseLabel": "Prepaid assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPrepaidExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r185",
      "r965"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "verboseLabel": "Fixed assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesWhichGiveRisetoDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r574"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Defined contribution plan matching contribution expense"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/RetirementPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsMember": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts held on account by the entity representing a liability to the depositor. Deposits may take various forms (for example, demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits) and may be categorized in multiple ways (such as, foreign and domestic, interest and noninterest bearing).",
        "label": "Deposits [Member]",
        "terseLabel": "Restricted Deposits"
       }
      }
     },
     "localname": "DepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r71",
      "r127"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 9.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense",
        "verboseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r71",
      "r127"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r328",
      "r329",
      "r678",
      "r820"
     ],
     "calculation": {
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative Asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r678"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Fair value of swap agreement"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r228",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r968",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "verboseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technologies"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails",
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r578",
      "r609",
      "r610",
      "r612",
      "r617",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock Incentive Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r125",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r123",
      "r125",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that either has been sold or is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Consideration on divestiture"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r840",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net earnings per common share attributable to Centene Corporation:",
        "verboseLabel": "Net earnings per common share attributable to Centene Corporation:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r349",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r377",
      "r379",
      "r385",
      "r386",
      "r387",
      "r391",
      "r671",
      "r672",
      "r746",
      "r761",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic earnings per common share (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.centene.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "netLabel": "Net earnings per common share attributable to Centene Corporation:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic, Other Disclosure [Abstract]",
        "terseLabel": "Shares used in computing per share amounts:"
       }
      }
     },
     "localname": "EarningsPerShareBasicOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r349",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r379",
      "r385",
      "r386",
      "r387",
      "r391",
      "r671",
      "r672",
      "r746",
      "r761",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted earnings per common share (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.centene.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r680"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "verboseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r611"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the plans"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r608"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Income tax benefit recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r155",
      "r304",
      "r340",
      "r341",
      "r342",
      "r364",
      "r365",
      "r366",
      "r368",
      "r374",
      "r376",
      "r393",
      "r453",
      "r552",
      "r613",
      "r614",
      "r615",
      "r643",
      "r644",
      "r670",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r687",
      "r703",
      "r768",
      "r769",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Impairment on equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r109",
      "r415",
      "r865"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": {
       "order": 3.0,
       "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Private equity investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r320",
      "r677",
      "r819"
     ],
     "calculation": {
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": {
       "order": 2.0,
       "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExternalCreditRatingByGroupingAxis": {
     "auth_ref": [
      "r91",
      "r667",
      "r828",
      "r903"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by external rating classified as investment grade or non investment grade.",
        "label": "External Credit Rating by Grouping [Axis]",
        "terseLabel": "External Credit Rating by Grouping [Axis]"
       }
      }
     },
     "localname": "ExternalCreditRatingByGroupingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExternalCreditRatingByGroupingDomain": {
     "auth_ref": [
      "r139",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External credit rating classified as investment grade or non-investment grade.",
        "label": "External Credit Rating by Grouping [Domain]",
        "terseLabel": "External Credit Rating by Grouping [Domain]"
       }
      }
     },
     "localname": "ExternalCreditRatingByGroupingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExternalCreditRatingInvestmentGradeMember": {
     "auth_ref": [
      "r139",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External credit-rating that could be used to describe the current status of the payment and performance risk of credit derivatives and guarantee obligations that connote investment grade.",
        "label": "External Credit Rating, Investment Grade [Member]",
        "terseLabel": "External Credit Rating, Investment Grade"
       }
      }
     },
     "localname": "ExternalCreditRatingInvestmentGradeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r673",
      "r674",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r230",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r522",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r674",
      "r709",
      "r710",
      "r711",
      "r830",
      "r831",
      "r837",
      "r838",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r522",
      "r568",
      "r573",
      "r674",
      "r709",
      "r837",
      "r838",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level I"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r522",
      "r568",
      "r573",
      "r674",
      "r710",
      "r830",
      "r831",
      "r837",
      "r838",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level II"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r522",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r674",
      "r711",
      "r830",
      "r831",
      "r837",
      "r838",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level III"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r522",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r709",
      "r710",
      "r711",
      "r830",
      "r831",
      "r837",
      "r838",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r233",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r442",
      "r443",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459",
      "r464",
      "r466",
      "r467",
      "r533",
      "r549",
      "r668",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r826",
      "r895",
      "r896",
      "r897",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]",
        "verboseLabel": "Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Weighted average life in years",
        "verboseLabel": "Amortization Period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r317",
      "r483"
     ],
     "calculation": {
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Total accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.",
        "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]",
        "terseLabel": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r484",
      "r739",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails",
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r119",
      "r740"
     ],
     "calculation": {
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r114",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails",
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r119",
      "r739"
     ],
     "calculation": {
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignLineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, outside the reporting entity's home country.",
        "label": "Foreign Line of Credit [Member]",
        "terseLabel": "Foreign Line of Credit"
       }
      }
     },
     "localname": "ForeignLineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnRepurchaseOfDebtInstrument": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from the difference between the repurchase price of a debt instrument initially issued by the entity and the net carrying amount of the debt at the time of its repurchase.",
        "label": "Gain (Loss) on Repurchase of Debt Instrument",
        "negatedTerseLabel": "Gain on redemption of notes"
       }
      }
     },
     "localname": "GainLossOnRepurchaseOfDebtInstrument",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r664",
      "r877"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "(Gain) on divestitures",
        "verboseLabel": "Gain on divestiture"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Loss on disposal of equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r71",
      "r147",
      "r148"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Debt extinguishment costs",
        "negatedNetLabel": "(Gain) loss on debt extinguishment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r316",
      "r468",
      "r741",
      "r827",
      "r849",
      "r906",
      "r913"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance end of period",
        "periodStartLabel": "Balance beginning of period",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r471",
      "r827"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "verboseLabel": "Acquisition and purchase accounting adjustments"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r111",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r475"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Translation impact"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r71",
      "r469",
      "r474",
      "r480",
      "r827"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedLabel": "Impairments",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r912"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Reallocation"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r473",
      "r827"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedLabel": "Divestitures"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsByNatureAxis": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of guarantee.",
        "label": "Guarantor Obligations, Nature [Axis]",
        "terseLabel": "Guarantor Obligations, Nature [Axis]"
       }
      }
     },
     "localname": "GuaranteeObligationsByNatureAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "terseLabel": "Surety bonds outstanding"
       }
      }
     },
     "localname": "GuaranteeObligationsMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsNatureDomain": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a description of the nature of the guarantee or each group of similar guarantees.",
        "label": "Guarantor Obligations, Nature [Domain]",
        "terseLabel": "Guarantor Obligations, Nature [Domain]"
       }
      }
     },
     "localname": "GuaranteeObligationsNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HealthCarePremiumMember": {
     "auth_ref": [
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money received from insurance for service provided for maintenance, diagnosis and treatment of physical and mental health.",
        "label": "Health Care, Premium [Member]",
        "verboseLabel": "Premium"
       }
      }
     },
     "localname": "HealthCarePremiumMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HealthInsuranceProductLineMember": {
     "auth_ref": [
      "r990"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product line consisting of insurance against loss by illness or injury.",
        "label": "Health Insurance Product Line [Member]",
        "terseLabel": "Health insurance product line"
       }
      }
     },
     "localname": "HealthInsuranceProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails",
      "http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Unrealized Loss Position, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r49",
      "r242",
      "r257",
      "r287",
      "r414",
      "r419",
      "r425",
      "r428",
      "r747",
      "r825"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Earnings before income tax"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r414",
      "r419",
      "r425",
      "r428",
      "r825"
     ],
     "calculation": {
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 2.0,
       "parentTag": "cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "(Loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r50",
      "r71",
      "r109",
      "r256",
      "r285",
      "r411"
     ],
     "calculation": {
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "verboseLabel": "Equity in earnings from subsidiaries"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r840",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "verboseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r10",
      "r11",
      "r12",
      "r13",
      "r133",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "verboseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r361",
      "r625",
      "r633",
      "r639",
      "r645",
      "r649",
      "r653",
      "r654",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r362",
      "r375",
      "r376",
      "r412",
      "r623",
      "r646",
      "r651",
      "r762"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": 1.0,
       "parentTag": "cnc_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestBeforeEquityInEarningsFromSubsidiaries",
       "weight": -1.0
      },
      "http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense",
        "totalLabel": "Income tax expense",
        "verboseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails",
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r339",
      "r619",
      "r620",
      "r633",
      "r634",
      "r638",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r963"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "verboseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationDispositionOfBusiness": {
     "auth_ref": [
      "r963"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Amount",
        "verboseLabel": "Nontaxable divestiture (gains) losses"
       }
      }
     },
     "localname": "IncomeTaxReconciliationDispositionOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r624"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "verboseLabel": "Tax provision at the U.S. federal statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r963"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "verboseLabel": "Nondeductible compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r963"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "verboseLabel": "Other, net"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r963"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "verboseLabel": "State income taxes, net of federal income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxSettlements": {
     "auth_ref": [
      "r963"
     ],
     "calculation": {
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Amount",
        "verboseLabel": "Audit settlement"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesReconciliationoftheTaxProvisionattheUSFederalStatutoryRatetotheProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "verboseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r737",
      "r876"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "verboseLabel": "Unearned revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in health care insurance liability balances during the period.",
        "label": "Increase (Decrease) in Health Care Insurance Liabilities",
        "verboseLabel": "Medical claims liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInHealthCareInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedNetLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPremiumsReceivable": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in the premium receivable balance on the balance sheet.",
        "label": "Increase (Decrease) in Premiums Receivable",
        "negatedLabel": "Premium and trade receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInPremiumsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r380",
      "r381",
      "r382",
      "r387",
      "r577"
     ],
     "calculation": {
      "http://www.centene.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "verboseLabel": "Common stock equivalents (as determined by applying the treasury stock method) (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InsuranceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]",
        "terseLabel": "Insurance [Abstract]"
       }
      }
     },
     "localname": "InsuranceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InsuranceContractsAcquiredInBusinessCombinationMember": {
     "auth_ref": [
      "r267",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written contracts detailing the terms and conditions of insurance acquired in a business combination.",
        "label": "Insurance Contracts Acquired in Business Combination [Member]",
        "terseLabel": "Provider contracts"
       }
      }
     },
     "localname": "InsuranceContractsAcquiredInBusinessCombinationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InsuranceDisclosureTextBlock": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.",
        "label": "Insurance Disclosure [Text Block]",
        "terseLabel": "Medical Claims Liability"
       }
      }
     },
     "localname": "InsuranceDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiability"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r112",
      "r117"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r240",
      "r259",
      "r343",
      "r408",
      "r690"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r351",
      "r354",
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "verboseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Foreign currency swap agreement"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r406",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r424",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentIncomeNonoperating": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.",
        "label": "Investment Income, Nonoperating",
        "verboseLabel": "Investment and other income"
       }
      }
     },
     "localname": "InvestmentIncomeNonoperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r451",
      "r987"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Contractual maturities of short-term and long-term investments and restricted deposits"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r867"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investment in subsidiaries"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r107",
      "r243",
      "r264",
      "r303",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "verboseLabel": "Short-term and Long-term Investments, Restricted Deposits"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets held for their financial return, rather than for the entity's operations.",
        "label": "Investments [Member]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LandImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to real estate held.",
        "label": "Land Improvements [Member]",
        "terseLabel": "Land improvements"
       }
      }
     },
     "localname": "LandImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r976"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "ROU Assets and Liabilities"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements",
        "verboseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "auth_ref": [
      "r975"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "terseLabel": "Operating lease not yet commenced, term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Operating Lease Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r701"
     ],
     "calculation": {
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails",
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r29",
      "r360",
      "r452",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r502",
      "r504",
      "r506",
      "r507",
      "r661",
      "r665",
      "r666",
      "r679",
      "r824",
      "r928",
      "r978",
      "r979"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r250",
      "r279",
      "r849",
      "r880",
      "r898",
      "r972"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable noncontrolling interests and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r31",
      "r311",
      "r360",
      "r452",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r502",
      "r504",
      "r506",
      "r507",
      "r661",
      "r665",
      "r666",
      "r679",
      "r849",
      "r928",
      "r978",
      "r979"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r126",
      "r132",
      "r308",
      "r309"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r289",
      "r292"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Balance, December 31",
        "periodStartLabel": "Balance, January 1",
        "verboseLabel": "Medical claims liability"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "terseLabel": "Acquisitions and divestitures"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Paid related to:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "verboseLabel": "Current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r290"
     ],
     "calculation": {
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total incurred"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Incurred related to:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": {
     "auth_ref": [
      "r268",
      "r289",
      "r292"
     ],
     "calculation": {
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net",
        "periodEndLabel": "Balance, December 31, net",
        "periodStartLabel": "Balance, January 1, net"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LifeInsuranceCorporateOrBankOwnedAmount": {
     "auth_ref": [
      "r110",
      "r866"
     ],
     "calculation": {
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": {
       "order": 4.0,
       "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the amount that could be realized under a life insurance contract or contracts owned by the Entity as of the date of the statement of financial position. Such Entity-owned life insurance policies are commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
        "label": "Life Insurance, Corporate or Bank Owned, Amount",
        "terseLabel": "Life insurance contracts"
       }
      }
     },
     "localname": "LifeInsuranceCorporateOrBankOwnedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r17",
      "r248",
      "r271"
     ],
     "calculation": {
      "http://www.centene.com/role/DebtScheduleofDebtDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "netLabel": "Revolving credit agreement",
        "terseLabel": "Credit facility"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r27"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails",
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r27",
      "r879"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r35",
      "r921"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated litigation reserve"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 8.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "verboseLabel": "Legal settlement"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayable": {
     "auth_ref": [
      "r17",
      "r248",
      "r270"
     ],
     "calculation": {
      "http://www.centene.com/role/DebtScheduleofDebtDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Loans Payable",
        "terseLabel": "Construction loan payable"
       }
      }
     },
     "localname": "LoansPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtAdditionalInformationDetails",
      "http://www.centene.com/role/DebtConstructionLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r17",
      "r248",
      "r274",
      "r521",
      "r535",
      "r830",
      "r831"
     ],
     "calculation": {
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Long-Term Debt, Total"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.centene.com/role/DebtScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "negatedTerseLabel": "Less: current portion",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-Term Debt, Fair Value",
        "terseLabel": "Fair value of outstanding debt"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r145",
      "r363",
      "r933"
     ],
     "calculation": {
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r145",
      "r363",
      "r526"
     ],
     "calculation": {
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r145",
      "r363",
      "r526"
     ],
     "calculation": {
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r145",
      "r363",
      "r526"
     ],
     "calculation": {
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r145",
      "r363",
      "r526"
     ],
     "calculation": {
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r145",
      "r363",
      "r526"
     ],
     "calculation": {
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofAggregateMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r321"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.centene.com/role/DebtScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r313"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-Term Investments",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermLineOfCredit": {
     "auth_ref": [
      "r33",
      "r143",
      "r144"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit, Noncurrent",
        "terseLabel": "Long-Term Line of Credit, Noncurrent"
       }
      }
     },
     "localname": "LongTermLineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtConstructionLoanDetails",
      "http://www.centene.com/role/DebtDebtRepurchaseProgramDetails",
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails",
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r33",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtConstructionLoanDetails",
      "http://www.centene.com/role/DebtDebtRepurchaseProgramDetails",
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails",
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r137",
      "r138",
      "r490",
      "r491",
      "r492",
      "r922",
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r922",
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Pending claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r14",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Acquisitions and Divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r39",
      "r249",
      "r278",
      "r360",
      "r452",
      "r495",
      "r498",
      "r499",
      "r500",
      "r506",
      "r507",
      "r679"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "verboseLabel": "Nonredeemable noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r160"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Dividend to noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r160",
      "r216",
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedTerseLabel": "Purchase of noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MunicipalBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
        "label": "Municipal Bonds [Member]",
        "terseLabel": "Municipal securities",
        "verboseLabel": "Municipal securities"
       }
      }
     },
     "localname": "MunicipalBondsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r396",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "verboseLabel": "Organization and Operations"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/OrganizationandOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r353"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r353"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r67",
      "r69",
      "r72"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r51",
      "r72",
      "r258",
      "r286",
      "r309",
      "r334",
      "r337",
      "r342",
      "r360",
      "r367",
      "r369",
      "r370",
      "r371",
      "r372",
      "r375",
      "r376",
      "r384",
      "r414",
      "r419",
      "r425",
      "r428",
      "r452",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r502",
      "r504",
      "r506",
      "r507",
      "r672",
      "r679",
      "r825",
      "r928"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings attributable to Centene Corporation",
        "verboseLabel": "Earnings attributable to Centene Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.centene.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "verboseLabel": "Net Income (Loss) Attributable to Parent [Abstract]"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r218",
      "r223",
      "r334",
      "r337",
      "r375",
      "r376",
      "r871"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r152",
      "r218",
      "r219"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net earnings (loss)"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Guidance and Recent Accounting Guidance Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation": {
     "auth_ref": [
      "r161",
      "r220"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.",
        "label": "Noncontrolling Interest, Decrease from Deconsolidation",
        "negatedLabel": "Divestiture of noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseFromDeconsolidation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r161",
      "r199",
      "r220"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Acquisition resulting in noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": {
     "auth_ref": [
      "r161",
      "r216",
      "r220"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.",
        "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest",
        "terseLabel": "Reclassification to non-redeemable"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": {
     "auth_ref": [
      "r161",
      "r216",
      "r220"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance",
        "terseLabel": "Contribution from noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r211",
      "r552",
      "r884",
      "r885",
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/OrganizationandOperationsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r414",
      "r419",
      "r425",
      "r428",
      "r825"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Earnings (loss) from operations",
        "totalLabel": "Earnings from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r974"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "auth_ref": [
      "r973"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
        "label": "Operating Lease, Impairment Loss",
        "terseLabel": "ROU asset impairments"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r693"
     ],
     "calculation": {
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease liability",
        "totalLabel": "Total lease liabilities",
        "verboseLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesNarrativeDetails",
      "http://www.centene.com/role/LeasesOperatingLeaseMaturityDetails",
      "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r693"
     ],
     "calculation": {
      "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Short-term (recorded within accounts payable and accrued expenses)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r693"
     ],
     "calculation": {
      "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term (recorded within other long-term liabilities)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r695",
      "r697"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Lease liabilities reduced by cash paid"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r692"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "ROU assets (recorded within other long-term assets)",
        "verboseLabel": "ROU assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesNarrativeDetails",
      "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesROUAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r700",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate for operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r699",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r183"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss and tax credit carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "auth_ref": [
      "r877",
      "r919"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.",
        "label": "Other Asset Impairment Charges",
        "terseLabel": "Remaining asset impairment charges"
       }
      }
     },
     "localname": "OtherAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesNarrativeDetails",
      "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets [Abstract]",
        "terseLabel": "Other long-term assets:"
       }
      }
     },
     "localname": "OtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r326",
      "r849"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "verboseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r318"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
        "label": "Other Commitment",
        "terseLabel": "Commitment to undertaking"
       }
      }
     },
     "localname": "OtherCommitment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of other commitment.",
        "label": "Other Commitments [Axis]",
        "terseLabel": "Other Commitments [Axis]"
       }
      }
     },
     "localname": "OtherCommitmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other future obligation.",
        "label": "Other Commitments [Domain]",
        "terseLabel": "Other Commitments [Domain]"
       }
      }
     },
     "localname": "OtherCommitmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r48",
      "r155",
      "r335",
      "r338",
      "r345",
      "r681",
      "r686",
      "r687",
      "r742",
      "r757",
      "r869",
      "r870"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive (loss) earnings, net of tax",
        "totalLabel": "Other comprehensive earnings (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r42",
      "r46",
      "r106",
      "r333"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "negatedTerseLabel": "Reclassification adjustment, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r43",
      "r340",
      "r345",
      "r623",
      "r650",
      "r652",
      "r681",
      "r684",
      "r687",
      "r742",
      "r757"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "terseLabel": "Other comprehensive earnings (loss), tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r330",
      "r332",
      "r448"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax",
        "terseLabel": "Change in unrealized gain (loss) on investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r330",
      "r332"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "totalLabel": "Change in unrealized gain (loss) on investments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r43",
      "r331"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
        "negatedTerseLabel": "Change in unrealized gain (loss) on investments, tax effect"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r30",
      "r849"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedNetLabel": "Other adjustments, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "verboseLabel": "Other long-term Assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "verboseLabel": "Other operating activities, net"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestrictedAssetsNoncurrent": {
     "auth_ref": [
      "r776",
      "r777"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets that are pledged or subject to withdrawal restrictions, classified as other.",
        "label": "Other Restricted Assets, Noncurrent",
        "terseLabel": "Restricted deposits"
       }
      }
     },
     "localname": "OtherRestrictedAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1": {
     "auth_ref": [
      "r76",
      "r77",
      "r78"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Other Significant Noncash Transaction, Value of Consideration Given",
        "verboseLabel": "Equity issued in connection with acquisitions"
       }
      }
     },
     "localname": "OtherSignificantNoncashTransactionValueOfConsiderationGiven1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForHedgeInvestingActivities": {
     "auth_ref": [
      "r355",
      "r873"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Payments for Hedge, Investing Activities",
        "terseLabel": "Payment for swap agreement"
       }
      }
     },
     "localname": "PaymentsForHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "negatedLabel": "Payments for legal settlement"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r68",
      "r291"
     ],
     "calculation": {
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "totalLabel": "Total paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r872",
      "r873"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedNetLabel": "Other investing activities, net",
        "negatedTerseLabel": "Other investing activities, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedNetLabel": "Common stock repurchases",
        "negatedTerseLabel": "Common stock repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedLabel": "Payments for debt extinguishment"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Debt issuance costs",
        "negatedTerseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).",
        "label": "Payments to Acquire Businesses and Interest in Affiliates",
        "negatedTerseLabel": "Investments in acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesAndInterestInAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r58",
      "r657"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash payments to acquire business"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedNetLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedNetLabel": "Purchases of investments",
        "negatedTerseLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedNetLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r288"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "verboseLabel": "Medical costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "verboseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r20",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "verboseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r20",
      "r849"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December\u00a031, 2022 and December\u00a031, 2021",
        "verboseLabel": "Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December\u00a031, 2022 and December\u00a031, 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumReceivableCreditLossExpenseReversal": {
     "auth_ref": [
      "r900"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on premium receivable.",
        "label": "Premium Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Amounts charged to expense"
       }
      }
     },
     "localname": "PremiumReceivableCreditLossExpenseReversal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAllowanceforUncollectibleAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsAndOtherReceivablesNet": {
     "auth_ref": [
      "r284"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date, net of allowance for doubtful accounts, of all premiums and other types of receivables due from other persons or entities.",
        "label": "Premiums and Other Receivables, Net",
        "terseLabel": "Premium and trade receivables"
       }
      }
     },
     "localname": "PremiumsAndOtherReceivablesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r755",
      "r890",
      "r892",
      "r899",
      "r902"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross premiums receivable to net realizable value.",
        "label": "Premium Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Balance, December 31",
        "periodStartLabel": "Balance, January 1"
       }
      }
     },
     "localname": "PremiumsReceivableAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAllowanceforUncollectibleAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance": {
     "auth_ref": [
      "r891",
      "r901"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of writeoff of premium receivable, charged against allowance for credit loss.",
        "label": "Premium Receivable, Allowance for Credit Loss, Writeoff",
        "negatedLabel": "Write-offs of uncollectible receivables"
       }
      }
     },
     "localname": "PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAllowanceforUncollectibleAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities": {
     "auth_ref": [
      "r350",
      "r821"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow provided by derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.",
        "label": "Proceeds from Derivative Instrument, Financing Activities",
        "terseLabel": "Proceeds from interest rate swap terminations"
       }
      }
     },
     "localname": "ProceedsFromDerivativeInstrumentFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtForeignCurrencySwapsandCircleHealthDebtRefinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from divestitures"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Divestiture proceeds, net of divested cash"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from common stock issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "verboseLabel": "Proceeds from long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r874",
      "r875"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "verboseLabel": "Other financing activities, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.",
        "label": "Proceeds from Sale, Maturity and Collection of Investments",
        "terseLabel": "Sales and maturities of investments",
        "verboseLabel": "Sales and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r309",
      "r334",
      "r337",
      "r352",
      "r360",
      "r367",
      "r375",
      "r376",
      "r414",
      "r419",
      "r425",
      "r428",
      "r452",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r502",
      "r504",
      "r506",
      "r507",
      "r659",
      "r662",
      "r663",
      "r672",
      "r679",
      "r747",
      "r825",
      "r845",
      "r846",
      "r871",
      "r928"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net earnings",
        "verboseLabel": "Net earnings"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment by Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails",
      "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r135",
      "r781",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Software and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r128",
      "r314"
     ],
     "calculation": {
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "verboseLabel": "Property, software and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails",
      "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r130",
      "r280",
      "r754",
      "r849"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, software and equipment, net",
        "totalLabel": "Property, software and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r130",
      "r781",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Software and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Software and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails",
      "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Depreciation Period"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of uncertainty related to unrecognized tax benefits.",
        "label": "Nature of Uncertainty [Axis]",
        "terseLabel": "Nature of Uncertainty [Axis]"
       }
      }
     },
     "localname": "ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r150",
      "r151",
      "r153",
      "r154"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable noncontrolling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": {
     "auth_ref": [
      "r289",
      "r292",
      "r986",
      "r988"
     ],
     "calculation": {
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.",
        "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments",
        "periodEndLabel": "Plus: reinsurance recoverable",
        "periodStartLabel": "Less: reinsurance recoverable"
       }
      }
     },
     "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfAssumedDebt": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the repayments of a long-term debt originally issued by another party but is assumed by the entity.",
        "label": "Repayments of Assumed Debt",
        "terseLabel": "Payoff of assumed debt"
       }
      }
     },
     "localname": "RepaymentsOfAssumedDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Payments and repurchases of long-term debt",
        "negatedTerseLabel": "Payments and repurchases of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "terseLabel": "Repurchase of senior notes"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtDebtRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResidentialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r893",
      "r936"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by residential real estate mortgage loans.",
        "label": "Residential Mortgage-Backed Securities [Member]",
        "terseLabel": "Residential mortgage-backed securities"
       }
      }
     },
     "localname": "ResidentialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r73",
      "r79",
      "r244",
      "r275",
      "r312"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "periodEndLabel": "Restricted cash and cash equivalents, included in restricted deposits"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units Awards"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r23",
      "r160",
      "r276",
      "r771",
      "r773",
      "r849"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r304",
      "r364",
      "r365",
      "r366",
      "r368",
      "r374",
      "r376",
      "r453",
      "r613",
      "r614",
      "r615",
      "r643",
      "r644",
      "r670",
      "r768",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r405",
      "r406",
      "r418",
      "r423",
      "r424",
      "r430",
      "r431",
      "r434",
      "r563",
      "r564",
      "r738"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r566",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r344",
      "r360",
      "r405",
      "r406",
      "r418",
      "r423",
      "r424",
      "r430",
      "r431",
      "r434",
      "r452",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r502",
      "r504",
      "r506",
      "r507",
      "r679",
      "r747",
      "r928"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving credit agreement",
        "verboseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r698",
      "r848"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Schedule Of Investments And Restricted Deposits By Type [Line Items]",
        "verboseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r96",
      "r101",
      "r102",
      "r103",
      "r104",
      "r105",
      "r262",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-Sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]",
        "verboseLabel": "Schedule Of Investments And Restricted Deposits By Type [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r195",
      "r196",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Consolidated Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule Of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Tax Effects Of Temporary Differences Which Give Rise To Deferred Tax Assets And Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r888"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Calculation Of Basic And Diluted Net Earnings Per Common Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation Of Tax Provision At The U.S. Federal Statutory Rate To Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r673",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "verboseLabel": "Schedule of Fair Values and Weighted Average Useful Lives for Identifiable Intangible Assets Acquired"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r114",
      "r118",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r114",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r827"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r827",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of changes In goodwill by operating segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule Of Change In Medical Claims Liability by Operating Segment"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule Of Aggregate Maturities Of Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentComponentsDetails",
      "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertySoftwareandEquipmentDepreciationPeriodsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r88",
      "r89",
      "r90",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SegmentInformationDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r88",
      "r89",
      "r90",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Non-Vested Restricted Stock And Restricted Stock"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Share Repurchase Activity"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of amortization expense related to intangible assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r970"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "SOFR"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtConstructionLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r434",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r486",
      "r487",
      "r827",
      "r989"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails",
      "http://www.centene.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r414",
      "r417",
      "r422",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r433",
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r254",
      "r282"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes",
        "verboseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtDebtRepurchaseProgramDetails",
      "http://www.centene.com/role/DebtScheduleofDebtDetails",
      "http://www.centene.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "verboseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettlementWithTaxingAuthorityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settlement reached with a taxing authority.",
        "label": "Settlement with Taxing Authority [Member]",
        "terseLabel": "Expiration of Statues of Limitations and Projected Settlements"
       }
      }
     },
     "localname": "SettlementWithTaxingAuthorityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Stock options, restricted stock and restricted stock unit awards vesting period, years"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r591",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Balance, end of period (in shares)",
        "periodStartLabel": "Balance, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r591",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Balance, end of period (usd per share)",
        "periodStartLabel": "Balance, beginning of period (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r598"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of restricted stock and restricted stock units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockandRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Available for future awards (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r579",
      "r580",
      "r581",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r582",
      "r601",
      "r602",
      "r603",
      "r604",
      "r607",
      "r616",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "terseLabel": "Income tax withholding (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2020Member": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2020 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2020 [Member]",
        "verboseLabel": "Short-Duration Insurance Contract, Accident Year 2020"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2020Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails",
      "http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2021Member": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2021 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2021 [Member]",
        "terseLabel": "Short-Duration Insurance Contract, Accident Year 2021"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2021Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails",
      "http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2022Member": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2022 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2022 [Member]",
        "terseLabel": "Short-Duration Insurance Contract, Accident Year 2022"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2022Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails",
      "http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r251",
      "r252",
      "r272",
      "r868"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearAxis": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-Duration Insurance Contracts, Accident Year [Axis]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Axis]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails",
      "http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearDomain": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-Duration Insurance Contracts, Accident Year [Domain]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Domain]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails",
      "http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about undiscounted information about claims development by accident year for short-duration insurance contracts.",
        "label": "Short-Duration Insurance Contracts, Claims Development [Table]",
        "terseLabel": "Short-duration Insurance Contracts, Claims Development [Table]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails",
      "http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts.",
        "label": "Short-Duration Insurance Contracts, Claims Development [Table Text Block]",
        "terseLabel": "Short-duration Insurance Contracts, Claims Development"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r295"
     ],
     "calculation": {
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Short-duration insurance contracts, cumulative paid claims and allocated claim adjustment expense, net"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r294"
     ],
     "calculation": {
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Short-duration insurance contracts, incurred claims and allocated claim adjustment expense, net"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails",
      "http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented": {
     "auth_ref": [
      "r296"
     ],
     "calculation": {
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts for accident years not separately presented in claim development information. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented",
        "totalLabel": "Medical claims liability, net of reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityCumulativeIncurredandPaidClaimsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative number of reported claims for short-duration insurance contracts.",
        "label": "Short-Duration Insurance Contract, Cumulative Number of Reported Claims",
        "terseLabel": "Short-duration Insurance contracts, number of reported claims"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsNumberOfReportedClaims",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityIncurredClaimsandAllocatedClaimsAdjustmentExpensesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r80",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The nature of the uncertainty for which it is reasonably possible that the total amount of the unrecognized tax benefit will significantly increase or decrease within twelve months of the balance sheet date.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]",
        "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r307",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r434",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r485",
      "r486",
      "r487",
      "r827",
      "r989"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillbyOperatingSegmentDetails",
      "http://www.centene.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r360",
      "r379",
      "r383",
      "r385",
      "r387",
      "r394",
      "r395",
      "r452",
      "r495",
      "r498",
      "r499",
      "r500",
      "r506",
      "r507",
      "r537",
      "r538",
      "r540",
      "r544",
      "r551",
      "r679",
      "r796",
      "r863",
      "r878",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r38",
      "r155",
      "r304",
      "r340",
      "r341",
      "r342",
      "r364",
      "r365",
      "r366",
      "r368",
      "r374",
      "r376",
      "r393",
      "r453",
      "r552",
      "r613",
      "r614",
      "r615",
      "r643",
      "r644",
      "r670",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r687",
      "r703",
      "r768",
      "r769",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "verboseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r364",
      "r365",
      "r366",
      "r393",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofCashFlowsDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedStatementsofOperationsDetails",
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends": {
     "auth_ref": [
      "r300"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of retained earnings as of the balance sheet date that cannot be distributed to stockholders pursuant to statutory rules and regulations.",
        "label": "Statutory Accounting Practices, Retained Earnings Not Available for Dividends",
        "terseLabel": "Capital and surplus or net worth not available for dividends"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance": {
     "auth_ref": [
      "r277",
      "r298"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus, Balance",
        "terseLabel": "Statutory capital and surplus"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus Required",
        "terseLabel": "Required minimum aggregate statutory capital and surplus"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StatutoryCapitalRequirementsandDividendRestrictionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r20",
      "r21",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Common stock issued for acquisitions (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r20",
      "r21",
      "r155",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Employee stock purchase plan issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockIncentivePlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r20",
      "r21",
      "r155",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Common stock issued for employee benefit plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r38",
      "r155",
      "r160"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Common stock issued for acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r20",
      "r21",
      "r160",
      "r171"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Common stock issued for employee benefit plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program increase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r21",
      "r24",
      "r25",
      "r92",
      "r849",
      "r880",
      "r898",
      "r972"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Centene stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r211",
      "r212",
      "r222",
      "r304",
      "r305",
      "r341",
      "r364",
      "r365",
      "r366",
      "r368",
      "r374",
      "r453",
      "r552",
      "r613",
      "r614",
      "r615",
      "r643",
      "r644",
      "r670",
      "r681",
      "r682",
      "r687",
      "r703",
      "r769",
      "r770",
      "r880",
      "r898",
      "r972"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity:",
        "verboseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r166",
      "r359",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r550",
      "r552",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r688",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r688",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r688",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.",
        "label": "Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]",
        "terseLabel": "Summary of Reserve for Uncertain Tax Positions"
       }
      }
     },
     "localname": "SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r764"
     ],
     "calculation": {
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "verboseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r764"
     ],
     "calculation": {
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SuretyBondMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An obligation arising from a three-party agreement that legally binds together a principal who needs the bond, an obligee who requires the bond and a surety company that sells the bond.",
        "label": "Surety Bond [Member]",
        "terseLabel": "Surety Bond"
       }
      }
     },
     "localname": "SuretyBondMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtLettersofCreditSuretyBondsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "auth_ref": [
      "r2",
      "r131"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.",
        "label": "Tangible Asset Impairment Charges",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "TangibleAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/PropertySoftwareandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r36",
      "r360",
      "r452",
      "r679"
     ],
     "calculation": {
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "terseLabel": "Mezzanine equity"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/AcquisitionsandDivestituresIdentifiableIntangibleAssetsDetails",
      "http://www.centene.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleAssetsDetails",
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesScheduleofAmortizationPeriodforIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r442",
      "r443",
      "r533",
      "r549",
      "r668",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r895",
      "r896",
      "r897",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r37",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "periodEndLabel": "Ending balance Treasury stock (in shares)",
        "periodStartLabel": "Beginning balance Treasury stock (in shares)",
        "terseLabel": "Treasury Stock, Shares",
        "verboseLabel": "Treasury stock, at cost (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsAdditionalDetails",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r21",
      "r155",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedLabel": "Common stock repurchases (in shares)",
        "terseLabel": "Common stock repurchases (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r37",
      "r162",
      "r165"
     ],
     "calculation": {
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost (57,093 and 20,225 shares, respectively)",
        "negatedTerseLabel": "Treasury stock, at cost (57,093 and 20,225 shares, respectively)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centene.com/role/CondensedFinancialInformationofRegistrantCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r155",
      "r160",
      "r162"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Common stock repurchases",
        "terseLabel": "Common stock repurchases"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.centene.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r748",
      "r837",
      "r991"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "U.S. Treasury securities and obligations of U.S. government corporations and agencies"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails",
      "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableforSaleInvestmentsinaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.centene.com/role/DebtScheduleofDebtDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "negatedTerseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy": {
     "auth_ref": [
      "r763",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]",
        "terseLabel": "Medical Claims Liability"
       }
      }
     },
     "localname": "UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r618",
      "r627"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Gross unrecognized tax benefits, December 31",
        "periodStartLabel": "Gross unrecognized tax benefits, January 1"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r628"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedNetLabel": "Prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r630"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r626"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties for uncertain tax position"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r626"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Net interest expense related to uncertain tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r629"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "verboseLabel": "Current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r628"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "verboseLabel": "Prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r631"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Statute of limitation lapses"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesScheduleofReserveforUncertainTaxPositionsThatMaybeChallengedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r632"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtRevolvingCreditFacilityandTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r85",
      "r86",
      "r87",
      "r397",
      "r398",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtAdditionalInformationDetails",
      "http://www.centene.com/role/DebtConstructionLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/DebtAdditionalInformationDetails",
      "http://www.centene.com/role/DebtConstructionLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r378",
      "r387"
     ],
     "calculation": {
      "http://www.centene.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted average number of common shares and potential dilutive common shares outstanding (in shares)",
        "verboseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r377",
      "r387"
     ],
     "calculation": {
      "http://www.centene.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centene.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted average number of common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "04",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1001": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1002": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1003": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1004": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1005": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126903467&loc=d3e32787-111569",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "325",
   "URI": "https://asc.fasb.org/extlink&oid=6384206&loc=d3e41899-111602",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2599-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "https://asc.fasb.org/topic&trid=2127225",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "https://asc.fasb.org/topic&trid=2197446",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4616395-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Subparagraph": "b.",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=122135039&loc=d3e569990-122904",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671317-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "805",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99383031&loc=d3e30256-158563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "https://asc.fasb.org/topic&trid=2303980",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-04(Schedule I))",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=126898705&loc=d3e5864-122674",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3581-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL121698322-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6284393-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL120267853-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL120267856-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14754-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14784-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3505-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r853": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r854": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r855": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r856": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r857": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r858": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r859": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r861": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r862": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=d3e5283-111683",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(b))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=122147696&loc=SL65671395-207642",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r993": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r994": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r995": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r996": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r997": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r998": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r999": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>138
<FILENAME>0001071739-23-000047-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001071739-23-000047-xbrl.zip
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M!F#[GD_&"(<S#HP&3\1#*KHW%J3I50%P8XE/8)2-2S.5O@$&AGNH9.SBH!'
M3&:QNGF FKF? )Z-EV?=2!F>6>'?V7 >FVW>N# (I):D_5@+YVIL+!7R)O)1
M\PH?PVR@;WYK==%I7"]2KV[CO?C?J0YCEWPB#L<@D9\/B1;'/)_SA=G[3650
M]\SY2,*:P\<4UJR=N_LK0[;O=0VH_H ?;(F^@Q7Z#KNO[B;OCPK\ R!M(//V
M5KYWBMD/# O66GM3DB&R2-@< 1)M"P."U61(6IX(>CB@*(6\:1X(2 HHC5D*
MT!P%/IY["P->2A)Z1*[++[DQ2[Z@9!,L(ZM@15Y] 2' JVG2_OXR!188B]/'
M=1D!&!:E#T&+B.'7;KKD,G7VO/$>J2'?\T%R,>K'H?SUR'H'AK6XBR#RGNC'
MX>!5=_AR:Q$0\,9W!>OZKY *P L)-U-O8B13@44(P$>4Q?!.@M+I&H\3#+JO
M>U+#?G<TV.))[=I1P?E@,"<5.0:6%[X$2&HM;E1"YX484!5@1=6I$$)6RS^C
M^84^&%9]P\TY!I3 HM3J,]K%*@Q*KD6)P0M_] &53(4H)!%<,AB3DB[ )6V
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M-G&<&S7((SZ'YDD+/4JC/!IP/J072Q5NA:?'GC$[,VV4<BB1Q8!\ ?F7^30
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M8#^CU4H*0(3$Q$ZRY\BZ*^4M(:+)'IA<\]'");R5T*A1&90RKUS4VC.'_TY
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M^X9<7@W.(5%9X_ZISOW!^O*YUCQEOZW7>!])^M*K^^*D_0KGV5]02P,$%
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M9*BH-:>8]:'FP-B'N\8I-Y@QO&EJ4R;HP7N43!(#)#Z"V4@']!BMIPASZ>"
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M-6OI:+XIX$47VBC=UZ5&BQ"^0)K?*NT9:&CP<&I\,MCH&HQ+E/LD+>&J@!]
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M];Q$DGW?Q!U3A67Q54VLY<4E]G)>D?<%ZP1GOF(KL*@< VF%V@"S.1P&ICB
M/0<H/S"DVP);GA^-YZ*=7W71F@XD-WO/GE'85-SRPB,N)ZO<L:PGW4R E[!H
M]\;M442?C3P.EG=^].CJE-K!Z?'AR<F-I=72T0@CYQ8)P9L:D"O?<Z V4I69
M*$KE]3HQ(<(60T?$[7*BB8NP\1W= [_IA:/3&[KM#VPB'O1I1EQ:!4..=S:[
MY@)>?KLU;A578,-GCM3#/ZC4E"R)WUO@[A\^N+D\;CHVB6NS+UE%TV:SF$4/
MK6U$V'73:AI% XF>D*@WPX9ZNY:].#-1E-/[+ JAD;V_@W-"G?A(^ERS;(*W
M<Y,H1KS##+"G!R=Y,I5N*MMRD+M;U[6*U]("!>N"L"Y^G2[2.CKSB26D_50%
MSH;VF4(Q,./8VC)U:7N+T%"$+!U^AVI9NIH0BHN1[5]!6.\-+^ 8PGJ6,>SW
MU@R/#A\_OD'-,#;5,'"<V6PM)<*-9Y0BG9S018:)"CO-@;M4%V6U3K?L4BW3
MI$&8))@R$JNK.O[LK-T+E6*8O5W1;@>NH _L@64K!D9&"0/PM@Z\&(-1T+,
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M7:_#Z*F.E0G&^0B$EJ?# \>1VG5D+7V9)D*74+CBESY*M/E\DDQ%DS%PW3T
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M6\G?UE<YJ6I5]\S$4BL3!_+ NMY:\LK08[$<L:H:<,/E#1Q@8$.]:D<@)#3
M61)\DEU!#.=B-'%2>$W2*FQ&ZJGY4W4PG^-SWC#+&UGOIV<4-VBR%;GC U>
MJR.7-X=%]I77(HDNKK+X(.WLA=^TDHXJU!T=%GS)Y5:&0,SE1*P:F)KH^UT9
MY(WJ<H+H>">Q?<T3/>QFHUB]Z'*E3?$%2D72FTVS?75XXP-^[""K/O0\K]I8
MC@=(^>0#(XC$?ABV3'R[P:>:YV";H&G\JCXJ73>AX(D<P\7.XQ?S'UG0WSC.
M!0]!3C$ZAO"4P:%Q"1=W7"$PX"0]U(<,D(+II;2^@BV43X 'C]D(_2&MZFHZ
M=0IQF2Y]6^L^V5K7L+&N7C=1+IW!#BTHLW@R ]; 3E+8=,<;M]&@7)V$+4R*
MR.GS=C],^QNB%Y9_D_IP7"IT9ZC,_%4X$9U06D5L(R>NC<JRN&+X0T+2O92N
MGLW@\GZL+'SD'MS2L.OHF'C''GDMDK&!0=A< _E%;M@W&*IL. S*88Q'#_PP
MQBT5X]&1CXY<C)^GU8B2EBC&E3@EE4VCM6&&85#&C_UC4.]XBG!>+PEP2R5]
M7-2 (Q?S\S<OWIZ-0<);ZOK<0+C?Z%K21^@V%QL;DMZY./3#T^LI\#]>WNCX
M+F\T;F4U+BZ3D2LKK_YF9"K+;\S3@Z5DAK%.LQXBZ?**C0:[S_O52N!V!>4I
MQ+AG*=OX+T$]AH=2(S5)'<5*SN0S9D9*12R+.%6W2)M[ID_#@*!'9L?(A? C
MQAII-^L+7X@QW0"]/#/ADJ(/DC!KE6,)I H^["^) 3X0_, K!.%>S0'TU;2B
M$*IP(@TL"UP@KR:*1P=;E!9>2^>.H[W2.5(<4",#&8&@(K%TIY*R)&]WYD=_
MG@GRVD&4!4(>Q7;N ^5K6.3!U2Q\#?5V_,$?<\7,5J6C:!\HN[JJR07)"XQH
MFRDD__'" 2&RMQ4,"7'6[:HOQ*-E1;XBGK M094-4@YVP^8(#8JS'_\[$Z0W
M%@9MB+<K)'J\8DX]9O)<=C$<*U@'14P0V::NTL0N)OV6 D_]K>(NJ6PKA8L(
M]$]T693$?BB/-U$FIM^@\<\L/KS+[=B:6I?6=9!6R3XI4 @V0D4548ZVE2H8
M&H[ EE1NI9R<[>F^OH$KU0"4VCCN%L^O#9ZEE2TU\MM2HFBHV@1N<]@CC%L]
M-GARKYU/1Y@#<&-*ZHP#<O9E(4NNQRF@_#:BPQAV9H6SB'7:O=9T@]JYM";"
M7>9B(V6$UX79$JDI9*_.7P,L,.$#S@S-%@K0?1]UQPB0J2K-*@XA[G\I/:SW
MK?V-OQ94'KC!ES.9JP%.=Z0C(#T-%[-+><I(-VDY1O46\IE;ZIN.)RMS_/CP
MP?@MOOYRR)$9?^JCZ>N0OZNEU8/NO3/JL]4IZ,8T0J"'\<Z(X6AQ>YE$*V[X
MZV)77_@8W90;>SJ>8W,%S<[/1?03J%&NO>74LZF' ,NETC?=3*E3 1U*&#8#
MXM)A\0^T?B_FL">^A?0,MJE\05]@"V$0_XU= ,M%)A[&5NT,-7+X7LR5TBIZ
M773""G8IV"%7@*H2D*^!"JL,]V/XQ&*!O9&JSN!OR8FX_]6<B#?:=I<8!0&D
M\EG]!O@5^]R8U' _")$J5N]T#6_7X8EH[Z7AV,S4L\XZK<>(&_%R7632.98:
M5LP8<10VD\(7]H#QX0<+&"U*KP-7NVP_M_P1XOP&=,),-,@@ K49:E1FVW!Y
M] X?8F+:E\J\%@<EF[<Q.NML"U,UP$Q*Z/J7CI!F1&/@O=Y.Q[3SDFDYJ]1T
MLE25K4H(U@Y+H1;8CK$HTQ46?U/]E &-6+I(@N,60VM:E'N?SUKJRG=T%V;Q
MI;,Q-Z68'GPUBNEOU+(43<N7ZI*OZK]39GC))A01BMXT<W/_">%NJP'.+C7Y
M;3@#-E+UMA;B'\>T:>Q,OD"Y20'5<2^SE/,I6&&W!1<N3K=PO^YI?C'S*&JN
M4JG'W(U@)AK)$-1S*AZ/^3]@=%4BG0T-^C1SEH3/PHN/<.TIN6^HZ*@@,VK)
M@7I"4CVOX" >EX6B*:-@1)IH7_HC+%>:^5>VY/8Z O)VA9RJT;.TC)NTQA]+
MUZVHLZM145K2F67 N[I6KAQL@Y6:9;C0$ZH_D-:!6]]DVQ(%,O6^,&M.-,E3
M.XQ?<C)K:305'AAN2$QCM:UZSU6%<NG^' BC*:0.#<'%CLJ_R$LBQMS:$B<S
MT!.F%\S"!&-HSI5K5&Q!HX9VF?MK";240K3<>C@7,;6 0B5H8Y@\BXLT%:$@
MW@H-RTZL'U]**#1PR"X5Q8L=--&K@G-DY>D&P;U<NPJ+V* \E BQY5KVDM]L
M3]:TPUW=NQHS.51X57?F>Y<;=3?5R5UN=%RFP\.OQG1X)M?E*#HC6R.TYY8R
M]WK5QDHK=QD:QCA#FX:Z+_9:O@5IE2)N+$UOM^GP@#LDY*,#]DS5H![3PKC&
MV4!O>"%CDKLIWF*1B6E9UU/,[%WWU^K#WM&NC*<.[D[7<=GX"O ,-M]M%233
MLB%S.L;J"0F-Q'5<;))+94:[(*U[$]X2=^#15W2F$QU@YF[8]!_@W)L);Z)E
M[K!)2Z\/&@'%A>P/C!AS4N@P84KI0K<R@JZ;A31@"O[<ZN(T<,8WV%>2#A'5
MDF)2&'E!+&-/J"CV,!-<.S1 JR+<H":H@9^@?)\UO\UBU=(]RC1J8EHD&]$T
M7*&]<TS;'23\LVMZRP?)]R7FF'6)L =_+3N=.GOM7].CM. XJV$V83I'HE&R
M[I;=&R^R(!IITV"-529/2P(U:-NB8KO.BNC$;/-UVP^+ZU*"C>08%6UV.DS
M>:V=MK,G/HBFW'D%9=)[D?8".;>Z;87VW7JBO.G:(::K/D).96I#A8$40UD"
M.C0Y'J^ #Q,]5)03SF?F2U%%B1CI4_BQ*2%ID(9"499XE_%,F(_/5%YZHV;I
MXGH47\"N/W9IZX:9ZJ3054NN_LF9-R_"P&) F^/Q>(3[UJ;SF/N,A]VFAL+<
MO"[*^H"JW^VL[,N,H^WB?':UKS\*< 8GCZ>$&)F<3:<S/XB9J9VH$Z+^95^/
MCY00KVH%5P1?V8C8(A0V9;X-8525?N">GOL1"D;>J!,RQSGP2(F7YI?6!W0
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M,K:P"(FBFV9GZ1=>CUE8%"G+\.N<\-FNTL); LD-&X^'BR=[GED3@1^#U+Q
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M]@Z6 81)UE8H="XW)MW04+S]8>Q,^(WX1]$[P;3@0_@#_+W2*UU5\%D08""
MIJ\ _"[=^(T5/7 K!/7IA*[I84']NF2?F>[<"SCTNK[14W GMG\7L7V=(W&S
M^OL%"V42Q[&46G1D-&L*>-&%MD+W^<;H5?)J1S8A/.75:F52D-2D!YP(7X"\
M!H>'/E&7N093$V]!9BI0'/ #"/'@TTZUO:XTFILPF@$]Q9:K2K9ZN_0O%"7
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M\ZY-95(:.\D0--&F#BMX\_:729A6=*H>PUZ,+&YX:N"D5OJ+6-W7$UG=\*Z
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M.FMS?< &^L.EZ$_O4O23 @$__&+L6$Y^:YU\IPL0]<T-&Z\="'N147).).M
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MG1?)]!XN9$*_5"@<%@E_CCR."C3\NJ '2S<[?.[*5%O$QL%&=9OO>E:?T4C
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MORW(XS*#7V&.9\=ZT+;D1H @IGK6-F$8/[A0^;[&=059^U[3:OFVWOZ;BZ2
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M\V_?AKL.U\F7J0PL%&X>HTY@RN2+VVK/0!QU?/H#15O8L32P%G]CH4I/_-K
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ML00 3=G#WSU,__1&P_07DQ9JZ,PN!0Z- $!2[!$I.U&^"#->J%@MP@'+5WX
M3=U(QX\1O" >#&T+ )?(V<O0<>$[(G]?'M/GD77#H_1CIQHL'A2]R^"9^UM;
MZ.3I(CF]?WIB4ZZN])&O#E$<1R$Y6WK$'+J-UA[QM=54&^K,F2LF01*M7-*\
MJS@ CRGG,L] 1F^Q=(68A.6]9-/AW2'H-TM>'B:\?[OT;>\.OOVV=M.<7$.Z
M:]138B)[35C:FP4QB7ONV]$,..HCE" $@BB9.)JJ&FS-NB0MP**!Z_-O3%M4
MX%:G+:,X[-PYFV'JX ; (I5K*=;JJ)7#77J0H&K=)UIQA19L@'4QA6@=P>B9
MB5G8OGWA?8)MS"^Q<*17:^2K<CKE.N3GF/=B96#;<_> D4(UM"=LA=HB;+JT
M+#.;. .G1AZ8#B*:L9 =F=R9\QL3?F4UA)*M8>:5U.W%7TCMB+-Y'PXCD*7Q
MA *CE@[0S<O#]3S"5PX7U'6.6EQ4YZVWU7RT?H]2816*OV2E<A:L=[D.UY?A
M+M<Q*4*QK:ESK3B>[V5/V$K$)3:6UF7T[ @Q@CS\-%DU2)M>(?\%=?;TH2IV
M63RU"G5+L +=2>CX76/%VXNX\-K+K%L*S5I-Q]IX=GS_*@XX-,;3"=@9+U>A
MMQ@6CG.1J\)>$[;.*"#?=JAH*BOB%@BFN("3P?PHA>89VK:9OEH\4=72(&ZE
MK&PSA*U *D=>+U!*ZR('5)P1P1F,@-]/L.S@]<KV1!$GR4C]U''R?8M/D@I@
M\MP=3T.7IN%C%@=^"I8%K8IE52I9F*!\%#L$2WQIMB+4CD*B9P+WU&FYXZ2@
MS^%5+F)%O5TD4@U?7&ODZ]EM3(JJ-]U(''V@:8VT+^EMA25[*C.XTORI8+X$
M-O)T#I5>Y5KLMJWZ8+;M5A)%"SON<$QHS""X0QI%A@O0V2F1K(-'A5F0HG%1
M+Q(:LO%%UDLM?>FC(X"GB$AN?*=T/%6FX'H!>C _*>TR[RBAO=YH7TP4'(0T
MQWS00#&>=1*%=OR6BMWU=,3N%8C8-WCZC-1=?4?WY [_^D?%OX8(E=%^4-PB
MVG(1$8OHP+<HD'4X;=7'OER/[G- @*-$6=+A9<<6_@GZ UU8^>68KN:1FXK!
M^B@4-PJI-'I<2 =J:&@$VQ+K"#.U)3B*RN%'WSF3.DZ"D?RO5E&_ KAR^[B#
M&FES#(,'LW)M#)B75!BZ/VZ:#M,74C#Y2B_R56PED @"=:' IQ>^;],,4XN7
M40_Q$!B @-Q_M0*D58TOU+QZ,;'.@_%**(QL(-^Z],3+'7ZY^&=;6'X+1RF5
M&[WR*2N5+,N"4<(<]J"D"6E J0B[X'8->U]=6@_9?;V%O4/J3"D%$-$R,U4:
M9K QQU3+74)J2\I%X1D6LQ<[799MX9J ']SQ'HT W6[A$1CCJG<,RT3T:+F7
ML8;,#) EA@$G^^)' 4$GW=S8 VC*0TQSH<#HB\ @!M;#,?5;(JKD_[9P/E?$
MX/(N@#/Q0@3U8\IW+NJ\/.A)188KD?74G85U[,W52IO&DBCD3 NDUFLL&\2W
M8-#F""NNI!:;-LVM,04E!A=T8#2SAB.KID#QR)U_Z96VQP)^!=Y$B^K$.G8+
M!C>&:2*H^P$WH*'Z]%+ VC(@URK9#5:$.\)+A!6 /SF/Z7?T!\S@UD2.1HD8
M7BZ2W%2CB5/4@4SG2"4Y$2B':72CPGV)@J]J6MU5+P/'WQ]#*UZ)^\T6QSMI
MS$(8O0O7G SF&H!3UW-DNR#2]#M\R+3E:#=1Z0Z2V]H5J>(> 'D])S,Q;;<M
MAZ<3VR?,U8;;(^=+9 >.Z>>P/OS![;S&34)(7NP+:@8Y2(?RLB!7UMVH??#/
MHZ5".:ZHHH("G+147-G<2T4=6%VBJ,_U@.0;9NQWN(3^Y2+@2M!MLV=%!I<\
MOM_=*TP=9L5$LE$E7$;Y/@M"N&0<8(B2&FNK ;W9EW0MX+L\A^^,>9?HF'9$
M9S,9N7U51.=M"V[ZA<IOGOWXH#DM#GA-HV7MX.+6(+&HMQX[:L.=F6R\&G5*
M!"@;;$'551^_HD]5%S\_NPHP/__<$):;$DZGTSG[5V20$*N"'L@;38+_IHOY
MX3P145.WT2:ALZA59= ^YK5K'\/\&ZFNF"]*(T6W%&;;X,<.-32>7J( 'C"]
M32,VC N_#<93' ]L0,7MDP&Q9:$0X,ZD^/#3:C[$M$>D5[P)]8&F= 0_)J,D
ME^=W+Z %J#@P,/:2UPWYV)@YDQR(\'*];8Z3'\O6U(OD)U/7)3BVB[&.;F?!
M5]^T 0'/V1:V.04[)?S$&3PM-;[S4LA_(_.,$BZ20*'?!<W1*=D'$]'4>MP-
M-\CE()$.<_EXB!'WDF<S,IRQR^G ,<&.$3JS?>]J\P';WCVV;>_(ZUQN#>%G
MZ.@%CR$3%$:9<KV0>VJ%$.G*/[373,_1_Q9DROOM"Y^^ <<6SN]Q\BHTU?>.
MEY<N:O!.N+$7=J4(7" 9+[#E&@%,^75[CF[YWN\VR73'T#C^Q?!\T [5:666
M'2/Z\6T1W ^^',$-7DTQA8;KWZ-P%;J>,2K1H(<Q62!\B*G!&:&-_5SPC'EQ
MNM3PM4]NM#Y=&WER+;NDA&ZJQ88N]3&!(L.PKQ4Y]Q3CH!; C)T*<512A"J(
M#U<:W:D"0B"'QAAJ'=*KV-8\;!P@1EU@)569]\I);BD\8%H-=:9^2_KM?J=U
M7^BDR^$?:"[,.J-N*2V 3#?#CB;\MCBR%1/?8;G56Y7CM9J!K<3Q1.O=@FG6
M.C@6)UWP3T&EM;?41P;5:<X@%(&83J(D]$X9,#LM%<V%LBVAL;*W-NE[_)<0
M?6+#-NW; W"H4BA?R,"4[9-45Q -/;1HUQO?<QX?9[$7-@GG^#A=L!0>-E19
M:^13W ML-DKOYXH&&?K@OC/W:;\17\,QDC.CJ&1TAKJ:2\<&;#!WS"32+X03
MR:Y?BZEXG'AR5A0M6+G?86 :WVP]2]LUG$J?B!2::M]6ID:T&2::V+[I(.W)
MQ/%&"_Y*!,)0IVU[_H6#N)/E(2?@RI;9"Y=7<_:_P. X_08O34 0$%0>,VP\
M8DY(2M+2[2>Q1LF!LPT,B3H9#@O6#%3[J*U@[XUR5-%_D-ER#Q)#6BJJ)J2@
M^H4_RPQ$)L\#' G0,WHL6'6=-N*8/("A<[B=1SFP_E'+NS=O?Z$C_)K^VS8V
M!N:W65V4)K.>?E:VRV: NCMN:-L)<PEUZ@;C]V,9X*&B3=L,)<R,#W=N!Q<R
MSI5' 8C&5N/;#B%AVN(!%IG$HL*O]"TU'B;'@SUQ^X&82:9E,2!\F2YN*9$9
M"]>HN!&$;4A!!6B;LM U%U%6JLW:7"SO '"!Y1-8#P9/DXB0/ ]KHVLFHEDY
MI$6E=VTSU,COL]%/+D*I\:,TB/L[W,J*JN9_-$K8+V9*- \*5?2.YU)]A1T4
M1A8II:QC4$R%0N:#] A ?->'7=EAV3I G7.=^5#]EQLS);QS1EEL5*7JVB85
M2.L8SUM=!-%"-R^86 <=,QQH8 7G/@%"&XQ#AFW#*4&#"'X^$*/S00J+IB^X
MMTN79\&7J9F+N3M*# G<:5()E5ZU-=(;.TKP!5/\#'QVI4R.F6OX+%U"HBU8
MHVD*?P&1KE<HVNOH60%'H1#&2Y7>-=(R=J6HC7(0V4;\J4TH6>:FT24:?DG0
M[6QT#3<8;_>Z[Y7G5P@L!('^=(;8K1-E&,"N+*LH1!]VNV6L!/7,P*+K0 20
ME$-V!4L/0>ZZ_-O9/$W%FX2NN6R>$,AG"%@MF2R<_HW\<\IN6DCV327A_V1F
MGGR?!(4+2\X^@.5TJ1R^:8G""QE ,<<PQLKS:V_F<?+ZDY:+6:O\5^X0"2YV
M?'*'2)A4,+],0=Y;3A+DM+%E4%)Q8R][G3 DB0")'*ZCWSJ1Y;T6JJ7&QP@!
M<P?VW@66^FNRU%V'@2\2G&[&"E4N_QK[2K:$L]._D2KF\.\S<IB8XH6')/0U
MJ/\PBE)RQK">PW<H$N">/1*Z=TD==!46TR:?.V I3<U^+?:!1<0*&!8;HUM\
M^DIKX\;B/F8OCCQ0QXN6:]=))C[LU.F"].NLG@^W<L:(E0M',,';R1P/SJ6J
M8P9RPFE<<-""6U6G K&3=#S2KA6E!%,<;L_I<N:T1E7JKZ!K#:+21D<FJA1A
M!&80!CH\/YY%V9'+C@/!NA2JLJ;FG&ZEA0H*#23#:$K*.D6]46$#3,VWBKI\
MB"M #>IP&9:$?A<^)8IEN/G?4H]Y6OTIINXN@\_&)+7/.2DS,=%#"5A3U71O
M6"F64;FVL^J'[&L7W0)?K:G,LI7X%>>DI" AK!9X>/_9F9=B2,"LDMX2'4"Z
MQ+%-&2^&QBS7L,!K<U!M&*&L5\8B_'UO9ILM>X?7_#AYH]?POTZS'>,8CQ[,
MS'SV:/[)Z>6[(LI/1-3CZ7K-[!)A> /UC(M:JOGLV=P>J[?$=$/^[OF'E,_6
M&8?S3YX]>$CI);5E;3-]!MUP"A,0'7/I]U3[OF+4W-+"M?RVU&@C9G/Z^,E#
M_)>+/O@9P>.H?H%C9,FZ*MN=T [5/CK?"RDDBTZR*=A&#GNGU*/DLM"5E7F=
MPX-0-1[A[,'<"9S>Z$9;E5I&I2'><\<2B0/'\ SQHZ14&?7P_G_,\6';TK>-
MASDL:5P7)7UE5U[J+H]DG-@,DA/!.$A"W]51WJ2TPC,"^K$%!83<IS:7_3=5
MM)@Z.R'NP0>+('82DO!,7QR]+-)VNZ2<.HYX&A*)Z50[B39B HMJ*/]95HR8
M8::7V1BE')67VVWT;5V4IWC%N!K2NG$E9&=S<=]K#\5=<!C0A;$)]6IANG'!
MJJ<&:,KT/?)!$ATW>AEAKA3KL#2F\())V=2_8WY$,4&9VHJY7/&OG<WS%I4D
M08/HM^YDL#M?Y<RP$]T+&Q"N;<0@P*8&:\DK0X_%FLJZ;L%ADS>P*\HF7=WU
M5<6)Y%0//LFM(,:D,20Z*X-6ES5V'P[$_$-U='*"SWG#?'MDYST\(P^SS=?D
MN(VH %\,+V^.F0+JH-$=*:ZJ_&"X&ZFP.=?2%PMW6\."K[AFS!)F^<2.$P-S
MFT*XJ^6\45E..*/@)G;5/)%A;[>*Q8NNUMK6&N"IR 93@JX[&F]\U T@@@:,
M/2\HF9;K :=\]H%A4&(_C%LFH=T0-M80>E^&!(6EB51_;X.&,[F&RWW IQ4^
MLJ2_<40$'H(<6G0-X2FC0^.*)>Z;18C&F3G6QXSR@ND96E\!2,HGP-?#E(K^
M $YG/9][@;@RJ]#6>D2VUC5LK*O7381+;[!C"\I\JLSX-+*3%&#;\\8QD>\5
M/,)1=,[]ALC4Y=\D/CPA#.D,E=N_"@>@/Y1.$#L?V_<76I57#'_LD/25TM6S
M&5W>CST+'[D'MS1 -SE.Y*G'Z,IL:H@6-M?@_")+[QL,:K4<,.,PQM/'81CC
MKO([**Z\R[-.6SA-CD)UXL+IA:DGE+1$X52+JUF[-%H7 1N'VL+8/X9J3^>(
M- ^2 +=4#4^+M7+BQ_S\S<NW9U,XX1TE?&ZK"][H1M)'& PIMR[1L/?9A2</
MKZ>6O^AC/2WJCHD?ZZ"(:&*'.VQ#-@ (99JT7FLR8AH+*J9,,?* L.0*W*ZH
MQH9H RWO7%1-$@"9Z"91X\2*D[T,JY!"%T>73;4Y*H<+IRHF?\-(8$#%Q\GM
M^"-6875[DL8OQ&!NA+U>^#9( UGK1:>83% W\.%P+6QNG#+401D+L5_'P%W;
M#40XL8GRL"IQ@8**+AX=[(TA;F_9AIZ'O=8%EO(38[^,0#"=6'A42U%5L"TG
M]_]C(;AQ#[ 6 'R2NKF/%-]AB0K7XK #,=C8#'\L%/-R59Z+?*1H[*H^(W1>
M8$2[7"')31 'B'')G2A(C!+OUJPA9"DOBS6QG.T(:&W!5+ ;+CDH>_$:K@SQ
M["X$F8Z%3%OB&8N)*:^8Q8#M="+[%H\./+DR)4AOV^";[?+1;RG&--P#\Y+*
MS SH'! UR659$5NC/-X&E)A8@L:_<'CV/A=E9VI]&MI1PB#WI$@$N& 457!Y
MFEFJN&@YV%I1>9CR)RL0LUV6N"UH3XM:Z>+..[S$+DYF:E<:%?;;Q<.@&ANC
M+6"/,$3US.+?@QY*O>,;(=X,"3".O;F7Q:R^ 0>""OLCCV/NF<7.(>QI]SK3
MC6K]3$,$P<P=1^('-8/=$JF!9%,_7 ,LB.$KS8S2+NO??Q\U?HC@BLKD-4<+
M#[^4'C;XUN&.ADLJ9Z3N;$P^:]&TO=,1D;3&B]FG:&7XD_12I/H0^<PMM>RF
MDX !U_SQ](V[X?+-B=EYZJ.)V9"9JB/5H[;D"VINUBM QXQ!)(=19Z1PM;AS
M2J85=S+W 8W/?(UN*N3X<#K7Y@I:H)_+Y"<0HUPKS%EF"Y)_M5K5^J;[!/4J
MMN,3AGUNN-19/ *MWXL!'!S?4IJANZR] "VPCR8<_ZU; ,>R)3[%3NTME7/\
M7DR+TBH&#6+BBGNIXB#CGZ#JR"]!A6"6U3!^8KG$MC]U;_"WY$8\^F)NQ!OM
MNF%,@MI0A7QU(\R!0XZ+L5P50A&*)1U]P]LW+R*:?NFEM;#UMXM>5RUB_;O<
ME+FTQ*8&&PL&%\5]DO"% PAM^,%A0\LJ:"[5I1DH'-^%N+L1_3%3Z#%>0&W'
M>G"Y#E,!'<6'E#H#2+E6AUV1S=L4W7.VA0DBOI"ZJN&E(U 9T2X$KW?3L9VJ
M9%K>*K7M0U7MH.K1VF%]S!)[8):566.Q.A756'R((T(DY&TYMJ9E=?#Y+*6N
M?$=_89:?.T1_4X+I\1<CF/Y*?6+1M/Q17;*J_CLE@5=L0A%5YDUS$@_?$&YQ
M&T'JC$UEPQUPL:FWC1 5>0Y):V>R N6F"E1WOLH-!]FQ[&H'+EQJ=J!?#S3K
M6 24.E>)U%/NGK 0B60)]3GKCM?\GS"Z.I.F?19HFGM+(N27Q4?XSHO<$E-D
M5)0N<V1& T&H@5=PV"YH"0XCTD13,QQAN=+,'PK)X7]<Z"9H=L?;%;.%)L]-
ME;:FP1\KWUVIMZM)63F2G%7$*+I1OD9HB^5[5;S0,RHUD*YXN]!DVQ&Y+_7J
ML&M.!,!S-XQ?"C)K:30U7ACN DUC=?V1SU6-Y]+_.3J,_:;S*!^7>ZH)(B^)
MN& ;1PG,F$Z87C0+&XRA.=>^._0=:,,3J]Z!-B:E)QUTV7)=<ZLZ 3A3OH!;
MD1<B01VL50GF'>XE2S+IST/QY37Z/+V,$]X'PD*F<Q!LE+SP -F@:L\SQ)LM
M0LRYUA;N=XNBJD*@-]?>5_QF)_3G/<+PP8NZ$'F/5F1OOK?$_GGRQ=@_ST7G
M3Z)SL;.D!U2M-4[J+K9;>8UN:?HL5QW>DC3HLQ?EALJT==S(_:; (SZ=,+Z.
M&&5UBR=>"\T=)S&#X<4T55[=O<6B&-LG<*!,-[!9EKJYU+I+76<U:(1^#^XA
MX[\C \!W1+8.#SR#?1!7M<E<>$ALC@D'0FXC6R 7QQ122=(MH.NK\UMRIY]^
M07<ZTQ$:[(;]EQ&BPX6053I."I=Y#9K/$;!=&!9!W=F;0I<)\V(7'61#T&Q"
MNEY%?^ZTSAJYXUMLYDF7B&I?,9>-C!>.BR86% =J[J\=WZ!5$4)6&YG!3U#2
MTOD0=K$::=EENV,Q%Y4+RUJ"UL$YFFZ#A_#NVM[O$69@A8ER72%:(US+7GO4
M02/>-H8M.5AL.3N80Q,#)=YG='L3A$=$(FU;K G+Y6E9) 9=+UKLD5H3AYMK
MCNZ:D'$=3;21'&BCS3;CK*?7VFDW>V(Z:*M]4  G#2]I+Y#HK-_UYY#6$^%-
M:H?HQ8984)6M917:5XS'"9S.)JJ"@D/,5E$143R?17B*:LHF27/(C\UK25<Z
M/!15A;J,9\(DB+92-!@UGRZNGPD/V/7'+KWT,-V>E;KNG*M_<?HP")/P,:#-
M"1@JXGWK$E6<A#23_4Z20I>]*:OFB*KUW:S<RVRTP <KW6I??Q3@T<Z>S0GV
M,CN;SQ=A)#97>Q$GQ+=<5OY*"=NM5J B6&4CPHSPQ92^MU1(M?G C50/PRSL
M>:/VTQRLP2LE]GQ(!1#1%XR E=WU"6^-X]PBRVW7+G-3;^"[ZU:8@?VUFA\@
M_Z5T*$MB0EFY*8\CH/ ;7:WEVM)^A)AUP>.E'UB7WNL9*4&WAR&_@],#<G-0
M3FFQ?GNKM_-=5N, .7AP3$[E)@+_A&M8;DT*#ZV9J_1"Y:VL*!X-+H3&USF:
M8K$F4>)8@3L+] @)"A@$-;8E*J?Y+3'[GGTQ9M\_X&1@"2U\X:8#UH, *SI&
M^$$BMI?!LN @94&97I<==K>;_B@MDA;<8HGO,Z+O<NQOK.N@4[JU(=T '#L1
M"PB*<V3N_136A#-;.FYOB]BB,0>ZS!L%&!NGA)"55K?CJ)_>_V*.^EF-GB@*
MVIL^Z</&_=*P><<6%.5<A5PX\&>&'&=A<\!0&'?44S337I,:;XK,^K8(=V (
M:MY]!"3L9H.'7*5T'[@/=]4!1M,O!;M1U[K'BRALRNPF4?6Y!\':25D#'@N#
ML[@P&!E!@CEO!B?>3333"(70!;6^U(U4@747V.RLT(89BTVWTAO?5P\8X-A:
MSY'Z.FTM'D6-RC1C@"\2'H)XZ";+5FU%:R\.43?HJ]Q9'K#_._X9V;D^=HN[
M4MD-YA[N??2R,VR(PH.:,A8:63IMK8$K04<4FQ\,0M?!UW(LU-%(V5%DL#"&
M> YQKD:04=G6X1%R1Q0ZK4'KB"'[ZI9(W),O1N*"I*NR(V[V^9VE_JK,S>?&
MK]^IO.<ZBT2H8Y2\.#%X/Q>LYE/M;ER I2]6C,R&'TSAT$U!BGH1IWE[PI/N
M'(ME]R&')^I:4%X"*@)49T><FW4T;%6_/M3=J_YMBONC]N4.X>_HQ7?I4P]
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M69)D-\AS;[(\*@A#%[-<X-.,D9H_:>:,#"0"9@/X/PBJ-)$%T2NR$MQX$"9
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MLDPQ)*\BSZ1R%!XSQA]CMJJ121M6X413-D-)&CD/;#)_9%'%P"G1K<4MO+!
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M.[4&B5B:MI+ NDKJ&J9_[Y["C!KMX#RR"FYTJ6KOZ8+1><0#;ZD1$N,#,;H
MK!!N&6N:/&DLNO=8#)!494>H"AB1ZOW%!24=Q06!;#0$N-<4($YXT.&%G&X'
MN]L8'MC:W9BMHP-W<-X5R)OHR*KI ^?M ,WEO 42)UCH0 PI-6&<Z?PD[?AW
MR(U;EE&?1*0-[$@519)]K%6*.D9(>G*2I,3XJ"-L'+F3 IW5* QM.7/SB4$
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M'T?SQ9BCGKE"LK\P<5%^8%,U*_#)WB*?F KL8V"QQ!UM4,([4[DL?@PFH"?
M4G]4T52U0,#T)X2/93#@7:RF>I5EHL9&<5 TX1"($^F&-_#4L_'2!;7=M[9T
MIOC@N&@S/4:%7(LJYE<I'F1I+=C0;"J,K^,$=8 8E81D4->7*&2/ND<\Y0\
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MQ>2] KU$.2>.ZH&<SG&Y**'NQOP2E9<:!A&FZG&'6$+H(GN=](%PU8DU-ZY
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ML'B EZ,UI45*"L3@=)CBL?+:_&@+$CDW4=Q[%<UK)K>1ZI"I= .;A%*J1H,
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M[3!L/Z,6:C,(6=SQ@BY,U; +5<QK2ID_8O_<6C[7$?O[!4OW7MUBZ\^]550
M5"@RHE$'6'?BCD!%$I]1)<M_99YMU:6TETO$\KBSYZD^'.RG:66N/FPN8+?9
M)?<N\PV%Z@_[Q"+:5>-1NJ5QYM2MLWGL$KS/K0(SH;='RVN]@KD.CW)[(R<-
M2/6,_4LZ[1TY3NWZK9\TI9/16K71SZTR/EA/7%GR?-9_\CR5 FX*BPCC0J7
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M'OU&2IP3E5;>[Z7C_#0^!F^N<*8%/);GZMXN-:\RNG),S2;U1:P,BZIEUWF
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M97@Q?/?F,46YSS&QESZUJU/U%J9:A#3,"RZJTH%K(QJ83<M;&59*A*#%%U5
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MI*"]S5*Y#-Z*_(,L@ZU@A-/XD#(3411] ?_-Y0_?P9^OJ! +C5KJ$-!/8-\
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MKT*F\=,Q,"/XSZR<)S__?U!+ P04    " "C@U56(-,03$P8  !RY@$ &@
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M'C%%/K!;<B$B&O_T1,%O9D<QR:^R'U3\;W9X< !W;![>9M_B!;Q/R&.6?RN
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M(^K-R \'!P6K,?M*U?H0M5!("Q ]+1#IS_E+#U044HW2LX)2#V[R2LB8KW'
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M?C,Z3,)<!1TC/B,C&J?S22>HNV7PSMZ1QR?'/^NB3L:L&LNI2MFW)U1LN=8
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MRCW1:5D)&0(!I[3#MU8-K^WL5MGV_&MV?7N7PI_!_X(T"M_\/U!+ P04
M" "C@U56J4'E,08#   $"0  &@   &$R,#(R,3(S,3$P+6ME>&AI8FET,C,N
M:'1MS59=<],Z$'WG5RSI "^Q+<>)';LA,Y"VMQU2R)0PY3[=D6TY$=A21I*;
M&WX]*]N!EE*F,##%#YJ5]D-GUT<K31X?O9DM_UT<P]I4)2S>O9R?S:#G>-YE
M,/.\H^41G"[/YS!TB0]+187FADM!2\\[?MV#WMJ83>)YV^W6W0:N5"MO>>'9
M4$.OE%(S-S=Y;SJQ*S@RFD\?31X[#AS)K*Z8,) I1@W+H=9<K. R9_HC.$YG
M-9.;G>*KM8$!&01P*=5'?D5;O>&F9--]G(G7SB=>L\DDE?EN.LGY%?#\>8\3
MW_<I)7D8A>DP#LAXF(9QD9(@2N-Q,2+_^0C20_/61YM=R9[W*BZ<-;/[)\.!
M&XTVYG#+<[-.?$*>]&Z8&O:_<6C)5R)I *.VD,(@$(6!6_%6_#N<]NI,EE(E
M!Z3Y#JW&*6C%RUWR;,DKIN$UV\*%K*AXUM?X9QS-%"]:0\T_L<3W$7$SW;99
M1!BGY(+ML_('-H_C]Z=G+\^6, AN(KTOWGLGF>&/8NH!O'Y?1<F]*CJ30EMR
MRP+.1,XV# ><7K 5UX@*Z;ZHTY)G\"++9"V,I?X)5]6MQ'XRZ0^U-KS8_?&L
MA]_-^I)!UB5N))@U RXRJ3924=LS(-V!8@6F+S*K:BQ44Y+.0!ML!?8T(R2I
M70B"P!F$?AP'_58>C:)@U,G!>!1'>SDD0=C)?A0&P[V,![Q;]^,H"CI[?TSB
M+^O8"T)<IR)OYK%5 8(YD:J"M\ZXT?P0+8)U]YC(B%QS#BP#9*W0$:N :>5-
MKSMAJ:JIVCT]\$-R./#[37OKPY:;-9KJ#<N^E-!65):\=2RXH"+CM+Q>*MQB
M9LDN&/;+K]6VL&T 5A08CE^A7C?&W!X,[. VM%&R!'G%U+70+5:DI'LGY2JJ
M5M@;4VF,K!+;%[L5(S=V^D $?'HPC YU,\*KQ?D_,)\O?NI(/0SLM\9MF3"7
M-==]..=:(VGX7P+O^VS]I5;US66ZD>UK(E&LI):B=UZO'=/(5Q>:XK&HS6V7
M.W'<&-OW0?-2F7X&4$L#!!0    ( *.#559)_J>7& @   <J   ;    83(P
M,C(Q,C,Q,3 M:V5X:&EB:70S,3$N:'1M[5IM;]LX$OY^OX+KX+HIX#?9<5,[
M:8 T2='@NNTBZT7O/ATH<63S0HE:DK+C^_4[0\KQ:UJG6S2^X K4L<2W&<[#
M9Q[2//WI\M/%\%^_7K&QRQ3[]?>W'ZXO6*W1:GWN7K1:E\-+]G[XRP=VU&Q'
M;&AX;J63.N>JU;KZ6&.UL7/%H-6:3J?-:;>IS:@UO&E15T<MI;6%IG"B=G9*
M;_ 3N#C[V^E/C0:[U$F90>Y88H [$*RT,A^QSP+L+6LTJEH7NI@9.1H[UFEW
MNNRS-K=RPD.YDT[!V;R?TU9X/FWY04YC+69GIT).F!1O:C(1HL=[R5&4)IVC
M3IOS5W$,<;O7Z72B*&D?_SM"(UM8/;2Q;J;@32V3>6,,-/[@J-,\[A7N9"J%
M&P^B=OOO-5_U[#35N</Q#+8/7S>Z<7#G&ES)43[PSM1"HWEQHI4V@X.V_W="
M)8V49U+-!C\/90:6?80IN]$9SW^N6PQ PX*1::AHY7]A$$5HF'^<!F./L1\E
M<Y@;'W7(W*M_OK]^>SUDW:@9K=JZJ\4[NYE@1,!\=S_;:WX>;?7SQ4'TJGVR
M1V9N#\?%U<WP^MWUQ?GP^M/'7:S]3VF=3&=[/ZM/:^=UG?W&#1^S7YKL@\Z%
MSNLL 4,6,3?F[L5![_7#;F3<C'#1.UT,^CA<P85 6FHH2-V@^PK?;/H97LE<
M()@&#:KT1)Y'S;E;/W[TU9GJO&[V:!JNV9A/@!F82)@BQ[NQM.P\STNNV T4
MVCBF<_9.FXQ%[<8_F$[9!2W)')#Y#99SRC48L?[SC%AG[R+VEEN,$P8EF[';
M7$\5B!'40^!,B)C0:$*N,7/C"%SFC.<S5N;.E( >8"[W:1U#R5F&3T9BL%.>
MX"O#="8=<SK4VZB00P+6<C.C*AF_!1QWJ4^+[P0:@T,JKPEP#*J02(,: *OE
MV!PM$6#8="R3,;,E?2S:3\% U0DYD$FK4"R0[IA*-T8';0&)-Y#Z+= T+=#-
M"383+)XM3\/S!67W?P>4P%*98]@)08LPUQ&16!V+S5*YS%/D&4\H^#U1I< ^
M$4I+,:TC#*51,U8@$@C$!&ZE%BBM &+7AL:%(+PJKE.-4F$%A*9&_/CAK+<G
MX7;,4J6G=HY; R-I'4IJQSB]#':CE?4E^-FY,1O6/E\$'NT= H<KX7IQ\+H3
M'9_8"F.5NB :T6DJ\=$'\IIQ QXR" $9*Z#0,D"<QDK:,56G:AE2*-$H/0MI
M$Z5MB>V(7(U6 3N%T0D(?&W9(4)% &(OX.'J+AGS? 3L''GKIE18(^KR1M0[
MA)>^:=03X2D\2A*\>< L]<^(W):@'*!%MNP\4+HR4(H#D9_K ,<:I 6^77T=
M=_8;M'Q_0-MOMH]I'B[!XDQA_'P>_#JXZI2B$U[:W9M0KHP!@5*-%+*O+@UV
M@ 0VD=;3(M:"W/=#$GQ!J,ND;$!QC[PJ_2[04Z\(FPHEDBO:8K62PI\;V#*V
M4DAN)#D@@TCP:2*GGDI+B=LO5.NSO"=1;0$-<DC:U*C@"/FD5)RX']WR1BP$
M +8(<F)9!>&W&*@BTC.V!_'M=+SOR([W!]D5':\">V=.V\#W[FRX,\QQ:4RD
M(/1RJW-.M,\M(I_$*4&:&S&'%P)>\E@JZ68D";8-2XO-(]&#+*R3E:I+XM9G
ME[O*H:+$[9/%*)"$21)MA#? R]P1[J\,ZIH9E4!!BXBJH(0/>,;%)@LD^.>+
MZ&1_$#WGZJL)5Z4G-(HWI"GJ3#G!2-DM>O%>@.Q T.%QNX3T",:&2*XV"-58
ME^YA"W9)(?R^-I *3[^^E6+Q7-_[10EA)N8;?QK@68)0[ \(Y[0:PKL)$]KA
M5_+/EVS%XB/(E#2 3I+2$!B6$NZ67C-M';ZGDUKLRR;8T1\EYFOL^O"!)BFB
M&FENK79E.&[#P!].T+F%/X@*=KT,5HVYO5<G1)!^%8#PF<//1\7J,Z;D+:CJ
MI&*M?OTO3]%?0_Z^[^]Z>X?\;]O?^<--,5\T]06/$:TN W=!:02]1^B5#2E\
M;QI'.>RTL?<2P;_ +K-,.@?PA:01:Q0A5"XDVN<[.41X(T=;R@'XET3Y?$W"
M'Z5$\_WZ*_/$'VB\_/\V[@=*@W.%.@_G2B+V:"]-N_)$ H*E2N_WVZDI\%O*
MUT'W^8SM%:L_>IT?1ST*@M7.)YQD;.$^+K"AA7OJ>Q"NE<[%)H@YE*/U(!HL
M*@9;9H@8G"7O3)5RMA[</6]!L'_[K'/,^ZE!9JDC#L"3(2+)'YU7D*N'M"GS
MB583H-R9\U'U"X"I^!.R0ND98.ETK -I\A5 (P"_B[!H[O^ODU_Y%74)OKVM
M8$6SG=]45@UB7$I@&FB^XH6%P?S+"::E0O'90.;>"-_HI.H^UL[IS(\PH=R&
M,JD:Q0\8BJN;#OU^\[A]3)<=G,'_8CYP=0^BZ>]!M)S8+.LUN[WHP=)V\^&R
M+_5ZU&]VN_UOZO9+99UFI]_Y[L9V^\U>]'JG;EM^>L,48Q!MP?,WM6YMWJ!:
MGH-.<<>B563X"QKK@0PQ_/$@]_=B+FD?NRH1*O<?YQEQT;ICF11"P1,Y]@YB
M4]+ODYVH[F\D/3/_UMCINSGUI&A\<7"$6<1_!O]^.[\Y?^^OAWSZ>+ET]>81
MR[!-7M>V3-&KYQWW*MU0?D*?F#^%9W/['NDQ=O)$[EZ,):3LZ@Z2DDZXV*>P
MJZ/+;8?5\2?*"K@OKW9]+S>1TO)Y=4LB7[LU6.AP;7(0?N28P,8]PL4,^]S<
M7C3A,4YSZ1YN\M"%MBVW]58^PQ5)?UGS[$]02P,$%     @ HX-55DRI_5HN
M"   A2D  !L   !A,C R,C$R,S$Q,"UK97AH:6)I=#,Q,BYH=&WM6MMR&[D1
M?<]78*F*5Z[B;7C1A9)5)4MT617'=BE,G#REP$$/B0@SF 4PI)BO3S<P%*^R
M*:_7IE71 \49W+K1!Z</0)S_<OWA:O"OCWTV=JEB'__^^MW-%:O4&HU/[:M&
MXWIPS=X._OJ.=>K-B T,SZQT4F=<-1K]]Q56&3N7]QJ-Z71:G[;KVHP:@]L&
M==5I**TMU(43E8MS>H.?P,7%G\Y_J=78M8Z+%#+'8@/<@6"%E=F(?1)@[UBM
M5M:ZTOG,R-'8L5:SU6:?M+F3$Q[*G70*+N;]G#?"\WG##W(^U&)V<2[DA$GQ
MJB+%Z?')L"VZHMWN=-JB>=KD401"M..H<]IM)O^.T,@&5@]MK)LI>%5)958;
M XW?Z[3JQ]W<G4VE<.->U&S^N>*K7IPG.G,XGL'VX>M&-P[N78TK.<IZWIE*
M:#0OCK72IG?0]']G5%)+>"K5K/?K0*9@V7N8LEN=\NS7JL4 U"P8F82*5OX7
M>E&$AOG':3#V&/M1,H.Y\5&+S.W_\^W-ZYL!:T?UUJJMNUJ\W<UO[4USS9O.
M5F]>'$1'S;-=YCQ&>(#YYI.^;N;V2;_JWPYNWMQ<70YN/KS_Z:;N/X5U,IG]
MX7.WW<Z;*KO,A,'.WM79I1V#J;(8#%G$W)B[%P?=D\?=2+D9X?IU.N^=XG Y
M%P(9IJ8@<;WV$;[9]#.\DIE Q/1J5.D'>1[5YVY]_]%79ZIU4N_2--RP,9\
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M@9P6$55!"1_PC(M-YDCPSQ?1\?X@>L[5_0E7A2<TBC<D">I,.<%(V2UZ\4&
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M)H]=--NB,E8^PP5%?U7RXG]02P,$%     @ HX-55B2T$]'D!   Q!0  !L
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M+4?#WFBX1?>1V]#5K"M[3-3XN?V^+C>F&N4(4R2<P@;?5S)&)<]$]\!90E_
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M['UW/&/?NF.NS"K*<'/[:8 S$ M0N@D/.TI.1#UXR=I='_4-)LF]4U.+-SK
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M9.TKCW"ZURMZ3#D8NU$$.")*9_Z6D5ZAMKO?B9*K6!/UURQU*;IM&*M4E=]
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MM<2.)==0QY;8!E^"YF8:BQME:)2,!F9-T'(*<5 LV<G'S5U1NSK*EE2,D[Z
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MCZNC1Y!"7-@ZU8G@A0HG(Y+$<#8IT@VIJKEA$G'(';0B]-[ %#V%# &@%).
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M#V ;XQTMKJ*563 $H1:)(8 X5VW.!IH8@2A$ RC66Q4B7\Y#_U[DBK\3NLI
M7$;Q+217)960P7%1"6^#"[UHL-J2!E =N./&5?F-QKDTL1&:22 F('$+H>7H
M&Y%!O_,;GQ&_S%MN>)\^XL9]J;,3G&D0\W\T<;(I?@/%!<%0*0)!!JG(CBB0
MK>2CM0.0&CMN7)7?,"FSR[749#PPIY*R*1&X>'!][]2=W_@,;KAWW# ?,N.
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MQL+%H^>:U;V76BA"BH9+RB%:.VAZ+WN&K]-9[MB]9G;;6FI6V>\M@?-8#'I
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M&P<=7/FF6JO29(:$ U8.T:@8Z\6\QHIIU7G/Y)-L-TZ'/T^'@E.A#%G U5B
M*U?;;*A (!$QL]MRG([4"0\$*9L2%NO1M@H:%2$WDT(H#5J&5LH&;[MRF=X
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M51@1:*,I%3B\POMP&2(^$B!#^ R/_=<M8P^/3L2+-%L%GH;.L#1WTL +6!(
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MCYKAQ5?1*$&[@&K>*"D8M%]#X0/X]8X\N<B559G"L(,=P+47J7/ Q> GB=B
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M-&-VW"(J@7XK:80B_"JZ_BW3& W"T#3&#/7BDI0D]Y*?,*22J^BI+E!]5,)
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M _N,$A0(#7D%>2UN[PW;213)OQ-8(&S4!&OI?A0/%U;!8EKNG/TI:RT+/;'
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MIUNCP)C/JL"L[C2ZSAJ,^_HV8O?.TLHR%Z2)-6_/6>8URL8O_45Y-Z^MS+V
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M4N02L'P4L .&- D\-/"L!H%4BAXS0#-%3P5QAJ-1$WCAQ*!8'!_!Z?31MA&
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MIRAD%]XDCBX]A_2!-J>\+Q!9Q_B&7^.DN%KF)<.+LCQQRJBH./"51$GEQZ*
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M0=2,0"5 G(7KSG%I<C*\3QJ*4SA3$^:BQ4JOJ!1RT$DI42B4\\ -$C>?B/2
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M]']ELBMOE/ >B9,-['*&UTKT93=N%N$<X*?B<=E+EMA)(@"&1/*^="0E\L/
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MWRB04(FUE,7#"(&H>&[(\L@=4P[-!+O0BR)*6@#T-.:(;Z^14TEB(H=0(*4
M!Z.^]"KZ*D,Q!&B'.64\&@NX)X63I'$XDA,%P]2[QX28SRID1HZHA[C; GJ?
MWEY$J,XR&+%8P5+,Y!3KK?G:!O.UN>2":M*XX!A$/"6=R=0$[22C=8 >_^<.
MM7 ]YZZTT9MID7.G 2C?(DU-GH$EV6HBEB! E@2W+.,*V))Z13+;M:U[B7T6
M-6#%82T2[8ID?0HEE4EI\F6^+'<N]HG",3*#Q8AB+-@N&JF510#ZT$$SBL5+
M.#:;TZU%XH9>GJAZ,H=3X]HR7^Y6"2NZZ>;DHN566=2%C2YBPJZ2P'0-*ET1
MH2/<H4 P7U&=(%36*F.;3WD1+([TM@"^1_X;2;->@)). ON1SX<<W!*1ABH8
M\A +#E UK1@<G[D$PM:Q1%7,3?G>X ZAIJ8":\\1"0&I-H(B-Z D'>47W'Z6
MNAT,E&+.GH@YZUEI52MHS;1"6=SCB4[3*H:K_#2SRJDNX+:(X;&IYO]&!1$+
M7^@$@KXS^\%E?%O@S^&7Q6D9$9J^N$C^9]*!IH6AI<,\RHR6AB%Z\316V'/2
MS232.BB[1GZ@42)UB#\]T2X+=LB+E7M*LHT\&X,-)XU+$6/^S*G?!BFN-%[!
M5-R+BB&J$(R+0/LB3\'4W0@!H>;AKL6W.8:95?K)4F5T6F2'GY>-I1'W#)>:
MM%)@%L4 I/(HT_;F(OR+=GE!D0B(<TEZ=$64"Y9?(AJ+BW+HE/*D52]),$CA
MB:.%Q9, JBK.KTR11%>["*Y+G@URR2V*DT0LGQ=4!>L?3(B3TWSF5'@T''*T
M&H@Y:PBPBP)6M8O:?I:ZK5KJD;"S*NJH(JOGY*<B(0Y]D@D?BWX>,*Y,=N!8
M'"OIFUIYF/!Q7XWCD#=!;TV+<R9C>3*139FL5)J(Z(PQ"PL$+CT0);XIBQAY
M!;.\"&5A5:;@P:KZ0>0;R7^C3B90D3&Q!M10T*=$76")L:LYWRO:EM8+J5%M
MI@9JH\ ^E 6+R&.F0GU;Y.P"_M>13960&0-7C1,LCBO'8'>:8V22V)X)NY*2
MUQ)WJ*'T+2K]K (#9SSD"O54<:476%ZUK6SB+Y0M35%A!\HV$NX:Q.B016C^
MKK3 GA#Y\$5>[Z4V>N5G%FTI/!Y63IW2)P+*# :F(Y&[$<M.GW=# O=J;9UD
MU"Z?X!<KC$=436@Y^]7QZ*Y 46I=6)^8[9!J.N^"*[0ADA*XIZ<AR+)6S96H
MWJAYK9XR\:!.Q%L@W6Z=B%<GXFTX(-5'Q:?N,-&*,-9D\:;D-&%%+U64J;"&
MC.HB.(LP&S5W9\EW%5Z&[$4AF^>JV*H6"U499]< :V!!#\B,9*9E8I"VK#ZB
MO7GN77,AG I8EBN*="E1&\OS"+YF"I:G-,Q+J$B6"0DJH\8)SX0U3&B;L,Q%
MF<S'5:,@><L%0)&8OL0?@8'CF_%MPL5++<\3M1)D>Q/R/6J[V(M07Z<8%%M>
MWDROG44<26,4$ #NV:I%+ES#!>Y'M>A8PT>A+@,"NA1=C[-5:WW=U]0"2$,
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M@+P%_DPFR_:-V]DO=&'9E]BXE\BK=KU@.[?3VD\BD.5)3V,8_*UO)\]9M2"
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M\[,U1JM(7V'2Z"[X4[1*D9]B)3[A@H/#SR;3,J1G'%XTVO10T:\Z22?Q&F9
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MH@.LA8@N$-&D Q^05:_;*",7QB6.O!7-I.\A\$.$?./AG/NA:6U8ER.4T;K
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M:)2D>:]0=8@?[H'JMN%A,S;CP#<\SD+:>:_!:6N]>GER=/CR.)SX2*U8._.
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M'7I9P.42J\$E%1I<68Q2WXQY%-XN"?>K_W40HW4@>*28>/_M2MA?)4SF)0\
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M:-)>=]^ H$GO'&[JG<0<3W1!@&N=/!V<8$:HYJ0420HU&<95&O]'0AR7R)I
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MN;*X>KKA[;/!)V15G2EG*[@ICC110(CG>O\\TYC/8+/A0]K%N.8&TS) RXW
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M(EE2BMVM%S>8%2B1-NR\2_+UFWS]R  E2"^@RR!.]):CT!8)2N; 99R7E<'
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M!39BK.4S+;XTWLK"@UYR U%&.I+5AE_@H2"Y+MABC\>.8VZY[\\WP)8#=&3
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M?92]?M]*Y"*8Z WH+7@^=B"2SU08$#!_<S]C;GDI?1Z0V+Y30TLY.6QE.2'
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M8=_L;J$TH5P1<>LP2UP4E3:&JQ)L8+Y;Y,"M<W7-R\E$V=)_W@:#(RNYJ*'
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MO6G2F(KI>^-TIKB(DPC$'9#M3%LLMU&'2]^INH*]B;&I+NK'*FKI&^A-LZG
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M@9YC+(BK/1)87%$^-SR;P6#@[PT[]7K%C^GH$,&:NU-:[5/JC*!-36D\ =&
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MW>BZ]4=G*1]/]ZYX]_>J10U2IH"3%=/:"T%3=D#WN61E<NU7F'9V<KB_=W(
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MSS6<?9G%<CPEL:Z+JRJ+,S@5,"0QK_*"L^'D(L;OU*,NY4C./623):^FP\F
MWFZ9XCG/@>/AGH"7)KR*RRP2PQ8O&'V9:3O515%.] G+AH,=[?(B SY'@VR!
MN?*J@@5A%^[?<.\X9G,Y_VV.)UDP3AL]!PZ6BY&EDT*+.$W=G+ <!:IDM#CS
M$?]%O%4<Z$L["Q:^/M&J:80OX1Q>. G\0:\F\/MA,<8QKLV7Y6#2ZP4%;73Q
M[%2X-5@=]OD]+RYS%!G*@> !^PYC0K=E#N]^.[.X'? *QZZ[+=201!DY5KKE
M"(S,<) GWLYD C@V%7,WX<X!+Q&YX8*)N0 EP)^P-#Z:@#@&*1P7@ _40797
MVTO$7_&F!WA5-6;3E<JQM/_Z]81FO K"F)MHVXRL'8C!P3_I+$.<IQL&]631
M@?;*":WV7[C>J\!KQNU*C-I9U#-04\I>@&1@EYAX4":"LG#'R30FA04 4&^J
MQ G%4P%?,:879]6)#^/LM0$>=,QC%/K#JUWM/6H@O!PT2E%9Q$"/"$D  ] "
M/EAI5QD?XH?K<<3RFE"'(LJ0*1$9#NO-4?.%?69YHTY%P"#2;%(IQU,N%W0B
MB0220^UJ^_-SL*<3(*R_Y*A=^D8]\5I\LSN$>%R,:W5.L#0-,!=$/>U6/=F(
M(:U7A1@5C#A%"+5L$+="X;/#FYL)TS1NF2/OQ&P1XBTK;P?17)PBPQG5.:FF
M@+TX[9O^RZJL&LCQT>J++6VD13RM\%4YK!J!$W'DQ#@57(!=3*"NB:Z>ATQ"
M0QR6WJ57!7.O;Y(),  )Q3'=\3E14'ZES.*M/S8 UOX#5?]S?!-E"HU]GD4.
MN$,V$?PUANTH6Q005S: ^V&S<@@18>9<*X*;H)T7DY8/3^>80PS&#(-#W>H&
MZ0K$N&HIA7'GM4#5D'#%4BB^Y4U,I(3)\G0XA2M!L-60Q',IT\E)/ $K[]R8
MI)VJ'5G=+"[V\'?86SP%S-W5#G.)08A3@$X)Q]'9&8X$!]G,B>'=!H[B[@4-
M-GN.68ZPC7BS/$]VM5\YB?T:W^("AYW_1'J2HC^: O<!%B0N-Y\2^) W3(A+
MP%4([0$(K1@3DQ\T]/\#+),1K2W9&1'?):_9V@#_3CI47DN.,8X'1P "4,$0
MRU$TBAL9C5E<R_P98I-CR.,ELNSPU^.3VXAPH2%G(+ER$)/"E;)-,OVLHV(1
M"Q-#[*M;L6*Z+.3'Q$!;?IS49)VR'P6EW76TLLE%64S/+S3X/"]7$1>_K%V[
MDLX;'3TUO]A>UWVSZ))UY98?^[:P7;GE_?-!/#$K;>&?'7"9#CJ-=M[NM?QM
M3FZ0-IASX,FB,1?PRHKXCJ#E;*)=%-4XPU^R9)2!_@)JWD!J;ED^!C1 3%GX
M$*EX$7)/B2S*[]"R(CE'>9_$3P_1H_$[6&"MS52+>CT2FE&9P2,9(UD'IR!T
M'!?#+ ;.VZ/0 Z+04<M7I# !M5AGTPG8GC4O&&85Z U@*6<3^"&@&*(6ZJZ2
M8\ %UI)4X$8UP<>$DOLC@\W#TLE4L*%&6_KO-!/,"-_(\F^@O^$#U7(IT-_W
M_>_[8,1+N)GX"N3!F)5"B:S-,G1$ "R%](!=#EE$#BBT>[3+HOPNZ+GF"4)/
M%II2A:]4$PY(D1>YSL5G)H+=H"H&^ -_4S2R5L2TRGO%)Q-$L->U@*K94*/^
M 8?* 0CX^A!81BZ4J:GR,;D&H"*?Q+MO>G1Z2'0Z;(Q;/AI?H*&%BA[=@Z*Q
MT$W7;)TB.5)K1EMBBIX&8"A5$6?P:T0S<OXW2Z G Z0+($K%AX H\+$+V)9>
M9M7W!OL:Q7W65%*\<XVZGZ'W#JT*0,P1Y[#!&M% X4=3/TNS6'TSYSSI&=-#
M8U)1CHO6;$ZR"C%+P:.!-&-$] FLH))?"*T&I!/8MAF\$F=C^!XKT0Q5&9C@
M/!@J(D]%"<(LUK+A$,TF.%@UA=^@F5Q-+D:LO^F'O.E/8%&04BH$?\I0S116
M3BV(GH4S=R[7GB[E1'@;M1,>%^<Y>4V6:[BKV[V/CUN=5(L- /?B?7Z<E@UR
M#6&=VC7&6[>OX@;$*(]T"U<R"@32I@G^+/>G=+XQ6+:&"-,(@87(OW]T*G1I
M^+F(6HD8$CJI!]+_)1>B]^MWI:8.+!#4+)*:ZN?)5\6D1TZ(.'((-4YXX8!&
M8P^_RT#>3N#%6/H/6(P.4'3OSH.*=H%!'V"U?/9T<)I=[0M70EOR]QAJRW[R
MI-T!+YM-4>0AQ[V#(H#.)-RQ.%VSF3PA;SF0RU]\WFT/ED4=M)*)!>H%(4B+
M"#"Q=:*3KZ_5!N3WFHL1Z0IL!'H*&C"L*M#S53NOP40A %?%"!U<&/XBNX?\
M<"BOFBLCE6,:H6%#&C!>"A*#$&59+L-LY4@XB4F=J6+4D@$EZ%_J\\)0+L1;
MPBG91OYHYQ?9>%?[K0:^\ 5>NZ@(/=9^QCJF1DB.3R-V@NP=7OU%D=!I5!OY
M(J)#WL$V^"1, 6';B: +QB@8GKSYQK5[!Q"F$YYK=7Y%[<%J@R^U>  E33WR
M%R6\J-P<?$ Y/>'0S/$%2*=C"=25CT2@F" ZX1.8LA)+W(JX\DOXMP!A4K_=
MH"P%*93M(/11>=[53A&M5#H<%I?$(UCC8E>Y2Q,:JGWNU70\'I*VM-"_7>LY
M"*PRQWM(^# 38:B7Y'[]V&$P9#Q(YH[.U!*=$Y0V0.P3X$JP99TX)]S)_+/5
M!5(]6K5Z17%\X>G^B8A%GCEY3>2M$YRZ_E&<E3%<:LU/LCP>3LE.4MB\%"_D
MIB%IACN(>+V)1,1U*>I:LTE)10U5"Z_:13%,D-E)+B1"5R(JA >(.*(=4!6P
MNZRZ@(7K#<\26QL^%"[_QI709=I-X)4^*>F@_GHL.\P*[KVK?207X?+[0(NM
MB3'Q$EDH.1OQD_^=,HHTCOBDS.*NJ=>(HY:4 "#I=#AL<&%*I$Z[V]7>%Z6Z
M?NVKK-&&(B-)0=$P]:3B; KG+WD*)J\&3"D;"@Z2H<61@I%)S@TZ$ZNF)5<_
M]PCD^")3W+P^Q:U/<=OR%+>36I% 9MVDN#0J8JL="0T%=IS)# QB/XTZH*I\
ME=3Y5"]+K9R0OD)J.NC!I*DL?)44%9 _Z&B9J)R6'@!-@XM_-#8);1&WM*N=
MD?A0M]IJ:C+'0\J=I-D)Q1K &@'Q0&[&F1=&+&EDC+0,*&N!I!BR\2R?%M.*
M#!4*4^!ZTW$B9%M1<25$#3I3#D]D.;%GLJPB@#O>*?O!LB'9!<(H/B3%&CAC
ME5' '$.TL^_&Q728S.D9WSNR23E.?2?B-=0R 0?12<G0-! B7MWN2U/E&N-Y
M+_D!(,%,<D6'+F4<D@Q41-.$CX?%5=75P<DDP"2XH00V&X^+4B!LHW%3 BD:
M<\.NS2UCGF2'%O5O*HZ*]43@::VP)'R$&M(8/J&EL+^BK CY:6.+MS/&)'P*
MGR!]-1YOPM#:/KG(*E@*HS2((7";\-.)1#Y CBN98M":*I0P@'YT)0& %,!=
M[3/E TY@R?D-<2",!&[V' Q,W'%=!$"Y"'S&IIGQ.&A32I)+,G:>%\A#B!F1
M[Z ),S>1YT'[LV(Z:7[8YM^V.5!UQ >)])+#S3"Z,<RI'1.U)>7T7*9V$>W7
MN2\+,G<K<AMS]+^@AQG3TR27 :M.I-=P5.99*:ZU(?[98TGK3R8;R^U@BF_"
M68)8/*-,ST*ZL15GK-29SSR@+?H<?+"+608J]F0HI%>(D&#K /]#9KX ;60>
M9DUV NN)(E,*6HU$AAXPA$$WBQR]%%).23J@"Z^-D)H??&+E1'N'^->X.82#
M[:IQU#7NM;H*IN*MMZIJO&O-UUKOFG"%S#B/6CDJ##[AS0'L1U@L!4 E(OXD
M2X'C418JY0&#KB:C<IE(\8JR!%,".PF^.7E_0$[QO$ZY5P2WM%'5"J'V$W!D
MY"]E8RTR-15.U@V=LS$&C&+R_$CXP>Z(-0AW2,.$LDHH!A&?7'+83DT7K5'=
M@5:2@84K\CWK-Z2SJ'5+U?=$#$$8D=*%A 199OCV-7DLSU,F4QP5^.M5ZX::
M=RB+U/-%GA@"9LHQ)WVHY(TK++LHSUDN<U3JI"3R'"@.D]EG6@'1..0QC56Z
MM!FYP;0Y[9HL^P0#UKET20J_6W,P18(DQ V +-A$>(U9B<[5AG@(95$V"H6T
MS>"NECD<I&^@JNE+<4 TCI1*W2=K9,,-+@;2\1OM57*G&3^&XF/$-*\<] P9
M46U./Y7Z M?.3@[W]TX.M',\9(Y$H5<@N*H"3RQ2C1)M'Z%U.B7MBJPV/$Q3
MX/>N> ><LUY(7KP04OAE1#(=$4Z:(0U<"\&R!%@'[5VE'&4HJ>J23R*BU"YI
M<? S9>LU=*4##E[^ 6@!9L(U-R,5?[P^JD9LY(#X->)FIP)&\5*3@G;!<(NP
M88DL-8N"7]%ZF+U79B-*^A]((;[PXML$\V<LO<E%+NU.GN-5-;Y.]A.A767P
M58946(&F)@VH3C;Y&'ZEMSE&=3Q,JGXBWVEF4:DS@NRA'W0M;Y+"%294X0VC
MXECD,J4N I[4\CMB4A0R1&$KJUWG$NB1RMO>F2IS O9%K ;L56&Y*FY&Q*J]
M_3WX1CYM0X*T#AP9Z$![_:_#]V\PG_P\RW-1KR)K7?!=^"65S,#VX(Y@^V08
MCV$93$(_(W- HMUL98T"*SKB@F_/^'SWD2L,LX1XRRE>IA"A +&/8UF[(#EB
MX^H5@=$VO-K<MY 7L[==GZFN6%AXZ4)FS]SE3(A1C<32$>LJY:)<=-+ZM[<Z
MZ<L@U]KA(6XL@;^2XMA<AN2&(%PHTH+.>#!,0'^=3NB2:@E$$I2(KKZ6UG*2
MS%CXD]IK7N&*.V8P,M]XB"8V92^B1Q?#/A2R&6'QCA+[K0N8AAEJF]J/K*I]
M6)(L@?7+U.Q)=ULB)M 8Z.1>4#UKR_'B1?KN_>6^>]QNEOSOS@I.8WNG=_CW
M#O_K'/[7<MBGR1L[/#LXTOR]W8=I-=9N@E;\!?UN6;S"MGZG^J^)S+$$)OH[
M!6#%O]^!10XLE(R7O:@ )BZRC;03X.K/5^+)0Y)/#10H++06PDUZ^0!W 2I*
M\59=-P=J7PHV24ZF:U-\K253(83JJNRVA*Y]>B2^.2Z%/8HF @4"-#3%1\J&
M0#NA&Z$819/Y)A-M9#EW.IRB%Z.)UY/] 0:,7/,A;^Z1Y,L2&CO^S\'IV='!
M\=FIMG?\3GMW\.O9\T73O6O:+4B=)M%D#PHP"0 +?O ZO 8OOK)V;2V21?F(
M<,,B/U_\I.GNAO6C:F8+XA0@[(2\XJ2.R.=WK?KQ5IM;MI4VW1 HALH$,.L?
MS@D_&6:@;Z*?)IZ60$M<.IC #J__W?KT2BX8F&E)#Z7RZ<5'4[XWFN99G(W9
M$(U(D<8N5ON\>PJV4TF>@"ME(X/%/A*9J2B\5<,LY8H=J/A]T-;!_+7X.T\Z
MBZ)^/>E^1Q@OV0_<D?RU>@@RUTCC;H%RCJ$5\JM@GY.<JRU 3A;<F0((=>DF
M*PDTVMJ)(C1__',Z$;F75.Q,"PG?V1C,S7/A<)*&'=8K98V7Y=VT20W,<<N-
M1T78&'^O/RLMP;H263DQ9F@-L:0DS80QT%YOR<]9F0QEMI;PU[6901)$%$6O
MH[VG<RU09&;C["<52[W#3V7L)4]$BQ-0D*BB!OGN#S9$BSEM&+A,/Q9/-$UF
MJNE(=(RYN!JC!Y1JLT5V_0AM&OR(^;?F/6K0(!;L,G8T>9:Q U%+G)5R3_*,
MPJ$F8R?J@448LCD+=OCJ-OQP [ONZ%'?*X\I+#8O<*23#WB? !$ED_$9(,M=
MR%AJ 1(5;+2D@+?1]L=\-T2N#(#%J?<"Z)Y($ZBFH"573F6H!=V0)2/V5 @G
M]E3FHXZG0-C5 \N_IP^,,0JD3"G5%^Y97$[=;V$&:TF#N1[9!\",N+:#&I_V
M7L2[-?UQ2E(6"_D-4Z _=K$8G>)I 61!BB%Z\ 'U45M$V:7D@% "K^0YZ,$2
MNB'^2R9D3DNIT(ER@<;31/$T$HO8UN+I:H-VWN[TO@W5MQ&LQ;?A];Z-WK>Q
M=;Z-"1]IP::Y-MXWQK7BM4=F>]K66(!._XY-V$;(LUOSBG#G%K;X#2H,*)3G
MP$ D S:1>\@?T= !JULI^Z16_@FGR#,V'0(J'7/*LM!.^'D=6/@T!2LLIG9=
MZ)\'3?!]5HXV7WL[$U;1Z:2(O]<%'HBOOQ9@TY"M3P$7T,!6O,:9.8-/W 41
M<29'W;XI$U_>E>AIS[&4T2S)EAEG.2G;\P'#I]3/GHP=+[%-%K#C5=F1L4F(
M_$5&"]DT(9^'*(J,A<DJ"KZ4B'$D9K-IU07G0I=?0 A(YL)0ZR0+O)ZTMO";
MF?:J6M-95?:YE%D =;Y/9Q-5)VS=&A.#;AL&RE^A3-S7:+*\P=!\RXO^+MU/
MPB45L^I"2X?%I;"YU;P9T;U4AL_),8>=#(SPG]3Y4B9.(=M.EKHKZOA_?9J\
M0#_":S7!H^Z$J!RS=:>W!WY#$5]*%!-DNN)[FO3[D]<$OX8%A,-A8[C5=:VR
M:5^[1&VZU-"H?1DW7U][Z,;N(X]J:_N13P@==@\*?"QF+*C8 7UEY'%%-ZAX
MK'77 L[S\42F+4E!.RZS'%MX7.=EV7#:IM)YE< 7]D23#DOL;Y\TOD:I>-0W
MKB@@']&\Q^](8?[Z<YXU^235&^WUI_V]C[^^&:@8\_=*N&QR)NL;BZ'PI+6X
M5I(J1,[#:X,!349LTZA-K0W-\@T3%8?UL??EL77J07=>$K6^+]F(4S>KUY9A
MV@\S7V%5&4L.R2;G VZ.$O;)!CP540&Z?C6-M<86C"HD8,B+M\A?-V@RF<7-
M:H(_O>=1.05;15RK):[5QE!@*0K>X>#37&3$HTN\Z"HD37^N7/&+WP')5B7I
M#5?7?J7$4^2;4G';2DXE\J-N%F/4OTVV8< PCTQLFL."MDV3B#G//)]1K$=B
M'.);%\=6VDK#A1#!B;G*<A[,#-/&@GDJPB3-1$2GMNL:QDO,4LG\:XOG(W1S
MMT8AO2$%=1UTJKGS$J9. ;\Z;UT)/ [99=MTFXW'L%=R]I3381VPY^>RZ6M#
M9*?M^_C$P4_9,;JE^&9).M/6"DU,=IA24+&]V]7%)AU=.Z."N/:W=;)AT] 8
M:THH&BH2N<5-X*>H!4Q$2:9-OQ=**)615T:Y*VJ7Y]7H)BT%)V]T/KRT^I%!
MLZ#,[^!EB;V @'66L"M!10TD*!>]V;I0E8J8)Y1;@\DAE/W:Y)A42S^KQ#6O
M/\$-^QNHH)S=#T)<, #9B!AOAO:UJYUB"Q+EX>9LV "9^FD/1+K_!&--LGE[
MTQI>!&CK?C\BB5X01Z(D&]6E0C>=L0-D4MS:W6"@4Z1IUP;:G(ZJ32M93Z#4
MXRI%PZ+.Z*K3PDXI09GY!-4R#8>UX<!4(V"%D\S.YE (J6YYQ%3TCAHQIA@W
MST1$[R/3Q"#X'I'W$0.=:F6OUV8Q1PQGQ_5Q!+<:B>-0G1/FG0@_ ;5L$67O
MXM<,"([$8-V^K-MG12ZV*H+5;)3:VRC?I8K_C@#M_%H*3?$MT?%U!+)/)K34
MVJX08FSRB_;:?".-=N)J@NI$^P"%OFDO\JR"Q<GOK,"7X5.OK3<8<RV&/Z3
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MH@$-1[4G/,NO@_[?Y_:TJ:KJ&BV[O31%_S0R:FIKLA=/YCIY@35<3@% FY]
MMA;+;A%(7N_M[[WIQ(Q9VV9B#F"RZ8MDC74+F E@596BHP&[Z<H&/FW,$EO>
M_<B2J:Q\J4;H2CTOB^E8*:$2A$8<3OK+9/^HME-XU3JL%[['H@)#^PO>DR1"
MR12B>)\4=(344&U$)9%H/I,#FW<L0QYJ&1P#Y*;#QM$VW[N=4H-*8=$V/1$1
M'.(?8,&>UDU[7N\?G:(73/OW-.<4#U;"_#.MY:*K3AD:<HJ,O'"BE\8>R.*A
M&,*\V#(..S:_TH<A5TA)U+11(6%CP[RN>YHL \L;JA<,[&!F7K ?&.U/U/&]
MRZWM]9?U;+)2=3N+_%K,O,XJ7V!)4]BU[CR9\',9(YNS\ZZUN!?(]:KC U!_
M(5J:U[A-H1XTQJE]5%JWRA.B=4[. O<A#[ ,RJH&^])FBUV51^U,-L-1!G5?
M1FHEV'"([?3Q;*V:?KVF+36Z6Q#$NM5LH?\*=KI4:U,:LPJ]NQVP6S]\+1&3
M5BK*>&DZ8!-MEZD,PT:WY?.#-)2/S[:RND9AO.Y@UY!=,W-RUI2X[GP#.0=;
MT9#;3:,L:U:=L5<6P@5T#?@ 835-0EZ@?R^VVE;?KNH-I._7+?:N5>S)!E%B
M\DQTXVXZ5;;C."5M%DU*Y_4LO@%>$T128$++J>VRFZQE92Z?TNYS%4YW6YG[
MI%5-BQGB/ZI_:/_WZ>@W[<.'3]NPWSHO'3VQHBY^QG$K)33@0(P:H^'.7]\&
M'NMTLJM]**:817*4554Q+;,-V=F2M,RUZZ$OT1GN&>LHIPVLOIRV]Z#?=C;(
MDU8W[A\<GQT<'VC['T\^?3S9.SO\>$R]C$X__WIZ^.YP[^3PX'3C&S'M?SP^
M_?CA\-W>V<$[[=>]#WO'^P?:Z;\.#LXV?^^OL4&D<#U@XN)/+'(1<\%D7F(Q
MA>63JLZ?E#/#ZAAP@E-KR^K-338@EM4NS<*C2>HM%T=%4J=QN..*_U+_Y9])
M5H$9>O5+EM,IZ*5_SN?Y@7E$)IG\"GU0_+KE:+N&X&J3$OZ?U%^6O]ZE7_UC
MDLS_SC=V0]];^FMCUUSZN^N6-:U=)[S;LM?_SK67?_1>FPU66O8?!%\!8[A&
MQ)#_W;%W6LE$XW9_L<8_-;.+&SB!=_8FQ24^OH V%@R0E2>_W:$$G3_1L>:H
MGXXUY]6]Q0D-/-_.,P:&V0'&5B+SXH/NG9ZJHFGY_4E>3#T14"Q@/$6K][>9
M)UX3^:Z W,\9. ^$[(I>T)FU'M9KU&/HPZ>8%$[ V)=9YQ3?J69:-MR-U6W#
MA3\DJ]^&\]\.X37\KR_,Y$T^Z#X6SC?M"S X]8,-.YTHNBJ<>DQ#VX:K?+7*
M2=03E/CR1AWA?[*?O^1%_IZ<\P66-F>3$_0:3*MDA^(^L'OZ098PB_M.XCI!
M&CI19(0L]@*+F59DIU9DV7\>H@YG6K:Y@]TL<21!];\[NK>CY6S$<47]G+'Q
M+X@7>WF"_SEHD6)OLL_*$GMZ_ >[9NYH8@ D?/?GY)=\.M*3@MP<N"Q0!H /
MEH2UR3F5V/^YBMX5/SY8)S^^VD?3Y-O!CS]^"[]]_#;\_L>7S^;Q7[]^^V/T
M[^]'[W[_ZX]W?UP<G<671^\.W8^_'?T\_NWPZOC=[]8'^WCX]:_"_>.W_PR/
MX?=?K3^R/][M&4?6[];7LP/[Z-W>U<>SBV]'9R?9T;??C>-AX!QEX2@>O<\_
MC@Z=H[]@S;,]>._0.3X[^7YD_3O[>O;9_./=5^/X[-?AT9???QZ_BW]^L$\N
MOHY^#C]^^VH>C8[<XR^?C:^C0^/K7R??81_NQW?XW4/[Z[=A=OS;@7ET=MZ\
M ]^:_F%]]HZ_?;[Z^M=W\P_8R]=O)]^.?X/]O/ON'.,9OR79QR^PWMGGGQ_?
MO4^/KHR?'\X.)D>GQE_'9[_#'L__3&.?FY')]<0)N>X8::I'4>KIL>7"?_PP
MY#S8>6M: \-W_N<?7119PL"OX56W(($[B(.>>VP%]_ B&Q".6XGCQDX0N8%C
M)FED1G%DIKX9N\0]S)Y[;![W^&N6>X2>YWAN9.DI7*KN>%&H!Y$1Z%88)*EO
M1![\#[B'/3#-X/&YQPW*%#8"QU2W/-$EE<0QYVDZ:S1MBY;UJ1[J@]D=)191
MBZF9Z*"<T[0:>%BW@\="AKK5[&A=RHP$?P4LZ2.F+9VTP#_FDYX/K8L/'>_/
M:S'<36)FV:YN>;&C.Z%GZ\QW8QT$C>DF'N@N;DA\R/*MV_&A6S&)]:@W-WYR
MJ1G\XFEY7:I%3\N/1LMS.@5SDRCF8:A'8<1T)^%<CXS(T0W7\2P[BIPPCL@B
ML>Q;ZA0/2LNW5C92^M^V*ANG"\?*W$G+6 "(Y\>9UJ5E$-S/ .R'+=1[?K0V
M?G0ZKUL8?A*$+C/UB*6![OC,UP,O=?30XBSQ0\](XW3GK36P,5!W/W9T#4MX
M*-5BYI-W4BU>! &O2[7H"?B!"7A.H; \+^&&%^AQY'JZP[FGAVF8Z*YI,I/;
MG'E6# K%P+7##2+@%^:\(#6[Z;4EHIZ]S^*AM0F"^AX!6P:<>U:T-E:4S>L2
ML1-Q-[1#W0U=C+8XGL[B.(6_F59B^)X?11[J$HYW;UVB=U-L+OFN2Y?HR?=!
MR7=.DW"BP+0XZ/Y)& #YAG:@!W:2Z%;L&J8=IY[A,=0D/&.3O(SK]$Q8[N:K
M$F?%! M5[Z]*2#BLG&#W_!C5NO2,GD<]#(]:D-!A6)Z#=Z0;L1."8A%%>I0:
MB1Z8J6F:<9HXH;'SUC8&IG5O]^EM"62+G!DOF.C7I9WT1/]01#^GF 1I9!F>
M8^LF2SS=2<'""),TU#W/"@(>^X9G)F!7! ,G]+>%Z-?D 'E.2>$?FHGKBV(N
MBU/#7[RQM2X=!H'?^VT?B*E]7)#487,_A9LR=,X<2W<<U]&#$*RMV/7,((F3
M*'0PN<P9>,$M4U-[;\DV$?"Z])&>@!^6@.>TDMA.G=#FAAZ&+-4=SXUU%G"F
M!Z[!3&X%H8NF"!"PX=@;1,!K\I<\)\7C! BFS*AM6\*IK<E]U(X7$2]>:XBF
MA;\PJHZ+/.[MJC5SL 6Y'[[!7,L.?-WW+5=WX+[TP+!M/3!M/W+<%#03<OA:
MYKK,JBUUESQO6EYKO*:GY4>AY?E:E21UHMCEH(-@I5MB,3V* Z8G@1L&%D]\
M.^5(RX:W+K]H[P5YH#H7;%B*+>>K(IU<ULV:L:QX+*8%YGS2>T4>J^I%7,:G
M(<LG>WER4-]"GR>_SMJ[LSWD94(_^>NS<?3NP/DS989KI(ZM>QZ+="<"#25P
M+%N/;>8"GV.1Y1N43&)O4C2Z=X]LJ'+24_*C4?+5#"6S%- TY5PW+#_4'=.,
M]"BTN)XP'GC<=9TP3'?>V@,[W*2TL-Y/,D>VOQ5%<ID-A[USY'&TCQK>/7]:
M'W\ZF-<TN >2)>"F'IIQHCM.:NN1'QNZP2//#;W C9D-IE,P",Q[JQJ]'V1S
MR79=JD9/M@]"MK-J11IQ[MM!JIL1I8*9ELZ8P70WM=,P3?R(Q]C;)QSX_B:5
MKO4NCSD:/<PG+#_/L#VQR&?M?1R/J&6TT)<>6SXY^"F''?:L;/VL['!> _%2
M!^P@[NA>[%FZ W)(9ZX5Z2YH'+81>XEOASMOO4%H;I*%U/LZ-E0!Z2GZT2EZ
M5CGQ4]L(C<36X\ #F\)/#3U@8:C[-DNXQ?P@L*V=M_X@L#8IN:OW>2RIW!TV
MJ:DS!3>]!^2Q*GC[0/)#L*ZC>64D\0/+CEQ'#^TP!64D]O3(]GV=NY$=QE:4
MVE:(@1<O\#;(K.J](1NJC/0D_/ D/.<:X0:+8H?KEL==W4EYHD=^Z.E^Q/W$
M-4$'L3E&7/S@&7I&MJR2=W$%[TUGOE\!W\:!8EF+Z#6<_]DPY/56*_<<>'T<
M^/=Y)8I9CFWX+M,C!STZMF?K@>^9>@"\. KBT(<[!/O/&P2^L28#<&/JE&_P
M]_2LK6=M#UJ3W;.VM;*V6>62<],Q;; * V;'NL.,4&<N2T'7#&T7?F9%$=B'
M?C"P?7=;6-N+=GPM'E_WX7#OU\,/AV>'!Z<#[>3@W<'!T=ZO'PZTXX_'^Q\!
M23]^^'!X_)MV>'QV<')P>G8J!LJ>?=S_OW]]_/#NX.3T[]K![Y\/S[ZN/-QK
ME6)\&RXX*:88*EQA"-SF,<65AX+=W7/QX@':1]B7SML;9BS*AMDDX[<8NG<7
M@&T%HJP[@/D"0/;"^L ?\02WHL5#EHVJAGRN[N,>>VYFRZ(C;C9>/T5[E1IS
MWA?E/B$3SO82?TEP1CN6(AS\'/.\ZH=ZK=%^B1>X9IC/X]1S=-N-4MV)4TN/
M3)OIOF^&?A2 P9EBXQ5OX#OWME\V+\#5<ZIGRJG6UD>FYU1/Q:EF/2U.%-@@
M:FP]CAU3=\+4UX,T<'3+\(+89;8=629UF+'NWV%F0^-X6Z C[L4Q'&92:6-V
MQ2B'.4\T%L?EE"<:%X32-_M_^+"6O(9/XA: :>V)._C0VKQ]M\ZULZWS>04K
M=!S; O$#&A5CR+8"G5F!H5L.@Y^'2>PS?^=M.'"M=?F'-RBZU1/VVH,Z/6$_
M$6'/ZB.Q9[F&#5I(&'D>3E.W=<;C2/?#(/4LW^>VR7;>8AO>9]CP;EO4D1,^
MF9:Y5J3:6$Y,EGK)"BK(\V9(]]4TXCS^14"W2.4(5<F3>KZS/K[S?5ZA,!+?
M\IG'])A9H>[$MJ$SQW;UV(M"SJR4N[X83&+?LICBX?2&6Z@'SYOH[JL%]$3W
M2$0W*^R-@'N>[WIZ:EJI[MAIJD>>[>EQY+E6REA@N:X8#'K+AG*]B^'6]/8Y
MYZS,>:*5_ ?/IZN(\A=J=*S+F[ /B^+GOF23B_UI!6?G9>,9;:R-GL>LSF.^
M+>CQQMR 6S%#"\)ENF-Q;$!K!GKHFZ87.DYD8)V"XV_2)/3>3[!A&D)/L@])
MLK-J0<)MYO@IT\W$28!D/5L/(^;J81@8<6+X-OP+2/:VFGCO 5A_LM>X*(GV
MBE2I7TYX-+F3^O BBA[7/4WG'4"[9SUW83T+^K299NB'-E@DB65%V$?2U1GV
M?W)Y I>5!F%@.3MO@[Y'VS,FT'5/R^D)]!X$.JL;F-BN"#BF;J91K#N!Y>F1
MQ9GNV3A8.+%CV[-VWEK>)DV3>)E%Q_%\/OA]? HO>)SHNA-$^V#F0S"K!3W7
M+-/C5IHXNNE$7'=<X%A!&$6Z'7+'-;W4,PU?#!7UUF7+;$N%;D_Z3Y)QV9/^
M Y'^7$-ZUS8]BT>Z9W)+=WCHZ\P*N1XQ*PEYF  +P-"&._"]OH)U>XO>/BQV
M>O0MVQ[-]=$W?'H(CK:H9UL0AG'@&+KK@$;C&$ZD1[')=>!S3N!Y,:@ZF"'A
M#T)[D\9_]>Z1355)>B)^>"*>54N\R G\( &UQ, 1?K;/=.;YAFYRWW6M)+!L
MPZ$Y%.Z+;FC_%"3XCJ<<2"#1)NSG\BK@/J:[;F6BAOMA'A<C?L9^*K82#>[J
M><XM>,Z"/F6^8UBV'=EZDH1@"AENHK,0+*/43TRPD4S0'(R=MY[95VH\8VI=
ME]9P([7VZL,:27E6?8@"UW.XY>N.$[BZ$[-4#U(< \P-TS(<PP=C +.DX6\;
M1,R]W^+&EO.+@C2]$^/A^\ZKW*NW@1Z B7U>4.IAI+'AAK;.$QKJY?EZ9(:A
MSN,@C8/ 2)D9[+QU!Y[9-Y]_QG2\UN;S/1T_/!W/*B-V&L9VXIE@2#!'!XX<
MZ&$0VWJ4VD9D\]0US5C0\;W;'V^>*V/+DD'Z))!-43L43M7SI_7QIZ\+ B9I
ME)AA%.I)&#+,)0WTR(@\/4E<9L4@:(*  W^R!IZ]KEKV/OOC6='\ V1_]#2_
M5IJ?U4DLFR6AQ0,=F+.O.V%HZ,R($CU)PR0*8X-%H0TT;PYL=VMHOG>?S)>_
M%*-11EWJ*FK%A50+^^1Y?+,#Y0[&V\-H"3^K[)<\&_[OSJ2<\OE*M^:$V)M/
M/5_/&U;@#0N:@IJN8T=NXNMN['+=\5BB1Y;!=!9XS'#CB)N80#''%9ZL@_O=
ML? V<JO'PH?%PKGBRB0-(MM+="]*<+0&#MF(@EAGW O#B#NI:T1+L;!O>[^@
M%U+"^8B:,@*\D S*8@B/G6L94$3)JWM-<GT1L<%UF;;M51QW;N)07L3!?Z=8
MILW*\@I^NC?"EF^]RGLKAK*@%6.2)(S'+M.-%!LL<-L',]>-]3!A3F $L9-R
M"U3>>_O2^^C^NB@XW%0[M2?@QR#@N9:+;FCXC-DZBV/LD&)9>NAQ4S<3/S)8
M:-J&P]=1\]Q']!]2WIY.BOC[13%,>%G]7>-$*?>9OW,SQ#9/Y]B,R5?;#K(;
MB"O)JO&072$GX-=#Z+&>W!2KQ QFV8%I[[I/QA$^E75&<86\8:"]NDZD?^+E
MZ04K^5I$^^'Q^UG9WNR&&-4G5GXL3R=LPI/_L.&4MU^7TMSHI?G-TOPOD.+[
M76D.ZPWYOTZN_OB2C"/+\6 ?/X]@CW^<'7_[>(8P^=T"N%P>?=O[^<>7?P]A
M7^;1M_<71Z-_8R'CGT$0.(Z;.KIM,0.'"@=Z:/%4MSTG9J#.6VZ<7J\;+D&D
MNQEY/2)M*R+QP#+B!##'M3!5E/N@53J 36GB,=-/$^ZDR<Y;8]<PY@M-YGZ@
MC5FI_<#[_:?&II.+H@0^F&A+T;!"%*C6XV:PKT= PK9JK]G4:@$VN\?*1\=*
M.,.?+ 4&QV-/=Y,(L-*QN!ZFH:6G0>); 3/3-(FO86\+\>J.UF^/5\\(KR+3
M8I;A,MU/8A";;ICH0>#Z>N2DC+M.Y'''W7EK&@-0^59@=P+/_GE+!O>0B/AQ
M.JDF+$=EMXN):?:3)_I?O"QZ)'Q*)#P[_]-R0B/BB:NGL9WHCLD\G7&?ZW;H
MNH'E6W[H1[=E;@\I-'N<VGR<<EPW#8S4T@.LVW/B".P!%L6Z"[CD.(;'/!RT
MM#E\ZK"JIK/"LD>GC4$GWXD-PS4#W3=0_[(-6P_<Q-!Y8#BV;P:>'0:;Q*)Z
M=-IH= J#R'.2*-2CT'-T)V),CW"(B^E:AN>9H>FXSL[;O+A9Y5I9*=,R0@FM
M*+6BE5\:FVCO>,Q'$2^%2]4V!QKB'>6'+?R5V><%/$Y>0)>PR4UT(T7WT<05
M*7HV'< )?<,TXA@4!LPO,CU79VF(^46.[<:>:X2^AV&' "[NGQL44GSA.0&;
MF[S>4^\#4N_<.&AL3@BXJ?M>"@(5>RR'H>V"? W"V&6>ZT;N)E+OIB0$;%@(
M$/-GB_P^\;^UA6W$5OJ8S?K(]_!&=?KCEZ_V'V=)]L<W^/Z7/X;'O_TQ_/KE
MX/+C;[__=30Z^ O@-_IJ_6X?_W:, ]K^--S4"SW7UN,4FY9&@:V'@865\7'@
MFD:8.H%]I^#?VJ+(/19M/A9Y1ARF-C? %$M2C+$DJ M&>AK0);/4Y?;C1O[6
MY7!2L*\/SVP+2L(>_XQBQPY2(X +\3'LY]EZA J.%?L>MVV#)19_*K=3CU1;
MBE2IX:1N:ENZ&4:^[E@NUT.?NW _EAU&<6QYF.$0& \;]'LP-%SD^NQ1<(-0
M\.SSGX%AQ:&+8ZICCN7&H+ %EH,<SK%=WW3B$,N-/<,?!,Y\1[;:E8D>R@U!
MNJ4AP1[S-@CSOGW_TS*=P.!NJ#,S!B7/\TR=!3S2 \^+XM1, Y>QG;>N:PQ\
M=WZVR6JN\\$=,//!5+V>'6XV4GX$=AC:ANOX((>Y@Y9'RERP06P3D=+S$S!?
MP8!%=F@-?&,!4MZ9'3X8TO7L< LP#\[H_FE9-C--.P'4B[$9&3;[L1G3XRCV
M@\1RS# U@!\&UL#QP[OQP_O$"U]$1[_U#69OR%"&&_JPPNVH:S8HF!J)%:6^
MIP>VQX$QVUR/(C?6T\1U_8@;J1'[.V\W:>) WVYS0\.!/7'>ESCGZG_-$#1Y
MR]89\TU0Y4%T!0$S=!Z2:\SR;2/9+.)<9P_-+1BVO@>[1HBSH39F6:)GN1:S
M<39APWXZR$/K BWL/P'H#_-] 7B%"_4=]=;'G1:,'?,=(_19:.N!F6*W;N!3
M(4L-/?0"AT569"8VWWEK&0/#NW>;WSZ=:',)>EWZ0T_0CTS0L^I&ZH4^=R)/
M#WW7!EL@B/00R%KWDR2T'2_E7H1S!,.!YV]1RY%GT!7A&@5M&Y2D.)Z.ID-,
M!]$*FFX2%Z-QR2]X7F4_N,99F<.Q*NWUL*BJ-W?2G+;74'O]**I3!>>$O\VQ
MW/9J:%C"OGHQ8I#3![B38S[YF)ZQGSW_71__73#^)+)B(S'=!" :@$+E!JX>
M)9:K<].Q/.Z8;L@XSG R[7GV.T<VO2MF4RC\*52IV])U3[JW(]U9U<D('1['
M1J"GH6$"Z?HI%O@RW79L(_(,RS=M8^>M?^_9:[VKYN[=8"<,?I@TZD;OH7GX
MKJ\"Y <2X@I7>L?3+,[Z.4QKY$H+YIQPB[N):QMZF,2@4'A^H#.?IWIJ\=#C
MOL^LV-UY&PYLY]X^Y-Y!L[GTO+XFL#T]/RH]SVH9H>4A6_;T,/!CW7$B2P_\
MQ-)=UTR-% P$YK&=MP$8"/.)#!OKGWFT"C"/E)2G&K96<E9-RZNZXHM- !;5
M1%MN_C]H>F>]'26CJ4]C6A_MQC>F,?WQV_&W/[Y]M;Y^.[P\/OOL'+\[NOSC
MR_N+X]'[T=%OO]L?WQTZ'\^^PSFP-_3W/STO,#PKX'KJV%C^:;@Z<WFB)Y'I
MN1X+4XMA%I,_,,+Y\45/F#C7(]HV(=I?7_]T@P0X21SKJ1UB$ "'!O#(T.,$
M_O32R+*\A*)ZEN4NJY08:/#'F,//?O#AU9L7F1WW.'[=:XAM03U^KY#=D]9F
M#2S+3WS;P>1ZUP<#B_% #YTDUB/FAZEAVV'H63MOG8%ESC/EWF/[+&AW7<95
M3[L/3+NSQA3S_8@Y8#UY5N3ICN<RG;'8U:W0#US/]PV'QQAM,<+Y@H0GH=V7
M.9]ZGP.QY5S833-3-/J!U4_JWU4'FX@!0#W+6A_+6C#0R^2)R;PPT"W?C'0G
M2ID>Q,S&!!W._)@'9NR ;NX,#/?>D:9^;O5S)/UU:2L]Z3\PZ<]J*Y%O.2SU
MF>XR'[O]FHG.4B?!?D!F9)D!<_T 2-\;^.&\6;ZAI/_"\N".B[R\<23I"\M^
M>P*MY2C+BQ(85CVZL.=-M^)-WQ?,&?42UXA=0P\-YNJ.$7,]2+Q 3QCS@S!@
MENT98$E9\W947T7X;,AS79I%3Y[W)<^YJ+%MVRDH"7K,(D-W$MO5 ^:'NA6F
MD6][L1&8$9"G<V^]8?-\'?>.&5O.DP:-R0-RK>?CS@W*7[ 1]'#^C\,\'DX1
M<I^*$G>Q-YF4632=H,9W5BP>G=P;3NOB?L?O]N:5$V;':8(=!5W&&"@G@0G*
MB6GK9A":211Y;A)S\IF8P;J2X'J?R;-B%P_G,^G9Q9.SBUEEB3/;-JP@TF.P
M6G0GMID>N1%H3(D=@L1P7";]+*&SKJ+FK?*S;$_@:)BQ*!MFDTSDH]SD>*DH
M26J5*---8)/W*4#PBPV 2XHI?KD^^?UXZ<:!^]43 NC9")EUZ:0?6JS?RY/>
M3?^0XF/!C!W/#VS32FP]]D,0'S:W],#RX&^<)2Q.S<1ASLY;WQL$_KW%Q]JI
MZ8E]:3U?[?GJQBKO/5]]5+XZUYK$L;CMQ:9N<TS6,J-4#T+7T_T@M/PP8-P(
M/>"KP<#VU^7&?'J^2GK[/\@:K#U]BI]26>O;M)IDZ96DQK?_$Y7_>-OU$"Y^
M+\;<JO+QB=@B+?V":RS&5B LOT)-/"\FL/JDT/Y_]MZ\J:T<>Q]_*RX^4_6;
MJ>)DM"_I*:KH0'J8[P#I0'<J^2>EY2@X;6S&-ME>_4\RD!"N23!<X!HT"R&Q
M?2WIZ'ET-ITSS:]D$,\6=%8U)/6';ACZ,U]H_H?#/.RLKH_SYX<S_?W=>%:
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M4>""$6!8UEZ%8DYH-DO5TITI#UD-F$X[(7X,YHK7Q?!ZT>&@I?1<!0H8%()
MI."%],!3B%)**FF<%4NO:'V8:&W;W5#1VB):FZX%8X+D1@-C+.;35>5S-II2
M*U$HR2WQLG1O%[6%8C> N(%^VLNCRS,Y[D\.:HF%NZF\]IOK#XN?<W>X^=W:
M[Z8BD,Q+@^.RCL_<Y.!%*15?&T,MR$QS&BPZ#-Y%-)!(*>#JHP,?2"FQD)4\
MB91FFEI9J[67EPB^?[];K7^29YM_JT"^6R!?- BD5=QF 0'JD%4,*C0XE[+&
M$96T,42#0I>TQV87QG]4$"\YB&]N#%00WP>(&W8"5RE3L<MF/.IRTXHK<(0X
M4"'1:'G2'FEI=]P!##_V8,$4Q]E@?HR%F1>AIEL($9PL_-=+GY5R%J"<.5T7
M;19+LH0 -82#T(J!HU& \I)FT6D:8LR4,Z=[\]4YI_H0.PG.6W#Y5W#>")P-
M+[]5)CJ5@*3H021?2J/+O$=#4DA%8M++"LZ'"<[V/?P5G#<!9T-9S\09O/$)
MA/,:A-$NGYR>0]9T1)"EQAJ;E5%K9NW?/3@?6S6$K[>(/*;1&,\R"*?N4ZV'
MT(E$G[.<YN?CT>&S_%W]X7%>O-VOU[U^G<GMY'W[[A-.-C]-QRZO?W_HQI^W
MIG@XV1D-RRC'H\%@EB9]0F\U3Z@]TIO3KM$2*84V#B0J"2)S(&2(.8@^T6 T
MH0%]R1.RJJWRD?5N]0-AD5LP-RJ++ >+- K#6<8]BR0+V@@0//]P##D8X2-R
M*WC69PN+&+H<E[0KBRQSYE-ED:5@D88!)O+I(9W0( VWV0H3)0?22F"&2$M1
M1U6B)6Q5Z^5@D<<>4CDST1YC4.7^K;%O77=_Q2&F_K02U$($-:>S)3/244T%
M$&<#"!\\&$X]R(0I"L*S">56UK3J3-IG]>$N@<%3@7ICH%ZT1Y1/1OJD(&7I
M@""&@8F>@3-&&Q5]E"D#5>@;-[&O0.TD4&_'IJA O2E0FTTJE9%:" +*V A"
MIPB64(1D&-,ZT<*T*VNV.Y<4?Z+3Q_[D:. ^EY'BC[&]S.^LB_ (0W [..WA
M:1BN!MTZ8.:]&(_R&50+";5[2,TI/QZ1(K7&@K)1@;#ED.(AE/I^5DOB*8EA
M=I>>U!A9!?WMFHP5]+<$^HLFI)54>^[+K1L=L@EIL_4H3 +J69(N&H+ZI(HG
MOW'[] KZ!P;ZMLW/"OK; 7W#'&7>"DF5 .[BK).J 5OR8AAW+J.>9TMUUN!,
MVQN7_5S""-0UPD]W9+',+S98 --ST^FX[X^GS@^P-QWUAM]%=GO]T]!NK4=^
M1U9+-B._1>C7SPEG?W25H'OM W=-MIM3J%QQPI%E0R8DDC+;Z0C>"0F4"6L5
MH9Q+V;D^<-53WC'[Y,)5XQO@O.)Y,3PWBI8+*8U06+)F,IZ%SWC.Q W:$6)2
MR(@FQ61IWC:N4'X(4&Z]:D"%\EU!N6&(!)EYF"J5H<P9B*@RE!,&D)(&6NXC
M\3#K>-@5*#_<8,A\T^)\,*1A8CS+UA .L?=L-#X:G>2<WII9.)?$NE69^F^W
M-_F'P=RW:V-5EU%K3/UE?<X%*BF\9T$ \ZA H,M,C=J!C-IGK9H*0_$1!H<J
MP56"N[TH6"6XVR.X1BXE\U9;K2 :D:U*36U)T;(@;;#>^&)GT%D@3-PXF[(2
M7"6X[LSZ/B-^E>!NC>":U\XDIYZI+!I/2"8X8L!%0< (9KE3Q@BN9Y=7R7*T
M%S^UQ<]&<;JGS8R]VG:Y7>$9YR;+\W3BZ+B8R1=G>Y-OJ*/\P2AKKFY=A+H(
M=1'J(BRV"!UL_'<%5_01CO-D#@^SNCHY<&.\BF_Z*MTW%SB\NOG6NN7K(M1%
MN/[EI1\$"KL5KYMOR__J)OUP.4W>)%[ZH/PW\^:WI"Z:%SC>*[)M-]C&+GIJ
MSBI3GGW=;*=]=<J0ZI3YJ5-F9V-._U+-K./)2E"J-&_W&,$@9X!($%':J)A;
M66-/2&=N!K?D#JC4\V"IYX9AL$H]MT,]%P->G"3*@[<0!9;.2R2!CT2!E8'8
MA)$S(PKU\(>62%FIY^%2S\T"5)5Z;H5Z&J$H&T**P4M(R2*(J"EXPP181W2(
MI;%C\"MK_ GM3.&B:DW71:B+4!?A,5?&V>@/CJ<86W O7;6YY;(J6O/F][ 4
MK=MV+YWNM:IJ+:1JO6XZF*2-,C+G@5&D($0R8*V1$+QF1"3!E+8S!U-;68W+
MDKA8R:<;$^N@@ZF2SS7)IY%3'8APP5E(GD<0,FKPD@; $*+R07.K6"&?.;W&
M*OET"*.5?.[.Q53)YWKDTW R&<6MM"1 3,2#R*<$&,KR;XIDV3%?_-\S)U-;
M%]8>6D9S?<85GO%0TNM>S?Z2K7N7A^3>86]X?.BS?3]*WYGXD][H>#J9NN%L
M5C6C[J&F$-4R8?FL/]GQ+=]BYQ<5@#/DK9\ ;V>&N]TT4P8FN]_0=AI[NLH=
M*5YUABOH#'-*A05.,4LN%A])N2,E4JF+:@"3,B(EZR.FE36IY2JU#RTL7B'>
MUCWN"O$.0?RB3\)D_4?K8$$)-JM]:L%E$8(WVABA:%2A0-RP5<-O;!E4B'<5
MXC>\R5PAWAV(-[OM6&V9,0&,U@R$5 Z\LA(252D&'@DQIISB9%6SSD#\L4:3
M;])CY6%SU%U9&J>2:%!59:G66&I_3D4M27U P3G$Q$QIWI=9*H0(D:>@D$GG
MA#]11+(2VA4794OQD0KRN[8U*LCO!.07K8WDA2-$1J"LU"I.WH U61^1QFLC
M"$/E,(/<DE5)VVJP4D'>.9#?D;5107X7(&_8&TY&*P5QP"EZ$,Y:,$(C1&'1
M:ZHL2E[L#;M*N>P*R&?VQC]G!1/RG['_8>U?^<?9]YY[T/OCR;2?/I\";>U?
M?OS/M:^C_<'G0BG!,+Y[?+*"S_T#[+D01H?YNS^7!BC#T30_?3KJ3?,K&9RS
M8E2N&""I/W3#T'>#/,;\#X=YV)/>K*;$<-8VY=TXOW3DQM,2"\N?GN"Y-SZY
M="5.AR/8B2EV-)KT9U4HQCAPT_X'_.5C/TX/SNCDW =/K+*GY-M'G,^CS<"^
M]"-=677%OE^.\S_+<&?T8B-BMKU#\I$('I6CFA!F3:#",R'4VV*<GW[HX&LP
M_"C3'/@QNK_ I3S#IV[PT7V>K/SSNX4X[ _APL)?8<V^W^%S%BVEZRR:N<*:
MG2 V,_%9D9*,=!R7=^71N*X,I7<P+N?8__U<=CI#;U:#)6/E63D"AZ7ED+L2
M8?R<:#I -XWH^6SC/]O<V=_<V>P]VWWY8O?E^O[6[DYO?6>CM_?'KWM;&UOK
M+[<V]SK$F9=,8G=G;_>_6QOK^YMYY/OYC^T\K;W>[O,\K^T7+S?_O;FSM_7G
M9F]S_>7.ULYO>[V__W=W;^\?G9_8W[>&O?S80=[4D\M'>^C&[S)]E*)S%WQG
MWS;F27VAKT0]JU*79S%P1Q-\>O;++V>71?K#V5AF'_KE]/&G["Z;/<1F7WCR
M\C?2>D).B.O4,7CZS:<O/YF]=$%C.'E-L2=<7OXR>4(O?>U'CZ7DB;3R6H_]
M\6N2U\$J<K7'MIMR=*].X/FZ[]=)47F569UP2Z?Z9KQ&-^YMYO,S]C8PX"R3
MBM/5[R;Z>,1XSH>P0$78CHNXN-S;FO%5LA(?U,K1NG+77#ER PZY?G_3^W.T
MG2_[>)F/Y#&4H']DE>9;[Q6T;+VE=Y^=.D/?O_QKY\OKCV\V!G]M__;R_?:7
MW_/[_Q"[K_[X^.:WG?=O]G^GK_>W/K]Y]?+@JS/T\+7<WMCFKP__D__^/'_W
MRX/=C4VQ_=OFEYTOZU]V]I\?;+_:.=PY_/.OB\[0-^__^KC])?;SY_JO7_WY
M?N>W_+G]=Q]?[V_G[]VFVZ\V/[UF>0:O7J;M_JDC=(_D9_[^,;_OK64V)!49
M<$LM"&4$N&@,:"0^::YY\OYZ?8+NH5O&SZYW5>)Y<,33>@^?2CRW0CQ?&L3#
MT0@J%5@>) CB+%CE#'!-0] FY)?"K'\/7S3.6HFG$L\2]M:IQ',KQ$,O$D_D
MJ$*D$:2E 826$O)9(2':("5'3464A7BT7;2-[5VTSVDEWU1W/]WTV8$;OL->
MOV!PC'E 7S#VWKG\][\/,D3^T1N5:.\'G$P/3V)6=YV5>J^K\_>[-<TN:<"]
M.SW \;/1X=$8#W XZ7_ D^9@?WR5V+]'@[*TOV6Y%6+;'>YA.![WIWV<K(_[
MD_S21O[K\-V+O RC^"MFWL-]]ZD28%L$N//LJ\E'=K[\Q78WPELN\BGE" ,D
MC&<"= $LXP0(X5QJ'1PGL1!@IL8& ?[C;O)>OH)KN?+;EH836K":[IX3*NP7
M@?V7[V"___O;I!A/F'%NC<]Z#U,1?(P.&#K)$XLLI%)9S#;-K0KZSH+^/@V6
M"O6.0)V>@WI^?>NM=11)Y!ZHY08$#1R\5PZ,LYP'Y0VC*D-=WOA*?(MX;[-N
MQ\.S;U9[4_>IE]<:P_3N:WTL"\4MCZE366Y!EMMKVC&&"NJ"Y9!4(""XEN U
M,D@>=68Q:2/A*VM<W&\KGNMI-?=>&&!9(+\\EDR%_,*0;]@P3K)2U,>#<TZ
M(%F[,2RYTA+'1R:T3$2LK,WQ6U3$=QOQ"SDONF[(5*0OC/2&"9.<%,$: 3+:
MC/1RY=Y098%$X3@1R425D:Z:%^VO[JQH$>2/K1C(PM;+$$^NX[E/-XG47!IA
M>^B4MSR&S0Y.=U,-X=Q.".=K#)M(*@+Q'BBJS(Z(% PR"3%H29BFR8M9#)NR
M%KRY5T/=$OEY'RV-+(^Q](U&*E-<)^KS+=LEH;4L" A.:Q#&4W!))A#4H,G[
M(..AN()9TQ5<>>)!\<1#,K J.]PL4/25';(^J97A'(C'$A.6OJ3C4K"*6TX\
MD4G2K$?<O';RG5!$[7+X^.)H+S$,W&323WE ,UYSL5S_+V;GC:W.Y76G==JT
M+ 1_46SK7Z7V?#PZ7-]]MO5\--[+W+Z;OIT$E?:O0?N[WV< \NW]O]ZZJ!D&
M*T#9TF#'6@G6*@W,&)DT54A%YA-ZOQ7SJQN]\\9@Q7LG\?[E(MY-5N\RJ5.(
M1%$0,5C(2(]@M'!H:?+$AW);O1O.] KUI8V85:C?,=1IXVBGU#FN#21!=;;H
MDBN>804^8O2&*NJ56UGCW4#Z([O3E/=]_NNPES?]&(?A<V\ZSD\;7+1;6@N7
M/7!6NQ_+Y52(STYEN%]$>#+6]6'<_R;0;[17N>TZWJHYM2JTL(YP[H%G\P6$
M$9G69#9;$C$HK>!%65U9FW-MLUY@>!" O_OP507\70*^$;R2E KNM((8# .A
MG 9#8H)LL?A(F!/AQ#U= ;\\@.^JV5)A?E<P;T:A2/3)$@)*TY1M%EYN)J8$
MG#KF, 9,O&2SW&\I_MN[K;0,"7\SY)3.TM^@\[7,WVG.WTU"+#<KD-,]DNN^
M&5/S]%IGML]-B\59S:07$IP6!(3G"5Q)V_.NN&<T\B#U276]F^@PBX)HB1RS
MCYD8[L?<J5K-];#?,%ZRT**.BD$D5H$@6+J4<YH) %70+)%@2^9=&U<8*O*[
MC_RNVCT5[]?#>\.*T98[I9("2U4$$71I'<@,$"\CT]Q1DV()LC9C+]?+JKAU
MT+<9G1'T2==-G&>M&S<_2WI<4B;KAG$SA\[.J"S_;7!<5O7%:#QSV4RGX[X_
MGO7UV1_MC(9EB./1($_MW59I&H"3::6_Z^64?:4_P9/&(#Q$F3@(A@*,(PJ\
M16)Y#!@865G3MWC-X"'>-%A2BKC/-+36B:$Z2%K/3/O*&DE%R[5R@-QGUI )
MP0;N0 C*(J4T"13%04)T6]V6*WT\+/IHVU:J]-%=^FC87-+XH(AE$#UC(&RB
MX+.V">B",TQE?5.E0A_6-A6/CM)'2Y&E)3*UBH'5<^>P5-H^#[]#TZRQ<X'3
M]0I]5Y=2Z_V9?D"3B]-BZG_""%]P/*J,N @C[C7-,&.3"M(SP,R&(#!9,"$R
M8(FK6)* LV)5&D":+.-?EL435=W/2V:1+>ZSJ3Z:]LFA86U1QQA/0H,M,6E!
M,SEX=!*0"<N2S_(.IL5[?Y47'A8OW-S4JKS0!5YHF%'..>F(*6Y;5Y2&F)4&
MGVDB):KS?SP2DY4&NF@_I!JYZD#DJF%9/2M]DH?8>S8:'XW&LYS6:QK!)Y-^
MRO-*Q=%Q>?S97-MO>'>O"WQIS[L[6*!N'Q^=CP76LV&1=GG[Z^5<.#$JO_Q!
MMO-WO W:1J^U!:[1E5M7#HR@!)BQA'-':2B'0WN!O19 <\^N^TJ?E3Z[:)4O
M0)HU:-$BHWZ^P*C*"Y&\8&"#,B \"G!4$XA*J12X]+*D2M!58EJ.6E1JK=1:
MJ?5>8\B56MNDUIV+RBKWD92$6Z!4(HCH-#B4":SC),D0F1=N98VMDIL[.3M#
MK3-OQS]G]GW^,_8_K/TK_S@;^+EGE8NK_?3Y%)!K__+C?ZY]G>X//A>*QV!\
M]SAF!<?[!]ASH=P\=,//)10\'$WSTZ>CWC2_DG$\6U WQ=A+_:$;AKX;Y#'F
M?YC54NFY<?[\<!9 ?C?.+QVY\4EME0.<X+DW/EEX)7ZR@*>S$.SD=N?1:-(O
MV^SI&,M%X@_XR\=^G!Z<L=6Y#YYN)?+M(\[G21Y/+_](5X2E^/?+<?YG&>Z,
MU&Q$E)J$E+$J>%1%]R',FD"%9T*HMY:NG'WH8'PVA2/W#L&/T?T%+N49/G6#
MC^[S9.6?WRW$87]X-B)15OT*"_8]*N:L6$K763%SA04[ 7HF_U,_W--,+S@N
M[\JC<5T92N]@7([)__NYX'2&Z\S-F/'UK)RPL\[L[DHD\W-RZ@!%Z;F[_MGF
MSO[FSF;OV>[+%[LOU_>W=G=ZZSL;O;T_?MW;VMA:?[FUN=<AGKUD$KL[>[O_
MW=I8W]_,(]_/?VSG:>WU=I_GO^T^^W__WOWOQN;+O?^OM_G['UO[KSL_G[]O
M#7OYL8.\ER>K/?P4L!R^!_DXF)2^-=.#T7%^?,P'Q##VCG!\\EHOGR2NO!Y'
M@X$;G[OX<7&>AV[\+I--.=8OQ >^[>03G_M76I_I :$\^&B"3\]^^>6LBG-_
M.)O%[$._G#[^]"PHWW!!!YA]X<G+IRQGS1-.9"&ZT]#'Z1>?<N"3&0=>4&M.
M7F/TB1;BTI?)$WKI:S]ZK'["M;[64W_\FJ2F];'R)Y9=[ZEW/U;]1+++7^W6
M6"E](LBR#%8]86Q9-FP%5P57WJ]<7NFI/XF(=R)Y^*=JZHQ'YEOIW^9DOSD7
MO[/,?VI[_]+07.YGV@UUYB3&?QJUWYN.PE\'HT&>V23K8O\[[D\_7[X8#0%?
MFOKT(/?"XYO^H\%Y ^97\J]U'..CP\/1\ 3B5]C45YKX%7;\=1=PR79,7;BZ
M<,NY< ^1Z_;'Z";'X\]79KM'<X0_\ND_&@WFENGP+EVR5X/\WWX4DG^!X[WB
M@+T0FD]:)$:259H%P:RRSB6BHC'$$V88?[LU+U5T:^?YG)!\UJUF9//"C7?'
M>R7P%_]T@V/\]M6GT7=RO]%WN;UW%GW?_OAFX^"OG2^#@S?[_QGLO/^=;N__
M(=^\7_^R\WZ;[K W![O[?Y'MC7?L6_3]C\^O7[V6._M_B-V-39(_\VGG2Y"O
M]Y_GSZ^3G?V8Q_[G^SQFTHB^[__GX,W[O^C._CNQO?\[V]G8Y.6[MU_]P?+[
M\_>]'+QYM?UQ9^-EVF[6Y_\0?_M3Q'__9_"&#3[X]R.Y\V7]X_:74"+S_/6K
M/\CNJS\/=U_MO'_]_MWGUU]>OG_SV_:7W5=_?'XS,.2M#89J9G2)W%L07A$P
M&B,X33AG(DEBQ8^S.B[90E%RPB5RQF,4SCBC+>56AL!)2BYAV4+4UBVT_%O(
M\R0\=;2$,2,(I@48ZP/HA#$([E(BZ5I;"%/41A$1C,O?P-%KU%KE_<2IQDQ#
M,Q9JI%S6+;1\6R@*3(RZS$*D;"&D&BP-";RT.@O=:B+9M;90)K2 @BB:'(H8
MF4_:)TQ"4QI53&JVA1JI974++>$60A4CC1:XLA2$M@J<S)M)9HGG0R[K,3H?
M9.0)(<T4M&O\0R_O@MY,_+V9\"<7DB:Z:\UWSRA=/YS>F2G6P=GGL98MY09Y
M3_4C](>]9^ZH/W6#Q[PH(1P?'@]F^84G31"^2^Z=I2F=&'J;7^]=_O>'%4,?
M_IJ]Q*G+_QA[9TO2[EI4<_E2+8,12;2D@D9&A+ \ZRZ*6,*X<Y;(9*JM<X]:
MQL6;E?EY _SWR\]O7L4CSX3:WACD.85/6:OXM)/_W-G8R>NU);>_;']^4\;W
MZO6G-X=_]E]_&:2=];>$QVR1V !"1@%"$ ?.1 34WG"5-<VHU;5454J5+\JH
M9]&)Q-$1II-TE&MM#:>D6CL/9Q,Q;DJE<@E(T8#@2H,QW(-$EA2+BN;_7FL3
M,>84X8EBD$Y@5"Y8&0GA7!J>S6BLCKN'LXE$Y)E^+ %%-68ZT@)<< JX3<$:
MP4C@^EJ;B#A" B5>ZL"%=]H3D6UHD@UF24TFOVHT/YQ-I&**,@6?F4B5=BDF
M'V><)!!)Y</'1.4UJV9S)_7]QVTV?U^3JG=6E.H1K\C^Z*+/8*F+VEYMTK^Z
M@1L&7.UM8,!#C^,>IZN]8FX]BI*U5PN)7ZH#G%S,:25R!_P'I_\)U^\>3R=3
M-RR+=[7[V+SJ!#_7">;T/[0RR>2]@B04!<%D*3W)\_%.(_(0I*:*KZP)1E<E
M,<M27:ZEJI.W"_VN)<-<O5#%PM-?3L9KEJ&X)MTUJD^<OR)P<D'@YHT+NE>A
M>UDXL5&$ER5MO= !,)02%9PYR"!@P)&$$*CDAL7'6J&[<F+EQ.]+\VB-U/B0
M04%%+#4CC=(^NHBESX>^5T[L:/&>92'&1A5BY5&+2#A0CRRKB#R!01W!6*X\
M%^A3R;W1JTK<N"Q:I<5*B\M,BX3H9!.3WEB7-0CCA1$\".TB,T+Q=->T6)EO
M$>;CC=Z9/F9E+VI@6>\OOF\/'@6%I!5'(SGWHA2$Y$M3@+WR7N6]V^"]S&V*
M$4&XHT1$;WS,EI2Q*7+"9"2BJH-+2XJRT92BJ/Z:E"JY-).B4!&\U%DG%$)Z
M9US6$G%E3:Q:\]AHL080KAA N%XZ7#. <'99]5P(H<8-VHP;-)H.V)B$0ZTA
M*)_!3W6YAR$44'2,:Y*(%W9E3:T*11X9^*M.]!ATHD7ZJER3Y2YOIU*MPOLA
MP8M] J(0+NH0P'BC0"A)P<20-2#C@F249_'&E34VIR_7U7NO5/:K[-<Y]EN
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MJ7R*(B5O%-7,!D>]%,1Y>H7S])+X9=L':ST[%SD[FSY]G94D'CD!HFP$$70
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M*54I52E5*54I/0[7WZ))9+\>3_*()Y-GHT/?'U9GP<+.@O?K\[Q^GG'#G75
M5/0@#*=@4<3\FQ'Y3ZHB*=5Y.Y0^5K&\] FA%<MM8+GA^$-M0T)G(690ETK;
M$0Q:"Y:AX\:JX)SK%I8?5"JHGHO$7]V@Y#JO]C8PX*''<8_3U5Y!TDW2/_UH
M''$,T]'1T[+V,P=Z[VPN#XBNYK8'P!2UR605C$O"<_0:M58\1DXU,L/>;EVM
M*\!)S[=S/0%VCZ>3J1N6Q:MM =HCJ\UF+S)/(J,9,*!=PDQ5GH)Q48)U#J.4
M6DJ7U0Y%V*HFS4C%]4*.5\;,/<<CKSV/GP._:Z&1O[4FP^_GOIQD-\?.NA[3
MS>_T>C :Y+6;G-[!&8;!<5FP%Z-Q&<7Z]*1FB?,#W!_-5^&JCK8H[7V^V()1
MANAL4H :"^U1EZVM@$!3:8223+(LK:S1VR:\!\%VCYSP'BSG28O>6JV%(5%@
MMENHSK I[6.\0"7477/>5?3 2HA7(\3&Q8:8!6L99^"4ER!*^IE-B8!"EK35
M26H_:YNXJC2K:F EQL=,C#P:%QP7*L0@B$1O''+GJ??4$32N*H/=YKZ+RB 1
MB7 ,'A)F A2"6O!:1>!.F6P#9_DRMK*FFXU?*N]5WGM$O,<D=U+(K/PE+KC2
MGK*H=%!*"R\X(U4A7%Y2W+VH$!H3520:(6O[*BN$(8&A#,$K[51@*A"52=&L
M4MZ\[?JP>;&&!ZX8'J!4^<P(Q+/H1.+H",N&A*-<:VLXO8POKM(TN$8%6G6/
MS6D63%@T5%I0GEC(6FX (US>WM'8D&P42JA2TGJ5L;9N(BT+_JM>]!CTHD6N
M:UV3Z"Z_=UDUI"Z29*,C<XPD,*\Y9 M2E)N:!KR@$6Q2,2F/Z -96:.KQ+9P
MR:O28Z7'[LQ[D8;SG**QA@0GB B*.%?^R*O!8Z2.F^HNZSCO-7-5A0FH=8#(
MF0:!WH )-$%0F*060H72[X2*JAE6ZGO4U*<\][34;! R"..ER=I!\M0'3Y.F
M05:/V3+S8B/OETNJC"0>M)(&!)<('K4 ;86TA-J0Q9^-9K5J!5D6:FRI+L )
MH9%N,]H.3GOHQL,\[DGO[X/19-+0TA_V;85Z/ZQ*J4JI2JE*J4JI2U):0.4F
M6E+M4',?L]:MM>'$2FN5U!8-D7QVBXZ=W:)C5[A%A^7*W.@0_YOU@9^JW6.,
MB(?EKU4'OVT=?*L9M>8V41'1  9/0&ABP:)VD%ATGIB$(>CBD<VB[]#MN\H!
ME:FKE*J4.AG<#"Q2345F3(%"..*E%$H%:92F-O]VA0/ULNJR+9^L]?!<Z/"<
MX]AWU*-D)H!S/D 6+@>O@P6EI-"4,I&"RL=G\^;ZU:.9%>J=59V]1V.Y)$8&
M(5@P+H/=6I)T\C9%E%5U?E#H;[BOK8J<44H@&)W13QV"Y]Y!T#&2))3P(1;E
MF9H;IWPN<>F*V/]P]NS31T!Y_U,[(Y5[0/CN] #'>>J'1V,\P.&D_P%[Q7>]
MVAOBM'0]^]M]<L!L=,_.#^X;)>R[3Q6W"^%V>[K]['N3-S]O@/]^^?G-JWCD
MF5!O-GX]W#[\/;^V3=[L;V9LOR/Y^1_?_+9SD-?M</O]\_S_>+!S^+R$L>3N
M_OKG[2];^?O_X#OK;S/$J8O$Y".?)A!,$W!:*$"K)?-:>"TS!W#19(#>U'WZ
MBO\,DL=2U[VVTZA2JE*J4GH\4EK$>T (.II\8&B#"#893#QZ94622&WPU_<>
M_$BQR(;';III%]5D:$_U:%R<14FDP:B!6**RP> U>"$1*&8ETD=F(Y4GWO;:
M$7%YX%U)N$JI2JE*J4JI2JE+4EI$[6S!C575SHZHG7,\U;I8%2)PB-1($"PZ
M\!1CN842;38KT,;8*<7S)T[JV)\<#=SG,D[\,2?4=]9W+ML[Z^:O[WRT[WP$
M?35/RK?G+QV%OWK]R>088U& >GAX-!A]1NQY'&+J3WMY<8:3QW6C9K&*.2HA
M2Y8SY8W)SW/.1*\X(C?!QL!^JK8V2N?,+@YNS42R<3PNR1=Y%J-X4D1G]O-7
M-\%8]-FLS)XV *FE==I27E\W"^X325,RS$%(KM35,BQKK3$ -21)+QWZ4E=+
MKE+1I?X@-=6JYKX^$"DMX$5(+C+!1"*6!<%#!F>BW$DJO?5)2KUP,LPE=/RG
M&QSC96Q<O04+$6ZCLK71+D03"6A-&0A:"-<S!=QK)S"FH*Q;6=,WKO5?<5S9
MMDJI2JE*J4JI2JE*J4JIRU*ZSY3X:@7<OMNE&3-4FM%HI83@?0*A2Y<'EP1(
M0TF(@F'P7;,#'E17UODX?.[ZX]Z'LO/+397CX0><3#'V<%;DK.<^NG&<]/K#
M@L@AGD#U8W]ZT',AOV/2+_]PD_:MRT=<-5>E2JE*:7E=@6$8GIZ$7TXT@-FI
MO_Z-S<Y%95ZXSX<XG*Z/QV[X#F>_IBF.GX_&"?O3XS%6M6 AM2"<<PZ^^[CS
M95V\50J54R2 #:7+"34.G+0:@D:-)E"I%"_MCUNJUEB17?FW2JE*J4JI2JE*
MJ4JI2JF34KH/YV"U"^[1+CCG+A3;&^'C[OK;H*V+-G 0G$<0-@7PDC'@+ I'
MB;*A<Y;!8TLU'>/1\3@<9$@\LJ32&F*J4JI26D8?X"67"K_K</KMY!^7*.!D
MNHW3@U&LA_JUG7VGF8"442*8#$!X\B"40'"&,_#&N" 4&A1I98W5O.LE@W E
MVBJE*J7[N*]$T$85LZ%$2134)4^DM)HK;AAS48:%[RO-:?5]=A+6>TGM6KR-
MEM_:$6J8Y: -R19O\A2\8 88"\F:P(Q59&6-JU6C3#TBEPO6"Y5LNR&H&_EN
M5]-N:\F,-M'=Z%5-B59)$P,ZB9+^)A0X*0PX)RQ&3$G:K/SR54IO4C*CXKHJ
M555*]URYJ++O?;-O(_DX,)*8-S8K4XJ "-R"E5G+LAR9UHSKD[+:J\2J;K#O
M(T@]G@%B5C?_+,V^AY_*[U@SBFM,NDJI2JGKT83O#_KU^/YX,BWI )/]T7I>
MN3("-WCA^G%K^,P=]:=N,'.I^(O7BU[B29H![N'X0S_@R7VDEQA&[X:SI\S4
MAJH'+*0'O&L&(*P-3@9O0(5 01 ;P"9#@#GBN,#\=ZI* $)T**F@PKZ2<Y52
ME5*54I52E5*54I72@T@WKD9#1XV&.<Y#IPWCB2I@@2<0#BU8SCPP&BE-6A//
M6=?,AEKSN;[ST;ZS;O[ZSD?[SKKYZSL?[3L?P16LK.$/W&323WD\,W-E.NKE
M)8 Q1L1#YP?7"Y\N;7)'3<&I4JI2JE*J4JI2JE*J4JI2JE*J4NIX'"6P2#45
MC#"!0CCBI11*!6F4IC;_MG <96<T+%\P'@WRN-YMY:\:XV2Z-0PE^QJ?CT>'
M>VZ N^F%&^-PNCDK;WOVKAHC621&\J5TA/WC-$8R>^^GG=_?$NVIMUQ#LEJ
MT):#Y3Z!H<:Y9%#2Z%?6J*X7UQXLIEN/C59,WRFFPWE,?]Y9?YM%9[EC#IA!
M!\(Y!A:U!QFY"<%II)IU#-./X-K$1K_4:)_5&2LEVX??@:37/]W_]0I%S;.I
M4JI2JE*J4JI2JE*J4JI2JE*J4NI2J84[<@)NX#>'0?Y]-)R,!OU8^[HM[B78
M.N?Y^YH=3:Q53!%>BE4)$,X&,,8KP"Q(0KGT&.+*&FTF1U^]KD(%<7=!?$=>
MOPKB-D'<K(\B*6%<.O"4&Q#>Y=]"1"""F^"314M\=T#\"++\-OH?^A&'\32[
MKS47W](&(FH(N$JI2JE*J4JI2JE*J4JI2JE*J4JIZ]Z!UEU\V_WA:'PNS^<[
MOT!_,AWW_?&L7=O^:+XCX=^C0<3QI#H-KIWS]ZU@O4Y$8=2 I3&;T"Z"(]I#
MI,()8E4P-*RLT6:+MEK/^B%@NW7/7\7VO>?^?2M7S[E03I<L7HT@A)9@A',0
M9&!9W)H&U-W!]B-(^WMQVFJQYOS5>'"54I52E5*54I52E5*54I52E5*5TI(X
M#5IP"%[2P_E'WH.7&/'P:.8[J,Z!A9P#O\]S_ 7''#>&@C#&@V T@E.1Y1\D
MJ$1ME*YD"W4C6:A"N'M^OPKA.X9PP[\73;34!PHN2 $B(0=OF0(J4K+"(14F
M=0;"#RK?3\\%X*]NX(8!5WMYS^.AQW&/T]5>P<]-TOS\:!QQ#"<3>\KS\L?1
ML1]@K\SG[-7IZ.AID<PLH[9W-M/EX[#%6F<G+1(CR2K-@F!66><24=$8X@DS
MC+_=NEK'[&>CP\/1\%R_[-WCZ63JAF7Q:LOL]ECL]2F#G6OG1(FV61418)U-
M(&+TX*AD@$B"M]0XJC*'*:)7C6BK2$%+B+KG(.8MS?+GI-&UJ,K?[DC^WZ_,
M<M+HG!9ZU^/01N!WQIX')\';LS(N87!<%NS%:%Q&L3X]B?Z6\K:717^K6K@H
MH7Z^0*B)2YD5>@M24 9"9,W0)TM 1ZX(\]HXQN8IA7=*I8^ 1RN5+K(X#X5-
M8W0R4J5=H$YPZ1VE 8F5T?IDLFUVUVQ:6Y*W1[6-5J3!,TR1>(C.9]V5H@#G
MK03EF+3(:!),KZPQLDI4,\>FJJZ5<BOEMA*.H-&0((+A,0IJT =B74CYP5XJ
M8L+EG'N)"[.2;P?)]Z*>:Q"I3>A $B4R^6H-UBL.- ;T/&NZ+);$Y57*V<WS
M&ROM5MI]#+2[ .L2KXQG/@141$1CK0Y&"Y^BRHH/3;%JNLM+MKL7-5U&O9*2
M(O@H,ME&P<!9Q\&QZ)-+A"OO5];L*A?W[%CH&./6.$\K<1[&G"(\40S2"8S*
MA6Q1$\*Y-#P8AU>-\^R72/3Q^/.Y2$\-[[3JC2RD<;&T5$J1L0@"!68]+9C,
M&DR#H4BH1^F\QY4UJ5>)Y94[JK96M;5;,9*O2:'52%XN^MUNI/E%'ICV IC3
MKO@H5=;AE .E*=4,C3$JKJR)54:;[%O-Y$J\E7AO9B:+E SEAA/)A'!,>N=4
M""Q*SK12B=7P>L<9M9$XG65)F.(&2$I9H;5!95LX$$"C$^716"WLRAIES3J+
M59NMI%I)M8THNV.H193")"N\+^$>99BCS//$_-WG+%4=MDW&;>2Y2^FY\$H"
MI\Y MEX26!,U>&>3CRPX3<G*&A.KU#P0]^,L6?Z?LUW7,A8I^1D8V<FEO;)J
MS9]?US'V/ZS]*_\X&]BY^04LP#@ED;5_^?$_UQ;^V%W/=_\ >RZ$T6'^[L^E
M'L=P-,U/GXYZT_S*MU+5&'NI/W3#T'>#/,;\#X=YV).>&^?/#V=5/-Z-\TM'
M;CPM53ZF!_W)M_<]^<DBG@Y)R#SFH]&D7S;PTS$.W+3_ 7_YV(_3@S.R//>I
MTTU*OGW$^3S<X^GE'^G*LBOQ_5J<_UF&.V-,&Q&E)B%CG8C_G[TW;XH;R?J%
MOXJ"^\8[W1$DCZ1,I3(]-QR!C>VFHP&WP=./_8\C-X'LVJ9490R?_IZ36DJU
M8(,I3 &:GJ:A2DMNYYS?V2DHKU$*"$P*$S$-H)I_DFRKONEL7$]AI$X=T6.G
MOA"5P0R?J=ZYNBBV_F=N(?KYH!X1BW=27/AKK-GG:3')LXNK%RW+[D1.PIJ5
MC 2$RW#L"Z<_ ][EQG@5C$9MRE""LS$*ZO_SX[U+@?:0S2&QO$09#]3T?_]'
M78MCS&_#*DZS ?QF*57('_R7KPY/7AV^"EX>O7M[]&[W9/_H,-@]W N.W[\X
MWM_;WWVW_^IX@YCF%9,X.CP^^FM_;_?D%8S\!/YS -,Z#HY>!R]WC_\(7O]U
M],_FS^*W_4$ C^UA5N+O5XZVK\:GP"M0Y"?SVL7L%'IY/>/*'B/ +'IJ5+AG
M]2__MGDQZJF+9_G C\7?]._J\14KQS<LX /_PO+KBD-)N9.&*3*I*JNN>G'%
MOW8\_UK .^5W*7S)KOXZW(FN_.Z[C]WA,OVIIW[_NX32)S[6-+S>;OT@QW(C
M4BE_C S"&0"],F\R2JXSJY*OW-.\5N>(?G!J'+P"06GGLD3G)OITMK%E4+J!
M2K7A6_S=A-\;SOC*@)+'NG)1MW(_N7+AK^ A+414/8+@]<]D_8P<6-M@\HQ(
MO_CWL10O57$69+WA>1%DXV$_&(X<ZB>@TZ-%Z"MHR*YXMJ FK/^,/%Q._ L(
MJ%N<E<]Y1'+_T$T"0#H#&&\17&%\W2"_C=Q);N6YV00ORW7G<)_5P=^.AUD^
M^6M87#/N\KZ=)H<O*Z=)_\.WCV_^S \_G[+#>/_\P^7?],/G#^SCWEG^L;\?
M?>P?7'Q\\_'+X6?SK7&:?#Z(CTX.OQR^@?=\_G#^\>3=EX^?3Y,/__SYY>CD
M[^3@\L_^P>7?,([W2TZ3@\L/"8PKA#GU#S^_Z!V^>=<_VNO!-7\GAWM?+@_Z
M'RX/]V#.)^^R)@/\.+P\//G[_.#D])-UD8NDD(1+RPF#S2*2&D-L*F6:A#H*
MR^08V+6;.4SNSJ/\ \=QQRPVG5GP2&F31#)3/&1A*H5*#$_3*%5QECF6>681
MU<PBZIC%/3&+RT5F(9,HU52G1*G4$!;*F"@F,A+I.$N4%:%+0V06E/*.673,
M8CW,PM&$9VEJ0V&8C+3@*<V44#$6$#7&>&81ULPB[)C%/3&+:)%9Q%JR).*,
M4&4583041#J>D)@J!=R",A8R9!:IO&'\VR^H,?B0%*A=BWZE,KA@,@S&V"[;
MY#T7#-J:%386AK\-FCQ&XR&V&[:!OEAI\[B!=GN_&63793=WH;1W*_#@5V!-
M?80\ XK%AK.)/3<"UI#[^(M #6R@^ABX>.D_>"R]A!Z"9:.]$;L#N]O:A@Z0
MK N0-!68VJ8.X01@CI@D!L/QX7<BF.:$QL:%+HYLDEH$)$ERZ_32KJ#Y!E/T
MVLT/'47_&HI>LD=P:F7$M"8F9(:P.%9$,RU)E"ECJ!81Z(M(T2R]H3VBH^B'
M1='KMA%T%/UK*'K):*!!%CL:122TE %%IY:(6("@#DULPBS4-N3>'9'(#:+H
M-74L>!B*A$^%"C !P@V*4IUPW_!W=YO>!8^<0ZU=B_ U:5ZHPMF7K9WH^,]-
M^$^^K".PA%KJ(D$$=8(P0!-$AU%*&(^T2Q/'&1-;SV.ZKI3=#<J[[:CU[C2$
MCEK70:U+^%\9!;R461)'A@-:$)8H*2) 8S:,.1:K49CN&:ZK7%1'K1M)K>M&
M_QVUKH-:EQV"D5&9Y#%Q"<=0HU 1:1DGW!I&8_P&0XWBM65FWPNR?\@N@OW^
M2.5C]"1V_H!?A^1WB\)-9DO_$IC/Z76K37:LZ!JL:$74(XU=E EGB#0I@'N1
M&J(1/5@;.2NC1#!A@15MTTALD)FA,QQN/-"_BI@[>KT)O2X!_22*!,U +0<.
MBV;!B!,IM254,Z>IX,PQ#?0:;Y)1L*/6C0?Z';6N@UJ7@#X0HXL9,R2-A0#I
M:AW1W%"21"I,1<1!WJJMY^D-$PHZ"_ZZ</YO;U0^^#WH#8LB (JS3D\"&"[,
M8YH79S^-_Q^PM>$7-T2?YT*X&P7&([OB:/!J;A^.LCW8G(XAW8 A';U<AOLN
MIM)2EQ"KM22,1@D!J>&(#:4.$YDE*74 'Y+;US7N+(0;"1QN#_.OJ&W>T>Z:
M:7<)^KN4:V;3C$B'?CB51D18E1'+8FDBFT368I?:%<3;V?@?$07?'OIW%/QK
M*'A)':"P92(%)2!B4F,B$"522X=Y09FE\$U,&?9UV2 "?E)F_TH=P+0 \U\X
M^_E3S BX5PW@Q;2  17%RV%?YP/O;3R>N-'N;#OJFM-E'>G]@?]J[-P[U_>-
MJGS16-S'CEO=A%NMR!*(J-'4V0384P;<RO",*,XI27DH5!BS*%(*=(5;J J=
MC7&3B7OM+H&.N.^-N)>4"4NMSJP*261E0I@VCNC8I20%)2(4UH:& Q2AX;(?
MH2/OS27O^W0AK)6ZVR[_+/_F++ETXV%']3>C^B4%Q%) 9C;)B(A#1ACGAJ@(
MF "G5@B>9?@?3! 6 -7^W3DE[BL_.7/CL;-!/C##O@LFZMMW*A$\4HO(+]9"
MKC")U%NQ[W?B1'U[5>9WO' #E^6=0>1&E5%.=JLF-:TFV<(8'L96D) GAC"'
MD9 1Y80#T,PR&TG H%O/.5V.A.P<$H^#>._.(]$1[YJ)]V*QP[VPBLE0DT0F
M(;:I5D2$-"+<A$IP*SCU1=#H;4P$'?%N-/'>F3.B(][U$N_AHN2U0+118B@H
M #PA+!&<"!'"CRC1<2*Y%(YO/4\V1/ ^43>$S;^"IIQ/0#?^.0W@ =LR[CT2
M"5VA1X-C8#-'66W<Z/C.C?C.JV7$KUAF+%5P0F--";.))8#_)+$13[5C+H4=
MVWJ>KHB)[ R/CX-8U^Y7Z(AU7<2ZB/ =C4U"!="IKXDNN"9"9XPP)5A$I0E3
M;K>>B^74H(Y6'PFMKMM+T-'JFFAU"="+.&59IBBQ,68&B<@1Q2B0;LS#4%B7
M)4:!-AXN%^RX%V)]4B;]O^H$@[P8#0O5P\ZM[K_3?/044PPVPK*_R(?>CK'^
M\^3B;4\-)J_JK>FXTHVXTGX#]P_W#L+#SZ_H)V>M-$X[(B1WA/$D)(HR242:
M1(RGG'+!,%]QDTH==(;"AY5VT-'Q^NGX8H&.8\W#U-&02!9%A+E8 1VGEH 6
M$%(>PD^&Y0AOG<G8D?$FD_&=YAYT9+QV,CY<%,>IUG&4)8JD(@/5()6.:!4R
M$CN:V5"ZD"9ZZ_DF91 ]*<O_T>3,C0,UZV.RC;U*.LO_+[3\^RTX' ZP/TSI
M?*P\CQWS^4E=H+%0)#IU$? 1DL8,DX^5(E*8B%"NPS@3"37";#V_5:Q/9TW<
M9&)=N^6_(]9U _Z&6'E$368TP'P588W"V&*/$$TB W ?NX5([!$2+Q<4[8CU
MD1#KNDW_';&N&];/G.JI86&<@#JNL#2 #CG122I)2+.,2L53ZX-Y-H-6UVGY
MC_A.FFPXJ']YI@:G\+A\$"@LLU7XIF.]7.F\=]TN@]==E WG/]=NOO?S5IIN
MS;HU>_(M#M^.73^?]CVCF8R5==@,U>5?E>YU@82_U)P 0&?L5.'V7/G?_4&U
M-\6[9D>Z"L?K T=_+YL=K.6@7S))DE@QT&1<2(3,)*%AHKG5BF<BPTY*/%XN
MO-(I,X^#KM=N>>CH^I?3]:*%@IE,L#2." ^IQ8 G2Q36,5"Q%2S+=$)C7[J<
MK>ABVM'U(Z'K=1LIKD?7'>G>B'27[!51+#C+3$HH3R+"0B&(ICPE*?8I4IE*
MPC3>>IYL2 [ DPI5K%R0WE#112;>0V3B,@?R6W(T<F.%-1E]J?8N7OIF/.C]
MLEK@E'.*IYP8%F)N@V5$T403Q7CL1!A1&3F,:+IUWY,NI&FC$<3=:P8=_:Z#
M?A?AO\T0* A%I*\^ )L&]"L9"17-9,(%4TYN/9>W*6#64>Y&4^[=8_^.<M=
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M 0=9:H$M2!&)C$<1-N"(MBE?]FW\G#^RXPV/C#>L6Q>Z"6_HR/]&Y+^D!FG
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M*.;(>O[-L]M(,4([#AZBN=VKJ-;KG_C44KKC4][O'(.,<VC,\>^%7=MSF1N
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ME#Z_$'5-OZL]R@\([Z\F@Z-!\*<"V 5P</D4^HX WB  '*92IZO^ 5[WFDZ
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M6.(#WW(LT.=*C:W.JM'3B=?B/-_PG@:?7][$<K42;-"# 12,S-23U2P8RHO
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M/O8_]H_V8!XG!]\.,(3\S3Z,_=7YATN3?(1Q'^X=?/NX]YY^N#Q#01=%P(0
MB -?BB1A(K)$&D9)+'G&G;1:,;'U/+VAH ,<+T.6R#1,+8A-+FTFI4F,-M32
M5.KN+#VZLP2"SD4TCE,X1E$F #0Q+8E.%!PM(U(LT1>;-+G;+(0'J-CMK707
M=LK=+Y%Y29@P31TW::19Z)AD-C+*&)5DUEG1&3,W@4_].%WJ< ] .+SO('X%
MGWV(#O?,M\,]S!'^FQZ>_-G']*F#-^^_'<8?4>99J>)(4DYHG K"HC0F*K81
M >C#;&A<I*,,^-1-C9DIG")+0<.+-:-,ZU@I:AU@I] *2EEWEA[=60*9%VF5
MAED6$V%41!C-)!'.< );KF+*&?8W7(6??E+DU>YS>)3[/FN_W97738.88_9=
M8---\C'J(/N)[X2(_8IR^" ?MRJEST>+; >MQO5+J0V^S]; ^0KD7\MH\7%0
MMD/Q<>7S#3-@JT!\^^9M:E)%VU?I(4T7-UB6,JX>^R?Z7Q JC(+?L)]7/O Q
MSL'896Y<-VDN@JW6A5N_!WUUX=M[Z;*/(@S.!XGHBZKC5A/O,FW*DK?*IP^P
M_2&&V&-X_M07YO%="[/>\+R8)7[ F\NX_#*<?M;G;V[4OL(!K(I?G*FO+U_4
MD>AU9LK\&E1Y*)DRD^&XB>??#O2T+(N-$^OE_;P<PW90P+G"^O(*6Y7,%K[O
M^MJ-T1N]71;@A[D,$%S5?[8"R7PQ^]K2/W"3\^'X2Q/!5EZT$^QG/[UF>5$F
M*\"N#U;,& ?0/H5UWD^3A5.WY"Z;4<Z:-K7NF:^<#SM=3+4?>;W7\ZT"%[>I
M2<-8/H\+E^X$NW.#A24?GV(K 3RY%]OE<)O>G>?YY PVXZK,BZM[!3WX1*!E
M7E-'(2XRG3+^3+5WR#?;4N;LN\W9\:F+SU(3WV!@TG1NA[.ER\#-8#+.3T_+
M-CZ>&NONG7!N,1F[I#.XKDU0UAD?"X=-0LM=*\/?/!@J&W_!*\_]$ZJQ+1QF
M/#I%4?9ZV*V&@G-I'=V2*0*QSW>KK5Y3>/[1+%[K1EP ' \@L>:4#Z?CR5GP
MWZFJNS3XII@H]N?7LCFCQ<)XR_-<=J^%ZRIB X(J%VNRG-*';VF&Y[[Y5"0_
MYMF&WJC-Z0,^Z%D^+NHM=]B"%P8X\?E)#3^?RVNLFP#GGH$-',C(0HTO\*)J
M]_V"PW, !E4/NNHDS._O*0CEL4]8M,.JV67#'U?P0U5U],5=G8(V #\\Q\YG
MW!B#B9O.6FIN;K,SOET21#F?_A"HH9=_\0TVD?7C**KOYWKHS<D'_&[AA-V$
M33[XCM;9\I9[3I=C5QG7Q_Z4]3F9YQ>SC?(8"EGH:(QYD\$LI=4;>_+_PIJW
M6^DN[OZ_YG9GUMJL83C8UFSNN)59L/!FE_L#7?9#!+0UX^5U6YBJ#V+]<<6%
M/8+T9Z:8S(T]:[K)-/F1\X,M![+XLB9WU^<&-_U_?#YI;?EJ898&K,  K.M5
MI[1N-=3WG+#5D;C.](1%K- .8(-S8+R^ ^!V\^2:ZK?KRR;J6WW-K!5WW6*\
M]89R4@M+-3>I69_C/N:&CGI++67]KX/<=R,:YTVR:=WFNGHX[*6:WTL8TZ!Z
M3IDHNP([+7"+%O2:19.OV/_%"2$\6D7P53KMCT749(8'ORNB:K'4%DG^V"P]
M%7E1@Z[+4S^<8'OX95D'QVEH5.O*Q8/Y<@;'82Z#83\WY;8W4 (^M7F5A M#
M*>%J^Z3YMM=-?F[=GU3!4;Y "6,JY.'U$+ALE7" CZO35\7M=QT)?R8M\?T
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M3ZMLKP5Y76N]+?]@[49#E-3K.51DT82;]]QVS7?Z>:E8S8+WO*6U9@B+$ZR
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M!+:>)BQM3)90:BN(PP7B'AKBSF8@CFH2#*<<:6D"X@8@3AOM$4DZ>*R8U#&
MJL=9@;@"<4\;XK0!+&/*$<T\]Y)H#\S#30B@!T@A6(8X8@K$/3#$[<QJ<<93
M3E02R$9E$/<.M#B1??F<VR"M=#81T.*$6A>(N\;.'KG-X4GBU:BXSI]<VMG@
M?8SSSH;J %2=Y+7* #T*N=9#N.L,T;H\^E*W%5UN,Q8*JK4&[.\*FMX N2^
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M(^98LH%Y90UECD<6K9&1&&RXD (+JA=VK;M*RZF\?F_&C_JR>M*BXUPBV3Z
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M_$J*6B.[<AS+K'[(S6*_P#=A><^N-CF?314\K[?:\<#6W]T:>5&Z("4/8%+
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MO%],K-F$^'J#>ZDPO!!+ES4H9 F$:E>R*R&FJ*27WHH6%;")8%^("A 932Z
MC'-!8"^@F3-<,$2N0\6[=*4:ZDV&;P[,-Q[ES4Y?J9U^252 $=I!]*PXDO,
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MO2^:>!*_L6#:TKCNTM#T[M>AY!(SUAP!!>K2T R]II6"A0?.?7:RU*7A]&*
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MFWERW)K8#FUN DN]670!E&"YUH8("K@F10,5"SQH6F\A"J4R.E':7L160]N
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MRE*1'"I""F8$5GLC&H996.: Y)342EO=3D9N.;2=R2B2#B9%@"*Q&!6"34I
M%#;III9L$+X7LE *KBV/F25G:LA0%BRXFA"WE)BDD3;5V&7QB,.MU9*&[G5$
MMPA%D]7A71 :-":,W%JR.3#:[%2ZU\CE)KAO#.P%?T(&97T0B26TFD%V@7E0
MR&*$Q'-0(8K5'4IHT%Y': <=A= I!*TBV%*0NQ*<-T'YD&QH*0TV"=\+@8)9
M*(O6,>,]9V <,%32L0*"IEJ)5*Q9,\']G04D/!T>'^=1O -WPO:[0I4W1CL
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MY"AB*3(DS44!H[F'R)TGK5B#M3[>>370IG8OHW;SR^)?D^>VI$1ZMB6U6]G
M/";#LLPQ)"ND#WQG3^JU2>AW3ZZ%1D;KT;$ER*B&FAF'J)0J(&WR*F%RN2;\
M2K'@G9<-:P[2%9'4POZ0\DH9'Q7C0F<&5A2&7EM6N([:^!1,6;F#M!%5(ZJ[
M\F0J+I5/RAB>(4%V.F>T'+V03DC>TI]O"E$M[.1(%WB,*K!2'&=0BF7.Z,*L
MKJDBHG8DDQI1-:+:$*(*1M3J'"KYE$! Q!2<5EJJ9!1D?^=;SHV0EB2DA5T5
M'4W(7 KF52%"LF3CH43#HN(8E+!*1EPK\VZ5QZBEV)67><^ZW_LG-4_Z8R;4
M;KUGG3QJ+W=_W>T=CC*.3T<7CUAW7K9AH 9BG:)Q;UAZW;UOAM3\DQHJ3F,V
M>C\<S:[7^_%-/HGM?/:5T=/2Z<!UR,*1+I83B6O0V@)7I**A;IDBUHKBQ!</
MUL_ZX.W+/PY^?IT$S5<QGCD0DH'7D07PD4F46@8,-?/WSI[BMXX<;&?-UA'
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M^ !D$430W#*92-F *"P+7B+SP28O$P_@^<Z>$6MSJ+$!>)4 UC[P*+(N(GA
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M]%F1;0;%2M4_PZ))V3C\E]UZQ=Y*N^>AW?2"O2>;E*=>6:*CEP2T$<0 Y4C
ME9?,QJ2X75FW-XX%6+*S,A6+'A\6I6Q3%%0)4& 3> K2,ER^$+G5P5;_Z /!
MJ)GM(14UA:@]\0$8 6X2L=8C9.%29B:J:!98V*\"506J6\\-DAD(%P/5X)3U
MGC/-><@\!!.MKD#U0(!J9B-'V.!R4N6D8BE?**0O&8T0K6@I0!)SC(E6H*I
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M??^G]>/N-\^YRGUW*+^\V:C<3478^JGD06MW6T/\_<]]E"'7&1ZV_DS]K^V
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M9Z9N AZG3)CCAX_;\+_8MC!JC)37S:W%J,(UA\LM)K1^BC[$=Q[LIL8JF6=
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MO]=EYU8[4/)F2MB'XCN;?K!(;L*_9LCM2A5%O#L]/BT)?6T,@N^&Q_^ A1N
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M.Q!+3=8T7Q:A7[WPZX_DC+>A^]U>QP-ZYA8+]DQ0!!I>ZYX.^@/;*29V3(Y
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M"Y&_><O79YL^7!_T5,QY@KWBA9,^AJ=KKL.0U&^,W)OK;ED/*,I!)]?JP"7
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MG[JCZ(MC<!][@VR4X%9"$0+LK]7REQ2GWNWVR#)-!EOL ?C2!\5Y.MR<;YV
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M\Q:3&JP2H5+J1'W@25"K<]ZBE#(Z"00S5E+S7%*SL[F]KPD.)"B*& U ]!Q
MC@,;AQ(X@]&PY+"X>]3.%=<)L6TO8D YP6->V& X.F5T@/]^G/HQ'#TPV>/H
M5O-W_0Q\VC:NU_ZXBII>G<[<G%?@LNLR2KQ8R[WZKJ=Y=$^&E1Z#VE_;?^Q\
M6JMM??E4_O!N,__[QQ_P#RA-#M8,,T=.VJ=%'XI:M+[HV!3S8\Z)^#XPIHNU
M%!0[)H N)NV=Q\0H@:-,Q'@<[AAB5T7W'C?3&>YYZ[)QL!\ S$AP#"D-6@3^
M@4&Y+"0#,+4!$\VS BTKI!N=B(Q0(8,RG%/PVQU0!2!Q@0B@"[S:]"??=%S_
MN,]52$E:@K12V=9:AZS.0;24HO$4MB-WLGF:B.X-V#8+J@N#VH/QZWZ/<SW1
M./O)-HN[[QX/C]'+^\D?&Q_$%^GN\T$^)_+EV[EJMOHC'>T<8<J,I#O%2#9\
MKF6%+W\?<]PC;@^?Y*],JRI:<B]:TOP"GC8'YR*[/B22/&0C(>TP1XQAXI3*
M7;W"_$:]5QG+(+[C4HH)*2F3S?I74MLJ\CKO)[4NMEOQ^VC03-%9:CJY[@R^
M/W<9ZI[5/N^\_U0>VI9='H=YGSDY=2KW\_0$;J100M#+T.J/*H7@#3])W&Q:
MNX>]H?ISLF=&^<&9R.5)/X-89@?GULNP_9TB;2>USG,IS2% 5-E4:B)SIW1]
MQUVGKGJ*76'C]>R?N>B<*S7A;SG+-RX:X2[.WAF8;.'!C'MM+<Y]89)*8,]#
MO&L"\52H>YYK-,KKR':A7V1TE,43S>Z6+1IU]?^(N?!YU$ZQ:<]C?S."Z<]M
MC^ )-CIA,FA>-HD:[()-V<D<?01L58+(Z*1W<V,?F*#4 9QN,"DN\X*$7*(.
M!0-XQ@&NN+T]062]M@U8TNYWK^1_!&'P;G2K+OQ>*WQW.VR)EYL.#*.,<:HK
M>6YBYL#B=F*__Z])/9CS,<"[SIPW 9RT0NR$R63\T7MR [WA<?*\JX\Z(0"Y
M.(Z@G3WXP8^;'[2&HS%#V?RAU@?A@LL4S6>N/]Z@!]!CAU<N2]]2 MG/Y.6N
MNI-[-HJ[6N_\_3?MP!4)NP',7C&$WW^9#^WS'X54!&P^D@%Z76[M"Y*(DQZC
M)*( YH49<@QK1'*(%ZM@/+- NO3-G&O23[G>.O@>09BU4?UJ*7"9+PVM]O6*
M&/B2Q8SMPR2)S_.4OPYO;:.\L\E>Q#^S@WQP5K\\V,=6$"4I1][(B+C$$6G-
M$@*R+H6A+'!:6#\])Q3RBB&R>6OD<=0[9H[_7G@2Q?%YS/:NK  J(9;( F+E
MRUZV17L&=(LX5:GR>:E>],/?5?"UXP==P#+89J*FNH:>1W\Z6+A"VYD88DH>
M"Q&X8<9ZIRG (<Y'O]X5!S%$ >K?V4"M&BNR$#B>-RZ_[8LHM:7&(B&X0=P8
MA9S)%=G)$6H%4P"7=QS/9?Z9Z_-/>_VB=_*5,A2'+).#F^,Y2$J_=35J[LJS
M]<->RKG#HPW_=VI[^6!XO?:ER-;)_+8]ZM X\?F37C>/LA\E'71]X2.4X^6N
MC] L[@58P(39OA8@['9B[1CD\G 8="SB-(L9=&4UB&D(-NG(@;-8\&V\T99K
M$&5#BGJ(+,F%]SPKTE44_&%RC.N;6_M*.>H]Q<A9$.9B%K3VE")MO'?!<$]$
M[DJQKN88^9'TE/4/1;/D!\L L3%9%3T)X%53)RTG &T6,V%$(#3<OQRJDH&%
M9."ROB\-,=Q(C###>1Q6GK^G34 LYEQ>KARPOBP#<\#LOTK^,@R>#L!F7D>R
M46_84,9=K\*J<^*!M_GDHW+^(H.]VQ_WFK]J1'^3KWXMWCO1-V 6$Z_=^! @
M9QJ'CR!QO?:JV<K&2:\L^J;37&50EJ>/ZPB&BU?F!>2&YM>B\T,0:( .]EI^
M*O]()D8Q9UA9@/T AI,%3TC1!P0K.CKQYJ,6,_#.FQ."M_*-90N9B?<UZ@*K
MX'\/I[VS;B_T8^?GTW&>)VN":RRE9 0@7@-?X2PBAY-$401!>7+6,^ KV9CG
MM.^1G@_W[6VI17&TQF/$'U."(1D8$9?BI.0A5B#* #<B@#SE9O;@@0::,%64
M"JVT87-%HK("CY40T0 )25J![=41>0UT@#L:D&-,(LM5$LPRI93,A^!Z7IIX
MQN[2M2V"KV/X8.LU0)-1/'$.H)S85LB=?DLN.1%A<L.&P// N0#@JA'FTS3"
MU%4CS*H1YF,;8;Z:QI83(]1&;2W'<SK^[G4/>O;X51/!/T\[<1:V_[M?^Z-K
M>Z$X+&KU@"AW>_V:/05NWALV&\Q9$0OE%7,IJ&$F2$6! 3(#[KY0*EBCB=.\
M+!*C6%ZW^-<S>/(&7>W/<'LVQG=5Q;5N8P'?SAI'&_O,.JVH"TA;G.>N<X*
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M37U0"<IUN?H\["6WD^KC%N$[:31:H:@VR6RN"=_Y1[OKO_U\TL-WBI9KDO-
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M42T8<YX2O[;!W\@Y\C//GI$]2[6$DWD+U$_ UNZW;EL#X@* 6&/@\C!PCJ*
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MVOKCTV'KZ("TOFZ?MW:;X V;9WM'?\$S6YUO\&]XQNFWK>]TY_VTEVWB;W^
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M]T-*@A#C$0V$(JZD0H:9A SU3"NLDY8TZW,1/GNF[\;Z(0]7(^TZR*T!Y%D
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M!6-?9V$>&A_GZ8UQ;!V6"3GA">),>^22,B@PF/:BBT*X6*Z6B=G Y==J(C]
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MZ)V\S3W3[W7:X>++6V%LY7KLOY^P@U8;WU<BVAIE==Y5BNTU@"\&X&3>*1$
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M)SU6C'O4'KY*'C[-1R1-DGG%D5!2(VZ80<8+""_R23RFO%4AY+SF,TJ)C#=
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M8P$%DUHD$;5,6*BU#7H#HF2;6L1.'O'<2&TG2[$3>!80]!"=DQ(ZA^>,!J-
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M,<*''SG1EM?_RTT7;QH'XPQFXTHWP&MYU/Z)#MLAQ.[;5VOJ.[MY.[9(2NJ
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MTP:^LHFIJE*5% .48^\T]*L4FG$$JK+45VREF1#E%3!XVYW3=N\BA"J]=+%
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MI^[V4N79@6=ZK;G,Z;(&>];E.[S6+=K^O:P9^)3_ >BV":,R1Z&1TPH;6^E
MZ+NT(?!/WA"X,D6O2*YWQZ:G84T[[1FLS]&TN3*WB\IT/Z@.XPLJ-[@P2_:>
MM038TO;?M_]W"*QQIPL489C#0GMI<V8?;/Y>N8$%ZUPN<YE/>SM/B+U0XED6
M..Q=[M)_6GN_?V[OTAWZ^=,VWCW9OCSHO#O9W3KXUCSY<MG\_?WEP?[F^>?6
M3('#DR;[_&F'?^Y\9 <GG]L'^^]I.FQW\*F9[@'C;)Y_WMH];F[]U@&R.M]-
MB#%P>)7T",=4KJ  OUM;HQ GBOHBX,@"<-5BG?"[]M5]775=?_2RK:^Z*NM?
MH9_!:BE829\!*D?4H&(&F1@D7I!H068%8Z#$-5#>#BAG&S09([2)S"/A L C
MC1BEU&I$A*:8&V,"]VMOI-A@2RZ=_6R%7N_4GX'H!< W'>A">M[C?>;N"?E@
MT@_6O^EN;/&A.W!/2!OS<@YVN@L2[&K6^" PW)EGC9%@(2/6B&B'$5=* AA:
MC;Q1PE)7&.;YVANZKOE\W/V.8%BW?EH5A+B>*#T0)IZ0,5U%B9HV+1TI9FE3
M)"XJ2BS2!8^("UH@2Z-'C!A"-7:.I?/GBF^0^2R YT.*I^X>-;4+4=T"I>M_
M(>ITGD4]$RZ\3<Y&/X7?1BNRU%'(#7&+82RHGI/X,6(;"S944CY2677E)_+S
M3-&1'Z.Q\#.QO?'!B4?!\+$@SE*^FM7= :N;\ZS.1EY8&@PJH@16AR5'EBF7
M&D19;G!T/KJU-WK!P?O[.;@K% 7\47'@\3G=LV!!3>R6#A:SQ(Y0&4,4%C'M
M+>*&1&3@3T1BS&6.E8D4B!W=D,OJC%2'O!X* __D8/$/%O&ZOI7Q2P]YE<M9
MA[R6CW?O%VR4:D=Y82AB5@?$>33(",N0-D210#'V1<HS71=B13H@U]&N%6=&
M3PT0-2E:.DC,DJ* ); B*I'0"20(T",3G$22F'2*P#,LY-H;66P4#]XD7+UH
MUPLE1=6!]WORHI?K$[Y>7C1>T3HT="]@^SC/?AS%!64RIE.J13K)[) ECB%%
M"F6LCTQH#]Y>,1\:NCWWJ:-"-?=9.@BD.B8U\5DZ/LP2'^J$-S0?[:4<<>L5
M4B I2 1J@XC:6JW6WA1X@SUXFV_UHD$KG?!YF[1Y^I"0T(^=3W_/JM-U/OUK
M ,*#>:)4<,(+D6JY$AQ3-U("1$DQY!46N<*'I!8\P'517-?<YJX>X,HDVG\G
MD/2X.+)RN'O[1/L[O_\+Q<_K6>7]0+1.M'\5"#I+)7G$45H?D"\(2U12 *GD
M#!'-/(DJ +YRH))\@RXKAO94B?8S#<%4AL<''V*=&CV#\?G>,!U1GQW^'4[#
M/LXS%W)M0N>>?DMLAT>O/48?IUNDH=%EI*$M==#Z5K4=&DU K';;=*?*<%89
M?64US&XH$7O<GM$X ,;R16<;WHV7]-^YNL%T([SIRK^S-2ZJ(#!1-Y8\6<7*
M&)-R:?<O!5OY83.%+>Y0<^;9*Z@]U5[5?IKI*:-:5T.Z136DR_>'7 9,"Z,0
M\S[U$Q$&:5EHI+G#WHEH5!1K;ZA>V9)KM8"MK(!]:VXU#[44TJ?-30.K7+6W
MUQK^4-B:P*6)WH& R9MJW#Y[C;9:R%99R(X.!4U&*[D @"&I.S!&RD:"B%)&
M>0X&S,BU-^Q&(;M2GNV^U=E>($_9O+&^5ED(_:XT8EFM]6Y5&W'L:V>-&V0=
MFOX^-3#=[9T=!!C<J$AMK5JW4JW]YB'5@*3.&N0,EHA'QI!20!6$\=I:&824
MJ20UU]?72TR5X3(1'DZU0U]0(K]?-IQ-S7\F9>/*,G#?+15<=8V<;3[Y:UEW
M/]^^-<B][5SU"'NE*T'N26<:YU6X!IFJ9%+9FBZ]PB/757PT42\MR[M>O_HH
M7;>X@TWR+7YTB0=*3 .EWL6 &!$4<1,,4H*G[E78,*>\#$:MO2$;:JZ/2';.
M9DM[WMCJ_<'%/E?1HBQN0OS]IL)3C7$;'=/*+3]2>[I&J'2C\HW'+6Q/<VP"
MR&%K,!BF<X;/G*"41K>3A[*5/?92]<I"=&/]3A?]5;U!;NC\NC?8EJ69NUM?
M#J50D7!)$74F(AXP1H92BU2TD2I6R*CLVAN^R!:-ZGE65477[R@K#W5;:UEY
M4EDY.3AD/%(I ,4+SZOT>ZN#1 Z3=)0\*3M=>R.(O(6LY Z9=Y.7!WJ@M;P\
MI;SL;>T<.L)M 306:2X<6'T-+J2R A788P]N)-66I]8#"YI(S\C+J#WY=RJ
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MT)5OE39WIW\Q2-^,7O3Y]W"O$?T4;'IQ$=6GUX"IGNA'%ZG)%>614&$<<H&
M9V)51)H1C"AWX%-Z*<!7 %K$KLOW7(U]UUHH'B 43;Y[=,B8-@J6'^D@& )3
MZX!]"8Y$ -.)@6^ %H,<X)7N7E6+P4/$0.QN'A+J#:PW1H1)B;BT$FGL(P(.
M1[FU1#))4A&EZ_=7[I\>='>']&I&(J<Y/KT@NVW<C^;_7JU65W6SP9.?&#OH
MM<%:7_N3N28;ST1[-9\)[$_]>1=?G8]]]>/^))GQ*"#;#^8+,A%>\1?3/C<7
M@[5_7VTXU.JBF9F_Q:1]UUF(\3ZSIFZ3]IB' 8K>*YM__I*WY\K<QO\VJS*4
MQG$_@>/_^?[B%6MO<ONRQ/@2Y*6MQ__^M[F'S[8H!+,*'M\U,9KB*6(T0+OS
M9NY6:Y"ZV@_[J],F;O_]R#2<[*: XN7GUN[E>_YY_SUN=CZ>'^Q_O-C;VFTW
M/S4O=NGVMX-/?[=VYTQ#$TS#$=OM[+#=K>,VC.7B\_YOQ[O[.[Q)4W!SAQWL
MOSO^_/L.^<_E1[RW[PA<GP*6YWO)3#!?%%R@2!Q-$1H'9J((J @PXUY%S8*>
M#4(HC1UGPN-@&8@OK(N-VM&H/55,8C4;H9E:@^]'9^XEX@LC!]\=YG,KQ6)[
ML#.? ]VSR8-,QK@?CH9@"GO]BX8Y/>WWOIKVR$T<9U7_3S!M^-%4TG3.MYFX
MB\G8Y63K*>\TP]:9^0(/&4P2K[?"J>GGE4M/:9HN/,./'O VQ4BJH'1NXPPN
MZ)7;I"5)]_YJ^JW>,/U[(@?VXNJ8P%O(A*$Q/,UY&^#SAFDG^(:WVVAL#AII
MG*-KIP9Q]<T'QRG0,^7)WX7C\B"-PUQ$7"@N#384@$AHJY6TA3*\3#X",.(W
M4]N<JC=1B9="8I\:J=Z+W2W'8>R7S<OWET".#T50D7.G4NV'U)57.&2L5 !5
M!9A4*957/CDV-_NWHQC(:#^KW_AM.  E' P:O_=[P]-&;RQC/_WUV^__\W.5
MU'-J6N-TGIMLEN.%]R%UEHZ:8T6-U\Y:9[D$R7#4CVT67Q@/G)&._=#O+ S[
MG??Z?A"Z/[98X-W+HT-=,"<Q82C E"-NHT<V]>&UC$K,"D,=S/";"-B"DALS
M%PVL4K%2]]U62F/*CD8&KT%KD*C8! XG_4<[K<&@0J=6@JJT5@F?\W;=*1#N
M=(8([M<%A,ZP!EA]U#>=0;["AL$9?)+$TX4<E6MU'?P( /2X%#V7L#6?[<CH
M9I)+-6R/$2[QF/2 67"<P_R[ -R])'<1TBV0XY?53OH9:=G>_O9E\^C0J4*)
MPCM41)$*>'F"K! 2A4!20K)71<IL6H!U8^_]ROX'2%C"LASSK:+%X^,_I?G^
M;KKNV(BF;98,AD\I6^(&V1K\!:.I)>O[DK7S;7?S$!O@OUB Q^2\!KB4 FEJ
M"<)&8N%52FK/:8C7AP?ODL7^PE(,[\N]W[5\:+<&)25>!O%.[W/0ZW]I?#A+
M;56O\O"*GF3J3=2C4^_K7FZCL=<-"SAWRE1Q[:%/3;;O!!)"!N.4]-;(P+%@
MIG!@O8430A&M=$@,FZCO!X]KAGWG6,!'!M!0*$ #S#S"V"H$5-L@3:1%E@C)
M"AJ53!G*C'^/85\Q/3/25K'O4JQ!=L:"?C>6+:V66C$FHY> 84$55A)72!:H
M5H%D>T)4%1D:R4S-LN_+LMTATY:SP"/"I%"I&H(%Y\M9Q!0OI(Y.TB(^)LM.
M>-O*I/H8\!K][Q#,Q=E%19<S6P8!^CIL=T,_1U)/>Z<)K/.N=[HS8.%53,VP
M>874Q&$[@@2G#?1C@+LI1&N8&]C1*S:'TS,$6-NKS$B58W"S!7L++P"KW6V9
M&>NUTQT,^ZG^5W:%;KSTFH#3O4QT=8_=<#9MPRHC*DMIF+IFVF!.Y57,F;IL
M$T%V>NUV[WSPR])EH6/Z1ZTNJO:W9-H4FV[,Q.35$A6+3GN@J=.#3RU!_\__
M493*7Q^EVL2MAG!UN@C?R.=>6OF\4SH#DKY-@@""<J>3B-ZR:&+A.3<\"*>,
M+ZSEEC"J<,%HIBJRIBK+IRK[1Z+Y_I '&FV@%'F.4QU8SI&61,%4!29(4#A$
M U3E!O_X[+C?&Q[-8=5>_\B41_=VLHQD* ) .$^&(Q.3](.;J$G$JJ"R2&4G
M _<F6(Z!/1D>"ZZ%CB13$SFB)K*F)@\0!=X\/TPT,##.$(^I!Z@. 2DC'8J"
M.U( 'V2X*)E)F<8P1TU*["Z3Y69]GRE3\>L5'GL#62BW1*;*/]68_A28;H>M
MM@>W85">=&V421UI-=)1/U#17B<50VI?-#PPSGX85"=_.PGF+])U$QA8;Y06
M(BWG7<Q"Q(X1F20O!FYU-(5A6DONA"%>1%R;A4?#@B_GS<U#; FGBBHDE6'I
MM$U UD:&-.=::Q8*FIJC4'R#7<@8?V-2@J)1$NQT ;Z/PLXJ:ZTKO+#"*,J+
M)>'[2N1U/^^"[FT>>BQ)P,$@*PN..- L9$@$<.?!$.4+6-0X'0>?R?%.'D:9
M/IV]N)E\_GF-[H;S4;;UC&8K3:/BD02I%"<\&D%L,)$[7D1LU.)5GZCXSNZ[
MFW9'1IGFJU.U\5FC49L"EA[#L@-W"LAQ)U-C-X.4YP9A22EUFFD>BD3Q%NCR
M:>B!'5]/1KP\]#&[?]'JNF$_A6+OE !/C39&,ET L9.:64JT\C0EE5A?$'%%
M!.K]L4?#A;2+(6$)@&8;5&#K$6 ^0487 ?XPG@0FK7(DX<(-Y4-&#D!:JYJK
M/2U7NV<*3@"G2A51,^$9#\H8)96(5'D3E3",U/3JT2!Y^WSW_:'UDCF=#K]3
M[A"WQ"(52"[R9P@-P08%6K>@T69C*OFFU4F!N= (W3XX7F&<\M ;G@$;3^?B
M!\/3= 2JT>YEOCXNTM,=).O>,(,4,LX1Q%%619E\GEA]]PC6MIL!?RHVG#:P
M@-==- 87@[/0N<$R3"3S;L:!@TTRG#A#K0-D\L9J@H$E*.<+RQ2NC<.CB>G.
MM[W$_D_@?OM'>&_KX# (5C#M"J2E >J TP'D6!A$"^Y)M+90P:^]N:FVU+1Q
M*(/,_="I@LQW$0M5!*.X,#*E,"OBK 87Q3A@"U%RSK];L6R1Q]#[+:2,AP-@
MN'O=L-G-?]L_[]7R<0OY8,V3CX>P((4VEJ 8L$!<AHC J0/VX(!36B4TDSI5
M$+A>/@;N./AA>USR*^];AK0KU;XH74A85S8Z$L-_37^[EF/4C&)I$?T[L0GN
M :A#((8*CH'/$\8\+12X<YYY'FLV\7A'#[XU@<-+EWBZ1M+&5!J%1J#OS""O
M)/-,&B8T^/;%#6PB95^>#:I878[4)]X0>_!EBN=]#6#BVV$P(A0)O"<QOG\-
MIAE"JQO[)I53=:E5U_ID;_*V\=[9?>#%]=EN>YBK6$;AE>M]F-4Y :2>\@00
MV,JW>4F.0M>UPDJ>"')CM3S8/V"?M_X ]6RF,D7XX&0'_MN\ *5K-4&M=D\.
M@.V\.]Y[.ZN6N_"=_]($]6Q>IC)%Z?X?>?-RY_* [GQK?MJFH((<_LO307+X
MCAQJ&JEE!B,I4G*]21MJ@DE46!J+X*R(0LZ> Y+&.B,H"#(A0*R _I.HO;38
M8*])*.;/ 4W-_7=. BT\T?/]!UX=H Y@>WFTA83K'96*!B$\-H7G!"B@>)3.
M#1/)SW?\I74&BN9NH0M[7]/.13C_@8H$3R>8 *H"YX;5"T"AJOH9);]JAR/3
MKOH9C/,[P/5S(?@JWS!C=3?9W72^9]@?Y.0R6YWL&*5(@E4^2\5?G.F.<A37
M,[N'YT[5Y[A+%L<]5Z .*ST&"2R3S+(-Z9RV6^,DHUYB:" \2;O*38%J>^^H
MRA"S%^-,V1C LE?B-LA9BM-)12/PJES"?,P]B6@?N']5A6J04H] XW,:6I4R
M-$EI&XGD>B6 ^8S:O BFQ.'>U9(NIV7]]R37<"WJ1=2MTA)<V[0Z.6YBJXRY
M?*;D;?-#SK?KMP9?&L8G&2HY4GDC^$&OS&9X!\06QICOTMAT9V76,O!45Z70
MI6=VRHI$C>:??U>J:&%D4\E1J:+W66]N%.4<CB=N_H4&:1CE53$/I'R=!I ]
M&.)I']RR(4Q&OW59CN4T=(&UM5*@Z P$"L"B7-@TR*-^*WQ-RUZN,BP$,+S)
MA?DSYX;]]+"I^1Q-H+NP  \!+L@[PJDLXO1"S:_)U;6MIG/R 5#%OD<IHPWD
M*W1]KS_X5V*:V3_(;F0.1PTF=+/*0)ODR/T%O-785DYV3!=M.H"W[O@C6*WT
M D1K.27I\S(,Y';H<]^6LU(E# AB:+3-^:".?3\M2,&Z5;C3 ,@ICW$-\RJ"
MCN1E&V%$4H'6UU8IZX-AJ@T%,F6^C>S8>LID.!V>756K*:?&EI4(!V71LURM
M*L%@JV.3A4S2#PHV/"M/J%5RGY04]*%Z.BAQ*9P=,+6 "/#H]NC@6E+.UE?C
M+E+!#_@J9%%+^G(6VJFFU1 ^!#,-J'QVL3ZU%YL>C$8C+G6O#I \MMA-B<J1
MZ?LR6[8UR<6=JGJ_/H;@J_(YDQ"5A,FWLAU-/G.Z8F1$07Q"=9]90:IN759T
M29A:E20+_0R+:2P)D5,8WI0BE'Z5"O=/?]:S[;'Q3J8D9X=GE>CD%&WX2[61
MWV^D7GNGU=,S/EXUOA9>KMNKC&]6H=+^&9#AE'P<3:L]+//+2V$&0W*:"L)5
M<Y3>*9TK#S!]XPIK\"+=,OEH?ILA,U>8H,'$[DS-2=6HH#+MQJ>@HKN8GKH\
ML-(<F;.Y#0P81LZ9SHG9N478&$[&)TYO%:IX8-#AARSE(ZXOY5,7Y5F)H:Q6
M49Z%48[O1BUFHARI:CUEIJ!6<:YQ,-Y%P>'5B-*2V%6M<[+9Z273D@EK.I]S
M-,BX.^6FI^*8U;GWUKA9)*R&-QU0(;@\U8@KW9@IIV!4YG783@?MIPN]9A/P
M;[BZ_++RV1)Z3T/WO*]V]:A0HC==GR__VCKJ@7$9I)S2$$/R*\\&H9T*BZ8>
M$V??CUS 3<KQMG(CF9R5U#U+KDJN:'+Q:^.X=QZ O(WF9OK'B>)-%1KMI-$-
MN]6QG#09&^!(- :]SOB4IC/)[,!D9?L_&N746Z]/SU>VNJ/,V3S+:3<E<<5J
M!1HER4SW&J3MTK/9)B6O]3!4ZO"3A!&D,_2_CKQ-Y_K#?*9M<#;(GO>X]&L6
M@RM+=U4D1A)?B2"\<O),LWT'P? !ONPD44RIS,FJ?^V5I]RJG(DD.G!WFS\;
MN9*FDQS%T<JW>X,R[I7[$YE!KPL77R3.WNHDTK'1^'3<:H?2S5CP6KYZ+4#/
MLESM54U)>V^C>XT>.1Y1?G::CWSSL?.2KBDG$NY>CK;4>=^*$4 AW:M?UF>.
M_5ZGHI\E)1R_6R[KDVZ;'C(M\5G4UT&$Y\<%5[;&XTH>4=+_]&W^ -8K?$L$
M+=^^&E8U"4 <\R/71U/9 8(&_W5F.!C?O]5-H9"LQ</N:3\Y3KDW;:-K1CSY
M>[@P0K$T&S;)@P%1LID<3H>J8#9Z5]CL=63V(M^IU?W::W]- QQ)5)J5BE6F
M]0%$#F<&AC+2[_39U \KO!V#[2),^#6%; 9)?+O@=+:K5X4Q]/K5+\I/K@#5
MK^-'5&Z*SR\'G_?#Z'9 (8Y;,9N"Z4GKM5ON8O)[TVB;/JQF=YAK5*:3HX"C
MV3#D%S55P&GJ%K;G\Q"JTX59 4UB^8.S<A+&XCQ:GNG'31XT2&<7<V3IJJ(G
MBV,:0-["1-).>TG#$\:.TIY^+4<UMG:569H.8T\1^+O@[$O?)-@<+X$?:W':
M+ AI3W=]5D6S(-\:<,]3&\*D,".P6<_*?WJ6;U,B5,;""8J C^7#P/5;-FEC
M:/?.YZ+!E4HE[1BO<_59*3C98I;G5 8CYS6K]G8E5W\=&W"&P>_[D#R?TGO>
MZ;J-QD_5%3^OYV#0!(53V($4O\+M1C\=1W\Z^1AM#G;^]-=OS9^SC6_Y%F@Z
MX&4F'F-,+&U.M^(?K10![C? !>VGLS1)D+O='-8ICW-?M0( #^"_YY?M=7U5
M *,4Z;R$R7DVU<L /!\W(DS>F)2U6T#'? IJCKG;E 4P/I7MST'<7*^BG*YD
M#MO5NDS;17AH-6_YN7U8,<"BWFF>@[%!KAY\'01/4'5^R3<:VU?%9%K6 ,/<
M,!\ORM=>+0("'[5"LJUC[WW\!B-K7IFU2NBGMQ] B.=%.]\H@=>$/<XR/" 1
M@^,\JTG6CTU&KM'LCN:VJ@22"J#=<R6G5_%E'XN_X];M)*OD!\+EO6YC#PB(
MS<ENJ18"$>LSB#!UL':".>O3Y^R3<SUU[*[$N*GO)U_^7+:=3\D=OC%J]0%R
M;KH58$T][,Q\.S4I]E=E@<56NPR)_=D;-#;!K*:LH+?);@#"#C.8]=._DSUQ
M)K=0+A_2!!9F@,5L;32:%\E@?-VH:I?\U@-W- U_.]>BN*RV[;:2;OW1RSQI
MLHN3<U#RGEA)%:Z40)E^_]_"&0QI?Z-Q$,)Z#COD).F;?Y1*&K0WUJ^\W-6W
M@LM!OW=[&XW?/A"AI!#)IVV-0K/) MB<\'I6=3J],ILIKI]2]3/0G";B>)8]
M$1#=%EBN9 _&$YYV_(8)78[2ED,W 6Y"F+3]=P&DMDK-'E\^A89A=%6NQ6%:
M57)E2-ME,(7E_1*HM0W [U_M3!UC&2HN'?(TO(6BLW[U?4"GRPIHTW4EJ@:I
M90^AG_[G[8>_0.!:^3W7<I@\]'-F7VH3"=:RXH7F6QFX ?-PVDKDP'WI]LYA
MZ#E 6SKU"7*OW*6<XBE<SV]4]B&9'J8!2!W]:K#6Z P'>?,V36Z_E^E@Z+2&
MG7)/Z*??_]K_>7V\:UN*+]U@XO\F0+_Z@ZJFX&0>X&W7%T_=I-S;S$'YMSV8
MADQWWR49!V$*C?TTCK?OTCBJ51[M:>68>2O;[*E[C(AM(K1W6M#)7*3GP)L#
MLZX"2::4,!C%]#T'(7Q)KWS>;V7, ?#+9-*W^JF22%7F_BJ"E :TVK=.K*[7
M'KN^\,CJS$%YX[094BYJBBFE7RX>=[GM7?Z\E<N!#<[*&TV<JIC]A8IA^?$N
M28;>ZESC:5;M*EHP 6$B$M)-%8;,>1!I#BIU3_N]PU(JR["-Z_727E"6E\QB
M!^ X)LI773FHH'-$),IP7:*T>:@_57.2*_VO-_ZN-C VRPV?G[,WWC1]=YPK
ME8VL0P*DI,W],H'ZBL7PH9-83#]/;/7FP*<2>EY]HSQI8#I;<[?H]$8U#P=G
M_=:7:B>GVBP:W;8? %E-6?>LGT HYL%N#H^29$U&>]9O52E%9PD'+])<M+,_
M._NV8](U<:XK_CDO=J.B6-/J-"P+&&^6.0O9$SWOC19RYEE7)U:O?_=N4Q,U
M,Y8RN#DVI54R5<ISF'V_,L0WRK:8?P4P.2D#9F1'RPB&#ZZ=^W'E))G\RW)_
M+/E? 'JGO6[%<L^&_7'9A?+KD8#?PFB7:SZ*,G4Z*8AQ,O1'F?!G)V^<L;^Q
M6#4G@K/X'B:G"_?]I*!9FN+69!DHOK(JB1)-KAOU$;_'H_-=/X"O47;=F-SY
M=(QN99[+6!'@@5F37&N0R_1=$[T>[2+D'.I1*+N4A$&8#@Z/<W*N1*-;@]$R
MM08WAZ%+@,O%=DI'8QRV[%ZY3^GWC5WF]L6LIS+Q ],I,E/Z*O?W0?.>ZLA[
MJ3=%'VM35-:;HO6FZ$,W15_H)N=O*5.C6YT2V03:UJZ:)0T2C )*C7E6ACH;
M0G>&<4W'CDRYPSCQI4MPG<L'F;+F$T<*C//79,FF3%"5*_.O1#8'N09:>D)U
M'A?(@2DW7DJJ&+XEM\<O*L!GRHN3^J:MS'&(<].YD$_J #"_2[M+^V &!VEO
M9_.TRL^]:ITR31GDZ-=YO]<]\KU14?76A+JEB$FGVXHM5\I''N/X4:.(W-AH
M9?LY;EI5SOX5\YDIS[7GQO)-9D^.$6R)2T>4M.0B>JVLBE(*:G0PA3'Y5.=<
ML[NI&B"CLRG ; :34Q$7?Y4,LLS$W<T;"_.U8;K#SKCVU\I4"WGJ4RL.[UZ^
M/S2%A'D6$1$?4Q4X2Y$VJD"1\, !KKQR8NW-&:!;F#]$-MK6&85**Y9;:=\T
M(SM-#D(B]#-E)5.MJ;.SLOC_7/G2:Y0UL^)R&S'?*8P)I2N9;!6GS1%L0(1.
M+WE=_>QTS(QXDDB:17Q4R7!1.EFI#V.LR44K0>I<ZW1TA0UEDFBIX+F;RM7*
MO?]*:C**9SG3A]?I7^E-D-\M[R!,YW!\-T?A:G3<]T(9,*D"0U5P^QKJ./V@
MY-V"L]?.)8:?D3>^[D#W>%_JM]'F4G.RN=0LE^)%S\?W(MZE>T?(^I0E&0=E
M]XY;O3& N-97L/:5.;G.FE\5PJM0\=O0?0D7XS,!.3#Y=ERO;G9C,-VMVAM,
MH:4<E?O23E7M2H]Y'!)(MX 1_95*8<U$N_/X9TKPYKSOEA]%F5, ?-2\>!0"
MS+I2?;U_-493Y="6S*",F8[2>">(><-CY_.$TV;IJ"CT7[\U)]NH:0*^MGJC
MHL^CY0#0NW*3G"PR&L/57;X%"6F @3^U?AY3C]&9D>RGCQ_<3OU>+B:)]3!9
M/[7@5SGP6QTW*<L.COJVC")W-[QX&7P:AIQW,X+^N1>&Y\"#6MU8O6!*GP#W
M/?TUABJ6F!(H7+]U6@:J^\.C*J%MB@!5H9V<750-$U9M,.SD0!&(1ZZ/.,Z[
MF\JVRZ'+\>;QU;A7:=6F5WN!2+]L^+QUQE@*HY=*D/9@X7DIS\,< 3,IST"-
ME6$3'/U^FO#?R\CY%1%- K->AM)*>C!)0O]W21+&@<XR,ZDTX?E@QA5",)5\
M$+ZVRA3&!7D("YL/34C/^D2*9X?]KT%C^J#+ OA+$;4JLIN"<IOC0LPIDCQ]
M82L3]&I3?93Q;W.0/5GM]O1N?WJU*H(-D@<THYM_7"KU.'.@G(_40'VV^GR*
M>TX]Z>I )LEJ\UDA,#=WJ3U!.%8!2Z.QDCQ&;;&'];),I%X75*G2@\"2X9MK
M3_PYGN._RQ&]E.H33^TP?(%[?#R,@D9%7$"8>8ZX3BWDJ(Y(>4^IQ#)H3=?>
MD'4JOM?CHDH4&Z3T6#])D(F9%EREWDE^TU'"2I$':<MA=)K&]KY.*]0H3ZD\
M6CEWOF.<".I'SY^<=9X*FR?.#9:JS 9UU<Y?SP_!WDWKV?CX274P-N=OS!R,
MG36_$ZX"KP4:G\^$):LT=6;MR@-'*8RC[67 EE(92QTL%6QT7G&R9YS',@"R
M&8Y[[;2Q5H))/IQ4\:9^*#=7&T<P^2FZ'J[""RQ4Z0>4$UV>E\S0EV:[X@$E
M?)9=!*:&-6H9L3 !;/;$S006T@&C,=BXE!]D1F:QG%V3*5&U&?<HT?/2\^D^
M=YS\EG5.))ZN<W*C=7^F^B3ZT>N3;)N<UC#X*_0_)(%?F5(D)YL51O>^-4%@
M=R\=V=MWWW8[.[BYU;P\.#EN-^FV2-5_/G>:[& ?,'<6HT^VO^W]OL-V+S^*
MW<MM>G#R_KQYN=O:^_WCY<'^%_BW[QQ<^N/FR?;Y?U*GF?-#@;FP/*0>,YC!
M'ZGV+V46"<TEE]C+J.;J?#@K&7&&*:,(5U*K8(4F--7F98QR/5N(9#3E#9CS
M1I[T)VQ+_-W!OGED@?M0[83NQ5G1^\T,6FZSZ[=::6?)YTC_#RR.9/?H$#P[
M'5Q@2"@I$9<>@SAJB0B+&@L/T%;,];M>66=DTNF@-$SID&[BBY7K,5/QP29I
M*-,L2GE(IU)3:GRI.Z?9YN180C;4C9_^*YFDBB -QHG4Z;KR@KQ)D*@\#&-4
MG3M_,THZ&,(+^L'/U]=?J2H2G/5.?Q'7E;&J7FVT;YK2<E!*4S&G@_#+Z"^_
M)D>Y;2Y^:77S5.4?_7JUX$%Z AC1L\1QJJ?D!Y9?5QN/6F\(2=+>XUD?_M^/
M'EQM2V[D;<E_G_GY[R39*+BZ]FN\0:[][J;;$KQ1:'ZOV][\G6#WN^OK&JR\
MU6W_G86A% @0N23-_^\:6YNI9_ +;I"<]3NZW_A2(N:NI:??TM6_SFWKS\IH
M*9Y/7\\M[\"G4J2-[6YBP^,M-T;6QPI]A\E9\,*IH,$SO>X<J.*RUD/R":^\
MW>*7JG H 1>\4V/0:[=\(XWOUY>UOHE3+.5UKQ7]5SEGI)ZS.\\97@0:,XE4
M))<VN2_*WF+:[CC]K^V1WX'J$8D"9R7<_.B7?&4]":_+:(^]?W-6EOH?5>I;
ML*\YB]L+7A<W7L)+_]=MWF3Z#?KIQROU"G=IU7.?*,E-^RR[X6RGFZ*N*6/K
MA>RQW#-@<O#IC\'G_=/V0>==JWFY>;%[V62[O[_'G[>^?-O;WV&[GSY>?C[9
M@3&VX9XPQE;UF__\<6P[OKW7^:=U\&GG$MZ!-2\=_.[O+WO[VZ)YXLCG_=U.
M\V3S?.]3^FZ;_N?R_5GS _[VY_[V6?/R(XQKFQ]J44A>6(<\=JGG%\-(V2(B
MSZ7S7FCB \F;-)A>LTES"UE/!O".,G\/(US#Q8N "TF,=8+H:"3FN-#*"">+
M@A2&QAAXS'!!1G QE]A9P\53PL7%#%P85WBI!4:!!HHX=PH9SQ1RQA?!.$RX
M80DN&"]JN*CA8AEP$9B0L2@\5HYK8I4L6#3*4*+!1#F7X0*/X +7</&,<+$[
MRRYH413,L8@$L0)Q+ TRE#E8*8:U(C28(K,+A=73P\7C1CE>_*6OR G]4.Y[
M#<<G:CJGPYQH,]DNJPH;_7*+V.$-;[YZ2'OKH/F+%$)KW)=4<;CK436ASH40
MXVP MK3KY1G&51;43_D?*;NI*B$^*7@VO?L[2&E)J7!D>L=KUY;>;9H6DI_5
M$^AKJ4,Y,TN.3;!9]C!:H<UR@<IS8WNQ1)B]R:KD[([;L0M6LXM;L LW'[MP
MC 18.8^T5ACQ@D=D3*%0B%+E/%\?XMH;48AUHLG=^,6=@&4Y?LIW'WDMAM:*
M_O"H0JWH*Z3HLU$'56!<%*EY(:<&<? =D($E1%852G%)O'1)T15=5^R.8<I:
MT5^:HC\P'E K^NHH^ER\P.I"4Z4<4D5!$1?2("NU0)'(Z!WS&"N5+#I>+^@J
M*?J=W928__=2W93J5.O@K.>^I$;,K:\@]NE S4^Y>.OXW(S-1_C;%Z.2;V>I
M&/HP=8;/O^R$L^.>__E>#LR""7R5<+=T!V:GZ\K6>:9=+F,)=)M3V_/[O5&"
M>O!_E8=P-Z<Z%M48N#P,/)KW:H@E5A@KD)."(^ZU1]85%I%">"H$EEX"V9'K
MBNN'(N -*/185&?FD?>B.C^*[B_=IZEU?\5T?];1T4ZIH$'M38P:<64=TA0;
M)"QETM("NP+X3[$N%:]U_W7K_K+=G%KW5TOWYWR?X!T.'%M4&&41#\(C;;%#
M0 "E9UAXSXJU-VJ=$[9"NE]OT"S>H"E+M8SZD>0S?:D4P:/LXMPJU?S5(N53
M;?%4YW3GXD(U+"X/%K_,NT."6!<X8\A'JA#'RH [Y#SR+#H9J#"&VS+V"QQY
M22&A6RO4"PH,_]@@\53;0S5(/ E(S/I-T7*#@2(AD@H,\6@5TDJ"WZ1LH3BF
M09H (*'QNB"R!HD:))YU:ZD&B:< B3D'RPBO!<<&,1+ P3):(\6+@#S7P19$
MZB!8VES2ZX2)EP(2#RU^L/# *H/!^-XPG=2[9JPK[:0]1LYC/3L_[.PL-Q$:
MYNB97FWWQH)"MSB?>Y?DZ-5*(UY>QO'J'1:O3^'7D[ JI0@RA:%D@RZ*XTYW
M8$5ZOM[7L^)^SNZZ'AZ769K@^2S <DX./M_X;SHV."JKN-SH,/U> =$J*W!5
M>L.\"-]LFV2_+/MG3;*[M?EM;_.PH-JPJ 624I%4BM0C%1A%(> 0@M!>4K/V
MAF[@.V:]W,_)*F7\B4\5U\#PA,#PP(AP#0R/! S-66!@.!+FK$:> R9P@B.R
M'DNDA<,Z!L^HX@D8V!V/^-3 4 /#0F!X6!2X!H9' H:/L\"@G8O>68%BU %Q
M7Q!D%>5(&UPX;PVLB5U[PS;(DY0BF0*&VG&L)Z&>A'H2[C )=\J3>Y$!EFK3
M\\XAEON?='P93.IV[_>Z*-9C!V4J6:M)UIU(UL[Y@K",T%YX:BRB)!#$>52I
MVH) SA84\\BI+'0.R]R19"WY..9WW;([I\W4\/-JX>>Q0S\U_-P7?N:"/])A
M;IS1*%KF$1>^0%80AX)S7EI7,"UI@A]ZQ_IQ-?S4\/-: TPU_-P7?N9"3$HR
M+31VR$=L$0=+@12A\#>)8?6H3;'I'&)ZWF(4L[&G?^<LGC=332.GN^V]MJ[/
M,YW4_/<<S=RG._D5H[;RZ:Q6TK341*T]]+D9[*299VP\\WFDS>Y9:W2 [$-P
MPWXK=2K=+L?JW_5[G;>YH&6>@?D^@YNYLN7KSBV^?]_!YGGS_- *HXUD$?$B
MJ7D('!D"?,,;8V)!!+;!K+TAZCH?9]1-KSK7MWY'B5GZX91:8AY38K[M;AY:
MJG 1B$"!<I[<8HVT 5Y*+!=,@=,<L%I[PZ\[I3\G,.GOSWQ8H1::QQ2:B[WW
MA]8%PA.1D,REEKM*(94R7HBTQ#!B@K4%L E]G2\S)S7PQVEP:<':%^O3?= -
MK"4:'SHNJRWU3LLNXV73\\$9<(%T=?EEDK7;-9NN#'QEA3DMSVR?]@:YK?4O
M90_SK^'741O'3)*G?ECU^\23GQ@[Z"63?>U/YKJG/1/9T,7,!$W]>9<^W&QM
M]*OC<?7Q4W,4D.T'\P69"*_XBVF?FXO!VK^OMF1M==',S-]BTKY+T6*\SZRI
M6TQ:25U]:MI>II #Y0W]=!6,QJS*4!K'_82I_^?[BP?ZF1LU)UKX-L%Q]VSP
MW_\V]V#*BQCV,_=?I_C1^Z]_"$>IELC?X;373Q78MUH#U^X-AJO4B;TYL@WG
MGW__ [X[@OLZWCQ)M@$P?^N [UX>8'CV2;(=GSO;9'?.-OSVY:#3A&LWSW<O
MCRZ:R3;L;_/=DR.V>_)W)W_W^Q^=@_V/^#^7V^=[6^\/@?@%%3U!A342\1@C
MTD)IQ+PHB(F<DHAG6[&'"$ZHQMA0(;B-\'\8O%4BC9=$%F2N%7LU^XV=;FFE
M<\^U)^O%_MW1KJ:+.3H(TP,_$NQK;I]]/54K9WBY+N'.[KNY)B;54=*]/"A0
MI&IIKQ;I@5=VB82=]_I^$+HK%!%Z:AUK7AYR+F@P7"%J>-[)PDBQ(B"%172%
M8-*DNGIGY[TY]M6H5G7P2Z-INF"H?>-M/C(%3.H#$+"6:9]=-#Z$_M>6"X.-
M1@I*7+FP^GT2BD%K<#;(UJ,4JW\-&L<!?G_<.&V;U,B]U4V$.U7,-.UVNC#%
M(N*PZTKVU@W!EQRODL?T?:=\YOQ8OO/DP?@'J26&Z;9231IP.?OY\<-OK7;+
M]"^J ;KR3:H;Y_HV_9X?.N"-C7<P4[W^I,/&J ;HJ/!G/^-]-IQV.  5&XR'
M-JC>.+\(2/D9V((TRMY(LAMI%;YF9V0]7Q.^P9N$KLN7#<*IR=, \MWJ]1N=
M/._YG<^"Z52N52X^>G&:?]&:@!^\01BDV<@3FBYZF^?A N;&'0-@38TBJ>,
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M6%8FE6&)*:$_LG(OBV[4ROUPY9X_/A(=+K F"!OC$7<.(RN=120R3*AG1ID
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M!<\[\,!.IH@XDFDA(RM.4IZ*!#!]DI8TID@^BP'5WR9%)^=IIS$66PY3I)A
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M COVXC"((^E\>:,4,!O;& TTL1(A%'GGZ%HT9=1MR:OXM,>WRBP<NM[5'4R
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M*=7FMQ*%N>3?$(^AMT>\=<\?BH-7(X.Z2U(T-HESC/]KM^@D\</L"8CCITR
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M/&H<F..V-9(T421]+:659AUX8"=3%!S)5)V K4Z\\I:5I*5]4M%[%ENYO$V
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M%("Y&/-M/MLZS>6;KDLO/MN_?##_*^8\*0!S,>:G-(K4ILI]-0V,EVB<(0(
M+@:\=G>KH\D5UQUU^19?[$4R9PL"L(MA/X;H<I&U#HU[];-MT8?TOY+.DP(P
M%V-^L11,B*3J2IUU.Y!'N;U(Z6Q! ':Y>KOSWNDV;X^ZQ*$A[)XITSI7#J::
M?J+][>\T-_R>XS-I;KAH@AG3Q;Y;O_P 4$L#!!0    ( *.#559C(D,11A\
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M-$I-3>7Z9HKZEH/R_HL;;7"^SJOM %DG_N2X"_XZWLW&JL)#ZB0.L_A5UL)
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M)DZ3CPF)0(I!EPZ92SXF)Q-X%6B/2^M)(2=+)%KMK$[&NM9GE_=3-"2GJ!U
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M,S)/RJ8VEU]_"".6?,5N<?)^$J:+VKF./OU:OS**B:R]M :8K.<<6=<,=F"
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M7V:?/ HL'7+'W,KU#[@X[J:UDFMY@_7T4D[M"9>U4!9D%):T@"W@-6H0A>7
M@^/Z^I%?R_VQ :4;-C[XG]UP.)P,TM.ZN<NOW4\;L9RT5HQ!1EE[JC(!WM3V
M7-JKH(6TBK4N:]_K H?4!6)(.VCX:'LD&^HLZ_$!O^'T&$>1<9:P4$PF92V
M<A9<RAJ*UX:CXNA=ZX$[>UW@ABTQ_F=##09M@]Q0I^?>,?K$0H@@HDID:8L&
M,J\2HBW2H=69Z];WC?NNDSBPHEH-.;X\,UEG\EJ*,, HUB7E2WK7JSIE,\M2
M1':EY-:7;OM=T5,]%-MB3_2JA7:#TB#5SJEF77WSHJ_1?.28MR&4 +8.H%4J
M6G+Y/0<A"[?(B@QFR 5;=ZWKJ9Z##6VKM(#5\#?,*I=J!0;NE8)$[GOM)J?
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MNC5#T-//ZW\B1;Y_^]/_!U!+ P04    " "C@U56#GME)@NP   OO0< %
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MCE99;;#U'+D/S^ZYT:DR[Z0X-=)$!X;LW5%?QE-?Q%*O%:.BN5/%N!J[2Q:
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M=)!N^AZG-%;,B^*]"R*'HI57D64>.=,Y>@;<<EK<T)5L,OK0VEY8CN08R-!
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M0*/CB**0E1M5))-' B._I; 2DLTB*RBY=8V9/1'F@6.J_?)E$S5TS9/Y%[3
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M'E>-OHLCQP^8SL>S7.XWESE4J2 J[ST#SRW3Q=6"Q6!8 A[06*LM;WYZMPG
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MYV9KN7=@S<TQ_8[3TU&^=F;12]Y'E9)C/#N@<9I4<T<40Z*M+<5S85N',ZZ
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MJ(&@2_3(HO#D#".2Y^H@LAQLT$YPY[!U 9@]$>4!RV<_/-E$_(T/A%[VQVF
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M"28+<VU4R+,;DF?7'RY^.WY[2T*$:7_XZ</<FG[\27!K!-L?%G<JDUOGR;D
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M#(FY/,I]5U^@+U[[3B>FTR?$';C6X;($4Z,,$G5M_FPRH.*^W@>ZB")ST[Q
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MCB#S#_GK_.KK=/;Q/KB;<T@BMTDA&9F!U1M'9B#0002I&/):I"5SM/5ESJ.
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MUA)O!!WHP_((LM_8O;_-5WFYO;Y6FKFZLIS3VORUX)G.()1'YIPP2;?.'GP
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MZ6T6K3O//0+GPG2B$>\/5<*WW2AVLIN_EVVO?UBW.#[AV4E49%C+;&N[/&O
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M@@1EK.ZPQ?1[Z^DWGX8:<'?G&9'L$;+W]Z/=1<EKE"%[7:]'4BV"$]D"NAB
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MA>0#.<:+::QAL3L-TY&[5%OM@V$H:O6-!L\P0-%&!IL$_;1UU'(OD+\TIX&
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MG3TUW4SQ/;Y(:L]#AM=$/85LIP2*:\:P2!=#<<I&C;&XC('^5_LD+9OL>=[
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M>;D943+AI! ^,08BU'1.^C @.-KI?$&)A0M+1M^HZ]V'ZO16>".-V U]-!;
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M+]1ZNJNLPTW5NB@^CM+U3>5_^5R;.$@IL]ED&&]F=5U?QIM7=B\^661E!]>
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MM+[_W1?DJS>0OFKIT#;P"/ @T'9D)$J0E11.L>0IXDP)LC!2F<)S,,US!,L
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M'^59W(7M8R$;;C][*J9ABUE-$+\?5I2C/"TK*=T-> =2>NE"988-B>)'"A#
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M2B.9&/])T\BRLS_4O;4*\,"74"5R5:F[J12$QQ$]M>-[/_2=?11F:*\5*WV
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M/-[F/I+!6^0]J5A[UC0.I/A;SG>540$?(]F&&X<C29U<"#N>(H5M 2.'#2J
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MD7 _V5);3C\SZ<1"Y(U9'TXCAK.\W"BF^7RNP 6P-032BF^/;.[X CNX#<L
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M];2'1HUF7%=1_N'OA^10RED%)0:\57\UU5_(&M (Y'^"53?Q_Q:LY'OD-)@
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MN3C_/H2.GG;/V7,7SYV[R,G,R,SY_[E06P!L%^@$Z 3HZ6X"SK#1T;/143L
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M1ZW<=IE9GI$LO\N[)3;AX]VRE!PQ"EX)"#>.ZA/I^Q"7P3-%H@)T!Q=>0ZD
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M8PP_H.+(H)^@-S](VC_+G%W'&X\-F87-(*H2%GRQF':%?^CV7<$?:R&G;PQ
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M:*+)S<1ZEFT6; +^NORZCAB'W;I:VU=)26O/])QG5<DG=O;IN]U"#];OPR6
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M3.YT7C]QN&^YR A<<(K?AZS"&! X/NBT>[)(G_JKAI,^4HUU?=*_26A1D'(
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M61)52L,F"SF-V_\=J+)W(9.U'0R&!"N_O(9577GR&'A8P=B+"HCGEJ#10"H
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MCFFX<=#3_AD7+H[(.)'5:" ))_1 -;$L?+=SSF,>-V?^+H5YW![\&GO8'\-
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MIXAQ(K/?&H=<$P@=!:^*[.02;PQ@4XT076KL50'0JW["6]'^7<]2)8 -(52
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M&$6>2X9:@)57:,(]KRO#G/RH^B1Y]Z+JD_TU3B -\!%)8TG<V5?ZI?)9^:O
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MI7DX<8W<B8@8\+B:9A+UENM!OS/<G(55C$N8P+?7H4P@3!FX:W:3"9!2EIC
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M\0?"$-1]4:.(_IZQ4,=U/&/Z PM<$Z4(_R4W]R!CJ &H2;C0:M-QNS^;>9G
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MM90H,/6^A0$I/4Z#_M7LHX!#?;P^0FIU?\5G<QG)&7W)7^QU>4U2] P5&(&
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MA#:,, $U)C!OH[\1LLS"I(/W.85L,AC#T!I(\]H$M/7;;[PPS> G$[B!5KQ
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ME.)W=VH^\]#6/[8&R?2 NIH>=$4^QI$W_*CY;]."8J7UI!][?5]_-'9ZI6!
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MD$(!MS.\C2T%MA2D<AZ.._:<CXFO!.W[W%AEBVZ-Z%X$X(!,_M)7-VAG$88
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M!9QO^?;II5[)J3&AN.L=W-K:BLM%BMW,SE8+%LCW;2$JC(UB0^K9L4U.A2H
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M_C-WS;=O1$$5D;'(,!:HA>V..*485;@@BE%[#A4!H'Q8(-7),*7AM78-<N:
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MW@K49\K7Y\G7'[ETF78M?2S?X>2Y?661/[V\;0YKE'^*CAZKO]ECJ/[J@_%
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M0;G7?IG^<R<*");L[WGIYYY0\YS,'M#L?JOE[.:$EK=>-4MH&G:0+(*T5E(
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M(IQ^4MA$H-;-\&Q3%%N$H?_8[TYV U[KI_>#(&*!YO>C.1-'-*&V!HO!QDL
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MZ]JR1V..,UV6&R?;,JF!CLY8LL/#$SJJ:^'K7FB+ LFA!=I#?\3QXQM8<+O
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M29,'1__:P[+@GDWO,W?_L",BU+DK=T#^0J(Z029#\](3_\-MO@RV0JZ1EFS
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M1SIYJ2[*)#3[:NFQ>PHAPV;U:T@K&ZV?$MFF8V0MG%+H8',S,4H)>L:D*CE
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MC.Y!P7="IWA["W>,(G6+.\+$$;!S*?VSB>T-\=2\RWN:_M"S5Z$<\.%%#[1
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M?>7D:"G!1_D=&P^=_7Y9KM7I*HSPI7<6I=A+[W&4,><$3T @T803D9C_"EW
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M.M$,[7UR#'/.BSN\PHDU3,SP7$G\<@C":\W41K^O9G%1MUK$;A,RO+^\%Q:
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M6P!&J>77V^L-M-W#@1MI8UFO7G?H#?(\JS8I*='D>:<\GO7/P=4IW:D5AB@
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M/K%.QN^0N>UVS8KP:=0G?".&)6'@P%WVAYQ^?"VA(P>XG4J&891XQM;JN13
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M@Y7/6V09[E\^YS9,I&5-DAK#.5(G:4X O(@%./?RR4BRTG\!HI*-S4GW58]
M]^C[0H-0O:[67]="E0_;">^K=$_Z6GAWUNB0P2,4[N+-/3)WAB$#TR2+8'B
M!W7<EC]8@7X:4=H?#E";B 24PNJ_8QKC-7C1HV]B5&POIN_,S5=O*3BJEC80
ME,LPPII?DXJT9>OC6N<2>C")XG- /++9(XZ91VL&:/M\P,J4],+R(<OB]A;)
M;7F'%P.#5'ILM-_W9?;\.'\IL^5&P-\%E@LWS\H*-B)CX.H]-P-9WF 6_NP4
M[P ^9!SOS%RB _'+-7\< RN6#IW-DV/JE5G?UK^>W'\W]?FP3&8%72V[B"U
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MXN)G3GVT,"^_$G!WMAK'OM;0&&.2Z_^8==':1_NC\\"L,@P:A9R+S(3.3Z@
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M/@XYTS<1*6WF57Y.ZP>'O)\6YFN^C#\O\&)03HR$J]@M\6^,VS>,%+%3"0@
MML&ZK=U8YTC?.]N<< 4B&S_!1>'"WG.]DG4SR2>KK?(%GI\P?WZH\6ILW8+>
MQ9RK#AE;G1E[Q&=">"+BH!++AVG;A8*TM'M75#B"[#/0R9Y9S8\6;H&^UYZ]
M99FTK!V)V?[XF4NE#O; UZ83/V>>Q<]^.RA^C5NV5?D7VF>3 6LG%49P6C&5
MW^(:.&H@CFNAE:\E-UK:.H$U'4%RCH3)]LBUC0MO_L9=\TG7$:M__^M9^X1-
M5CW@B9F987WCPG!)*R\^ /OW57@I:-@ZL+L;J;N^,A>ZL<FSRN"/15UB1==R
MB\05U[[3>QU5.G?_?3!CY7I<37:>Z)^1:E;9C8&.VM.H/2HGZ4(I!BNK1*^!
MGJG&-^(.[K:.(R79SJ_T=6=<+<BA\V_5;>TQ1]MOOU6Y6/!G6)SWWD.-VP*G
MP:^!E?FYM00XHL>U*^/<:&G]W63^3D;0 7?3BTS!"<XO>V)59!;=B3$Z>\3'
MA%G>$_QV]0/[1)P>W]?9K:=A#W@48J/MLO,]-I;W=E:/R2MBI+2ZI6'IU$XV
M<CK[RF1C9*!#N@_;,F>VK.">T53XP7\]+6L&#]K\3.RX%>\[SJW>$@$1= 3$
M#):]&;#=HL3OH/A-5_@8 _K2?9B=;1%TT6IWS*GQ DW_H&^O7N8=HOR-^Y7R
M#VG VOLZYBH-H!63MBI\5P/@:2J?->PY7?]I.=C+[.\+1 L%R)M@A'G[(/GS
M+;&V$T:O?"/VN)]@$+]\NG]8\LV'WV?V)CY:?_>=!%[ ;AW?R4LF'";TOIX?
M[LR0Q?\SV;X;[];"].VMP73,*F3^7CD@=,G%:?J1=G%F7FB:/+[O"%_VPK67
M_$U,[ J<1PM*<]/S.N& CEP19+;2IWHP*1A5@B&ZA*/)E,NA+=Z941'J'G&M
M&9K_,__@H4)9<YK&],T&J6&CXZO*-]7'.*)!\!C&D"T;[T?=96%;T\MT8Q&9
MR)B%5Q.<\!K713.?&KI#F-:#\M>]/GO9EQK?JR$B=KZ_DJTC^8#G#E_ZDIM+
M#,A(4T5">]FW"5U6<JIJ4![;"K? DXK4[72--KD=N.$^Z%BS\DCZAE=^EDYG
M6O.KD_LS9F]<6$36K:\DL:_S*+S#(TU825X7P0P2HPT)>Y-Z&_#HP#O U(%!
M<9F[H6G/OJ$;GF<)S_X\+D?XD/G$M'!O*G\:-P?P%Z=D\T0J0: ?:$Q8GF;;
MNG'TP<B,-&.,.$<C9J KS+62->BT<Z]9\;.I@.41])'(7%;%E](D&^^P&^1T
M-]CX/5&!V%04:)N11FP2C_I-$H20<Y7+?Y[_:%>%2DH"[LKVE5<VEU36ZXVZ
MB#?]<\U%=KTD[\,.IL6-=,3=4=@0+T!*<Y4<R4I;*('-Q_'C%O'4H(:.L.(C
M[5,\$?QQ..NV^S,0=,&^E=)]MM7MW-"U4*42S5J!X*T:2FTBS];>00T\82X,
MU;0UCI0HZ\78'V2LZV0-LY#UG#F<A+_,VP;VMK#NO[:@U/0M!9G8T;7XOIY0
MF'\(Y'TS?V+QZ$2''!"$GH&%4,[>!R_'K!TVRL[+0OT&?!ZXNS.V8,Y:&D&R
M,OJDRO7A\_:7YXN:3NY_[6[1D"#9O=/Q'XU/%E1=?'L<^R9A' F>'_YD,%?9
M04HG2A-,(&D/*(2)F2-D@+]Z &$CHN!NX(7T1>D(4Y.-QJS\-<W[Q^:_E,8?
MW;WSI&*S_ =X_I4H8<!/G"+$$Z. 6Q6X22Q_*.X9WJ$5S(AM+"3MR!#Y;&T<
M]R%WXTY>,3YK?]?3]I/[7][61/U8%[S='@T;4NMHNSYO'"6*\FF&^-A'\+9,
M?6H\T5]<%,?N>1T*Q*Y>*[0?A>-J<_EPT<(SG<<647K[71[AY[YZ^2":V,<)
M4U3P/!L#Z96AP+/D&%43R!<+8[H47N@5,S[ZV8]BZ9<?XE>>*:$:/?COK#VU
M$SFNG2>C-:%Q[_XOQ.7I=-]E%W@.?-QF @*6H#4'CH$"_;""RW#K7;/[B[OI
M@R0) A)_&61%&3W]HZ^HK1NLTOO<ZYG,]"$EFXN4,Z*G%4UJW5C1T$<K97B
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MYK$*6T.JWSJZ4H,9L3/:R;RJUO[O,[O=:FT#+"=N+!!(I+CQQ-:G4+0')#G
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MOS\%[MKGWID(88</\+7']HGJU[I/]'17=/?L'L?$#06>5?2HR#))]73YTQ\
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M-2VW1:-HM*M=M^:<T3B,?!BI^J(HI@BF&?*A1R/$ N$AW[-B0%L!EL:2O<0
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MF#.K[>RS72Z-K_82 Y7V".8%H*W0EKO4Y\$VW'YV"N'$S#1 3TFKLAET\JY
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MU>VJV3&#9+L=^A5_UP&\G^[U#D%Q\X'+]C_DF.C$8G(@S#SJD0"2!*G3!9A
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M 419EL!4Y9KQ/28$#V*$XMBV!M&9/I?VBNNXM6H780JPEM*^&-$YJ$U= *<
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MG0#8@8G,IG_S C\Q"1M%1.^$U[4RAA'2^\-VZBC)\3AII3Z0,+Q,E/1I"[Q
M=/0S BTV*OHT@)=$0Y]I>6QNT[=WO+I1U4&K\O?F5A7#P,7#FI/,XWX<0YQ$
M'D1<TF\F8@9CED5I'&6IGQH=E3O3S](XM<OIV<L*6F%!)ZUMQM/CT)ZF38>
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M7J5_6W,>^&D<^9#Y.(4HQ#[,$%*ENWGLQZG H=J@-S_[.ZVX5MPUPQ'@G3Y
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M$TER@GD0^S&':>1'0F1AB'!FFWK%A6!+\]WZT)Y=:I9<I\MQ&LPU<]C6?]\
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M':%<>/5'.S;0V);AO:P2"]4S.^<LN6ZF?@C*>EX6.[+5H5;H:2J"%0D],LS
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M9@Q70:5(*,MP[M7+Z>A08U/X-3PPVR'^5\\&3L=I=5/*8<CJ6;$>*GD)OC=
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M*=;M ;'MC#-SV!2_U50/[P^Y? +_G*Z1%S$#H_>3G)ZE$;I,C@#^TWI/3D]
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M8+D]^R,,G-9S5,3]C)[CEU[8/OK3_&FS7GU6/]0LKM<R'>'$&  9C%">&8.
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M;K]-@*R1EFT^-RL)GM2R*H'HV.VSTS2<UHM]D]NS,FQ!KYI[M@)W5Q/0P)^
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M6AE&PEEYE1/33%Q295C9PS(J9YZWOP896>B.G"UTIX_>-B^.WJI%&F8I)ED
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MU8 3]N\<H^C++IZC1AC9<*+K:7_L\HUD24:C+(:A##.(<HHA%H3#)*8)#X*
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M;Q7XM>X*7">BOLX5;E)3U_O45#:#K&+[;Y$9T<[WN^'[:L11GO)5&^J\ZT$
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M'K06Y*;D8H$D%9)G&&*&%.<'5$(2I3G$,2-9E$9Y'AD=;KX>>&Y.MY8-:.&
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M;R6H90=*>-!*K[N*@DY#H%34#0$>U<.UJI;QBR.7SHQU)U@0SW3;::##G%Y
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M _<7+3DH5K_V#H]]1._8(^:N^9;IQ%-WYK($Y$C;+ML1+HWL::][D<@Y3T4
MTTS73DOS4!N/RL<,*45I+'@HT;AH'OM[WXDC>&H!QT;M6-Z6CP?%NTEHB,<%
M$3F>[K!?#?]&D3?G;J!//.>TAOB[HGIJ.V[?RM^V5;$25;4(6!3&-$EA*DD
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M7X/1E.]W=1QO#9Z$?9,MQ"_PI[8:S[..;)/>3O&LW(0_5D^DX$UDO>X!U_S
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MMNM>^6W&LR2+!(*$XP2B(,"0X$Q SD*6AQE/$D;LNL,<G6=NQ*#%M&T,<QQ
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M]5I-N\N#N94[\NTN0-__W(A552A3XU-1;1:8!ZE(@Q0&B >*#[,08I0R2,-
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ME]NGYB^"W\K?GK^1I?A<;M0_L2881/WS+A:DJXZ'\C!E.(=!F(00"1)!FO)
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M?B$LS[]&PSAX F8_ZH1G8*-5?GD*-GX8^XWFFC&QU/N=X-\>R%I\%4_J._A
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MF@00!<JG)['Z:\@XXC*C81P948S%G'.CF?\57:D)02LXB/Z6!/\;-,*#6GK
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M.0 M7 $B$"&<DS(J%5PQ]24)7+N\9YFRDZN377;+NZ(4BU6Y7:NYU))A:;B
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MR1.8)T0H'LF$1LX]*@;4<VJ\VY@*6EL!L[VMP=Y<Z[5J;-BUL02-R?9OC='
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MO;K ZNOK:0DS9F[D-=XXC-5VBF_ WH 9V!D(C;+0FEB=0FS- B='S&8 6=N
M,2X<)P;%.A!WAM%I5(X-"N-++@[[\)Z<O9=21>-M2'^MOBFSIO^NZHJ(3:T4
MK'+!,T4@2WED,Y E)$H@&*%$1RI5F59>J=S.DJ>V4.Q^T74JSH'JX">VMNE\
M9AEI!\ISD>@^'HZ<.P3* _/JW?W;#^!N4[>'JT+TFQ7XQ-;#%++Q1B@4&SK+
M'9?Q?.$X8C7O!_@QEU3%_&XK"S.J[XOUXP<Y-]#&*I8<8HDSB%0601)E&&:9
MSJ@F69;2W(69CIX\.>:IE0-6._#AG1NS'.-UF3EN0F%H9G $P)D$SAI[XB,O
ME?C;P^K[OYM[ZN_;_+#_K(^?-,IG>]: ]K,\?X'_9_>N.5%8G1VNJB%_5D^K
M]69.S5XM8I1 D1-;9CB1D&'[02)*99QJBIC3VN"2D*E]C*V>8*\HJ#5U_R[/
M GK]$PT!T]#[(W^$O#[<:Q#T^H;//G2TS_F:6=TO^^JU/?/KS-ZB>%B^M;[^
M]7-;RI+&1 C.(>6V;V>&,.0*$7L,")$\83'*D5=.W0DA4_O(&QWMWAS<;3??
M5FOG$^,7L71;O-^*T,#?]TEP!EBA7X(A5(+<*1'C)L5=,/(H$>[2M?[3^B]F
M!!:?OJV6JCWP)U5,TCR!0F:VPC:)($UD!AG+9"3S2"294_;LJ8=/[0NO] .5
M@M=.SEP'[OJT?0L< W_.'DAX3=/G3.XU/1\];+1I^9P9W>GX[#4]6_\56G4*
MGM4%D=7]^@U;_O/^CZ62=31^GNHTB12+86[^#YK)6$,:IP1*36F69)Q@OSPM
M1[F3^Y2-VJ#8E0(4;84XSZYUCJ"[3>$#0#DT#5@4=RK;#*=&:?/J JLVJ/2>
M-9E, ;O;^4$5JM.=H]1QN][Y07'4 <_S]AM3=&JGGG5VSR7/(IFE"$HF$XAB
MBB%5BD%,A8CR3.>1/7>SVK"%&Q.=D.'%.CM)PWTO.W>_'<:V$\=JV3<QIP.F
MP(HB'"4PDYF$*!(4\C3B!E81,<+-'Y'JE8[3$\PQ2G;O8B<+&SL)CZD;:]^(
MU, ,O4^NJ=6[%FCJGU!S;'[H-)J.A-=)GCDV\6S*S(E+^S'G1_7'G1"6@LU3
M/ZU72_.CJ/,L/ZT6A7BN_W??.4Q0(9' $=34K/*0U!DDL9(PUX0)G7"5Y$X1
MCKX*3(TF/BMA=%T\@SNY>K)QV+TUX.=M(:OUGSTU4U]X\L\?5[8R]*9]A!^U
M>(^@&^\,.2X#DY)1O0OSH?(S4"L.?F_^&[0-W*WH!>(T;_&C$EY?<%ZR8>_G
M^)>5O4N,H;\6BX69^M/HBUH6J[7Y:E7Y;JONQ69E-MA)E$:-2S7C-#9O*3)K
MS<RLD7*50Y(C 2,2BQQG1*7:*0;E+7EJY/AOR<P(!(^U^B#]6Q3]+U#; "HC
M9D!N%6CL '$V ]88]SJH?N-RF?D&17M@RFN _G4/]"'.!S!;"Z[[QF_$VKWH
M[&"8CU1UUAO[,"5G>\%VH>:LW_-&*SK;R\QNU=E^#[BA[.S=4E;.U_^]71>E
M+(1]^YJ/(DUM9U#.H,;VP#Z12;UXCM.(IIS*)"=>+?BNR)O:=%"I6Y=-K1S\
M78U[U$"] +3;&C<@? /S^R7D!@AS.@(3LG+J!6GCEU&];OK)FJH.M_7CE7>J
M;H_PE?U9%QDQ/[2_:\[Q?U:V+XDJ[3E_(=9;MBBK_^YK:A>JG&>)R' ><YCD
M0D+$8D- ,I=0:"EHKF5NPS->IQ5#J>;SL8USL/%798;0?&MBP8K'<M\>P8^I
M@@V=&Z6]QG ,S'VM^G5R1U,$R?Z\^T-CV RTIM5E2AKC9J QKUNL.QQ7AD8\
M$*D&4VM4]@T-YDN:#O[\?GS^7\J>=E3RSC 9>V@B]/>ZJE59WF\WY<:\P,7R
MX5VQV)K+WA6E6*QL;?FJ6O<=+ZMH\EQ%L4(YR2"*$V26DQF&U/P;YBH5.(T(
ME43Z+"?#J#6U56=K%6"U66!9V67K7MCN-JNVJ#%8[2W\#S^2#S2>;A0__B@-
M3/"[ 6HL:E)^[ #51H&.5=:/;KC$?(=U<9/?6X,"+G_#(AR(T ,I-2J=AP7R
M)9D'?GK?4GU5-\!FWRD(RF4N$!0"8XBBF$*6H02*!.4\RC,B<L_U]<'SI[=(
M_M*G&>(A9HY[];XX#+TSK_4:8A-^RN)@U>ZZSQZYJ-T)LXYKUYVZR#]N\RM;
M&F:0;PTC-&\;2V,6$[M(PLI\H2PED&<9@W&J4YJ2&(O$*9/EY-.GMO1I%/R_
M_Z\XC_Y?JV;]D[O/_QB_ZS&4FU 9^&MM= -6N1XAD&,XW,,<-\$R4BCC2,<P
MH8JSIE\(1QS?,UK(X:RZW;#"^8MZ5C_8-2<NOZ[:-:[ZJ#;[5)^OJ[>L_/9I
MO?I>2"7?//]6VNK#NYR@.[$IOM?U&MH-!9%12B*D(*,H,F2G$LAB;,@.)URD
MA'(JO6J/#Z'DU#BS8Z,][+]NK01+M0&J30HT?['_%L96\-08:]NGK'8)<6QG
MJ6?9A2%>!+<UUFL/[\#D_V)D=P8"8^%A_J+]L[43?.H,[0_65E L?^ST%]W;
M.\A&=,@!"54[8@@5QRTS,2#(1Q4IAI35;^+Y>;62?Q0+6R#Z92G[_8YYGSW(
M=9HAC3F4.:40$8X@8\SL<'FJ8I;$<::\0MA^XJ<V6;3:5P&'HUX-?L3O.1!N
ME#X<O .3]65DP5YY\/L@&9S]@ M$JI["1Z7+?L"\),*>3^GIH]ORLI %6S_?
MK^O.7[^JS;>5D5SU^%*VXMF]_K(QDMX\'U_<7O;5%H":"YKB"&4"QH(Q>ZZ(
M0$9R"DF>\4B)E!'E=10FI')3H\>]NO;$7M,_L#8/M(K/@+6P<O9;&ZL>A*=N
M:Z\WW[LUU;=I<LA7P-%C^4H#.[3#\S7&U-]Y.@#XH7RO(54;UW4[ *A'GM\A
M9/2;-LP:W*RZ-\^?S/N_,1.5E?!DU^XO3]1$!$>4\!PRE*80B2B&C.<19"K7
M*L9*D\RK'J6KX*G1?:NW^?Q7>O.'];':U=M.?3_*=H;?C8Z' '5@JMWC62E]
M".8X!YE\40O$D<YB1^4_7S!><IOW_7UYJ\EHJECR$UO?KZOT5/F?;+%5G]2Z
MBI#/54QY)@2#6!CJ0CDS"UF>$)@P@62$TD3X):.[B9T>9[59A*55>P:>V!I\
MMQI7_<ZWI;3MS^L4(<\"NH[CX$I?H=$=G+Q:8+_4P!J=[=*OUAI4:@.C=YWC
M$Y*Q?( *QE=.0D=F*Q\@CKG*Z^Z>5864V?&KPT80N[X]3;]N>T[G'XJMWYLW
M<RY43!@C$51,VI461O8 30(I0C'&1"1F >957LA3@:FQEWD1<\^:0KZ0N]'3
MD$ .3%2UZK-.5*=I%+/3?V;C0=RP%2OD#%@3@+4A8+VAGNB%*CSD*W[<"D0]
MP3DJ1=3W.?VXK8[H5)QIG[P+Q:8IQECJ""99+B$BBD-*.84B1QG%*)*8>OD/
MS\B9&E,U\=6=GB[Q4B]<W7@J %H#TU$?H+P)YPH,@7CEG)11Z>.*J2]9XMKE
M?;-[9%42F2WL'/)A^98]%1NV:',2%4\S%&'#!K9K ,D(I&FL(,UQG.4XQRKW
M3-.Y(&UJQ+!7MII?H=ET-?KZYLU<@M@U 280<(-GLIS#;(BN)"Z@!,LFN21K
MY+00![./\SM<;NK?[N!]4=JRKFI=K.1[\[MR+C)):409Q,@P!L*VS&&>)E!%
M+,H81BGFSAU'SDJ9&F?LROG7FH):55#IZM_RX!C4RVP1#*J!6:(72KW:'IQ%
MX::^!\=/';WQP5G#3G4^.']QOT5#6X&R=;:\864A=NM=BE.>*I*8;UYKVYP2
M0<,#"8RR+!=Y0C,L\'RI-FY+AHNRG-[I7</)S< ?_\=N'J[US79/<0+VHEG7
M6S,P:JEVM8,-.7L>[KP\#&X+B]OA'8<R=D5/=X[9&:AT'607XH1*H)7%95FC
MKBR<S'ZYLG"[R?^$5/LP)6UW-+4L7_9;?_.\OZ3QDMS]P=:RC;<;#2KV*ZL6
M:U^_L>7]4U4A]^UJ^5VMJYZ1S/SYP[)FQA>G-JL_OC.[K?>L6%>^Y7F4<I9$
M#,%8*;,=DH)#&D<,RM@0&\DIT]BI]_<TS9O:6FIG!_BA3[!KFB ['%.;GM(3
MF@<JRV%E.NC" SKX5%E=G>L:C$ %TFR?XK7#J6E1NC%(@08J6]._ 6L&:KB
MV<S6@,W 466 ZA)@40,6MCJ*^)=^4=T/$$Y/>9\7=J03C/\S7EROTY73?2\N
M'.^<H-*CG2^=H.TO%IT3U_+F(GJ=2DZ?UNJ)%6WQIW+.<"*1B(EY9:6 *$DH
MI"PU>VM,&(T%C7&4]*Z0=UZN#Y6.4]FC41"P'D>9W*!VVSH'AV]HKUNW7%U'
MXQEH$6V5'J0&W76,PA>8NR#SM:K'78?A0FDXAYN#UGUK"A0=%2Z:9PE1'$D-
MN<0,HBS-(&%I#E,1:X$SE2<X\R,C3PVF1TN-IE5R9EVWS3,KTW<,%)-293*'
M,4T3B!!'D/.(PIB()$)11M(X]^DC-> (C-%CRKF:GDU6?UIMS *@8 L@K7G%
M=W6^Y-YX(^HV[PPX3@//0%[U]&:@L6CP\GG7D!NV3MY9Z5,HB'<-&L?*=U<?
MX^\>_GF]*LMW2JQMMMR^G@A/",I5JJ#,DAPB9>8DFJ<QC!*&TPQ+$<72;6(Z
M+V1Z<T^E)Y"MHHYQI LP7O=2W@[-P&138[+3T#NM[P(Z[JZQVU$:R3W5 RTO
M7]!E("[X8\[<.)I/Y++B7;_$E2M[]';2VEQJX\6VF->=V/Q:+(O'[6-3_]W6
M9/EL7XMY$J>4YUD,28[MX0-FZVJE%!)%%(TYR6(>SY?JP9Z2N$YZKF+]@N][
MX<.]Q(VBX+$ID&_[8X(JM.[13,@5].L4&13(D?+W=BK7E0B-TJ!%M6T[8/4&
MGP="U:,[TP#HCD2V)U">]8'9KRV3)UZ7.C*Y/FJ\9DR>QAWT8?*]MY^+Y<VV
M+):J+-^N'GFQK-XP6V?K85G\2\D/TFY'=<%VQ6;NQ/_9%FNSDEYVR_N;OYD7
M5+[=KM?FALX??EDM'[ZJ]>,[Q3=S)DF49!F%<8YL,Q4J(+%G_RE"A&FA2"*\
M>MV/I_KD<A!J;<'3:ET%Z\Q.=6'4A4;VHUEO<\_* 2.^ VZ^A&F.[,"37&LT
MZ%@] WN[0=?PMJY7:WK=ZVIO(VBLGX'V73EPK5L(H,4 O+OTMGB[,L8?N$!>
MD!$5']6!,OZ O/2]O((&_69"&[9=+:L K*Y/-7UE?S:!C#=JJ72Q>;NRO7.W
MQ?+A?M?8?K?]CI',B%8)S#-JIK<TBB##BL-(\Q0S@C477O4A;M1G<G/6SAP[
M736G]FS,KS$)_- 8]6.5*]+8!?:&]3X!>>O NLU9(P[7P!/1*"/E/;4$PC?0
M?'&K-J-. H&@>\GLH1[;PP45DUV/V@1EATUJ?S6/^F8&C#1'&:,<J9@CV\$B
MC2"*4 YIAF*8H1311#*6NW>P\!$\-0+^MWA&.GV7D[^A[$3CY<H(8*WP<*/X
M#(>#@VH@D >F35]\^[04]P':PV<U$.!C-10/]6+[.:YZ@';)>>7SN/$<6#V,
M/'!B];F_9]%B\4W)K2UV>?>=%0N[HWB_6MOREU^4V*[KW8+9B53-S.8T4R35
M0L/85F1'&8LAIUI S%F")4MUG"G/QF,^\J<7J[4;*+#7= 9V5D"]6L/2UJ?]
MW>H/*@-\RPE[#0[)M(ATQ*%.:0Q1G%)(B=*01EA0@1.61EY].@<;FE%J0C?*
M@WO=U/^M<^S-!MGV[]VL"V%S5]ZIIU59F-^_>09?C1*C#9;;[FBP(1AX4K_R
M67QQ_BS\*S+W02Q4R64OV>/65.X#RU'1Y%X/Z1M@*18VJ<A\K^V/'QYM"Z3J
M4$#9+-:(3-.,$@H1SC*($,H@S1&' B4HU2K%1'D5ZG.2.C6J:S6MDR&+CKZ^
M\0P7R%U#$8&!'#R*4"M90;C[1U?E 4K>>($4S&/O(G-D9[L'#,=^<I^;_4OB
M?!!Z?;>5A1G)NXU9@->[LO<+]C!/8Y10)3/(4<X- ^4",B85I#%&+$E4I#AR
MK8ES7LS4V.;#V_>?0:,JZ.@*K++N57$NX'J98<*A-3"E] /*JS#.=1QZ5<:Y
M\-C12N-<-ZU;&\?AZI[1+59^>U?8'FE+6=IB6U]7GY@-IEDO+EL^S]-$XY0Q
M F6F;64]%4&>1!E,&2:<)A%/,L]6W-=$3G 3W&H+[!B"LFV74:W\UVJS75>Y
M%L5N&^89B+HV!HZ1IH"X#DP=7WYZ"]K%]@S$"8S0K.X4N8?:6E#WEWPH;&3
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MHFQ7%XN]IG[\> Y/-\(+@-+ #%9I.'!-TBLH!"*D<U)&99@KIKZDC&N7^W%
MN=[,W]HLIV6IY/MBR9:B8(O.'O!>URG3-H67+9_OEXOG??.).UY6L?XYQQ%.
MB5*0$FZH0L<*<I1C&!$4)9@F3$FG_5L8=2;'**U%8&=2U]URT*BEM<%Q319H
M_"Y3T_BC,C"#A1T09W(+B^,E#C22.OQG_K7GOD!*C$*180%KF33P4_LMNKZ:
M][%HBT-],'**M?6TF37?^D&5<Y[S*,NY@ F*"42*8<@YXE!DJ8H4TIAAK[77
M97%3(\R]@D#4&OJMP*Z Z[80"P?9P&S6*EJ7T0,=\-Y> <][6>:&2:#5V15A
MHR[2W Q_N59SO*OGMJVN^KY\^*7J!KM[NCT%-T_26&0XC:$A"EN-(8T@BQ/#
M)!)CSG1*J?(JQWQ)V-38X_/];X!5GT*QT]-W"W<)6\=]7"#$AM[,M6J"2L]9
MESZLJ@&W= Z A-K771(U[N;.P>BC'9[+/3U3%FR#GKHUS[OMVHCXI-;%2M8M
M>WYZ?%JLGI6J+OID7K!O1OPG\[:4\XSCG&G-8*P%-LL1F4*28@0302,9,97F
M>>Z5LM!/CZDQ3:MIW:P+/#6Z@B=SU<TMN_J.E6,ZP_ C,'0Z0X5Y;0*H;0"U
M$?L&8+L!JB]N30&5+0'S&&X#,U0>0T\MQLUCN VJHSR&&Q]W:^;7<<5?)1WJ
M_58Y-?L,))T+I6S-W83EO#F,CD4"4\[B7#.=QSSNEQ$61+^IT6XWD>E$27'S
MHV-!\;[Y96%&W9&H7V\LAR;P4,,X4HY:4/R#YZZ%T>Z5<MJ"0GL^URVLF)M[
M6N[<[S1/N60BAX10:?;HQ-9.S,R^72').)41%;AGG\JIQD2ZG[%OT.,2E&ZD
M>B-  Q.C)S:W-'ST"2IXT-(I":_5F/%<&,#ETI[]AUA9E/?Z3@A;:M$N2JLB
M:R_+^^$DDEPG%,98FE5?@A0T+*"@I#E5/)-92KQ6?6YBIT8$E=9V"?#)/+4]
M+^/9^,<-;S=J"(_BP&RQ W"O\CA%%OV0"M75QDWHN.UHO( XZB/C=W?/GJY5
MI9M[_=.?HLHJ^\PVZGYI>S;8_[?=([^SA?63?U:& @MA.[&9/YCET.$O.E?.
M,:(Q2P6"DD<:(ATED"?V#'^:49*FRBQAD%\UF@&T]/E0QSGK7QMI/UC5F G6
MMK]L_;/YDI=5UYE9W7M&[4V95?N?]<[2Z@+/'K0#O 9NM/K*0SLP!^_'M+4/
M6 /M6+ZMQK)J=O-3=RSW9C67V,%]\<O#.][6_9ZMGW/7\3ED<]WA1BA48]X!
M-!RWJ>]P$!\U!!Y05+\IZ--Z9=[:S;-UP&Z,'/OD)QO7^J@V<ZERGD>)@HEF
M*41FSPO-GE?"1*$DQ9$44<I\UL*7A$UM!=SJ.@/E2F_^L"?=+1>H5N496"K/
MW@(7L<YRI"CE"B(191#9+0?/90I5C'&2$!E5#4O="S$'PWJ$2LQC8^TV.89"
M<.!9;@]>I6B%W$][Y#Y>0,Y[-G*!)-"T<E'4J/.#B]$OB=[IGMO"7"O]OE@6
M&_5+\=UV==MTLYK*]UM[GNGNT9X+_%>U)FD*9;Z(=J19HHBDAF:0(! A&4%"
ML@AJ''.6Y9G.6=HGQA5"N:G-"-W(".LH;W8,E?:[OO*;E:T4W^;_54E/GIE.
M0<?8+Z(U]LB-&,ZJ#8.596!O6A/0FH':.M UKRT</$HP*R3T@2-9051[E3!6
M2%#/Q;""RK@U^>&"*KMX6OF)K<TVY$2SY#UMY)%@*&(4IGDB(,*40!8E!-*4
M("I9IB7R+6L<6L?IN9$.Z(85:_"?;+%59;4H^R]5/'RS\\.=T84]*/!;J?1V
M 2P,)="K]6'[]2."VD7<^R9(A'HS?%,D7F&T)S.K=-(D2MOGI')'M5:"CIDC
MI4L$'HO@"1.A]'NEE(G \)Y/F@@MR+\>Y%Z7N\5B]8>M,OU^M?YM*5:+A:J+
M\S?1D_+%@A2+),=$9!!%.(=(YPBR+!(PI<3^5\61=FI*>9,6D]U=W&NP,P48
M6\"!,6T\T7%#<=M 72;ZT> ?B\P=D?=AZH"#X5XB<Y1!&:F2YI"#XU5_\V90
M+Y3I[/_LT:IYWFQ^M^CG[0_KV]Z%K=4;5BII#Q&;/5CU\MZMUS868U_F-\_[
M2SZQ9_NKNS_8NG+?;9[W+5O+JM[#UV]L>?]4!?R,^EJ9"=E,QG6N^YP)%,>4
M)1"KQ%;09Q)R$N50I%R8716F0B7SI7JP'J.O'@ZV\4QP8@-:L\&1(<,QPD[/
M&P[QC/@>.&Z6)C:L8S6I,2;!RB;0M1MT#*^JGG:N:XP'E?4S4-O?Z6==@KH2
MSL9  !H,9F#_TIAWIL8A9(^;T0<O6&N<\30?N:/.Z$-RW(AG?!5Z)K^OE@^&
MN1]M6_)YFG.F8HH@8I&"B&,,28X0E#3-2)*I&*6I3QRZ^_"IQ9VM;M J!ZQV
M,_#5RO3,=N]BY\;U?1$9F(P/P0B8UW["W% )[=U'CYO)?L*HHQ3V4]?T^T)_
MWC)#&QNE[OFB>*ASS.J2E>]6CZQ8SJ,\Y2C*<A@I&D&D)8$$)01J(96644Y(
M[%6]_IK J7E/&GW-MK"C\ PT93U_KY7V/,AR%72WSSTDE -3P(TH>E.#*S2!
MZ.*JN%$IQ-7XE[3B?%\_JC$;[^WCMDIDJ-8=)[J$VY(7NP;V"4<4&>J!4:PU
M1#(BD&O*892@!%.%%.+(AWD\Y4^-B#KJ@U6U$1%= X!BZV6Q?"C!#PMCA>>^
MU7=LW AJ0,0'YJLNV/6N[T#WMCWT#U;]'ZM4.!M],S:$H[">X 5B-%_IHQ)<
M3VA>\EW?Q_2COR;=^EHZ]HN_U\>"YG'"L(BR%,98:'M..(-<Y3',<TTCDE"B
M8N[#A;<H,S5B[!RB>*>>5F7AFQ-WT\BX,>%8> ],B]4A%9MQ<O5\RYFKQCBG
M& +K0"QZDRJC4FH(T%[R:Y!G]EQK5OD*;25V&J=)E$L$N=#*L*<P["E2;,@T
MC^,8R11'B8_GZ>#I4W,]5:XF()JJ]GURA _!<USJ]85DZ(5<DX$;O&+]28-#
M+;X.GCWNTNJ464<+IY,7^2?Z_&PVE7:%=;]\5Y35S%U58V[3BG:[#:TB%:$,
M0XHEABA6!+(T83!-4[/NR1DCTNDL@8?,J2UR?K!Z_V@/F$J;U+DI[+:\K(XO
MV9W'YL+.HS?LE[_\@< <VA%E-&ZV;:"N_-ZJW4V?=-K1]<;5/=]F 'Q'RJX)
MB+-7,HTG8A=29UR?-%JBC*=IW;08WUO[+;KJ+;-YCBH_L4+:\Y"8QTJPC,),
MV5-@7#+(2:Q@8I@\U6F:Q)CXI?H?"_%Y^\?)U6^\0QNK)'@R6OJMOT[@Z+8(
MNPV;@9FW :72#ECU I\@/6]\H%79"0&C+LW.&_AR?7;ARIYG^>LD IL?\(MZ
M8(LO:K-95*D&Y9PD&FLE--08V]850D$F409EG,<L3FDN&&W3T=P^\0O2>F2.
M#?RMM\I6QVP65EU0[O3U/%E^ 64W K@5N9'.E7<AJ_0$'44#GBF_CD:H(^47
M)(U[HORZR4<'RAUN\=_:V=7&3TU$ZFZS61=\NZD2;E?O%ZL_OGY;K[8/WSX:
MHU;+C3%P476B-ALIL[692ZJRU.889#JR#5YU#GFF&52)2-(,HXQJIT)Y-^HQ
MM2V@-07\T(;Y?@2L8XX]&:Z-06!36P26!R;94^.53>Z;F5L&\/K&<:1A&9C(
M_CHCXK[E'&ED1MJ&AA@AP)69J-1%'XO7'C4 Q!?VK;<\?;2];  (NOO;$(_S
MF^/VK=*_/++%HMU)ST4:)7F2"H@Q$A#1)(-<1]SN>GF,$R:3Q*ESRIGG3VU.
MJE4$E8X[KXX;I9U#\/+D$0"7@2<%/TB<B>.*X2<6LJ42?WM8??]W<V>]AC4_
M[)>NYYXW"@5<,:;]M*]==D/_Z[>KQ\=B4ZURJX-@<ZVYB%)%(>.:0B2S&%(5
MIS!.LDAS0[ T4=[=KU]*F=KGNTMM:K5L#CEZYK.>1M1MRWHS3@-_SOX0]6M^
M?0Z"D*VOCV2,W_CZG)DGVUZ?O;C?A_]9?5?+;:=Y0"15IE!J-IJ$V9.4F82$
MYA)J%,LT4;GB6>+GG7XI8GJ^Z5;#__#[Q(^P<_NZ;\%CX ^[56V0E@OG[ [T
M-1\]?M0/^9QQ+[_AL]?U^WPO%":Q(1**4D8CQ2#3>0H1HPDD,:90YC'6*!,I
M1<PGR>>R.*^9?(2LGP\ORP+VJ&QZ!6"W+SX<; -__]=J]@4-3KFA$H@=K@@;
ME2O<#'_)'(YW]>.1WY8V)%NG&;Y=L.*QM$F(]0_RO[=EM>!H*NDU2;Z<2)XI
M+,QN@&40Q22!/%<$4I%(3JF0.98^FP-_%::V<_A5R4*P!:B5WG5I>_9CG!Y#
MX<9"PP(\,#/5RK>YT@W"53YU_>/>@K:(Z#B)U?U!#41L/108E>SZ _22 &]X
M4C]2_+58KM95<8#:+?I.B;5M1_W>&/FN*&N7JCT0^'5UVH_Z]]7"2"OGL2)<
M)CB%6F<4(A)Q2"*50LJ$IIE]]UG>HSI-*/UZ)!",47KF7?&]D&I957B^*5 4
M?#S=^';4X1F'A0_U!*VB,]#:!BP!@ /K[/"=N0\T%H:CX]"8!R+I8&J-2MVA
MP7Q)Z,&?W[-.6?&P++19N2TW+QJ0%:KLMBI4(LV5+:&IL"%Q(2!-TA@*GFHD
M,XD)\VI0ZB9V:FO<+]O'1[9^MOG)'0,Z??= :X)GD3"W07!CWO#0#LRK5Z $
MOP]3I]@+IE!%L-R$CEN_R@N(H])3?G?W;%[X^+18/2OU1:V_%T*=+G=E6-*>
M@U&RJFQ55J?>NG]_NRHW'U>;?ZC-O@OTG'.B$J$EQ#)5$-$L@CSA9JV*B.(B
M3B3CF0^O#:;IU*CPM^5ZW[%== OJ":-]MS^)6;W"VMRZ@B+D57&]@WO8OE19
M"1ZJFB,2;)>R*JZGP),1[4FIP[TR;BP\B1=A:.(^52MQ/Y(SL+.O+:%H#3*_
MW8!GM0%[FV:V$<HVY&',P>$/U=%P,#W'[6LX--Q'W0T'%^B?X7RB^/W^N=U^
M&R]JYR]EMP-Y66X?5:<'8UO!8LX2F25813!7FI@E..:0Q;F")%89S?+,Z..4
M2#:\JE.;JSJ5**17/9 11O7R;#*ML1IX.CG5JF36F24.>]:\['EB[ 4=@T%C
M\4$=$K]J,".,OGL6]G3>@I$2M2?P-GCE<(\S0!?2O =68+1,\'& [":+CR0Q
M<-?D=T4I%JMRN^XT[D X98)@9C:QN81(" $)21&,198A1C%*J5?.JH_PJ<WZ
M^V:U7[J=?G<F!&KR>VH8W+:(0X$[\#1]L0DPV.L^D-^N#VI#]PD^)7H:?8,O
M@.+<1_C2,V[IY64X5A7?+:^6G]AS]=_/M=OHZ^KK-W6GM7FF_?5;\^W>B8U1
M\&'-'E\V*XH2(AG+"$PXL;6 .(4DPPF,)*8$)0CIV(GSAE!N:IS8;2:XWEL(
M?GAJ;/RQZ[FSKK>_*[;8?+--+[;KJA_2KVS]3[5Y6A@!X*DQND]/JD"C?WW_
M])IC.K0#KM.QZG-W.#_MAK,Q$'Q= 6,BV-L(K)%FP;P!K9F!FHT%&M@^/<C&
M'^"Q6Y.MK@YT\]U>&NC07<K"PN[4O"R0R%?H:186K-.MS@++Z-L!;;7>2#-K
MV$]C-W^\M8D,3&S*78)HU8[-)K?MTMILIS9AM:U^<Y3>]E%9K^T7]<3,L]7B
M^9/YTI2-&,UIS!5*50Y336QK"J0AH=+\$U.IHHCF3&0^&?_CF^"U8!CA%$&;
MU2OJ1--%:_&NSN!:%2TNOHW11G\]'/,G)CWH@X?TC/'P76-]9]FWLW^V3^VN
MRO4TN<F=I.0=#/4O3V8G&RQF52!P#P?8X1&R7=IKC66PKFFC&S!R\[37&J#C
M'FJOIHG_)OI7]J 6YL/]\J1$839HS_4V[5?UR-5Z+KA*94HE1#R+(<J5ABR3
M&O(X0@QAHF+FO".^*&EJV]M66;#3MMF_NN]C+B-[?;<9#*^!B?XL5.#W6E>/
MO=]ES-PW<L&P&VE7YO^Z>6VPG."XL%NZ?/]H6Q\G,[K[&+<;7CL_8[-=+^^U
M(?/'8OO8[++FB=EAY )G,+)1%X14"AE)I(V_J(P2@J1FKY.C<4K=J=%WK:7=
M53S5>H+&+?E:\?J38SQVQL:M(_=7S=JHWH5[#1K+P:<)O@NOE;]QZSOQ5\_A
M\'TW7C&3X])0C9;-<5*)OVA&QR5 A\OJN"@U<&;'5_.\IN\K3_)<"1[!/$5F
M*\=0!FG"%)02,VW6&((RKSH##C*GMBJXF&\P U;QGEUW70;@QE2.?K ./&57
M[;?K,B=?#XJ<#-!WUP.9H;,T.A*GD9QQ#(%S3L:)6WN3D%!*EO;8Z1>V4+_:
M]K[%YME6%U@M%DI49U#O]8<JE;XN/1\G&*><(YA3;'8Y(HLA432'S![SYU)$
MB?#JP]M#AZF1E%6[]GX_ULK;!8O9R!1[E;VYR7M<"&$YYXI G$02(HIS:/26
M4&H2932G-"/<KWK=P",S3H&[28R-\SPR)-X#SRNM]G4=!*O_#+06U.5J=C98
M_#\XX-]GONF+8+CYQUN#L>>COA"=F)]Z/\IOOBK7F_E;\ZS5HI VUE)5 ;8+
M]#\+,R&EA"J:(,B$G9"2B$!&!88QXSAE/*)YY'0TZI*0J<TX73U!JRCXW:KJ
MN R^".EEO@H%U,"$U LC9\IQ >$2IYC[.WQB_K7GDHN/'H4L7(QKV<#I6G]_
M?=V9CBU^7J^V3Q^68K&5Q?+!9B.O;)6!K9+W9G%<;>Q+*[Z0S;_>5G]_,&QS
M\.O/]F#RO;[?;FPSK/(_V6*K_EX\?)LC$N>"(P)1'&<099& ')D5%-%8:$YH
MDD5.Q4W&5'J"=-2H#T17_YGYYW8AFVQC!7[8/H'-ZD=W+^YH;\%UO_X4QW9@
M!FU-!I7-,["S&G3-!GN[[1G_@^'OO!@O_E*9;Q>"+0 S4$$ + 83?$'<G?U3
M?%%&<OE/[X7Q\OV//7(7(@"CJ3):'&!L<+O1@-%E]W/'V9(4-J>LR1TKYRGB
MF)),PU@+!I&,-:0Z(5!%"659PLQ+0WU2FE\*F%K"<56D ZSJL3"LH1H]_3PT
M1S"ZN5]N 6?PK8Q1K8Y]7$/$VV=RSNQ #I&CQX_J[3AGW$M7QMGK^GW([Q3?
M?%B6FW4UZ?Y2+-6'C7HLY]KL-7*,<IB)B$*$M8)4(@JED'&6<,%QZN2JN")G
M:ML#JR;8ZPE^MYJ"2E7/H-TY8-V^\ !P#;WB[H.4]R=_!8= 7_XY*:,2P!53
M7_+ M<O[T<&)9 2;.6Z#KE7B05E4O_+KI>/WT F]XZ?R@NJC(U44NJ/\(+UX
M^N$6Z)OP%#[JI](/F)=?4,^G^#L([W 6_5HL%N9I68JS+VI9K-8?5QM5OMNJ
M_[U=*@-^WIZ)$#Q26@F(%-4011I#IF0&<R8(4QE-A5)NL5%/R=.+AV9_,RK_
M+U K#996ZQF09AMME7;WN_B@?]VW-A"B Q/9OQFM0:,V.,2UTKV"U6I?8=OC
M:(4/R.[^J8' 'LG%%!IT+P=1#^@N^'A\GC::FZ:'B5U/2Y_;>YXPWZS$/S^4
MY5;)=]NUK3NMUL5*5L5 R],E0><X2GA,A83<T+_9?R48$KL=B_(4:Q'GA&BO
M"ED]=)C:WLPVU31?4FDM 45E2G6R5S4U5@%72Z6+35V&&?Q0+.M"SJ5C%.>6
MX7);" \\" -/(K6:H-9_!NI_-O^]5%V9:?-V@/>KM5;%9KL.D/T> ,]0YYY[
M:##NP>7^$!V=/+[A43V3/NO7J;S7U6[7B*[/.I>;<HYDDF0\UQ"CV"R4,<TA
M$8K!/!(*Y31-<"YZM&NZ(-+I4WR%#DS6$5,TBE95[7W3!"^@3!A17,48<HVE
M[:>20)KKR'P(B(H\I5QD<8OR:P#\5\;6;<ZX%:^14BH;+6W4L_8,MJ"]O0B:
M?][D=3A"Y4=>D#1N'N1UDX_R'1UNZ4?)]VW$ZQ?;!&I7;6*NA50(*T,42&*(
M,JH@B2B!Q-8T8@SGA*8^Z]4S<J:V)MVI"1959[5=X2$_FCB'*L9)GFC$H(S3
M#"**.&0LE3 U$Q^AE.M<)CY1U1"HCA9</434NUG5V3<5H2A+(PP-F@2B"*>0
M2<IAG)!,89PB$7F>/@B ZC@>M4%Q=9O. F U\%2V_Z0K%6<.+8*]9[$K* 2:
MP<Y)&77VNF+JRYGKVN5]:_R=VIW</S4^_P_&DN6F^*[L^;6RZ==,><IBG1G:
M55)!E. ,VJI]D'"I8RES3G+NY8'QUV%JLUVU P3U5K]KA&]%/?_!</2O# OQ
M&/Z5\XZ485MDWP!=L!)R_AJ,7 .N-T3'1=SZ/ZIGGD\WK_#O:B'?K];V)-3]
MNOZ+DO?ZS;/]S<?5YG2Z81.^T5JE&4<4QFDJS$H?:\BC/(,,I5@R+*B4L5=F
M4"C-IL:6+U.,K6U0K];0_$Z9P0.M?7;3S)^;@XBVV.29%&3/!*1@(^Y&OJ\R
MC@-3<O A#!CE&PSW4$E5P?0:-PTK-)Q'B5O!!?2;$3IG7:V3J*G:L'G^HD1S
M^'R7YH65IC3#&,;*'CSCFD!.J(1)3GE"2)RGU*NKMKOHJ7%Z1_-9[>ALR[QL
MS->_4]\E'>S607%CY6&@'IAV Z+L3:?^@ 7B2P_!HQ*B/R O&:_'$_I1VOMB
M66Q453'HPW+3E QJRF8]KM:;XE\5?S:I\_]0;/WUC]4\(RSC/.=0(64V^EDF
M(:&*04[3U/!>*A+DM='OI<74B,Z\GLB/NOJ![\9B@T,Z,*'5^C>UK/86U'G$
ML^JH3-7JL6O,#%@[@#$D'+G=A&,@GNNGPZB4=Q-,+]GOMH?Y9QN_+=9BH0Y*
M6R,L!=-1 B/!A3V<9W;KL=20$2EUJH04B7/A@./'3XVZ:@V]*ZJ?P.TR.=V.
MQL"L<P!$CZ3>$XBXY^[>ALQ(*;INKXI7XNUYNR_DUYZX:;0TVO,*=[-E+US5
M,R2SY:5ZJ!>%=0G++,:<)XQ $0M;XT3DD&&S(HLR0UMY+B3.G(J2GY4P-:+J
M*-BS,N@QB(Z!DEN@&3H,XH.*?YSCG.6AHAA'SQ\W1G'.O*,(Q-D+^YXCUFJ]
M5O(K^[->VY@?VM\U2YO/JE1KLQ.TAZR$6&_9HIRK6">IK18<<YLVI-(<4IDF
M$.="QPS%.<VD7S)&/T6FEZOQ<;642F[%IMHH],[6Z#DNCB[_P;$>VK_?* N,
MXDU=]UGU\^X/NTY@K2'U^<_&E) 'G6^!,M@YZ%Y*C'Q,^A:@CD]1W_2T0%SY
M46UV;ET>RS1'600S; _^)%Q#2C"#$2$24XXR%7L5+;XD;&H+HMU7MS&?(*NT
M_8\;Z:X+;4]2ZPG8:U#71UL;?0"GN LF0W%05]3K,LT)HZ_RR:E[_'TZAH,V
MZ\*Z"-^R\IOUGG]G"[MV:[;E.46I0A&!&9<4(JT1Y'F4PYS&G,B8$!(35P?/
M%5E3XXR]ND 8?8':*^SNZ;B&[W5'4$#4!B:.#F!65=#1M8>/Z!IR[@ZC@ B.
MY#VZ"4DOIY(C-A<\3->>,)J[R=&4KN_)]98>O/KGG?QNC\8T;RN-E,Z()E!)
M87@T)022C"8PCQE/129E:AMS._+HX;,GQYNM>A[?^@NT'%BQ/P9#LV"K61_.
M>X&#!\?UQV,L3KOZ6O@1UVF#+Q'5BSO&(Z;3JAX0T9E+^B9@B;4]Y/!.U?_]
ML+S??%/KW0F(>@$Y9P+C/"42XBP19D/(%&24&'9"/(U0A,VR+VV/X)K5IMNN
MT$VVT_MY>""WU6"X-[12M-D=^B97.0'NMDT,B.!8256UHN"'5N4?0;$$-9S[
M0T]WEX'MD4_E@U.P7"HGH2/G4?D <9Q#Y76W_U+(?+A&QNI1_;(JRUWAX4\V
M06&UO-N8!1C?;FPWP:^KC\9@VV]^M3#/>OBP-,L5LT)[H_1JK>K,K@_+G]AZ
M:?Y8=US9\K*0!5L7JISG."(R)QH2FAD2(W$&.149E%FL4IHK3&+F<J1U1)V]
MEFXC'(^U7IX?%L;D'P&O#*@VO9MG^SF7';W=5S1C#?[U%>,$AW1@7K:C650F
M-X,ZL__\_\K[MMZX<6S=]_TK^#;=@#E'%'6AYF$#CI/TSD$F"1+W##;ZH<!K
MK#/E*F]55=(^O_Z0NE3)=5&1$B5K<(!&.K$E<:V/TL=%KEM=C/ZI4AS0EN9@
MNP:K%[KK&RKE3]\'60-0];J:]]MA;T?/\"V9R#Z?W=OBM!V8>-XZMAE323+9
M]F5B:-O;HJF'[K?=,MUD[V7Q:$+0_[YOL/A5/NUKI7PI]*>4/]'EAY4)PWRO
M/]H%(0ASG$20!$FBS16F=U\BP# 1*"1IB!!FW"U H9<<\XM/L"_".FP"['9C
MHX,ZLA%0MCHV"I3I+H=VE'40N)'6WY9L$%B>=FC]9)ATPS8(IN/]V["'#<[P
MNUO2S297N11OGDVG&../W-%E\YJ]I5MY7S*T_'-;EA98!(S&:21#F,1"P2B,
M"21*22BR)*1AENKMFM51N ]AYG9VWA+ZJ%?OYD&O>G!K/F03)[0TGW7YKU83
MW_(WQ<%W).33>I.['V8-F%S;(ZYIIFST@Z\#] <]3+IV>Q[W#8"-+N"/4IMQ
M2FWX@-5_SJ&[**^5A=@;M(Z\Q/[/=*-F(?/%K3:/]1ORT;PH9J,K5,A"DL20
M15B;F ISF&4B-OUV..=IC%,>V##MF6?/C3AK\4 CGQWEG0.MF\$&0C$R(5FC
M8$TM'?J>88J-Y'_]OO[QO_1=%4GHOQRXX=RS)OG4.Y1HOMRN2_K92)_,%VX:
MY.V+*RS,"30/D80Q,JWL:$PA2_0.,([C@&))4BDSMRW?Z2#SV\]]+K[359V+
M6%HH?>O.G$'4SMP8AM+8I[2E<&53SU8QEU'L@\LX>%KUSPPPZ5I^6<'C%;KC
MRIX5 M:%S+^O/N8K_=2[0FHJ:1KOF#JUG"!(1*A7840B2$V!*\QHE"$F0DJ=
M&BY<'&EN:W(M*#"2FO>[DM4Q]_\BK':?OA>P1F: \SB-4-#I*AB^$O$OCC-M
MLOTU=4\2ZJ_>T(\;WOVI/[<575:/_%JZU0];A-\**IJ +\0#E%&4P5AE0G-%
MQ"%)N8)9E!GS/15".54,L1YY;MS1"-Y\#)7HIIMV(SPHI7=C$_N)L&.74> =
MF6ULD1V!?YSA\L1']N-.RD_.<!SSE?L#W,\4WJVV^?;Y?;Z4Q1W=RN_KXGFA
M%"4L$@1&6.D_,AI!$M(4)F%&$Q[%-!16+'7A^;/CHE)$4,H(&B'M#QC.(7C]
MD&$@+F.3B!,D3J<-'8KW.G$X][S)3ATZE&F?/'1=-J SW,-ZJ>_8-.YO=_?Y
MH4XCES)B".LO/D0PBG$,*8\P% QGF,<41](QF]ZO@/,[]6CK]Y<Z$,8QY=3S
M'(J0)!Q%!")*]1SR,(.:QF,8B2B(I4)A+)QJ;;[>#$Y6D7Y6\V=GDK[>K(R\
MY+R<D$HU8[4V(6JU=N#V*$3MI8*@T7"4;.9QP/?94="?<-,W&_0.[-D^A/Y'
MZ;>"W^V*0EOQ[Z6^A2[OZ9]UU8@W52_2148EX@D*(,>F@U/,""124FV.2T%E
M0A,6.ATK7AEO;OQ<R^G&R-<PM:-8CTB-S)FUI* 6M:SH4 L+?JG%O=S#UIG^
M+('QQ&?71IN4H"Q5/V8<V]OZ4<CMLIPS*<YW!:G'6@1!A%)#(G$8,VT8<@Q9
M%&#(HY#%!$="H,2%2>R&G1NA[*6N>CM#5K;+X2W!@:PD=^,<RTFPHQ[_T(YM
MM5WKX?SN"J;.).0&D2<NLAQT4DIR ^*8F1SO[FGCK!\?\RI.ZG8E[LI^%-_E
MBIN<'468%%DL8)Q&$8Q02""E^I],T(2G3*1!F#G9-Y?'FAL5M40M R9X6UA'
MBZ<#84MKQP]N8ULZ1Y#=64'F;N%<!\.7==,QTK26S7653ZP:BUMZ$@;=/!R5
M:GE9PT6/=[&HRXO^./N=W?E&. N%.*8A"V 490A&(8\A(X&$2:!"EHF4!S3L
MT05^,@6LOLWI>\J7Y8Q*3CLJJ04*R0\AU+]LU[]6J8(/<BF 6A? -,9RY+[)
M7A9+)IW5W$_$RUJ+FY,B5F71TW:%JYORG>@H>W4#CCNF'4[^7)O:N;/^U!/G
M:PV93.YI5Z2II^-D?9M< '>_?=T"Z?G=G_S![+8^Z8]TH1*<1BJ,8283!2,I
M]4X_9AE$H0HE%0%+D)4+Z-( <S.D&QE!(R0P4MJ[[L^">-UW/Q2:L??D;J@X
M>>^[5._EOC_[P,G\]UWJM!WXG=?U/+SCFC,**3JZ_/Q3YM\?-,/<_M"$\5W^
MOI%JM_R8*_VA!RRDL42FSP76F^<L@!FC 90Q"117L8Q2)U_O$&'F1@J-+D!5
MO;.69>^L_- [B]8UCW_6&@%:J01VI4Y@J95R/ ,<,I>6)X,3S=#(W+2?G,[&
M9GIR&F5 K0VHU $?NR;'_3#1 ZJ^CAB'B#+MP:,'T$Z.(WT\LR<1ET__K!P,
MM]JMLTB0B+,X#"$*)(-1&I:I[H:+B4(<A9PQI\9#_469'0F7F@S9W0^8%DM&
MG03LD?G4===\LR?86A>/7#H83U],VE^0:7ET,& G+#K\B3U+),FM894FJ^;S
M;KO1Y&T&O7U<[_0G*0).<*H4#)!I),E""6F"0BA4J!2)!59N!NNU >?&A[6\
M)OV+5WD9ZX/(CM60KF%M1W\^$1R9Y%K@U4DM+6EO0"6OQRI'ELCX*FAT;;AI
M:Q=9*G]2ILCVOGX$\V:WR5=RL[E;/[)\53+75\G7WU?Y_]66HM ,EJN<'OKC
MUN;D[4I\/#1 T[_;/4IAPOHJUFO]KBR*NQ"9"&.9(DU3FJ$BDE'( A3 ) XE
M)D&:H(B[T-0T8L^-[*K*T(<21KU[T$TTZW:$.;^Y')EV&X5!2V/CV6ET!FVE
M:[L2[#?XQN'34@[4FM^ @^[MW]]4]<3]L?BTT^5I+9A(Z$E7E&DGXGA=FGAT
M]_+IW_B#%+NE-'7\UMHJWSY_6ZOM3UI(+8/Q*SV90(NW\JF0/"_E_R*+?"TV
M1Y79PD1P@2(!!949C#(<01:G 0Q-*Z]09D$J0ML.-)YDFMNZU*@%/BO0* 8:
MS8!6#>QU VWE0*V=?>%K7Y/:O3*]TE2-[;X:.$LN)?A&FSC[BN2O,($351R?
M<B*=BHE[AKRC6+BOD28K!NX9FG:Q;]^/[K>1_"I_R-5.FA+A3;G&?^;;A[O=
M9KM^E,6[/^O#,F,.Z/],/\Y%&L49%Y)#PBB!412F,$NHA#A00D:)H#R-W;*C
M>TCA\H%/DP)=*^&XI^LS 78;M)%!'7G9JZ6OHB(;^<%/K0!H-##9%,WQ?J.$
MR?GRMVD: *&G'5 ?"2;=S@R Z'AO,N11WH[1],B;7-3>@/N"KC9U$_,Z0;9*
M>MU\T%N@<EMD_F((>9$F(0F2F,!0" XC;FI9A43"*.5)S"F/0^:4H.I1MKEM
M/"IYP0^ZU!]X7DIKFJ:PYH"%FEWG)K<O;#O&?/8^!9MBEE[EJ.N%8J"EV4U=
MGV!?;6 #*NW*4Z]&OU'/LH:"/MZ!56_)7OM4:BBD%D=/@X?HGU9C,G7.-MI&
M+%1$1@J*) EA%&(%LS#E,%"I"C(9X(1851&W&6QNQ'PQ7<4]$^4BOG:\Z@NU
MD8ER#]B(?<M=(/&827%QJ,F3'ZXI?2Y?X>H][BD&=VN]C]R7)Y*QQ%E,,\AH
M:&+=2M<H#B'!3,J$4Y78G2^?/'EVG&"$LRD?= 6P[N]^$ QC?^2V"#BE#IS5
MME?.P,LG398L<%:!=I; ^0OZUN3\QWJY6VUI4=4-W"PPRF2"8@R3E,0PBO3.
M*PO#%"*12!&$..7**F'^X@AS^Q#K(I1[*:MRE)9+\V4<KW^7@]$9^?MT!:9'
M?<X+R@^HT'G\Q(EK=%Y0Z+1*YZ4+^UG>OZW7XF>^7'YX?*)Y80ZX3:O+1<!8
MD!+!H(I# 2,J(M/5&D'.,,8D0 (GJLD^M[.ZSP]D]=*^S!(?^:,^R.=H8U]
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MJKZU'];\7U_EDY[V![HQ.[GO!7W\*A]I;E*5;W?;AW5A6D,=KJGZ%Z)%AIG
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M]6<)(3%B898X)6A>'W)N*W@K6];1_+> U^Y;]PO:Z!N JR4&1MD&V(,T>B&
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M__R/YB?Z#Z;WQO_Y'_\/4$L#!!0    ( *.#55;@')F3> \! &Q/#  4
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MODY23@/@.DMI41[G1Q_\,+T;G_LO0PR&UM@:>&&D5\F06.HO)76BE/(#;I=
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M3MJ&^#),./I@A.1:<U$[:7,BR8U4N/8+[>JZ;:*4>@?# TEQ SHA2'9E-](
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MM6N -A+2"&9.5_33DO^3I=X =)#\Z\EX89E7(R$SYS3:@%Y<S+BKG$D8]\9
M#,^<*1VXTK5K]Y\1T?/3HM,5^]QU/D'*#<#D+*5A$;\???##]&Y\[K\,T1E?
M,:,SITJ[1+PHC5RTD<1+:XFEH$R26NM<^Y3:25#/[XNJPZ>>]%N 4HPWUS>C
MDBO8EH)>,08^2Q^E) ;*-;FFD;@(G!@FHS-29Z9J%[OO35R_U4$=0*P3K30
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MXSK>:*67"%$#>(BE6S?ZWE)9=,!SYL1RP7U.PL3824G+"[TY^5/<@O6@ZD9
MONFY@PV!VY);%CR61]*\U)EE4^YF7.".*^5J!U3'/CGA?]:;L8.44!5+?755
M72;9KF ^C'[TF+/*+58?K_2R_59W</FBS5>-E#%@)$(L+1-NDW$D.&L(>&^"
M%IRRZA/:^VB^JI/T6:I$!(.2I!6>!"$YB0IT,DPQKNH_^/S1FJ\>@H7O-%\]
M1-X-I'!V-X=4AL94JJPI*\TA::3$B<1(R-RJ(!Q2U!EXFF^^>I"F#VJ^>HC8
M&\#0Y@XV.24M3 K$FS+_D F.>PHY\5FD**6@2=:VKS]<\]6#%+U7\]5#I-X
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M:+T ZV'OR: "RY(2#ZY$V[*\0XJ*&+3\V@='&8?*P#R:V/W@^:/=1KR,[AH
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MF9[@QWW_,ZO,VSV,\DH>VX8'6W@^+JS1&D$/W;)M1$=?>*(%!IW2<%X"T42
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M<1EC<DS4=T^VT%+1<WNRPIJ,7]VN_G$-\\;@WM*44+,8P"4H\<P)HJ+D&67
MK.[00SN$U'X-514,[?"Q.E-:HX;J?((;>XP^Y=OAV(_CT(_66)[DCW Y+ (^
MH670H2O4,&LG<76BM9M-YX.=ZU_D#PNH%R_>CV\OQJ/;3567UE"IN2?6,8<Q
M@Q'$6I=)=!JAP56V^XU80W+6C %^]6 (ZE!ZK,4LJZ]?3*WH>.5'Y:75IRN
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M=GK5!1!84;9N%N4I>E!16?!*&HB:V1Q2Y$QL50Z[ U0?)&A<[(V'D_E02NL
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M_4#!N#&NH2%T@+1'Q$IUEC?@_Q<N4@7_A@/47,L40>LU!]D1+UJ#""5*7:/
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MX:PG(P,E@A)&@/>)#@\=4=3:2F=$8^:?2^G#+KC9N_1A%_WT[%]<2ZF*['1
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M@%[,?6>ID!3)J9.E5MEYLHQ0($+)9"2)%*)MWN2_,Y%=@_0PR.P/SSWTUPM
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MO]W:AY^D<F\?#ZB)[/O SAT51K%D'IQVP.FV!F5X'?B-B>P+GHQ66<JRU7;
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M<U/O(6/:)\ &>K^;<QXJZ@Y>.FZSL"T\\LH'E*D.*Z[;X)UW$$2]@#-S7NK
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MAHN?IL6VN)REK?N]8S:@F*NIZ$1A3';>915XY&/T#S^'%MM#]+Y/B^TAHN[
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M?9?_KHGUCS^_;M.MLUS0D^T.(*W0)"Z?(*3B:UU_R(8K8VQK#VD/LGJZ]]I
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M)>UDS,P 9P7K\RD';RQ%8M$4;<B8N^:E7D\2-;$U.@VBCM1!OZ":&6V+\MZ
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MM@I?MK.*4S1"ED*<"#2@7"0G748$EHQ$+PKZU!R>#U(S+=BF0\A=J+915[?
MVTU##MP$[BQYXDE47D* R*4!D4TL/"1EL77$_A@]$X.OD<[W@M(1"IAXK-.+
ME/"\NH&8[[#TXFR%VWJAW5ALHX@MI6LU$J_[=)6!Z+($90-RB@:LC>X);^V@
M+^P1-L?H=SFVL'LP1U>U92_/PWJ]L^7;,\:\RR4;7I?_$?G&DH_A$T*0S/%(
M_V=*ZS;:!XF9MDBAGUNPB;(Z0-U-^G<G,\40K? <K,MT;K(+X*-+$(TU10B7
MDFR]LN]G*B:V7&W4NVPJZQ[0LOSR9;G8,G"U@2J[8M.V6*=V@=9N!!]$A$PF
MEEGGO?2M;=-/1$R+E:%:O0N202+N "/OS\/B;?ARN=U.)%]8\+YVY JRL;F.
M#78.2 A1:,S*F-9E)S>_?]J2IFYNJZ-5TA&<=D?+*X[!"0V:24?4IPR.T[$0
MH7!AZP)M;#VZ^38%TQJ;XS7Y "2.$.O$T=8?7[Z>+[_3Z:GGAJQE7>ZQE7]E
M:6<R/8LVD=$$M#J 2C:"U[)6MS!>&'?!F#LC'NZ-L_;XJC[@<(P6E^.)M .S
M\=#Z,VN3H4C0@+6FCO:B@^.BUI"UY=(+1VY<:W]ER,;!T<H=N[F;6BBJ4[S=
MWJ_&I<B9F0A(_APH910$7:?M9"ZSDM*KYNTPSW1%X4&J/WA%X2%ZF/BJ^P>>
MG[\D45ZNUJO&>/UZD78&.19FF>';/IU4RY@TN%(,W?Y!*^&#<V*?7.)CW]$?
M/ :H<CF"7#LP/#]L\PV3_>9ZE&4()!:O$:0S"$IG#\$D#9%Q+J+B!D/S=XQ'
M*9JVT+J;:Z^AVB8V4EO*?\KRTWE:U8J8%Q<DWM7\/YAW%6^F2&XU>:8BU^F[
M5M&9)4<2DA6V"):BL7H/LW78M_;R=CM<U\N3"+X'NW8O=W>YXG5\+GJM'!E]
M[4$)M!!<BL"S9,%HXS"T+CS<D[1>GDJ:@6Y,U73[A+N^?E;<G2/R-Y*4O(#3
M.I/3(03414-00I;H;?"I[+,B>O]O["6)V=1XC23P#@S7IVI^+TA<55!;WM8[
MMS7/LE;6!"N L[KPC.D(/ED.IA0?==)!JM:S^QXAIY<,1',#U4H%$QNE6VS\
M/9Q?X!47N]GQX8SD]G99-1;.+T_+N[(SQS.=1<:$F=A3M?0\2XCH+ AN4I&A
M;ND.>]BI043TXNPW-5VG4TN_E^+5(H/WJWFJFPRV?SY37#DZ10F,3(%X\X6X
MC &,X9*CC;R$?;;5'?J]TS9-GOZ"'"[\#J[)2[/\/LSSJ^7J4_CS'_/-Y]H=
M,%^<T0^V?_H;,9MO/D?,C!8IF>@AHZ88!D.$(%,]/*YV*G.*<5JW\1Y#Y[0]
ME6-Z_F,KK0-@/FS>7R[7F\MTT4QHQQ6)#0H3-?/(&(4V]<0QYWGA6$<$C^G(
M/4#7M-V4I_+H6BBE Z#='T9?;ZSZ$4_?*''=1=;2FD@\";+UF(#L/G%JR)-P
M)EJO62RL^5O2\=1.VY!Y\CQ(<P5V -5[GF*N$N+T);C>K%^OUQ>8WZWJ_];D
M^-N+^IA"XM[>&)=_.BM&%2-R 4;.+JA <O9:,B@4WT>95&*V]?7=AO*)%S>.
MB.$)--L1GLE/B?/%5I$OEPN2\;:9=[GXM J+]25E]TKCQ2)?B6/&;4!IZNX<
MR2PH)C2$E")$E4T0R.D_K4L<&Y(_\6+($R#[U#KN -Y7TTX^+7=>TI4L</V7
M5=WPRXHKLJZMD.RRE#V#S\2>2-$6(S5B\T5S3]$T\4K($8'85!L=H.N @[7=
M"LQGAMQP74S=3.#DI;?C'-T3J&7*SEJG;.NBW8.)W ]_S^F9Y33ZZG1V^<_3
M)NYV"Z;-_-N@0>8'?\4X4S0.X6N<F1KH'1;&,T2MR/G+@L I**Q!7WA!H97!
MUC6U'<_4,-)8#*[Z"IF!XLZ YQB!*\MS0?26->_6_%5G:AR"K%%G:ARBU ZN
MZ(?[%X7)+M>.:QFC **>G%AF"C@E.-/!B,):7\7#>HF?QT2-@_"Q=R_Q(<KJ
M '7W=$+*F*,)/A'=C/R6X!"\E0R8LJPD+GB1K2>X/)]>XH/4^W0O\2&R[@$M
M/S6ZYF*\\.CIZ*0ZF#.0*)+)4&(R01<E6&G>>-Y]+_%!6GVRE_@0$7> D5OM
MCI8L:@@>@=D0R!E@$D)P!7A@FFG+>0RMIX@?W$O\/"9?#+FMCE9)1W"Z&D$3
M>,C*:) J$O6*3E4040.ZS$V*Q,W=:3R_;B_Q09I\O)?X$+$^@UYB9)G92/1'
MS%B'.3CPFEFPS$L2F$L:[SSU_Q*]Q =I\<!>XD-$VH'9>"(WQXKE*AH%)==I
M'\5Q\N *0HY2JB ]^7B\L1EIT&+U/*9>#(JKVJFMIT+@V_7,?_R9SB]J_=7E
MC[<%67C^<WG6NW@^/[NLQ[))9&GI4#/I?<TE<PB..9#<*&X,EA#$'@:M*5&]
MI *&(^6A0N&3JJT'HWE4J2"=:%F2K0L(Z;@K*\!ERR$FYBG\B3XT?TL?K;YS
MJJ?*8]!Z,J5U ,S'FD.2C-QBS"!<W:@>#%TW* IH'4-V4NML6K^+#^W/F>I%
M<@C,6JF@IVOY@:+41PW]^XO5U^4:US,2F=/:AUH!4.>5:@U>.'*V&<H2R>W6
M;%BOSH$$==T9UN0Z/IFZ.K!X+_+_NUAOMC4H'_"\=I1\6NYMW%V03%!LQEUV
MY'7HFIZF,\F,RBIF*X0SC2WB '*[[C<;8C%/I<(.T+I7J;]DKGBK+!@G)*B4
M!02M)?#DA&;%E-Q\K$FS_HNI.M&:W=@ME-)MV5#87! ^O[\,7^>;</X!MUQN
M#UY8Y-_GW^89%_D#KC>K>:I?MAY20'3TE[4I)6K#Z\"BHLM1)@^3\N)^4G[4
MB$AA$\6_P$*HXPAK^*$P [F+!=%HPYS=PW<:0$*+:HWM5[](V[Y.LN;OZ^?.
M$Z[ODD6D?"0WY/QB_5LX#XM4:Y-U'8.@ZMNQ!R5=@&"D :M9,KFHQ+'U3(%!
M!$^3ZCDERNXK\#B-?CNXOH]C=J<*ND.48D5S!YX+#0H=0LP^0M;DK)3@O$O-
M.WP'43Q-+NCYP?DH#7>.YP_U.EQ@_B.L:L/?^NUR\^(;79#UZ8+\\2L-K&=6
M*R3_BIB4N@[FU0C>!!)!=G5'F&2J>65+"[JG24#UBNU1M-VI'_QZ0;]$BC!Q
M77L%EN?S7(/.ZQ__\6>-+P<LG3SP"UKXNT-X:E0X?_U==83'^9(B*KR&+1>E
M"%G'W+H2@0)T!4Y+ 47)F)#7F*JUC7B$G,'5?1>K>L9?8>TR.?\AW=]()66^
MF3DEL^*(X(HD;E6@6)%G#;X(@4$HJWCSPM#'29KV";(5,GXJ 6RHAPYNXQT[
MVYI:N@?>T#^XARF#J 26 -[5FLEDB3WE"TAR+K)@-OJQP/4X8=.^&XX,L88Z
MZ0=H=*_C_&SQ,SOD8'!T5@,:QT$Y;\$E9D F57<A%#3-NWR>(&G:U\*Q[5<+
M/?0#J[L^QQ4W*EHGO"PDFE3'*-@:)3D#VC).9EE9ST8R7 ]0-.U#X,B@:J&%
MXS&UI+"F":9^QQO-NS]S$PU:4U@"ZT.^'#CH4T8(!F-0GAR 9!MCZG&*IGVD
M&PM3#;70@9UZZ&@(E$87P^J*!8JM:T>Z+XR#(;8"'1K'4^L>C"&6:;2GMK%0
MU$+NS4S2:"F%#YB6BS0_GV\_<UGHR-3RBM7RVWQ=AZ9NZ =_^[B+6:Y3,A_(
MOR02/^/U7RS+U8U/;9*,&)>TQFF,$\KQ% D0EQ2SA&P6W79?LX#(O :; Q=>
M&.MDZSKZ$1,@EQ_]9KE>OR+K\7)9<XD7M:+WZV[LQOHW)+GC#<'_\2=],UFN
M^2*LOF_?[-^2>NE?DM[I:\ZN!A3-2C)**\_ F5(''4H-49@",?*4M L.C1]%
M4J.PTW'BY0!$WF_)I]?_A YJ3>17 5PES%]L-JMYO-C4A/FGY:OSY;\_?5XM
M+\X^/\"F-2KD$AE86P2HNH3)\[IK68@4BZ8ODND)RSZ0A(X3-D= \Y3ZF+@T
MM\GI>X/K1TZ@#-FGNE_3@4).4D"E0*?D?)3X\X[T>Z$Y,ID=IX2.A&]/>NTI
M3+OM"3X01;S8W'4%?_Q[\@EGQL6</"-ND1FHN^X@*)TAL12Y,B&J,IH#UH*!
MCI-5@QV)*71\-,"_X2HNQX7XK=>&&Z=]%E,J&%D!&6WM6RYU/9]0D.N41>Y$
MW?!R&A _1&+'^:_V,&VBIYZ!2!<)A<47:3,G+VIW%N\OQ*^5TC.#V9.KA"!2
MCC61H\ %N5UPRRS2KWCS^K8FA'><;FL/VA%U.BF4M_,92L$Z(A)OW0M/\_]F
MOMEU(G_$S>9\6XHU*Q0(>)<YG5ICZ1#7L:1U4E_V6=M0HE,B[^$&MZ1IVMTK
M8_B\DVFL9[-+\OVZO)Q7_ZY<3;B=11$"+R4!R9).8AU('TK@0)1%76)45HV3
M&-N/OFG7LYS8B [7T+.PE5?O?ENOYE5-I-?Y)5^VS\O7#5ES<GC0R4!2-I"*
MI).7<X)@3(0HDU1D#IUEOI&MW)>F:3>S3&4K1]'8U*OZ7KZX7&;_>E'EN'J%
M.',"K398@ +" LK5.FAI288\2U>2TSZY/0!WST=/O YE#. ,%6#/=R7]X(<'
ML"81*8;*&Q!UHX5BPH+7A8-%Z=!D5(FU;AC;B[")5Y&<^'H<H)2>L?;R<UB<
MD?6]861?K->X6=>FX4MEGI\O_[WM;%/):V-9!NOKWHN0<EV%FH',3W *F>7B
M1$ \@.J)]Y2<&*5CJ;-'U^[)@.HORV7^]_S\?!8MYA(PU0B_#LM$!>35*KH8
M7'1!>)7R/J\_0VB8>%W)B7RW<532L_W<E@]>_VAQ=CFZP4>NI2\*&->"/!&L
MFP(%_58P*>OJM9!:KQL]A+[]P/BKO+P,5U%? +Q;J9H+<JLY:.7)C'/O(::@
MZ$RI%'3R/-ZMNIBTQ),_WY>2 8+OO\:S\K<UZ.ME^81?OBY78?7]]SG]B&2?
M</V/S_/T^2]D[3_,R9]8_N1@A$5^,P^13MAFWJBV<QR2&M=TGD!N)ZCE%%&5
MN)WBEQ,#52N7 Q*@,12TQ6B/KG4CRXBUG#\)^2UNKEGU7!LG,(*T=:P21@[>
M.@$\DVGP&C-K/G_E,7KZK:8\!!,/=5<,UD '13L_\5+%M?O9[DKX0%I;?<,Z
MZN!%2JN+<+[>_B_>/-LS'B2Y%24!3]LQZI:!SS6KGHK(BL=LFR_$:$7[M"AM
MAZ:G8'H*U7;A31['^4Q)*U1T%H2N52 L>W#D6(&4DBOZY\:Q/B \;25P9X ]
M2&V3IWI^XG%7++HXJW6D+\-J];TL5_\.JUQYI+_UDO[R?'/K#^KT=<MKUQZ7
MUH/R@H$KP0 K%/=9)0N[VYE[;\JG!2W35O4VA^(D*GHN-O-FK1%QO@L5UX\4
M(T4?DF?<@W6U2-\G!QYE H>L."Q",=^ZP&P,/J:MY9W2WHZK\NZL\?L5?IE?
M?*G'>A5R?:K'^;?:D4*W3,HULZ) YE@3(CE \"4#<J]\-BXS<8S-??@;IZW,
M/8EE;23N[F#TX\+ 4$O?+EWI[S/IN)9T L 45FLS>9V>J1"D$&A$;:2V^RR[
MV?/KIJV2/0F 6@BZ._2L?]0 _6VQPG ^_P_FOX3YHKH?LVB9B24IJ-6\Q)J/
M$%70P-'%DGEF9:\^Q(.^=-HRUM,X><V$/G'QU5W&/B[+AEQ2_!V_X?GRZW;W
M+]W3ZUE)VF!==!>**S66IU\9+0%3Y*(D9W(T1P#IH>^;MMST)!AJ(NH><X+;
M1\:9ML:%& N8[;K>H.MTOD G(3+4D3L,9?3TR):2:2M%3^>.'R[V/B/)OZRJ
M#<W6(Y?;/351@LH4'?@<4ZTQLX(GE5CSD:+W4S)QP>CI\'.XW#L:(/98<5>*
M* L7 E*IN^J-%Q!-9E"2]"0S^N^[L5A[*!U;C/<+O",,U,CA(/.7(%O@69V1
M3'R-@S3ZX%F1KMAB(Q15=[SJ$(@1$T!HLKX\EV1BZZ6/]]$Q<6'GZ;!TJ,S[
MLE W7LEN2DC+(H25&AR*6I##(P16L!X)+1U:+%F-!Z+[B>IW>DRCI_@&NNC+
M][[!T%5EZ8M%?DU:6YS5JM/+ S1+@E, H1)PDV4=FEVGA!"#@8Z4)^9MPM.
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MXTW2N$-+)X9H@)Z?A,X10N\ /$0UKC?S]+)N %]]_RM^B11+&AEY?2L"*6M
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MN$\"EZ M3%KRE93N\OSZ"1XI-^6FA2</J^H"-SO;=DNQ? Q&!&.9%DQ-5'\
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M#=_GMROI*F,SQXRQ=;F<L,.,%LG Z^C!R! U!5RH1?.GZ1>IFGB84C\0;*S
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MWR[7F_4L)263CPRR<10B62LA^)(A>:X3N1#<E];S;5\DJLL7C[&QUT9%791
MWV?IVE/8,N-=+!@<0G2\MEI9 ]$;">17(/FL+!L<%V_WR.GR+>-UD':Z6OK
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MDL='ZVMN<Y@.K<>H[DRTOEO<C>&>'$:Z^XOZ(]*5\#__Q_\'4$L! A0#%
M  @ HX-55N"R1SIF$P  F6T  !P              ( !     &$R,#(R,3(S
M,3$P+6ME>&AI8FET,3 Q,RYH=&U02P$"% ,4    " "C@U56HO'60JD9  "6
MEP  '               @ &@$P  83(P,C(Q,C,Q,3 M:V5X:&EB:70Q,#$T
M+FAT;5!+ 0(4 Q0    ( *.#55:S+"+D>PH  !TZ   =              "
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M2P$"% ,4    " "C@U56(-,03$P8  !RY@$ &@              @ ']+P$
M83(P,C(Q,C,Q,3 M:V5X:&EB:70R,2YH=&U02P$"% ,4    " "C@U56J4'E
M,08#   $"0  &@              @ &!2 $ 83(P,C(Q,C,Q,3 M:V5X:&EB
M:70R,RYH=&U02P$"% ,4    " "C@U562?ZGEQ@(   '*@  &P
M    @ &_2P$ 83(P,C(Q,C,Q,3 M:V5X:&EB:70S,3$N:'1M4$L! A0#%
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M>&AI8FET-#$N:'1M4$L! A0#%     @ HX-55D,Z%KXIUP0 N'4U !
M         ( ![GP! &-N8RTR,#(R,3(S,2YH=&U02P$"% ,4    " "C@U56
M8R)#$48?  !G80$ $               @ %%5 8 8VYC+3(P,C(Q,C,Q+GAS
M9%!+ 0(4 Q0    ( *.#559WJA9<%#P  ,>! @ 4              "  ;ES
M!@!C;F,M,C R,C$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( *.#558.>V4F"[
M "^]!P 4              "  ?^O!@!C;F,M,C R,C$R,S%?9&5F+GAM;%!+
M 0(4 Q0    ( *.#55;<.7\/]S@  + [   3              "  3Q@!P!C
M;F,M,C R,C$R,S%?9S$N:G!G4$L! A0#%     @ HX-55I?$%/A.0   ET(
M !,              ( !9)D' &-N8RTR,#(R,3(S,5]G,BYJ<&=02P$"% ,4
M    " "C@U56%0@[8.4N  "X,0  $P              @ 'CV0< 8VYC+3(P
M,C(Q,C,Q7V<S+FIP9U!+ 0(4 Q0    ( *.#55;_8WO=65P! "W+ 0 3
M          "  ?D(" !C;F,M,C R,C$R,S%?9S0N:G!G4$L! A0#%     @
MHX-55LI4:N\YH0$ A" 1 !0              ( !@V4) &-N8RTR,#(R,3(S
M,5]L86(N>&UL4$L! A0#%     @ HX-55N <F9-X#P$ ;$\, !0
M     ( ![@8+ &-N8RTR,#(R,3(S,5]P<F4N>&UL4$L%!@     9 !D U08
' )@6#     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
